Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,group,-log10_p
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),10/408,5.546370354208554e-08,4.154231395302207e-05,0,0,12.28140703517588,205.19206270245337,CDH5;CLDN5;EDN1;ACE;PODXL;FAM107A;PDGFB;SEMA3G;CDH13;FGF2,AEC,7.255991134141689
GO_Biological_Process_2021,circulatory system development (GO:0072359),6/126,7.023936415473683e-07,0.00026304641875948945,0,0,22.53409090909091,319.2803928734677,CDH5;RAMP2;HEY1;SOX17;SOX18;PDGFB,AEC,6.153419428556098
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),7/221,1.2202546441040247e-06,0.0003046569094779715,0,0,15.013257987394043,204.4272916805155,CDH5;EDN1;PODXL;FAM107A;PDGFB;SEMA3G;CDH13,AEC,5.9135495308093935
GO_Biological_Process_2021,heart looping (GO:0001947),4/43,3.968757264734964e-06,0.0005331042440148106,0,0,44.39464882943144,552.1388021294391,NDRG4;SOX17;SOX18;TBX3,AEC,5.401345462395402
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),7/269,4.488356775821032e-06,0.0005331042440148106,0,0,12.232913190129594,150.63638535807164,CDH5;EDN1;PODXL;FAM107A;PDGFB;SEMA3G;CDH13,AEC,5.3479126286654575
GO_Biological_Process_2021,positive regulation of smooth muscle cell proliferation (GO:0048661),4/46,5.219023612482669e-06,0.0005331042440148106,0,0,41.21739130434783,501.3353830213611,EDN1;PDGFB;CDH13;FGF2,AEC,5.282410738257065
GO_Biological_Process_2021,determination of heart left/right asymmetry (GO:0061371),4/47,5.694037319250313e-06,0.0005331042440148106,0,0,40.25682507583418,486.145083590463,NDRG4;SOX17;SOX18;TBX3,AEC,5.244579690773299
GO_Biological_Process_2021,embryonic heart tube morphogenesis (GO:0003143),4/47,5.694037319250313e-06,0.0005331042440148106,0,0,40.25682507583418,486.145083590463,NDRG4;SOX17;SOX18;TBX3,AEC,5.244579690773299
GO_Biological_Process_2021,regulation of smooth muscle cell proliferation (GO:0048660),4/49,6.73900499395603e-06,0.0005608349711636741,0,0,38.46376811594203,458.01109871151647,EDN1;NDRG4;PDGFB;CDH13,AEC,5.171404221793197
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),6/203,1.1124184064625287e-05,0.0007292206964811605,0,0,13.673050299953854,155.9601315647856,CDH5;CLDN5;RAMP2;NPR1;TIE1;FGF2,AEC,4.953731833760617
GO_Biological_Process_2021,blood vessel morphogenesis (GO:0048514),4/56,1.153281738315398e-05,0.0007292206964811605,0,0,33.274247491638796,378.3386388039555,RAMP2;SOX17;SOX18;GJA5,AEC,4.938064584770356
GO_Biological_Process_2021,embryonic heart tube development (GO:0035050),3/18,1.1683108621861051e-05,0.0007292206964811605,0,0,84.82978723404256,963.4429809213964,NDRG4;SOX17;SOX18,AEC,4.932441585503229
GO_Biological_Process_2021,regulation of smooth muscle cell migration (GO:0014910),3/20,1.626462332560456e-05,0.000870157347919844,0,0,74.84230287859825,825.2500115945311,NDRG4;ACE;PDGFB,AEC,4.7887559901445425
GO_Biological_Process_2021,cardiac ventricle development (GO:0003231),3/20,1.626462332560456e-05,0.000870157347919844,0,0,74.84230287859825,825.2500115945311,DLL4;HEY1;GJA5,AEC,4.7887559901445425
GO_Biological_Process_2021,cell-cell junction assembly (GO:0007043),4/66,2.2218375806853115e-05,0.0010400977174583,0,0,27.893408134642357,298.86645620028213,CDH5;CLDN5;RAMP2;GJA5,AEC,4.653287691745406
GO_Biological_Process_2021,embryonic organ development (GO:0048568),4/66,2.2218375806853115e-05,0.0010400977174583,0,0,27.893408134642357,298.86645620028213,NDRG4;HEY1;SOX17;SOX18,AEC,4.653287691745406
GO_Biological_Process_2021,blood vessel endothelial cell migration (GO:0043534),3/23,2.5134148576039852e-05,0.0011073810166737,0,0,63.6063829787234,673.6732113483868,CDH5;SOX18;FGF2,AEC,4.59973582199312
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),7/384,4.4668105427337386e-05,0.0018586894980597,0,0,8.45173030658195,84.654650750135,DLL4;CDH5;CLDN5;RAMP2;HEY1;PDGFB;FGF2,AEC,4.350002467494628
GO_Biological_Process_2021,heart development (GO:0007507),5/164,5.48427106106235e-05,0.0021619573814398,0,0,13.830188679245284,135.68855199901313,NDRG4;RAMP2;SOX17;SOX18;PDGFB,AEC,4.260881088270851
GO_Biological_Process_2021,cardiac endothelial cell differentiation (GO:0003348),2/5,6.0956786529959696e-05,0.0021741253862352,0,0,277.0416666666667,2688.78505476905,SOX17;SOX18,AEC,4.214977935846465
GO_Biological_Process_2021,endocardial cell differentiation (GO:0060956),2/5,6.0956786529959696e-05,0.0021741253862352,0,0,277.0416666666667,2688.78505476905,SOX17;SOX18,AEC,4.214977935846465
GO_Biological_Process_2021,aortic valve morphogenesis (GO:0003180),3/32,6.928645627860575e-05,0.0023588888978488,0,0,43.84666177549523,419.9309284926422,DLL4;HEY1;TIE1,AEC,4.159351650500962
GO_Biological_Process_2021,vasculogenesis (GO:0001570),3/33,7.608112255540456e-05,0.0024775982953912,0,0,42.38297872340426,401.9478954622147,RAMP2;SOX17;SOX18,AEC,4.118723088131352
GO_Biological_Process_2021,regulation of endothelial cell proliferation (GO:0001936),4/92,8.212184135698631e-05,0.002532431985739,0,0,19.626482213438734,184.6323345485555,TIE1;PDGFB;CDH13;FGF2,AEC,4.085541321330028
GO_Biological_Process_2021,blood vessel diameter maintenance (GO:0097746),3/35,9.094610315590577e-05,0.002532431985739,0,0,39.73005319148936,369.69781921167737,EDN1;ACE;NPR1,AEC,4.041215904782398
GO_Biological_Process_2021,positive regulation of endothelial cell development (GO:1901552),2/6,9.128927051395768e-05,0.002532431985739,0,0,207.77083333333337,1932.5756890799971,CDH5;CLDN5,AEC,4.039580263324499
GO_Biological_Process_2021,positive regulation of establishment of endothelial barrier (GO:1903142),2/6,9.128927051395768e-05,0.002532431985739,0,0,207.77083333333337,1932.5756890799971,CDH5;CLDN5,AEC,4.039580263324499
GO_Biological_Process_2021,aortic valve development (GO:0003176),3/36,9.903955378900077e-05,0.0026493080638557,0,0,38.524177949709866,355.1925837792589,DLL4;HEY1;TIE1,AEC,4.004191324981987
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),4/102,0.0001226260480091412,0.0029866602224231,0,0,17.614906832298136,158.64638771191477,CDH5;RAMP2;TIE1;FGF2,AEC,3.9114172679492665
GO_Biological_Process_2021,endothelial cell migration (GO:0043542),3/39,0.00012610069935787855,0.0029866602224231,0,0,35.308510638297875,317.0149830122188,CDH5;SOX18;CDH13,AEC,3.899282504811333
GO_Biological_Process_2021,dorsal aorta development (GO:0035907),2/7,0.00012760097078443218,0.0029866602224231,0,0,166.20833333333334,1490.3240703269437,DLL4;HEY1,AEC,3.8941460215026447
GO_Biological_Process_2021,dorsal aorta morphogenesis (GO:0035912),2/7,0.00012760097078443218,0.0029866602224231,0,0,166.20833333333334,1490.3240703269437,DLL4;HEY1,AEC,3.8941460215026447
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),7/474,0.0001662278374910961,0.0036350684102745,0,0,6.7915442458044915,59.10104487886197,DLL4;CLDN5;EDN1;PDGFB;CDH13;FGF2;TBX3,AEC,3.7792962449537546
GO_Biological_Process_2021,cardiac atrium development (GO:0003230),2/8,0.0001698630098259154,0.0036350684102745,0,0,138.5,1202.2517804391236,DLL4;GJA5,AEC,3.7699011848597213
GO_Biological_Process_2021,lymphatic endothelial cell differentiation (GO:0060836),2/8,0.0001698630098259154,0.0036350684102745,0,0,138.5,1202.2517804391236,SOX18;TIE1,AEC,3.7699011848597213
GO_Biological_Process_2021,branching morphogenesis of an epithelial tube (GO:0048754),3/44,0.0001811421903351466,0.00372913733059,0,0,30.994810586403737,267.0583626754283,DLL4;TIE1;FGF2,AEC,3.74198038515947
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),7/482,0.0001842163968382279,0.00372913733059,0,0,6.674418604651163,57.39599148842437,DLL4;CDH5;CLDN5;RAMP2;HEY1;PDGFB;FGF2,AEC,3.734671716487508
GO_Biological_Process_2021,positive regulation of chemotaxis (GO:0050921),3/45,0.00019374001249454243,0.003818717614695,0,0,30.25531914893617,258.65252491347,PDGFB;CDH13;FGF2,AEC,3.7127806765909845
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),4/116,0.0002013774170245257,0.0038674791115735,0,0,15.402173913043478,131.07757831135987,CDH5;RAMP2;TIE1;FGF2,AEC,3.6959892339390095
GO_Biological_Process_2021,adherens junction organization (GO:0034332),3/49,0.0002497855682645102,0.0046772347657529,0,0,27.618871415356153,229.09599013803128,CDH5;RAMP2;CDH13,AEC,3.6024326572514935
GO_Biological_Process_2021,blood circulation (GO:0008015),3/51,0.00028134681783249164,0.005095345400131,0,0,26.465425531914892,216.37926602740956,DLL4;ACE;NPR1,AEC,3.550757992561188
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),10/1079,0.00028572030281108973,0.005095345400131,0,0,4.415575304022451,36.03328985126125,BTNL9;DLL4;CDH5;CLDN5;RAMP2;HEY1;SOX17;SOX18;PDGFB;FGF2,AEC,3.544058898274796
GO_Biological_Process_2021,sprouting angiogenesis (GO:0002040),3/52,0.0002980479544608097,0.0051915794858406,0,0,25.924012158054712,210.4577714820763,RAMP2;CDH13;FGF2,AEC,3.5257138544398763
GO_Biological_Process_2021,bicellular tight junction assembly (GO:0070830),3/53,0.000315376219123607,0.0052492619583018,0,0,25.404255319148938,204.80261014345277,CDH5;CLDN5;RAMP2,AEC,3.501171057655084
GO_Biological_Process_2021,heart morphogenesis (GO:0003007),3/53,0.000315376219123607,0.0052492619583018,0,0,25.404255319148938,204.80261014345277,HEY1;SOX17;TBX3,AEC,3.501171057655084
GO_Biological_Process_2021,Notch signaling involved in heart development (GO:0061314),2/11,0.000332063883264561,0.0054068662731555,0,0,92.31944444444444,739.4956618223716,DLL4;HEY1,AEC,3.478778357620151
GO_Biological_Process_2021,tight junction assembly (GO:0120192),3/56,0.0003712232496723555,0.0059158768937147,0,0,23.962665596146127,189.274072690484,CDH5;CLDN5;RAMP2,AEC,3.430364831784506
GO_Biological_Process_2021,negative regulation of vascular permeability (GO:0043116),2/12,0.0003978405023918531,0.0062079695060728,0,0,83.08333333333333,650.4975835514635,CLDN5;RAMP2,AEC,3.4002910053496507
GO_Biological_Process_2021,apical junction assembly (GO:0043297),3/60,0.000455062391672894,0.0067615193431048,0,0,22.27659574468085,171.42009780807578,CDH5;CLDN5;RAMP2,AEC,3.3419290549876433
GO_Biological_Process_2021,Notch signaling pathway (GO:0007219),3/60,0.000455062391672894,0.0067615193431048,0,0,22.27659574468085,171.42009780807578,DLL4;JAG2;HEY1,AEC,3.3419290549876433
GO_Biological_Process_2021,regulation of tube diameter (GO:0035296),2/13,0.00046942457388711873,0.0067615193431048,0,0,75.52651515151516,578.8354329773197,ACE;NPR1,AEC,3.3284341792789096
GO_Biological_Process_2021,vascular process in circulatory system (GO:0003018),2/13,0.00046942457388711873,0.0067615193431048,0,0,75.52651515151516,578.8354329773197,ACE;NPR1,AEC,3.3284341792789096
GO_Biological_Process_2021,endothelial cell differentiation (GO:0045446),2/14,0.0005467878206419364,0.0077272467483171,0,0,69.22916666666667,520.0114050756229,SOX18;TIE1,AEC,3.2621811676355046
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),8/764,0.0005660791215212328,0.0078517270744333,0,0,4.835978835978836,36.15753387701381,DLL4;JAG2;CLDN5;EDN1;PDGFB;CDH13;FGF2;TBX3,AEC,3.2471228627365543
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),5/274,0.0005957168046908393,0.0081125797584261,0,0,8.129285419248244,60.36600188662742,EDN1;NDRG4;PDGFB;ADRA2C;FGF2,AEC,3.2249601486311157
GO_Biological_Process_2021,positive regulation of MAP kinase activity (GO:0043406),3/69,0.0006858216610371124,0.0091728647163713,0,0,19.230174081237912,140.08975927188362,EDN1;PDGFB;FGF2,AEC,3.163788802218554
GO_Biological_Process_2021,regulation of systemic arterial blood pressure by hormone (GO:0001990),2/16,0.0007187392304892979,0.0092816497178704,0,0,59.333333333333336,429.45537567816734,EDN1;ACE,AEC,3.14342864967499
GO_Biological_Process_2021,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),2/16,0.0007187392304892979,0.0092816497178704,0,0,59.333333333333336,429.45537567816734,DLL4;FGF2,AEC,3.14342864967499
GO_Biological_Process_2021,pulmonary valve morphogenesis (GO:0003184),2/17,0.0008132713373134499,0.0095178161194964,0,0,55.375,393.96243373102385,HEY1;GJA5,AEC,3.089764533572175
GO_Biological_Process_2021,positive regulation of cardiac muscle tissue growth (GO:0055023),2/17,0.0008132713373134499,0.0095178161194964,0,0,55.375,393.96243373102385,EDN1;FGF2,AEC,3.089764533572175
GO_Biological_Process_2021,aorta morphogenesis (GO:0035909),2/17,0.0008132713373134499,0.0095178161194964,0,0,55.375,393.96243373102385,DLL4;HEY1,AEC,3.089764533572175
GO_Biological_Process_2021,cell surface receptor signaling pathway involved in heart development (GO:0061311),2/17,0.0008132713373134499,0.0095178161194964,0,0,55.375,393.96243373102385,DLL4;HEY1,AEC,3.089764533572175
GO_Biological_Process_2021,regulation of establishment of endothelial barrier (GO:1903140),2/17,0.0008132713373134499,0.0095178161194964,0,0,55.375,393.96243373102385,CDH5;CLDN5,AEC,3.089764533572175
GO_Biological_Process_2021,vasculature development (GO:0001944),2/17,0.0008132713373134499,0.0095178161194964,0,0,55.375,393.96243373102385,CDH5;SOX18,AEC,3.089764533572175
GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),3/77,0.0009441676964961806,0.0108797169950098,0,0,17.14433582518689,119.41384383677423,PDGFB;CDH13;FGF2,AEC,3.024950862487107
GO_Biological_Process_2021,heart trabecula morphogenesis (GO:0061384),2/19,0.0010193089566942,0.0115676122509696,0,0,48.85539215686274,336.54673838088314,DLL4;HEY1,AEC,2.9916941596143727
GO_Biological_Process_2021,cardiac epithelial to mesenchymal transition (GO:0060317),2/20,0.0011307590059983,0.0122997946075725,0,0,46.138888888888886,313.0461870363529,HEY1;TBX3,AEC,2.9466299446036754
GO_Biological_Process_2021,mesoderm development (GO:0007498),2/20,0.0011307590059983,0.0122997946075725,0,0,46.138888888888886,313.0461870363529,TIE1;TBX3,AEC,2.9466299446036754
GO_Biological_Process_2021,cell-cell junction organization (GO:0045216),3/82,0.0011330918930874,0.0122997946075725,0,0,16.055211419337464,108.89937140961504,CDH5;CLDN5;CDH13,AEC,2.9457348676807733
GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),3/83,0.0011735239744728,0.0125567065268597,0,0,15.85372340425532,106.97686877010656,DLL4;JAG2;HEY1,AEC,2.9305080335686804
GO_Biological_Process_2021,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),2/21,0.0012477930702112,0.0131633381632141,0,0,43.708333333333336,292.25047477799524,PDGFB;FGF2,AEC,2.9038574306125264
GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),3/86,0.0013002540770145,0.0135262542178321,0,0,15.27839015637016,101.52789088565108,EDN1;PDGFB;FGF2,AEC,2.8859717757979877
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),4/194,0.0013948699927373,0.0143117482816474,0,0,9.043478260869565,59.46045413696525,DLL4;CLDN5;PDGFB;FGF2,AEC,2.8554662684247405
GO_Biological_Process_2021,regulation of endothelial cell migration (GO:0010594),3/89,0.0014352931477222,0.0145274941573509,0,0,14.743196437407224,96.51465720793364,DLL4;EDN1;FGF2,AEC,2.8430593885216617
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),7/684,0.0014750347729053,0.0147306805987483,0,0,4.634365016660369,30.211767164051803,DLL4;EDN1;IFI27;HEY1;SOX18;PDGFB;TBX3,AEC,2.831197741378778
GO_Biological_Process_2021,positive regulation of protein autophosphorylation (GO:0031954),2/23,0.0014985033958486,0.0147681453090877,0,0,39.541666666666664,257.15086234948103,ACE;PDGFB,AEC,2.8243422685363964
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),6/511,0.0016551108442681,0.0160997145760625,0,0,5.250675067506751,33.6247313655193,MECOM;HEY1;SOX17;SOX18;PDGFB;FGF2,AEC,2.7811729158205933
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),8/908,0.001725028167961,0.016564693561575,0,0,4.031746031746032,25.65203210225952,EDN1;HEY1;SOX17;SOX18;PDGFB;CDH13;FGF2;TBX3,AEC,2.763203808944243
GO_Biological_Process_2021,negative regulation of cell junction assembly (GO:1901889),2/25,0.0017712212130127,0.0165830586068316,0,0,36.09963768115942,228.73040961874747,ACE;FAM107A,AEC,2.751727195110795
GO_Biological_Process_2021,cardiac conduction system development (GO:0003161),2/25,0.0017712212130127,0.0165830586068316,0,0,36.09963768115942,228.73040961874747,HEY1;GJA5,AEC,2.751727195110795
GO_Biological_Process_2021,regulation of MAP kinase activity (GO:0043405),3/97,0.001837512611877,0.016991320324641,0,0,13.483023992756904,84.93418557118899,EDN1;PDGFB;FGF2,AEC,2.735769671427555
GO_Biological_Process_2021,lamellipodium assembly (GO:0030032),2/26,0.0019157650058532,0.0174988779193183,0,0,34.59375,216.47517339281177,ABLIM3;CDH13,AEC,2.7176577640050135
GO_Biological_Process_2021,negative regulation of endothelial cell apoptotic process (GO:2000352),2/27,0.0020657293545543,0.0184194200781095,0,0,33.208333333333336,205.3029465636782,CDH5;RAMP2,AEC,2.684926579003782
GO_Biological_Process_2021,positive regulation of nuclear division (GO:0051785),2/27,0.0020657293545543,0.0184194200781095,0,0,33.208333333333336,205.3029465636782,EDN1;PDGFB,AEC,2.684926579003782
GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),2/28,0.0022210873543451,0.0195716991576997,0,0,31.92948717948718,195.08145262248803,PDGFB;FGF2,AEC,2.6534343605132076
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",8/948,0.0022603542981203,0.0196861089452578,0,0,3.8520770010131713,23.467753354870556,DLL4;EDN1;IFI27;MECOM;HEY1;SOX18;PDGFB;TBX3,AEC,2.645823482242489
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),3/106,0.0023667454978385,0.0196873797478415,0,0,12.299318322660609,74.36462396066707,EDN1;PDGFB;FGF2,AEC,2.625848440350125
GO_Biological_Process_2021,regulation of DNA biosynthetic process (GO:2000278),2/29,0.0023818121959682,0.0196873797478415,0,0,30.74537037037037,185.6987673947897,PDGFB;FGF2,AEC,2.623092485284041
GO_Biological_Process_2021,lamellipodium organization (GO:0097581),2/29,0.0023818121959682,0.0196873797478415,0,0,30.74537037037037,185.6987673947897,ABLIM3;CDH13,AEC,2.623092485284041
GO_Biological_Process_2021,negative regulation of wound healing (GO:0061045),2/29,0.0023818121959682,0.0196873797478415,0,0,30.74537037037037,185.6987673947897,EDN1;FGF2,AEC,2.623092485284041
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",9/1183,0.0023919246422611,0.0196873797478415,0,0,3.5106992977936593,21.18937660717635,EDN1;MECOM;HEY1;SOX17;SOX18;PDGFB;CDH13;FGF2;TBX3,AEC,2.621252506943538
GO_Biological_Process_2021,negative regulation of Notch signaling pathway (GO:0045746),2/30,0.0025478771667966,0.0203017021056454,0,0,29.645833333333332,177.0595839464994,DLL4;HEY1,AEC,2.5938215131766835
GO_Biological_Process_2021,positive regulation of lipid kinase activity (GO:0090218),2/30,0.0025478771667966,0.0203017021056454,0,0,29.645833333333332,177.0595839464994,PDGFB;FGF2,AEC,2.5938215131766835
GO_Biological_Process_2021,maintenance of blood-brain barrier (GO:0035633),2/30,0.0025478771667966,0.0203017021056454,0,0,29.645833333333332,177.0595839464994,CDH5;CLDN5,AEC,2.5938215131766835
GO_Biological_Process_2021,activation of protein kinase B activity (GO:0032148),2/31,0.0027192556482504,0.0214391840056797,0,0,28.62212643678161,169.08226656127547,PDGFB;ADRA2C,AEC,2.565549960707733
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),6/566,0.0027630028571042,0.0215571785413657,0,0,4.721590909090909,27.81695632019651,DLL4;SOX17;NPR1;PODXL;CDH13;FGF2,AEC,2.5586186659977317
GO_Biological_Process_2021,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),2/32,0.0028959211173454,0.0223612878030074,0,0,27.666666666666668,161.69650653172428,DLL4;FGF2,AEC,2.5382132721600397
GO_Biological_Process_2021,actin filament bundle assembly (GO:0051017),2/33,0.0030778471463162,0.0232859344706149,0,0,26.772849462365592,154.84144163978604,FAM107A;AIF1L,AEC,2.511752952132796
GO_Biological_Process_2021,actin filament bundle organization (GO:0061572),2/33,0.0030778471463162,0.0232859344706149,0,0,26.772849462365592,154.84144163978604,FAM107A;AIF1L,AEC,2.511752952132796
GO_Biological_Process_2021,epithelial tube morphogenesis (GO:0060562),2/34,0.0032650074009337,0.0237426266339746,0,0,25.934895833333332,148.46413612460563,SOX17;PODXL,AEC,2.4861158299536776
GO_Biological_Process_2021,negative regulation of blood vessel endothelial cell migration (GO:0043537),2/34,0.0032650074009337,0.0237426266339746,0,0,25.934895833333332,148.46413612460563,DLL4;FGF2,AEC,2.4861158299536776
GO_Biological_Process_2021,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),2/34,0.0032650074009337,0.0237426266339746,0,0,25.934895833333332,148.46413612460563,PDGFB;FGF2,AEC,2.4861158299536776
GO_Biological_Process_2021,cellular response to vascular endothelial growth factor stimulus (GO:0035924),2/34,0.0032650074009337,0.0237426266339746,0,0,25.934895833333332,148.46413612460563,DLL4;RAMP2,AEC,2.4861158299536776
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),2/35,0.0034573756419477,0.0248997534213352,0,0,25.147727272727273,142.5183432834292,PDGFB;FGF2,AEC,2.461253432039241
GO_Biological_Process_2021,epithelium development (GO:0060429),3/122,0.0035220951104472,0.0251242784545234,0,0,10.637046307884855,60.085475656896094,NDRG4;SOX17;SOX18,AEC,2.4531989205479943
GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),3/123,0.0036038459511044,0.0253475867257038,0,0,10.547872340425531,59.33973167768229,PDGFB;CDH13;FGF2,AEC,2.443233781515167
GO_Biological_Process_2021,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),2/36,0.0036549257227984,0.0253475867257038,0,0,24.40686274509804,136.96349152286243,CDH5;CDH13,AEC,2.437121444562911
GO_Biological_Process_2021,positive regulation of mitotic nuclear division (GO:0045840),2/36,0.0036549257227984,0.0253475867257038,0,0,24.40686274509804,136.96349152286243,EDN1;PDGFB,AEC,2.437121444562911
GO_Biological_Process_2021,negative regulation of cell growth (GO:0030308),3/126,0.0038560473771467,0.0257979112744373,0,0,10.289050337311885,57.18770048343562,SOX17;NPR1;SEMA3G,AEC,2.41385763879748
GO_Biological_Process_2021,negative regulation of epithelial cell apoptotic process (GO:1904036),2/37,0.0038576315924392,0.0257979112744373,0,0,23.708333333333332,131.76384828572083,CDH5;RAMP2,AEC,2.4136792502562754
GO_Biological_Process_2021,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),2/37,0.0038576315924392,0.0257979112744373,0,0,23.708333333333332,131.76384828572083,PDGFB;FGF2,AEC,2.4136792502562754
GO_Biological_Process_2021,positive regulation of signaling receptor activity (GO:2000273),2/37,0.0038576315924392,0.0257979112744373,0,0,23.708333333333332,131.76384828572083,EDN1;ADRA2C,AEC,2.4136792502562754
GO_Biological_Process_2021,negative regulation of endothelial cell migration (GO:0010596),2/38,0.0040654672914765,0.0267108333448763,0,0,23.04861111111111,126.88782669928548,DLL4;FGF2,AEC,2.390889528680986
GO_Biological_Process_2021,ventricular septum development (GO:0003281),2/38,0.0040654672914765,0.0267108333448763,0,0,23.04861111111111,126.88782669928548,HEY1;GJA5,AEC,2.390889528680986
GO_Biological_Process_2021,regulation of protein tyrosine kinase activity (GO:0061097),2/39,0.0042784069542198,0.0278654505105274,0,0,22.42454954954955,122.3074073504305,ACE;PDGFB,AEC,2.368717908505425
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),4/267,0.0044179168964334,0.0285260323743846,0,0,6.5091750702595474,35.29331342753395,DLL4;NDRG4;HEY1;FGF2,AEC,2.3547824577176053
GO_Biological_Process_2021,negative regulation of blood coagulation (GO:0030195),2/40,0.0044964248068071,0.0287848049598167,0,0,21.833333333333332,117.99765363023796,EDN1;PDGFB,AEC,2.3471326648462743
GO_Biological_Process_2021,T cell differentiation (GO:0030217),2/41,0.0047194951697385,0.0299567956113067,0,0,21.272435897435894,113.93630347986566,DLL4;JAG2,AEC,2.3261044540613445
GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),3/136,0.0047734885794893,0.0300448987061976,0,0,9.51063829787234,50.83129816395182,CDH5;EDN1;TMEM178A,AEC,2.3211641121418585
GO_Biological_Process_2021,positive regulation of protein tyrosine kinase activity (GO:0061098),2/42,0.0049475924537835,0.0308812228990323,0,0,20.739583333333332,110.1034239545967,ACE;PDGFB,AEC,2.3056060815494894
GO_Biological_Process_2021,cardiac ventricle morphogenesis (GO:0003208),2/44,0.0054187658916089,0.0332676692853699,0,0,19.75,103.05327189846057,DLL4;HEY1,AEC,2.266099611522887
GO_Biological_Process_2021,regulation of endothelial cell apoptotic process (GO:2000351),2/44,0.0054187658916089,0.0332676692853699,0,0,19.75,103.05327189846057,CDH5;RAMP2,AEC,2.266099611522887
GO_Biological_Process_2021,negative regulation of cell migration (GO:0030336),3/144,0.0055948013085478,0.0339254536294483,0,0,8.967406066093256,46.504227600937675,CLDN5;NDRG4;FGF2,AEC,2.2522153322157954
GO_Biological_Process_2021,positive regulation of Notch signaling pathway (GO:0045747),2/45,0.0056617913266769,0.0339254536294483,0,0,19.289728682170544,99.80534454493326,DLL4;JAG2,AEC,2.2470461412130196
GO_Biological_Process_2021,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),2/45,0.0056617913266769,0.0339254536294483,0,0,19.289728682170544,99.80534454493326,PDGFB;FGF2,AEC,2.2470461412130196
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),5/464,0.0059082599537978,0.0351213230586874,0,0,4.718228031953522,24.211133794918997,MECOM;HEY1;SOX18;PDGFB;TBX3,AEC,2.2285404046911195
GO_Biological_Process_2021,epithelial to mesenchymal transition (GO:0001837),2/47,0.0061625935135597,0.0363447444224899,0,0,18.430555555555557,93.79784429037068,HEY1;TBX3,AEC,2.210236477513525
GO_Biological_Process_2021,positive regulation of blood vessel endothelial cell migration (GO:0043536),2/48,0.0064203200925442,0.0375689042915286,0,0,18.028985507246375,91.01549863791358,PDGFB;FGF2,AEC,2.192443319133604
GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),3/158,0.0072257561149995,0.041954196357633,0,0,8.151681537405628,40.18863284587075,DLL4;RAMP2;PDGFB,AEC,2.1411167009049183
GO_Biological_Process_2021,cardiac muscle tissue development (GO:0048738),2/53,0.0077812124839393,0.0448317550036196,0,0,16.25735294117647,78.94640668269977,HEY1;GJA5,AEC,2.108952725111067
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),3/166,0.0082715898220491,0.0470734122507677,0,0,7.748466257668712,37.153342067959336,PDGFB;ADRA2C;FGF2,AEC,2.082411009844599
GO_Biological_Process_2021,regulation of blood vessel endothelial cell migration (GO:0043535),2/55,0.0083588302127531,0.0470734122507677,0,0,15.642295597484276,74.83957451132376,PDGFB;FGF2,AEC,2.077854496208505
GO_Biological_Process_2021,regulation of cardiac conduction (GO:1903779),2/55,0.0083588302127531,0.0470734122507677,0,0,15.642295597484276,74.83957451132376,NPR1;GJA5,AEC,2.077854496208505
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),4/322,0.0084881069325774,0.0474447171082127,0,0,5.368334700574241,25.602067470141,DLL4;CLDN5;PDGFB;FGF2,AEC,2.071189157860748
GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),3/170,0.0088262295002795,0.0489592369820153,0,0,7.5613453943177475,35.76537063679844,CDH5;CLDN5;CDH13,AEC,2.0542247841844135
GO_Biological_Process_2021,renal system development (GO:0072001),2/57,0.0089551608364968,0.0489592369820153,0,0,15.071969696969695,71.07225417227201,ACE;SOX17,AEC,2.0479266097283184
GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),2/57,0.0089551608364968,0.0489592369820153,0,0,15.071969696969695,71.07225417227201,EDN1;PDGFB,AEC,2.0479266097283184
GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),3/172,0.0091115611350234,0.0494533281893664,0,0,7.471106634772756,35.10083699792174,NDRG4;PDGFB;FGF2,AEC,2.0404072065351544
GO_Biological_Process_2021,positive regulation of DNA biosynthetic process (GO:2000573),2/61,0.0102031878981958,0.0549797678830842,0,0,14.04731638418079,64.40771918587598,PDGFB;FGF2,AEC,1.9912641154648159
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),3/180,0.01030679429305,0.0551413494678176,0,0,7.130544536602957,32.621898711524636,EDN1;PDGFB;FGF2,AEC,1.9868763916831889
GO_Biological_Process_2021,positive regulation of DNA metabolic process (GO:0051054),2/63,0.0108545013893802,0.0576597272386225,0,0,13.585382513661202,61.44906812714711,PDGFB;FGF2,AEC,1.9643901214324337
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),5/547,0.0115664855464796,0.0578673547663765,0,0,3.978679786797868,17.74349360743299,MECOM;HEY1;SOX18;PDGFB;TBX3,AEC,1.9367985805149848
GO_Biological_Process_2021,positive regulation of cell cycle (GO:0045787),2/66,0.0118650634107129,0.0578673547663765,0,0,12.946614583333334,57.4073222604629,PDGFB;TBX3,AEC,1.9257299364311244
GO_Biological_Process_2021,positive regulation of bicellular tight junction assembly (GO:1903348),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,CLDN5,AEC,1.9052223113279663
GO_Biological_Process_2021,positive regulation of cell fate commitment (GO:0010455),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,FGF2,AEC,1.9052223113279663
GO_Biological_Process_2021,female genitalia development (GO:0030540),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,TBX3,AEC,1.9052223113279663
GO_Biological_Process_2021,regulation of systemic arterial blood pressure by endothelin (GO:0003100),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,EDN1,AEC,1.9052223113279663
GO_Biological_Process_2021,receptor transactivation (GO:0035624),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,ADRA2C,AEC,1.9052223113279663
GO_Biological_Process_2021,regulation of cell proliferation involved in heart morphogenesis (GO:2000136),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,TBX3,AEC,1.9052223113279663
GO_Biological_Process_2021,cardiac cell fate commitment (GO:0060911),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,SOX17,AEC,1.9052223113279663
GO_Biological_Process_2021,cardiac muscle cell proliferation (GO:0060038),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,NDRG4,AEC,1.9052223113279663
GO_Biological_Process_2021,sinoatrial node cell differentiation (GO:0060921),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,TBX3,AEC,1.9052223113279663
GO_Biological_Process_2021,regulation of glomerular mesangial cell proliferation (GO:0072124),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,PDGFB,AEC,1.9052223113279663
GO_Biological_Process_2021,striated muscle cell proliferation (GO:0014855),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,NDRG4,AEC,1.9052223113279663
GO_Biological_Process_2021,tight junction organization (GO:0120193),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,CLDN5,AEC,1.9052223113279663
GO_Biological_Process_2021,tonic smooth muscle contraction (GO:0014820),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,EDN1,AEC,1.9052223113279663
GO_Biological_Process_2021,regulation of microvillus assembly (GO:0032534),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,PODXL,AEC,1.9052223113279663
GO_Biological_Process_2021,vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,CLEC14A,AEC,1.9052223113279663
GO_Biological_Process_2021,regulation of phosphatidylinositol biosynthetic process (GO:0010511),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,PDGFB,AEC,1.9052223113279663
GO_Biological_Process_2021,endodermal cell fate specification (GO:0001714),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,SOX17,AEC,1.9052223113279663
GO_Biological_Process_2021,endothelin receptor signaling pathway (GO:0086100),1/5,0.0124387771927725,0.0578673547663765,0,0,101.76530612244898,446.4379351400606,EDN1,AEC,1.9052223113279663
GO_Biological_Process_2021,positive regulation of cell-substrate adhesion (GO:0010811),2/70,0.013274200561286,0.0605182992849427,0,0,12.182598039215684,52.65237170003471,PDGFB;CDH13,AEC,1.8769916248436092
GO_Biological_Process_2021,kidney development (GO:0001822),2/70,0.013274200561286,0.0605182992849427,0,0,12.182598039215684,52.65237170003471,ACE;SOX17,AEC,1.8769916248436092
GO_Biological_Process_2021,negative regulation of cell adhesion (GO:0007162),2/73,0.0143765335552059,0.0605182992849427,0,0,11.666079812206572,49.48935398933624,PODXL;CDH13,AEC,1.8423458176616205
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),4/379,0.014731626177976,0.0605182992849427,0,0,4.539130434782609,19.14495667998926,DLL4;NDRG4;CDH13;TBX3,AEC,1.8317493101064308
GO_Biological_Process_2021,epithelial tube formation (GO:0072175),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,PODXL,AEC,1.8265723193247598
GO_Biological_Process_2021,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,DLL4,AEC,1.8265723193247598
GO_Biological_Process_2021,regulation of sarcomere organization (GO:0060297),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,EDN1,AEC,1.8265723193247598
GO_Biological_Process_2021,amylin receptor signaling pathway (GO:0097647),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,RAMP2,AEC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,PODXL,AEC,1.8265723193247598
GO_Biological_Process_2021,"anterior/posterior axis specification, embryo (GO:0008595)",1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,TBX3,AEC,1.8265723193247598
GO_Biological_Process_2021,negative regulation of fibroblast migration (GO:0010764),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,FGF2,AEC,1.8265723193247598
GO_Biological_Process_2021,regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,GJA5,AEC,1.8265723193247598
GO_Biological_Process_2021,response to heparin (GO:0071503),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,GPIHBP1,AEC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of lipoprotein particle clearance (GO:0010986),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,GPIHBP1,AEC,1.8265723193247598
GO_Biological_Process_2021,inner ear auditory receptor cell differentiation (GO:0042491),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,JAG2,AEC,1.8265723193247598
GO_Biological_Process_2021,ruffle assembly (GO:0097178),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,AIF1L,AEC,1.8265723193247598
GO_Biological_Process_2021,regulation of epinephrine secretion (GO:0014060),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,ADRA2C,AEC,1.8265723193247598
GO_Biological_Process_2021,regulation of glomerular filtration (GO:0003093),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,PDGFB,AEC,1.8265723193247598
GO_Biological_Process_2021,regulation of hematopoietic stem cell proliferation (GO:1902033),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,ACE,AEC,1.8265723193247598
GO_Biological_Process_2021,spinal cord dorsal/ventral patterning (GO:0021513),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,DLL4,AEC,1.8265723193247598
GO_Biological_Process_2021,regulation of hyaluronan biosynthetic process (GO:1900125),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,PDGFB,AEC,1.8265723193247598
GO_Biological_Process_2021,tripartite regional subdivision (GO:0007351),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,TBX3,AEC,1.8265723193247598
GO_Biological_Process_2021,regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),1/6,0.0149082847993736,0.0605182992849427,0,0,81.40816326530613,342.3895623444841,ACE,AEC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),2/77,0.0159057771109684,0.0605182992849427,0,0,11.041666666666666,45.72434655376785,PDGFB;FGF2,AEC,1.7984451076467942
GO_Biological_Process_2021,negative regulation of blood vessel morphogenesis (GO:2000181),2/78,0.0162985561731684,0.0605182992849427,0,0,10.895833333333334,44.85464558420347,CLDN5;NPR1,AEC,1.7878508663812431
GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),3/214,0.0163712299817738,0.0605182992849427,0,0,5.971261470202682,24.55519908720985,CDH5;ACE;FGF2,AEC,1.785918690519014
GO_Biological_Process_2021,regulation of neuron differentiation (GO:0045664),2/79,0.0166954776383478,0.0605182992849427,0,0,10.75378787878788,44.01113934918422,HEY1;ADRA2C,AEC,1.7774011517679502
GO_Biological_Process_2021,regulation of cell growth (GO:0001558),3/217,0.0169842657929789,0.0605182992849427,0,0,5.886657387154504,23.99088324962961,SOX17;NPR1;FAM107A,AEC,1.7699532223559038
GO_Biological_Process_2021,negative regulation of catecholamine secretion (GO:0033604),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,ADRA2C,AEC,1.7601566430186848
GO_Biological_Process_2021,regulation of skeletal muscle satellite cell proliferation (GO:0014842),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,FGF2,AEC,1.7601566430186848
GO_Biological_Process_2021,regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,ACE,AEC,1.7601566430186848
GO_Biological_Process_2021,gap junction assembly (GO:0016264),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,GJA5,AEC,1.7601566430186848
GO_Biological_Process_2021,glomerular epithelial cell development (GO:0072310),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,PODXL,AEC,1.7601566430186848
GO_Biological_Process_2021,glomerular visceral epithelial cell development (GO:0072015),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,PODXL,AEC,1.7601566430186848
GO_Biological_Process_2021,regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,GJA5,AEC,1.7601566430186848
GO_Biological_Process_2021,atrioventricular valve formation (GO:0003190),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,HEY1,AEC,1.7601566430186848
GO_Biological_Process_2021,regulation of vascular associated smooth muscle cell differentiation (GO:1905063),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,PDGFB,AEC,1.7601566430186848
GO_Biological_Process_2021,AV node cell to bundle of His cell communication (GO:0086067),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,GJA5,AEC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of epithelial tube formation (GO:1905278),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,FGF2,AEC,1.7601566430186848
GO_Biological_Process_2021,calcitonin family receptor signaling pathway (GO:0097646),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,RAMP2,AEC,1.7601566430186848
GO_Biological_Process_2021,heart trabecula formation (GO:0060347),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,HEY1,AEC,1.7601566430186848
GO_Biological_Process_2021,cardiac pacemaker cell development (GO:0060926),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,TBX3,AEC,1.7601566430186848
GO_Biological_Process_2021,regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,FGF2,AEC,1.7601566430186848
GO_Biological_Process_2021,interleukin-18-mediated signaling pathway (GO:0035655),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,PDGFB,AEC,1.7601566430186848
GO_Biological_Process_2021,regulation of extracellular matrix assembly (GO:1901201),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,TIE1,AEC,1.7601566430186848
GO_Biological_Process_2021,keratinocyte proliferation (GO:0043616),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,CDH13,AEC,1.7601566430186848
GO_Biological_Process_2021,cellular response to interleukin-18 (GO:0071351),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,PDGFB,AEC,1.7601566430186848
GO_Biological_Process_2021,regulation of lens fiber cell differentiation (GO:1902746),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,FGF2,AEC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of urine volume (GO:0035810),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,NPR1,AEC,1.7601566430186848
GO_Biological_Process_2021,ureter development (GO:0072189),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,SOX17,AEC,1.7601566430186848
GO_Biological_Process_2021,vascular associated smooth muscle cell development (GO:0097084),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,RAMP2,AEC,1.7601566430186848
GO_Biological_Process_2021,mitral valve development (GO:0003174),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,GJA5,AEC,1.7601566430186848
GO_Biological_Process_2021,regulation of norepinephrine secretion (GO:0014061),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,ADRA2C,AEC,1.7601566430186848
GO_Biological_Process_2021,pericardium morphogenesis (GO:0003344),1/7,0.0173717414502839,0.0605182992849427,0,0,67.83673469387755,274.9362107684438,DLL4,AEC,1.7601566430186848
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),11/2206,0.0184730178315744,0.0640568997955983,0,0,2.281467204018457,9.106348827086247,DLL4;EDN1;IFI27;MECOM;HEY1;SOX17;SOX18;CDH13;HIF3A;FGF2;TBX3,AEC,1.73346215055113
GO_Biological_Process_2021,lymphocyte differentiation (GO:0030098),2/84,0.0187414436957378,0.0642945537962668,0,0,10.095528455284551,40.15009805248223,DLL4;JAG2,AEC,1.7271969574747794
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),5/625,0.0195349467399156,0.0642945537962668,0,0,3.46415770609319,13.633366819342184,CLDN5;EDN1;PDGFB;FGF2;TBX3,AEC,1.7091877684981829
GO_Biological_Process_2021,negative regulation of long-term synaptic potentiation (GO:1900272),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,FAM107A,AEC,1.702695651141308
GO_Biological_Process_2021,regulation of chemokine-mediated signaling pathway (GO:0070099),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,EDN1,AEC,1.702695651141308
GO_Biological_Process_2021,cell-cell adhesion mediated by cadherin (GO:0044331),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,CDH5,AEC,1.702695651141308
GO_Biological_Process_2021,positive regulation of lipoprotein lipase activity (GO:0051006),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,GPIHBP1,AEC,1.702695651141308
GO_Biological_Process_2021,negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,PDGFB,AEC,1.702695651141308
GO_Biological_Process_2021,regulation of microvillus organization (GO:0032530),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,PODXL,AEC,1.702695651141308
GO_Biological_Process_2021,positive regulation of vascular associated smooth muscle cell migration (GO:1904754),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,PDGFB,AEC,1.702695651141308
GO_Biological_Process_2021,vascular associated smooth muscle cell differentiation (GO:0035886),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,RAMP2,AEC,1.702695651141308
GO_Biological_Process_2021,vascular associated smooth muscle contraction (GO:0014829),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,EDN1,AEC,1.702695651141308
GO_Biological_Process_2021,ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,DLL4,AEC,1.702695651141308
GO_Biological_Process_2021,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,PTPRB,AEC,1.702695651141308
GO_Biological_Process_2021,regulation of positive chemotaxis (GO:0050926),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,CDH13,AEC,1.702695651141308
GO_Biological_Process_2021,myeloid leukocyte mediated immunity (GO:0002444),1/8,0.0198291614511851,0.0642945537962668,0,0,58.142857142857146,227.9549801512961,ACE,AEC,1.702695651141308
GO_Biological_Process_2021,negative regulation of angiogenesis (GO:0016525),2/87,0.0200173181098975,0.0646248761392811,0,0,9.737745098039216,38.08585452607372,CLDN5;NPR1,AEC,1.6985941090791523
GO_Biological_Process_2021,transforming growth factor beta receptor signaling pathway (GO:0007179),2/89,0.0208876608034354,0.0671453130548202,0,0,9.512931034482758,36.80169347929862,CDH5;CLDN5,AEC,1.6801101936742149
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),3/238,0.0216346238036121,0.0678379625351277,0,0,5.354911724762336,20.527841473575418,NDRG4;PDGFB;FGF2,AEC,1.6648506521840387
GO_Biological_Process_2021,cellular response to fibroblast growth factor stimulus (GO:0044344),2/92,0.0222223839756269,0.0678379625351277,0,0,9.194444444444445,35.00007985571613,DLL4;FGF2,AEC,1.6532093525993499
GO_Biological_Process_2021,T cell activation (GO:0042110),2/92,0.0222223839756269,0.0678379625351277,0,0,9.194444444444445,35.00007985571613,DLL4;JAG2,AEC,1.6532093525993499
GO_Biological_Process_2021,negative regulation of biomineralization (GO:0110150),1/9,0.0222805591236868,0.0678379625351277,0,0,50.87244897959184,193.52086993316271,HEY1,AEC,1.652073914876897
GO_Biological_Process_2021,positive regulation of blood pressure (GO:0045777),1/9,0.0222805591236868,0.0678379625351277,0,0,50.87244897959184,193.52086993316271,ACE,AEC,1.652073914876897
GO_Biological_Process_2021,basement membrane assembly (GO:0070831),1/9,0.0222805591236868,0.0678379625351277,0,0,50.87244897959184,193.52086993316271,RAMP2,AEC,1.652073914876897
GO_Biological_Process_2021,bundle of His cell to Purkinje myocyte communication (GO:0086069),1/9,0.0222805591236868,0.0678379625351277,0,0,50.87244897959184,193.52086993316271,GJA5,AEC,1.652073914876897
GO_Biological_Process_2021,regulation of gap junction assembly (GO:1903596),1/9,0.0222805591236868,0.0678379625351277,0,0,50.87244897959184,193.52086993316271,ACE,AEC,1.652073914876897
GO_Biological_Process_2021,negative regulation of smooth muscle cell differentiation (GO:0051151),1/9,0.0222805591236868,0.0678379625351277,0,0,50.87244897959184,193.52086993316271,PDGFB,AEC,1.652073914876897
GO_Biological_Process_2021,chylomicron remodeling (GO:0034371),1/9,0.0222805591236868,0.0678379625351277,0,0,50.87244897959184,193.52086993316271,GPIHBP1,AEC,1.652073914876897
GO_Biological_Process_2021,positive regulation of triglyceride lipase activity (GO:0061365),1/9,0.0222805591236868,0.0678379625351277,0,0,50.87244897959184,193.52086993316271,GPIHBP1,AEC,1.652073914876897
GO_Biological_Process_2021,pericardium development (GO:0060039),1/9,0.0222805591236868,0.0678379625351277,0,0,50.87244897959184,193.52086993316271,DLL4,AEC,1.652073914876897
GO_Biological_Process_2021,embryonic forelimb morphogenesis (GO:0035115),1/9,0.0222805591236868,0.0678379625351277,0,0,50.87244897959184,193.52086993316271,TBX3,AEC,1.652073914876897
GO_Biological_Process_2021,regulation of epithelial cell proliferation (GO:0050678),2/93,0.0226749954090764,0.0684821433927348,0,0,9.092948717948715,34.43038199107018,TIE1;FGF2,AEC,1.6444527921978775
GO_Biological_Process_2021,regulation of heart contraction (GO:0008016),2/93,0.0226749954090764,0.0684821433927348,0,0,9.092948717948715,34.43038199107018,NPR1;GJA5,AEC,1.6444527921978775
GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),2/94,0.0231314233527167,0.069025641797549,0,0,8.993659420289855,33.87518721331595,MECOM;FGF2,AEC,1.6357976428363092
GO_Biological_Process_2021,positive regulation of epithelial cell migration (GO:0010634),2/94,0.0231314233527167,0.069025641797549,0,0,8.993659420289855,33.87518721331595,EDN1;FGF2,AEC,1.6357976428363092
GO_Biological_Process_2021,hemopoiesis (GO:0030097),2/94,0.0231314233527167,0.069025641797549,0,0,8.993659420289855,33.87518721331595,MECOM;PDGFB,AEC,1.6357976428363092
GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),2/97,0.024523395696302,0.0704172458712025,0,0,8.708333333333334,32.29161197321332,CDH5;EDN1,AEC,1.6104193942653626
GO_Biological_Process_2021,adherens junction assembly (GO:0034333),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,RAMP2,AEC,1.606847034080906
GO_Biological_Process_2021,receptor guanylyl cyclase signaling pathway (GO:0007168),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,NPR1,AEC,1.606847034080906
GO_Biological_Process_2021,forelimb morphogenesis (GO:0035136),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,TBX3,AEC,1.606847034080906
GO_Biological_Process_2021,arachidonate transport (GO:1903963),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,ACE,AEC,1.606847034080906
GO_Biological_Process_2021,arachidonic acid secretion (GO:0050482),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,ACE,AEC,1.606847034080906
GO_Biological_Process_2021,regulation of urine volume (GO:0035809),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,NPR1,AEC,1.606847034080906
GO_Biological_Process_2021,hematopoietic stem cell differentiation (GO:0060218),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,ACE,AEC,1.606847034080906
GO_Biological_Process_2021,regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,PODXL,AEC,1.606847034080906
GO_Biological_Process_2021,cGMP biosynthetic process (GO:0006182),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,NPR1,AEC,1.606847034080906
GO_Biological_Process_2021,morphogenesis of an epithelial sheet (GO:0002011),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,DLL4,AEC,1.606847034080906
GO_Biological_Process_2021,endodermal cell fate commitment (GO:0001711),1/10,0.024725948817258,0.0704172458712025,0,0,45.21768707482993,167.3010120823387,SOX17,AEC,1.606847034080906
GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),2/101,0.0264315192050235,0.0749894238051615,0,0,8.35479797979798,30.35463590957481,EDN1;PDGFB,AEC,1.577877874197194
GO_Biological_Process_2021,cell junction assembly (GO:0034329),2/102,0.0269177264019109,0.0753586788838381,0,0,8.270833333333334,29.898816321570965,CDH5;CLDN5,AEC,1.5699616254585989
GO_Biological_Process_2021,hematopoietic stem cell proliferation (GO:0071425),1/11,0.0271653448579923,0.0753586788838381,0,0,40.69387755102041,146.73452100035948,MECOM,AEC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/11,0.0271653448579923,0.0753586788838381,0,0,40.69387755102041,146.73452100035948,NDRG4,AEC,1.5659847773237099
GO_Biological_Process_2021,inositol phosphate biosynthetic process (GO:0032958),1/11,0.0271653448579923,0.0753586788838381,0,0,40.69387755102041,146.73452100035948,FGF2,AEC,1.5659847773237099
GO_Biological_Process_2021,vasoconstriction (GO:0042310),1/11,0.0271653448579923,0.0753586788838381,0,0,40.69387755102041,146.73452100035948,EDN1,AEC,1.5659847773237099
GO_Biological_Process_2021,protein kinase C signaling (GO:0070528),1/11,0.0271653448579923,0.0753586788838381,0,0,40.69387755102041,146.73452100035948,PDGFB,AEC,1.5659847773237099
GO_Biological_Process_2021,cellular component assembly (GO:0022607),3/261,0.0274521329320867,0.0758732382514131,0,0,4.871845620979713,17.515802156668258,SLC9A3R2;FAM107A;AIF1L,AEC,1.5614239067822424
GO_Biological_Process_2021,cellular metal ion homeostasis (GO:0006875),2/104,0.0279010087799889,0.0768303513831312,0,0,8.107843137254902,29.018720027145317,CDH5;EDN1,AEC,1.5543800942295387
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),2/106,0.0288986461861609,0.0780615225884204,0,0,7.951121794871795,28.178461808105727,PDGFB;FGF2,AEC,1.5391225021448902
GO_Biological_Process_2021,angiotensin maturation (GO:0002003),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,ACE,AEC,1.5287264597194943
GO_Biological_Process_2021,regulation of angiotensin levels in blood (GO:0002002),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,ACE,AEC,1.5287264597194943
GO_Biological_Process_2021,glomerular visceral epithelial cell differentiation (GO:0072112),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,PODXL,AEC,1.5287264597194943
GO_Biological_Process_2021,regulation of vascular associated smooth muscle cell migration (GO:1904752),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,PDGFB,AEC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of hemostasis (GO:1900047),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,EDN1,AEC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of microtubule polymerization (GO:0031115),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,CDH5,AEC,1.5287264597194943
GO_Biological_Process_2021,smooth muscle cell differentiation (GO:0051145),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,HEY1,AEC,1.5287264597194943
GO_Biological_Process_2021,cGMP metabolic process (GO:0046068),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,NPR1,AEC,1.5287264597194943
GO_Biological_Process_2021,mesoderm morphogenesis (GO:0048332),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,TBX3,AEC,1.5287264597194943
GO_Biological_Process_2021,modulation by host of viral process (GO:0044788),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,IFI27,AEC,1.5287264597194943
GO_Biological_Process_2021,phasic smooth muscle contraction (GO:0014821),1/12,0.029598761568907,0.0780615225884204,0,0,36.99257884972171,130.2147194065139,EDN1,AEC,1.5287264597194943
GO_Biological_Process_2021,cellular divalent inorganic cation homeostasis (GO:0072503),2/111,0.0314544847807964,0.0815905908956581,0,0,7.584480122324159,26.23633758944092,CDH5;EDN1,AEC,1.5023174240917434
GO_Biological_Process_2021,positive regulation of calcium ion import (GO:0090280),1/13,0.032026213248763,0.0815905908956581,0,0,33.90816326530612,116.6847899929619,PDGFB,AEC,1.4944944088974865
GO_Biological_Process_2021,positive regulation of calcium-mediated signaling (GO:0050850),1/13,0.032026213248763,0.0815905908956581,0,0,33.90816326530612,116.6847899929619,CDH13,AEC,1.4944944088974865
GO_Biological_Process_2021,negative regulation of macromolecule biosynthetic process (GO:0010558),1/13,0.032026213248763,0.0815905908956581,0,0,33.90816326530612,116.6847899929619,EDN1,AEC,1.4944944088974865
GO_Biological_Process_2021,negative regulation of myoblast differentiation (GO:0045662),1/13,0.032026213248763,0.0815905908956581,0,0,33.90816326530612,116.6847899929619,TBX3,AEC,1.4944944088974865
GO_Biological_Process_2021,icosanoid secretion (GO:0032309),1/13,0.032026213248763,0.0815905908956581,0,0,33.90816326530612,116.6847899929619,ACE,AEC,1.4944944088974865
GO_Biological_Process_2021,triglyceride-rich lipoprotein particle remodeling (GO:0034370),1/13,0.032026213248763,0.0815905908956581,0,0,33.90816326530612,116.6847899929619,GPIHBP1,AEC,1.4944944088974865
GO_Biological_Process_2021,positive regulation of vascular endothelial cell proliferation (GO:1905564),1/13,0.032026213248763,0.0815905908956581,0,0,33.90816326530612,116.6847899929619,FGF2,AEC,1.4944944088974865
GO_Biological_Process_2021,regulation of nucleocytoplasmic transport (GO:0046822),1/13,0.032026213248763,0.0815905908956581,0,0,33.90816326530612,116.6847899929619,IFI27,AEC,1.4944944088974865
GO_Biological_Process_2021,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/13,0.032026213248763,0.0815905908956581,0,0,33.90816326530612,116.6847899929619,NDRG4,AEC,1.4944944088974865
GO_Biological_Process_2021,plasma membrane bounded cell projection assembly (GO:0120031),3/278,0.0322382341018516,0.0816498035228908,0,0,4.566731141199226,15.684904533742785,ABLIM3;CDH13;AIF1L,AEC,1.4916287553540954
GO_Biological_Process_2021,activation of protein kinase activity (GO:0032147),2/114,0.0330295301793541,0.0816498035228908,0,0,7.380208333333333,25.169117576656426,PDGFB;ADRA2C,AEC,1.4810976037825534
GO_Biological_Process_2021,cellular response to transforming growth factor beta stimulus (GO:0071560),2/114,0.0330295301793541,0.0816498035228908,0,0,7.380208333333333,25.169117576656426,CDH5;CLDN5,AEC,1.4810976037825534
GO_Biological_Process_2021,negative regulation of cell activation (GO:0050866),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,PDGFB,AEC,1.4628395910668823
GO_Biological_Process_2021,positive regulation of cardiac muscle cell proliferation (GO:0060045),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,FGF2,AEC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,DLL4,AEC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of coagulation (GO:0050819),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,EDN1,AEC,1.4628395910668823
GO_Biological_Process_2021,genitalia development (GO:0048806),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,TBX3,AEC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,FGF2,AEC,1.4628395910668823
GO_Biological_Process_2021,atrial septum development (GO:0003283),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,GJA5,AEC,1.4628395910668823
GO_Biological_Process_2021,atrioventricular valve development (GO:0003171),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,GJA5,AEC,1.4628395910668823
GO_Biological_Process_2021,regulation of vasculogenesis (GO:2001212),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,HEY1,AEC,1.4628395910668823
GO_Biological_Process_2021,branching involved in blood vessel morphogenesis (GO:0001569),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,DLL4,AEC,1.4628395910668823
GO_Biological_Process_2021,heart process (GO:0003015),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,ACE,AEC,1.4628395910668823
GO_Biological_Process_2021,heterochromatin organization (GO:0070828),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,MECOM,AEC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,PDGFB,AEC,1.4628395910668823
GO_Biological_Process_2021,secretion (GO:0046903),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,NPR1,AEC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of smooth muscle cell migration (GO:0014912),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,NDRG4,AEC,1.4628395910668823
GO_Biological_Process_2021,cellular response to low-density lipoprotein particle stimulus (GO:0071404),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,CDH13,AEC,1.4628395910668823
GO_Biological_Process_2021,neuron fate commitment (GO:0048663),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,DLL4,AEC,1.4628395910668823
GO_Biological_Process_2021,regulation of lipase activity (GO:0060191),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,GPIHBP1,AEC,1.4628395910668823
GO_Biological_Process_2021,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/14,0.0344477141698711,0.0816498035228908,0,0,31.298273155416013,105.4223689491126,EDN1,AEC,1.4628395910668823
GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),2/118,0.0351769550093681,0.0825941670909616,0,0,7.124281609195402,23.8475644827565,RAMP2;ADRA2C,AEC,1.4537417566881954
GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),2/118,0.0351769550093681,0.0825941670909616,0,0,7.124281609195402,23.8475644827565,CDH5;FGF2,AEC,1.4537417566881954
GO_Biological_Process_2021,regulation of protein binding (GO:0043393),2/118,0.0351769550093681,0.0825941670909616,0,0,7.124281609195402,23.8475644827565,CLDN5;PDGFB,AEC,1.4537417566881954
GO_Biological_Process_2021,positive regulation of endothelial cell chemotaxis (GO:2001028),1/15,0.0368632785936063,0.0839227831811888,0,0,29.06122448979592,95.91771596133704,FGF2,AEC,1.4334060415588732
GO_Biological_Process_2021,regulation of endothelial cell chemotaxis (GO:2001026),1/15,0.0368632785936063,0.0839227831811888,0,0,29.06122448979592,95.91771596133704,FGF2,AEC,1.4334060415588732
GO_Biological_Process_2021,regulation of extracellular matrix organization (GO:1903053),1/15,0.0368632785936063,0.0839227831811888,0,0,29.06122448979592,95.91771596133704,TIE1,AEC,1.4334060415588732
GO_Biological_Process_2021,positive regulation of secretion (GO:0051047),1/15,0.0368632785936063,0.0839227831811888,0,0,29.06122448979592,95.91771596133704,NPR1,AEC,1.4334060415588732
GO_Biological_Process_2021,positive regulation of sprouting angiogenesis (GO:1903672),1/15,0.0368632785936063,0.0839227831811888,0,0,29.06122448979592,95.91771596133704,FGF2,AEC,1.4334060415588732
GO_Biological_Process_2021,modulation by host of viral genome replication (GO:0044827),1/15,0.0368632785936063,0.0839227831811888,0,0,29.06122448979592,95.91771596133704,IFI27,AEC,1.4334060415588732
GO_Biological_Process_2021,prostanoid biosynthetic process (GO:0046457),1/15,0.0368632785936063,0.0839227831811888,0,0,29.06122448979592,95.91771596133704,EDN1,AEC,1.4334060415588732
GO_Biological_Process_2021,regulation of phospholipase C activity (GO:1900274),1/15,0.0368632785936063,0.0839227831811888,0,0,29.06122448979592,95.91771596133704,FGF2,AEC,1.4334060415588732
GO_Biological_Process_2021,endoderm development (GO:0007492),1/15,0.0368632785936063,0.0839227831811888,0,0,29.06122448979592,95.91771596133704,SOX17,AEC,1.4334060415588732
GO_Biological_Process_2021,protein localization to cell-cell junction (GO:0150105),1/15,0.0368632785936063,0.0839227831811888,0,0,29.06122448979592,95.91771596133704,CDH5,AEC,1.4334060415588732
GO_Biological_Process_2021,cellular response to organic substance (GO:0071310),2/123,0.0379356146383277,0.0855099349712629,0,0,6.828168044077135,22.34084340876857,RAMP2;PDGFB,AEC,1.420952875040757
GO_Biological_Process_2021,negative regulation of cell-substrate junction organization (GO:0150118),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,FAM107A,AEC,1.405906798966597
GO_Biological_Process_2021,regulation of systemic arterial blood pressure (GO:0003073),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,ACE,AEC,1.405906798966597
GO_Biological_Process_2021,negative regulation of focal adhesion assembly (GO:0051895),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,FAM107A,AEC,1.405906798966597
GO_Biological_Process_2021,basement membrane organization (GO:0071711),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,RAMP2,AEC,1.405906798966597
GO_Biological_Process_2021,body fluid secretion (GO:0007589),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,NPR1,AEC,1.405906798966597
GO_Biological_Process_2021,negative regulation of platelet activation (GO:0010544),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,PDGFB,AEC,1.405906798966597
GO_Biological_Process_2021,regulation of ERBB signaling pathway (GO:1901184),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,CDH13,AEC,1.405906798966597
GO_Biological_Process_2021,regulation of establishment of cell polarity (GO:2000114),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,CDH5,AEC,1.405906798966597
GO_Biological_Process_2021,cellular response to corticosteroid stimulus (GO:0071384),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,FAM107A,AEC,1.405906798966597
GO_Biological_Process_2021,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,HEY1,AEC,1.405906798966597
GO_Biological_Process_2021,regulation of hormone secretion (GO:0046883),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,EDN1,AEC,1.405906798966597
GO_Biological_Process_2021,digestive tract morphogenesis (GO:0048546),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,SOX17,AEC,1.405906798966597
GO_Biological_Process_2021,platelet-derived growth factor receptor signaling pathway (GO:0048008),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,PDGFB,AEC,1.405906798966597
GO_Biological_Process_2021,polyol biosynthetic process (GO:0046173),1/16,0.0392729207344652,0.0855099349712629,0,0,27.122448979591837,87.80133530116419,FGF2,AEC,1.405906798966597
GO_Biological_Process_2021,negative regulation of growth (GO:0045926),2/126,0.0396295625933463,0.0860363547316416,0,0,6.661962365591398,21.50601306379386,SOX17;NPR1,AEC,1.4019807211138142
GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),2/129,0.0413519534712599,0.0874392561306271,0,0,6.5036089238845145,20.718128222258283,PDGFB;FGF2,AEC,1.383503969503222
GO_Biological_Process_2021,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,ADRA2C,AEC,1.3801071472903907
GO_Biological_Process_2021,regulation of stem cell proliferation (GO:0072091),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,ACE,AEC,1.3801071472903907
GO_Biological_Process_2021,amyloid-beta metabolic process (GO:0050435),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,ACE,AEC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,PDGFB,AEC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of heart rate (GO:0010460),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,EDN1,AEC,1.3801071472903907
GO_Biological_Process_2021,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,GJA5,AEC,1.3801071472903907
GO_Biological_Process_2021,ruffle organization (GO:0031529),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,AIF1L,AEC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of muscle hypertrophy (GO:0014742),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,EDN1,AEC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of positive chemotaxis (GO:0050927),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,CDH13,AEC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of smooth muscle cell migration (GO:0014911),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,PDGFB,AEC,1.3801071472903907
GO_Biological_Process_2021,mesenchyme morphogenesis (GO:0072132),1/17,0.0416766547912334,0.0874392561306271,0,0,25.426020408163264,80.79916728086499,HEY1,AEC,1.3801071472903907
GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),2/133,0.043691853040543,0.0887413889888113,0,0,6.303753180661578,19.734489511742076,PODXL;CDH13,AEC,1.3595995357844428
GO_Biological_Process_2021,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),2/133,0.043691853040543,0.0887413889888113,0,0,6.303753180661578,19.734489511742076,CDH5;CLDN5,AEC,1.3595995357844428
GO_Biological_Process_2021,pulmonary valve development (GO:0003177),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,HEY1,AEC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of cardiac muscle hypertrophy (GO:0010613),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,EDN1,AEC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,PODXL,AEC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,FGF2,AEC,1.3558126557645607
GO_Biological_Process_2021,regulation of vascular endothelial cell proliferation (GO:1905562),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,FGF2,AEC,1.3558126557645607
GO_Biological_Process_2021,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,GJA5,AEC,1.3558126557645607
GO_Biological_Process_2021,hyaluronan catabolic process (GO:0030214),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,FGF2,AEC,1.3558126557645607
GO_Biological_Process_2021,cell migration involved in sprouting angiogenesis (GO:0002042),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,FGF2,AEC,1.3558126557645607
GO_Biological_Process_2021,regulation of establishment or maintenance of cell polarity (GO:0032878),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,CDH5,AEC,1.3558126557645607
GO_Biological_Process_2021,cellular response to glucocorticoid stimulus (GO:0071385),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,FAM107A,AEC,1.3558126557645607
GO_Biological_Process_2021,regulation of membrane depolarization (GO:0003254),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,GJA5,AEC,1.3558126557645607
GO_Biological_Process_2021,embryonic axis specification (GO:0000578),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,TBX3,AEC,1.3558126557645607
GO_Biological_Process_2021,embryonic digit morphogenesis (GO:0042733),1/18,0.0440744949316926,0.0887413889888113,0,0,23.92917166866747,74.70385911458476,TBX3,AEC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/134,0.0442844516217812,0.0889250784576787,0,0,6.255681818181818,19.49972118549308,ACE;PDGFB,AEC,1.3537487288592545
GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),2/136,0.0454786698217006,0.0908704308515339,0,0,6.161691542288557,19.042780777221537,SLC9A3R2;RAMP2,AEC,1.3421922462170102
GO_Biological_Process_2021,Rac protein signal transduction (GO:0016601),1/19,0.0464664552952436,0.0908704308515339,0,0,22.598639455782312,69.35578082800635,CDH13,AEC,1.3328604565168853
GO_Biological_Process_2021,atrioventricular valve morphogenesis (GO:0003181),1/19,0.0464664552952436,0.0908704308515339,0,0,22.598639455782312,69.35578082800635,HEY1,AEC,1.3328604565168853
GO_Biological_Process_2021,regulation of bicellular tight junction assembly (GO:2000810),1/19,0.0464664552952436,0.0908704308515339,0,0,22.598639455782312,69.35578082800635,CLDN5,AEC,1.3328604565168853
GO_Biological_Process_2021,branching involved in ureteric bud morphogenesis (GO:0001658),1/19,0.0464664552952436,0.0908704308515339,0,0,22.598639455782312,69.35578082800635,FGF2,AEC,1.3328604565168853
GO_Biological_Process_2021,cardiac atrium morphogenesis (GO:0003209),1/19,0.0464664552952436,0.0908704308515339,0,0,22.598639455782312,69.35578082800635,DLL4,AEC,1.3328604565168853
GO_Biological_Process_2021,positive regulation of oxidoreductase activity (GO:0051353),1/19,0.0464664552952436,0.0908704308515339,0,0,22.598639455782312,69.35578082800635,EDN1,AEC,1.3328604565168853
GO_Biological_Process_2021,ureteric bud morphogenesis (GO:0060675),1/19,0.0464664552952436,0.0908704308515339,0,0,22.598639455782312,69.35578082800635,FGF2,AEC,1.3328604565168853
GO_Biological_Process_2021,prostaglandin biosynthetic process (GO:0001516),1/19,0.0464664552952436,0.0908704308515339,0,0,22.598639455782312,69.35578082800635,EDN1,AEC,1.3328604565168853
GO_Biological_Process_2021,endocardial cushion morphogenesis (GO:0003203),1/19,0.0464664552952436,0.0908704308515339,0,0,22.598639455782312,69.35578082800635,HEY1,AEC,1.3328604565168853
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),4/546,0.0471837441916468,0.0919360802425597,0,0,3.1137493983635487,9.50847474832882,PDGFB;CDH13;ADRA2C;FGF2,AEC,1.3262075993289288
GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),2/139,0.0472922793944307,0.0919360802425597,0,0,6.025851581508515,18.3873330672393,FAM107A;CDH13,AEC,1.3252097533441285
GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),2/140,0.0479026862337682,0.0919360802425597,0,0,5.981884057971015,18.176455370515885,SLC9A3R2;RAMP2,AEC,1.319640132017756
GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),2/140,0.0479026862337682,0.0919360802425597,0,0,5.981884057971015,18.176455370515885,NPR1;TIE1,AEC,1.319640132017756
GO_Biological_Process_2021,negative regulation of axon extension involved in axon guidance (GO:0048843),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,SEMA3G,AEC,1.3111127622579986
GO_Biological_Process_2021,adrenergic receptor signaling pathway (GO:0071875),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,ADRA2C,AEC,1.3111127622579986
GO_Biological_Process_2021,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,PDGFB,AEC,1.3111127622579986
GO_Biological_Process_2021,positive regulation of epithelial cell differentiation (GO:0030858),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,FGF2,AEC,1.3111127622579986
GO_Biological_Process_2021,positive regulation of heart contraction (GO:0045823),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,EDN1,AEC,1.3111127622579986
GO_Biological_Process_2021,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,CLDN5,AEC,1.3111127622579986
GO_Biological_Process_2021,positive regulation of hormone secretion (GO:0046887),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,EDN1,AEC,1.3111127622579986
GO_Biological_Process_2021,negative regulation of osteoclast differentiation (GO:0045671),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,TMEM178A,AEC,1.3111127622579986
GO_Biological_Process_2021,inositol phosphate-mediated signaling (GO:0048016),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,EDN1,AEC,1.3111127622579986
GO_Biological_Process_2021,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,FGF2,AEC,1.3111127622579986
GO_Biological_Process_2021,positive regulation of nitrogen compound metabolic process (GO:0051173),1/20,0.0488525499820277,0.0919360802425597,0,0,21.40816326530612,64.63014669364038,PDGFB,AEC,1.3111127622579986
GO_Biological_Process_2021,Ras protein signal transduction (GO:0007265),2/142,0.049132198764417,0.0922306187332039,0,0,5.895833333333333,17.765564841290935,CDH13;FGF2,AEC,1.3086337998813415
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),2/143,0.0497512691479657,0.0931592514795659,0,0,5.8537234042553195,17.565380826397597,EDN1;RAMP2,AEC,1.3031958359850326
GO_Biological_Process_2021,anterior/posterior axis specification (GO:0009948),1/21,0.0512327930672156,0.0942834447354901,0,0,20.336734693877553,60.42807445408675,TBX3,AEC,1.2904519669693806
GO_Biological_Process_2021,regulation of cardiac muscle cell proliferation (GO:0060043),1/21,0.0512327930672156,0.0942834447354901,0,0,20.336734693877553,60.42807445408675,FGF2,AEC,1.2904519669693806
GO_Biological_Process_2021,negative regulation of response to wounding (GO:1903035),1/21,0.0512327930672156,0.0942834447354901,0,0,20.336734693877553,60.42807445408675,FGF2,AEC,1.2904519669693806
GO_Biological_Process_2021,regulation of fibroblast migration (GO:0010762),1/21,0.0512327930672156,0.0942834447354901,0,0,20.336734693877553,60.42807445408675,FGF2,AEC,1.2904519669693806
GO_Biological_Process_2021,regulation of lipoprotein lipase activity (GO:0051004),1/21,0.0512327930672156,0.0942834447354901,0,0,20.336734693877553,60.42807445408675,GPIHBP1,AEC,1.2904519669693806
GO_Biological_Process_2021,cyclic purine nucleotide metabolic process (GO:0052652),1/21,0.0512327930672156,0.0942834447354901,0,0,20.336734693877553,60.42807445408675,NPR1,AEC,1.2904519669693806
GO_Biological_Process_2021,endocardial cushion development (GO:0003197),1/21,0.0512327930672156,0.0942834447354901,0,0,20.336734693877553,60.42807445408675,HEY1,AEC,1.2904519669693806
GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),2/148,0.052889062238365,0.0970929108248417,0,0,5.651826484018265,16.61387585032132,EDN1;TMEM178A,AEC,1.2766341332705589
GO_Biological_Process_2021,negative regulation of biomineral tissue development (GO:0070168),1/22,0.0536071985992547,0.097219834747801,0,0,19.367346938775512,56.67024999786951,HEY1,AEC,1.2707768875084013
GO_Biological_Process_2021,regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.0536071985992547,0.097219834747801,0,0,19.367346938775512,56.67024999786951,GJA5,AEC,1.2707768875084013
GO_Biological_Process_2021,positive regulation of neural precursor cell proliferation (GO:2000179),1/22,0.0536071985992547,0.097219834747801,0,0,19.367346938775512,56.67024999786951,DLL4,AEC,1.2707768875084013
GO_Biological_Process_2021,limb morphogenesis (GO:0035108),1/22,0.0536071985992547,0.097219834747801,0,0,19.367346938775512,56.67024999786951,TBX3,AEC,1.2707768875084013
GO_Biological_Process_2021,regulation of platelet activation (GO:0010543),1/22,0.0536071985992547,0.097219834747801,0,0,19.367346938775512,56.67024999786951,PDGFB,AEC,1.2707768875084013
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),3/345,0.0550388186280638,0.0995750607546373,0,0,3.6595744680851063,10.611728649113475,NPR1;PDGFB;FGF2,AEC,1.2593308965170802
GO_Biological_Process_2021,artery development (GO:0060840),1/23,0.0559757805878795,0.0995863649888877,0,0,18.4860853432282,53.29235549319145,GJA5,AEC,1.2519998414265567
GO_Biological_Process_2021,response to nutrient levels (GO:0031667),1/23,0.0559757805878795,0.0995863649888877,0,0,18.4860853432282,53.29235549319145,FAM107A,AEC,1.2519998414265567
GO_Biological_Process_2021,positive regulation of JUN kinase activity (GO:0043507),1/23,0.0559757805878795,0.0995863649888877,0,0,18.4860853432282,53.29235549319145,EDN1,AEC,1.2519998414265567
GO_Biological_Process_2021,hyaluronan metabolic process (GO:0030212),1/23,0.0559757805878795,0.0995863649888877,0,0,18.4860853432282,53.29235549319145,FGF2,AEC,1.2519998414265567
GO_Biological_Process_2021,positive regulation of morphogenesis of an epithelium (GO:1905332),1/23,0.0559757805878795,0.0995863649888877,0,0,18.4860853432282,53.29235549319145,FGF2,AEC,1.2519998414265567
GO_Biological_Process_2021,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.0559757805878795,0.0995863649888877,0,0,18.4860853432282,53.29235549319145,DLL4,AEC,1.2519998414265567
GO_Biological_Process_2021,regulation of protein export from nucleus (GO:0046825),1/23,0.0559757805878795,0.0995863649888877,0,0,18.4860853432282,53.29235549319145,IFI27,AEC,1.2519998414265567
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),2/154,0.0567455048100272,0.1007165476367544,0,0,5.427083333333333,15.571272642043729,ACE;PDGFB,AEC,1.2460685361352464
GO_Biological_Process_2021,positive regulation of carbohydrate metabolic process (GO:0045913),1/24,0.0583385530130099,0.1016176190854522,0,0,17.68145519077196,50.24171555062859,PDGFB,AEC,1.2340443470047993
GO_Biological_Process_2021,extracellular matrix assembly (GO:0085029),1/24,0.0583385530130099,0.1016176190854522,0,0,17.68145519077196,50.24171555062859,RAMP2,AEC,1.2340443470047993
GO_Biological_Process_2021,regulation of axon extension involved in axon guidance (GO:0048841),1/24,0.0583385530130099,0.1016176190854522,0,0,17.68145519077196,50.24171555062859,SEMA3G,AEC,1.2340443470047993
GO_Biological_Process_2021,regulation of cardiac muscle hypertrophy (GO:0010611),1/24,0.0583385530130099,0.1016176190854522,0,0,17.68145519077196,50.24171555062859,EDN1,AEC,1.2340443470047993
GO_Biological_Process_2021,regulation of cell size (GO:0008361),1/24,0.0583385530130099,0.1016176190854522,0,0,17.68145519077196,50.24171555062859,EDN1,AEC,1.2340443470047993
GO_Biological_Process_2021,negative regulation of neuron differentiation (GO:0045665),1/24,0.0583385530130099,0.1016176190854522,0,0,17.68145519077196,50.24171555062859,HEY1,AEC,1.2340443470047993
GO_Biological_Process_2021,positive regulation of phospholipase activity (GO:0010518),1/24,0.0583385530130099,0.1016176190854522,0,0,17.68145519077196,50.24171555062859,FGF2,AEC,1.2340443470047993
GO_Biological_Process_2021,mammary gland development (GO:0030879),1/24,0.0583385530130099,0.1016176190854522,0,0,17.68145519077196,50.24171555062859,TBX3,AEC,1.2340443470047993
GO_Biological_Process_2021,acylglycerol homeostasis (GO:0055090),1/25,0.0606955298241754,0.1045079352604767,0,0,16.943877551020407,47.47480020477031,GPIHBP1,AEC,1.2168432931781568
GO_Biological_Process_2021,regulation of calcium ion import (GO:0090279),1/25,0.0606955298241754,0.1045079352604767,0,0,16.943877551020407,47.47480020477031,PDGFB,AEC,1.2168432931781568
GO_Biological_Process_2021,regulation of cardiac muscle cell action potential (GO:0098901),1/25,0.0606955298241754,0.1045079352604767,0,0,16.943877551020407,47.47480020477031,GJA5,AEC,1.2168432931781568
GO_Biological_Process_2021,negative regulation of sequestering of calcium ion (GO:0051283),1/25,0.0606955298241754,0.1045079352604767,0,0,16.943877551020407,47.47480020477031,FGF2,AEC,1.2168432931781568
GO_Biological_Process_2021,peptide catabolic process (GO:0043171),1/25,0.0606955298241754,0.1045079352604767,0,0,16.943877551020407,47.47480020477031,ACE,AEC,1.2168432931781568
GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),2/161,0.0613656526664216,0.1054194354292427,0,0,5.186320754716981,14.474528542436865,PDGFB;FGF2,AEC,1.212074642397333
GO_Biological_Process_2021,regulation of biomineral tissue development (GO:0070167),1/26,0.0630467249540435,0.1075671913225025,0,0,16.26530612244898,44.95534064809558,HEY1,AEC,1.2003374685092782
GO_Biological_Process_2021,metanephros development (GO:0001656),1/26,0.0630467249540435,0.1075671913225025,0,0,16.26530612244898,44.95534064809558,SOX17,AEC,1.2003374685092782
GO_Biological_Process_2021,endothelial cell development (GO:0001885),1/26,0.0630467249540435,0.1075671913225025,0,0,16.26530612244898,44.95534064809558,SOX18,AEC,1.2003374685092782
GO_Biological_Process_2021,positive regulation of BMP signaling pathway (GO:0030513),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,CDH5,AEC,1.184474368421492
GO_Biological_Process_2021,regulation of transcription regulatory region DNA binding (GO:2000677),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,HEY1,AEC,1.184474368421492
GO_Biological_Process_2021,regulation of blood coagulation (GO:0030193),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,EDN1,AEC,1.184474368421492
GO_Biological_Process_2021,regulation of vasculature development (GO:1901342),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,FGF2,AEC,1.184474368421492
GO_Biological_Process_2021,regulation of cardiac muscle cell contraction (GO:0086004),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,GJA5,AEC,1.184474368421492
GO_Biological_Process_2021,release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,FGF2,AEC,1.184474368421492
GO_Biological_Process_2021,regulation of cell junction assembly (GO:1901888),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,CLDN5,AEC,1.184474368421492
GO_Biological_Process_2021,response to glucocorticoid (GO:0051384),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,FAM107A,AEC,1.184474368421492
GO_Biological_Process_2021,negative regulation of protein polymerization (GO:0032272),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,CDH5,AEC,1.184474368421492
GO_Biological_Process_2021,positive regulation of nitric oxide biosynthetic process (GO:0045429),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,EDN1,AEC,1.184474368421492
GO_Biological_Process_2021,cellular senescence (GO:0090398),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,TBX3,AEC,1.184474368421492
GO_Biological_Process_2021,positive regulation of striated muscle cell differentiation (GO:0051155),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,EDN1,AEC,1.184474368421492
GO_Biological_Process_2021,peptide hormone secretion (GO:0030072),1/27,0.0653921522588676,0.1083600045174598,0,0,15.638932496075354,42.652889831563165,EDN1,AEC,1.184474368421492
GO_Biological_Process_2021,negative regulation of axonogenesis (GO:0050771),1/28,0.0677318256109869,0.1102850812665851,0,0,15.058956916099774,40.54171043527237,SEMA3G,AEC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of cell communication (GO:0010647),1/28,0.0677318256109869,0.1102850812665851,0,0,15.058956916099774,40.54171043527237,EDN1,AEC,1.1692072184717057
GO_Biological_Process_2021,regulation of calcium-mediated signaling (GO:0050848),1/28,0.0677318256109869,0.1102850812665851,0,0,15.058956916099774,40.54171043527237,CDH13,AEC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of fibroblast proliferation (GO:0048146),1/28,0.0677318256109869,0.1102850812665851,0,0,15.058956916099774,40.54171043527237,PDGFB,AEC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of nitric oxide metabolic process (GO:1904407),1/28,0.0677318256109869,0.1102850812665851,0,0,15.058956916099774,40.54171043527237,EDN1,AEC,1.1692072184717057
GO_Biological_Process_2021,regulation of multicellular organismal development (GO:2000026),1/28,0.0677318256109869,0.1102850812665851,0,0,15.058956916099774,40.54171043527237,SOX17,AEC,1.1692072184717057
GO_Biological_Process_2021,ventricular septum morphogenesis (GO:0060412),1/28,0.0677318256109869,0.1102850812665851,0,0,15.058956916099774,40.54171043527237,HEY1,AEC,1.1692072184717057
GO_Biological_Process_2021,protein localization to cell surface (GO:0034394),1/28,0.0677318256109869,0.1102850812665851,0,0,15.058956916099774,40.54171043527237,GPIHBP1,AEC,1.1692072184717057
GO_Biological_Process_2021,actin filament polymerization (GO:0030041),1/29,0.0700657588372089,0.1131018391574773,0,0,14.520408163265309,38.5999069065122,FAM107A,AEC,1.1544941700666143
GO_Biological_Process_2021,establishment of endothelial barrier (GO:0061028),1/29,0.0700657588372089,0.1131018391574773,0,0,14.520408163265309,38.5999069065122,SOX18,AEC,1.1544941700666143
GO_Biological_Process_2021,positive regulation of dephosphorylation (GO:0035306),1/29,0.0700657588372089,0.1131018391574773,0,0,14.520408163265309,38.5999069065122,CDH5,AEC,1.1544941700666143
GO_Biological_Process_2021,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.0700657588372089,0.1131018391574773,0,0,14.520408163265309,38.5999069065122,TMEM178A,AEC,1.1544941700666143
GO_Biological_Process_2021,regulation of striated muscle contraction (GO:0006942),1/30,0.0723939657090184,0.1156142437442532,0,0,14.019000703729768,36.80874147674154,GJA5,AEC,1.1402976322627019
GO_Biological_Process_2021,artery morphogenesis (GO:0048844),1/30,0.0723939657090184,0.1156142437442532,0,0,14.019000703729768,36.80874147674154,GJA5,AEC,1.1402976322627019
GO_Biological_Process_2021,regulation of vasoconstriction (GO:0019229),1/30,0.0723939657090184,0.1156142437442532,0,0,14.019000703729768,36.80874147674154,ACE,AEC,1.1402976322627019
GO_Biological_Process_2021,respiratory tube development (GO:0030323),1/30,0.0723939657090184,0.1156142437442532,0,0,14.019000703729768,36.80874147674154,FGF2,AEC,1.1402976322627019
GO_Biological_Process_2021,regulation of long-term synaptic potentiation (GO:1900271),1/30,0.0723939657090184,0.1156142437442532,0,0,14.019000703729768,36.80874147674154,FAM107A,AEC,1.1402976322627019
GO_Biological_Process_2021,protein stabilization (GO:0050821),2/179,0.0738061123878065,0.1175685473570758,0,0,4.654661016949152,12.131506903576025,SOX17;GPIHBP1,AEC,1.1319076697979504
GO_Biological_Process_2021,negative regulation of axon extension (GO:0030517),1/31,0.0747164600026276,0.1175685473570758,0,0,13.551020408163266,35.15209038871121,SEMA3G,AEC,1.126583712764908
GO_Biological_Process_2021,negative regulation of DNA binding (GO:0043392),1/31,0.0747164600026276,0.1175685473570758,0,0,13.551020408163266,35.15209038871121,HEY1,AEC,1.126583712764908
GO_Biological_Process_2021,positive regulation of locomotion (GO:0040017),1/31,0.0747164600026276,0.1175685473570758,0,0,13.551020408163266,35.15209038871121,PDGFB,AEC,1.126583712764908
GO_Biological_Process_2021,positive regulation of protein targeting to mitochondrion (GO:1903955),1/31,0.0747164600026276,0.1175685473570758,0,0,13.551020408163266,35.15209038871121,ABLIM3,AEC,1.126583712764908
GO_Biological_Process_2021,triglyceride homeostasis (GO:0070328),1/31,0.0747164600026276,0.1175685473570758,0,0,13.551020408163266,35.15209038871121,GPIHBP1,AEC,1.126583712764908
GO_Biological_Process_2021,prostaglandin metabolic process (GO:0006693),1/31,0.0747164600026276,0.1175685473570758,0,0,13.551020408163266,35.15209038871121,EDN1,AEC,1.126583712764908
GO_Biological_Process_2021,negative regulation of cell-matrix adhesion (GO:0001953),1/32,0.0770332554327668,0.1194573671203775,0,0,13.113232389730086,33.61600807740255,FAM107A,AEC,1.1133217484244988
GO_Biological_Process_2021,negative regulation of chemotaxis (GO:0050922),1/32,0.0770332554327668,0.1194573671203775,0,0,13.113232389730086,33.61600807740255,SEMA3G,AEC,1.1133217484244988
GO_Biological_Process_2021,negative regulation of developmental growth (GO:0048640),1/32,0.0770332554327668,0.1194573671203775,0,0,13.113232389730086,33.61600807740255,SEMA3G,AEC,1.1133217484244988
GO_Biological_Process_2021,hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.0770332554327668,0.1194573671203775,0,0,13.113232389730086,33.61600807740255,ACE,AEC,1.1133217484244988
GO_Biological_Process_2021,negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/32,0.0770332554327668,0.1194573671203775,0,0,13.113232389730086,33.61600807740255,CDH5,AEC,1.1133217484244988
GO_Biological_Process_2021,regulation of chemotaxis (GO:0050920),1/32,0.0770332554327668,0.1194573671203775,0,0,13.113232389730086,33.61600807740255,PDGFB,AEC,1.1133217484244988
GO_Biological_Process_2021,regulation of intracellular protein transport (GO:0033157),1/32,0.0770332554327668,0.1194573671203775,0,0,13.113232389730086,33.61600807740255,IFI27,AEC,1.1133217484244988
GO_Biological_Process_2021,regulation of sprouting angiogenesis (GO:1903670),1/33,0.0793443657059371,0.1215315540158423,0,0,12.70280612244898,32.18837516559274,FGF2,AEC,1.1004839073426347
GO_Biological_Process_2021,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/33,0.0793443657059371,0.1215315540158423,0,0,12.70280612244898,32.18837516559274,ACE,AEC,1.1004839073426347
GO_Biological_Process_2021,negative regulation of JNK cascade (GO:0046329),1/33,0.0793443657059371,0.1215315540158423,0,0,12.70280612244898,32.18837516559274,MECOM,AEC,1.1004839073426347
GO_Biological_Process_2021,negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.0793443657059371,0.1215315540158423,0,0,12.70280612244898,32.18837516559274,NDRG4,AEC,1.1004839073426347
GO_Biological_Process_2021,muscle cell development (GO:0055001),1/33,0.0793443657059371,0.1215315540158423,0,0,12.70280612244898,32.18837516559274,RAMP2,AEC,1.1004839073426347
GO_Biological_Process_2021,negative chemotaxis (GO:0050919),1/33,0.0793443657059371,0.1215315540158423,0,0,12.70280612244898,32.18837516559274,SEMA3G,AEC,1.1004839073426347
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),3/404,0.0800241417045532,0.1223226166055313,0,0,3.1117419217912663,7.858476812794824,TIE1;PDGFB;FGF2,AEC,1.0967789751654027
GO_Biological_Process_2021,positive regulation of protein dephosphorylation (GO:0035307),1/34,0.0816498044624026,0.1235468758431102,0,0,12.317254174397032,30.85861216573232,CDH5,AEC,1.0880448509885652
GO_Biological_Process_2021,regulation of myoblast differentiation (GO:0045661),1/34,0.0816498044624026,0.1235468758431102,0,0,12.317254174397032,30.85861216573232,TBX3,AEC,1.0880448509885652
GO_Biological_Process_2021,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.0816498044624026,0.1235468758431102,0,0,12.317254174397032,30.85861216573232,DLL4,AEC,1.0880448509885652
GO_Biological_Process_2021,phosphatidylinositol 3-kinase signaling (GO:0014065),1/34,0.0816498044624026,0.1235468758431102,0,0,12.317254174397032,30.85861216573232,EDN1,AEC,1.0880448509885652
GO_Biological_Process_2021,protein destabilization (GO:0031648),1/34,0.0816498044624026,0.1235468758431102,0,0,12.317254174397032,30.85861216573232,SOX17,AEC,1.0880448509885652
GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),2/191,0.0825129134198004,0.1246011535311099,0,0,4.356481481481482,10.868552054472469,HEY1;TBX3,AEC,1.083478078261104
GO_Biological_Process_2021,negative regulation of cell cycle G1/S phase transition (GO:1902807),1/35,0.0839495853612937,0.1247584115785893,0,0,11.95438175270108,29.61744503578088,FAM107A,AEC,1.0759814445616303
GO_Biological_Process_2021,negative regulation of epithelial cell migration (GO:0010633),1/35,0.0839495853612937,0.1247584115785893,0,0,11.95438175270108,29.61744503578088,DLL4,AEC,1.0759814445616303
GO_Biological_Process_2021,regulation of blood circulation (GO:1903522),1/35,0.0839495853612937,0.1247584115785893,0,0,11.95438175270108,29.61744503578088,ACE,AEC,1.0759814445616303
GO_Biological_Process_2021,respiratory system development (GO:0060541),1/35,0.0839495853612937,0.1247584115785893,0,0,11.95438175270108,29.61744503578088,FGF2,AEC,1.0759814445616303
GO_Biological_Process_2021,semaphorin-plexin signaling pathway (GO:0071526),1/35,0.0839495853612937,0.1247584115785893,0,0,11.95438175270108,29.61744503578088,SEMA3G,AEC,1.0759814445616303
GO_Biological_Process_2021,lung development (GO:0030324),1/35,0.0839495853612937,0.1247584115785893,0,0,11.95438175270108,29.61744503578088,FGF2,AEC,1.0759814445616303
GO_Biological_Process_2021,regulation of JUN kinase activity (GO:0043506),1/35,0.0839495853612937,0.1247584115785893,0,0,11.95438175270108,29.61744503578088,EDN1,AEC,1.0759814445616303
GO_Biological_Process_2021,peptidyl-tyrosine dephosphorylation (GO:0035335),1/35,0.0839495853612937,0.1247584115785893,0,0,11.95438175270108,29.61744503578088,PTPRB,AEC,1.0759814445616303
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),2/195,0.0854831524975729,0.126165132341321,0,0,4.265328151986183,10.490301477724982,SLC9A3R2;RAMP2,AEC,1.0681194700473418
GO_Biological_Process_2021,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/36,0.0862437219743075,0.126165132341321,0,0,11.612244897959185,28.456712045041098,EDN1,AEC,1.0642725091375862
GO_Biological_Process_2021,regulation of cardiac muscle contraction (GO:0055117),1/36,0.0862437219743075,0.126165132341321,0,0,11.612244897959185,28.456712045041098,GJA5,AEC,1.0642725091375862
GO_Biological_Process_2021,regulation of embryonic development (GO:0045995),1/36,0.0862437219743075,0.126165132341321,0,0,11.612244897959185,28.456712045041098,SOX17,AEC,1.0642725091375862
GO_Biological_Process_2021,regulation of microtubule-based process (GO:0032886),1/36,0.0862437219743075,0.126165132341321,0,0,11.612244897959185,28.456712045041098,FAM107A,AEC,1.0642725091375862
GO_Biological_Process_2021,regulation of osteoclast differentiation (GO:0045670),1/36,0.0862437219743075,0.126165132341321,0,0,11.612244897959185,28.456712045041098,TMEM178A,AEC,1.0642725091375862
GO_Biological_Process_2021,embryonic limb morphogenesis (GO:0030326),1/36,0.0862437219743075,0.126165132341321,0,0,11.612244897959185,28.456712045041098,TBX3,AEC,1.0642725091375862
GO_Biological_Process_2021,endoderm formation (GO:0001706),1/36,0.0862437219743075,0.126165132341321,0,0,11.612244897959185,28.456712045041098,SOX17,AEC,1.0642725091375862
GO_Biological_Process_2021,positive regulation of calcium ion transport (GO:0051928),1/37,0.0885322278902676,0.1277661631788256,0,0,11.289115646258503,27.36920368672352,PDGFB,AEC,1.0528986067362665
GO_Biological_Process_2021,negative regulation of endothelial cell proliferation (GO:0001937),1/37,0.0885322278902676,0.1277661631788256,0,0,11.289115646258503,27.36920368672352,DLL4,AEC,1.0528986067362665
GO_Biological_Process_2021,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/37,0.0885322278902676,0.1277661631788256,0,0,11.289115646258503,27.36920368672352,FAM107A,AEC,1.0528986067362665
GO_Biological_Process_2021,negative regulation of stress-activated MAPK cascade (GO:0032873),1/37,0.0885322278902676,0.1277661631788256,0,0,11.289115646258503,27.36920368672352,MECOM,AEC,1.0528986067362665
GO_Biological_Process_2021,neural crest cell migration (GO:0001755),1/37,0.0885322278902676,0.1277661631788256,0,0,11.289115646258503,27.36920368672352,SEMA3G,AEC,1.0528986067362665
GO_Biological_Process_2021,regulation of microtubule cytoskeleton organization (GO:0070507),1/37,0.0885322278902676,0.1277661631788256,0,0,11.289115646258503,27.36920368672352,FAM107A,AEC,1.0528986067362665
GO_Biological_Process_2021,regulation of protein autophosphorylation (GO:0031952),1/37,0.0885322278902676,0.1277661631788256,0,0,11.289115646258503,27.36920368672352,PDGFB,AEC,1.0528986067362665
GO_Biological_Process_2021,regulation of axon extension (GO:0030516),1/38,0.0908151166313484,0.1303075140936398,0,0,10.983452840595698,26.34852930034076,SEMA3G,AEC,1.0418418549683985
GO_Biological_Process_2021,regulation of cell communication (GO:0010646),1/38,0.0908151166313484,0.1303075140936398,0,0,10.983452840595698,26.34852930034076,GJA5,AEC,1.0418418549683985
GO_Biological_Process_2021,positive regulation of signaling (GO:0023056),1/38,0.0908151166313484,0.1303075140936398,0,0,10.983452840595698,26.34852930034076,EDN1,AEC,1.0418418549683985
GO_Biological_Process_2021,regulation of protein targeting to mitochondrion (GO:1903214),1/39,0.0930924017046572,0.1323077967301485,0,0,10.693877551020408,25.38900533231373,ABLIM3,AEC,1.0310857651239858
GO_Biological_Process_2021,negative regulation of cellular metabolic process (GO:0031324),1/39,0.0930924017046572,0.1323077967301485,0,0,10.693877551020408,25.38900533231373,EDN1,AEC,1.0310857651239858
GO_Biological_Process_2021,regulation of cellular component biogenesis (GO:0044087),1/39,0.0930924017046572,0.1323077967301485,0,0,10.693877551020408,25.38900533231373,TIE1,AEC,1.0310857651239858
GO_Biological_Process_2021,odontogenesis (GO:0042476),1/39,0.0930924017046572,0.1323077967301485,0,0,10.693877551020408,25.38900533231373,SSUH2,AEC,1.0310857651239858
GO_Biological_Process_2021,organophosphate biosynthetic process (GO:0090407),1/39,0.0930924017046572,0.1323077967301485,0,0,10.693877551020408,25.38900533231373,FGF2,AEC,1.0310857651239858
GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),2/207,0.0945848472510804,0.1341743382406425,0,0,4.013211382113822,9.464187818681536,PDGFB;FGF2,AEC,1.0241784331789758
GO_Biological_Process_2021,response to organonitrogen compound (GO:0010243),1/40,0.0953640965755271,0.1342626096523869,0,0,10.419152276295131,24.485561288951835,GPIHBP1,AEC,1.0206151011238414
GO_Biological_Process_2021,stem cell differentiation (GO:0048863),1/40,0.0953640965755271,0.1342626096523869,0,0,10.419152276295131,24.485561288951835,ACE,AEC,1.0206151011238414
GO_Biological_Process_2021,regulation of microtubule polymerization (GO:0031113),1/40,0.0953640965755271,0.1342626096523869,0,0,10.419152276295131,24.485561288951835,CDH5,AEC,1.0206151011238414
GO_Biological_Process_2021,regulation of nitric oxide biosynthetic process (GO:0045428),1/40,0.0953640965755271,0.1342626096523869,0,0,10.419152276295131,24.485561288951835,EDN1,AEC,1.0206151011238414
GO_Biological_Process_2021,epithelial cell migration (GO:0010631),1/41,0.0976302146847681,0.1359201315964523,0,0,10.158163265306122,23.633660200289185,CDH13,AEC,1.0104157556925017
GO_Biological_Process_2021,negative regulation of cell-cell adhesion (GO:0022408),1/41,0.0976302146847681,0.1359201315964523,0,0,10.158163265306122,23.633660200289185,PODXL,AEC,1.0104157556925017
GO_Biological_Process_2021,regulation of cell development (GO:0060284),1/41,0.0976302146847681,0.1359201315964523,0,0,10.158163265306122,23.633660200289185,HEY1,AEC,1.0104157556925017
GO_Biological_Process_2021,heart contraction (GO:0060047),1/41,0.0976302146847681,0.1359201315964523,0,0,10.158163265306122,23.633660200289185,ACE,AEC,1.0104157556925017
GO_Biological_Process_2021,response to growth factor (GO:0070848),1/41,0.0976302146847681,0.1359201315964523,0,0,10.158163265306122,23.633660200289185,PDGFB,AEC,1.0104157556925017
GO_Biological_Process_2021,regulation of protein dephosphorylation (GO:0035304),1/41,0.0976302146847681,0.1359201315964523,0,0,10.158163265306122,23.633660200289185,CDH5,AEC,1.0104157556925017
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),2/212,0.0984576089228105,0.1368177162953341,0,0,3.9166666666666665,9.079339326341122,CDH5;RAMP2,AEC,1.0067507154273545
GO_Biological_Process_2021,calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.0998907694703361,0.1380409341942468,0,0,9.909905425584869,22.829231064333683,FGF2,AEC,1.00047464143678
GO_Biological_Process_2021,regulation of nervous system development (GO:0051960),1/42,0.0998907694703361,0.1380409341942468,0,0,9.909905425584869,22.829231064333683,HEY1,AEC,1.00047464143678
GO_Biological_Process_2021,monocyte chemotaxis (GO:0002548),1/42,0.0998907694703361,0.1380409341942468,0,0,9.909905425584869,22.829231064333683,PDGFB,AEC,1.00047464143678
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),2/216,0.1015881472155216,0.1398668828798583,0,0,3.842679127725857,8.78754780712842,PDGFB;FGF2,AEC,0.9931569603511173
GO_Biological_Process_2021,regulation of cell-cell adhesion (GO:0022407),1/43,0.1021457742794159,0.1398668828798583,0,0,9.673469387755102,22.068611238785657,PODXL,AEC,0.9907795952096249
GO_Biological_Process_2021,regulation of cell-substrate adhesion (GO:0010810),1/43,0.1021457742794159,0.1398668828798583,0,0,9.673469387755102,22.068611238785657,PDGFB,AEC,0.9907795952096249
GO_Biological_Process_2021,positive regulation of neuron differentiation (GO:0045666),1/43,0.1021457742794159,0.1398668828798583,0,0,9.673469387755102,22.068611238785657,ADRA2C,AEC,0.9907795952096249
GO_Biological_Process_2021,positive regulation of phospholipase C activity (GO:0010863),1/43,0.1021457742794159,0.1398668828798583,0,0,9.673469387755102,22.068611238785657,FGF2,AEC,0.9907795952096249
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),2/217,0.1023751607426323,0.1399251740807147,0,0,3.824612403100775,8.716716836108898,PDGFB;FGF2,AEC,0.9898054033308324
GO_Biological_Process_2021,positive regulation of cell-matrix adhesion (GO:0001954),1/44,0.1043952424647777,0.1421673392838518,0,0,9.448030374940672,21.34849709415977,CDH13,AEC,0.9813192926974915
GO_Biological_Process_2021,embryonic organ morphogenesis (GO:0048562),1/44,0.1043952424647777,0.1421673392838518,0,0,9.448030374940672,21.34849709415977,SOX17,AEC,0.9813192926974915
GO_Biological_Process_2021,neural crest cell development (GO:0014032),1/45,0.1066391873529346,0.1449596212837533,0,0,9.232838589981448,20.665901611884028,SEMA3G,AEC,0.9720831731354668
GO_Biological_Process_2021,regulation of fibroblast proliferation (GO:0048145),1/46,0.1088776222085674,0.147734309844596,0,0,9.02721088435374,20.01811780873028,PDGFB,AEC,0.9630613723103648
GO_Biological_Process_2021,positive regulation of cell-cell adhesion (GO:0022409),1/47,0.1111105603036554,0.1502198730459168,0,0,8.830523513753327,19.4026870705364,PODXL,AEC,0.9542446623584087
GO_Biological_Process_2021,regulation of wound healing (GO:0061041),1/47,0.1111105603036554,0.1502198730459168,0,0,8.830523513753327,19.4026870705364,FGF2,AEC,0.9542446623584087
GO_Biological_Process_2021,purine ribonucleotide biosynthetic process (GO:0009152),1/48,0.1133380148369131,0.1518607747993701,0,0,8.642205818497612,18.81737166641443,NPR1,AEC,0.9456243984787533
GO_Biological_Process_2021,inositol phosphate metabolic process (GO:0043647),1/48,0.1133380148369131,0.1518607747993701,0,0,8.642205818497612,18.81737166641443,FGF2,AEC,0.9456243984787533
GO_Biological_Process_2021,cognition (GO:0050890),1/48,0.1133380148369131,0.1518607747993701,0,0,8.642205818497612,18.81737166641443,FAM107A,AEC,0.9456243984787533
GO_Biological_Process_2021,myelination (GO:0042552),1/48,0.1133380148369131,0.1518607747993701,0,0,8.642205818497612,18.81737166641443,PLLP,AEC,0.9456243984787533
GO_Biological_Process_2021,regulation of protein metabolic process (GO:0051246),1/48,0.1133380148369131,0.1518607747993701,0,0,8.642205818497612,18.81737166641443,ACE,AEC,0.9456243984787533
GO_Biological_Process_2021,receptor internalization (GO:0031623),1/49,0.1155599990222406,0.1540114577716339,0,0,8.46173469387755,18.260130793597916,RAMP2,AEC,0.9371924705024297
GO_Biological_Process_2021,regulation of cellular protein metabolic process (GO:0032268),1/49,0.1155599990222406,0.1540114577716339,0,0,8.46173469387755,18.260130793597916,EDN1,AEC,0.9371924705024297
GO_Biological_Process_2021,positive regulation of reactive oxygen species metabolic process (GO:2000379),1/49,0.1155599990222406,0.1540114577716339,0,0,8.46173469387755,18.260130793597916,PDGFB,AEC,0.9371924705024297
GO_Biological_Process_2021,actin polymerization or depolymerization (GO:0008154),1/50,0.1177765260040411,0.1566867104387687,0,0,8.28862973760933,17.7290996615035,FAM107A,AEC,0.928941259997044
GO_Biological_Process_2021,regulation of protein modification process (GO:0031399),1/51,0.1199876089220907,0.1593452466004361,0,0,8.122448979591837,17.22257115519733,CDH5,AEC,0.9208636010741894
GO_Biological_Process_2021,ameboidal-type cell migration (GO:0001667),1/52,0.1221932608707862,0.1614157890515324,0,0,7.962785114045619,16.738979733033663,SEMA3G,AEC,0.9129527453809976
GO_Biological_Process_2021,cartilage development (GO:0051216),1/52,0.1221932608707862,0.1614157890515324,0,0,7.962785114045619,16.738979733033663,FGF2,AEC,0.9129527453809976
GO_Biological_Process_2021,negative regulation of protein metabolic process (GO:0051248),1/52,0.1221932608707862,0.1614157890515324,0,0,7.962785114045619,16.738979733033663,EDN1,AEC,0.9129527453809976
GO_Biological_Process_2021,regulation of focal adhesion assembly (GO:0051893),1/54,0.1265883240687765,0.1669272090273126,0,0,7.661532537543319,15.834970375184442,FAM107A,AEC,0.8976063498190403
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),2/252,0.1309169770529217,0.1711874398622016,0,0,3.283333333333333,6.675646802845627,DLL4;JAG2,AEC,0.8830040313535863
GO_Biological_Process_2021,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/56,0.1309618198144747,0.1711874398622016,0,0,7.382189239332097,15.00687933540933,ABLIM3,AEC,0.8828552987007785
GO_Biological_Process_2021,glycosaminoglycan catabolic process (GO:0006027),1/56,0.1309618198144747,0.1711874398622016,0,0,7.382189239332097,15.00687933540933,FGF2,AEC,0.8828552987007785
GO_Biological_Process_2021,Rho protein signal transduction (GO:0007266),1/56,0.1309618198144747,0.1711874398622016,0,0,7.382189239332097,15.00687933540933,CDH13,AEC,0.8828552987007785
GO_Biological_Process_2021,peptidyl-tyrosine modification (GO:0018212),1/56,0.1309618198144747,0.1711874398622016,0,0,7.382189239332097,15.00687933540933,PDGFB,AEC,0.8828552987007785
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),2/253,0.1317582069542016,0.1719283920012143,0,0,3.270086321381142,6.627767796360294,TIE1;FGF2,AEC,0.880222323941479
GO_Biological_Process_2021,regulation of reactive oxygen species metabolic process (GO:2000377),1/57,0.1331405122852093,0.1728288452367795,0,0,7.25,14.618539131965724,PDGFB,AEC,0.8756897763447542
GO_Biological_Process_2021,positive regulation of cell junction assembly (GO:1901890),1/57,0.1331405122852093,0.1728288452367795,0,0,7.25,14.618539131965724,CLDN5,AEC,0.8756897763447542
GO_Biological_Process_2021,protein K48-linked ubiquitination (GO:0070936),1/57,0.1331405122852093,0.1728288452367795,0,0,7.25,14.618539131965724,IFI27,AEC,0.8756897763447542
GO_Biological_Process_2021,receptor metabolic process (GO:0043112),1/58,0.1353138517398134,0.1750433073456309,0,0,7.122448979591836,14.246025949065045,RAMP2,AEC,0.8686577434892403
GO_Biological_Process_2021,positive regulation of protein binding (GO:0032092),1/58,0.1353138517398134,0.1750433073456309,0,0,7.122448979591836,14.246025949065045,CLDN5,AEC,0.8686577434892403
GO_Biological_Process_2021,protein polymerization (GO:0051258),1/59,0.1374818510452552,0.177541217987752,0,0,6.9992962702322306,13.8884471557023,FAM107A,AEC,0.8617546291873563
GO_Biological_Process_2021,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/60,0.1396445230534406,0.1800236622496162,0,0,6.88031822898651,13.544974303558986,CDH13,AEC,0.8549760929333525
GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.182490736364193,0,0,6.76530612244898,13.214837540593155,CDH13,AEC,0.848318009451734
GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),2/266,0.1428070813555834,0.1834691319645488,0,0,3.1070075757575757,6.047046555927847,CDH5;FGF2,AEC,0.8452502567236859
GO_Biological_Process_2021,regulation of neurogenesis (GO:0050767),1/62,0.1439539364695556,0.1846258534515363,0,0,6.654064904650385,12.897320592663672,HEY1,AEC,0.8417764546925935
GO_Biological_Process_2021,central nervous system development (GO:0007417),2/268,0.1445246328363994,0.1850409401614755,0,0,3.0833333333333335,5.964108059214085,NDRG4;TBX3,AEC,0.8400581252728833
GO_Biological_Process_2021,anterior/posterior pattern specification (GO:0009952),1/63,0.1461007034145454,0.1864215108304846,0,0,6.54641211323239,12.591756250239603,HEY1,AEC,0.8353476931121088
GO_Biological_Process_2021,organonitrogen compound catabolic process (GO:1901565),1/63,0.1461007034145454,0.1864215108304846,0,0,6.54641211323239,12.591756250239603,ACE,AEC,0.8353476931121088
GO_Biological_Process_2021,diterpenoid metabolic process (GO:0016101),1/64,0.1482421941802595,0.1888323187772354,0,0,6.442176870748299,12.297522293260638,GPIHBP1,AEC,0.8290281655096747
GO_Biological_Process_2021,regulation of cell-matrix adhesion (GO:0001952),1/65,0.1503784214913892,0.1905811128545694,0,0,6.341198979591836,12.01403781811508,CDH13,AEC,0.8228144782361342
GO_Biological_Process_2021,cellular response to type I interferon (GO:0071357),1/65,0.1503784214913892,0.1905811128545694,0,0,6.341198979591836,12.01403781811508,IFI27,AEC,0.8228144782361342
GO_Biological_Process_2021,type I interferon signaling pathway (GO:0060337),1/65,0.1503784214913892,0.1905811128545694,0,0,6.341198979591836,12.01403781811508,IFI27,AEC,0.8228144782361342
GO_Biological_Process_2021,cellular response to nutrient levels (GO:0031669),1/66,0.1525093979756266,0.1929553025063249,0,0,6.243328100470958,11.740759916332207,FAM107A,AEC,0.8167033932798328
GO_Biological_Process_2021,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/67,0.1546351363099914,0.1949860557174808,0,0,6.148423005565863,11.477180657220888,CDH13,AEC,0.8106918184915987
GO_Biological_Process_2021,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/67,0.1546351363099914,0.1949860557174808,0,0,6.148423005565863,11.477180657220888,CLEC14A,AEC,0.8106918184915987
GO_Biological_Process_2021,cell chemotaxis (GO:0060326),1/69,0.158870948881139,0.1996549340804919,0,0,5.966986794717887,10.977245117600177,PDGFB,AEC,0.7989555105590889
GO_Biological_Process_2021,peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.158870948881139,0.1996549340804919,0,0,5.966986794717887,10.977245117600177,PDGFB,AEC,0.7989555105590889
GO_Biological_Process_2021,neutrophil chemotaxis (GO:0030593),1/70,0.1609810482853106,0.2012934977724502,0,0,5.880212954747116,10.740024519792764,EDN1,AEC,0.7932252488723367
GO_Biological_Process_2021,wound healing (GO:0042060),1/70,0.1609810482853106,0.2012934977724502,0,0,5.880212954747116,10.740024519792764,FGF2,AEC,0.7932252488723367
GO_Biological_Process_2021,regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/70,0.1609810482853106,0.2012934977724502,0,0,5.880212954747116,10.740024519792764,PODXL,AEC,0.7932252488723367
GO_Biological_Process_2021,gland development (GO:0048732),1/71,0.16308595979881,0.2025727759358354,0,0,5.795918367346939,10.51076961698872,TBX3,AEC,0.7875834261109624
GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.16308595979881,0.2025727759358354,0,0,5.795918367346939,10.51076961698872,FAM107A,AEC,0.7875834261109624
GO_Biological_Process_2021,cholesterol homeostasis (GO:0042632),1/71,0.16308595979881,0.2025727759358354,0,0,5.795918367346939,10.51076961698872,GPIHBP1,AEC,0.7875834261109624
GO_Biological_Process_2021,phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.16308595979881,0.2025727759358354,0,0,5.795918367346939,10.51076961698872,EDN1,AEC,0.7875834261109624
GO_Biological_Process_2021,extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.1651856959101235,0.2038288076386862,0,0,5.713998275366484,10.28911103101624,IFI27,AEC,0.78202756268309
GO_Biological_Process_2021,negative regulation of supramolecular fiber organization (GO:1902904),1/72,0.1651856959101235,0.2038288076386862,0,0,5.713998275366484,10.28911103101624,CDH5,AEC,0.78202756268309
GO_Biological_Process_2021,sterol homeostasis (GO:0055092),1/72,0.1651856959101235,0.2038288076386862,0,0,5.713998275366484,10.28911103101624,GPIHBP1,AEC,0.78202756268309
GO_Biological_Process_2021,positive regulation of secretion by cell (GO:1903532),1/72,0.1651856959101235,0.2038288076386862,0,0,5.713998275366484,10.28911103101624,EDN1,AEC,0.78202756268309
GO_Biological_Process_2021,regulation of actin filament-based process (GO:0032970),1/73,0.1672802691231711,0.2057355034043598,0,0,5.634353741496598,10.074701240888364,FAM107A,AEC,0.7765552814899175
GO_Biological_Process_2021,granulocyte chemotaxis (GO:0071621),1/73,0.1672802691231711,0.2057355034043598,0,0,5.634353741496598,10.074701240888364,EDN1,AEC,0.7765552814899175
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),2/296,0.1690031560036776,0.2072841489839039,0,0,2.7857142857142856,4.952548406897344,MECOM;TBX3,AEC,0.7721051851958874
GO_Biological_Process_2021,negative regulation of protein binding (GO:0032091),1/74,0.1693696918266344,0.2072841489839039,0,0,5.556891249650545,9.867213018330611,PDGFB,AEC,0.7711643026835198
GO_Biological_Process_2021,regulation of peptide hormone secretion (GO:0090276),1/74,0.1693696918266344,0.2072841489839039,0,0,5.556891249650545,9.867213018330611,ADRA2C,AEC,0.7711643026835198
GO_Biological_Process_2021,fibroblast growth factor receptor signaling pathway (GO:0008543),1/75,0.1714539764404576,0.2091515119770403,0,0,5.4815223386651954,9.666337985731484,FGF2,AEC,0.7658524380723842
GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/75,0.1714539764404576,0.2091515119770403,0,0,5.4815223386651954,9.666337985731484,HIF3A,AEC,0.7658524380723842
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),2/300,0.1725587566609558,0.2101569247789527,0,0,2.7477628635346756,4.8278673881252745,PDGFB;FGF2,AEC,0.7630629971198796
GO_Biological_Process_2021,regulation of BMP signaling pathway (GO:0030510),1/76,0.1735331353639065,0.2106585387156661,0,0,5.408163265306122,9.4717853003048,CDH5,AEC,0.7606175863963804
GO_Biological_Process_2021,cellular response to hormone stimulus (GO:0032870),1/76,0.1735331353639065,0.2106585387156661,0,0,5.408163265306122,9.4717853003048,RAMP2,AEC,0.7606175863963804
GO_Biological_Process_2021,MAPK cascade (GO:0000165),2/303,0.1752338998526144,0.2118031859951541,0,0,2.7199612403100777,4.737175959955004,PDGFB;FGF2,AEC,0.7563818736544428
GO_Biological_Process_2021,negative regulation of developmental process (GO:0051093),1/77,0.1756071809118701,0.2118031859951541,0,0,5.336734693877551,9.283280446293812,HEY1,AEC,0.7554577289388229
GO_Biological_Process_2021,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/77,0.1756071809118701,0.2118031859951541,0,0,5.336734693877551,9.283280446293812,FAM107A,AEC,0.7554577289388229
GO_Biological_Process_2021,neutrophil migration (GO:1990266),1/77,0.1756071809118701,0.2118031859951541,0,0,5.336734693877551,9.283280446293812,EDN1,AEC,0.7554577289388229
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2185670491290701,0,0,5.133298889175924,8.751529842637671,PDGFB,AEC,0.7404090821369118
GO_Biological_Process_2021,negative regulation of cellular response to growth factor stimulus (GO:0090288),1/80,0.181798760490535,0.2185670491290701,0,0,5.133298889175924,8.751529842637671,FGF2,AEC,0.7404090821369118
GO_Biological_Process_2021,positive regulation of cytoskeleton organization (GO:0051495),1/82,0.1859011384602527,0.2220732898033959,0,0,5.00604686318972,8.422875391899517,EDN1,AEC,0.7307179505966239
GO_Biological_Process_2021,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.1859011384602527,0.2220732898033959,0,0,5.00604686318972,8.422875391899517,PDGFB,AEC,0.7307179505966239
GO_Biological_Process_2021,regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.1859011384602527,0.2220732898033959,0,0,5.00604686318972,8.422875391899517,EDN1,AEC,0.7307179505966239
GO_Biological_Process_2021,positive regulation of protein ubiquitination (GO:0031398),1/82,0.1859011384602527,0.2220732898033959,0,0,5.00604686318972,8.422875391899517,FAM107A,AEC,0.7307179505966239
GO_Biological_Process_2021,peptide metabolic process (GO:0006518),1/83,0.1879447615357932,0.2241570483922119,0,0,4.944748631159781,8.265677319811374,ACE,AEC,0.7259697745939766
GO_Biological_Process_2021,negative regulation of defense response (GO:0031348),1/85,0.1920169366451308,0.2286497385488124,0,0,4.826530612244898,7.964604221414354,CDH5,AEC,0.716660463134361
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",8/2244,0.193124009270605,0.2296029887994971,0,0,1.5089871368941137,2.481412794468422,MECOM;HEY1;SOX17;SOX18;PDGFB;HIF3A;FGF2;TBX3,AEC,0.7141637311633254
GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.196069097589664,0.2327349510216456,0,0,4.713811105837684,7.6801565438185,HIF3A,AEC,0.7075908500030543
GO_Biological_Process_2021,negative regulation of binding (GO:0051100),1/88,0.1980877029036425,0.2340184376574578,0,0,4.659394792399718,7.5437717166037235,PDGFB,AEC,0.703142484213379
GO_Biological_Process_2021,positive regulation of neuron projection development (GO:0010976),1/88,0.1980877029036425,0.2340184376574578,0,0,4.659394792399718,7.5437717166037235,NDRG4,AEC,0.703142484213379
GO_Biological_Process_2021,metal ion transport (GO:0030001),1/88,0.1980877029036425,0.2340184376574578,0,0,4.659394792399718,7.5437717166037235,RAMP2,AEC,0.703142484213379
GO_Biological_Process_2021,second-messenger-mediated signaling (GO:0019932),1/89,0.2001013407742902,0.2356539374841877,0,0,4.6062152133580705,7.411084001248333,EDN1,AEC,0.6987500013741589
GO_Biological_Process_2021,protein import (GO:0017038),1/89,0.2001013407742902,0.2356539374841877,0,0,4.6062152133580705,7.411084001248333,GPIHBP1,AEC,0.6987500013741589
GO_Biological_Process_2021,positive regulation of binding (GO:0051099),1/90,0.2021100231923967,0.2369020459641708,0,0,4.55423068103646,7.281955543769811,CLDN5,AEC,0.6944121480917811
GO_Biological_Process_2021,negative regulation of protein kinase activity (GO:0006469),1/90,0.2021100231923967,0.2369020459641708,0,0,4.55423068103646,7.281955543769811,PTPRB,AEC,0.6944121480917811
GO_Biological_Process_2021,sodium ion transport (GO:0006814),1/90,0.2021100231923967,0.2369020459641708,0,0,4.55423068103646,7.281955543769811,SLC5A4,AEC,0.6944121480917811
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),3/621,0.2024454460334983,0.2369244360610785,0,0,1.9966948977483991,3.1892904723776496,IFI27;PDGFB;FGF2,AEC,0.6936919881460838
GO_Biological_Process_2021,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.2041137620931186,0.2381327224419717,0,0,4.503401360544218,7.156255051106618,FAM107A,AEC,0.6901277125812961
GO_Biological_Process_2021,positive regulation of supramolecular fiber organization (GO:1902905),1/91,0.2041137620931186,0.2381327224419717,0,0,4.503401360544218,7.156255051106618,EDN1,AEC,0.6901277125812961
GO_Biological_Process_2021,positive regulation of cellular component biogenesis (GO:0044089),1/92,0.2061125694363157,0.2386063593629065,0,0,4.453689167974883,7.03385741012878,CDH5,AEC,0.6858955226779435
GO_Biological_Process_2021,negative regulation of mitotic cell cycle phase transition (GO:1901991),1/92,0.2061125694363157,0.2386063593629065,0,0,4.453689167974883,7.03385741012878,FAM107A,AEC,0.6858955226779435
GO_Biological_Process_2021,retinoid metabolic process (GO:0001523),1/92,0.2061125694363157,0.2386063593629065,0,0,4.453689167974883,7.03385741012878,GPIHBP1,AEC,0.6858955226779435
GO_Biological_Process_2021,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),1/92,0.2061125694363157,0.2386063593629065,0,0,4.453689167974883,7.03385741012878,CDH5,AEC,0.6858955226779435
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2386063593629065,0,0,4.453689167974883,7.03385741012878,PDGFB,AEC,0.6858955226779435
GO_Biological_Process_2021,negative regulation of cellular protein metabolic process (GO:0032269),1/94,0.2100954368002021,0.2424676150436847,0,0,4.357472021066491,6.79849904676328,EDN1,AEC,0.6775833802166729
GO_Biological_Process_2021,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.2424676150436847,0,0,4.357472021066491,6.79849904676328,TIE1,AEC,0.6775833802166729
GO_Biological_Process_2021,regulation of vesicle-mediated transport (GO:0060627),1/96,0.2140587201245348,0.2466615098050408,0,0,4.26530612244898,6.5749903239841245,CDH13,AEC,0.6694670755856718
GO_Biological_Process_2021,positive regulation of cell growth (GO:0030307),1/102,0.2258320069783284,0.2590324245432894,0,0,4.010709234188725,5.967790506031058,EDN1,AEC,0.6462145058611213
GO_Biological_Process_2021,regulation of cell death (GO:0010941),1/102,0.2258320069783284,0.2590324245432894,0,0,4.010709234188725,5.967790506031058,FGF2,AEC,0.6462145058611213
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2590324245432894,0,0,4.010709234188725,5.967790506031058,EDN1,AEC,0.6462145058611213
GO_Biological_Process_2021,regulation of insulin secretion (GO:0050796),1/104,0.2297178930745814,0.2630867001725711,0,0,3.932435109966317,5.78423168094792,ADRA2C,AEC,0.6388051756325536
GO_Biological_Process_2021,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.2644948056380997,0,0,3.894427001569859,5.6956456810845415,PDGFB,AEC,0.6351608308934773
GO_Biological_Process_2021,regulation of JNK cascade (GO:0046328),1/105,0.2316536615468536,0.2644948056380997,0,0,3.894427001569859,5.6956456810845415,MECOM,AEC,0.6351608308934773
GO_Biological_Process_2021,small GTPase mediated signal transduction (GO:0007264),1/106,0.2335846623503299,0.2662936257235876,0,0,3.857142857142857,5.6090983677319475,FGF2,AEC,0.6315556772929499
GO_Biological_Process_2021,protein transport (GO:0015031),2/369,0.2354374823833979,0.2679979852662083,0,0,2.2233197093551316,3.215609236148146,RAMP2;GPIHBP1,AEC,0.6281243949487266
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.2696960367192917,0,0,2.2110433604336044,3.18053102486219,PDGFB;FGF2,AEC,0.6247218387200065
GO_Biological_Process_2021,regulation of protein ubiquitination (GO:0031396),1/109,0.239349173739861,0.271625047168418,0,0,3.749433106575964,5.361058744932435,FAM107A,AEC,0.6209680674126086
GO_Biological_Process_2021,protein-containing complex subunit organization (GO:0043933),1/112,0.2450711886958998,0.2768602116639954,0,0,3.647545504688362,5.129202360192396,SLC9A3R2,AEC,0.6107077427090284
GO_Biological_Process_2021,regulation of cytoskeleton organization (GO:0051493),1/112,0.2450711886958998,0.2768602116639954,0,0,3.647545504688362,5.129202360192396,FAM107A,AEC,0.6107077427090284
GO_Biological_Process_2021,phosphatidylinositol metabolic process (GO:0046488),1/112,0.2450711886958998,0.2768602116639954,0,0,3.647545504688362,5.129202360192396,FGF2,AEC,0.6107077427090284
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),2/381,0.2465612635256485,0.2781240758745643,0,0,2.15160510114336,3.012558657024939,MECOM;TBX3,AEC,0.6080751530383309
GO_Biological_Process_2021,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.2794571866360746,0,0,3.582625970742279,4.982913653406146,CLDN5,AEC,0.6040407011916724
GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.2794571866360746,0,0,3.582625970742279,4.982913653406146,CDH5,AEC,0.6040407011916724
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.2794571866360746,0,0,3.582625970742279,4.982913653406146,TIE1,AEC,0.6040407011916724
GO_Biological_Process_2021,calcium ion transport (GO:0006816),1/115,0.2507510141385882,0.2811564514817404,0,0,3.5510204081632653,4.9121080927455,RAMP2,AEC,0.6007573018413346
GO_Biological_Process_2021,regulation of protein-containing complex assembly (GO:0043254),1/116,0.2526349665899778,0.2828454259729349,0,0,3.5199645075421473,4.8428011439058265,CDH5,AEC,0.5975065399797567
GO_Biological_Process_2021,positive regulation of cell projection organization (GO:0031346),1/117,0.2545142764118688,0.2845241687052086,0,0,3.4894440534834623,4.774949480472317,NDRG4,AEC,0.5942878518616017
GO_Biological_Process_2021,positive regulation of protein-containing complex assembly (GO:0031334),1/118,0.2563889548341396,0.2861927379594196,0,0,3.4594453165881736,4.708511372057024,CDH5,AEC,0.5911006880374128
GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.2656932663769877,0.2961372864826842,0,0,3.316828370692539,4.396166676729281,FGF2,AEC,0.5756194520344882
GO_Biological_Process_2021,defense response to symbiont (GO:0140546),1/124,0.2675403902734135,0.2977529752077068,0,0,3.2896963663514187,4.337414433160371,IFI27,AEC,0.5726106437410472
GO_Biological_Process_2021,regulation of phosphorylation (GO:0042325),1/125,0.2693829605231016,0.2984731322955667,0,0,3.263001974983542,4.279822783786303,CDH5,AEC,0.5696298784899082
GO_Biological_Process_2021,platelet degranulation (GO:0002576),1/125,0.2693829605231016,0.2984731322955667,0,0,3.263001974983542,4.279822783786303,PDGFB,AEC,0.5696298784899082
GO_Biological_Process_2021,regulation of protein secretion (GO:0050708),1/125,0.2693829605231016,0.2984731322955667,0,0,3.263001974983542,4.279822783786303,ADRA2C,AEC,0.5696298784899082
GO_Biological_Process_2021,phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.2712209880572274,0.3000657607900491,0,0,3.236734693877551,4.223360488574632,FGF2,AEC,0.5666767062328689
GO_Biological_Process_2021,cellular response to hypoxia (GO:0071456),1/131,0.2803433684983951,0.30970085988982,0,0,3.111459968602826,3.956968446025251,HIF3A,AEC,0.5523097126477655
GO_Biological_Process_2021,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3127745838295249,0,0,3.0640074211502784,3.857336278341556,FGF2,AEC,0.546741450090894
GO_Biological_Process_2021,defense response to virus (GO:0051607),1/133,0.2839609038772722,0.3127745838295249,0,0,3.0640074211502784,3.857336278341556,IFI27,AEC,0.546741450090894
GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3177800711964795,0,0,2.99546485260771,3.714691124222948,RAMP2,AEC,0.5385707850387818
GO_Biological_Process_2021,organic substance transport (GO:0071702),1/136,0.289353816496661,0.3177800711964795,0,0,2.99546485260771,3.714691124222948,RAMP2,AEC,0.5385707850387818
GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3192764306102524,0,0,2.9732893157262907,3.668866926816198,RAMP2,AEC,0.5358942544628899
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),2/430,0.2921183511246394,0.3198781359537352,0,0,1.900506230529595,2.3387558342335666,SOX17;SOX18,AEC,0.5344411594186865
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3217718392879825,0,0,2.929902395740905,3.579678317757992,PDGFB,AEC,0.5306096689947516
GO_Biological_Process_2021,protein dephosphorylation (GO:0006470),1/139,0.2947069182263764,0.3217718392879825,0,0,2.929902395740905,3.579678317757992,PTPRB,AEC,0.5306096689947516
GO_Biological_Process_2021,chromatin organization (GO:0006325),1/142,0.3000204969826995,0.3270965825910363,0,0,2.8671298306556667,3.4517504575709377,MECOM,AEC,0.522849073872343
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3285398755741973,0,0,2.8467950560505892,3.410594866305226,RAMP2,AEC,0.5203052911363482
GO_Biological_Process_2021,nervous system development (GO:0007399),2/447,0.3078904676985005,0.334702409733203,0,0,1.826310861423221,2.1514146195112085,FGF2;TBX3,AEC,0.5116037566636256
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.3087894082520855,0.3351931402620465,0,0,2.7682415431926195,3.252948903166252,EDN1,AEC,0.5103376047629952
GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3361085838857268,0,0,2.749271137026239,3.215201203875706,ABLIM3,AEC,0.5078961191737069
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3361085838857268,0,0,2.749271137026239,3.215201203875706,TIE1,AEC,0.5078961191737069
GO_Biological_Process_2021,brain development (GO:0007420),1/150,0.3139989845586295,0.3383960279631849,0,0,2.712094233666621,3.141596466170354,NDRG4,AEC,0.5030717563895143
GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),1/150,0.3139989845586295,0.3383960279631849,0,0,2.712094233666621,3.141596466170354,BTNL9,AEC,0.5030717563895143
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3383960279631849,0,0,2.712094233666621,3.141596466170354,PDGFB,AEC,0.5030717563895143
GO_Biological_Process_2021,dephosphorylation (GO:0016311),1/153,0.3191700762858281,0.3434746941639156,0,0,2.6581632653061225,3.0357052873752,PTPRB,AEC,0.4959778325880012
GO_Biological_Process_2021,regulation of cell differentiation (GO:0045595),1/156,0.3243029619756543,0.3479984506013826,0,0,2.6063199473337724,2.934917292064671,HEY1,AEC,0.4890490847411261
GO_Biological_Process_2021,peptidyl-serine phosphorylation (GO:0018105),1/156,0.3243029619756543,0.3479984506013826,0,0,2.6063199473337724,2.934917292064671,PDGFB,AEC,0.4890490847411261
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),2/468,0.3272907950685003,0.3501428585514821,0,0,1.742131616595136,1.9457976416065603,SOX17;SOX18,AEC,0.48506620889050567
GO_Biological_Process_2021,skeletal system development (GO:0001501),1/158,0.3277037968552589,0.3501428585514821,0,0,2.5728584427401535,2.8703970097526006,TBX3,AEC,0.48451852674781976
GO_Biological_Process_2021,T cell receptor signaling pathway (GO:0050852),1/158,0.3277037968552589,0.3501428585514821,0,0,2.5728584427401535,2.8703970097526006,BTNL9,AEC,0.48451852674781976
GO_Biological_Process_2021,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/165,0.3394751386404204,0.3611745438091973,0,0,2.4621702339472376,2.6600168495918335,SOX17,AEC,0.46919202564454415
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.3611745438091973,0,0,2.4621702339472376,2.6600168495918335,RAMP2,AEC,0.46919202564454415
GO_Biological_Process_2021,regulation of neuron projection development (GO:0010975),1/165,0.3394751386404204,0.3611745438091973,0,0,2.4621702339472376,2.6600168495918335,NDRG4,AEC,0.46919202564454415
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),2/488,0.3456467916703843,0.3671910772709388,0,0,1.668724279835391,1.7727489781212855,PTPRB;ACE,AEC,0.4613674699295729
GO_Biological_Process_2021,peptidyl-serine modification (GO:0018209),1/169,0.3461106816465725,0.3671910772709388,0,0,2.403061224489796,2.5496399471999527,PDGFB,AEC,0.4607849973294511
GO_Biological_Process_2021,cation transport (GO:0006812),1/174,0.3543133002736421,0.3753616151413832,0,0,2.333018756635602,2.4206789693623425,SLC5A4,AEC,0.45061254473982715
GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),1/177,0.359186378521905,0.3794507722325907,0,0,2.2929035250463823,2.3477357103628296,PDGFB,AEC,0.44468014150624274
GO_Biological_Process_2021,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.359186378521905,0.3794507722325907,0,0,2.2929035250463823,2.3477357103628296,FGF2,AEC,0.44468014150624274
GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.3806214550419627,0,0,2.279833967485299,2.3241173885161555,RAMP2,AEC,0.44273020383203454
GO_Biological_Process_2021,regulation of immune response (GO:0050776),1/179,0.3624150547196057,0.3817846357032133,0,0,2.266911258885577,2.300835957547096,CD300LG,AEC,0.4407937700298507
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.3829403559585977,0,0,2.2541329380914377,2.2778849681371156,PDGFB,AEC,0.4388706874182523
GO_Biological_Process_2021,antigen receptor-mediated signaling pathway (GO:0050851),1/185,0.3720057294778557,0.3907886274599074,0,0,2.192324755989352,2.1678716160963645,BTNL9,AEC,0.4294503712432232
GO_Biological_Process_2021,negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.3814549819175133,0.4001537555409208,0,0,2.122448979591837,2.045536603225051,SOX17,AEC,0.41855670871419515
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4044885085700879,0,0,2.089140319340171,1.988001678572607,MECOM,AEC,0.4132695879859197
GO_Biological_Process_2021,generation of neurons (GO:0048699),1/202,0.398418067592006,0.4167809114894029,0,0,2.0051781906792567,1.8452720554356252,HEY1,AEC,0.39966097527446726
GO_Biological_Process_2021,axon guidance (GO:0007411),1/203,0.3999373645428959,0.4177867308823277,0,0,1.9951505354617096,1.8284503867148747,SEMA3G,AEC,0.398008019580524
GO_Biological_Process_2021,proteasomal protein catabolic process (GO:0010498),1/205,0.4029646862685204,0.4203628830294176,0,0,1.975390156062425,1.7954446526222323,IFI27,AEC,0.3947330115033212
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),1/206,0.4044727291727134,0.4213491990964705,0,0,1.9656545545047288,1.7792534267442264,CDH5,AEC,0.39311075456855427
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4300954681546928,0,0,1.909178837411742,1.6862551884518755,PTPRB,AEC,0.3835844547796231
GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4325744440671871,0,0,1.8910606496119575,1.656759537391559,HEY1,AEC,0.3804856946694876
GO_Biological_Process_2021,cilium organization (GO:0044782),1/228,0.4367210295579323,0.4530527024084367,0,0,1.7731727052054302,1.469003836799846,ABLIM3,AEC,0.359795894863476
GO_Biological_Process_2021,apoptotic process (GO:0006915),1/231,0.4409837467017168,0.4568420833742544,0,0,1.749778172138421,1.4326260836369302,IFI27,AEC,0.35557741698984124
GO_Biological_Process_2021,axonogenesis (GO:0007409),1/240,0.4535831041409784,0.4692455041458465,0,0,1.6831184356587825,1.3306343458644796,SEMA3G,AEC,0.34334313117644527
GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.4618276248188864,0.4771157117094426,0,0,1.641399416909621,1.2680853834334544,EDN1,AEC,0.33552009275365935
GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.4862229769145779,0,0,1.5952380952380951,1.2000608149186214,SOX17,AEC,0.32670971902140344
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),3/1025,0.4760222919123325,0.4904273681462682,0,0,1.1821626348003498,0.8775082045072261,PTPRB;PDGFB;HIF3A,AEC,0.3223727089857482
GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),1/258,0.4779525975371456,0.4917396916968709,0,0,1.563805288652426,1.154469433244659,ADRA2C,AEC,0.3206151737830371
GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5031704578969798,0,0,1.510204081632653,1.0781219104526054,SLC9A3R2,AEC,0.3100391544580995
GO_Biological_Process_2021,proteolysis (GO:0006508),1/287,0.51499186851511,0.5283957664627636,0,0,1.4031682603111175,0.9311483055746664,ACE,AEC,0.28819962821492023
GO_Biological_Process_2021,innate immune response (GO:0045087),1/302,0.5331267023920349,0.5462543092908811,0,0,1.3322259136212624,0.8379649939237771,IFI27,AEC,0.2731695646873957
GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),1/314,0.5471545986718139,0.5590979459825219,0,0,1.2803677381495728,0.7720923294539072,IFI27,AEC,0.26188994631047774
GO_Biological_Process_2021,cilium assembly (GO:0060271),1/314,0.5471545986718139,0.5590979459825219,0,0,1.2803677381495728,0.7720923294539072,ABLIM3,AEC,0.26188994631047774
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.5551458962416416,0.5664908396253263,0,0,1.2519132653061225,0.7367814077584223,IFI27,AEC,0.25559286623594474
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5680208399096975,0,0,1.2440106477373558,0.7270814983759607,PDGFB,AEC,0.2538302089398956
GO_Biological_Process_2021,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.574073552332221,0,0,1.2208810353409656,0.6989624697257846,GPIHBP1,AEC,0.24863646405532092
GO_Biological_Process_2021,intracellular protein transport (GO:0006886),1/336,0.5718075736459911,0.5811178733525744,0,0,1.1949436491014316,0.6679170434332091,GPIHBP1,AEC,0.2427500966679934
GO_Biological_Process_2021,post-translational protein modification (GO:0043687),1/345,0.5815093765862647,0.5901768605191222,0,0,1.1631466540104414,0.6305745813190116,HIF3A,AEC,0.23544327806907975
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.5909956578792304,0.5989928927625758,0,0,1.1329710354396716,0.5958822738188654,IFI27,AEC,0.22841570992418872
GO_Biological_Process_2021,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6440237755384125,0,0,1.0,0.4521084323403523,PDGFB,AEC,0.19634819738734471
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),1/409,0.644552703427983,0.6515114370682312,0,0,0.9774909963985594,0.4293127610136149,HIF3A,AEC,0.19074156570833578
GO_Biological_Process_2021,organelle assembly (GO:0070925),1/425,0.658798168385351,0.6650132454455903,0,0,0.939834424335772,0.3922286762298742,ABLIM3,AEC,0.18124761694193237
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),1/481,0.7043872370804651,0.7098833513301157,0,0,0.8278061224489796,0.2900856337670249,PTPRB,AEC,0.15218852169360617
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7098833513301157,0,0,0.8260426831855403,0.2885801301950252,FGF2,AEC,0.1517218912312197
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7102496011953678,0,0,0.8207960870298533,0.2841203737887477,TBX3,AEC,0.15033199168778996
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),1/485,0.7074048097353064,0.7102496011953678,0,0,0.8207960870298533,0.2841203737887477,PTPRB,AEC,0.15033199168778996
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7174641313352876,0,0,0.8021026592455164,0.2684686706444305,PDGFB,AEC,0.1453610219101508
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.7369517366282775,0,0,0.7565820221218258,0.231944503707841,HIF3A,AEC,0.13314117322745964
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8493267155112211,0,0,0.5290423861852434,0.0863986224716518,TBX3,AEC,0.07092521499844862
GO_Biological_Process_2021,positive regulation of neuron projection development (GO:0010976),4/88,6.904073911723393e-05,0.0263900933118077,0,0,20.565217391304348,197.03151869795084,WNT5A;STMN2;PTN;EPHA3,APOD+ MSC,4.1608945679183105
GO_Biological_Process_2021,negative regulation of actin filament depolymerization (GO:0030835),2/6,9.128927051395768e-05,0.0263900933118077,0,0,207.77083333333337,1932.5756890799971,PLEKHH2;GSN,APOD+ MSC,4.039580263324499
GO_Biological_Process_2021,sulfur compound catabolic process (GO:0044273),3/40,0.00013608554044552048,0.0263900933118077,0,0,34.35250143760782,305.8137622456798,LUM;PRELP;DCN,APOD+ MSC,3.8661880176205408
GO_Biological_Process_2021,negative regulation of neural precursor cell proliferation (GO:2000178),2/8,0.0001698630098259154,0.0263900933118077,0,0,138.5,1202.2517804391236,WNT5A;PTN,APOD+ MSC,3.7699011848597213
GO_Biological_Process_2021,positive regulation of cell projection organization (GO:0031346),4/117,0.00020812376428870505,0.0263900933118077,0,0,15.26510196229319,129.40803396501394,WNT5A;STMN2;PTN;EPHA3,APOD+ MSC,3.681678327716283
GO_Biological_Process_2021,glycosaminoglycan catabolic process (GO:0006027),3/56,0.0003712232496723555,0.0360329826452049,0,0,23.962665596146127,189.274072690484,LUM;PRELP;DCN,APOD+ MSC,3.430364831784506
GO_Biological_Process_2021,keratan sulfate catabolic process (GO:0042340),2/12,0.0003978405023918531,0.0360329826452049,0,0,83.08333333333333,650.4975835514635,LUM;PRELP,APOD+ MSC,3.4002910053496507
GO_Biological_Process_2021,regulation of neuron projection development (GO:0010975),4/165,0.0007654381829128567,0.0567890867628365,0,0,10.688090737240076,76.68771477009875,WNT5A;STMN2;PTN;EPHA3,APOD+ MSC,3.1160898773417935
GO_Biological_Process_2021,regulation of cell killing (GO:0031341),2/17,0.0008132713373134499,0.0567890867628365,0,0,55.375,393.96243373102385,CFH;WNT5A,APOD+ MSC,3.089764533572175
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),5/300,0.0008957269205494731,0.0567890867628365,0,0,7.4030131826742,51.953420899616845,GSN;LAMA2;LUM;SERPINE1;DCN,APOD+ MSC,3.047824373122375
GO_Biological_Process_2021,ephrin receptor signaling pathway (GO:0048013),3/82,0.0011330918930874,0.0653072963834041,0,0,16.055211419337464,108.89937140961504,DNM1;EPHA3;ANKS1B,APOD+ MSC,2.9457348676807733
GO_Biological_Process_2021,regulation of endothelial cell migration (GO:0010594),3/89,0.0014352931477222,0.0741141780344629,0,0,14.743196437407224,96.51465720793364,WNT5A;PTN;DCN,APOD+ MSC,2.8430593885216617
GO_Biological_Process_2021,negative regulation of protein depolymerization (GO:1901880),2/24,0.0016321249773357,0.0741141780344629,0,0,37.74242424242424,242.22606459531664,PLEKHH2;STMN2,APOD+ MSC,2.7872465889099036
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),4/203,0.0016472867079228,0.0741141780344629,0,0,8.630544024470177,55.30992679300502,GPNMB;WNT5A;SERPINE1;DCN,APOD+ MSC,2.783230805910833
GO_Biological_Process_2021,glycosaminoglycan biosynthetic process (GO:0006024),3/97,0.001837512611877,0.0741141780344629,0,0,13.483023992756904,84.93418557118899,LUM;PRELP;DCN,APOD+ MSC,2.735769671427555
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),4/216,0.002065697356164,0.0741141780344629,0,0,8.095980311730926,50.05167712719815,LAMA2;LUM;SERPINE1;DCN,APOD+ MSC,2.6849333063284138
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),4/217,0.002100649710268,0.0741141780344629,0,0,8.057562767911818,49.678972510470935,LAMA2;LUM;SERPINE1;DCN,APOD+ MSC,2.677646361483123
GO_Biological_Process_2021,keratan sulfate biosynthetic process (GO:0018146),2/28,0.0022210873543451,0.0741141780344629,0,0,31.92948717948718,195.08145262248803,LUM;PRELP,APOD+ MSC,2.6534343605132076
GO_Biological_Process_2021,protein depolymerization (GO:0051261),2/28,0.0022210873543451,0.0741141780344629,0,0,31.92948717948718,195.08145262248803,GSN;STMN2,APOD+ MSC,2.6534343605132076
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),5/379,0.0025046631439755,0.0793978216640235,0,0,5.815805109922757,34.83435225893759,GPNMB;WNT5A;FBLN1;APOD;IGFBP6,APOD+ MSC,2.601250674806674
GO_Biological_Process_2021,sulfur compound biosynthetic process (GO:0044272),3/113,0.0028374324702645,0.0834551812907728,0,0,11.512572533849127,67.51957659481218,LUM;PRELP;DCN,APOD+ MSC,2.5470744657073614
GO_Biological_Process_2021,negative regulation of cell-matrix adhesion (GO:0001953),2/32,0.0028959211173454,0.0834551812907728,0,0,27.666666666666668,161.69650653172428,SERPINE1;APOD,APOD+ MSC,2.5382132721600397
GO_Biological_Process_2021,keratan sulfate metabolic process (GO:0042339),2/33,0.0030778471463162,0.0848415256854135,0,0,26.772849462365592,154.84144163978604,LUM;PRELP,APOD+ MSC,2.511752952132796
GO_Biological_Process_2021,regulation of ossification (GO:0030278),2/36,0.0036549257227984,0.0953997618195326,0,0,24.40686274509804,136.96349152286243,WNT5A;PTN,APOD+ MSC,2.437121444562911
GO_Biological_Process_2021,regulation of microtubule cytoskeleton organization (GO:0070507),2/37,0.0038576315924392,0.0953997618195326,0,0,23.708333333333332,131.76384828572083,STMN2;EPHA3,APOD+ MSC,2.4136792502562754
GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),4/258,0.0039122930714634,0.0953997618195326,0,0,6.742896268401233,37.38013292071673,TMEM100;PTN;TP63;MEDAG,APOD+ MSC,2.4075686194897616
GO_Biological_Process_2021,positive regulation of ossification (GO:0045778),2/40,0.0044964248068071,0.105582715833916,0,0,21.833333333333332,117.99765363023796,WNT5A;PTN,APOD+ MSC,2.3471326648462743
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),3/139,0.0050722381718543,0.1132606274900132,0,0,9.299436795994994,49.137973919606814,WNT5A;SERPINE1;PTN,APOD+ MSC,2.294800361929647
GO_Biological_Process_2021,cellular response to retinoic acid (GO:0071300),2/43,0.0051806911627924,0.1132606274900132,0,0,20.232723577235777,106.48111760263689,WNT5A;EPHA3,APOD+ MSC,2.2856122965939503
GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),3/158,0.0072257561149995,0.1335503921619794,0,0,8.151681537405628,40.18863284587075,TMEM100;WNT5A;STMN2,APOD+ MSC,2.1411167009049183
GO_Biological_Process_2021,positive regulation of leukocyte chemotaxis (GO:0002690),2/54,0.0080676700842631,0.1335503921619794,0,0,15.943910256410255,76.8479024006269,SERPINE1;PTN,APOD+ MSC,2.0932518699428635
GO_Biological_Process_2021,regulation of focal adhesion assembly (GO:0051893),2/54,0.0080676700842631,0.1335503921619794,0,0,15.943910256410255,76.8479024006269,APOD;EPHA3,APOD+ MSC,2.0932518699428635
GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),3/177,0.0098484301051983,0.1335503921619794,0,0,7.254585473220836,33.51940023959328,WNT5A;PTN;DCN,APOD+ MSC,2.0066329929529223
GO_Biological_Process_2021,response to retinoic acid (GO:0032526),2/62,0.0105265894654256,0.1335503921619794,0,0,13.8125,62.9000654557375,WNT5A;EPHA3,APOD+ MSC,1.977712314119832
GO_Biological_Process_2021,negative regulation of plasminogen activation (GO:0010757),1/5,0.0124387771927725,0.1335503921619794,0,0,101.76530612244898,446.4379351400606,SERPINE1,APOD+ MSC,1.9052223113279663
GO_Biological_Process_2021,positive regulation of mitochondrial depolarization (GO:0051901),1/5,0.0124387771927725,0.1335503921619794,0,0,101.76530612244898,446.4379351400606,DCN,APOD+ MSC,1.9052223113279663
GO_Biological_Process_2021,negative regulation of T cell migration (GO:2000405),1/5,0.0124387771927725,0.1335503921619794,0,0,101.76530612244898,446.4379351400606,APOD,APOD+ MSC,1.9052223113279663
GO_Biological_Process_2021,positive regulation of protein kinase C activity (GO:1900020),1/5,0.0124387771927725,0.1335503921619794,0,0,101.76530612244898,446.4379351400606,WNT5A,APOD+ MSC,1.9052223113279663
GO_Biological_Process_2021,positive regulation of protein localization to synapse (GO:1902474),1/5,0.0124387771927725,0.1335503921619794,0,0,101.76530612244898,446.4379351400606,WNT5A,APOD+ MSC,1.9052223113279663
GO_Biological_Process_2021,regulation of mRNA binding (GO:1902415),1/5,0.0124387771927725,0.1335503921619794,0,0,101.76530612244898,446.4379351400606,LARP6,APOD+ MSC,1.9052223113279663
GO_Biological_Process_2021,postsynaptic endocytosis (GO:0140239),1/5,0.0124387771927725,0.1335503921619794,0,0,101.76530612244898,446.4379351400606,DNM1,APOD+ MSC,1.9052223113279663
GO_Biological_Process_2021,postsynaptic neurotransmitter receptor internalization (GO:0098884),1/5,0.0124387771927725,0.1335503921619794,0,0,101.76530612244898,446.4379351400606,DNM1,APOD+ MSC,1.9052223113279663
GO_Biological_Process_2021,regulation of plasma membrane organization (GO:1903729),1/5,0.0124387771927725,0.1335503921619794,0,0,101.76530612244898,446.4379351400606,GSN,APOD+ MSC,1.9052223113279663
GO_Biological_Process_2021,regulation of protein kinase C activity (GO:1900019),1/5,0.0124387771927725,0.1335503921619794,0,0,101.76530612244898,446.4379351400606,WNT5A,APOD+ MSC,1.9052223113279663
GO_Biological_Process_2021,wound healing (GO:0042060),2/70,0.013274200561286,0.1335503921619794,0,0,12.182598039215684,52.65237170003471,WNT5A;PPL,APOD+ MSC,1.8769916248436092
GO_Biological_Process_2021,negative regulation of supramolecular fiber organization (GO:1902904),2/72,0.0140048037295852,0.1335503921619794,0,0,11.833333333333334,50.50886613536219,PLEKHH2;STMN2,APOD+ MSC,1.8537229732206628
GO_Biological_Process_2021,axon guidance (GO:0007411),3/203,0.0142323787832344,0.1335503921619794,0,0,6.303191489361702,26.80265596371328,LAMA2;WNT5A;EPHA3,APOD+ MSC,1.8467225063744226
GO_Biological_Process_2021,negative regulation of cell adhesion (GO:0007162),2/73,0.0143765335552059,0.1335503921619794,0,0,11.666079812206572,49.48935398933624,SERPINE1;FBLN1,APOD+ MSC,1.8423458176616205
GO_Biological_Process_2021,leukocyte chemotaxis involved in inflammatory response (GO:0002232),1/6,0.0149082847993736,0.1335503921619794,0,0,81.40816326530613,342.3895623444841,PTN,APOD+ MSC,1.8265723193247598
GO_Biological_Process_2021,regulation of hepatocyte proliferation (GO:2000345),1/6,0.0149082847993736,0.1335503921619794,0,0,81.40816326530613,342.3895623444841,PTN,APOD+ MSC,1.8265723193247598
GO_Biological_Process_2021,regulation of keratinocyte apoptotic process (GO:1902172),1/6,0.0149082847993736,0.1335503921619794,0,0,81.40816326530613,342.3895623444841,GSN,APOD+ MSC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of RNA binding (GO:1905216),1/6,0.0149082847993736,0.1335503921619794,0,0,81.40816326530613,342.3895623444841,LARP6,APOD+ MSC,1.8265723193247598
GO_Biological_Process_2021,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,0.0149082847993736,0.1335503921619794,0,0,81.40816326530613,342.3895623444841,PTN,APOD+ MSC,1.8265723193247598
GO_Biological_Process_2021,integrin-mediated signaling pathway (GO:0007229),2/75,0.0151327357621299,0.1335503921619794,0,0,11.345319634703197,47.54704276850611,FBLN1;PTN,APOD+ MSC,1.820082551223806
GO_Biological_Process_2021,response to interferon-gamma (GO:0034341),2/80,0.0170965192165363,0.1335503921619794,0,0,10.615384615384617,43.19273030214829,CCL13;WNT5A,APOD+ MSC,1.7670923012410087
GO_Biological_Process_2021,regulation of fat cell differentiation (GO:0045598),2/80,0.0170965192165363,0.1335503921619794,0,0,10.615384615384617,43.19273030214829,WNT5A;MEDAG,APOD+ MSC,1.7670923012410087
GO_Biological_Process_2021,skin development (GO:0043588),2/80,0.0170965192165363,0.1335503921619794,0,0,10.615384615384617,43.19273030214829,WNT5A;TP63,APOD+ MSC,1.7670923012410087
GO_Biological_Process_2021,positive regulation of fibroblast apoptotic process (GO:2000271),1/7,0.0173717414502839,0.1335503921619794,0,0,67.83673469387755,274.9362107684438,TP63,APOD+ MSC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of membrane depolarization (GO:1904181),1/7,0.0173717414502839,0.1335503921619794,0,0,67.83673469387755,274.9362107684438,DCN,APOD+ MSC,1.7601566430186848
GO_Biological_Process_2021,negative regulation of protein import (GO:1904590),1/7,0.0173717414502839,0.1335503921619794,0,0,67.83673469387755,274.9362107684438,APOD,APOD+ MSC,1.7601566430186848
GO_Biological_Process_2021,negative regulation of protein import into nucleus (GO:0042308),1/7,0.0173717414502839,0.1335503921619794,0,0,67.83673469387755,274.9362107684438,APOD,APOD+ MSC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of mRNA binding (GO:1902416),1/7,0.0173717414502839,0.1335503921619794,0,0,67.83673469387755,274.9362107684438,LARP6,APOD+ MSC,1.7601566430186848
GO_Biological_Process_2021,synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),1/7,0.0173717414502839,0.1335503921619794,0,0,67.83673469387755,274.9362107684438,DNM1,APOD+ MSC,1.7601566430186848
GO_Biological_Process_2021,neuron projection arborization (GO:0140058),1/7,0.0173717414502839,0.1335503921619794,0,0,67.83673469387755,274.9362107684438,PTN,APOD+ MSC,1.7601566430186848
GO_Biological_Process_2021,dendrite arborization (GO:0140059),1/7,0.0173717414502839,0.1335503921619794,0,0,67.83673469387755,274.9362107684438,PTN,APOD+ MSC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of type I interferon-mediated signaling pathway (GO:0060340),1/7,0.0173717414502839,0.1335503921619794,0,0,67.83673469387755,274.9362107684438,WNT5A,APOD+ MSC,1.7601566430186848
GO_Biological_Process_2021,cellular response to lipid (GO:0071396),3/219,0.0174000582463563,0.1335503921619794,0,0,5.831560283687943,23.625293607147455,WNT5A;SERPINE1;EPHA3,APOD+ MSC,1.7594492979226422
GO_Biological_Process_2021,regulation of neuron death (GO:1901214),2/86,0.0195880530452788,0.1335503921619794,0,0,9.854166666666666,38.754815869716495,GPNMB;WNT5A,APOD+ MSC,1.7080087285643422
GO_Biological_Process_2021,actin filament reorganization (GO:0090527),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,GSN,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,excitatory synapse assembly (GO:1904861),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,WNT5A,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,forebrain neuron development (GO:0021884),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,WNT5A,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,GSN,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,regulation of vascular wound healing (GO:0061043),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,SERPINE1,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,negative regulation of long-term synaptic potentiation (GO:1900272),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,PTN,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,positive regulation of neuron projection arborization (GO:0150012),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,WNT5A,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,positive regulation of oligodendrocyte differentiation (GO:0048714),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,PTN,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,synaptic vesicle budding (GO:0070142),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,DNM1,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,postsynapse organization (GO:0099173),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,WNT5A,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,dynamin family protein polymerization involved in membrane fission (GO:0003373),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,DNM1,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1/8,0.0198291614511851,0.1335503921619794,0,0,58.142857142857146,227.9549801512961,DNM1,APOD+ MSC,1.702695651141308
GO_Biological_Process_2021,negative regulation of angiogenesis (GO:0016525),2/87,0.0200173181098975,0.1335503921619794,0,0,9.737745098039216,38.08585452607372,SERPINE1;DCN,APOD+ MSC,1.6985941090791523
GO_Biological_Process_2021,positive regulation of inflammatory response (GO:0050729),2/89,0.0208876608034354,0.1335503921619794,0,0,9.512931034482758,36.80169347929862,WNT5A;SERPINE1,APOD+ MSC,1.6801101936742149
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),3/238,0.0216346238036121,0.1335503921619794,0,0,5.354911724762336,20.527841473575418,CCL13;GPNMB;FBLN1,APOD+ MSC,1.6648506521840387
GO_Biological_Process_2021,axonogenesis (GO:0007409),3/240,0.022110403168695,0.1335503921619794,0,0,5.3091839482897925,20.237053883333378,LAMA2;WNT5A;EPHA3,APOD+ MSC,1.6554033382741515
GO_Biological_Process_2021,epithelial cell apoptotic process (GO:1904019),1/9,0.0222805591236868,0.1335503921619794,0,0,50.87244897959184,193.52086993316271,GSN,APOD+ MSC,1.652073914876897
GO_Biological_Process_2021,actin-mediated cell contraction (GO:0070252),1/9,0.0222805591236868,0.1335503921619794,0,0,50.87244897959184,193.52086993316271,GSN,APOD+ MSC,1.652073914876897
GO_Biological_Process_2021,negative regulation of exocytosis (GO:0045920),1/9,0.0222805591236868,0.1335503921619794,0,0,50.87244897959184,193.52086993316271,STXBP6,APOD+ MSC,1.652073914876897
GO_Biological_Process_2021,negative regulation of fibrinolysis (GO:0051918),1/9,0.0222805591236868,0.1335503921619794,0,0,50.87244897959184,193.52086993316271,SERPINE1,APOD+ MSC,1.652073914876897
GO_Biological_Process_2021,axon regeneration (GO:0031103),1/9,0.0222805591236868,0.1335503921619794,0,0,50.87244897959184,193.52086993316271,APOD,APOD+ MSC,1.652073914876897
GO_Biological_Process_2021,regulation of complement-dependent cytotoxicity (GO:1903659),1/9,0.0222805591236868,0.1335503921619794,0,0,50.87244897959184,193.52086993316271,CFH,APOD+ MSC,1.652073914876897
GO_Biological_Process_2021,positive regulation of macrophage cytokine production (GO:0060907),1/9,0.0222805591236868,0.1335503921619794,0,0,50.87244897959184,193.52086993316271,WNT5A,APOD+ MSC,1.652073914876897
GO_Biological_Process_2021,regulation of endothelial cell differentiation (GO:0045601),1/9,0.0222805591236868,0.1335503921619794,0,0,50.87244897959184,193.52086993316271,TMEM100,APOD+ MSC,1.652073914876897
GO_Biological_Process_2021,regulation of fibroblast apoptotic process (GO:2000269),1/9,0.0222805591236868,0.1335503921619794,0,0,50.87244897959184,193.52086993316271,TP63,APOD+ MSC,1.652073914876897
GO_Biological_Process_2021,positive regulation of protein kinase C signaling (GO:0090037),1/9,0.0222805591236868,0.1335503921619794,0,0,50.87244897959184,193.52086993316271,WNT5A,APOD+ MSC,1.652073914876897
GO_Biological_Process_2021,negative regulation of cell adhesion mediated by integrin (GO:0033629),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,SERPINE1,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,positive regulation of coagulation (GO:0050820),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,SERPINE1,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,positive regulation of hemostasis (GO:1900048),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,SERPINE1,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,sequestering of actin monomers (GO:0042989),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,GSN,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,iron ion transmembrane transport (GO:0034755),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,SCARA5,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,SNARE complex assembly (GO:0035493),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,STXBP6,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,cellular response to prostaglandin stimulus (GO:0071379),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,PTGFR,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,DCN,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,neuron projection regeneration (GO:0031102),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,PTN,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,positive regulation of vasculogenesis (GO:2001214),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,TMEM100,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,WNT5A,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,regulation of podosome assembly (GO:0071801),1/10,0.024725948817258,0.1335503921619794,0,0,45.21768707482993,167.3010120823387,GSN,APOD+ MSC,1.606847034080906
GO_Biological_Process_2021,positive regulation of defense response (GO:0031349),2/98,0.0249948795228368,0.1335503921619794,0,0,8.6171875,31.789531066243494,WNT5A;SERPINE1,APOD+ MSC,1.6021489522377872
GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),2/101,0.0264315192050235,0.1335503921619794,0,0,8.35479797979798,30.35463590957481,EPHA3;TP63,APOD+ MSC,1.577877874197194
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),2/102,0.0269177264019109,0.1335503921619794,0,0,8.270833333333334,29.898816321570965,WNT5A;SERPINE1,APOD+ MSC,1.5699616254585989
GO_Biological_Process_2021,positive regulation of actin nucleation (GO:0051127),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,GSN,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,actin filament depolymerization (GO:0030042),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,GSN,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,positive regulation of dendrite development (GO:1900006),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,PTN,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,hematopoietic stem cell proliferation (GO:0071425),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,WNT5A,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of lymphocyte migration (GO:2000402),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,APOD,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,GSN,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,inhibitory synapse assembly (GO:1904862),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,WNT5A,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,APOD,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,regulation of mesenchymal cell proliferation (GO:0010464),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,WNT5A,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,regulation of mitochondrial depolarization (GO:0051900),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,DCN,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,midbrain dopaminergic neuron differentiation (GO:1904948),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,WNT5A,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,regulation of monocyte chemotactic protein-1 production (GO:0071637),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,APOD,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,postsynapse assembly (GO:0099068),1/11,0.0271653448579923,0.1335503921619794,0,0,40.69387755102041,146.73452100035948,WNT5A,APOD+ MSC,1.5659847773237099
GO_Biological_Process_2021,regulation of sensory perception (GO:0051931),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,TMEM100,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,ethanol oxidation (GO:0006069),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,ADH1B,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,DCN,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,regulation of actin filament depolymerization (GO:0030834),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,PLEKHH2,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,regulation of actin nucleation (GO:0051125),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,GSN,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,regulation of axon regeneration (GO:0048679),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,PTN,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of hemostasis (GO:1900047),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,SERPINE1,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,axonal fasciculation (GO:0007413),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,EPHA3,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,replicative senescence (GO:0090399),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,SERPINE1,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of microtubule polymerization (GO:0031115),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,STMN2,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,regulation of hemopoiesis (GO:1903706),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,PTN,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,positive regulation of protein depolymerization (GO:1901881),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,STMN2,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,dermatan sulfate biosynthetic process (GO:0030208),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,DCN,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,presynapse organization (GO:0099172),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,WNT5A,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,regulation of nucleobase-containing compound metabolic process (GO:0019219),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,NOVA1,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,regulation of plasminogen activation (GO:0010755),1/12,0.029598761568907,0.1335503921619794,0,0,36.99257884972171,130.2147194065139,SERPINE1,APOD+ MSC,1.5287264597194943
GO_Biological_Process_2021,lipid transport (GO:0006869),2/109,0.0304216645881743,0.1335503921619794,0,0,7.72702492211838,26.987409356009476,ABCA10;ABCA6,APOD+ MSC,1.5168170262567133
GO_Biological_Process_2021,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/13,0.032026213248763,0.1335503921619794,0,0,33.90816326530612,116.6847899929619,FBLN1,APOD+ MSC,1.4944944088974865
GO_Biological_Process_2021,relaxation of cardiac muscle (GO:0055119),1/13,0.032026213248763,0.1335503921619794,0,0,33.90816326530612,116.6847899929619,GSN,APOD+ MSC,1.4944944088974865
GO_Biological_Process_2021,negative regulation of locomotion (GO:0040013),1/13,0.032026213248763,0.1335503921619794,0,0,33.90816326530612,116.6847899929619,FBLN1,APOD+ MSC,1.4944944088974865
GO_Biological_Process_2021,negative regulation of nucleocytoplasmic transport (GO:0046823),1/13,0.032026213248763,0.1335503921619794,0,0,33.90816326530612,116.6847899929619,APOD,APOD+ MSC,1.4944944088974865
GO_Biological_Process_2021,regulation of fibrinolysis (GO:0051917),1/13,0.032026213248763,0.1335503921619794,0,0,33.90816326530612,116.6847899929619,SERPINE1,APOD+ MSC,1.4944944088974865
GO_Biological_Process_2021,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),1/13,0.032026213248763,0.1335503921619794,0,0,33.90816326530612,116.6847899929619,FBLN1,APOD+ MSC,1.4944944088974865
GO_Biological_Process_2021,chondroitin sulfate catabolic process (GO:0030207),1/13,0.032026213248763,0.1335503921619794,0,0,33.90816326530612,116.6847899929619,DCN,APOD+ MSC,1.4944944088974865
GO_Biological_Process_2021,dermatan sulfate metabolic process (GO:0030205),1/13,0.032026213248763,0.1335503921619794,0,0,33.90816326530612,116.6847899929619,DCN,APOD+ MSC,1.4944944088974865
GO_Biological_Process_2021,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/13,0.032026213248763,0.1335503921619794,0,0,33.90816326530612,116.6847899929619,APOD,APOD+ MSC,1.4944944088974865
GO_Biological_Process_2021,negative regulation of cell motility (GO:2000146),2/114,0.0330295301793541,0.1335503921619794,0,0,7.380208333333333,25.169117576656426,SERPINE1;FBLN1,APOD+ MSC,1.4810976037825534
GO_Biological_Process_2021,cellular response to molecule of bacterial origin (GO:0071219),2/115,0.033561350657856,0.1335503921619794,0,0,7.31452802359882,24.82828874550635,WNT5A;SERPINE1,APOD+ MSC,1.4741605695522084
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),2/116,0.0340965412337713,0.1335503921619794,0,0,7.25,24.49455514200503,WNT5A;SERPINE1,APOD+ MSC,1.467289673772098
GO_Biological_Process_2021,regulation of sensory perception of pain (GO:0051930),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,TMEM100,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of coagulation (GO:0050819),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,SERPINE1,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,genitalia development (GO:0048806),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,WNT5A,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,regulation of vasculogenesis (GO:2001212),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,TMEM100,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,relaxation of muscle (GO:0090075),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,GSN,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,renal absorption (GO:0070293),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,GSN,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,secondary palate development (GO:0062009),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,WNT5A,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of smooth muscle cell migration (GO:0014912),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,SERPINE1,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,regulation of macrophage cytokine production (GO:0010935),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,WNT5A,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,positive regulation of T cell chemotaxis (GO:0010820),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,WNT5A,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,regulation of protein kinase C signaling (GO:0090036),1/14,0.0344477141698711,0.1335503921619794,0,0,31.298273155416013,105.4223689491126,WNT5A,APOD+ MSC,1.4628395910668823
GO_Biological_Process_2021,cellular response to lipopolysaccharide (GO:0071222),2/120,0.0362706169091182,0.1335503921619794,0,0,7.002824858757062,23.22660056193845,WNT5A;SERPINE1,APOD+ MSC,1.4404450576550938
GO_Biological_Process_2021,cellular response to interferon-gamma (GO:0071346),2/121,0.0368223679095263,0.1335503921619794,0,0,6.943627450980392,22.92542614889691,CCL13;WNT5A,APOD+ MSC,1.4338882870711436
GO_Biological_Process_2021,protein trimerization (GO:0070206),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,SCARA5,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,negative regulation of cellular component movement (GO:0051271),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,FBLN1,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,positive regulation of cell killing (GO:0031343),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,WNT5A,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,fibrinolysis (GO:0042730),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,SERPINE1,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,regulation of T cell chemotaxis (GO:0010819),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,WNT5A,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,response to muscle stretch (GO:0035994),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,GSN,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,negative regulation of protein processing (GO:0010955),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,SERPINE1,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,positive regulation of response to cytokine stimulus (GO:0060760),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,WNT5A,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,DCN,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,regulation of neuron projection arborization (GO:0150011),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,WNT5A,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,protein homotrimerization (GO:0070207),1/15,0.0368632785936063,0.1335503921619794,0,0,29.06122448979592,95.91771596133704,SCARA5,APOD+ MSC,1.4334060415588732
GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),2/123,0.0379356146383277,0.1351363883357085,0,0,6.828168044077135,22.34084340876857,WNT5A;PTN,APOD+ MSC,1.420952875040757
GO_Biological_Process_2021,negative regulation of cell-substrate junction organization (GO:0150118),1/16,0.0392729207344652,0.1351363883357085,0,0,27.122448979591837,87.80133530116419,APOD,APOD+ MSC,1.405906798966597
GO_Biological_Process_2021,positive regulation of collagen biosynthetic process (GO:0032967),1/16,0.0392729207344652,0.1351363883357085,0,0,27.122448979591837,87.80133530116419,LARP6,APOD+ MSC,1.405906798966597
GO_Biological_Process_2021,negative regulation of focal adhesion assembly (GO:0051895),1/16,0.0392729207344652,0.1351363883357085,0,0,27.122448979591837,87.80133530116419,APOD,APOD+ MSC,1.405906798966597
GO_Biological_Process_2021,regulation of establishment of cell polarity (GO:2000114),1/16,0.0392729207344652,0.1351363883357085,0,0,27.122448979591837,87.80133530116419,GSN,APOD+ MSC,1.405906798966597
GO_Biological_Process_2021,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),1/16,0.0392729207344652,0.1351363883357085,0,0,27.122448979591837,87.80133530116419,WNT5A,APOD+ MSC,1.405906798966597
GO_Biological_Process_2021,oogenesis (GO:0048477),1/16,0.0392729207344652,0.1351363883357085,0,0,27.122448979591837,87.80133530116419,PTN,APOD+ MSC,1.405906798966597
GO_Biological_Process_2021,eosinophil chemotaxis (GO:0048245),1/16,0.0392729207344652,0.1351363883357085,0,0,27.122448979591837,87.80133530116419,CCL13,APOD+ MSC,1.405906798966597
GO_Biological_Process_2021,eosinophil migration (GO:0072677),1/16,0.0392729207344652,0.1351363883357085,0,0,27.122448979591837,87.80133530116419,CCL13,APOD+ MSC,1.405906798966597
GO_Biological_Process_2021,positive regulation of blood coagulation (GO:0030194),1/17,0.0416766547912334,0.1351363883357085,0,0,25.426020408163264,80.79916728086499,SERPINE1,APOD+ MSC,1.3801071472903907
GO_Biological_Process_2021,regulation of stem cell proliferation (GO:0072091),1/17,0.0416766547912334,0.1351363883357085,0,0,25.426020408163264,80.79916728086499,FBLN1,APOD+ MSC,1.3801071472903907
GO_Biological_Process_2021,negative regulation of chemokine production (GO:0032682),1/17,0.0416766547912334,0.1351363883357085,0,0,25.426020408163264,80.79916728086499,APOD,APOD+ MSC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of collagen metabolic process (GO:0010714),1/17,0.0416766547912334,0.1351363883357085,0,0,25.426020408163264,80.79916728086499,LARP6,APOD+ MSC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of macrophage activation (GO:0043032),1/17,0.0416766547912334,0.1351363883357085,0,0,25.426020408163264,80.79916728086499,WNT5A,APOD+ MSC,1.3801071472903907
GO_Biological_Process_2021,negative regulation of viral entry into host cell (GO:0046597),1/17,0.0416766547912334,0.1351363883357085,0,0,25.426020408163264,80.79916728086499,GSN,APOD+ MSC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of stem cell differentiation (GO:2000738),1/17,0.0416766547912334,0.1351363883357085,0,0,25.426020408163264,80.79916728086499,PTN,APOD+ MSC,1.3801071472903907
GO_Biological_Process_2021,regulation of neuroblast proliferation (GO:1902692),1/17,0.0416766547912334,0.1351363883357085,0,0,25.426020408163264,80.79916728086499,PTN,APOD+ MSC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of glial cell differentiation (GO:0045687),1/18,0.0440744949316926,0.1351363883357085,0,0,23.92917166866747,74.70385911458476,PTN,APOD+ MSC,1.3558126557645607
GO_Biological_Process_2021,response to axon injury (GO:0048678),1/18,0.0440744949316926,0.1351363883357085,0,0,23.92917166866747,74.70385911458476,APOD,APOD+ MSC,1.3558126557645607
GO_Biological_Process_2021,negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/18,0.0440744949316926,0.1351363883357085,0,0,23.92917166866747,74.70385911458476,GPNMB,APOD+ MSC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of lymphocyte chemotaxis (GO:0140131),1/18,0.0440744949316926,0.1351363883357085,0,0,23.92917166866747,74.70385911458476,WNT5A,APOD+ MSC,1.3558126557645607
GO_Biological_Process_2021,microtubule depolymerization (GO:0007019),1/18,0.0440744949316926,0.1351363883357085,0,0,23.92917166866747,74.70385911458476,STMN2,APOD+ MSC,1.3558126557645607
GO_Biological_Process_2021,mitochondrial fission (GO:0000266),1/18,0.0440744949316926,0.1351363883357085,0,0,23.92917166866747,74.70385911458476,DNM1,APOD+ MSC,1.3558126557645607
GO_Biological_Process_2021,presynapse assembly (GO:0099054),1/18,0.0440744949316926,0.1351363883357085,0,0,23.92917166866747,74.70385911458476,WNT5A,APOD+ MSC,1.3558126557645607
GO_Biological_Process_2021,positive chemotaxis (GO:0050918),1/18,0.0440744949316926,0.1351363883357085,0,0,23.92917166866747,74.70385911458476,GPNMB,APOD+ MSC,1.3558126557645607
GO_Biological_Process_2021,organic substance transport (GO:0071702),2/136,0.0454786698217006,0.1351363883357085,0,0,6.161691542288557,19.042780777221537,ABCA10;ABCA6,APOD+ MSC,1.3421922462170102
GO_Biological_Process_2021,actin filament capping (GO:0051693),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,GSN,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,establishment of skin barrier (GO:0061436),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,TP63,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,ethanol metabolic process (GO:0006067),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,ADH1B,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of stem cell population maintenance (GO:2000036),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,PTN,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,negative regulation of cytokine production involved in inflammatory response (GO:1900016),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,APOD,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,DCN,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,barbed-end actin filament capping (GO:0051016),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,GSN,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of water loss via skin (GO:0033561),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,TP63,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,cardiac muscle cell contraction (GO:0086003),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,GSN,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of collagen biosynthetic process (GO:0032965),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,LARP6,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,positive regulation of leukocyte activation (GO:0002696),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,WNT5A,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,negative regulation of protein localization to nucleus (GO:1900181),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,APOD,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,positive regulation of mitochondrial fission (GO:0090141),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,DCN,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,positive regulation of monocyte chemotaxis (GO:0090026),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,SERPINE1,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,IGFBP6,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of leukocyte chemotaxis (GO:0002688),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,PTN,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of oligodendrocyte differentiation (GO:0048713),1/19,0.0464664552952436,0.1351363883357085,0,0,22.598639455782312,69.35578082800635,PTN,APOD+ MSC,1.3328604565168853
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),3/323,0.0468728629064742,0.1356958679575554,0,0,3.9155585106382977,11.982847874596391,WNT5A;SERPINE1;EPHA3,APOD+ MSC,1.3290785197780062
GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),2/140,0.0479026862337682,0.1370465340203787,0,0,5.981884057971015,18.176455370515885,PTN;EPHA3,APOD+ MSC,1.319640132017756
GO_Biological_Process_2021,regulation of smooth muscle cell migration (GO:0014910),1/20,0.0488525499820277,0.1370465340203787,0,0,21.40816326530612,64.63014669364038,SERPINE1,APOD+ MSC,1.3111127622579986
GO_Biological_Process_2021,regulation of T cell migration (GO:2000404),1/20,0.0488525499820277,0.1370465340203787,0,0,21.40816326530612,64.63014669364038,APOD,APOD+ MSC,1.3111127622579986
GO_Biological_Process_2021,regulation of tissue remodeling (GO:0034103),1/20,0.0488525499820277,0.1370465340203787,0,0,21.40816326530612,64.63014669364038,GPNMB,APOD+ MSC,1.3111127622579986
GO_Biological_Process_2021,positive regulation of epithelial cell differentiation (GO:0030858),1/20,0.0488525499820277,0.1370465340203787,0,0,21.40816326530612,64.63014669364038,TMEM100,APOD+ MSC,1.3111127622579986
GO_Biological_Process_2021,negative regulation of viral life cycle (GO:1903901),1/20,0.0488525499820277,0.1370465340203787,0,0,21.40816326530612,64.63014669364038,GSN,APOD+ MSC,1.3111127622579986
GO_Biological_Process_2021,positive regulation of protein processing (GO:0010954),1/20,0.0488525499820277,0.1370465340203787,0,0,21.40816326530612,64.63014669364038,GSN,APOD+ MSC,1.3111127622579986
GO_Biological_Process_2021,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.0512327930672156,0.1400068569164426,0,0,20.336734693877553,60.42807445408675,PTGFR,APOD+ MSC,1.2904519669693806
GO_Biological_Process_2021,regulation of cell-substrate junction assembly (GO:0090109),1/21,0.0512327930672156,0.1400068569164426,0,0,20.336734693877553,60.42807445408675,EPHA3,APOD+ MSC,1.2904519669693806
GO_Biological_Process_2021,negative regulation of microtubule depolymerization (GO:0007026),1/21,0.0512327930672156,0.1400068569164426,0,0,20.336734693877553,60.42807445408675,STMN2,APOD+ MSC,1.2904519669693806
GO_Biological_Process_2021,retinol metabolic process (GO:0042572),1/21,0.0512327930672156,0.1400068569164426,0,0,20.336734693877553,60.42807445408675,ADH1B,APOD+ MSC,1.2904519669693806
GO_Biological_Process_2021,negative regulation of response to wounding (GO:1903035),1/21,0.0512327930672156,0.1400068569164426,0,0,20.336734693877553,60.42807445408675,SERPINE1,APOD+ MSC,1.2904519669693806
GO_Biological_Process_2021,chondroitin sulfate biosynthetic process (GO:0030206),1/21,0.0512327930672156,0.1400068569164426,0,0,20.336734693877553,60.42807445408675,DCN,APOD+ MSC,1.2904519669693806
GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),2/148,0.052889062238365,0.1434049110207912,0,0,5.651826484018265,16.61387585032132,PTGFR;WNT5A,APOD+ MSC,1.2766341332705589
GO_Biological_Process_2021,regulation of response to cytokine stimulus (GO:0060759),1/22,0.0536071985992547,0.1434049110207912,0,0,19.367346938775512,56.67024999786951,WNT5A,APOD+ MSC,1.2707768875084013
GO_Biological_Process_2021,negative regulation of lymphocyte activation (GO:0051250),1/22,0.0536071985992547,0.1434049110207912,0,0,19.367346938775512,56.67024999786951,GPNMB,APOD+ MSC,1.2707768875084013
GO_Biological_Process_2021,cell projection assembly (GO:0030031),1/22,0.0536071985992547,0.1434049110207912,0,0,19.367346938775512,56.67024999786951,GSN,APOD+ MSC,1.2707768875084013
GO_Biological_Process_2021,cellular response to nerve growth factor stimulus (GO:1990090),1/22,0.0536071985992547,0.1434049110207912,0,0,19.367346938775512,56.67024999786951,STMN2,APOD+ MSC,1.2707768875084013
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),3/345,0.0550388186280638,0.1466160126478677,0,0,3.6595744680851063,10.611728649113475,WNT5A;SERPINE1;PTN,APOD+ MSC,1.2593308965170802
GO_Biological_Process_2021,positive regulation of epithelial cell apoptotic process (GO:1904037),1/23,0.0559757805878795,0.1472557879365792,0,0,18.4860853432282,53.29235549319145,GSN,APOD+ MSC,1.2519998414265567
GO_Biological_Process_2021,negative regulation of intracellular protein transport (GO:0090317),1/23,0.0559757805878795,0.1472557879365792,0,0,18.4860853432282,53.29235549319145,APOD,APOD+ MSC,1.2519998414265567
GO_Biological_Process_2021,positive regulation of protein autophosphorylation (GO:0031954),1/23,0.0559757805878795,0.1472557879365792,0,0,18.4860853432282,53.29235549319145,GPNMB,APOD+ MSC,1.2519998414265567
GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),3/351,0.0573776228581519,0.1503198879837533,0,0,3.595377842993397,10.275952639346544,GSN;LUM;STMN2,APOD+ MSC,1.2412574484387946
GO_Biological_Process_2021,negative regulation of lipid metabolic process (GO:0045833),1/24,0.0583385530130099,0.1515846008616734,0,0,17.68145519077196,50.24171555062859,APOD,APOD+ MSC,1.2340443470047993
GO_Biological_Process_2021,regulation of cytokine production involved in immune response (GO:0002718),1/24,0.0583385530130099,0.1515846008616734,0,0,17.68145519077196,50.24171555062859,WNT5A,APOD+ MSC,1.2340443470047993
GO_Biological_Process_2021,skeletal system development (GO:0001501),2/158,0.0593699722530508,0.1527022456687587,0,0,5.2868589743589745,14.929913680908546,WNT5A;PRELP,APOD+ MSC,1.2264331540442923
GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),2/159,0.060032623780291,0.1527022456687587,0,0,5.25291932059448,14.77576411894998,WNT5A;SERPINE1,APOD+ MSC,1.2216126749949432
GO_Biological_Process_2021,negative regulation of cell junction assembly (GO:1901889),1/25,0.0606955298241754,0.1527022456687587,0,0,16.943877551020407,47.47480020477031,APOD,APOD+ MSC,1.2168432931781568
GO_Biological_Process_2021,negative regulation of endocytosis (GO:0045806),1/25,0.0606955298241754,0.1527022456687587,0,0,16.943877551020407,47.47480020477031,EPHA3,APOD+ MSC,1.2168432931781568
GO_Biological_Process_2021,positive regulation of T cell migration (GO:2000406),1/25,0.0606955298241754,0.1527022456687587,0,0,16.943877551020407,47.47480020477031,WNT5A,APOD+ MSC,1.2168432931781568
GO_Biological_Process_2021,regulation of microtubule depolymerization (GO:0031114),1/25,0.0606955298241754,0.1527022456687587,0,0,16.943877551020407,47.47480020477031,STMN2,APOD+ MSC,1.2168432931781568
GO_Biological_Process_2021,regulation of mitochondrial fission (GO:0090140),1/25,0.0606955298241754,0.1527022456687587,0,0,16.943877551020407,47.47480020477031,DCN,APOD+ MSC,1.2168432931781568
GO_Biological_Process_2021,negative regulation of actin filament polymerization (GO:0030837),1/25,0.0606955298241754,0.1527022456687587,0,0,16.943877551020407,47.47480020477031,GSN,APOD+ MSC,1.2168432931781568
GO_Biological_Process_2021,regulation of synapse organization (GO:0050807),1/26,0.0630467249540435,0.1537370139263985,0,0,16.26530612244898,44.95534064809558,WNT5A,APOD+ MSC,1.2003374685092782
GO_Biological_Process_2021,retinoic acid metabolic process (GO:0042573),1/26,0.0630467249540435,0.1537370139263985,0,0,16.26530612244898,44.95534064809558,ADH1B,APOD+ MSC,1.2003374685092782
GO_Biological_Process_2021,positive regulation of microtubule polymerization or depolymerization (GO:0031112),1/26,0.0630467249540435,0.1537370139263985,0,0,16.26530612244898,44.95534064809558,STMN2,APOD+ MSC,1.2003374685092782
GO_Biological_Process_2021,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/26,0.0630467249540435,0.1537370139263985,0,0,16.26530612244898,44.95534064809558,TP63,APOD+ MSC,1.2003374685092782
GO_Biological_Process_2021,regulation of monocyte chemotaxis (GO:0090025),1/26,0.0630467249540435,0.1537370139263985,0,0,16.26530612244898,44.95534064809558,SERPINE1,APOD+ MSC,1.2003374685092782
GO_Biological_Process_2021,organelle fission (GO:0048285),1/26,0.0630467249540435,0.1537370139263985,0,0,16.26530612244898,44.95534064809558,DNM1,APOD+ MSC,1.2003374685092782
GO_Biological_Process_2021,regulation of myelination (GO:0031641),1/26,0.0630467249540435,0.1537370139263985,0,0,16.26530612244898,44.95534064809558,PTN,APOD+ MSC,1.2003374685092782
GO_Biological_Process_2021,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/26,0.0630467249540435,0.1537370139263985,0,0,16.26530612244898,44.95534064809558,TP63,APOD+ MSC,1.2003374685092782
GO_Biological_Process_2021,negative regulation of canonical Wnt signaling pathway (GO:0090090),2/165,0.0640621553999463,0.1552757473113186,0,0,5.058026584867076,13.898958782878776,WNT5A;IGFBP6,APOD+ MSC,1.1933984533937798
GO_Biological_Process_2021,negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.0653921522588676,0.1552757473113186,0,0,15.638932496075354,42.652889831563165,SERPINE1,APOD+ MSC,1.184474368421492
GO_Biological_Process_2021,regulation of blood coagulation (GO:0030193),1/27,0.0653921522588676,0.1552757473113186,0,0,15.638932496075354,42.652889831563165,SERPINE1,APOD+ MSC,1.184474368421492
GO_Biological_Process_2021,regulation of vasculature development (GO:1901342),1/27,0.0653921522588676,0.1552757473113186,0,0,15.638932496075354,42.652889831563165,GPNMB,APOD+ MSC,1.184474368421492
GO_Biological_Process_2021,negative regulation of protein polymerization (GO:0032272),1/27,0.0653921522588676,0.1552757473113186,0,0,15.638932496075354,42.652889831563165,STMN2,APOD+ MSC,1.184474368421492
GO_Biological_Process_2021,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),1/27,0.0653921522588676,0.1552757473113186,0,0,15.638932496075354,42.652889831563165,DCN,APOD+ MSC,1.184474368421492
GO_Biological_Process_2021,microtubule polymerization or depolymerization (GO:0031109),1/27,0.0653921522588676,0.1552757473113186,0,0,15.638932496075354,42.652889831563165,STMN2,APOD+ MSC,1.184474368421492
GO_Biological_Process_2021,receptor clustering (GO:0043113),1/28,0.0677318256109869,0.1572966206496912,0,0,15.058956916099774,40.54171043527237,PTN,APOD+ MSC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of fibroblast proliferation (GO:0048146),1/28,0.0677318256109869,0.1572966206496912,0,0,15.058956916099774,40.54171043527237,WNT5A,APOD+ MSC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of response to wounding (GO:1903036),1/28,0.0677318256109869,0.1572966206496912,0,0,15.058956916099774,40.54171043527237,PTN,APOD+ MSC,1.1692072184717057
GO_Biological_Process_2021,regulation of microtubule polymerization or depolymerization (GO:0031110),1/28,0.0677318256109869,0.1572966206496912,0,0,15.058956916099774,40.54171043527237,STMN2,APOD+ MSC,1.1692072184717057
GO_Biological_Process_2021,regulation of multicellular organismal development (GO:2000026),1/28,0.0677318256109869,0.1572966206496912,0,0,15.058956916099774,40.54171043527237,PTN,APOD+ MSC,1.1692072184717057
GO_Biological_Process_2021,regulation of postsynapse organization (GO:0099175),1/28,0.0677318256109869,0.1572966206496912,0,0,15.058956916099774,40.54171043527237,WNT5A,APOD+ MSC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),2/172,0.0688760185279422,0.1593700574697641,0,0,4.848039215686274,12.970673059288286,CCL13;GPNMB,APOD+ MSC,1.1619319658128364
GO_Biological_Process_2021,actin filament polymerization (GO:0030041),1/29,0.0700657588372089,0.1603671158945504,0,0,14.520408163265309,38.5999069065122,GSN,APOD+ MSC,1.1544941700666143
GO_Biological_Process_2021,positive regulation of leukocyte migration (GO:0002687),1/29,0.0700657588372089,0.1603671158945504,0,0,14.520408163265309,38.5999069065122,PTN,APOD+ MSC,1.1544941700666143
GO_Biological_Process_2021,negative regulation of wound healing (GO:0061045),1/29,0.0700657588372089,0.1603671158945504,0,0,14.520408163265309,38.5999069065122,SERPINE1,APOD+ MSC,1.1544941700666143
GO_Biological_Process_2021,negative regulation of cytoskeleton organization (GO:0051494),1/30,0.0723939657090184,0.1604817281801317,0,0,14.019000703729768,36.80874147674154,PLEKHH2,APOD+ MSC,1.1402976322627019
GO_Biological_Process_2021,regulation of type I interferon-mediated signaling pathway (GO:0060338),1/30,0.0723939657090184,0.1604817281801317,0,0,14.019000703729768,36.80874147674154,WNT5A,APOD+ MSC,1.1402976322627019
GO_Biological_Process_2021,cell projection organization (GO:0030030),1/30,0.0723939657090184,0.1604817281801317,0,0,14.019000703729768,36.80874147674154,GSN,APOD+ MSC,1.1402976322627019
GO_Biological_Process_2021,maintenance of blood-brain barrier (GO:0035633),1/30,0.0723939657090184,0.1604817281801317,0,0,14.019000703729768,36.80874147674154,LAMA2,APOD+ MSC,1.1402976322627019
GO_Biological_Process_2021,chondroitin sulfate metabolic process (GO:0030204),1/30,0.0723939657090184,0.1604817281801317,0,0,14.019000703729768,36.80874147674154,DCN,APOD+ MSC,1.1402976322627019
GO_Biological_Process_2021,regulation of long-term synaptic potentiation (GO:1900271),1/30,0.0723939657090184,0.1604817281801317,0,0,14.019000703729768,36.80874147674154,PTN,APOD+ MSC,1.1402976322627019
GO_Biological_Process_2021,regulation of macrophage activation (GO:0043030),1/30,0.0723939657090184,0.1604817281801317,0,0,14.019000703729768,36.80874147674154,WNT5A,APOD+ MSC,1.1402976322627019
GO_Biological_Process_2021,plasma membrane invagination (GO:0099024),1/30,0.0723939657090184,0.1604817281801317,0,0,14.019000703729768,36.80874147674154,GSN,APOD+ MSC,1.1402976322627019
GO_Biological_Process_2021,regulation of protein localization to membrane (GO:1905475),1/30,0.0723939657090184,0.1604817281801317,0,0,14.019000703729768,36.80874147674154,GSN,APOD+ MSC,1.1402976322627019
GO_Biological_Process_2021,activation of protein kinase B activity (GO:0032148),1/31,0.0747164600026276,0.1644799848668955,0,0,13.551020408163266,35.15209038871121,WNT5A,APOD+ MSC,1.126583712764908
GO_Biological_Process_2021,positive regulation of mononuclear cell migration (GO:0071677),1/31,0.0747164600026276,0.1644799848668955,0,0,13.551020408163266,35.15209038871121,SERPINE1,APOD+ MSC,1.126583712764908
GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),2/182,0.0759532712589317,0.1666241314123277,0,0,4.576388888888889,11.79626923326343,GPNMB;APOD,APOD+ MSC,1.1194535166121444
GO_Biological_Process_2021,negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/32,0.0770332554327668,0.1684106342909455,0,0,13.113232389730086,33.61600807740255,STMN2,APOD+ MSC,1.1133217484244988
GO_Biological_Process_2021,positive regulation of cytokine production involved in immune response (GO:0002720),1/33,0.0793443657059371,0.1716871257937342,0,0,12.70280612244898,32.18837516559274,WNT5A,APOD+ MSC,1.1004839073426347
GO_Biological_Process_2021,negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.0793443657059371,0.1716871257937342,0,0,12.70280612244898,32.18837516559274,APOD,APOD+ MSC,1.1004839073426347
GO_Biological_Process_2021,primary alcohol metabolic process (GO:0034308),1/33,0.0793443657059371,0.1716871257937342,0,0,12.70280612244898,32.18837516559274,ADH1B,APOD+ MSC,1.1004839073426347
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),3/404,0.0800241417045532,0.1719799868078513,0,0,3.1117419217912663,7.858476812794824,DNM1;EPHA3;ANKS1B,APOD+ MSC,1.0967789751654027
GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),2/189,0.0810402447075638,0.1719799868078513,0,0,4.403520499108734,11.065207700859313,CCL13;EPHA3,APOD+ MSC,1.0912992562585337
GO_Biological_Process_2021,female gamete generation (GO:0007292),1/34,0.0816498044624026,0.1719799868078513,0,0,12.317254174397032,30.85861216573232,PTN,APOD+ MSC,1.0880448509885652
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/34,0.0816498044624026,0.1719799868078513,0,0,12.317254174397032,30.85861216573232,SERPINE1,APOD+ MSC,1.0880448509885652
GO_Biological_Process_2021,regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.0816498044624026,0.1719799868078513,0,0,12.317254174397032,30.85861216573232,SERPINE1,APOD+ MSC,1.0880448509885652
GO_Biological_Process_2021,cardiac muscle contraction (GO:0060048),1/34,0.0816498044624026,0.1719799868078513,0,0,12.317254174397032,30.85861216573232,GSN,APOD+ MSC,1.0880448509885652
GO_Biological_Process_2021,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/34,0.0816498044624026,0.1719799868078513,0,0,12.317254174397032,30.85861216573232,TP63,APOD+ MSC,1.0880448509885652
GO_Biological_Process_2021,protein destabilization (GO:0031648),1/34,0.0816498044624026,0.1719799868078513,0,0,12.317254174397032,30.85861216573232,GSN,APOD+ MSC,1.0880448509885652
GO_Biological_Process_2021,negative regulation of Wnt signaling pathway (GO:0030178),2/191,0.0825129134198004,0.1730332902902247,0,0,4.356481481481482,10.868552054472469,WNT5A;IGFBP6,APOD+ MSC,1.083478078261104
GO_Biological_Process_2021,negative regulation of cell cycle G1/S phase transition (GO:1902807),1/35,0.0839495853612937,0.1730332902902247,0,0,11.95438175270108,29.61744503578088,GPNMB,APOD+ MSC,1.0759814445616303
GO_Biological_Process_2021,negative regulation of epithelial cell migration (GO:0010633),1/35,0.0839495853612937,0.1730332902902247,0,0,11.95438175270108,29.61744503578088,DCN,APOD+ MSC,1.0759814445616303
GO_Biological_Process_2021,negative regulation of neurogenesis (GO:0050768),1/35,0.0839495853612937,0.1730332902902247,0,0,11.95438175270108,29.61744503578088,PTN,APOD+ MSC,1.0759814445616303
GO_Biological_Process_2021,negative regulation of T cell proliferation (GO:0042130),1/35,0.0839495853612937,0.1730332902902247,0,0,11.95438175270108,29.61744503578088,GPNMB,APOD+ MSC,1.0759814445616303
GO_Biological_Process_2021,embryonic skeletal system development (GO:0048706),1/35,0.0839495853612937,0.1730332902902247,0,0,11.95438175270108,29.61744503578088,WNT5A,APOD+ MSC,1.0759814445616303
GO_Biological_Process_2021,positive regulation of bone mineralization (GO:0030501),1/36,0.0862437219743075,0.1730332902902247,0,0,11.612244897959185,28.456712045041098,PTN,APOD+ MSC,1.0642725091375862
GO_Biological_Process_2021,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/36,0.0862437219743075,0.1730332902902247,0,0,11.612244897959185,28.456712045041098,WNT5A,APOD+ MSC,1.0642725091375862
GO_Biological_Process_2021,negative regulation of fat cell differentiation (GO:0045599),1/36,0.0862437219743075,0.1730332902902247,0,0,11.612244897959185,28.456712045041098,WNT5A,APOD+ MSC,1.0642725091375862
GO_Biological_Process_2021,positive regulation of innate immune response (GO:0045089),1/36,0.0862437219743075,0.1730332902902247,0,0,11.612244897959185,28.456712045041098,WNT5A,APOD+ MSC,1.0642725091375862
GO_Biological_Process_2021,membrane fusion (GO:0061025),1/36,0.0862437219743075,0.1730332902902247,0,0,11.612244897959185,28.456712045041098,DNM1,APOD+ MSC,1.0642725091375862
GO_Biological_Process_2021,regulation of microtubule-based process (GO:0032886),1/36,0.0862437219743075,0.1730332902902247,0,0,11.612244897959185,28.456712045041098,EPHA3,APOD+ MSC,1.0642725091375862
GO_Biological_Process_2021,dendrite morphogenesis (GO:0048813),1/36,0.0862437219743075,0.1730332902902247,0,0,11.612244897959185,28.456712045041098,PTN,APOD+ MSC,1.0642725091375862
GO_Biological_Process_2021,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",1/36,0.0862437219743075,0.1730332902902247,0,0,11.612244897959185,28.456712045041098,WNT5A,APOD+ MSC,1.0642725091375862
GO_Biological_Process_2021,regulation of protein import into nucleus (GO:0042306),1/36,0.0862437219743075,0.1730332902902247,0,0,11.612244897959185,28.456712045041098,APOD,APOD+ MSC,1.0642725091375862
GO_Biological_Process_2021,negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.0885322278902676,0.1754044765075928,0,0,11.289115646258503,27.36920368672352,SERPINE1,APOD+ MSC,1.0528986067362665
GO_Biological_Process_2021,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/37,0.0885322278902676,0.1754044765075928,0,0,11.289115646258503,27.36920368672352,GPNMB,APOD+ MSC,1.0528986067362665
GO_Biological_Process_2021,"phagocytosis, engulfment (GO:0006911)",1/37,0.0885322278902676,0.1754044765075928,0,0,11.289115646258503,27.36920368672352,GSN,APOD+ MSC,1.0528986067362665
GO_Biological_Process_2021,regulation of protein autophosphorylation (GO:0031952),1/37,0.0885322278902676,0.1754044765075928,0,0,11.289115646258503,27.36920368672352,GPNMB,APOD+ MSC,1.0528986067362665
GO_Biological_Process_2021,negative regulation of endothelial cell migration (GO:0010596),1/38,0.0908151166313484,0.1782562970410988,0,0,10.983452840595698,26.34852930034076,DCN,APOD+ MSC,1.0418418549683985
GO_Biological_Process_2021,positive regulation of production of molecular mediator of immune response (GO:0002702),1/38,0.0908151166313484,0.1782562970410988,0,0,10.983452840595698,26.34852930034076,WNT5A,APOD+ MSC,1.0418418549683985
GO_Biological_Process_2021,synaptic vesicle endocytosis (GO:0048488),1/38,0.0908151166313484,0.1782562970410988,0,0,10.983452840595698,26.34852930034076,DNM1,APOD+ MSC,1.0418418549683985
GO_Biological_Process_2021,regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.0930924017046572,0.1793938683305553,0,0,10.693877551020408,25.38900533231373,SERPINE1,APOD+ MSC,1.0310857651239858
GO_Biological_Process_2021,regulation of viral entry into host cell (GO:0046596),1/39,0.0930924017046572,0.1793938683305553,0,0,10.693877551020408,25.38900533231373,GSN,APOD+ MSC,1.0310857651239858
GO_Biological_Process_2021,negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.0930924017046572,0.1793938683305553,0,0,10.693877551020408,25.38900533231373,GPNMB,APOD+ MSC,1.0310857651239858
GO_Biological_Process_2021,regulation of dendrite development (GO:0050773),1/39,0.0930924017046572,0.1793938683305553,0,0,10.693877551020408,25.38900533231373,PTN,APOD+ MSC,1.0310857651239858
GO_Biological_Process_2021,negative regulation of secretion by cell (GO:1903531),1/39,0.0930924017046572,0.1793938683305553,0,0,10.693877551020408,25.38900533231373,STXBP6,APOD+ MSC,1.0310857651239858
GO_Biological_Process_2021,cellular response to ketone (GO:1901655),1/39,0.0930924017046572,0.1793938683305553,0,0,10.693877551020408,25.38900533231373,PTGFR,APOD+ MSC,1.0310857651239858
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),2/206,0.0938158179234975,0.1802400865560527,0,0,4.033088235294118,9.543987931843056,WNT5A;SERPINE1,APOD+ MSC,1.0277239307283335
GO_Biological_Process_2021,negative regulation of blood coagulation (GO:0030195),1/40,0.0953640965755271,0.1804801111309976,0,0,10.419152276295131,24.485561288951835,SERPINE1,APOD+ MSC,1.0206151011238414
GO_Biological_Process_2021,negative regulation of cell-substrate adhesion (GO:0010812),1/40,0.0953640965755271,0.1804801111309976,0,0,10.419152276295131,24.485561288951835,FBLN1,APOD+ MSC,1.0206151011238414
GO_Biological_Process_2021,lymphocyte migration (GO:0072676),1/40,0.0953640965755271,0.1804801111309976,0,0,10.419152276295131,24.485561288951835,CCL13,APOD+ MSC,1.0206151011238414
GO_Biological_Process_2021,regulation of microtubule polymerization (GO:0031113),1/40,0.0953640965755271,0.1804801111309976,0,0,10.419152276295131,24.485561288951835,STMN2,APOD+ MSC,1.0206151011238414
GO_Biological_Process_2021,positive regulation of wound healing (GO:0090303),1/40,0.0953640965755271,0.1804801111309976,0,0,10.419152276295131,24.485561288951835,SERPINE1,APOD+ MSC,1.0206151011238414
GO_Biological_Process_2021,positive regulation of biomineral tissue development (GO:0070169),1/41,0.0976302146847681,0.1825886610918673,0,0,10.158163265306122,23.633660200289185,PTN,APOD+ MSC,1.0104157556925017
GO_Biological_Process_2021,hexose metabolic process (GO:0019318),1/41,0.0976302146847681,0.1825886610918673,0,0,10.158163265306122,23.633660200289185,APOD,APOD+ MSC,1.0104157556925017
GO_Biological_Process_2021,keratinocyte differentiation (GO:0030216),1/41,0.0976302146847681,0.1825886610918673,0,0,10.158163265306122,23.633660200289185,WNT5A,APOD+ MSC,1.0104157556925017
GO_Biological_Process_2021,endosome organization (GO:0007032),1/41,0.0976302146847681,0.1825886610918673,0,0,10.158163265306122,23.633660200289185,DNM1,APOD+ MSC,1.0104157556925017
GO_Biological_Process_2021,regulation of chemokine production (GO:0032642),1/42,0.0998907694703361,0.1843379851491951,0,0,9.909905425584869,22.829231064333683,WNT5A,APOD+ MSC,1.00047464143678
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/42,0.0998907694703361,0.1843379851491951,0,0,9.909905425584869,22.829231064333683,SERPINE1,APOD+ MSC,1.00047464143678
GO_Biological_Process_2021,regulation of nervous system development (GO:0051960),1/42,0.0998907694703361,0.1843379851491951,0,0,9.909905425584869,22.829231064333683,PTN,APOD+ MSC,1.00047464143678
GO_Biological_Process_2021,monocyte chemotaxis (GO:0002548),1/42,0.0998907694703361,0.1843379851491951,0,0,9.909905425584869,22.829231064333683,CCL13,APOD+ MSC,1.00047464143678
GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),2/214,0.100019348409027,0.1843379851491951,0,0,3.879323899371069,8.931722866735825,GPNMB;NOVA1,APOD+ MSC,0.9999159790553556
GO_Biological_Process_2021,regulation of cell-substrate adhesion (GO:0010810),1/43,0.1021457742794159,0.1860931634860623,0,0,9.673469387755102,22.068611238785657,FBLN2,APOD+ MSC,0.9907795952096249
GO_Biological_Process_2021,regulation of cytokine production involved in inflammatory response (GO:1900015),1/43,0.1021457742794159,0.1860931634860623,0,0,9.673469387755102,22.068611238785657,APOD,APOD+ MSC,0.9907795952096249
GO_Biological_Process_2021,male gonad development (GO:0008584),1/43,0.1021457742794159,0.1860931634860623,0,0,9.673469387755102,22.068611238785657,WNT5A,APOD+ MSC,0.9907795952096249
GO_Biological_Process_2021,development of primary male sexual characteristics (GO:0046546),1/43,0.1021457742794159,0.1860931634860623,0,0,9.673469387755102,22.068611238785657,WNT5A,APOD+ MSC,0.9907795952096249
GO_Biological_Process_2021,positive regulation of biosynthetic process (GO:0009891),1/44,0.1043952424647777,0.1874974043135101,0,0,9.448030374940672,21.34849709415977,LARP6,APOD+ MSC,0.9813192926974915
GO_Biological_Process_2021,regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.1043952424647777,0.1874974043135101,0,0,9.448030374940672,21.34849709415977,SERPINE1,APOD+ MSC,0.9813192926974915
GO_Biological_Process_2021,positive regulation of osteoblast differentiation (GO:0045669),1/44,0.1043952424647777,0.1874974043135101,0,0,9.448030374940672,21.34849709415977,TP63,APOD+ MSC,0.9813192926974915
GO_Biological_Process_2021,lymphocyte chemotaxis (GO:0048247),1/44,0.1043952424647777,0.1874974043135101,0,0,9.448030374940672,21.34849709415977,CCL13,APOD+ MSC,0.9813192926974915
GO_Biological_Process_2021,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.1043952424647777,0.1874974043135101,0,0,9.448030374940672,21.34849709415977,SERPINE1,APOD+ MSC,0.9813192926974915
GO_Biological_Process_2021,positive regulation of chemotaxis (GO:0050921),1/45,0.1066391873529346,0.1899136089375297,0,0,9.232838589981448,20.665901611884028,PTN,APOD+ MSC,0.9720831731354668
GO_Biological_Process_2021,positive regulation of Notch signaling pathway (GO:0045747),1/45,0.1066391873529346,0.1899136089375297,0,0,9.232838589981448,20.665901611884028,TP63,APOD+ MSC,0.9720831731354668
GO_Biological_Process_2021,negative regulation of T cell activation (GO:0050868),1/45,0.1066391873529346,0.1899136089375297,0,0,9.232838589981448,20.665901611884028,GPNMB,APOD+ MSC,0.9720831731354668
GO_Biological_Process_2021,regulation of fibroblast proliferation (GO:0048145),1/46,0.1088776222085674,0.1922797005020383,0,0,9.02721088435374,20.01811780873028,WNT5A,APOD+ MSC,0.9630613723103648
GO_Biological_Process_2021,positive regulation of response to stimulus (GO:0048584),1/46,0.1088776222085674,0.1922797005020383,0,0,9.02721088435374,20.01811780873028,WNT5A,APOD+ MSC,0.9630613723103648
GO_Biological_Process_2021,vesicle organization (GO:0016050),1/46,0.1088776222085674,0.1922797005020383,0,0,9.02721088435374,20.01811780873028,DNM1,APOD+ MSC,0.9630613723103648
GO_Biological_Process_2021,epithelial to mesenchymal transition (GO:0001837),1/47,0.1111105603036554,0.193527734155268,0,0,8.830523513753327,19.4026870705364,WNT5A,APOD+ MSC,0.9542446623584087
GO_Biological_Process_2021,negative regulation of cold-induced thermogenesis (GO:0120163),1/47,0.1111105603036554,0.193527734155268,0,0,8.830523513753327,19.4026870705364,NOVA1,APOD+ MSC,0.9542446623584087
GO_Biological_Process_2021,regulation of T cell activation (GO:0050863),1/47,0.1111105603036554,0.193527734155268,0,0,8.830523513753327,19.4026870705364,GPNMB,APOD+ MSC,0.9542446623584087
GO_Biological_Process_2021,regulation of wound healing (GO:0061041),1/47,0.1111105603036554,0.193527734155268,0,0,8.830523513753327,19.4026870705364,SERPINE1,APOD+ MSC,0.9542446623584087
GO_Biological_Process_2021,positive regulation of neuron death (GO:1901216),1/47,0.1111105603036554,0.193527734155268,0,0,8.830523513753327,19.4026870705364,WNT5A,APOD+ MSC,0.9542446623584087
GO_Biological_Process_2021,inflammatory response (GO:0006954),2/230,0.1127586124121412,0.1952616886048992,0,0,3.6041666666666665,7.866115081211615,PTGFR;CCL13,APOD+ MSC,0.9478502771198579
GO_Biological_Process_2021,positive regulation of endocytosis (GO:0045807),1/48,0.1133380148369131,0.1952616886048992,0,0,8.642205818497612,18.81737166641443,SERPINE1,APOD+ MSC,0.9456243984787533
GO_Biological_Process_2021,Golgi to plasma membrane transport (GO:0006893),1/48,0.1133380148369131,0.1952616886048992,0,0,8.642205818497612,18.81737166641443,STXBP6,APOD+ MSC,0.9456243984787533
GO_Biological_Process_2021,cellular response to alcohol (GO:0097306),1/48,0.1133380148369131,0.1952616886048992,0,0,8.642205818497612,18.81737166641443,PTGFR,APOD+ MSC,0.9456243984787533
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),3/474,0.1149270413547105,0.1958958272195202,0,0,2.6397885892397346,5.711071147622478,PTGFR;WNT5A;PTN,APOD+ MSC,0.9395777734927033
GO_Biological_Process_2021,negative regulation of cell projection organization (GO:0031345),1/49,0.1155599990222406,0.1958958272195202,0,0,8.46173469387755,18.260130793597916,STMN2,APOD+ MSC,0.9371924705024297
GO_Biological_Process_2021,regulation of smooth muscle cell proliferation (GO:0048660),1/49,0.1155599990222406,0.1958958272195202,0,0,8.46173469387755,18.260130793597916,APOD,APOD+ MSC,0.9371924705024297
GO_Biological_Process_2021,receptor internalization (GO:0031623),1/49,0.1155599990222406,0.1958958272195202,0,0,8.46173469387755,18.260130793597916,DNM1,APOD+ MSC,0.9371924705024297
GO_Biological_Process_2021,regulation of cellular localization (GO:0060341),1/49,0.1155599990222406,0.1958958272195202,0,0,8.46173469387755,18.260130793597916,GSN,APOD+ MSC,0.9371924705024297
GO_Biological_Process_2021,positive regulation of actin filament polymerization (GO:0030838),1/49,0.1155599990222406,0.1958958272195202,0,0,8.46173469387755,18.260130793597916,GSN,APOD+ MSC,0.9371924705024297
GO_Biological_Process_2021,actin polymerization or depolymerization (GO:0008154),1/50,0.1177765260040411,0.1975405224512223,0,0,8.28862973760933,17.7290996615035,GSN,APOD+ MSC,0.928941259997044
GO_Biological_Process_2021,negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/50,0.1177765260040411,0.1975405224512223,0,0,8.28862973760933,17.7290996615035,FBLN1,APOD+ MSC,0.928941259997044
GO_Biological_Process_2021,regulation of complement activation (GO:0030449),1/50,0.1177765260040411,0.1975405224512223,0,0,8.28862973760933,17.7290996615035,CFH,APOD+ MSC,0.928941259997044
GO_Biological_Process_2021,iron ion transport (GO:0006826),1/50,0.1177765260040411,0.1975405224512223,0,0,8.28862973760933,17.7290996615035,SCARA5,APOD+ MSC,0.928941259997044
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),3/482,0.1192389583091006,0.1975899845626118,0,0,2.5946342113445566,5.517815916066961,GSN;WNT5A;LARP6,APOD+ MSC,0.92358182668994
GO_Biological_Process_2021,regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.1199876089220907,0.1975899845626118,0,0,8.122448979591837,17.22257115519733,FBLN1,APOD+ MSC,0.9208636010741894
GO_Biological_Process_2021,positive regulation of fat cell differentiation (GO:0045600),1/51,0.1199876089220907,0.1975899845626118,0,0,8.122448979591837,17.22257115519733,MEDAG,APOD+ MSC,0.9208636010741894
GO_Biological_Process_2021,gonad development (GO:0008406),1/51,0.1199876089220907,0.1975899845626118,0,0,8.122448979591837,17.22257115519733,WNT5A,APOD+ MSC,0.9208636010741894
GO_Biological_Process_2021,regulation of epithelial cell migration (GO:0010632),1/51,0.1199876089220907,0.1975899845626118,0,0,8.122448979591837,17.22257115519733,PTN,APOD+ MSC,0.9208636010741894
GO_Biological_Process_2021,negative regulation of transport (GO:0051051),1/51,0.1199876089220907,0.1975899845626118,0,0,8.122448979591837,17.22257115519733,EPHA3,APOD+ MSC,0.9208636010741894
GO_Biological_Process_2021,mesenchymal cell differentiation (GO:0048762),1/51,0.1199876089220907,0.1975899845626118,0,0,8.122448979591837,17.22257115519733,WNT5A,APOD+ MSC,0.9208636010741894
GO_Biological_Process_2021,negative regulation of BMP signaling pathway (GO:0030514),1/52,0.1221932608707862,0.1991530267148547,0,0,7.962785114045619,16.738979733033663,HTRA3,APOD+ MSC,0.9129527453809976
GO_Biological_Process_2021,regulation of exocytosis (GO:0017157),1/52,0.1221932608707862,0.1991530267148547,0,0,7.962785114045619,16.738979733033663,STXBP6,APOD+ MSC,0.9129527453809976
GO_Biological_Process_2021,positive regulation of protein localization to cell periphery (GO:1904377),1/52,0.1221932608707862,0.1991530267148547,0,0,7.962785114045619,16.738979733033663,EPHA3,APOD+ MSC,0.9129527453809976
GO_Biological_Process_2021,positive regulation of protein localization to plasma membrane (GO:1903078),1/52,0.1221932608707862,0.1991530267148547,0,0,7.962785114045619,16.738979733033663,EPHA3,APOD+ MSC,0.9129527453809976
GO_Biological_Process_2021,membrane organization (GO:0061024),2/242,0.122577893374113,0.1992676523056093,0,0,3.421875,7.182545007938849,WNT5A;DNM1,APOD+ MSC,0.9115878467125743
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),4/764,0.1230654595125794,0.1995485967544126,0,0,2.1956521739130435,4.5999766581612365,PTGFR;GPNMB;IGFBP6;PTN,APOD+ MSC,0.9098638223570947
GO_Biological_Process_2021,epidermal cell differentiation (GO:0009913),1/53,0.1243934949128716,0.1996594323411661,0,0,7.809262166405024,16.276887238960814,WNT5A,APOD+ MSC,0.9052023302345248
GO_Biological_Process_2021,positive regulation of chemokine production (GO:0032722),1/53,0.1243934949128716,0.1996594323411661,0,0,7.809262166405024,16.276887238960814,WNT5A,APOD+ MSC,0.9052023302345248
GO_Biological_Process_2021,positive regulation of macroautophagy (GO:0016239),1/53,0.1243934949128716,0.1996594323411661,0,0,7.809262166405024,16.276887238960814,DCN,APOD+ MSC,0.9052023302345248
GO_Biological_Process_2021,regulation of immune effector process (GO:0002697),1/53,0.1243934949128716,0.1996594323411661,0,0,7.809262166405024,16.276887238960814,CFH,APOD+ MSC,0.9052023302345248
GO_Biological_Process_2021,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/54,0.1265883240687765,0.2021586837773407,0,0,7.661532537543319,15.834970375184442,NOVA1,APOD+ MSC,0.8976063498190403
GO_Biological_Process_2021,regulation of humoral immune response (GO:0002920),1/54,0.1265883240687765,0.2021586837773407,0,0,7.661532537543319,15.834970375184442,CFH,APOD+ MSC,0.8976063498190403
GO_Biological_Process_2021,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/56,0.1309618198144747,0.2060961757509296,0,0,7.382189239332097,15.00687933540933,TP63,APOD+ MSC,0.8828552987007785
GO_Biological_Process_2021,negative regulation of metabolic process (GO:0009892),1/56,0.1309618198144747,0.2060961757509296,0,0,7.382189239332097,15.00687933540933,NOVA1,APOD+ MSC,0.8828552987007785
GO_Biological_Process_2021,positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.1309618198144747,0.2060961757509296,0,0,7.382189239332097,15.00687933540933,WNT5A,APOD+ MSC,0.8828552987007785
GO_Biological_Process_2021,chemokine-mediated signaling pathway (GO:0070098),1/56,0.1309618198144747,0.2060961757509296,0,0,7.382189239332097,15.00687933540933,CCL13,APOD+ MSC,0.8828552987007785
GO_Biological_Process_2021,peptidyl-tyrosine modification (GO:0018212),1/56,0.1309618198144747,0.2060961757509296,0,0,7.382189239332097,15.00687933540933,EPHA3,APOD+ MSC,0.8828552987007785
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),5/1079,0.1310043514631303,0.2060961757509296,0,0,1.952824332712601,3.969163767270571,GSN;CRABP2;NOVA1;PRRX2;WNT5A,APOD+ MSC,0.8827142785042424
GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),2/253,0.1317582069542016,0.206258526441886,0,0,3.270086321381142,6.627767796360294,WNT5A;IGFBP6,APOD+ MSC,0.880222323941479
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),2/253,0.1317582069542016,0.206258526441886,0,0,3.270086321381142,6.627767796360294,GPNMB;EPHA3,APOD+ MSC,0.880222323941479
GO_Biological_Process_2021,regulation of bone mineralization (GO:0030500),1/57,0.1331405122852093,0.2079090758345387,0,0,7.25,14.618539131965724,PTN,APOD+ MSC,0.8756897763447542
GO_Biological_Process_2021,receptor metabolic process (GO:0043112),1/58,0.1353138517398134,0.2082256844734022,0,0,7.122448979591836,14.246025949065045,DNM1,APOD+ MSC,0.8686577434892403
GO_Biological_Process_2021,negative regulation of neuron projection development (GO:0010977),1/58,0.1353138517398134,0.2082256844734022,0,0,7.122448979591836,14.246025949065045,STMN2,APOD+ MSC,0.8686577434892403
GO_Biological_Process_2021,cellular iron ion homeostasis (GO:0006879),1/58,0.1353138517398134,0.2082256844734022,0,0,7.122448979591836,14.246025949065045,SCARA5,APOD+ MSC,0.8686577434892403
GO_Biological_Process_2021,positive regulation of mitochondrion organization (GO:0010822),1/58,0.1353138517398134,0.2082256844734022,0,0,7.122448979591836,14.246025949065045,DCN,APOD+ MSC,0.8686577434892403
GO_Biological_Process_2021,chordate embryonic development (GO:0043009),1/58,0.1353138517398134,0.2082256844734022,0,0,7.122448979591836,14.246025949065045,WNT5A,APOD+ MSC,0.8686577434892403
GO_Biological_Process_2021,muscle organ development (GO:0007517),1/58,0.1353138517398134,0.2082256844734022,0,0,7.122448979591836,14.246025949065045,LAMA2,APOD+ MSC,0.8686577434892403
GO_Biological_Process_2021,protein polymerization (GO:0051258),1/59,0.1374818510452552,0.2105398395234101,0,0,6.9992962702322306,13.8884471557023,GSN,APOD+ MSC,0.8617546291873563
GO_Biological_Process_2021,response to reactive oxygen species (GO:0000302),1/59,0.1374818510452552,0.2105398395234101,0,0,6.9992962702322306,13.8884471557023,APOD,APOD+ MSC,0.8617546291873563
GO_Biological_Process_2021,cellular component assembly (GO:0022607),2/261,0.1385333711760542,0.211638933314743,0,0,3.1677927927927927,6.261598728808151,GSN;WNT5A,APOD+ MSC,0.8584455971996626
GO_Biological_Process_2021,cellular response to chemokine (GO:1990869),1/60,0.1396445230534406,0.2128236240766378,0,0,6.88031822898651,13.544974303558986,CCL13,APOD+ MSC,0.8549760929333525
GO_Biological_Process_2021,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2145641820902041,0,0,6.76530612244898,13.214837540593155,SERPINE1,APOD+ MSC,0.848318009451734
GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.2145641820902041,0,0,6.76530612244898,13.214837540593155,EPHA3,APOD+ MSC,0.848318009451734
GO_Biological_Process_2021,iron ion homeostasis (GO:0055072),1/61,0.1418018805927374,0.2145641820902041,0,0,6.76530612244898,13.214837540593155,SCARA5,APOD+ MSC,0.848318009451734
GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),2/266,0.1428070813555834,0.2155706894748568,0,0,3.1070075757575757,6.047046555927847,GPNMB;FBLN1,APOD+ MSC,0.8452502567236859
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),2/267,0.1436652916283004,0.2157607463869936,0,0,3.095125786163522,6.005376764494242,APOD;DCN,APOD+ MSC,0.8426481412255155
GO_Biological_Process_2021,glucose metabolic process (GO:0006006),1/62,0.1439539364695556,0.2157607463869936,0,0,6.654064904650385,12.897320592663672,APOD,APOD+ MSC,0.8417764546925935
GO_Biological_Process_2021,positive regulation of interleukin-1 production (GO:0032732),1/62,0.1439539364695556,0.2157607463869936,0,0,6.654064904650385,12.897320592663672,WNT5A,APOD+ MSC,0.8417764546925935
GO_Biological_Process_2021,central nervous system development (GO:0007417),2/268,0.1445246328363994,0.2161052292883897,0,0,3.0833333333333335,5.964108059214085,GSN;APOD,APOD+ MSC,0.8400581252728833
GO_Biological_Process_2021,actin cytoskeleton reorganization (GO:0031532),1/63,0.1461007034145454,0.2164202008523873,0,0,6.54641211323239,12.591756250239603,GSN,APOD+ MSC,0.8353476931121088
GO_Biological_Process_2021,amyloid fibril formation (GO:1990000),1/63,0.1461007034145454,0.2164202008523873,0,0,6.54641211323239,12.591756250239603,GSN,APOD+ MSC,0.8353476931121088
GO_Biological_Process_2021,negative regulation of endopeptidase activity (GO:0010951),1/63,0.1461007034145454,0.2164202008523873,0,0,6.54641211323239,12.591756250239603,SERPINE1,APOD+ MSC,0.8353476931121088
GO_Biological_Process_2021,negative regulation of peptidase activity (GO:0010466),1/63,0.1461007034145454,0.2164202008523873,0,0,6.54641211323239,12.591756250239603,SERPINE1,APOD+ MSC,0.8353476931121088
GO_Biological_Process_2021,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.1482421941802595,0.218571049093685,0,0,6.442176870748299,12.297522293260638,CCL13,APOD+ MSC,0.8290281655096747
GO_Biological_Process_2021,diterpenoid metabolic process (GO:0016101),1/64,0.1482421941802595,0.218571049093685,0,0,6.442176870748299,12.297522293260638,ADH1B,APOD+ MSC,0.8290281655096747
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),2/274,0.1497038344955427,0.2196772332385732,0,0,3.014399509803922,5.724635176902424,CCL13;GPNMB,APOD+ MSC,0.8247670755492156
GO_Biological_Process_2021,regulation of RNA metabolic process (GO:0051252),1/65,0.1503784214913892,0.2196772332385732,0,0,6.341198979591836,12.01403781811508,NOVA1,APOD+ MSC,0.8228144782361342
GO_Biological_Process_2021,BMP signaling pathway (GO:0030509),1/65,0.1503784214913892,0.2196772332385732,0,0,6.341198979591836,12.01403781811508,TMEM100,APOD+ MSC,0.8228144782361342
GO_Biological_Process_2021,regulation of cell-matrix adhesion (GO:0001952),1/65,0.1503784214913892,0.2196772332385732,0,0,6.341198979591836,12.01403781811508,EPHA3,APOD+ MSC,0.8228144782361342
GO_Biological_Process_2021,extracellular matrix disassembly (GO:0022617),1/66,0.1525093979756266,0.2212607741797421,0,0,6.243328100470958,11.740759916332207,GSN,APOD+ MSC,0.8167033932798328
GO_Biological_Process_2021,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.2212607741797421,0,0,6.243328100470958,11.740759916332207,WNT5A,APOD+ MSC,0.8167033932798328
GO_Biological_Process_2021,cellular component disassembly (GO:0022411),1/66,0.1525093979756266,0.2212607741797421,0,0,6.243328100470958,11.740759916332207,GSN,APOD+ MSC,0.8167033932798328
GO_Biological_Process_2021,positive regulation of catabolic process (GO:0009896),1/67,0.1546351363099914,0.2238325945674305,0,0,6.148423005565863,11.477180657220888,WNT5A,APOD+ MSC,0.8106918184915987
GO_Biological_Process_2021,canonical Wnt signaling pathway (GO:0060070),1/68,0.1567556490806558,0.2258706398116723,0,0,6.0563508985683825,11.222824361971773,WNT5A,APOD+ MSC,0.8047767993307415
GO_Biological_Process_2021,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/68,0.1567556490806558,0.2258706398116723,0,0,6.0563508985683825,11.222824361971773,HTRA3,APOD+ MSC,0.8047767993307415
GO_Biological_Process_2021,cellular response to calcium ion (GO:0071277),1/69,0.158870948881139,0.2273683557350839,0,0,5.966986794717887,10.977245117600177,WNT5A,APOD+ MSC,0.7989555105590889
GO_Biological_Process_2021,synapse assembly (GO:0007416),1/69,0.158870948881139,0.2273683557350839,0,0,5.966986794717887,10.977245117600177,WNT5A,APOD+ MSC,0.7989555105590889
GO_Biological_Process_2021,peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.158870948881139,0.2273683557350839,0,0,5.966986794717887,10.977245117600177,EPHA3,APOD+ MSC,0.7989555105590889
GO_Biological_Process_2021,positive regulation of cell-substrate adhesion (GO:0010811),1/70,0.1609810482853106,0.2293527744109819,0,0,5.880212954747116,10.740024519792764,FBLN2,APOD+ MSC,0.7932252488723367
GO_Biological_Process_2021,neutrophil chemotaxis (GO:0030593),1/70,0.1609810482853106,0.2293527744109819,0,0,5.880212954747116,10.740024519792764,CCL13,APOD+ MSC,0.7932252488723367
GO_Biological_Process_2021,regulation of endopeptidase activity (GO:0052548),1/71,0.16308595979881,0.2307957556081374,0,0,5.795918367346939,10.51076961698872,SERPINE1,APOD+ MSC,0.7875834261109624
GO_Biological_Process_2021,cellular response to BMP stimulus (GO:0071773),1/71,0.16308595979881,0.2307957556081374,0,0,5.795918367346939,10.51076961698872,TMEM100,APOD+ MSC,0.7875834261109624
GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.16308595979881,0.2307957556081374,0,0,5.795918367346939,10.51076961698872,GPNMB,APOD+ MSC,0.7875834261109624
GO_Biological_Process_2021,regulation of actin filament-based process (GO:0032970),1/73,0.1672802691231711,0.2346364836816161,0,0,5.634353741496598,10.074701240888364,EPHA3,APOD+ MSC,0.7765552814899175
GO_Biological_Process_2021,granulocyte chemotaxis (GO:0071621),1/73,0.1672802691231711,0.2346364836816161,0,0,5.634353741496598,10.074701240888364,CCL13,APOD+ MSC,0.7765552814899175
GO_Biological_Process_2021,regulation of hydrolase activity (GO:0051336),1/73,0.1672802691231711,0.2346364836816161,0,0,5.634353741496598,10.074701240888364,EPHA3,APOD+ MSC,0.7765552814899175
GO_Biological_Process_2021,defense response to Gram-negative bacterium (GO:0050829),1/73,0.1672802691231711,0.2346364836816161,0,0,5.634353741496598,10.074701240888364,SERPINE1,APOD+ MSC,0.7765552814899175
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),3/566,0.1678713329989042,0.2349457508196585,0,0,2.197989493972261,3.922438566092192,GPNMB;FBLN1;IGFBP6,APOD+ MSC,0.7750234609992368
GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),1/76,0.1735331353639065,0.2402183576871545,0,0,5.408163265306122,9.4717853003048,GPNMB,APOD+ MSC,0.7606175863963804
GO_Biological_Process_2021,regulation of BMP signaling pathway (GO:0030510),1/76,0.1735331353639065,0.2402183576871545,0,0,5.408163265306122,9.4717853003048,HTRA3,APOD+ MSC,0.7606175863963804
GO_Biological_Process_2021,regulation of cell division (GO:0051302),1/76,0.1735331353639065,0.2402183576871545,0,0,5.408163265306122,9.4717853003048,TP63,APOD+ MSC,0.7606175863963804
GO_Biological_Process_2021,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.2402183576871545,0,0,5.408163265306122,9.4717853003048,WNT5A,APOD+ MSC,0.7606175863963804
GO_Biological_Process_2021,regulation of epithelial to mesenchymal transition (GO:0010717),1/76,0.1735331353639065,0.2402183576871545,0,0,5.408163265306122,9.4717853003048,EPHA3,APOD+ MSC,0.7606175863963804
GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1756071809118701,0.2404642606870964,0,0,5.336734693877551,9.283280446293812,WNT5A,APOD+ MSC,0.7554577289388229
GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.1756071809118701,0.2404642606870964,0,0,5.336734693877551,9.283280446293812,DCN,APOD+ MSC,0.7554577289388229
GO_Biological_Process_2021,neutrophil migration (GO:1990266),1/77,0.1756071809118701,0.2404642606870964,0,0,5.336734693877551,9.283280446293812,CCL13,APOD+ MSC,0.7554577289388229
GO_Biological_Process_2021,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.1756071809118701,0.2404642606870964,0,0,5.336734693877551,9.283280446293812,WNT5A,APOD+ MSC,0.7554577289388229
GO_Biological_Process_2021,regulation of organelle assembly (GO:1902115),1/77,0.1756071809118701,0.2404642606870964,0,0,5.336734693877551,9.283280446293812,GSN,APOD+ MSC,0.7554577289388229
GO_Biological_Process_2021,negative regulation of blood vessel morphogenesis (GO:2000181),1/78,0.1776761254379788,0.2427729817406866,0,0,5.267161410018553,9.10056411919043,DCN,APOD+ MSC,0.7503709249641564
GO_Biological_Process_2021,negative regulation of cellular component organization (GO:0051129),1/80,0.181798760490535,0.2457578126886976,0,0,5.133298889175924,8.751529842637671,EPHA3,APOD+ MSC,0.7404090821369118
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2457578126886976,0,0,5.133298889175924,8.751529842637671,FBLN2,APOD+ MSC,0.7404090821369118
GO_Biological_Process_2021,negative regulation of cellular response to growth factor stimulus (GO:0090288),1/80,0.181798760490535,0.2457578126886976,0,0,5.133298889175924,8.751529842637671,HTRA3,APOD+ MSC,0.7404090821369118
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.2457578126886976,0,0,5.133298889175924,8.751529842637671,SERPINE1,APOD+ MSC,0.7404090821369118
GO_Biological_Process_2021,regulation of protein localization to plasma membrane (GO:1903076),1/80,0.181798760490535,0.2457578126886976,0,0,5.133298889175924,8.751529842637671,EPHA3,APOD+ MSC,0.7404090821369118
GO_Biological_Process_2021,positive regulation of cellular amide metabolic process (GO:0034250),1/81,0.1838524754991919,0.2464322821701642,0,0,5.0688775510204085,8.584760541358477,LARP6,APOD+ MSC,0.7355305181562768
GO_Biological_Process_2021,negative regulation of protein modification process (GO:0031400),1/81,0.1838524754991919,0.2464322821701642,0,0,5.0688775510204085,8.584760541358477,FBLN1,APOD+ MSC,0.7355305181562768
GO_Biological_Process_2021,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2464322821701642,0,0,5.0688775510204085,8.584760541358477,SERPINE1,APOD+ MSC,0.7355305181562768
GO_Biological_Process_2021,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.1838524754991919,0.2464322821701642,0,0,5.0688775510204085,8.584760541358477,WNT5A,APOD+ MSC,0.7355305181562768
GO_Biological_Process_2021,epidermis development (GO:0008544),1/83,0.1879447615357932,0.2492823824554245,0,0,4.944748631159781,8.265677319811374,CRABP2,APOD+ MSC,0.7259697745939766
GO_Biological_Process_2021,regulation of defense response (GO:0031347),1/83,0.1879447615357932,0.2492823824554245,0,0,4.944748631159781,8.265677319811374,WNT5A,APOD+ MSC,0.7259697745939766
GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.2492823824554245,0,0,4.944748631159781,8.265677319811374,WNT5A,APOD+ MSC,0.7259697745939766
GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.2492823824554245,0,0,4.944748631159781,8.265677319811374,TP63,APOD+ MSC,0.7259697745939766
GO_Biological_Process_2021,regulation of osteoblast differentiation (GO:0045667),1/83,0.1879447615357932,0.2492823824554245,0,0,4.944748631159781,8.265677319811374,TP63,APOD+ MSC,0.7259697745939766
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),4/908,0.1908851520255107,0.2526538337874192,0,0,1.8320507887649096,3.0340287711400475,WNT5A;SERPINE1;DCN;TP63,APOD+ MSC,0.7192278518272621
GO_Biological_Process_2021,positive regulation of protein catabolic process (GO:0045732),1/85,0.1920169366451308,0.253095089049923,0,0,4.826530612244898,7.964604221414354,WNT5A,APOD+ MSC,0.716660463134361
GO_Biological_Process_2021,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",1/85,0.1920169366451308,0.253095089049923,0,0,4.826530612244898,7.964604221414354,WNT5A,APOD+ MSC,0.716660463134361
GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),1/86,0.1940455128548384,0.2541835850205942,0,0,4.769507803121249,7.820383303288144,WNT5A,APOD+ MSC,0.7120963955156414
GO_Biological_Process_2021,response to interleukin-1 (GO:0070555),1/86,0.1940455128548384,0.2541835850205942,0,0,4.769507803121249,7.820383303288144,CCL13,APOD+ MSC,0.7120963955156414
GO_Biological_Process_2021,negative regulation of phosphorylation (GO:0042326),1/86,0.1940455128548384,0.2541835850205942,0,0,4.769507803121249,7.820383303288144,FBLN1,APOD+ MSC,0.7120963955156414
GO_Biological_Process_2021,regulation of establishment of planar polarity (GO:0090175),1/88,0.1980877029036425,0.2589435126616688,0,0,4.659394792399718,7.5437717166037235,WNT5A,APOD+ MSC,0.703142484213379
GO_Biological_Process_2021,collagen fibril organization (GO:0030199),1/89,0.2001013407742902,0.2605015401455853,0,0,4.6062152133580705,7.411084001248333,LUM,APOD+ MSC,0.6987500013741589
GO_Biological_Process_2021,post-Golgi vesicle-mediated transport (GO:0006892),1/89,0.2001013407742902,0.2605015401455853,0,0,4.6062152133580705,7.411084001248333,STXBP6,APOD+ MSC,0.6987500013741589
GO_Biological_Process_2021,positive regulation of autophagy (GO:0010508),1/90,0.2021100231923967,0.2620403981676473,0,0,4.55423068103646,7.281955543769811,DCN,APOD+ MSC,0.6944121480917811
GO_Biological_Process_2021,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.2021100231923967,0.2620403981676473,0,0,4.55423068103646,7.281955543769811,NOVA1,APOD+ MSC,0.6944121480917811
GO_Biological_Process_2021,regulation of stem cell differentiation (GO:2000736),1/91,0.2041137620931186,0.2624003394028598,0,0,4.503401360544218,7.156255051106618,PTN,APOD+ MSC,0.6901277125812961
GO_Biological_Process_2021,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.2041137620931186,0.2624003394028598,0,0,4.503401360544218,7.156255051106618,EPHA3,APOD+ MSC,0.6901277125812961
GO_Biological_Process_2021,positive regulation of supramolecular fiber organization (GO:1902905),1/91,0.2041137620931186,0.2624003394028598,0,0,4.503401360544218,7.156255051106618,STMN2,APOD+ MSC,0.6901277125812961
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),2/335,0.2041536136242794,0.2624003394028598,0,0,2.4545795795795797,3.9000386874614623,WNT5A;SERPINE1,APOD+ MSC,0.6900429284365769
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),3/625,0.2050267003954304,0.2624003394028598,0,0,1.9834439351440103,3.142995135240803,PTGFR;WNT5A;PTN,APOD+ MSC,0.6881895775817527
GO_Biological_Process_2021,negative regulation of mitotic cell cycle phase transition (GO:1901991),1/92,0.2061125694363157,0.2624003394028598,0,0,4.453689167974883,7.03385741012878,GPNMB,APOD+ MSC,0.6858955226779435
GO_Biological_Process_2021,retinoid metabolic process (GO:0001523),1/92,0.2061125694363157,0.2624003394028598,0,0,4.453689167974883,7.03385741012878,ADH1B,APOD+ MSC,0.6858955226779435
GO_Biological_Process_2021,regulation of endothelial cell proliferation (GO:0001936),1/92,0.2061125694363157,0.2624003394028598,0,0,4.453689167974883,7.03385741012878,WNT5A,APOD+ MSC,0.6858955226779435
GO_Biological_Process_2021,Wnt signaling pathway (GO:0016055),1/92,0.2061125694363157,0.2624003394028598,0,0,4.453689167974883,7.03385741012878,WNT5A,APOD+ MSC,0.6858955226779435
GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),1/94,0.2100954368002021,0.2648121410165569,0,0,4.357472021066491,6.79849904676328,GPNMB,APOD+ MSC,0.6775833802166729
GO_Biological_Process_2021,positive regulation of epithelial cell migration (GO:0010634),1/94,0.2100954368002021,0.2648121410165569,0,0,4.357472021066491,6.79849904676328,WNT5A,APOD+ MSC,0.6775833802166729
GO_Biological_Process_2021,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2648121410165569,0,0,4.357472021066491,6.79849904676328,WNT5A,APOD+ MSC,0.6775833802166729
GO_Biological_Process_2021,negative regulation of MAPK cascade (GO:0043409),1/94,0.2100954368002021,0.2648121410165569,0,0,4.357472021066491,6.79849904676328,FBLN1,APOD+ MSC,0.6775833802166729
GO_Biological_Process_2021,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.2648121410165569,0,0,4.357472021066491,6.79849904676328,EPHA3,APOD+ MSC,0.6775833802166729
GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.2140587201245348,0.2692722788868156,0,0,4.26530612244898,6.5749903239841245,SCARA5,APOD+ MSC,0.6694670755856718
GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2712177266856237,0,0,4.220663265306122,6.46742313757927,CCL13,APOD+ MSC,0.6654798083211632
GO_Biological_Process_2021,negative regulation of neuron death (GO:1901215),1/98,0.2180025137484037,0.2726106384940591,0,0,4.176940879444562,6.362519703204576,GPNMB,APOD+ MSC,0.6615384985937142
GO_Biological_Process_2021,RNA splicing (GO:0008380),1/98,0.2180025137484037,0.2726106384940591,0,0,4.176940879444562,6.362519703204576,NOVA1,APOD+ MSC,0.6615384985937142
GO_Biological_Process_2021,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1/100,0.2219269115603851,0.2764276265801261,0,0,4.092145949288806,6.1603458876211565,HTRA3,APOD+ MSC,0.6537900306498672
GO_Biological_Process_2021,positive regulation of translation (GO:0045727),1/100,0.2219269115603851,0.2764276265801261,0,0,4.092145949288806,6.1603458876211565,LARP6,APOD+ MSC,0.6537900306498672
GO_Biological_Process_2021,positive regulation of cellular protein metabolic process (GO:0032270),1/102,0.2258320069783284,0.2796435398911332,0,0,4.010709234188725,5.967790506031058,LARP6,APOD+ MSC,0.6462145058611213
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2796435398911332,0,0,4.010709234188725,5.967790506031058,PTGFR,APOD+ MSC,0.6462145058611213
GO_Biological_Process_2021,regulation of protein catabolic process (GO:0042176),1/102,0.2258320069783284,0.2796435398911332,0,0,4.010709234188725,5.967790506031058,WNT5A,APOD+ MSC,0.6462145058611213
GO_Biological_Process_2021,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2839008659050383,0,0,3.932435109966317,5.78423168094792,CCL13,APOD+ MSC,0.6388051756325536
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2875585940390469,0,0,3.857142857142857,5.6090983677319475,WNT5A,APOD+ MSC,0.6315556772929499
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.2335846623503299,0.2875585940390469,0,0,3.857142857142857,5.6090983677319475,DCN,APOD+ MSC,0.6315556772929499
GO_Biological_Process_2021,response to calcium ion (GO:0051592),1/107,0.2355109070084182,0.2893680524095681,0,0,3.8205621871390063,5.524525481436682,WNT5A,APOD+ MSC,0.6279889749729552
GO_Biological_Process_2021,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/108,0.2374324069826741,0.2911646925087339,0,0,3.7846652679763495,5.441865346754643,HTRA3,APOD+ MSC,0.6244600047865677
GO_Biological_Process_2021,response to tumor necrosis factor (GO:0034612),1/110,0.241261218690496,0.2947198702307794,0,0,3.714847406852649,5.282048795926194,CCL13,APOD+ MSC,0.6175124827423236
GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),1/110,0.241261218690496,0.2947198702307794,0,0,3.714847406852649,5.282048795926194,WNT5A,APOD+ MSC,0.6175124827423236
GO_Biological_Process_2021,cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.2431685532271013,0.296478582203812,0,0,3.6808905380333954,5.20478084558139,CCL13,APOD+ MSC,0.6140925891155178
GO_Biological_Process_2021,regulation of cytoskeleton organization (GO:0051493),1/112,0.2450711886958998,0.2976535127072806,0,0,3.647545504688362,5.129202360192396,EPHA3,APOD+ MSC,0.6107077427090284
GO_Biological_Process_2021,regulation of macroautophagy (GO:0016241),1/112,0.2450711886958998,0.2976535127072806,0,0,3.647545504688362,5.129202360192396,DCN,APOD+ MSC,0.6107077427090284
GO_Biological_Process_2021,activation of protein kinase activity (GO:0032147),1/114,0.2488624078588274,0.3005309839666602,0,0,3.582625970742279,4.982913653406146,WNT5A,APOD+ MSC,0.6040407011916724
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.3005309839666602,0,0,3.582625970742279,4.982913653406146,EPHA3,APOD+ MSC,0.6040407011916724
GO_Biological_Process_2021,cellular response to transforming growth factor beta stimulus (GO:0071560),1/114,0.2488624078588274,0.3005309839666602,0,0,3.582625970742279,4.982913653406146,WNT5A,APOD+ MSC,0.6040407011916724
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),2/384,0.2493463820044915,0.30054297754914,0,0,2.1343804537521813,2.9644671728961822,GSN;WNT5A,APOD+ MSC,0.6031969289771376
GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),1/115,0.2507510141385882,0.3016625103678652,0,0,3.5510204081632653,4.9121080927455,WNT5A,APOD+ MSC,0.6007573018413346
GO_Biological_Process_2021,regulation of protein-containing complex assembly (GO:0043254),1/116,0.2526349665899778,0.3033533500341779,0,0,3.5199645075421473,4.8428011439058265,GSN,APOD+ MSC,0.5975065399797567
GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.2563889548341396,0.3066992403110273,0,0,3.4594453165881736,4.708511372057024,PTGFR,APOD+ MSC,0.5911006880374128
GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.3066992403110273,0,0,3.4594453165881736,4.708511372057024,SERPINE1,APOD+ MSC,0.5911006880374128
GO_Biological_Process_2021,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),1/119,0.2582590130323782,0.3083544524718037,0,0,3.429955032860602,4.6434466139665425,GSN,APOD+ MSC,0.5879445130148351
GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),1/120,0.2601244621662815,0.3099979492733505,0,0,3.4009603841536613,4.579716458908873,CCL13,APOD+ MSC,0.5848188047272944
GO_Biological_Process_2021,protein homooligomerization (GO:0051260),1/121,0.2619853133921213,0.311629809926088,0,0,3.372448979591837,4.517283552621874,SCARA5,APOD+ MSC,0.5817230540677998
GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.2656932663769877,0.3154485597060117,0,0,3.316828370692539,4.396166676729281,GPNMB,APOD+ MSC,0.5756194520344882
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),1/124,0.2675403902734135,0.3164563571517614,0,0,3.2896963663514187,4.337414433160371,WNT5A,APOD+ MSC,0.5726106437410472
GO_Biological_Process_2021,non-canonical Wnt signaling pathway (GO:0035567),1/124,0.2675403902734135,0.3164563571517614,0,0,3.2896963663514187,4.337414433160371,WNT5A,APOD+ MSC,0.5726106437410472
GO_Biological_Process_2021,platelet degranulation (GO:0002576),1/125,0.2693829605231016,0.3180424524611665,0,0,3.263001974983542,4.279822783786303,SERPINE1,APOD+ MSC,0.5696298784899082
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),2/408,0.2716606168083876,0.3201353737109995,0,0,2.0057471264367814,2.6138931132295458,GPNMB;SERPINE1,APOD+ MSC,0.5659733175722854
GO_Biological_Process_2021,plasma membrane bounded cell projection organization (GO:0120036),1/128,0.274883458910421,0.3233323060282133,0,0,3.1854411055760887,4.113704308580095,STMN2,APOD+ MSC,0.5608513930050725
GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.3248755997836169,0,0,3.1603954081632653,4.060453122404681,LARP6,APOD+ MSC,0.5579784037567757
GO_Biological_Process_2021,regulation of response to external stimulus (GO:0032101),1/130,0.2785278903472666,0.3264079158598281,0,0,3.135738016136687,4.008216604624779,WNT5A,APOD+ MSC,0.5551313103019286
GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.327929327726905,0,0,3.111459968602826,3.956968446025251,WNT5A,APOD+ MSC,0.5523097126477655
GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3297274964435726,0,0,3.0640074211502784,3.857336278341556,FBLN1,APOD+ MSC,0.546741450090894
GO_Biological_Process_2021,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3297274964435726,0,0,3.0640074211502784,3.857336278341556,FBLN1,APOD+ MSC,0.546741450090894
GO_Biological_Process_2021,RNA metabolic process (GO:0016070),1/133,0.2839609038772722,0.3297274964435726,0,0,3.0640074211502784,3.857336278341556,NOVA1,APOD+ MSC,0.546741450090894
GO_Biological_Process_2021,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1/133,0.2839609038772722,0.3297274964435726,0,0,3.0640074211502784,3.857336278341556,TMEM100,APOD+ MSC,0.546741450090894
GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),1/136,0.289353816496661,0.335375355866331,0,0,2.99546485260771,3.714691124222948,CCL13,APOD+ MSC,0.5385707850387818
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),2/430,0.2921183511246394,0.3379617419945646,0,0,1.900506230529595,2.3387558342335666,CRABP2;PRRX2,APOD+ MSC,0.5344411594186865
GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),1/139,0.2947069182263764,0.3403354939080559,0,0,2.929902395740905,3.579678317757992,WNT5A,APOD+ MSC,0.5306096689947516
GO_Biological_Process_2021,positive regulation of cellular catabolic process (GO:0031331),1/141,0.2982536777952956,0.3436007317986778,0,0,2.8877551020408165,3.4936375609484274,DCN,APOD+ MSC,0.5254141922968343
GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),2/437,0.2986183016105228,0.3436007317986778,0,0,1.8692528735632183,2.259158656282815,WNT5A;TP63,APOD+ MSC,0.5248835789121016
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3453617227457555,0,0,2.8467950560505892,3.410594866305226,DNM1,APOD+ MSC,0.5203052911363482
GO_Biological_Process_2021,neuron development (GO:0048666),1/143,0.3017829564686885,0.3453617227457555,0,0,2.8467950560505892,3.410594866305226,STMN2,APOD+ MSC,0.5203052911363482
GO_Biological_Process_2021,monocarboxylic acid metabolic process (GO:0032787),1/143,0.3017829564686885,0.3453617227457555,0,0,2.8467950560505892,3.410594866305226,ADH1B,APOD+ MSC,0.5203052911363482
GO_Biological_Process_2021,negative regulation of cell migration (GO:0030336),1/144,0.3035410668561185,0.346747813309512,0,0,2.826744683887541,3.370153465117457,SERPINE1,APOD+ MSC,0.5177825437898177
GO_Biological_Process_2021,nervous system development (GO:0007399),2/447,0.3078904676985005,0.351083734749729,0,0,1.826310861423221,2.1514146195112085,GSN;PTN,APOD+ MSC,0.5116037566636256
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.3087894082520855,0.3514766334503092,0,0,2.7682415431926195,3.252948903166252,PTGFR,APOD+ MSC,0.5103376047629952
GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3521934954202912,0,0,2.749271137026239,3.215201203875706,TP63,APOD+ MSC,0.5078961191737069
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3521934954202912,0,0,2.749271137026239,3.215201203875706,EPHA3,APOD+ MSC,0.5078961191737069
GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),1/149,0.3122667490151626,0.3535305694207376,0,0,2.7305570876999448,3.1780885451938787,CCL13,APOD+ MSC,0.5054742581266645
GO_Biological_Process_2021,brain development (GO:0007420),1/150,0.3139989845586295,0.3542266124736141,0,0,2.712094233666621,3.141596466170354,APOD,APOD+ MSC,0.5030717563895143
GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),1/150,0.3139989845586295,0.3542266124736141,0,0,2.712094233666621,3.141596466170354,GPNMB,APOD+ MSC,0.5030717563895143
GO_Biological_Process_2021,actin filament organization (GO:0007015),1/152,0.3174506378807152,0.356850539745343,0,0,2.6759021489390458,3.0704182805545575,GSN,APOD+ MSC,0.4983237959237088
GO_Biological_Process_2021,negative regulation of protein phosphorylation (GO:0001933),1/152,0.3174506378807152,0.356850539745343,0,0,2.6759021489390458,3.0704182805545575,FBLN1,APOD+ MSC,0.4983237959237088
GO_Biological_Process_2021,cellular response to interleukin-1 (GO:0071347),1/155,0.3225962281219006,0.3613498732734004,0,0,2.6233766233766236,2.9679671260643183,CCL13,APOD+ MSC,0.4913407148001928
GO_Biological_Process_2021,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/155,0.3225962281219006,0.3613498732734004,0,0,2.6233766233766236,2.9679671260643183,WNT5A,APOD+ MSC,0.4913407148001928
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),2/464,0.3236043277850015,0.3613498732734004,0,0,1.7575757575757576,1.982956235178162,WNT5A;TP63,APOD+ MSC,0.48998567889976286
GO_Biological_Process_2021,regulation of signal transduction by p53 class mediator (GO:1901796),1/156,0.3243029619756543,0.3613498732734004,0,0,2.6063199473337724,2.934917292064671,TP63,APOD+ MSC,0.4890490847411261
GO_Biological_Process_2021,regulation of cell differentiation (GO:0045595),1/156,0.3243029619756543,0.3613498732734004,0,0,2.6063199473337724,2.934917292064671,EPHA3,APOD+ MSC,0.4890490847411261
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),2/468,0.3272907950685003,0.3640392352165424,0,0,1.742131616595136,1.9457976416065603,CRABP2;PRRX2,APOD+ MSC,0.48506620889050567
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.3769303640946174,0,0,2.4621702339472376,2.6600168495918335,PTGFR,APOD+ MSC,0.46919202564454415
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),2/482,0.3401543782991926,0.3770242584644896,0,0,1.6901041666666667,1.8225334796372663,CCL13;WNT5A,APOD+ MSC,0.46832393464331673
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",4/1183,0.3428517320675613,0.3793507820782441,0,0,1.384445181989158,1.481989303783668,WNT5A;SERPINE1;DCN;TP63,APOD+ MSC,0.4648936521619021
GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.38046400334307,0,0,2.4175730172308443,2.5766088705447237,STXBP6,APOD+ MSC,0.46286379212748074
GO_Biological_Process_2021,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.3852557907628684,0,0,2.3745498199279713,2.4969025061029213,STMN2,APOD+ MSC,0.4566722378913039
GO_Biological_Process_2021,neuron differentiation (GO:0030182),1/174,0.3543133002736421,0.3899906812039741,0,0,2.333018756635602,2.4206789693623425,WNT5A,APOD+ MSC,0.45061254473982715
GO_Biological_Process_2021,mitochondrion organization (GO:0007005),1/175,0.3559416811668189,0.3911040309527958,0,0,2.319493314567206,2.396009637948729,DNM1,APOD+ MSC,0.4486211526513072
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),1/176,0.3575660373570176,0.3922091136407425,0,0,2.306122448979592,2.3716975343886144,SERPINE1,APOD+ MSC,0.4466437384468818
GO_Biological_Process_2021,regulation of translation (GO:0006417),1/178,0.3608027143922477,0.3950758565193178,0,0,2.279833967485299,2.3241173885161555,LARP6,APOD+ MSC,0.44273020383203454
GO_Biological_Process_2021,RNA processing (GO:0006396),1/179,0.3624150547196057,0.3961571460210862,0,0,2.266911258885577,2.300835957547096,NOVA1,APOD+ MSC,0.4407937700298507
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.3965478374431858,0,0,2.2541329380914377,2.2778849681371156,LARP6,APOD+ MSC,0.4388706874182523
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.3965478374431858,0,0,2.2541329380914377,2.2778849681371156,SERPINE1,APOD+ MSC,0.4388706874182523
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),2/511,0.3665685304553946,0.3986354173391427,0,0,1.591437459070072,1.5971185548456277,WNT5A;TP63,APOD+ MSC,0.43584482152384213
GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.4141137988625059,0,0,2.122448979591837,2.045536603225051,WNT5A,APOD+ MSC,0.41855670871419515
GO_Biological_Process_2021,cellular response to tumor necrosis factor (GO:0071356),1/194,0.3861272144560919,0.4177553821931097,0,0,2.089140319340171,1.988001678572607,CCL13,APOD+ MSC,0.4132695879859197
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4177553821931097,0,0,2.089140319340171,1.988001678572607,TP63,APOD+ MSC,0.4132695879859197
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.4187174974327729,0,0,2.0782663580896275,1.969329769675335,PTN,APOD+ MSC,0.4115300469974289
GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),1/198,0.3923030921692546,0.4229934701280738,0,0,2.0463068476121413,1.914771355908193,IGFBP6,APOD+ MSC,0.4063782687077012
GO_Biological_Process_2021,endomembrane system organization (GO:0010256),1/199,0.3938375225272607,0.4239269767101583,0,0,2.03586889301175,1.897056906545971,DNM1,APOD+ MSC,0.4046829091978336
GO_Biological_Process_2021,regulation of macromolecule metabolic process (GO:0060255),1/200,0.3953681557510544,0.4248532385528279,0,0,2.025535842477695,1.8795714928238216,NOVA1,APOD+ MSC,0.40299831311675843
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),2/546,0.3979281971141292,0.4263886333423667,0,0,1.4863664215686274,1.3696624285648409,WNT5A;DCN,APOD+ MSC,0.40019528574129115
GO_Biological_Process_2021,generation of neurons (GO:0048699),1/202,0.398418067592006,0.4263886333423667,0,0,2.0051781906792567,1.8452720554356252,WNT5A,APOD+ MSC,0.39966097527446726
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/547,0.3988146050031916,0.4263886333423667,0,0,1.4835626911314983,1.3637777909312412,WNT5A;TP63,APOD+ MSC,0.3992289457561903
GO_Biological_Process_2021,proteasomal protein catabolic process (GO:0010498),1/205,0.4029646862685204,0.4301003553775117,0,0,1.975390156062425,1.7954446526222323,TRIM9,APOD+ MSC,0.3947330115033212
GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),1/214,0.416403436812339,0.4429526492265486,0,0,1.8910606496119575,1.656759537391559,CCL13,APOD+ MSC,0.3804856946694876
GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),1/214,0.416403436812339,0.4429526492265486,0,0,1.8910606496119575,1.656759537391559,GPNMB,APOD+ MSC,0.3804856946694876
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4530927464536016,0,0,1.8302411873840445,1.5589816483293069,GPNMB,APOD+ MSC,0.3699278171231457
GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.4569335771808704,0,0,1.805344559348403,1.519514184420898,WNT5A,APOD+ MSC,0.36553500108915365
GO_Biological_Process_2021,cilium organization (GO:0044782),1/228,0.4367210295579323,0.4622389528209167,0,0,1.7731727052054302,1.469003836799846,GSN,APOD+ MSC,0.359795894863476
GO_Biological_Process_2021,apoptotic process (GO:0006915),1/231,0.4409837467017168,0.4651974965206131,0,0,1.749778172138421,1.4326260836369302,TP63,APOD+ MSC,0.35557741698984124
GO_Biological_Process_2021,regulation of autophagy (GO:0010506),1/231,0.4409837467017168,0.4651974965206131,0,0,1.749778172138421,1.4326260836369302,DCN,APOD+ MSC,0.35557741698984124
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.4834967081075963,0,0,1.655076845553036,1.2884811006593149,NOVA1,APOD+ MSC,0.33809924509335265
GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.4618276248188864,0.4855700068576683,0,0,1.641399416909621,1.2680853834334544,WNT5A,APOD+ MSC,0.33552009275365935
GO_Biological_Process_2021,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",1/251,0.4686048306829435,0.4918799050546129,0,0,1.6081632653061224,1.21898042864121,NOVA1,APOD+ MSC,0.32919323872639555
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.4924767386279987,0,0,1.6016749329213755,1.2094704650298027,TP63,APOD+ MSC,0.32794816113488356
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.515064629637094,0,0,1.498781602193116,1.0620843946744252,GPNMB,APOD+ MSC,0.30775490655057164
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),1/274,0.4987179596066677,0.5200447144582687,0,0,1.4709576138147566,1.0233666205889618,SCARA5,APOD+ MSC,0.30214499188263844
GO_Biological_Process_2021,"mRNA splicing, via spliceosome (GO:0000398)",1/274,0.4987179596066677,0.5200447144582687,0,0,1.4709576138147566,1.0233666205889618,NOVA1,APOD+ MSC,0.30214499188263844
GO_Biological_Process_2021,plasma membrane bounded cell projection assembly (GO:0120031),1/278,0.5037814900878317,0.5244621752310104,0,0,1.4494216459146836,0.9937418248041268,GSN,APOD+ MSC,0.2977577933690553
GO_Biological_Process_2021,proteolysis (GO:0006508),1/287,0.51499186851511,0.5352538436698029,0,0,1.4031682603111175,0.9311483055746664,HTRA3,APOD+ MSC,0.28819962821492023
GO_Biological_Process_2021,mRNA processing (GO:0006397),1/300,0.5307476794848257,0.5507267247027487,0,0,1.341273633199099,0.8496546643160489,NOVA1,APOD+ MSC,0.2751118959639202
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.557183795550045,0,0,1.314486450317832,0.8152139890333826,NOVA1,APOD+ MSC,0.2693393582885023
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5611108463537254,0,0,1.2972062611452349,0.7932686422257892,TP63,APOD+ MSC,0.2655801196036423
GO_Biological_Process_2021,cilium assembly (GO:0060271),1/314,0.5471545986718139,0.5649772240357167,0,0,1.2803677381495728,0.7720923294539072,GSN,APOD+ MSC,0.26188994631047774
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.5551458962416416,0.5722967450686192,0,0,1.2519132653061225,0.7367814077584223,TRIM9,APOD+ MSC,0.25559286623594474
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5725309924340174,0,0,1.2479496471485791,0.7319104885681406,GPNMB,APOD+ MSC,0.2547095446988111
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),2/742,0.5583209845238664,0.5737042207263068,0,0,1.0816441441441442,0.6304051823091851,WNT5A;TP63,APOD+ MSC,0.25311604886163686
GO_Biological_Process_2021,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.5787144397135128,0,0,1.2208810353409656,0.6989624697257846,WNT5A,APOD+ MSC,0.24863646405532092
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.5909956578792304,0.6053170389263847,0,0,1.1329710354396716,0.5958822738188654,TRIM9,APOD+ MSC,0.22841570992418872
GO_Biological_Process_2021,gene expression (GO:0010467),1/356,0.5930749260701463,0.6064669405297948,0,0,1.126473124461052,0.5885084653208599,NOVA1,APOD+ MSC,0.2268904366133749
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6210777095445129,0,0,1.0799779371207945,0.5367673309131087,GPNMB,APOD+ MSC,0.21585171499242045
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.630134633633848,0,0,1.0510204081632653,0.5054679174936134,WNT5A,APOD+ MSC,0.20886552310647807
GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),1/417,0.6517468120762254,0.6632543801867206,0,0,0.9583006279434853,0.41024765313154,IGFBP6,APOD+ MSC,0.1859210844420885
GO_Biological_Process_2021,organelle organization (GO:0006996),1/420,0.6544076492323022,0.6648949513033326,0,0,0.9512931664312504,0.4033718992390181,CCL13,APOD+ MSC,0.18415163293091988
GO_Biological_Process_2021,organelle assembly (GO:0070925),1/425,0.658798168385351,0.667326855608752,0,0,0.939834424335772,0.3922286762298742,GSN,APOD+ MSC,0.18124761694193237
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),5/2206,0.6589063274622694,0.667326855608752,0,0,0.8960068655661568,0.3737906767782196,PRRX2;WNT5A;SERPINE1;DCN;TP63,APOD+ MSC,0.1811763219125431
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",2/948,0.6926945411260426,0.7004279730046428,0,0,0.8370331219168429,0.3073302326128318,WNT5A;TP63,APOD+ MSC,0.15945823486666727
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),1/481,0.7043872370804651,0.7111170514474761,0,0,0.8278061224489796,0.2900856337670249,GSN,APOD+ MSC,0.15218852169360617
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7118962688447369,0,0,0.8207960870298533,0.2841203737887477,WNT5A,APOD+ MSC,0.15033199168778996
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),1/485,0.7074048097353064,0.7118962688447369,0,0,0.8207960870298533,0.2841203737887477,GSN,APOD+ MSC,0.15033199168778996
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),1/488,0.7096481586491704,0.7130220801641428,0,0,0.815614130662532,0.2797442143304909,GSN,APOD+ MSC,0.14895691977455572
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7178127327409743,0,0,0.8021026592455164,0.2684686706444305,EPHA3,APOD+ MSC,0.1453610219101508
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),1/621,0.7938341129137421,0.79508819524062,0,0,0.6362738643844634,0.1469033967904298,CCL13,APOD+ MSC,0.10027024237534503
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",4/2244,0.8272634931131488,0.8272634931131488,0,0,0.6875,0.130372014787288,CRABP2;PRRX2;WNT5A;TP63,APOD+ MSC,0.08235614053342308
KEGG_2021_Human,sprouting angiogenesis (GO:0002040),4/52,8.563425546229254e-06,0.0035538216016851,0,0,36.05434782608695,420.6825006129661,CCBE1;ESM1;ANGPT1;VEGFC,Adipo-MSC,5.067352473847294
KEGG_2021_Human,regulation of macrophage derived foam cell differentiation (GO:0010743),3/31,6.290143262997964e-05,0.0126283490877641,0,0,45.41489361702128,439.34102944809894,ADIPOQ;LPL;APOB,Adipo-MSC,4.2013394630410685
KEGG_2021_Human,positive regulation of cholesterol storage (GO:0010886),2/6,9.128927051395768e-05,0.0126283490877641,0,0,207.77083333333337,1932.5756890799971,LPL;APOB,Adipo-MSC,4.039580263324499
KEGG_2021_Human,positive regulation of protein modification process (GO:0031401),5/214,0.00019169029203686572,0.018097868617719,0,0,10.494949494949497,89.83287982934151,ANGPT1;ADIPOQ;VEGFC;RSPO1;TRABD2B,Adipo-MSC,3.7173998809747197
KEGG_2021_Human,chylomicron remodeling (GO:0034371),2/9,0.00021804660985203623,0.018097868617719,0,0,118.70833333333331,1000.8064198202924,LPL;APOB,Adipo-MSC,3.6614506612675517
KEGG_2021_Human,positive regulation of lipid localization (GO:1905954),2/11,0.000332063883264561,0.0229677519257988,0,0,92.31944444444444,739.4956618223716,LPL;APOB,Adipo-MSC,3.478778357620151
KEGG_2021_Human,triglyceride-rich lipoprotein particle remodeling (GO:0034370),2/13,0.00046942457388711873,0.0278301711661648,0,0,75.52651515151516,578.8354329773197,LPL;APOB,Adipo-MSC,3.3284341792789096
KEGG_2021_Human,regulation of lipase activity (GO:0060191),2/14,0.0005467878206419364,0.0283646181958004,0,0,69.22916666666667,520.0114050756229,LPL;PCSK6,Adipo-MSC,3.2621811676355046
KEGG_2021_Human,regulation of cholesterol storage (GO:0010885),2/16,0.0007187392304892979,0.0331418645170065,0,0,59.333333333333336,429.45537567816734,LPL;APOB,Adipo-MSC,3.14342864967499
KEGG_2021_Human,positive regulation of macrophage derived foam cell differentiation (GO:0010744),2/18,0.000913470506242016,0.0379090260090436,0,0,51.911458333333336,363.2898548418271,LPL;APOB,Adipo-MSC,3.039305470405725
KEGG_2021_Human,positive regulation of lipid storage (GO:0010884),2/21,0.0012477930702112,0.0431528436781381,0,0,43.708333333333336,292.25047477799524,LPL;APOB,Adipo-MSC,2.9038574306125264
KEGG_2021_Human,regulation of lipoprotein lipase activity (GO:0051004),2/21,0.0012477930702112,0.0431528436781381,0,0,43.708333333333336,292.25047477799524,LPL;PCSK6,Adipo-MSC,2.9038574306125264
KEGG_2021_Human,regulation of lipid storage (GO:0010883),2/22,0.001370383663162,0.0437468630932485,0,0,41.520833333333336,273.7329252658829,LPL;APOB,Adipo-MSC,2.8631578273928713
KEGG_2021_Human,response to hexose (GO:0009746),2/25,0.0017712212130127,0.0490037868933522,0,0,36.09963768115942,228.73040961874747,ADIPOQ;LPL,Adipo-MSC,2.751727195110795
KEGG_2021_Human,peptide catabolic process (GO:0043171),2/25,0.0017712212130127,0.0490037868933522,0,0,36.09963768115942,228.73040961874747,LVRN;TRHDE,Adipo-MSC,2.751727195110795
KEGG_2021_Human,positive regulation of signal transduction (GO:0009967),4/252,0.0035980131226239,0.084266343053408,0,0,6.9081346423562415,38.87465379499725,CCBE1;ESM1;ADIPOQ;RSPO1,Adipo-MSC,2.443937257034727
KEGG_2021_Human,positive regulation of phosphorylation (GO:0042327),4/253,0.0036491527059517,0.084266343053408,0,0,6.880041906757465,38.61946591653091,ANGPT1;ADIPOQ;VEGFC;RSPO1,Adipo-MSC,2.437807962350746
KEGG_2021_Human,regulation of receptor internalization (GO:0002090),2/36,0.0036549257227984,0.084266343053408,0,0,24.40686274509804,136.96349152286243,ANGPT1;RSPO1,Adipo-MSC,2.437121444562911
KEGG_2021_Human,regulation of protein phosphorylation (GO:0001932),4/266,0.0043596676837796,0.095224320461503,0,0,6.534351145038168,35.516547205567086,ANGPT1;ADIPOQ;VEGFC;RSPO1,Adipo-MSC,2.3605466136215862
KEGG_2021_Human,proteolysis (GO:0006508),4/287,0.0056959581367739,0.1181911313380591,0,0,6.043017360577662,31.23030437987747,LVRN;PCSK6;TRHDE;TRABD2B,Adipo-MSC,2.2444332112663723
KEGG_2021_Human,response to glucose (GO:0009749),2/49,0.0066828970303688,0.1303027303748691,0,0,17.64450354609929,88.36726791367238,ADIPOQ;LPL,Adipo-MSC,2.175035230405133
KEGG_2021_Human,positive regulation of chemokine production (GO:0032722),2/53,0.0077812124839393,0.1303027303748691,0,0,16.25735294117647,78.94640668269977,ADIPOQ;LPL,Adipo-MSC,2.108952725111067
KEGG_2021_Human,triglyceride metabolic process (GO:0006641),2/55,0.0083588302127531,0.1303027303748691,0,0,15.642295597484276,74.83957451132376,LPL;APOB,Adipo-MSC,2.077854496208505
KEGG_2021_Human,organonitrogen compound catabolic process (GO:1901565),2/63,0.0108545013893802,0.1303027303748691,0,0,13.585382513661202,61.44906812714711,LVRN;TRHDE,Adipo-MSC,1.9643901214324337
KEGG_2021_Human,diterpenoid metabolic process (GO:0016101),2/64,0.0111869000374274,0.1303027303748691,0,0,13.365591397849462,60.051760195429935,LPL;APOB,Adipo-MSC,1.9512902426187388
KEGG_2021_Human,positive regulation of blood-brain barrier permeability (GO:1905605),1/5,0.0124387771927725,0.1303027303748691,0,0,101.76530612244898,446.4379351400606,ANGPT1,Adipo-MSC,1.9052223113279663
KEGG_2021_Human,positive regulation of cAMP-dependent protein kinase activity (GO:2000481),1/5,0.0124387771927725,0.1303027303748691,0,0,101.76530612244898,446.4379351400606,ADIPOQ,Adipo-MSC,1.9052223113279663
KEGG_2021_Human,heparin metabolic process (GO:0030202),1/5,0.0124387771927725,0.1303027303748691,0,0,101.76530612244898,446.4379351400606,ANGPT1,Adipo-MSC,1.9052223113279663
KEGG_2021_Human,negative regulation of macrophage differentiation (GO:0045650),1/5,0.0124387771927725,0.1303027303748691,0,0,101.76530612244898,446.4379351400606,ADIPOQ,Adipo-MSC,1.9052223113279663
KEGG_2021_Human,positive regulation of mast cell chemotaxis (GO:0060754),1/5,0.0124387771927725,0.1303027303748691,0,0,101.76530612244898,446.4379351400606,VEGFC,Adipo-MSC,1.9052223113279663
KEGG_2021_Human,cellular response to nutrient (GO:0031670),1/5,0.0124387771927725,0.1303027303748691,0,0,101.76530612244898,446.4379351400606,LPL,Adipo-MSC,1.9052223113279663
KEGG_2021_Human,ciliary neurotrophic factor-mediated signaling pathway (GO:0070120),1/5,0.0124387771927725,0.1303027303748691,0,0,101.76530612244898,446.4379351400606,CNTFR,Adipo-MSC,1.9052223113279663
KEGG_2021_Human,tryptophan catabolic process to kynurenine (GO:0019441),1/5,0.0124387771927725,0.1303027303748691,0,0,101.76530612244898,446.4379351400606,TDO2,Adipo-MSC,1.9052223113279663
KEGG_2021_Human,cholesterol homeostasis (GO:0042632),2/71,0.0136373517747766,0.1303027303748691,0,0,12.005434782608695,51.56265564232933,LPL;APOB,Adipo-MSC,1.8652699567516449
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),4/371,0.01371944672388,0.1303027303748691,0,0,4.63997156734984,19.9005642186198,ANGPT1;ADIPOQ;VEGFC;RSPO1,Adipo-MSC,1.862663402449304
KEGG_2021_Human,sterol homeostasis (GO:0055092),2/72,0.0140048037295852,0.1303027303748691,0,0,11.833333333333334,50.50886613536219,LPL;APOB,Adipo-MSC,1.8537229732206628
KEGG_2021_Human,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.0149082847993736,0.1303027303748691,0,0,81.40816326530613,342.3895623444841,ANGPT1,Adipo-MSC,1.8265723193247598
KEGG_2021_Human,glomerulus vasculature development (GO:0072012),1/6,0.0149082847993736,0.1303027303748691,0,0,81.40816326530613,342.3895623444841,ANGPT1,Adipo-MSC,1.8265723193247598
KEGG_2021_Human,regulation of mast cell chemotaxis (GO:0060753),1/6,0.0149082847993736,0.1303027303748691,0,0,81.40816326530613,342.3895623444841,VEGFC,Adipo-MSC,1.8265723193247598
KEGG_2021_Human,positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),1/6,0.0149082847993736,0.1303027303748691,0,0,81.40816326530613,342.3895623444841,CCBE1,Adipo-MSC,1.8265723193247598
KEGG_2021_Human,venous blood vessel morphogenesis (GO:0048845),1/6,0.0149082847993736,0.1303027303748691,0,0,81.40816326530613,342.3895623444841,CCBE1,Adipo-MSC,1.8265723193247598
KEGG_2021_Human,regulation of fat cell differentiation (GO:0045598),2/80,0.0170965192165363,0.1303027303748691,0,0,10.615384615384617,43.19273030214829,ADIPOQ;LPL,Adipo-MSC,1.7670923012410087
KEGG_2021_Human,regulation of skeletal muscle satellite cell proliferation (GO:0014842),1/7,0.0173717414502839,0.1303027303748691,0,0,67.83673469387755,274.9362107684438,ANGPT1,Adipo-MSC,1.7601566430186848
KEGG_2021_Human,positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),1/7,0.0173717414502839,0.1303027303748691,0,0,67.83673469387755,274.9362107684438,LPL,Adipo-MSC,1.7601566430186848
KEGG_2021_Human,regulation of blood-brain barrier permeability (GO:1905603),1/7,0.0173717414502839,0.1303027303748691,0,0,67.83673469387755,274.9362107684438,ANGPT1,Adipo-MSC,1.7601566430186848
KEGG_2021_Human,negative regulation of intracellular transport (GO:0032387),1/7,0.0173717414502839,0.1303027303748691,0,0,67.83673469387755,274.9362107684438,ADIPOQ,Adipo-MSC,1.7601566430186848
KEGG_2021_Human,negative regulation of low-density lipoprotein receptor activity (GO:1905598),1/7,0.0173717414502839,0.1303027303748691,0,0,67.83673469387755,274.9362107684438,ADIPOQ,Adipo-MSC,1.7601566430186848
KEGG_2021_Human,serine transport (GO:0032329),1/7,0.0173717414502839,0.1303027303748691,0,0,67.83673469387755,274.9362107684438,SLC7A10,Adipo-MSC,1.7601566430186848
KEGG_2021_Human,regulation of glycogen (starch) synthase activity (GO:2000465),1/7,0.0173717414502839,0.1303027303748691,0,0,67.83673469387755,274.9362107684438,ADIPOQ,Adipo-MSC,1.7601566430186848
KEGG_2021_Human,maintenance of synapse structure (GO:0099558),1/7,0.0173717414502839,0.1303027303748691,0,0,67.83673469387755,274.9362107684438,CBLN2,Adipo-MSC,1.7601566430186848
KEGG_2021_Human,chylomicron remnant clearance (GO:0034382),1/7,0.0173717414502839,0.1303027303748691,0,0,67.83673469387755,274.9362107684438,APOB,Adipo-MSC,1.7601566430186848
KEGG_2021_Human,peptide metabolic process (GO:0006518),2/83,0.0183241429417302,0.1303027303748691,0,0,10.22067901234568,40.877971632620635,LVRN;TRHDE,Adipo-MSC,1.7369763290678308
KEGG_2021_Human,amine metabolic process (GO:0009308),1/8,0.0198291614511851,0.1303027303748691,0,0,58.142857142857146,227.9549801512961,VCAM1,Adipo-MSC,1.702695651141308
KEGG_2021_Human,brown fat cell differentiation (GO:0050873),1/8,0.0198291614511851,0.1303027303748691,0,0,58.142857142857146,227.9549801512961,ADIPOQ,Adipo-MSC,1.702695651141308
KEGG_2021_Human,positive regulation of monocyte chemotactic protein-1 production (GO:0071639),1/8,0.0198291614511851,0.1303027303748691,0,0,58.142857142857146,227.9549801512961,ADIPOQ,Adipo-MSC,1.702695651141308
KEGG_2021_Human,positive regulation of myeloid cell apoptotic process (GO:0033034),1/8,0.0198291614511851,0.1303027303748691,0,0,58.142857142857146,227.9549801512961,ADIPOQ,Adipo-MSC,1.702695651141308
KEGG_2021_Human,venous blood vessel development (GO:0060841),1/8,0.0198291614511851,0.1303027303748691,0,0,58.142857142857146,227.9549801512961,CCBE1,Adipo-MSC,1.702695651141308
KEGG_2021_Human,retinoid metabolic process (GO:0001523),2/92,0.0222223839756269,0.1303027303748691,0,0,9.194444444444445,35.00007985571613,LPL;APOB,Adipo-MSC,1.6532093525993499
KEGG_2021_Human,regulation of endothelial cell proliferation (GO:0001936),2/92,0.0222223839756269,0.1303027303748691,0,0,9.194444444444445,35.00007985571613,ANGPT1;VEGFC,Adipo-MSC,1.6532093525993499
KEGG_2021_Human,kynurenine metabolic process (GO:0070189),1/9,0.0222805591236868,0.1303027303748691,0,0,50.87244897959184,193.52086993316271,TDO2,Adipo-MSC,1.652073914876897
KEGG_2021_Human,positive regulation of protein kinase A signaling (GO:0010739),1/9,0.0222805591236868,0.1303027303748691,0,0,50.87244897959184,193.52086993316271,ADIPOQ,Adipo-MSC,1.652073914876897
KEGG_2021_Human,positive regulation of sequestering of triglyceride (GO:0010890),1/9,0.0222805591236868,0.1303027303748691,0,0,50.87244897959184,193.52086993316271,LPL,Adipo-MSC,1.652073914876897
KEGG_2021_Human,very-low-density lipoprotein particle remodeling (GO:0034372),1/9,0.0222805591236868,0.1303027303748691,0,0,50.87244897959184,193.52086993316271,LPL,Adipo-MSC,1.652073914876897
KEGG_2021_Human,regulation of epithelial cell proliferation (GO:0050678),2/93,0.0226749954090764,0.1303027303748691,0,0,9.092948717948715,34.43038199107018,EPB41L4B;ANGPT1,Adipo-MSC,1.6444527921978775
KEGG_2021_Human,positive regulation of epithelial cell migration (GO:0010634),2/94,0.0231314233527167,0.1303027303748691,0,0,8.993659420289855,33.87518721331595,EPB41L4B;ANGPT1,Adipo-MSC,1.6357976428363092
KEGG_2021_Human,regulation of receptor binding (GO:1900120),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,ADIPOQ,Adipo-MSC,1.606847034080906
KEGG_2021_Human,alanine transport (GO:0032328),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,SLC7A10,Adipo-MSC,1.606847034080906
KEGG_2021_Human,negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,ADIPOQ,Adipo-MSC,1.606847034080906
KEGG_2021_Human,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,ADIPOQ,Adipo-MSC,1.606847034080906
KEGG_2021_Human,positive regulation of keratinocyte migration (GO:0051549),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,EPB41L4B,Adipo-MSC,1.606847034080906
KEGG_2021_Human,indolalkylamine catabolic process (GO:0046218),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,TDO2,Adipo-MSC,1.606847034080906
KEGG_2021_Human,negative regulation of protein autophosphorylation (GO:0031953),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,ADIPOQ,Adipo-MSC,1.606847034080906
KEGG_2021_Human,negative regulation of receptor binding (GO:1900121),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,ADIPOQ,Adipo-MSC,1.606847034080906
KEGG_2021_Human,regulation of glycoprotein biosynthetic process (GO:0010559),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,NECAB1,Adipo-MSC,1.606847034080906
KEGG_2021_Human,regulation of granulocyte differentiation (GO:0030852),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,ADIPOQ,Adipo-MSC,1.606847034080906
KEGG_2021_Human,lipoprotein transport (GO:0042953),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,APOB,Adipo-MSC,1.606847034080906
KEGG_2021_Human,chylomicron assembly (GO:0034378),1/10,0.024725948817258,0.1303027303748691,0,0,45.21768707482993,167.3010120823387,APOB,Adipo-MSC,1.606847034080906
KEGG_2021_Human,nervous system development (GO:0007399),4/447,0.0252678658610057,0.1303027303748691,0,0,3.829031308273629,14.084026486919814,CNTFR;SH3GL3;GRIK1;NAV2,Adipo-MSC,1.5974314373016392
KEGG_2021_Human,regulation of amyloid precursor protein biosynthetic process (GO:0042984),1/11,0.0271653448579923,0.1303027303748691,0,0,40.69387755102041,146.73452100035948,NECAB1,Adipo-MSC,1.5659847773237099
KEGG_2021_Human,induction of positive chemotaxis (GO:0050930),1/11,0.0271653448579923,0.1303027303748691,0,0,40.69387755102041,146.73452100035948,VEGFC,Adipo-MSC,1.5659847773237099
KEGG_2021_Human,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/11,0.0271653448579923,0.1303027303748691,0,0,40.69387755102041,146.73452100035948,ADIPOQ,Adipo-MSC,1.5659847773237099
KEGG_2021_Human,lipoprotein localization (GO:0044872),1/11,0.0271653448579923,0.1303027303748691,0,0,40.69387755102041,146.73452100035948,APOB,Adipo-MSC,1.5659847773237099
KEGG_2021_Human,tryptophan catabolic process (GO:0006569),1/11,0.0271653448579923,0.1303027303748691,0,0,40.69387755102041,146.73452100035948,TDO2,Adipo-MSC,1.5659847773237099
KEGG_2021_Human,regulation of monocyte chemotactic protein-1 production (GO:0071637),1/11,0.0271653448579923,0.1303027303748691,0,0,40.69387755102041,146.73452100035948,ADIPOQ,Adipo-MSC,1.5659847773237099
KEGG_2021_Human,tryptophan metabolic process (GO:0006568),1/11,0.0271653448579923,0.1303027303748691,0,0,40.69387755102041,146.73452100035948,TDO2,Adipo-MSC,1.5659847773237099
KEGG_2021_Human,peptidyl-proline hydroxylation (GO:0019511),1/11,0.0271653448579923,0.1303027303748691,0,0,40.69387755102041,146.73452100035948,P3H2,Adipo-MSC,1.5659847773237099
KEGG_2021_Human,positive regulation of cellular metabolic process (GO:0031325),2/105,0.0283980432384044,0.1303027303748691,0,0,8.028721682847896,28.593770697553435,ANGPT1;ADIPOQ,Adipo-MSC,1.546711583898058
KEGG_2021_Human,regulation of vascular associated smooth muscle cell migration (GO:1904752),1/12,0.029598761568907,0.1303027303748691,0,0,36.99257884972171,130.2147194065139,ADIPOQ,Adipo-MSC,1.5287264597194943
KEGG_2021_Human,negative regulation of vascular permeability (GO:0043116),1/12,0.029598761568907,0.1303027303748691,0,0,36.99257884972171,130.2147194065139,ANGPT1,Adipo-MSC,1.5287264597194943
KEGG_2021_Human,positive regulation of protein maturation (GO:1903319),1/12,0.029598761568907,0.1303027303748691,0,0,36.99257884972171,130.2147194065139,CCBE1,Adipo-MSC,1.5287264597194943
KEGG_2021_Human,regulation of keratinocyte migration (GO:0051547),1/12,0.029598761568907,0.1303027303748691,0,0,36.99257884972171,130.2147194065139,EPB41L4B,Adipo-MSC,1.5287264597194943
KEGG_2021_Human,positive regulation of vascular permeability (GO:0043117),1/12,0.029598761568907,0.1303027303748691,0,0,36.99257884972171,130.2147194065139,ANGPT1,Adipo-MSC,1.5287264597194943
KEGG_2021_Human,very-low-density lipoprotein particle assembly (GO:0034379),1/12,0.029598761568907,0.1303027303748691,0,0,36.99257884972171,130.2147194065139,APOB,Adipo-MSC,1.5287264597194943
KEGG_2021_Human,modulation of chemical synaptic transmission (GO:0050804),2/109,0.0304216645881743,0.1303027303748691,0,0,7.72702492211838,26.987409356009476,ADIPOQ;GRIK1,Adipo-MSC,1.5168170262567133
KEGG_2021_Human,regulation of Wnt signaling pathway (GO:0030111),2/111,0.0314544847807964,0.1303027303748691,0,0,7.584480122324159,26.23633758944092,RSPO1;TRABD2B,Adipo-MSC,1.5023174240917434
KEGG_2021_Human,negative regulation of gluconeogenesis (GO:0045721),1/13,0.032026213248763,0.1303027303748691,0,0,33.90816326530612,116.6847899929619,ADIPOQ,Adipo-MSC,1.4944944088974865
KEGG_2021_Human,negative regulation of macrophage derived foam cell differentiation (GO:0010745),1/13,0.032026213248763,0.1303027303748691,0,0,33.90816326530612,116.6847899929619,ADIPOQ,Adipo-MSC,1.4944944088974865
KEGG_2021_Human,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),1/13,0.032026213248763,0.1303027303748691,0,0,33.90816326530612,116.6847899929619,LPL,Adipo-MSC,1.4944944088974865
KEGG_2021_Human,positive regulation of lipid transport (GO:0032370),1/13,0.032026213248763,0.1303027303748691,0,0,33.90816326530612,116.6847899929619,ADIPOQ,Adipo-MSC,1.4944944088974865
KEGG_2021_Human,lipid oxidation (GO:0034440),1/13,0.032026213248763,0.1303027303748691,0,0,33.90816326530612,116.6847899929619,ADIPOQ,Adipo-MSC,1.4944944088974865
KEGG_2021_Human,positive regulation of transporter activity (GO:0032411),1/13,0.032026213248763,0.1303027303748691,0,0,33.90816326530612,116.6847899929619,ADIPOQ,Adipo-MSC,1.4944944088974865
KEGG_2021_Human,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/13,0.032026213248763,0.1303027303748691,0,0,33.90816326530612,116.6847899929619,ADIPOQ,Adipo-MSC,1.4944944088974865
KEGG_2021_Human,regulation of cAMP-dependent protein kinase activity (GO:2000479),1/14,0.0344477141698711,0.1311541411054727,0,0,31.298273155416013,105.4223689491126,ADIPOQ,Adipo-MSC,1.4628395910668823
KEGG_2021_Human,cell junction maintenance (GO:0034331),1/14,0.0344477141698711,0.1311541411054727,0,0,31.298273155416013,105.4223689491126,CBLN2,Adipo-MSC,1.4628395910668823
KEGG_2021_Human,negative regulation of smooth muscle cell migration (GO:0014912),1/14,0.0344477141698711,0.1311541411054727,0,0,31.298273155416013,105.4223689491126,ADIPOQ,Adipo-MSC,1.4628395910668823
KEGG_2021_Human,cellular response to low-density lipoprotein particle stimulus (GO:0071404),1/14,0.0344477141698711,0.1311541411054727,0,0,31.298273155416013,105.4223689491126,LPL,Adipo-MSC,1.4628395910668823
KEGG_2021_Human,low-density lipoprotein particle remodeling (GO:0034374),1/14,0.0344477141698711,0.1311541411054727,0,0,31.298273155416013,105.4223689491126,APOB,Adipo-MSC,1.4628395910668823
KEGG_2021_Human,substrate-dependent cell migration (GO:0006929),1/14,0.0344477141698711,0.1311541411054727,0,0,31.298273155416013,105.4223689491126,VEGFC,Adipo-MSC,1.4628395910668823
KEGG_2021_Human,vascular endothelial growth factor signaling pathway (GO:0038084),1/14,0.0344477141698711,0.1311541411054727,0,0,31.298273155416013,105.4223689491126,VEGFC,Adipo-MSC,1.4628395910668823
KEGG_2021_Human,acetyl-CoA metabolic process (GO:0006084),1/15,0.0368632785936063,0.134195268564444,0,0,29.06122448979592,95.91771596133704,TDO2,Adipo-MSC,1.4334060415588732
KEGG_2021_Human,negative regulation of blood pressure (GO:0045776),1/15,0.0368632785936063,0.134195268564444,0,0,29.06122448979592,95.91771596133704,ADIPOQ,Adipo-MSC,1.4334060415588732
KEGG_2021_Human,regulation of sequestering of triglyceride (GO:0010889),1/15,0.0368632785936063,0.134195268564444,0,0,29.06122448979592,95.91771596133704,LPL,Adipo-MSC,1.4334060415588732
KEGG_2021_Human,regulation of macrophage differentiation (GO:0045649),1/15,0.0368632785936063,0.134195268564444,0,0,29.06122448979592,95.91771596133704,ADIPOQ,Adipo-MSC,1.4334060415588732
KEGG_2021_Human,protein hydroxylation (GO:0018126),1/15,0.0368632785936063,0.134195268564444,0,0,29.06122448979592,95.91771596133704,P3H2,Adipo-MSC,1.4334060415588732
KEGG_2021_Human,fatty acid metabolic process (GO:0006631),2/124,0.038497072428768,0.1346963810314303,0,0,6.771857923497268,22.05711333941876,ADIPOQ;LPL,Adipo-MSC,1.4145722958518654
KEGG_2021_Human,regulation of tumor necrosis factor production (GO:0032680),2/124,0.038497072428768,0.1346963810314303,0,0,6.771857923497268,22.05711333941876,ADIPOQ;LPL,Adipo-MSC,1.4145722958518654
KEGG_2021_Human,extracellular matrix organization (GO:0030198),3/300,0.0390400715124679,0.1346963810314303,0,0,4.223726627981947,13.698249489225711,VCAM1;ADAMTSL3;P3H2,Adipo-MSC,1.4084893954766124
KEGG_2021_Human,aromatic amino acid family catabolic process (GO:0009074),1/16,0.0392729207344652,0.1346963810314303,0,0,27.122448979591837,87.80133530116419,TDO2,Adipo-MSC,1.405906798966597
KEGG_2021_Human,regulation of cellular carbohydrate metabolic process (GO:0010675),1/16,0.0392729207344652,0.1346963810314303,0,0,27.122448979591837,87.80133530116419,ADIPOQ,Adipo-MSC,1.405906798966597
KEGG_2021_Human,neuron cell-cell adhesion (GO:0007158),1/16,0.0392729207344652,0.1346963810314303,0,0,27.122448979591837,87.80133530116419,NRXN3,Adipo-MSC,1.405906798966597
KEGG_2021_Human,positive regulation of small molecule metabolic process (GO:0062013),1/16,0.0392729207344652,0.1346963810314303,0,0,27.122448979591837,87.80133530116419,ADIPOQ,Adipo-MSC,1.405906798966597
KEGG_2021_Human,regulation of cellular response to growth factor stimulus (GO:0090287),1/17,0.0416766547912334,0.1372683471298563,0,0,25.426020408163264,80.79916728086499,PCSK6,Adipo-MSC,1.3801071472903907
KEGG_2021_Human,negative regulation of phagocytosis (GO:0050765),1/17,0.0416766547912334,0.1372683471298563,0,0,25.426020408163264,80.79916728086499,ADIPOQ,Adipo-MSC,1.3801071472903907
KEGG_2021_Human,cellular response to fatty acid (GO:0071398),1/17,0.0416766547912334,0.1372683471298563,0,0,25.426020408163264,80.79916728086499,LPL,Adipo-MSC,1.3801071472903907
KEGG_2021_Human,positive regulation of positive chemotaxis (GO:0050927),1/17,0.0416766547912334,0.1372683471298563,0,0,25.426020408163264,80.79916728086499,VEGFC,Adipo-MSC,1.3801071472903907
KEGG_2021_Human,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),1/17,0.0416766547912334,0.1372683471298563,0,0,25.426020408163264,80.79916728086499,ADIPOQ,Adipo-MSC,1.3801071472903907
KEGG_2021_Human,regulation of cell adhesion (GO:0030155),2/133,0.043691853040543,0.1375256796740786,0,0,6.303753180661578,19.734489511742076,EPB41L4B;ANGPT1,Adipo-MSC,1.3595995357844428
KEGG_2021_Human,positive regulation of fatty acid metabolic process (GO:0045923),1/18,0.0440744949316926,0.1375256796740786,0,0,23.92917166866747,74.70385911458476,ADIPOQ,Adipo-MSC,1.3558126557645607
KEGG_2021_Human,regulation of fatty acid metabolic process (GO:0019217),1/18,0.0440744949316926,0.1375256796740786,0,0,23.92917166866747,74.70385911458476,ADIPOQ,Adipo-MSC,1.3558126557645607
KEGG_2021_Human,leukocyte tethering or rolling (GO:0050901),1/18,0.0440744949316926,0.1375256796740786,0,0,23.92917166866747,74.70385911458476,VCAM1,Adipo-MSC,1.3558126557645607
KEGG_2021_Human,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),1/18,0.0440744949316926,0.1375256796740786,0,0,23.92917166866747,74.70385911458476,ADIPOQ,Adipo-MSC,1.3558126557645607
KEGG_2021_Human,"synaptic transmission, glutamatergic (GO:0035249)",1/18,0.0440744949316926,0.1375256796740786,0,0,23.92917166866747,74.70385911458476,GRIK1,Adipo-MSC,1.3558126557645607
KEGG_2021_Human,positive chemotaxis (GO:0050918),1/18,0.0440744949316926,0.1375256796740786,0,0,23.92917166866747,74.70385911458476,ANGPT1,Adipo-MSC,1.3558126557645607
KEGG_2021_Human,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),1/19,0.0464664552952436,0.1417910216729861,0,0,22.598639455782312,69.35578082800635,CCBE1,Adipo-MSC,1.3328604565168853
KEGG_2021_Human,response to fatty acid (GO:0070542),1/19,0.0464664552952436,0.1417910216729861,0,0,22.598639455782312,69.35578082800635,LPL,Adipo-MSC,1.3328604565168853
KEGG_2021_Human,leukocyte adhesion to vascular endothelial cell (GO:0061756),1/19,0.0464664552952436,0.1417910216729861,0,0,22.598639455782312,69.35578082800635,VCAM1,Adipo-MSC,1.3328604565168853
KEGG_2021_Human,positive regulation of protein processing (GO:0010954),1/20,0.0488525499820277,0.1469116539314603,0,0,21.40816326530612,64.63014669364038,CCBE1,Adipo-MSC,1.3111127622579986
KEGG_2021_Human,regulation of protein kinase A signaling (GO:0010738),1/20,0.0488525499820277,0.1469116539314603,0,0,21.40816326530612,64.63014669364038,ADIPOQ,Adipo-MSC,1.3111127622579986
KEGG_2021_Human,negative regulation of cell communication (GO:0010648),1/21,0.0512327930672156,0.1497699617383422,0,0,20.336734693877553,60.42807445408675,ADIPOQ,Adipo-MSC,1.2904519669693806
KEGG_2021_Human,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.0512327930672156,0.1497699617383422,0,0,20.336734693877553,60.42807445408675,VCAM1,Adipo-MSC,1.2904519669693806
KEGG_2021_Human,sterol transport (GO:0015918),1/21,0.0512327930672156,0.1497699617383422,0,0,20.336734693877553,60.42807445408675,APOB,Adipo-MSC,1.2904519669693806
KEGG_2021_Human,positive regulation of cytokine production (GO:0001819),3/335,0.0512465893176978,0.1497699617383422,0,0,3.7717251986670086,11.206196171777655,CCBE1;ADIPOQ;LPL,Adipo-MSC,1.2903350334876962
KEGG_2021_Human,negative regulation of small molecule metabolic process (GO:0062014),1/22,0.0536071985992547,0.1555733385922429,0,0,19.367346938775512,56.67024999786951,ADIPOQ,Adipo-MSC,1.2707768875084013
KEGG_2021_Human,positive regulation of cholesterol efflux (GO:0010875),1/23,0.0559757805878795,0.1580268635644217,0,0,18.4860853432282,53.29235549319145,ADIPOQ,Adipo-MSC,1.2519998414265567
KEGG_2021_Human,negative regulation of intracellular protein transport (GO:0090317),1/23,0.0559757805878795,0.1580268635644217,0,0,18.4860853432282,53.29235549319145,ADIPOQ,Adipo-MSC,1.2519998414265567
KEGG_2021_Human,positive regulation of receptor internalization (GO:0002092),1/23,0.0559757805878795,0.1580268635644217,0,0,18.4860853432282,53.29235549319145,ANGPT1,Adipo-MSC,1.2519998414265567
KEGG_2021_Human,triglyceride catabolic process (GO:0019433),1/23,0.0559757805878795,0.1580268635644217,0,0,18.4860853432282,53.29235549319145,LPL,Adipo-MSC,1.2519998414265567
KEGG_2021_Human,negative regulation of synaptic transmission (GO:0050805),1/24,0.0583385530130099,0.1614656722886717,0,0,17.68145519077196,50.24171555062859,ADIPOQ,Adipo-MSC,1.2340443470047993
KEGG_2021_Human,regulation of keratinocyte proliferation (GO:0010837),1/24,0.0583385530130099,0.1614656722886717,0,0,17.68145519077196,50.24171555062859,EPB41L4B,Adipo-MSC,1.2340443470047993
KEGG_2021_Human,acylglycerol homeostasis (GO:0055090),1/25,0.0606955298241754,0.1614656722886717,0,0,16.943877551020407,47.47480020477031,LPL,Adipo-MSC,1.2168432931781568
KEGG_2021_Human,negative regulation of cellular carbohydrate metabolic process (GO:0010677),1/25,0.0606955298241754,0.1614656722886717,0,0,16.943877551020407,47.47480020477031,ADIPOQ,Adipo-MSC,1.2168432931781568
KEGG_2021_Human,positive regulation of lipid metabolic process (GO:0045834),1/25,0.0606955298241754,0.1614656722886717,0,0,16.943877551020407,47.47480020477031,ADIPOQ,Adipo-MSC,1.2168432931781568
KEGG_2021_Human,negative regulation of signaling (GO:0023057),1/25,0.0606955298241754,0.1614656722886717,0,0,16.943877551020407,47.47480020477031,ADIPOQ,Adipo-MSC,1.2168432931781568
KEGG_2021_Human,regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.0606955298241754,0.1614656722886717,0,0,16.943877551020407,47.47480020477031,ADIPOQ,Adipo-MSC,1.2168432931781568
KEGG_2021_Human,positive regulation of vascular endothelial growth factor production (GO:0010575),1/25,0.0606955298241754,0.1614656722886717,0,0,16.943877551020407,47.47480020477031,CCBE1,Adipo-MSC,1.2168432931781568
KEGG_2021_Human,regulation of protein processing (GO:0070613),1/25,0.0606955298241754,0.1614656722886717,0,0,16.943877551020407,47.47480020477031,CCBE1,Adipo-MSC,1.2168432931781568
KEGG_2021_Human,positive regulation of glucose import (GO:0046326),1/26,0.0630467249540435,0.1635274428495504,0,0,16.26530612244898,44.95534064809558,ADIPOQ,Adipo-MSC,1.2003374685092782
KEGG_2021_Human,negative regulation of protein transport (GO:0051224),1/26,0.0630467249540435,0.1635274428495504,0,0,16.26530612244898,44.95534064809558,ADIPOQ,Adipo-MSC,1.2003374685092782
KEGG_2021_Human,negative regulation of receptor-mediated endocytosis (GO:0048261),1/26,0.0630467249540435,0.1635274428495504,0,0,16.26530612244898,44.95534064809558,ADIPOQ,Adipo-MSC,1.2003374685092782
KEGG_2021_Human,cellular response to drug (GO:0035690),1/26,0.0630467249540435,0.1635274428495504,0,0,16.26530612244898,44.95534064809558,ADIPOQ,Adipo-MSC,1.2003374685092782
KEGG_2021_Human,negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.0653921522588676,0.1675169332557411,0,0,15.638932496075354,42.652889831563165,ANGPT1,Adipo-MSC,1.184474368421492
KEGG_2021_Human,regulation of vascular endothelial growth factor production (GO:0010574),1/27,0.0653921522588676,0.1675169332557411,0,0,15.638932496075354,42.652889831563165,CCBE1,Adipo-MSC,1.184474368421492
KEGG_2021_Human,regulation of small molecule metabolic process (GO:0062012),1/28,0.0677318256109869,0.1680768203320329,0,0,15.058956916099774,40.54171043527237,ADIPOQ,Adipo-MSC,1.1692072184717057
KEGG_2021_Human,positive regulation of cell communication (GO:0010647),1/28,0.0677318256109869,0.1680768203320329,0,0,15.058956916099774,40.54171043527237,ADIPOQ,Adipo-MSC,1.1692072184717057
KEGG_2021_Human,leukocyte cell-cell adhesion (GO:0007159),1/28,0.0677318256109869,0.1680768203320329,0,0,15.058956916099774,40.54171043527237,VCAM1,Adipo-MSC,1.1692072184717057
KEGG_2021_Human,neutral amino acid transport (GO:0015804),1/28,0.0677318256109869,0.1680768203320329,0,0,15.058956916099774,40.54171043527237,SLC7A10,Adipo-MSC,1.1692072184717057
KEGG_2021_Human,protein localization to cell surface (GO:0034394),1/28,0.0677318256109869,0.1680768203320329,0,0,15.058956916099774,40.54171043527237,ANGPT1,Adipo-MSC,1.1692072184717057
KEGG_2021_Human,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.0700657588372089,0.1680768203320329,0,0,14.520408163265309,38.5999069065122,ADIPOQ,Adipo-MSC,1.1544941700666143
KEGG_2021_Human,regulation of DNA biosynthetic process (GO:2000278),1/29,0.0700657588372089,0.1680768203320329,0,0,14.520408163265309,38.5999069065122,ADIPOQ,Adipo-MSC,1.1544941700666143
KEGG_2021_Human,regulation of fatty acid biosynthetic process (GO:0042304),1/29,0.0700657588372089,0.1680768203320329,0,0,14.520408163265309,38.5999069065122,ADIPOQ,Adipo-MSC,1.1544941700666143
KEGG_2021_Human,regulation of gluconeogenesis (GO:0006111),1/29,0.0700657588372089,0.1680768203320329,0,0,14.520408163265309,38.5999069065122,ADIPOQ,Adipo-MSC,1.1544941700666143
KEGG_2021_Human,lipid catabolic process (GO:0016042),1/29,0.0700657588372089,0.1680768203320329,0,0,14.520408163265309,38.5999069065122,LPL,Adipo-MSC,1.1544941700666143
KEGG_2021_Human,transition metal ion homeostasis (GO:0055076),1/29,0.0700657588372089,0.1680768203320329,0,0,14.520408163265309,38.5999069065122,CP,Adipo-MSC,1.1544941700666143
KEGG_2021_Human,alpha-amino acid catabolic process (GO:1901606),1/30,0.0723939657090184,0.1716771186813865,0,0,14.019000703729768,36.80874147674154,TDO2,Adipo-MSC,1.1402976322627019
KEGG_2021_Human,heterotypic cell-cell adhesion (GO:0034113),1/30,0.0723939657090184,0.1716771186813865,0,0,14.019000703729768,36.80874147674154,VCAM1,Adipo-MSC,1.1402976322627019
KEGG_2021_Human,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/31,0.0747164600026276,0.1751826604581382,0,0,13.551020408163266,35.15209038871121,PCSK6,Adipo-MSC,1.126583712764908
KEGG_2021_Human,triglyceride homeostasis (GO:0070328),1/31,0.0747164600026276,0.1751826604581382,0,0,13.551020408163266,35.15209038871121,LPL,Adipo-MSC,1.126583712764908
KEGG_2021_Human,negative regulation of DNA biosynthetic process (GO:2000279),1/32,0.0770332554327668,0.1756527527725178,0,0,13.113232389730086,33.61600807740255,ADIPOQ,Adipo-MSC,1.1133217484244988
KEGG_2021_Human,positive regulation of glucose transmembrane transport (GO:0010828),1/32,0.0770332554327668,0.1756527527725178,0,0,13.113232389730086,33.61600807740255,ADIPOQ,Adipo-MSC,1.1133217484244988
KEGG_2021_Human,regulation of cellular biosynthetic process (GO:0031326),1/32,0.0770332554327668,0.1756527527725178,0,0,13.113232389730086,33.61600807740255,ADIPOQ,Adipo-MSC,1.1133217484244988
KEGG_2021_Human,regulation of intracellular protein transport (GO:0033157),1/32,0.0770332554327668,0.1756527527725178,0,0,13.113232389730086,33.61600807740255,ADIPOQ,Adipo-MSC,1.1133217484244988
KEGG_2021_Human,peptidyl-proline modification (GO:0018208),1/32,0.0770332554327668,0.1756527527725178,0,0,13.113232389730086,33.61600807740255,P3H2,Adipo-MSC,1.1133217484244988
KEGG_2021_Human,positive regulation of cholesterol transport (GO:0032376),1/33,0.0793443657059371,0.1779887122592643,0,0,12.70280612244898,32.18837516559274,ADIPOQ,Adipo-MSC,1.1004839073426347
KEGG_2021_Human,regulation of cholesterol efflux (GO:0010874),1/33,0.0793443657059371,0.1779887122592643,0,0,12.70280612244898,32.18837516559274,ADIPOQ,Adipo-MSC,1.1004839073426347
KEGG_2021_Human,negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.0793443657059371,0.1779887122592643,0,0,12.70280612244898,32.18837516559274,ADIPOQ,Adipo-MSC,1.1004839073426347
KEGG_2021_Human,regulation of glucose metabolic process (GO:0010906),1/34,0.0816498044624026,0.1812014377106795,0,0,12.317254174397032,30.85861216573232,ADIPOQ,Adipo-MSC,1.0880448509885652
KEGG_2021_Human,cellular response to vascular endothelial growth factor stimulus (GO:0035924),1/34,0.0816498044624026,0.1812014377106795,0,0,12.317254174397032,30.85861216573232,VEGFC,Adipo-MSC,1.0880448509885652
KEGG_2021_Human,acylglycerol catabolic process (GO:0046464),1/35,0.0839495853612937,0.1824035493452194,0,0,11.95438175270108,29.61744503578088,LPL,Adipo-MSC,1.0759814445616303
KEGG_2021_Human,regulation of trans-synaptic signaling (GO:0099177),1/35,0.0839495853612937,0.1824035493452194,0,0,11.95438175270108,29.61744503578088,GRIK1,Adipo-MSC,1.0759814445616303
KEGG_2021_Human,cellular response to amyloid-beta (GO:1904646),1/35,0.0839495853612937,0.1824035493452194,0,0,11.95438175270108,29.61744503578088,VCAM1,Adipo-MSC,1.0759814445616303
KEGG_2021_Human,regulation of lipid biosynthetic process (GO:0046890),1/35,0.0839495853612937,0.1824035493452194,0,0,11.95438175270108,29.61744503578088,ADIPOQ,Adipo-MSC,1.0759814445616303
KEGG_2021_Human,cellular protein metabolic process (GO:0044267),3/417,0.0860988143705088,0.1826078807109063,0,0,3.012025901942646,7.386269548006634,PAPPA;APOB;CP,Adipo-MSC,1.0650028289864255
KEGG_2021_Human,negative regulation of cellular protein localization (GO:1903828),1/36,0.0862437219743075,0.1826078807109063,0,0,11.612244897959185,28.456712045041098,ADIPOQ,Adipo-MSC,1.0642725091375862
KEGG_2021_Human,negative regulation of DNA metabolic process (GO:0051053),1/36,0.0862437219743075,0.1826078807109063,0,0,11.612244897959185,28.456712045041098,ADIPOQ,Adipo-MSC,1.0642725091375862
KEGG_2021_Human,negative regulation of fat cell differentiation (GO:0045599),1/36,0.0862437219743075,0.1826078807109063,0,0,11.612244897959185,28.456712045041098,ADIPOQ,Adipo-MSC,1.0642725091375862
KEGG_2021_Human,transition metal ion transport (GO:0000041),1/36,0.0862437219743075,0.1826078807109063,0,0,11.612244897959185,28.456712045041098,CP,Adipo-MSC,1.0642725091375862
KEGG_2021_Human,negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.0885322278902676,0.182790420768463,0,0,11.289115646258503,27.36920368672352,ANGPT1,Adipo-MSC,1.0528986067362665
KEGG_2021_Human,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),1/37,0.0885322278902676,0.182790420768463,0,0,11.289115646258503,27.36920368672352,ADIPOQ,Adipo-MSC,1.0528986067362665
KEGG_2021_Human,glutamate receptor signaling pathway (GO:0007215),1/37,0.0885322278902676,0.182790420768463,0,0,11.289115646258503,27.36920368672352,GRIK1,Adipo-MSC,1.0528986067362665
KEGG_2021_Human,regulation of glucose import (GO:0046324),1/37,0.0885322278902676,0.182790420768463,0,0,11.289115646258503,27.36920368672352,ADIPOQ,Adipo-MSC,1.0528986067362665
KEGG_2021_Human,regulation of protein autophosphorylation (GO:0031952),1/37,0.0885322278902676,0.182790420768463,0,0,11.289115646258503,27.36920368672352,ADIPOQ,Adipo-MSC,1.0528986067362665
KEGG_2021_Human,positive regulation of cell development (GO:0010720),1/38,0.0908151166313484,0.1856565192217222,0,0,10.983452840595698,26.34852930034076,ADIPOQ,Adipo-MSC,1.0418418549683985
KEGG_2021_Human,positive regulation of signaling (GO:0023056),1/38,0.0908151166313484,0.1856565192217222,0,0,10.983452840595698,26.34852930034076,ADIPOQ,Adipo-MSC,1.0418418549683985
KEGG_2021_Human,regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.0930924017046572,0.1893791505266311,0,0,10.693877551020408,25.38900533231373,RSPO1,Adipo-MSC,1.0310857651239858
KEGG_2021_Human,regulation of inflammatory response (GO:0050727),2/206,0.0938158179234975,0.1899198265280559,0,0,4.033088235294118,9.543987931843056,ADIPOQ;LPL,Adipo-MSC,1.0277239307283335
KEGG_2021_Human,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.0953640965755271,0.1921169906739989,0,0,10.419152276295131,24.485561288951835,ADIPOQ,Adipo-MSC,1.0206151011238414
KEGG_2021_Human,acylglycerol metabolic process (GO:0006639),1/41,0.0976302146847681,0.1929359004484704,0,0,10.158163265306122,23.633660200289185,LPL,Adipo-MSC,1.0104157556925017
KEGG_2021_Human,negative regulation of cell-cell adhesion (GO:0022408),1/41,0.0976302146847681,0.1929359004484704,0,0,10.158163265306122,23.633660200289185,ADIPOQ,Adipo-MSC,1.0104157556925017
KEGG_2021_Human,hexose metabolic process (GO:0019318),1/41,0.0976302146847681,0.1929359004484704,0,0,10.158163265306122,23.633660200289185,ADIPOQ,Adipo-MSC,1.0104157556925017
KEGG_2021_Human,carboxylic acid transmembrane transport (GO:1905039),1/41,0.0976302146847681,0.1929359004484704,0,0,10.158163265306122,23.633660200289185,SLC7A10,Adipo-MSC,1.0104157556925017
KEGG_2021_Human,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.0998907694703361,0.1955408930669316,0,0,9.909905425584869,22.829231064333683,VCAM1,Adipo-MSC,1.00047464143678
KEGG_2021_Human,regulation of chemokine production (GO:0032642),1/42,0.0998907694703361,0.1955408930669316,0,0,9.909905425584869,22.829231064333683,LPL,Adipo-MSC,1.00047464143678
KEGG_2021_Human,extracellular structure organization (GO:0043062),2/216,0.1015881472155216,0.1979299581898661,0,0,3.842679127725857,8.78754780712842,VCAM1;ADAMTSL3,Adipo-MSC,0.9931569603511173
KEGG_2021_Human,external encapsulating structure organization (GO:0045229),2/217,0.1023751607426323,0.1985312696644506,0,0,3.824612403100775,8.716716836108898,VCAM1;ADAMTSL3,Adipo-MSC,0.9898054033308324
KEGG_2021_Human,response to amyloid-beta (GO:1904645),1/44,0.1043952424647777,0.1996498876630542,0,0,9.448030374940672,21.34849709415977,VCAM1,Adipo-MSC,0.9813192926974915
KEGG_2021_Human,regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.1043952424647777,0.1996498876630542,0,0,9.448030374940672,21.34849709415977,ANGPT1,Adipo-MSC,0.9813192926974915
KEGG_2021_Human,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.1043952424647777,0.1996498876630542,0,0,9.448030374940672,21.34849709415977,ANGPT1,Adipo-MSC,0.9813192926974915
KEGG_2021_Human,amino acid transmembrane transport (GO:0003333),1/45,0.1066391873529346,0.2020788253491684,0,0,9.232838589981448,20.665901611884028,SLC7A10,Adipo-MSC,0.9720831731354668
KEGG_2021_Human,cellular response to radiation (GO:0071478),1/45,0.1066391873529346,0.2020788253491684,0,0,9.232838589981448,20.665901611884028,GPR88,Adipo-MSC,0.9720831731354668
KEGG_2021_Human,"regulation of synaptic transmission, glutamatergic (GO:0051966)",1/46,0.1088776222085674,0.2035324919664662,0,0,9.02721088435374,20.01811780873028,GRIK1,Adipo-MSC,0.9630613723103648
KEGG_2021_Human,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.1088776222085674,0.2035324919664662,0,0,9.02721088435374,20.01811780873028,ADIPOQ,Adipo-MSC,0.9630613723103648
KEGG_2021_Human,positive regulation of response to stimulus (GO:0048584),1/46,0.1088776222085674,0.2035324919664662,0,0,9.02721088435374,20.01811780873028,ADIPOQ,Adipo-MSC,0.9630613723103648
KEGG_2021_Human,negative regulation of cold-induced thermogenesis (GO:0120163),1/47,0.1111105603036554,0.2058521541340046,0,0,8.830523513753327,19.4026870705364,ADIPOQ,Adipo-MSC,0.9542446623584087
KEGG_2021_Human,regulation of cellular metabolic process (GO:0031323),1/47,0.1111105603036554,0.2058521541340046,0,0,8.830523513753327,19.4026870705364,RSPO1,Adipo-MSC,0.9542446623584087
KEGG_2021_Human,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.1133380148369131,0.207203859723872,0,0,8.642205818497612,18.81737166641443,ANGPT1,Adipo-MSC,0.9456243984787533
KEGG_2021_Human,negative regulation of MAP kinase activity (GO:0043407),1/48,0.1133380148369131,0.207203859723872,0,0,8.642205818497612,18.81737166641443,ADIPOQ,Adipo-MSC,0.9456243984787533
KEGG_2021_Human,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.1133380148369131,0.207203859723872,0,0,8.642205818497612,18.81737166641443,ADIPOQ,Adipo-MSC,0.9456243984787533
KEGG_2021_Human,secondary alcohol metabolic process (GO:1902652),1/49,0.1155599990222406,0.2103394719045169,0,0,8.46173469387755,18.260130793597916,APOB,Adipo-MSC,0.9371924705024297
KEGG_2021_Human,amino acid transport (GO:0006865),1/50,0.1177765260040411,0.2106778374641252,0,0,8.28862973760933,17.7290996615035,SLC7A10,Adipo-MSC,0.928941259997044
KEGG_2021_Human,negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/50,0.1177765260040411,0.2106778374641252,0,0,8.28862973760933,17.7290996615035,ADIPOQ,Adipo-MSC,0.928941259997044
KEGG_2021_Human,regulation of complement activation (GO:0030449),1/50,0.1177765260040411,0.2106778374641252,0,0,8.28862973760933,17.7290996615035,C6,Adipo-MSC,0.928941259997044
KEGG_2021_Human,iron ion transport (GO:0006826),1/50,0.1177765260040411,0.2106778374641252,0,0,8.28862973760933,17.7290996615035,CP,Adipo-MSC,0.928941259997044
KEGG_2021_Human,regulation of ERK1 and ERK2 cascade (GO:0070372),2/238,0.1192811662769016,0.2109951597570663,0,0,3.4805790960451977,7.400657287256659,ANGPT1;ADIPOQ,Adipo-MSC,0.9234281232007147
KEGG_2021_Human,positive regulation of fat cell differentiation (GO:0045600),1/51,0.1199876089220907,0.2109951597570663,0,0,8.122448979591837,17.22257115519733,LPL,Adipo-MSC,0.9208636010741894
KEGG_2021_Human,negative regulation of transport (GO:0051051),1/51,0.1199876089220907,0.2109951597570663,0,0,8.122448979591837,17.22257115519733,ADIPOQ,Adipo-MSC,0.9208636010741894
KEGG_2021_Human,cholesterol transport (GO:0030301),1/51,0.1199876089220907,0.2109951597570663,0,0,8.122448979591837,17.22257115519733,APOB,Adipo-MSC,0.9208636010741894
KEGG_2021_Human,negative regulation of cellular biosynthetic process (GO:0031327),1/52,0.1221932608707862,0.2121765826835828,0,0,7.962785114045619,16.738979733033663,ADIPOQ,Adipo-MSC,0.9129527453809976
KEGG_2021_Human,fatty acid beta-oxidation (GO:0006635),1/52,0.1221932608707862,0.2121765826835828,0,0,7.962785114045619,16.738979733033663,ADIPOQ,Adipo-MSC,0.9129527453809976
KEGG_2021_Human,protein homotetramerization (GO:0051289),1/52,0.1221932608707862,0.2121765826835828,0,0,7.962785114045619,16.738979733033663,TDO2,Adipo-MSC,0.9129527453809976
KEGG_2021_Human,regulation of immune effector process (GO:0002697),1/53,0.1243934949128716,0.2150970849535072,0,0,7.809262166405024,16.276887238960814,C6,Adipo-MSC,0.9052023302345248
KEGG_2021_Human,positive regulation of leukocyte chemotaxis (GO:0002690),1/54,0.1265883240687765,0.2170832830105051,0,0,7.661532537543319,15.834970375184442,VEGFC,Adipo-MSC,0.8976063498190403
KEGG_2021_Human,regulation of humoral immune response (GO:0002920),1/54,0.1265883240687765,0.2170832830105051,0,0,7.661532537543319,15.834970375184442,C6,Adipo-MSC,0.8976063498190403
KEGG_2021_Human,negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/55,0.1287777613922166,0.2181337590929384,0,0,7.519274376417234,15.412009607623004,ADIPOQ,Adipo-MSC,0.8901591287349465
KEGG_2021_Human,regulation of blood vessel endothelial cell migration (GO:0043535),1/55,0.1287777613922166,0.2181337590929384,0,0,7.519274376417234,15.412009607623004,ANGPT1,Adipo-MSC,0.8901591287349465
KEGG_2021_Human,glycoprotein metabolic process (GO:0009100),1/55,0.1287777613922166,0.2181337590929384,0,0,7.519274376417234,15.412009607623004,PCSK6,Adipo-MSC,0.8901591287349465
KEGG_2021_Human,blood vessel morphogenesis (GO:0048514),1/56,0.1309618198144747,0.2191498194476089,0,0,7.382189239332097,15.00687933540933,CCBE1,Adipo-MSC,0.8828552987007785
KEGG_2021_Human,negative regulation of metabolic process (GO:0009892),1/56,0.1309618198144747,0.2191498194476089,0,0,7.382189239332097,15.00687933540933,ADIPOQ,Adipo-MSC,0.8828552987007785
KEGG_2021_Human,positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.1309618198144747,0.2191498194476089,0,0,7.382189239332097,15.00687933540933,LPL,Adipo-MSC,0.8828552987007785
KEGG_2021_Human,cellular response to peptide (GO:1901653),1/57,0.1331405122852093,0.2210132503934474,0,0,7.25,14.618539131965724,VCAM1,Adipo-MSC,0.8756897763447542
KEGG_2021_Human,positive regulation of proteolysis (GO:0045862),1/57,0.1331405122852093,0.2210132503934474,0,0,7.25,14.618539131965724,CCBE1,Adipo-MSC,0.8756897763447542
KEGG_2021_Human,fat cell differentiation (GO:0045444),1/58,0.1353138517398134,0.2210836554016637,0,0,7.122448979591836,14.246025949065045,ADIPOQ,Adipo-MSC,0.8686577434892403
KEGG_2021_Human,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/58,0.1353138517398134,0.2210836554016637,0,0,7.122448979591836,14.246025949065045,ADIPOQ,Adipo-MSC,0.8686577434892403
KEGG_2021_Human,cellular iron ion homeostasis (GO:0006879),1/58,0.1353138517398134,0.2210836554016637,0,0,7.122448979591836,14.246025949065045,CP,Adipo-MSC,0.8686577434892403
KEGG_2021_Human,regulation of phagocytosis (GO:0050764),1/58,0.1353138517398134,0.2210836554016637,0,0,7.122448979591836,14.246025949065045,ADIPOQ,Adipo-MSC,0.8686577434892403
KEGG_2021_Human,positive regulation of cell differentiation (GO:0045597),2/258,0.1359834100026853,0.2213063339259388,0,0,3.2054036458333335,6.395493110208526,LPL;APOB,Adipo-MSC,0.8665140723928182
KEGG_2021_Human,fatty acid oxidation (GO:0019395),1/59,0.1374818510452552,0.2228709694678941,0,0,6.9992962702322306,13.8884471557023,ADIPOQ,Adipo-MSC,0.8617546291873563
KEGG_2021_Human,B cell differentiation (GO:0030183),1/61,0.1418018805927374,0.2254704231646974,0,0,6.76530612244898,13.214837540593155,VCAM1,Adipo-MSC,0.848318009451734
KEGG_2021_Human,response to light stimulus (GO:0009416),1/61,0.1418018805927374,0.2254704231646974,0,0,6.76530612244898,13.214837540593155,GPR88,Adipo-MSC,0.848318009451734
KEGG_2021_Human,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2254704231646974,0,0,6.76530612244898,13.214837540593155,ADIPOQ,Adipo-MSC,0.848318009451734
KEGG_2021_Human,iron ion homeostasis (GO:0055072),1/61,0.1418018805927374,0.2254704231646974,0,0,6.76530612244898,13.214837540593155,CP,Adipo-MSC,0.848318009451734
KEGG_2021_Human,pattern recognition receptor signaling pathway (GO:0002221),1/61,0.1418018805927374,0.2254704231646974,0,0,6.76530612244898,13.214837540593155,APOB,Adipo-MSC,0.848318009451734
KEGG_2021_Human,negative regulation of signal transduction (GO:0009968),2/267,0.1436652916283004,0.2262912258896424,0,0,3.095125786163522,6.005376764494242,ADIPOQ;TRABD2B,Adipo-MSC,0.8426481412255155
KEGG_2021_Human,glucose metabolic process (GO:0006006),1/62,0.1439539364695556,0.2262912258896424,0,0,6.654064904650385,12.897320592663672,ADIPOQ,Adipo-MSC,0.8417764546925935
KEGG_2021_Human,positive regulation of interleukin-1 production (GO:0032732),1/62,0.1439539364695556,0.2262912258896424,0,0,6.654064904650385,12.897320592663672,LPL,Adipo-MSC,0.8417764546925935
KEGG_2021_Human,central nervous system development (GO:0007417),2/268,0.1445246328363994,0.2263310287815312,0,0,3.0833333333333335,5.964108059214085,SH3GL3;GRIK1,Adipo-MSC,0.8400581252728833
KEGG_2021_Human,monocarboxylic acid biosynthetic process (GO:0072330),1/63,0.1461007034145454,0.2279390673572794,0,0,6.54641211323239,12.591756250239603,LPL,Adipo-MSC,0.8353476931121088
KEGG_2021_Human,cellular response to nutrient levels (GO:0031669),1/66,0.1525093979756266,0.2361619408950935,0,0,6.243328100470958,11.740759916332207,LPL,Adipo-MSC,0.8167033932798328
KEGG_2021_Human,positive regulation of T cell proliferation (GO:0042102),1/66,0.1525093979756266,0.2361619408950935,0,0,6.243328100470958,11.740759916332207,VCAM1,Adipo-MSC,0.8167033932798328
KEGG_2021_Human,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/67,0.1546351363099914,0.2385635002551912,0,0,6.148423005565863,11.477180657220888,VEGFC,Adipo-MSC,0.8106918184915987
KEGG_2021_Human,interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.1567556490806558,0.2409392384017488,0,0,6.0563508985683825,11.222824361971773,VCAM1,Adipo-MSC,0.8047767993307415
KEGG_2021_Human,fatty acid catabolic process (GO:0009062),1/70,0.1609810482853106,0.2429350365032869,0,0,5.880212954747116,10.740024519792764,ADIPOQ,Adipo-MSC,0.7932252488723367
KEGG_2021_Human,carbohydrate homeostasis (GO:0033500),1/70,0.1609810482853106,0.2429350365032869,0,0,5.880212954747116,10.740024519792764,ADIPOQ,Adipo-MSC,0.7932252488723367
KEGG_2021_Human,cellular response to light stimulus (GO:0071482),1/70,0.1609810482853106,0.2429350365032869,0,0,5.880212954747116,10.740024519792764,GPR88,Adipo-MSC,0.7932252488723367
KEGG_2021_Human,sterol metabolic process (GO:0016125),1/70,0.1609810482853106,0.2429350365032869,0,0,5.880212954747116,10.740024519792764,APOB,Adipo-MSC,0.7932252488723367
KEGG_2021_Human,wound healing (GO:0042060),1/70,0.1609810482853106,0.2429350365032869,0,0,5.880212954747116,10.740024519792764,EPB41L4B,Adipo-MSC,0.7932252488723367
KEGG_2021_Human,protein tetramerization (GO:0051262),1/71,0.16308595979881,0.2443345607094086,0,0,5.795918367346939,10.51076961698872,TDO2,Adipo-MSC,0.7875834261109624
KEGG_2021_Human,fatty acid biosynthetic process (GO:0006633),1/71,0.16308595979881,0.2443345607094086,0,0,5.795918367346939,10.51076961698872,LPL,Adipo-MSC,0.7875834261109624
KEGG_2021_Human,cell junction organization (GO:0034330),1/72,0.1651856959101235,0.2465901575636737,0,0,5.713998275366484,10.28911103101624,CBLN2,Adipo-MSC,0.78202756268309
KEGG_2021_Human,negative regulation of cell adhesion (GO:0007162),1/73,0.1672802691231711,0.2488092971233759,0,0,5.634353741496598,10.074701240888364,ANGPT1,Adipo-MSC,0.7765552814899175
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),3/566,0.1678713329989042,0.2488092971233759,0,0,2.197989493972261,3.922438566092192,ANGPT1;ADIPOQ;P3H2,Adipo-MSC,0.7750234609992368
KEGG_2021_Human,negative regulation of protein binding (GO:0032091),1/74,0.1693696918266344,0.2495786988987195,0,0,5.556891249650545,9.867213018330611,ADIPOQ,Adipo-MSC,0.7711643026835198
KEGG_2021_Human,positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.1714539764404576,0.2495786988987195,0,0,5.4815223386651954,9.666337985731484,VCAM1,Adipo-MSC,0.7658524380723842
KEGG_2021_Human,positive regulation of T cell activation (GO:0050870),1/75,0.1714539764404576,0.2495786988987195,0,0,5.4815223386651954,9.666337985731484,VCAM1,Adipo-MSC,0.7658524380723842
KEGG_2021_Human,actomyosin structure organization (GO:0031032),1/76,0.1735331353639065,0.2495786988987195,0,0,5.408163265306122,9.4717853003048,EPB41L4B,Adipo-MSC,0.7606175863963804
KEGG_2021_Human,regulation of T cell proliferation (GO:0042129),1/76,0.1735331353639065,0.2495786988987195,0,0,5.408163265306122,9.4717853003048,VCAM1,Adipo-MSC,0.7606175863963804
KEGG_2021_Human,regulation of BMP signaling pathway (GO:0030510),1/76,0.1735331353639065,0.2495786988987195,0,0,5.408163265306122,9.4717853003048,PCSK6,Adipo-MSC,0.7606175863963804
KEGG_2021_Human,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.2495786988987195,0,0,5.408163265306122,9.4717853003048,LPL,Adipo-MSC,0.7606175863963804
KEGG_2021_Human,phospholipid metabolic process (GO:0006644),1/76,0.1735331353639065,0.2495786988987195,0,0,5.408163265306122,9.4717853003048,LPL,Adipo-MSC,0.7606175863963804
KEGG_2021_Human,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1756071809118701,0.2495786988987195,0,0,5.336734693877551,9.283280446293812,VEGFC,Adipo-MSC,0.7554577289388229
KEGG_2021_Human,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/77,0.1756071809118701,0.2495786988987195,0,0,5.336734693877551,9.283280446293812,ANGPT1,Adipo-MSC,0.7554577289388229
KEGG_2021_Human,cholesterol metabolic process (GO:0008203),1/77,0.1756071809118701,0.2495786988987195,0,0,5.336734693877551,9.283280446293812,APOB,Adipo-MSC,0.7554577289388229
KEGG_2021_Human,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.1756071809118701,0.2495786988987195,0,0,5.336734693877551,9.283280446293812,LPL,Adipo-MSC,0.7554577289388229
KEGG_2021_Human,negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.1776761254379788,0.2511399342921628,0,0,5.267161410018553,9.10056411919043,ADIPOQ,Adipo-MSC,0.7503709249641564
KEGG_2021_Human,chemical synaptic transmission (GO:0007268),2/306,0.1779160016431225,0.2511399342921628,0,0,2.6927083333333335,4.648809448291678,GRIK1;CBLN2,Adipo-MSC,0.7497849900117082
KEGG_2021_Human,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2548867756877433,0,0,5.133298889175924,8.751529842637671,EPB41L4B,Adipo-MSC,0.7404090821369118
KEGG_2021_Human,lipid biosynthetic process (GO:0008610),1/80,0.181798760490535,0.2548867756877433,0,0,5.133298889175924,8.751529842637671,LPL,Adipo-MSC,0.7404090821369118
KEGG_2021_Human,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2560361655441767,0,0,5.0688775510204085,8.584760541358477,ADIPOQ,Adipo-MSC,0.7355305181562768
KEGG_2021_Human,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.1838524754991919,0.2560361655441767,0,0,5.0688775510204085,8.584760541358477,LPL,Adipo-MSC,0.7355305181562768
KEGG_2021_Human,positive regulation of protein ubiquitination (GO:0031398),1/82,0.1859011384602527,0.2580233192675748,0,0,5.00604686318972,8.422875391899517,ANGPT1,Adipo-MSC,0.7307179505966239
KEGG_2021_Human,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.2599902534578473,0,0,4.944748631159781,8.265677319811374,LPL,Adipo-MSC,0.7259697745939766
KEGG_2021_Human,response to insulin (GO:0032868),1/84,0.1899833569114356,0.2610698447624032,0,0,4.884927464961889,8.112979399077096,ADIPOQ,Adipo-MSC,0.7212844428267129
KEGG_2021_Human,lymphocyte differentiation (GO:0030098),1/84,0.1899833569114356,0.2610698447624032,0,0,4.884927464961889,8.112979399077096,VCAM1,Adipo-MSC,0.7212844428267129
KEGG_2021_Human,negative regulation of defense response (GO:0031348),1/85,0.1920169366451308,0.2621283839070042,0,0,4.826530612244898,7.964604221414354,ADIPOQ,Adipo-MSC,0.716660463134361
KEGG_2021_Human,B cell activation (GO:0042113),1/85,0.1920169366451308,0.2621283839070042,0,0,4.826530612244898,7.964604221414354,VCAM1,Adipo-MSC,0.716660463134361
KEGG_2021_Human,glucose homeostasis (GO:0042593),1/86,0.1940455128548384,0.2631663001135881,0,0,4.769507803121249,7.820383303288144,ADIPOQ,Adipo-MSC,0.7120963955156414
KEGG_2021_Human,positive regulation of endothelial cell migration (GO:0010595),1/86,0.1940455128548384,0.2631663001135881,0,0,4.769507803121249,7.820383303288144,ANGPT1,Adipo-MSC,0.7120963955156414
KEGG_2021_Human,positive regulation of inflammatory response (GO:0050729),1/89,0.2001013407742902,0.2687445191628817,0,0,4.6062152133580705,7.411084001248333,LPL,Adipo-MSC,0.6987500013741589
KEGG_2021_Human,regulation of endothelial cell migration (GO:0010594),1/89,0.2001013407742902,0.2687445191628817,0,0,4.6062152133580705,7.411084001248333,ANGPT1,Adipo-MSC,0.6987500013741589
KEGG_2021_Human,collagen fibril organization (GO:0030199),1/89,0.2001013407742902,0.2687445191628817,0,0,4.6062152133580705,7.411084001248333,P3H2,Adipo-MSC,0.6987500013741589
KEGG_2021_Human,cellular amino acid catabolic process (GO:0009063),1/90,0.2021100231923967,0.2705666439511118,0,0,4.55423068103646,7.281955543769811,TDO2,Adipo-MSC,0.6944121480917811
KEGG_2021_Human,toll-like receptor signaling pathway (GO:0002224),1/91,0.2041137620931186,0.2723704542400136,0,0,4.503401360544218,7.156255051106618,APOB,Adipo-MSC,0.6901277125812961
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),3/625,0.2050267003954304,0.2724099245734747,0,0,1.9834439351440103,3.142995135240803,EPB41L4B;ESM1;VEGFC,Adipo-MSC,0.6881895775817527
KEGG_2021_Human,positive regulation of cellular component biogenesis (GO:0044089),1/92,0.2061125694363157,0.2724099245734747,0,0,4.453689167974883,7.03385741012878,TRABD2B,Adipo-MSC,0.6858955226779435
KEGG_2021_Human,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2724099245734747,0,0,4.453689167974883,7.03385741012878,ANGPT1,Adipo-MSC,0.6858955226779435
KEGG_2021_Human,negative regulation of MAPK cascade (GO:0043409),1/94,0.2100954368002021,0.2767924008637583,0,0,4.357472021066491,6.79849904676328,ADIPOQ,Adipo-MSC,0.6775833802166729
KEGG_2021_Human,post-translational protein modification (GO:0043687),2/345,0.2133084926466024,0.2792950611267017,0,0,2.381802721088435,3.6799229289674416,APOB;CP,Adipo-MSC,0.6709918532419347
KEGG_2021_Human,cellular transition metal ion homeostasis (GO:0046916),1/96,0.2140587201245348,0.2792950611267017,0,0,4.26530612244898,6.5749903239841245,CP,Adipo-MSC,0.6694670755856718
KEGG_2021_Human,protein maturation (GO:0051604),1/97,0.2160330472811356,0.2792950611267017,0,0,4.220663265306122,6.46742313757927,PCSK6,Adipo-MSC,0.6654798083211632
KEGG_2021_Human,positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.2160330472811356,0.2792950611267017,0,0,4.220663265306122,6.46742313757927,ADIPOQ,Adipo-MSC,0.6654798083211632
KEGG_2021_Human,glycosaminoglycan biosynthetic process (GO:0006024),1/97,0.2160330472811356,0.2792950611267017,0,0,4.220663265306122,6.46742313757927,ANGPT1,Adipo-MSC,0.6654798083211632
KEGG_2021_Human,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2792950611267017,0,0,4.220663265306122,6.46742313757927,ADIPOQ,Adipo-MSC,0.6654798083211632
KEGG_2021_Human,positive regulation of defense response (GO:0031349),1/98,0.2180025137484037,0.2809659726881601,0,0,4.176940879444562,6.362519703204576,LPL,Adipo-MSC,0.6615384985937142
KEGG_2021_Human,cell-matrix adhesion (GO:0007160),1/100,0.2219269115603851,0.2842582354862957,0,0,4.092145949288806,6.1603458876211565,VCAM1,Adipo-MSC,0.6537900306498672
KEGG_2021_Human,organic acid transport (GO:0015849),1/100,0.2219269115603851,0.2842582354862957,0,0,4.092145949288806,6.1603458876211565,SLC7A10,Adipo-MSC,0.6537900306498672
KEGG_2021_Human,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2874855303558475,0,0,4.010709234188725,5.967790506031058,VCAM1,Adipo-MSC,0.6462145058611213
KEGG_2021_Human,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.2874855303558475,0,0,4.010709234188725,5.967790506031058,VEGFC,Adipo-MSC,0.6462145058611213
KEGG_2021_Human,protein processing (GO:0016485),1/106,0.2335846623503299,0.2946432670984404,0,0,3.857142857142857,5.6090983677319475,PCSK6,Adipo-MSC,0.6315556772929499
KEGG_2021_Human,cellular response to peptide hormone stimulus (GO:0071375),1/106,0.2335846623503299,0.2946432670984404,0,0,3.857142857142857,5.6090983677319475,ADIPOQ,Adipo-MSC,0.6315556772929499
KEGG_2021_Human,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2946432670984404,0,0,3.857142857142857,5.6090983677319475,ADIPOQ,Adipo-MSC,0.6315556772929499
KEGG_2021_Human,regulation of protein ubiquitination (GO:0031396),1/109,0.239349173739861,0.3009997184910374,0,0,3.749433106575964,5.361058744932435,ANGPT1,Adipo-MSC,0.6209680674126086
KEGG_2021_Human,response to tumor necrosis factor (GO:0034612),1/110,0.241261218690496,0.3015765233631201,0,0,3.714847406852649,5.282048795926194,ADIPOQ,Adipo-MSC,0.6175124827423236
KEGG_2021_Human,regulation of interleukin-6 production (GO:0032675),1/110,0.241261218690496,0.3015765233631201,0,0,3.714847406852649,5.282048795926194,LPL,Adipo-MSC,0.6175124827423236
KEGG_2021_Human,positive regulation of metabolic process (GO:0009893),1/113,0.2469691364760274,0.3061501435853964,0,0,3.614795918367347,5.055262825364014,ADIPOQ,Adipo-MSC,0.6073573167632206
KEGG_2021_Human,sulfur compound biosynthetic process (GO:0044272),1/113,0.2469691364760274,0.3061501435853964,0,0,3.614795918367347,5.055262825364014,ANGPT1,Adipo-MSC,0.6073573167632206
KEGG_2021_Human,activation of protein kinase activity (GO:0032147),1/114,0.2488624078588274,0.3061501435853964,0,0,3.582625970742279,4.982913653406146,ANGPT1,Adipo-MSC,0.6040407011916724
KEGG_2021_Human,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.3061501435853964,0,0,3.582625970742279,4.982913653406146,ADIPOQ,Adipo-MSC,0.6040407011916724
KEGG_2021_Human,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.3061501435853964,0,0,3.582625970742279,4.982913653406146,TRABD2B,Adipo-MSC,0.6040407011916724
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),2/384,0.2493463820044915,0.3061501435853964,0,0,2.1343804537521813,2.9644671728961822,EPB41L4B;ANGPT1,Adipo-MSC,0.6031969289771376
KEGG_2021_Human,regulation of protein-containing complex assembly (GO:0043254),1/116,0.2526349665899778,0.3083632680436495,0,0,3.5199645075421473,4.8428011439058265,TRABD2B,Adipo-MSC,0.5975065399797567
KEGG_2021_Human,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.3083632680436495,0,0,3.5199645075421473,4.8428011439058265,VEGFC,Adipo-MSC,0.5975065399797567
KEGG_2021_Human,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.3111152522110174,0,0,3.4594453165881736,4.708511372057024,ADIPOQ,Adipo-MSC,0.5911006880374128
KEGG_2021_Human,positive regulation of protein-containing complex assembly (GO:0031334),1/118,0.2563889548341396,0.3111152522110174,0,0,3.4594453165881736,4.708511372057024,TRABD2B,Adipo-MSC,0.5911006880374128
KEGG_2021_Human,cellular response to interferon-gamma (GO:0071346),1/121,0.2619853133921213,0.3160578635399138,0,0,3.372448979591837,4.517283552621874,VCAM1,Adipo-MSC,0.5817230540677998
KEGG_2021_Human,protein homooligomerization (GO:0051260),1/121,0.2619853133921213,0.3160578635399138,0,0,3.372448979591837,4.517283552621874,TDO2,Adipo-MSC,0.5817230540677998
KEGG_2021_Human,positive regulation of epithelial cell proliferation (GO:0050679),1/123,0.2656932663769877,0.3196020450621736,0,0,3.316828370692539,4.396166676729281,VEGFC,Adipo-MSC,0.5756194520344882
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),2/404,0.2679393411370432,0.3213723311325807,0,0,2.026119402985074,2.6683884405969245,ANGPT1;VEGFC,Adipo-MSC,0.5719635148936996
KEGG_2021_Human,platelet degranulation (GO:0002576),1/125,0.2693829605231016,0.3221727049483781,0,0,3.263001974983542,4.279822783786303,VEGFC,Adipo-MSC,0.5696298784899082
KEGG_2021_Human,synapse organization (GO:0050808),1/126,0.2712209880572274,0.323438821964797,0,0,3.236734693877551,4.223360488574632,CBLN2,Adipo-MSC,0.5666767062328689
KEGG_2021_Human,cellular response to insulin stimulus (GO:0032869),1/129,0.2767079241059198,0.329036643277813,0,0,3.1603954081632653,4.060453122404681,ADIPOQ,Adipo-MSC,0.5579784037567757
KEGG_2021_Human,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.2785278903472666,0.3302544985546161,0,0,3.135738016136687,4.008216604624779,RSPO1,Adipo-MSC,0.5551313103019286
KEGG_2021_Human,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3378679140418969,0,0,3.0408163265306123,3.80890385676326,ANGPT1,Adipo-MSC,0.5439940297149167
KEGG_2021_Human,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.341141573426461,0,0,2.99546485260771,3.714691124222948,ADIPOQ,Adipo-MSC,0.5385707850387818
KEGG_2021_Human,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3464684732689695,0,0,2.929902395740905,3.579678317757992,LPL,Adipo-MSC,0.5306096689947516
KEGG_2021_Human,protein localization to cell periphery (GO:1990778),1/140,0.2964824884084789,0.3475712787839512,0,0,2.9086771399207163,3.5362740390257685,ADIPOQ,Adipo-MSC,0.5280009529309525
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),3/764,0.2984210193557987,0.3488583747398773,0,0,1.6095003774428942,1.9462882878583572,ESM1;P3H2;VEGFC,Adipo-MSC,0.5251705904864272
KEGG_2021_Human,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3498321981410775,0,0,2.8467950560505892,3.410594866305226,APOB,Adipo-MSC,0.5203052911363482
KEGG_2021_Human,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3498321981410775,0,0,2.8467950560505892,3.410594866305226,SLC7A10,Adipo-MSC,0.5203052911363482
KEGG_2021_Human,monocarboxylic acid metabolic process (GO:0032787),1/143,0.3017829564686885,0.3498321981410775,0,0,2.8467950560505892,3.410594866305226,LPL,Adipo-MSC,0.5203052911363482
KEGG_2021_Human,negative regulation of cell migration (GO:0030336),1/144,0.3035410668561185,0.3508900912125047,0,0,2.826744683887541,3.370153465117457,ADIPOQ,Adipo-MSC,0.5177825437898177
KEGG_2021_Human,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3579723450537866,0,0,2.749271137026239,3.215201203875706,ADIPOQ,Adipo-MSC,0.5078961191737069
KEGG_2021_Human,response to cytokine (GO:0034097),1/150,0.3139989845586295,0.360968361750225,0,0,2.712094233666621,3.141596466170354,ADIPOQ,Adipo-MSC,0.5030717563895143
KEGG_2021_Human,negative regulation of protein phosphorylation (GO:0001933),1/152,0.3174506378807152,0.363928217459936,0,0,2.6759021489390458,3.0704182805545575,ADIPOQ,Adipo-MSC,0.4983237959237088
KEGG_2021_Human,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.3191700762858281,0.3648914095278751,0,0,2.6581632653061225,3.0357052873752,RSPO1,Adipo-MSC,0.4959778325880012
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3784021501378038,0,0,2.524234693877551,2.7773973646136283,ANGPT1,Adipo-MSC,0.4778511096570981
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),2/474,0.3328115296392732,0.3784021501378038,0,0,1.7194562146892656,1.8917094920733264,ESM1;VEGFC,Adipo-MSC,0.47780163679243126
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),2/482,0.3401543782991926,0.3846432343165256,0,0,1.6901041666666667,1.8225334796372663,EPB41L4B;ANGPT1,Adipo-MSC,0.46832393464331673
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),2/482,0.3401543782991926,0.3846432343165256,0,0,1.6901041666666667,1.8225334796372663,CNTFR;VCAM1,Adipo-MSC,0.46832393464331673
KEGG_2021_Human,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3884512165527393,0,0,2.4175730172308443,2.5766088705447237,ANGPT1,Adipo-MSC,0.46286379212748074
KEGG_2021_Human,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.3477593333218013,0.3911114453348173,0,0,2.388721168940949,2.523073857975914,VCAM1,Adipo-MSC,0.45872120538836164
KEGG_2021_Human,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.3494039111808349,0.3918989814595851,0,0,2.3745498199279713,2.4969025061029213,ADIPOQ,Adipo-MSC,0.4566722378913039
KEGG_2021_Human,positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.3510444250368044,0.3926777261193365,0,0,2.360544217687075,2.4711180018684864,ANGPT1,Adipo-MSC,0.45463791963821665
KEGG_2021_Human,regulation of immune response (GO:0050776),1/179,0.3624150547196057,0.4043071174963343,0,0,2.266911258885577,2.300835957547096,VCAM1,Adipo-MSC,0.4407937700298507
KEGG_2021_Human,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.4050126401910195,0,0,2.2541329380914377,2.2778849681371156,VEGFC,Adipo-MSC,0.4388706874182523
KEGG_2021_Human,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.4221435133220481,0,0,2.122448979591837,2.045536603225051,ADIPOQ,Adipo-MSC,0.41855670871419515
KEGG_2021_Human,negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.3814549819175133,0.4221435133220481,0,0,2.122448979591837,2.045536603225051,TRABD2B,Adipo-MSC,0.41855670871419515
KEGG_2021_Human,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.4278880963576023,0,0,2.0782663580896275,1.969329769675335,ADIPOQ,Adipo-MSC,0.4115300469974289
KEGG_2021_Human,regulation of signal transduction (GO:0009966),1/198,0.3923030921692546,0.430703130291642,0,0,2.0463068476121413,1.914771355908193,ADIPOQ,Adipo-MSC,0.4063782687077012
KEGG_2021_Human,negative regulation of intracellular signal transduction (GO:1902532),1/198,0.3923030921692546,0.430703130291642,0,0,2.0463068476121413,1.914771355908193,ADIPOQ,Adipo-MSC,0.4063782687077012
KEGG_2021_Human,regulation of macromolecule metabolic process (GO:0060255),1/200,0.3953681557510544,0.4329229146086744,0,0,2.025535842477695,1.8795714928238216,RSPO1,Adipo-MSC,0.40299831311675843
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),2/546,0.3979281971141292,0.434486927448434,0,0,1.4863664215686274,1.3696624285648409,ANGPT1;ADIPOQ,Adipo-MSC,0.40019528574129115
KEGG_2021_Human,regulation of angiogenesis (GO:0045765),1/203,0.3999373645428959,0.434486927448434,0,0,1.9951505354617096,1.8284503867148747,VEGFC,Adipo-MSC,0.398008019580524
KEGG_2021_Human,axon guidance (GO:0007411),1/203,0.3999373645428959,0.434486927448434,0,0,1.9951505354617096,1.8284503867148747,NRXN3,Adipo-MSC,0.398008019580524
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4398967915722871,0,0,1.9560134733505052,1.7632653144438126,ANGPT1,Adipo-MSC,0.3914985283218076
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),1/212,0.4134429066373548,0.4456592370246812,0,0,1.909178837411742,1.6862551884518755,ADIPOQ,Adipo-MSC,0.3835844547796231
KEGG_2021_Human,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4456592370246812,0,0,1.909178837411742,1.6862551884518755,LPL,Adipo-MSC,0.3835844547796231
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4476876328422816,0,0,1.8910606496119575,1.656759537391559,ADIPOQ,Adipo-MSC,0.3804856946694876
KEGG_2021_Human,cellular response to lipid (GO:0071396),1/219,0.4237408440429794,0.4543990963251588,0,0,1.8472196217936716,1.5860841457604238,LPL,Adipo-MSC,0.372899672681652
KEGG_2021_Human,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.4609792426134859,0,0,1.805344559348403,1.519514184420898,ADIPOQ,Adipo-MSC,0.36553500108915365
KEGG_2021_Human,axonogenesis (GO:0007409),1/240,0.4535831041409784,0.4838997126439744,0,0,1.6831184356587825,1.3306343458644796,NRXN3,Adipo-MSC,0.34334313117644527
KEGG_2021_Human,membrane organization (GO:0061024),1/242,0.4563449373288627,0.4855978179268667,0,0,1.6689812854602422,1.3093263562491473,APOB,Adipo-MSC,0.3407067631514444
KEGG_2021_Human,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.4872727157031666,0,0,1.655076845553036,1.2884811006593149,GRIK1,Adipo-MSC,0.33809924509335265
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),2/621,0.4626694381715867,0.4898158592887971,0,0,1.3012250942380184,1.0029093993298663,CNTFR;VCAM1,Adipo-MSC,0.33472918706115434
KEGG_2021_Human,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.4976750025125721,0,0,1.5952380952380951,1.2000608149186214,RSPO1,Adipo-MSC,0.32670971902140344
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5252993736973784,0,0,1.4709576138147566,1.0233666205889618,ANGPT1,Adipo-MSC,0.30214499188263844
KEGG_2021_Human,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.561365538099598,0,0,1.32774699283687,0.8321996277505203,ANGPT1,Adipo-MSC,0.2722052530518486
KEGG_2021_Human,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5685554032364496,0,0,1.2972062611452349,0.7932686422257892,ADIPOQ,Adipo-MSC,0.2655801196036423
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5826763365207531,0,0,1.2440106477373558,0.7270814983759607,LPL,Adipo-MSC,0.2538302089398956
KEGG_2021_Human,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.588204795084748,0,0,1.2208810353409656,0.6989624697257846,ANGPT1,Adipo-MSC,0.24863646405532092
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),1/345,0.5815093765862647,0.6048280483290722,0,0,1.1631466540104414,0.6305745813190116,ADIPOQ,Adipo-MSC,0.23544327806907975
KEGG_2021_Human,supramolecular fiber organization (GO:0097435),1/351,0.5878572192841084,0.6099018650072625,0,0,1.1428571428571428,0.6071670684764225,P3H2,Adipo-MSC,0.23072814400359865
KEGG_2021_Human,protein transport (GO:0015031),1/369,0.6063398885560332,0.6275088622213311,0,0,1.0859582963620231,0.5433207667028247,APOB,Adipo-MSC,0.21728386041430361
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),1/379,0.6162544539128882,0.6361830805319617,0,0,1.056689342403628,0.5115383719098227,P3H2,Adipo-MSC,0.2102399288866402
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.6366159677024258,0,0,1.0510204081632653,0.5054679174936134,ANGPT1,Adipo-MSC,0.20886552310647807
KEGG_2021_Human,regulation of cell migration (GO:0030334),1/408,0.643643262264238,0.6611682025734128,0,0,0.9799428370856942,0.4317732474155183,ADIPOQ,Adipo-MSC,0.19135477263518083
KEGG_2021_Human,negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.6912187085983104,0.7082858372056762,0,0,0.8589500595054437,0.3172093937483807,ADIPOQ,Adipo-MSC,0.16038451570993173
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.723086197143232,0,0,0.8207960870298533,0.2841203737887477,ANGPT1,Adipo-MSC,0.15033199168778996
KEGG_2021_Human,positive regulation of nucleic acid-templated transcription (GO:1903508),1/511,0.7262961571675228,0.7405722487088992,0,0,0.7779111644657863,0.2487739813280452,EBF3,Adipo-MSC,0.13888625368433627
KEGG_2021_Human,cellular protein modification process (GO:0006464),2/1025,0.7337546800798972,0.7463436084146012,0,0,0.7708944281524927,0.2386539053000475,APOB;CP,Adipo-MSC,0.13444911569132442
KEGG_2021_Human,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7504933808556635,0.7615030637044018,0,0,0.7252747252747253,0.2081715773755284,ADIPOQ,Adipo-MSC,0.1246531337611999
KEGG_2021_Human,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7690327624616352,0,0,0.7301532033426184,0.200604530418796,EPB41L4B;ANGPT1,Adipo-MSC,0.11931939791106433
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8575926689468534,0,0,0.5290423861852434,0.0863986224716518,ANGPT1,Adipo-MSC,0.07092521499844862
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",1/948,0.912055183209665,0.918696361728182,0,0,0.4095209361463698,0.0376983608425212,ADIPOQ,Adipo-MSC,0.039978884217174375
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",3/2244,0.9302128294243438,0.9347174920365684,0,0,0.5044005810475947,0.036489281349511,ADIPOQ;EBF3;VGLL3,Adipo-MSC,0.03141767502685046
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1183,0.952754544972228,0.9550558844528374,0,0,0.3240443385476018,0.0156830878086274,EBF3,Adipo-MSC,0.021018970814361417
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),2/2206,0.9792407454532416,0.9792407454532416,0,0,0.3354885057471264,0.0070377963929841,EBF3;VGLL3,Adipo-MSC,0.009110524163636814
GO_Biological_Process_2021,negative regulation of endothelial cell apoptotic process (GO:2000352),3/27,4.122055222407173e-05,0.0192912184408655,0,0,52.994680851063826,535.0646948580581,IL4;IL13;GATA2,Ba/Eo/Ma,4.384886194355431
GO_Biological_Process_2021,negative regulation of epithelial cell apoptotic process (GO:1904036),3/37,0.00010758892051640564,0.0251758074008389,0,0,37.3892365456821,341.6326661301949,IL4;IL13;GATA2,Ba/Eo/Ma,3.9682324499181036
GO_Biological_Process_2021,regulation of endothelial cell apoptotic process (GO:2000351),3/44,0.0001811421903351466,0.0255114533526882,0,0,30.994810586403737,267.0583626754283,IL4;IL13;GATA2,Ba/Eo/Ma,3.74198038515947
GO_Biological_Process_2021,regulation of complement-dependent cytotoxicity (GO:1903659),2/9,0.00021804660985203623,0.0255114533526882,0,0,118.70833333333331,1000.8064198202924,IL4;IL13,Ba/Eo/Ma,3.6614506612675517
GO_Biological_Process_2021,prostanoid metabolic process (GO:0006692),2/18,0.000913470506242016,0.0840459447613491,0,0,51.911458333333336,363.2898548418271,HPGDS;HPGD,Ba/Eo/Ma,3.039305470405725
GO_Biological_Process_2021,innate immune response in mucosa (GO:0002227),2/21,0.0012477930702112,0.0840459447613491,0,0,43.708333333333336,292.25047477799524,IL4;RNASE2,Ba/Eo/Ma,2.9038574306125264
GO_Biological_Process_2021,negative regulation of defense response (GO:0031348),3/85,0.0012570974643791,0.0840459447613491,0,0,15.465490399584846,103.29323424451243,IL4;IL13;ENPP3,Ba/Eo/Ma,2.900631049600358
GO_Biological_Process_2021,mucosal immune response (GO:0002385),2/28,0.0022210873543451,0.1128687334389401,0,0,31.92948717948718,195.08145262248803,IL4;RNASE2,Ba/Eo/Ma,2.6534343605132076
GO_Biological_Process_2021,negative regulation of myeloid leukocyte differentiation (GO:0002762),2/29,0.0023818121959682,0.1128687334389401,0,0,30.74537037037037,185.6987673947897,IL4;INHA,Ba/Eo/Ma,2.623092485284041
GO_Biological_Process_2021,prostaglandin metabolic process (GO:0006693),2/31,0.0027192556482504,0.1128687334389401,0,0,28.62212643678161,169.08226656127547,HPGDS;HPGD,Ba/Eo/Ma,2.565549960707733
GO_Biological_Process_2021,positive regulation of interleukin-10 production (GO:0032733),2/32,0.0028959211173454,0.1128687334389401,0,0,27.666666666666668,161.69650653172428,IL4;IL13,Ba/Eo/Ma,2.5382132721600397
GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),3/118,0.0032065354536986,0.1128687334389401,0,0,11.009250693802036,63.22132915202483,IL4;IL13;ENPP3,Ba/Eo/Ma,2.4939639538566616
GO_Biological_Process_2021,macrophage activation (GO:0042116),2/36,0.0036549257227984,0.1128687334389401,0,0,24.40686274509804,136.96349152286243,IL4;IL13,Ba/Eo/Ma,2.437121444562911
GO_Biological_Process_2021,proteolysis (GO:0006508),4/287,0.0056959581367739,0.1128687334389401,0,0,6.043017360577662,31.23030437987747,CPA3;TPSD1;TPSB2;TPSAB1,Ba/Eo/Ma,2.2444332112663723
GO_Biological_Process_2021,regulation of interleukin-10 production (GO:0032653),2/48,0.0064203200925442,0.1128687334389401,0,0,18.028985507246375,91.01549863791358,IL4;IL13,Ba/Eo/Ma,2.192443319133604
GO_Biological_Process_2021,organonitrogen compound biosynthetic process (GO:1901566),3/158,0.0072257561149995,0.1128687334389401,0,0,8.151681537405628,40.18863284587075,HPGDS;ELOVL7;INHA,Ba/Eo/Ma,2.1411167009049183
GO_Biological_Process_2021,regulation of blood vessel endothelial cell migration (GO:0043535),2/55,0.0083588302127531,0.1128687334389401,0,0,15.642295597484276,74.83957451132376,ANGPT2;GATA2,Ba/Eo/Ma,2.077854496208505
GO_Biological_Process_2021,negative regulation of B cell differentiation (GO:0045578),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,INHA,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,amine transport (GO:0015837),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,SLC18A2,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,pyrimidine nucleotide metabolic process (GO:0006220),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,ENPP3,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,gastro-intestinal system smooth muscle contraction (GO:0014831),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,PTGER3,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,negative regulation of gonadotropin secretion (GO:0032277),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,INHA,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,positive regulation of heat generation (GO:0031652),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,PTGER3,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,hemoglobin metabolic process (GO:0020027),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,INHA,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,negative regulation of macrophage differentiation (GO:0045650),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,INHA,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,negative regulation of mast cell activation involved in immune response (GO:0033007),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,ENPP3,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,positive regulation of mast cell activation involved in immune response (GO:0033008),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,IL4,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,regulation of fever generation (GO:0031620),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,PTGER3,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,neuroinflammatory response (GO:0150076),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,IL4,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,nucleoside triphosphate catabolic process (GO:0009143),1/5,0.0124387771927725,0.1128687334389401,0,0,101.76530612244898,446.4379351400606,ENPP3,Ba/Eo/Ma,1.9052223113279663
GO_Biological_Process_2021,peptidyl-tyrosine phosphorylation (GO:0018108),2/69,0.0129153730394233,0.1128687334389401,0,0,12.36504975124378,53.77976800231812,IL4;NTRK1,Ba/Eo/Ma,1.888893045423814
GO_Biological_Process_2021,fatty acid biosynthetic process (GO:0006633),2/71,0.0136373517747766,0.1128687334389401,0,0,12.005434782608695,51.56265564232933,HPGD;ELOVL7,Ba/Eo/Ma,1.8652699567516449
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),3/206,0.0147987734204783,0.1128687334389401,0,0,6.209097578870139,26.160238086750542,IL4;IL13;ENPP3,Ba/Eo/Ma,1.8297742791181009
GO_Biological_Process_2021,activation of Janus kinase activity (GO:0042976),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,IL4,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,negative regulation of fat cell proliferation (GO:0070345),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,GATA2,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,glomerulus vasculature development (GO:0072012),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,ANGPT2,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,positive regulation of fever generation (GO:0031622),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,PTGER3,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,glycosylceramide catabolic process (GO:0046477),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,GALC,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,negative regulation of mast cell activation (GO:0033004),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,ENPP3,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,histamine metabolic process (GO:0001692),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,HDC,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,induction of bacterial agglutination (GO:0043152),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,RNASE2,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,cellular response to magnesium ion (GO:0071286),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,RYR3,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,lipoxin metabolic process (GO:2001300),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,HPGD,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,regulation of immunoglobulin mediated immune response (GO:0002889),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,IL4,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,lymphocyte apoptotic process (GO:0070227),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,CLC,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,neurotransmitter loading into synaptic vesicle (GO:0098700),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,SLC18A2,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,regulation of microtubule motor activity (GO:2000574),1/6,0.0149082847993736,0.1128687334389401,0,0,81.40816326530613,342.3895623444841,MTCL1,Ba/Eo/Ma,1.8265723193247598
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),4/384,0.0153877459849858,0.1128687334389401,0,0,4.478260869565218,18.69308398095575,IL4;SLC24A3;IL13;GATA2,Ba/Eo/Ma,1.8128249914729373
GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),2/76,0.0155171628224907,0.1128687334389401,0,0,11.19144144144144,46.62140287744705,IL4;CLC,Ba/Eo/Ma,1.8091876827669675
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),3/212,0.0159696302578282,0.1128687334389401,0,0,6.029013539651838,24.942429757967023,IL4;IL13;ENPP3,Ba/Eo/Ma,1.7967051388924395
GO_Biological_Process_2021,negative regulation of cell cycle (GO:0045786),2/80,0.0170965192165363,0.1128687334389401,0,0,10.615384615384617,43.19273030214829,HPGD;INHA,Ba/Eo/Ma,1.7670923012410087
GO_Biological_Process_2021,positive regulation of amyloid-beta clearance (GO:1900223),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,IL4,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,ELOVL7,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,ELOVL7,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,"fatty acid elongation, saturated fatty acid (GO:0019367)",1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,ELOVL7,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,"fatty acid elongation, unsaturated fatty acid (GO:0019368)",1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,ELOVL7,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,regulation of T cell tolerance induction (GO:0002664),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,CLC,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,negative regulation of digestive system process (GO:0060457),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,PTGER3,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,response to caffeine (GO:0031000),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,RYR3,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,negative regulation of lymphocyte differentiation (GO:0045620),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,INHA,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,positive regulation of interleukin-5 production (GO:0032754),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,CRLF2,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,positive regulation of mast cell activation (GO:0033005),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,CRLF2,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,cellular response to caffeine (GO:0071313),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,RYR3,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,regulation of fat cell proliferation (GO:0070344),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,GATA2,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,regulation of glial cell differentiation (GO:0045685),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,SLC45A3,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,negative regulation of T-helper 17 type immune response (GO:2000317),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,IL4,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,lipoxin biosynthetic process (GO:2001301),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,HPGD,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,T cell apoptotic process (GO:0070231),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,CLC,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,vascular wound healing (GO:0061042),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,GATA2,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,dopamine transport (GO:0015872),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,SLC18A2,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,negative regulation of acute inflammatory response (GO:0002674),1/7,0.0173717414502839,0.1128687334389401,0,0,67.83673469387755,274.9362107684438,IL4,Ba/Eo/Ma,1.7601566430186848
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),5/621,0.0190565584570887,0.1128687334389401,0,0,3.4873737373737375,13.811199519498388,IL4;IL1RL1;IL13;IL3RA;CRLF2,Ba/Eo/Ma,1.719955528569201
GO_Biological_Process_2021,galactosylceramide metabolic process (GO:0006681),1/8,0.0198291614511851,0.1128687334389401,0,0,58.142857142857146,227.9549801512961,GALC,Ba/Eo/Ma,1.702695651141308
GO_Biological_Process_2021,aromatic compound biosynthetic process (GO:0019438),1/8,0.0198291614511851,0.1128687334389401,0,0,58.142857142857146,227.9549801512961,HDC,Ba/Eo/Ma,1.702695651141308
GO_Biological_Process_2021,histidine catabolic process (GO:0006548),1/8,0.0198291614511851,0.1128687334389401,0,0,58.142857142857146,227.9549801512961,HDC,Ba/Eo/Ma,1.702695651141308
GO_Biological_Process_2021,histidine metabolic process (GO:0006547),1/8,0.0198291614511851,0.1128687334389401,0,0,58.142857142857146,227.9549801512961,HDC,Ba/Eo/Ma,1.702695651141308
GO_Biological_Process_2021,negative regulation of neural precursor cell proliferation (GO:2000178),1/8,0.0198291614511851,0.1128687334389401,0,0,58.142857142857146,227.9549801512961,GATA2,Ba/Eo/Ma,1.702695651141308
GO_Biological_Process_2021,positive regulation of MHC class II biosynthetic process (GO:0045348),1/8,0.0198291614511851,0.1128687334389401,0,0,58.142857142857146,227.9549801512961,IL4,Ba/Eo/Ma,1.702695651141308
GO_Biological_Process_2021,negative regulation of T-helper 17 cell differentiation (GO:2000320),1/8,0.0198291614511851,0.1128687334389401,0,0,58.142857142857146,227.9549801512961,IL4,Ba/Eo/Ma,1.702695651141308
GO_Biological_Process_2021,positive regulation of T-helper 2 cell cytokine production (GO:2000553),1/8,0.0198291614511851,0.1128687334389401,0,0,58.142857142857146,227.9549801512961,IL4,Ba/Eo/Ma,1.702695651141308
GO_Biological_Process_2021,monoamine transport (GO:0015844),1/8,0.0198291614511851,0.1128687334389401,0,0,58.142857142857146,227.9549801512961,SLC18A2,Ba/Eo/Ma,1.702695651141308
GO_Biological_Process_2021,regulation of positive chemotaxis (GO:0050926),1/8,0.0198291614511851,0.1128687334389401,0,0,58.142857142857146,227.9549801512961,ANGPT2,Ba/Eo/Ma,1.702695651141308
GO_Biological_Process_2021,calcium ion transmembrane transport (GO:0070588),2/87,0.0200173181098975,0.1128687334389401,0,0,9.737745098039216,38.08585452607372,SLC24A3;RYR3,Ba/Eo/Ma,1.6985941090791523
GO_Biological_Process_2021,positive regulation of ATP biosynthetic process (GO:2001171),1/9,0.0222805591236868,0.1141597944331039,0,0,50.87244897959184,193.52086993316271,IL4,Ba/Eo/Ma,1.652073914876897
GO_Biological_Process_2021,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),1/9,0.0222805591236868,0.1141597944331039,0,0,50.87244897959184,193.52086993316271,GATA2,Ba/Eo/Ma,1.652073914876897
GO_Biological_Process_2021,negative regulation of leukocyte proliferation (GO:0070664),1/9,0.0222805591236868,0.1141597944331039,0,0,50.87244897959184,193.52086993316271,ENPP3,Ba/Eo/Ma,1.652073914876897
GO_Biological_Process_2021,response to magnesium ion (GO:0032026),1/9,0.0222805591236868,0.1141597944331039,0,0,50.87244897959184,193.52086993316271,RYR3,Ba/Eo/Ma,1.652073914876897
GO_Biological_Process_2021,positive regulation of mast cell degranulation (GO:0043306),1/9,0.0222805591236868,0.1141597944331039,0,0,50.87244897959184,193.52086993316271,IL4,Ba/Eo/Ma,1.652073914876897
GO_Biological_Process_2021,positive regulation of cold-induced thermogenesis (GO:0120162),2/97,0.024523395696302,0.1141597944331039,0,0,8.708333333333334,32.29161197321332,IL4;IL13,Ba/Eo/Ma,1.6104193942653626
GO_Biological_Process_2021,regulation of T-helper 17 cell differentiation (GO:2000319),1/10,0.024725948817258,0.1141597944331039,0,0,45.21768707482993,167.3010120823387,IL4,Ba/Eo/Ma,1.606847034080906
GO_Biological_Process_2021,positive regulation of myoblast fusion (GO:1901741),1/10,0.024725948817258,0.1141597944331039,0,0,45.21768707482993,167.3010120823387,IL4,Ba/Eo/Ma,1.606847034080906
GO_Biological_Process_2021,cellular response to purine-containing compound (GO:0071415),1/10,0.024725948817258,0.1141597944331039,0,0,45.21768707482993,167.3010120823387,RYR3,Ba/Eo/Ma,1.606847034080906
GO_Biological_Process_2021,nerve growth factor signaling pathway (GO:0038180),1/10,0.024725948817258,0.1141597944331039,0,0,45.21768707482993,167.3010120823387,NTRK1,Ba/Eo/Ma,1.606847034080906
GO_Biological_Process_2021,regulation of mast cell activation (GO:0033003),1/10,0.024725948817258,0.1141597944331039,0,0,45.21768707482993,167.3010120823387,CRLF2,Ba/Eo/Ma,1.606847034080906
GO_Biological_Process_2021,myeloid dendritic cell differentiation (GO:0043011),1/10,0.024725948817258,0.1141597944331039,0,0,45.21768707482993,167.3010120823387,IL4,Ba/Eo/Ma,1.606847034080906
GO_Biological_Process_2021,angiogenesis involved in wound healing (GO:0060055),1/11,0.0271653448579923,0.1141597944331039,0,0,40.69387755102041,146.73452100035948,GATA2,Ba/Eo/Ma,1.5659847773237099
GO_Biological_Process_2021,positive regulation of cellular respiration (GO:1901857),1/11,0.0271653448579923,0.1141597944331039,0,0,40.69387755102041,146.73452100035948,IL4,Ba/Eo/Ma,1.5659847773237099
GO_Biological_Process_2021,regulation of T cell mediated immunity (GO:0002709),1/11,0.0271653448579923,0.1141597944331039,0,0,40.69387755102041,146.73452100035948,CLC,Ba/Eo/Ma,1.5659847773237099
GO_Biological_Process_2021,regulation of T-helper 2 cell cytokine production (GO:2000551),1/11,0.0271653448579923,0.1141597944331039,0,0,40.69387755102041,146.73452100035948,IL4,Ba/Eo/Ma,1.5659847773237099
GO_Biological_Process_2021,positive regulation of interleukin-13 production (GO:0032736),1/11,0.0271653448579923,0.1141597944331039,0,0,40.69387755102041,146.73452100035948,IL4,Ba/Eo/Ma,1.5659847773237099
GO_Biological_Process_2021,negative regulation of T-helper cell differentiation (GO:0045623),1/11,0.0271653448579923,0.1141597944331039,0,0,40.69387755102041,146.73452100035948,IL4,Ba/Eo/Ma,1.5659847773237099
GO_Biological_Process_2021,regulation of mast cell activation involved in immune response (GO:0033006),1/11,0.0271653448579923,0.1141597944331039,0,0,40.69387755102041,146.73452100035948,ENPP3,Ba/Eo/Ma,1.5659847773237099
GO_Biological_Process_2021,cyclooxygenase pathway (GO:0019371),1/11,0.0271653448579923,0.1141597944331039,0,0,40.69387755102041,146.73452100035948,HPGDS,Ba/Eo/Ma,1.5659847773237099
GO_Biological_Process_2021,pyrimidine-containing compound metabolic process (GO:0072527),1/12,0.029598761568907,0.1141597944331039,0,0,36.99257884972171,130.2147194065139,ENPP3,Ba/Eo/Ma,1.5287264597194943
GO_Biological_Process_2021,angiotensin maturation (GO:0002003),1/12,0.029598761568907,0.1141597944331039,0,0,36.99257884972171,130.2147194065139,CPA3,Ba/Eo/Ma,1.5287264597194943
GO_Biological_Process_2021,regulation of angiotensin levels in blood (GO:0002002),1/12,0.029598761568907,0.1141597944331039,0,0,36.99257884972171,130.2147194065139,CPA3,Ba/Eo/Ma,1.5287264597194943
GO_Biological_Process_2021,regulation of MHC class II biosynthetic process (GO:0045346),1/12,0.029598761568907,0.1141597944331039,0,0,36.99257884972171,130.2147194065139,IL4,Ba/Eo/Ma,1.5287264597194943
GO_Biological_Process_2021,regulation of myoblast fusion (GO:1901739),1/12,0.029598761568907,0.1141597944331039,0,0,36.99257884972171,130.2147194065139,IL4,Ba/Eo/Ma,1.5287264597194943
GO_Biological_Process_2021,phasic smooth muscle contraction (GO:0014821),1/12,0.029598761568907,0.1141597944331039,0,0,36.99257884972171,130.2147194065139,PTGER3,Ba/Eo/Ma,1.5287264597194943
GO_Biological_Process_2021,Fc-epsilon receptor signaling pathway (GO:0038095),2/111,0.0314544847807964,0.1141597944331039,0,0,7.584480122324159,26.23633758944092,FCER1A;MS4A2,Ba/Eo/Ma,1.5023174240917434
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),4/481,0.0318938223451042,0.1141597944331039,0,0,3.549904293136451,12.230637711209717,MS4A3;PRG2;EPX;RNASE2,Ba/Eo/Ma,1.4962934292076782
GO_Biological_Process_2021,Fc receptor signaling pathway (GO:0038093),2/112,0.031976077624072,0.1141597944331039,0,0,7.515151515151516,25.872917364872013,FCER1A;MS4A2,Ba/Eo/Ma,1.4951748104677034
GO_Biological_Process_2021,regulation of receptor signaling pathway via STAT (GO:1904892),1/13,0.032026213248763,0.1141597944331039,0,0,33.90816326530612,116.6847899929619,CRLF2,Ba/Eo/Ma,1.4944944088974865
GO_Biological_Process_2021,fatty acid elongation (GO:0030497),1/13,0.032026213248763,0.1141597944331039,0,0,33.90816326530612,116.6847899929619,ELOVL7,Ba/Eo/Ma,1.4944944088974865
GO_Biological_Process_2021,positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,0.032026213248763,0.1141597944331039,0,0,33.90816326530612,116.6847899929619,SLC45A3,Ba/Eo/Ma,1.4944944088974865
GO_Biological_Process_2021,positive regulation of fatty acid biosynthetic process (GO:0045723),1/13,0.032026213248763,0.1141597944331039,0,0,33.90816326530612,116.6847899929619,SLC45A3,Ba/Eo/Ma,1.4944944088974865
GO_Biological_Process_2021,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1/13,0.032026213248763,0.1141597944331039,0,0,33.90816326530612,116.6847899929619,SLC18A2,Ba/Eo/Ma,1.4944944088974865
GO_Biological_Process_2021,regulation of interleukin-5 production (GO:0032674),1/13,0.032026213248763,0.1141597944331039,0,0,33.90816326530612,116.6847899929619,CRLF2,Ba/Eo/Ma,1.4944944088974865
GO_Biological_Process_2021,positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/13,0.032026213248763,0.1141597944331039,0,0,33.90816326530612,116.6847899929619,IL4,Ba/Eo/Ma,1.4944944088974865
GO_Biological_Process_2021,very long-chain fatty acid biosynthetic process (GO:0042761),1/13,0.032026213248763,0.1141597944331039,0,0,33.90816326530612,116.6847899929619,ELOVL7,Ba/Eo/Ma,1.4944944088974865
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),4/482,0.0321028352334031,0.1141597944331039,0,0,3.5422957977078404,12.181285498368895,IL4;SLC24A3;IL13;GATA2,Ba/Eo/Ma,1.4934566102167288
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),4/482,0.0321028352334031,0.1141597944331039,0,0,3.5422957977078404,12.181285498368895,IL4;IL13;IL3RA;CRLF2,Ba/Eo/Ma,1.4934566102167288
GO_Biological_Process_2021,positive regulation of metabolic process (GO:0009893),2/113,0.032501099312465,0.1141597944331039,0,0,7.447072072072072,25.51725368040207,IL4;IL13,Ba/Eo/Ma,1.4881019492591823
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),4/485,0.0327347557645973,0.1141597944331039,0,0,3.5196601283557807,12.03483687212892,MS4A3;PRG2;EPX;RNASE2,Ba/Eo/Ma,1.4849908950194666
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),4/488,0.0333740074148611,0.1141597944331039,0,0,3.497305066475027,11.890759946354155,MS4A3;PRG2;EPX;RNASE2,Ba/Eo/Ma,1.476591641901793
GO_Biological_Process_2021,calcium ion transport (GO:0006816),2/115,0.033561350657856,0.1141597944331039,0,0,7.31452802359882,24.82828874550635,SLC24A3;RYR3,Ba/Eo/Ma,1.4741605695522084
GO_Biological_Process_2021,ion transport (GO:0006811),2/116,0.0340965412337713,0.1141597944331039,0,0,7.25,24.49455514200503,SLC24A3;ATP10D,Ba/Eo/Ma,1.467289673772098
GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),2/116,0.0340965412337713,0.1141597944331039,0,0,7.25,24.49455514200503,GALC;ELOVL7,Ba/Eo/Ma,1.467289673772098
GO_Biological_Process_2021,positive regulation of glucose metabolic process (GO:0010907),1/14,0.0344477141698711,0.1141597944331039,0,0,31.298273155416013,105.4223689491126,SLC45A3,Ba/Eo/Ma,1.4628395910668823
GO_Biological_Process_2021,negative regulation of neuroinflammatory response (GO:0150079),1/14,0.0344477141698711,0.1141597944331039,0,0,31.298273155416013,105.4223689491126,IL4,Ba/Eo/Ma,1.4628395910668823
GO_Biological_Process_2021,positive regulation of leukocyte degranulation (GO:0043302),1/14,0.0344477141698711,0.1141597944331039,0,0,31.298273155416013,105.4223689491126,IL4,Ba/Eo/Ma,1.4628395910668823
GO_Biological_Process_2021,negative regulation of secretion (GO:0051048),1/14,0.0344477141698711,0.1141597944331039,0,0,31.298273155416013,105.4223689491126,PTGER3,Ba/Eo/Ma,1.4628395910668823
GO_Biological_Process_2021,T-helper cell differentiation (GO:0042093),1/14,0.0344477141698711,0.1141597944331039,0,0,31.298273155416013,105.4223689491126,IL4,Ba/Eo/Ma,1.4628395910668823
GO_Biological_Process_2021,nucleoside phosphate catabolic process (GO:1901292),1/14,0.0344477141698711,0.1141597944331039,0,0,31.298273155416013,105.4223689491126,ENPP3,Ba/Eo/Ma,1.4628395910668823
GO_Biological_Process_2021,nucleoside triphosphate metabolic process (GO:0009141),1/14,0.0344477141698711,0.1141597944331039,0,0,31.298273155416013,105.4223689491126,ENPP3,Ba/Eo/Ma,1.4628395910668823
GO_Biological_Process_2021,positive regulation of type 2 immune response (GO:0002830),1/14,0.0344477141698711,0.1141597944331039,0,0,31.298273155416013,105.4223689491126,IL4,Ba/Eo/Ma,1.4628395910668823
GO_Biological_Process_2021,ovarian follicle development (GO:0001541),1/14,0.0344477141698711,0.1141597944331039,0,0,31.298273155416013,105.4223689491126,INHA,Ba/Eo/Ma,1.4628395910668823
GO_Biological_Process_2021,myeloid dendritic cell activation (GO:0001773),1/14,0.0344477141698711,0.1141597944331039,0,0,31.298273155416013,105.4223689491126,IL4,Ba/Eo/Ma,1.4628395910668823
GO_Biological_Process_2021,positive regulation of acute inflammatory response (GO:0002675),1/15,0.0368632785936063,0.1141597944331039,0,0,29.06122448979592,95.91771596133704,PTGER3,Ba/Eo/Ma,1.4334060415588732
GO_Biological_Process_2021,negative regulation of leukocyte activation (GO:0002695),1/15,0.0368632785936063,0.1141597944331039,0,0,29.06122448979592,95.91771596133704,IL4,Ba/Eo/Ma,1.4334060415588732
GO_Biological_Process_2021,heterocycle biosynthetic process (GO:0018130),1/15,0.0368632785936063,0.1141597944331039,0,0,29.06122448979592,95.91771596133704,HDC,Ba/Eo/Ma,1.4334060415588732
GO_Biological_Process_2021,cellular response to ATP (GO:0071318),1/15,0.0368632785936063,0.1141597944331039,0,0,29.06122448979592,95.91771596133704,RYR3,Ba/Eo/Ma,1.4334060415588732
GO_Biological_Process_2021,lipoxygenase pathway (GO:0019372),1/15,0.0368632785936063,0.1141597944331039,0,0,29.06122448979592,95.91771596133704,HPGD,Ba/Eo/Ma,1.4334060415588732
GO_Biological_Process_2021,neurotrophin TRK receptor signaling pathway (GO:0048011),1/15,0.0368632785936063,0.1141597944331039,0,0,29.06122448979592,95.91771596133704,NTRK1,Ba/Eo/Ma,1.4334060415588732
GO_Biological_Process_2021,regulation of macrophage differentiation (GO:0045649),1/15,0.0368632785936063,0.1141597944331039,0,0,29.06122448979592,95.91771596133704,INHA,Ba/Eo/Ma,1.4334060415588732
GO_Biological_Process_2021,peptidyl-tyrosine autophosphorylation (GO:0038083),1/15,0.0368632785936063,0.1141597944331039,0,0,29.06122448979592,95.91771596133704,NTRK1,Ba/Eo/Ma,1.4334060415588732
GO_Biological_Process_2021,regulation of phosphorylation (GO:0042325),2/125,0.0390617280151273,0.1141597944331039,0,0,6.716463414634147,21.77888563484535,IL4;INHA,Ba/Eo/Ma,1.408248548277182
GO_Biological_Process_2021,negative regulation of epithelial cell differentiation (GO:0030857),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,IL13,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,regulation of amyloid-beta clearance (GO:1900221),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,IL4,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,regulation of ATP biosynthetic process (GO:2001169),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,IL4,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,GATA2,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,negative regulation of immune effector process (GO:0002698),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,ENPP3,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,negative regulation of macrophage activation (GO:0043031),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,IL4,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,positive regulation of isotype switching (GO:0045830),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,IL4,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,sympathetic nervous system development (GO:0048485),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,NTRK1,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,regulation of interleukin-13 production (GO:0032656),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,IL4,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,regulation of isotype switching (GO:0045191),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,IL4,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,positive regulation of small molecule metabolic process (GO:0062013),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,SLC45A3,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,regulation of mast cell degranulation (GO:0043304),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,IL4,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,IL4,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,regulation of phosphate metabolic process (GO:0019220),1/16,0.0392729207344652,0.1141597944331039,0,0,27.122448979591837,87.80133530116419,IL4,Ba/Eo/Ma,1.405906798966597
GO_Biological_Process_2021,regulation of cellular respiration (GO:0043457),1/17,0.0416766547912334,0.1189309417213248,0,0,25.426020408163264,80.79916728086499,IL4,Ba/Eo/Ma,1.3801071472903907
GO_Biological_Process_2021,cellular biogenic amine biosynthetic process (GO:0042401),1/17,0.0416766547912334,0.1189309417213248,0,0,25.426020408163264,80.79916728086499,HDC,Ba/Eo/Ma,1.3801071472903907
GO_Biological_Process_2021,monosaccharide transmembrane transport (GO:0015749),1/17,0.0416766547912334,0.1189309417213248,0,0,25.426020408163264,80.79916728086499,SLC45A3,Ba/Eo/Ma,1.3801071472903907
GO_Biological_Process_2021,negative regulation of biosynthetic process (GO:0009890),1/18,0.0440744949316926,0.1194851707591979,0,0,23.92917166866747,74.70385911458476,SLC18A2,Ba/Eo/Ma,1.3558126557645607
GO_Biological_Process_2021,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/18,0.0440744949316926,0.1194851707591979,0,0,23.92917166866747,74.70385911458476,GATA2,Ba/Eo/Ma,1.3558126557645607
GO_Biological_Process_2021,regulation of B cell differentiation (GO:0045577),1/18,0.0440744949316926,0.1194851707591979,0,0,23.92917166866747,74.70385911458476,INHA,Ba/Eo/Ma,1.3558126557645607
GO_Biological_Process_2021,positive regulation of fatty acid metabolic process (GO:0045923),1/18,0.0440744949316926,0.1194851707591979,0,0,23.92917166866747,74.70385911458476,SLC45A3,Ba/Eo/Ma,1.3558126557645607
GO_Biological_Process_2021,regulation of catabolic process (GO:0009894),1/18,0.0440744949316926,0.1194851707591979,0,0,23.92917166866747,74.70385911458476,HPGD,Ba/Eo/Ma,1.3558126557645607
GO_Biological_Process_2021,cellular response to alkaloid (GO:0071312),1/18,0.0440744949316926,0.1194851707591979,0,0,23.92917166866747,74.70385911458476,RYR3,Ba/Eo/Ma,1.3558126557645607
GO_Biological_Process_2021,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,0.0440744949316926,0.1194851707591979,0,0,23.92917166866747,74.70385911458476,ELOVL7,Ba/Eo/Ma,1.3558126557645607
GO_Biological_Process_2021,organic substance transport (GO:0071702),2/136,0.0454786698217006,0.1194851707591979,0,0,6.161691542288557,19.042780777221537,SLC35F3;SLC18A2,Ba/Eo/Ma,1.3421922462170102
GO_Biological_Process_2021,establishment or maintenance of apical/basal cell polarity (GO:0035088),1/19,0.0464664552952436,0.1194851707591979,0,0,22.598639455782312,69.35578082800635,MTCL1,Ba/Eo/Ma,1.3328604565168853
GO_Biological_Process_2021,regulation of T cell cytokine production (GO:0002724),1/19,0.0464664552952436,0.1194851707591979,0,0,22.598639455782312,69.35578082800635,CLC,Ba/Eo/Ma,1.3328604565168853
GO_Biological_Process_2021,response to ATP (GO:0033198),1/19,0.0464664552952436,0.1194851707591979,0,0,22.598639455782312,69.35578082800635,RYR3,Ba/Eo/Ma,1.3328604565168853
GO_Biological_Process_2021,positive regulation of leukocyte activation (GO:0002696),1/19,0.0464664552952436,0.1194851707591979,0,0,22.598639455782312,69.35578082800635,CRLF2,Ba/Eo/Ma,1.3328604565168853
GO_Biological_Process_2021,interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.0464664552952436,0.1194851707591979,0,0,22.598639455782312,69.35578082800635,CRLF2,Ba/Eo/Ma,1.3328604565168853
GO_Biological_Process_2021,cellular response to interleukin-7 (GO:0098761),1/19,0.0464664552952436,0.1194851707591979,0,0,22.598639455782312,69.35578082800635,CRLF2,Ba/Eo/Ma,1.3328604565168853
GO_Biological_Process_2021,regulation of neuroinflammatory response (GO:0150077),1/19,0.0464664552952436,0.1194851707591979,0,0,22.598639455782312,69.35578082800635,IL4,Ba/Eo/Ma,1.3328604565168853
GO_Biological_Process_2021,regulation of oligodendrocyte differentiation (GO:0048713),1/19,0.0464664552952436,0.1194851707591979,0,0,22.598639455782312,69.35578082800635,SLC45A3,Ba/Eo/Ma,1.3328604565168853
GO_Biological_Process_2021,prostaglandin biosynthetic process (GO:0001516),1/19,0.0464664552952436,0.1194851707591979,0,0,22.598639455782312,69.35578082800635,HPGDS,Ba/Eo/Ma,1.3328604565168853
GO_Biological_Process_2021,myeloid cell activation involved in immune response (GO:0002275),1/19,0.0464664552952436,0.1194851707591979,0,0,22.598639455782312,69.35578082800635,ENPP3,Ba/Eo/Ma,1.3328604565168853
GO_Biological_Process_2021,regulation of acute inflammatory response (GO:0002673),1/20,0.0488525499820277,0.1229193193096182,0,0,21.40816326530612,64.63014669364038,IL4,Ba/Eo/Ma,1.3111127622579986
GO_Biological_Process_2021,positive regulation of epithelial cell differentiation (GO:0030858),1/20,0.0488525499820277,0.1229193193096182,0,0,21.40816326530612,64.63014669364038,IL13,Ba/Eo/Ma,1.3111127622579986
GO_Biological_Process_2021,negative regulation of osteoclast differentiation (GO:0045671),1/20,0.0488525499820277,0.1229193193096182,0,0,21.40816326530612,64.63014669364038,IL4,Ba/Eo/Ma,1.3111127622579986
GO_Biological_Process_2021,positive regulation of lymphocyte differentiation (GO:0045621),1/20,0.0488525499820277,0.1229193193096182,0,0,21.40816326530612,64.63014669364038,IL4,Ba/Eo/Ma,1.3111127622579986
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),2/143,0.0497512691479657,0.1245111976537325,0,0,5.8537234042553195,17.565380826397597,SLC35F3;SLC18A2,Ba/Eo/Ma,1.3031958359850326
GO_Biological_Process_2021,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/21,0.0512327930672156,0.1248167609176678,0,0,20.336734693877553,60.42807445408675,IL4,Ba/Eo/Ma,1.2904519669693806
GO_Biological_Process_2021,autonomic nervous system development (GO:0048483),1/21,0.0512327930672156,0.1248167609176678,0,0,20.336734693877553,60.42807445408675,NTRK1,Ba/Eo/Ma,1.2904519669693806
GO_Biological_Process_2021,neurotrophin signaling pathway (GO:0038179),1/21,0.0512327930672156,0.1248167609176678,0,0,20.336734693877553,60.42807445408675,NTRK1,Ba/Eo/Ma,1.2904519669693806
GO_Biological_Process_2021,positive regulation of T cell cytokine production (GO:0002726),1/21,0.0512327930672156,0.1248167609176678,0,0,20.336734693877553,60.42807445408675,IL4,Ba/Eo/Ma,1.2904519669693806
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),3/335,0.0512465893176978,0.1248167609176678,0,0,3.7717251986670086,11.206196171777655,IL4;IL13;CRLF2,Ba/Eo/Ma,1.2903350334876962
GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),2/149,0.0535249876216422,0.1248167609176678,0,0,5.613095238095238,16.432935090777736,NTRK1;MTCL1,Ba/Eo/Ma,1.271443424469827
GO_Biological_Process_2021,negative regulation of B cell activation (GO:0050869),1/22,0.0536071985992547,0.1248167609176678,0,0,19.367346938775512,56.67024999786951,INHA,Ba/Eo/Ma,1.2707768875084013
GO_Biological_Process_2021,female gonad development (GO:0008585),1/22,0.0536071985992547,0.1248167609176678,0,0,19.367346938775512,56.67024999786951,INHA,Ba/Eo/Ma,1.2707768875084013
GO_Biological_Process_2021,glutathione derivative biosynthetic process (GO:1901687),1/22,0.0536071985992547,0.1248167609176678,0,0,19.367346938775512,56.67024999786951,HPGDS,Ba/Eo/Ma,1.2707768875084013
GO_Biological_Process_2021,glutathione derivative metabolic process (GO:1901685),1/22,0.0536071985992547,0.1248167609176678,0,0,19.367346938775512,56.67024999786951,HPGDS,Ba/Eo/Ma,1.2707768875084013
GO_Biological_Process_2021,positive regulation of granulocyte chemotaxis (GO:0071624),1/22,0.0536071985992547,0.1248167609176678,0,0,19.367346938775512,56.67024999786951,IL4,Ba/Eo/Ma,1.2707768875084013
GO_Biological_Process_2021,negative regulation of phosphate metabolic process (GO:0045936),1/22,0.0536071985992547,0.1248167609176678,0,0,19.367346938775512,56.67024999786951,INHA,Ba/Eo/Ma,1.2707768875084013
GO_Biological_Process_2021,cellular response to nerve growth factor stimulus (GO:1990090),1/22,0.0536071985992547,0.1248167609176678,0,0,19.367346938775512,56.67024999786951,NTRK1,Ba/Eo/Ma,1.2707768875084013
GO_Biological_Process_2021,microglial cell activation (GO:0001774),1/22,0.0536071985992547,0.1248167609176678,0,0,19.367346938775512,56.67024999786951,IL4,Ba/Eo/Ma,1.2707768875084013
GO_Biological_Process_2021,hexose transmembrane transport (GO:0008645),1/23,0.0559757805878795,0.1271682782287748,0,0,18.4860853432282,53.29235549319145,SLC45A3,Ba/Eo/Ma,1.2519998414265567
GO_Biological_Process_2021,negative regulation of reactive oxygen species metabolic process (GO:2000378),1/23,0.0559757805878795,0.1271682782287748,0,0,18.4860853432282,53.29235549319145,SLC18A2,Ba/Eo/Ma,1.2519998414265567
GO_Biological_Process_2021,nucleotide metabolic process (GO:0009117),1/23,0.0559757805878795,0.1271682782287748,0,0,18.4860853432282,53.29235549319145,ENPP3,Ba/Eo/Ma,1.2519998414265567
GO_Biological_Process_2021,regulation of mononuclear cell migration (GO:0071675),1/23,0.0559757805878795,0.1271682782287748,0,0,18.4860853432282,53.29235549319145,IL4,Ba/Eo/Ma,1.2519998414265567
GO_Biological_Process_2021,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.0559757805878795,0.1271682782287748,0,0,18.4860853432282,53.29235549319145,GATA2,Ba/Eo/Ma,1.2519998414265567
GO_Biological_Process_2021,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),1/24,0.0583385530130099,0.1287851075947578,0,0,17.68145519077196,50.24171555062859,IL4,Ba/Eo/Ma,1.2340443470047993
GO_Biological_Process_2021,regulation of cytokine production involved in immune response (GO:0002718),1/24,0.0583385530130099,0.1287851075947578,0,0,17.68145519077196,50.24171555062859,CLC,Ba/Eo/Ma,1.2340443470047993
GO_Biological_Process_2021,lipid translocation (GO:0034204),1/24,0.0583385530130099,0.1287851075947578,0,0,17.68145519077196,50.24171555062859,ATP10D,Ba/Eo/Ma,1.2340443470047993
GO_Biological_Process_2021,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/24,0.0583385530130099,0.1287851075947578,0,0,17.68145519077196,50.24171555062859,ELOVL7,Ba/Eo/Ma,1.2340443470047993
GO_Biological_Process_2021,positive regulation of protein targeting to membrane (GO:0090314),1/24,0.0583385530130099,0.1287851075947578,0,0,17.68145519077196,50.24171555062859,MTCL1,Ba/Eo/Ma,1.2340443470047993
GO_Biological_Process_2021,dendritic cell differentiation (GO:0097028),1/24,0.0583385530130099,0.1287851075947578,0,0,17.68145519077196,50.24171555062859,IL4,Ba/Eo/Ma,1.2340443470047993
GO_Biological_Process_2021,negative regulation of sequestering of calcium ion (GO:0051283),1/25,0.0606955298241754,0.1333591922897375,0,0,16.943877551020407,47.47480020477031,RYR3,Ba/Eo/Ma,1.2168432931781568
GO_Biological_Process_2021,mononuclear cell differentiation (GO:1903131),1/26,0.0630467249540435,0.1378778844789363,0,0,16.26530612244898,44.95534064809558,IL4,Ba/Eo/Ma,1.2003374685092782
GO_Biological_Process_2021,release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.0653921522588676,0.1423419872425583,0,0,15.638932496075354,42.652889831563165,RYR3,Ba/Eo/Ma,1.184474368421492
GO_Biological_Process_2021,regulation of reactive oxygen species biosynthetic process (GO:1903426),1/28,0.0677318256109869,0.1434321012938546,0,0,15.058956916099774,40.54171043527237,SLC18A2,Ba/Eo/Ma,1.1692072184717057
GO_Biological_Process_2021,positive regulation of defense response to virus by host (GO:0002230),1/28,0.0677318256109869,0.1434321012938546,0,0,15.058956916099774,40.54171043527237,IL4,Ba/Eo/Ma,1.1692072184717057
GO_Biological_Process_2021,regulation of B cell activation (GO:0050864),1/28,0.0677318256109869,0.1434321012938546,0,0,15.058956916099774,40.54171043527237,IL4,Ba/Eo/Ma,1.1692072184717057
GO_Biological_Process_2021,RNA phosphodiester bond hydrolysis (GO:0090501),1/28,0.0677318256109869,0.1434321012938546,0,0,15.058956916099774,40.54171043527237,RNASE2,Ba/Eo/Ma,1.1692072184717057
GO_Biological_Process_2021,regulation of immunoglobulin production (GO:0002637),1/28,0.0677318256109869,0.1434321012938546,0,0,15.058956916099774,40.54171043527237,IL4,Ba/Eo/Ma,1.1692072184717057
GO_Biological_Process_2021,sulfur compound transport (GO:0072348),1/28,0.0677318256109869,0.1434321012938546,0,0,15.058956916099774,40.54171043527237,SLC35F3,Ba/Eo/Ma,1.1692072184717057
GO_Biological_Process_2021,regulation of protein targeting to membrane (GO:0090313),1/29,0.0700657588372089,0.1441718125609387,0,0,14.520408163265309,38.5999069065122,MTCL1,Ba/Eo/Ma,1.1544941700666143
GO_Biological_Process_2021,negative regulation of interferon-gamma production (GO:0032689),1/29,0.0700657588372089,0.1441718125609387,0,0,14.520408163265309,38.5999069065122,INHA,Ba/Eo/Ma,1.1544941700666143
GO_Biological_Process_2021,positive regulation of leukocyte migration (GO:0002687),1/29,0.0700657588372089,0.1441718125609387,0,0,14.520408163265309,38.5999069065122,IL4,Ba/Eo/Ma,1.1544941700666143
GO_Biological_Process_2021,regulation of fatty acid biosynthetic process (GO:0042304),1/29,0.0700657588372089,0.1441718125609387,0,0,14.520408163265309,38.5999069065122,SLC45A3,Ba/Eo/Ma,1.1544941700666143
GO_Biological_Process_2021,cation transport (GO:0006812),2/174,0.0702729911306294,0.1441718125609387,0,0,4.791182170542636,12.722350612514177,ATP10D;SLC18A2,Ba/Eo/Ma,1.1532115605672306
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),2/176,0.0716793261504705,0.1441718125609387,0,0,4.735632183908046,12.48100918849243,EPX;RNASE2,Ba/Eo/Ma,1.144606086081811
GO_Biological_Process_2021,positive regulation of B cell proliferation (GO:0030890),1/30,0.0723939657090184,0.1441718125609387,0,0,14.019000703729768,36.80874147674154,IL4,Ba/Eo/Ma,1.1402976322627019
GO_Biological_Process_2021,fatty-acyl-CoA biosynthetic process (GO:0046949),1/30,0.0723939657090184,0.1441718125609387,0,0,14.019000703729768,36.80874147674154,ELOVL7,Ba/Eo/Ma,1.1402976322627019
GO_Biological_Process_2021,artery morphogenesis (GO:0048844),1/30,0.0723939657090184,0.1441718125609387,0,0,14.019000703729768,36.80874147674154,HPGD,Ba/Eo/Ma,1.1402976322627019
GO_Biological_Process_2021,negative regulation of Notch signaling pathway (GO:0045746),1/30,0.0723939657090184,0.1441718125609387,0,0,14.019000703729768,36.80874147674154,GATA2,Ba/Eo/Ma,1.1402976322627019
GO_Biological_Process_2021,long-chain fatty acid biosynthetic process (GO:0042759),1/30,0.0723939657090184,0.1441718125609387,0,0,14.019000703729768,36.80874147674154,HPGD,Ba/Eo/Ma,1.1402976322627019
GO_Biological_Process_2021,synaptic vesicle cycle (GO:0099504),1/30,0.0723939657090184,0.1441718125609387,0,0,14.019000703729768,36.80874147674154,SLC18A2,Ba/Eo/Ma,1.1402976322627019
GO_Biological_Process_2021,positive regulation of small GTPase mediated signal transduction (GO:0051057),1/30,0.0723939657090184,0.1441718125609387,0,0,14.019000703729768,36.80874147674154,NTRK1,Ba/Eo/Ma,1.1402976322627019
GO_Biological_Process_2021,regulation of macrophage activation (GO:0043030),1/30,0.0723939657090184,0.1441718125609387,0,0,14.019000703729768,36.80874147674154,IL4,Ba/Eo/Ma,1.1402976322627019
GO_Biological_Process_2021,regulation of immune response (GO:0050776),2/179,0.0738061123878065,0.1463067082896641,0,0,4.654661016949152,12.131506903576025,IL4;FCER1A,Ba/Eo/Ma,1.1319076697979504
GO_Biological_Process_2021,positive regulation of mononuclear cell migration (GO:0071677),1/31,0.0747164600026276,0.1463067082896641,0,0,13.551020408163266,35.15209038871121,IL4,Ba/Eo/Ma,1.126583712764908
GO_Biological_Process_2021,vitamin transport (GO:0051180),1/31,0.0747164600026276,0.1463067082896641,0,0,13.551020408163266,35.15209038871121,SLC35F3,Ba/Eo/Ma,1.126583712764908
GO_Biological_Process_2021,phospholipid translocation (GO:0045332),1/31,0.0747164600026276,0.1463067082896641,0,0,13.551020408163266,35.15209038871121,ATP10D,Ba/Eo/Ma,1.126583712764908
GO_Biological_Process_2021,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/32,0.0770332554327668,0.1477523096005528,0,0,13.113232389730086,33.61600807740255,MTCL1,Ba/Eo/Ma,1.1133217484244988
GO_Biological_Process_2021,negative regulation of chemotaxis (GO:0050922),1/32,0.0770332554327668,0.1477523096005528,0,0,13.113232389730086,33.61600807740255,ANGPT2,Ba/Eo/Ma,1.1133217484244988
GO_Biological_Process_2021,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/32,0.0770332554327668,0.1477523096005528,0,0,13.113232389730086,33.61600807740255,CDK15,Ba/Eo/Ma,1.1133217484244988
GO_Biological_Process_2021,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/32,0.0770332554327668,0.1477523096005528,0,0,13.113232389730086,33.61600807740255,GATA2,Ba/Eo/Ma,1.1133217484244988
GO_Biological_Process_2021,positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.0770332554327668,0.1477523096005528,0,0,13.113232389730086,33.61600807740255,CRLF2,Ba/Eo/Ma,1.1133217484244988
GO_Biological_Process_2021,positive regulation of ATP metabolic process (GO:1903580),1/33,0.0793443657059371,0.1503366929165124,0,0,12.70280612244898,32.18837516559274,IL4,Ba/Eo/Ma,1.1004839073426347
GO_Biological_Process_2021,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),1/33,0.0793443657059371,0.1503366929165124,0,0,12.70280612244898,32.18837516559274,IL4,Ba/Eo/Ma,1.1004839073426347
GO_Biological_Process_2021,very long-chain fatty acid metabolic process (GO:0000038),1/33,0.0793443657059371,0.1503366929165124,0,0,12.70280612244898,32.18837516559274,ELOVL7,Ba/Eo/Ma,1.1004839073426347
GO_Biological_Process_2021,negative regulation of blood vessel endothelial cell migration (GO:0043537),1/34,0.0816498044624026,0.1516353511444619,0,0,12.317254174397032,30.85861216573232,ANGPT2,Ba/Eo/Ma,1.0880448509885652
GO_Biological_Process_2021,regulation of activated T cell proliferation (GO:0046006),1/34,0.0816498044624026,0.1516353511444619,0,0,12.317254174397032,30.85861216573232,CLC,Ba/Eo/Ma,1.0880448509885652
GO_Biological_Process_2021,regulation of glucose metabolic process (GO:0010906),1/34,0.0816498044624026,0.1516353511444619,0,0,12.317254174397032,30.85861216573232,SLC45A3,Ba/Eo/Ma,1.0880448509885652
GO_Biological_Process_2021,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.0816498044624026,0.1516353511444619,0,0,12.317254174397032,30.85861216573232,GATA2,Ba/Eo/Ma,1.0880448509885652
GO_Biological_Process_2021,organic cyclic compound biosynthetic process (GO:1901362),1/34,0.0816498044624026,0.1516353511444619,0,0,12.317254174397032,30.85861216573232,HDC,Ba/Eo/Ma,1.0880448509885652
GO_Biological_Process_2021,negative regulation of epithelial cell migration (GO:0010633),1/35,0.0839495853612937,0.1540721801924921,0,0,11.95438175270108,29.61744503578088,IL4,Ba/Eo/Ma,1.0759814445616303
GO_Biological_Process_2021,positive regulation of lipid biosynthetic process (GO:0046889),1/35,0.0839495853612937,0.1540721801924921,0,0,11.95438175270108,29.61744503578088,SLC45A3,Ba/Eo/Ma,1.0759814445616303
GO_Biological_Process_2021,cellular response to amyloid-beta (GO:1904646),1/35,0.0839495853612937,0.1540721801924921,0,0,11.95438175270108,29.61744503578088,NTRK1,Ba/Eo/Ma,1.0759814445616303
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),2/194,0.0847375162198589,0.1549107718394295,0,0,4.287760416666667,10.58303673172677,SLC24A3;GATA2,Ba/Eo/Ma,1.0719242699529004
GO_Biological_Process_2021,negative regulation of fat cell differentiation (GO:0045599),1/36,0.0862437219743075,0.1558380767721079,0,0,11.612244897959185,28.456712045041098,GATA2,Ba/Eo/Ma,1.0642725091375862
GO_Biological_Process_2021,regulation of defense response to virus by host (GO:0050691),1/36,0.0862437219743075,0.1558380767721079,0,0,11.612244897959185,28.456712045041098,IL4,Ba/Eo/Ma,1.0642725091375862
GO_Biological_Process_2021,regulation of osteoclast differentiation (GO:0045670),1/36,0.0862437219743075,0.1558380767721079,0,0,11.612244897959185,28.456712045041098,IL4,Ba/Eo/Ma,1.0642725091375862
GO_Biological_Process_2021,negative regulation of endothelial cell migration (GO:0010596),1/38,0.0908151166313484,0.1634672099364272,0,0,10.983452840595698,26.34852930034076,ANGPT2,Ba/Eo/Ma,1.0418418549683985
GO_Biological_Process_2021,regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.0930924017046572,0.1662871908312198,0,0,10.693877551020408,25.38900533231373,IL4,Ba/Eo/Ma,1.0310857651239858
GO_Biological_Process_2021,regulation of T cell differentiation (GO:0045580),1/39,0.0930924017046572,0.1662871908312198,0,0,10.693877551020408,25.38900533231373,IL4,Ba/Eo/Ma,1.0310857651239858
GO_Biological_Process_2021,fatty acid derivative biosynthetic process (GO:1901570),1/40,0.0953640965755271,0.1696973277465654,0,0,10.419152276295131,24.485561288951835,HPGD,Ba/Eo/Ma,1.0206151011238414
GO_Biological_Process_2021,nucleobase-containing compound catabolic process (GO:0034655),1/41,0.0976302146847681,0.1730717442139072,0,0,10.158163265306122,23.633660200289185,RNASE2,Ba/Eo/Ma,1.0104157556925017
GO_Biological_Process_2021,calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.0998907694703361,0.1753148129416653,0,0,9.909905425584869,22.829231064333683,RYR3,Ba/Eo/Ma,1.00047464143678
GO_Biological_Process_2021,regulation of DNA recombination (GO:0000018),1/42,0.0998907694703361,0.1753148129416653,0,0,9.909905425584869,22.829231064333683,IL4,Ba/Eo/Ma,1.00047464143678
GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),2/214,0.100019348409027,0.1753148129416653,0,0,3.879323899371069,8.931722866735825,IL4;IL13,Ba/Eo/Ma,0.9999159790553556
GO_Biological_Process_2021,glutathione metabolic process (GO:0006749),1/43,0.1021457742794159,0.1777108638021065,0,0,9.673469387755102,22.068611238785657,HPGDS,Ba/Eo/Ma,0.9907795952096249
GO_Biological_Process_2021,positive regulation of T cell differentiation (GO:0045582),1/43,0.1021457742794159,0.1777108638021065,0,0,9.673469387755102,22.068611238785657,IL4,Ba/Eo/Ma,0.9907795952096249
GO_Biological_Process_2021,antibacterial humoral response (GO:0019731),1/44,0.1043952424647777,0.1796212260055734,0,0,9.448030374940672,21.34849709415977,RNASE2,Ba/Eo/Ma,0.9813192926974915
GO_Biological_Process_2021,response to amyloid-beta (GO:1904645),1/44,0.1043952424647777,0.1796212260055734,0,0,9.448030374940672,21.34849709415977,NTRK1,Ba/Eo/Ma,0.9813192926974915
GO_Biological_Process_2021,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.1043952424647777,0.1796212260055734,0,0,9.448030374940672,21.34849709415977,IL4,Ba/Eo/Ma,0.9813192926974915
GO_Biological_Process_2021,microtubule bundle formation (GO:0001578),1/45,0.1066391873529346,0.1821428455517278,0,0,9.232838589981448,20.665901611884028,MTCL1,Ba/Eo/Ma,0.9720831731354668
GO_Biological_Process_2021,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.1066391873529346,0.1821428455517278,0,0,9.232838589981448,20.665901611884028,GATA2,Ba/Eo/Ma,0.9720831731354668
GO_Biological_Process_2021,erythrocyte differentiation (GO:0030218),1/46,0.1088776222085674,0.1839520837314425,0,0,9.02721088435374,20.01811780873028,INHA,Ba/Eo/Ma,0.9630613723103648
GO_Biological_Process_2021,regulation of B cell proliferation (GO:0030888),1/46,0.1088776222085674,0.1839520837314425,0,0,9.02721088435374,20.01811780873028,IL4,Ba/Eo/Ma,0.9630613723103648
GO_Biological_Process_2021,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.1088776222085674,0.1839520837314425,0,0,9.02721088435374,20.01811780873028,IL4,Ba/Eo/Ma,0.9630613723103648
GO_Biological_Process_2021,glycosphingolipid metabolic process (GO:0006687),1/47,0.1111105603036554,0.1863790043803253,0,0,8.830523513753327,19.4026870705364,GALC,Ba/Eo/Ma,0.9542446623584087
GO_Biological_Process_2021,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/47,0.1111105603036554,0.1863790043803253,0,0,8.830523513753327,19.4026870705364,INHA,Ba/Eo/Ma,0.9542446623584087
GO_Biological_Process_2021,inflammatory response (GO:0006954),2/230,0.1127586124121412,0.1874282365500895,0,0,3.6041666666666665,7.866115081211615,IL4;PTGER3,Ba/Eo/Ma,0.9478502771198579
GO_Biological_Process_2021,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.1133380148369131,0.1874282365500895,0,0,8.642205818497612,18.81737166641443,GATA2,Ba/Eo/Ma,0.9456243984787533
GO_Biological_Process_2021,positive regulation of endocytosis (GO:0045807),1/48,0.1133380148369131,0.1874282365500895,0,0,8.642205818497612,18.81737166641443,IL4,Ba/Eo/Ma,0.9456243984787533
GO_Biological_Process_2021,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.1133380148369131,0.1874282365500895,0,0,8.642205818497612,18.81737166641443,IL4,Ba/Eo/Ma,0.9456243984787533
GO_Biological_Process_2021,RNA catabolic process (GO:0006401),1/49,0.1155599990222406,0.1897616826049425,0,0,8.46173469387755,18.260130793597916,RNASE2,Ba/Eo/Ma,0.9371924705024297
GO_Biological_Process_2021,secondary alcohol metabolic process (GO:1902652),1/49,0.1155599990222406,0.1897616826049425,0,0,8.46173469387755,18.260130793597916,IL4,Ba/Eo/Ma,0.9371924705024297
GO_Biological_Process_2021,inositol lipid-mediated signaling (GO:0048017),1/51,0.1199876089220907,0.1956592368485661,0,0,8.122448979591837,17.22257115519733,NTRK1,Ba/Eo/Ma,0.9208636010741894
GO_Biological_Process_2021,regulation of epithelial cell migration (GO:0010632),1/51,0.1199876089220907,0.1956592368485661,0,0,8.122448979591837,17.22257115519733,IL4,Ba/Eo/Ma,0.9208636010741894
GO_Biological_Process_2021,glycolipid metabolic process (GO:0006664),1/52,0.1221932608707862,0.1971946416811309,0,0,7.962785114045619,16.738979733033663,GALC,Ba/Eo/Ma,0.9129527453809976
GO_Biological_Process_2021,protein homotetramerization (GO:0051289),1/52,0.1221932608707862,0.1971946416811309,0,0,7.962785114045619,16.738979733033663,RYR3,Ba/Eo/Ma,0.9129527453809976
GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),1/52,0.1221932608707862,0.1971946416811309,0,0,7.962785114045619,16.738979733033663,INHA,Ba/Eo/Ma,0.9129527453809976
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),4/764,0.1230654595125794,0.1973429004041489,0,0,2.1956521739130435,4.5999766581612365,IL4;NTRK1;INHA;CRLF2,Ba/Eo/Ma,0.9098638223570947
GO_Biological_Process_2021,positive regulation of B cell activation (GO:0050871),1/53,0.1243934949128716,0.1973429004041489,0,0,7.809262166405024,16.276887238960814,IL4,Ba/Eo/Ma,0.9052023302345248
GO_Biological_Process_2021,positive regulation of macroautophagy (GO:0016239),1/53,0.1243934949128716,0.1973429004041489,0,0,7.809262166405024,16.276887238960814,IL4,Ba/Eo/Ma,0.9052023302345248
GO_Biological_Process_2021,cellular macromolecule catabolic process (GO:0044265),1/53,0.1243934949128716,0.1973429004041489,0,0,7.809262166405024,16.276887238960814,RNASE2,Ba/Eo/Ma,0.9052023302345248
GO_Biological_Process_2021,positive regulation of phagocytosis (GO:0050766),1/53,0.1243934949128716,0.1973429004041489,0,0,7.809262166405024,16.276887238960814,GATA2,Ba/Eo/Ma,0.9052023302345248
GO_Biological_Process_2021,inorganic anion transport (GO:0015698),1/54,0.1265883240687765,0.2001464042709033,0,0,7.661532537543319,15.834970375184442,ENPP3,Ba/Eo/Ma,0.8976063498190403
GO_Biological_Process_2021,regulation of cardiac conduction (GO:1903779),1/55,0.1287777613922166,0.2029225331028868,0,0,7.519274376417234,15.412009607623004,RYR3,Ba/Eo/Ma,0.8901591287349465
GO_Biological_Process_2021,peptidyl-tyrosine modification (GO:0018212),1/56,0.1309618198144747,0.2056715827958864,0,0,7.382189239332097,15.00687933540933,NTRK1,Ba/Eo/Ma,0.8828552987007785
GO_Biological_Process_2021,arachidonic acid metabolic process (GO:0019369),1/57,0.1331405122852093,0.2070091686029168,0,0,7.25,14.618539131965724,HPGDS,Ba/Eo/Ma,0.8756897763447542
GO_Biological_Process_2021,icosanoid metabolic process (GO:0006690),1/57,0.1331405122852093,0.2070091686029168,0,0,7.25,14.618539131965724,HPGD,Ba/Eo/Ma,0.8756897763447542
GO_Biological_Process_2021,cellular response to peptide (GO:1901653),1/57,0.1331405122852093,0.2070091686029168,0,0,7.25,14.618539131965724,NTRK1,Ba/Eo/Ma,0.8756897763447542
GO_Biological_Process_2021,membrane lipid biosynthetic process (GO:0046467),1/58,0.1353138517398134,0.2083121138626076,0,0,7.122448979591836,14.246025949065045,ELOVL7,Ba/Eo/Ma,0.8686577434892403
GO_Biological_Process_2021,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/58,0.1353138517398134,0.2083121138626076,0,0,7.122448979591836,14.246025949065045,INHA,Ba/Eo/Ma,0.8686577434892403
GO_Biological_Process_2021,regulation of phagocytosis (GO:0050764),1/58,0.1353138517398134,0.2083121138626076,0,0,7.122448979591836,14.246025949065045,GATA2,Ba/Eo/Ma,0.8686577434892403
GO_Biological_Process_2021,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/59,0.1374818510452552,0.210266360422155,0,0,6.9992962702322306,13.8884471557023,IL4,Ba/Eo/Ma,0.8617546291873563
GO_Biological_Process_2021,phospholipid transport (GO:0015914),1/59,0.1374818510452552,0.210266360422155,0,0,6.9992962702322306,13.8884471557023,ATP10D,Ba/Eo/Ma,0.8617546291873563
GO_Biological_Process_2021,B cell differentiation (GO:0030183),1/61,0.1418018805927374,0.2161670362130329,0,0,6.76530612244898,13.214837540593155,IL4,Ba/Eo/Ma,0.848318009451734
GO_Biological_Process_2021,positive regulation of Ras protein signal transduction (GO:0046579),1/63,0.1461007034145454,0.2219971727208027,0,0,6.54641211323239,12.591756250239603,NTRK1,Ba/Eo/Ma,0.8353476931121088
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway (GO:2001236),1/64,0.1482421941802595,0.2245221581759271,0,0,6.442176870748299,12.297522293260638,IL4,Ba/Eo/Ma,0.8290281655096747
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),2/274,0.1497038344955427,0.2260044985287548,0,0,3.014399509803922,5.724635176902424,SLC24A3;RYR3,Ba/Eo/Ma,0.8247670755492156
GO_Biological_Process_2021,extracellular matrix disassembly (GO:0022617),1/66,0.1525093979756266,0.2273070008044372,0,0,6.243328100470958,11.740759916332207,TPSAB1,Ba/Eo/Ma,0.8167033932798328
GO_Biological_Process_2021,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.2273070008044372,0,0,6.243328100470958,11.740759916332207,NTRK1,Ba/Eo/Ma,0.8167033932798328
GO_Biological_Process_2021,cellular component disassembly (GO:0022411),1/66,0.1525093979756266,0.2273070008044372,0,0,6.243328100470958,11.740759916332207,TPSAB1,Ba/Eo/Ma,0.8167033932798328
GO_Biological_Process_2021,positive regulation of T cell proliferation (GO:0042102),1/66,0.1525093979756266,0.2273070008044372,0,0,6.243328100470958,11.740759916332207,IL4,Ba/Eo/Ma,0.8167033932798328
GO_Biological_Process_2021,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/68,0.1567556490806558,0.2328941072055458,0,0,6.0563508985683825,11.222824361971773,IL4,Ba/Eo/Ma,0.8047767993307415
GO_Biological_Process_2021,cellular response to calcium ion (GO:0071277),1/69,0.158870948881139,0.2352898863176363,0,0,5.966986794717887,10.977245117600177,RYR3,Ba/Eo/Ma,0.7989555105590889
GO_Biological_Process_2021,sterol metabolic process (GO:0016125),1/70,0.1609810482853106,0.2362979231759849,0,0,5.880212954747116,10.740024519792764,IL4,Ba/Eo/Ma,0.7932252488723367
GO_Biological_Process_2021,defense response to Gram-positive bacterium (GO:0050830),1/70,0.1609810482853106,0.2362979231759849,0,0,5.880212954747116,10.740024519792764,RNASE2,Ba/Eo/Ma,0.7932252488723367
GO_Biological_Process_2021,protein tetramerization (GO:0051262),1/71,0.16308595979881,0.2362979231759849,0,0,5.795918367346939,10.51076961698872,RYR3,Ba/Eo/Ma,0.7875834261109624
GO_Biological_Process_2021,negative regulation of neuron apoptotic process (GO:0043524),1/71,0.16308595979881,0.2362979231759849,0,0,5.795918367346939,10.51076961698872,NTRK1,Ba/Eo/Ma,0.7875834261109624
GO_Biological_Process_2021,regulation of hematopoietic stem cell differentiation (GO:1902036),1/71,0.16308595979881,0.2362979231759849,0,0,5.795918367346939,10.51076961698872,GATA2,Ba/Eo/Ma,0.7875834261109624
GO_Biological_Process_2021,phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.16308595979881,0.2362979231759849,0,0,5.795918367346939,10.51076961698872,NTRK1,Ba/Eo/Ma,0.7875834261109624
GO_Biological_Process_2021,myeloid leukocyte differentiation (GO:0002573),1/71,0.16308595979881,0.2362979231759849,0,0,5.795918367346939,10.51076961698872,IL4,Ba/Eo/Ma,0.7875834261109624
GO_Biological_Process_2021,extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.1651856959101235,0.2386015607590673,0,0,5.713998275366484,10.28911103101624,IL4,Ba/Eo/Ma,0.78202756268309
GO_Biological_Process_2021,neurotransmitter transport (GO:0006836),1/73,0.1672802691231711,0.240144680827129,0,0,5.634353741496598,10.074701240888364,SLC18A2,Ba/Eo/Ma,0.7765552814899175
GO_Biological_Process_2021,defense response to Gram-negative bacterium (GO:0050829),1/73,0.1672802691231711,0.240144680827129,0,0,5.634353741496598,10.074701240888364,RNASE2,Ba/Eo/Ma,0.7765552814899175
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),3/566,0.1678713329989042,0.2402562197048538,0,0,2.197989493972261,3.922438566092192,NTRK1;HPGD;INHA,Ba/Eo/Ma,0.7750234609992368
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),2/296,0.1690031560036776,0.2409270996196502,0,0,2.7857142857142856,4.952548406897344,HPGD;INHA,Ba/Eo/Ma,0.7721051851958874
GO_Biological_Process_2021,sphingolipid biosynthetic process (GO:0030148),1/74,0.1693696918266344,0.2409270996196502,0,0,5.556891249650545,9.867213018330611,ELOVL7,Ba/Eo/Ma,0.7711643026835198
GO_Biological_Process_2021,positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.1714539764404576,0.2409623452676701,0,0,5.4815223386651954,9.666337985731484,IL4,Ba/Eo/Ma,0.7658524380723842
GO_Biological_Process_2021,regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/75,0.1714539764404576,0.2409623452676701,0,0,5.4815223386651954,9.666337985731484,GATA2,Ba/Eo/Ma,0.7658524380723842
GO_Biological_Process_2021,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.1714539764404576,0.2409623452676701,0,0,5.4815223386651954,9.666337985731484,RNASE2,Ba/Eo/Ma,0.7658524380723842
GO_Biological_Process_2021,positive regulation of T cell activation (GO:0050870),1/75,0.1714539764404576,0.2409623452676701,0,0,5.4815223386651954,9.666337985731484,IL4,Ba/Eo/Ma,0.7658524380723842
GO_Biological_Process_2021,innate immune response (GO:0045087),2/302,0.1743414000182094,0.2438699129577305,0,0,2.7291666666666665,4.767144127673996,IL4;RNASE2,Ba/Eo/Ma,0.7585994708102503
GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1756071809118701,0.2438699129577305,0,0,5.336734693877551,9.283280446293812,GATA2,Ba/Eo/Ma,0.7554577289388229
GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.1756071809118701,0.2438699129577305,0,0,5.336734693877551,9.283280446293812,NTRK1,Ba/Eo/Ma,0.7554577289388229
GO_Biological_Process_2021,cholesterol metabolic process (GO:0008203),1/77,0.1756071809118701,0.2438699129577305,0,0,5.336734693877551,9.283280446293812,IL4,Ba/Eo/Ma,0.7554577289388229
GO_Biological_Process_2021,negative regulation of apoptotic signaling pathway (GO:2001234),1/78,0.1776761254379788,0.2460130967602783,0,0,5.267161410018553,9.10056411919043,IL4,Ba/Eo/Ma,0.7503709249641564
GO_Biological_Process_2021,negative regulation of cellular response to growth factor stimulus (GO:0090288),1/80,0.181798760490535,0.249506803253872,0,0,5.133298889175924,8.751529842637671,IL4,Ba/Eo/Ma,0.7404090821369118
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.249506803253872,0,0,5.133298889175924,8.751529842637671,IL4,Ba/Eo/Ma,0.7404090821369118
GO_Biological_Process_2021,regulation of fat cell differentiation (GO:0045598),1/80,0.181798760490535,0.249506803253872,0,0,5.133298889175924,8.751529842637671,GATA2,Ba/Eo/Ma,0.7404090821369118
GO_Biological_Process_2021,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.1838524754991919,0.2515875980515258,0,0,5.0688775510204085,8.584760541358477,PTGER3,Ba/Eo/Ma,0.7355305181562768
GO_Biological_Process_2021,long-chain fatty acid metabolic process (GO:0001676),1/83,0.1879447615357932,0.254951154778989,0,0,4.944748631159781,8.265677319811374,HPGD,Ba/Eo/Ma,0.7259697745939766
GO_Biological_Process_2021,peptide metabolic process (GO:0006518),1/83,0.1879447615357932,0.254951154778989,0,0,4.944748631159781,8.265677319811374,HPGDS,Ba/Eo/Ma,0.7259697745939766
GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.254951154778989,0,0,4.944748631159781,8.265677319811374,GATA2,Ba/Eo/Ma,0.7259697745939766
GO_Biological_Process_2021,lymphocyte differentiation (GO:0030098),1/84,0.1899833569114356,0.2558121127213082,0,0,4.884927464961889,8.112979399077096,IL4,Ba/Eo/Ma,0.7212844428267129
GO_Biological_Process_2021,vascular transport (GO:0010232),1/84,0.1899833569114356,0.2558121127213082,0,0,4.884927464961889,8.112979399077096,SLC24A3,Ba/Eo/Ma,0.7212844428267129
GO_Biological_Process_2021,G1/S transition of mitotic cell cycle (GO:0000082),1/85,0.1920169366451308,0.2558121127213082,0,0,4.826530612244898,7.964604221414354,CDK15,Ba/Eo/Ma,0.716660463134361
GO_Biological_Process_2021,B cell activation (GO:0042113),1/85,0.1920169366451308,0.2558121127213082,0,0,4.826530612244898,7.964604221414354,IL4,Ba/Eo/Ma,0.716660463134361
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),2/322,0.1923280195400404,0.2558121127213082,0,0,2.5559895833333335,4.213684115542283,SLC24A3;GATA2,Ba/Eo/Ma,0.7159574404356035
GO_Biological_Process_2021,regulation of Ras protein signal transduction (GO:0046578),1/86,0.1940455128548384,0.2558121127213082,0,0,4.769507803121249,7.820383303288144,NTRK1,Ba/Eo/Ma,0.7120963955156414
GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),1/86,0.1940455128548384,0.2558121127213082,0,0,4.769507803121249,7.820383303288144,GATA2,Ba/Eo/Ma,0.7120963955156414
GO_Biological_Process_2021,negative regulation of phosphorylation (GO:0042326),1/86,0.1940455128548384,0.2558121127213082,0,0,4.769507803121249,7.820383303288144,INHA,Ba/Eo/Ma,0.7120963955156414
GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),1/86,0.1940455128548384,0.2558121127213082,0,0,4.769507803121249,7.820383303288144,INHA,Ba/Eo/Ma,0.7120963955156414
GO_Biological_Process_2021,transport across blood-brain barrier (GO:0150104),1/86,0.1940455128548384,0.2558121127213082,0,0,4.769507803121249,7.820383303288144,SLC24A3,Ba/Eo/Ma,0.7120963955156414
GO_Biological_Process_2021,sodium ion transmembrane transport (GO:0035725),1/87,0.196069097589664,0.2577537575055134,0,0,4.713811105837684,7.6801565438185,SLC24A3,Ba/Eo/Ma,0.7075908500030543
GO_Biological_Process_2021,positive regulation of neuron projection development (GO:0010976),1/88,0.1980877029036425,0.2589526395500131,0,0,4.659394792399718,7.5437717166037235,NTRK1,Ba/Eo/Ma,0.703142484213379
GO_Biological_Process_2021,metal ion transport (GO:0030001),1/88,0.1980877029036425,0.2589526395500131,0,0,4.659394792399718,7.5437717166037235,RYR3,Ba/Eo/Ma,0.703142484213379
GO_Biological_Process_2021,transforming growth factor beta receptor signaling pathway (GO:0007179),1/89,0.2001013407742902,0.2608563439620274,0,0,4.6062152133580705,7.411084001248333,HPGD,Ba/Eo/Ma,0.6987500013741589
GO_Biological_Process_2021,positive regulation of autophagy (GO:0010508),1/90,0.2021100231923967,0.2612914111990101,0,0,4.55423068103646,7.281955543769811,IL4,Ba/Eo/Ma,0.6944121480917811
GO_Biological_Process_2021,cellular amino acid catabolic process (GO:0009063),1/90,0.2021100231923967,0.2612914111990101,0,0,4.55423068103646,7.281955543769811,HDC,Ba/Eo/Ma,0.6944121480917811
GO_Biological_Process_2021,sodium ion transport (GO:0006814),1/90,0.2021100231923967,0.2612914111990101,0,0,4.55423068103646,7.281955543769811,SLC24A3,Ba/Eo/Ma,0.6944121480917811
GO_Biological_Process_2021,regulation of stem cell differentiation (GO:2000736),1/91,0.2041137620931186,0.2624319798340097,0,0,4.503401360544218,7.156255051106618,GATA2,Ba/Eo/Ma,0.6901277125812961
GO_Biological_Process_2021,positive regulation of transport (GO:0051050),1/91,0.2041137620931186,0.2624319798340097,0,0,4.503401360544218,7.156255051106618,GATA2,Ba/Eo/Ma,0.6901277125812961
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),3/625,0.2050267003954304,0.2628356471285988,0,0,1.9834439351440103,3.142995135240803,IL4;GATA2;CRLF2,Ba/Eo/Ma,0.6881895775817527
GO_Biological_Process_2021,T cell activation (GO:0042110),1/92,0.2061125694363157,0.2628356471285988,0,0,4.453689167974883,7.03385741012878,IL4,Ba/Eo/Ma,0.6858955226779435
GO_Biological_Process_2021,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),1/92,0.2061125694363157,0.2628356471285988,0,0,4.453689167974883,7.03385741012878,INHA,Ba/Eo/Ma,0.6858955226779435
GO_Biological_Process_2021,regulation of heart contraction (GO:0008016),1/93,0.2081064570390282,0.2646571247126771,0,0,4.40505767524401,6.914643337844717,RYR3,Ba/Eo/Ma,0.6817144444740324
GO_Biological_Process_2021,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.2664625052100124,0,0,4.357472021066491,6.79849904676328,NTRK1,Ba/Eo/Ma,0.6775833802166729
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),2/345,0.2133084926466024,0.2698064177259728,0,0,2.381802721088435,3.6799229289674416,IL4;IL13,Ba/Eo/Ma,0.6709918532419347
GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2725160812063921,0,0,4.220663265306122,6.46742313757927,SLC24A3,Ba/Eo/Ma,0.6654798083211632
GO_Biological_Process_2021,negative regulation of neuron death (GO:1901215),1/98,0.2180025137484037,0.2735259421829837,0,0,4.176940879444562,6.362519703204576,NTRK1,Ba/Eo/Ma,0.6615384985937142
GO_Biological_Process_2021,regulation of neuron apoptotic process (GO:0043523),1/98,0.2180025137484037,0.2735259421829837,0,0,4.176940879444562,6.362519703204576,NTRK1,Ba/Eo/Ma,0.6615384985937142
GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),1/101,0.2238818662412048,0.2801516401093151,0,0,4.051020408163265,6.062906014187368,MTCL1,Ba/Eo/Ma,0.6499810815451941
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.2818383447089538,0,0,4.010709234188725,5.967790506031058,GATA2,Ba/Eo/Ma,0.6462145058611213
GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),1/103,0.2277773453985499,0.283510100123727,0,0,3.971188475390156,5.874923343943355,RYR3,Ba/Eo/Ma,0.64248947278397
GO_Biological_Process_2021,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2851670396787908,0,0,3.932435109966317,5.78423168094792,SLC24A3,Ba/Eo/Ma,0.6388051756325536
GO_Biological_Process_2021,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.2868092952484855,0,0,3.894427001569859,5.6956456810845415,IL4,Ba/Eo/Ma,0.6351608308934773
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.2335846623503299,0.2884369973085868,0,0,3.857142857142857,5.6090983677319475,NTRK1,Ba/Eo/Ma,0.6315556772929499
GO_Biological_Process_2021,response to calcium ion (GO:0051592),1/107,0.2355109070084182,0.2900502749472098,0,0,3.8205621871390063,5.524525481436682,RYR3,Ba/Eo/Ma,0.6279889749729552
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.2914734749628382,0,0,2.2110433604336044,3.18053102486219,NTRK1;INHA,Ba/Eo/Ma,0.6247218387200065
GO_Biological_Process_2021,cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.2431685532271013,0.2979133060478623,0,0,3.6808905380333954,5.20478084558139,SLC24A3,Ba/Eo/Ma,0.6140925891155178
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),2/379,0.24470533557908,0.2986805112231279,0,0,2.163240495137047,3.045194735705852,NTRK1;GATA2,Ba/Eo/Ma,0.6113565611455968
GO_Biological_Process_2021,regulation of macroautophagy (GO:0016241),1/112,0.2450711886958998,0.2986805112231279,0,0,3.647545504688362,5.129202360192396,IL4,Ba/Eo/Ma,0.6107077427090284
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),2/381,0.2465612635256485,0.2994025883751446,0,0,2.15160510114336,3.012558657024939,IL4;NTRK1,Ba/Eo/Ma,0.6080751530383309
GO_Biological_Process_2021,sulfur compound biosynthetic process (GO:0044272),1/113,0.2469691364760274,0.2994025883751446,0,0,3.614795918367347,5.055262825364014,HPGDS,Ba/Eo/Ma,0.6073573167632206
GO_Biological_Process_2021,activation of protein kinase activity (GO:0032147),1/114,0.2488624078588274,0.2994025883751446,0,0,3.582625970742279,4.982913653406146,IL4,Ba/Eo/Ma,0.6040407011916724
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.2994025883751446,0,0,3.582625970742279,4.982913653406146,NTRK1,Ba/Eo/Ma,0.6040407011916724
GO_Biological_Process_2021,cellular response to transforming growth factor beta stimulus (GO:0071560),1/114,0.2488624078588274,0.2994025883751446,0,0,3.582625970742279,4.982913653406146,HPGD,Ba/Eo/Ma,0.6040407011916724
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.3031619599079734,0,0,3.5199645075421473,4.8428011439058265,GATA2,Ba/Eo/Ma,0.5975065399797567
GO_Biological_Process_2021,positive regulation of cell projection organization (GO:0031346),1/117,0.2545142764118688,0.3046360137103698,0,0,3.4894440534834623,4.774949480472317,NTRK1,Ba/Eo/Ma,0.5942878518616017
GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.2563889548341396,0.3060970175060646,0,0,3.4594453165881736,4.708511372057024,PTGER3,Ba/Eo/Ma,0.5911006880374128
GO_Biological_Process_2021,protein homooligomerization (GO:0051260),1/121,0.2619853133921213,0.3119825106043582,0,0,3.372448979591837,4.517283552621874,RYR3,Ba/Eo/Ma,0.5817230540677998
GO_Biological_Process_2021,potassium ion transport (GO:0006813),1/122,0.2638415777635164,0.3130486958810247,0,0,3.3444088379153314,4.456111874258477,SLC24A3,Ba/Eo/Ma,0.5786567646257991
GO_Biological_Process_2021,phosphorylation (GO:0016310),2/400,0.2642184505833435,0.3130486958810247,0,0,2.046901172529313,2.7243825855585304,NTRK1;CDK15,Ba/Eo/Ma,0.5780368585354551
GO_Biological_Process_2021,fatty acid metabolic process (GO:0006631),1/124,0.2675403902734135,0.3142747159201409,0,0,3.2896963663514187,4.337414433160371,HPGD,Ba/Eo/Ma,0.5726106437410472
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),1/124,0.2675403902734135,0.3142747159201409,0,0,3.2896963663514187,4.337414433160371,IL4,Ba/Eo/Ma,0.5726106437410472
GO_Biological_Process_2021,defense response to symbiont (GO:0140546),1/124,0.2675403902734135,0.3142747159201409,0,0,3.2896963663514187,4.337414433160371,RNASE2,Ba/Eo/Ma,0.5726106437410472
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),2/404,0.2679393411370432,0.3142747159201409,0,0,2.026119402985074,2.6683884405969245,NTRK1;ANGPT2,Ba/Eo/Ma,0.5719635148936996
GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.3237482712039262,0,0,3.1603954081632653,4.060453122404681,IL4,Ba/Eo/Ma,0.5579784037567757
GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.3271837816889,0,0,3.111459968602826,3.956968446025251,RYR3,Ba/Eo/Ma,0.5523097126477655
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),4/1079,0.2833172179011324,0.328132600035959,0,0,1.5267947421638015,1.925575356569311,IL4;SLC24A3;IL13;GATA2,Ba/Eo/Ma,0.5477270315076967
GO_Biological_Process_2021,RNA metabolic process (GO:0016070),1/133,0.2839609038772722,0.328132600035959,0,0,3.0640074211502784,3.857336278341556,RNASE2,Ba/Eo/Ma,0.546741450090894
GO_Biological_Process_2021,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1/133,0.2839609038772722,0.328132600035959,0,0,3.0640074211502784,3.857336278341556,HPGD,Ba/Eo/Ma,0.546741450090894
GO_Biological_Process_2021,defense response to virus (GO:0051607),1/133,0.2839609038772722,0.328132600035959,0,0,3.0640074211502784,3.857336278341556,RNASE2,Ba/Eo/Ma,0.546741450090894
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3294016648099846,0,0,3.0408163265306123,3.80890385676326,IL4,Ba/Eo/Ma,0.5439940297149167
GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),1/136,0.289353816496661,0.3327213418192563,0,0,2.99546485260771,3.714691124222948,SLC24A3,Ba/Eo/Ma,0.5385707850387818
GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),1/139,0.2947069182263764,0.3380461709067259,0,0,2.929902395740905,3.579678317757992,SLC24A3,Ba/Eo/Ma,0.5306096689947516
GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.2964824884084789,0.3392513559295064,0,0,2.9086771399207163,3.5362740390257685,NTRK1,Ba/Eo/Ma,0.5280009529309525
GO_Biological_Process_2021,negative regulation of cell migration (GO:0030336),1/144,0.3035410668561185,0.3464810226552767,0,0,2.826744683887541,3.370153465117457,IL4,Ba/Eo/Ma,0.5177825437898177
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.3087894082520855,0.3510341696912983,0,0,2.7682415431926195,3.252948903166252,PTGER3,Ba/Eo/Ma,0.5103376047629952
GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3510341696912983,0,0,2.749271137026239,3.215201203875706,MTCL1,Ba/Eo/Ma,0.5078961191737069
GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),1/148,0.3105302270346101,0.3510341696912983,0,0,2.749271137026239,3.215201203875706,PTGER3,Ba/Eo/Ma,0.5078961191737069
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3510341696912983,0,0,2.749271137026239,3.215201203875706,NTRK1,Ba/Eo/Ma,0.5078961191737069
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3541000596950328,0,0,2.712094233666621,3.141596466170354,RYR3,Ba/Eo/Ma,0.5030717563895143
GO_Biological_Process_2021,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/155,0.3225962281219006,0.3629207566371382,0,0,2.6233766233766236,2.9679671260643183,NTRK1,Ba/Eo/Ma,0.4913407148001928
GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),1/158,0.3277037968552589,0.3669028156178497,0,0,2.5728584427401535,2.8703970097526006,NTRK1,Ba/Eo/Ma,0.48451852674781976
GO_Biological_Process_2021,skeletal system development (GO:0001501),1/158,0.3277037968552589,0.3669028156178497,0,0,2.5728584427401535,2.8703970097526006,INHA,Ba/Eo/Ma,0.48451852674781976
GO_Biological_Process_2021,protein autophosphorylation (GO:0046777),1/159,0.329397918202972,0.3679193931240833,0,0,2.556445362955309,2.8389038953772054,NTRK1,Ba/Eo/Ma,0.4822791499015975
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),2/474,0.3328115296392732,0.3708471330266187,0,0,1.7194562146892656,1.8917094920733264,IL4;CRLF2,Ba/Eo/Ma,0.47780163679243126
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.3764795376391392,0,0,2.4621702339472376,2.6600168495918335,PTGER3,Ba/Eo/Ma,0.46919202564454415
GO_Biological_Process_2021,regulation of neuron projection development (GO:0010975),1/165,0.3394751386404204,0.3764795376391392,0,0,2.4621702339472376,2.6600168495918335,NTRK1,Ba/Eo/Ma,0.46919202564454415
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.377431693740674,0,0,2.4471243042671613,2.6317886779390967,NTRK1,Ba/Eo/Ma,0.4670671197091842
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),2/485,0.3429022272693128,0.3784864206651849,0,0,1.6793478260869563,1.797422644350721,IL4;NTRK1,Ba/Eo/Ma,0.46482969398207885
GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.3510444250368044,0.3865618609817046,0,0,2.360544217687075,2.4711180018684864,NTRK1,Ba/Eo/Ma,0.45463791963821665
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),2/496,0.3529487892748932,0.3877465572315728,0,0,1.641025641025641,1.709017116633574,NTRK1;CDK15,Ba/Eo/Ma,0.4522883035321021
GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.3954465347437282,0,0,2.279833967485299,2.3241173885161555,ENPP3,Ba/Eo/Ma,0.44273020383203454
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.3980442884940047,0,0,2.2541329380914377,2.2778849681371156,SLC45A3,Ba/Eo/Ma,0.4388706874182523
GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.4006125804703255,0,0,2.2289998872477166,2.2329492942532405,INHA,Ba/Eo/Ma,0.4350639775318079
GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),1/189,0.3783208179838206,0.4117538205033211,0,0,2.1452453321754232,2.085205747179162,NTRK1,Ba/Eo/Ma,0.42213975998471215
GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.4142016973025434,0,0,2.122448979591837,2.045536603225051,GATA2,Ba/Eo/Ma,0.41855670871419515
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4183044823274328,0,0,2.089140319340171,1.988001678572607,NTRK1,Ba/Eo/Ma,0.4132695879859197
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),1/203,0.3999373645428959,0.4322648651410515,0,0,1.9951505354617096,1.8284503867148747,GATA2,Ba/Eo/Ma,0.398008019580524
GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4377816917915886,0,0,1.9560134733505052,1.7632653144438126,NTRK1,Ba/Eo/Ma,0.3914985283218076
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4448075409339817,0,0,1.909178837411742,1.6862551884518755,ENPP3,Ba/Eo/Ma,0.3835844547796231
GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),1/214,0.416403436812339,0.4459423533825508,0,0,1.8910606496119575,1.656759537391559,NTRK1,Ba/Eo/Ma,0.3804856946694876
GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),1/214,0.416403436812339,0.4459423533825508,0,0,1.8910606496119575,1.656759537391559,NTRK1,Ba/Eo/Ma,0.3804856946694876
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4558730571573919,0,0,1.8302411873840445,1.5589816483293069,IL4,Ba/Eo/Ma,0.3699278171231457
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.4508075224789805,0.4805875182691637,0,0,1.697494187548437,1.352418759111272,NTRK1,Ba/Eo/Ma,0.34600884563424106
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.488308103510904,0,0,1.655076845553036,1.2884811006593149,SLC18A2,Ba/Eo/Ma,0.33809924509335265
GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.4618276248188864,0.4901027855220835,0,0,1.641399416909621,1.2680853834334544,NTRK1,Ba/Eo/Ma,0.33552009275365935
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.4975943295285679,0,0,1.6016749329213755,1.2094704650298027,CRLF2,Ba/Eo/Ma,0.32794816113488356
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),1/253,0.4712922312950381,0.4978888583432909,0,0,1.5952380952380951,1.2000608149186214,NTRK1,Ba/Eo/Ma,0.32670971902140344
GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),1/266,0.4884385252284191,0.5148406076731984,0,0,1.5159799768964188,1.086262808220724,NTRK1,Ba/Eo/Ma,0.3111900887192418
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.515046793362321,0,0,1.510204081632653,1.0781219104526054,GATA2,Ba/Eo/Ma,0.3100391544580995
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.5166020054961628,0,0,1.498781602193116,1.0620843946744252,IL4,Ba/Eo/Ma,0.30775490655057164
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5221476624069811,0,0,1.4709576138147566,1.0233666205889618,NTRK1,Ba/Eo/Ma,0.30214499188263844
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.536694286005433,0,0,1.4081632653061225,0.937839142501346,NTRK1,Ba/Eo/Ma,0.289240867544339
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),1/300,0.5307476794848257,0.5532069354095733,0,0,1.341273633199099,0.8496546643160489,TPSAB1,Ba/Eo/Ma,0.2751118959639202
GO_Biological_Process_2021,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.5556842483164213,0,0,1.32774699283687,0.8321996277505203,IL3RA,Ba/Eo/Ma,0.2722052530518486
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5581230423323622,0,0,1.314486450317832,0.8152139890333826,SLC18A2,Ba/Eo/Ma,0.2693393582885023
GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),1/314,0.5471545986718139,0.5665229030495773,0,0,1.2803677381495728,0.7720923294539072,INHA,Ba/Eo/Ma,0.26188994631047774
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5755379311831926,0,0,1.2440106477373558,0.7270814983759607,RYR3,Ba/Eo/Ma,0.2538302089398956
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),2/742,0.5583209845238664,0.5755379311831926,0,0,1.0816441441441442,0.6304051823091851,IL4;NTRK1,Ba/Eo/Ma,0.25311604886163686
GO_Biological_Process_2021,gene expression (GO:0010467),1/356,0.5930749260701463,0.6100199239578648,0,0,1.126473124461052,0.5885084653208599,ANGPT2,Ba/Eo/Ma,0.2268904366133749
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),1/408,0.643643262264238,0.660581242850139,0,0,0.9799428370856942,0.4317732474155183,IL4,Ba/Eo/Ma,0.19135477263518083
GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),1/437,0.6691136001848389,0.6840597827277355,0,0,0.9134057292641828,0.3670077257341264,NTRK1,Ba/Eo/Ma,0.1745001427028418
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),2/908,0.6694431207036386,0.6840597827277355,0,0,0.8758278145695364,0.3514776504163603,IL4;GATA2,Ba/Eo/Ma,0.17428631695508484
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.6912187085983104,0.7047720166100419,0,0,0.8589500595054437,0.3172093937483807,IL4,Ba/Eo/Ma,0.16038451570993173
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),1/511,0.7262961571675228,0.7389273946834797,0,0,0.7779111644657863,0.2487739813280452,IL4,Ba/Eo/Ma,0.13888625368433627
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),2/1025,0.7337546800798972,0.7448962912741689,0,0,0.7708944281524927,0.2386539053000475,NTRK1;CDK15,Ba/Eo/Ma,0.13444911569132442
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.7585980609944936,0,0,0.726642950758285,0.2091870484536521,NTRK1,Ba/Eo/Ma,0.12502533841998253
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7504933808556635,0.7585980609944936,0,0,0.7252747252747253,0.2081715773755284,IL4,Ba/Eo/Ma,0.1246531337611999
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",2/1183,0.8038594904607679,0.8107893136543951,0,0,0.6621860005644934,0.1445755914280007,IL4;GATA2,Ba/Eo/Ma,0.09481985653812466
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8301678533564913,0,0,0.5757014372366809,0.1108560647358729,IL4,Ba/Eo/Ma,0.0836269880293983
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",1/948,0.912055183209665,0.9159695831376036,0,0,0.4095209361463698,0.0376983608425212,IL4,Ba/Eo/Ma,0.039978884217174375
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",3/2244,0.9302128294243438,0.9322047198513768,0,0,0.5044005810475947,0.036489281349511,IL4;GATA2;CDK15,Ba/Eo/Ma,0.03141767502685046
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),2/2206,0.9792407454532416,0.9792407454532416,0,0,0.3354885057471264,0.0070377963929841,IL4;GATA2,Ba/Eo/Ma,0.009110524163636814
KEGG_2021_Human,T cell receptor signaling pathway (GO:0050852),12/158,3.624946151618197e-15,1.5007277067699336e-12,0,0,42.83489545782264,1424.30040861795,ITK;LCK;TRAT1;GRAP2;THEMIS;CD28;CTLA4;CD3G;CD247;GATA3;CD3E;CD3D,CD4+ T-Cell,14.440698440466443
KEGG_2021_Human,antigen receptor-mediated signaling pathway (GO:0050851),12/185,2.446359863488659e-14,5.063964917421524e-12,0,0,36.100395497414056,1131.4438000128332,ITK;LCK;TRAT1;GRAP2;THEMIS;CD28;CTLA4;CD3G;CD247;GATA3;CD3E;CD3D,CD4+ T-Cell,13.611479657180443
KEGG_2021_Human,T cell activation (GO:0042110),9/92,1.3250408280723094e-12,1.828556342739787e-10,0,0,52.54275639141934,1437.0222060300175,CD2;ITK;LCK;CD7;CD28;CD3G;CCR7;GATA3;CD3E,CD4+ T-Cell,11.877770739739754
KEGG_2021_Human,positive regulation of T cell activation (GO:0050870),8/75,1.2599370166854836e-11,1.3040348122694755e-09,0,0,56.52594171997157,1418.652716439612,CD40LG;CD6;LCK;SIRPG;CD28;CCR7;GATA3;CD3E,CD4+ T-Cell,10.899651164398009
KEGG_2021_Human,positive thymic T cell selection (GO:0045059),3/5,1.4648687711442908e-07,1.2129113425074727e-05,0,0,636.6382978723404,10018.350338643862,CD3G;CD3E;CD3D,CD4+ T-Cell,6.834201279419503
KEGG_2021_Human,regulation of immune response (GO:0050776),7/179,2.952661464572975e-07,2.0373364105553528e-05,0,0,18.719037317468903,281.44800208224956,CD96;CD40LG;KLRB1;CD3G;CD247;CD3E;CD3D,CD4+ T-Cell,6.529786343924199
KEGG_2021_Human,regulation of T cell differentiation (GO:0045580),4/39,2.6646434639029728e-06,0.00015207558252429272,0,0,49.47826086956522,635.0752632396991,CD2;CAMK4;CTLA4;GATA3,CD4+ T-Cell,5.5743608924603665
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),6/161,2.938658599503241e-06,0.00015207558252429272,0,0,17.414956011730204,221.82400076260683,LCK;TRAT1;CD28;CCR7;GATA3;ICOS,CD4+ T-Cell,5.531850865429297
KEGG_2021_Human,positive regulation of interleukin-4 production (GO:0032753),3/18,1.1683108621861051e-05,0.0005145941239595638,0,0,84.82978723404256,963.4429809213964,CD40LG;CD28;GATA3,CD4+ T-Cell,4.932441585503229
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),6/207,1.2429809757477386e-05,0.0005145941239595638,0,0,13.398236092265943,151.33860956649198,LCK;TRAT1;CD28;CCR7;GATA3;ICOS,CD4+ T-Cell,4.905535518334226
KEGG_2021_Human,positive regulation of cytokine production (GO:0001819),7/335,1.869512476672057e-05,0.0007036165139474832,0,0,9.738655700510494,106.02715761423524,CD2;ITK;CD40LG;CD6;CD28;CCR7;GATA3,CD4+ T-Cell,4.728271632124233
KEGG_2021_Human,positive regulation of T cell proliferation (GO:0042102),4/66,2.2218375806853115e-05,0.0007665339653364324,0,0,27.893408134642357,298.86645620028213,CD40LG;CD6;CD28;CD3E,CD4+ T-Cell,4.653287691745406
KEGG_2021_Human,regulation of interleukin-4 production (GO:0032673),3/23,2.5134148576039852e-05,0.0008004259623446537,0,0,63.6063829787234,673.6732113483868,CD40LG;CD28;GATA3,CD4+ T-Cell,4.59973582199312
KEGG_2021_Human,positive regulation of lymphocyte proliferation (GO:0050671),4/75,3.685550808876545e-05,0.0010717534365321,0,0,24.346601347213717,248.542413205756,CD40LG;CD6;CD28;CD3E,CD4+ T-Cell,4.433497597254195
KEGG_2021_Human,regulation of T cell proliferation (GO:0042129),4/76,3.88316462511635e-05,0.0010717534365321,0,0,24.00724637681159,243.8241966457016,CD40LG;CD6;CD28;CD3E,CD4+ T-Cell,4.410814197333408
KEGG_2021_Human,membrane raft distribution (GO:0031580),2/5,6.0956786529959696e-05,0.0015772568514627,0,0,277.0416666666667,2688.78505476905,CD2;MAL,CD4+ T-Cell,4.214977935846465
KEGG_2021_Human,B cell receptor signaling pathway (GO:0050853),3/34,8.329713391830358e-05,0.002028530202481,0,0,41.01372683596431,385.24589055488593,ITK;LCK;CTLA4,CD4+ T-Cell,4.079369941508931
KEGG_2021_Human,regulation of T cell receptor signaling pathway (GO:0050856),3/35,9.094610315590577e-05,0.0020917603725858,0,0,39.73005319148936,369.69781921167737,TRAT1;LCK;UBASH3A,CD4+ T-Cell,4.041215904782398
KEGG_2021_Human,T cell differentiation (GO:0030217),3/41,0.00014657115641659294,0.0031937083556036,0,0,33.4468085106383,295.2684100827493,LCK;CD28;GATA3,CD4+ T-Cell,3.833951485640186
KEGG_2021_Human,positive regulation of dendritic cell chemotaxis (GO:2000510),2/8,0.0001698630098259154,0.0031965130030876,0,0,138.5,1202.2517804391236,CCR7;CCR6,CD4+ T-Cell,3.7699011848597213
KEGG_2021_Human,immunological synapse formation (GO:0001771),2/8,0.0001698630098259154,0.0031965130030876,0,0,138.5,1202.2517804391236,CD6;CCR7,CD4+ T-Cell,3.7699011848597213
KEGG_2021_Human,regulation of dendritic cell chemotaxis (GO:2000508),2/8,0.0001698630098259154,0.0031965130030876,0,0,138.5,1202.2517804391236,CCR7;CCR6,CD4+ T-Cell,3.7699011848597213
KEGG_2021_Human,positive regulation of cell-cell adhesion (GO:0022409),3/47,0.0002206109248491568,0.0038055384536479,0,0,28.87717601547389,243.12011931420915,LCK;SIRPG;CD3E,CD4+ T-Cell,3.6563729847143955
KEGG_2021_Human,regulation of T cell activation (GO:0050863),3/47,0.0002206109248491568,0.0038055384536479,0,0,28.87717601547389,243.12011931420915,CD2;LCK;SIRPG,CD4+ T-Cell,3.6563729847143955
KEGG_2021_Human,cellular defense response (GO:0006968),3/49,0.0002497855682645102,0.0041364490104602,0,0,27.618871415356153,229.09599013803128,ITK;TRAT1;CCR6,CD4+ T-Cell,3.6024326572514935
KEGG_2021_Human,isotype switching (GO:0045190),2/11,0.000332063883264561,0.0052874787565972,0,0,92.31944444444444,739.4956618223716,CD40LG;CCR6,CD4+ T-Cell,3.478778357620151
KEGG_2021_Human,regulation of cytokine production (GO:0001817),4/150,0.0005353827589376326,0.00808464849092,0,0,11.795116140559855,88.84705001828203,ITK;CD28;CCR7;GATA3,CD4+ T-Cell,3.271335618615674
KEGG_2021_Human,positive regulation of T cell receptor signaling pathway (GO:0050862),2/14,0.0005467878206419364,0.00808464849092,0,0,69.22916666666667,520.0114050756229,TRAT1;LCK,CD4+ T-Cell,3.2621811676355046
KEGG_2021_Human,dendritic cell chemotaxis (GO:0002407),2/16,0.0007187392304892979,0.0102606221180196,0,0,59.333333333333336,429.45537567816734,CCR7;CCR6,CD4+ T-Cell,3.14342864967499
KEGG_2021_Human,dendritic cell migration (GO:0036336),2/18,0.000913470506242016,0.0126058929861398,0,0,51.911458333333336,363.2898548418271,CCR7;CCR6,CD4+ T-Cell,3.039305470405725
KEGG_2021_Human,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),2/21,0.0012477930702112,0.016664075195724,0,0,43.708333333333336,292.25047477799524,TRAT1;LCK,CD4+ T-Cell,2.9038574306125264
KEGG_2021_Human,dendritic cell differentiation (GO:0097028),2/24,0.0016321249773357,0.0211156168942815,0,0,37.74242424242424,242.22606459531664,CAMK4;CCR7,CD4+ T-Cell,2.7872465889099036
KEGG_2021_Human,negative regulation of sequestering of calcium ion (GO:0051283),2/25,0.0017712212130127,0.022220775217796,0,0,36.09963768115942,228.73040961874747,LCK;CCR7,CD4+ T-Cell,2.751727195110795
KEGG_2021_Human,positive regulation of cellular component movement (GO:0051272),2/27,0.0020657293545543,0.0244346272224428,0,0,33.208333333333336,205.3029465636782,SPOCK2;CCR7,CD4+ T-Cell,2.684926579003782
KEGG_2021_Human,release of sequestered calcium ion into cytosol (GO:0051209),2/27,0.0020657293545543,0.0244346272224428,0,0,33.208333333333336,205.3029465636782,LCK;CCR7,CD4+ T-Cell,2.684926579003782
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),6/546,0.0023099350230478,0.0265642527650506,0,0,4.901515151515151,29.75482361027579,LCK;TRAT1;CD28;CCR7;GATA3;ICOS,CD4+ T-Cell,2.6364002363540378
KEGG_2021_Human,positive regulation of leukocyte cell-cell adhesion (GO:1903039),2/31,0.0027192556482504,0.0279393072885705,0,0,28.62212643678161,169.08226656127547,LCK;SIRPG,CD4+ T-Cell,2.565549960707733
KEGG_2021_Human,positive regulation of locomotion (GO:0040017),2/31,0.0027192556482504,0.0279393072885705,0,0,28.62212643678161,169.08226656127547,SPOCK2;CCR7,CD4+ T-Cell,2.565549960707733
KEGG_2021_Human,positive regulation of mononuclear cell migration (GO:0071677),2/31,0.0027192556482504,0.0279393072885705,0,0,28.62212643678161,169.08226656127547,CCR7;CCR6,CD4+ T-Cell,2.565549960707733
KEGG_2021_Human,peptide cross-linking (GO:0018149),2/31,0.0027192556482504,0.0279393072885705,0,0,28.62212643678161,169.08226656127547,CD3G;CD247,CD4+ T-Cell,2.565549960707733
KEGG_2021_Human,protein-containing complex subunit organization (GO:0043933),3/112,0.0027669362290613,0.0279393072885705,0,0,11.618778059730626,68.43477270112554,CD3G;CD247;CD3E,CD4+ T-Cell,2.5580008501420024
KEGG_2021_Human,positive regulation of interleukin-10 production (GO:0032733),2/32,0.0028959211173454,0.0285455081566906,0,0,27.666666666666668,161.69650653172428,CD40LG;CD28,CD4+ T-Cell,2.5382132721600397
KEGG_2021_Human,positive regulation of interleukin-12 production (GO:0032735),2/34,0.0032650074009337,0.0314351875345715,0,0,25.934895833333332,148.46413612460563,CD40LG;CCR7,CD4+ T-Cell,2.4861158299536776
KEGG_2021_Human,positive regulation of lymphocyte activation (GO:0051251),2/35,0.0034573756419477,0.0325307617219628,0,0,25.147727272727273,142.5183432834292,LCK;SIRPG,CD4+ T-Cell,2.461253432039241
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),6/621,0.0043552416698362,0.0396068057450672,0,0,4.287139689578714,23.30649979183367,IL32;CD40LG;LCK;GRAP2;GATA3;IL7R,CD4+ T-Cell,2.360987741238573
KEGG_2021_Human,regulation of cell motility (GO:2000145),3/133,0.0044856884054486,0.0396068057450672,0,0,9.731587561374797,52.6173636813508,SPOCK2;CCR7;GATA3,CD4+ T-Cell,2.348170897604195
KEGG_2021_Human,lymphocyte migration (GO:0072676),2/40,0.0044964248068071,0.0396068057450672,0,0,21.833333333333332,117.99765363023796,GATA3;CCR6,CD4+ T-Cell,2.3471326648462743
KEGG_2021_Human,calcium ion transmembrane import into cytosol (GO:0097553),2/42,0.0049475924537835,0.0426729849138831,0,0,20.739583333333332,110.1034239545967,LCK;CCR7,CD4+ T-Cell,2.3056060815494894
KEGG_2021_Human,enzyme linked receptor protein signaling pathway (GO:0007167),3/140,0.005174274872555,0.0437173428007711,0,0,9.231091784438576,48.59298474885369,LCK;CD7;CD3E,CD4+ T-Cell,2.286150504018583
KEGG_2021_Human,positive regulation of cell-matrix adhesion (GO:0001954),2/44,0.0054187658916089,0.043987629002473,0,0,19.75,103.05327189846057,CCR7;CD3E,CD4+ T-Cell,2.266099611522887
KEGG_2021_Human,regulation of endothelial cell apoptotic process (GO:2000351),2/44,0.0054187658916089,0.043987629002473,0,0,19.75,103.05327189846057,CD40LG;GATA3,CD4+ T-Cell,2.266099611522887
KEGG_2021_Human,regulation of interleukin-10 production (GO:0032653),2/48,0.0064203200925442,0.0511156253521794,0,0,18.028985507246375,91.01549863791358,CD40LG;CD28,CD4+ T-Cell,2.192443319133604
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),5/482,0.0069168190120408,0.0540294919053754,0,0,4.535988819007687,22.5610979918269,IL32;LCK;GRAP2;CCR7;GATA3,CD4+ T-Cell,2.1600935880773298
KEGG_2021_Human,regulation of interleukin-12 production (GO:0032655),2/51,0.0072225026271421,0.0553725201414229,0,0,16.922619047619047,83.43788300609687,CD40LG;CCR7,CD4+ T-Cell,2.1413122915117184
KEGG_2021_Human,positive regulation of leukocyte chemotaxis (GO:0002690),2/54,0.0080676700842631,0.0607275529979081,0,0,15.943910256410255,76.8479024006269,CCR7;CCR6,CD4+ T-Cell,2.0932518699428635
KEGG_2021_Human,sensory organ development (GO:0007423),2/56,0.0086546685435214,0.0639827281610334,0,0,15.351851851851851,72.91602120992282,PBX4;GATA3,CD4+ T-Cell,2.0627495600792987
KEGG_2021_Human,regulation of cell-matrix adhesion (GO:0001952),2/65,0.0115237618661231,0.074361806107719,0,0,13.15277777777778,58.70537343689256,CCR7;CD3E,CD4+ T-Cell,1.9384057248186684
KEGG_2021_Human,embryonic organ development (GO:0048568),2/66,0.0118650634107129,0.074361806107719,0,0,12.946614583333334,57.4073222604629,PBX4;GATA3,CD4+ T-Cell,1.9257299364311244
KEGG_2021_Human,establishment of T cell polarity (GO:0001768),1/5,0.0124387771927725,0.074361806107719,0,0,101.76530612244898,446.4379351400606,CCR7,CD4+ T-Cell,1.9052223113279663
KEGG_2021_Human,alpha-beta T cell differentiation (GO:0046632),1/5,0.0124387771927725,0.074361806107719,0,0,101.76530612244898,446.4379351400606,ITK,CD4+ T-Cell,1.9052223113279663
KEGG_2021_Human,hematopoietic stem cell migration (GO:0035701),1/5,0.0124387771927725,0.074361806107719,0,0,101.76530612244898,446.4379351400606,BCL11B,CD4+ T-Cell,1.9052223113279663
KEGG_2021_Human,response to prostaglandin (GO:0034694),1/5,0.0124387771927725,0.074361806107719,0,0,101.76530612244898,446.4379351400606,CCR7,CD4+ T-Cell,1.9052223113279663
KEGG_2021_Human,negative regulation of regulatory T cell differentiation (GO:0045590),1/5,0.0124387771927725,0.074361806107719,0,0,101.76530612244898,446.4379351400606,CTLA4,CD4+ T-Cell,1.9052223113279663
KEGG_2021_Human,nephric duct development (GO:0072176),1/5,0.0124387771927725,0.074361806107719,0,0,101.76530612244898,446.4379351400606,GATA3,CD4+ T-Cell,1.9052223113279663
KEGG_2021_Human,mature conventional dendritic cell differentiation (GO:0097029),1/5,0.0124387771927725,0.074361806107719,0,0,101.76530612244898,446.4379351400606,CCR7,CD4+ T-Cell,1.9052223113279663
KEGG_2021_Human,negative regulation of macromolecule metabolic process (GO:0010605),3/194,0.0126088864195478,0.074361806107719,0,0,6.603208198730088,28.878163305605018,TRAT1;CD28;CD3E,CD4+ T-Cell,1.899323267368311
KEGG_2021_Human,cell chemotaxis (GO:0060326),2/69,0.0129153730394233,0.074361806107719,0,0,12.36504975124378,53.77976800231812,CCR7;CCR6,CD4+ T-Cell,1.888893045423814
KEGG_2021_Human,peptidyl-tyrosine phosphorylation (GO:0018108),2/69,0.0129153730394233,0.074361806107719,0,0,12.36504975124378,53.77976800231812,ITK;LCK,CD4+ T-Cell,1.888893045423814
KEGG_2021_Human,positive regulation of cell-substrate adhesion (GO:0010811),2/70,0.013274200561286,0.074361806107719,0,0,12.182598039215684,52.65237170003471,CCR7;CD3E,CD4+ T-Cell,1.8769916248436092
KEGG_2021_Human,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),2/71,0.0136373517747766,0.074361806107719,0,0,12.005434782608695,51.56265564232933,CD3G;CD247,CD4+ T-Cell,1.8652699567516449
KEGG_2021_Human,myeloid leukocyte differentiation (GO:0002573),2/71,0.0136373517747766,0.074361806107719,0,0,12.005434782608695,51.56265564232933,CAMK4;CCR7,CD4+ T-Cell,1.8652699567516449
KEGG_2021_Human,Fc-gamma receptor signaling pathway (GO:0038094),2/72,0.0140048037295852,0.074361806107719,0,0,11.833333333333334,50.50886613536219,CD3G;CD247,CD4+ T-Cell,1.8537229732206628
KEGG_2021_Human,Fc receptor mediated stimulatory signaling pathway (GO:0002431),2/74,0.0147525184670075,0.074361806107719,0,0,11.50347222222222,48.50256694786101,CD3G;CD247,CD4+ T-Cell,1.8311338330445346
KEGG_2021_Human,epithelial tube formation (GO:0072175),1/6,0.0149082847993736,0.074361806107719,0,0,81.40816326530613,342.3895623444841,GATA3,CD4+ T-Cell,1.8265723193247598
KEGG_2021_Human,positive regulation of animal organ morphogenesis (GO:0110110),1/6,0.0149082847993736,0.074361806107719,0,0,81.40816326530613,342.3895623444841,GATA3,CD4+ T-Cell,1.8265723193247598
KEGG_2021_Human,positive regulation of antigen processing and presentation (GO:0002579),1/6,0.0149082847993736,0.074361806107719,0,0,81.40816326530613,342.3895623444841,CCR7,CD4+ T-Cell,1.8265723193247598
KEGG_2021_Human,establishment of lymphocyte polarity (GO:0001767),1/6,0.0149082847993736,0.074361806107719,0,0,81.40816326530613,342.3895623444841,CCR7,CD4+ T-Cell,1.8265723193247598
KEGG_2021_Human,positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),1/6,0.0149082847993736,0.074361806107719,0,0,81.40816326530613,342.3895623444841,CD3E,CD4+ T-Cell,1.8265723193247598
KEGG_2021_Human,positive regulation of dendritic cell antigen processing and presentation (GO:0002606),1/6,0.0149082847993736,0.074361806107719,0,0,81.40816326530613,342.3895623444841,CCR7,CD4+ T-Cell,1.8265723193247598
KEGG_2021_Human,signal complex assembly (GO:0007172),1/6,0.0149082847993736,0.074361806107719,0,0,81.40816326530613,342.3895623444841,CD3E,CD4+ T-Cell,1.8265723193247598
KEGG_2021_Human,nephric duct morphogenesis (GO:0072178),1/6,0.0149082847993736,0.074361806107719,0,0,81.40816326530613,342.3895623444841,GATA3,CD4+ T-Cell,1.8265723193247598
KEGG_2021_Human,norepinephrine biosynthetic process (GO:0042421),1/6,0.0149082847993736,0.074361806107719,0,0,81.40816326530613,342.3895623444841,GATA3,CD4+ T-Cell,1.8265723193247598
KEGG_2021_Human,ear development (GO:0043583),1/6,0.0149082847993736,0.074361806107719,0,0,81.40816326530613,342.3895623444841,GATA3,CD4+ T-Cell,1.8265723193247598
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),3/212,0.0159696302578282,0.0781728365262777,0,0,6.029013539651838,24.942429757967023,CD3G;CD247;GATA3,CD4+ T-Cell,1.7967051388924395
KEGG_2021_Human,positive regulation of cell adhesion (GO:0045785),2/80,0.0170965192165363,0.0781728365262777,0,0,10.615384615384617,43.19273030214829,SIRPG;CCR7,CD4+ T-Cell,1.7670923012410087
KEGG_2021_Human,negative regulation of dendritic cell apoptotic process (GO:2000669),1/7,0.0173717414502839,0.0781728365262777,0,0,67.83673469387755,274.9362107684438,CCR7,CD4+ T-Cell,1.7601566430186848
KEGG_2021_Human,gamma-delta T cell activation (GO:0046629),1/7,0.0173717414502839,0.0781728365262777,0,0,67.83673469387755,274.9362107684438,ITK,CD4+ T-Cell,1.7601566430186848
KEGG_2021_Human,positive regulation of epithelial tube formation (GO:1905278),1/7,0.0173717414502839,0.0781728365262777,0,0,67.83673469387755,274.9362107684438,GATA3,CD4+ T-Cell,1.7601566430186848
KEGG_2021_Human,positive regulation of hormone metabolic process (GO:0032352),1/7,0.0173717414502839,0.0781728365262777,0,0,67.83673469387755,274.9362107684438,GATA3,CD4+ T-Cell,1.7601566430186848
KEGG_2021_Human,positive regulation of humoral immune response (GO:0002922),1/7,0.0173717414502839,0.0781728365262777,0,0,67.83673469387755,274.9362107684438,CCR7,CD4+ T-Cell,1.7601566430186848
KEGG_2021_Human,positive regulation of interleukin-5 production (GO:0032754),1/7,0.0173717414502839,0.0781728365262777,0,0,67.83673469387755,274.9362107684438,GATA3,CD4+ T-Cell,1.7601566430186848
KEGG_2021_Human,norepinephrine metabolic process (GO:0042415),1/7,0.0173717414502839,0.0781728365262777,0,0,67.83673469387755,274.9362107684438,GATA3,CD4+ T-Cell,1.7601566430186848
KEGG_2021_Human,lymphocyte differentiation (GO:0030098),2/84,0.0187414436957378,0.0829219478867741,0,0,10.095528455284551,40.15009805248223,LCK;GATA3,CD4+ T-Cell,1.7271969574747794
KEGG_2021_Human,regulation of interferon-gamma production (GO:0032649),2/86,0.0195880530452788,0.0829219478867741,0,0,9.854166666666666,38.754815869716495,CD2;CCR7,CD4+ T-Cell,1.7080087285643422
KEGG_2021_Human,inflammatory response (GO:0006954),3/230,0.0197887787787987,0.0829219478867741,0,0,5.545880588621239,21.75449430923437,CD96;CD40LG;CCR7,CD4+ T-Cell,1.7035810065007222
KEGG_2021_Human,positive regulation of dendritic cell cytokine production (GO:0002732),1/8,0.0198291614511851,0.0829219478867741,0,0,58.142857142857146,227.9549801512961,CAMK4,CD4+ T-Cell,1.702695651141308
KEGG_2021_Human,cellular response to interferon-alpha (GO:0035457),1/8,0.0198291614511851,0.0829219478867741,0,0,58.142857142857146,227.9549801512961,GATA3,CD4+ T-Cell,1.702695651141308
KEGG_2021_Human,regulation of lymphocyte apoptotic process (GO:0070228),1/8,0.0198291614511851,0.0829219478867741,0,0,58.142857142857146,227.9549801512961,CD3G,CD4+ T-Cell,1.702695651141308
KEGG_2021_Human,regulation of myeloid leukocyte differentiation (GO:0002761),1/8,0.0198291614511851,0.0829219478867741,0,0,58.142857142857146,227.9549801512961,CAMK4,CD4+ T-Cell,1.702695651141308
KEGG_2021_Human,second-messenger-mediated signaling (GO:0019932),2/89,0.0208876608034354,0.0864749157262225,0,0,9.512931034482758,36.80169347929862,CCR7;CCR6,CD4+ T-Cell,1.6801101936742149
KEGG_2021_Human,CD40 signaling pathway (GO:0023035),1/9,0.0222805591236868,0.0878490616876793,0,0,50.87244897959184,193.52086993316271,CD40LG,CD4+ T-Cell,1.652073914876897
KEGG_2021_Human,regulation of dendritic cell antigen processing and presentation (GO:0002604),1/9,0.0222805591236868,0.0878490616876793,0,0,50.87244897959184,193.52086993316271,CCR7,CD4+ T-Cell,1.652073914876897
KEGG_2021_Human,somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),1/9,0.0222805591236868,0.0878490616876793,0,0,50.87244897959184,193.52086993316271,CD40LG,CD4+ T-Cell,1.652073914876897
KEGG_2021_Human,regulation of mammary gland epithelial cell proliferation (GO:0033599),1/9,0.0222805591236868,0.0878490616876793,0,0,50.87244897959184,193.52086993316271,GATA3,CD4+ T-Cell,1.652073914876897
KEGG_2021_Human,regulation of nephron tubule epithelial cell differentiation (GO:0072182),1/9,0.0222805591236868,0.0878490616876793,0,0,50.87244897959184,193.52086993316271,GATA3,CD4+ T-Cell,1.652073914876897
KEGG_2021_Human,membrane organization (GO:0061024),3/242,0.0225919136857967,0.0882363421313192,0,0,5.264221490251936,19.95225877032457,CD3G;IL7R;CD3D,CD4+ T-Cell,1.6460469798817345
KEGG_2021_Human,apical protein localization (GO:0045176),1/10,0.024725948817258,0.0913977036637931,0,0,45.21768707482993,167.3010120823387,MAL,CD4+ T-Cell,1.606847034080906
KEGG_2021_Human,regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/10,0.024725948817258,0.0913977036637931,0,0,45.21768707482993,167.3010120823387,CD3E,CD4+ T-Cell,1.606847034080906
KEGG_2021_Human,response to interleukin-4 (GO:0070670),1/10,0.024725948817258,0.0913977036637931,0,0,45.21768707482993,167.3010120823387,GATA3,CD4+ T-Cell,1.606847034080906
KEGG_2021_Human,cellular response to interleukin-4 (GO:0071353),1/10,0.024725948817258,0.0913977036637931,0,0,45.21768707482993,167.3010120823387,GATA3,CD4+ T-Cell,1.606847034080906
KEGG_2021_Human,mesenchymal to epithelial transition (GO:0060231),1/10,0.024725948817258,0.0913977036637931,0,0,45.21768707482993,167.3010120823387,GATA3,CD4+ T-Cell,1.606847034080906
KEGG_2021_Human,myeloid dendritic cell differentiation (GO:0043011),1/10,0.024725948817258,0.0913977036637931,0,0,45.21768707482993,167.3010120823387,CAMK4,CD4+ T-Cell,1.606847034080906
KEGG_2021_Human,calcium-mediated signaling (GO:0019722),2/102,0.0269177264019109,0.0953089217899055,0,0,8.270833333333334,29.898816321570965,CCR7;CCR6,CD4+ T-Cell,1.5699616254585989
KEGG_2021_Human,positive regulation of interleukin-13 production (GO:0032736),1/11,0.0271653448579923,0.0953089217899055,0,0,40.69387755102041,146.73452100035948,GATA3,CD4+ T-Cell,1.5659847773237099
KEGG_2021_Human,response to prostaglandin E (GO:0034695),1/11,0.0271653448579923,0.0953089217899055,0,0,40.69387755102041,146.73452100035948,CCR7,CD4+ T-Cell,1.5659847773237099
KEGG_2021_Human,regulation of dendritic cell apoptotic process (GO:2000668),1/11,0.0271653448579923,0.0953089217899055,0,0,40.69387755102041,146.73452100035948,CCR7,CD4+ T-Cell,1.5659847773237099
KEGG_2021_Human,regulation of lymphocyte migration (GO:2000401),1/11,0.0271653448579923,0.0953089217899055,0,0,40.69387755102041,146.73452100035948,CCR6,CD4+ T-Cell,1.5659847773237099
KEGG_2021_Human,mesonephros development (GO:0001823),1/11,0.0271653448579923,0.0953089217899055,0,0,40.69387755102041,146.73452100035948,GATA3,CD4+ T-Cell,1.5659847773237099
KEGG_2021_Human,cellular component assembly (GO:0022607),3/261,0.0274521329320867,0.095505739780537,0,0,4.871845620979713,17.515802156668258,CD3G;CD247;CD3E,CD4+ T-Cell,1.5614239067822424
KEGG_2021_Human,protein-containing complex assembly (GO:0065003),3/267,0.0290942849381526,0.0964873014923428,0,0,4.759671179883946,16.83597323857966,CD3G;CD247;CD3E,CD4+ T-Cell,1.5361923121681382
KEGG_2021_Human,regulation of pseudopodium assembly (GO:0031272),1/12,0.029598761568907,0.0964873014923428,0,0,36.99257884972171,130.2147194065139,CCR7,CD4+ T-Cell,1.5287264597194943
KEGG_2021_Human,negative regulation of B cell proliferation (GO:0030889),1/12,0.029598761568907,0.0964873014923428,0,0,36.99257884972171,130.2147194065139,CTLA4,CD4+ T-Cell,1.5287264597194943
KEGG_2021_Human,negative regulation of leukocyte apoptotic process (GO:2000107),1/12,0.029598761568907,0.0964873014923428,0,0,36.99257884972171,130.2147194065139,CCR7,CD4+ T-Cell,1.5287264597194943
KEGG_2021_Human,catecholamine biosynthetic process (GO:0042423),1/12,0.029598761568907,0.0964873014923428,0,0,36.99257884972171,130.2147194065139,GATA3,CD4+ T-Cell,1.5287264597194943
KEGG_2021_Human,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/12,0.029598761568907,0.0964873014923428,0,0,36.99257884972171,130.2147194065139,CAMK4,CD4+ T-Cell,1.5287264597194943
KEGG_2021_Human,positive regulation of pseudopodium assembly (GO:0031274),1/12,0.029598761568907,0.0964873014923428,0,0,36.99257884972171,130.2147194065139,CCR7,CD4+ T-Cell,1.5287264597194943
KEGG_2021_Human,regulation of leukocyte cell-cell adhesion (GO:1903037),1/12,0.029598761568907,0.0964873014923428,0,0,36.99257884972171,130.2147194065139,LCK,CD4+ T-Cell,1.5287264597194943
KEGG_2021_Human,Fc-epsilon receptor signaling pathway (GO:0038095),2/111,0.0314544847807964,0.0974915609190286,0,0,7.584480122324159,26.23633758944092,ITK;GRAP2,CD4+ T-Cell,1.5023174240917434
KEGG_2021_Human,Fc receptor signaling pathway (GO:0038093),2/112,0.031976077624072,0.0974915609190286,0,0,7.515151515151516,25.872917364872013,ITK;GRAP2,CD4+ T-Cell,1.4951748104677034
KEGG_2021_Human,regulation of receptor signaling pathway via STAT (GO:1904892),1/13,0.032026213248763,0.0974915609190286,0,0,33.90816326530612,116.6847899929619,IL7R,CD4+ T-Cell,1.4944944088974865
KEGG_2021_Human,positive regulation of calcium-mediated signaling (GO:0050850),1/13,0.032026213248763,0.0974915609190286,0,0,33.90816326530612,116.6847899929619,TRAT1,CD4+ T-Cell,1.4944944088974865
KEGG_2021_Human,regulation of T cell differentiation in thymus (GO:0033081),1/13,0.032026213248763,0.0974915609190286,0,0,33.90816326530612,116.6847899929619,CAMK4,CD4+ T-Cell,1.4944944088974865
KEGG_2021_Human,negative regulation of locomotion (GO:0040013),1/13,0.032026213248763,0.0974915609190286,0,0,33.90816326530612,116.6847899929619,GATA3,CD4+ T-Cell,1.4944944088974865
KEGG_2021_Human,response to nitric oxide (GO:0071731),1/13,0.032026213248763,0.0974915609190286,0,0,33.90816326530612,116.6847899929619,CCR7,CD4+ T-Cell,1.4944944088974865
KEGG_2021_Human,cardiac right ventricle morphogenesis (GO:0003215),1/13,0.032026213248763,0.0974915609190286,0,0,33.90816326530612,116.6847899929619,GATA3,CD4+ T-Cell,1.4944944088974865
KEGG_2021_Human,regulation of interleukin-5 production (GO:0032674),1/13,0.032026213248763,0.0974915609190286,0,0,33.90816326530612,116.6847899929619,GATA3,CD4+ T-Cell,1.4944944088974865
KEGG_2021_Human,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),1/14,0.0344477141698711,0.1004320680727229,0,0,31.298273155416013,105.4223689491126,GATA3,CD4+ T-Cell,1.4628395910668823
KEGG_2021_Human,negative regulation of interleukin-12 production (GO:0032695),1/14,0.0344477141698711,0.1004320680727229,0,0,31.298273155416013,105.4223689491126,CCR7,CD4+ T-Cell,1.4628395910668823
KEGG_2021_Human,positive regulation of glycoprotein biosynthetic process (GO:0010560),1/14,0.0344477141698711,0.1004320680727229,0,0,31.298273155416013,105.4223689491126,CCR7,CD4+ T-Cell,1.4628395910668823
KEGG_2021_Human,negative regulation of T cell differentiation (GO:0045581),1/14,0.0344477141698711,0.1004320680727229,0,0,31.298273155416013,105.4223689491126,CTLA4,CD4+ T-Cell,1.4628395910668823
KEGG_2021_Human,T cell differentiation in thymus (GO:0033077),1/14,0.0344477141698711,0.1004320680727229,0,0,31.298273155416013,105.4223689491126,CCR6,CD4+ T-Cell,1.4628395910668823
KEGG_2021_Human,myeloid dendritic cell activation (GO:0001773),1/14,0.0344477141698711,0.1004320680727229,0,0,31.298273155416013,105.4223689491126,CAMK4,CD4+ T-Cell,1.4628395910668823
KEGG_2021_Human,negative regulation of cellular component movement (GO:0051271),1/15,0.0368632785936063,0.1045301187517329,0,0,29.06122448979592,95.91771596133704,GATA3,CD4+ T-Cell,1.4334060415588732
KEGG_2021_Human,positive regulation of heterotypic cell-cell adhesion (GO:0034116),1/15,0.0368632785936063,0.1045301187517329,0,0,29.06122448979592,95.91771596133704,LCK,CD4+ T-Cell,1.4334060415588732
KEGG_2021_Human,regulation of lymphocyte activation (GO:0051249),1/15,0.0368632785936063,0.1045301187517329,0,0,29.06122448979592,95.91771596133704,LCK,CD4+ T-Cell,1.4334060415588732
KEGG_2021_Human,peptidyl-tyrosine autophosphorylation (GO:0038083),1/15,0.0368632785936063,0.1045301187517329,0,0,29.06122448979592,95.91771596133704,ITK,CD4+ T-Cell,1.4334060415588732
KEGG_2021_Human,positive regulation of endothelial cell apoptotic process (GO:2000353),1/16,0.0392729207344652,0.1062679031638471,0,0,27.122448979591837,87.80133530116419,CD40LG,CD4+ T-Cell,1.405906798966597
KEGG_2021_Human,B cell activation involved in immune response (GO:0002312),1/16,0.0392729207344652,0.1062679031638471,0,0,27.122448979591837,87.80133530116419,CD40LG,CD4+ T-Cell,1.405906798966597
KEGG_2021_Human,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),1/16,0.0392729207344652,0.1062679031638471,0,0,27.122448979591837,87.80133530116419,CAMK4,CD4+ T-Cell,1.405906798966597
KEGG_2021_Human,regulation of interleukin-1 production (GO:0032652),1/16,0.0392729207344652,0.1062679031638471,0,0,27.122448979591837,87.80133530116419,CCR7,CD4+ T-Cell,1.405906798966597
KEGG_2021_Human,sympathetic nervous system development (GO:0048485),1/16,0.0392729207344652,0.1062679031638471,0,0,27.122448979591837,87.80133530116419,GATA3,CD4+ T-Cell,1.405906798966597
KEGG_2021_Human,regulation of interleukin-13 production (GO:0032656),1/16,0.0392729207344652,0.1062679031638471,0,0,27.122448979591837,87.80133530116419,GATA3,CD4+ T-Cell,1.405906798966597
KEGG_2021_Human,regulation of leukocyte activation (GO:0002694),1/16,0.0392729207344652,0.1062679031638471,0,0,27.122448979591837,87.80133530116419,LCK,CD4+ T-Cell,1.405906798966597
KEGG_2021_Human,plasma membrane bounded cell projection organization (GO:0120036),2/128,0.0407746939326368,0.1092033866048776,0,0,6.555555555555555,20.975769396496517,BICDL1;CCR7,CD4+ T-Cell,1.3896092902230834
KEGG_2021_Human,regulation of receptor recycling (GO:0001919),1/17,0.0416766547912334,0.1092033866048776,0,0,25.426020408163264,80.79916728086499,TRAT1,CD4+ T-Cell,1.3801071472903907
KEGG_2021_Human,positive regulation of cytokine production involved in inflammatory response (GO:1900017),1/17,0.0416766547912334,0.1092033866048776,0,0,25.426020408163264,80.79916728086499,CD6,CD4+ T-Cell,1.3801071472903907
KEGG_2021_Human,ruffle organization (GO:0031529),1/17,0.0416766547912334,0.1092033866048776,0,0,25.426020408163264,80.79916728086499,CCR7,CD4+ T-Cell,1.3801071472903907
KEGG_2021_Human,pharyngeal system development (GO:0060037),1/17,0.0416766547912334,0.1092033866048776,0,0,25.426020408163264,80.79916728086499,GATA3,CD4+ T-Cell,1.3801071472903907
KEGG_2021_Human,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.0440744949316926,0.1124977338726951,0,0,23.92917166866747,74.70385911458476,CD3E,CD4+ T-Cell,1.3558126557645607
KEGG_2021_Human,response to interferon-alpha (GO:0035455),1/18,0.0440744949316926,0.1124977338726951,0,0,23.92917166866747,74.70385911458476,GATA3,CD4+ T-Cell,1.3558126557645607
KEGG_2021_Human,T cell migration (GO:0072678),1/18,0.0440744949316926,0.1124977338726951,0,0,23.92917166866747,74.70385911458476,CCR6,CD4+ T-Cell,1.3558126557645607
KEGG_2021_Human,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),2/136,0.0454786698217006,0.1124977338726951,0,0,6.161691542288557,19.042780777221537,CD3G;CD247,CD4+ T-Cell,1.3421922462170102
KEGG_2021_Human,regulation of inflammatory response to antigenic stimulus (GO:0002861),2/137,0.0460802533373535,0.1124977338726951,0,0,6.1157407407407405,18.820401760879264,CD3G;CD247,CD4+ T-Cell,1.3364851419391792
KEGG_2021_Human,positive regulation of leukocyte activation (GO:0002696),1/19,0.0464664552952436,0.1124977338726951,0,0,22.598639455782312,69.35578082800635,CD2,CD4+ T-Cell,1.3328604565168853
KEGG_2021_Human,interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.0464664552952436,0.1124977338726951,0,0,22.598639455782312,69.35578082800635,IL7R,CD4+ T-Cell,1.3328604565168853
KEGG_2021_Human,regulation of epithelial cell differentiation (GO:0030856),1/19,0.0464664552952436,0.1124977338726951,0,0,22.598639455782312,69.35578082800635,GATA3,CD4+ T-Cell,1.3328604565168853
KEGG_2021_Human,positive regulation of neutrophil chemotaxis (GO:0090023),1/19,0.0464664552952436,0.1124977338726951,0,0,22.598639455782312,69.35578082800635,CCR7,CD4+ T-Cell,1.3328604565168853
KEGG_2021_Human,cellular response to interleukin-7 (GO:0098761),1/19,0.0464664552952436,0.1124977338726951,0,0,22.598639455782312,69.35578082800635,IL7R,CD4+ T-Cell,1.3328604565168853
KEGG_2021_Human,negative regulation of T cell receptor signaling pathway (GO:0050860),1/19,0.0464664552952436,0.1124977338726951,0,0,22.598639455782312,69.35578082800635,UBASH3A,CD4+ T-Cell,1.3328604565168853
KEGG_2021_Human,long-term memory (GO:0007616),1/19,0.0464664552952436,0.1124977338726951,0,0,22.598639455782312,69.35578082800635,CAMK4,CD4+ T-Cell,1.3328604565168853
KEGG_2021_Human,ureteric bud morphogenesis (GO:0060675),1/19,0.0464664552952436,0.1124977338726951,0,0,22.598639455782312,69.35578082800635,GATA3,CD4+ T-Cell,1.3328604565168853
KEGG_2021_Human,regulation of T cell migration (GO:2000404),1/20,0.0488525499820277,0.1142652863986412,0,0,21.40816326530612,64.63014669364038,CCR6,CD4+ T-Cell,1.3111127622579986
KEGG_2021_Human,cardiac ventricle development (GO:0003231),1/20,0.0488525499820277,0.1142652863986412,0,0,21.40816326530612,64.63014669364038,GATA3,CD4+ T-Cell,1.3111127622579986
KEGG_2021_Human,positive regulation of lymphocyte differentiation (GO:0045621),1/20,0.0488525499820277,0.1142652863986412,0,0,21.40816326530612,64.63014669364038,GATA3,CD4+ T-Cell,1.3111127622579986
KEGG_2021_Human,positive regulation of nitrogen compound metabolic process (GO:0051173),1/20,0.0488525499820277,0.1142652863986412,0,0,21.40816326530612,64.63014669364038,GATA3,CD4+ T-Cell,1.3111127622579986
KEGG_2021_Human,lipopolysaccharide-mediated signaling pathway (GO:0031663),1/20,0.0488525499820277,0.1142652863986412,0,0,21.40816326530612,64.63014669364038,CD6,CD4+ T-Cell,1.3111127622579986
KEGG_2021_Human,regulation of lymphocyte differentiation (GO:0045619),1/20,0.0488525499820277,0.1142652863986412,0,0,21.40816326530612,64.63014669364038,CD2,CD4+ T-Cell,1.3111127622579986
KEGG_2021_Human,neuron development (GO:0048666),2/143,0.0497512691479657,0.1157136259958305,0,0,5.8537234042553195,17.565380826397597,BICDL1;PBX4,CD4+ T-Cell,1.3031958359850326
KEGG_2021_Human,autonomic nervous system development (GO:0048483),1/21,0.0512327930672156,0.1178354240545958,0,0,20.336734693877553,60.42807445408675,GATA3,CD4+ T-Cell,1.2904519669693806
KEGG_2021_Human,positive regulation of transcription regulatory region DNA binding (GO:2000679),1/21,0.0512327930672156,0.1178354240545958,0,0,20.336734693877553,60.42807445408675,GATA3,CD4+ T-Cell,1.2904519669693806
KEGG_2021_Human,positive regulation of cytosolic calcium ion concentration (GO:0007204),2/147,0.0522559027547516,0.1195245510523048,0,0,5.691091954022989,16.797840801779476,CCR7;CCR6,CD4+ T-Cell,1.281864645139883
KEGG_2021_Human,regulation of cytosolic calcium ion concentration (GO:0051480),2/148,0.052889062238365,0.1199642174058998,0,0,5.651826484018265,16.61387585032132,CCR7;CCR6,CD4+ T-Cell,1.2766341332705589
KEGG_2021_Human,negative regulation of B cell activation (GO:0050869),1/22,0.0536071985992547,0.1199642174058998,0,0,19.367346938775512,56.67024999786951,CTLA4,CD4+ T-Cell,1.2707768875084013
KEGG_2021_Human,positive regulation of granulocyte chemotaxis (GO:0071624),1/22,0.0536071985992547,0.1199642174058998,0,0,19.367346938775512,56.67024999786951,CCR7,CD4+ T-Cell,1.2707768875084013
KEGG_2021_Human,positive regulation of neutrophil migration (GO:1902624),1/22,0.0536071985992547,0.1199642174058998,0,0,19.367346938775512,56.67024999786951,CCR7,CD4+ T-Cell,1.2707768875084013
KEGG_2021_Human,positive regulation of epithelial cell apoptotic process (GO:1904037),1/23,0.0559757805878795,0.123924990178514,0,0,18.4860853432282,53.29235549319145,CD40LG,CD4+ T-Cell,1.2519998414265567
KEGG_2021_Human,vesicle transport along microtubule (GO:0047496),1/23,0.0559757805878795,0.123924990178514,0,0,18.4860853432282,53.29235549319145,BICDL1,CD4+ T-Cell,1.2519998414265567
KEGG_2021_Human,regulation of cell differentiation (GO:0045595),2/156,0.058052477548913,0.1278389665172871,0,0,5.356060606060606,15.245533180091437,SPOCK2;GATA3,CD4+ T-Cell,1.2361792408201375
KEGG_2021_Human,protein autophosphorylation (GO:0046777),2/159,0.060032623780291,0.1301966287420135,0,0,5.25291932059448,14.77576411894998,ITK;CAMK4,CD4+ T-Cell,1.2216126749949432
KEGG_2021_Human,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/25,0.0606955298241754,0.1301966287420135,0,0,16.943877551020407,47.47480020477031,UBASH3A,CD4+ T-Cell,1.2168432931781568
KEGG_2021_Human,negative regulation of signaling (GO:0023057),1/25,0.0606955298241754,0.1301966287420135,0,0,16.943877551020407,47.47480020477031,TRAT1,CD4+ T-Cell,1.2168432931781568
KEGG_2021_Human,regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.0606955298241754,0.1301966287420135,0,0,16.943877551020407,47.47480020477031,LCK,CD4+ T-Cell,1.2168432931781568
KEGG_2021_Human,regulation of neutrophil chemotaxis (GO:0090022),1/25,0.0606955298241754,0.1301966287420135,0,0,16.943877551020407,47.47480020477031,CCR7,CD4+ T-Cell,1.2168432931781568
KEGG_2021_Human,regulation of regulatory T cell differentiation (GO:0045589),1/26,0.0630467249540435,0.1324941326445382,0,0,16.26530612244898,44.95534064809558,CTLA4,CD4+ T-Cell,1.2003374685092782
KEGG_2021_Human,positive regulation of filopodium assembly (GO:0051491),1/26,0.0630467249540435,0.1324941326445382,0,0,16.26530612244898,44.95534064809558,CCR7,CD4+ T-Cell,1.2003374685092782
KEGG_2021_Human,positive regulation of interleukin-2 production (GO:0032743),1/26,0.0630467249540435,0.1324941326445382,0,0,16.26530612244898,44.95534064809558,CD28,CD4+ T-Cell,1.2003374685092782
KEGG_2021_Human,TOR signaling (GO:0031929),1/26,0.0630467249540435,0.1324941326445382,0,0,16.26530612244898,44.95534064809558,GATA3,CD4+ T-Cell,1.2003374685092782
KEGG_2021_Human,acute inflammatory response (GO:0002526),1/27,0.0653921522588676,0.1346883136078168,0,0,15.638932496075354,42.652889831563165,CD6,CD4+ T-Cell,1.184474368421492
KEGG_2021_Human,negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.0653921522588676,0.1346883136078168,0,0,15.638932496075354,42.652889831563165,GATA3,CD4+ T-Cell,1.184474368421492
KEGG_2021_Human,regulation of transcription regulatory region DNA binding (GO:2000677),1/27,0.0653921522588676,0.1346883136078168,0,0,15.638932496075354,42.652889831563165,GATA3,CD4+ T-Cell,1.184474368421492
KEGG_2021_Human,positive regulation of nuclear division (GO:0051785),1/27,0.0653921522588676,0.1346883136078168,0,0,15.638932496075354,42.652889831563165,CD28,CD4+ T-Cell,1.184474368421492
KEGG_2021_Human,positive regulation of cell communication (GO:0010647),1/28,0.0677318256109869,0.134812383668022,0,0,15.058956916099774,40.54171043527237,GATA3,CD4+ T-Cell,1.1692072184717057
KEGG_2021_Human,regulation of calcium-mediated signaling (GO:0050848),1/28,0.0677318256109869,0.134812383668022,0,0,15.058956916099774,40.54171043527237,TRAT1,CD4+ T-Cell,1.1692072184717057
KEGG_2021_Human,response to ketone (GO:1901654),1/28,0.0677318256109869,0.134812383668022,0,0,15.058956916099774,40.54171043527237,CCR7,CD4+ T-Cell,1.1692072184717057
KEGG_2021_Human,leukocyte cell-cell adhesion (GO:0007159),1/28,0.0677318256109869,0.134812383668022,0,0,15.058956916099774,40.54171043527237,CD40LG,CD4+ T-Cell,1.1692072184717057
KEGG_2021_Human,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/28,0.0677318256109869,0.134812383668022,0,0,15.058956916099774,40.54171043527237,CCR7,CD4+ T-Cell,1.1692072184717057
KEGG_2021_Human,cellular zinc ion homeostasis (GO:0006882),1/28,0.0677318256109869,0.134812383668022,0,0,15.058956916099774,40.54171043527237,LCK,CD4+ T-Cell,1.1692072184717057
KEGG_2021_Human,regulation of multicellular organismal development (GO:2000026),1/28,0.0677318256109869,0.134812383668022,0,0,15.058956916099774,40.54171043527237,GATA3,CD4+ T-Cell,1.1692072184717057
KEGG_2021_Human,negative regulation of epithelial to mesenchymal transition (GO:0010719),1/29,0.0700657588372089,0.1381296388504976,0,0,14.520408163265309,38.5999069065122,GATA3,CD4+ T-Cell,1.1544941700666143
KEGG_2021_Human,positive regulation of viral genome replication (GO:0045070),1/29,0.0700657588372089,0.1381296388504976,0,0,14.520408163265309,38.5999069065122,CD28,CD4+ T-Cell,1.1544941700666143
KEGG_2021_Human,response to alcohol (GO:0097305),1/30,0.0723939657090184,0.1400518775866057,0,0,14.019000703729768,36.80874147674154,CCR7,CD4+ T-Cell,1.1402976322627019
KEGG_2021_Human,heterotypic cell-cell adhesion (GO:0034113),1/30,0.0723939657090184,0.1400518775866057,0,0,14.019000703729768,36.80874147674154,CD2,CD4+ T-Cell,1.1402976322627019
KEGG_2021_Human,positive regulation of lipid kinase activity (GO:0090218),1/30,0.0723939657090184,0.1400518775866057,0,0,14.019000703729768,36.80874147674154,CCR7,CD4+ T-Cell,1.1402976322627019
KEGG_2021_Human,zinc ion homeostasis (GO:0055069),1/30,0.0723939657090184,0.1400518775866057,0,0,14.019000703729768,36.80874147674154,LCK,CD4+ T-Cell,1.1402976322627019
KEGG_2021_Human,negative regulation of immune response (GO:0050777),2/178,0.073094899664538,0.1407501788889244,0,0,4.681344696969697,12.246382216533686,CD3G;CD247,CD4+ T-Cell,1.1361129257073213
KEGG_2021_Human,organelle transport along microtubule (GO:0072384),1/31,0.0747164600026276,0.1432065483383696,0,0,13.551020408163266,35.15209038871121,BICDL1,CD4+ T-Cell,1.126583712764908
KEGG_2021_Human,activation of phospholipase C activity (GO:0007202),1/32,0.0770332554327668,0.1449625806780249,0,0,13.113232389730086,33.61600807740255,ITK,CD4+ T-Cell,1.1133217484244988
KEGG_2021_Human,aortic valve morphogenesis (GO:0003180),1/32,0.0770332554327668,0.1449625806780249,0,0,13.113232389730086,33.61600807740255,GATA3,CD4+ T-Cell,1.1133217484244988
KEGG_2021_Human,B cell proliferation (GO:0042100),1/32,0.0770332554327668,0.1449625806780249,0,0,13.113232389730086,33.61600807740255,CD40LG,CD4+ T-Cell,1.1133217484244988
KEGG_2021_Human,positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.0770332554327668,0.1449625806780249,0,0,13.113232389730086,33.61600807740255,IL7R,CD4+ T-Cell,1.1133217484244988
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),3/404,0.0800241417045532,0.1499094781252716,0,0,3.1117419217912663,7.858476812794824,LCK;CD7;CD3E,CD4+ T-Cell,1.0967789751654027
KEGG_2021_Human,epithelial tube morphogenesis (GO:0060562),1/34,0.0816498044624026,0.1502356402108207,0,0,12.317254174397032,30.85861216573232,GATA3,CD4+ T-Cell,1.0880448509885652
KEGG_2021_Human,positive regulation of DNA binding (GO:0043388),1/34,0.0816498044624026,0.1502356402108207,0,0,12.317254174397032,30.85861216573232,GATA3,CD4+ T-Cell,1.0880448509885652
KEGG_2021_Human,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.0816498044624026,0.1502356402108207,0,0,12.317254174397032,30.85861216573232,GATA3,CD4+ T-Cell,1.0880448509885652
KEGG_2021_Human,phosphatidylinositol 3-kinase signaling (GO:0014065),1/34,0.0816498044624026,0.1502356402108207,0,0,12.317254174397032,30.85861216573232,GATA3,CD4+ T-Cell,1.0880448509885652
KEGG_2021_Human,response to estrogen (GO:0043627),1/35,0.0839495853612937,0.1531062922448265,0,0,11.95438175270108,29.61744503578088,GATA3,CD4+ T-Cell,1.0759814445616303
KEGG_2021_Human,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/35,0.0839495853612937,0.1531062922448265,0,0,11.95438175270108,29.61744503578088,CCR7,CD4+ T-Cell,1.0759814445616303
KEGG_2021_Human,cellular response to tumor necrosis factor (GO:0071356),2/194,0.0847375162198589,0.1538654899781649,0,0,4.287760416666667,10.58303673172677,CD40LG;GATA3,CD4+ T-Cell,1.0719242699529004
KEGG_2021_Human,aortic valve development (GO:0003176),1/36,0.0862437219743075,0.1539004349024282,0,0,11.612244897959185,28.456712045041098,GATA3,CD4+ T-Cell,1.0642725091375862
KEGG_2021_Human,negative regulation of fat cell differentiation (GO:0045599),1/36,0.0862437219743075,0.1539004349024282,0,0,11.612244897959185,28.456712045041098,GATA3,CD4+ T-Cell,1.0642725091375862
KEGG_2021_Human,positive regulation of mitotic nuclear division (GO:0045840),1/36,0.0862437219743075,0.1539004349024282,0,0,11.612244897959185,28.456712045041098,CD28,CD4+ T-Cell,1.0642725091375862
KEGG_2021_Human,regulation of osteoclast differentiation (GO:0045670),1/36,0.0862437219743075,0.1539004349024282,0,0,11.612244897959185,28.456712045041098,CAMK4,CD4+ T-Cell,1.0642725091375862
KEGG_2021_Human,regulation of signal transduction (GO:0009966),2/198,0.0877321663879582,0.1558846218223808,0,0,4.199404761904762,10.219111519148855,GATA3;CD3E,CD4+ T-Cell,1.0568411463883935
KEGG_2021_Human,negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.0885322278902676,0.1559674142407268,0,0,11.289115646258503,27.36920368672352,GATA3,CD4+ T-Cell,1.0528986067362665
KEGG_2021_Human,regulation of transport (GO:0051049),1/37,0.0885322278902676,0.1559674142407268,0,0,11.289115646258503,27.36920368672352,TRAT1,CD4+ T-Cell,1.0528986067362665
KEGG_2021_Human,lymphocyte proliferation (GO:0046651),1/38,0.0908151166313484,0.1579725138041104,0,0,10.983452840595698,26.34852930034076,CD40LG,CD4+ T-Cell,1.0418418549683985
KEGG_2021_Human,positive regulation of signaling (GO:0023056),1/38,0.0908151166313484,0.1579725138041104,0,0,10.983452840595698,26.34852930034076,GATA3,CD4+ T-Cell,1.0418418549683985
KEGG_2021_Human,ventricular septum development (GO:0003281),1/38,0.0908151166313484,0.1579725138041104,0,0,10.983452840595698,26.34852930034076,GATA3,CD4+ T-Cell,1.0418418549683985
KEGG_2021_Human,negative regulation of cellular metabolic process (GO:0031324),1/39,0.0930924017046572,0.1599180676586228,0,0,10.693877551020408,25.38900533231373,TRAT1,CD4+ T-Cell,1.0310857651239858
KEGG_2021_Human,negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.0930924017046572,0.1599180676586228,0,0,10.693877551020408,25.38900533231373,CTLA4,CD4+ T-Cell,1.0310857651239858
KEGG_2021_Human,vesicle cytoskeletal trafficking (GO:0099518),1/39,0.0930924017046572,0.1599180676586228,0,0,10.693877551020408,25.38900533231373,BICDL1,CD4+ T-Cell,1.0310857651239858
KEGG_2021_Human,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/40,0.0953640965755271,0.1631435371168109,0,0,10.419152276295131,24.485561288951835,LCK,CD4+ T-Cell,1.0206151011238414
KEGG_2021_Human,regulation of filopodium assembly (GO:0051489),1/41,0.0976302146847681,0.1656512658995656,0,0,10.158163265306122,23.633660200289185,CCR7,CD4+ T-Cell,1.0104157556925017
KEGG_2021_Human,visual system development (GO:0150063),1/41,0.0976302146847681,0.1656512658995656,0,0,10.158163265306122,23.633660200289185,PBX4,CD4+ T-Cell,1.0104157556925017
KEGG_2021_Human,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.0998907694703361,0.1671476306390442,0,0,9.909905425584869,22.829231064333683,CD6,CD4+ T-Cell,1.00047464143678
KEGG_2021_Human,regulation of DNA recombination (GO:0000018),1/42,0.0998907694703361,0.1671476306390442,0,0,9.909905425584869,22.829231064333683,IL7R,CD4+ T-Cell,1.00047464143678
KEGG_2021_Human,regulation of cell-cell adhesion (GO:0022407),1/43,0.1021457742794159,0.1671476306390442,0,0,9.673469387755102,22.068611238785657,SIRPG,CD4+ T-Cell,0.9907795952096249
KEGG_2021_Human,regulation of cytokine production involved in inflammatory response (GO:1900015),1/43,0.1021457742794159,0.1671476306390442,0,0,9.673469387755102,22.068611238785657,CD6,CD4+ T-Cell,0.9907795952096249
KEGG_2021_Human,positive regulation of phospholipase C activity (GO:0010863),1/43,0.1021457742794159,0.1671476306390442,0,0,9.673469387755102,22.068611238785657,ITK,CD4+ T-Cell,0.9907795952096249
KEGG_2021_Human,male gonad development (GO:0008584),1/43,0.1021457742794159,0.1671476306390442,0,0,9.673469387755102,22.068611238785657,GATA3,CD4+ T-Cell,0.9907795952096249
KEGG_2021_Human,positive regulation of T cell differentiation (GO:0045582),1/43,0.1021457742794159,0.1671476306390442,0,0,9.673469387755102,22.068611238785657,GATA3,CD4+ T-Cell,0.9907795952096249
KEGG_2021_Human,development of primary male sexual characteristics (GO:0046546),1/43,0.1021457742794159,0.1671476306390442,0,0,9.673469387755102,22.068611238785657,GATA3,CD4+ T-Cell,0.9907795952096249
KEGG_2021_Human,natural killer cell activation (GO:0030101),1/43,0.1021457742794159,0.1671476306390442,0,0,9.673469387755102,22.068611238785657,CD2,CD4+ T-Cell,0.9907795952096249
KEGG_2021_Human,cardiac ventricle morphogenesis (GO:0003208),1/44,0.1043952424647777,0.1701560251197558,0,0,9.448030374940672,21.34849709415977,GATA3,CD4+ T-Cell,0.9813192926974915
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),2/221,0.1055403360927836,0.1713478397741663,0,0,3.7539954337899544,8.441467129790793,SPOCK2;CCR7,CD4+ T-Cell,0.97658152714763
KEGG_2021_Human,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.1066391873529346,0.172455560797324,0,0,9.232838589981448,20.665901611884028,GATA3,CD4+ T-Cell,0.9720831731354668
KEGG_2021_Human,regulation of B cell proliferation (GO:0030888),1/46,0.1088776222085674,0.1740360447658182,0,0,9.02721088435374,20.01811780873028,CTLA4,CD4+ T-Cell,0.9630613723103648
KEGG_2021_Human,regulation of DNA metabolic process (GO:0051052),1/46,0.1088776222085674,0.1740360447658182,0,0,9.02721088435374,20.01811780873028,IL7R,CD4+ T-Cell,0.9630613723103648
KEGG_2021_Human,positive regulation of response to stimulus (GO:0048584),1/46,0.1088776222085674,0.1740360447658182,0,0,9.02721088435374,20.01811780873028,GATA3,CD4+ T-Cell,0.9630613723103648
KEGG_2021_Human,regulation of interleukin-2 production (GO:0032663),1/48,0.1133380148369131,0.1791510567716704,0,0,8.642205818497612,18.81737166641443,CD28,CD4+ T-Cell,0.9456243984787533
KEGG_2021_Human,myelination (GO:0042552),1/48,0.1133380148369131,0.1791510567716704,0,0,8.642205818497612,18.81737166641443,MAL,CD4+ T-Cell,0.9456243984787533
KEGG_2021_Human,apoptotic process (GO:0006915),2/231,0.1135686052781033,0.1791510567716704,0,0,3.5882459970887917,7.805684373606142,CD2;MAL,CD4+ T-Cell,0.9447417076995079
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),4/742,0.1138085215723413,0.1791510567716704,0,0,2.2636974195828916,4.919552976765135,CD40LG;CD28;CTLA4;CD3E,CD4+ T-Cell,0.943825218316277
KEGG_2021_Human,positive regulation of actin filament polymerization (GO:0030838),1/49,0.1155599990222406,0.1812190893757864,0,0,8.46173469387755,18.260130793597916,CCR7,CD4+ T-Cell,0.9371924705024297
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),3/482,0.1192389583091006,0.186048202598298,0,0,2.5946342113445566,5.517815916066961,ITK;CD28;CD3E,CD4+ T-Cell,0.92358182668994
KEGG_2021_Human,gonad development (GO:0008406),1/51,0.1199876089220907,0.186048202598298,0,0,8.122448979591837,17.22257115519733,GATA3,CD4+ T-Cell,0.9208636010741894
KEGG_2021_Human,negative regulation of transport (GO:0051051),1/51,0.1199876089220907,0.186048202598298,0,0,8.122448979591837,17.22257115519733,TRAT1,CD4+ T-Cell,0.9208636010741894
KEGG_2021_Human,regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/52,0.1221932608707862,0.1887612313451697,0,0,7.962785114045619,16.738979733033663,LCK,CD4+ T-Cell,0.9129527453809976
KEGG_2021_Human,positive regulation of phagocytosis (GO:0050766),1/53,0.1243934949128716,0.1914457505350515,0,0,7.809262166405024,16.276887238960814,SIRPG,CD4+ T-Cell,0.9052023302345248
KEGG_2021_Human,regulation of humoral immune response (GO:0002920),1/54,0.1265883240687765,0.1941020969054573,0,0,7.661532537543319,15.834970375184442,CCR7,CD4+ T-Cell,0.8976063498190403
KEGG_2021_Human,positive regulation of signal transduction (GO:0009967),2/252,0.1309169770529217,0.1993315933940901,0,0,3.283333333333333,6.675646802845627,GATA3;IL7R,CD4+ T-Cell,0.8830040313535863
KEGG_2021_Human,peptidyl-tyrosine modification (GO:0018212),1/56,0.1309618198144747,0.1993315933940901,0,0,7.382189239332097,15.00687933540933,LCK,CD4+ T-Cell,0.8828552987007785
KEGG_2021_Human,renal system development (GO:0072001),1/57,0.1331405122852093,0.2004369894039151,0,0,7.25,14.618539131965724,GATA3,CD4+ T-Cell,0.8756897763447542
KEGG_2021_Human,positive regulation of interferon-gamma production (GO:0032729),1/57,0.1331405122852093,0.2004369894039151,0,0,7.25,14.618539131965724,CD2,CD4+ T-Cell,0.8756897763447542
KEGG_2021_Human,regulation of mitotic nuclear division (GO:0007088),1/57,0.1331405122852093,0.2004369894039151,0,0,7.25,14.618539131965724,CD28,CD4+ T-Cell,0.8756897763447542
KEGG_2021_Human,eye development (GO:0001654),1/58,0.1353138517398134,0.2008667502036773,0,0,7.122448979591836,14.246025949065045,PBX4,CD4+ T-Cell,0.8686577434892403
KEGG_2021_Human,chordate embryonic development (GO:0043009),1/58,0.1353138517398134,0.2008667502036773,0,0,7.122448979591836,14.246025949065045,GATA3,CD4+ T-Cell,0.8686577434892403
KEGG_2021_Human,regulation of phagocytosis (GO:0050764),1/58,0.1353138517398134,0.2008667502036773,0,0,7.122448979591836,14.246025949065045,SIRPG,CD4+ T-Cell,0.8686577434892403
KEGG_2021_Human,positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.1353667229633477,0.2008667502036773,0,0,2.442871502764282,4.885175568190959,CAMK4;PBX4;GATA3,CD4+ T-Cell,0.8684880846140173
KEGG_2021_Human,positive regulation of apoptotic signaling pathway (GO:2001235),1/59,0.1374818510452552,0.2032767369026273,0,0,6.9992962702322306,13.8884471557023,LCK,CD4+ T-Cell,0.8617546291873563
KEGG_2021_Human,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2089180731864529,0,0,6.76530612244898,13.214837540593155,CD2,CD4+ T-Cell,0.848318009451734
KEGG_2021_Human,central nervous system development (GO:0007417),2/268,0.1445246328363994,0.2121744609725864,0,0,3.0833333333333335,5.964108059214085,MAL;PBX4,CD4+ T-Cell,0.8400581252728833
KEGG_2021_Human,negative regulation of endopeptidase activity (GO:0010951),1/63,0.1461007034145454,0.2122304954863922,0,0,6.54641211323239,12.591756250239603,SPOCK2,CD4+ T-Cell,0.8353476931121088
KEGG_2021_Human,negative regulation of peptidase activity (GO:0010466),1/63,0.1461007034145454,0.2122304954863922,0,0,6.54641211323239,12.591756250239603,SPOCK2,CD4+ T-Cell,0.8353476931121088
KEGG_2021_Human,positive regulation of viral process (GO:0048524),1/63,0.1461007034145454,0.2122304954863922,0,0,6.54641211323239,12.591756250239603,CD28,CD4+ T-Cell,0.8353476931121088
KEGG_2021_Human,regulation of viral genome replication (GO:0045069),1/67,0.1546351363099914,0.2238424700431344,0,0,6.148423005565863,11.477180657220888,CD28,CD4+ T-Cell,0.8106918184915987
KEGG_2021_Human,canonical Wnt signaling pathway (GO:0060070),1/68,0.1567556490806558,0.2261213892661725,0,0,6.0563508985683825,11.222824361971773,GATA3,CD4+ T-Cell,0.8047767993307415
KEGG_2021_Human,synapse assembly (GO:0007416),1/69,0.158870948881139,0.227586757220732,0,0,5.966986794717887,10.977245117600177,SPOCK2,CD4+ T-Cell,0.7989555105590889
KEGG_2021_Human,positive regulation of protein polymerization (GO:0032273),1/69,0.158870948881139,0.227586757220732,0,0,5.966986794717887,10.977245117600177,CCR7,CD4+ T-Cell,0.7989555105590889
KEGG_2021_Human,kidney development (GO:0001822),1/70,0.1609810482853106,0.2290245841584831,0,0,5.880212954747116,10.740024519792764,GATA3,CD4+ T-Cell,0.7932252488723367
KEGG_2021_Human,regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/70,0.1609810482853106,0.2290245841584831,0,0,5.880212954747116,10.740024519792764,CCR7,CD4+ T-Cell,0.7932252488723367
KEGG_2021_Human,regulation of endopeptidase activity (GO:0052548),1/71,0.16308595979881,0.2296516576758754,0,0,5.795918367346939,10.51076961698872,SPOCK2,CD4+ T-Cell,0.7875834261109624
KEGG_2021_Human,regulation of hematopoietic stem cell differentiation (GO:1902036),1/71,0.16308595979881,0.2296516576758754,0,0,5.795918367346939,10.51076961698872,GATA3,CD4+ T-Cell,0.7875834261109624
KEGG_2021_Human,phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.16308595979881,0.2296516576758754,0,0,5.795918367346939,10.51076961698872,GATA3,CD4+ T-Cell,0.7875834261109624
KEGG_2021_Human,negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.1651856959101235,0.2318199257857327,0,0,5.713998275366484,10.28911103101624,GATA3,CD4+ T-Cell,0.78202756268309
KEGG_2021_Human,regulation of actin filament polymerization (GO:0030833),1/73,0.1672802691231711,0.2323960785805128,0,0,5.634353741496598,10.074701240888364,CCR7,CD4+ T-Cell,0.7765552814899175
KEGG_2021_Human,response to molecule of bacterial origin (GO:0002237),1/73,0.1672802691231711,0.2323960785805128,0,0,5.634353741496598,10.074701240888364,CD6,CD4+ T-Cell,0.7765552814899175
KEGG_2021_Human,positive regulation of JNK cascade (GO:0046330),1/73,0.1672802691231711,0.2323960785805128,0,0,5.634353741496598,10.074701240888364,CCR7,CD4+ T-Cell,0.7765552814899175
KEGG_2021_Human,positive regulation of immune response (GO:0050778),1/75,0.1714539764404576,0.2358204194230878,0,0,5.4815223386651954,9.666337985731484,CCR7,CD4+ T-Cell,0.7658524380723842
KEGG_2021_Human,integrin-mediated signaling pathway (GO:0007229),1/75,0.1714539764404576,0.2358204194230878,0,0,5.4815223386651954,9.666337985731484,CD40LG,CD4+ T-Cell,0.7658524380723842
KEGG_2021_Human,regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/75,0.1714539764404576,0.2358204194230878,0,0,5.4815223386651954,9.666337985731484,GATA3,CD4+ T-Cell,0.7658524380723842
KEGG_2021_Human,regulation of epithelial to mesenchymal transition (GO:0010717),1/76,0.1735331353639065,0.2378897948366136,0,0,5.408163265306122,9.4717853003048,GATA3,CD4+ T-Cell,0.7606175863963804
KEGG_2021_Human,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.1756071809118701,0.2399385244142383,0,0,5.336734693877551,9.283280446293812,CD2,CD4+ T-Cell,0.7554577289388229
KEGG_2021_Human,negative regulation of cell cycle (GO:0045786),1/80,0.181798760490535,0.2463266176591115,0,0,5.133298889175924,8.751529842637671,GATA3,CD4+ T-Cell,0.7404090821369118
KEGG_2021_Human,regulation of fat cell differentiation (GO:0045598),1/80,0.181798760490535,0.2463266176591115,0,0,5.133298889175924,8.751529842637671,GATA3,CD4+ T-Cell,0.7404090821369118
KEGG_2021_Human,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),1/81,0.1838524754991919,0.2463266176591115,0,0,5.0688775510204085,8.584760541358477,LCK,CD4+ T-Cell,0.7355305181562768
KEGG_2021_Human,positive regulation of cellular amide metabolic process (GO:0034250),1/81,0.1838524754991919,0.2463266176591115,0,0,5.0688775510204085,8.584760541358477,CD28,CD4+ T-Cell,0.7355305181562768
KEGG_2021_Human,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2463266176591115,0,0,5.0688775510204085,8.584760541358477,CD2,CD4+ T-Cell,0.7355305181562768
KEGG_2021_Human,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.1838524754991919,0.2463266176591115,0,0,5.0688775510204085,8.584760541358477,CD2,CD4+ T-Cell,0.7355305181562768
KEGG_2021_Human,positive regulation of cytoskeleton organization (GO:0051495),1/82,0.1859011384602527,0.2482679720082084,0,0,5.00604686318972,8.422875391899517,CCR7,CD4+ T-Cell,0.7307179505966239
KEGG_2021_Human,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1/83,0.1879447615357932,0.2493882412686487,0,0,4.944748631159781,8.265677319811374,CCR7,CD4+ T-Cell,0.7259697745939766
KEGG_2021_Human,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.2493882412686487,0,0,4.944748631159781,8.265677319811374,CCR7,CD4+ T-Cell,0.7259697745939766
KEGG_2021_Human,negative regulation of defense response (GO:0031348),1/85,0.1920169366451308,0.2527739685383389,0,0,4.826530612244898,7.964604221414354,GATA3,CD4+ T-Cell,0.716660463134361
KEGG_2021_Human,B cell activation (GO:0042113),1/85,0.1920169366451308,0.2527739685383389,0,0,4.826530612244898,7.964604221414354,CD40LG,CD4+ T-Cell,0.716660463134361
KEGG_2021_Human,negative regulation of gene expression (GO:0010629),2/322,0.1923280195400404,0.2527739685383389,0,0,2.5559895833333335,4.213684115542283,CD28;CD3E,CD4+ T-Cell,0.7159574404356035
KEGG_2021_Human,positive regulation of endothelial cell migration (GO:0010595),1/86,0.1940455128548384,0.2542241845629846,0,0,4.769507803121249,7.820383303288144,GATA3,CD4+ T-Cell,0.7120963955156414
KEGG_2021_Human,regulation of endothelial cell migration (GO:0010594),1/89,0.2001013407742902,0.2613310885821961,0,0,4.6062152133580705,7.411084001248333,GATA3,CD4+ T-Cell,0.6987500013741589
KEGG_2021_Human,regulation of stem cell differentiation (GO:2000736),1/91,0.2041137620931186,0.2640721797079722,0,0,4.503401360544218,7.156255051106618,GATA3,CD4+ T-Cell,0.6901277125812961
KEGG_2021_Human,positive regulation of supramolecular fiber organization (GO:1902905),1/91,0.2041137620931186,0.2640721797079722,0,0,4.503401360544218,7.156255051106618,CCR7,CD4+ T-Cell,0.6901277125812961
KEGG_2021_Human,positive regulation of transport (GO:0051050),1/91,0.2041137620931186,0.2640721797079722,0,0,4.503401360544218,7.156255051106618,SIRPG,CD4+ T-Cell,0.6901277125812961
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),3/625,0.2050267003954304,0.2644269593884991,0,0,1.9834439351440103,3.142995135240803,SIRPG;CCR7;IL7R,CD4+ T-Cell,0.6881895775817527
KEGG_2021_Human,positive regulation of epithelial cell migration (GO:0010634),1/94,0.2100954368002021,0.2692864112547481,0,0,4.357472021066491,6.79849904676328,GATA3,CD4+ T-Cell,0.6775833802166729
KEGG_2021_Human,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2692864112547481,0,0,4.357472021066491,6.79849904676328,LCK,CD4+ T-Cell,0.6775833802166729
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),2/345,0.2133084926466024,0.2725608517151031,0,0,2.381802721088435,3.6799229289674416,ITK;CD28,CD4+ T-Cell,0.6709918532419347
KEGG_2021_Human,cellular transition metal ion homeostasis (GO:0046916),1/96,0.2140587201245348,0.2726778773278689,0,0,4.26530612244898,6.5749903239841245,LCK,CD4+ T-Cell,0.6694670755856718
KEGG_2021_Human,positive regulation of stress-activated MAPK cascade (GO:0032874),1/99,0.2199671313012003,0.2793447618364936,0,0,4.134110787172012,6.26018948804807,CCR7,CD4+ T-Cell,0.6576422090003602
KEGG_2021_Human,cell-matrix adhesion (GO:0007160),1/100,0.2219269115603851,0.2801150652012178,0,0,4.092145949288806,6.1603458876211565,CD96,CD4+ T-Cell,0.6537900306498672
KEGG_2021_Human,positive regulation of translation (GO:0045727),1/100,0.2219269115603851,0.2801150652012178,0,0,4.092145949288806,6.1603458876211565,CD28,CD4+ T-Cell,0.6537900306498672
KEGG_2021_Human,epithelial cell differentiation (GO:0030855),1/101,0.2238818662412048,0.280869977648057,0,0,4.051020408163265,6.062906014187368,GATA3,CD4+ T-Cell,0.6499810815451941
KEGG_2021_Human,positive regulation of cell cycle process (GO:0090068),1/101,0.2238818662412048,0.280869977648057,0,0,4.051020408163265,6.062906014187368,CD28,CD4+ T-Cell,0.6499810815451941
KEGG_2021_Human,positive regulation of cellular protein metabolic process (GO:0032270),1/102,0.2258320069783284,0.2816097918344215,0,0,4.010709234188725,5.967790506031058,CD28,CD4+ T-Cell,0.6462145058611213
KEGG_2021_Human,cell junction assembly (GO:0034329),1/102,0.2258320069783284,0.2816097918344215,0,0,4.010709234188725,5.967790506031058,SPOCK2,CD4+ T-Cell,0.6462145058611213
KEGG_2021_Human,activation of GTPase activity (GO:0090630),1/105,0.2316536615468536,0.2862824354638729,0,0,3.894427001569859,5.6956456810845415,CCR7,CD4+ T-Cell,0.6351608308934773
KEGG_2021_Human,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.2862824354638729,0,0,3.894427001569859,5.6956456810845415,GATA3,CD4+ T-Cell,0.6351608308934773
KEGG_2021_Human,regulation of JNK cascade (GO:0046328),1/105,0.2316536615468536,0.2862824354638729,0,0,3.894427001569859,5.6956456810845415,CCR7,CD4+ T-Cell,0.6351608308934773
KEGG_2021_Human,small GTPase mediated signal transduction (GO:0007264),1/106,0.2335846623503299,0.2878096732530851,0,0,3.857142857142857,5.6090983677319475,GRAP2,CD4+ T-Cell,0.6315556772929499
KEGG_2021_Human,response to tumor necrosis factor (GO:0034612),1/110,0.241261218690496,0.2955093033664656,0,0,3.714847406852649,5.282048795926194,GATA3,CD4+ T-Cell,0.6175124827423236
KEGG_2021_Human,regulation of protein kinase activity (GO:0045859),1/110,0.241261218690496,0.2955093033664656,0,0,3.714847406852649,5.282048795926194,CCR7,CD4+ T-Cell,0.6175124827423236
KEGG_2021_Human,cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.2431685532271013,0.2969669057109733,0,0,3.6808905380333954,5.20478084558139,LCK,CD4+ T-Cell,0.6140925891155178
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),2/379,0.24470533557908,0.2979647321462915,0,0,2.163240495137047,3.045194735705852,SIRPG;GATA3,CD4+ T-Cell,0.6113565611455968
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),2/381,0.2465612635256485,0.2992156584053899,0,0,2.15160510114336,3.012558657024939,CD40LG;CD28,CD4+ T-Cell,0.6080751530383309
KEGG_2021_Human,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.2992156584053899,0,0,3.582625970742279,4.982913653406146,GATA3,CD4+ T-Cell,0.6040407011916724
KEGG_2021_Human,response to lipid (GO:0033993),1/114,0.2488624078588274,0.2992156584053899,0,0,3.582625970742279,4.982913653406146,CD6,CD4+ T-Cell,0.6040407011916724
KEGG_2021_Human,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.2992156584053899,0,0,3.582625970742279,4.982913653406146,CCR7,CD4+ T-Cell,0.6040407011916724
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),2/384,0.2493463820044915,0.2992156584053899,0,0,2.1343804537521813,2.9644671728961822,CD28;CD3E,CD4+ T-Cell,0.6031969289771376
KEGG_2021_Human,tumor necrosis factor-mediated signaling pathway (GO:0033209),1/116,0.2526349665899778,0.3020268277573369,0,0,3.5199645075421473,4.8428011439058265,CD40LG,CD4+ T-Cell,0.5975065399797567
KEGG_2021_Human,cellular protein modification process (GO:0006464),4/1025,0.2531480899318741,0.3020268277573369,0,0,1.6121449559255632,2.2147335064279132,LCK;CAMK4;CD3G;CD247,CD4+ T-Cell,0.596625345129507
KEGG_2021_Human,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.3050144462682005,0,0,3.4594453165881736,4.708511372057024,GATA3,CD4+ T-Cell,0.5911006880374128
KEGG_2021_Human,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),1/119,0.2582590130323782,0.3063588292131937,0,0,3.429955032860602,4.6434466139665425,LCK,CD4+ T-Cell,0.5879445130148351
KEGG_2021_Human,cellular response to lipopolysaccharide (GO:0071222),1/120,0.2601244621662815,0.3076900781052587,0,0,3.4009603841536613,4.579716458908873,CD6,CD4+ T-Cell,0.5848188047272944
KEGG_2021_Human,phosphorylation (GO:0016310),2/400,0.2642184505833435,0.3116422750470205,0,0,2.046901172529313,2.7243825855585304,LCK;CAMK4,CD4+ T-Cell,0.5780368585354551
KEGG_2021_Human,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.3124915121592981,0,0,3.316828370692539,4.396166676729281,CCR7,CD4+ T-Cell,0.5756194520344882
KEGG_2021_Human,regulation of tumor necrosis factor production (GO:0032680),1/124,0.2675403902734135,0.3137725823603206,0,0,3.2896963663514187,4.337414433160371,CD2,CD4+ T-Cell,0.5726106437410472
KEGG_2021_Human,synapse organization (GO:0050808),1/126,0.2712209880572274,0.3171906470499778,0,0,3.236734693877551,4.223360488574632,SPOCK2,CD4+ T-Cell,0.5666767062328689
KEGG_2021_Human,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.3226960016333826,0,0,3.1603954081632653,4.060453122404681,CD28,CD4+ T-Cell,0.5579784037567757
KEGG_2021_Human,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3302241972055919,0,0,3.0640074211502784,3.857336278341556,CCR7,CD4+ T-Cell,0.546741450090894
KEGG_2021_Human,organic substance transport (GO:0071702),1/136,0.289353816496661,0.335553165349069,0,0,2.99546485260771,3.714691124222948,CD3G,CD4+ T-Cell,0.5385707850387818
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),3/764,0.2984210193557987,0.3451014022717895,0,0,1.6095003774428942,1.9462882878583572,SIRPG;GATA3;IL7R,CD4+ T-Cell,0.5251705904864272
KEGG_2021_Human,Ras protein signal transduction (GO:0007265),1/142,0.3000204969826995,0.345984639974478,0,0,2.8671298306556667,3.4517504575709377,GRAP2,CD4+ T-Cell,0.522849073872343
KEGG_2021_Human,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3470503999389918,0,0,2.8467950560505892,3.410594866305226,CD3G,CD4+ T-Cell,0.5203052911363482
KEGG_2021_Human,nervous system development (GO:0007399),2/447,0.3078904676985005,0.3530932233439867,0,0,1.826310861423221,2.1514146195112085,SPOCK2;MAL,CD4+ T-Cell,0.5116037566636256
KEGG_2021_Human,brain development (GO:0007420),1/150,0.3139989845586295,0.3581145443726518,0,0,2.712094233666621,3.141596466170354,PBX4,CD4+ T-Cell,0.5030717563895143
KEGG_2021_Human,response to cytokine (GO:0034097),1/150,0.3139989845586295,0.3581145443726518,0,0,2.712094233666621,3.141596466170354,CCR7,CD4+ T-Cell,0.5030717563895143
KEGG_2021_Human,positive regulation of protein kinase activity (GO:0045860),1/154,0.3208852696222714,0.3649629165484076,0,0,2.640656262505002,3.0015590720273457,CCR7,CD4+ T-Cell,0.493650218923809
KEGG_2021_Human,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/155,0.3225962281219006,0.3658349489316645,0,0,2.6233766233766236,2.9679671260643183,CD40LG,CD4+ T-Cell,0.4913407148001928
KEGG_2021_Human,negative regulation of nucleic acid-templated transcription (GO:1903507),2/464,0.3236043277850015,0.3658349489316645,0,0,1.7575757575757576,1.982956235178162,SCML4;GATA3,CD4+ T-Cell,0.48998567889976286
KEGG_2021_Human,peptidyl-serine phosphorylation (GO:0018105),1/156,0.3243029619756543,0.3658349489316645,0,0,2.6063199473337724,2.934917292064671,CAMK4,CD4+ T-Cell,0.4890490847411261
KEGG_2021_Human,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.3705726579783435,0,0,2.556445362955309,2.8389038953772054,CD6,CD4+ T-Cell,0.4822791499015975
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),2/474,0.3328115296392732,0.3733983015465017,0,0,1.7194562146892656,1.8917094920733264,SIRPG;IL7R,CD4+ T-Cell,0.47780163679243126
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",4/1183,0.3428517320675613,0.382645612101066,0,0,1.384445181989158,1.481989303783668,BCL11B;CAMK4;PBX4;GATA3,CD4+ T-Cell,0.4648936521619021
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),2/485,0.3429022272693128,0.382645612101066,0,0,1.6793478260869563,1.797422644350721,CD40LG;CD28,CD4+ T-Cell,0.46482969398207885
KEGG_2021_Human,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3833483595300099,0,0,2.4175730172308443,2.5766088705447237,CD3E,CD4+ T-Cell,0.46286379212748074
KEGG_2021_Human,peptidyl-serine modification (GO:0018209),1/169,0.3461106816465725,0.3841550193074559,0,0,2.403061224489796,2.5496399471999527,CAMK4,CD4+ T-Cell,0.4607849973294511
KEGG_2021_Human,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.3477593333218013,0.3847160085874086,0,0,2.388721168940949,2.523073857975914,CD6,CD4+ T-Cell,0.45872120538836164
KEGG_2021_Human,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.3494039111808349,0.3847160085874086,0,0,2.3745498199279713,2.4969025061029213,CCR7,CD4+ T-Cell,0.4566722378913039
KEGG_2021_Human,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.3847160085874086,0,0,2.3745498199279713,2.4969025061029213,BICDL1,CD4+ T-Cell,0.4566722378913039
KEGG_2021_Human,positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.3510444250368044,0.3854970609157481,0,0,2.360544217687075,2.4711180018684864,CCR7,CD4+ T-Cell,0.45463791963821665
KEGG_2021_Human,protein phosphorylation (GO:0006468),2/496,0.3529487892748932,0.3865629596820259,0,0,1.641025641025641,1.709017116633574,LCK;CAMK4,CD4+ T-Cell,0.4522883035321021
KEGG_2021_Human,neuron differentiation (GO:0030182),1/174,0.3543133002736421,0.38703352589258,0,0,2.333018756635602,2.4206789693623425,PBX4,CD4+ T-Cell,0.45061254473982715
KEGG_2021_Human,regulation of translation (GO:0006417),1/178,0.3608027143922477,0.3930850625220804,0,0,2.279833967485299,2.3241173885161555,CD28,CD4+ T-Cell,0.44273020383203454
KEGG_2021_Human,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.395552995753582,0,0,2.2541329380914377,2.2778849681371156,CD28,CD4+ T-Cell,0.4388706874182523
KEGG_2021_Human,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.3979907703887134,0,0,2.2289998872477166,2.2329492942532405,CCR7,CD4+ T-Cell,0.4350639775318079
KEGG_2021_Human,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.4123299282345967,0,0,2.122448979591837,2.045536603225051,GATA3,CD4+ T-Cell,0.41855670871419515
KEGG_2021_Human,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4162934030854741,0,0,2.089140319340171,1.988001678572607,CD3E,CD4+ T-Cell,0.4132695879859197
KEGG_2021_Human,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/547,0.3988146050031916,0.4288551856397957,0,0,1.4835626911314983,1.3637777909312412,SCML4;GATA3,CD4+ T-Cell,0.3992289457561903
KEGG_2021_Human,regulation of inflammatory response (GO:0050727),1/206,0.4044727291727134,0.4338127198899051,0,0,1.9656545545047288,1.7792534267442264,GATA3,CD4+ T-Cell,0.39311075456855427
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),2/566,0.4155454754335446,0.4431645831370395,0,0,1.43218085106383,1.2576885523498746,SIRPG;GATA3,CD4+ T-Cell,0.38138144203835345
KEGG_2021_Human,positive regulation of GTPase activity (GO:0043547),1/214,0.416403436812339,0.4431645831370395,0,0,1.8910606496119575,1.656759537391559,CCR7,CD4+ T-Cell,0.3804856946694876
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4431645831370395,0,0,1.8910606496119575,1.656759537391559,GATA3,CD4+ T-Cell,0.3804856946694876
KEGG_2021_Human,extracellular structure organization (GO:0043062),1/216,0.41934932166703,0.4451554337696165,0,0,1.8732795443758896,1.627975467192003,SPOCK2,CD4+ T-Cell,0.3774240551539837
KEGG_2021_Human,external encapsulating structure organization (GO:0045229),1/217,0.4208167942393084,0.445570723312209,0,0,1.8645124716553287,1.613843141672166,SPOCK2,CD4+ T-Cell,0.375906936392536
KEGG_2021_Human,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.4551759140612826,0,0,1.805344559348403,1.519514184420898,CCR7,CD4+ T-Cell,0.36553500108915365
KEGG_2021_Human,regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.4508075224789805,0.4748964740618268,0,0,1.697494187548437,1.352418759111272,CCR7,CD4+ T-Cell,0.34600884563424106
KEGG_2021_Human,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.4823973064750437,0,0,1.655076845553036,1.2884811006593149,CAMK4,CD4+ T-Cell,0.33809924509335265
KEGG_2021_Human,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.4618276248188864,0.484042118164605,0,0,1.641399416909621,1.2680853834334544,CD40LG,CD4+ T-Cell,0.33552009275365935
KEGG_2021_Human,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5107056704188486,0,0,1.510204081632653,1.0781219104526054,GATA3,CD4+ T-Cell,0.3100391544580995
KEGG_2021_Human,protein deubiquitination (GO:0016579),1/267,0.4897346646287026,0.5107056704188486,0,0,1.510204081632653,1.0781219104526054,GATA3,CD4+ T-Cell,0.3100391544580995
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5187669228069358,0,0,1.4709576138147566,1.0233666205889618,CCR7,CD4+ T-Cell,0.30214499188263844
KEGG_2021_Human,protein modification by small protein removal (GO:0070646),1/276,0.50125602230015,0.5201002336648173,0,0,1.4601113172541744,1.0084087773272885,GATA3,CD4+ T-Cell,0.29994039654430615
KEGG_2021_Human,regulation of gene expression (GO:0010468),3/1079,0.5107084384516999,0.5285832337975094,0,0,1.1196314165941628,0.7523435208329574,CD28;GATA3;CD3E,CD4+ T-Cell,0.2918269662236996
KEGG_2021_Human,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.5304141495300194,0,0,1.4081632653061225,0.937839142501346,CTLA4,CD4+ T-Cell,0.289240867544339
KEGG_2021_Human,regulation of cell cycle (GO:0051726),1/296,0.5259539383992272,0.5416540559633833,0,0,1.359737115185057,0.8736877155004001,GATA3,CD4+ T-Cell,0.2790522884983112
KEGG_2021_Human,extracellular matrix organization (GO:0030198),1/300,0.5307476794848257,0.5452345888504164,0,0,1.341273633199099,0.8496546643160489,SPOCK2,CD4+ T-Cell,0.2751118959639202
KEGG_2021_Human,innate immune response (GO:0045087),1/302,0.5331267023920349,0.5463229078967882,0,0,1.3322259136212624,0.8379649939237771,LCK,CD4+ T-Cell,0.2731695646873957
KEGG_2021_Human,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5498015496784039,0,0,1.314486450317832,0.8152139890333826,CAMK4,CD4+ T-Cell,0.2693393582885023
KEGG_2021_Human,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5532153067137308,0,0,1.2972062611452349,0.7932686422257892,CTLA4,CD4+ T-Cell,0.2655801196036423
KEGG_2021_Human,cellular response to DNA damage stimulus (GO:0006974),1/350,0.5868058377702841,0.596898321466579,0,0,1.1461902812701013,0.6109896633619631,CTLA4,CD4+ T-Cell,0.23150557427863594
KEGG_2021_Human,protein transport (GO:0015031),1/369,0.6063398885560332,0.6152566516230337,0,0,1.0859582963620231,0.5433207667028247,CD3G,CD4+ T-Cell,0.21728386041430361
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.615779629694789,0,0,1.0799779371207945,0.5367673309131087,CCR7,CD4+ T-Cell,0.21585171499242045
KEGG_2021_Human,positive regulation of transcription by RNA polymerase II (GO:0045944),2/908,0.6694431207036386,0.6759742731007473,0,0,0.8758278145695364,0.3514776504163603,BCL11B;GATA3,CD4+ T-Cell,0.17428631695508484
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",5/2244,0.6741952652975136,0.6791163986208532,0,0,0.8789141978065604,0.3464991772661544,BCL11B;SCML4;CAMK4;PBX4;GATA3,CD4+ T-Cell,0.1712143017444203
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",2/948,0.6926945411260426,0.6960571359858777,0,0,0.8370331219168429,0.3073302326128318,SCML4;GATA3,CD4+ T-Cell,0.15945823486666727
KEGG_2021_Human,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8268434710046262,0,0,0.5757014372366809,0.1108560647358729,GATA3,CD4+ T-Cell,0.0836269880293983
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),3/2206,0.924809545507298,0.924809545507298,0,0,0.5142021035145498,0.0401938720592393,BCL11B;PBX4;GATA3,CD4+ T-Cell,0.03394769628973127
GO_Biological_Process_2021,regulation of immune response (GO:0050776),12/179,1.6438886820645417e-14,8.745487788583362e-12,0,0,37.40876142451938,1187.3214192616936,CD8B;CD160;CD8A;CRTAM;SH2D1A;KLRF1;CD3G;CD247;PDCD1;KLRC1;SLA2;CD3D,CD8+ T-Cell,13.784127594583031
GO_Biological_Process_2021,lymphocyte migration (GO:0072676),6/40,6.438650987564527e-10,1.7126811626921644e-07,0,0,79.87700534759358,1690.479549611828,CCL5;TBX21;CCL4;CRTAM;XCL2;XCL1,CD8+ T-Cell,9.191205115563703
GO_Biological_Process_2021,positive regulation of lymphocyte chemotaxis (GO:0140131),4/18,1.0303520171829828e-07,1.827157577137823e-05,0,0,123.82608695652172,1992.1382507319795,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,6.987014374322259
GO_Biological_Process_2021,positive regulation of natural killer cell chemotaxis (GO:2000503),3/5,1.4648687711442908e-07,1.9482754656219067e-05,0,0,636.6382978723404,10018.350338643862,CCL5;CCL4;XCL1,CD8+ T-Cell,6.834201279419503
GO_Biological_Process_2021,regulation of natural killer cell chemotaxis (GO:2000501),3/7,5.109076037011196e-07,5.4360569033799126e-05,0,0,318.28723404255317,4611.051692443593,CCL5;CCL4;XCL1,CD8+ T-Cell,6.291657633781106
GO_Biological_Process_2021,T cell activation (GO:0042110),5/92,3.320217744689286e-06,0.0002740707553403477,0,0,25.367816091954023,320.02718140805626,CD8B;CD8A;CRTAM;CD3G;SLA2,CD8+ T-Cell,5.478833433700757
GO_Biological_Process_2021,monocyte chemotaxis (GO:0002548),4/42,3.606194149215101e-06,0.0002740707553403477,0,0,45.56521739130435,571.0623808062053,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,5.442950895566195
GO_Biological_Process_2021,lymphocyte chemotaxis (GO:0048247),4/44,4.357614639431624e-06,0.000289781373522203,0,0,43.28260869565217,534.2625919775811,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,5.360751178717646
GO_Biological_Process_2021,positive regulation of T cell chemotaxis (GO:0010820),3/14,5.248409745304486e-06,0.0003029227853841167,0,0,115.70019342359768,1406.6349861507,CCL5;XCL2;XCL1,CD8+ T-Cell,5.279972266776789
GO_Biological_Process_2021,regulation of T cell activation (GO:0050863),4/47,5.694037319250313e-06,0.0003029227853841167,0,0,40.25682507583418,486.145083590463,CCL5;TBX21;CRTAM;TIGIT,CD8+ T-Cell,5.244579690773299
GO_Biological_Process_2021,regulation of T cell chemotaxis (GO:0010819),3/15,6.548973936635469e-06,0.00031673219402636997,0,0,106.05319148936172,1265.8723345480742,CCL5;XCL2;XCL1,CD8+ T-Cell,5.183826737956894
GO_Biological_Process_2021,chemokine-mediated signaling pathway (GO:0070098),4/56,1.153281738315398e-05,0.0005112882373198264,0,0,33.274247491638796,378.3386388039555,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,4.938064584770356
GO_Biological_Process_2021,cellular response to interferon-gamma (GO:0071346),5/121,1.2711496424379855e-05,0.0005201935459823141,0,0,18.99808429118774,214.16547533782855,IFNG;CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,4.895803320366833
GO_Biological_Process_2021,negative regulation of T cell receptor signaling pathway (GO:0050860),3/19,1.3849289100030806e-05,0.0005262729858011707,0,0,79.52393617021276,889.6562746439253,CD160;SH2D1A;SLA2,CD8+ T-Cell,4.858572518863624
GO_Biological_Process_2021,cellular response to chemokine (GO:1990869),4/60,1.5199477972841366e-05,0.0005390748187701071,0,0,30.89130434782609,342.71583703038743,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,4.818171327674149
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),9/621,2.03244853600119e-05,0.0006757891382203957,0,0,6.936154949784792,74.93602780198945,IFNG;CCL5;TNFRSF9;IL2RB;CCL4;XCL2;XCL1;FASLG;SLA2,CD8+ T-Cell,4.691980442444186
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),8/482,2.3693149490305143e-05,0.0007414562075789609,0,0,7.826401446654611,83.35371587750917,PYHIN1;CCL5;IL2RB;CCL4;XCL2;XCL1;FASLG;SLA2,CD8+ T-Cell,4.6253772054086735
GO_Biological_Process_2021,neutrophil chemotaxis (GO:0030593),4/70,2.805910287912977e-05,0.0008293023739831687,0,0,26.197628458498023,274.5825167346738,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,4.551926218584636
GO_Biological_Process_2021,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),3/25,3.252704029670916e-05,0.0008391770861001156,0,0,57.81818181818182,597.4606436592223,CD160;SH2D1A;SLA2,CD8+ T-Cell,4.487755452281791
GO_Biological_Process_2021,positive regulation of T cell migration (GO:2000406),3/25,3.252704029670916e-05,0.0008391770861001156,0,0,57.81818181818182,597.4606436592223,CCL5;XCL2;XCL1,CD8+ T-Cell,4.487755452281791
GO_Biological_Process_2021,granulocyte chemotaxis (GO:0071621),4/73,3.312541129342562e-05,0.0008391770861001156,0,0,25.054820415879018,258.4457305274999,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,4.479838720712305
GO_Biological_Process_2021,neutrophil migration (GO:1990266),4/77,4.088424652163623e-05,0.00098865541588684,0,0,23.677188802858844,239.25244622831585,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,4.3884440016910355
GO_Biological_Process_2021,response to interferon-gamma (GO:0034341),4/80,4.751910548580115e-05,0.0010991375703672,0,0,22.73913043478261,226.3539158165837,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,4.323131743242287
GO_Biological_Process_2021,regulation of natural killer cell mediated cytotoxicity (GO:0042269),3/30,5.691425903052129e-05,0.0012615994085098,0,0,47.09929078014184,460.3468031322656,CD160;CRTAM;KLRC1,CD8+ T-Cell,4.244778913877808
GO_Biological_Process_2021,positive thymic T cell selection (GO:0045059),2/5,6.0956786529959696e-05,0.0012912012367353,0,0,277.0416666666667,2688.78505476905,CD3G;CD3D,CD8+ T-Cell,4.214977935846465
GO_Biological_Process_2021,response to interleukin-1 (GO:0070555),4/86,6.310381984044947e-05,0.0012912012367353,0,0,21.068928950159066,203.75190754771063,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,4.19994435097111
GO_Biological_Process_2021,regulation of T cell receptor signaling pathway (GO:0050856),3/35,9.094610315590577e-05,0.0017344961397651,0,0,39.73005319148936,369.69781921167737,CD160;SH2D1A;SLA2,CD8+ T-Cell,4.041215904782398
GO_Biological_Process_2021,positive regulation of killing of cells of other organism (GO:0051712),2/6,9.128927051395768e-05,0.0017344961397651,0,0,207.77083333333337,1932.5756890799971,IFNG;PRF1,CD8+ T-Cell,4.039580263324499
GO_Biological_Process_2021,antigen receptor-mediated signaling pathway (GO:0050851),5/185,9.69922998181679e-05,0.0017793070173539,0,0,12.203703703703704,112.7729488619948,THEMIS;CD3G;CD247;SLA2;CD3D,CD8+ T-Cell,4.013262742839127
GO_Biological_Process_2021,cellular response to tumor necrosis factor (GO:0071356),5/194,0.00012124827565673686,0.0021213661392911,0,0,11.617283950617283,104.76083586304996,CCL5;TNFRSF9;CCL4;XCL2;XCL1,CD8+ T-Cell,3.916324429039836
GO_Biological_Process_2021,regulation of T cell differentiation (GO:0045580),3/39,0.00012610069935787855,0.0021213661392911,0,0,35.308510638297875,317.0149830122188,IFNG;TBX21;CRTAM,CD8+ T-Cell,3.899282504811333
GO_Biological_Process_2021,positive regulation of lymphocyte apoptotic process (GO:0070230),2/7,0.00012760097078443218,0.0021213661392911,0,0,166.20833333333334,1490.3240703269437,CCL5;PDCD1,CD8+ T-Cell,3.8941460215026447
GO_Biological_Process_2021,response to tumor necrosis factor (GO:0034612),4/110,0.00016416405485274464,0.0026457394877611,0,0,16.278917145200985,141.86497243916284,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,3.7847219293605328
GO_Biological_Process_2021,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),3/43,0.0001690886138794749,0.0026457394877611,0,0,31.77127659574468,275.93632160450045,CD160;CRTAM;XCL1,CD8+ T-Cell,3.771885636020247
GO_Biological_Process_2021,negative regulation of T cell cytokine production (GO:0002725),2/9,0.00021804660985203623,0.0033143084697509,0,0,118.70833333333331,1000.8064198202924,TBX21;XCL1,CD8+ T-Cell,3.6614506612675517
GO_Biological_Process_2021,inflammatory response (GO:0006954),5/230,0.00026766899909689315,0.0038231122408421,0,0,9.74074074074074,80.12498989411526,IFNG;CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,3.5724019250431107
GO_Biological_Process_2021,positive regulation of T cell apoptotic process (GO:0070234),2/10,0.00027212309342677823,0.0038231122408421,0,0,103.86458333333331,852.6509585567859,CCL5;PDCD1,CD8+ T-Cell,3.5652346007331377
GO_Biological_Process_2021,apoptotic process (GO:0006915),5/231,0.0002730794457744397,0.0038231122408421,0,0,9.697148475909538,79.57235472351466,IFNG;GZMA;PRF1;FASLG;GZMH,CD8+ T-Cell,3.5637109872373327
GO_Biological_Process_2021,regulation of T cell apoptotic process (GO:0070232),2/11,0.000332063883264561,0.0044164496474186,0,0,92.31944444444444,739.4956618223716,CCL5;PDCD1,CD8+ T-Cell,3.478778357620151
GO_Biological_Process_2021,regulation of T-helper 2 cell cytokine production (GO:2000551),2/11,0.000332063883264561,0.0044164496474186,0,0,92.31944444444444,739.4956618223716,TBX21;XCL1,CD8+ T-Cell,3.478778357620151
GO_Biological_Process_2021,lymphocyte mediated immunity (GO:0002449),2/13,0.00046942457388711873,0.0059460446025701,0,0,75.52651515151516,578.8354329773197,CD8A;SLA2,CD8+ T-Cell,3.3284341792789096
GO_Biological_Process_2021,negative regulation by host of viral transcription (GO:0043922),2/13,0.00046942457388711873,0.0059460446025701,0,0,75.52651515151516,578.8354329773197,CCL5;CCL4,CD8+ T-Cell,3.3284341792789096
GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),4/149,0.0005220612351235411,0.0064589901647842,0,0,11.877061469265367,89.76357233019593,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,3.2822785534795065
GO_Biological_Process_2021,negative regulation of T cell mediated immunity (GO:0002710),2/14,0.0005467878206419364,0.0066111618313979,0,0,69.22916666666667,520.0114050756229,XCL1;KLRC1,CD8+ T-Cell,3.2621811676355046
GO_Biological_Process_2021,cellular response to interleukin-1 (GO:0071347),4/155,0.000605645352340058,0.0071299552940859,0,0,11.401670025914196,84.47743564487912,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,3.217781611160633
GO_Biological_Process_2021,positive regulation of cell killing (GO:0031343),2/15,0.0006299020654549659,0.0071299552940859,0,0,63.90064102564103,470.9442866528224,IFNG;PRF1,CD8+ T-Cell,3.200726967591985
GO_Biological_Process_2021,regulation of lymphocyte activation (GO:0051249),2/15,0.0006299020654549659,0.0071299552940859,0,0,63.90064102564103,470.9442866528224,CCL5;CRTAM,CD8+ T-Cell,3.200726967591985
GO_Biological_Process_2021,T cell receptor signaling pathway (GO:0050852),4/158,0.0006508160707344692,0.0072132114506403,0,0,11.17786561264822,82.01516880317187,THEMIS;CD3G;CD247;CD3D,CD8+ T-Cell,3.18654173148022
GO_Biological_Process_2021,positive regulation of endothelial cell apoptotic process (GO:2000353),2/16,0.0007187392304892979,0.0073532552042366,0,0,59.333333333333336,429.45537567816734,CD160;FASLG,CD8+ T-Cell,3.14342864967499
GO_Biological_Process_2021,T cell mediated immunity (GO:0002456),2/16,0.0007187392304892979,0.0073532552042366,0,0,59.333333333333336,429.45537567816734,CD8A;CRTAM,CD8+ T-Cell,3.14342864967499
GO_Biological_Process_2021,eosinophil chemotaxis (GO:0048245),2/16,0.0007187392304892979,0.0073532552042366,0,0,59.333333333333336,429.45537567816734,CCL5;CCL4,CD8+ T-Cell,3.14342864967499
GO_Biological_Process_2021,eosinophil migration (GO:0072677),2/16,0.0007187392304892979,0.0073532552042366,0,0,59.333333333333336,429.45537567816734,CCL5;CCL4,CD8+ T-Cell,3.14342864967499
GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),4/172,0.000893667581933279,0.0089703991243114,0,0,10.23913043478261,71.88050474501917,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,3.0488239959456203
GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),4/182,0.0011021628390365,0.010553750722651,0,0,9.659013190034196,65.78252399693514,IFNG;TBX21;XCL1;TIGIT,CD8+ T-Cell,2.957754235910311
GO_Biological_Process_2021,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),2/20,0.0011307590059983,0.010553750722651,0,0,46.138888888888886,313.0461870363529,CD8A;SLA2,CD8+ T-Cell,2.9466299446036754
GO_Biological_Process_2021,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),2/20,0.0011307590059983,0.010553750722651,0,0,46.138888888888886,313.0461870363529,CD160;CRTAM,CD8+ T-Cell,2.9466299446036754
GO_Biological_Process_2021,regulation of lymphocyte differentiation (GO:0045619),2/20,0.0011307590059983,0.010553750722651,0,0,46.138888888888886,313.0461870363529,TBX21;CRTAM,CD8+ T-Cell,2.9466299446036754
GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),4/189,0.0012670233065111,0.0116216620528267,0,0,9.290246768507638,61.97602570367333,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,2.897215396327239
GO_Biological_Process_2021,negative regulation of interleukin-2 production (GO:0032703),2/22,0.001370383663162,0.0123566798102065,0,0,41.520833333333336,273.7329252658829,TBX21;XCL1,CD8+ T-Cell,2.8631578273928713
GO_Biological_Process_2021,positive regulation of epithelial cell apoptotic process (GO:1904037),2/23,0.0014985033958486,0.0130689148621558,0,0,39.541666666666664,257.15086234948103,CD160;FASLG,CD8+ T-Cell,2.8243422685363964
GO_Biological_Process_2021,positive regulation of natural killer cell mediated immunity (GO:0002717),2/23,0.0014985033958486,0.0130689148621558,0,0,39.541666666666664,257.15086234948103,CD160;CRTAM,CD8+ T-Cell,2.8243422685363964
GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),4/214,0.001997005570499,0.0171355961855723,0,0,8.173913043478262,50.80991346966578,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,2.699620723695345
GO_Biological_Process_2021,release of sequestered calcium ion into cytosol (GO:0051209),2/27,0.0020657293545543,0.0174439367717922,0,0,33.208333333333336,205.3029465636782,XCL1;FASLG,CD8+ T-Cell,2.684926579003782
GO_Biological_Process_2021,regulation of calcium-mediated signaling (GO:0050848),2/28,0.0022210873543451,0.0184627886329936,0,0,31.92948717948718,195.08145262248803,CCL4;SLA2,CD8+ T-Cell,2.6534343605132076
GO_Biological_Process_2021,regulation of T cell mediated cytotoxicity (GO:0001914),2/29,0.0023818121959682,0.0194942167423865,0,0,30.74537037037037,185.6987673947897,XCL1;KLRC1,CD8+ T-Cell,2.623092485284041
GO_Biological_Process_2021,positive regulation of phosphate metabolic process (GO:0045937),2/30,0.0025478771667966,0.0205374341323607,0,0,29.645833333333332,177.0595839464994,IFNG;CCL5,CD8+ T-Cell,2.5938215131766835
GO_Biological_Process_2021,peptide cross-linking (GO:0018149),2/31,0.0027192556482504,0.0215917015652124,0,0,28.62212643678161,169.08226656127547,CD3G;CD247,CD8+ T-Cell,2.565549960707733
GO_Biological_Process_2021,protein-containing complex subunit organization (GO:0043933),3/112,0.0027669362290613,0.0216472069685387,0,0,11.618778059730626,68.43477270112554,IL2RB;CD3G;CD247,CD8+ T-Cell,2.5580008501420024
GO_Biological_Process_2021,positive regulation of interleukin-10 production (GO:0032733),2/32,0.0028959211173454,0.0219734249218413,0,0,27.666666666666668,161.69650653172428,XCL1;TIGIT,CD8+ T-Cell,2.5382132721600397
GO_Biological_Process_2021,modulation by host of symbiont process (GO:0051851),2/32,0.0028959211173454,0.0219734249218413,0,0,27.666666666666668,161.69650653172428,CCL5;CCL4,CD8+ T-Cell,2.5382132721600397
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),4/238,0.0029325435515991,0.0219734249218413,0,0,7.326644370122631,42.72814832701451,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,2.5327555293987185
GO_Biological_Process_2021,positive regulation of cytokine production involved in immune response (GO:0002720),2/33,0.0030778471463162,0.0227418705811146,0,0,26.772849462365592,154.84144163978604,CD160;XCL1,CD8+ T-Cell,2.511752952132796
GO_Biological_Process_2021,positive regulation of calcium ion transport (GO:0051928),2/37,0.0038576315924392,0.0281131507832557,0,0,23.708333333333332,131.76384828572083,CCL5;CCL4,CD8+ T-Cell,2.4136792502562754
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),4/274,0.0048404730359388,0.0347990764205332,0,0,6.338164251207729,33.78712362691089,CCL5;CCL4;XCL2;XCL1,CD8+ T-Cell,2.315112194789583
GO_Biological_Process_2021,heart looping (GO:0001947),2/43,0.0051806911627924,0.0367483693147408,0,0,20.232723577235777,106.48111760263689,EOMES;TBX21,CD8+ T-Cell,2.2856122965939503
GO_Biological_Process_2021,regulation of endothelial cell apoptotic process (GO:2000351),2/44,0.0054187658916089,0.0379313612412629,0,0,19.75,103.05327189846057,CD160;FASLG,CD8+ T-Cell,2.266099611522887
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),4/286,0.0056268057726134,0.0388761126107838,0,0,6.064754856614246,31.416724110112767,IFNG;GZMA;PRF1;FASLG,CD8+ T-Cell,2.249738075664926
GO_Biological_Process_2021,regulation of DNA binding (GO:0051101),2/47,0.0061625935135597,0.040981246865172,0,0,18.430555555555557,93.79784429037068,GZMA;PYHIN1,CD8+ T-Cell,2.210236477513525
GO_Biological_Process_2021,determination of heart left/right asymmetry (GO:0061371),2/47,0.0061625935135597,0.040981246865172,0,0,18.430555555555557,93.79784429037068,EOMES;TBX21,CD8+ T-Cell,2.210236477513525
GO_Biological_Process_2021,embryonic heart tube morphogenesis (GO:0003143),2/47,0.0061625935135597,0.040981246865172,0,0,18.430555555555557,93.79784429037068,EOMES;TBX21,CD8+ T-Cell,2.210236477513525
GO_Biological_Process_2021,regulation of interleukin-10 production (GO:0032653),2/48,0.0064203200925442,0.0416537840150433,0,0,18.028985507246375,91.01549863791358,XCL1;TIGIT,CD8+ T-Cell,2.192443319133604
GO_Biological_Process_2021,regulation of interleukin-2 production (GO:0032663),2/48,0.0064203200925442,0.0416537840150433,0,0,18.028985507246375,91.01549863791358,TBX21;XCL1,CD8+ T-Cell,2.192443319133604
GO_Biological_Process_2021,regulation of smooth muscle cell proliferation (GO:0048660),2/49,0.0066828970303688,0.0423250145256694,0,0,17.64450354609929,88.36726791367238,IFNG;CCL5,CD8+ T-Cell,2.175035230405133
GO_Biological_Process_2021,cellular defense response (GO:0006968),2/49,0.0066828970303688,0.0423250145256694,0,0,17.64450354609929,88.36726791367238,GNLY;PRF1,CD8+ T-Cell,2.175035230405133
GO_Biological_Process_2021,positive regulation of ion transport (GO:0043270),2/50,0.0069502994651568,0.043500697828982,0,0,17.276041666666668,85.84414194819459,CCL5;CCL4,CD8+ T-Cell,2.157996482710139
GO_Biological_Process_2021,regulation of interleukin-12 production (GO:0032655),2/51,0.0072225026271421,0.0446787371818559,0,0,16.922619047619047,83.43788300609687,IFNG;TIGIT,CD8+ T-Cell,2.1413122915117184
GO_Biological_Process_2021,positive regulation of phagocytosis (GO:0050766),2/53,0.0077812124839393,0.0475816671431692,0,0,16.25735294117647,78.94640668269977,IFNG;IL2RB,CD8+ T-Cell,2.108952725111067
GO_Biological_Process_2021,positive regulation of leukocyte chemotaxis (GO:0002690),2/54,0.0080676700842631,0.0487727327821363,0,0,15.943910256410255,76.8479024006269,CCL5;XCL1,CD8+ T-Cell,2.0932518699428635
GO_Biological_Process_2021,positive regulation of interleukin-1 beta production (GO:0032731),2/56,0.0086546685435214,0.0517335243275662,0,0,15.351851851851851,72.91602120992282,IFNG;PYHIN1,CD8+ T-Cell,2.0627495600792987
GO_Biological_Process_2021,regulation of calcium ion transport (GO:0051924),2/58,0.0092602829393189,0.0541370387221725,0,0,14.802083333333334,69.30366021141536,CCL5;CCL4,CD8+ T-Cell,2.033375743652011
GO_Biological_Process_2021,regulation of phagocytosis (GO:0050764),2/58,0.0092602829393189,0.0541370387221725,0,0,14.802083333333334,69.30366021141536,IFNG;IL2RB,CD8+ T-Cell,2.033375743652011
GO_Biological_Process_2021,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),2/59,0.0095700107879558,0.0553396275999183,0,0,14.541666666666666,67.6059670933825,IFNG;CCL5,CD8+ T-Cell,2.019087572657113
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),4/335,0.0097191113097967,0.0555974969549663,0,0,5.1540785498489425,23.88225325042697,IFNG;CRTAM;XCL1;TIGIT,CD8+ T-Cell,2.0123734440136594
GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),3/178,0.009999859714763,0.0565949507261059,0,0,7.212765957446808,33.21611593091175,CD3G;CD247;PDCD1,CD8+ T-Cell,2.000006092553167
GO_Biological_Process_2021,positive regulation of interleukin-1 production (GO:0032732),2/62,0.0105265894654256,0.0589489010063837,0,0,13.8125,62.9000654557375,IFNG;PYHIN1,CD8+ T-Cell,1.977712314119832
GO_Biological_Process_2021,establishment of T cell polarity (GO:0001768),1/5,0.0124387771927725,0.0630414591929083,0,0,101.76530612244898,446.4379351400606,CRTAM,CD8+ T-Cell,1.9052223113279663
GO_Biological_Process_2021,"positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)",1/5,0.0124387771927725,0.0630414591929083,0,0,101.76530612244898,446.4379351400606,XCL1,CD8+ T-Cell,1.9052223113279663
GO_Biological_Process_2021,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",1/5,0.0124387771927725,0.0630414591929083,0,0,101.76530612244898,446.4379351400606,IFNG,CD8+ T-Cell,1.9052223113279663
GO_Biological_Process_2021,regulation of T-helper 1 cell cytokine production (GO:2000554),1/5,0.0124387771927725,0.0630414591929083,0,0,101.76530612244898,446.4379351400606,XCL1,CD8+ T-Cell,1.9052223113279663
GO_Biological_Process_2021,regulation of core promoter binding (GO:1904796),1/5,0.0124387771927725,0.0630414591929083,0,0,101.76530612244898,446.4379351400606,IFNG,CD8+ T-Cell,1.9052223113279663
GO_Biological_Process_2021,neuroinflammatory response (GO:0150076),1/5,0.0124387771927725,0.0630414591929083,0,0,101.76530612244898,446.4379351400606,IFNG,CD8+ T-Cell,1.9052223113279663
GO_Biological_Process_2021,positive regulation of T-helper 1 cell cytokine production (GO:2000556),1/5,0.0124387771927725,0.0630414591929083,0,0,101.76530612244898,446.4379351400606,XCL1,CD8+ T-Cell,1.9052223113279663
GO_Biological_Process_2021,endodermal cell fate specification (GO:0001714),1/5,0.0124387771927725,0.0630414591929083,0,0,101.76530612244898,446.4379351400606,EOMES,CD8+ T-Cell,1.9052223113279663
GO_Biological_Process_2021,negative regulation of adaptive immune response (GO:0002820),1/5,0.0124387771927725,0.0630414591929083,0,0,101.76530612244898,446.4379351400606,CD160,CD8+ T-Cell,1.9052223113279663
GO_Biological_Process_2021,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),2/68,0.0125608922452035,0.0630414591929083,0,0,12.553030303030305,54.94671101969335,IFNG;CCL5,CD8+ T-Cell,1.9009795100092206
GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),2/68,0.0125608922452035,0.0630414591929083,0,0,12.553030303030305,54.94671101969335,IFNG;PYHIN1,CD8+ T-Cell,1.9009795100092206
GO_Biological_Process_2021,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),2/71,0.0136373517747766,0.0666488026324939,0,0,12.005434782608695,51.56265564232933,CD3G;CD247,CD8+ T-Cell,1.8652699567516449
GO_Biological_Process_2021,extrinsic apoptotic signaling pathway (GO:0097191),2/72,0.0140048037295852,0.0666488026324939,0,0,11.833333333333334,50.50886613536219,IFNG;FASLG,CD8+ T-Cell,1.8537229732206628
GO_Biological_Process_2021,Fc-gamma receptor signaling pathway (GO:0038094),2/72,0.0140048037295852,0.0666488026324939,0,0,11.833333333333334,50.50886613536219,CD3G;CD247,CD8+ T-Cell,1.8537229732206628
GO_Biological_Process_2021,Fc receptor mediated stimulatory signaling pathway (GO:0002431),2/74,0.0147525184670075,0.0666488026324939,0,0,11.50347222222222,48.50256694786101,CD3G;CD247,CD8+ T-Cell,1.8311338330445346
GO_Biological_Process_2021,regulation of peptide hormone secretion (GO:0090276),2/74,0.0147525184670075,0.0666488026324939,0,0,11.50347222222222,48.50256694786101,IFNG;CCL5,CD8+ T-Cell,1.8311338330445346
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),3/206,0.0147987734204783,0.0666488026324939,0,0,6.209097578870139,26.160238086750542,IFNG;CCL5;XCL1,CD8+ T-Cell,1.8297742791181009
GO_Biological_Process_2021,establishment of lymphocyte polarity (GO:0001767),1/6,0.0149082847993736,0.0666488026324939,0,0,81.40816326530613,342.3895623444841,CRTAM,CD8+ T-Cell,1.8265723193247598
GO_Biological_Process_2021,positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),1/6,0.0149082847993736,0.0666488026324939,0,0,81.40816326530613,342.3895623444841,CCL5,CD8+ T-Cell,1.8265723193247598
GO_Biological_Process_2021,regulation of T-helper 17 cell lineage commitment (GO:2000328),1/6,0.0149082847993736,0.0666488026324939,0,0,81.40816326530613,342.3895623444841,TBX21,CD8+ T-Cell,1.8265723193247598
GO_Biological_Process_2021,regulation of vitamin D biosynthetic process (GO:0060556),1/6,0.0149082847993736,0.0666488026324939,0,0,81.40816326530613,342.3895623444841,IFNG,CD8+ T-Cell,1.8265723193247598
GO_Biological_Process_2021,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),1/6,0.0149082847993736,0.0666488026324939,0,0,81.40816326530613,342.3895623444841,CRTAM,CD8+ T-Cell,1.8265723193247598
GO_Biological_Process_2021,positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),1/6,0.0149082847993736,0.0666488026324939,0,0,81.40816326530613,342.3895623444841,CRTAM,CD8+ T-Cell,1.8265723193247598
GO_Biological_Process_2021,lymphocyte apoptotic process (GO:0070227),1/6,0.0149082847993736,0.0666488026324939,0,0,81.40816326530613,342.3895623444841,FASLG,CD8+ T-Cell,1.8265723193247598
GO_Biological_Process_2021,positive regulation of immune response (GO:0050778),2/75,0.0151327357621299,0.0670884618787761,0,0,11.345319634703197,47.54704276850611,IFNG;CCL5,CD8+ T-Cell,1.820082551223806
GO_Biological_Process_2021,negative regulation of blood vessel morphogenesis (GO:2000181),2/78,0.0162985561731684,0.0689484568106567,0,0,10.895833333333334,44.85464558420347,CD160;FASLG,CD8+ T-Cell,1.7878508663812431
GO_Biological_Process_2021,positive regulation of activation of Janus kinase activity (GO:0010536),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,CCL5,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,regulation of calcidiol 1-monooxygenase activity (GO:0060558),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,IFNG,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,FASLG,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,positive regulation of interleukin-23 production (GO:0032747),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,IFNG,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,positive regulation of natural killer cell cytokine production (GO:0002729),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,CD160,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,negative regulation of T cell apoptotic process (GO:0070233),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,CCL5,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,negative regulation of T-helper 17 type immune response (GO:2000317),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,TBX21,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,negative regulation of type 2 immune response (GO:0002829),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,TBX21,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,T cell apoptotic process (GO:0070231),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,FASLG,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,regulation of natural killer cell cytokine production (GO:0002727),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,CD160,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),1/7,0.0173717414502839,0.0689484568106567,0,0,67.83673469387755,274.9362107684438,CRTAM,CD8+ T-Cell,1.7601566430186848
GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),2/83,0.0183241429417302,0.0689484568106567,0,0,10.22067901234568,40.877971632620635,IFNG;PYHIN1,CD8+ T-Cell,1.7369763290678308
GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),2/86,0.0195880530452788,0.0689484568106567,0,0,9.854166666666666,38.754815869716495,CRTAM;XCL1,CD8+ T-Cell,1.7080087285643422
GO_Biological_Process_2021,regulation of neuron death (GO:1901214),2/86,0.0195880530452788,0.0689484568106567,0,0,9.854166666666666,38.754815869716495,IFNG;CCL5,CD8+ T-Cell,1.7080087285643422
GO_Biological_Process_2021,"negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)",1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,XCL1,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,regulation of activation of Janus kinase activity (GO:0010533),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,CCL5,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,XCL1,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,positive regulation of homotypic cell-cell adhesion (GO:0034112),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,CCL5,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,immune response-inhibiting cell surface receptor signaling pathway (GO:0002767),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,KLRC1,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,immunological synapse formation (GO:0001771),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,PRF1,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,regulation of endodeoxyribonuclease activity (GO:0032071),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,GZMA,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,positive regulation of MHC class II biosynthetic process (GO:0045348),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,IFNG,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,cellular response to interferon-alpha (GO:0035457),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,PYHIN1,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,negative regulation of T cell mediated cytotoxicity (GO:0001915),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,KLRC1,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,negative regulation of T-helper 17 cell differentiation (GO:2000320),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,TBX21,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,T cell mediated cytotoxicity (GO:0001913),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,CRTAM,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,regulation of lymphocyte apoptotic process (GO:0070228),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,CD3G,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,positive regulation of steroid biosynthetic process (GO:0010893),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,IFNG,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,positive regulation of T-helper 2 cell cytokine production (GO:2000553),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,XCL1,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,regulation of nitrogen compound metabolic process (GO:0051171),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,IFNG,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,regulation of protein ADP-ribosylation (GO:0010835),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,IFNG,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,negative regulation of amyloid-beta clearance (GO:1900222),1/8,0.0198291614511851,0.0689484568106567,0,0,58.142857142857146,227.9549801512961,IFNG,CD8+ T-Cell,1.702695651141308
GO_Biological_Process_2021,negative regulation of angiogenesis (GO:0016525),2/87,0.0200173181098975,0.0691507352887368,0,0,9.737745098039216,38.08585452607372,CD160;FASLG,CD8+ T-Cell,1.6985941090791523
GO_Biological_Process_2021,positive regulation of transport (GO:0051050),2/91,0.0217736102157896,0.0731682558876628,0,0,9.298220973782772,35.5848177883064,IFNG;IL2RB,CD8+ T-Cell,1.6620695559472094
GO_Biological_Process_2021,regulation of smooth muscle cell apoptotic process (GO:0034391),1/9,0.0222805591236868,0.0731682558876628,0,0,50.87244897959184,193.52086993316271,IFNG,CD8+ T-Cell,1.652073914876897
GO_Biological_Process_2021,"positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",1/9,0.0222805591236868,0.0731682558876628,0,0,50.87244897959184,193.52086993316271,XCL1,CD8+ T-Cell,1.652073914876897
GO_Biological_Process_2021,regulation of T-helper 1 type immune response (GO:0002825),1/9,0.0222805591236868,0.0731682558876628,0,0,50.87244897959184,193.52086993316271,XCL1,CD8+ T-Cell,1.652073914876897
GO_Biological_Process_2021,"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",1/9,0.0222805591236868,0.0731682558876628,0,0,50.87244897959184,193.52086993316271,CRTAM,CD8+ T-Cell,1.652073914876897
GO_Biological_Process_2021,regulation of interleukin-23 production (GO:0032667),1/9,0.0222805591236868,0.0731682558876628,0,0,50.87244897959184,193.52086993316271,IFNG,CD8+ T-Cell,1.652073914876897
GO_Biological_Process_2021,positive regulation of smooth muscle cell apoptotic process (GO:0034393),1/9,0.0222805591236868,0.0731682558876628,0,0,50.87244897959184,193.52086993316271,IFNG,CD8+ T-Cell,1.652073914876897
GO_Biological_Process_2021,regulation of protein deacetylation (GO:0090311),1/9,0.0222805591236868,0.0731682558876628,0,0,50.87244897959184,193.52086993316271,IFNG,CD8+ T-Cell,1.652073914876897
GO_Biological_Process_2021,regulation of T-helper 17 cell differentiation (GO:2000319),1/10,0.024725948817258,0.0764779347138446,0,0,45.21768707482993,167.3010120823387,TBX21,CD8+ T-Cell,1.606847034080906
GO_Biological_Process_2021,regulation of tau-protein kinase activity (GO:1902947),1/10,0.024725948817258,0.0764779347138446,0,0,45.21768707482993,167.3010120823387,IFNG,CD8+ T-Cell,1.606847034080906
GO_Biological_Process_2021,granulocyte activation (GO:0036230),1/10,0.024725948817258,0.0764779347138446,0,0,45.21768707482993,167.3010120823387,CCL5,CD8+ T-Cell,1.606847034080906
GO_Biological_Process_2021,regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/10,0.024725948817258,0.0764779347138446,0,0,45.21768707482993,167.3010120823387,CCL5,CD8+ T-Cell,1.606847034080906
GO_Biological_Process_2021,negative regulation of lymphocyte apoptotic process (GO:0070229),1/10,0.024725948817258,0.0764779347138446,0,0,45.21768707482993,167.3010120823387,CCL5,CD8+ T-Cell,1.606847034080906
GO_Biological_Process_2021,response to interleukin-4 (GO:0070670),1/10,0.024725948817258,0.0764779347138446,0,0,45.21768707482993,167.3010120823387,XCL1,CD8+ T-Cell,1.606847034080906
GO_Biological_Process_2021,cellular response to interleukin-4 (GO:0071353),1/10,0.024725948817258,0.0764779347138446,0,0,45.21768707482993,167.3010120823387,XCL1,CD8+ T-Cell,1.606847034080906
GO_Biological_Process_2021,defense response to tumor cell (GO:0002357),1/10,0.024725948817258,0.0764779347138446,0,0,45.21768707482993,167.3010120823387,PRF1,CD8+ T-Cell,1.606847034080906
GO_Biological_Process_2021,endodermal cell fate commitment (GO:0001711),1/10,0.024725948817258,0.0764779347138446,0,0,45.21768707482993,167.3010120823387,EOMES,CD8+ T-Cell,1.606847034080906
GO_Biological_Process_2021,negative regulation of alpha-beta T cell proliferation (GO:0046642),1/10,0.024725948817258,0.0764779347138446,0,0,45.21768707482993,167.3010120823387,XCL1,CD8+ T-Cell,1.606847034080906
GO_Biological_Process_2021,positive regulation of defense response (GO:0031349),2/98,0.0249948795228368,0.076862866509533,0,0,8.6171875,31.789531066243494,IFNG;CCL5,CD8+ T-Cell,1.6021489522377872
GO_Biological_Process_2021,positive regulation of cellular respiration (GO:1901857),1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,IFNG,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,B cell mediated immunity (GO:0019724),1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,SLA2,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,negative regulation of interleukin-17 production (GO:0032700),1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,IFNG,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,"regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,XCL1,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,negative regulation of natural killer cell mediated immunity (GO:0002716),1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,KLRC1,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,interleukin-2-mediated signaling pathway (GO:0038110),1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,IL2RB,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,cellular response to interleukin-2 (GO:0071352),1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,IL2RB,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,IFNG,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,negative regulation of T-helper cell differentiation (GO:0045623),1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,TBX21,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,positive regulation of transforming growth factor beta production (GO:0071636),1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,XCL1,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,negative regulation of activated T cell proliferation (GO:0046007),1/11,0.0271653448579923,0.0785432796981084,0,0,40.69387755102041,146.73452100035948,CRTAM,CD8+ T-Cell,1.5659847773237099
GO_Biological_Process_2021,cellular component assembly (GO:0022607),3/261,0.0274521329320867,0.0787513615008379,0,0,4.871845620979713,17.515802156668258,IL2RB;CD3G;CD247,CD8+ T-Cell,1.5614239067822424
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),5/684,0.0275333707502929,0.0787513615008379,0,0,3.1534936998854524,11.32847367927841,EOMES;IFNG;TBX21;FASLG;SLA2,CD8+ T-Cell,1.560140617206737
GO_Biological_Process_2021,regulation of insulin secretion (GO:0050796),2/104,0.0279010087799889,0.0793761319302358,0,0,8.107843137254902,29.018720027145317,IFNG;CCL5,CD8+ T-Cell,1.5543800942295387
GO_Biological_Process_2021,positive regulation of cellular metabolic process (GO:0031325),2/105,0.0283980432384044,0.0803604202278252,0,0,8.028721682847896,28.593770697553435,IFNG;CCL5,CD8+ T-Cell,1.546711583898058
GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),3/267,0.0290942849381526,0.0811677379106112,0,0,4.759671179883946,16.83597323857966,IL2RB;CD3G;CD247,CD8+ T-Cell,1.5361923121681382
GO_Biological_Process_2021,negative regulation of oxidoreductase activity (GO:0051354),1/12,0.029598761568907,0.0811677379106112,0,0,36.99257884972171,130.2147194065139,GZMA,CD8+ T-Cell,1.5287264597194943
GO_Biological_Process_2021,macrophage chemotaxis (GO:0048246),1/12,0.029598761568907,0.0811677379106112,0,0,36.99257884972171,130.2147194065139,CCL5,CD8+ T-Cell,1.5287264597194943
GO_Biological_Process_2021,mesoderm morphogenesis (GO:0048332),1/12,0.029598761568907,0.0811677379106112,0,0,36.99257884972171,130.2147194065139,EOMES,CD8+ T-Cell,1.5287264597194943
GO_Biological_Process_2021,regulation of MHC class II biosynthetic process (GO:0045346),1/12,0.029598761568907,0.0811677379106112,0,0,36.99257884972171,130.2147194065139,IFNG,CD8+ T-Cell,1.5287264597194943
GO_Biological_Process_2021,positive regulation of T-helper 1 type immune response (GO:0002827),1/12,0.029598761568907,0.0811677379106112,0,0,36.99257884972171,130.2147194065139,XCL1,CD8+ T-Cell,1.5287264597194943
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",6/948,0.0300445041436553,0.0819675702791006,0,0,2.751592356687898,9.644539024538345,EOMES;IFNG;TBX21;XCL1;FASLG;SLA2,CD8+ T-Cell,1.5222349592144426
GO_Biological_Process_2021,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",1/13,0.032026213248763,0.0839307657553789,0,0,33.90816326530612,116.6847899929619,XCL1,CD8+ T-Cell,1.4944944088974865
GO_Biological_Process_2021,positive regulation of calcium-mediated signaling (GO:0050850),1/13,0.032026213248763,0.0839307657553789,0,0,33.90816326530612,116.6847899929619,CCL4,CD8+ T-Cell,1.4944944088974865
GO_Biological_Process_2021,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/13,0.032026213248763,0.0839307657553789,0,0,33.90816326530612,116.6847899929619,XCL1,CD8+ T-Cell,1.4944944088974865
GO_Biological_Process_2021,interleukin-15-mediated signaling pathway (GO:0035723),1/13,0.032026213248763,0.0839307657553789,0,0,33.90816326530612,116.6847899929619,IL2RB,CD8+ T-Cell,1.4944944088974865
GO_Biological_Process_2021,cellular response to interleukin-15 (GO:0071350),1/13,0.032026213248763,0.0839307657553789,0,0,33.90816326530612,116.6847899929619,IL2RB,CD8+ T-Cell,1.4944944088974865
GO_Biological_Process_2021,regulation of homotypic cell-cell adhesion (GO:0034110),1/13,0.032026213248763,0.0839307657553789,0,0,33.90816326530612,116.6847899929619,CCL5,CD8+ T-Cell,1.4944944088974865
GO_Biological_Process_2021,macrophage activation involved in immune response (GO:0002281),1/13,0.032026213248763,0.0839307657553789,0,0,33.90816326530612,116.6847899929619,IFNG,CD8+ T-Cell,1.4944944088974865
GO_Biological_Process_2021,regulation of oxidoreductase activity (GO:0051341),1/13,0.032026213248763,0.0839307657553789,0,0,33.90816326530612,116.6847899929619,GZMA,CD8+ T-Cell,1.4944944088974865
GO_Biological_Process_2021,regulation of response to interferon-gamma (GO:0060330),1/14,0.0344477141698711,0.0872675425636736,0,0,31.298273155416013,105.4223689491126,IFNG,CD8+ T-Cell,1.4628395910668823
GO_Biological_Process_2021,negative regulation of interleukin-12 production (GO:0032695),1/14,0.0344477141698711,0.0872675425636736,0,0,31.298273155416013,105.4223689491126,TIGIT,CD8+ T-Cell,1.4628395910668823
GO_Biological_Process_2021,positive regulation of lymphocyte migration (GO:2000403),1/14,0.0344477141698711,0.0872675425636736,0,0,31.298273155416013,105.4223689491126,CCL5,CD8+ T-Cell,1.4628395910668823
GO_Biological_Process_2021,positive regulation of macrophage chemotaxis (GO:0010759),1/14,0.0344477141698711,0.0872675425636736,0,0,31.298273155416013,105.4223689491126,CCL5,CD8+ T-Cell,1.4628395910668823
GO_Biological_Process_2021,positive regulation of protein deacetylation (GO:0090312),1/14,0.0344477141698711,0.0872675425636736,0,0,31.298273155416013,105.4223689491126,IFNG,CD8+ T-Cell,1.4628395910668823
GO_Biological_Process_2021,positive regulation of type 2 immune response (GO:0002830),1/14,0.0344477141698711,0.0872675425636736,0,0,31.298273155416013,105.4223689491126,XCL1,CD8+ T-Cell,1.4628395910668823
GO_Biological_Process_2021,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/14,0.0344477141698711,0.0872675425636736,0,0,31.298273155416013,105.4223689491126,IFNG,CD8+ T-Cell,1.4628395910668823
GO_Biological_Process_2021,cellular response to lipopolysaccharide (GO:0071222),2/120,0.0362706169091182,0.0891421100536298,0,0,7.002824858757062,23.22660056193845,TNIP3;CCL5,CD8+ T-Cell,1.4404450576550938
GO_Biological_Process_2021,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/15,0.0368632785936063,0.0891421100536298,0,0,29.06122448979592,95.91771596133704,PYHIN1,CD8+ T-Cell,1.4334060415588732
GO_Biological_Process_2021,positive regulation of exosomal secretion (GO:1903543),1/15,0.0368632785936063,0.0891421100536298,0,0,29.06122448979592,95.91771596133704,IFNG,CD8+ T-Cell,1.4334060415588732
GO_Biological_Process_2021,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),1/15,0.0368632785936063,0.0891421100536298,0,0,29.06122448979592,95.91771596133704,KLRC1,CD8+ T-Cell,1.4334060415588732
GO_Biological_Process_2021,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/15,0.0368632785936063,0.0891421100536298,0,0,29.06122448979592,95.91771596133704,IFNG,CD8+ T-Cell,1.4334060415588732
GO_Biological_Process_2021,positive regulation of osteoclast differentiation (GO:0045672),1/15,0.0368632785936063,0.0891421100536298,0,0,29.06122448979592,95.91771596133704,IFNG,CD8+ T-Cell,1.4334060415588732
GO_Biological_Process_2021,macrophage differentiation (GO:0030225),1/15,0.0368632785936063,0.0891421100536298,0,0,29.06122448979592,95.91771596133704,IFNG,CD8+ T-Cell,1.4334060415588732
GO_Biological_Process_2021,macrophage migration (GO:1905517),1/15,0.0368632785936063,0.0891421100536298,0,0,29.06122448979592,95.91771596133704,CCL5,CD8+ T-Cell,1.4334060415588732
GO_Biological_Process_2021,T cell proliferation (GO:0042098),1/15,0.0368632785936063,0.0891421100536298,0,0,29.06122448979592,95.91771596133704,CRTAM,CD8+ T-Cell,1.4334060415588732
GO_Biological_Process_2021,endoderm development (GO:0007492),1/15,0.0368632785936063,0.0891421100536298,0,0,29.06122448979592,95.91771596133704,EOMES,CD8+ T-Cell,1.4334060415588732
GO_Biological_Process_2021,regulation of protein secretion (GO:0050708),2/125,0.0390617280151273,0.0912366542826878,0,0,6.716463414634147,21.77888563484535,IFNG;CCL5,CD8+ T-Cell,1.408248548277182
GO_Biological_Process_2021,positive regulation of alpha-beta T cell proliferation (GO:0046641),1/16,0.0392729207344652,0.0912366542826878,0,0,27.122448979591837,87.80133530116419,XCL1,CD8+ T-Cell,1.405906798966597
GO_Biological_Process_2021,negative regulation of epithelial cell differentiation (GO:0030857),1/16,0.0392729207344652,0.0912366542826878,0,0,27.122448979591837,87.80133530116419,IFNG,CD8+ T-Cell,1.405906798966597
GO_Biological_Process_2021,regulation of amyloid-beta clearance (GO:1900221),1/16,0.0392729207344652,0.0912366542826878,0,0,27.122448979591837,87.80133530116419,IFNG,CD8+ T-Cell,1.405906798966597
GO_Biological_Process_2021,positive regulation of immunoglobulin mediated immune response (GO:0002891),1/16,0.0392729207344652,0.0912366542826878,0,0,27.122448979591837,87.80133530116419,XCL1,CD8+ T-Cell,1.405906798966597
GO_Biological_Process_2021,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),1/16,0.0392729207344652,0.0912366542826878,0,0,27.122448979591837,87.80133530116419,KLRC1,CD8+ T-Cell,1.405906798966597
GO_Biological_Process_2021,neutrophil activation (GO:0042119),1/16,0.0392729207344652,0.0912366542826878,0,0,27.122448979591837,87.80133530116419,CCL5,CD8+ T-Cell,1.405906798966597
GO_Biological_Process_2021,dendritic cell chemotaxis (GO:0002407),1/16,0.0392729207344652,0.0912366542826878,0,0,27.122448979591837,87.80133530116419,CCL5,CD8+ T-Cell,1.405906798966597
GO_Biological_Process_2021,necroptotic process (GO:0070266),1/16,0.0392729207344652,0.0912366542826878,0,0,27.122448979591837,87.80133530116419,FASLG,CD8+ T-Cell,1.405906798966597
GO_Biological_Process_2021,negative regulation of cytokine production involved in immune response (GO:0002719),1/17,0.0416766547912334,0.0955688808143802,0,0,25.426020408163264,80.79916728086499,XCL1,CD8+ T-Cell,1.3801071472903907
GO_Biological_Process_2021,regulation of cellular respiration (GO:0043457),1/17,0.0416766547912334,0.0955688808143802,0,0,25.426020408163264,80.79916728086499,IFNG,CD8+ T-Cell,1.3801071472903907
GO_Biological_Process_2021,positive regulation of smooth muscle cell migration (GO:0014911),1/17,0.0416766547912334,0.0955688808143802,0,0,25.426020408163264,80.79916728086499,CCL5,CD8+ T-Cell,1.3801071472903907
GO_Biological_Process_2021,positive regulation of amyloid-beta formation (GO:1902004),1/18,0.0440744949316926,0.0973234417994866,0,0,23.92917166866747,74.70385911458476,IFNG,CD8+ T-Cell,1.3558126557645607
GO_Biological_Process_2021,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.0440744949316926,0.0973234417994866,0,0,23.92917166866747,74.70385911458476,CCL5,CD8+ T-Cell,1.3558126557645607
GO_Biological_Process_2021,regulation of transforming growth factor beta production (GO:0071634),1/18,0.0440744949316926,0.0973234417994866,0,0,23.92917166866747,74.70385911458476,XCL1,CD8+ T-Cell,1.3558126557645607
GO_Biological_Process_2021,negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/18,0.0440744949316926,0.0973234417994866,0,0,23.92917166866747,74.70385911458476,TIGIT,CD8+ T-Cell,1.3558126557645607
GO_Biological_Process_2021,response to interferon-alpha (GO:0035455),1/18,0.0440744949316926,0.0973234417994866,0,0,23.92917166866747,74.70385911458476,PYHIN1,CD8+ T-Cell,1.3558126557645607
GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),1/18,0.0440744949316926,0.0973234417994866,0,0,23.92917166866747,74.70385911458476,IFNG,CD8+ T-Cell,1.3558126557645607
GO_Biological_Process_2021,dendritic cell migration (GO:0036336),1/18,0.0440744949316926,0.0973234417994866,0,0,23.92917166866747,74.70385911458476,CCL5,CD8+ T-Cell,1.3558126557645607
GO_Biological_Process_2021,programmed necrotic cell death (GO:0097300),1/18,0.0440744949316926,0.0973234417994866,0,0,23.92917166866747,74.70385911458476,FASLG,CD8+ T-Cell,1.3558126557645607
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/134,0.0442844516217812,0.0973234417994866,0,0,6.255681818181818,19.49972118549308,IFNG;CCL5,CD8+ T-Cell,1.3537487288592545
GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),2/136,0.0454786698217006,0.0973234417994866,0,0,6.161691542288557,19.042780777221537,CD3G;CD247,CD8+ T-Cell,1.3421922462170102
GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),2/137,0.0460802533373535,0.0973234417994866,0,0,6.1157407407407405,18.820401760879264,CD3G;CD247,CD8+ T-Cell,1.3364851419391792
GO_Biological_Process_2021,pyroptosis (GO:0070269),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,GZMA,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,regulation of T cell cytokine production (GO:0002724),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,XCL1,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,negative regulation of immune system process (GO:0002683),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,PDCD1,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,positive regulation of macrophage migration (GO:1905523),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,CCL5,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,regulation of epithelial cell differentiation (GO:0030856),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,IFNG,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,positive regulation of monocyte chemotaxis (GO:0090026),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,CCL5,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,regulation of exosomal secretion (GO:1903541),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,IFNG,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,positive regulation of neutrophil chemotaxis (GO:0090023),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,XCL1,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,regulation of leukocyte chemotaxis (GO:0002688),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,XCL1,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,IFNG,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,myeloid cell activation involved in immune response (GO:0002275),1/19,0.0464664552952436,0.0973234417994866,0,0,22.598639455782312,69.35578082800635,IFNG,CD8+ T-Cell,1.3328604565168853
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),2/139,0.0472922793944307,0.0980737984544859,0,0,6.025851581508515,18.3873330672393,IFNG;CCL5,CD8+ T-Cell,1.3252097533441285
GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),2/140,0.0479026862337682,0.0980737984544859,0,0,5.981884057971015,18.176455370515885,CD8B;CD8A,CD8+ T-Cell,1.319640132017756
GO_Biological_Process_2021,regulation of smooth muscle cell migration (GO:0014910),1/20,0.0488525499820277,0.0980737984544859,0,0,21.40816326530612,64.63014669364038,CCL5,CD8+ T-Cell,1.3111127622579986
GO_Biological_Process_2021,regulation of T cell migration (GO:2000404),1/20,0.0488525499820277,0.0980737984544859,0,0,21.40816326530612,64.63014669364038,CCL5,CD8+ T-Cell,1.3111127622579986
GO_Biological_Process_2021,gastrulation (GO:0007369),1/20,0.0488525499820277,0.0980737984544859,0,0,21.40816326530612,64.63014669364038,EOMES,CD8+ T-Cell,1.3111127622579986
GO_Biological_Process_2021,cellular response to interferon-beta (GO:0035458),1/20,0.0488525499820277,0.0980737984544859,0,0,21.40816326530612,64.63014669364038,PYHIN1,CD8+ T-Cell,1.3111127622579986
GO_Biological_Process_2021,positive regulation of nitrogen compound metabolic process (GO:0051173),1/20,0.0488525499820277,0.0980737984544859,0,0,21.40816326530612,64.63014669364038,IFNG,CD8+ T-Cell,1.3111127622579986
GO_Biological_Process_2021,regulation of granulocyte chemotaxis (GO:0071622),1/20,0.0488525499820277,0.0980737984544859,0,0,21.40816326530612,64.63014669364038,CCL5,CD8+ T-Cell,1.3111127622579986
GO_Biological_Process_2021,lipopolysaccharide-mediated signaling pathway (GO:0031663),1/20,0.0488525499820277,0.0980737984544859,0,0,21.40816326530612,64.63014669364038,CCL5,CD8+ T-Cell,1.3111127622579986
GO_Biological_Process_2021,toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.0488525499820277,0.0980737984544859,0,0,21.40816326530612,64.63014669364038,TNIP3,CD8+ T-Cell,1.3111127622579986
GO_Biological_Process_2021,mesoderm formation (GO:0001707),1/20,0.0488525499820277,0.0980737984544859,0,0,21.40816326530612,64.63014669364038,EOMES,CD8+ T-Cell,1.3111127622579986
GO_Biological_Process_2021,negative regulation of DNA-binding transcription factor activity (GO:0043433),2/143,0.0497512691479657,0.0995025382959315,0,0,5.8537234042553195,17.565380826397597,EOMES;XCL1,CD8+ T-Cell,1.3031958359850326
GO_Biological_Process_2021,positive regulation of glycolytic process (GO:0045821),1/21,0.0512327930672156,0.1005750771651612,0,0,20.336734693877553,60.42807445408675,IFNG,CD8+ T-Cell,1.2904519669693806
GO_Biological_Process_2021,positive regulation of phosphatase activity (GO:0010922),1/21,0.0512327930672156,0.1005750771651612,0,0,20.336734693877553,60.42807445408675,IFNG,CD8+ T-Cell,1.2904519669693806
GO_Biological_Process_2021,positive regulation of purine nucleotide metabolic process (GO:1900544),1/21,0.0512327930672156,0.1005750771651612,0,0,20.336734693877553,60.42807445408675,IFNG,CD8+ T-Cell,1.2904519669693806
GO_Biological_Process_2021,positive regulation of T cell cytokine production (GO:0002726),1/21,0.0512327930672156,0.1005750771651612,0,0,20.336734693877553,60.42807445408675,XCL1,CD8+ T-Cell,1.2904519669693806
GO_Biological_Process_2021,positive regulation of transcription regulatory region DNA binding (GO:2000679),1/21,0.0512327930672156,0.1005750771651612,0,0,20.336734693877553,60.42807445408675,IFNG,CD8+ T-Cell,1.2904519669693806
GO_Biological_Process_2021,positive regulation of amyloid precursor protein catabolic process (GO:1902993),1/22,0.0536071985992547,0.1022187442824499,0,0,19.367346938775512,56.67024999786951,IFNG,CD8+ T-Cell,1.2707768875084013
GO_Biological_Process_2021,positive regulation of granulocyte chemotaxis (GO:0071624),1/22,0.0536071985992547,0.1022187442824499,0,0,19.367346938775512,56.67024999786951,XCL1,CD8+ T-Cell,1.2707768875084013
GO_Biological_Process_2021,negative regulation of lymphocyte activation (GO:0051250),1/22,0.0536071985992547,0.1022187442824499,0,0,19.367346938775512,56.67024999786951,TIGIT,CD8+ T-Cell,1.2707768875084013
GO_Biological_Process_2021,positive regulation of neutrophil migration (GO:1902624),1/22,0.0536071985992547,0.1022187442824499,0,0,19.367346938775512,56.67024999786951,XCL1,CD8+ T-Cell,1.2707768875084013
GO_Biological_Process_2021,regulation of macrophage chemotaxis (GO:0010758),1/22,0.0536071985992547,0.1022187442824499,0,0,19.367346938775512,56.67024999786951,CCL5,CD8+ T-Cell,1.2707768875084013
GO_Biological_Process_2021,regulation of membrane protein ectodomain proteolysis (GO:0051043),1/22,0.0536071985992547,0.1022187442824499,0,0,19.367346938775512,56.67024999786951,IFNG,CD8+ T-Cell,1.2707768875084013
GO_Biological_Process_2021,microglial cell activation (GO:0001774),1/22,0.0536071985992547,0.1022187442824499,0,0,19.367346938775512,56.67024999786951,IFNG,CD8+ T-Cell,1.2707768875084013
GO_Biological_Process_2021,positive regulation of translational initiation (GO:0045948),1/22,0.0536071985992547,0.1022187442824499,0,0,19.367346938775512,56.67024999786951,CCL5,CD8+ T-Cell,1.2707768875084013
GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),2/150,0.0541636617411515,0.1029109573081878,0,0,5.574887387387387,16.25495026487543,IFNG;CRTAM,CD8+ T-Cell,1.2662919827974375
GO_Biological_Process_2021,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),1/23,0.0559757805878795,0.1052265557341056,0,0,18.4860853432282,53.29235549319145,CCL5,CD8+ T-Cell,1.2519998414265567
GO_Biological_Process_2021,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/23,0.0559757805878795,0.1052265557341056,0,0,18.4860853432282,53.29235549319145,IFNG,CD8+ T-Cell,1.2519998414265567
GO_Biological_Process_2021,regulation of mononuclear cell migration (GO:0071675),1/23,0.0559757805878795,0.1052265557341056,0,0,18.4860853432282,53.29235549319145,CCL5,CD8+ T-Cell,1.2519998414265567
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),2/154,0.0567455048100272,0.1062979174610368,0,0,5.427083333333333,15.571272642043729,IFNG;CCL5,CD8+ T-Cell,1.2460685361352464
GO_Biological_Process_2021,positive regulation of carbohydrate metabolic process (GO:0045913),1/24,0.0583385530130099,0.1077642715379211,0,0,17.68145519077196,50.24171555062859,IFNG,CD8+ T-Cell,1.2340443470047993
GO_Biological_Process_2021,immune response-activating cell surface receptor signaling pathway (GO:0002429),1/24,0.0583385530130099,0.1077642715379211,0,0,17.68145519077196,50.24171555062859,SLA2,CD8+ T-Cell,1.2340443470047993
GO_Biological_Process_2021,positive regulation of phospholipase activity (GO:0010518),1/24,0.0583385530130099,0.1077642715379211,0,0,17.68145519077196,50.24171555062859,CCL5,CD8+ T-Cell,1.2340443470047993
GO_Biological_Process_2021,protein kinase B signaling (GO:0043491),1/24,0.0583385530130099,0.1077642715379211,0,0,17.68145519077196,50.24171555062859,CCL5,CD8+ T-Cell,1.2340443470047993
GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),2/158,0.0593699722530508,0.1092900527287994,0,0,5.2868589743589745,14.929913680908546,CCL5;XCL1,CD8+ T-Cell,1.2264331540442923
GO_Biological_Process_2021,receptor signaling pathway via STAT (GO:0097696),1/25,0.0606955298241754,0.1105822666659634,0,0,16.943877551020407,47.47480020477031,IFNG,CD8+ T-Cell,1.2168432931781568
GO_Biological_Process_2021,negative regulation of sequestering of calcium ion (GO:0051283),1/25,0.0606955298241754,0.1105822666659634,0,0,16.943877551020407,47.47480020477031,XCL1,CD8+ T-Cell,1.2168432931781568
GO_Biological_Process_2021,regulation of neutrophil chemotaxis (GO:0090022),1/25,0.0606955298241754,0.1105822666659634,0,0,16.943877551020407,47.47480020477031,XCL1,CD8+ T-Cell,1.2168432931781568
GO_Biological_Process_2021,regulation of regulatory T cell differentiation (GO:0045589),1/26,0.0630467249540435,0.1136978226289869,0,0,16.26530612244898,44.95534064809558,IFNG,CD8+ T-Cell,1.2003374685092782
GO_Biological_Process_2021,positive regulation of T cell mediated cytotoxicity (GO:0001916),1/26,0.0630467249540435,0.1136978226289869,0,0,16.26530612244898,44.95534064809558,XCL1,CD8+ T-Cell,1.2003374685092782
GO_Biological_Process_2021,regulation of monocyte chemotaxis (GO:0090025),1/26,0.0630467249540435,0.1136978226289869,0,0,16.26530612244898,44.95534064809558,CCL5,CD8+ T-Cell,1.2003374685092782
GO_Biological_Process_2021,negative regulation of catalytic activity (GO:0043086),1/27,0.0653921522588676,0.1167403523547569,0,0,15.638932496075354,42.652889831563165,GZMA,CD8+ T-Cell,1.184474368421492
GO_Biological_Process_2021,positive regulation of calcium ion transmembrane transport (GO:1904427),1/27,0.0653921522588676,0.1167403523547569,0,0,15.638932496075354,42.652889831563165,XCL1,CD8+ T-Cell,1.184474368421492
GO_Biological_Process_2021,positive regulation of nitric oxide biosynthetic process (GO:0045429),1/27,0.0653921522588676,0.1167403523547569,0,0,15.638932496075354,42.652889831563165,IFNG,CD8+ T-Cell,1.184474368421492
GO_Biological_Process_2021,response to interferon-beta (GO:0035456),1/28,0.0677318256109869,0.1189218852311717,0,0,15.058956916099774,40.54171043527237,PYHIN1,CD8+ T-Cell,1.1692072184717057
GO_Biological_Process_2021,positive regulation of monooxygenase activity (GO:0032770),1/28,0.0677318256109869,0.1189218852311717,0,0,15.058956916099774,40.54171043527237,IFNG,CD8+ T-Cell,1.1692072184717057
GO_Biological_Process_2021,positive regulation of nitric oxide metabolic process (GO:1904407),1/28,0.0677318256109869,0.1189218852311717,0,0,15.058956916099774,40.54171043527237,IFNG,CD8+ T-Cell,1.1692072184717057
GO_Biological_Process_2021,leukocyte cell-cell adhesion (GO:0007159),1/28,0.0677318256109869,0.1189218852311717,0,0,15.058956916099774,40.54171043527237,CCL5,CD8+ T-Cell,1.1692072184717057
GO_Biological_Process_2021,positive regulation of protein import into nucleus (GO:0042307),1/28,0.0677318256109869,0.1189218852311717,0,0,15.058956916099774,40.54171043527237,IFNG,CD8+ T-Cell,1.1692072184717057
GO_Biological_Process_2021,negative regulation of interferon-gamma production (GO:0032689),1/29,0.0700657588372089,0.1218136722267815,0,0,14.520408163265309,38.5999069065122,XCL1,CD8+ T-Cell,1.1544941700666143
GO_Biological_Process_2021,positive regulation of leukocyte migration (GO:0002687),1/29,0.0700657588372089,0.1218136722267815,0,0,14.520408163265309,38.5999069065122,XCL1,CD8+ T-Cell,1.1544941700666143
GO_Biological_Process_2021,positive regulation of viral genome replication (GO:0045070),1/29,0.0700657588372089,0.1218136722267815,0,0,14.520408163265309,38.5999069065122,CCL5,CD8+ T-Cell,1.1544941700666143
GO_Biological_Process_2021,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/30,0.0723939657090184,0.1250441225883045,0,0,14.019000703729768,36.80874147674154,FASLG,CD8+ T-Cell,1.1402976322627019
GO_Biological_Process_2021,positive regulation of protein import (GO:1904591),1/30,0.0723939657090184,0.1250441225883045,0,0,14.019000703729768,36.80874147674154,IFNG,CD8+ T-Cell,1.1402976322627019
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),2/180,0.0745195887056104,0.1265896710872544,0,0,4.628277153558052,12.018216055401329,IFNG;CCL5,CD8+ T-Cell,1.1277295507615273
GO_Biological_Process_2021,receptor signaling pathway via JAK-STAT (GO:0007259),1/31,0.0747164600026276,0.1265896710872544,0,0,13.551020408163266,35.15209038871121,IFNG,CD8+ T-Cell,1.126583712764908
GO_Biological_Process_2021,negative regulation of DNA binding (GO:0043392),1/31,0.0747164600026276,0.1265896710872544,0,0,13.551020408163266,35.15209038871121,GZMA,CD8+ T-Cell,1.126583712764908
GO_Biological_Process_2021,positive regulation of mononuclear cell migration (GO:0071677),1/31,0.0747164600026276,0.1265896710872544,0,0,13.551020408163266,35.15209038871121,CCL5,CD8+ T-Cell,1.126583712764908
GO_Biological_Process_2021,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/31,0.0747164600026276,0.1265896710872544,0,0,13.551020408163266,35.15209038871121,PYHIN1,CD8+ T-Cell,1.126583712764908
GO_Biological_Process_2021,MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/31,0.0747164600026276,0.1265896710872544,0,0,13.551020408163266,35.15209038871121,TNIP3,CD8+ T-Cell,1.126583712764908
GO_Biological_Process_2021,regulation of cellular biosynthetic process (GO:0031326),1/32,0.0770332554327668,0.1288732449378364,0,0,13.113232389730086,33.61600807740255,CCL5,CD8+ T-Cell,1.1133217484244988
GO_Biological_Process_2021,positive regulation of immune effector process (GO:0002699),1/32,0.0770332554327668,0.1288732449378364,0,0,13.113232389730086,33.61600807740255,IFNG,CD8+ T-Cell,1.1133217484244988
GO_Biological_Process_2021,positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.0770332554327668,0.1288732449378364,0,0,13.113232389730086,33.61600807740255,CCL5,CD8+ T-Cell,1.1133217484244988
GO_Biological_Process_2021,regulation of NMDA receptor activity (GO:2000310),1/32,0.0770332554327668,0.1288732449378364,0,0,13.113232389730086,33.61600807740255,IFNG,CD8+ T-Cell,1.1133217484244988
GO_Biological_Process_2021,positive regulation of ATP metabolic process (GO:1903580),1/33,0.0793443657059371,0.130836433656621,0,0,12.70280612244898,32.18837516559274,IFNG,CD8+ T-Cell,1.1004839073426347
GO_Biological_Process_2021,negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.0793443657059371,0.130836433656621,0,0,12.70280612244898,32.18837516559274,IFNG,CD8+ T-Cell,1.1004839073426347
GO_Biological_Process_2021,regulation of interleukin-17 production (GO:0032660),1/33,0.0793443657059371,0.130836433656621,0,0,12.70280612244898,32.18837516559274,IFNG,CD8+ T-Cell,1.1004839073426347
GO_Biological_Process_2021,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),1/33,0.0793443657059371,0.130836433656621,0,0,12.70280612244898,32.18837516559274,CCL5,CD8+ T-Cell,1.1004839073426347
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),3/404,0.0800241417045532,0.130836433656621,0,0,3.1117419217912663,7.858476812794824,CD8B;CD8A;SH2D2A,CD8+ T-Cell,1.0967789751654027
GO_Biological_Process_2021,positive regulation of calcium ion transport into cytosol (GO:0010524),1/34,0.0816498044624026,0.130836433656621,0,0,12.317254174397032,30.85861216573232,XCL1,CD8+ T-Cell,1.0880448509885652
GO_Biological_Process_2021,regulation of activated T cell proliferation (GO:0046006),1/34,0.0816498044624026,0.130836433656621,0,0,12.317254174397032,30.85861216573232,CRTAM,CD8+ T-Cell,1.0880448509885652
GO_Biological_Process_2021,regulation of amyloid-beta formation (GO:1902003),1/34,0.0816498044624026,0.130836433656621,0,0,12.317254174397032,30.85861216573232,IFNG,CD8+ T-Cell,1.0880448509885652
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/34,0.0816498044624026,0.130836433656621,0,0,12.317254174397032,30.85861216573232,FASLG,CD8+ T-Cell,1.0880448509885652
GO_Biological_Process_2021,positive regulation of DNA binding (GO:0043388),1/34,0.0816498044624026,0.130836433656621,0,0,12.317254174397032,30.85861216573232,PYHIN1,CD8+ T-Cell,1.0880448509885652
GO_Biological_Process_2021,positive regulation of interleukin-12 production (GO:0032735),1/34,0.0816498044624026,0.130836433656621,0,0,12.317254174397032,30.85861216573232,IFNG,CD8+ T-Cell,1.0880448509885652
GO_Biological_Process_2021,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/34,0.0816498044624026,0.130836433656621,0,0,12.317254174397032,30.85861216573232,XCL1,CD8+ T-Cell,1.0880448509885652
GO_Biological_Process_2021,phosphatidylinositol 3-kinase signaling (GO:0014065),1/34,0.0816498044624026,0.130836433656621,0,0,12.317254174397032,30.85861216573232,CD160,CD8+ T-Cell,1.0880448509885652
GO_Biological_Process_2021,protein destabilization (GO:0031648),1/34,0.0816498044624026,0.130836433656621,0,0,12.317254174397032,30.85861216573232,PYHIN1,CD8+ T-Cell,1.0880448509885652
GO_Biological_Process_2021,positive regulation of immunoglobulin production (GO:0002639),1/35,0.0839495853612937,0.1333169534692784,0,0,11.95438175270108,29.61744503578088,XCL1,CD8+ T-Cell,1.0759814445616303
GO_Biological_Process_2021,negative regulation of T cell proliferation (GO:0042130),1/35,0.0839495853612937,0.1333169534692784,0,0,11.95438175270108,29.61744503578088,CRTAM,CD8+ T-Cell,1.0759814445616303
GO_Biological_Process_2021,cellular response to virus (GO:0098586),1/35,0.0839495853612937,0.1333169534692784,0,0,11.95438175270108,29.61744503578088,CCL5,CD8+ T-Cell,1.0759814445616303
GO_Biological_Process_2021,positive regulation of innate immune response (GO:0045089),1/36,0.0862437219743075,0.1341569008489229,0,0,11.612244897959185,28.456712045041098,CCL5,CD8+ T-Cell,1.0642725091375862
GO_Biological_Process_2021,positive regulation of myeloid leukocyte differentiation (GO:0002763),1/36,0.0862437219743075,0.1341569008489229,0,0,11.612244897959185,28.456712045041098,IFNG,CD8+ T-Cell,1.0642725091375862
GO_Biological_Process_2021,macrophage activation (GO:0042116),1/36,0.0862437219743075,0.1341569008489229,0,0,11.612244897959185,28.456712045041098,IFNG,CD8+ T-Cell,1.0642725091375862
GO_Biological_Process_2021,positive regulation of T cell mediated immunity (GO:0002711),1/36,0.0862437219743075,0.1341569008489229,0,0,11.612244897959185,28.456712045041098,XCL1,CD8+ T-Cell,1.0642725091375862
GO_Biological_Process_2021,regulation of osteoclast differentiation (GO:0045670),1/36,0.0862437219743075,0.1341569008489229,0,0,11.612244897959185,28.456712045041098,IFNG,CD8+ T-Cell,1.0642725091375862
GO_Biological_Process_2021,endoderm formation (GO:0001706),1/36,0.0862437219743075,0.1341569008489229,0,0,11.612244897959185,28.456712045041098,EOMES,CD8+ T-Cell,1.0642725091375862
GO_Biological_Process_2021,regulation of protein import into nucleus (GO:0042306),1/36,0.0862437219743075,0.1341569008489229,0,0,11.612244897959185,28.456712045041098,IFNG,CD8+ T-Cell,1.0642725091375862
GO_Biological_Process_2021,negative regulation of intracellular signal transduction (GO:1902532),2/198,0.0877321663879582,0.1360743805200985,0,0,4.199404761904762,10.219111519148855,TNIP3;SLA2,CD8+ T-Cell,1.0568411463883935
GO_Biological_Process_2021,positive regulation of exocytosis (GO:0045921),1/37,0.0885322278902676,0.1365192615583258,0,0,11.289115646258503,27.36920368672352,IFNG,CD8+ T-Cell,1.0528986067362665
GO_Biological_Process_2021,positive regulation of signaling receptor activity (GO:2000273),1/37,0.0885322278902676,0.1365192615583258,0,0,11.289115646258503,27.36920368672352,IFNG,CD8+ T-Cell,1.0528986067362665
GO_Biological_Process_2021,positive regulation of cell development (GO:0010720),1/38,0.0908151166313484,0.1392323978324997,0,0,10.983452840595698,26.34852930034076,IFNG,CD8+ T-Cell,1.0418418549683985
GO_Biological_Process_2021,positive regulation of production of molecular mediator of immune response (GO:0002702),1/38,0.0908151166313484,0.1392323978324997,0,0,10.983452840595698,26.34852930034076,XCL1,CD8+ T-Cell,1.0418418549683985
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),2/203,0.0915200219539462,0.1399099186192511,0,0,4.093905472636816,9.789336578359592,CD160;FASLG,CD8+ T-Cell,1.0384838843718929
GO_Biological_Process_2021,positive regulation of cation channel activity (GO:2001259),1/40,0.0953640965755271,0.1445404540688901,0,0,10.419152276295131,24.485561288951835,IFNG,CD8+ T-Cell,1.0206151011238414
GO_Biological_Process_2021,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.0953640965755271,0.1445404540688901,0,0,10.419152276295131,24.485561288951835,TNIP3,CD8+ T-Cell,1.0206151011238414
GO_Biological_Process_2021,regulation of nitric oxide biosynthetic process (GO:0045428),1/40,0.0953640965755271,0.1445404540688901,0,0,10.419152276295131,24.485561288951835,IFNG,CD8+ T-Cell,1.0206151011238414
GO_Biological_Process_2021,T cell differentiation (GO:0030217),1/41,0.0976302146847681,0.1475547562849337,0,0,10.158163265306122,23.633660200289185,CD8A,CD8+ T-Cell,1.0104157556925017
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),2/212,0.0984576089228105,0.1480275469588268,0,0,3.9166666666666665,9.079339326341122,CD3G;CD247,CD8+ T-Cell,1.0067507154273545
GO_Biological_Process_2021,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),1/42,0.0998907694703361,0.1480275469588268,0,0,9.909905425584869,22.829231064333683,PYHIN1,CD8+ T-Cell,1.00047464143678
GO_Biological_Process_2021,calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.0998907694703361,0.1480275469588268,0,0,9.909905425584869,22.829231064333683,XCL1,CD8+ T-Cell,1.00047464143678
GO_Biological_Process_2021,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.0998907694703361,0.1480275469588268,0,0,9.909905425584869,22.829231064333683,CRTAM,CD8+ T-Cell,1.00047464143678
GO_Biological_Process_2021,regulation of chemokine production (GO:0032642),1/42,0.0998907694703361,0.1480275469588268,0,0,9.909905425584869,22.829231064333683,IFNG,CD8+ T-Cell,1.00047464143678
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/42,0.0998907694703361,0.1480275469588268,0,0,9.909905425584869,22.829231064333683,FASLG,CD8+ T-Cell,1.00047464143678
GO_Biological_Process_2021,phosphatidylinositol phosphate biosynthetic process (GO:0046854),1/42,0.0998907694703361,0.1480275469588268,0,0,9.909905425584869,22.829231064333683,SLA2,CD8+ T-Cell,1.00047464143678
GO_Biological_Process_2021,positive regulation of biosynthetic process (GO:0009891),1/44,0.1043952424647777,0.1542729694201715,0,0,9.448030374940672,21.34849709415977,CCL5,CD8+ T-Cell,0.9813192926974915
GO_Biological_Process_2021,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),1/45,0.1066391873529346,0.1554302675938664,0,0,9.232838589981448,20.665901611884028,CCL5,CD8+ T-Cell,0.9720831731354668
GO_Biological_Process_2021,positive regulation of chemotaxis (GO:0050921),1/45,0.1066391873529346,0.1554302675938664,0,0,9.232838589981448,20.665901611884028,XCL1,CD8+ T-Cell,0.9720831731354668
GO_Biological_Process_2021,positive regulation of nervous system development (GO:0051962),1/45,0.1066391873529346,0.1554302675938664,0,0,9.232838589981448,20.665901611884028,IFNG,CD8+ T-Cell,0.9720831731354668
GO_Biological_Process_2021,negative regulation of T cell activation (GO:0050868),1/45,0.1066391873529346,0.1554302675938664,0,0,9.232838589981448,20.665901611884028,TIGIT,CD8+ T-Cell,0.9720831731354668
GO_Biological_Process_2021,positive regulation of response to biotic stimulus (GO:0002833),1/45,0.1066391873529346,0.1554302675938664,0,0,9.232838589981448,20.665901611884028,CCL5,CD8+ T-Cell,0.9720831731354668
GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),2/224,0.1079318309204139,0.1568845192613667,0,0,3.702702702702702,8.2431620580209,TNIP3;FASLG,CD8+ T-Cell,0.9668504556467957
GO_Biological_Process_2021,interleukin-12-mediated signaling pathway (GO:0035722),1/46,0.1088776222085674,0.156972615216688,0,0,9.02721088435374,20.01811780873028,IFNG,CD8+ T-Cell,0.9630613723103648
GO_Biological_Process_2021,positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.1088776222085674,0.156972615216688,0,0,9.02721088435374,20.01811780873028,IFNG,CD8+ T-Cell,0.9630613723103648
GO_Biological_Process_2021,positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.1088776222085674,0.156972615216688,0,0,9.02721088435374,20.01811780873028,CCL5,CD8+ T-Cell,0.9630613723103648
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),3/464,0.1096249049131507,0.1576228362535031,0,0,2.69843540868602,5.965406050856904,IFNG;TBX21;XCL1,CD8+ T-Cell,0.9600907703256691
GO_Biological_Process_2021,epithelial to mesenchymal transition (GO:0001837),1/47,0.1111105603036554,0.1580503157260553,0,0,8.830523513753327,19.4026870705364,EOMES,CD8+ T-Cell,0.9542446623584087
GO_Biological_Process_2021,positive regulation of cell-cell adhesion (GO:0022409),1/47,0.1111105603036554,0.1580503157260553,0,0,8.830523513753327,19.4026870705364,CCL5,CD8+ T-Cell,0.9542446623584087
GO_Biological_Process_2021,positive regulation of neuron death (GO:1901216),1/47,0.1111105603036554,0.1580503157260553,0,0,8.830523513753327,19.4026870705364,IFNG,CD8+ T-Cell,0.9542446623584087
GO_Biological_Process_2021,regulation of protein localization to nucleus (GO:1900180),1/47,0.1111105603036554,0.1580503157260553,0,0,8.830523513753327,19.4026870705364,PYHIN1,CD8+ T-Cell,0.9542446623584087
GO_Biological_Process_2021,cellular response to interleukin-12 (GO:0071349),1/48,0.1133380148369131,0.1603612337586111,0,0,8.642205818497612,18.81737166641443,IFNG,CD8+ T-Cell,0.9456243984787533
GO_Biological_Process_2021,cognition (GO:0050890),1/48,0.1133380148369131,0.1603612337586111,0,0,8.642205818497612,18.81737166641443,JAKMIP1,CD8+ T-Cell,0.9456243984787533
GO_Biological_Process_2021,blood circulation (GO:0008015),1/51,0.1199876089220907,0.1684258784869453,0,0,8.122448979591837,17.22257115519733,XCL2,CD8+ T-Cell,0.9208636010741894
GO_Biological_Process_2021,regulation of epithelial cell migration (GO:0010632),1/51,0.1199876089220907,0.1684258784869453,0,0,8.122448979591837,17.22257115519733,IFNG,CD8+ T-Cell,0.9208636010741894
GO_Biological_Process_2021,regulation of protein modification process (GO:0031399),1/51,0.1199876089220907,0.1684258784869453,0,0,8.122448979591837,17.22257115519733,IFNG,CD8+ T-Cell,0.9208636010741894
GO_Biological_Process_2021,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.1221932608707862,0.1701749078095766,0,0,7.962785114045619,16.738979733033663,XCL1,CD8+ T-Cell,0.9129527453809976
GO_Biological_Process_2021,positive regulation of protein localization to cell periphery (GO:1904377),1/52,0.1221932608707862,0.1701749078095766,0,0,7.962785114045619,16.738979733033663,IFNG,CD8+ T-Cell,0.9129527453809976
GO_Biological_Process_2021,positive regulation of protein localization to plasma membrane (GO:1903078),1/52,0.1221932608707862,0.1701749078095766,0,0,7.962785114045619,16.738979733033663,IFNG,CD8+ T-Cell,0.9129527453809976
GO_Biological_Process_2021,membrane organization (GO:0061024),2/242,0.122577893374113,0.1702648545039898,0,0,3.421875,7.182545007938849,CD3G;CD3D,CD8+ T-Cell,0.9115878467125743
GO_Biological_Process_2021,positive regulation of chemokine production (GO:0032722),1/53,0.1243934949128716,0.1723368210772076,0,0,7.809262166405024,16.276887238960814,IFNG,CD8+ T-Cell,0.9052023302345248
GO_Biological_Process_2021,negative regulation of viral genome replication (GO:0045071),1/54,0.1265883240687765,0.1749220478041275,0,0,7.661532537543319,15.834970375184442,CCL5,CD8+ T-Cell,0.8976063498190403
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),2/253,0.1317582069542016,0.1815942126933556,0,0,3.270086321381142,6.627767796360294,IFNG;CCL5,CD8+ T-Cell,0.880222323941479
GO_Biological_Process_2021,positive regulation of interferon-gamma production (GO:0032729),1/57,0.1331405122852093,0.1825534859168334,0,0,7.25,14.618539131965724,CRTAM,CD8+ T-Cell,0.8756897763447542
GO_Biological_Process_2021,positive regulation of proteolysis (GO:0045862),1/57,0.1331405122852093,0.1825534859168334,0,0,7.25,14.618539131965724,IFNG,CD8+ T-Cell,0.8756897763447542
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.1353667229633477,0.185128783075838,0,0,2.442871502764282,4.885175568190959,EOMES;PYHIN1;TBX21,CD8+ T-Cell,0.8684880846140173
GO_Biological_Process_2021,response to organic cyclic compound (GO:0014070),1/60,0.1396445230534406,0.1900022666609473,0,0,6.88031822898651,13.544974303558986,CCL5,CD8+ T-Cell,0.8549760929333525
GO_Biological_Process_2021,cellular protein catabolic process (GO:0044257),1/60,0.1396445230534406,0.1900022666609473,0,0,6.88031822898651,13.544974303558986,GZMA,CD8+ T-Cell,0.8549760929333525
GO_Biological_Process_2021,negative regulation of response to stimulus (GO:0048585),1/61,0.1418018805927374,0.1924454093758579,0,0,6.76530612244898,13.214837540593155,PDCD1,CD8+ T-Cell,0.848318009451734
GO_Biological_Process_2021,regulation of neurogenesis (GO:0050767),1/62,0.1439539364695556,0.1948689419893222,0,0,6.654064904650385,12.897320592663672,IFNG,CD8+ T-Cell,0.8417764546925935
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),2/269,0.1453850943051252,0.1963067770820473,0,0,3.071629213483146,5.923235274252741,IFNG;CCL5,CD8+ T-Cell,0.837480117499467
GO_Biological_Process_2021,positive regulation of viral process (GO:0048524),1/63,0.1461007034145454,0.196773605611489,0,0,6.54641211323239,12.591756250239603,CCL5,CD8+ T-Cell,0.8353476931121088
GO_Biological_Process_2021,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.1482421941802595,0.1981528826731108,0,0,6.442176870748299,12.297522293260638,GNLY,CD8+ T-Cell,0.8290281655096747
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway (GO:2001236),1/64,0.1482421941802595,0.1981528826731108,0,0,6.442176870748299,12.297522293260638,FASLG,CD8+ T-Cell,0.8290281655096747
GO_Biological_Process_2021,regulation of innate immune response (GO:0045088),1/64,0.1482421941802595,0.1981528826731108,0,0,6.442176870748299,12.297522293260638,CCL5,CD8+ T-Cell,0.8290281655096747
GO_Biological_Process_2021,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.2028374993075835,0,0,6.243328100470958,11.740759916332207,IFNG,CD8+ T-Cell,0.8167033932798328
GO_Biological_Process_2021,positive regulation of T cell proliferation (GO:0042102),1/66,0.1525093979756266,0.2028374993075835,0,0,6.243328100470958,11.740759916332207,CCL5,CD8+ T-Cell,0.8167033932798328
GO_Biological_Process_2021,regulation of viral genome replication (GO:0045069),1/67,0.1546351363099914,0.204641523673919,0,0,6.148423005565863,11.477180657220888,CCL5,CD8+ T-Cell,0.8106918184915987
GO_Biological_Process_2021,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/67,0.1546351363099914,0.204641523673919,0,0,6.148423005565863,11.477180657220888,SH2D2A,CD8+ T-Cell,0.8106918184915987
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),3/546,0.1557845334346044,0.2054039539677559,0,0,2.281297754790173,4.241574534432652,CCL5;CCL4;FASLG,CD8+ T-Cell,0.807475662051351
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),3/547,0.1563819881642389,0.2054039539677559,0,0,2.2769868585732165,4.224843515564561,IFNG;TBX21;XCL1,CD8+ T-Cell,0.80581326976307
GO_Biological_Process_2021,regulation of translational initiation (GO:0006446),1/68,0.1567556490806558,0.2054039539677559,0,0,6.0563508985683825,11.222824361971773,CCL5,CD8+ T-Cell,0.8047767993307415
GO_Biological_Process_2021,interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.1567556490806558,0.2054039539677559,0,0,6.0563508985683825,11.222824361971773,IFNG,CD8+ T-Cell,0.8047767993307415
GO_Biological_Process_2021,cell chemotaxis (GO:0060326),1/69,0.158870948881139,0.2076642378495478,0,0,5.966986794717887,10.977245117600177,CXCR6,CD8+ T-Cell,0.7989555105590889
GO_Biological_Process_2021,negative regulation of viral process (GO:0048525),1/70,0.1609810482853106,0.2099066609994736,0,0,5.880212954747116,10.740024519792764,CCL5,CD8+ T-Cell,0.7932252488723367
GO_Biological_Process_2021,positive regulation of cellular protein localization (GO:1903829),1/71,0.16308595979881,0.2105867247887548,0,0,5.795918367346939,10.51076961698872,PYHIN1,CD8+ T-Cell,0.7875834261109624
GO_Biological_Process_2021,regulation of glycolytic process (GO:0006110),1/71,0.16308595979881,0.2105867247887548,0,0,5.795918367346939,10.51076961698872,IFNG,CD8+ T-Cell,0.7875834261109624
GO_Biological_Process_2021,phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.16308595979881,0.2105867247887548,0,0,5.795918367346939,10.51076961698872,CD160,CD8+ T-Cell,0.7875834261109624
GO_Biological_Process_2021,myeloid leukocyte differentiation (GO:0002573),1/71,0.16308595979881,0.2105867247887548,0,0,5.795918367346939,10.51076961698872,IFNG,CD8+ T-Cell,0.7875834261109624
GO_Biological_Process_2021,positive regulation of neurogenesis (GO:0050769),1/72,0.1651856959101235,0.2127815743927015,0,0,5.713998275366484,10.28911103101624,IFNG,CD8+ T-Cell,0.78202756268309
GO_Biological_Process_2021,proteolysis involved in cellular protein catabolic process (GO:0051603),1/74,0.1693696918266344,0.2171197013295651,0,0,5.556891249650545,9.867213018330611,GZMA,CD8+ T-Cell,0.7711643026835198
GO_Biological_Process_2021,regulation of cytokine-mediated signaling pathway (GO:0001959),1/74,0.1693696918266344,0.2171197013295651,0,0,5.556891249650545,9.867213018330611,IFNG,CD8+ T-Cell,0.7711643026835198
GO_Biological_Process_2021,positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.1714539764404576,0.2187374471614471,0,0,5.4815223386651954,9.666337985731484,CCL5,CD8+ T-Cell,0.7658524380723842
GO_Biological_Process_2021,positive regulation of T cell activation (GO:0050870),1/75,0.1714539764404576,0.2187374471614471,0,0,5.4815223386651954,9.666337985731484,CCL5,CD8+ T-Cell,0.7658524380723842
GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),1/76,0.1735331353639065,0.2203332410825734,0,0,5.408163265306122,9.4717853003048,CCL5,CD8+ T-Cell,0.7606175863963804
GO_Biological_Process_2021,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.2203332410825734,0,0,5.408163265306122,9.4717853003048,IFNG,CD8+ T-Cell,0.7606175863963804
GO_Biological_Process_2021,MAPK cascade (GO:0000165),2/303,0.1752338998526144,0.2213815645618836,0,0,2.7199612403100777,4.737175959955004,CCL5;IL2RB,CD8+ T-Cell,0.7563818736544428
GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.1756071809118701,0.2213815645618836,0,0,5.336734693877551,9.283280446293812,CCL5,CD8+ T-Cell,0.7554577289388229
GO_Biological_Process_2021,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.1756071809118701,0.2213815645618836,0,0,5.336734693877551,9.283280446293812,IFNG,CD8+ T-Cell,0.7554577289388229
GO_Biological_Process_2021,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.1797399811935544,0.2260559574349195,0,0,5.199372056514914,8.923391206941128,PYHIN1,CD8+ T-Cell,0.745355308086215
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),2/310,0.181502535739734,0.2265033737259124,0,0,2.6571969696969697,4.53446850958879,GZMA;FASLG,CD8+ T-Cell,0.7411173031343081
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2265033737259124,0,0,5.133298889175924,8.751529842637671,CCL5,CD8+ T-Cell,0.7404090821369118
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.2265033737259124,0,0,5.133298889175924,8.751529842637671,FASLG,CD8+ T-Cell,0.7404090821369118
GO_Biological_Process_2021,regulation of protein localization to plasma membrane (GO:1903076),1/80,0.181798760490535,0.2265033737259124,0,0,5.133298889175924,8.751529842637671,IFNG,CD8+ T-Cell,0.7404090821369118
GO_Biological_Process_2021,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),1/81,0.1838524754991919,0.2274639929431863,0,0,5.0688775510204085,8.584760541358477,FASLG,CD8+ T-Cell,0.7355305181562768
GO_Biological_Process_2021,positive regulation of cellular amide metabolic process (GO:0034250),1/81,0.1838524754991919,0.2274639929431863,0,0,5.0688775510204085,8.584760541358477,IFNG,CD8+ T-Cell,0.7355305181562768
GO_Biological_Process_2021,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.1838524754991919,0.2274639929431863,0,0,5.0688775510204085,8.584760541358477,IFNG,CD8+ T-Cell,0.7355305181562768
GO_Biological_Process_2021,regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.1859011384602527,0.2294649783314488,0,0,5.00604686318972,8.422875391899517,CCL5,CD8+ T-Cell,0.7307179505966239
GO_Biological_Process_2021,regulation of defense response (GO:0031347),1/83,0.1879447615357932,0.2314504933727824,0,0,4.944748631159781,8.265677319811374,XCL1,CD8+ T-Cell,0.7259697745939766
GO_Biological_Process_2021,positive regulation of protein catabolic process (GO:0045732),1/85,0.1920169366451308,0.2359191923676896,0,0,4.826530612244898,7.964604221414354,IFNG,CD8+ T-Cell,0.716660463134361
GO_Biological_Process_2021,negative regulation of binding (GO:0051100),1/88,0.1980877029036425,0.2422589837810064,0,0,4.659394792399718,7.5437717166037235,GZMA,CD8+ T-Cell,0.703142484213379
GO_Biological_Process_2021,metal ion transport (GO:0030001),1/88,0.1980877029036425,0.2422589837810064,0,0,4.659394792399718,7.5437717166037235,CCL5,CD8+ T-Cell,0.703142484213379
GO_Biological_Process_2021,positive regulation of inflammatory response (GO:0050729),1/89,0.2001013407742902,0.243601632246962,0,0,4.6062152133580705,7.411084001248333,IFNG,CD8+ T-Cell,0.6987500013741589
GO_Biological_Process_2021,second-messenger-mediated signaling (GO:0019932),1/89,0.2001013407742902,0.243601632246962,0,0,4.6062152133580705,7.411084001248333,CXCR6,CD8+ T-Cell,0.6987500013741589
GO_Biological_Process_2021,positive regulation of autophagy (GO:0010508),1/90,0.2021100231923967,0.2438152660733675,0,0,4.55423068103646,7.281955543769811,IFNG,CD8+ T-Cell,0.6944121480917811
GO_Biological_Process_2021,positive regulation of binding (GO:0051099),1/90,0.2021100231923967,0.2438152660733675,0,0,4.55423068103646,7.281955543769811,PYHIN1,CD8+ T-Cell,0.6944121480917811
GO_Biological_Process_2021,negative regulation of protein kinase activity (GO:0006469),1/90,0.2021100231923967,0.2438152660733675,0,0,4.55423068103646,7.281955543769811,IFNG,CD8+ T-Cell,0.6944121480917811
GO_Biological_Process_2021,protein complex oligomerization (GO:0051259),1/90,0.2021100231923967,0.2438152660733675,0,0,4.55423068103646,7.281955543769811,PRF1,CD8+ T-Cell,0.6944121480917811
GO_Biological_Process_2021,toll-like receptor signaling pathway (GO:0002224),1/91,0.2041137620931186,0.2456753878586857,0,0,4.503401360544218,7.156255051106618,TNIP3,CD8+ T-Cell,0.6901277125812961
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),3/625,0.2050267003954304,0.2462171661633611,0,0,1.9834439351440103,3.142995135240803,IFNG;CCL5;IL2RB,CD8+ T-Cell,0.6881895775817527
GO_Biological_Process_2021,positive regulation of cellular component biogenesis (GO:0044089),1/92,0.2061125694363157,0.2464087346968988,0,0,4.453689167974883,7.03385741012878,IFNG,CD8+ T-Cell,0.6858955226779435
GO_Biological_Process_2021,cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.2061125694363157,0.2464087346968988,0,0,4.453689167974883,7.03385741012878,CCL5,CD8+ T-Cell,0.6858955226779435
GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.2081064570390282,0.2482346079478991,0,0,4.40505767524401,6.914643337844717,IFNG,CD8+ T-Cell,0.6817144444740324
GO_Biological_Process_2021,positive regulation of epithelial cell migration (GO:0010634),1/94,0.2100954368002021,0.250046470643641,0,0,4.357472021066491,6.79849904676328,IFNG,CD8+ T-Cell,0.6775833802166729
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),2/345,0.2133084926466024,0.2533038350178404,0,0,2.381802721088435,3.6799229289674416,IFNG;CRTAM,CD8+ T-Cell,0.6709918532419347
GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2559678867562676,0,0,4.220663265306122,6.46742313757927,CCL5,CD8+ T-Cell,0.6654798083211632
GO_Biological_Process_2021,positive regulation of translation (GO:0045727),1/100,0.2219269115603851,0.2623669265558331,0,0,4.092145949288806,6.1603458876211565,CCL5,CD8+ T-Cell,0.6537900306498672
GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),1/101,0.2238818662412048,0.2640912479829734,0,0,4.051020408163265,6.062906014187368,IFNG,CD8+ T-Cell,0.6499810815451941
GO_Biological_Process_2021,regulation of cell death (GO:0010941),1/102,0.2258320069783284,0.2652155137140634,0,0,4.010709234188725,5.967790506031058,CCL5,CD8+ T-Cell,0.6462145058611213
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2652155137140634,0,0,4.010709234188725,5.967790506031058,CXCR6,CD8+ T-Cell,0.6462145058611213
GO_Biological_Process_2021,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2691848438671307,0,0,3.932435109966317,5.78423168094792,CCL5,CD8+ T-Cell,0.6388051756325536
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2725154394087182,0,0,3.857142857142857,5.6090983677319475,IFNG,CD8+ T-Cell,0.6315556772929499
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.2335846623503299,0.2725154394087182,0,0,3.857142857142857,5.6090983677319475,CCL5,CD8+ T-Cell,0.6315556772929499
GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),1/110,0.241261218690496,0.2808555105981267,0,0,3.714847406852649,5.282048795926194,IFNG,CD8+ T-Cell,0.6175124827423236
GO_Biological_Process_2021,cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.2431685532271013,0.2818424189908887,0,0,3.6808905380333954,5.20478084558139,CCL5,CD8+ T-Cell,0.6140925891155178
GO_Biological_Process_2021,regulation of protein serine/threonine kinase activity (GO:0071900),1/111,0.2431685532271013,0.2818424189908887,0,0,3.6808905380333954,5.20478084558139,IFNG,CD8+ T-Cell,0.6140925891155178
GO_Biological_Process_2021,positive regulation of metabolic process (GO:0009893),1/113,0.2469691364760274,0.2856251752287969,0,0,3.614795918367347,5.055262825364014,IFNG,CD8+ T-Cell,0.6073573167632206
GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.2865688332919832,0,0,3.582625970742279,4.982913653406146,IFNG,CD8+ T-Cell,0.6040407011916724
GO_Biological_Process_2021,cellular response to transforming growth factor beta stimulus (GO:0071560),1/114,0.2488624078588274,0.2865688332919832,0,0,3.582625970742279,4.982913653406146,XCL1,CD8+ T-Cell,0.6040407011916724
GO_Biological_Process_2021,calcium ion transport (GO:0006816),1/115,0.2507510141385882,0.2874990075899331,0,0,3.5510204081632653,4.9121080927455,CCL5,CD8+ T-Cell,0.6007573018413346
GO_Biological_Process_2021,cellular response to molecule of bacterial origin (GO:0071219),1/115,0.2507510141385882,0.2874990075899331,0,0,3.5510204081632653,4.9121080927455,TNIP3,CD8+ T-Cell,0.6007573018413346
GO_Biological_Process_2021,regulation of protein-containing complex assembly (GO:0043254),1/116,0.2526349665899778,0.2884158846048674,0,0,3.5199645075421473,4.8428011439058265,IFNG,CD8+ T-Cell,0.5975065399797567
GO_Biological_Process_2021,tumor necrosis factor-mediated signaling pathway (GO:0033209),1/116,0.2526349665899778,0.2884158846048674,0,0,3.5199645075421473,4.8428011439058265,TNFRSF9,CD8+ T-Cell,0.5975065399797567
GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.2563889548341396,0.2914506922473552,0,0,3.4594453165881736,4.708511372057024,S1PR5,CD8+ T-Cell,0.5911006880374128
GO_Biological_Process_2021,positive regulation of protein-containing complex assembly (GO:0031334),1/118,0.2563889548341396,0.2914506922473552,0,0,3.4594453165881736,4.708511372057024,IFNG,CD8+ T-Cell,0.5911006880374128
GO_Biological_Process_2021,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),1/119,0.2582590130323782,0.2929505222456828,0,0,3.429955032860602,4.6434466139665425,FASLG,CD8+ T-Cell,0.5879445130148351
GO_Biological_Process_2021,protein homooligomerization (GO:0051260),1/121,0.2619853133921213,0.296545078137465,0,0,3.372448979591837,4.517283552621874,PRF1,CD8+ T-Cell,0.5817230540677998
GO_Biological_Process_2021,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.300103646948105,0,0,3.316828370692539,4.396166676729281,CCL5,CD8+ T-Cell,0.5756194520344882
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),1/124,0.2675403902734135,0.3009122359946215,0,0,3.2896963663514187,4.337414433160371,IFNG,CD8+ T-Cell,0.5726106437410472
GO_Biological_Process_2021,defense response to symbiont (GO:0140546),1/124,0.2675403902734135,0.3009122359946215,0,0,3.2896963663514187,4.337414433160371,PRF1,CD8+ T-Cell,0.5726106437410472
GO_Biological_Process_2021,regulation of phosphorylation (GO:0042325),1/125,0.2693829605231016,0.302345432485844,0,0,3.263001974983542,4.279822783786303,CCL5,CD8+ T-Cell,0.5696298784899082
GO_Biological_Process_2021,phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.2712209880572274,0.3037675066240947,0,0,3.236734693877551,4.223360488574632,SLA2,CD8+ T-Cell,0.5666767062328689
GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.3092617975301457,0,0,3.1603954081632653,4.060453122404681,IFNG,CD8+ T-Cell,0.5579784037567757
GO_Biological_Process_2021,regulation of response to external stimulus (GO:0032101),1/130,0.2785278903472666,0.3106432655445405,0,0,3.135738016136687,4.008216604624779,XCL1,CD8+ T-Cell,0.5551313103019286
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),3/742,0.2833046813486276,0.3147233351306434,0,0,1.6593153485158207,2.092782192966935,GZMA;IL2RB;FASLG,CD8+ T-Cell,0.5477462491044153
GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3147233351306434,0,0,3.0640074211502784,3.857336278341556,CCL5,CD8+ T-Cell,0.546741450090894
GO_Biological_Process_2021,defense response to virus (GO:0051607),1/133,0.2839609038772722,0.3147233351306434,0,0,3.0640074211502784,3.857336278341556,PRF1,CD8+ T-Cell,0.546741450090894
GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),1/136,0.289353816496661,0.3193697725647793,0,0,2.99546485260771,3.714691124222948,CCL5,CD8+ T-Cell,0.5385707850387818
GO_Biological_Process_2021,organic substance transport (GO:0071702),1/136,0.289353816496661,0.3193697725647793,0,0,2.99546485260771,3.714691124222948,CD3G,CD8+ T-Cell,0.5385707850387818
GO_Biological_Process_2021,positive regulation of cellular catabolic process (GO:0031331),1/141,0.2982536777952956,0.3285112972817749,0,0,2.8877551020408165,3.4936375609484274,IFNG,CD8+ T-Cell,0.5254141922968343
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3317118447135171,0,0,2.8467950560505892,3.410594866305226,CD3G,CD8+ T-Cell,0.5203052911363482
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.3087894082520855,0.3387133302888856,0,0,2.7682415431926195,3.252948903166252,CXCR6,CD8+ T-Cell,0.5103376047629952
GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3392239851794919,0,0,2.749271137026239,3.215201203875706,IFNG,CD8+ T-Cell,0.5078961191737069
GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),1/148,0.3105302270346101,0.3392239851794919,0,0,2.749271137026239,3.215201203875706,CXCR6,CD8+ T-Cell,0.5078961191737069
GO_Biological_Process_2021,brain development (GO:0007420),1/150,0.3139989845586295,0.3416103472089793,0,0,2.712094233666621,3.141596466170354,EOMES,CD8+ T-Cell,0.5030717563895143
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3416103472089793,0,0,2.712094233666621,3.141596466170354,CCL5,CD8+ T-Cell,0.5030717563895143
GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.3576320254775125,0,0,2.556445362955309,2.8389038953772054,TNIP3,CD8+ T-Cell,0.4822791499015975
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),2/474,0.3328115296392732,0.3606023090999865,0,0,1.7194562146892656,1.8917094920733264,IFNG;CCL5,CD8+ T-Cell,0.47780163679243126
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.3670631425054168,0,0,2.4621702339472376,2.6600168495918335,S1PR5,CD8+ T-Cell,0.46919202564454415
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),2/482,0.3401543782991926,0.3670631425054168,0,0,1.6901041666666667,1.8225334796372663,IFNG;CRTAM,CD8+ T-Cell,0.46832393464331673
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",4/1183,0.3428517320675613,0.3692249422266044,0,0,1.384445181989158,1.481989303783668,EOMES;PYHIN1;TNIP3;TBX21,CD8+ T-Cell,0.4648936521619021
GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.3477593333218013,0.3737534653074714,0,0,2.388721168940949,2.523073857975914,CRTAM,CD8+ T-Cell,0.45872120538836164
GO_Biological_Process_2021,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.3494039111808349,0.374763872476218,0,0,2.3745498199279713,2.4969025061029213,FASLG,CD8+ T-Cell,0.4566722378913039
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),1/176,0.3575660373570176,0.3827467442131456,0,0,2.306122448979592,2.3716975343886144,GNLY,CD8+ T-Cell,0.4466437384468818
GO_Biological_Process_2021,protein stabilization (GO:0050821),1/179,0.3624150547196057,0.3871582512265667,0,0,2.266911258885577,2.300835957547096,PYHIN1,CD8+ T-Cell,0.4407937700298507
GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.4066814636876094,0,0,2.122448979591837,2.045536603225051,IFNG,CD8+ T-Cell,0.41855670871419515
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.4108393561812818,0,0,2.089140319340171,1.988001678572607,IFNG,CD8+ T-Cell,0.4132695879859197
GO_Biological_Process_2021,proteasomal protein catabolic process (GO:0010498),1/205,0.4029646862685204,0.4278986289318421,0,0,1.975390156062425,1.7954446526222323,TBX21,CD8+ T-Cell,0.3947330115033212
GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4404107920162313,0,0,1.8910606496119575,1.656759537391559,IFNG,CD8+ T-Cell,0.3804856946694876
GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),1/214,0.416403436812339,0.4404107920162313,0,0,1.8910606496119575,1.656759537391559,IFNG,CD8+ T-Cell,0.3804856946694876
GO_Biological_Process_2021,cellular response to lipid (GO:0071396),1/219,0.4237408440429794,0.4472820020453672,0,0,1.8472196217936716,1.5860841457604238,TNIP3,CD8+ T-Cell,0.372899672681652
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4494614381255261,0,0,1.8302411873840445,1.5589816483293069,CCL5,CD8+ T-Cell,0.3699278171231457
GO_Biological_Process_2021,regulation of autophagy (GO:0010506),1/231,0.4409837467017168,0.4636429906033861,0,0,1.749778172138421,1.4326260836369302,IFNG,CD8+ T-Cell,0.35557741698984124
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),6/2206,0.478857675442218,0.5024699868545562,0,0,1.100206611570248,0.8101391784721939,EOMES;IFNG;TNIP3;TBX21;FASLG;SLA2,CD8+ T-Cell,0.31979354703381785
GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),1/266,0.4884385252284191,0.5108604736911173,0,0,1.5159799768964188,1.086262808220724,IFNG,CD8+ T-Cell,0.3111900887192418
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5108604736911173,0,0,1.510204081632653,1.0781219104526054,CCL5,CD8+ T-Cell,0.3100391544580995
GO_Biological_Process_2021,protein deubiquitination (GO:0016579),1/267,0.4897346646287026,0.5108604736911173,0,0,1.510204081632653,1.0781219104526054,TNIP3,CD8+ T-Cell,0.3100391544580995
GO_Biological_Process_2021,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5112068013968357,0,0,1.504471451501949,1.0700627976731167,EOMES,CD8+ T-Cell,0.3088941088615854
GO_Biological_Process_2021,protein modification by small protein removal (GO:0070646),1/276,0.50125602230015,0.5208363356712495,0,0,1.4601113172541744,1.0084087773272885,TNIP3,CD8+ T-Cell,0.29994039654430615
GO_Biological_Process_2021,proteolysis (GO:0006508),1/287,0.51499186851511,0.534065641423077,0,0,1.4031682603111175,0.9311483055746664,GZMA,CD8+ T-Cell,0.28819962821492023
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),1/296,0.5259539383992272,0.5443725588100952,0,0,1.359737115185057,0.8736877155004001,IFNG,CD8+ T-Cell,0.2790522884983112
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.5551458962416416,0.5734711005835986,0,0,1.2519132653061225,0.7367814077584223,TBX21,CD8+ T-Cell,0.25559286623594474
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.573525042771797,0,0,1.2479496471485791,0.7319104885681406,IFNG,CD8+ T-Cell,0.2547095446988111
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5735758802103383,0,0,1.2440106477373558,0.7270814983759607,TNIP3,CD8+ T-Cell,0.2538302089398956
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),2/764,0.5744134768292987,0.5899381653922526,0,0,1.0492125984251968,0.5816895490313783,IFNG;TNFRSF9,CD8+ T-Cell,0.24077537927422193
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.5909956578792304,0.6057990173251456,0,0,1.1329710354396716,0.5958822738188654,TBX21,CD8+ T-Cell,0.22841570992418872
GO_Biological_Process_2021,protein transport (GO:0015031),1/369,0.6063398885560332,0.6203323475227108,0,0,1.0859582963620231,0.5433207667028247,CD3G,CD8+ T-Cell,0.21728386041430361
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6211867648892865,0,0,1.0799779371207945,0.5367673309131087,IFNG,CD8+ T-Cell,0.21585171499242045
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),1/379,0.6162544539128882,0.6280600947924454,0,0,1.056689342403628,0.5115383719098227,IFNG,CD8+ T-Cell,0.2102399288866402
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.6288461702021667,0,0,1.0510204081632653,0.5054679174936134,IL2RB,CD8+ T-Cell,0.20886552310647807
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6306022910999176,0,0,1.042628017264347,0.4965325169788531,IFNG,CD8+ T-Cell,0.20682480102083725
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),1/408,0.643643262264238,0.6522251724277612,0,0,0.9799428370856942,0.4317732474155183,CCL5,CD8+ T-Cell,0.19135477263518083
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.663134010332821,0.6706982766103817,0,0,0.928642785785643,0.3814661952932429,TBX21,CD8+ T-Cell,0.17839869773857764
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),2/908,0.6694431207036386,0.6757945734617377,0,0,0.8758278145695364,0.3514776504163603,EOMES;TNIP3,CD8+ T-Cell,0.17428631695508484
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",5/2244,0.6741952652975136,0.6793028051861312,0,0,0.8789141978065604,0.3464991772661544,EOMES;IFNG;PYHIN1;TBX21;XCL1,CD8+ T-Cell,0.1712143017444203
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),1/468,0.6943679720033368,0.698305786589367,0,0,0.8514180832932745,0.3105575044475373,TBX21,CD8+ T-Cell,0.15841031937391015
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7100742618475151,0,0,0.8207960870298533,0.2841203737887477,IL2RB,CD8+ T-Cell,0.15033199168778996
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),2/1025,0.7337546800798972,0.7351365156356032,0,0,0.7708944281524927,0.2386539053000475,CD3G;CD247,CD8+ T-Cell,0.13444911569132442
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7597673074922179,0,0,0.7301532033426184,0.200604530418796,IFNG;TBX21,CD8+ T-Cell,0.11931939791106433
KEGG_2021_Human,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),2/14,0.0005467878206419364,0.1346456223396145,0,0,69.22916666666667,520.0114050756229,LRRC26;GALR2,CLP,3.2621811676355046
KEGG_2021_Human,regulation of adaptive immune response (GO:0002819),2/18,0.000913470506242016,0.1346456223396145,0,0,51.911458333333336,363.2898548418271,IL4I1;TNFSF4,CLP,3.039305470405725
KEGG_2021_Human,regulation of regulatory T cell differentiation (GO:0045589),2/26,0.0019157650058532,0.1346456223396145,0,0,34.59375,216.47517339281177,IL4I1;TNFSF4,CLP,2.7176577640050135
KEGG_2021_Human,regulation of B cell activation (GO:0050864),2/28,0.0022210873543451,0.1346456223396145,0,0,31.92948717948718,195.08145262248803,IL4I1;TNFSF4,CLP,2.6534343605132076
KEGG_2021_Human,regulation of cell adhesion mediated by integrin (GO:0033628),2/34,0.0032650074009337,0.1346456223396145,0,0,25.934895833333332,148.46413612460563,RET;ADA,CLP,2.4861158299536776
KEGG_2021_Human,proton transmembrane transport (GO:1902600),2/37,0.0038576315924392,0.1346456223396145,0,0,23.708333333333332,131.76384828572083,ATP1A3;ATP6V0A4,CLP,2.4136792502562754
KEGG_2021_Human,positive regulation of cation channel activity (GO:2001259),2/40,0.0044964248068071,0.1346456223396145,0,0,21.833333333333332,117.99765363023796,LRRC26;GALR2,CLP,2.3471326648462743
KEGG_2021_Human,inorganic cation transmembrane transport (GO:0098662),4/274,0.0048404730359388,0.1346456223396145,0,0,6.338164251207729,33.78712362691089,LRRC26;ATP1A3;ATP6V0A4;SCN3A,CLP,2.315112194789583
KEGG_2021_Human,enzyme linked receptor protein signaling pathway (GO:0007167),3/140,0.005174274872555,0.1346456223396145,0,0,9.231091784438576,48.59298474885369,RET;FLT3;CLNK,CLP,2.286150504018583
KEGG_2021_Human,positive regulation of T cell differentiation (GO:0045582),2/43,0.0051806911627924,0.1346456223396145,0,0,20.232723577235777,106.48111760263689,IL4I1;TNFSF4,CLP,2.2856122965939503
KEGG_2021_Human,regulation of immune response (GO:0050776),3/179,0.0101526469873867,0.1346456223396145,0,0,7.17142166344294,32.916974748208716,IL4I1;TNFSF4;LAIR1,CLP,1.993420714189676
KEGG_2021_Human,negative regulation of endopeptidase activity (GO:0010951),2/63,0.0108545013893802,0.1346456223396145,0,0,13.585382513661202,61.44906812714711,SPINK2;SPOCK3,CLP,1.9643901214324337
KEGG_2021_Human,positive regulation of T cell proliferation (GO:0042102),2/66,0.0118650634107129,0.1346456223396145,0,0,12.946614583333334,57.4073222604629,TMIGD2;TNFSF4,CLP,1.9257299364311244
KEGG_2021_Human,positive regulation of amino acid transport (GO:0051957),1/5,0.0124387771927725,0.1346456223396145,0,0,101.76530612244898,446.4379351400606,TRH,CLP,1.9052223113279663
KEGG_2021_Human,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),1/5,0.0124387771927725,0.1346456223396145,0,0,101.76530612244898,446.4379351400606,IL4I1,CLP,1.9052223113279663
KEGG_2021_Human,L-phenylalanine catabolic process (GO:0006559),1/5,0.0124387771927725,0.1346456223396145,0,0,101.76530612244898,446.4379351400606,IL4I1,CLP,1.9052223113279663
KEGG_2021_Human,glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),1/5,0.0124387771927725,0.1346456223396145,0,0,101.76530612244898,446.4379351400606,RET,CLP,1.9052223113279663
KEGG_2021_Human,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),1/5,0.0124387771927725,0.1346456223396145,0,0,101.76530612244898,446.4379351400606,UHRF1,CLP,1.9052223113279663
KEGG_2021_Human,"CD4-positive, alpha-beta T cell activation (GO:0035710)",1/5,0.0124387771927725,0.1346456223396145,0,0,101.76530612244898,446.4379351400606,TNFSF4,CLP,1.9052223113279663
KEGG_2021_Human,regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),1/5,0.0124387771927725,0.1346456223396145,0,0,101.76530612244898,446.4379351400606,UHRF1,CLP,1.9052223113279663
KEGG_2021_Human,inosine metabolic process (GO:0046102),1/5,0.0124387771927725,0.1346456223396145,0,0,101.76530612244898,446.4379351400606,ADA,CLP,1.9052223113279663
KEGG_2021_Human,negative regulation of regulatory T cell differentiation (GO:0045590),1/5,0.0124387771927725,0.1346456223396145,0,0,101.76530612244898,446.4379351400606,TNFSF4,CLP,1.9052223113279663
KEGG_2021_Human,negative regulation of anion transport (GO:1903792),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,TRH,CLP,1.8265723193247598
KEGG_2021_Human,negative regulation of serine-type peptidase activity (GO:1902572),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,SPINK2,CLP,1.8265723193247598
KEGG_2021_Human,positive regulation of anion transport (GO:1903793),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,TRH,CLP,1.8265723193247598
KEGG_2021_Human,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,IL4I1,CLP,1.8265723193247598
KEGG_2021_Human,regulation of resting membrane potential (GO:0060075),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,ATP1A3,CLP,1.8265723193247598
KEGG_2021_Human,regulation of serine-type endopeptidase activity (GO:1900003),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,SPINK2,CLP,1.8265723193247598
KEGG_2021_Human,purine ribonucleoside catabolic process (GO:0046130),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,ADA,CLP,1.8265723193247598
KEGG_2021_Human,regulation of immunoglobulin mediated immune response (GO:0002889),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,TNFSF4,CLP,1.8265723193247598
KEGG_2021_Human,maintenance of DNA methylation (GO:0010216),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,UHRF1,CLP,1.8265723193247598
KEGG_2021_Human,regulation of type 2 immune response (GO:0002828),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,TNFSF4,CLP,1.8265723193247598
KEGG_2021_Human,positive regulation of T-helper 2 cell differentiation (GO:0045630),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,TNFSF4,CLP,1.8265723193247598
KEGG_2021_Human,tyrosine catabolic process (GO:0006572),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,IL4I1,CLP,1.8265723193247598
KEGG_2021_Human,histamine metabolic process (GO:0001692),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,TRH,CLP,1.8265723193247598
KEGG_2021_Human,negative regulation of amino acid transport (GO:0051956),1/6,0.0149082847993736,0.1346456223396145,0,0,81.40816326530613,342.3895623444841,TRH,CLP,1.8265723193247598
KEGG_2021_Human,regulation of T cell proliferation (GO:0042129),2/76,0.0155171628224907,0.1346456223396145,0,0,11.19144144144144,46.62140287744705,IL4I1;TNFSF4,CLP,1.8091876827669675
KEGG_2021_Human,cellular response to prostaglandin E stimulus (GO:0071380),1/7,0.0173717414502839,0.1346456223396145,0,0,67.83673469387755,274.9362107684438,TNFSF4,CLP,1.7601566430186848
KEGG_2021_Human,lymphoid progenitor cell differentiation (GO:0002320),1/7,0.0173717414502839,0.1346456223396145,0,0,67.83673469387755,274.9362107684438,FLT3,CLP,1.7601566430186848
KEGG_2021_Human,regulation of T cell mediated immune response to tumor cell (GO:0002840),1/7,0.0173717414502839,0.1346456223396145,0,0,67.83673469387755,274.9362107684438,IL4I1,CLP,1.7601566430186848
KEGG_2021_Human,regulation of T-helper 1 cell differentiation (GO:0045625),1/7,0.0173717414502839,0.1346456223396145,0,0,67.83673469387755,274.9362107684438,TNFSF4,CLP,1.7601566430186848
KEGG_2021_Human,cellular response to lipid (GO:0071396),3/219,0.0174000582463563,0.1346456223396145,0,0,5.831560283687943,23.625293607147455,RET;TNFSF4;ATP1A3,CLP,1.7594492979226422
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),4/404,0.0181965439550163,0.1346456223396145,0,0,4.25,17.027725280929346,RET;FLT3;CLNK;ATP6V0A4,CLP,1.74001108914638
KEGG_2021_Human,"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",1/8,0.0198291614511851,0.1346456223396145,0,0,58.142857142857146,227.9549801512961,TNFSF4,CLP,1.702695651141308
KEGG_2021_Human,regulation of T-helper 2 cell differentiation (GO:0045628),1/8,0.0198291614511851,0.1346456223396145,0,0,58.142857142857146,227.9549801512961,TNFSF4,CLP,1.702695651141308
KEGG_2021_Human,regulation of alpha-beta T cell proliferation (GO:0046640),1/8,0.0198291614511851,0.1346456223396145,0,0,58.142857142857146,227.9549801512961,TNFSF4,CLP,1.702695651141308
KEGG_2021_Human,positive regulation of isomerase activity (GO:0010912),1/8,0.0198291614511851,0.1346456223396145,0,0,58.142857142857146,227.9549801512961,UHRF1,CLP,1.702695651141308
KEGG_2021_Human,sodium ion transmembrane transport (GO:0035725),2/87,0.0200173181098975,0.1346456223396145,0,0,9.737745098039216,38.08585452607372,ATP1A3;SCN3A,CLP,1.6985941090791523
KEGG_2021_Human,T cell activation (GO:0042110),2/92,0.0222223839756269,0.1346456223396145,0,0,9.194444444444445,35.00007985571613,TNFSF4;ADA,CLP,1.6532093525993499
KEGG_2021_Human,L-phenylalanine metabolic process (GO:0006558),1/9,0.0222805591236868,0.1346456223396145,0,0,50.87244897959184,193.52086993316271,IL4I1,CLP,1.652073914876897
KEGG_2021_Human,adenosine metabolic process (GO:0046085),1/9,0.0222805591236868,0.1346456223396145,0,0,50.87244897959184,193.52086993316271,ADA,CLP,1.652073914876897
KEGG_2021_Human,positive regulation of memory T cell differentiation (GO:0043382),1/9,0.0222805591236868,0.1346456223396145,0,0,50.87244897959184,193.52086993316271,TNFSF4,CLP,1.652073914876897
KEGG_2021_Human,regulation of kinase activity (GO:0043549),2/94,0.0231314233527167,0.1346456223396145,0,0,8.993659420289855,33.87518721331595,RET;FLT3,CLP,1.6357976428363092
KEGG_2021_Human,cellular response to prostaglandin stimulus (GO:0071379),1/10,0.024725948817258,0.1346456223396145,0,0,45.21768707482993,167.3010120823387,TNFSF4,CLP,1.606847034080906
KEGG_2021_Human,neuron projection maintenance (GO:1990535),1/10,0.024725948817258,0.1346456223396145,0,0,45.21768707482993,167.3010120823387,ATP1A3,CLP,1.606847034080906
KEGG_2021_Human,aromatic amino acid family metabolic process (GO:0009072),1/10,0.024725948817258,0.1346456223396145,0,0,45.21768707482993,167.3010120823387,IL4I1,CLP,1.606847034080906
KEGG_2021_Human,regulation of memory T cell differentiation (GO:0043380),1/10,0.024725948817258,0.1346456223396145,0,0,45.21768707482993,167.3010120823387,TNFSF4,CLP,1.606847034080906
KEGG_2021_Human,granulocyte migration (GO:0097530),1/10,0.024725948817258,0.1346456223396145,0,0,45.21768707482993,167.3010120823387,UMODL1,CLP,1.606847034080906
KEGG_2021_Human,regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/10,0.024725948817258,0.1346456223396145,0,0,45.21768707482993,167.3010120823387,ADA,CLP,1.606847034080906
KEGG_2021_Human,indolalkylamine catabolic process (GO:0046218),1/10,0.024725948817258,0.1346456223396145,0,0,45.21768707482993,167.3010120823387,IL4I1,CLP,1.606847034080906
KEGG_2021_Human,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),1/10,0.024725948817258,0.1346456223396145,0,0,45.21768707482993,167.3010120823387,NPTX2,CLP,1.606847034080906
KEGG_2021_Human,negative regulation of T-helper cell differentiation (GO:0045623),1/11,0.0271653448579923,0.1346456223396145,0,0,40.69387755102041,146.73452100035948,TNFSF4,CLP,1.5659847773237099
KEGG_2021_Human,negative regulation of interleukin-17 production (GO:0032700),1/11,0.0271653448579923,0.1346456223396145,0,0,40.69387755102041,146.73452100035948,TNFSF4,CLP,1.5659847773237099
KEGG_2021_Human,tryptophan catabolic process (GO:0006569),1/11,0.0271653448579923,0.1346456223396145,0,0,40.69387755102041,146.73452100035948,IL4I1,CLP,1.5659847773237099
KEGG_2021_Human,tryptophan metabolic process (GO:0006568),1/11,0.0271653448579923,0.1346456223396145,0,0,40.69387755102041,146.73452100035948,IL4I1,CLP,1.5659847773237099
KEGG_2021_Human,positive regulation of voltage-gated potassium channel activity (GO:1903818),1/11,0.0271653448579923,0.1346456223396145,0,0,40.69387755102041,146.73452100035948,LRRC26,CLP,1.5659847773237099
KEGG_2021_Human,positive regulation of interleukin-13 production (GO:0032736),1/11,0.0271653448579923,0.1346456223396145,0,0,40.69387755102041,146.73452100035948,TNFSF4,CLP,1.5659847773237099
KEGG_2021_Human,response to prostaglandin E (GO:0034695),1/11,0.0271653448579923,0.1346456223396145,0,0,40.69387755102041,146.73452100035948,TNFSF4,CLP,1.5659847773237099
KEGG_2021_Human,regulation of pH (GO:0006885),1/11,0.0271653448579923,0.1346456223396145,0,0,40.69387755102041,146.73452100035948,ATP6V0A4,CLP,1.5659847773237099
KEGG_2021_Human,purine nucleotide biosynthetic process (GO:0006164),1/12,0.029598761568907,0.1354151522539762,0,0,36.99257884972171,130.2147194065139,ADA,CLP,1.5287264597194943
KEGG_2021_Human,positive regulation of protein maturation (GO:1903319),1/12,0.029598761568907,0.1354151522539762,0,0,36.99257884972171,130.2147194065139,NKD2,CLP,1.5287264597194943
KEGG_2021_Human,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",1/12,0.029598761568907,0.1354151522539762,0,0,36.99257884972171,130.2147194065139,TNFSF4,CLP,1.5287264597194943
KEGG_2021_Human,tyrosine metabolic process (GO:0006570),1/12,0.029598761568907,0.1354151522539762,0,0,36.99257884972171,130.2147194065139,IL4I1,CLP,1.5287264597194943
KEGG_2021_Human,carboxylic acid catabolic process (GO:0046395),1/12,0.029598761568907,0.1354151522539762,0,0,36.99257884972171,130.2147194065139,IL4I1,CLP,1.5287264597194943
KEGG_2021_Human,sodium ion export across plasma membrane (GO:0036376),1/13,0.032026213248763,0.1354151522539762,0,0,33.90816326530612,116.6847899929619,ATP1A3,CLP,1.4944944088974865
KEGG_2021_Human,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/13,0.032026213248763,0.1354151522539762,0,0,33.90816326530612,116.6847899929619,TNFSF4,CLP,1.4944944088974865
KEGG_2021_Human,purine-containing compound salvage (GO:0043101),1/13,0.032026213248763,0.1354151522539762,0,0,33.90816326530612,116.6847899929619,ADA,CLP,1.4944944088974865
KEGG_2021_Human,negative regulation of locomotion (GO:0040013),1/13,0.032026213248763,0.1354151522539762,0,0,33.90816326530612,116.6847899929619,SPOCK3,CLP,1.4944944088974865
KEGG_2021_Human,cellular biogenic amine metabolic process (GO:0006576),1/13,0.032026213248763,0.1354151522539762,0,0,33.90816326530612,116.6847899929619,TRH,CLP,1.4944944088974865
KEGG_2021_Human,cellular potassium ion homeostasis (GO:0030007),1/13,0.032026213248763,0.1354151522539762,0,0,33.90816326530612,116.6847899929619,ATP1A3,CLP,1.4944944088974865
KEGG_2021_Human,positive regulation of kinase activity (GO:0033674),2/114,0.0330295301793541,0.1354151522539762,0,0,7.380208333333333,25.169117576656426,RET;FLT3,CLP,1.4810976037825534
KEGG_2021_Human,positive regulation of alpha-beta T cell differentiation (GO:0046638),1/14,0.0344477141698711,0.1354151522539762,0,0,31.298273155416013,105.4223689491126,TNFSF4,CLP,1.4628395910668823
KEGG_2021_Human,negative regulation of T cell differentiation (GO:0045581),1/14,0.0344477141698711,0.1354151522539762,0,0,31.298273155416013,105.4223689491126,TNFSF4,CLP,1.4628395910668823
KEGG_2021_Human,negative regulation of T cell mediated immunity (GO:0002710),1/14,0.0344477141698711,0.1354151522539762,0,0,31.298273155416013,105.4223689491126,IL4I1,CLP,1.4628395910668823
KEGG_2021_Human,positive regulation of regulatory T cell differentiation (GO:0045591),1/14,0.0344477141698711,0.1354151522539762,0,0,31.298273155416013,105.4223689491126,IL4I1,CLP,1.4628395910668823
KEGG_2021_Human,positive regulation of T-helper cell differentiation (GO:0045624),1/14,0.0344477141698711,0.1354151522539762,0,0,31.298273155416013,105.4223689491126,TNFSF4,CLP,1.4628395910668823
KEGG_2021_Human,positive regulation of type 2 immune response (GO:0002830),1/14,0.0344477141698711,0.1354151522539762,0,0,31.298273155416013,105.4223689491126,TNFSF4,CLP,1.4628395910668823
KEGG_2021_Human,aflatoxin metabolic process (GO:0046222),1/15,0.0368632785936063,0.1355617341829393,0,0,29.06122448979592,95.91771596133704,ACY3,CLP,1.4334060415588732
KEGG_2021_Human,negative regulation of cellular component movement (GO:0051271),1/15,0.0368632785936063,0.1355617341829393,0,0,29.06122448979592,95.91771596133704,SPOCK3,CLP,1.4334060415588732
KEGG_2021_Human,cellular sodium ion homeostasis (GO:0006883),1/15,0.0368632785936063,0.1355617341829393,0,0,29.06122448979592,95.91771596133704,ATP1A3,CLP,1.4334060415588732
KEGG_2021_Human,positive regulation of secretion (GO:0051047),1/15,0.0368632785936063,0.1355617341829393,0,0,29.06122448979592,95.91771596133704,TRH,CLP,1.4334060415588732
KEGG_2021_Human,organic heteropentacyclic compound metabolic process (GO:1901376),1/15,0.0368632785936063,0.1355617341829393,0,0,29.06122448979592,95.91771596133704,ACY3,CLP,1.4334060415588732
KEGG_2021_Human,mycotoxin metabolic process (GO:0043385),1/15,0.0368632785936063,0.1355617341829393,0,0,29.06122448979592,95.91771596133704,ACY3,CLP,1.4334060415588732
KEGG_2021_Human,positive regulation of alpha-beta T cell proliferation (GO:0046641),1/16,0.0392729207344652,0.1356700898099708,0,0,27.122448979591837,87.80133530116419,TNFSF4,CLP,1.405906798966597
KEGG_2021_Human,regulation of interleukin-13 production (GO:0032656),1/16,0.0392729207344652,0.1356700898099708,0,0,27.122448979591837,87.80133530116419,TNFSF4,CLP,1.405906798966597
KEGG_2021_Human,neuron cell-cell adhesion (GO:0007158),1/16,0.0392729207344652,0.1356700898099708,0,0,27.122448979591837,87.80133530116419,RET,CLP,1.405906798966597
KEGG_2021_Human,neuron projection organization (GO:0106027),1/16,0.0392729207344652,0.1356700898099708,0,0,27.122448979591837,87.80133530116419,ATP1A3,CLP,1.405906798966597
KEGG_2021_Human,aromatic amino acid family catabolic process (GO:0009074),1/16,0.0392729207344652,0.1356700898099708,0,0,27.122448979591837,87.80133530116419,IL4I1,CLP,1.405906798966597
KEGG_2021_Human,positive regulation of immunoglobulin mediated immune response (GO:0002891),1/16,0.0392729207344652,0.1356700898099708,0,0,27.122448979591837,87.80133530116419,TNFSF4,CLP,1.405906798966597
KEGG_2021_Human,muscle contraction (GO:0006936),2/129,0.0413519534712599,0.1411229300851668,0,0,6.5036089238845145,20.718128222258283,GALR2;MYOM2,CLP,1.383503969503222
KEGG_2021_Human,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/17,0.0416766547912334,0.1411229300851668,0,0,25.426020408163264,80.79916728086499,ATP1A3,CLP,1.3801071472903907
KEGG_2021_Human,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.0440744949316926,0.1435569263489418,0,0,23.92917166866747,74.70385911458476,RET,CLP,1.3558126557645607
KEGG_2021_Human,regulation of B cell differentiation (GO:0045577),1/18,0.0440744949316926,0.1435569263489418,0,0,23.92917166866747,74.70385911458476,IL4I1,CLP,1.3558126557645607
KEGG_2021_Human,negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/18,0.0440744949316926,0.1435569263489418,0,0,23.92917166866747,74.70385911458476,IL4I1,CLP,1.3558126557645607
KEGG_2021_Human,positive regulation of interleukin-4 production (GO:0032753),1/18,0.0440744949316926,0.1435569263489418,0,0,23.92917166866747,74.70385911458476,TNFSF4,CLP,1.3558126557645607
KEGG_2021_Human,regulation of T cell cytokine production (GO:0002724),1/19,0.0464664552952436,0.1465576499460832,0,0,22.598639455782312,69.35578082800635,TNFSF4,CLP,1.3328604565168853
KEGG_2021_Human,regulation of nervous system process (GO:0031644),1/19,0.0464664552952436,0.1465576499460832,0,0,22.598639455782312,69.35578082800635,NPTX2,CLP,1.3328604565168853
KEGG_2021_Human,potassium ion transmembrane transport (GO:0071805),2/139,0.0472922793944307,0.1465576499460832,0,0,6.025851581508515,18.3873330672393,LRRC26;ATP1A3,CLP,1.3252097533441285
KEGG_2021_Human,positive regulation of activated T cell proliferation (GO:0042104),1/20,0.0488525499820277,0.1465576499460832,0,0,21.40816326530612,64.63014669364038,TMIGD2,CLP,1.3111127622579986
KEGG_2021_Human,positive regulation of alpha-beta T cell activation (GO:0046635),1/20,0.0488525499820277,0.1465576499460832,0,0,21.40816326530612,64.63014669364038,TNFSF4,CLP,1.3111127622579986
KEGG_2021_Human,positive regulation of protein processing (GO:0010954),1/20,0.0488525499820277,0.1465576499460832,0,0,21.40816326530612,64.63014669364038,NKD2,CLP,1.3111127622579986
KEGG_2021_Human,regulation of lymphocyte differentiation (GO:0045619),1/20,0.0488525499820277,0.1465576499460832,0,0,21.40816326530612,64.63014669364038,IL4I1,CLP,1.3111127622579986
KEGG_2021_Human,nucleobase-containing compound biosynthetic process (GO:0034654),1/20,0.0488525499820277,0.1465576499460832,0,0,21.40816326530612,64.63014669364038,ADA,CLP,1.3111127622579986
KEGG_2021_Human,cellular monovalent inorganic cation homeostasis (GO:0030004),1/20,0.0488525499820277,0.1465576499460832,0,0,21.40816326530612,64.63014669364038,ATP1A3,CLP,1.3111127622579986
KEGG_2021_Human,cellular response to steroid hormone stimulus (GO:0071383),1/21,0.0512327930672156,0.1484882646524384,0,0,20.336734693877553,60.42807445408675,ATP1A3,CLP,1.2904519669693806
KEGG_2021_Human,positive regulation of T cell cytokine production (GO:0002726),1/21,0.0512327930672156,0.1484882646524384,0,0,20.336734693877553,60.42807445408675,TNFSF4,CLP,1.2904519669693806
KEGG_2021_Human,vacuolar acidification (GO:0007035),1/21,0.0512327930672156,0.1484882646524384,0,0,20.336734693877553,60.42807445408675,ATP6V0A4,CLP,1.2904519669693806
KEGG_2021_Human,histone ubiquitination (GO:0016574),1/21,0.0512327930672156,0.1484882646524384,0,0,20.336734693877553,60.42807445408675,UHRF1,CLP,1.2904519669693806
KEGG_2021_Human,positive regulation of transferase activity (GO:0051347),2/148,0.052889062238365,0.151517867115249,0,0,5.651826484018265,16.61387585032132,RET;FLT3,CLP,1.2766341332705589
KEGG_2021_Human,neuronal action potential (GO:0019228),1/22,0.0536071985992547,0.151517867115249,0,0,19.367346938775512,56.67024999786951,SCN3A,CLP,1.2707768875084013
KEGG_2021_Human,negative regulation of lymphocyte activation (GO:0051250),1/22,0.0536071985992547,0.151517867115249,0,0,19.367346938775512,56.67024999786951,IL4I1,CLP,1.2707768875084013
KEGG_2021_Human,regulation of cytokine production (GO:0001817),2/150,0.0541636617411515,0.1518358386514247,0,0,5.574887387387387,16.25495026487543,TMIGD2;TNFSF4,CLP,1.2662919827974375
KEGG_2021_Human,regulation of interleukin-4 production (GO:0032673),1/23,0.0559757805878795,0.1543848142020548,0,0,18.4860853432282,53.29235549319145,TNFSF4,CLP,1.2519998414265567
KEGG_2021_Human,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),1/23,0.0559757805878795,0.1543848142020548,0,0,18.4860853432282,53.29235549319145,ADA,CLP,1.2519998414265567
KEGG_2021_Human,dendritic cell differentiation (GO:0097028),1/24,0.0583385530130099,0.1571006703184992,0,0,17.68145519077196,50.24171555062859,FLT3,CLP,1.2340443470047993
KEGG_2021_Human,potassium ion homeostasis (GO:0055075),1/24,0.0583385530130099,0.1571006703184992,0,0,17.68145519077196,50.24171555062859,ATP1A3,CLP,1.2340443470047993
KEGG_2021_Human,histone monoubiquitination (GO:0010390),1/24,0.0583385530130099,0.1571006703184992,0,0,17.68145519077196,50.24171555062859,UHRF1,CLP,1.2340443470047993
KEGG_2021_Human,sodium ion homeostasis (GO:0055078),1/25,0.0606955298241754,0.1609137302315348,0,0,16.943877551020407,47.47480020477031,ATP1A3,CLP,1.2168432931781568
KEGG_2021_Human,regulation of protein processing (GO:0070613),1/25,0.0606955298241754,0.1609137302315348,0,0,16.943877551020407,47.47480020477031,NKD2,CLP,1.2168432931781568
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),2/161,0.0613656526664216,0.1614388708608938,0,0,5.186320754716981,14.474528542436865,RET;FLT3,CLP,1.212074642397333
KEGG_2021_Human,purine-containing compound biosynthetic process (GO:0072522),1/26,0.0630467249540435,0.1621201498818262,0,0,16.26530612244898,44.95534064809558,ADA,CLP,1.2003374685092782
KEGG_2021_Human,membrane depolarization during action potential (GO:0086010),1/26,0.0630467249540435,0.1621201498818262,0,0,16.26530612244898,44.95534064809558,SCN3A,CLP,1.2003374685092782
KEGG_2021_Human,mononuclear cell differentiation (GO:1903131),1/26,0.0630467249540435,0.1621201498818262,0,0,16.26530612244898,44.95534064809558,FLT3,CLP,1.2003374685092782
KEGG_2021_Human,regulation of MAPK cascade (GO:0043408),2/166,0.0647425290365929,0.1631287630912501,0,0,5.0269308943089435,13.760403766207606,RET;FLT3,CLP,1.1888103397622347
KEGG_2021_Human,acute inflammatory response (GO:0002526),1/27,0.0653921522588676,0.1631287630912501,0,0,15.638932496075354,42.652889831563165,TNFSF4,CLP,1.184474368421492
KEGG_2021_Human,monovalent inorganic cation homeostasis (GO:0055067),1/27,0.0653921522588676,0.1631287630912501,0,0,15.638932496075354,42.652889831563165,ATP6V0A4,CLP,1.184474368421492
KEGG_2021_Human,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.0677318256109869,0.1631287630912501,0,0,15.058956916099774,40.54171043527237,RET,CLP,1.1692072184717057
KEGG_2021_Human,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/28,0.0677318256109869,0.1631287630912501,0,0,15.058956916099774,40.54171043527237,FLT3,CLP,1.1692072184717057
KEGG_2021_Human,regulation of immunoglobulin production (GO:0002637),1/28,0.0677318256109869,0.1631287630912501,0,0,15.058956916099774,40.54171043527237,TNFSF4,CLP,1.1692072184717057
KEGG_2021_Human,phagosome acidification (GO:0090383),1/28,0.0677318256109869,0.1631287630912501,0,0,15.058956916099774,40.54171043527237,ATP6V0A4,CLP,1.1692072184717057
KEGG_2021_Human,sarcomere organization (GO:0045214),1/28,0.0677318256109869,0.1631287630912501,0,0,15.058956916099774,40.54171043527237,MYOM2,CLP,1.1692072184717057
KEGG_2021_Human,protein localization to Golgi apparatus (GO:0034067),1/28,0.0677318256109869,0.1631287630912501,0,0,15.058956916099774,40.54171043527237,ARL5C,CLP,1.1692072184717057
KEGG_2021_Human,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/29,0.0700657588372089,0.1664061772383712,0,0,14.520408163265309,38.5999069065122,RET,CLP,1.1544941700666143
KEGG_2021_Human,negative regulation of interferon-gamma production (GO:0032689),1/29,0.0700657588372089,0.1664061772383712,0,0,14.520408163265309,38.5999069065122,TNFSF4,CLP,1.1544941700666143
KEGG_2021_Human,alpha-amino acid catabolic process (GO:1901606),1/30,0.0723939657090184,0.1695803854279746,0,0,14.019000703729768,36.80874147674154,IL4I1,CLP,1.1402976322627019
KEGG_2021_Human,positive regulation of lipid kinase activity (GO:0090218),1/30,0.0723939657090184,0.1695803854279746,0,0,14.019000703729768,36.80874147674154,FLT3,CLP,1.1402976322627019
KEGG_2021_Human,membrane depolarization (GO:0051899),1/32,0.0770332554327668,0.1744726712450746,0,0,13.113232389730086,33.61600807740255,SCN3A,CLP,1.1133217484244988
KEGG_2021_Human,metal ion export (GO:0070839),1/32,0.0770332554327668,0.1744726712450746,0,0,13.113232389730086,33.61600807740255,ATP1A3,CLP,1.1133217484244988
KEGG_2021_Human,hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.0770332554327668,0.1744726712450746,0,0,13.113232389730086,33.61600807740255,FLT3,CLP,1.1133217484244988
KEGG_2021_Human,positive regulation of immune effector process (GO:0002699),1/32,0.0770332554327668,0.1744726712450746,0,0,13.113232389730086,33.61600807740255,TNFSF4,CLP,1.1133217484244988
KEGG_2021_Human,positive regulation of interleukin-10 production (GO:0032733),1/32,0.0770332554327668,0.1744726712450746,0,0,13.113232389730086,33.61600807740255,TNFSF4,CLP,1.1133217484244988
KEGG_2021_Human,regulation of interleukin-17 production (GO:0032660),1/33,0.0793443657059371,0.1772269024293979,0,0,12.70280612244898,32.18837516559274,TNFSF4,CLP,1.1004839073426347
KEGG_2021_Human,positive regulation of cytokine production involved in immune response (GO:0002720),1/33,0.0793443657059371,0.1772269024293979,0,0,12.70280612244898,32.18837516559274,TNFSF4,CLP,1.1004839073426347
KEGG_2021_Human,regulation of activated T cell proliferation (GO:0046006),1/34,0.0816498044624026,0.1772269024293979,0,0,12.317254174397032,30.85861216573232,TMIGD2,CLP,1.0880448509885652
KEGG_2021_Human,positive regulation of interleukin-12 production (GO:0032735),1/34,0.0816498044624026,0.1772269024293979,0,0,12.317254174397032,30.85861216573232,TNFSF4,CLP,1.0880448509885652
KEGG_2021_Human,response to steroid hormone (GO:0048545),1/34,0.0816498044624026,0.1772269024293979,0,0,12.317254174397032,30.85861216573232,ATP1A3,CLP,1.0880448509885652
KEGG_2021_Human,negative regulation of T cell proliferation (GO:0042130),1/35,0.0839495853612937,0.1772269024293979,0,0,11.95438175270108,29.61744503578088,IL4I1,CLP,1.0759814445616303
KEGG_2021_Human,positive regulation of immunoglobulin production (GO:0002639),1/35,0.0839495853612937,0.1772269024293979,0,0,11.95438175270108,29.61744503578088,TNFSF4,CLP,1.0759814445616303
KEGG_2021_Human,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/35,0.0839495853612937,0.1772269024293979,0,0,11.95438175270108,29.61744503578088,FLT3,CLP,1.0759814445616303
KEGG_2021_Human,positive regulation of lymphocyte activation (GO:0051251),1/35,0.0839495853612937,0.1772269024293979,0,0,11.95438175270108,29.61744503578088,TNFSF4,CLP,1.0759814445616303
KEGG_2021_Human,cellular response to amyloid-beta (GO:1904646),1/35,0.0839495853612937,0.1772269024293979,0,0,11.95438175270108,29.61744503578088,ATP1A3,CLP,1.0759814445616303
KEGG_2021_Human,intracellular pH reduction (GO:0051452),1/35,0.0839495853612937,0.1772269024293979,0,0,11.95438175270108,29.61744503578088,ATP6V0A4,CLP,1.0759814445616303
KEGG_2021_Human,protein localization to membrane (GO:0072657),2/195,0.0854831524975729,0.1787597146376557,0,0,4.265328151986183,10.490301477724982,ARL5C;NKD2,CLP,1.0681194700473418
KEGG_2021_Human,transferrin transport (GO:0033572),1/36,0.0862437219743075,0.1787597146376557,0,0,11.612244897959185,28.456712045041098,ATP6V0A4,CLP,1.0642725091375862
KEGG_2021_Human,positive regulation of T cell mediated immunity (GO:0002711),1/36,0.0862437219743075,0.1787597146376557,0,0,11.612244897959185,28.456712045041098,TNFSF4,CLP,1.0642725091375862
KEGG_2021_Human,phagosome maturation (GO:0090382),1/37,0.0885322278902676,0.1823977225209129,0,0,11.289115646258503,27.36920368672352,ATP6V0A4,CLP,1.0528986067362665
KEGG_2021_Human,positive regulation of production of molecular mediator of immune response (GO:0002702),1/38,0.0908151166313484,0.1829747205919125,0,0,10.983452840595698,26.34852930034076,TNFSF4,CLP,1.0418418549683985
KEGG_2021_Human,lymphocyte proliferation (GO:0046651),1/38,0.0908151166313484,0.1829747205919125,0,0,10.983452840595698,26.34852930034076,FLT3,CLP,1.0418418549683985
KEGG_2021_Human,positive regulation of insulin secretion (GO:0032024),1/38,0.0908151166313484,0.1829747205919125,0,0,10.983452840595698,26.34852930034076,TRH,CLP,1.0418418549683985
KEGG_2021_Human,protein monoubiquitination (GO:0006513),1/39,0.0930924017046572,0.1829747205919125,0,0,10.693877551020408,25.38900533231373,UHRF1,CLP,1.0310857651239858
KEGG_2021_Human,negative regulation of secretion by cell (GO:1903531),1/39,0.0930924017046572,0.1829747205919125,0,0,10.693877551020408,25.38900533231373,TRH,CLP,1.0310857651239858
KEGG_2021_Human,cellular response to ketone (GO:1901655),1/39,0.0930924017046572,0.1829747205919125,0,0,10.693877551020408,25.38900533231373,TNFSF4,CLP,1.0310857651239858
KEGG_2021_Human,membrane protein proteolysis (GO:0033619),1/39,0.0930924017046572,0.1829747205919125,0,0,10.693877551020408,25.38900533231373,RET,CLP,1.0310857651239858
KEGG_2021_Human,negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.0930924017046572,0.1829747205919125,0,0,10.693877551020408,25.38900533231373,IL4I1,CLP,1.0310857651239858
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),2/207,0.0945848472510804,0.1848458157706829,0,0,4.013211382113822,9.464187818681536,RET;FLT3,CLP,1.0241784331789758
KEGG_2021_Human,lymphocyte migration (GO:0072676),1/40,0.0953640965755271,0.1853097785728993,0,0,10.419152276295131,24.485561288951835,RET,CLP,1.0206151011238414
KEGG_2021_Human,positive regulation of ATPase activity (GO:0032781),1/42,0.0998907694703361,0.1898579065410882,0,0,9.909905425584869,22.829231064333683,UHRF1,CLP,1.00047464143678
KEGG_2021_Human,regulation of chemokine production (GO:0032642),1/42,0.0998907694703361,0.1898579065410882,0,0,9.909905425584869,22.829231064333683,TNFSF4,CLP,1.00047464143678
KEGG_2021_Human,potassium ion import across plasma membrane (GO:1990573),1/42,0.0998907694703361,0.1898579065410882,0,0,9.909905425584869,22.829231064333683,ATP1A3,CLP,1.00047464143678
KEGG_2021_Human,positive regulation of peptide hormone secretion (GO:0090277),1/43,0.1021457742794159,0.1898579065410882,0,0,9.673469387755102,22.068611238785657,TRH,CLP,0.9907795952096249
KEGG_2021_Human,spermatid development (GO:0007286),1/43,0.1021457742794159,0.1898579065410882,0,0,9.673469387755102,22.068611238785657,SPINK2,CLP,0.9907795952096249
KEGG_2021_Human,cellular response to retinoic acid (GO:0071300),1/43,0.1021457742794159,0.1898579065410882,0,0,9.673469387755102,22.068611238785657,RET,CLP,0.9907795952096249
KEGG_2021_Human,regulation of cell-cell adhesion (GO:0022407),1/43,0.1021457742794159,0.1898579065410882,0,0,9.673469387755102,22.068611238785657,ADA,CLP,0.9907795952096249
KEGG_2021_Human,myofibril assembly (GO:0030239),1/43,0.1021457742794159,0.1898579065410882,0,0,9.673469387755102,22.068611238785657,MYOM2,CLP,0.9907795952096249
KEGG_2021_Human,response to amyloid-beta (GO:1904645),1/44,0.1043952424647777,0.1929901239078593,0,0,9.448030374940672,21.34849709415977,ATP1A3,CLP,0.9813192926974915
KEGG_2021_Human,action potential (GO:0001508),1/45,0.1066391873529346,0.1950299576187361,0,0,9.232838589981448,20.665901611884028,SCN3A,CLP,0.9720831731354668
KEGG_2021_Human,negative regulation of T cell activation (GO:0050868),1/45,0.1066391873529346,0.1950299576187361,0,0,9.232838589981448,20.665901611884028,IL4I1,CLP,0.9720831731354668
KEGG_2021_Human,regulation of T cell activation (GO:0050863),1/47,0.1111105603036554,0.2021266575736711,0,0,8.830523513753327,19.4026870705364,IL4I1,CLP,0.9542446623584087
KEGG_2021_Human,regulation of interleukin-10 production (GO:0032653),1/48,0.1133380148369131,0.2040084267064436,0,0,8.642205818497612,18.81737166641443,TNFSF4,CLP,0.9456243984787533
KEGG_2021_Human,cellular response to alcohol (GO:0097306),1/48,0.1133380148369131,0.2040084267064436,0,0,8.642205818497612,18.81737166641443,TNFSF4,CLP,0.9456243984787533
KEGG_2021_Human,regulation of cellular protein metabolic process (GO:0032268),1/49,0.1155599990222406,0.2069189511288288,0,0,8.46173469387755,18.260130793597916,UHRF1,CLP,0.9371924705024297
KEGG_2021_Human,iron ion transport (GO:0006826),1/50,0.1177765260040411,0.2097894369446982,0,0,8.28862973760933,17.7290996615035,ATP6V0A4,CLP,0.928941259997044
KEGG_2021_Human,regulation of interleukin-12 production (GO:0032655),1/51,0.1199876089220907,0.212620529799767,0,0,8.122448979591837,17.22257115519733,TNFSF4,CLP,0.9208636010741894
KEGG_2021_Human,positive regulation of protein localization to cell periphery (GO:1904377),1/52,0.1221932608707862,0.2143081806041482,0,0,7.962785114045619,16.738979733033663,NKD2,CLP,0.9129527453809976
KEGG_2021_Human,positive regulation of protein localization to plasma membrane (GO:1903078),1/52,0.1221932608707862,0.2143081806041482,0,0,7.962785114045619,16.738979733033663,NKD2,CLP,0.9129527453809976
KEGG_2021_Human,positive regulation of B cell activation (GO:0050871),1/53,0.1243934949128716,0.215952158681229,0,0,7.809262166405024,16.276887238960814,TNFSF4,CLP,0.9052023302345248
KEGG_2021_Human,positive regulation of chemokine production (GO:0032722),1/53,0.1243934949128716,0.215952158681229,0,0,7.809262166405024,16.276887238960814,TNFSF4,CLP,0.9052023302345248
KEGG_2021_Human,regulation of cardiac conduction (GO:1903779),1/55,0.1287777613922166,0.2224343151320105,0,0,7.519274376417234,15.412009607623004,ATP1A3,CLP,0.8901591287349465
KEGG_2021_Human,peptidyl-tyrosine modification (GO:0018212),1/56,0.1309618198144747,0.2243056906479881,0,0,7.382189239332097,15.00687933540933,FLT3,CLP,0.8828552987007785
KEGG_2021_Human,positive regulation of phosphorylation (GO:0042327),2/253,0.1317582069542016,0.2243056906479881,0,0,3.270086321381142,6.627767796360294,RET;FLT3,CLP,0.880222323941479
KEGG_2021_Human,cellular response to peptide (GO:1901653),1/57,0.1331405122852093,0.2243056906479881,0,0,7.25,14.618539131965724,ATP1A3,CLP,0.8756897763447542
KEGG_2021_Human,positive regulation of proteolysis (GO:0045862),1/57,0.1331405122852093,0.2243056906479881,0,0,7.25,14.618539131965724,NKD2,CLP,0.8756897763447542
KEGG_2021_Human,positive regulation of interferon-gamma production (GO:0032729),1/57,0.1331405122852093,0.2243056906479881,0,0,7.25,14.618539131965724,TNFSF4,CLP,0.8756897763447542
KEGG_2021_Human,regulation of neurotransmitter receptor activity (GO:0099601),1/58,0.1353138517398134,0.2268496926226284,0,0,7.122448979591836,14.246025949065045,NPTX2,CLP,0.8686577434892403
KEGG_2021_Human,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/59,0.1374818510452552,0.2293599661340355,0,0,6.9992962702322306,13.8884471557023,FLT3,CLP,0.8617546291873563
KEGG_2021_Human,B cell differentiation (GO:0030183),1/61,0.1418018805927374,0.2354186561296902,0,0,6.76530612244898,13.214837540593155,FLT3,CLP,0.848318009451734
KEGG_2021_Human,response to retinoic acid (GO:0032526),1/62,0.1439539364695556,0.2366934916951348,0,0,6.654064904650385,12.897320592663672,RET,CLP,0.8417764546925935
KEGG_2021_Human,double-strand break repair via nonhomologous end joining (GO:0006303),1/62,0.1439539364695556,0.2366934916951348,0,0,6.654064904650385,12.897320592663672,DNTT,CLP,0.8417764546925935
KEGG_2021_Human,neuropeptide signaling pathway (GO:0007218),1/63,0.1461007034145454,0.2368077752027229,0,0,6.54641211323239,12.591756250239603,GALR2,CLP,0.8353476931121088
KEGG_2021_Human,organonitrogen compound catabolic process (GO:1901565),1/63,0.1461007034145454,0.2368077752027229,0,0,6.54641211323239,12.591756250239603,IL4I1,CLP,0.8353476931121088
KEGG_2021_Human,negative regulation of peptidase activity (GO:0010466),1/63,0.1461007034145454,0.2368077752027229,0,0,6.54641211323239,12.591756250239603,SPOCK3,CLP,0.8353476931121088
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),2/274,0.1497038344955427,0.2414526767608221,0,0,3.014399509803922,5.724635176902424,RET;FLT3,CLP,0.8247670755492156
KEGG_2021_Human,protein autoubiquitination (GO:0051865),1/65,0.1503784214913892,0.2414526767608221,0,0,6.341198979591836,12.01403781811508,UHRF1,CLP,0.8228144782361342
KEGG_2021_Human,DNA metabolic process (GO:0006259),2/277,0.1523078472737738,0.2434078680730405,0,0,2.981060606060606,5.609913359099665,UHRF1;DNTT,CLP,0.8172777201708421
KEGG_2021_Human,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/68,0.1567556490806558,0.2493508464445781,0,0,6.0563508985683825,11.222824361971773,FLT3,CLP,0.8047767993307415
KEGG_2021_Human,peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.158870948881139,0.2503864724301823,0,0,5.966986794717887,10.977245117600177,FLT3,CLP,0.7989555105590889
KEGG_2021_Human,positive regulation of MAP kinase activity (GO:0043406),1/69,0.158870948881139,0.2503864724301823,0,0,5.966986794717887,10.977245117600177,FLT3,CLP,0.7989555105590889
KEGG_2021_Human,nucleic acid metabolic process (GO:0090304),1/71,0.16308595979881,0.254682183795402,0,0,5.795918367346939,10.51076961698872,DNTT,CLP,0.7875834261109624
KEGG_2021_Human,regulation of endopeptidase activity (GO:0052548),1/71,0.16308595979881,0.254682183795402,0,0,5.795918367346939,10.51076961698872,SPOCK3,CLP,0.7875834261109624
KEGG_2021_Human,positive regulation of protein secretion (GO:0050714),1/72,0.1651856959101235,0.2567886727330102,0,0,5.713998275366484,10.28911103101624,TRH,CLP,0.78202756268309
KEGG_2021_Human,insulin receptor signaling pathway (GO:0008286),1/73,0.1672802691231711,0.258868108778844,0,0,5.634353741496598,10.074701240888364,ATP6V0A4,CLP,0.7765552814899175
KEGG_2021_Human,positive regulation of T cell activation (GO:0050870),1/75,0.1714539764404576,0.2588692063442223,0,0,5.4815223386651954,9.666337985731484,TNFSF4,CLP,0.7658524380723842
KEGG_2021_Human,positive regulation of immune response (GO:0050778),1/75,0.1714539764404576,0.2588692063442223,0,0,5.4815223386651954,9.666337985731484,TNFSF4,CLP,0.7658524380723842
KEGG_2021_Human,positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.1714539764404576,0.2588692063442223,0,0,5.4815223386651954,9.666337985731484,TNFSF4,CLP,0.7658524380723842
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",5/1183,0.1720230163025516,0.2588692063442223,0,0,1.7706093189964158,3.116497260687803,RET;IL4I1;TOX2;UHRF1;GALR2,CLP,0.7644134415549481
KEGG_2021_Human,cellular response to hormone stimulus (GO:0032870),1/76,0.1735331353639065,0.2588692063442223,0,0,5.408163265306122,9.4717853003048,ATP1A3,CLP,0.7606175863963804
KEGG_2021_Human,actomyosin structure organization (GO:0031032),1/76,0.1735331353639065,0.2588692063442223,0,0,5.408163265306122,9.4717853003048,MYOM2,CLP,0.7606175863963804
KEGG_2021_Human,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.2588692063442223,0,0,5.408163265306122,9.4717853003048,TNFSF4,CLP,0.7606175863963804
KEGG_2021_Human,MAPK cascade (GO:0000165),2/303,0.1752338998526144,0.2588692063442223,0,0,2.7199612403100777,4.737175959955004,RET;FLT3,CLP,0.7563818736544428
KEGG_2021_Human,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.1756071809118701,0.2588692063442223,0,0,5.336734693877551,9.283280446293812,FLT3,CLP,0.7554577289388229
KEGG_2021_Human,neutrophil migration (GO:1990266),1/77,0.1756071809118701,0.2588692063442223,0,0,5.336734693877551,9.283280446293812,UMODL1,CLP,0.7554577289388229
KEGG_2021_Human,inorganic cation import across plasma membrane (GO:0098659),1/77,0.1756071809118701,0.2588692063442223,0,0,5.336734693877551,9.283280446293812,ATP1A3,CLP,0.7554577289388229
KEGG_2021_Human,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/79,0.1797399811935544,0.2626968955905795,0,0,5.199372056514914,8.923391206941128,NKD2,CLP,0.745355308086215
KEGG_2021_Human,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.1797399811935544,0.2626968955905795,0,0,5.199372056514914,8.923391206941128,NKD2,CLP,0.745355308086215
KEGG_2021_Human,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2634541359650973,0,0,5.133298889175924,8.751529842637671,RET,CLP,0.7404090821369118
KEGG_2021_Human,regulation of protein localization to plasma membrane (GO:1903076),1/80,0.181798760490535,0.2634541359650973,0,0,5.133298889175924,8.751529842637671,NKD2,CLP,0.7404090821369118
KEGG_2021_Human,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.1838524754991919,0.2653061038849099,0,0,5.0688775510204085,8.584760541358477,GALR2,CLP,0.7355305181562768
KEGG_2021_Human,regulation of defense response (GO:0031347),1/83,0.1879447615357932,0.2700718842237029,0,0,4.944748631159781,8.265677319811374,TNFSF4,CLP,0.7259697745939766
KEGG_2021_Human,lymphocyte differentiation (GO:0030098),1/84,0.1899833569114356,0.2718590295552761,0,0,4.884927464961889,8.112979399077096,FLT3,CLP,0.7212844428267129
KEGG_2021_Human,positive regulation of transcription by RNA polymerase II (GO:0045944),4/908,0.1908851520255107,0.2719818253948965,0,0,1.8320507887649096,3.0340287711400475,IL4I1;TOX2;UHRF1;GALR2,CLP,0.7192278518272621
KEGG_2021_Human,B cell activation (GO:0042113),1/85,0.1920169366451308,0.2719818253948965,0,0,4.826530612244898,7.964604221414354,FLT3,CLP,0.716660463134361
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),2/323,0.1932342825020938,0.2719818253948965,0,0,2.5478971962616823,4.188365716592005,RET;TNFSF4,CLP,0.7139158210847405
KEGG_2021_Human,positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.1940455128548384,0.2719818253948965,0,0,4.769507803121249,7.820383303288144,NKD2,CLP,0.7120963955156414
KEGG_2021_Human,regulation of interferon-gamma production (GO:0032649),1/86,0.1940455128548384,0.2719818253948965,0,0,4.769507803121249,7.820383303288144,TNFSF4,CLP,0.7120963955156414
KEGG_2021_Human,positive regulation of neuron projection development (GO:0010976),1/88,0.1980877029036425,0.275390221109942,0,0,4.659394792399718,7.5437717166037235,RET,CLP,0.703142484213379
KEGG_2021_Human,sensory perception of mechanical stimulus (GO:0050954),1/88,0.1980877029036425,0.275390221109942,0,0,4.659394792399718,7.5437717166037235,ATP6V0A4,CLP,0.703142484213379
KEGG_2021_Human,positive regulation of inflammatory response (GO:0050729),1/89,0.2001013407742902,0.277063394918248,0,0,4.6062152133580705,7.411084001248333,TNFSF4,CLP,0.6987500013741589
KEGG_2021_Human,sodium ion transport (GO:0006814),1/90,0.2021100231923967,0.2775968993244967,0,0,4.55423068103646,7.281955543769811,SCN3A,CLP,0.6944121480917811
KEGG_2021_Human,cellular amino acid catabolic process (GO:0009063),1/90,0.2021100231923967,0.2775968993244967,0,0,4.55423068103646,7.281955543769811,IL4I1,CLP,0.6944121480917811
KEGG_2021_Human,sensory perception of sound (GO:0007605),1/91,0.2041137620931186,0.2781694655757114,0,0,4.503401360544218,7.156255051106618,ATP6V0A4,CLP,0.6901277125812961
KEGG_2021_Human,positive regulation of cytokine production (GO:0001819),2/335,0.2041536136242794,0.2781694655757114,0,0,2.4545795795795797,3.9000386874614623,TMIGD2;TNFSF4,CLP,0.6900429284365769
KEGG_2021_Human,regulation of heart contraction (GO:0008016),1/93,0.2081064570390282,0.281313866827461,0,0,4.40505767524401,6.914643337844717,ATP1A3,CLP,0.6817144444740324
KEGG_2021_Human,regulation of epithelial cell proliferation (GO:0050678),1/93,0.2081064570390282,0.281313866827461,0,0,4.40505767524401,6.914643337844717,UHRF1,CLP,0.6817144444740324
KEGG_2021_Human,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2828844070301934,0,0,4.357472021066491,6.79849904676328,FLT3,CLP,0.6775833802166729
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),2/345,0.2133084926466024,0.2860843313142667,0,0,2.381802721088435,3.6799229289674416,TMIGD2;TNFSF4,CLP,0.6709918532419347
KEGG_2021_Human,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.288606649102142,0,0,4.220663265306122,6.46742313757927,FLT3,CLP,0.6654798083211632
KEGG_2021_Human,positive regulation of defense response (GO:0031349),1/98,0.2180025137484037,0.2901045124589653,0,0,4.176940879444562,6.362519703204576,TNFSF4,CLP,0.6615384985937142
KEGG_2021_Human,positive regulation of protein localization to membrane (GO:1905477),1/101,0.2238818662412048,0.2959178022474648,0,0,4.051020408163265,6.062906014187368,NKD2,CLP,0.6499810815451941
KEGG_2021_Human,positive regulation of cellular protein metabolic process (GO:0032270),1/102,0.2258320069783284,0.2959178022474648,0,0,4.010709234188725,5.967790506031058,UHRF1,CLP,0.6462145058611213
KEGG_2021_Human,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.2959178022474648,0,0,4.010709234188725,5.967790506031058,TMIGD2,CLP,0.6462145058611213
KEGG_2021_Human,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/102,0.2258320069783284,0.2959178022474648,0,0,4.010709234188725,5.967790506031058,NKD2,CLP,0.6462145058611213
KEGG_2021_Human,regulation of insulin secretion (GO:0050796),1/104,0.2297178930745814,0.2987206062034481,0,0,3.932435109966317,5.78423168094792,TRH,CLP,0.6388051756325536
KEGG_2021_Human,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2987206062034481,0,0,3.932435109966317,5.78423168094792,ATP1A3,CLP,0.6388051756325536
KEGG_2021_Human,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.3000967888220603,0,0,3.894427001569859,5.6956456810845415,UHRF1,CLP,0.6351608308934773
KEGG_2021_Human,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.300323137307567,0,0,3.857142857142857,5.6090983677319475,FLT3,CLP,0.6315556772929499
KEGG_2021_Human,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.2335846623503299,0.300323137307567,0,0,3.857142857142857,5.6090983677319475,FLT3,CLP,0.6315556772929499
KEGG_2021_Human,protein transport (GO:0015031),2/369,0.2354374823833979,0.3015716066483974,0,0,2.2233197093551316,3.215609236148146,ARL5C;ATP6V0A4,CLP,0.6281243949487266
KEGG_2021_Human,modulation of chemical synaptic transmission (GO:0050804),1/109,0.239349173739861,0.3054381246978824,0,0,3.749433106575964,5.361058744932435,NPTX2,CLP,0.6209680674126086
KEGG_2021_Human,regulation of interleukin-6 production (GO:0032675),1/110,0.241261218690496,0.3067335940228612,0,0,3.714847406852649,5.282048795926194,TNFSF4,CLP,0.6175124827423236
KEGG_2021_Human,regulation of Wnt signaling pathway (GO:0030111),1/111,0.2431685532271013,0.3080135007543283,0,0,3.6808905380333954,5.20478084558139,NKD2,CLP,0.6140925891155178
KEGG_2021_Human,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.3129078804695551,0,0,3.582625970742279,4.982913653406146,SPOCK3,CLP,0.6040407011916724
KEGG_2021_Human,histone modification (GO:0016570),1/114,0.2488624078588274,0.3129078804695551,0,0,3.582625970742279,4.982913653406146,UHRF1,CLP,0.6040407011916724
KEGG_2021_Human,cellular response to molecule of bacterial origin (GO:0071219),1/115,0.2507510141385882,0.3129811928299167,0,0,3.5510204081632653,4.9121080927455,TNFSF4,CLP,0.6007573018413346
KEGG_2021_Human,positive regulation of protein metabolic process (GO:0051247),1/115,0.2507510141385882,0.3129811928299167,0,0,3.5510204081632653,4.9121080927455,UHRF1,CLP,0.6007573018413346
KEGG_2021_Human,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.313047675991929,0,0,3.5199645075421473,4.8428011439058265,TMIGD2,CLP,0.5975065399797567
KEGG_2021_Human,tumor necrosis factor-mediated signaling pathway (GO:0033209),1/116,0.2526349665899778,0.313047675991929,0,0,3.5199645075421473,4.8428011439058265,TNFSF4,CLP,0.5975065399797567
KEGG_2021_Human,positive regulation of cell projection organization (GO:0031346),1/117,0.2545142764118688,0.3142378430789139,0,0,3.4894440534834623,4.774949480472317,RET,CLP,0.5942878518616017
KEGG_2021_Human,cellular response to lipopolysaccharide (GO:0071222),1/120,0.2601244621662815,0.3200092304347779,0,0,3.4009603841536613,4.579716458908873,TNFSF4,CLP,0.5848188047272944
KEGG_2021_Human,potassium ion transport (GO:0006813),1/122,0.2638415777635164,0.323418708226246,0,0,3.3444088379153314,4.456111874258477,LRRC26,CLP,0.5786567646257991
KEGG_2021_Human,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.324525346789035,0,0,3.316828370692539,4.396166676729281,FLT3,CLP,0.5756194520344882
KEGG_2021_Human,cellular response to insulin stimulus (GO:0032869),1/129,0.2767079241059198,0.3367761923282014,0,0,3.1603954081632653,4.060453122404681,ATP6V0A4,CLP,0.5579784037567757
KEGG_2021_Human,regulation of response to external stimulus (GO:0032101),1/130,0.2785278903472666,0.3377891436126425,0,0,3.135738016136687,4.008216604624779,TNFSF4,CLP,0.5551313103019286
KEGG_2021_Human,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3419529194578419,0,0,3.0640074211502784,3.857336278341556,RET,CLP,0.546741450090894
KEGG_2021_Human,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3419529194578419,0,0,3.0640074211502784,3.857336278341556,SPOCK3,CLP,0.546741450090894
KEGG_2021_Human,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3429155792637276,0,0,3.0408163265306123,3.80890385676326,FLT3,CLP,0.5439940297149167
KEGG_2021_Human,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.3460105078386645,0,0,2.99546485260771,3.714691124222948,NKD2,CLP,0.5385707850387818
KEGG_2021_Human,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3511838537749852,0,0,2.929902395740905,3.579678317757992,TNFSF4,CLP,0.5306096689947516
KEGG_2021_Human,protein localization to cell periphery (GO:1990778),1/140,0.2964824884084789,0.3520729549850687,0,0,2.9086771399207163,3.5362740390257685,NKD2,CLP,0.5280009529309525
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),3/764,0.2984210193557987,0.3531487495490766,0,0,1.6095003774428942,1.9462882878583572,FLT3;UHRF1;TNFSF4,CLP,0.5251705904864272
KEGG_2021_Human,negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.3017829564686885,0.3558957624561775,0,0,2.8467950560505892,3.410594866305226,TNFSF4,CLP,0.5203052911363482
KEGG_2021_Human,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3677659339693537,0,0,2.712094233666621,3.141596466170354,ATP1A3,CLP,0.5030717563895143
KEGG_2021_Human,response to cytokine (GO:0034097),1/150,0.3139989845586295,0.3677659339693537,0,0,2.712094233666621,3.141596466170354,FLT3,CLP,0.5030717563895143
KEGG_2021_Human,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.3831771701544776,0,0,2.556445362955309,2.8389038953772054,TNFSF4,CLP,0.4822791499015975
KEGG_2021_Human,protein autophosphorylation (GO:0046777),1/159,0.329397918202972,0.3831771701544776,0,0,2.556445362955309,2.8389038953772054,FLT3,CLP,0.4822791499015975
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),2/474,0.3328115296392732,0.3858357394462083,0,0,1.7194562146892656,1.8917094920733264,FLT3;TNFSF4,CLP,0.47780163679243126
KEGG_2021_Human,double-strand break repair (GO:0006302),1/164,0.3378059691212722,0.3877759912610795,0,0,2.4774007762614247,2.6886824434754057,DNTT,CLP,0.4713326805982654
KEGG_2021_Human,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/165,0.3394751386404204,0.3877759912610795,0,0,2.4621702339472376,2.6600168495918335,NKD2,CLP,0.46919202564454415
KEGG_2021_Human,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.3877759912610795,0,0,2.4621702339472376,2.6600168495918335,GALR2,CLP,0.46919202564454415
KEGG_2021_Human,regulation of neuron projection development (GO:0010975),1/165,0.3394751386404204,0.3877759912610795,0,0,2.4621702339472376,2.6600168495918335,RET,CLP,0.46919202564454415
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),2/482,0.3401543782991926,0.3877759912610795,0,0,1.6901041666666667,1.8225334796372663,TMIGD2;TNFSF4,CLP,0.46832393464331673
KEGG_2021_Human,protein phosphorylation (GO:0006468),2/496,0.3529487892748932,0.4010248702060248,0,0,1.641025641025641,1.709017116633574,RET;FLT3,CLP,0.4522883035321021
KEGG_2021_Human,cation transport (GO:0006812),1/174,0.3543133002736421,0.4012422142171709,0,0,2.333018756635602,2.4206789693623425,SCN3A,CLP,0.45061254473982715
KEGG_2021_Human,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.4144951946450397,0,0,2.2289998872477166,2.2329492942532405,TNFSF4,CLP,0.4350639775318079
KEGG_2021_Human,negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.3814549819175133,0.4291368546572024,0,0,2.122448979591837,2.045536603225051,NKD2,CLP,0.41855670871419515
KEGG_2021_Human,cellular response to tumor necrosis factor (GO:0071356),1/194,0.3861272144560919,0.4315539455685733,0,0,2.089140319340171,1.988001678572607,TNFSF4,CLP,0.4132695879859197
KEGG_2021_Human,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4315539455685733,0,0,2.089140319340171,1.988001678572607,FLT3,CLP,0.4132695879859197
KEGG_2021_Human,modification-dependent protein catabolic process (GO:0019941),1/201,0.3968950010648283,0.441221221527969,0,0,2.0153061224489797,1.8623111638641865,UHRF1,CLP,0.40132437104403956
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),2/546,0.3979281971141292,0.441221221527969,0,0,1.4863664215686274,1.3696624285648409,RET;FLT3,CLP,0.40019528574129115
KEGG_2021_Human,regulation of angiogenesis (GO:0045765),1/203,0.3999373645428959,0.441221221527969,0,0,1.9951505354617096,1.8284503867148747,TMIGD2,CLP,0.398008019580524
KEGG_2021_Human,axon guidance (GO:0007411),1/203,0.3999373645428959,0.441221221527969,0,0,1.9951505354617096,1.8284503867148747,RET,CLP,0.398008019580524
KEGG_2021_Human,regulation of inflammatory response (GO:0050727),1/206,0.4044727291727134,0.4447899465500578,0,0,1.9656545545047288,1.7792534267442264,TNFSF4,CLP,0.39311075456855427
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4676745046429753,0,0,1.8302411873840445,1.5589816483293069,RET,CLP,0.3699278171231457
KEGG_2021_Human,inflammatory response (GO:0006954),1/230,0.4395663655385589,0.4802929617066682,0,0,1.7575082434720612,1.4446130242039086,TNFSF4,CLP,0.35697554604801474
KEGG_2021_Human,axonogenesis (GO:0007409),1/240,0.4535831041409784,0.4940300051471804,0,0,1.6831184356587825,1.3306343458644796,RET,CLP,0.34334313117644527
KEGG_2021_Human,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.4984439249513012,0,0,1.655076845553036,1.2884811006593149,NPTX2,CLP,0.33809924509335265
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),2/621,0.4626694381715867,0.5007371767553248,0,0,1.3012250942380184,1.0029093993298663,FLT3;TNFSF4,CLP,0.33472918706115434
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),2/625,0.4660144680358849,0.5027663976917118,0,0,1.2926029962546817,0.9869522795970046,FLT3;TNFSF4,CLP,0.33160059985375573
KEGG_2021_Human,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.5068614562984373,0,0,1.5952380952380951,1.2000608149186214,NKD2,CLP,0.32670971902140344
KEGG_2021_Human,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5250446874702706,0,0,1.510204081632653,1.0781219104526054,NKD2,CLP,0.3100391544580995
KEGG_2021_Human,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.5261641099248178,0,0,1.498781602193116,1.0620843946744252,RET,CLP,0.30775490655057164
KEGG_2021_Human,proteolysis (GO:0006508),1/287,0.51499186851511,0.5486829253338555,0,0,1.4031682603111175,0.9311483055746664,RET,CLP,0.28819962821492023
KEGG_2021_Human,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5712561335100349,0,0,1.314486450317832,0.8152139890333826,NPTX2,CLP,0.2693393582885023
KEGG_2021_Human,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.5972925800123509,0,0,1.2208810353409656,0.6989624697257846,ARL5C,CLP,0.24863646405532092
KEGG_2021_Human,intracellular protein transport (GO:0006886),1/336,0.5718075736459911,0.6035746610707684,0,0,1.1949436491014316,0.6679170434332091,ARL5C,CLP,0.2427500966679934
KEGG_2021_Human,ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.5909956578792304,0.6219092769067593,0,0,1.1329710354396716,0.5958822738188654,UHRF1,CLP,0.22841570992418872
KEGG_2021_Human,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6675138921967999,0,0,1.0,0.4521084323403523,RET,CLP,0.19634819738734471
KEGG_2021_Human,regulation of cell migration (GO:0030334),1/408,0.643643262264238,0.6720640993060066,0,0,0.9799428370856942,0.4317732474155183,RET,CLP,0.19135477263518083
KEGG_2021_Human,protein modification by small protein conjugation (GO:0032446),1/409,0.644552703427983,0.6720640993060066,0,0,0.9774909963985594,0.4293127610136149,UHRF1,CLP,0.19074156570833578
KEGG_2021_Human,negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.6912187085983104,0.7178834335306259,0,0,0.8589500595054437,0.3172093937483807,TNFSF4,CLP,0.16038451570993173
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",2/948,0.6926945411260426,0.7178834335306259,0,0,0.8370331219168429,0.3073302326128318,UHRF1;TNFSF4,CLP,0.15945823486666727
KEGG_2021_Human,neutrophil degranulation (GO:0043312),1/481,0.7043872370804651,0.7263837686362751,0,0,0.8278061224489796,0.2900856337670249,LAIR1,CLP,0.15218852169360617
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7263837686362751,0,0,0.8260426831855403,0.2885801301950252,FLT3,CLP,0.1517218912312197
KEGG_2021_Human,neutrophil activation involved in immune response (GO:0002283),1/485,0.7074048097353064,0.7265238586470714,0,0,0.8207960870298533,0.2841203737887477,LAIR1,CLP,0.15033199168778996
KEGG_2021_Human,neutrophil mediated immunity (GO:0002446),1/488,0.7096481586491704,0.726645719335378,0,0,0.815614130662532,0.2797442143304909,LAIR1,CLP,0.14895691977455572
KEGG_2021_Human,positive regulation of nucleic acid-templated transcription (GO:1903508),1/511,0.7262961571675228,0.7414724947799786,0,0,0.7779111644657863,0.2487739813280452,RET,CLP,0.13888625368433627
KEGG_2021_Human,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.749110104970514,0,0,0.7565820221218258,0.231944503707841,UHRF1,CLP,0.13314117322745964
KEGG_2021_Human,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7504933808556635,0.7616282974855695,0,0,0.7252747252747253,0.2081715773755284,TNFSF4,CLP,0.1246531337611999
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),4/2206,0.8166523886858273,0.8263169139957188,0,0,0.7008648264423647,0.1419543867132323,IL4I1;TOX2;UHRF1;GALR2,CLP,0.08796276329696344
KEGG_2021_Human,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8321457890179943,0,0,0.5757014372366809,0.1108560647358729,UHRF1,CLP,0.0836269880293983
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8543227550142283,0,0,0.5290423861852434,0.0863986224716518,FLT3,CLP,0.07092521499844862
KEGG_2021_Human,cellular protein modification process (GO:0006464),1/1025,0.9281942108891912,0.9302128294243438,0,0,0.3771922831632653,0.0281062148400667,RET,CLP,0.032361144586154744
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",3/2244,0.9302128294243438,0.9302128294243438,0,0,0.5044005810475947,0.036489281349511,RET;TOX2;TNFSF4,CLP,0.03141767502685046
GO_Biological_Process_2021,regulation of interferon-alpha production (GO:0032647),3/25,3.252704029670916e-05,0.0120350049097823,0,0,57.81818181818182,597.4606436592223,IRF7;TLR7;LILRA4,Cycling DCs,4.487755452281791
GO_Biological_Process_2021,positive regulation of interferon-alpha production (GO:0032727),2/20,0.0011307590059983,0.1557612350783473,0,0,46.138888888888886,313.0461870363529,IRF7;TLR7,Cycling DCs,2.9466299446036754
GO_Biological_Process_2021,positive regulation of neuron projection development (GO:0010976),3/88,0.0013893445250705,0.1557612350783473,0,0,14.917396745932416,98.14040765115747,RET;CUX2;PACSIN1,Cycling DCs,2.8571900459948085
GO_Biological_Process_2021,regulation of dendritic spine morphogenesis (GO:0061001),2/32,0.0028959211173454,0.1557612350783473,0,0,27.666666666666668,161.69650653172428,CUX2;KIF1A,Cycling DCs,2.5382132721600397
GO_Biological_Process_2021,positive regulation of interferon-beta production (GO:0032728),2/36,0.0036549257227984,0.1557612350783473,0,0,24.40686274509804,136.96349152286243,IRF7;TLR7,Cycling DCs,2.437121444562911
GO_Biological_Process_2021,regulation of chemokine production (GO:0032642),2/42,0.0049475924537835,0.1557612350783473,0,0,20.739583333333332,110.1034239545967,TLR7;LILRB4,Cycling DCs,2.3056060815494894
GO_Biological_Process_2021,regulation of cytokine production involved in inflammatory response (GO:1900015),2/43,0.0051806911627924,0.1557612350783473,0,0,20.232723577235777,106.48111760263689,PLD4;LILRB4,Cycling DCs,2.2856122965939503
GO_Biological_Process_2021,proteolysis (GO:0006508),4/287,0.0056959581367739,0.1557612350783473,0,0,6.043017360577662,31.23030437987747,RET;PROC;VASH2;CTSV,Cycling DCs,2.2444332112663723
GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),3/150,0.0062631723305451,0.1557612350783473,0,0,8.598784194528875,43.62222089301041,IRF7;IRF8;PLD4,Cycling DCs,2.2032056385661116
GO_Biological_Process_2021,regulation of interferon-beta production (GO:0032648),2/49,0.0066828970303688,0.1557612350783473,0,0,17.64450354609929,88.36726791367238,IRF7;TLR7,Cycling DCs,2.175035230405133
GO_Biological_Process_2021,cellular response to type I interferon (GO:0071357),2/65,0.0115237618661231,0.1557612350783473,0,0,13.15277777777778,58.70537343689256,IRF7;IRF8,Cycling DCs,1.9384057248186684
GO_Biological_Process_2021,type I interferon signaling pathway (GO:0060337),2/65,0.0115237618661231,0.1557612350783473,0,0,13.15277777777778,58.70537343689256,IRF7;IRF8,Cycling DCs,1.9384057248186684
GO_Biological_Process_2021,short-term memory (GO:0007614),1/5,0.0124387771927725,0.1557612350783473,0,0,101.76530612244898,446.4379351400606,CUX2,Cycling DCs,1.9052223113279663
GO_Biological_Process_2021,"positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",1/5,0.0124387771927725,0.1557612350783473,0,0,101.76530612244898,446.4379351400606,LILRB4,Cycling DCs,1.9052223113279663
GO_Biological_Process_2021,glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860),1/5,0.0124387771927725,0.1557612350783473,0,0,101.76530612244898,446.4379351400606,RET,Cycling DCs,1.9052223113279663
GO_Biological_Process_2021,thorax and anterior abdomen determination (GO:0007356),1/5,0.0124387771927725,0.1557612350783473,0,0,101.76530612244898,446.4379351400606,TIFAB,Cycling DCs,1.9052223113279663
GO_Biological_Process_2021,negative regulation of interferon-alpha production (GO:0032687),1/5,0.0124387771927725,0.1557612350783473,0,0,101.76530612244898,446.4379351400606,LILRA4,Cycling DCs,1.9052223113279663
GO_Biological_Process_2021,negative regulation of interleukin-5 production (GO:0032714),1/5,0.0124387771927725,0.1557612350783473,0,0,101.76530612244898,446.4379351400606,LILRB4,Cycling DCs,1.9052223113279663
GO_Biological_Process_2021,trophoblast giant cell differentiation (GO:0060707),1/5,0.0124387771927725,0.1557612350783473,0,0,101.76530612244898,446.4379351400606,E2F7,Cycling DCs,1.9052223113279663
GO_Biological_Process_2021,peristalsis (GO:0030432),1/5,0.0124387771927725,0.1557612350783473,0,0,101.76530612244898,446.4379351400606,TIFAB,Cycling DCs,1.9052223113279663
GO_Biological_Process_2021,"zygotic determination of anterior/posterior axis, embryo (GO:0007354)",1/5,0.0124387771927725,0.1557612350783473,0,0,101.76530612244898,446.4379351400606,TIFAB,Cycling DCs,1.9052223113279663
GO_Biological_Process_2021,interferon-gamma-mediated signaling pathway (GO:0060333),2/68,0.0125608922452035,0.1557612350783473,0,0,12.553030303030305,54.94671101969335,IRF7;IRF8,Cycling DCs,1.9009795100092206
GO_Biological_Process_2021,regulation of saliva secretion (GO:0046877),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,TIFAB,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,cellular water homeostasis (GO:0009992),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,SCT,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,negative regulation of cytokinesis (GO:0032466),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,E2F7,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,neurotransmitter loading into synaptic vesicle (GO:0098700),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,SLC32A1,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,regulation of macrophage apoptotic process (GO:2000109),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,IRF7,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,positive regulation of endothelial cell development (GO:1901552),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,PROC,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,positive regulation of establishment of endothelial barrier (GO:1903142),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,PROC,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,trigeminal nerve development (GO:0021559),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,TIFAB,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,hepatocyte differentiation (GO:0070365),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,E2F7,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,negative regulation of myeloid cell apoptotic process (GO:0033033),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,IRF7,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,negative regulation of relaxation of muscle (GO:1901078),1/6,0.0149082847993736,0.1557612350783473,0,0,81.40816326530613,342.3895623444841,TIFAB,Cycling DCs,1.8265723193247598
GO_Biological_Process_2021,positive regulation of type I interferon production (GO:0032481),2/77,0.0159057771109684,0.1557612350783473,0,0,11.041666666666666,45.72434655376785,IRF7;TLR7,Cycling DCs,1.7984451076467942
GO_Biological_Process_2021,axon development (GO:0061564),2/79,0.0166954776383478,0.1557612350783473,0,0,10.75378787878788,44.01113934918422,VASH2;SLITRK5,Cycling DCs,1.7774011517679502
GO_Biological_Process_2021,regulation of relaxation of muscle (GO:1901077),1/7,0.0173717414502839,0.1557612350783473,0,0,67.83673469387755,274.9362107684438,TIFAB,Cycling DCs,1.7601566430186848
GO_Biological_Process_2021,negative regulation of digestive system process (GO:0060457),1/7,0.0173717414502839,0.1557612350783473,0,0,67.83673469387755,274.9362107684438,TIFAB,Cycling DCs,1.7601566430186848
GO_Biological_Process_2021,regulation of toll-like receptor 7 signaling pathway (GO:0034155),1/7,0.0173717414502839,0.1557612350783473,0,0,67.83673469387755,274.9362107684438,LILRA4,Cycling DCs,1.7601566430186848
GO_Biological_Process_2021,"regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",1/7,0.0173717414502839,0.1557612350783473,0,0,67.83673469387755,274.9362107684438,LILRB4,Cycling DCs,1.7601566430186848
GO_Biological_Process_2021,dense core granule cytoskeletal transport (GO:0099519),1/7,0.0173717414502839,0.1557612350783473,0,0,67.83673469387755,274.9362107684438,KIF1A,Cycling DCs,1.7601566430186848
GO_Biological_Process_2021,regulation of muscle organ development (GO:0048634),1/7,0.0173717414502839,0.1557612350783473,0,0,67.83673469387755,274.9362107684438,TIFAB,Cycling DCs,1.7601566430186848
GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),2/86,0.0195880530452788,0.1557612350783473,0,0,9.854166666666666,38.754815869716495,TLR7;LILRB4,Cycling DCs,1.7080087285643422
GO_Biological_Process_2021,regulation of microvillus organization (GO:0032530),1/8,0.0198291614511851,0.1557612350783473,0,0,58.142857142857146,227.9549801512961,CDHR5,Cycling DCs,1.702695651141308
GO_Biological_Process_2021,regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),1/8,0.0198291614511851,0.1557612350783473,0,0,58.142857142857146,227.9549801512961,IRF7,Cycling DCs,1.702695651141308
GO_Biological_Process_2021,regulation of myeloid leukocyte differentiation (GO:0002761),1/8,0.0198291614511851,0.1557612350783473,0,0,58.142857142857146,227.9549801512961,IRF7,Cycling DCs,1.702695651141308
GO_Biological_Process_2021,water homeostasis (GO:0030104),1/8,0.0198291614511851,0.1557612350783473,0,0,58.142857142857146,227.9549801512961,SCT,Cycling DCs,1.702695651141308
GO_Biological_Process_2021,immune response-inhibiting cell surface receptor signaling pathway (GO:0002767),1/8,0.0198291614511851,0.1557612350783473,0,0,58.142857142857146,227.9549801512961,LILRB4,Cycling DCs,1.702695651141308
GO_Biological_Process_2021,regulation of type I interferon production (GO:0032479),2/89,0.0208876608034354,0.1557612350783473,0,0,9.512931034482758,36.80169347929862,IRF7;IRF8,Cycling DCs,1.6801101936742149
GO_Biological_Process_2021,negative regulation of T cell cytokine production (GO:0002725),1/9,0.0222805591236868,0.1557612350783473,0,0,50.87244897959184,193.52086993316271,LILRB4,Cycling DCs,1.652073914876897
GO_Biological_Process_2021,"positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",1/9,0.0222805591236868,0.1557612350783473,0,0,50.87244897959184,193.52086993316271,LILRB4,Cycling DCs,1.652073914876897
GO_Biological_Process_2021,positive regulation of dendritic spine morphogenesis (GO:0061003),1/10,0.024725948817258,0.1557612350783473,0,0,45.21768707482993,167.3010120823387,CUX2,Cycling DCs,1.606847034080906
GO_Biological_Process_2021,cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),1/10,0.024725948817258,0.1557612350783473,0,0,45.21768707482993,167.3010120823387,IRF7,Cycling DCs,1.606847034080906
GO_Biological_Process_2021,I-kappaB phosphorylation (GO:0007252),1/10,0.024725948817258,0.1557612350783473,0,0,45.21768707482993,167.3010120823387,TLR7,Cycling DCs,1.606847034080906
GO_Biological_Process_2021,sphingomyelin metabolic process (GO:0006684),1/11,0.0271653448579923,0.1557612350783473,0,0,40.69387755102041,146.73452100035948,SMPD3,Cycling DCs,1.5659847773237099
GO_Biological_Process_2021,positive regulation of ceramide biosynthetic process (GO:2000304),1/11,0.0271653448579923,0.1557612350783473,0,0,40.69387755102041,146.73452100035948,SMPD3,Cycling DCs,1.5659847773237099
GO_Biological_Process_2021,regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/11,0.0271653448579923,0.1557612350783473,0,0,40.69387755102041,146.73452100035948,LILRA4,Cycling DCs,1.5659847773237099
GO_Biological_Process_2021,positive regulation of dendrite development (GO:1900006),1/11,0.0271653448579923,0.1557612350783473,0,0,40.69387755102041,146.73452100035948,PACSIN1,Cycling DCs,1.5659847773237099
GO_Biological_Process_2021,positive regulation of DNA-dependent DNA replication (GO:2000105),1/11,0.0271653448579923,0.1557612350783473,0,0,40.69387755102041,146.73452100035948,E2F7,Cycling DCs,1.5659847773237099
GO_Biological_Process_2021,positive regulation of sphingolipid biosynthetic process (GO:0090154),1/11,0.0271653448579923,0.1557612350783473,0,0,40.69387755102041,146.73452100035948,SMPD3,Cycling DCs,1.5659847773237099
GO_Biological_Process_2021,regulation of coagulation (GO:0050818),1/11,0.0271653448579923,0.1557612350783473,0,0,40.69387755102041,146.73452100035948,PROC,Cycling DCs,1.5659847773237099
GO_Biological_Process_2021,negative regulation of activated T cell proliferation (GO:0046007),1/11,0.0271653448579923,0.1557612350783473,0,0,40.69387755102041,146.73452100035948,LILRB4,Cycling DCs,1.5659847773237099
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),5/684,0.0275333707502929,0.1557612350783473,0,0,3.1534936998854524,11.32847367927841,CUX2;IRF7;IRF8;LILRB4;E2F7,Cycling DCs,1.560140617206737
GO_Biological_Process_2021,negative regulation of cell division (GO:0051782),1/12,0.029598761568907,0.1557612350783473,0,0,36.99257884972171,130.2147194065139,E2F7,Cycling DCs,1.5287264597194943
GO_Biological_Process_2021,cochlea morphogenesis (GO:0090103),1/12,0.029598761568907,0.1557612350783473,0,0,36.99257884972171,130.2147194065139,TIFAB,Cycling DCs,1.5287264597194943
GO_Biological_Process_2021,negative regulation of hemostasis (GO:1900047),1/12,0.029598761568907,0.1557612350783473,0,0,36.99257884972171,130.2147194065139,PROC,Cycling DCs,1.5287264597194943
GO_Biological_Process_2021,negative regulation of leukocyte apoptotic process (GO:2000107),1/12,0.029598761568907,0.1557612350783473,0,0,36.99257884972171,130.2147194065139,IRF7,Cycling DCs,1.5287264597194943
GO_Biological_Process_2021,phasic smooth muscle contraction (GO:0014821),1/12,0.029598761568907,0.1557612350783473,0,0,36.99257884972171,130.2147194065139,TIFAB,Cycling DCs,1.5287264597194943
GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),2/110,0.0309363405009925,0.1557612350783473,0,0,7.655092592592593,26.607752397672005,TLR7;LILRB4,Cycling DCs,1.5095310608442127
GO_Biological_Process_2021,regulation of interleukin-5 production (GO:0032674),1/13,0.032026213248763,0.1557612350783473,0,0,33.90816326530612,116.6847899929619,LILRB4,Cycling DCs,1.4944944088974865
GO_Biological_Process_2021,toll-like receptor 9 signaling pathway (GO:0034162),1/13,0.032026213248763,0.1557612350783473,0,0,33.90816326530612,116.6847899929619,TLR7,Cycling DCs,1.4944944088974865
GO_Biological_Process_2021,cranial nerve development (GO:0021545),1/13,0.032026213248763,0.1557612350783473,0,0,33.90816326530612,116.6847899929619,TIFAB,Cycling DCs,1.4944944088974865
GO_Biological_Process_2021,plasma membrane tubulation (GO:0097320),1/13,0.032026213248763,0.1557612350783473,0,0,33.90816326530612,116.6847899929619,PACSIN1,Cycling DCs,1.4944944088974865
GO_Biological_Process_2021,positive regulation of alpha-beta T cell differentiation (GO:0046638),1/14,0.0344477141698711,0.1557612350783473,0,0,31.298273155416013,105.4223689491126,LILRB4,Cycling DCs,1.4628395910668823
GO_Biological_Process_2021,negative regulation of secretion (GO:0051048),1/14,0.0344477141698711,0.1557612350783473,0,0,31.298273155416013,105.4223689491126,TIFAB,Cycling DCs,1.4628395910668823
GO_Biological_Process_2021,negative regulation of T cell differentiation (GO:0045581),1/14,0.0344477141698711,0.1557612350783473,0,0,31.298273155416013,105.4223689491126,LILRB4,Cycling DCs,1.4628395910668823
GO_Biological_Process_2021,negative regulation of T cell mediated immunity (GO:0002710),1/14,0.0344477141698711,0.1557612350783473,0,0,31.298273155416013,105.4223689491126,LILRB4,Cycling DCs,1.4628395910668823
GO_Biological_Process_2021,negative regulation of coagulation (GO:0050819),1/14,0.0344477141698711,0.1557612350783473,0,0,31.298273155416013,105.4223689491126,PROC,Cycling DCs,1.4628395910668823
GO_Biological_Process_2021,neuromuscular process controlling balance (GO:0050885),1/14,0.0344477141698711,0.1557612350783473,0,0,31.298273155416013,105.4223689491126,TIFAB,Cycling DCs,1.4628395910668823
GO_Biological_Process_2021,positive regulation of regulatory T cell differentiation (GO:0045591),1/14,0.0344477141698711,0.1557612350783473,0,0,31.298273155416013,105.4223689491126,LILRB4,Cycling DCs,1.4628395910668823
GO_Biological_Process_2021,genitalia development (GO:0048806),1/14,0.0344477141698711,0.1557612350783473,0,0,31.298273155416013,105.4223689491126,TIFAB,Cycling DCs,1.4628395910668823
GO_Biological_Process_2021,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),1/14,0.0344477141698711,0.1557612350783473,0,0,31.298273155416013,105.4223689491126,LILRB4,Cycling DCs,1.4628395910668823
GO_Biological_Process_2021,positive regulation of cell projection organization (GO:0031346),2/117,0.0346350824710412,0.1557612350783473,0,0,7.186594202898551,24.167712601380277,RET;CUX2,Cycling DCs,1.4604837739091847
GO_Biological_Process_2021,cellular response to interferon-gamma (GO:0071346),2/121,0.0368223679095263,0.1557612350783473,0,0,6.943627450980392,22.92542614889691,IRF7;IRF8,Cycling DCs,1.4338882870711436
GO_Biological_Process_2021,positive regulation of secretion (GO:0051047),1/15,0.0368632785936063,0.1557612350783473,0,0,29.06122448979592,95.91771596133704,SCT,Cycling DCs,1.4334060415588732
GO_Biological_Process_2021,positive regulation of exosomal secretion (GO:1903543),1/15,0.0368632785936063,0.1557612350783473,0,0,29.06122448979592,95.91771596133704,SMPD3,Cycling DCs,1.4334060415588732
GO_Biological_Process_2021,placenta development (GO:0001890),1/15,0.0368632785936063,0.1557612350783473,0,0,29.06122448979592,95.91771596133704,E2F7,Cycling DCs,1.4334060415588732
GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),2/123,0.0379356146383277,0.1557612350783473,0,0,6.828168044077135,22.34084340876857,VASH2;KIF1A,Cycling DCs,1.420952875040757
GO_Biological_Process_2021,defense response to symbiont (GO:0140546),2/124,0.038497072428768,0.1557612350783473,0,0,6.771857923497268,22.05711333941876,IRF7;TLR7,Cycling DCs,1.4145722958518654
GO_Biological_Process_2021,neuron cell-cell adhesion (GO:0007158),1/16,0.0392729207344652,0.1557612350783473,0,0,27.122448979591837,87.80133530116419,RET,Cycling DCs,1.405906798966597
GO_Biological_Process_2021,regulation of leukocyte activation (GO:0002694),1/16,0.0392729207344652,0.1557612350783473,0,0,27.122448979591837,87.80133530116419,LILRB4,Cycling DCs,1.405906798966597
GO_Biological_Process_2021,regulation of monocyte differentiation (GO:0045655),1/16,0.0392729207344652,0.1557612350783473,0,0,27.122448979591837,87.80133530116419,IRF7,Cycling DCs,1.405906798966597
GO_Biological_Process_2021,regulation of ceramide biosynthetic process (GO:2000303),1/16,0.0392729207344652,0.1557612350783473,0,0,27.122448979591837,87.80133530116419,SMPD3,Cycling DCs,1.405906798966597
GO_Biological_Process_2021,retrograde axonal transport (GO:0008090),1/16,0.0392729207344652,0.1557612350783473,0,0,27.122448979591837,87.80133530116419,KIF1A,Cycling DCs,1.405906798966597
GO_Biological_Process_2021,stabilization of membrane potential (GO:0030322),1/17,0.0416766547912334,0.1557612350783473,0,0,25.426020408163264,80.79916728086499,KCNK10,Cycling DCs,1.3801071472903907
GO_Biological_Process_2021,negative regulation of chemokine production (GO:0032682),1/17,0.0416766547912334,0.1557612350783473,0,0,25.426020408163264,80.79916728086499,LILRB4,Cycling DCs,1.3801071472903907
GO_Biological_Process_2021,negative regulation of cytokine production involved in immune response (GO:0002719),1/17,0.0416766547912334,0.1557612350783473,0,0,25.426020408163264,80.79916728086499,LILRB4,Cycling DCs,1.3801071472903907
GO_Biological_Process_2021,negative regulation of interleukin-10 production (GO:0032693),1/17,0.0416766547912334,0.1557612350783473,0,0,25.426020408163264,80.79916728086499,LILRB4,Cycling DCs,1.3801071472903907
GO_Biological_Process_2021,midbody abscission (GO:0061952),1/17,0.0416766547912334,0.1557612350783473,0,0,25.426020408163264,80.79916728086499,CEP55,Cycling DCs,1.3801071472903907
GO_Biological_Process_2021,regulation of establishment of endothelial barrier (GO:1903140),1/17,0.0416766547912334,0.1557612350783473,0,0,25.426020408163264,80.79916728086499,PROC,Cycling DCs,1.3801071472903907
GO_Biological_Process_2021,defense response to virus (GO:0051607),2/133,0.043691853040543,0.1562962587203649,0,0,6.303753180661578,19.734489511742076,IRF7;TLR7,Cycling DCs,1.3595995357844428
GO_Biological_Process_2021,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.0440744949316926,0.1562962587203649,0,0,23.92917166866747,74.70385911458476,RET,Cycling DCs,1.3558126557645607
GO_Biological_Process_2021,regulation of adaptive immune response (GO:0002819),1/18,0.0440744949316926,0.1562962587203649,0,0,23.92917166866747,74.70385911458476,IRF7,Cycling DCs,1.3558126557645607
GO_Biological_Process_2021,positive regulation of excitatory postsynaptic potential (GO:2000463),1/18,0.0440744949316926,0.1562962587203649,0,0,23.92917166866747,74.70385911458476,CUX2,Cycling DCs,1.3558126557645607
GO_Biological_Process_2021,negative regulation of T cell receptor signaling pathway (GO:0050860),1/19,0.0464664552952436,0.1562962587203649,0,0,22.598639455782312,69.35578082800635,LILRB4,Cycling DCs,1.3328604565168853
GO_Biological_Process_2021,regulation of T cell cytokine production (GO:0002724),1/19,0.0464664552952436,0.1562962587203649,0,0,22.598639455782312,69.35578082800635,LILRB4,Cycling DCs,1.3328604565168853
GO_Biological_Process_2021,negative regulation of cytokine production involved in inflammatory response (GO:1900016),1/19,0.0464664552952436,0.1562962587203649,0,0,22.598639455782312,69.35578082800635,LILRB4,Cycling DCs,1.3328604565168853
GO_Biological_Process_2021,neuromuscular process (GO:0050905),1/19,0.0464664552952436,0.1562962587203649,0,0,22.598639455782312,69.35578082800635,TIFAB,Cycling DCs,1.3328604565168853
GO_Biological_Process_2021,negative regulation of immune system process (GO:0002683),1/19,0.0464664552952436,0.1562962587203649,0,0,22.598639455782312,69.35578082800635,LILRB4,Cycling DCs,1.3328604565168853
GO_Biological_Process_2021,negative regulation of protein localization to nucleus (GO:1900181),1/19,0.0464664552952436,0.1562962587203649,0,0,22.598639455782312,69.35578082800635,LILRB4,Cycling DCs,1.3328604565168853
GO_Biological_Process_2021,regulation of exosomal secretion (GO:1903541),1/19,0.0464664552952436,0.1562962587203649,0,0,22.598639455782312,69.35578082800635,SMPD3,Cycling DCs,1.3328604565168853
GO_Biological_Process_2021,neuron projection morphogenesis (GO:0048812),2/140,0.0479026862337682,0.1571777695073936,0,0,5.981884057971015,18.176455370515885,SLITRK5;PACSIN1,Cycling DCs,1.319640132017756
GO_Biological_Process_2021,skeletal muscle contraction (GO:0003009),1/20,0.0488525499820277,0.1571777695073936,0,0,21.40816326530612,64.63014669364038,TNNI2,Cycling DCs,1.3111127622579986
GO_Biological_Process_2021,positive regulation of dendrite morphogenesis (GO:0050775),1/20,0.0488525499820277,0.1571777695073936,0,0,21.40816326530612,64.63014669364038,CUX2,Cycling DCs,1.3111127622579986
GO_Biological_Process_2021,mitotic cytokinetic process (GO:1902410),1/20,0.0488525499820277,0.1571777695073936,0,0,21.40816326530612,64.63014669364038,CEP55,Cycling DCs,1.3111127622579986
GO_Biological_Process_2021,negative regulation of osteoclast differentiation (GO:0045671),1/20,0.0488525499820277,0.1571777695073936,0,0,21.40816326530612,64.63014669364038,LILRB4,Cycling DCs,1.3111127622579986
GO_Biological_Process_2021,regulation of lipid catabolic process (GO:0050994),1/21,0.0512327930672156,0.1620182344860664,0,0,20.336734693877553,60.42807445408675,SCT,Cycling DCs,1.2904519669693806
GO_Biological_Process_2021,regulation of dendritic spine development (GO:0060998),1/21,0.0512327930672156,0.1620182344860664,0,0,20.336734693877553,60.42807445408675,KIF1A,Cycling DCs,1.2904519669693806
GO_Biological_Process_2021,positive regulation of dendritic spine development (GO:0060999),1/22,0.0536071985992547,0.1652888623477022,0,0,19.367346938775512,56.67024999786951,CUX2,Cycling DCs,1.2707768875084013
GO_Biological_Process_2021,negative regulation of interleukin-2 production (GO:0032703),1/22,0.0536071985992547,0.1652888623477022,0,0,19.367346938775512,56.67024999786951,LILRB4,Cycling DCs,1.2707768875084013
GO_Biological_Process_2021,positive regulation of lipid catabolic process (GO:0050996),1/22,0.0536071985992547,0.1652888623477022,0,0,19.367346938775512,56.67024999786951,SCT,Cycling DCs,1.2707768875084013
GO_Biological_Process_2021,cytoskeleton-dependent intracellular transport (GO:0030705),1/23,0.0559757805878795,0.1670245065928662,0,0,18.4860853432282,53.29235549319145,KIF1A,Cycling DCs,1.2519998414265567
GO_Biological_Process_2021,response to nutrient levels (GO:0031667),1/23,0.0559757805878795,0.1670245065928662,0,0,18.4860853432282,53.29235549319145,SCT,Cycling DCs,1.2519998414265567
GO_Biological_Process_2021,vesicle transport along microtubule (GO:0047496),1/23,0.0559757805878795,0.1670245065928662,0,0,18.4860853432282,53.29235549319145,KIF1A,Cycling DCs,1.2519998414265567
GO_Biological_Process_2021,ear morphogenesis (GO:0042471),1/23,0.0559757805878795,0.1670245065928662,0,0,18.4860853432282,53.29235549319145,TIFAB,Cycling DCs,1.2519998414265567
GO_Biological_Process_2021,dendritic cell differentiation (GO:0097028),1/24,0.0583385530130099,0.1699627135024699,0,0,17.68145519077196,50.24171555062859,IRF8,Cycling DCs,1.2340443470047993
GO_Biological_Process_2021,inner ear morphogenesis (GO:0042472),1/24,0.0583385530130099,0.1699627135024699,0,0,17.68145519077196,50.24171555062859,TIFAB,Cycling DCs,1.2340443470047993
GO_Biological_Process_2021,negative regulation of protein tyrosine kinase activity (GO:0061099),1/24,0.0583385530130099,0.1699627135024699,0,0,17.68145519077196,50.24171555062859,LILRB4,Cycling DCs,1.2340443470047993
GO_Biological_Process_2021,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/25,0.0606955298241754,0.1715964279133405,0,0,16.943877551020407,47.47480020477031,LILRB4,Cycling DCs,1.2168432931781568
GO_Biological_Process_2021,positive regulation of lipid metabolic process (GO:0045834),1/25,0.0606955298241754,0.1715964279133405,0,0,16.943877551020407,47.47480020477031,SCT,Cycling DCs,1.2168432931781568
GO_Biological_Process_2021,regulation of epidermal cell differentiation (GO:0045604),1/25,0.0606955298241754,0.1715964279133405,0,0,16.943877551020407,47.47480020477031,CTSV,Cycling DCs,1.2168432931781568
GO_Biological_Process_2021,regulation of regulatory T cell differentiation (GO:0045589),1/26,0.0630467249540435,0.1715964279133405,0,0,16.26530612244898,44.95534064809558,LILRB4,Cycling DCs,1.2003374685092782
GO_Biological_Process_2021,negative regulation of signaling receptor activity (GO:2000272),1/26,0.0630467249540435,0.1715964279133405,0,0,16.26530612244898,44.95534064809558,LILRB4,Cycling DCs,1.2003374685092782
GO_Biological_Process_2021,negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.0630467249540435,0.1715964279133405,0,0,16.26530612244898,44.95534064809558,LILRB4,Cycling DCs,1.2003374685092782
GO_Biological_Process_2021,mononuclear cell differentiation (GO:1903131),1/26,0.0630467249540435,0.1715964279133405,0,0,16.26530612244898,44.95534064809558,IRF8,Cycling DCs,1.2003374685092782
GO_Biological_Process_2021,regulation of neuron projection development (GO:0010975),2/165,0.0640621553999463,0.1715964279133405,0,0,5.058026584867076,13.898958782878776,RET;KIF1A,Cycling DCs,1.1933984533937798
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),2/166,0.0647425290365929,0.1715964279133405,0,0,5.0269308943089435,13.760403766207606,RET;LILRB4,Cycling DCs,1.1888103397622347
GO_Biological_Process_2021,regulation of toll-like receptor signaling pathway (GO:0034121),1/27,0.0653921522588676,0.1715964279133405,0,0,15.638932496075354,42.652889831563165,IRF7,Cycling DCs,1.184474368421492
GO_Biological_Process_2021,regulation of blood coagulation (GO:0030193),1/27,0.0653921522588676,0.1715964279133405,0,0,15.638932496075354,42.652889831563165,PROC,Cycling DCs,1.184474368421492
GO_Biological_Process_2021,regulation of vasculature development (GO:1901342),1/27,0.0653921522588676,0.1715964279133405,0,0,15.638932496075354,42.652889831563165,VASH2,Cycling DCs,1.184474368421492
GO_Biological_Process_2021,modulation of excitatory postsynaptic potential (GO:0098815),1/27,0.0653921522588676,0.1715964279133405,0,0,15.638932496075354,42.652889831563165,CUX2,Cycling DCs,1.184474368421492
GO_Biological_Process_2021,presynaptic endocytosis (GO:0140238),1/27,0.0653921522588676,0.1715964279133405,0,0,15.638932496075354,42.652889831563165,PACSIN1,Cycling DCs,1.184474368421492
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.0677318256109869,0.172787673884145,0,0,15.058956916099774,40.54171043527237,RET,Cycling DCs,1.1692072184717057
GO_Biological_Process_2021,sulfur compound transport (GO:0072348),1/28,0.0677318256109869,0.172787673884145,0,0,15.058956916099774,40.54171043527237,SLC35F3,Cycling DCs,1.1692072184717057
GO_Biological_Process_2021,positive regulation of synapse assembly (GO:0051965),1/28,0.0677318256109869,0.172787673884145,0,0,15.058956916099774,40.54171043527237,CUX2,Cycling DCs,1.1692072184717057
GO_Biological_Process_2021,regulation of postsynapse organization (GO:0099175),1/28,0.0677318256109869,0.172787673884145,0,0,15.058956916099774,40.54171043527237,KIF1A,Cycling DCs,1.1692072184717057
GO_Biological_Process_2021,neuron projection development (GO:0031175),2/171,0.0681810821272572,0.172787673884145,0,0,4.876972386587771,13.097539204308813,VASH2;PACSIN1,Cycling DCs,1.166336110203534
GO_Biological_Process_2021,negative regulation of wound healing (GO:0061045),1/29,0.0700657588372089,0.1728288717984487,0,0,14.520408163265309,38.5999069065122,PROC,Cycling DCs,1.1544941700666143
GO_Biological_Process_2021,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/29,0.0700657588372089,0.1728288717984487,0,0,14.520408163265309,38.5999069065122,RET,Cycling DCs,1.1544941700666143
GO_Biological_Process_2021,negative regulation of interferon-gamma production (GO:0032689),1/29,0.0700657588372089,0.1728288717984487,0,0,14.520408163265309,38.5999069065122,LILRB4,Cycling DCs,1.1544941700666143
GO_Biological_Process_2021,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.0700657588372089,0.1728288717984487,0,0,14.520408163265309,38.5999069065122,LILRB4,Cycling DCs,1.1544941700666143
GO_Biological_Process_2021,synaptic vesicle cycle (GO:0099504),1/30,0.0723939657090184,0.174968925322609,0,0,14.019000703729768,36.80874147674154,SLC32A1,Cycling DCs,1.1402976322627019
GO_Biological_Process_2021,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/30,0.0723939657090184,0.174968925322609,0,0,14.019000703729768,36.80874147674154,IRF7,Cycling DCs,1.1402976322627019
GO_Biological_Process_2021,negative regulation of interleukin-1 production (GO:0032692),1/30,0.0723939657090184,0.174968925322609,0,0,14.019000703729768,36.80874147674154,LILRB4,Cycling DCs,1.1402976322627019
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",6/1183,0.0733152102404084,0.174968925322609,0,0,2.1749826214567083,5.6832017173023495,RET;SPIB;IRF7;IRF8;TNNI2;E2F7,Cycling DCs,1.1348059156971166
GO_Biological_Process_2021,negative regulation of interleukin-6 production (GO:0032715),1/31,0.0747164600026276,0.174968925322609,0,0,13.551020408163266,35.15209038871121,LILRB4,Cycling DCs,1.126583712764908
GO_Biological_Process_2021,vitamin transport (GO:0051180),1/31,0.0747164600026276,0.174968925322609,0,0,13.551020408163266,35.15209038871121,SLC35F3,Cycling DCs,1.126583712764908
GO_Biological_Process_2021,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/31,0.0747164600026276,0.174968925322609,0,0,13.551020408163266,35.15209038871121,LILRB4,Cycling DCs,1.126583712764908
GO_Biological_Process_2021,MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/31,0.0747164600026276,0.174968925322609,0,0,13.551020408163266,35.15209038871121,IRF7,Cycling DCs,1.126583712764908
GO_Biological_Process_2021,liver development (GO:0001889),1/32,0.0770332554327668,0.1759401512970601,0,0,13.113232389730086,33.61600807740255,E2F7,Cycling DCs,1.1133217484244988
GO_Biological_Process_2021,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/32,0.0770332554327668,0.1759401512970601,0,0,13.113232389730086,33.61600807740255,E2F7,Cycling DCs,1.1133217484244988
GO_Biological_Process_2021,hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.0770332554327668,0.1759401512970601,0,0,13.113232389730086,33.61600807740255,PLD4,Cycling DCs,1.1133217484244988
GO_Biological_Process_2021,regulation of dendrite morphogenesis (GO:0048814),1/32,0.0770332554327668,0.1759401512970601,0,0,13.113232389730086,33.61600807740255,CUX2,Cycling DCs,1.1133217484244988
GO_Biological_Process_2021,signal transduction by p53 class mediator (GO:0072331),1/33,0.0793443657059371,0.1798239741136247,0,0,12.70280612244898,32.18837516559274,E2F7,Cycling DCs,1.1004839073426347
GO_Biological_Process_2021,synaptic vesicle recycling (GO:0036465),1/34,0.0816498044624026,0.1798239741136247,0,0,12.317254174397032,30.85861216573232,PACSIN1,Cycling DCs,1.0880448509885652
GO_Biological_Process_2021,regulation of activated T cell proliferation (GO:0046006),1/34,0.0816498044624026,0.1798239741136247,0,0,12.317254174397032,30.85861216573232,LILRB4,Cycling DCs,1.0880448509885652
GO_Biological_Process_2021,regulation of keratinocyte differentiation (GO:0045616),1/34,0.0816498044624026,0.1798239741136247,0,0,12.317254174397032,30.85861216573232,CTSV,Cycling DCs,1.0880448509885652
GO_Biological_Process_2021,regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.0816498044624026,0.1798239741136247,0,0,12.317254174397032,30.85861216573232,RET,Cycling DCs,1.0880448509885652
GO_Biological_Process_2021,cardiac muscle contraction (GO:0060048),1/34,0.0816498044624026,0.1798239741136247,0,0,12.317254174397032,30.85861216573232,TNNI2,Cycling DCs,1.0880448509885652
GO_Biological_Process_2021,negative regulation of T cell proliferation (GO:0042130),1/35,0.0839495853612937,0.1816453016589397,0,0,11.95438175270108,29.61744503578088,LILRB4,Cycling DCs,1.0759814445616303
GO_Biological_Process_2021,negative regulation of cell cycle G1/S phase transition (GO:1902807),1/35,0.0839495853612937,0.1816453016589397,0,0,11.95438175270108,29.61744503578088,E2F7,Cycling DCs,1.0759814445616303
GO_Biological_Process_2021,regulation of T cell receptor signaling pathway (GO:0050856),1/35,0.0839495853612937,0.1816453016589397,0,0,11.95438175270108,29.61744503578088,LILRB4,Cycling DCs,1.0759814445616303
GO_Biological_Process_2021,negative regulation of toll-like receptor signaling pathway (GO:0034122),1/36,0.0862437219743075,0.1823438693171074,0,0,11.612244897959185,28.456712045041098,LILRA4,Cycling DCs,1.0642725091375862
GO_Biological_Process_2021,negative regulation of cellular protein localization (GO:1903828),1/36,0.0862437219743075,0.1823438693171074,0,0,11.612244897959185,28.456712045041098,LILRB4,Cycling DCs,1.0642725091375862
GO_Biological_Process_2021,axonal transport (GO:0098930),1/36,0.0862437219743075,0.1823438693171074,0,0,11.612244897959185,28.456712045041098,KIF1A,Cycling DCs,1.0642725091375862
GO_Biological_Process_2021,regulation of osteoclast differentiation (GO:0045670),1/36,0.0862437219743075,0.1823438693171074,0,0,11.612244897959185,28.456712045041098,LILRB4,Cycling DCs,1.0642725091375862
GO_Biological_Process_2021,anterograde axonal transport (GO:0008089),1/37,0.0885322278902676,0.1840276647157249,0,0,11.289115646258503,27.36920368672352,KIF1A,Cycling DCs,1.0528986067362665
GO_Biological_Process_2021,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/37,0.0885322278902676,0.1840276647157249,0,0,11.289115646258503,27.36920368672352,E2F7,Cycling DCs,1.0528986067362665
GO_Biological_Process_2021,positive regulation of exocytosis (GO:0045921),1/37,0.0885322278902676,0.1840276647157249,0,0,11.289115646258503,27.36920368672352,SMPD3,Cycling DCs,1.0528986067362665
GO_Biological_Process_2021,actin-myosin filament sliding (GO:0033275),1/38,0.0908151166313484,0.1851838098425977,0,0,10.983452840595698,26.34852930034076,TNNI2,Cycling DCs,1.0418418549683985
GO_Biological_Process_2021,synaptic vesicle endocytosis (GO:0048488),1/38,0.0908151166313484,0.1851838098425977,0,0,10.983452840595698,26.34852930034076,PACSIN1,Cycling DCs,1.0418418549683985
GO_Biological_Process_2021,muscle filament sliding (GO:0030049),1/38,0.0908151166313484,0.1851838098425977,0,0,10.983452840595698,26.34852930034076,TNNI2,Cycling DCs,1.0418418549683985
GO_Biological_Process_2021,regulation of protein tyrosine kinase activity (GO:0061097),1/39,0.0930924017046572,0.1851838098425977,0,0,10.693877551020408,25.38900533231373,LILRB4,Cycling DCs,1.0310857651239858
GO_Biological_Process_2021,membrane protein proteolysis (GO:0033619),1/39,0.0930924017046572,0.1851838098425977,0,0,10.693877551020408,25.38900533231373,RET,Cycling DCs,1.0310857651239858
GO_Biological_Process_2021,negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.0930924017046572,0.1851838098425977,0,0,10.693877551020408,25.38900533231373,LILRB4,Cycling DCs,1.0310857651239858
GO_Biological_Process_2021,vesicle cytoskeletal trafficking (GO:0099518),1/39,0.0930924017046572,0.1851838098425977,0,0,10.693877551020408,25.38900533231373,KIF1A,Cycling DCs,1.0310857651239858
GO_Biological_Process_2021,regulation of dendrite development (GO:0050773),1/39,0.0930924017046572,0.1851838098425977,0,0,10.693877551020408,25.38900533231373,PACSIN1,Cycling DCs,1.0310857651239858
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),2/206,0.0938158179234975,0.1856248803833907,0,0,4.033088235294118,9.543987931843056,PROC;TLR7,Cycling DCs,1.0277239307283335
GO_Biological_Process_2021,negative regulation of blood coagulation (GO:0030195),1/40,0.0953640965755271,0.185709030173395,0,0,10.419152276295131,24.485561288951835,PROC,Cycling DCs,1.0206151011238414
GO_Biological_Process_2021,lymphocyte migration (GO:0072676),1/40,0.0953640965755271,0.185709030173395,0,0,10.419152276295131,24.485561288951835,RET,Cycling DCs,1.0206151011238414
GO_Biological_Process_2021,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.0953640965755271,0.185709030173395,0,0,10.419152276295131,24.485561288951835,LILRB4,Cycling DCs,1.0206151011238414
GO_Biological_Process_2021,heart contraction (GO:0060047),1/41,0.0976302146847681,0.1891265938919592,0,0,10.158163265306122,23.633660200289185,TNNI2,Cycling DCs,1.0104157556925017
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),2/212,0.0984576089228105,0.1897360171949995,0,0,3.9166666666666665,9.079339326341122,PROC;SCT,Cycling DCs,1.0067507154273545
GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),2/214,0.100019348409027,0.1908784670877974,0,0,3.879323899371069,8.931722866735825,TIFAB;PROC,Cycling DCs,0.9999159790553556
GO_Biological_Process_2021,signal release from synapse (GO:0099643),1/43,0.1021457742794159,0.1908784670877974,0,0,9.673469387755102,22.068611238785657,SLC32A1,Cycling DCs,0.9907795952096249
GO_Biological_Process_2021,positive regulation of peptide hormone secretion (GO:0090277),1/43,0.1021457742794159,0.1908784670877974,0,0,9.673469387755102,22.068611238785657,SCT,Cycling DCs,0.9907795952096249
GO_Biological_Process_2021,cellular response to retinoic acid (GO:0071300),1/43,0.1021457742794159,0.1908784670877974,0,0,9.673469387755102,22.068611238785657,RET,Cycling DCs,0.9907795952096249
GO_Biological_Process_2021,negative regulation of type I interferon production (GO:0032480),1/43,0.1021457742794159,0.1908784670877974,0,0,9.673469387755102,22.068611238785657,LILRA4,Cycling DCs,0.9907795952096249
GO_Biological_Process_2021,positive regulation of T cell differentiation (GO:0045582),1/43,0.1021457742794159,0.1908784670877974,0,0,9.673469387755102,22.068611238785657,LILRB4,Cycling DCs,0.9907795952096249
GO_Biological_Process_2021,neurotransmitter secretion (GO:0007269),1/44,0.1043952424647777,0.1941017070953153,0,0,9.448030374940672,21.34849709415977,SLC32A1,Cycling DCs,0.9813192926974915
GO_Biological_Process_2021,positive regulation of nervous system development (GO:0051962),1/45,0.1066391873529346,0.1953292045573555,0,0,9.232838589981448,20.665901611884028,CUX2,Cycling DCs,0.9720831731354668
GO_Biological_Process_2021,negative regulation of T cell activation (GO:0050868),1/45,0.1066391873529346,0.1953292045573555,0,0,9.232838589981448,20.665901611884028,LILRB4,Cycling DCs,0.9720831731354668
GO_Biological_Process_2021,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.1066391873529346,0.1953292045573555,0,0,9.232838589981448,20.665901611884028,LILRB4,Cycling DCs,0.9720831731354668
GO_Biological_Process_2021,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.1088776222085674,0.1968782417354828,0,0,9.02721088435374,20.01811780873028,LILRA4,Cycling DCs,0.9630613723103648
GO_Biological_Process_2021,regulation of synapse assembly (GO:0051963),1/47,0.1111105603036554,0.1968782417354828,0,0,8.830523513753327,19.4026870705364,CUX2,Cycling DCs,0.9542446623584087
GO_Biological_Process_2021,glycosphingolipid metabolic process (GO:0006687),1/47,0.1111105603036554,0.1968782417354828,0,0,8.830523513753327,19.4026870705364,SMPD3,Cycling DCs,0.9542446623584087
GO_Biological_Process_2021,polyol metabolic process (GO:0019751),1/47,0.1111105603036554,0.1968782417354828,0,0,8.830523513753327,19.4026870705364,PLD4,Cycling DCs,0.9542446623584087
GO_Biological_Process_2021,regulation of protein localization to nucleus (GO:1900180),1/47,0.1111105603036554,0.1968782417354828,0,0,8.830523513753327,19.4026870705364,LILRB4,Cycling DCs,0.9542446623584087
GO_Biological_Process_2021,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.1133380148369131,0.1968782417354828,0,0,8.642205818497612,18.81737166641443,LILRA4,Cycling DCs,0.9456243984787533
GO_Biological_Process_2021,regulation of interleukin-10 production (GO:0032653),1/48,0.1133380148369131,0.1968782417354828,0,0,8.642205818497612,18.81737166641443,LILRB4,Cycling DCs,0.9456243984787533
GO_Biological_Process_2021,regulation of interleukin-2 production (GO:0032663),1/48,0.1133380148369131,0.1968782417354828,0,0,8.642205818497612,18.81737166641443,LILRB4,Cycling DCs,0.9456243984787533
GO_Biological_Process_2021,cognition (GO:0050890),1/48,0.1133380148369131,0.1968782417354828,0,0,8.642205818497612,18.81737166641443,CUX2,Cycling DCs,0.9456243984787533
GO_Biological_Process_2021,nucleus organization (GO:0006997),1/48,0.1133380148369131,0.1968782417354828,0,0,8.642205818497612,18.81737166641443,CEP55,Cycling DCs,0.9456243984787533
GO_Biological_Process_2021,inositol phosphate metabolic process (GO:0043647),1/48,0.1133380148369131,0.1968782417354828,0,0,8.642205818497612,18.81737166641443,PLD4,Cycling DCs,0.9456243984787533
GO_Biological_Process_2021,cellular response to mechanical stimulus (GO:0071260),1/49,0.1155599990222406,0.1979499983251344,0,0,8.46173469387755,18.260130793597916,TLR7,Cycling DCs,0.9371924705024297
GO_Biological_Process_2021,receptor internalization (GO:0031623),1/49,0.1155599990222406,0.1979499983251344,0,0,8.46173469387755,18.260130793597916,LILRB4,Cycling DCs,0.9371924705024297
GO_Biological_Process_2021,mitotic cytokinesis (GO:0000281),1/49,0.1155599990222406,0.1979499983251344,0,0,8.46173469387755,18.260130793597916,CEP55,Cycling DCs,0.9371924705024297
GO_Biological_Process_2021,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/50,0.1177765260040411,0.2008171180714064,0,0,8.28862973760933,17.7290996615035,CUX2,Cycling DCs,0.928941259997044
GO_Biological_Process_2021,mitotic metaphase plate congression (GO:0007080),1/51,0.1199876089220907,0.2027421817138605,0,0,8.122448979591837,17.22257115519733,CEP55,Cycling DCs,0.9208636010741894
GO_Biological_Process_2021,axonogenesis (GO:0007409),2/240,0.1209266562339864,0.2027421817138605,0,0,3.450980392156863,7.290441318878535,RET;SLITRK5,Cycling DCs,0.9174779557207333
GO_Biological_Process_2021,signal transduction in response to DNA damage (GO:0042770),1/52,0.1221932608707862,0.2027421817138605,0,0,7.962785114045619,16.738979733033663,E2F7,Cycling DCs,0.9129527453809976
GO_Biological_Process_2021,sprouting angiogenesis (GO:0002040),1/52,0.1221932608707862,0.2027421817138605,0,0,7.962785114045619,16.738979733033663,E2F7,Cycling DCs,0.9129527453809976
GO_Biological_Process_2021,glycolipid metabolic process (GO:0006664),1/52,0.1221932608707862,0.2027421817138605,0,0,7.962785114045619,16.738979733033663,SMPD3,Cycling DCs,0.9129527453809976
GO_Biological_Process_2021,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.1221932608707862,0.2027421817138605,0,0,7.962785114045619,16.738979733033663,PACSIN1,Cycling DCs,0.9129527453809976
GO_Biological_Process_2021,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.1243934949128716,0.2045581916345001,0,0,7.809262166405024,16.276887238960814,TLR7,Cycling DCs,0.9052023302345248
GO_Biological_Process_2021,positive regulation of chemokine production (GO:0032722),1/53,0.1243934949128716,0.2045581916345001,0,0,7.809262166405024,16.276887238960814,TLR7,Cycling DCs,0.9052023302345248
GO_Biological_Process_2021,striated muscle contraction (GO:0006941),1/54,0.1265883240687765,0.2072463712630411,0,0,7.661532537543319,15.834970375184442,TNNI2,Cycling DCs,0.8976063498190403
GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/56,0.1309618198144747,0.2134619970544301,0,0,7.382189239332097,15.00687933540933,E2F7,Cycling DCs,0.8828552987007785
GO_Biological_Process_2021,positive regulation of cell junction assembly (GO:1901890),1/57,0.1331405122852093,0.2151178582774124,0,0,7.25,14.618539131965724,CUX2,Cycling DCs,0.8756897763447542
GO_Biological_Process_2021,positive regulation of interferon-gamma production (GO:0032729),1/57,0.1331405122852093,0.2151178582774124,0,0,7.25,14.618539131965724,TLR7,Cycling DCs,0.8756897763447542
GO_Biological_Process_2021,receptor metabolic process (GO:0043112),1/58,0.1353138517398134,0.2168211579932409,0,0,7.122448979591836,14.246025949065045,LILRB4,Cycling DCs,0.8686577434892403
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.1353667229633477,0.2168211579932409,0,0,2.442871502764282,4.885175568190959,RET;IRF7;TNNI2,Cycling DCs,0.8684880846140173
GO_Biological_Process_2021,cellular protein catabolic process (GO:0044257),1/60,0.1396445230534406,0.222708937628332,0,0,6.88031822898651,13.544974303558986,CTSV,Cycling DCs,0.8549760929333525
GO_Biological_Process_2021,pattern recognition receptor signaling pathway (GO:0002221),1/61,0.1418018805927374,0.2232625354013312,0,0,6.76530612244898,13.214837540593155,TLR7,Cycling DCs,0.848318009451734
GO_Biological_Process_2021,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2232625354013312,0,0,6.76530612244898,13.214837540593155,TLR7,Cycling DCs,0.848318009451734
GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.2232625354013312,0,0,6.76530612244898,13.214837540593155,PACSIN1,Cycling DCs,0.848318009451734
GO_Biological_Process_2021,response to retinoic acid (GO:0032526),1/62,0.1439539364695556,0.2247382130537367,0,0,6.654064904650385,12.897320592663672,RET,Cycling DCs,0.8417764546925935
GO_Biological_Process_2021,I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/62,0.1439539364695556,0.2247382130537367,0,0,6.654064904650385,12.897320592663672,TLR7,Cycling DCs,0.8417764546925935
GO_Biological_Process_2021,anterior/posterior pattern specification (GO:0009952),1/63,0.1461007034145454,0.2271313456444613,0,0,6.54641211323239,12.591756250239603,TIFAB,Cycling DCs,0.8353476931121088
GO_Biological_Process_2021,negative regulation of cell cycle process (GO:0010948),1/64,0.1482421941802595,0.2285400493612335,0,0,6.442176870748299,12.297522293260638,E2F7,Cycling DCs,0.8290281655096747
GO_Biological_Process_2021,plasma membrane organization (GO:0007009),1/64,0.1482421941802595,0.2285400493612335,0,0,6.442176870748299,12.297522293260638,PACSIN1,Cycling DCs,0.8290281655096747
GO_Biological_Process_2021,mitotic G1 DNA damage checkpoint signaling (GO:0031571),1/65,0.1503784214913892,0.2308714354847054,0,0,6.341198979591836,12.01403781811508,E2F7,Cycling DCs,0.8228144782361342
GO_Biological_Process_2021,extracellular matrix disassembly (GO:0022617),1/66,0.1525093979756266,0.2322159557653575,0,0,6.243328100470958,11.740759916332207,CTSV,Cycling DCs,0.8167033932798328
GO_Biological_Process_2021,cellular component disassembly (GO:0022411),1/66,0.1525093979756266,0.2322159557653575,0,0,6.243328100470958,11.740759916332207,CTSV,Cycling DCs,0.8167033932798328
GO_Biological_Process_2021,positive regulation of catabolic process (GO:0009896),1/67,0.1546351363099914,0.2344877066995772,0,0,6.148423005565863,11.477180657220888,SCT,Cycling DCs,0.8106918184915987
GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.16308595979881,0.2462930821451417,0,0,5.795918367346939,10.51076961698872,E2F7,Cycling DCs,0.7875834261109624
GO_Biological_Process_2021,positive regulation of neurogenesis (GO:0050769),1/72,0.1651856959101235,0.2474441598653673,0,0,5.713998275366484,10.28911103101624,CUX2,Cycling DCs,0.78202756268309
GO_Biological_Process_2021,cytoskeleton-dependent cytokinesis (GO:0061640),1/72,0.1651856959101235,0.2474441598653673,0,0,5.713998275366484,10.28911103101624,CEP55,Cycling DCs,0.78202756268309
GO_Biological_Process_2021,neurotransmitter transport (GO:0006836),1/73,0.1672802691231711,0.2495713692563439,0,0,5.634353741496598,10.074701240888364,SLC32A1,Cycling DCs,0.7765552814899175
GO_Biological_Process_2021,proteolysis involved in cellular protein catabolic process (GO:0051603),1/74,0.1693696918266344,0.250667143903419,0,0,5.556891249650545,9.867213018330611,CTSV,Cycling DCs,0.7711643026835198
GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",1/74,0.1693696918266344,0.250667143903419,0,0,5.556891249650545,9.867213018330611,E2F7,Cycling DCs,0.7711643026835198
GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),1/76,0.1735331353639065,0.252784488522226,0,0,5.408163265306122,9.4717853003048,LILRB4,Cycling DCs,0.7606175863963804
GO_Biological_Process_2021,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.252784488522226,0,0,5.408163265306122,9.4717853003048,TLR7,Cycling DCs,0.7606175863963804
GO_Biological_Process_2021,cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.1735331353639065,0.252784488522226,0,0,5.408163265306122,9.4717853003048,SLITRK5,Cycling DCs,0.7606175863963804
GO_Biological_Process_2021,phospholipid metabolic process (GO:0006644),1/76,0.1735331353639065,0.252784488522226,0,0,5.408163265306122,9.4717853003048,SMPD3,Cycling DCs,0.7606175863963804
GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1756071809118701,0.2548025762250664,0,0,5.336734693877551,9.283280446293812,VASH2,Cycling DCs,0.7554577289388229
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2607191526414649,0,0,5.133298889175924,8.751529842637671,RET,Cycling DCs,0.7404090821369118
GO_Biological_Process_2021,response to interferon-gamma (GO:0034341),1/80,0.181798760490535,0.2607191526414649,0,0,5.133298889175924,8.751529842637671,IRF8,Cycling DCs,0.7404090821369118
GO_Biological_Process_2021,regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.181798760490535,0.2607191526414649,0,0,5.133298889175924,8.751529842637671,TLR7,Cycling DCs,0.7404090821369118
GO_Biological_Process_2021,positive regulation of cellular amide metabolic process (GO:0034250),1/81,0.1838524754991919,0.2616362151334654,0,0,5.0688775510204085,8.584760541358477,SMPD3,Cycling DCs,0.7355305181562768
GO_Biological_Process_2021,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2616362151334654,0,0,5.0688775510204085,8.584760541358477,TLR7,Cycling DCs,0.7355305181562768
GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.2664351025603199,0,0,4.944748631159781,8.265677319811374,LILRB4,Cycling DCs,0.7259697745939766
GO_Biological_Process_2021,regulation of cytokinesis (GO:0032465),1/84,0.1899833569114356,0.2682971070886686,0,0,4.884927464961889,8.112979399077096,E2F7,Cycling DCs,0.7212844428267129
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),4/908,0.1908851520255107,0.2685456511385512,0,0,1.8320507887649096,3.0340287711400475,SPIB;IRF7;IRF8;E2F7,Cycling DCs,0.7192278518272621
GO_Biological_Process_2021,negative regulation of defense response (GO:0031348),1/85,0.1920169366451308,0.2691146460556758,0,0,4.826530612244898,7.964604221414354,PROC,Cycling DCs,0.716660463134361
GO_Biological_Process_2021,positive regulation of inflammatory response (GO:0050729),1/89,0.2001013407742902,0.2793867776848581,0,0,4.6062152133580705,7.411084001248333,TLR7,Cycling DCs,0.6987500013741589
GO_Biological_Process_2021,negative regulation of protein kinase activity (GO:0006469),1/90,0.2021100231923967,0.2803737157773412,0,0,4.55423068103646,7.281955543769811,LILRB4,Cycling DCs,0.6944121480917811
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),3/621,0.2024454460334983,0.2803737157773412,0,0,1.9966948977483991,3.1892904723776496,IRF7;IRF8;LILRB4,Cycling DCs,0.6936919881460838
GO_Biological_Process_2021,toll-like receptor signaling pathway (GO:0002224),1/91,0.2041137620931186,0.2803737157773412,0,0,4.503401360544218,7.156255051106618,TLR7,Cycling DCs,0.6901277125812961
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),2/335,0.2041536136242794,0.2803737157773412,0,0,2.4545795795795797,3.9000386874614623,IRF7;TLR7,Cycling DCs,0.6900429284365769
GO_Biological_Process_2021,positive regulation of cellular component biogenesis (GO:0044089),1/92,0.2061125694363157,0.2803737157773412,0,0,4.453689167974883,7.03385741012878,SMPD3,Cycling DCs,0.6858955226779435
GO_Biological_Process_2021,negative regulation of mitotic cell cycle phase transition (GO:1901991),1/92,0.2061125694363157,0.2803737157773412,0,0,4.453689167974883,7.03385741012878,E2F7,Cycling DCs,0.6858955226779435
GO_Biological_Process_2021,regulation of endothelial cell proliferation (GO:0001936),1/92,0.2061125694363157,0.2803737157773412,0,0,4.453689167974883,7.03385741012878,VASH2,Cycling DCs,0.6858955226779435
GO_Biological_Process_2021,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.2826738604220901,0,0,4.357472021066491,6.79849904676328,RET,Cycling DCs,0.6775833802166729
GO_Biological_Process_2021,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2826738604220901,0,0,4.357472021066491,6.79849904676328,PLD4,Cycling DCs,0.6775833802166729
GO_Biological_Process_2021,negative regulation of MAPK cascade (GO:0043409),1/94,0.2100954368002021,0.2826738604220901,0,0,4.357472021066491,6.79849904676328,LILRB4,Cycling DCs,0.6775833802166729
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",4/948,0.21159142351009,0.283655169198309,0,0,1.7507369196757554,2.7190662035683872,CUX2;IRF7;IRF8;E2F7,Cycling DCs,0.6745019396506919
GO_Biological_Process_2021,regulation of vesicle-mediated transport (GO:0060627),1/96,0.2140587201245348,0.2859268102746494,0,0,4.26530612244898,6.5749903239841245,PACSIN1,Cycling DCs,0.6694670755856718
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,0.2180025137484037,0.2891072762971662,0,0,4.176940879444562,6.362519703204576,CTSV,Cycling DCs,0.6615384985937142
GO_Biological_Process_2021,positive regulation of defense response (GO:0031349),1/98,0.2180025137484037,0.2891072762971662,0,0,4.176940879444562,6.362519703204576,TLR7,Cycling DCs,0.6615384985937142
GO_Biological_Process_2021,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),1/100,0.2219269115603851,0.2932605617047946,0,0,4.092145949288806,6.1603458876211565,CTSV,Cycling DCs,0.6537900306498672
GO_Biological_Process_2021,epithelial cell differentiation (GO:0030855),1/101,0.2238818662412048,0.2937457110256943,0,0,4.051020408163265,6.062906014187368,E2F7,Cycling DCs,0.6499810815451941
GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),1/101,0.2238818662412048,0.2937457110256943,0,0,4.051020408163265,6.062906014187368,E2F7,Cycling DCs,0.6499810815451941
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.2942177555703574,0,0,4.010709234188725,5.967790506031058,VASH2,Cycling DCs,0.6462145058611213
GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),1/102,0.2258320069783284,0.2942177555703574,0,0,4.010709234188725,5.967790506031058,CEP55,Cycling DCs,0.6462145058611213
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/103,0.2277773453985499,0.2957109396402227,0,0,3.971188475390156,5.874923343943355,CTSV,Cycling DCs,0.64248947278397
GO_Biological_Process_2021,DNA replication (GO:0006260),1/108,0.2374324069826741,0.3071677992433198,0,0,3.7846652679763495,5.441865346754643,FAM111B,Cycling DCs,0.6244600047865677
GO_Biological_Process_2021,Fc-epsilon receptor signaling pathway (GO:0038095),1/111,0.2431685532271013,0.3134925599095035,0,0,3.6808905380333954,5.20478084558139,LILRA4,Cycling DCs,0.6140925891155178
GO_Biological_Process_2021,Fc receptor signaling pathway (GO:0038093),1/112,0.2450711886958998,0.314848402144038,0,0,3.647545504688362,5.129202360192396,LILRA4,Cycling DCs,0.6107077427090284
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.31686419538404,0,0,3.582625970742279,4.982913653406146,RET,Cycling DCs,0.6040407011916724
GO_Biological_Process_2021,cellular response to lectin (GO:1990858),1/115,0.2507510141385882,0.31686419538404,0,0,3.5510204081632653,4.9121080927455,CLEC4C,Cycling DCs,0.6007573018413346
GO_Biological_Process_2021,stimulatory C-type lectin receptor signaling pathway (GO:0002223),1/115,0.2507510141385882,0.31686419538404,0,0,3.5510204081632653,4.9121080927455,CLEC4C,Cycling DCs,0.6007573018413346
GO_Biological_Process_2021,cellular amide metabolic process (GO:0043603),1/115,0.2507510141385882,0.31686419538404,0,0,3.5510204081632653,4.9121080927455,SMPD3,Cycling DCs,0.6007573018413346
GO_Biological_Process_2021,ion transport (GO:0006811),1/116,0.2526349665899778,0.31686419538404,0,0,3.5199645075421473,4.8428011439058265,SLC32A1,Cycling DCs,0.5975065399797567
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.31686419538404,0,0,3.5199645075421473,4.8428011439058265,VASH2,Cycling DCs,0.5975065399797567
GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),1/116,0.2526349665899778,0.31686419538404,0,0,3.5199645075421473,4.8428011439058265,SMPD3,Cycling DCs,0.5975065399797567
GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.3204861935426745,0,0,3.4594453165881736,4.708511372057024,PROC,Cycling DCs,0.5911006880374128
GO_Biological_Process_2021,innate immune response activating cell surface receptor signaling pathway (GO:0002220),1/119,0.2582590130323782,0.3217368175824241,0,0,3.429955032860602,4.6434466139665425,CLEC4C,Cycling DCs,0.5879445130148351
GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),1/120,0.2601244621662815,0.3229733255084704,0,0,3.4009603841536613,4.579716458908873,PACSIN1,Cycling DCs,0.5848188047272944
GO_Biological_Process_2021,potassium ion transport (GO:0006813),1/122,0.2638415777635164,0.3264929223160572,0,0,3.3444088379153314,4.456111874258477,KCNK10,Cycling DCs,0.5786567646257991
GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),1/123,0.2656932663769877,0.3276883618649516,0,0,3.316828370692539,4.396166676729281,VASH2,Cycling DCs,0.5756194520344882
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),1/124,0.2675403902734135,0.3288702471799435,0,0,3.2896963663514187,4.337414433160371,LILRA4,Cycling DCs,0.5726106437410472
GO_Biological_Process_2021,muscle contraction (GO:0006936),1/129,0.2767079241059198,0.339013019599968,0,0,3.1603954081632653,4.060453122404681,TNNI2,Cycling DCs,0.5579784037567757
GO_Biological_Process_2021,organelle organization (GO:0006996),2/420,0.2828230936231133,0.345361533467168,0,0,1.946969696969697,2.4588936191845474,CEP55;PACSIN1,Cycling DCs,0.5484851315667836
GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.345610310640101,0,0,3.0640074211502784,3.857336278341556,RET,Cycling DCs,0.546741450090894
GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.3487326127158455,0,0,2.99546485260771,3.714691124222948,PACSIN1,Cycling DCs,0.5385707850387818
GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3487326127158455,0,0,2.99546485260771,3.714691124222948,SCT,Cycling DCs,0.5385707850387818
GO_Biological_Process_2021,organic substance transport (GO:0071702),1/136,0.289353816496661,0.3487326127158455,0,0,2.99546485260771,3.714691124222948,SLC35F3,Cycling DCs,0.5385707850387818
GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3497492187831259,0,0,2.9732893157262907,3.668866926816198,SCT,Cycling DCs,0.5358942544628899
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3504745070643361,0,0,2.929902395740905,3.579678317757992,TLR7,Cycling DCs,0.5306096689947516
GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),1/139,0.2947069182263764,0.3504745070643361,0,0,2.929902395740905,3.579678317757992,PACSIN1,Cycling DCs,0.5306096689947516
GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),1/139,0.2947069182263764,0.3504745070643361,0,0,2.929902395740905,3.579678317757992,KCNK10,Cycling DCs,0.5306096689947516
GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),1/140,0.2964824884084789,0.3504745070643361,0,0,2.9086771399207163,3.5362740390257685,PACSIN1,Cycling DCs,0.5280009529309525
GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.2964824884084789,0.3504745070643361,0,0,2.9086771399207163,3.5362740390257685,RET,Cycling DCs,0.5280009529309525
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3544752187092532,0,0,2.8467950560505892,3.410594866305226,LILRB4,Cycling DCs,0.5203052911363482
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3544752187092532,0,0,2.8467950560505892,3.410594866305226,SLC35F3,Cycling DCs,0.5203052911363482
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3635955189962206,0,0,2.749271137026239,3.215201203875706,RET,Cycling DCs,0.5078961191737069
GO_Biological_Process_2021,brain development (GO:0007420),1/150,0.3139989845586295,0.366497237497454,0,0,2.712094233666621,3.141596466170354,SCT,Cycling DCs,0.5030717563895143
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",7/2244,0.3272299631980314,0.3807392653562,0,0,1.289008327182377,1.439941024131167,RET;SPIB;CUX2;IRF7;IRF8;TNNI2;E2F7,Cycling DCs,0.48514693649283425
GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3859756714197189,0,0,2.524234693877551,2.7773973646136283,RET,Cycling DCs,0.4778511096570981
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),2/496,0.3529487892748932,0.4080970375990952,0,0,1.641025641025641,1.709017116633574,RET;TLR7,Cycling DCs,0.4522883035321021
GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),1/177,0.359186378521905,0.4140154518788312,0,0,2.2929035250463823,2.3477357103628296,PACSIN1,Cycling DCs,0.44468014150624274
GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.414586969953825,0,0,2.279833967485299,2.3241173885161555,SCT,Cycling DCs,0.44273020383203454
GO_Biological_Process_2021,regulation of immune response (GO:0050776),1/179,0.3624150547196057,0.4151503722794245,0,0,2.266911258885577,2.300835957547096,IRF7,Cycling DCs,0.4407937700298507
GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.4193655356260866,0,0,2.2289998872477166,2.2329492942532405,LILRB4,Cycling DCs,0.4350639775318079
GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),1/185,0.3720057294778557,0.4235142150978665,0,0,2.192324755989352,2.1678716160963645,PROC,Cycling DCs,0.4294503712432232
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.4400014189169164,0,0,2.0782663580896275,1.969329769675335,PACSIN1,Cycling DCs,0.4115300469974289
GO_Biological_Process_2021,negative regulation of intracellular signal transduction (GO:1902532),1/198,0.3923030921692546,0.4438903489376887,0,0,2.0463068476121413,1.914771355908193,LILRB4,Cycling DCs,0.4063782687077012
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),2/546,0.3979281971141292,0.4484146208511256,0,0,1.4863664215686274,1.3696624285648409,RET;TLR7,Cycling DCs,0.40019528574129115
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),1/203,0.3999373645428959,0.4484146208511256,0,0,1.9951505354617096,1.8284503867148747,VASH2,Cycling DCs,0.398008019580524
GO_Biological_Process_2021,axon guidance (GO:0007411),1/203,0.3999373645428959,0.4484146208511256,0,0,1.9951505354617096,1.8284503867148747,RET,Cycling DCs,0.398008019580524
GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4538111915969046,0,0,1.9560134733505052,1.7632653144438126,RET,Cycling DCs,0.3914985283218076
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4607646851078955,0,0,1.909178837411742,1.6862551884518755,PLD4,Cycling DCs,0.3835844547796231
GO_Biological_Process_2021,cellular response to lipid (GO:0071396),1/219,0.4237408440429794,0.470823160047755,0,0,1.8472196217936716,1.5860841457604238,RET,Cycling DCs,0.372899672681652
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.472636698672699,0,0,1.8302411873840445,1.5589816483293069,RET,Cycling DCs,0.3699278171231457
GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.4760164004286427,0,0,1.805344559348403,1.519514184420898,LILRB4,Cycling DCs,0.36553500108915365
GO_Biological_Process_2021,membrane organization (GO:0061024),1/242,0.4563449373288627,0.5025226988442834,0,0,1.6689812854602422,1.3093263562491473,CEP55,Cycling DCs,0.3407067631514444
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.5159116141395388,0,0,1.6016749329213755,1.2094704650298027,CUX2,Cycling DCs,0.32794816113488356
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),1/253,0.4712922312950381,0.5159116141395388,0,0,1.5952380952380951,1.2000608149186214,RET,Cycling DCs,0.32670971902140344
GO_Biological_Process_2021,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5357570572333885,0,0,1.504471451501949,1.0700627976731167,SCT,Cycling DCs,0.3088941088615854
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.5357570572333885,0,0,1.498781602193116,1.0620843946744252,RET,Cycling DCs,0.30775490655057164
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5395486697499038,0,0,1.4709576138147566,1.0233666205889618,RET,Cycling DCs,0.30214499188263844
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),1/274,0.4987179596066677,0.5395486697499038,0,0,1.4709576138147566,1.0233666205889618,KCNK10,Cycling DCs,0.30214499188263844
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),1/300,0.5307476794848257,0.5725266513393164,0,0,1.341273633199099,0.8496546643160489,CTSV,Cycling DCs,0.2751118959639202
GO_Biological_Process_2021,innate immune response (GO:0045087),1/302,0.5331267023920349,0.5730300219539461,0,0,1.3322259136212624,0.8379649939237771,IRF7,Cycling DCs,0.2731695646873957
GO_Biological_Process_2021,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.5730300219539461,0,0,1.32774699283687,0.8321996277505203,RET,Cycling DCs,0.2722052530518486
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5751568108912682,0,0,1.314486450317832,0.8152139890333826,SLC32A1,Cycling DCs,0.2693393582885023
GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),1/314,0.5471545986718139,0.5834213299958824,0,0,1.2803677381495728,0.7720923294539072,FAM111B,Cycling DCs,0.26188994631047774
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5926417883363345,0,0,1.2440106477373558,0.7270814983759607,RET,Cycling DCs,0.2538302089398956
GO_Biological_Process_2021,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.5980532200378362,0,0,1.2208810353409656,0.6989624697257846,PACSIN1,Cycling DCs,0.24863646405532092
GO_Biological_Process_2021,post-translational protein modification (GO:0043687),1/345,0.5815093765862647,0.6147384838197655,0,0,1.1631466540104414,0.6305745813190116,PROC,Cycling DCs,0.23544327806907975
GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),1/350,0.5868058377702841,0.6185702563390459,0,0,1.1461902812701013,0.6109896633619631,IRF7,Cycling DCs,0.23150557427863594
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),1/379,0.6162544539128882,0.6477674657607063,0,0,1.056689342403628,0.5115383719098227,E2F7,Cycling DCs,0.2102399288866402
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.6479798419339138,0,0,1.0510204081632653,0.5054679174936134,PROC,Cycling DCs,0.20886552310647807
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.649192749874963,0,0,1.042628017264347,0.4965325169788531,CUX2,Cycling DCs,0.20682480102083725
GO_Biological_Process_2021,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6631704610557451,0,0,1.0,0.4521084323403523,RET,Cycling DCs,0.19634819738734471
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.6651504955991133,0,0,0.989871879272801,0.4417939051458828,RET,Cycling DCs,0.19383180708628664
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),1/408,0.643643262264238,0.6670812522066333,0,0,0.9799428370856942,0.4317732474155183,RET,Cycling DCs,0.19135477263518083
GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),1/417,0.6517468120762254,0.6735930739335291,0,0,0.9583006279434853,0.41024765313154,PROC,Cycling DCs,0.1859210844420885
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),5/2206,0.6589063274622694,0.6790956578301941,0,0,0.8960068655661568,0.3737906767782196,SPIB;CUX2;IRF7;IRF8;E2F7,Cycling DCs,0.1811763219125431
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),1/481,0.7043872370804651,0.7190653285770972,0,0,0.8278061224489796,0.2900856337670249,CLEC4C,Cycling DCs,0.15218852169360617
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),1/482,0.7051444771556823,0.7190653285770972,0,0,0.8260426831855403,0.2885801301950252,CUX2,Cycling DCs,0.1517218912312197
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7190653285770972,0,0,0.8260426831855403,0.2885801301950252,IRF8,Cycling DCs,0.1517218912312197
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7190653285770972,0,0,0.8207960870298533,0.2841203737887477,PROC,Cycling DCs,0.15033199168778996
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),1/485,0.7074048097353064,0.7190653285770972,0,0,0.8207960870298533,0.2841203737887477,CLEC4C,Cycling DCs,0.15033199168778996
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),1/488,0.7096481586491704,0.7193693663018988,0,0,0.815614130662532,0.2797442143304909,CLEC4C,Cycling DCs,0.14895691977455572
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),2/1025,0.7337546800798972,0.7417738569113715,0,0,0.7708944281524927,0.2386539053000475,RET;PROC,Cycling DCs,0.13444911569132442
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),1/566,0.7624057114769476,0.7686379107533259,0,0,0.700198663536211,0.1899473973942179,E2F7,Cycling DCs,0.11781385888910202
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.853942621573782,0,0,0.5290423861852434,0.0863986224716518,PROC,Cycling DCs,0.07092521499844862
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),1/764,0.8577067842472734,0.8600311928766697,0,0,0.5131997753229732,0.0787725634671716,E2F7,Cycling DCs,0.06666115474745983
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),1/1079,0.9377418517471742,0.9377418517471742,0,0,0.3572753776835409,0.0229658682151355,CUX2,Cycling DCs,0.027916700844649738
GO_Biological_Process_2021,DNA metabolic process (GO:0006259),7/277,5.440127304864341e-06,0.0014972237141609,0,0,11.8656330749354,143.83174050553382,POLQ;ORC6;CDC45;TERT;EXO1;XRCC2;MCM10,Cycling HSPC,5.2643909372221875
GO_Biological_Process_2021,DNA replication (GO:0006260),5/108,7.303530312980346e-06,0.0014972237141609,0,0,21.40992448759439,253.21844668535684,BRIP1;ORC6;CDC45;EXO1;MCM10,Cycling HSPC,5.136467163874597
GO_Biological_Process_2021,proteolysis (GO:0006508),6/287,7.748561793803869e-05,0.0104028135060844,0,0,9.544969265609836,90.34712593704772,CPA3;PRSS57;CTSG;PRTN3;AZU1;ELANE,Cycling HSPC,4.110778899168209
GO_Biological_Process_2021,DNA replication initiation (GO:0006270),3/38,0.00011660554961914327,0.0104028135060844,0,0,36.319148936170215,328.93213337279053,CDC45;ORC6;MCM10,Cycling HSPC,3.9332807796660614
GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),6/314,0.0001268635793424938,0.0104028135060844,0,0,8.696280991735538,78.02649615395364,BRIP1;ORC6;CDC45;TERT;EXO1;MCM10,Cycling HSPC,3.8966630395350834
GO_Biological_Process_2021,angiotensin maturation (GO:0002003),2/12,0.0003978405023918531,0.0211032731280078,0,0,83.08333333333333,650.4975835514635,CPA3;CTSG,Cycling HSPC,3.4002910053496507
GO_Biological_Process_2021,regulation of angiotensin levels in blood (GO:0002002),2/12,0.0003978405023918531,0.0211032731280078,0,0,83.08333333333333,650.4975835514635,CPA3;CTSG,Cycling HSPC,3.4002910053496507
GO_Biological_Process_2021,positive regulation of mitotic cell cycle phase transition (GO:1901992),3/58,0.00041177118298551824,0.0211032731280078,0,0,23.088974854932303,179.97954590931704,CDCA5;DTL;CDC25A,Cycling HSPC,3.3853440499187784
GO_Biological_Process_2021,double-strand break repair (GO:0006302),4/164,0.0007482505237115204,0.0324016298396192,0,0,10.755434782608695,77.4151749766057,POLQ;BRIP1;XRCC2;CDCA5,Cycling HSPC,3.1259529705185845
GO_Biological_Process_2021,defense response to Gram-negative bacterium (GO:0050829),3/73,0.0008084332971786784,0.0324016298396192,0,0,18.127659574468087,129.07641173230985,CTSG;AZU1;ELANE,Cycling HSPC,3.0923558073744988
GO_Biological_Process_2021,DNA repair (GO:0006281),5/298,0.000869312020087346,0.0324016298396192,0,0,7.454304133485021,52.53650759120063,POLQ;BRIP1;EXO1;XRCC2;CDCA5,Cycling HSPC,3.0608243152885284
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),4/176,0.0009733818874053012,0.0332572144863477,0,0,9.998988877654195,69.34032881835857,CTSG;AZU1;MPO;ELANE,Cycling HSPC,3.011716739326452
GO_Biological_Process_2021,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),2/20,0.0011307590059983,0.0356623994199471,0,0,46.138888888888886,313.0461870363529,DTL;CDC25A,Cycling HSPC,2.9466299446036754
GO_Biological_Process_2021,positive regulation of cell cycle G2/M phase transition (GO:1902751),2/23,0.0014985033958486,0.0438847423069974,0,0,39.541666666666664,257.15086234948103,DTL;CDC25A,Cycling HSPC,2.8243422685363964
GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),5/350,0.0017719017380804,0.046979792642395,0,0,6.314009661835748,40.00368289043371,POLQ;EXO1;XRCC2;MCM10;DTL,Cycling HSPC,2.7515603658534347
GO_Biological_Process_2021,double-strand break repair via homologous recombination (GO:0000724),3/97,0.001837512611877,0.046979792642395,0,0,13.483023992756904,84.93418557118899,POLQ;CDC45;XRCC2,Cycling HSPC,2.735769671427555
GO_Biological_Process_2021,response to UV (GO:0009411),3/99,0.0019479426217578,0.046979792642395,0,0,13.200797872340424,82.3859356912581,DTL;CDC25A;ELANE,Cycling HSPC,2.710423839767963
GO_Biological_Process_2021,DNA-dependent DNA replication (GO:0006261),3/129,0.0041187773755245,0.0766494113283946,0,0,10.04255319148936,55.15569972379198,ORC6;CDC45;MCM10,Cycling HSPC,2.385231681506596
GO_Biological_Process_2021,G2/M transition of mitotic cell cycle (GO:0000086),3/130,0.0042087165784917,0.0766494113283946,0,0,9.962975372759256,54.503428450512054,MELK;NEK2;CDC25A,Cycling HSPC,2.3758503193319243
GO_Biological_Process_2021,regulation of exit from mitosis (GO:0007096),2/39,0.0042784069542198,0.0766494113283946,0,0,22.42454954954955,122.3074073504305,CDCA5;NEK2,Cycling HSPC,2.368717908505425
GO_Biological_Process_2021,DNA integrity checkpoint signaling (GO:0031570),2/39,0.0042784069542198,0.0766494113283946,0,0,22.42454954954955,122.3074073504305,BRIP1;CDC45,Cycling HSPC,2.368717908505425
GO_Biological_Process_2021,DNA recombination (GO:0006310),2/39,0.0042784069542198,0.0766494113283946,0,0,22.42454954954955,122.3074073504305,EXO1;XRCC2,Cycling HSPC,2.368717908505425
GO_Biological_Process_2021,cell cycle G2/M phase transition (GO:0044839),3/131,0.0042998450257392,0.0766494113283946,0,0,9.884640957446807,53.86315121420032,MELK;NEK2;CDC25A,Cycling HSPC,2.3665471969039427
GO_Biological_Process_2021,regulation of G2/M transition of mitotic cell cycle (GO:0010389),3/149,0.0061486161723867,0.1050388596116069,0,0,8.658117167006704,44.08304801864367,NEK2;DTL;CDC25A,Cycling HSPC,2.2112226169597906
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),5/474,0.0064546964501927,0.1058570217831608,0,0,4.615257048092869,23.274497983277463,TERT;SAPCD2;PRTN3;TTK;ELANE,Cycling HSPC,2.1901241768067132
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),5/481,0.006857817428032,0.1065759179313812,0,0,4.545751633986928,22.648598599483577,CTSG;PRTN3;AZU1;MPO;ELANE,Cycling HSPC,2.163814081054509
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),5/485,0.0070959676294594,0.1065759179313812,0,0,4.506944444444445,22.30139137962044,CTSG;PRTN3;AZU1;MPO;ELANE,Cycling HSPC,2.148988374345894
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),5/488,0.0072783553709236,0.1065759179313812,0,0,4.478260869565218,22.045808102039476,CTSG;PRTN3;AZU1;MPO;ELANE,Cycling HSPC,2.1379667434923895
GO_Biological_Process_2021,regulation of phagocytosis (GO:0050764),2/58,0.0092602829393189,0.1309212415558891,0,0,14.802083333333334,69.30366021141536,PRTN3;AZU1,Cycling HSPC,2.033375743652011
GO_Biological_Process_2021,response to light stimulus (GO:0009416),2/61,0.0102031878981958,0.1319017731532408,0,0,14.04731638418079,64.40771918587598,DTL;ELANE,Cycling HSPC,1.9912641154648159
GO_Biological_Process_2021,extracellular matrix disassembly (GO:0022617),2/66,0.0118650634107129,0.1319017731532408,0,0,12.946614583333334,57.4073222604629,CTSG;ELANE,Cycling HSPC,1.9257299364311244
GO_Biological_Process_2021,cellular component disassembly (GO:0022411),2/66,0.0118650634107129,0.1319017731532408,0,0,12.946614583333334,57.4073222604629,CTSG;ELANE,Cycling HSPC,1.9257299364311244
GO_Biological_Process_2021,establishment of protein localization to telomere (GO:0070200),1/5,0.0124387771927725,0.1319017731532408,0,0,101.76530612244898,446.4379351400606,TERT,Cycling HSPC,1.9052223113279663
GO_Biological_Process_2021,camera-type eye photoreceptor cell differentiation (GO:0060219),1/5,0.0124387771927725,0.1319017731532408,0,0,101.76530612244898,446.4379351400606,PROM1,Cycling HSPC,1.9052223113279663
GO_Biological_Process_2021,mature conventional dendritic cell differentiation (GO:0097029),1/5,0.0124387771927725,0.1319017731532408,0,0,101.76530612244898,446.4379351400606,PRTN3,Cycling HSPC,1.9052223113279663
GO_Biological_Process_2021,glomerular epithelial cell differentiation (GO:0072311),1/6,0.0149082847993736,0.1319017731532408,0,0,81.40816326530613,342.3895623444841,PROM1,Cycling HSPC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),1/6,0.0149082847993736,0.1319017731532408,0,0,81.40816326530613,342.3895623444841,PROM1,Cycling HSPC,1.8265723193247598
GO_Biological_Process_2021,renal filtration cell differentiation (GO:0061318),1/6,0.0149082847993736,0.1319017731532408,0,0,81.40816326530613,342.3895623444841,PROM1,Cycling HSPC,1.8265723193247598
GO_Biological_Process_2021,neutrophil extravasation (GO:0072672),1/6,0.0149082847993736,0.1319017731532408,0,0,81.40816326530613,342.3895623444841,PRTN3,Cycling HSPC,1.8265723193247598
GO_Biological_Process_2021,mitotic cell cycle phase transition (GO:0044772),3/209,0.0153778461568471,0.1319017731532408,0,0,6.117744267713283,25.54052619027468,MELK;NEK2;CDC25A,Cycling HSPC,1.8131044881821832
GO_Biological_Process_2021,positive regulation of tumor necrosis factor production (GO:0032760),2/77,0.0159057771109684,0.1319017731532408,0,0,11.041666666666666,45.72434655376785,C1QTNF4;AZU1,Cycling HSPC,1.7984451076467942
GO_Biological_Process_2021,recombinational repair (GO:0000725),2/79,0.0166954776383478,0.1319017731532408,0,0,10.75378787878788,44.01113934918422,POLQ;XRCC2,Cycling HSPC,1.7774011517679502
GO_Biological_Process_2021,glial cell migration (GO:0008347),1/7,0.0173717414502839,0.1319017731532408,0,0,67.83673469387755,274.9362107684438,AZU1,Cycling HSPC,1.7601566430186848
GO_Biological_Process_2021,regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),1/7,0.0173717414502839,0.1319017731532408,0,0,67.83673469387755,274.9362107684438,KCNE5,Cycling HSPC,1.7601566430186848
GO_Biological_Process_2021,modulation by symbiont of host apoptotic process (GO:0052150),1/7,0.0173717414502839,0.1319017731532408,0,0,67.83673469387755,274.9362107684438,CTSG,Cycling HSPC,1.7601566430186848
GO_Biological_Process_2021,regulation of potassium ion export across plasma membrane (GO:1903764),1/7,0.0173717414502839,0.1319017731532408,0,0,67.83673469387755,274.9362107684438,KCNE5,Cycling HSPC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/81,0.0175016586979588,0.1319017731532408,0,0,10.48048523206751,42.398379802278754,C1QTNF4;AZU1,Cycling HSPC,1.7569207896432026
GO_Biological_Process_2021,G1/S transition of mitotic cell cycle (GO:0000082),2/85,0.0191627543313976,0.1319017731532408,0,0,9.973393574297187,39.44264488506008,CDC45;CDC25A,Cycling HSPC,1.717542068067663
GO_Biological_Process_2021,atrial cardiac muscle cell to AV node cell signaling (GO:0086026),1/8,0.0198291614511851,0.1319017731532408,0,0,58.142857142857146,227.9549801512961,KCNE5,Cycling HSPC,1.702695651141308
GO_Biological_Process_2021,positive regulation of MHC class II biosynthetic process (GO:0045348),1/8,0.0198291614511851,0.1319017731532408,0,0,58.142857142857146,227.9549801512961,AZU1,Cycling HSPC,1.702695651141308
GO_Biological_Process_2021,somatic hypermutation of immunoglobulin genes (GO:0016446),1/8,0.0198291614511851,0.1319017731532408,0,0,58.142857142857146,227.9549801512961,POLQ,Cycling HSPC,1.702695651141308
GO_Biological_Process_2021,positive regulation of steroid biosynthetic process (GO:0010893),1/8,0.0198291614511851,0.1319017731532408,0,0,58.142857142857146,227.9549801512961,STAR,Cycling HSPC,1.702695651141308
GO_Biological_Process_2021,regulation of protein localization to cell cortex (GO:1904776),1/8,0.0198291614511851,0.1319017731532408,0,0,58.142857142857146,227.9549801512961,SAPCD2,Cycling HSPC,1.702695651141308
GO_Biological_Process_2021,negative regulation by symbiont of host apoptotic process (GO:0033668),1/8,0.0198291614511851,0.1319017731532408,0,0,58.142857142857146,227.9549801512961,CTSG,Cycling HSPC,1.702695651141308
GO_Biological_Process_2021,negative regulation by symbiont of host programmed cell death (GO:0052041),1/8,0.0198291614511851,0.1319017731532408,0,0,58.142857142857146,227.9549801512961,CTSG,Cycling HSPC,1.702695651141308
GO_Biological_Process_2021,regulation of protein localization to chromatin (GO:1905634),1/8,0.0198291614511851,0.1319017731532408,0,0,58.142857142857146,227.9549801512961,CDCA5,Cycling HSPC,1.702695651141308
GO_Biological_Process_2021,regulation of protein localization to nucleolus (GO:1904749),1/8,0.0198291614511851,0.1319017731532408,0,0,58.142857142857146,227.9549801512961,TERT,Cycling HSPC,1.702695651141308
GO_Biological_Process_2021,regulation of animal organ morphogenesis (GO:2000027),1/9,0.0222805591236868,0.1319017731532408,0,0,50.87244897959184,193.52086993316271,SAPCD2,Cycling HSPC,1.652073914876897
GO_Biological_Process_2021,regulation of mitotic centrosome separation (GO:0046602),1/9,0.0222805591236868,0.1319017731532408,0,0,50.87244897959184,193.52086993316271,NEK2,Cycling HSPC,1.652073914876897
GO_Biological_Process_2021,regulation of nephron tubule epithelial cell differentiation (GO:0072182),1/9,0.0222805591236868,0.1319017731532408,0,0,50.87244897959184,193.52086993316271,PROM1,Cycling HSPC,1.652073914876897
GO_Biological_Process_2021,negative regulation of delayed rectifier potassium channel activity (GO:1902260),1/10,0.024725948817258,0.1319017731532408,0,0,45.21768707482993,167.3010120823387,KCNE5,Cycling HSPC,1.606847034080906
GO_Biological_Process_2021,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),1/10,0.024725948817258,0.1319017731532408,0,0,45.21768707482993,167.3010120823387,NEK2,Cycling HSPC,1.606847034080906
GO_Biological_Process_2021,regulation of bile acid biosynthetic process (GO:0070857),1/10,0.024725948817258,0.1319017731532408,0,0,45.21768707482993,167.3010120823387,STAR,Cycling HSPC,1.606847034080906
GO_Biological_Process_2021,regulation of hair cycle (GO:0042634),1/10,0.024725948817258,0.1319017731532408,0,0,45.21768707482993,167.3010120823387,TERT,Cycling HSPC,1.606847034080906
GO_Biological_Process_2021,mitotic DNA replication (GO:1902969),1/10,0.024725948817258,0.1319017731532408,0,0,45.21768707482993,167.3010120823387,CDC45,Cycling HSPC,1.606847034080906
GO_Biological_Process_2021,production of siRNA involved in RNA interference (GO:0030422),1/10,0.024725948817258,0.1319017731532408,0,0,45.21768707482993,167.3010120823387,TERT,Cycling HSPC,1.606847034080906
GO_Biological_Process_2021,monocyte activation (GO:0042117),1/10,0.024725948817258,0.1319017731532408,0,0,45.21768707482993,167.3010120823387,AZU1,Cycling HSPC,1.606847034080906
GO_Biological_Process_2021,pyrimidine nucleoside salvage (GO:0043097),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,TK1,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,pyrimidine-containing compound salvage (GO:0008655),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,TK1,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,formation of extrachromosomal circular DNA (GO:0001325),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,EXO1,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,cell-cell junction maintenance (GO:0045217),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,PRTN3,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,induction of positive chemotaxis (GO:0050930),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,AZU1,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of potassium ion transmembrane transport (GO:1901380),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,KCNE5,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of voltage-gated potassium channel activity (GO:1903817),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,KCNE5,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,t-circle formation (GO:0090656),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,EXO1,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,telomere maintenance via telomere trimming (GO:0090737),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,EXO1,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,protein kinase C signaling (GO:0070528),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,AZU1,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),1/11,0.0271653448579923,0.1319017731532408,0,0,40.69387755102041,146.73452100035948,AZU1,Cycling HSPC,1.5659847773237099
GO_Biological_Process_2021,regulation of sister chromatid cohesion (GO:0007063),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,CDCA5,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of cell division (GO:0051782),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,ORC6,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,eye photoreceptor cell differentiation (GO:0001754),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,PROM1,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,glomerular visceral epithelial cell differentiation (GO:0072112),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,PROM1,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of gene silencing by miRNA (GO:0060965),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,TERT,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,replicative senescence (GO:0090399),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,TERT,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,TERT,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,macrophage chemotaxis (GO:0048246),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,AZU1,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,regulation of MHC class II biosynthetic process (GO:0045346),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,AZU1,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,nucleoside salvage (GO:0043174),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,TK1,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,double-strand break repair via break-induced replication (GO:0000727),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,CDC45,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,protein localization to condensed chromosome (GO:1903083),1/12,0.029598761568907,0.1319017731532408,0,0,36.99257884972171,130.2147194065139,TTK,Cycling HSPC,1.5287264597194943
GO_Biological_Process_2021,establishment of protein localization to chromosome (GO:0070199),1/13,0.032026213248763,0.1319017731532408,0,0,33.90816326530612,116.6847899929619,TERT,Cycling HSPC,1.4944944088974865
GO_Biological_Process_2021,negative regulation of cellular senescence (GO:2000773),1/13,0.032026213248763,0.1319017731532408,0,0,33.90816326530612,116.6847899929619,TERT,Cycling HSPC,1.4944944088974865
GO_Biological_Process_2021,atrial cardiac muscle cell action potential (GO:0086014),1/13,0.032026213248763,0.1319017731532408,0,0,33.90816326530612,116.6847899929619,KCNE5,Cycling HSPC,1.4944944088974865
GO_Biological_Process_2021,negative regulation of locomotion (GO:0040013),1/13,0.032026213248763,0.1319017731532408,0,0,33.90816326530612,116.6847899929619,ELANE,Cycling HSPC,1.4944944088974865
GO_Biological_Process_2021,negative regulation of potassium ion transport (GO:0043267),1/13,0.032026213248763,0.1319017731532408,0,0,33.90816326530612,116.6847899929619,KCNE5,Cycling HSPC,1.4944944088974865
GO_Biological_Process_2021,intracellular sterol transport (GO:0032366),1/13,0.032026213248763,0.1319017731532408,0,0,33.90816326530612,116.6847899929619,STAR,Cycling HSPC,1.4944944088974865
GO_Biological_Process_2021,regulation of membrane repolarization (GO:0060306),1/13,0.032026213248763,0.1319017731532408,0,0,33.90816326530612,116.6847899929619,KCNE5,Cycling HSPC,1.4944944088974865
GO_Biological_Process_2021,pyrimidine nucleoside biosynthetic process (GO:0046134),1/14,0.0344477141698711,0.1319017731532408,0,0,31.298273155416013,105.4223689491126,TK1,Cycling HSPC,1.4628395910668823
GO_Biological_Process_2021,cell junction maintenance (GO:0034331),1/14,0.0344477141698711,0.1319017731532408,0,0,31.298273155416013,105.4223689491126,PRTN3,Cycling HSPC,1.4628395910668823
GO_Biological_Process_2021,low-density lipoprotein particle remodeling (GO:0034374),1/14,0.0344477141698711,0.1319017731532408,0,0,31.298273155416013,105.4223689491126,MPO,Cycling HSPC,1.4628395910668823
GO_Biological_Process_2021,membrane repolarization during action potential (GO:0086011),1/14,0.0344477141698711,0.1319017731532408,0,0,31.298273155416013,105.4223689491126,KCNE5,Cycling HSPC,1.4628395910668823
GO_Biological_Process_2021,potassium ion export across plasma membrane (GO:0097623),1/14,0.0344477141698711,0.1319017731532408,0,0,31.298273155416013,105.4223689491126,KCNE5,Cycling HSPC,1.4628395910668823
GO_Biological_Process_2021,protein localization to kinetochore (GO:0034501),1/14,0.0344477141698711,0.1319017731532408,0,0,31.298273155416013,105.4223689491126,TTK,Cycling HSPC,1.4628395910668823
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),4/496,0.0351145943571396,0.1319017731532408,0,0,3.4390243902439024,11.51776878585794,MELK;CTSG;TTK;NEK2,Cycling HSPC,1.454512344177025
GO_Biological_Process_2021,protein homooligomerization (GO:0051260),2/121,0.0368223679095263,0.1319017731532408,0,0,6.943627450980392,22.92542614889691,POLQ;TK1,Cycling HSPC,1.4338882870711436
GO_Biological_Process_2021,C21-steroid hormone biosynthetic process (GO:0006700),1/15,0.0368632785936063,0.1319017731532408,0,0,29.06122448979592,95.91771596133704,STAR,Cycling HSPC,1.4334060415588732
GO_Biological_Process_2021,intracellular cholesterol transport (GO:0032367),1/15,0.0368632785936063,0.1319017731532408,0,0,29.06122448979592,95.91771596133704,STAR,Cycling HSPC,1.4334060415588732
GO_Biological_Process_2021,macrophage migration (GO:1905517),1/15,0.0368632785936063,0.1319017731532408,0,0,29.06122448979592,95.91771596133704,AZU1,Cycling HSPC,1.4334060415588732
GO_Biological_Process_2021,"protein localization to chromosome, telomeric region (GO:0070198)",1/15,0.0368632785936063,0.1319017731532408,0,0,29.06122448979592,95.91771596133704,TERT,Cycling HSPC,1.4334060415588732
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),2/124,0.038497072428768,0.1319017731532408,0,0,6.771857923497268,22.05711333941876,C1QTNF4;AZU1,Cycling HSPC,1.4145722958518654
GO_Biological_Process_2021,regulation of chromatin silencing (GO:0031935),1/16,0.0392729207344652,0.1319017731532408,0,0,27.122448979591837,87.80133530116419,CDC45,Cycling HSPC,1.405906798966597
GO_Biological_Process_2021,regulation of hormone secretion (GO:0046883),1/16,0.0392729207344652,0.1319017731532408,0,0,27.122448979591837,87.80133530116419,SCG5,Cycling HSPC,1.405906798966597
GO_Biological_Process_2021,membrane repolarization (GO:0086009),1/16,0.0392729207344652,0.1319017731532408,0,0,27.122448979591837,87.80133530116419,KCNE5,Cycling HSPC,1.405906798966597
GO_Biological_Process_2021,mitotic sister chromatid cohesion (GO:0007064),1/16,0.0392729207344652,0.1319017731532408,0,0,27.122448979591837,87.80133530116419,CDCA5,Cycling HSPC,1.405906798966597
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),5/764,0.0413571138631448,0.1319017731532408,0,0,2.8093983311374617,8.949368815489745,SAPCD2;CDCA7;PRTN3;TTK;SHCBP1,Cycling HSPC,1.3834497764190727
GO_Biological_Process_2021,negative regulation of cell aging (GO:0090344),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,TERT,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,regulation of stem cell proliferation (GO:0072091),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,TERT,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,regulation of steroid biosynthetic process (GO:0050810),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,STAR,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,negative regulation of chemokine production (GO:0032682),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,ELANE,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,gliogenesis (GO:0042063),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,AZU1,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,negative regulation of phagocytosis (GO:0050765),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,PRTN3,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,RNA interference (GO:0016246),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,TERT,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of positive chemotaxis (GO:0050927),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,AZU1,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of stem cell proliferation (GO:2000648),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,TERT,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of telomere capping (GO:1904355),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,NEK2,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,DNA biosynthetic process (GO:0071897),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,TERT,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,DNA replication checkpoint signaling (GO:0000076),1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,CDC45,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,"protein localization to chromosome, centromeric region (GO:0071459)",1/17,0.0416766547912334,0.1319017731532408,0,0,25.426020408163264,80.79916728086499,TTK,Cycling HSPC,1.3801071472903907
GO_Biological_Process_2021,negative regulation of cation transmembrane transport (GO:1904063),1/18,0.0440744949316926,0.1319017731532408,0,0,23.92917166866747,74.70385911458476,KCNE5,Cycling HSPC,1.3558126557645607
GO_Biological_Process_2021,negative regulation of double-strand break repair via homologous recombination (GO:2000042),1/18,0.0440744949316926,0.1319017731532408,0,0,23.92917166866747,74.70385911458476,POLQ,Cycling HSPC,1.3558126557645607
GO_Biological_Process_2021,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/18,0.0440744949316926,0.1319017731532408,0,0,23.92917166866747,74.70385911458476,KCNE5,Cycling HSPC,1.3558126557645607
GO_Biological_Process_2021,negative regulation of interleukin-8 production (GO:0032717),1/18,0.0440744949316926,0.1319017731532408,0,0,23.92917166866747,74.70385911458476,ELANE,Cycling HSPC,1.3558126557645607
GO_Biological_Process_2021,regulation of delayed rectifier potassium channel activity (GO:1902259),1/18,0.0440744949316926,0.1319017731532408,0,0,23.92917166866747,74.70385911458476,KCNE5,Cycling HSPC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of nitric-oxide synthase activity (GO:0051000),1/18,0.0440744949316926,0.1319017731532408,0,0,23.92917166866747,74.70385911458476,TERT,Cycling HSPC,1.3558126557645607
GO_Biological_Process_2021,ventricular cardiac muscle cell action potential (GO:0086005),1/18,0.0440744949316926,0.1319017731532408,0,0,23.92917166866747,74.70385911458476,KCNE5,Cycling HSPC,1.3558126557645607
GO_Biological_Process_2021,DNA strand elongation (GO:0022616),1/18,0.0440744949316926,0.1319017731532408,0,0,23.92917166866747,74.70385911458476,TERT,Cycling HSPC,1.3558126557645607
GO_Biological_Process_2021,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/18,0.0440744949316926,0.1319017731532408,0,0,23.92917166866747,74.70385911458476,TERT,Cycling HSPC,1.3558126557645607
GO_Biological_Process_2021,negative regulation of RNA metabolic process (GO:0051253),1/19,0.0464664552952436,0.1380525121090571,0,0,22.598639455782312,69.35578082800635,TERT,Cycling HSPC,1.3328604565168853
GO_Biological_Process_2021,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1/20,0.0488525499820277,0.1409761419970362,0,0,21.40816326530612,64.63014669364038,CLDN10,Cycling HSPC,1.3111127622579986
GO_Biological_Process_2021,nucleobase-containing compound biosynthetic process (GO:0034654),1/20,0.0488525499820277,0.1409761419970362,0,0,21.40816326530612,64.63014669364038,TERT,Cycling HSPC,1.3111127622579986
GO_Biological_Process_2021,regulation of nuclear division (GO:0051783),1/20,0.0488525499820277,0.1409761419970362,0,0,21.40816326530612,64.63014669364038,NEK2,Cycling HSPC,1.3111127622579986
GO_Biological_Process_2021,production of small RNA involved in gene silencing by RNA (GO:0070918),1/20,0.0488525499820277,0.1409761419970362,0,0,21.40816326530612,64.63014669364038,TERT,Cycling HSPC,1.3111127622579986
GO_Biological_Process_2021,purinergic nucleotide receptor signaling pathway (GO:0035590),1/21,0.0512327930672156,0.1409761419970362,0,0,20.336734693877553,60.42807445408675,CTSG,Cycling HSPC,1.2904519669693806
GO_Biological_Process_2021,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.0512327930672156,0.1409761419970362,0,0,20.336734693877553,60.42807445408675,AZU1,Cycling HSPC,1.2904519669693806
GO_Biological_Process_2021,hydrogen peroxide catabolic process (GO:0042744),1/21,0.0512327930672156,0.1409761419970362,0,0,20.336734693877553,60.42807445408675,MPO,Cycling HSPC,1.2904519669693806
GO_Biological_Process_2021,negative regulation of protein localization to cell periphery (GO:1904376),1/21,0.0512327930672156,0.1409761419970362,0,0,20.336734693877553,60.42807445408675,SAPCD2,Cycling HSPC,1.2904519669693806
GO_Biological_Process_2021,spindle assembly checkpoint signaling (GO:0071173),1/21,0.0512327930672156,0.1409761419970362,0,0,20.336734693877553,60.42807445408675,TTK,Cycling HSPC,1.2904519669693806
GO_Biological_Process_2021,mitotic spindle assembly checkpoint signaling (GO:0007094),1/21,0.0512327930672156,0.1409761419970362,0,0,20.336734693877553,60.42807445408675,TTK,Cycling HSPC,1.2904519669693806
GO_Biological_Process_2021,mitotic spindle checkpoint signaling (GO:0071174),1/21,0.0512327930672156,0.1409761419970362,0,0,20.336734693877553,60.42807445408675,TTK,Cycling HSPC,1.2904519669693806
GO_Biological_Process_2021,regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.0536071985992547,0.1445983646427267,0,0,19.367346938775512,56.67024999786951,KCNE5,Cycling HSPC,1.2707768875084013
GO_Biological_Process_2021,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),1/22,0.0536071985992547,0.1445983646427267,0,0,19.367346938775512,56.67024999786951,TTK,Cycling HSPC,1.2707768875084013
GO_Biological_Process_2021,microglial cell activation (GO:0001774),1/22,0.0536071985992547,0.1445983646427267,0,0,19.367346938775512,56.67024999786951,AZU1,Cycling HSPC,1.2707768875084013
GO_Biological_Process_2021,regulation of steroid metabolic process (GO:0019218),1/23,0.0559757805878795,0.145253607854624,0,0,18.4860853432282,53.29235549319145,STAR,Cycling HSPC,1.2519998414265567
GO_Biological_Process_2021,regulation of telomere capping (GO:1904353),1/23,0.0559757805878795,0.145253607854624,0,0,18.4860853432282,53.29235549319145,NEK2,Cycling HSPC,1.2519998414265567
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.0559757805878795,0.145253607854624,0,0,18.4860853432282,53.29235549319145,TERT,Cycling HSPC,1.2519998414265567
GO_Biological_Process_2021,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.0559757805878795,0.145253607854624,0,0,18.4860853432282,53.29235549319145,TERT,Cycling HSPC,1.2519998414265567
GO_Biological_Process_2021,membrane protein ectodomain proteolysis (GO:0006509),1/23,0.0559757805878795,0.145253607854624,0,0,18.4860853432282,53.29235549319145,PRTN3,Cycling HSPC,1.2519998414265567
GO_Biological_Process_2021,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.0559757805878795,0.145253607854624,0,0,18.4860853432282,53.29235549319145,SHCBP1,Cycling HSPC,1.2519998414265567
GO_Biological_Process_2021,regulation of signal transduction by p53 class mediator (GO:1901796),2/156,0.058052477548913,0.1476469551563832,0,0,5.356060606060606,15.245533180091437,BRIP1;EXO1,Cycling HSPC,1.2361792408201375
GO_Biological_Process_2021,establishment of mitotic spindle orientation (GO:0000132),1/24,0.0583385530130099,0.1476469551563832,0,0,17.68145519077196,50.24171555062859,SAPCD2,Cycling HSPC,1.2340443470047993
GO_Biological_Process_2021,C21-steroid hormone metabolic process (GO:0008207),1/24,0.0583385530130099,0.1476469551563832,0,0,17.68145519077196,50.24171555062859,STAR,Cycling HSPC,1.2340443470047993
GO_Biological_Process_2021,dendritic cell differentiation (GO:0097028),1/24,0.0583385530130099,0.1476469551563832,0,0,17.68145519077196,50.24171555062859,PRTN3,Cycling HSPC,1.2340443470047993
GO_Biological_Process_2021,protein autophosphorylation (GO:0046777),2/159,0.060032623780291,0.151002305214229,0,0,5.25291932059448,14.77576411894998,MELK;NEK2,Cycling HSPC,1.2216126749949432
GO_Biological_Process_2021,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/25,0.0606955298241754,0.1517388245604385,0,0,16.943877551020407,47.47480020477031,AZU1,Cycling HSPC,1.2168432931781568
GO_Biological_Process_2021,acute inflammatory response (GO:0002526),1/27,0.0653921522588676,0.1615107375068417,0,0,15.638932496075354,42.652889831563165,ELANE,Cycling HSPC,1.184474368421492
GO_Biological_Process_2021,mitotic chromosome condensation (GO:0007076),1/27,0.0653921522588676,0.1615107375068417,0,0,15.638932496075354,42.652889831563165,CDCA5,Cycling HSPC,1.184474368421492
GO_Biological_Process_2021,positive regulation of monooxygenase activity (GO:0032770),1/28,0.0677318256109869,0.1631383487253911,0,0,15.058956916099774,40.54171043527237,TERT,Cycling HSPC,1.1692072184717057
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.0677318256109869,0.1631383487253911,0,0,15.058956916099774,40.54171043527237,TERT,Cycling HSPC,1.1692072184717057
GO_Biological_Process_2021,macromolecule catabolic process (GO:0009057),1/28,0.0677318256109869,0.1631383487253911,0,0,15.058956916099774,40.54171043527237,ELANE,Cycling HSPC,1.1692072184717057
GO_Biological_Process_2021,regulation of microtubule polymerization or depolymerization (GO:0031110),1/28,0.0677318256109869,0.1631383487253911,0,0,15.058956916099774,40.54171043527237,SKA3,Cycling HSPC,1.1692072184717057
GO_Biological_Process_2021,actin filament polymerization (GO:0030041),1/29,0.0700657588372089,0.1631383487253911,0,0,14.520408163265309,38.5999069065122,DIAPH3,Cycling HSPC,1.1544941700666143
GO_Biological_Process_2021,establishment of mitotic spindle localization (GO:0040001),1/29,0.0700657588372089,0.1631383487253911,0,0,14.520408163265309,38.5999069065122,SAPCD2,Cycling HSPC,1.1544941700666143
GO_Biological_Process_2021,beta-catenin-TCF complex assembly (GO:1904837),1/29,0.0700657588372089,0.1631383487253911,0,0,14.520408163265309,38.5999069065122,TERT,Cycling HSPC,1.1544941700666143
GO_Biological_Process_2021,hydrogen peroxide metabolic process (GO:0042743),1/29,0.0700657588372089,0.1631383487253911,0,0,14.520408163265309,38.5999069065122,MPO,Cycling HSPC,1.1544941700666143
GO_Biological_Process_2021,telomere maintenance via telomerase (GO:0007004),1/29,0.0700657588372089,0.1631383487253911,0,0,14.520408163265309,38.5999069065122,TERT,Cycling HSPC,1.1544941700666143
GO_Biological_Process_2021,mismatch repair (GO:0006298),1/29,0.0700657588372089,0.1631383487253911,0,0,14.520408163265309,38.5999069065122,EXO1,Cycling HSPC,1.1544941700666143
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),4/625,0.0704280188399859,0.1631383487253911,0,0,2.7065742491073306,7.180985632016276,SAPCD2;PRTN3;TTK;AZU1,Cycling HSPC,1.1522545282619854
GO_Biological_Process_2021,establishment of spindle orientation (GO:0051294),1/30,0.0723939657090184,0.1644980975387208,0,0,14.019000703729768,36.80874147674154,SAPCD2,Cycling HSPC,1.1402976322627019
GO_Biological_Process_2021,regulation of cation transmembrane transport (GO:1904062),1/30,0.0723939657090184,0.1644980975387208,0,0,14.019000703729768,36.80874147674154,KCNE5,Cycling HSPC,1.1402976322627019
GO_Biological_Process_2021,RNA-dependent DNA biosynthetic process (GO:0006278),1/30,0.0723939657090184,0.1644980975387208,0,0,14.019000703729768,36.80874147674154,TERT,Cycling HSPC,1.1402976322627019
GO_Biological_Process_2021,regulation of cellular senescence (GO:2000772),1/31,0.0747164600026276,0.1644980975387208,0,0,13.551020408163266,35.15209038871121,TERT,Cycling HSPC,1.126583712764908
GO_Biological_Process_2021,cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.0747164600026276,0.1644980975387208,0,0,13.551020408163266,35.15209038871121,KCNE5,Cycling HSPC,1.126583712764908
GO_Biological_Process_2021,steroid hormone biosynthetic process (GO:0120178),1/31,0.0747164600026276,0.1644980975387208,0,0,13.551020408163266,35.15209038871121,STAR,Cycling HSPC,1.126583712764908
GO_Biological_Process_2021,regulation of potassium ion transport (GO:0043266),1/31,0.0747164600026276,0.1644980975387208,0,0,13.551020408163266,35.15209038871121,KCNE5,Cycling HSPC,1.126583712764908
GO_Biological_Process_2021,negative regulation of chemotaxis (GO:0050922),1/32,0.0770332554327668,0.1644980975387208,0,0,13.113232389730086,33.61600807740255,ELANE,Cycling HSPC,1.1133217484244988
GO_Biological_Process_2021,negative regulation of double-strand break repair (GO:2000780),1/32,0.0770332554327668,0.1644980975387208,0,0,13.113232389730086,33.61600807740255,POLQ,Cycling HSPC,1.1133217484244988
GO_Biological_Process_2021,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/32,0.0770332554327668,0.1644980975387208,0,0,13.113232389730086,33.61600807740255,CDC45,Cycling HSPC,1.1133217484244988
GO_Biological_Process_2021,regulation of chemotaxis (GO:0050920),1/32,0.0770332554327668,0.1644980975387208,0,0,13.113232389730086,33.61600807740255,ELANE,Cycling HSPC,1.1133217484244988
GO_Biological_Process_2021,RNA biosynthetic process (GO:0032774),1/32,0.0770332554327668,0.1644980975387208,0,0,13.113232389730086,33.61600807740255,TERT,Cycling HSPC,1.1133217484244988
GO_Biological_Process_2021,metal ion export (GO:0070839),1/32,0.0770332554327668,0.1644980975387208,0,0,13.113232389730086,33.61600807740255,KCNE5,Cycling HSPC,1.1133217484244988
GO_Biological_Process_2021,positive regulation of telomere maintenance (GO:0032206),1/32,0.0770332554327668,0.1644980975387208,0,0,13.113232389730086,33.61600807740255,NEK2,Cycling HSPC,1.1133217484244988
GO_Biological_Process_2021,DNA damage checkpoint signaling (GO:0000077),1/32,0.0770332554327668,0.1644980975387208,0,0,13.113232389730086,33.61600807740255,BRIP1,Cycling HSPC,1.1133217484244988
GO_Biological_Process_2021,phosphorylation (GO:0016310),3/400,0.0781947688239712,0.1661132394706125,0,0,3.143737606516962,8.011980426037384,MELK;CTSG;NEK2,Cycling HSPC,1.1068222999692412
GO_Biological_Process_2021,positive regulation of telomere maintenance via telomerase (GO:0032212),1/33,0.0793443657059371,0.1668266150740216,0,0,12.70280612244898,32.18837516559274,NEK2,Cycling HSPC,1.1004839073426347
GO_Biological_Process_2021,mitotic G2 DNA damage checkpoint signaling (GO:0007095),1/33,0.0793443657059371,0.1668266150740216,0,0,12.70280612244898,32.18837516559274,DTL,Cycling HSPC,1.1004839073426347
GO_Biological_Process_2021,cardiac muscle contraction (GO:0060048),1/34,0.0816498044624026,0.1682232152240455,0,0,12.317254174397032,30.85861216573232,KCNE5,Cycling HSPC,1.0880448509885652
GO_Biological_Process_2021,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.0816498044624026,0.1682232152240455,0,0,12.317254174397032,30.85861216573232,TERT,Cycling HSPC,1.0880448509885652
GO_Biological_Process_2021,positive regulation of telomerase activity (GO:0051973),1/34,0.0816498044624026,0.1682232152240455,0,0,12.317254174397032,30.85861216573232,NEK2,Cycling HSPC,1.0880448509885652
GO_Biological_Process_2021,organic cyclic compound biosynthetic process (GO:1901362),1/34,0.0816498044624026,0.1682232152240455,0,0,12.317254174397032,30.85861216573232,STAR,Cycling HSPC,1.0880448509885652
GO_Biological_Process_2021,regulation of blood circulation (GO:1903522),1/35,0.0839495853612937,0.170392722763022,0,0,11.95438175270108,29.61744503578088,KCNE5,Cycling HSPC,1.0759814445616303
GO_Biological_Process_2021,regulation of ion transmembrane transport (GO:0034765),1/35,0.0839495853612937,0.170392722763022,0,0,11.95438175270108,29.61744503578088,KCNE5,Cycling HSPC,1.0759814445616303
GO_Biological_Process_2021,regulation of lipid biosynthetic process (GO:0046890),1/35,0.0839495853612937,0.170392722763022,0,0,11.95438175270108,29.61744503578088,STAR,Cycling HSPC,1.0759814445616303
GO_Biological_Process_2021,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/36,0.0862437219743075,0.1716501262595442,0,0,11.612244897959185,28.456712045041098,C1QTNF4,Cycling HSPC,1.0642725091375862
GO_Biological_Process_2021,macrophage activation (GO:0042116),1/36,0.0862437219743075,0.1716501262595442,0,0,11.612244897959185,28.456712045041098,AZU1,Cycling HSPC,1.0642725091375862
GO_Biological_Process_2021,telomere maintenance via telomere lengthening (GO:0010833),1/36,0.0862437219743075,0.1716501262595442,0,0,11.612244897959185,28.456712045041098,TERT,Cycling HSPC,1.0642725091375862
GO_Biological_Process_2021,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/36,0.0862437219743075,0.1716501262595442,0,0,11.612244897959185,28.456712045041098,NEK2,Cycling HSPC,1.0642725091375862
GO_Biological_Process_2021,regulation of transport (GO:0051049),1/37,0.0885322278902676,0.1745106415144699,0,0,11.289115646258503,27.36920368672352,CLDN10,Cycling HSPC,1.0528986067362665
GO_Biological_Process_2021,regulation of microtubule cytoskeleton organization (GO:0070507),1/37,0.0885322278902676,0.1745106415144699,0,0,11.289115646258503,27.36920368672352,SKA3,Cycling HSPC,1.0528986067362665
GO_Biological_Process_2021,regulation of cell communication (GO:0010646),1/38,0.0908151166313484,0.1767031699023586,0,0,10.983452840595698,26.34852930034076,SCG5,Cycling HSPC,1.0418418549683985
GO_Biological_Process_2021,positive regulation of potassium ion transport (GO:0043268),1/38,0.0908151166313484,0.1767031699023586,0,0,10.983452840595698,26.34852930034076,KCNE5,Cycling HSPC,1.0418418549683985
GO_Biological_Process_2021,protein monoubiquitination (GO:0006513),1/39,0.0930924017046572,0.1767031699023586,0,0,10.693877551020408,25.38900533231373,DTL,Cycling HSPC,1.0310857651239858
GO_Biological_Process_2021,regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.0930924017046572,0.1767031699023586,0,0,10.693877551020408,25.38900533231373,KCNE5,Cycling HSPC,1.0310857651239858
GO_Biological_Process_2021,regulation of ion transmembrane transporter activity (GO:0032412),1/39,0.0930924017046572,0.1767031699023586,0,0,10.693877551020408,25.38900533231373,KCNE5,Cycling HSPC,1.0310857651239858
GO_Biological_Process_2021,membrane protein proteolysis (GO:0033619),1/39,0.0930924017046572,0.1767031699023586,0,0,10.693877551020408,25.38900533231373,PRTN3,Cycling HSPC,1.0310857651239858
GO_Biological_Process_2021,regulation of nitric-oxide synthase activity (GO:0050999),1/39,0.0930924017046572,0.1767031699023586,0,0,10.693877551020408,25.38900533231373,TERT,Cycling HSPC,1.0310857651239858
GO_Biological_Process_2021,regulation of peptidyl-threonine phosphorylation (GO:0010799),1/39,0.0930924017046572,0.1767031699023586,0,0,10.693877551020408,25.38900533231373,AZU1,Cycling HSPC,1.0310857651239858
GO_Biological_Process_2021,positive regulation of cation transmembrane transport (GO:1904064),1/41,0.0976302146847681,0.1836164588108025,0,0,10.158163265306122,23.633660200289185,KCNE5,Cycling HSPC,1.0104157556925017
GO_Biological_Process_2021,heart contraction (GO:0060047),1/41,0.0976302146847681,0.1836164588108025,0,0,10.158163265306122,23.633660200289185,KCNE5,Cycling HSPC,1.0104157556925017
GO_Biological_Process_2021,regulation of chemokine production (GO:0032642),1/42,0.0998907694703361,0.1853177171169132,0,0,9.909905425584869,22.829231064333683,ELANE,Cycling HSPC,1.00047464143678
GO_Biological_Process_2021,nucleic acid-templated transcription (GO:0097659),1/42,0.0998907694703361,0.1853177171169132,0,0,9.909905425584869,22.829231064333683,TERT,Cycling HSPC,1.00047464143678
GO_Biological_Process_2021,translesion synthesis (GO:0019985),1/42,0.0998907694703361,0.1853177171169132,0,0,9.909905425584869,22.829231064333683,DTL,Cycling HSPC,1.00047464143678
GO_Biological_Process_2021,DNA synthesis involved in DNA repair (GO:0000731),1/43,0.1021457742794159,0.188647601146669,0,0,9.673469387755102,22.068611238785657,DTL,Cycling HSPC,0.9907795952096249
GO_Biological_Process_2021,antibacterial humoral response (GO:0019731),1/44,0.1043952424647777,0.1910805777257092,0,0,9.448030374940672,21.34849709415977,CTSG,Cycling HSPC,0.9813192926974915
GO_Biological_Process_2021,positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.1043952424647777,0.1910805777257092,0,0,9.448030374940672,21.34849709415977,KCNE5,Cycling HSPC,0.9813192926974915
GO_Biological_Process_2021,action potential (GO:0001508),1/45,0.1066391873529346,0.1917634509416807,0,0,9.232838589981448,20.665901611884028,KCNE5,Cycling HSPC,0.9720831731354668
GO_Biological_Process_2021,chromosome condensation (GO:0030261),1/45,0.1066391873529346,0.1917634509416807,0,0,9.232838589981448,20.665901611884028,CDCA5,Cycling HSPC,0.9720831731354668
GO_Biological_Process_2021,mitotic G2/M transition checkpoint (GO:0044818),1/45,0.1066391873529346,0.1917634509416807,0,0,9.232838589981448,20.665901611884028,DTL,Cycling HSPC,0.9720831731354668
GO_Biological_Process_2021,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.1066391873529346,0.1917634509416807,0,0,9.232838589981448,20.665901611884028,TERT,Cycling HSPC,0.9720831731354668
GO_Biological_Process_2021,regulation of telomerase activity (GO:0051972),1/46,0.1088776222085674,0.1924130392478993,0,0,9.02721088435374,20.01811780873028,NEK2,Cycling HSPC,0.9630613723103648
GO_Biological_Process_2021,regulation of double-strand break repair via homologous recombination (GO:0010569),1/46,0.1088776222085674,0.1924130392478993,0,0,9.02721088435374,20.01811780873028,POLQ,Cycling HSPC,0.9630613723103648
GO_Biological_Process_2021,positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.1088776222085674,0.1924130392478993,0,0,9.02721088435374,20.01811780873028,ELANE,Cycling HSPC,0.9630613723103648
GO_Biological_Process_2021,postreplication repair (GO:0006301),1/46,0.1088776222085674,0.1924130392478993,0,0,9.02721088435374,20.01811780873028,DTL,Cycling HSPC,0.9630613723103648
GO_Biological_Process_2021,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/47,0.1111105603036554,0.1946808962585416,0,0,8.830523513753327,19.4026870705364,TTK,Cycling HSPC,0.9542446623584087
GO_Biological_Process_2021,telomere organization (GO:0032200),1/47,0.1111105603036554,0.1946808962585416,0,0,8.830523513753327,19.4026870705364,TERT,Cycling HSPC,0.9542446623584087
GO_Biological_Process_2021,base-excision repair (GO:0006284),1/48,0.1133380148369131,0.1977386641835505,0,0,8.642205818497612,18.81737166641443,POLQ,Cycling HSPC,0.9456243984787533
GO_Biological_Process_2021,regulation of smooth muscle cell proliferation (GO:0048660),1/49,0.1155599990222406,0.2007610152505028,0,0,8.46173469387755,18.260130793597916,ELANE,Cycling HSPC,0.9371924705024297
GO_Biological_Process_2021,actin polymerization or depolymerization (GO:0008154),1/50,0.1177765260040411,0.20374842051332,0,0,8.28862973760933,17.7290996615035,DIAPH3,Cycling HSPC,0.928941259997044
GO_Biological_Process_2021,negative regulation of transport (GO:0051051),1/51,0.1199876089220907,0.2049788319085717,0,0,8.122448979591837,17.22257115519733,PRTN3,Cycling HSPC,0.9208636010741894
GO_Biological_Process_2021,cholesterol transport (GO:0030301),1/51,0.1199876089220907,0.2049788319085717,0,0,8.122448979591837,17.22257115519733,STAR,Cycling HSPC,0.9208636010741894
GO_Biological_Process_2021,mitotic metaphase plate congression (GO:0007080),1/51,0.1199876089220907,0.2049788319085717,0,0,8.122448979591837,17.22257115519733,CDCA5,Cycling HSPC,0.9208636010741894
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),3/485,0.1208716599427582,0.2053247416271408,0,0,2.578087754921868,5.447566347932984,CTSG;AZU1;MPO,Cycling HSPC,0.9176755136408634
GO_Biological_Process_2021,regulation of telomere maintenance via telomerase (GO:0032210),1/52,0.1221932608707862,0.2053247416271408,0,0,7.962785114045619,16.738979733033663,NEK2,Cycling HSPC,0.9129527453809976
GO_Biological_Process_2021,signal transduction in response to DNA damage (GO:0042770),1/52,0.1221932608707862,0.2053247416271408,0,0,7.962785114045619,16.738979733033663,BRIP1,Cycling HSPC,0.9129527453809976
GO_Biological_Process_2021,protein homotetramerization (GO:0051289),1/52,0.1221932608707862,0.2053247416271408,0,0,7.962785114045619,16.738979733033663,TK1,Cycling HSPC,0.9129527453809976
GO_Biological_Process_2021,positive regulation of chemokine production (GO:0032722),1/53,0.1243934949128716,0.2056505359446669,0,0,7.809262166405024,16.276887238960814,AZU1,Cycling HSPC,0.9052023302345248
GO_Biological_Process_2021,bicellular tight junction assembly (GO:0070830),1/53,0.1243934949128716,0.2056505359446669,0,0,7.809262166405024,16.276887238960814,CLDN10,Cycling HSPC,0.9052023302345248
GO_Biological_Process_2021,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.1243934949128716,0.2056505359446669,0,0,7.809262166405024,16.276887238960814,C1QTNF4,Cycling HSPC,0.9052023302345248
GO_Biological_Process_2021,positive regulation of phagocytosis (GO:0050766),1/53,0.1243934949128716,0.2056505359446669,0,0,7.809262166405024,16.276887238960814,AZU1,Cycling HSPC,0.9052023302345248
GO_Biological_Process_2021,regulation of cyclin-dependent protein kinase activity (GO:1904029),1/54,0.1265883240687765,0.2067777405107504,0,0,7.661532537543319,15.834970375184442,CDC25A,Cycling HSPC,0.8976063498190403
GO_Biological_Process_2021,striated muscle contraction (GO:0006941),1/54,0.1265883240687765,0.2067777405107504,0,0,7.661532537543319,15.834970375184442,KCNE5,Cycling HSPC,0.8976063498190403
GO_Biological_Process_2021,regulation of potassium ion transmembrane transport (GO:1901379),1/54,0.1265883240687765,0.2067777405107504,0,0,7.661532537543319,15.834970375184442,KCNE5,Cycling HSPC,0.8976063498190403
GO_Biological_Process_2021,positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.1309618198144747,0.2113950634800576,0,0,7.382189239332097,15.00687933540933,AZU1,Cycling HSPC,0.8828552987007785
GO_Biological_Process_2021,telomere maintenance (GO:0000723),1/56,0.1309618198144747,0.2113950634800576,0,0,7.382189239332097,15.00687933540933,TERT,Cycling HSPC,0.8828552987007785
GO_Biological_Process_2021,tight junction assembly (GO:0120192),1/56,0.1309618198144747,0.2113950634800576,0,0,7.382189239332097,15.00687933540933,CLDN10,Cycling HSPC,0.8828552987007785
GO_Biological_Process_2021,negative regulation of DNA recombination (GO:0045910),1/57,0.1331405122852093,0.2132328517067805,0,0,7.25,14.618539131965724,POLQ,Cycling HSPC,0.8756897763447542
GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),1/57,0.1331405122852093,0.2132328517067805,0,0,7.25,14.618539131965724,NEK2,Cycling HSPC,0.8756897763447542
GO_Biological_Process_2021,positive regulation of protein binding (GO:0032092),1/58,0.1353138517398134,0.215033640361719,0,0,7.122448979591836,14.246025949065045,TERT,Cycling HSPC,0.8686577434892403
GO_Biological_Process_2021,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/58,0.1353138517398134,0.215033640361719,0,0,7.122448979591836,14.246025949065045,TTK,Cycling HSPC,0.8686577434892403
GO_Biological_Process_2021,protein polymerization (GO:0051258),1/59,0.1374818510452552,0.2159676587300943,0,0,6.9992962702322306,13.8884471557023,DIAPH3,Cycling HSPC,0.8617546291873563
GO_Biological_Process_2021,regulation of secretion by cell (GO:1903530),1/59,0.1374818510452552,0.2159676587300943,0,0,6.9992962702322306,13.8884471557023,SCG5,Cycling HSPC,0.8617546291873563
GO_Biological_Process_2021,mitotic DNA damage checkpoint signaling (GO:0044773),1/59,0.1374818510452552,0.2159676587300943,0,0,6.9992962702322306,13.8884471557023,DTL,Cycling HSPC,0.8617546291873563
GO_Biological_Process_2021,apical junction assembly (GO:0043297),1/60,0.1396445230534406,0.2185276887477506,0,0,6.88031822898651,13.544974303558986,CLDN10,Cycling HSPC,0.8549760929333525
GO_Biological_Process_2021,positive regulation of DNA biosynthetic process (GO:2000573),1/61,0.1418018805927374,0.2193915888415937,0,0,6.76530612244898,13.214837540593155,NEK2,Cycling HSPC,0.848318009451734
GO_Biological_Process_2021,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2193915888415937,0,0,6.76530612244898,13.214837540593155,ELANE,Cycling HSPC,0.848318009451734
GO_Biological_Process_2021,negative regulation of response to stimulus (GO:0048585),1/61,0.1418018805927374,0.2193915888415937,0,0,6.76530612244898,13.214837540593155,TERT,Cycling HSPC,0.848318009451734
GO_Biological_Process_2021,positive regulation of interleukin-1 production (GO:0032732),1/62,0.1439539364695556,0.2210528612453851,0,0,6.654064904650385,12.897320592663672,AZU1,Cycling HSPC,0.8417764546925935
GO_Biological_Process_2021,double-strand break repair via nonhomologous end joining (GO:0006303),1/62,0.1439539364695556,0.2210528612453851,0,0,6.654064904650385,12.897320592663672,POLQ,Cycling HSPC,0.8417764546925935
GO_Biological_Process_2021,cell cycle G1/S phase transition (GO:0044843),1/63,0.1461007034145454,0.2226813695165933,0,0,6.54641211323239,12.591756250239603,CDC25A,Cycling HSPC,0.8353476931121088
GO_Biological_Process_2021,organonitrogen compound catabolic process (GO:1901565),1/63,0.1461007034145454,0.2226813695165933,0,0,6.54641211323239,12.591756250239603,ELANE,Cycling HSPC,0.8353476931121088
GO_Biological_Process_2021,negative regulation of cell cycle process (GO:0010948),1/64,0.1482421941802595,0.2234533074040677,0,0,6.442176870748299,12.297522293260638,NEK2,Cycling HSPC,0.8290281655096747
GO_Biological_Process_2021,pre-replicative complex assembly (GO:0036388),1/64,0.1482421941802595,0.2234533074040677,0,0,6.442176870748299,12.297522293260638,ORC6,Cycling HSPC,0.8290281655096747
GO_Biological_Process_2021,protein catabolic process (GO:0030163),1/64,0.1482421941802595,0.2234533074040677,0,0,6.442176870748299,12.297522293260638,ELANE,Cycling HSPC,0.8290281655096747
GO_Biological_Process_2021,steroid biosynthetic process (GO:0006694),1/65,0.1503784214913892,0.2258430505914636,0,0,6.341198979591836,12.01403781811508,STAR,Cycling HSPC,0.8228144782361342
GO_Biological_Process_2021,positive regulation of catabolic process (GO:0009896),1/67,0.1546351363099914,0.2313883426536368,0,0,6.148423005565863,11.477180657220888,DTL,Cycling HSPC,0.8106918184915987
GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.1567556490806558,0.2337084222657051,0,0,6.0563508985683825,11.222824361971773,TERT,Cycling HSPC,0.8047767993307415
GO_Biological_Process_2021,cell chemotaxis (GO:0060326),1/69,0.158870948881139,0.2343060756880108,0,0,5.966986794717887,10.977245117600177,AZU1,Cycling HSPC,0.7989555105590889
GO_Biological_Process_2021,positive regulation of MAP kinase activity (GO:0043406),1/69,0.158870948881139,0.2343060756880108,0,0,5.966986794717887,10.977245117600177,ELANE,Cycling HSPC,0.7989555105590889
GO_Biological_Process_2021,cellular response to decreased oxygen levels (GO:0036294),1/69,0.158870948881139,0.2343060756880108,0,0,5.966986794717887,10.977245117600177,TERT,Cycling HSPC,0.7989555105590889
GO_Biological_Process_2021,cellular response to light stimulus (GO:0071482),1/70,0.1609810482853106,0.2365671318888077,0,0,5.880212954747116,10.740024519792764,CDC25A,Cycling HSPC,0.7932252488723367
GO_Biological_Process_2021,protein tetramerization (GO:0051262),1/71,0.16308595979881,0.2379546032651677,0,0,5.795918367346939,10.51076961698872,TK1,Cycling HSPC,0.7875834261109624
GO_Biological_Process_2021,myeloid leukocyte differentiation (GO:0002573),1/71,0.16308595979881,0.2379546032651677,0,0,5.795918367346939,10.51076961698872,PRTN3,Cycling HSPC,0.7875834261109624
GO_Biological_Process_2021,regulation of actin filament-based process (GO:0032970),1/73,0.1672802691231711,0.2432089019166672,0,0,5.634353741496598,10.074701240888364,IQGAP3,Cycling HSPC,0.7765552814899175
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),2/296,0.1690031560036776,0.2448455617014411,0,0,2.7857142857142856,4.952548406897344,DTL;CDC25A,Cycling HSPC,0.7721051851958874
GO_Biological_Process_2021,fibroblast growth factor receptor signaling pathway (GO:0008543),1/75,0.1714539764404576,0.2475215857062944,0,0,5.4815223386651954,9.666337985731484,SHCBP1,Cycling HSPC,0.7658524380723842
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),2/300,0.1725587566609558,0.247904479091295,0,0,2.7477628635346756,4.8278673881252745,CTSG;ELANE,Cycling HSPC,0.7630629971198796
GO_Biological_Process_2021,regulation of cell division (GO:0051302),1/76,0.1735331353639065,0.247904479091295,0,0,5.408163265306122,9.4717853003048,ORC6,Cycling HSPC,0.7606175863963804
GO_Biological_Process_2021,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.247904479091295,0,0,5.408163265306122,9.4717853003048,C1QTNF4,Cycling HSPC,0.7606175863963804
GO_Biological_Process_2021,cellular response to UV (GO:0034644),1/77,0.1756071809118701,0.2491312947192621,0,0,5.336734693877551,9.283280446293812,CDC25A,Cycling HSPC,0.7554577289388229
GO_Biological_Process_2021,neutrophil migration (GO:1990266),1/77,0.1756071809118701,0.2491312947192621,0,0,5.336734693877551,9.283280446293812,PRTN3,Cycling HSPC,0.7554577289388229
GO_Biological_Process_2021,regulation of ion transport (GO:0043269),1/79,0.1797399811935544,0.2535288836772767,0,0,5.199372056514914,8.923391206941128,CLDN10,Cycling HSPC,0.745355308086215
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2535288836772767,0,0,5.133298889175924,8.751529842637671,AZU1,Cycling HSPC,0.7404090821369118
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.2535288836772767,0,0,5.133298889175924,8.751529842637671,TERT,Cycling HSPC,0.7404090821369118
GO_Biological_Process_2021,lipid biosynthetic process (GO:0008610),1/80,0.181798760490535,0.2535288836772767,0,0,5.133298889175924,8.751529842637671,STAR,Cycling HSPC,0.7404090821369118
GO_Biological_Process_2021,regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.181798760490535,0.2535288836772767,0,0,5.133298889175924,8.751529842637671,C1QTNF4,Cycling HSPC,0.7404090821369118
GO_Biological_Process_2021,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2555237795073515,0,0,5.0688775510204085,8.584760541358477,ELANE,Cycling HSPC,0.7355305181562768
GO_Biological_Process_2021,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.1859011384602527,0.2566312012414262,0,0,5.00604686318972,8.422875391899517,CDC25A,Cycling HSPC,0.7307179505966239
GO_Biological_Process_2021,cell-cell junction organization (GO:0045216),1/82,0.1859011384602527,0.2566312012414262,0,0,5.00604686318972,8.422875391899517,PRTN3,Cycling HSPC,0.7307179505966239
GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.2585817188915276,0,0,4.944748631159781,8.265677319811374,AZU1,Cycling HSPC,0.7259697745939766
GO_Biological_Process_2021,spindle assembly (GO:0051225),1/84,0.1899833569114356,0.2605122954303966,0,0,4.884927464961889,8.112979399077096,NEK2,Cycling HSPC,0.7212844428267129
GO_Biological_Process_2021,negative regulation of defense response (GO:0031348),1/85,0.1920169366451308,0.2606852451142505,0,0,4.826530612244898,7.964604221414354,ELANE,Cycling HSPC,0.716660463134361
GO_Biological_Process_2021,regulation of cell cycle G2/M phase transition (GO:1902749),1/85,0.1920169366451308,0.2606852451142505,0,0,4.826530612244898,7.964604221414354,NEK2,Cycling HSPC,0.716660463134361
GO_Biological_Process_2021,positive regulation of protein catabolic process (GO:0045732),1/85,0.1920169366451308,0.2606852451142505,0,0,4.826530612244898,7.964604221414354,DTL,Cycling HSPC,0.716660463134361
GO_Biological_Process_2021,regulation of establishment of planar polarity (GO:0090175),1/88,0.1980877029036425,0.2680394659752259,0,0,4.659394792399718,7.5437717166037235,SAPCD2,Cycling HSPC,0.703142484213379
GO_Biological_Process_2021,regulation of cation channel activity (GO:2001257),1/89,0.2001013407742902,0.2698735188074309,0,0,4.6062152133580705,7.411084001248333,KCNE5,Cycling HSPC,0.6987500013741589
GO_Biological_Process_2021,positive regulation of binding (GO:0051099),1/90,0.2021100231923967,0.2708010114669368,0,0,4.55423068103646,7.281955543769811,TERT,Cycling HSPC,0.6944121480917811
GO_Biological_Process_2021,protein complex oligomerization (GO:0051259),1/90,0.2021100231923967,0.2708010114669368,0,0,4.55423068103646,7.281955543769811,POLQ,Cycling HSPC,0.6944121480917811
GO_Biological_Process_2021,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.2041137620931186,0.270883435553251,0,0,4.503401360544218,7.156255051106618,IQGAP3,Cycling HSPC,0.6901277125812961
GO_Biological_Process_2021,positive regulation of transport (GO:0051050),1/91,0.2041137620931186,0.270883435553251,0,0,4.503401360544218,7.156255051106618,AZU1,Cycling HSPC,0.6901277125812961
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),2/335,0.2041536136242794,0.270883435553251,0,0,2.4545795795795797,3.9000386874614623,C1QTNF4;ELANE,Cycling HSPC,0.6900429284365769
GO_Biological_Process_2021,cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.2061125694363157,0.2717239661379082,0,0,4.453689167974883,7.03385741012878,SHCBP1,Cycling HSPC,0.6858955226779435
GO_Biological_Process_2021,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),1/92,0.2061125694363157,0.2717239661379082,0,0,4.453689167974883,7.03385741012878,TTK,Cycling HSPC,0.6858955226779435
GO_Biological_Process_2021,regulation of heart contraction (GO:0008016),1/93,0.2081064570390282,0.273473228801287,0,0,4.40505767524401,6.914643337844717,KCNE5,Cycling HSPC,0.6817144444740324
GO_Biological_Process_2021,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2752048852654404,0,0,4.357472021066491,6.79849904676328,MELK,Cycling HSPC,0.6775833802166729
GO_Biological_Process_2021,ciliary basal body-plasma membrane docking (GO:0097711),1/95,0.2120795205832498,0.2769191192329058,0,0,4.310898827616153,6.685315939697291,NEK2,Cycling HSPC,0.6735012670190429
GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2802960423584354,0,0,4.220663265306122,6.46742313757927,ELANE,Cycling HSPC,0.6654798083211632
GO_Biological_Process_2021,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2802960423584354,0,0,4.220663265306122,6.46742313757927,ELANE,Cycling HSPC,0.6654798083211632
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2902543036398578,0,0,4.010709234188725,5.967790506031058,AZU1,Cycling HSPC,0.6462145058611213
GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),1/102,0.2258320069783284,0.2902543036398578,0,0,4.010709234188725,5.967790506031058,CDCA5,Cycling HSPC,0.6462145058611213
GO_Biological_Process_2021,regulation of protein catabolic process (GO:0042176),1/102,0.2258320069783284,0.2902543036398578,0,0,4.010709234188725,5.967790506031058,DTL,Cycling HSPC,0.6462145058611213
GO_Biological_Process_2021,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2934091469176897,0,0,3.932435109966317,5.78423168094792,ELANE,Cycling HSPC,0.6388051756325536
GO_Biological_Process_2021,steroid metabolic process (GO:0008202),1/104,0.2297178930745814,0.2934091469176897,0,0,3.932435109966317,5.78423168094792,STAR,Cycling HSPC,0.6388051756325536
GO_Biological_Process_2021,nucleotide-excision repair (GO:0006289),1/105,0.2316536615468536,0.2949627367522049,0,0,3.894427001569859,5.6956456810845415,BRIP1,Cycling HSPC,0.6351608308934773
GO_Biological_Process_2021,regulation of cell cycle process (GO:0010564),1/106,0.2335846623503299,0.2955855295173928,0,0,3.857142857142857,5.6090983677319475,NEK2,Cycling HSPC,0.6315556772929499
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2955855295173928,0,0,3.857142857142857,5.6090983677319475,ELANE,Cycling HSPC,0.6315556772929499
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.2993495826689347,0,0,2.2110433604336044,3.18053102486219,TTK;AZU1,Cycling HSPC,0.6247218387200065
GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),1/110,0.241261218690496,0.3021185055245804,0,0,3.714847406852649,5.282048795926194,C1QTNF4,Cycling HSPC,0.6175124827423236
GO_Biological_Process_2021,regulation of protein kinase activity (GO:0045859),1/110,0.241261218690496,0.3021185055245804,0,0,3.714847406852649,5.282048795926194,AZU1,Cycling HSPC,0.6175124827423236
GO_Biological_Process_2021,regulation of Wnt signaling pathway (GO:0030111),1/111,0.2431685532271013,0.3021185055245804,0,0,3.6808905380333954,5.20478084558139,TERT,Cycling HSPC,0.6140925891155178
GO_Biological_Process_2021,cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.2431685532271013,0.3021185055245804,0,0,3.6808905380333954,5.20478084558139,ELANE,Cycling HSPC,0.6140925891155178
GO_Biological_Process_2021,regulation of protein serine/threonine kinase activity (GO:0071900),1/111,0.2431685532271013,0.3021185055245804,0,0,3.6808905380333954,5.20478084558139,CDC25A,Cycling HSPC,0.6140925891155178
GO_Biological_Process_2021,regulation of cytoskeleton organization (GO:0051493),1/112,0.2450711886958998,0.3035624995931085,0,0,3.647545504688362,5.129202360192396,IQGAP3,Cycling HSPC,0.6107077427090284
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),2/381,0.2465612635256485,0.3044883073660117,0,0,2.15160510114336,3.012558657024939,AZU1;MPO,Cycling HSPC,0.6080751530383309
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.306407168835193,0,0,3.582625970742279,4.982913653406146,AZU1,Cycling HSPC,0.6040407011916724
GO_Biological_Process_2021,cellular response to molecule of bacterial origin (GO:0071219),1/115,0.2507510141385882,0.3068893008860334,0,0,3.5510204081632653,4.9121080927455,CTSG,Cycling HSPC,0.6007573018413346
GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),1/115,0.2507510141385882,0.3068893008860334,0,0,3.5510204081632653,4.9121080927455,DTL,Cycling HSPC,0.6007573018413346
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),4/1025,0.2531480899318741,0.3089009430716322,0,0,1.6121449559255632,2.2147335064279132,MELK;CTSG;NEK2;DTL,Cycling HSPC,0.596625345129507
GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.2563889548341396,0.3100869365250656,0,0,3.4594453165881736,4.708511372057024,GPR12,Cycling HSPC,0.5911006880374128
GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.3100869365250656,0,0,3.4594453165881736,4.708511372057024,ELANE,Cycling HSPC,0.5911006880374128
GO_Biological_Process_2021,regulation of protein binding (GO:0043393),1/118,0.2563889548341396,0.3100869365250656,0,0,3.4594453165881736,4.708511372057024,TERT,Cycling HSPC,0.5911006880374128
GO_Biological_Process_2021,cellular response to lipopolysaccharide (GO:0071222),1/120,0.2601244621662815,0.3127596172673766,0,0,3.4009603841536613,4.579716458908873,CTSG,Cycling HSPC,0.5848188047272944
GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),1/120,0.2601244621662815,0.3127596172673766,0,0,3.4009603841536613,4.579716458908873,DIAPH3,Cycling HSPC,0.5848188047272944
GO_Biological_Process_2021,defense response to symbiont (GO:0140546),1/124,0.2675403902734135,0.3207355555909343,0,0,3.2896963663514187,4.337414433160371,AZU1,Cycling HSPC,0.5726106437410472
GO_Biological_Process_2021,microtubule cytoskeleton organization involved in mitosis (GO:1902850),1/128,0.274883458910421,0.3285778954905907,0,0,3.1854411055760887,4.113704308580095,TTK,Cycling HSPC,0.5608513930050725
GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.3297972351262416,0,0,3.1603954081632653,4.060453122404681,AZU1,Cycling HSPC,0.5579784037567757
GO_Biological_Process_2021,cellular response to hypoxia (GO:0071456),1/131,0.2803433684983951,0.3331616843024406,0,0,3.111459968602826,3.956968446025251,TERT,Cycling HSPC,0.5523097126477655
GO_Biological_Process_2021,organelle organization (GO:0006996),2/420,0.2828230936231133,0.3335930389389158,0,0,1.946969696969697,2.4588936191845474,DIAPH3;TERT,Cycling HSPC,0.5484851315667836
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),3/742,0.2833046813486276,0.3335930389389158,0,0,1.6593153485158207,2.092782192966935,MELK;AZU1;MPO,Cycling HSPC,0.5477462491044153
GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3335930389389158,0,0,3.0640074211502784,3.857336278341556,AZU1,Cycling HSPC,0.546741450090894
GO_Biological_Process_2021,defense response to virus (GO:0051607),1/133,0.2839609038772722,0.3335930389389158,0,0,3.0640074211502784,3.857336278341556,AZU1,Cycling HSPC,0.546741450090894
GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),1/136,0.289353816496661,0.3389573278960885,0,0,2.99546485260771,3.714691124222948,ELANE,Cycling HSPC,0.5385707850387818
GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),1/139,0.2947069182263764,0.3442445483555964,0,0,2.929902395740905,3.579678317757992,KCNE5,Cycling HSPC,0.5306096689947516
GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),2/437,0.2986183016105228,0.3478224535804385,0,0,1.8692528735632183,2.259158656282815,BRIP1;EXO1,Cycling HSPC,0.5248835789121016
GO_Biological_Process_2021,protein-DNA complex assembly (GO:0065004),1/143,0.3017829564686885,0.350512782300743,0,0,2.8467950560505892,3.410594866305226,ORC6,Cycling HSPC,0.5203052911363482
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3596536527801982,0,0,2.749271137026239,3.215201203875706,NEK2,Cycling HSPC,0.5078961191737069
GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),1/149,0.3122667490151626,0.3606461044963849,0,0,2.7305570876999448,3.1780885451938787,PRTN3,Cycling HSPC,0.5054742581266645
GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.3191700762858281,0.3675835148235661,0,0,2.6581632653061225,3.0357052873752,TERT,Cycling HSPC,0.4959778325880012
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),1/154,0.3208852696222714,0.36852369900597,0,0,2.640656262505002,3.0015590720273457,AZU1,Cycling HSPC,0.493650218923809
GO_Biological_Process_2021,peptidyl-serine phosphorylation (GO:0018105),1/156,0.3243029619756543,0.3714084201397158,0,0,2.6063199473337724,2.934917292064671,TTK,Cycling HSPC,0.4890490847411261
GO_Biological_Process_2021,mitotic spindle organization (GO:0007052),1/157,0.3260054815208176,0.372318237948566,0,0,2.5894819466248036,2.902397750177957,TTK,Cycling HSPC,0.48677509755712384
GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.3751476290644959,0,0,2.556445362955309,2.8389038953772054,CTSG,Cycling HSPC,0.4822791499015975
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.3852577212780911,0,0,2.4621702339472376,2.6600168495918335,GPR12,Cycling HSPC,0.46919202564454415
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),2/482,0.3401543782991926,0.3852577212780911,0,0,1.6901041666666667,1.8225334796372663,CTSG;PRTN3,Cycling HSPC,0.46832393464331673
GO_Biological_Process_2021,peptidyl-serine modification (GO:0018209),1/169,0.3461106816465725,0.3909239103997101,0,0,2.403061224489796,2.5496399471999527,TTK,Cycling HSPC,0.4607849973294511
GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.3477593333218013,0.391706941378952,0,0,2.388721168940949,2.523073857975914,CLDN10,Cycling HSPC,0.45872120538836164
GO_Biological_Process_2021,mitochondrion organization (GO:0007005),1/175,0.3559416811668189,0.3998249021325911,0,0,2.319493314567206,2.396009637948729,TERT,Cycling HSPC,0.4486211526513072
GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),1/178,0.3608027143922477,0.4041779041006053,0,0,2.279833967485299,2.3241173885161555,NEK2,Cycling HSPC,0.44273020383203454
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.4066746532576909,0,0,2.2541329380914377,2.2778849681371156,STAR,Cycling HSPC,0.4388706874182523
GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.4091401127538877,0,0,2.2289998872477166,2.2329492942532405,ELANE,Cycling HSPC,0.4350639775318079
GO_Biological_Process_2021,regulation of mitotic cell cycle phase transition (GO:1901990),1/188,0.3767479051184041,0.4186087834648935,0,0,2.1568263669104004,2.105448610107896,NEK2,Cycling HSPC,0.4239491538721143
GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),1/189,0.3783208179838206,0.4192203658739634,0,0,2.1452453321754232,2.085205747179162,PRTN3,Cycling HSPC,0.42213975998471215
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.4267174068113145,0,0,2.089140319340171,1.988001678572607,TERT,Cycling HSPC,0.4132695879859197
GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),1/201,0.3968950010648283,0.4374380388080097,0,0,2.0153061224489797,1.8623111638641865,DTL,Cycling HSPC,0.40132437104403956
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),1/206,0.4044727291727134,0.4445946889029826,0,0,1.9656545545047288,1.7792534267442264,ELANE,Cycling HSPC,0.39311075456855427
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),1/212,0.4134429066373548,0.4532395500569932,0,0,1.909178837411742,1.6862551884518755,ELANE,Cycling HSPC,0.3835844547796231
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),2/566,0.4155454754335446,0.4540569390772846,0,0,1.43218085106383,1.2576885523498746,ORC6;PRTN3,Cycling HSPC,0.38138144203835345
GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),1/214,0.416403436812339,0.4540569390772846,0,0,1.8910606496119575,1.656759537391559,PRTN3,Cycling HSPC,0.3804856946694876
GO_Biological_Process_2021,cellular response to lipid (GO:0071396),1/219,0.4237408440429794,0.4608322176594736,0,0,1.8472196217936716,1.5860841457604238,CTSG,Cycling HSPC,0.372899672681652
GO_Biological_Process_2021,inflammatory response (GO:0006954),1/230,0.4395663655385589,0.4767783329915586,0,0,1.7575082434720612,1.4446130242039086,AZU1,Cycling HSPC,0.35697554604801474
GO_Biological_Process_2021,apoptotic process (GO:0006915),1/231,0.4409837467017168,0.4770536573818045,0,0,1.749778172138421,1.4326260836369302,MELK,Cycling HSPC,0.35557741698984124
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),2/621,0.4626694381715867,0.4991959727640804,0,0,1.3012250942380184,1.0029093993298663,CTSG;PRTN3,Cycling HSPC,0.33472918706115434
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.5057206877827528,0,0,1.6016749329213755,1.2094704650298027,TERT,Cycling HSPC,0.32794816113488356
GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5242590404641464,0,0,1.510204081632653,1.0781219104526054,TERT,Cycling HSPC,0.3100391544580995
GO_Biological_Process_2021,protein deubiquitination (GO:0016579),1/267,0.4897346646287026,0.5242590404641464,0,0,1.510204081632653,1.0781219104526054,CDC25A,Cycling HSPC,0.3100391544580995
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5324853214550358,0,0,1.4709576138147566,1.0233666205889618,ELANE,Cycling HSPC,0.30214499188263844
GO_Biological_Process_2021,protein modification by small protein removal (GO:0070646),1/276,0.50125602230015,0.5338051146573025,0,0,1.4601113172541744,1.0084087773272885,CDC25A,Cycling HSPC,0.29994039654430615
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.5457021746904362,0,0,1.4081632653061225,0.937839142501346,MELK,Cycling HSPC,0.289240867544339
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5747682529776156,0,0,1.2972062611452349,0.7932686422257892,MELK,Cycling HSPC,0.2655801196036423
GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),1/314,0.5471545986718139,0.5766925075975416,0,0,1.2803677381495728,0.7720923294539072,DTL,Cycling HSPC,0.26188994631047774
GO_Biological_Process_2021,cilium assembly (GO:0060271),1/314,0.5471545986718139,0.5766925075975416,0,0,1.2803677381495728,0.7720923294539072,NEK2,Cycling HSPC,0.26188994631047774
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5844897377467907,0,0,1.2479496471485791,0.7319104885681406,TERT,Cycling HSPC,0.2547095446988111
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5844897377467907,0,0,1.2440106477373558,0.7270814983759607,CTSG,Cycling HSPC,0.2538302089398956
GO_Biological_Process_2021,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.5900126534419055,0,0,1.2208810353409656,0.6989624697257846,SCG5,Cycling HSPC,0.24863646405532092
GO_Biological_Process_2021,intracellular protein transport (GO:0006886),1/336,0.5718075736459911,0.5965422524042147,0,0,1.1949436491014316,0.6679170434332091,SCG5,Cycling HSPC,0.2427500966679934
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),1/345,0.5815093765862647,0.6035920111401735,0,0,1.1631466540104414,0.6305745813190116,TERT,Cycling HSPC,0.23544327806907975
GO_Biological_Process_2021,post-translational protein modification (GO:0043687),1/345,0.5815093765862647,0.6035920111401735,0,0,1.1631466540104414,0.6305745813190116,DTL,Cycling HSPC,0.23544327806907975
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.5909956578792304,0.6118894437638496,0,0,1.1329710354396716,0.5958822738188654,DTL,Cycling HSPC,0.22841570992418872
GO_Biological_Process_2021,protein transport (GO:0015031),1/369,0.6063398885560332,0.6261948471233592,0,0,1.0859582963620231,0.5433207667028247,SCG5,Cycling HSPC,0.21728386041430361
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6398467724898284,0,0,1.042628017264347,0.4965325169788531,AZU1,Cycling HSPC,0.20682480102083725
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.6576262706607505,0,0,0.989871879272801,0.4417939051458828,SHCBP1,Cycling HSPC,0.19383180708628664
GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),1/417,0.6517468120762254,0.668040482378131,0,0,0.9583006279434853,0.41024765313154,CTSG,Cycling HSPC,0.1859210844420885
GO_Biological_Process_2021,organelle assembly (GO:0070925),1/425,0.658798168385351,0.673584162189511,0,0,0.939834424335772,0.3922286762298742,NEK2,Cycling HSPC,0.18124761694193237
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),1/482,0.7051444771556823,0.7191772030692282,0,0,0.8260426831855403,0.2885801301950252,AZU1,Cycling HSPC,0.1517218912312197
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.7487513826182145,0,0,0.7565820221218258,0.231944503707841,DTL,Cycling HSPC,0.13314117322745964
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.7609868518335532,0,0,0.726642950758285,0.2091870484536521,C1QTNF4,Cycling HSPC,0.12502533841998253
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.769147150794591,0,0,0.7301532033426184,0.200604530418796,TERT;AZU1,Cycling HSPC,0.11931939791106433
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8329728287357117,0,0,0.5757014372366809,0.1108560647358729,ELANE,Cycling HSPC,0.0836269880293983
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),1/908,0.9023188918982462,0.9089698911014272,0,0,0.4284814256463335,0.0440424414337815,TERT,Cycling HSPC,0.044639949690669034
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",1/948,0.912055183209665,0.9165260419508888,0,0,0.4095209361463698,0.0376983608425212,ELANE,Cycling HSPC,0.039978884217174375
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),2/2206,0.9792407454532416,0.9810359386268036,0,0,0.3354885057471264,0.0070377963929841,BRIP1;ELANE,Cycling HSPC,0.009110524163636814
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",2/2244,0.9810359386268036,0.9810359386268036,0,0,0.3290960451977401,0.006300933896412,BRIP1;CDC45,Cycling HSPC,0.008315082669573565
KEGG_2021_Human,neutrophil degranulation (GO:0043312),13/481,1.2086908061153411e-10,2.1998231379652115e-08,0,0,14.626126126126126,334.00679616105515,ATP8B4;MS4A3;DEFA4;AZU1;RNASE3;SLC2A5;ABCA13;CEACAM6;CLEC5A;CTSG;BPI;CEACAM8;ELANE,Early Myeloid Progenitor,9.917684781332483
KEGG_2021_Human,neutrophil activation involved in immune response (GO:0002283),13/485,1.3385108653429072e-10,2.1998231379652115e-08,0,0,14.499198350893266,329.62902688657147,ATP8B4;MS4A3;DEFA4;AZU1;RNASE3;SLC2A5;ABCA13;CEACAM6;CLEC5A;CTSG;BPI;CEACAM8;ELANE,Early Myeloid Progenitor,9.873378099083462
KEGG_2021_Human,neutrophil mediated immunity (GO:0002446),13/488,1.444085210918082e-10,2.1998231379652115e-08,0,0,14.405405405405403,326.40307598672763,ATP8B4;MS4A3;DEFA4;AZU1;RNASE3;SLC2A5;ABCA13;CEACAM6;CLEC5A;CTSG;BPI;CEACAM8;ELANE,Early Myeloid Progenitor,9.84040717966134
KEGG_2021_Human,defense response to Gram-negative bacterium (GO:0050829),7/73,5.663380640605061e-10,6.470412381891283e-08,0,0,49.04439746300211,1044.2449697870406,DEFA4;DEFA3;CTSG;BPI;AZU1;RNASE3;ELANE,Early Myeloid Progenitor,9.24692424809289
KEGG_2021_Human,defense response to bacterium (GO:0042742),7/176,2.632691296200134e-07,2.4062798447269223e-05,0,0,19.054217696435945,288.6730943350905,DEFA4;DEFA3;CTSG;BPI;AZU1;RNASE3;ELANE,Early Myeloid Progenitor,6.579600062358726
KEGG_2021_Human,antibacterial humoral response (GO:0019731),4/44,4.357614639431624e-06,0.0003319049817033754,0,0,43.28260869565217,534.2625919775811,DEFA4;DEFA3;CTSG;RNASE3,Early Myeloid Progenitor,5.360751178717646
KEGG_2021_Human,innate immune response in mucosa (GO:0002227),3/21,1.8942018936649912e-05,0.0012366432362927,0,0,70.68085106382979,768.592613095972,DEFA4;DEFA3;RNASE3,Early Myeloid Progenitor,4.722573733552538
KEGG_2021_Human,mucosal immune response (GO:0002385),3/28,4.6085838596253206e-05,0.0026326535298109,0,0,50.87234042553192,507.9605655722774,DEFA4;DEFA3;RNASE3,Early Myeloid Progenitor,4.336432505507012
KEGG_2021_Human,cellular response to lipopolysaccharide (GO:0071222),4/120,0.0002293410804448021,0.010735161660765,0,0,14.868065967016491,124.59885661717742,DEFA4;DEFA3;CTSG;BPI,Early Myeloid Progenitor,3.6395181458260075
KEGG_2021_Human,base-excision repair (GO:0006284),3/48,0.00023490506916334973,0.010735161660765,0,0,28.23404255319149,235.93295101505728,POLQ;NEIL3;POLE,Early Myeloid Progenitor,3.6291076112091263
KEGG_2021_Human,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),3/64,0.0005501762524487967,0.0228573224881,0,0,20.81164980816184,156.1970899166922,DEFA4;DEFA3;RNASE3,Early Myeloid Progenitor,3.259498159226279
KEGG_2021_Human,defense response to Gram-positive bacterium (GO:0050830),3/70,0.0007152738836628206,0.027240013736159,0,0,18.94220387424579,137.19544727387992,DEFA4;DEFA3;RNASE3,Early Myeloid Progenitor,3.145527631782337
KEGG_2021_Human,negative regulation of interleukin-8 production (GO:0032717),2/18,0.000913470506242016,0.0301207637012304,0,0,51.911458333333336,363.2898548418271,BPI;ELANE,Early Myeloid Progenitor,3.039305470405725
KEGG_2021_Human,innate immune response (GO:0045087),5/302,0.0009227367435825514,0.0301207637012304,0,0,7.352413019079686,51.37988695967284,DEFA4;CLEC5A;DEFA3;BPI;RNASE3,Early Myeloid Progenitor,3.03492218534152
KEGG_2021_Human,protein complex oligomerization (GO:0051259),3/90,0.0014821871128384,0.0451573007044783,0,0,14.573000733675716,94.93197333904207,POLQ;ECT2;MCU,Early Myeloid Progenitor,2.829096967109936
KEGG_2021_Human,cellular response to molecule of bacterial origin (GO:0071219),3/115,0.0029817324390132,0.0851657327893164,0,0,11.305851063829786,65.74635935331509,DEFA4;DEFA3;CTSG,Early Myeloid Progenitor,2.5255313298546898
KEGG_2021_Human,positive regulation of cytokinesis (GO:0032467),2/37,0.0038576315924392,0.1037022139849838,0,0,23.708333333333332,131.76384828572083,KIF14;ECT2,Early Myeloid Progenitor,2.4136792502562754
KEGG_2021_Human,regulation of exit from mitosis (GO:0007096),2/39,0.0042784069542198,0.108623998782137,0,0,22.42454954954955,122.3074073504305,ANLN;BUB1B,Early Myeloid Progenitor,2.368717908505425
KEGG_2021_Human,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/42,0.0049475924537835,0.119002618493636,0,0,20.739583333333332,110.1034239545967,CEACAM6;CEACAM8,Early Myeloid Progenitor,2.3056060815494894
KEGG_2021_Human,positive regulation of cell division (GO:0051781),2/44,0.0054187658916089,0.1238188006232655,0,0,19.75,103.05327189846057,KIF14;ECT2,Early Myeloid Progenitor,2.266099611522887
KEGG_2021_Human,DNA repair (GO:0006281),4/298,0.006494535276948,0.13380492756423,0,0,5.813664596273292,29.282232016426978,POLQ;NEIL3;BRIP1;POLE,Early Myeloid Progenitor,2.187451919860835
KEGG_2021_Human,mitotic cytokinesis (GO:0000281),2/49,0.0066828970303688,0.13380492756423,0,0,17.64450354609929,88.36726791367238,ANLN;ECT2,Early Myeloid Progenitor,2.175035230405133
KEGG_2021_Human,positive regulation of protein kinase activity (GO:0045860),3/154,0.0067341648445892,0.13380492756423,0,0,8.369310976468931,41.85125407551329,KIF14;AZU1;ECT2,Early Myeloid Progenitor,2.171716256789745
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),5/485,0.0070959676294594,0.1343926983796133,0,0,4.506944444444445,22.30139137962044,CEACAM6;CLEC5A;KIF14;CTSG;AZU1,Early Myeloid Progenitor,2.148988374345894
KEGG_2021_Human,response to lipopolysaccharide (GO:0032496),3/159,0.0073518981608103,0.1343926983796133,0,0,8.099018003273322,39.78882929168961,DEFA4;DEFA3;CTSG,Early Myeloid Progenitor,2.133600517468579
KEGG_2021_Human,regulation of RNA metabolic process (GO:0051252),2/65,0.0115237618661231,0.1373019209574484,0,0,13.15277777777778,58.70537343689256,PCBP3;AFF2,Early Myeloid Progenitor,1.9384057248186684
KEGG_2021_Human,regulation of mitotic cell cycle phase transition (GO:1901990),3/188,0.0115892041162952,0.1373019209574484,0,0,6.81943645773433,30.398874332245907,ANLN;KIF14;BUB1B,Early Myeloid Progenitor,1.9359463880027175
KEGG_2021_Human,extracellular matrix disassembly (GO:0022617),2/66,0.0118650634107129,0.1373019209574484,0,0,12.946614583333334,57.4073222604629,CTSG;ELANE,Early Myeloid Progenitor,1.9257299364311244
KEGG_2021_Human,cellular component disassembly (GO:0022411),2/66,0.0118650634107129,0.1373019209574484,0,0,12.946614583333334,57.4073222604629,CTSG;ELANE,Early Myeloid Progenitor,1.9257299364311244
KEGG_2021_Human,pyrimidine nucleoside transport (GO:0015864),1/5,0.0124387771927725,0.1373019209574484,0,0,101.76530612244898,446.4379351400606,SLC28A3,Early Myeloid Progenitor,1.9052223113279663
KEGG_2021_Human,antifungal humoral response (GO:0019732),1/5,0.0124387771927725,0.1373019209574484,0,0,101.76530612244898,446.4379351400606,DEFA4,Early Myeloid Progenitor,1.9052223113279663
KEGG_2021_Human,fructose transmembrane transport (GO:0015755),1/5,0.0124387771927725,0.1373019209574484,0,0,101.76530612244898,446.4379351400606,SLC2A5,Early Myeloid Progenitor,1.9052223113279663
KEGG_2021_Human,glomerular visceral epithelial cell migration (GO:0090521),1/5,0.0124387771927725,0.1373019209574484,0,0,101.76530612244898,446.4379351400606,ANLN,Early Myeloid Progenitor,1.9052223113279663
KEGG_2021_Human,positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906),1/5,0.0124387771927725,0.1373019209574484,0,0,101.76530612244898,446.4379351400606,CEACAM6,Early Myeloid Progenitor,1.9052223113279663
KEGG_2021_Human,response to fructose (GO:0009750),1/5,0.0124387771927725,0.1373019209574484,0,0,101.76530612244898,446.4379351400606,SLC2A5,Early Myeloid Progenitor,1.9052223113279663
KEGG_2021_Human,maintenance of animal organ identity (GO:0048496),1/5,0.0124387771927725,0.1373019209574484,0,0,101.76530612244898,446.4379351400606,PKP2,Early Myeloid Progenitor,1.9052223113279663
KEGG_2021_Human,nucleoside transport (GO:0015858),1/5,0.0124387771927725,0.1373019209574484,0,0,101.76530612244898,446.4379351400606,SLC28A3,Early Myeloid Progenitor,1.9052223113279663
KEGG_2021_Human,uridine transport (GO:0015862),1/5,0.0124387771927725,0.1373019209574484,0,0,101.76530612244898,446.4379351400606,SLC28A3,Early Myeloid Progenitor,1.9052223113279663
KEGG_2021_Human,regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),1/5,0.0124387771927725,0.1373019209574484,0,0,101.76530612244898,446.4379351400606,SLC15A2,Early Myeloid Progenitor,1.9052223113279663
KEGG_2021_Human,cytoskeleton-dependent cytokinesis (GO:0061640),2/72,0.0140048037295852,0.1373019209574484,0,0,11.833333333333334,50.50886613536219,ANLN;ECT2,Early Myeloid Progenitor,1.8537229732206628
KEGG_2021_Human,protein sulfation (GO:0006477),1/6,0.0149082847993736,0.1373019209574484,0,0,81.40816326530613,342.3895623444841,HS3ST5,Early Myeloid Progenitor,1.8265723193247598
KEGG_2021_Human,purine nucleobase transport (GO:0006863),1/6,0.0149082847993736,0.1373019209574484,0,0,81.40816326530613,342.3895623444841,SLC28A3,Early Myeloid Progenitor,1.8265723193247598
KEGG_2021_Human,bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),1/6,0.0149082847993736,0.1373019209574484,0,0,81.40816326530613,342.3895623444841,PKP2,Early Myeloid Progenitor,1.8265723193247598
KEGG_2021_Human,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",1/6,0.0149082847993736,0.1373019209574484,0,0,81.40816326530613,342.3895623444841,HS3ST5,Early Myeloid Progenitor,1.8265723193247598
KEGG_2021_Human,hexose import across plasma membrane (GO:0140271),1/6,0.0149082847993736,0.1373019209574484,0,0,81.40816326530613,342.3895623444841,SLC2A5,Early Myeloid Progenitor,1.8265723193247598
KEGG_2021_Human,induction of bacterial agglutination (GO:0043152),1/6,0.0149082847993736,0.1373019209574484,0,0,81.40816326530613,342.3895623444841,RNASE3,Early Myeloid Progenitor,1.8265723193247598
KEGG_2021_Human,regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904),1/6,0.0149082847993736,0.1373019209574484,0,0,81.40816326530613,342.3895623444841,CEACAM6,Early Myeloid Progenitor,1.8265723193247598
KEGG_2021_Human,centromeric sister chromatid cohesion (GO:0070601),1/6,0.0149082847993736,0.1373019209574484,0,0,81.40816326530613,342.3895623444841,BUB1B,Early Myeloid Progenitor,1.8265723193247598
KEGG_2021_Human,positive regulation of sterol transport (GO:0032373),1/6,0.0149082847993736,0.1373019209574484,0,0,81.40816326530613,342.3895623444841,ABCA13,Early Myeloid Progenitor,1.8265723193247598
KEGG_2021_Human,glial cell migration (GO:0008347),1/7,0.0173717414502839,0.1373019209574484,0,0,67.83673469387755,274.9362107684438,AZU1,Early Myeloid Progenitor,1.7601566430186848
KEGG_2021_Human,cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),1/7,0.0173717414502839,0.1373019209574484,0,0,67.83673469387755,274.9362107684438,PKP2,Early Myeloid Progenitor,1.7601566430186848
KEGG_2021_Human,intermediate filament bundle assembly (GO:0045110),1/7,0.0173717414502839,0.1373019209574484,0,0,67.83673469387755,274.9362107684438,PKP2,Early Myeloid Progenitor,1.7601566430186848
KEGG_2021_Human,desmosome organization (GO:0002934),1/7,0.0173717414502839,0.1373019209574484,0,0,67.83673469387755,274.9362107684438,PKP2,Early Myeloid Progenitor,1.7601566430186848
KEGG_2021_Human,modulation by symbiont of host apoptotic process (GO:0052150),1/7,0.0173717414502839,0.1373019209574484,0,0,67.83673469387755,274.9362107684438,CTSG,Early Myeloid Progenitor,1.7601566430186848
KEGG_2021_Human,protein localization to basolateral plasma membrane (GO:1903361),1/7,0.0173717414502839,0.1373019209574484,0,0,67.83673469387755,274.9362107684438,LIN7A,Early Myeloid Progenitor,1.7601566430186848
KEGG_2021_Human,cellular response to lipid (GO:0071396),3/219,0.0174000582463563,0.1373019209574484,0,0,5.831560283687943,23.625293607147455,DEFA4;DEFA3;CTSG,Early Myeloid Progenitor,1.7594492979226422
KEGG_2021_Human,regulation of interleukin-8 production (GO:0032677),2/81,0.0175016586979588,0.1373019209574484,0,0,10.48048523206751,42.398379802278754,BPI;ELANE,Early Myeloid Progenitor,1.7569207896432026
KEGG_2021_Human,regulation of cytokinesis (GO:0032465),2/84,0.0187414436957378,0.1373019209574484,0,0,10.095528455284551,40.15009805248223,KIF14;ECT2,Early Myeloid Progenitor,1.7271969574747794
KEGG_2021_Human,actin filament reorganization (GO:0090527),1/8,0.0198291614511851,0.1373019209574484,0,0,58.142857142857146,227.9549801512961,MCU,Early Myeloid Progenitor,1.702695651141308
KEGG_2021_Human,positive regulation of MHC class II biosynthetic process (GO:0045348),1/8,0.0198291614511851,0.1373019209574484,0,0,58.142857142857146,227.9549801512961,AZU1,Early Myeloid Progenitor,1.702695651141308
KEGG_2021_Human,somatic hypermutation of immunoglobulin genes (GO:0016446),1/8,0.0198291614511851,0.1373019209574484,0,0,58.142857142857146,227.9549801512961,POLQ,Early Myeloid Progenitor,1.702695651141308
KEGG_2021_Human,meiotic sister chromatid cohesion (GO:0051177),1/8,0.0198291614511851,0.1373019209574484,0,0,58.142857142857146,227.9549801512961,BUB1B,Early Myeloid Progenitor,1.702695651141308
KEGG_2021_Human,osteoblast development (GO:0002076),1/8,0.0198291614511851,0.1373019209574484,0,0,58.142857142857146,227.9549801512961,CLEC5A,Early Myeloid Progenitor,1.702695651141308
KEGG_2021_Human,regulation of pattern recognition receptor signaling pathway (GO:0062207),1/8,0.0198291614511851,0.1373019209574484,0,0,58.142857142857146,227.9549801512961,SLC15A2,Early Myeloid Progenitor,1.702695651141308
KEGG_2021_Human,negative regulation by symbiont of host apoptotic process (GO:0033668),1/8,0.0198291614511851,0.1373019209574484,0,0,58.142857142857146,227.9549801512961,CTSG,Early Myeloid Progenitor,1.702695651141308
KEGG_2021_Human,negative regulation by symbiont of host programmed cell death (GO:0052041),1/8,0.0198291614511851,0.1373019209574484,0,0,58.142857142857146,227.9549801512961,CTSG,Early Myeloid Progenitor,1.702695651141308
KEGG_2021_Human,bundle of His cell to Purkinje myocyte communication (GO:0086069),1/9,0.0222805591236868,0.1454158292893327,0,0,50.87244897959184,193.52086993316271,PKP2,Early Myeloid Progenitor,1.652073914876897
KEGG_2021_Human,positive regulation of mitochondrial calcium ion concentration (GO:0051561),1/9,0.0222805591236868,0.1454158292893327,0,0,50.87244897959184,193.52086993316271,MCU,Early Myeloid Progenitor,1.652073914876897
KEGG_2021_Human,maintenance of apical/basal cell polarity (GO:0035090),1/9,0.0222805591236868,0.1454158292893327,0,0,50.87244897959184,193.52086993316271,LIN7A,Early Myeloid Progenitor,1.652073914876897
KEGG_2021_Human,maintenance of epithelial cell apical/basal polarity (GO:0045199),1/9,0.0222805591236868,0.1454158292893327,0,0,50.87244897959184,193.52086993316271,LIN7A,Early Myeloid Progenitor,1.652073914876897
KEGG_2021_Human,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),1/10,0.024725948817258,0.1454158292893327,0,0,45.21768707482993,167.3010120823387,ECT2,Early Myeloid Progenitor,1.606847034080906
KEGG_2021_Human,calcium import into the mitochondrion (GO:0036444),1/10,0.024725948817258,0.1454158292893327,0,0,45.21768707482993,167.3010120823387,MCU,Early Myeloid Progenitor,1.606847034080906
KEGG_2021_Human,lipid phosphorylation (GO:0046834),1/10,0.024725948817258,0.1454158292893327,0,0,45.21768707482993,167.3010120823387,DGKG,Early Myeloid Progenitor,1.606847034080906
KEGG_2021_Human,monocyte activation (GO:0042117),1/10,0.024725948817258,0.1454158292893327,0,0,45.21768707482993,167.3010120823387,AZU1,Early Myeloid Progenitor,1.606847034080906
KEGG_2021_Human,positive regulation of cell cycle process (GO:0090068),2/101,0.0264315192050235,0.1454158292893327,0,0,8.35479797979798,30.35463590957481,KIF14;ECT2,Early Myeloid Progenitor,1.577877874197194
KEGG_2021_Human,calcium-mediated signaling (GO:0019722),2/102,0.0269177264019109,0.1454158292893327,0,0,8.270833333333334,29.898816321570965,AZU1;MCU,Early Myeloid Progenitor,1.5699616254585989
KEGG_2021_Human,glycerolipid metabolic process (GO:0046486),1/11,0.0271653448579923,0.1454158292893327,0,0,40.69387755102041,146.73452100035948,DGKG,Early Myeloid Progenitor,1.5659847773237099
KEGG_2021_Human,regulation of coagulation (GO:0050818),1/11,0.0271653448579923,0.1454158292893327,0,0,40.69387755102041,146.73452100035948,HS3ST5,Early Myeloid Progenitor,1.5659847773237099
KEGG_2021_Human,cell proliferation in forebrain (GO:0021846),1/11,0.0271653448579923,0.1454158292893327,0,0,40.69387755102041,146.73452100035948,KIF14,Early Myeloid Progenitor,1.5659847773237099
KEGG_2021_Human,induction of positive chemotaxis (GO:0050930),1/11,0.0271653448579923,0.1454158292893327,0,0,40.69387755102041,146.73452100035948,AZU1,Early Myeloid Progenitor,1.5659847773237099
KEGG_2021_Human,protein kinase C signaling (GO:0070528),1/11,0.0271653448579923,0.1454158292893327,0,0,40.69387755102041,146.73452100035948,AZU1,Early Myeloid Progenitor,1.5659847773237099
KEGG_2021_Human,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),1/11,0.0271653448579923,0.1454158292893327,0,0,40.69387755102041,146.73452100035948,AZU1,Early Myeloid Progenitor,1.5659847773237099
KEGG_2021_Human,nucleotide-excision repair (GO:0006289),2/105,0.0283980432384044,0.1454158292893327,0,0,8.028721682847896,28.593770697553435,BRIP1;POLE,Early Myeloid Progenitor,1.546711583898058
KEGG_2021_Human,angiotensin maturation (GO:0002003),1/12,0.029598761568907,0.1454158292893327,0,0,36.99257884972171,130.2147194065139,CTSG,Early Myeloid Progenitor,1.5287264597194943
KEGG_2021_Human,regulation of angiotensin levels in blood (GO:0002002),1/12,0.029598761568907,0.1454158292893327,0,0,36.99257884972171,130.2147194065139,CTSG,Early Myeloid Progenitor,1.5287264597194943
KEGG_2021_Human,regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/12,0.029598761568907,0.1454158292893327,0,0,36.99257884972171,130.2147194065139,PKP2,Early Myeloid Progenitor,1.5287264597194943
KEGG_2021_Human,cell cycle checkpoint signaling (GO:0000075),1/12,0.029598761568907,0.1454158292893327,0,0,36.99257884972171,130.2147194065139,BUB1B,Early Myeloid Progenitor,1.5287264597194943
KEGG_2021_Human,macrophage chemotaxis (GO:0048246),1/12,0.029598761568907,0.1454158292893327,0,0,36.99257884972171,130.2147194065139,AZU1,Early Myeloid Progenitor,1.5287264597194943
KEGG_2021_Human,nuclear body organization (GO:0030575),1/12,0.029598761568907,0.1454158292893327,0,0,36.99257884972171,130.2147194065139,AFF2,Early Myeloid Progenitor,1.5287264597194943
KEGG_2021_Human,regulation of MHC class II biosynthetic process (GO:0045346),1/12,0.029598761568907,0.1454158292893327,0,0,36.99257884972171,130.2147194065139,AZU1,Early Myeloid Progenitor,1.5287264597194943
KEGG_2021_Human,depurination (GO:0045007),1/12,0.029598761568907,0.1454158292893327,0,0,36.99257884972171,130.2147194065139,NEIL3,Early Myeloid Progenitor,1.5287264597194943
KEGG_2021_Human,regulation of nucleobase-containing compound metabolic process (GO:0019219),1/12,0.029598761568907,0.1454158292893327,0,0,36.99257884972171,130.2147194065139,PCBP3,Early Myeloid Progenitor,1.5287264597194943
KEGG_2021_Human,protein localization to condensed chromosome (GO:1903083),1/12,0.029598761568907,0.1454158292893327,0,0,36.99257884972171,130.2147194065139,KNL1,Early Myeloid Progenitor,1.5287264597194943
KEGG_2021_Human,DNA replication (GO:0006260),2/108,0.029910476921657,0.1454158292893327,0,0,7.800314465408805,27.37556602865933,BRIP1;POLE,Early Myeloid Progenitor,1.5241766621009911
KEGG_2021_Human,regulation of protein kinase activity (GO:0045859),2/110,0.0309363405009925,0.145764864589177,0,0,7.655092592592593,26.607752397672005,AZU1;ECT2,Early Myeloid Progenitor,1.5095310608442127
KEGG_2021_Human,DNA metabolic process (GO:0006259),3/277,0.0319453076723714,0.145764864589177,0,0,4.583630998602268,15.784787458078153,POLQ;NEIL3;POLE,Early Myeloid Progenitor,1.4955929247248396
KEGG_2021_Human,negative regulation of locomotion (GO:0040013),1/13,0.032026213248763,0.145764864589177,0,0,33.90816326530612,116.6847899929619,ELANE,Early Myeloid Progenitor,1.4944944088974865
KEGG_2021_Human,positive regulation of sodium ion transport (GO:0010765),1/13,0.032026213248763,0.145764864589177,0,0,33.90816326530612,116.6847899929619,PKP2,Early Myeloid Progenitor,1.4944944088974865
KEGG_2021_Human,activation of protein kinase activity (GO:0032147),2/114,0.0330295301793541,0.145764864589177,0,0,7.380208333333333,25.169117576656426,KIF14;ECT2,Early Myeloid Progenitor,1.4810976037825534
KEGG_2021_Human,ion transport (GO:0006811),2/116,0.0340965412337713,0.145764864589177,0,0,7.25,24.49455514200503,SLC15A2;SLC26A8,Early Myeloid Progenitor,1.467289673772098
KEGG_2021_Human,negative regulation of coagulation (GO:0050819),1/14,0.0344477141698711,0.145764864589177,0,0,31.298273155416013,105.4223689491126,HS3ST5,Early Myeloid Progenitor,1.4628395910668823
KEGG_2021_Human,renal absorption (GO:0070293),1/14,0.0344477141698711,0.145764864589177,0,0,31.298273155416013,105.4223689491126,SLC15A2,Early Myeloid Progenitor,1.4628395910668823
KEGG_2021_Human,carbohydrate transport (GO:0008643),1/14,0.0344477141698711,0.145764864589177,0,0,31.298273155416013,105.4223689491126,SLC2A5,Early Myeloid Progenitor,1.4628395910668823
KEGG_2021_Human,intestinal absorption (GO:0050892),1/14,0.0344477141698711,0.145764864589177,0,0,31.298273155416013,105.4223689491126,SLC2A5,Early Myeloid Progenitor,1.4628395910668823
KEGG_2021_Human,sulfate transport (GO:0008272),1/14,0.0344477141698711,0.145764864589177,0,0,31.298273155416013,105.4223689491126,SLC26A8,Early Myeloid Progenitor,1.4628395910668823
KEGG_2021_Human,ceramide transport (GO:0035627),1/14,0.0344477141698711,0.145764864589177,0,0,31.298273155416013,105.4223689491126,ABCA13,Early Myeloid Progenitor,1.4628395910668823
KEGG_2021_Human,regulation of protein kinase C signaling (GO:0090036),1/14,0.0344477141698711,0.145764864589177,0,0,31.298273155416013,105.4223689491126,DGKG,Early Myeloid Progenitor,1.4628395910668823
KEGG_2021_Human,protein localization to kinetochore (GO:0034501),1/14,0.0344477141698711,0.145764864589177,0,0,31.298273155416013,105.4223689491126,KNL1,Early Myeloid Progenitor,1.4628395910668823
KEGG_2021_Human,proteolysis (GO:0006508),3/287,0.0349383450324741,0.145956841911475,0,0,4.419988013185496,14.82539270309656,CTSG;AZU1;ELANE,Early Myeloid Progenitor,1.4566976706263206
KEGG_2021_Human,protein homooligomerization (GO:0051260),2/121,0.0368223679095263,0.145956841911475,0,0,6.943627450980392,22.92542614889691,POLQ;ECT2,Early Myeloid Progenitor,1.4338882870711436
KEGG_2021_Human,negative regulation of leukocyte activation (GO:0002695),1/15,0.0368632785936063,0.145956841911475,0,0,29.06122448979592,95.91771596133704,BPI,Early Myeloid Progenitor,1.4334060415588732
KEGG_2021_Human,positive regulation of heterotypic cell-cell adhesion (GO:0034116),1/15,0.0368632785936063,0.145956841911475,0,0,29.06122448979592,95.91771596133704,CEACAM6,Early Myeloid Progenitor,1.4334060415588732
KEGG_2021_Human,regulation of integrin activation (GO:0033623),1/15,0.0368632785936063,0.145956841911475,0,0,29.06122448979592,95.91771596133704,KIF14,Early Myeloid Progenitor,1.4334060415588732
KEGG_2021_Human,macrophage migration (GO:1905517),1/15,0.0368632785936063,0.145956841911475,0,0,29.06122448979592,95.91771596133704,AZU1,Early Myeloid Progenitor,1.4334060415588732
KEGG_2021_Human,regulation of tumor necrosis factor production (GO:0032680),2/124,0.038497072428768,0.145956841911475,0,0,6.771857923497268,22.05711333941876,BPI;AZU1,Early Myeloid Progenitor,1.4145722958518654
KEGG_2021_Human,extracellular matrix organization (GO:0030198),3/300,0.0390400715124679,0.145956841911475,0,0,4.223726627981947,13.698249489225711,COL23A1;CTSG;ELANE,Early Myeloid Progenitor,1.4084893954766124
KEGG_2021_Human,negative regulation of anoikis (GO:2000811),1/16,0.0392729207344652,0.145956841911475,0,0,27.122448979591837,87.80133530116419,CEACAM6,Early Myeloid Progenitor,1.405906798966597
KEGG_2021_Human,regulation of systemic arterial blood pressure (GO:0003073),1/16,0.0392729207344652,0.145956841911475,0,0,27.122448979591837,87.80133530116419,SLC2A5,Early Myeloid Progenitor,1.405906798966597
KEGG_2021_Human,negative regulation of macrophage activation (GO:0043031),1/16,0.0392729207344652,0.145956841911475,0,0,27.122448979591837,87.80133530116419,BPI,Early Myeloid Progenitor,1.405906798966597
KEGG_2021_Human,microtubule cytoskeleton organization involved in mitosis (GO:1902850),2/128,0.0407746939326368,0.145956841911475,0,0,6.555555555555555,20.975769396496517,BUB1B;KNL1,Early Myeloid Progenitor,1.3896092902230834
KEGG_2021_Human,negative regulation of chemokine production (GO:0032682),1/17,0.0416766547912334,0.145956841911475,0,0,25.426020408163264,80.79916728086499,ELANE,Early Myeloid Progenitor,1.3801071472903907
KEGG_2021_Human,gliogenesis (GO:0042063),1/17,0.0416766547912334,0.145956841911475,0,0,25.426020408163264,80.79916728086499,AZU1,Early Myeloid Progenitor,1.3801071472903907
KEGG_2021_Human,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/17,0.0416766547912334,0.145956841911475,0,0,25.426020408163264,80.79916728086499,PKP2,Early Myeloid Progenitor,1.3801071472903907
KEGG_2021_Human,positive regulation of positive chemotaxis (GO:0050927),1/17,0.0416766547912334,0.145956841911475,0,0,25.426020408163264,80.79916728086499,AZU1,Early Myeloid Progenitor,1.3801071472903907
KEGG_2021_Human,sulfation (GO:0051923),1/17,0.0416766547912334,0.145956841911475,0,0,25.426020408163264,80.79916728086499,HS3ST5,Early Myeloid Progenitor,1.3801071472903907
KEGG_2021_Human,DNA biosynthetic process (GO:0071897),1/17,0.0416766547912334,0.145956841911475,0,0,25.426020408163264,80.79916728086499,POLE,Early Myeloid Progenitor,1.3801071472903907
KEGG_2021_Human,embryo development ending in birth or egg hatching (GO:0009792),1/17,0.0416766547912334,0.145956841911475,0,0,25.426020408163264,80.79916728086499,STOX2,Early Myeloid Progenitor,1.3801071472903907
KEGG_2021_Human,"protein localization to chromosome, centromeric region (GO:0071459)",1/17,0.0416766547912334,0.145956841911475,0,0,25.426020408163264,80.79916728086499,KNL1,Early Myeloid Progenitor,1.3801071472903907
KEGG_2021_Human,regulation of cell adhesion (GO:0030155),2/133,0.043691853040543,0.145956841911475,0,0,6.303753180661578,19.734489511742076,KIF14;AZU1,Early Myeloid Progenitor,1.3595995357844428
KEGG_2021_Human,RNA metabolic process (GO:0016070),2/133,0.043691853040543,0.145956841911475,0,0,6.303753180661578,19.734489511742076,PCBP3;RNASE3,Early Myeloid Progenitor,1.3595995357844428
KEGG_2021_Human,epithelial structure maintenance (GO:0010669),1/18,0.0440744949316926,0.145956841911475,0,0,23.92917166866747,74.70385911458476,PIWIL4,Early Myeloid Progenitor,1.3558126557645607
KEGG_2021_Human,negative regulation of double-strand break repair via homologous recombination (GO:2000042),1/18,0.0440744949316926,0.145956841911475,0,0,23.92917166866747,74.70385911458476,POLQ,Early Myeloid Progenitor,1.3558126557645607
KEGG_2021_Human,carbohydrate derivative transport (GO:1901264),1/18,0.0440744949316926,0.145956841911475,0,0,23.92917166866747,74.70385911458476,SLC15A2,Early Myeloid Progenitor,1.3558126557645607
KEGG_2021_Human,intermediate filament organization (GO:0045109),1/18,0.0440744949316926,0.145956841911475,0,0,23.92917166866747,74.70385911458476,PKP2,Early Myeloid Progenitor,1.3558126557645607
KEGG_2021_Human,intracellular estrogen receptor signaling pathway (GO:0030520),1/18,0.0440744949316926,0.145956841911475,0,0,23.92917166866747,74.70385911458476,DEFA3,Early Myeloid Progenitor,1.3558126557645607
KEGG_2021_Human,microtubule depolymerization (GO:0007019),1/18,0.0440744949316926,0.145956841911475,0,0,23.92917166866747,74.70385911458476,KIF14,Early Myeloid Progenitor,1.3558126557645607
KEGG_2021_Human,ventricular cardiac muscle cell action potential (GO:0086005),1/18,0.0440744949316926,0.145956841911475,0,0,23.92917166866747,74.70385911458476,PKP2,Early Myeloid Progenitor,1.3558126557645607
KEGG_2021_Human,DNA strand elongation involved in DNA replication (GO:0006271),1/18,0.0440744949316926,0.145956841911475,0,0,23.92917166866747,74.70385911458476,POLE,Early Myeloid Progenitor,1.3558126557645607
KEGG_2021_Human,cellular calcium ion homeostasis (GO:0006874),2/136,0.0454786698217006,0.1463336651982345,0,0,6.161691542288557,19.042780777221537,MCU;ELANE,Early Myeloid Progenitor,1.3421922462170102
KEGG_2021_Human,heparan sulfate proteoglycan biosynthetic process (GO:0015012),1/19,0.0464664552952436,0.1463336651982345,0,0,22.598639455782312,69.35578082800635,HS3ST5,Early Myeloid Progenitor,1.3328604565168853
KEGG_2021_Human,cardiac muscle cell contraction (GO:0086003),1/19,0.0464664552952436,0.1463336651982345,0,0,22.598639455782312,69.35578082800635,PKP2,Early Myeloid Progenitor,1.3328604565168853
KEGG_2021_Human,positive regulation of mitochondrial fission (GO:0090141),1/19,0.0464664552952436,0.1463336651982345,0,0,22.598639455782312,69.35578082800635,MCU,Early Myeloid Progenitor,1.3328604565168853
KEGG_2021_Human,positive regulation of neutrophil chemotaxis (GO:0090023),1/19,0.0464664552952436,0.1463336651982345,0,0,22.598639455782312,69.35578082800635,MCU,Early Myeloid Progenitor,1.3328604565168853
KEGG_2021_Human,piRNA metabolic process (GO:0034587),1/19,0.0464664552952436,0.1463336651982345,0,0,22.598639455782312,69.35578082800635,PIWIL4,Early Myeloid Progenitor,1.3328604565168853
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),3/323,0.0468728629064742,0.1463336651982345,0,0,3.9155585106382977,11.982847874596391,DEFA4;DEFA3;CTSG,Early Myeloid Progenitor,1.3290785197780062
KEGG_2021_Human,protein localization to cell periphery (GO:1990778),2/140,0.0479026862337682,0.1463336651982345,0,0,5.981884057971015,18.176455370515885,PKP2;LIN7A,Early Myeloid Progenitor,1.319640132017756
KEGG_2021_Human,glucose transmembrane transport (GO:1904659),1/20,0.0488525499820277,0.1463336651982345,0,0,21.40816326530612,64.63014669364038,SLC2A5,Early Myeloid Progenitor,1.3111127622579986
KEGG_2021_Human,"base-excision repair, AP site formation (GO:0006285)",1/20,0.0488525499820277,0.1463336651982345,0,0,21.40816326530612,64.63014669364038,NEIL3,Early Myeloid Progenitor,1.3111127622579986
KEGG_2021_Human,lipopolysaccharide-mediated signaling pathway (GO:0031663),1/20,0.0488525499820277,0.1463336651982345,0,0,21.40816326530612,64.63014669364038,BPI,Early Myeloid Progenitor,1.3111127622579986
KEGG_2021_Human,modulation by symbiont of entry into host (GO:0052372),1/20,0.0488525499820277,0.1463336651982345,0,0,21.40816326530612,64.63014669364038,HS3ST5,Early Myeloid Progenitor,1.3111127622579986
KEGG_2021_Human,xenobiotic transport (GO:0042908),1/20,0.0488525499820277,0.1463336651982345,0,0,21.40816326530612,64.63014669364038,SLC15A2,Early Myeloid Progenitor,1.3111127622579986
KEGG_2021_Human,purinergic nucleotide receptor signaling pathway (GO:0035590),1/21,0.0512327930672156,0.1463336651982345,0,0,20.336734693877553,60.42807445408675,CTSG,Early Myeloid Progenitor,1.2904519669693806
KEGG_2021_Human,regulation of anoikis (GO:2000209),1/21,0.0512327930672156,0.1463336651982345,0,0,20.336734693877553,60.42807445408675,CEACAM6,Early Myeloid Progenitor,1.2904519669693806
KEGG_2021_Human,regulation of transposition (GO:0010528),1/21,0.0512327930672156,0.1463336651982345,0,0,20.336734693877553,60.42807445408675,PIWIL4,Early Myeloid Progenitor,1.2904519669693806
KEGG_2021_Human,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.0512327930672156,0.1463336651982345,0,0,20.336734693877553,60.42807445408675,AZU1,Early Myeloid Progenitor,1.2904519669693806
KEGG_2021_Human,heparan sulfate proteoglycan metabolic process (GO:0030201),1/21,0.0512327930672156,0.1463336651982345,0,0,20.336734693877553,60.42807445408675,HS3ST5,Early Myeloid Progenitor,1.2904519669693806
KEGG_2021_Human,spindle assembly checkpoint signaling (GO:0071173),1/21,0.0512327930672156,0.1463336651982345,0,0,20.336734693877553,60.42807445408675,BUB1B,Early Myeloid Progenitor,1.2904519669693806
KEGG_2021_Human,mitochondrial calcium ion transmembrane transport (GO:0006851),1/21,0.0512327930672156,0.1463336651982345,0,0,20.336734693877553,60.42807445408675,MCU,Early Myeloid Progenitor,1.2904519669693806
KEGG_2021_Human,mitotic spindle assembly checkpoint signaling (GO:0007094),1/21,0.0512327930672156,0.1463336651982345,0,0,20.336734693877553,60.42807445408675,BUB1B,Early Myeloid Progenitor,1.2904519669693806
KEGG_2021_Human,mitotic spindle checkpoint signaling (GO:0071174),1/21,0.0512327930672156,0.1463336651982345,0,0,20.336734693877553,60.42807445408675,BUB1B,Early Myeloid Progenitor,1.2904519669693806
KEGG_2021_Human,positive regulation of granulocyte chemotaxis (GO:0071624),1/22,0.0536071985992547,0.1484756955142996,0,0,19.367346938775512,56.67024999786951,MCU,Early Myeloid Progenitor,1.2707768875084013
KEGG_2021_Human,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),1/22,0.0536071985992547,0.1484756955142996,0,0,19.367346938775512,56.67024999786951,BUB1B,Early Myeloid Progenitor,1.2707768875084013
KEGG_2021_Human,positive regulation of neutrophil migration (GO:1902624),1/22,0.0536071985992547,0.1484756955142996,0,0,19.367346938775512,56.67024999786951,MCU,Early Myeloid Progenitor,1.2707768875084013
KEGG_2021_Human,microglial cell activation (GO:0001774),1/22,0.0536071985992547,0.1484756955142996,0,0,19.367346938775512,56.67024999786951,AZU1,Early Myeloid Progenitor,1.2707768875084013
KEGG_2021_Human,mitochondrial calcium ion homeostasis (GO:0051560),1/22,0.0536071985992547,0.1484756955142996,0,0,19.367346938775512,56.67024999786951,MCU,Early Myeloid Progenitor,1.2707768875084013
KEGG_2021_Human,hexose transmembrane transport (GO:0008645),1/23,0.0559757805878795,0.1513664599329049,0,0,18.4860853432282,53.29235549319145,SLC2A5,Early Myeloid Progenitor,1.2519998414265567
KEGG_2021_Human,diacylglycerol metabolic process (GO:0046339),1/23,0.0559757805878795,0.1513664599329049,0,0,18.4860853432282,53.29235549319145,DGKG,Early Myeloid Progenitor,1.2519998414265567
KEGG_2021_Human,mitotic cell cycle checkpoint signaling (GO:0007093),1/23,0.0559757805878795,0.1513664599329049,0,0,18.4860853432282,53.29235549319145,BUB1B,Early Myeloid Progenitor,1.2519998414265567
KEGG_2021_Human,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.0559757805878795,0.1513664599329049,0,0,18.4860853432282,53.29235549319145,SHCBP1,Early Myeloid Progenitor,1.2519998414265567
KEGG_2021_Human,lipid translocation (GO:0034204),1/24,0.0583385530130099,0.1524058084046602,0,0,17.68145519077196,50.24171555062859,ATP8B4,Early Myeloid Progenitor,1.2340443470047993
KEGG_2021_Human,defense response to fungus (GO:0050832),1/24,0.0583385530130099,0.1524058084046602,0,0,17.68145519077196,50.24171555062859,DEFA4,Early Myeloid Progenitor,1.2340443470047993
KEGG_2021_Human,"nucleotide-excision repair, DNA gap filling (GO:0006297)",1/24,0.0583385530130099,0.1524058084046602,0,0,17.68145519077196,50.24171555062859,POLE,Early Myeloid Progenitor,1.2340443470047993
KEGG_2021_Human,mitotic spindle organization (GO:0007052),2/157,0.058709917979055,0.1524058084046602,0,0,5.321236559139785,15.086485770152208,BUB1B;KNL1,Early Myeloid Progenitor,1.231288526354898
KEGG_2021_Human,regulation of cardiac muscle cell action potential (GO:0098901),1/25,0.0606955298241754,0.1524058084046602,0,0,16.943877551020407,47.47480020477031,PKP2,Early Myeloid Progenitor,1.2168432931781568
KEGG_2021_Human,response to hexose (GO:0009746),1/25,0.0606955298241754,0.1524058084046602,0,0,16.943877551020407,47.47480020477031,SLC2A5,Early Myeloid Progenitor,1.2168432931781568
KEGG_2021_Human,regulation of cholesterol transport (GO:0032374),1/25,0.0606955298241754,0.1524058084046602,0,0,16.943877551020407,47.47480020477031,ABCA13,Early Myeloid Progenitor,1.2168432931781568
KEGG_2021_Human,cellular response to hexose stimulus (GO:0071331),1/25,0.0606955298241754,0.1524058084046602,0,0,16.943877551020407,47.47480020477031,SLC2A5,Early Myeloid Progenitor,1.2168432931781568
KEGG_2021_Human,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/25,0.0606955298241754,0.1524058084046602,0,0,16.943877551020407,47.47480020477031,AZU1,Early Myeloid Progenitor,1.2168432931781568
KEGG_2021_Human,regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.0606955298241754,0.1524058084046602,0,0,16.943877551020407,47.47480020477031,CEACAM6,Early Myeloid Progenitor,1.2168432931781568
KEGG_2021_Human,regulation of mitochondrial fission (GO:0090140),1/25,0.0606955298241754,0.1524058084046602,0,0,16.943877551020407,47.47480020477031,MCU,Early Myeloid Progenitor,1.2168432931781568
KEGG_2021_Human,ventricular cardiac muscle tissue development (GO:0003229),1/25,0.0606955298241754,0.1524058084046602,0,0,16.943877551020407,47.47480020477031,PKP2,Early Myeloid Progenitor,1.2168432931781568
KEGG_2021_Human,regulation of neutrophil chemotaxis (GO:0090022),1/25,0.0606955298241754,0.1524058084046602,0,0,16.943877551020407,47.47480020477031,MCU,Early Myeloid Progenitor,1.2168432931781568
KEGG_2021_Human,regulation of viral life cycle (GO:1903900),1/26,0.0630467249540435,0.1540767556363524,0,0,16.26530612244898,44.95534064809558,HS3ST5,Early Myeloid Progenitor,1.2003374685092782
KEGG_2021_Human,positive regulation of glucose import (GO:0046326),1/26,0.0630467249540435,0.1540767556363524,0,0,16.26530612244898,44.95534064809558,CLTCL1,Early Myeloid Progenitor,1.2003374685092782
KEGG_2021_Human,negative regulation of transposition (GO:0010529),1/26,0.0630467249540435,0.1540767556363524,0,0,16.26530612244898,44.95534064809558,PIWIL4,Early Myeloid Progenitor,1.2003374685092782
KEGG_2021_Human,regulation of myelination (GO:0031641),1/26,0.0630467249540435,0.1540767556363524,0,0,16.26530612244898,44.95534064809558,KIF14,Early Myeloid Progenitor,1.2003374685092782
KEGG_2021_Human,DNA modification (GO:0006304),1/26,0.0630467249540435,0.1540767556363524,0,0,16.26530612244898,44.95534064809558,NEIL3,Early Myeloid Progenitor,1.2003374685092782
KEGG_2021_Human,double-strand break repair (GO:0006302),2/164,0.0633842647819243,0.1540777074752097,0,0,5.089506172839506,14.03960451512792,POLQ;BRIP1,Early Myeloid Progenitor,1.1980185428525092
KEGG_2021_Human,acute inflammatory response (GO:0002526),1/27,0.0653921522588676,0.1555449462523669,0,0,15.638932496075354,42.652889831563165,ELANE,Early Myeloid Progenitor,1.184474368421492
KEGG_2021_Human,regulation of cardiac muscle cell contraction (GO:0086004),1/27,0.0653921522588676,0.1555449462523669,0,0,15.638932496075354,42.652889831563165,PKP2,Early Myeloid Progenitor,1.184474368421492
KEGG_2021_Human,microtubule polymerization or depolymerization (GO:0031109),1/27,0.0653921522588676,0.1555449462523669,0,0,15.638932496075354,42.652889831563165,KIF14,Early Myeloid Progenitor,1.184474368421492
KEGG_2021_Human,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/170,0.067488533240135,0.1555449462523669,0,0,4.90625,13.226256844780602,CEACAM6;CEACAM8,Early Myeloid Progenitor,1.1707700104811887
KEGG_2021_Human,amide transport (GO:0042886),1/28,0.0677318256109869,0.1555449462523669,0,0,15.058956916099774,40.54171043527237,ABCA13,Early Myeloid Progenitor,1.1692072184717057
KEGG_2021_Human,calcium ion import (GO:0070509),1/28,0.0677318256109869,0.1555449462523669,0,0,15.058956916099774,40.54171043527237,MCU,Early Myeloid Progenitor,1.1692072184717057
KEGG_2021_Human,positive regulation of protein import into nucleus (GO:0042307),1/28,0.0677318256109869,0.1555449462523669,0,0,15.058956916099774,40.54171043527237,ECT2,Early Myeloid Progenitor,1.1692072184717057
KEGG_2021_Human,sulfur compound transport (GO:0072348),1/28,0.0677318256109869,0.1555449462523669,0,0,15.058956916099774,40.54171043527237,SLC26A8,Early Myeloid Progenitor,1.1692072184717057
KEGG_2021_Human,macromolecule catabolic process (GO:0009057),1/28,0.0677318256109869,0.1555449462523669,0,0,15.058956916099774,40.54171043527237,ELANE,Early Myeloid Progenitor,1.1692072184717057
KEGG_2021_Human,cytosolic calcium ion transport (GO:0060401),1/28,0.0677318256109869,0.1555449462523669,0,0,15.058956916099774,40.54171043527237,MCU,Early Myeloid Progenitor,1.1692072184717057
KEGG_2021_Human,protein depolymerization (GO:0051261),1/28,0.0677318256109869,0.1555449462523669,0,0,15.058956916099774,40.54171043527237,KIF14,Early Myeloid Progenitor,1.1692072184717057
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),3/381,0.0697677490315496,0.1585151078643786,0,0,3.3049645390070923,8.799743799293005,CLEC5A;KIF14;AZU1,Early Myeloid Progenitor,1.1563452887586665
KEGG_2021_Human,negative regulation of mRNA catabolic process (GO:1902373),1/29,0.0700657588372089,0.1585151078643786,0,0,14.520408163265309,38.5999069065122,TENT5A,Early Myeloid Progenitor,1.1544941700666143
KEGG_2021_Human,dicarboxylic acid transport (GO:0006835),1/29,0.0700657588372089,0.1585151078643786,0,0,14.520408163265309,38.5999069065122,SLC26A8,Early Myeloid Progenitor,1.1544941700666143
KEGG_2021_Human,heterotypic cell-cell adhesion (GO:0034113),1/30,0.0723939657090184,0.1590578958126029,0,0,14.019000703729768,36.80874147674154,PKP2,Early Myeloid Progenitor,1.1402976322627019
KEGG_2021_Human,cardiac muscle cell action potential (GO:0086001),1/30,0.0723939657090184,0.1590578958126029,0,0,14.019000703729768,36.80874147674154,PKP2,Early Myeloid Progenitor,1.1402976322627019
KEGG_2021_Human,positive regulation of protein import (GO:1904591),1/30,0.0723939657090184,0.1590578958126029,0,0,14.019000703729768,36.80874147674154,ECT2,Early Myeloid Progenitor,1.1402976322627019
KEGG_2021_Human,CENP-A containing chromatin organization (GO:0061641),1/30,0.0723939657090184,0.1590578958126029,0,0,14.019000703729768,36.80874147674154,KNL1,Early Myeloid Progenitor,1.1402976322627019
KEGG_2021_Human,CENP-A containing nucleosome assembly (GO:0034080),1/30,0.0723939657090184,0.1590578958126029,0,0,14.019000703729768,36.80874147674154,KNL1,Early Myeloid Progenitor,1.1402976322627019
KEGG_2021_Human,regulation of macrophage activation (GO:0043030),1/30,0.0723939657090184,0.1590578958126029,0,0,14.019000703729768,36.80874147674154,BPI,Early Myeloid Progenitor,1.1402976322627019
KEGG_2021_Human,negative regulation of interleukin-6 production (GO:0032715),1/31,0.0747164600026276,0.1600190806035202,0,0,13.551020408163266,35.15209038871121,BPI,Early Myeloid Progenitor,1.126583712764908
KEGG_2021_Human,cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.0747164600026276,0.1600190806035202,0,0,13.551020408163266,35.15209038871121,PKP2,Early Myeloid Progenitor,1.126583712764908
KEGG_2021_Human,phospholipid translocation (GO:0045332),1/31,0.0747164600026276,0.1600190806035202,0,0,13.551020408163266,35.15209038871121,ATP8B4,Early Myeloid Progenitor,1.126583712764908
KEGG_2021_Human,negative regulation of cytokine production (GO:0001818),2/182,0.0759532712589317,0.1600190806035202,0,0,4.576388888888889,11.79626923326343,BPI;ELANE,Early Myeloid Progenitor,1.1194535166121444
KEGG_2021_Human,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/32,0.0770332554327668,0.1600190806035202,0,0,13.113232389730086,33.61600807740255,LIN7A,Early Myeloid Progenitor,1.1133217484244988
KEGG_2021_Human,negative regulation of chemotaxis (GO:0050922),1/32,0.0770332554327668,0.1600190806035202,0,0,13.113232389730086,33.61600807740255,ELANE,Early Myeloid Progenitor,1.1133217484244988
KEGG_2021_Human,negative regulation of double-strand break repair (GO:2000780),1/32,0.0770332554327668,0.1600190806035202,0,0,13.113232389730086,33.61600807740255,POLQ,Early Myeloid Progenitor,1.1133217484244988
KEGG_2021_Human,positive regulation of glucose transmembrane transport (GO:0010828),1/32,0.0770332554327668,0.1600190806035202,0,0,13.113232389730086,33.61600807740255,CLTCL1,Early Myeloid Progenitor,1.1133217484244988
KEGG_2021_Human,regulation of chemotaxis (GO:0050920),1/32,0.0770332554327668,0.1600190806035202,0,0,13.113232389730086,33.61600807740255,ELANE,Early Myeloid Progenitor,1.1133217484244988
KEGG_2021_Human,cardiac muscle tissue morphogenesis (GO:0055008),1/32,0.0770332554327668,0.1600190806035202,0,0,13.113232389730086,33.61600807740255,PKP2,Early Myeloid Progenitor,1.1133217484244988
KEGG_2021_Human,chromatin remodeling at centromere (GO:0031055),1/32,0.0770332554327668,0.1600190806035202,0,0,13.113232389730086,33.61600807740255,KNL1,Early Myeloid Progenitor,1.1133217484244988
KEGG_2021_Human,DNA damage checkpoint signaling (GO:0000077),1/32,0.0770332554327668,0.1600190806035202,0,0,13.113232389730086,33.61600807740255,BRIP1,Early Myeloid Progenitor,1.1133217484244988
KEGG_2021_Human,positive regulation of cholesterol transport (GO:0032376),1/33,0.0793443657059371,0.163335023097357,0,0,12.70280612244898,32.18837516559274,ABCA13,Early Myeloid Progenitor,1.1004839073426347
KEGG_2021_Human,RNA stabilization (GO:0043489),1/33,0.0793443657059371,0.163335023097357,0,0,12.70280612244898,32.18837516559274,TENT5A,Early Myeloid Progenitor,1.1004839073426347
KEGG_2021_Human,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.0816498044624026,0.1673271777547891,0,0,12.317254174397032,30.85861216573232,PKP2,Early Myeloid Progenitor,1.0880448509885652
KEGG_2021_Human,"base-excision repair, gap-filling (GO:0006287)",1/35,0.0839495853612937,0.1705109356004944,0,0,11.95438175270108,29.61744503578088,POLE,Early Myeloid Progenitor,1.0759814445616303
KEGG_2021_Human,cellular response to hydrogen peroxide (GO:0070301),1/35,0.0839495853612937,0.1705109356004944,0,0,11.95438175270108,29.61744503578088,ECT2,Early Myeloid Progenitor,1.0759814445616303
KEGG_2021_Human,protein localization to membrane (GO:0072657),2/195,0.0854831524975729,0.1713625258359068,0,0,4.265328151986183,10.490301477724982,PKP2;LIN7A,Early Myeloid Progenitor,1.0681194700473418
KEGG_2021_Human,regulation of sodium ion transport (GO:0002028),1/36,0.0862437219743075,0.1713625258359068,0,0,11.612244897959185,28.456712045041098,PKP2,Early Myeloid Progenitor,1.0642725091375862
KEGG_2021_Human,regulation of cell cycle G1/S phase transition (GO:1902806),1/36,0.0862437219743075,0.1713625258359068,0,0,11.612244897959185,28.456712045041098,KIF14,Early Myeloid Progenitor,1.0642725091375862
KEGG_2021_Human,macrophage activation (GO:0042116),1/36,0.0862437219743075,0.1713625258359068,0,0,11.612244897959185,28.456712045041098,AZU1,Early Myeloid Progenitor,1.0642725091375862
KEGG_2021_Human,regulation of protein import into nucleus (GO:0042306),1/36,0.0862437219743075,0.1713625258359068,0,0,11.612244897959185,28.456712045041098,ECT2,Early Myeloid Progenitor,1.0642725091375862
KEGG_2021_Human,regulation of glucose import (GO:0046324),1/37,0.0885322278902676,0.1736447559907825,0,0,11.289115646258503,27.36920368672352,CLTCL1,Early Myeloid Progenitor,1.0528986067362665
KEGG_2021_Human,centromere complex assembly (GO:0034508),1/37,0.0885322278902676,0.1736447559907825,0,0,11.289115646258503,27.36920368672352,KNL1,Early Myeloid Progenitor,1.0528986067362665
KEGG_2021_Human,ncRNA metabolic process (GO:0034660),1/37,0.0885322278902676,0.1736447559907825,0,0,11.289115646258503,27.36920368672352,PIWIL4,Early Myeloid Progenitor,1.0528986067362665
KEGG_2021_Human,regulation of macromolecule metabolic process (GO:0060255),2/200,0.0892414542606553,0.1742877974235875,0,0,4.156565656565657,10.043965211617904,PCBP3;AFF2,Early Myeloid Progenitor,1.0494333611556608
KEGG_2021_Human,positive regulation of insulin secretion (GO:0032024),1/38,0.0908151166313484,0.1751160687785918,0,0,10.983452840595698,26.34852930034076,MCU,Early Myeloid Progenitor,1.0418418549683985
KEGG_2021_Human,histone exchange (GO:0043486),1/38,0.0908151166313484,0.1751160687785918,0,0,10.983452840595698,26.34852930034076,KNL1,Early Myeloid Progenitor,1.0418418549683985
KEGG_2021_Human,DNA replication initiation (GO:0006270),1/38,0.0908151166313484,0.1751160687785918,0,0,10.983452840595698,26.34852930034076,POLE,Early Myeloid Progenitor,1.0418418549683985
KEGG_2021_Human,regulation of viral entry into host cell (GO:0046596),1/39,0.0930924017046572,0.1757984610703651,0,0,10.693877551020408,25.38900533231373,HS3ST5,Early Myeloid Progenitor,1.0310857651239858
KEGG_2021_Human,regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.0930924017046572,0.1757984610703651,0,0,10.693877551020408,25.38900533231373,PKP2,Early Myeloid Progenitor,1.0310857651239858
KEGG_2021_Human,DNA integrity checkpoint signaling (GO:0031570),1/39,0.0930924017046572,0.1757984610703651,0,0,10.693877551020408,25.38900533231373,BRIP1,Early Myeloid Progenitor,1.0310857651239858
KEGG_2021_Human,DNA replication-independent nucleosome assembly (GO:0006336),1/39,0.0930924017046572,0.1757984610703651,0,0,10.693877551020408,25.38900533231373,KNL1,Early Myeloid Progenitor,1.0310857651239858
KEGG_2021_Human,regulation of peptidyl-threonine phosphorylation (GO:0010799),1/39,0.0930924017046572,0.1757984610703651,0,0,10.693877551020408,25.38900533231373,AZU1,Early Myeloid Progenitor,1.0310857651239858
KEGG_2021_Human,regulation of intracellular signal transduction (GO:1902531),3/437,0.0958190274323666,0.1802028622905002,0,0,2.8702814001372685,6.731653738942884,BRIP1;SLC15A2;ECT2,Early Myeloid Progenitor,1.018548241564912
KEGG_2021_Human,epithelial cell migration (GO:0010631),1/41,0.0976302146847681,0.1813699516704839,0,0,10.158163265306122,23.633660200289185,ANLN,Early Myeloid Progenitor,1.0104157556925017
KEGG_2021_Human,acylglycerol metabolic process (GO:0006639),1/41,0.0976302146847681,0.1813699516704839,0,0,10.158163265306122,23.633660200289185,DGKG,Early Myeloid Progenitor,1.0104157556925017
KEGG_2021_Human,nucleobase-containing compound catabolic process (GO:0034655),1/41,0.0976302146847681,0.1813699516704839,0,0,10.158163265306122,23.633660200289185,RNASE3,Early Myeloid Progenitor,1.0104157556925017
KEGG_2021_Human,regulation of chemokine production (GO:0032642),1/42,0.0998907694703361,0.1830612503752669,0,0,9.909905425584869,22.829231064333683,ELANE,Early Myeloid Progenitor,1.00047464143678
KEGG_2021_Human,regulation of nervous system development (GO:0051960),1/42,0.0998907694703361,0.1830612503752669,0,0,9.909905425584869,22.829231064333683,KIF14,Early Myeloid Progenitor,1.00047464143678
KEGG_2021_Human,anion transport (GO:0006820),1/43,0.1021457742794159,0.1830612503752669,0,0,9.673469387755102,22.068611238785657,SLC26A8,Early Myeloid Progenitor,0.9907795952096249
KEGG_2021_Human,signal release from synapse (GO:0099643),1/43,0.1021457742794159,0.1830612503752669,0,0,9.673469387755102,22.068611238785657,LIN7A,Early Myeloid Progenitor,0.9907795952096249
KEGG_2021_Human,positive regulation of neuron differentiation (GO:0045666),1/43,0.1021457742794159,0.1830612503752669,0,0,9.673469387755102,22.068611238785657,ECT2,Early Myeloid Progenitor,0.9907795952096249
KEGG_2021_Human,positive regulation of peptide hormone secretion (GO:0090277),1/43,0.1021457742794159,0.1830612503752669,0,0,9.673469387755102,22.068611238785657,MCU,Early Myeloid Progenitor,0.9907795952096249
KEGG_2021_Human,lipid modification (GO:0030258),1/43,0.1021457742794159,0.1830612503752669,0,0,9.673469387755102,22.068611238785657,DGKG,Early Myeloid Progenitor,0.9907795952096249
KEGG_2021_Human,DNA synthesis involved in DNA repair (GO:0000731),1/43,0.1021457742794159,0.1830612503752669,0,0,9.673469387755102,22.068611238785657,POLE,Early Myeloid Progenitor,0.9907795952096249
KEGG_2021_Human,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/43,0.1021457742794159,0.1830612503752669,0,0,9.673469387755102,22.068611238785657,POLE,Early Myeloid Progenitor,0.9907795952096249
KEGG_2021_Human,positive regulation of cell-matrix adhesion (GO:0001954),1/44,0.1043952424647777,0.1834947146400131,0,0,9.448030374940672,21.34849709415977,CEACAM6,Early Myeloid Progenitor,0.9813192926974915
KEGG_2021_Human,cardiac ventricle morphogenesis (GO:0003208),1/44,0.1043952424647777,0.1834947146400131,0,0,9.448030374940672,21.34849709415977,PKP2,Early Myeloid Progenitor,0.9813192926974915
KEGG_2021_Human,intracellular steroid hormone receptor signaling pathway (GO:0030518),1/44,0.1043952424647777,0.1834947146400131,0,0,9.448030374940672,21.34849709415977,DEFA3,Early Myeloid Progenitor,0.9813192926974915
KEGG_2021_Human,neurotransmitter secretion (GO:0007269),1/44,0.1043952424647777,0.1834947146400131,0,0,9.448030374940672,21.34849709415977,LIN7A,Early Myeloid Progenitor,0.9813192926974915
KEGG_2021_Human,mRNA stabilization (GO:0048255),1/44,0.1043952424647777,0.1834947146400131,0,0,9.448030374940672,21.34849709415977,TENT5A,Early Myeloid Progenitor,0.9813192926974915
KEGG_2021_Human,cellular response to radiation (GO:0071478),1/45,0.1066391873529346,0.1867207226831078,0,0,9.232838589981448,20.665901611884028,ECT2,Early Myeloid Progenitor,0.9720831731354668
KEGG_2021_Human,regulation of double-strand break repair via homologous recombination (GO:0010569),1/46,0.1088776222085674,0.1877625409408125,0,0,9.02721088435374,20.01811780873028,POLQ,Early Myeloid Progenitor,0.9630613723103648
KEGG_2021_Human,positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.1088776222085674,0.1877625409408125,0,0,9.02721088435374,20.01811780873028,ECT2,Early Myeloid Progenitor,0.9630613723103648
KEGG_2021_Human,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.1088776222085674,0.1877625409408125,0,0,9.02721088435374,20.01811780873028,BPI,Early Myeloid Progenitor,0.9630613723103648
KEGG_2021_Human,positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.1088776222085674,0.1877625409408125,0,0,9.02721088435374,20.01811780873028,ELANE,Early Myeloid Progenitor,0.9630613723103648
KEGG_2021_Human,positive regulation of cell-cell adhesion (GO:0022409),1/47,0.1111105603036554,0.1892864500113404,0,0,8.830523513753327,19.4026870705364,CEACAM6,Early Myeloid Progenitor,0.9542446623584087
KEGG_2021_Human,positive regulation of endocytosis (GO:0045807),1/48,0.1133380148369131,0.1892864500113404,0,0,8.642205818497612,18.81737166641443,ABCA13,Early Myeloid Progenitor,0.9456243984787533
KEGG_2021_Human,negative regulation of mitotic cell cycle (GO:0045930),1/48,0.1133380148369131,0.1892864500113404,0,0,8.642205818497612,18.81737166641443,BUB1B,Early Myeloid Progenitor,0.9456243984787533
KEGG_2021_Human,cellular response to ionizing radiation (GO:0071479),1/48,0.1133380148369131,0.1892864500113404,0,0,8.642205818497612,18.81737166641443,ECT2,Early Myeloid Progenitor,0.9456243984787533
KEGG_2021_Human,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.1133380148369131,0.1892864500113404,0,0,8.642205818497612,18.81737166641443,BPI,Early Myeloid Progenitor,0.9456243984787533
KEGG_2021_Human,substrate adhesion-dependent cell spreading (GO:0034446),1/48,0.1133380148369131,0.1892864500113404,0,0,8.642205818497612,18.81737166641443,KIF14,Early Myeloid Progenitor,0.9456243984787533
KEGG_2021_Human,phosphatidic acid biosynthetic process (GO:0006654),1/48,0.1133380148369131,0.1892864500113404,0,0,8.642205818497612,18.81737166641443,DGKG,Early Myeloid Progenitor,0.9456243984787533
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),4/742,0.1138085215723413,0.1892864500113404,0,0,2.2636974195828916,4.919552976765135,CLEC5A;KIF14;AZU1;ECT2,Early Myeloid Progenitor,0.943825218316277
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),3/474,0.1149270413547105,0.1892864500113404,0,0,2.6397885892397346,5.711071147622478,CEACAM6;KIF14;ELANE,Early Myeloid Progenitor,0.9395777734927033
KEGG_2021_Human,regulation of smooth muscle cell proliferation (GO:0048660),1/49,0.1155599990222406,0.1892864500113404,0,0,8.46173469387755,18.260130793597916,ELANE,Early Myeloid Progenitor,0.9371924705024297
KEGG_2021_Human,aminoglycan biosynthetic process (GO:0006023),1/49,0.1155599990222406,0.1892864500113404,0,0,8.46173469387755,18.260130793597916,HS3ST5,Early Myeloid Progenitor,0.9371924705024297
KEGG_2021_Human,response to hydrogen peroxide (GO:0042542),1/49,0.1155599990222406,0.1892864500113404,0,0,8.46173469387755,18.260130793597916,ECT2,Early Myeloid Progenitor,0.9371924705024297
KEGG_2021_Human,RNA catabolic process (GO:0006401),1/49,0.1155599990222406,0.1892864500113404,0,0,8.46173469387755,18.260130793597916,RNASE3,Early Myeloid Progenitor,0.9371924705024297
KEGG_2021_Human,cellular defense response (GO:0006968),1/49,0.1155599990222406,0.1892864500113404,0,0,8.46173469387755,18.260130793597916,CLEC5A,Early Myeloid Progenitor,0.9371924705024297
KEGG_2021_Human,positive regulation of ion transport (GO:0043270),1/50,0.1177765260040411,0.1915440298357536,0,0,8.28862973760933,17.7290996615035,PKP2,Early Myeloid Progenitor,0.928941259997044
KEGG_2021_Human,phosphatidic acid metabolic process (GO:0046473),1/50,0.1177765260040411,0.1915440298357536,0,0,8.28862973760933,17.7290996615035,DGKG,Early Myeloid Progenitor,0.928941259997044
KEGG_2021_Human,mitotic metaphase plate congression (GO:0007080),1/51,0.1199876089220907,0.1944480045297712,0,0,8.122448979591837,17.22257115519733,KIF14,Early Myeloid Progenitor,0.9208636010741894
KEGG_2021_Human,negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.1221932608707862,0.1966278880913708,0,0,7.962785114045619,16.738979733033663,KIF14,Early Myeloid Progenitor,0.9129527453809976
KEGG_2021_Human,signal transduction in response to DNA damage (GO:0042770),1/52,0.1221932608707862,0.1966278880913708,0,0,7.962785114045619,16.738979733033663,BRIP1,Early Myeloid Progenitor,0.9129527453809976
KEGG_2021_Human,positive regulation of chemokine production (GO:0032722),1/53,0.1243934949128716,0.1973882888027165,0,0,7.809262166405024,16.276887238960814,AZU1,Early Myeloid Progenitor,0.9052023302345248
KEGG_2021_Human,bicellular tight junction assembly (GO:0070830),1/53,0.1243934949128716,0.1973882888027165,0,0,7.809262166405024,16.276887238960814,ECT2,Early Myeloid Progenitor,0.9052023302345248
KEGG_2021_Human,cellular macromolecule catabolic process (GO:0044265),1/53,0.1243934949128716,0.1973882888027165,0,0,7.809262166405024,16.276887238960814,RNASE3,Early Myeloid Progenitor,0.9052023302345248
KEGG_2021_Human,positive regulation of phagocytosis (GO:0050766),1/53,0.1243934949128716,0.1973882888027165,0,0,7.809262166405024,16.276887238960814,AZU1,Early Myeloid Progenitor,0.9052023302345248
KEGG_2021_Human,glycosaminoglycan metabolic process (GO:0030203),1/54,0.1265883240687765,0.1994857382738994,0,0,7.661532537543319,15.834970375184442,HS3ST5,Early Myeloid Progenitor,0.8976063498190403
KEGG_2021_Human,inorganic anion transport (GO:0015698),1/54,0.1265883240687765,0.1994857382738994,0,0,7.661532537543319,15.834970375184442,SLC26A8,Early Myeloid Progenitor,0.8976063498190403
KEGG_2021_Human,interstrand cross-link repair (GO:0036297),1/55,0.1287777613922166,0.2022386149699072,0,0,7.519274376417234,15.412009607623004,NEIL3,Early Myeloid Progenitor,0.8901591287349465
KEGG_2021_Human,positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.1309618198144747,0.2042646814171158,0,0,7.382189239332097,15.00687933540933,AZU1,Early Myeloid Progenitor,0.8828552987007785
KEGG_2021_Human,tight junction assembly (GO:0120192),1/56,0.1309618198144747,0.2042646814171158,0,0,7.382189239332097,15.00687933540933,ECT2,Early Myeloid Progenitor,0.8828552987007785
KEGG_2021_Human,negative regulation of DNA recombination (GO:0045910),1/57,0.1331405122852093,0.2069565105929954,0,0,7.25,14.618539131965724,POLQ,Early Myeloid Progenitor,0.8756897763447542
KEGG_2021_Human,positive regulation of mitochondrion organization (GO:0010822),1/58,0.1353138517398134,0.2089136156928877,0,0,7.122448979591836,14.246025949065045,MCU,Early Myeloid Progenitor,0.8686577434892403
KEGG_2021_Human,regulation of phagocytosis (GO:0050764),1/58,0.1353138517398134,0.2089136156928877,0,0,7.122448979591836,14.246025949065045,AZU1,Early Myeloid Progenitor,0.8686577434892403
KEGG_2021_Human,phospholipid transport (GO:0015914),1/59,0.1374818510452552,0.2115461479046519,0,0,6.9992962702322306,13.8884471557023,ATP8B4,Early Myeloid Progenitor,0.8617546291873563
KEGG_2021_Human,cellular component assembly (GO:0022607),2/261,0.1385333711760542,0.2124488276089153,0,0,3.1677927927927927,6.261598728808151,PKP2;LIN7A,Early Myeloid Progenitor,0.8584455971996626
KEGG_2021_Human,apical junction assembly (GO:0043297),1/60,0.1396445230534406,0.2127251567847412,0,0,6.88031822898651,13.544974303558986,ECT2,Early Myeloid Progenitor,0.8549760929333525
KEGG_2021_Human,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/60,0.1396445230534406,0.2127251567847412,0,0,6.88031822898651,13.544974303558986,CEACAM6,Early Myeloid Progenitor,0.8549760929333525
KEGG_2021_Human,response to light stimulus (GO:0009416),1/61,0.1418018805927374,0.2145809914929834,0,0,6.76530612244898,13.214837540593155,ELANE,Early Myeloid Progenitor,0.848318009451734
KEGG_2021_Human,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2145809914929834,0,0,6.76530612244898,13.214837540593155,ELANE,Early Myeloid Progenitor,0.848318009451734
KEGG_2021_Human,protein-containing complex assembly (GO:0065003),2/267,0.1436652916283004,0.2156949146445473,0,0,3.095125786163522,6.005376764494242,LIN7A;MCU,Early Myeloid Progenitor,0.8426481412255155
KEGG_2021_Human,positive regulation of interleukin-1 production (GO:0032732),1/62,0.1439539364695556,0.2156949146445473,0,0,6.654064904650385,12.897320592663672,AZU1,Early Myeloid Progenitor,0.8417764546925935
KEGG_2021_Human,double-strand break repair via nonhomologous end joining (GO:0006303),1/62,0.1439539364695556,0.2156949146445473,0,0,6.654064904650385,12.897320592663672,POLQ,Early Myeloid Progenitor,0.8417764546925935
KEGG_2021_Human,actin cytoskeleton reorganization (GO:0031532),1/63,0.1461007034145454,0.2160777393541982,0,0,6.54641211323239,12.591756250239603,MCU,Early Myeloid Progenitor,0.8353476931121088
KEGG_2021_Human,cell cycle G1/S phase transition (GO:0044843),1/63,0.1461007034145454,0.2160777393541982,0,0,6.54641211323239,12.591756250239603,POLE,Early Myeloid Progenitor,0.8353476931121088
KEGG_2021_Human,cellular response to reactive oxygen species (GO:0034614),1/63,0.1461007034145454,0.2160777393541982,0,0,6.54641211323239,12.591756250239603,ECT2,Early Myeloid Progenitor,0.8353476931121088
KEGG_2021_Human,organonitrogen compound catabolic process (GO:1901565),1/63,0.1461007034145454,0.2160777393541982,0,0,6.54641211323239,12.591756250239603,ELANE,Early Myeloid Progenitor,0.8353476931121088
KEGG_2021_Human,protein catabolic process (GO:0030163),1/64,0.1482421941802595,0.2185376862592858,0,0,6.442176870748299,12.297522293260638,ELANE,Early Myeloid Progenitor,0.8290281655096747
KEGG_2021_Human,cell-cell junction assembly (GO:0007043),1/66,0.1525093979756266,0.2241054497583967,0,0,6.243328100470958,11.740759916332207,PKP2,Early Myeloid Progenitor,0.8167033932798328
KEGG_2021_Human,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.1567556490806558,0.2296068321469863,0,0,6.0563508985683825,11.222824361971773,ECT2,Early Myeloid Progenitor,0.8047767993307415
KEGG_2021_Human,cell chemotaxis (GO:0060326),1/69,0.158870948881139,0.2304889639323192,0,0,5.966986794717887,10.977245117600177,AZU1,Early Myeloid Progenitor,0.7989555105590889
KEGG_2021_Human,positive regulation of MAP kinase activity (GO:0043406),1/69,0.158870948881139,0.2304889639323192,0,0,5.966986794717887,10.977245117600177,ELANE,Early Myeloid Progenitor,0.7989555105590889
KEGG_2021_Human,cellular response to calcium ion (GO:0071277),1/69,0.158870948881139,0.2304889639323192,0,0,5.966986794717887,10.977245117600177,ECT2,Early Myeloid Progenitor,0.7989555105590889
KEGG_2021_Human,carbohydrate homeostasis (GO:0033500),1/70,0.1609810482853106,0.2328111995771739,0,0,5.880212954747116,10.740024519792764,MCU,Early Myeloid Progenitor,0.7932252488723367
KEGG_2021_Human,negative regulation of neuron apoptotic process (GO:0043524),1/71,0.16308595979881,0.2343719610945163,0,0,5.795918367346939,10.51076961698872,KIF14,Early Myeloid Progenitor,0.7875834261109624
KEGG_2021_Human,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.16308595979881,0.2343719610945163,0,0,5.795918367346939,10.51076961698872,KIF14,Early Myeloid Progenitor,0.7875834261109624
KEGG_2021_Human,response to ionizing radiation (GO:0010212),1/72,0.1651856959101235,0.2351709128689298,0,0,5.713998275366484,10.28911103101624,ECT2,Early Myeloid Progenitor,0.78202756268309
KEGG_2021_Human,cell morphogenesis involved in differentiation (GO:0000904),1/72,0.1651856959101235,0.2351709128689298,0,0,5.713998275366484,10.28911103101624,KIF14,Early Myeloid Progenitor,0.78202756268309
KEGG_2021_Human,positive regulation of protein secretion (GO:0050714),1/72,0.1651856959101235,0.2351709128689298,0,0,5.713998275366484,10.28911103101624,MCU,Early Myeloid Progenitor,0.78202756268309
KEGG_2021_Human,neurotransmitter transport (GO:0006836),1/73,0.1672802691231711,0.2374133012089726,0,0,5.634353741496598,10.074701240888364,LIN7A,Early Myeloid Progenitor,0.7765552814899175
KEGG_2021_Human,fibroblast growth factor receptor signaling pathway (GO:0008543),1/75,0.1714539764404576,0.242583489886344,0,0,5.4815223386651954,9.666337985731484,SHCBP1,Early Myeloid Progenitor,0.7658524380723842
KEGG_2021_Human,regulation of RNA splicing (GO:0043484),1/76,0.1735331353639065,0.2440142857270932,0,0,5.408163265306122,9.4717853003048,AFF2,Early Myeloid Progenitor,0.7606175863963804
KEGG_2021_Human,chloride transport (GO:0006821),1/76,0.1735331353639065,0.2440142857270932,0,0,5.408163265306122,9.4717853003048,SLC26A8,Early Myeloid Progenitor,0.7606175863963804
KEGG_2021_Human,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.1756071809118701,0.2461732566770694,0,0,5.336734693877551,9.283280446293812,AZU1,Early Myeloid Progenitor,0.7554577289388229
KEGG_2021_Human,recombinational repair (GO:0000725),1/79,0.1797399811935544,0.2504304006263853,0,0,5.199372056514914,8.923391206941128,POLQ,Early Myeloid Progenitor,0.745355308086215
KEGG_2021_Human,regulation of neuron differentiation (GO:0045664),1/79,0.1797399811935544,0.2504304006263853,0,0,5.199372056514914,8.923391206941128,ECT2,Early Myeloid Progenitor,0.745355308086215
KEGG_2021_Human,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2525289773379164,0,0,5.133298889175924,8.751529842637671,AZU1,Early Myeloid Progenitor,0.7404090821369118
KEGG_2021_Human,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.1838524754991919,0.2546078221306991,0,0,5.0688775510204085,8.584760541358477,AZU1,Early Myeloid Progenitor,0.7355305181562768
KEGG_2021_Human,cellular macromolecule biosynthetic process (GO:0034645),2/314,0.1851004260524556,0.255561615425898,0,0,2.6225961538461537,4.423944044737091,BRIP1;POLE,Early Myeloid Progenitor,0.7325925816143702
KEGG_2021_Human,cell-cell junction organization (GO:0045216),1/82,0.1859011384602527,0.2558940369769141,0,0,5.00604686318972,8.422875391899517,PKP2,Early Myeloid Progenitor,0.7307179505966239
KEGG_2021_Human,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1/83,0.1879447615357932,0.25715795216125,0,0,4.944748631159781,8.265677319811374,ANLN,Early Myeloid Progenitor,0.7259697745939766
KEGG_2021_Human,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.25715795216125,0,0,4.944748631159781,8.265677319811374,AZU1,Early Myeloid Progenitor,0.7259697745939766
KEGG_2021_Human,anaphase-promoting complex-dependent catabolic process (GO:0031145),1/84,0.1899833569114356,0.2577872074844802,0,0,4.884927464961889,8.112979399077096,BUB1B,Early Myeloid Progenitor,0.7212844428267129
KEGG_2021_Human,vascular transport (GO:0010232),1/84,0.1899833569114356,0.2577872074844802,0,0,4.884927464961889,8.112979399077096,SLC15A2,Early Myeloid Progenitor,0.7212844428267129
KEGG_2021_Human,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),2/321,0.1914223619241526,0.2577872074844802,0,0,2.5641327063740857,4.239211303475318,KIF14;BUB1B,Early Myeloid Progenitor,0.7180073293962443
KEGG_2021_Human,negative regulation of defense response (GO:0031348),1/85,0.1920169366451308,0.2577872074844802,0,0,4.826530612244898,7.964604221414354,ELANE,Early Myeloid Progenitor,0.716660463134361
KEGG_2021_Human,G1/S transition of mitotic cell cycle (GO:0000082),1/85,0.1920169366451308,0.2577872074844802,0,0,4.826530612244898,7.964604221414354,POLE,Early Myeloid Progenitor,0.716660463134361
KEGG_2021_Human,regulation of cell cycle G2/M phase transition (GO:1902749),1/85,0.1920169366451308,0.2577872074844802,0,0,4.826530612244898,7.964604221414354,KIF14,Early Myeloid Progenitor,0.716660463134361
KEGG_2021_Human,regulation of Ras protein signal transduction (GO:0046578),1/86,0.1940455128548384,0.2577872074844802,0,0,4.769507803121249,7.820383303288144,KIF14,Early Myeloid Progenitor,0.7120963955156414
KEGG_2021_Human,glucose homeostasis (GO:0042593),1/86,0.1940455128548384,0.2577872074844802,0,0,4.769507803121249,7.820383303288144,MCU,Early Myeloid Progenitor,0.7120963955156414
KEGG_2021_Human,transport across blood-brain barrier (GO:0150104),1/86,0.1940455128548384,0.2577872074844802,0,0,4.769507803121249,7.820383303288144,SLC15A2,Early Myeloid Progenitor,0.7120963955156414
KEGG_2021_Human,regulation of neuron death (GO:1901214),1/86,0.1940455128548384,0.2577872074844802,0,0,4.769507803121249,7.820383303288144,KIF14,Early Myeloid Progenitor,0.7120963955156414
KEGG_2021_Human,calcium ion transmembrane transport (GO:0070588),1/87,0.196069097589664,0.2597205147781926,0,0,4.713811105837684,7.6801565438185,MCU,Early Myeloid Progenitor,0.7075908500030543
KEGG_2021_Human,"retrograde transport, endosome to Golgi (GO:0042147)",1/88,0.1980877029036425,0.261636070020129,0,0,4.659394792399718,7.5437717166037235,CLTCL1,Early Myeloid Progenitor,0.703142484213379
KEGG_2021_Human,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),1/89,0.2001013407742902,0.2620238187216351,0,0,4.6062152133580705,7.411084001248333,KIF14,Early Myeloid Progenitor,0.6987500013741589
KEGG_2021_Human,second-messenger-mediated signaling (GO:0019932),1/89,0.2001013407742902,0.2620238187216351,0,0,4.6062152133580705,7.411084001248333,MCU,Early Myeloid Progenitor,0.6987500013741589
KEGG_2021_Human,collagen fibril organization (GO:0030199),1/89,0.2001013407742902,0.2620238187216351,0,0,4.6062152133580705,7.411084001248333,COL23A1,Early Myeloid Progenitor,0.6987500013741589
KEGG_2021_Human,positive regulation of transport (GO:0051050),1/91,0.2041137620931186,0.266514255075872,0,0,4.503401360544218,7.156255051106618,AZU1,Early Myeloid Progenitor,0.6901277125812961
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),3/625,0.2050267003954304,0.2669435956715433,0,0,1.9834439351440103,3.142995135240803,CEACAM6;KIF14;AZU1,Early Myeloid Progenitor,0.6881895775817527
KEGG_2021_Human,cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.2061125694363157,0.2675950120238531,0,0,4.453689167974883,7.03385741012878,SHCBP1,Early Myeloid Progenitor,0.6858955226779435
KEGG_2021_Human,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.2719932425430378,0,0,4.357472021066491,6.79849904676328,ECT2,Early Myeloid Progenitor,0.6775833802166729
KEGG_2021_Human,regulation of cell cycle phase transition (GO:1901987),1/95,0.2120795205832498,0.2730150448071695,0,0,4.310898827616153,6.685315939697291,BUB1B,Early Myeloid Progenitor,0.6735012670190429
KEGG_2021_Human,mRNA metabolic process (GO:0016071),1/95,0.2120795205832498,0.2730150448071695,0,0,4.310898827616153,6.685315939697291,PCBP3,Early Myeloid Progenitor,0.6735012670190429
KEGG_2021_Human,glycosaminoglycan biosynthetic process (GO:0006024),1/97,0.2160330472811356,0.2750058568453453,0,0,4.220663265306122,6.46742313757927,HS3ST5,Early Myeloid Progenitor,0.6654798083211632
KEGG_2021_Human,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2750058568453453,0,0,4.220663265306122,6.46742313757927,ELANE,Early Myeloid Progenitor,0.6654798083211632
KEGG_2021_Human,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2750058568453453,0,0,4.220663265306122,6.46742313757927,ELANE,Early Myeloid Progenitor,0.6654798083211632
KEGG_2021_Human,double-strand break repair via homologous recombination (GO:0000724),1/97,0.2160330472811356,0.2750058568453453,0,0,4.220663265306122,6.46742313757927,POLQ,Early Myeloid Progenitor,0.6654798083211632
KEGG_2021_Human,negative regulation of neuron death (GO:1901215),1/98,0.2180025137484037,0.2759754813934086,0,0,4.176940879444562,6.362519703204576,KIF14,Early Myeloid Progenitor,0.6615384985937142
KEGG_2021_Human,regulation of neuron apoptotic process (GO:0043523),1/98,0.2180025137484037,0.2759754813934086,0,0,4.176940879444562,6.362519703204576,KIF14,Early Myeloid Progenitor,0.6615384985937142
KEGG_2021_Human,supramolecular fiber organization (GO:0097435),2/351,0.2188220798658953,0.2762477638086027,0,0,2.3401384909264564,3.5558317785950937,COL23A1;KIF14,Early Myeloid Progenitor,0.6599088583892734
KEGG_2021_Human,response to UV (GO:0009411),1/99,0.2199671313012003,0.2769283168172136,0,0,4.134110787172012,6.26018948804807,ELANE,Early Myeloid Progenitor,0.6576422090003602
KEGG_2021_Human,ubiquitin-dependent protein catabolic process (GO:0006511),2/354,0.2215840331594591,0.2778646536523178,0,0,2.319839015151515,3.495889243162455,KIF14;BUB1B,Early Myeloid Progenitor,0.6544615370869727
KEGG_2021_Human,organic acid transport (GO:0015849),1/100,0.2219269115603851,0.2778646536523178,0,0,4.092145949288806,6.1603458876211565,SLC26A8,Early Myeloid Progenitor,0.6537900306498672
KEGG_2021_Human,cell junction assembly (GO:0034329),1/102,0.2258320069783284,0.281213153103804,0,0,4.010709234188725,5.967790506031058,PKP2,Early Myeloid Progenitor,0.6462145058611213
KEGG_2021_Human,mitotic sister chromatid segregation (GO:0000070),1/102,0.2258320069783284,0.281213153103804,0,0,4.010709234188725,5.967790506031058,KIF14,Early Myeloid Progenitor,0.6462145058611213
KEGG_2021_Human,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2845015640517174,0,0,3.932435109966317,5.78423168094792,ELANE,Early Myeloid Progenitor,0.6388051756325536
KEGG_2021_Human,regulation of insulin secretion (GO:0050796),1/104,0.2297178930745814,0.2845015640517174,0,0,3.932435109966317,5.78423168094792,MCU,Early Myeloid Progenitor,0.6388051756325536
KEGG_2021_Human,activation of GTPase activity (GO:0090630),1/105,0.2316536615468536,0.2861235765592219,0,0,3.894427001569859,5.6956456810845415,ECT2,Early Myeloid Progenitor,0.6351608308934773
KEGG_2021_Human,regulation of cell cycle process (GO:0010564),1/106,0.2335846623503299,0.2869575018658623,0,0,3.857142857142857,5.6090983677319475,ECT2,Early Myeloid Progenitor,0.6315556772929499
KEGG_2021_Human,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2869575018658623,0,0,3.857142857142857,5.6090983677319475,ELANE,Early Myeloid Progenitor,0.6315556772929499
KEGG_2021_Human,response to calcium ion (GO:0051592),1/107,0.2355109070084182,0.2885482158253274,0,0,3.8205621871390063,5.524525481436682,ECT2,Early Myeloid Progenitor,0.6279889749729552
KEGG_2021_Human,lipid transport (GO:0006869),1/109,0.239349173739861,0.2924667711206323,0,0,3.749433106575964,5.361058744932435,ABCA13,Early Myeloid Progenitor,0.6209680674126086
KEGG_2021_Human,regulation of interleukin-6 production (GO:0032675),1/110,0.241261218690496,0.2940170051774845,0,0,3.714847406852649,5.282048795926194,BPI,Early Myeloid Progenitor,0.6175124827423236
KEGG_2021_Human,cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.2431685532271013,0.2955532681510247,0,0,3.6808905380333954,5.20478084558139,ELANE,Early Myeloid Progenitor,0.6140925891155178
KEGG_2021_Human,protein-containing complex subunit organization (GO:0043933),1/112,0.2450711886958998,0.2970756849708919,0,0,3.647545504688362,5.129202360192396,LIN7A,Early Myeloid Progenitor,0.6107077427090284
KEGG_2021_Human,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.3008733343690057,0,0,3.582625970742279,4.982913653406146,AZU1,Early Myeloid Progenitor,0.6040407011916724
KEGG_2021_Human,cytosolic transport (GO:0016482),1/116,0.2526349665899778,0.3046284425636408,0,0,3.5199645075421473,4.8428011439058265,CLTCL1,Early Myeloid Progenitor,0.5975065399797567
KEGG_2021_Human,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.3083414535768468,0,0,3.4594453165881736,4.708511372057024,ELANE,Early Myeloid Progenitor,0.5911006880374128
KEGG_2021_Human,phosphorylation (GO:0016310),2/400,0.2642184505833435,0.3169234433506245,0,0,2.046901172529313,2.7243825855585304,DGKG;CTSG,Early Myeloid Progenitor,0.5780368585354551
KEGG_2021_Human,defense response to symbiont (GO:0140546),1/124,0.2675403902734135,0.3200679538087695,0,0,3.2896963663514187,4.337414433160371,AZU1,Early Myeloid Progenitor,0.5726106437410472
KEGG_2021_Human,circulatory system development (GO:0072359),1/126,0.2712209880572274,0.3233044319828988,0,0,3.236734693877551,4.223360488574632,PKP2,Early Myeloid Progenitor,0.5666767062328689
KEGG_2021_Human,regulation of cell migration (GO:0030334),2/408,0.2716606168083876,0.3233044319828988,0,0,2.0057471264367814,2.6138931132295458,CEACAM6;KIF14,Early Myeloid Progenitor,0.5659733175722854
KEGG_2021_Human,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.3276049775036408,0,0,3.1603954081632653,4.060453122404681,AZU1,Early Myeloid Progenitor,0.5579784037567757
KEGG_2021_Human,DNA-dependent DNA replication (GO:0006261),1/129,0.2767079241059198,0.3276049775036408,0,0,3.1603954081632653,4.060453122404681,POLE,Early Myeloid Progenitor,0.5579784037567757
KEGG_2021_Human,Golgi organization (GO:0007030),1/130,0.2785278903472666,0.328907612115506,0,0,3.135738016136687,4.008216604624779,ATP8B4,Early Myeloid Progenitor,0.5551313103019286
KEGG_2021_Human,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.3301982458859963,0,0,3.111459968602826,3.956968446025251,ECT2,Early Myeloid Progenitor,0.5523097126477655
KEGG_2021_Human,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3327439309536241,0,0,3.0640074211502784,3.857336278341556,KIF14,Early Myeloid Progenitor,0.546741450090894
KEGG_2021_Human,defense response to virus (GO:0051607),1/133,0.2839609038772722,0.3327439309536241,0,0,3.0640074211502784,3.857336278341556,AZU1,Early Myeloid Progenitor,0.546741450090894
KEGG_2021_Human,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.3373334034157502,0,0,2.99546485260771,3.714691124222948,PKP2,Early Myeloid Progenitor,0.5385707850387818
KEGG_2021_Human,organic substance transport (GO:0071702),1/136,0.289353816496661,0.3373334034157502,0,0,2.99546485260771,3.714691124222948,ABCA13,Early Myeloid Progenitor,0.5385707850387818
KEGG_2021_Human,regulation of cellular component organization (GO:0051128),1/139,0.2947069182263764,0.3426999023650229,0,0,2.929902395740905,3.579678317757992,KIF14,Early Myeloid Progenitor,0.5306096689947516
KEGG_2021_Human,regulation of small GTPase mediated signal transduction (GO:0051056),1/141,0.2982536777952956,0.345261786950886,0,0,2.8877551020408165,3.4936375609484274,ECT2,Early Myeloid Progenitor,0.5254141922968343
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),3/764,0.2984210193557987,0.345261786950886,0,0,1.6095003774428942,1.9462882878583572,CEACAM6;KIF14;SHCBP1,Early Myeloid Progenitor,0.5251705904864272
KEGG_2021_Human,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3473924713002284,0,0,2.8467950560505892,3.410594866305226,CLTCL1,Early Myeloid Progenitor,0.5203052911363482
KEGG_2021_Human,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3473924713002284,0,0,2.8467950560505892,3.410594866305226,SLC15A2,Early Myeloid Progenitor,0.5203052911363482
KEGG_2021_Human,regulation of mRNA stability (GO:0043488),1/146,0.307044282279795,0.3525608969896139,0,0,2.7874736101337088,3.291346538126983,TENT5A,Early Myeloid Progenitor,0.5127989855557247
KEGG_2021_Human,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3556699592852552,0,0,2.749271137026239,3.215201203875706,ECT2,Early Myeloid Progenitor,0.5078961191737069
KEGG_2021_Human,positive regulation of hydrolase activity (GO:0051345),1/149,0.3122667490151626,0.3558750730671554,0,0,2.7305570876999448,3.1780885451938787,ECT2,Early Myeloid Progenitor,0.5054742581266645
KEGG_2021_Human,regulation of G2/M transition of mitotic cell cycle (GO:0010389),1/149,0.3122667490151626,0.3558750730671554,0,0,2.7305570876999448,3.1780885451938787,KIF14,Early Myeloid Progenitor,0.5054742581266645
KEGG_2021_Human,brain development (GO:0007420),1/150,0.3139989845586295,0.3569590446350589,0,0,2.712094233666621,3.141596466170354,AFF2,Early Myeloid Progenitor,0.5030717563895143
KEGG_2021_Human,actin filament organization (GO:0007015),1/152,0.3174506378807152,0.3599874479193222,0,0,2.6759021489390458,3.0704182805545575,MCU,Early Myeloid Progenitor,0.4983237959237088
KEGG_2021_Human,regulation of signal transduction by p53 class mediator (GO:1901796),1/156,0.3243029619756543,0.3668476574823614,0,0,2.6063199473337724,2.934917292064671,BRIP1,Early Myeloid Progenitor,0.4890490847411261
KEGG_2021_Human,heart development (GO:0007507),1/164,0.3378059691212722,0.3811785873788183,0,0,2.4774007762614247,2.6886824434754057,PKP2,Early Myeloid Progenitor,0.4713326805982654
KEGG_2021_Human,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3877272941716035,0,0,2.4175730172308443,2.5766088705447237,ANLN,Early Myeloid Progenitor,0.46286379212748074
KEGG_2021_Human,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.3494039111808349,0.3923282245937139,0,0,2.3745498199279713,2.4969025061029213,ECT2,Early Myeloid Progenitor,0.4566722378913039
KEGG_2021_Human,positive regulation of developmental process (GO:0051094),1/177,0.359186378521905,0.4013402811357227,0,0,2.2929035250463823,2.3477357103628296,MCU,Early Myeloid Progenitor,0.44468014150624274
KEGG_2021_Human,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.359186378521905,0.4013402811357227,0,0,2.2929035250463823,2.3477357103628296,DGKG,Early Myeloid Progenitor,0.44468014150624274
KEGG_2021_Human,regulation of mitotic cell cycle (GO:0007346),1/178,0.3608027143922477,0.4021630255542859,0,0,2.279833967485299,2.3241173885161555,BUB1B,Early Myeloid Progenitor,0.44273020383203454
KEGG_2021_Human,regulation of GTPase activity (GO:0043087),1/189,0.3783208179838206,0.4206632939625451,0,0,2.1452453321754232,2.085205747179162,ECT2,Early Myeloid Progenitor,0.42213975998471215
KEGG_2021_Human,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.4231187542143291,0,0,2.122448979591837,2.045536603225051,PKP2,Early Myeloid Progenitor,0.41855670871419515
KEGG_2021_Human,negative regulation of intracellular signal transduction (GO:1902532),1/198,0.3923030921692546,0.4340980947248168,0,0,2.0463068476121413,1.914771355908193,DGKG,Early Myeloid Progenitor,0.4063782687077012
KEGG_2021_Human,endomembrane system organization (GO:0010256),1/199,0.3938375225272607,0.4347433521617346,0,0,2.03586889301175,1.897056906545971,ATP8B4,Early Myeloid Progenitor,0.4046829091978336
KEGG_2021_Human,modification-dependent protein catabolic process (GO:0019941),1/201,0.3968950010648283,0.437062687919582,0,0,2.0153061224489797,1.8623111638641865,BUB1B,Early Myeloid Progenitor,0.40132437104403956
KEGG_2021_Human,proteasomal protein catabolic process (GO:0010498),1/205,0.4029646862685204,0.442679955828639,0,0,1.975390156062425,1.7954446526222323,KIF14,Early Myeloid Progenitor,0.3947330115033212
KEGG_2021_Human,regulation of inflammatory response (GO:0050727),1/206,0.4044727291727134,0.4432710724986332,0,0,1.9656545545047288,1.7792534267442264,ELANE,Early Myeloid Progenitor,0.39311075456855427
KEGG_2021_Human,mitotic cell cycle phase transition (GO:0044772),1/209,0.4089744952578169,0.4471324027101012,0,0,1.937009419152276,1.731884932549588,POLE,Early Myeloid Progenitor,0.3883037749123832
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),1/212,0.4134429066373548,0.4509389220364467,0,0,1.909178837411742,1.6862551884518755,ELANE,Early Myeloid Progenitor,0.3835844547796231
KEGG_2021_Human,positive regulation of GTPase activity (GO:0043547),1/214,0.416403436812339,0.4520103815278835,0,0,1.8910606496119575,1.656759537391559,ECT2,Early Myeloid Progenitor,0.3804856946694876
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4520103815278835,0,0,1.8910606496119575,1.656759537391559,HS3ST5,Early Myeloid Progenitor,0.3804856946694876
KEGG_2021_Human,extracellular structure organization (GO:0043062),1/216,0.41934932166703,0.4535690447343489,0,0,1.8732795443758896,1.627975467192003,COL23A1,Early Myeloid Progenitor,0.3774240551539837
KEGG_2021_Human,external encapsulating structure organization (GO:0045229),1/217,0.4208167942393084,0.4535690447343489,0,0,1.8645124716553287,1.613843141672166,COL23A1,Early Myeloid Progenitor,0.375906936392536
KEGG_2021_Human,regulation of cell growth (GO:0001558),1/217,0.4208167942393084,0.4535690447343489,0,0,1.8645124716553287,1.613843141672166,KIF14,Early Myeloid Progenitor,0.375906936392536
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4587746926041553,0,0,1.8302411873840445,1.5589816483293069,CEACAM6,Early Myeloid Progenitor,0.3699278171231457
KEGG_2021_Human,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.462350785583194,0,0,1.805344559348403,1.519514184420898,ECT2,Early Myeloid Progenitor,0.36553500108915365
KEGG_2021_Human,inflammatory response (GO:0006954),1/230,0.4395663655385589,0.470449248363282,0,0,1.7575082434720612,1.4446130242039086,AZU1,Early Myeloid Progenitor,0.35697554604801474
KEGG_2021_Human,membrane organization (GO:0061024),1/242,0.4563449373288627,0.4872655055123604,0,0,1.6689812854602422,1.3093263562491473,CLTCL1,Early Myeloid Progenitor,0.3407067631514444
KEGG_2021_Human,positive regulation of cell differentiation (GO:0045597),1/258,0.4779525975371456,0.5091476388682414,0,0,1.563805288652426,1.154469433244659,ECT2,Early Myeloid Progenitor,0.3206151737830371
KEGG_2021_Human,regulation of protein phosphorylation (GO:0001932),1/266,0.4884385252284191,0.5191079209985756,0,0,1.5159799768964188,1.086262808220724,ECT2,Early Myeloid Progenitor,0.3111900887192418
KEGG_2021_Human,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5206487392050262,0,0,1.504471451501949,1.0700627976731167,AFF2,Early Myeloid Progenitor,0.3088941088615854
KEGG_2021_Human,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.5208078800858603,0,0,1.498781602193116,1.0620843946744252,CEACAM6,Early Myeloid Progenitor,0.30775490655057164
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5263605254971067,0,0,1.4709576138147566,1.0233666205889618,ELANE,Early Myeloid Progenitor,0.30214499188263844
KEGG_2021_Human,regulation of gene expression (GO:0010468),3/1079,0.5107084384516999,0.5377736321945319,0,0,1.1196314165941628,0.7523435208329574,PCBP3;AZU1;AFF2,Early Myeloid Progenitor,0.2918269662236996
KEGG_2021_Human,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.5397418279772489,0,0,1.4081632653061225,0.937839142501346,ECT2,Early Myeloid Progenitor,0.289240867544339
KEGG_2021_Human,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5637549296537884,0,0,1.314486450317832,0.8152139890333826,LIN7A,Early Myeloid Progenitor,0.2693393582885023
KEGG_2021_Human,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5673546824433116,0,0,1.2972062611452349,0.7932686422257892,ECT2,Early Myeloid Progenitor,0.2655801196036423
KEGG_2021_Human,positive regulation of cytokine production (GO:0001819),1/335,0.5707160845076258,0.5954731749314726,0,0,1.1985824269827692,0.6722410367689661,ELANE,Early Myeloid Progenitor,0.2435798875448389
KEGG_2021_Human,cellular response to DNA damage stimulus (GO:0006974),1/350,0.5868058377702841,0.6108662138064233,0,0,1.1461902812701013,0.6109896633619631,POLQ,Early Myeloid Progenitor,0.23150557427863594
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6318468265543594,0,0,1.0799779371207945,0.5367673309131087,AZU1,Early Myeloid Progenitor,0.21585171499242045
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6436544995358936,0,0,1.042628017264347,0.4965325169788531,AZU1,Early Myeloid Progenitor,0.20682480102083725
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.6617015068485445,0,0,0.989871879272801,0.4417939051458828,SHCBP1,Early Myeloid Progenitor,0.19383180708628664
KEGG_2021_Human,cellular protein metabolic process (GO:0044267),1/417,0.6517468120762254,0.6723437767919527,0,0,0.9583006279434853,0.41024765313154,CTSG,Early Myeloid Progenitor,0.1859210844420885
KEGG_2021_Human,organelle organization (GO:0006996),1/420,0.6544076492323022,0.6735682335566714,0,0,0.9512931664312504,0.4033718992390181,ATP8B4,Early Myeloid Progenitor,0.18415163293091988
KEGG_2021_Human,organelle assembly (GO:0070925),1/425,0.658798168385351,0.6765635122519222,0,0,0.939834424335772,0.3922286762298742,ANLN,Early Myeloid Progenitor,0.18124761694193237
KEGG_2021_Human,nervous system development (GO:0007399),1/447,0.677475806229693,0.6941848507779589,0,0,0.8924681980415484,0.3475105496336908,ECT2,Early Myeloid Progenitor,0.16910620954367267
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),1/482,0.7051444771556823,0.7193103260271134,0,0,0.8260426831855403,0.2885801301950252,AZU1,Early Myeloid Progenitor,0.1517218912312197
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7193103260271134,0,0,0.8260426831855403,0.2885801301950252,CTSG,Early Myeloid Progenitor,0.1517218912312197
KEGG_2021_Human,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7282975301622925,0,0,0.8021026592455164,0.2684686706444305,CTSG,Early Myeloid Progenitor,0.1453610219101508
KEGG_2021_Human,cellular protein modification process (GO:0006464),2/1025,0.7337546800798972,0.745168641770029,0,0,0.7708944281524927,0.2386539053000475,HS3ST5;CTSG,Early Myeloid Progenitor,0.13444911569132442
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.7598262964703112,0,0,0.726642950758285,0.2091870484536521,ECT2,Early Myeloid Progenitor,0.12502533841998253
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),1/566,0.7624057114769476,0.7708394029755864,0,0,0.700198663536211,0.1899473973942179,PIWIL4,Early Myeloid Progenitor,0.11781385888910202
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),1/621,0.7938341129137421,0.8008436856547023,0,0,0.6362738643844634,0.1469033967904298,CTSG,Early Myeloid Progenitor,0.10027024237534503
KEGG_2021_Human,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8302967905301462,0,0,0.5757014372366809,0.1108560647358729,ELANE,Early Myeloid Progenitor,0.0836269880293983
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",1/948,0.912055183209665,0.9160642169820152,0,0,0.4095209361463698,0.0376983608425212,ELANE,Early Myeloid Progenitor,0.039978884217174375
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),2/2206,0.9792407454532416,0.9813882032283584,0,0,0.3354885057471264,0.0070377963929841,BRIP1;ELANE,Early Myeloid Progenitor,0.009110524163636814
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",1/2244,0.9974129150066312,0.9974129150066312,0,0,0.1611089375562976,0.00041734259811053735,BRIP1,Early Myeloid Progenitor,0.001125012616753463
GO_Biological_Process_2021,positive regulation of ubiquitin protein ligase activity (GO:1904668),3/12,3.183301843206519e-06,0.0012287545114777,0,0,141.4255319148936,1790.1066225817303,CDC20;UBE2C;PLK1,Erythroblast,5.497122179279147
GO_Biological_Process_2021,regulation of ubiquitin protein ligase activity (GO:1904666),3/21,1.8942018936649912e-05,0.0036558096547734,0,0,70.68085106382979,768.592613095972,CDC20;UBE2C;PLK1,Erythroblast,4.722573733552538
GO_Biological_Process_2021,regulation of mitotic metaphase/anaphase transition (GO:0030071),3/26,3.6705035971544355e-05,0.0047227146283387,0,0,55.30157261794635,564.7726520715403,UBE2C;PLK1;DLGAP5,Erythroblast,4.435274345976522
GO_Biological_Process_2021,positive regulation of ubiquitin-protein transferase activity (GO:0051443),3/31,6.290143262997964e-05,0.006069988248793,0,0,45.41489361702128,439.34102944809894,CDC20;UBE2C;PLK1,Erythroblast,4.2013394630410685
GO_Biological_Process_2021,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),2/8,0.0001698630098259154,0.0131134243585606,0,0,138.5,1202.2517804391236,UBE2C;PLK1,Erythroblast,3.7699011848597213
GO_Biological_Process_2021,regulation of mitotic sister chromatid separation (GO:0010965),2/16,0.0007187392304892979,0.040137343758461,0,0,59.333333333333336,429.45537567816734,UBE2C;PLK1,Erythroblast,3.14342864967499
GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),4/178,0.0010150608236442,0.040137343758461,0,0,9.88305847076462,68.12201207380177,CDC20;UBE2C;PLK1;DLGAP5,Erythroblast,2.993507933532434
GO_Biological_Process_2021,anaphase-promoting complex-dependent catabolic process (GO:0031145),3/84,0.0012148566191106,0.040137343758461,0,0,15.657210401891254,105.10887662312086,CDC20;UBE2C;PLK1,Erythroblast,2.91547497573114
GO_Biological_Process_2021,regulation of mitotic cell cycle phase transition (GO:1901990),4/188,0.0012424779544873,0.040137343758461,0,0,9.341209829867674,62.49874259702174,CDC20;UBE2C;PLK1;HMMR,Erythroblast,2.9057113082923807
GO_Biological_Process_2021,spindle assembly checkpoint signaling (GO:0071173),2/21,0.0012477930702112,0.040137343758461,0,0,43.708333333333336,292.25047477799524,CDC20;PLK1,Erythroblast,2.9038574306125264
GO_Biological_Process_2021,mitotic spindle assembly checkpoint signaling (GO:0007094),2/21,0.0012477930702112,0.040137343758461,0,0,43.708333333333336,292.25047477799524,CDC20;PLK1,Erythroblast,2.9038574306125264
GO_Biological_Process_2021,mitotic spindle checkpoint signaling (GO:0071174),2/21,0.0012477930702112,0.040137343758461,0,0,43.708333333333336,292.25047477799524,CDC20;PLK1,Erythroblast,2.9038574306125264
GO_Biological_Process_2021,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),2/22,0.001370383663162,0.0406898533831179,0,0,41.520833333333336,273.7329252658829,CDC20;PLK1,Erythroblast,2.8631578273928713
GO_Biological_Process_2021,regulation of cell cycle phase transition (GO:1901987),3/95,0.0017310874850999,0.0477285549463284,0,0,13.777520814061054,87.61133013502065,CDC20;UBE2C;PLK1,Erythroblast,2.761680983345838
GO_Biological_Process_2021,regulation of cation transmembrane transport (GO:1904062),2/30,0.0025478771667966,0.0614675366489686,0,0,29.645833333333332,177.0595839464994,DPP10;KCNH2,Erythroblast,2.5938215131766835
GO_Biological_Process_2021,long-chain fatty acid biosynthetic process (GO:0042759),2/30,0.0025478771667966,0.0614675366489686,0,0,29.645833333333332,177.0595839464994,ALOX12B;ACSBG1,Erythroblast,2.5938215131766835
GO_Biological_Process_2021,regulation of potassium ion transport (GO:0043266),2/31,0.0027192556482504,0.0617430988367452,0,0,28.62212643678161,169.08226656127547,DPP10;KCNH2,Erythroblast,2.565549960707733
GO_Biological_Process_2021,microtubule cytoskeleton organization involved in mitosis (GO:1902850),3/128,0.0040300226589612,0.0864215970199459,0,0,10.12340425531915,55.82028180525176,CDC20;PLK1;DLGAP5,Erythroblast,2.3946925120141884
GO_Biological_Process_2021,regulation of exit from mitosis (GO:0007096),2/39,0.0042784069542198,0.0869192149646767,0,0,22.42454954954955,122.3074073504305,CDC20;UBE2C,Erythroblast,2.368717908505425
GO_Biological_Process_2021,erythrocyte differentiation (GO:0030218),2/46,0.0059097422436154,0.1140580253017778,0,0,18.85037878787879,96.72417883948356,GATA1;KLF1,Erythroblast,2.2284314606782503
GO_Biological_Process_2021,mitotic spindle organization (GO:0007052),3/157,0.0071009150987215,0.130521582290786,0,0,8.205029013539653,40.594640455474256,CDC20;PLK1;DLGAP5,Erythroblast,2.14868567991247
GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),2/52,0.007499481830469,0.1315818175709573,0,0,16.583333333333332,81.14094572244915,GATA1;KLF1,Erythroblast,2.12496874273393
GO_Biological_Process_2021,regulation of potassium ion transmembrane transport (GO:1901379),2/54,0.0080676700842631,0.1353965501098079,0,0,15.943910256410255,76.8479024006269,KCNH2;DPP10,Erythroblast,2.0932518699428635
GO_Biological_Process_2021,positive regulation of mitotic cell cycle phase transition (GO:1901992),2/58,0.0092602829393189,0.1358474540002475,0,0,14.802083333333334,69.30366021141536,UBE2C;DLGAP5,Erythroblast,2.033375743652011
GO_Biological_Process_2021,gamma-aminobutyric acid metabolic process (GO:0009448),1/5,0.0124387771927725,0.1358474540002475,0,0,101.76530612244898,446.4379351400606,GAD1,Erythroblast,1.9052223113279663
GO_Biological_Process_2021,glutamate catabolic process (GO:0006538),1/5,0.0124387771927725,0.1358474540002475,0,0,101.76530612244898,446.4379351400606,GAD1,Erythroblast,1.9052223113279663
GO_Biological_Process_2021,carbon dioxide transport (GO:0015670),1/5,0.0124387771927725,0.1358474540002475,0,0,101.76530612244898,446.4379351400606,RHAG,Erythroblast,1.9052223113279663
GO_Biological_Process_2021,catechol-containing compound biosynthetic process (GO:0009713),1/5,0.0124387771927725,0.1358474540002475,0,0,101.76530612244898,446.4379351400606,PNMT,Erythroblast,1.9052223113279663
GO_Biological_Process_2021,regulation of glycoprotein metabolic process (GO:1903018),1/5,0.0124387771927725,0.1358474540002475,0,0,101.76530612244898,446.4379351400606,GATA1,Erythroblast,1.9052223113279663
GO_Biological_Process_2021,membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),1/5,0.0124387771927725,0.1358474540002475,0,0,101.76530612244898,446.4379351400606,KCNH2,Erythroblast,1.9052223113279663
GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),3/201,0.0138618079930174,0.1358474540002475,0,0,6.367504835589942,27.24411982978463,CDC20;UBE2C;PLK1,Erythroblast,1.8581801210819526
GO_Biological_Process_2021,mitotic nuclear division (GO:0140014),2/74,0.0147525184670075,0.1358474540002475,0,0,11.50347222222222,48.50256694786101,UBE2C;PLK1,Erythroblast,1.8311338330445346
GO_Biological_Process_2021,free ubiquitin chain polymerization (GO:0010994),1/6,0.0149082847993736,0.1358474540002475,0,0,81.40816326530613,342.3895623444841,UBE2C,Erythroblast,1.8265723193247598
GO_Biological_Process_2021,cellular response to iron ion (GO:0071281),1/6,0.0149082847993736,0.1358474540002475,0,0,81.40816326530613,342.3895623444841,TFR2,Erythroblast,1.8265723193247598
GO_Biological_Process_2021,cellular response to magnesium ion (GO:0071286),1/6,0.0149082847993736,0.1358474540002475,0,0,81.40816326530613,342.3895623444841,RYR3,Erythroblast,1.8265723193247598
GO_Biological_Process_2021,protein localization to nuclear envelope (GO:0090435),1/6,0.0149082847993736,0.1358474540002475,0,0,81.40816326530613,342.3895623444841,PLK1,Erythroblast,1.8265723193247598
GO_Biological_Process_2021,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),2/79,0.0166954776383478,0.1358474540002475,0,0,10.75378787878788,44.01113934918422,CDC20;PLK1,Erythroblast,1.7774011517679502
GO_Biological_Process_2021,ammonium transport (GO:0015696),1/7,0.0173717414502839,0.1358474540002475,0,0,67.83673469387755,274.9362107684438,RHAG,Erythroblast,1.7601566430186848
GO_Biological_Process_2021,response to caffeine (GO:0031000),1/7,0.0173717414502839,0.1358474540002475,0,0,67.83673469387755,274.9362107684438,RYR3,Erythroblast,1.7601566430186848
GO_Biological_Process_2021,cellular amino acid biosynthetic process (GO:0008652),1/7,0.0173717414502839,0.1358474540002475,0,0,67.83673469387755,274.9362107684438,GAD1,Erythroblast,1.7601566430186848
GO_Biological_Process_2021,cellular ion homeostasis (GO:0006873),1/7,0.0173717414502839,0.1358474540002475,0,0,67.83673469387755,274.9362107684438,RHAG,Erythroblast,1.7601566430186848
GO_Biological_Process_2021,cellular response to caffeine (GO:0071313),1/7,0.0173717414502839,0.1358474540002475,0,0,67.83673469387755,274.9362107684438,RYR3,Erythroblast,1.7601566430186848
GO_Biological_Process_2021,iron import into cell (GO:0033212),1/7,0.0173717414502839,0.1358474540002475,0,0,67.83673469387755,274.9362107684438,TFR2,Erythroblast,1.7601566430186848
GO_Biological_Process_2021,positive regulation of synaptic plasticity (GO:0031915),1/7,0.0173717414502839,0.1358474540002475,0,0,67.83673469387755,274.9362107684438,CDC20,Erythroblast,1.7601566430186848
GO_Biological_Process_2021,regulation of potassium ion export across plasma membrane (GO:1903764),1/7,0.0173717414502839,0.1358474540002475,0,0,67.83673469387755,274.9362107684438,KCNH2,Erythroblast,1.7601566430186848
GO_Biological_Process_2021,long-chain fatty acid metabolic process (GO:0001676),2/83,0.0183241429417302,0.1358474540002475,0,0,10.22067901234568,40.877971632620635,ALOX12B;ACSBG1,Erythroblast,1.7369763290678308
GO_Biological_Process_2021,regulation of cell cycle G2/M phase transition (GO:1902749),2/85,0.0191627543313976,0.1358474540002475,0,0,9.973393574297187,39.44264488506008,PLK1;HMMR,Erythroblast,1.717542068067663
GO_Biological_Process_2021,ammonium transmembrane transport (GO:0072488),1/8,0.0198291614511851,0.1358474540002475,0,0,58.142857142857146,227.9549801512961,RHAG,Erythroblast,1.702695651141308
GO_Biological_Process_2021,positive regulation of muscle contraction (GO:0045933),1/8,0.0198291614511851,0.1358474540002475,0,0,58.142857142857146,227.9549801512961,NMU,Erythroblast,1.702695651141308
GO_Biological_Process_2021,positive regulation of peptide secretion (GO:0002793),1/8,0.0198291614511851,0.1358474540002475,0,0,58.142857142857146,227.9549801512961,TFR2,Erythroblast,1.702695651141308
GO_Biological_Process_2021,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/8,0.0198291614511851,0.1358474540002475,0,0,58.142857142857146,227.9549801512961,KCNH2,Erythroblast,1.702695651141308
GO_Biological_Process_2021,regulation of protein localization to cell cortex (GO:1904776),1/8,0.0198291614511851,0.1358474540002475,0,0,58.142857142857146,227.9549801512961,PLK1,Erythroblast,1.702695651141308
GO_Biological_Process_2021,cellular amino acid catabolic process (GO:0009063),2/90,0.0213286953840061,0.1358474540002475,0,0,9.40435606060606,36.18515879365064,GAD1;SLC25A21,Erythroblast,1.6710357083037395
GO_Biological_Process_2021,hepoxilin biosynthetic process (GO:0051122),1/9,0.0222805591236868,0.1358474540002475,0,0,50.87244897959184,193.52086993316271,ALOX12B,Erythroblast,1.652073914876897
GO_Biological_Process_2021,hepoxilin metabolic process (GO:0051121),1/9,0.0222805591236868,0.1358474540002475,0,0,50.87244897959184,193.52086993316271,ALOX12B,Erythroblast,1.652073914876897
GO_Biological_Process_2021,response to magnesium ion (GO:0032026),1/9,0.0222805591236868,0.1358474540002475,0,0,50.87244897959184,193.52086993316271,RYR3,Erythroblast,1.652073914876897
GO_Biological_Process_2021,kinetochore assembly (GO:0051382),1/9,0.0222805591236868,0.1358474540002475,0,0,50.87244897959184,193.52086993316271,DLGAP5,Erythroblast,1.652073914876897
GO_Biological_Process_2021,maintenance of apical/basal cell polarity (GO:0035090),1/9,0.0222805591236868,0.1358474540002475,0,0,50.87244897959184,193.52086993316271,ANK1,Erythroblast,1.652073914876897
GO_Biological_Process_2021,maintenance of epithelial cell apical/basal polarity (GO:0045199),1/9,0.0222805591236868,0.1358474540002475,0,0,50.87244897959184,193.52086993316271,ANK1,Erythroblast,1.652073914876897
GO_Biological_Process_2021,positive regulation of smooth muscle contraction (GO:0045987),1/9,0.0222805591236868,0.1358474540002475,0,0,50.87244897959184,193.52086993316271,NMU,Erythroblast,1.652073914876897
GO_Biological_Process_2021,positive regulation of synapse maturation (GO:0090129),1/9,0.0222805591236868,0.1358474540002475,0,0,50.87244897959184,193.52086993316271,CDC20,Erythroblast,1.652073914876897
GO_Biological_Process_2021,one-carbon compound transport (GO:0019755),1/9,0.0222805591236868,0.1358474540002475,0,0,50.87244897959184,193.52086993316271,RHAG,Erythroblast,1.652073914876897
GO_Biological_Process_2021,regulation of glycoprotein biosynthetic process (GO:0010559),1/10,0.024725948817258,0.1358474540002475,0,0,45.21768707482993,167.3010120823387,GATA1,Erythroblast,1.606847034080906
GO_Biological_Process_2021,cellular response to purine-containing compound (GO:0071415),1/10,0.024725948817258,0.1358474540002475,0,0,45.21768707482993,167.3010120823387,RYR3,Erythroblast,1.606847034080906
GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),2/102,0.0269177264019109,0.1358474540002475,0,0,8.270833333333334,29.898816321570965,PLK1;DLGAP5,Erythroblast,1.5699616254585989
GO_Biological_Process_2021,erythrocyte development (GO:0048821),1/11,0.0271653448579923,0.1358474540002475,0,0,40.69387755102041,146.73452100035948,GATA1,Erythroblast,1.5659847773237099
GO_Biological_Process_2021,regulation of synapse maturation (GO:0090128),1/11,0.0271653448579923,0.1358474540002475,0,0,40.69387755102041,146.73452100035948,CDC20,Erythroblast,1.5659847773237099
GO_Biological_Process_2021,cardiac muscle cell membrane repolarization (GO:0099622),1/11,0.0271653448579923,0.1358474540002475,0,0,40.69387755102041,146.73452100035948,KCNH2,Erythroblast,1.5659847773237099
GO_Biological_Process_2021,negative regulation of potassium ion transmembrane transport (GO:1901380),1/11,0.0271653448579923,0.1358474540002475,0,0,40.69387755102041,146.73452100035948,KCNH2,Erythroblast,1.5659847773237099
GO_Biological_Process_2021,lipoprotein biosynthetic process (GO:0042158),1/11,0.0271653448579923,0.1358474540002475,0,0,40.69387755102041,146.73452100035948,ALOX12B,Erythroblast,1.5659847773237099
GO_Biological_Process_2021,vasoconstriction (GO:0042310),1/11,0.0271653448579923,0.1358474540002475,0,0,40.69387755102041,146.73452100035948,KEL,Erythroblast,1.5659847773237099
GO_Biological_Process_2021,exit from mitosis (GO:0010458),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,UBE2C,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,gas transport (GO:0015669),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,RHAG,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,catecholamine biosynthetic process (GO:0042423),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,PNMT,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,inorganic ion transmembrane transport (GO:0098660),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,RHAG,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,DLGAP5,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,DLGAP5,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,positive regulation of mitotic sister chromatid separation (GO:1901970),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,DLGAP5,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,cellular response to thyroid hormone stimulus (GO:0097067),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,GATA1,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,lysine catabolic process (GO:0006554),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,SLC25A21,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,lysine metabolic process (GO:0006553),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,SLC25A21,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,positive regulation of protein maturation (GO:1903319),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,TFR2,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,megakaryocyte differentiation (GO:0030219),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,GATA1,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,mitotic nuclear membrane disassembly (GO:0007077),1/12,0.029598761568907,0.1358474540002475,0,0,36.99257884972171,130.2147194065139,PLK1,Erythroblast,1.5287264597194943
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),3/274,0.0310750535699626,0.1358474540002475,0,0,4.63507890398053,16.089980771839137,KCNH2;RHAG;RYR3,Erythroblast,1.5075881140099185
GO_Biological_Process_2021,response to iron ion (GO:0010039),1/13,0.032026213248763,0.1358474540002475,0,0,33.90816326530612,116.6847899929619,TFR2,Erythroblast,1.4944944088974865
GO_Biological_Process_2021,response to thyroid hormone (GO:0097066),1/13,0.032026213248763,0.1358474540002475,0,0,33.90816326530612,116.6847899929619,GATA1,Erythroblast,1.4944944088974865
GO_Biological_Process_2021,negative regulation of potassium ion transport (GO:0043267),1/13,0.032026213248763,0.1358474540002475,0,0,33.90816326530612,116.6847899929619,KCNH2,Erythroblast,1.4944944088974865
GO_Biological_Process_2021,kinetochore organization (GO:0051383),1/13,0.032026213248763,0.1358474540002475,0,0,33.90816326530612,116.6847899929619,DLGAP5,Erythroblast,1.4944944088974865
GO_Biological_Process_2021,lipid oxidation (GO:0034440),1/13,0.032026213248763,0.1358474540002475,0,0,33.90816326530612,116.6847899929619,ALOX12B,Erythroblast,1.4944944088974865
GO_Biological_Process_2021,regulation of membrane repolarization (GO:0060306),1/13,0.032026213248763,0.1358474540002475,0,0,33.90816326530612,116.6847899929619,KCNH2,Erythroblast,1.4944944088974865
GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),2/114,0.0330295301793541,0.1385085173913569,0,0,7.380208333333333,25.169117576656426,CDC20;TFR2,Erythroblast,1.4810976037825534
GO_Biological_Process_2021,nuclear membrane disassembly (GO:0051081),1/14,0.0344477141698711,0.1385085173913569,0,0,31.298273155416013,105.4223689491126,PLK1,Erythroblast,1.4628395910668823
GO_Biological_Process_2021,membrane repolarization during action potential (GO:0086011),1/14,0.0344477141698711,0.1385085173913569,0,0,31.298273155416013,105.4223689491126,KCNH2,Erythroblast,1.4628395910668823
GO_Biological_Process_2021,dicarboxylic acid catabolic process (GO:0043649),1/14,0.0344477141698711,0.1385085173913569,0,0,31.298273155416013,105.4223689491126,GAD1,Erythroblast,1.4628395910668823
GO_Biological_Process_2021,potassium ion export across plasma membrane (GO:0097623),1/14,0.0344477141698711,0.1385085173913569,0,0,31.298273155416013,105.4223689491126,KCNH2,Erythroblast,1.4628395910668823
GO_Biological_Process_2021,regulation of protein binding (GO:0043393),2/118,0.0351769550093681,0.1395022111483533,0,0,7.124281609195402,23.8475644827565,PLK1;ADD2,Erythroblast,1.4537417566881954
GO_Biological_Process_2021,catecholamine metabolic process (GO:0006584),1/15,0.0368632785936063,0.1395022111483533,0,0,29.06122448979592,95.91771596133704,PNMT,Erythroblast,1.4334060415588732
GO_Biological_Process_2021,cellular response to ATP (GO:0071318),1/15,0.0368632785936063,0.1395022111483533,0,0,29.06122448979592,95.91771596133704,RYR3,Erythroblast,1.4334060415588732
GO_Biological_Process_2021,lipoxygenase pathway (GO:0019372),1/15,0.0368632785936063,0.1395022111483533,0,0,29.06122448979592,95.91771596133704,ALOX12B,Erythroblast,1.4334060415588732
GO_Biological_Process_2021,positive regulation of secretion (GO:0051047),1/15,0.0368632785936063,0.1395022111483533,0,0,29.06122448979592,95.91771596133704,ALOX12B,Erythroblast,1.4334060415588732
GO_Biological_Process_2021,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,0.0368632785936063,0.1395022111483533,0,0,29.06122448979592,95.91771596133704,KCNH2,Erythroblast,1.4334060415588732
GO_Biological_Process_2021,fatty acid metabolic process (GO:0006631),2/124,0.038497072428768,0.1407245096497217,0,0,6.771857923497268,22.05711333941876,ALOX12B;ACSBG1,Erythroblast,1.4145722958518654
GO_Biological_Process_2021,glutamine family amino acid catabolic process (GO:0009065),1/16,0.0392729207344652,0.1407245096497217,0,0,27.122448979591837,87.80133530116419,GAD1,Erythroblast,1.405906798966597
GO_Biological_Process_2021,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.0392729207344652,0.1407245096497217,0,0,27.122448979591837,87.80133530116419,GATA1,Erythroblast,1.405906798966597
GO_Biological_Process_2021,membrane repolarization (GO:0086009),1/16,0.0392729207344652,0.1407245096497217,0,0,27.122448979591837,87.80133530116419,KCNH2,Erythroblast,1.405906798966597
GO_Biological_Process_2021,cellular biogenic amine biosynthetic process (GO:0042401),1/17,0.0416766547912334,0.1407245096497217,0,0,25.426020408163264,80.79916728086499,PNMT,Erythroblast,1.3801071472903907
GO_Biological_Process_2021,positive regulation of transcription of Notch receptor target (GO:0007221),1/17,0.0416766547912334,0.1407245096497217,0,0,25.426020408163264,80.79916728086499,DLGAP5,Erythroblast,1.3801071472903907
GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),2/131,0.0425157677463691,0.1407245096497217,0,0,6.4021317829457365,20.217165618082923,TFR2;RYR3,Erythroblast,1.3714499740612387
GO_Biological_Process_2021,negative regulation of cation transmembrane transport (GO:1904063),1/18,0.0440744949316926,0.1407245096497217,0,0,23.92917166866747,74.70385911458476,KCNH2,Erythroblast,1.3558126557645607
GO_Biological_Process_2021,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/18,0.0440744949316926,0.1407245096497217,0,0,23.92917166866747,74.70385911458476,KCNH2,Erythroblast,1.3558126557645607
GO_Biological_Process_2021,hyaluronan catabolic process (GO:0030214),1/18,0.0440744949316926,0.1407245096497217,0,0,23.92917166866747,74.70385911458476,HMMR,Erythroblast,1.3558126557645607
GO_Biological_Process_2021,cellular response to alkaloid (GO:0071312),1/18,0.0440744949316926,0.1407245096497217,0,0,23.92917166866747,74.70385911458476,RYR3,Erythroblast,1.3558126557645607
GO_Biological_Process_2021,leukocyte tethering or rolling (GO:0050901),1/18,0.0440744949316926,0.1407245096497217,0,0,23.92917166866747,74.70385911458476,ADD2,Erythroblast,1.3558126557645607
GO_Biological_Process_2021,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,0.0440744949316926,0.1407245096497217,0,0,23.92917166866747,74.70385911458476,ACSBG1,Erythroblast,1.3558126557645607
GO_Biological_Process_2021,ventricular cardiac muscle cell action potential (GO:0086005),1/18,0.0440744949316926,0.1407245096497217,0,0,23.92917166866747,74.70385911458476,KCNH2,Erythroblast,1.3558126557645607
GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),2/136,0.0454786698217006,0.1407245096497217,0,0,6.161691542288557,19.042780777221537,DPP10;ANK1,Erythroblast,1.3421922462170102
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),3/321,0.0461628825953757,0.1407245096497217,0,0,3.940586109995986,12.119584718370708,CDC20;UBE2C;PLK1,Erythroblast,1.3357070799177986
GO_Biological_Process_2021,actin filament capping (GO:0051693),1/19,0.0464664552952436,0.1407245096497217,0,0,22.598639455782312,69.35578082800635,ADD2,Erythroblast,1.3328604565168853
GO_Biological_Process_2021,establishment of skin barrier (GO:0061436),1/19,0.0464664552952436,0.1407245096497217,0,0,22.598639455782312,69.35578082800635,ALOX12B,Erythroblast,1.3328604565168853
GO_Biological_Process_2021,aspartate family amino acid catabolic process (GO:0009068),1/19,0.0464664552952436,0.1407245096497217,0,0,22.598639455782312,69.35578082800635,SLC25A21,Erythroblast,1.3328604565168853
GO_Biological_Process_2021,barbed-end actin filament capping (GO:0051016),1/19,0.0464664552952436,0.1407245096497217,0,0,22.598639455782312,69.35578082800635,ADD2,Erythroblast,1.3328604565168853
GO_Biological_Process_2021,regulation of water loss via skin (GO:0033561),1/19,0.0464664552952436,0.1407245096497217,0,0,22.598639455782312,69.35578082800635,ALOX12B,Erythroblast,1.3328604565168853
GO_Biological_Process_2021,response to ATP (GO:0033198),1/19,0.0464664552952436,0.1407245096497217,0,0,22.598639455782312,69.35578082800635,RYR3,Erythroblast,1.3328604565168853
GO_Biological_Process_2021,leukocyte adhesion to vascular endothelial cell (GO:0061756),1/19,0.0464664552952436,0.1407245096497217,0,0,22.598639455782312,69.35578082800635,ADD2,Erythroblast,1.3328604565168853
GO_Biological_Process_2021,nuclear membrane organization (GO:0071763),1/19,0.0464664552952436,0.1407245096497217,0,0,22.598639455782312,69.35578082800635,PLK1,Erythroblast,1.3328604565168853
GO_Biological_Process_2021,regulation of mitotic spindle assembly (GO:1901673),1/19,0.0464664552952436,0.1407245096497217,0,0,22.598639455782312,69.35578082800635,PLK1,Erythroblast,1.3328604565168853
GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),2/140,0.0479026862337682,0.1407245096497217,0,0,5.981884057971015,18.176455370515885,DPP10;ANK1,Erythroblast,1.319640132017756
GO_Biological_Process_2021,regulation of smooth muscle contraction (GO:0006940),1/20,0.0488525499820277,0.1407245096497217,0,0,21.40816326530612,64.63014669364038,NMU,Erythroblast,1.3111127622579986
GO_Biological_Process_2021,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/20,0.0488525499820277,0.1407245096497217,0,0,21.40816326530612,64.63014669364038,PLK1,Erythroblast,1.3111127622579986
GO_Biological_Process_2021,granulocyte differentiation (GO:0030851),1/20,0.0488525499820277,0.1407245096497217,0,0,21.40816326530612,64.63014669364038,GATA1,Erythroblast,1.3111127622579986
GO_Biological_Process_2021,positive regulation of hormone secretion (GO:0046887),1/20,0.0488525499820277,0.1407245096497217,0,0,21.40816326530612,64.63014669364038,TFR2,Erythroblast,1.3111127622579986
GO_Biological_Process_2021,myeloid cell development (GO:0061515),1/20,0.0488525499820277,0.1407245096497217,0,0,21.40816326530612,64.63014669364038,GATA1,Erythroblast,1.3111127622579986
GO_Biological_Process_2021,regulation of protein localization to cell periphery (GO:1904375),1/20,0.0488525499820277,0.1407245096497217,0,0,21.40816326530612,64.63014669364038,PLK1,Erythroblast,1.3111127622579986
GO_Biological_Process_2021,hydrogen peroxide catabolic process (GO:0042744),1/21,0.0512327930672156,0.1443493293718629,0,0,20.336734693877553,60.42807445408675,HBD,Erythroblast,1.2904519669693806
GO_Biological_Process_2021,linoleic acid metabolic process (GO:0043651),1/21,0.0512327930672156,0.1443493293718629,0,0,20.336734693877553,60.42807445408675,ALOX12B,Erythroblast,1.2904519669693806
GO_Biological_Process_2021,protein localization to chromatin (GO:0071168),1/21,0.0512327930672156,0.1443493293718629,0,0,20.336734693877553,60.42807445408675,PLK1,Erythroblast,1.2904519669693806
GO_Biological_Process_2021,regulation of G2/M transition of mitotic cell cycle (GO:0010389),2/149,0.0535249876216422,0.1457209764740306,0,0,5.613095238095238,16.432935090777736,PLK1;HMMR,Erythroblast,1.271443424469827
GO_Biological_Process_2021,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/22,0.0536071985992547,0.1457209764740306,0,0,19.367346938775512,56.67024999786951,PLK1,Erythroblast,1.2707768875084013
GO_Biological_Process_2021,glutamate metabolic process (GO:0006536),1/22,0.0536071985992547,0.1457209764740306,0,0,19.367346938775512,56.67024999786951,GAD1,Erythroblast,1.2707768875084013
GO_Biological_Process_2021,regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.0536071985992547,0.1457209764740306,0,0,19.367346938775512,56.67024999786951,KCNH2,Erythroblast,1.2707768875084013
GO_Biological_Process_2021,membrane lipid metabolic process (GO:0006643),1/22,0.0536071985992547,0.1457209764740306,0,0,19.367346938775512,56.67024999786951,ALOX12B,Erythroblast,1.2707768875084013
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.0559757805878795,0.1490113883235965,0,0,18.4860853432282,53.29235549319145,GATA1,Erythroblast,1.2519998414265567
GO_Biological_Process_2021,hyaluronan metabolic process (GO:0030212),1/23,0.0559757805878795,0.1490113883235965,0,0,18.4860853432282,53.29235549319145,HMMR,Erythroblast,1.2519998414265567
GO_Biological_Process_2021,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.0559757805878795,0.1490113883235965,0,0,18.4860853432282,53.29235549319145,GATA1,Erythroblast,1.2519998414265567
GO_Biological_Process_2021,establishment of mitotic spindle orientation (GO:0000132),1/24,0.0583385530130099,0.1497084326936618,0,0,17.68145519077196,50.24171555062859,PLK1,Erythroblast,1.2340443470047993
GO_Biological_Process_2021,glucose catabolic process to pyruvate (GO:0061718),1/24,0.0583385530130099,0.1497084326936618,0,0,17.68145519077196,50.24171555062859,PKLR,Erythroblast,1.2340443470047993
GO_Biological_Process_2021,canonical glycolysis (GO:0061621),1/24,0.0583385530130099,0.1497084326936618,0,0,17.68145519077196,50.24171555062859,PKLR,Erythroblast,1.2340443470047993
GO_Biological_Process_2021,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/24,0.0583385530130099,0.1497084326936618,0,0,17.68145519077196,50.24171555062859,ACSBG1,Erythroblast,1.2340443470047993
GO_Biological_Process_2021,potassium ion homeostasis (GO:0055075),1/24,0.0583385530130099,0.1497084326936618,0,0,17.68145519077196,50.24171555062859,KCNH2,Erythroblast,1.2340443470047993
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),3/354,0.0585646977635827,0.1497084326936618,0,0,3.5641025641025643,10.113580091620108,CDC20;UBE2C;PLK1,Erythroblast,1.232364093647559
GO_Biological_Process_2021,regulation of spindle assembly (GO:0090169),1/25,0.0606955298241754,0.1511514484653658,0,0,16.943877551020407,47.47480020477031,PLK1,Erythroblast,1.2168432931781568
GO_Biological_Process_2021,glycolytic process through glucose-6-phosphate (GO:0061620),1/25,0.0606955298241754,0.1511514484653658,0,0,16.943877551020407,47.47480020477031,PKLR,Erythroblast,1.2168432931781568
GO_Biological_Process_2021,negative regulation of sequestering of calcium ion (GO:0051283),1/25,0.0606955298241754,0.1511514484653658,0,0,16.943877551020407,47.47480020477031,RYR3,Erythroblast,1.2168432931781568
GO_Biological_Process_2021,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/25,0.0606955298241754,0.1511514484653658,0,0,16.943877551020407,47.47480020477031,PLK1,Erythroblast,1.2168432931781568
GO_Biological_Process_2021,cellular response to drug (GO:0035690),1/26,0.0630467249540435,0.1550065976577121,0,0,16.26530612244898,44.95534064809558,KCNH2,Erythroblast,1.2003374685092782
GO_Biological_Process_2021,membrane depolarization during action potential (GO:0086010),1/26,0.0630467249540435,0.1550065976577121,0,0,16.26530612244898,44.95534064809558,KCNH2,Erythroblast,1.2003374685092782
GO_Biological_Process_2021,regulation of transcription regulatory region DNA binding (GO:2000677),1/27,0.0653921522588676,0.1558109306908821,0,0,15.638932496075354,42.652889831563165,GATA1,Erythroblast,1.184474368421492
GO_Biological_Process_2021,positive regulation of erythrocyte differentiation (GO:0045648),1/27,0.0653921522588676,0.1558109306908821,0,0,15.638932496075354,42.652889831563165,GATA1,Erythroblast,1.184474368421492
GO_Biological_Process_2021,release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.0653921522588676,0.1558109306908821,0,0,15.638932496075354,42.652889831563165,RYR3,Erythroblast,1.184474368421492
GO_Biological_Process_2021,mitotic chromosome condensation (GO:0007076),1/27,0.0653921522588676,0.1558109306908821,0,0,15.638932496075354,42.652889831563165,PLK1,Erythroblast,1.184474368421492
GO_Biological_Process_2021,monovalent inorganic cation homeostasis (GO:0055067),1/27,0.0653921522588676,0.1558109306908821,0,0,15.638932496075354,42.652889831563165,KCNH2,Erythroblast,1.184474368421492
GO_Biological_Process_2021,positive regulation of cell communication (GO:0010647),1/28,0.0677318256109869,0.1581601339834073,0,0,15.058956916099774,40.54171043527237,NMU,Erythroblast,1.1692072184717057
GO_Biological_Process_2021,bile acid and bile salt transport (GO:0015721),1/28,0.0677318256109869,0.1581601339834073,0,0,15.058956916099774,40.54171043527237,SLC10A4,Erythroblast,1.1692072184717057
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.0677318256109869,0.1581601339834073,0,0,15.058956916099774,40.54171043527237,GATA1,Erythroblast,1.1692072184717057
GO_Biological_Process_2021,establishment of mitotic spindle localization (GO:0040001),1/29,0.0700657588372089,0.1581601339834073,0,0,14.520408163265309,38.5999069065122,PLK1,Erythroblast,1.1544941700666143
GO_Biological_Process_2021,regulation of ubiquitin-protein transferase activity (GO:0051438),1/29,0.0700657588372089,0.1581601339834073,0,0,14.520408163265309,38.5999069065122,PLK1,Erythroblast,1.1544941700666143
GO_Biological_Process_2021,glycolytic process (GO:0006096),1/29,0.0700657588372089,0.1581601339834073,0,0,14.520408163265309,38.5999069065122,PKLR,Erythroblast,1.1544941700666143
GO_Biological_Process_2021,hydrogen peroxide metabolic process (GO:0042743),1/29,0.0700657588372089,0.1581601339834073,0,0,14.520408163265309,38.5999069065122,HBD,Erythroblast,1.1544941700666143
GO_Biological_Process_2021,transition metal ion homeostasis (GO:0055076),1/29,0.0700657588372089,0.1581601339834073,0,0,14.520408163265309,38.5999069065122,TFR2,Erythroblast,1.1544941700666143
GO_Biological_Process_2021,protein K11-linked ubiquitination (GO:0070979),1/29,0.0700657588372089,0.1581601339834073,0,0,14.520408163265309,38.5999069065122,UBE2C,Erythroblast,1.1544941700666143
GO_Biological_Process_2021,establishment of spindle orientation (GO:0051294),1/30,0.0723939657090184,0.159680404363892,0,0,14.019000703729768,36.80874147674154,PLK1,Erythroblast,1.1402976322627019
GO_Biological_Process_2021,fatty-acyl-CoA biosynthetic process (GO:0046949),1/30,0.0723939657090184,0.159680404363892,0,0,14.019000703729768,36.80874147674154,ACSBG1,Erythroblast,1.1402976322627019
GO_Biological_Process_2021,cardiac muscle cell action potential (GO:0086001),1/30,0.0723939657090184,0.159680404363892,0,0,14.019000703729768,36.80874147674154,KCNH2,Erythroblast,1.1402976322627019
GO_Biological_Process_2021,ion homeostasis (GO:0050801),1/30,0.0723939657090184,0.159680404363892,0,0,14.019000703729768,36.80874147674154,RHAG,Erythroblast,1.1402976322627019
GO_Biological_Process_2021,negative regulation of DNA binding (GO:0043392),1/31,0.0747164600026276,0.162940980570702,0,0,13.551020408163266,35.15209038871121,GATA1,Erythroblast,1.126583712764908
GO_Biological_Process_2021,cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.0747164600026276,0.162940980570702,0,0,13.551020408163266,35.15209038871121,KCNH2,Erythroblast,1.126583712764908
GO_Biological_Process_2021,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/32,0.0770332554327668,0.1651935366502667,0,0,13.113232389730086,33.61600807740255,ANK1,Erythroblast,1.1133217484244988
GO_Biological_Process_2021,membrane depolarization (GO:0051899),1/32,0.0770332554327668,0.1651935366502667,0,0,13.113232389730086,33.61600807740255,KCNH2,Erythroblast,1.1133217484244988
GO_Biological_Process_2021,metal ion export (GO:0070839),1/32,0.0770332554327668,0.1651935366502667,0,0,13.113232389730086,33.61600807740255,KCNH2,Erythroblast,1.1133217484244988
GO_Biological_Process_2021,actin filament bundle assembly (GO:0051017),1/33,0.0793443657059371,0.1664506802309333,0,0,12.70280612244898,32.18837516559274,ADD2,Erythroblast,1.1004839073426347
GO_Biological_Process_2021,actin filament bundle organization (GO:0061572),1/33,0.0793443657059371,0.1664506802309333,0,0,12.70280612244898,32.18837516559274,ADD2,Erythroblast,1.1004839073426347
GO_Biological_Process_2021,mitotic G2 DNA damage checkpoint signaling (GO:0007095),1/33,0.0793443657059371,0.1664506802309333,0,0,12.70280612244898,32.18837516559274,PLK1,Erythroblast,1.1004839073426347
GO_Biological_Process_2021,very long-chain fatty acid metabolic process (GO:0000038),1/33,0.0793443657059371,0.1664506802309333,0,0,12.70280612244898,32.18837516559274,ACSBG1,Erythroblast,1.1004839073426347
GO_Biological_Process_2021,cardiac muscle contraction (GO:0060048),1/34,0.0816498044624026,0.1676426836302521,0,0,12.317254174397032,30.85861216573232,KCNH2,Erythroblast,1.0880448509885652
GO_Biological_Process_2021,sister chromatid segregation (GO:0000819),1/34,0.0816498044624026,0.1676426836302521,0,0,12.317254174397032,30.85861216573232,PLK1,Erythroblast,1.0880448509885652
GO_Biological_Process_2021,protein destabilization (GO:0031648),1/34,0.0816498044624026,0.1676426836302521,0,0,12.317254174397032,30.85861216573232,PLK1,Erythroblast,1.0880448509885652
GO_Biological_Process_2021,protein localization to chromosome (GO:0034502),1/34,0.0816498044624026,0.1676426836302521,0,0,12.317254174397032,30.85861216573232,PLK1,Erythroblast,1.0880448509885652
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),3/409,0.0823373314361704,0.1678991707225875,0,0,3.0726338958180484,7.672153819056269,UBE2C;PLK1;RNF182,Erythroblast,1.0844032126521876
GO_Biological_Process_2021,bicarbonate transport (GO:0015701),1/35,0.0839495853612937,0.1678991707225875,0,0,11.95438175270108,29.61744503578088,RHAG,Erythroblast,1.0759814445616303
GO_Biological_Process_2021,blood vessel diameter maintenance (GO:0097746),1/35,0.0839495853612937,0.1678991707225875,0,0,11.95438175270108,29.61744503578088,KEL,Erythroblast,1.0759814445616303
GO_Biological_Process_2021,regulation of ion transmembrane transport (GO:0034765),1/35,0.0839495853612937,0.1678991707225875,0,0,11.95438175270108,29.61744503578088,KCNH2,Erythroblast,1.0759814445616303
GO_Biological_Process_2021,regulation of mitotic spindle organization (GO:0060236),1/35,0.0839495853612937,0.1678991707225875,0,0,11.95438175270108,29.61744503578088,PLK1,Erythroblast,1.0759814445616303
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),2/195,0.0854831524975729,0.1681317004145592,0,0,4.265328151986183,10.490301477724982,DPP10;ANK1,Erythroblast,1.0681194700473418
GO_Biological_Process_2021,positive regulation of mitotic nuclear division (GO:0045840),1/36,0.0862437219743075,0.1681317004145592,0,0,11.612244897959185,28.456712045041098,DLGAP5,Erythroblast,1.0642725091375862
GO_Biological_Process_2021,transferrin transport (GO:0033572),1/36,0.0862437219743075,0.1681317004145592,0,0,11.612244897959185,28.456712045041098,TFR2,Erythroblast,1.0642725091375862
GO_Biological_Process_2021,transition metal ion transport (GO:0000041),1/36,0.0862437219743075,0.1681317004145592,0,0,11.612244897959185,28.456712045041098,TFR2,Erythroblast,1.0642725091375862
GO_Biological_Process_2021,platelet aggregation (GO:0070527),1/36,0.0862437219743075,0.1681317004145592,0,0,11.612244897959185,28.456712045041098,GATA1,Erythroblast,1.0642725091375862
GO_Biological_Process_2021,regulation of erythrocyte differentiation (GO:0045646),1/37,0.0885322278902676,0.1700171142569319,0,0,11.289115646258503,27.36920368672352,GATA1,Erythroblast,1.0528986067362665
GO_Biological_Process_2021,positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.0885322278902676,0.1700171142569319,0,0,11.289115646258503,27.36920368672352,GATA1,Erythroblast,1.0528986067362665
GO_Biological_Process_2021,centromere complex assembly (GO:0034508),1/37,0.0885322278902676,0.1700171142569319,0,0,11.289115646258503,27.36920368672352,DLGAP5,Erythroblast,1.0528986067362665
GO_Biological_Process_2021,positive regulation of potassium ion transport (GO:0043268),1/38,0.0908151166313484,0.1726829311315296,0,0,10.983452840595698,26.34852930034076,KCNH2,Erythroblast,1.0418418549683985
GO_Biological_Process_2021,positive regulation of signaling (GO:0023056),1/38,0.0908151166313484,0.1726829311315296,0,0,10.983452840595698,26.34852930034076,NMU,Erythroblast,1.0418418549683985
GO_Biological_Process_2021,regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.0930924017046572,0.1752861807707204,0,0,10.693877551020408,25.38900533231373,KCNH2,Erythroblast,1.0310857651239858
GO_Biological_Process_2021,regulation of peptidyl-threonine phosphorylation (GO:0010799),1/39,0.0930924017046572,0.1752861807707204,0,0,10.693877551020408,25.38900533231373,PLK1,Erythroblast,1.0310857651239858
GO_Biological_Process_2021,organic hydroxy compound transport (GO:0015850),1/40,0.0953640965755271,0.1786031415560214,0,0,10.419152276295131,24.485561288951835,SLC10A4,Erythroblast,1.0206151011238414
GO_Biological_Process_2021,mitotic cell cycle phase transition (GO:0044772),2/209,0.0961284696354655,0.1786031415560214,0,0,3.9740338164251208,9.30746441383207,UBE2C;PLK1,Erythroblast,1.0171479715978702
GO_Biological_Process_2021,positive regulation of cation transmembrane transport (GO:1904064),1/41,0.0976302146847681,0.1786031415560214,0,0,10.158163265306122,23.633660200289185,KCNH2,Erythroblast,1.0104157556925017
GO_Biological_Process_2021,heart contraction (GO:0060047),1/41,0.0976302146847681,0.1786031415560214,0,0,10.158163265306122,23.633660200289185,KCNH2,Erythroblast,1.0104157556925017
GO_Biological_Process_2021,carbohydrate catabolic process (GO:0016052),1/41,0.0976302146847681,0.1786031415560214,0,0,10.158163265306122,23.633660200289185,PKLR,Erythroblast,1.0104157556925017
GO_Biological_Process_2021,carboxylic acid transmembrane transport (GO:1905039),1/41,0.0976302146847681,0.1786031415560214,0,0,10.158163265306122,23.633660200289185,SLC25A21,Erythroblast,1.0104157556925017
GO_Biological_Process_2021,calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.0998907694703361,0.1798953731759116,0,0,9.909905425584869,22.829231064333683,RYR3,Erythroblast,1.00047464143678
GO_Biological_Process_2021,ceramide biosynthetic process (GO:0046513),1/42,0.0998907694703361,0.1798953731759116,0,0,9.909905425584869,22.829231064333683,ALOX12B,Erythroblast,1.00047464143678
GO_Biological_Process_2021,potassium ion import across plasma membrane (GO:1990573),1/42,0.0998907694703361,0.1798953731759116,0,0,9.909905425584869,22.829231064333683,KCNH2,Erythroblast,1.00047464143678
GO_Biological_Process_2021,signal release from synapse (GO:0099643),1/43,0.1021457742794159,0.1798953731759116,0,0,9.673469387755102,22.068611238785657,GAD1,Erythroblast,0.9907795952096249
GO_Biological_Process_2021,positive regulation of peptide hormone secretion (GO:0090277),1/43,0.1021457742794159,0.1798953731759116,0,0,9.673469387755102,22.068611238785657,TFR2,Erythroblast,0.9907795952096249
GO_Biological_Process_2021,lipid modification (GO:0030258),1/43,0.1021457742794159,0.1798953731759116,0,0,9.673469387755102,22.068611238785657,ALOX12B,Erythroblast,0.9907795952096249
GO_Biological_Process_2021,male gonad development (GO:0008584),1/43,0.1021457742794159,0.1798953731759116,0,0,9.673469387755102,22.068611238785657,GATA1,Erythroblast,0.9907795952096249
GO_Biological_Process_2021,development of primary male sexual characteristics (GO:0046546),1/43,0.1021457742794159,0.1798953731759116,0,0,9.673469387755102,22.068611238785657,GATA1,Erythroblast,0.9907795952096249
GO_Biological_Process_2021,cation transmembrane transport (GO:0098655),1/44,0.1043952424647777,0.1798953731759116,0,0,9.448030374940672,21.34849709415977,RHAG,Erythroblast,0.9813192926974915
GO_Biological_Process_2021,homotypic cell-cell adhesion (GO:0034109),1/44,0.1043952424647777,0.1798953731759116,0,0,9.448030374940672,21.34849709415977,GATA1,Erythroblast,0.9813192926974915
GO_Biological_Process_2021,positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.1043952424647777,0.1798953731759116,0,0,9.448030374940672,21.34849709415977,KCNH2,Erythroblast,0.9813192926974915
GO_Biological_Process_2021,neurotransmitter secretion (GO:0007269),1/44,0.1043952424647777,0.1798953731759116,0,0,9.448030374940672,21.34849709415977,GAD1,Erythroblast,0.9813192926974915
GO_Biological_Process_2021,metal ion homeostasis (GO:0055065),1/44,0.1043952424647777,0.1798953731759116,0,0,9.448030374940672,21.34849709415977,KCNH2,Erythroblast,0.9813192926974915
GO_Biological_Process_2021,action potential (GO:0001508),1/45,0.1066391873529346,0.1805382733255823,0,0,9.232838589981448,20.665901611884028,KCNH2,Erythroblast,0.9720831731354668
GO_Biological_Process_2021,chromosome condensation (GO:0030261),1/45,0.1066391873529346,0.1805382733255823,0,0,9.232838589981448,20.665901611884028,PLK1,Erythroblast,0.9720831731354668
GO_Biological_Process_2021,microtubule bundle formation (GO:0001578),1/45,0.1066391873529346,0.1805382733255823,0,0,9.232838589981448,20.665901611884028,PLK1,Erythroblast,0.9720831731354668
GO_Biological_Process_2021,mitotic G2/M transition checkpoint (GO:0044818),1/45,0.1066391873529346,0.1805382733255823,0,0,9.232838589981448,20.665901611884028,PLK1,Erythroblast,0.9720831731354668
GO_Biological_Process_2021,regulation of protein localization to nucleus (GO:1900180),1/47,0.1111105603036554,0.1872867959703537,0,0,8.830523513753327,19.4026870705364,PLK1,Erythroblast,0.9542446623584087
GO_Biological_Process_2021,positive regulation of endocytosis (GO:0045807),1/48,0.1133380148369131,0.1893873321517249,0,0,8.642205818497612,18.81737166641443,TFR2,Erythroblast,0.9456243984787533
GO_Biological_Process_2021,myelination (GO:0042552),1/48,0.1133380148369131,0.1893873321517249,0,0,8.642205818497612,18.81737166641443,ACSBG1,Erythroblast,0.9456243984787533
GO_Biological_Process_2021,mitotic cytokinesis (GO:0000281),1/49,0.1155599990222406,0.1922679294076935,0,0,8.46173469387755,18.260130793597916,PLK1,Erythroblast,0.9371924705024297
GO_Biological_Process_2021,iron ion transport (GO:0006826),1/50,0.1177765260040411,0.1951147598178534,0,0,8.28862973760933,17.7290996615035,TFR2,Erythroblast,0.928941259997044
GO_Biological_Process_2021,gonad development (GO:0008406),1/51,0.1199876089220907,0.1979282779655001,0,0,8.122448979591837,17.22257115519733,GATA1,Erythroblast,0.9208636010741894
GO_Biological_Process_2021,amide biosynthetic process (GO:0043604),1/52,0.1221932608707862,0.1981789861181659,0,0,7.962785114045619,16.738979733033663,ALOX12B,Erythroblast,0.9129527453809976
GO_Biological_Process_2021,positive regulation of protein localization to cell periphery (GO:1904377),1/52,0.1221932608707862,0.1981789861181659,0,0,7.962785114045619,16.738979733033663,DPP10,Erythroblast,0.9129527453809976
GO_Biological_Process_2021,positive regulation of protein localization to plasma membrane (GO:1903078),1/52,0.1221932608707862,0.1981789861181659,0,0,7.962785114045619,16.738979733033663,DPP10,Erythroblast,0.9129527453809976
GO_Biological_Process_2021,protein homotetramerization (GO:0051289),1/52,0.1221932608707862,0.1981789861181659,0,0,7.962785114045619,16.738979733033663,RYR3,Erythroblast,0.9129527453809976
GO_Biological_Process_2021,regulation of proteolysis (GO:0030162),1/54,0.1265883240687765,0.2019136078121806,0,0,7.661532537543319,15.834970375184442,PLK1,Erythroblast,0.8976063498190403
GO_Biological_Process_2021,striated muscle contraction (GO:0006941),1/54,0.1265883240687765,0.2019136078121806,0,0,7.661532537543319,15.834970375184442,KCNH2,Erythroblast,0.8976063498190403
GO_Biological_Process_2021,regulation of megakaryocyte differentiation (GO:0045652),1/54,0.1265883240687765,0.2019136078121806,0,0,7.661532537543319,15.834970375184442,GATA1,Erythroblast,0.8976063498190403
GO_Biological_Process_2021,unsaturated fatty acid metabolic process (GO:0033559),1/54,0.1265883240687765,0.2019136078121806,0,0,7.661532537543319,15.834970375184442,ALOX12B,Erythroblast,0.8976063498190403
GO_Biological_Process_2021,pyruvate metabolic process (GO:0006090),1/55,0.1287777613922166,0.202890677132227,0,0,7.519274376417234,15.412009607623004,PKLR,Erythroblast,0.8901591287349465
GO_Biological_Process_2021,regulation of cardiac conduction (GO:1903779),1/55,0.1287777613922166,0.202890677132227,0,0,7.519274376417234,15.412009607623004,RYR3,Erythroblast,0.8901591287349465
GO_Biological_Process_2021,ceramide metabolic process (GO:0006672),1/55,0.1287777613922166,0.202890677132227,0,0,7.519274376417234,15.412009607623004,ALOX12B,Erythroblast,0.8901591287349465
GO_Biological_Process_2021,glycosaminoglycan catabolic process (GO:0006027),1/56,0.1309618198144747,0.2047499511637083,0,0,7.382189239332097,15.00687933540933,HMMR,Erythroblast,0.8828552987007785
GO_Biological_Process_2021,arachidonic acid metabolic process (GO:0019369),1/57,0.1331405122852093,0.2047499511637083,0,0,7.25,14.618539131965724,ALOX12B,Erythroblast,0.8756897763447542
GO_Biological_Process_2021,icosanoid metabolic process (GO:0006690),1/57,0.1331405122852093,0.2047499511637083,0,0,7.25,14.618539131965724,ALOX12B,Erythroblast,0.8756897763447542
GO_Biological_Process_2021,positive regulation of proteolysis (GO:0045862),1/57,0.1331405122852093,0.2047499511637083,0,0,7.25,14.618539131965724,PLK1,Erythroblast,0.8756897763447542
GO_Biological_Process_2021,monocarboxylic acid transport (GO:0015718),1/57,0.1331405122852093,0.2047499511637083,0,0,7.25,14.618539131965724,SLC10A4,Erythroblast,0.8756897763447542
GO_Biological_Process_2021,protein K48-linked ubiquitination (GO:0070936),1/57,0.1331405122852093,0.2047499511637083,0,0,7.25,14.618539131965724,UBE2C,Erythroblast,0.8756897763447542
GO_Biological_Process_2021,cellular iron ion homeostasis (GO:0006879),1/58,0.1353138517398134,0.2057147837159536,0,0,7.122448979591836,14.246025949065045,TFR2,Erythroblast,0.8686577434892403
GO_Biological_Process_2021,positive regulation of protein binding (GO:0032092),1/58,0.1353138517398134,0.2057147837159536,0,0,7.122448979591836,14.246025949065045,ADD2,Erythroblast,0.8686577434892403
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.1353667229633477,0.2057147837159536,0,0,2.442871502764282,4.885175568190959,KCNH2;GATA1;KLF1,Erythroblast,0.8684880846140173
GO_Biological_Process_2021,protein polymerization (GO:0051258),1/59,0.1374818510452552,0.2072968535291738,0,0,6.9992962702322306,13.8884471557023,UBE2C,Erythroblast,0.8617546291873563
GO_Biological_Process_2021,mitotic DNA damage checkpoint signaling (GO:0044773),1/59,0.1374818510452552,0.2072968535291738,0,0,6.9992962702322306,13.8884471557023,PLK1,Erythroblast,0.8617546291873563
GO_Biological_Process_2021,Notch signaling pathway (GO:0007219),1/60,0.1396445230534406,0.2097384665316267,0,0,6.88031822898651,13.544974303558986,DLGAP5,Erythroblast,0.8549760929333525
GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.2105212534953717,0,0,6.76530612244898,13.214837540593155,TFR2,Erythroblast,0.848318009451734
GO_Biological_Process_2021,iron ion homeostasis (GO:0055072),1/61,0.1418018805927374,0.2105212534953717,0,0,6.76530612244898,13.214837540593155,TFR2,Erythroblast,0.848318009451734
GO_Biological_Process_2021,protein lipidation (GO:0006497),1/61,0.1418018805927374,0.2105212534953717,0,0,6.76530612244898,13.214837540593155,ALOX12B,Erythroblast,0.848318009451734
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),3/525,0.1434153792783945,0.2121009057527214,0,0,2.375641966250917,4.613520714200694,UBE2C;PLK1;RNF182,Erythroblast,0.8434042742079119
GO_Biological_Process_2021,neuropeptide signaling pathway (GO:0007218),1/63,0.1461007034145454,0.2152476012137958,0,0,6.54641211323239,12.591756250239603,NMU,Erythroblast,0.8353476931121088
GO_Biological_Process_2021,anion transmembrane transport (GO:0098656),1/67,0.1546351363099914,0.2269549909340558,0,0,6.148423005565863,11.477180657220888,SLC25A21,Erythroblast,0.8106918184915987
GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.1567556490806558,0.2283308699816345,0,0,6.0563508985683825,11.222824361971773,PLK1,Erythroblast,0.8047767993307415
GO_Biological_Process_2021,regulation of myeloid cell differentiation (GO:0045637),1/68,0.1567556490806558,0.2283308699816345,0,0,6.0563508985683825,11.222824361971773,GATA1,Erythroblast,0.8047767993307415
GO_Biological_Process_2021,cellular response to calcium ion (GO:0071277),1/69,0.158870948881139,0.2305420536395476,0,0,5.966986794717887,10.977245117600177,RYR3,Erythroblast,0.7989555105590889
GO_Biological_Process_2021,proteolysis (GO:0006508),2/287,0.1610530437699783,0.2314381635380172,0,0,2.875,5.249811823566885,KEL;CTSE,Erythroblast,0.7930310629584509
GO_Biological_Process_2021,protein tetramerization (GO:0051262),1/71,0.16308595979881,0.2314381635380172,0,0,5.795918367346939,10.51076961698872,RYR3,Erythroblast,0.7875834261109624
GO_Biological_Process_2021,fatty acid biosynthetic process (GO:0006633),1/71,0.16308595979881,0.2314381635380172,0,0,5.795918367346939,10.51076961698872,ACSBG1,Erythroblast,0.7875834261109624
GO_Biological_Process_2021,positive regulation of cellular protein localization (GO:1903829),1/71,0.16308595979881,0.2314381635380172,0,0,5.795918367346939,10.51076961698872,PLK1,Erythroblast,0.7875834261109624
GO_Biological_Process_2021,response to metal ion (GO:0010038),1/71,0.16308595979881,0.2314381635380172,0,0,5.795918367346939,10.51076961698872,TFR2,Erythroblast,0.7875834261109624
GO_Biological_Process_2021,regulation of hematopoietic stem cell differentiation (GO:1902036),1/71,0.16308595979881,0.2314381635380172,0,0,5.795918367346939,10.51076961698872,GATA1,Erythroblast,0.7875834261109624
GO_Biological_Process_2021,cytoskeleton-dependent cytokinesis (GO:0061640),1/72,0.1651856959101235,0.2335592623491124,0,0,5.713998275366484,10.28911103101624,PLK1,Erythroblast,0.78202756268309
GO_Biological_Process_2021,neurotransmitter transport (GO:0006836),1/73,0.1672802691231711,0.2348006686601601,0,0,5.634353741496598,10.074701240888364,GAD1,Erythroblast,0.7765552814899175
GO_Biological_Process_2021,positive regulation of synaptic transmission (GO:0050806),1/73,0.1672802691231711,0.2348006686601601,0,0,5.634353741496598,10.074701240888364,NMU,Erythroblast,0.7765552814899175
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),2/296,0.1690031560036776,0.2351679893707946,0,0,2.7857142857142856,4.952548406897344,PLK1;DLGAP5,Erythroblast,0.7721051851958874
GO_Biological_Process_2021,sphingolipid biosynthetic process (GO:0030148),1/74,0.1693696918266344,0.2351679893707946,0,0,5.556891249650545,9.867213018330611,ALOX12B,Erythroblast,0.7711643026835198
GO_Biological_Process_2021,regulation of peptide hormone secretion (GO:0090276),1/74,0.1693696918266344,0.2351679893707946,0,0,5.556891249650545,9.867213018330611,TFR2,Erythroblast,0.7711643026835198
GO_Biological_Process_2021,regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/75,0.1714539764404576,0.2372087272617083,0,0,5.4815223386651954,9.666337985731484,GATA1,Erythroblast,0.7658524380723842
GO_Biological_Process_2021,regulation of cell division (GO:0051302),1/76,0.1735331353639065,0.2383764777596723,0,0,5.408163265306122,9.4717853003048,PLK1,Erythroblast,0.7606175863963804
GO_Biological_Process_2021,cellular response to hormone stimulus (GO:0032870),1/76,0.1735331353639065,0.2383764777596723,0,0,5.408163265306122,9.4717853003048,GATA1,Erythroblast,0.7606175863963804
GO_Biological_Process_2021,inorganic cation import across plasma membrane (GO:0098659),1/77,0.1756071809118701,0.2403701128793683,0,0,5.336734693877551,9.283280446293812,KCNH2,Erythroblast,0.7554577289388229
GO_Biological_Process_2021,negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.1776761254379788,0.2423427011274198,0,0,5.267161410018553,9.10056411919043,PLK1,Erythroblast,0.7503709249641564
GO_Biological_Process_2021,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.1797399811935544,0.2436608387130087,0,0,5.199372056514914,8.923391206941128,PLK1,Erythroblast,0.745355308086215
GO_Biological_Process_2021,negative regulation of cell cycle (GO:0045786),1/80,0.181798760490535,0.2436608387130087,0,0,5.133298889175924,8.751529842637671,PLK1,Erythroblast,0.7404090821369118
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.2436608387130087,0,0,5.133298889175924,8.751529842637671,GATA1,Erythroblast,0.7404090821369118
GO_Biological_Process_2021,skin development (GO:0043588),1/80,0.181798760490535,0.2436608387130087,0,0,5.133298889175924,8.751529842637671,ALOX12B,Erythroblast,0.7404090821369118
GO_Biological_Process_2021,regulation of protein localization to plasma membrane (GO:1903076),1/80,0.181798760490535,0.2436608387130087,0,0,5.133298889175924,8.751529842637671,DPP10,Erythroblast,0.7404090821369118
GO_Biological_Process_2021,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.1859011384602527,0.2474408256746811,0,0,5.00604686318972,8.422875391899517,PLK1,Erythroblast,0.7307179505966239
GO_Biological_Process_2021,positive regulation of protein ubiquitination (GO:0031398),1/82,0.1859011384602527,0.2474408256746811,0,0,5.00604686318972,8.422875391899517,PLK1,Erythroblast,0.7307179505966239
GO_Biological_Process_2021,glycoprotein biosynthetic process (GO:0009101),1/83,0.1879447615357932,0.2493012988069284,0,0,4.944748631159781,8.265677319811374,ST6GALNAC1,Erythroblast,0.7259697745939766
GO_Biological_Process_2021,response to insulin (GO:0032868),1/84,0.1899833569114356,0.2502852415283759,0,0,4.884927464961889,8.112979399077096,PKLR,Erythroblast,0.7212844428267129
GO_Biological_Process_2021,regulation of cytokinesis (GO:0032465),1/84,0.1899833569114356,0.2502852415283759,0,0,4.884927464961889,8.112979399077096,PLK1,Erythroblast,0.7212844428267129
GO_Biological_Process_2021,positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.1940455128548384,0.2547672379658763,0,0,4.769507803121249,7.820383303288144,PLK1,Erythroblast,0.7120963955156414
GO_Biological_Process_2021,calcium ion transmembrane transport (GO:0070588),1/87,0.196069097589664,0.2565514293885095,0,0,4.713811105837684,7.6801565438185,RYR3,Erythroblast,0.7075908500030543
GO_Biological_Process_2021,metal ion transport (GO:0030001),1/88,0.1980877029036425,0.25831707202975,0,0,4.659394792399718,7.5437717166037235,RYR3,Erythroblast,0.703142484213379
GO_Biological_Process_2021,positive regulation of binding (GO:0051099),1/90,0.2021100231923967,0.2626749796372564,0,0,4.55423068103646,7.281955543769811,ADD2,Erythroblast,0.6944121480917811
GO_Biological_Process_2021,regulation of stem cell differentiation (GO:2000736),1/91,0.2041137620931186,0.2635047229697116,0,0,4.503401360544218,7.156255051106618,GATA1,Erythroblast,0.6901277125812961
GO_Biological_Process_2021,positive regulation of transport (GO:0051050),1/91,0.2041137620931186,0.2635047229697116,0,0,4.503401360544218,7.156255051106618,TFR2,Erythroblast,0.6901277125812961
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2651981726747263,0,0,4.453689167974883,7.03385741012878,GATA1,Erythroblast,0.6858955226779435
GO_Biological_Process_2021,regulation of heart contraction (GO:0008016),1/93,0.2081064570390282,0.266874061186262,0,0,4.40505767524401,6.914643337844717,RYR3,Erythroblast,0.6817144444740324
GO_Biological_Process_2021,ciliary basal body-plasma membrane docking (GO:0097711),1/95,0.2120795205832498,0.2710685263083922,0,0,4.310898827616153,6.685315939697291,PLK1,Erythroblast,0.6735012670190429
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),2/345,0.2133084926466024,0.2717395318864308,0,0,2.381802721088435,3.6799229289674416,ALOX12B;PTH2R,Erythroblast,0.6709918532419347
GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.2140587201245348,0.2717982433160211,0,0,4.26530612244898,6.5749903239841245,TFR2,Erythroblast,0.6694670755856718
GO_Biological_Process_2021,protein maturation (GO:0051604),1/97,0.2160330472811356,0.2725122753284913,0,0,4.220663265306122,6.46742313757927,KEL,Erythroblast,0.6654798083211632
GO_Biological_Process_2021,positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.2160330472811356,0.2725122753284913,0,0,4.220663265306122,6.46742313757927,PTH2R,Erythroblast,0.6654798083211632
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,0.2180025137484037,0.274100880478449,0,0,4.176940879444562,6.362519703204576,CTSE,Erythroblast,0.6615384985937142
GO_Biological_Process_2021,organic anion transport (GO:0015711),1/99,0.2199671313012003,0.2756730931242315,0,0,4.134110787172012,6.26018948804807,RHAG,Erythroblast,0.6576422090003602
GO_Biological_Process_2021,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),1/100,0.2219269115603851,0.2763347995558344,0,0,4.092145949288806,6.1603458876211565,CTSE,Erythroblast,0.6537900306498672
GO_Biological_Process_2021,organic acid transport (GO:0015849),1/100,0.2219269115603851,0.2763347995558344,0,0,4.092145949288806,6.1603458876211565,SLC10A4,Erythroblast,0.6537900306498672
GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),1/101,0.2238818662412048,0.2778726699971224,0,0,4.051020408163265,6.062906014187368,DPP10,Erythroblast,0.6499810815451941
GO_Biological_Process_2021,positive regulation of cellular protein metabolic process (GO:0032270),1/102,0.2258320069783284,0.2785020916729545,0,0,4.010709234188725,5.967790506031058,PLK1,Erythroblast,0.6462145058611213
GO_Biological_Process_2021,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/102,0.2258320069783284,0.2785020916729545,0,0,4.010709234188725,5.967790506031058,PLK1,Erythroblast,0.6462145058611213
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/103,0.2277773453985499,0.2791176359486992,0,0,3.971188475390156,5.874923343943355,CTSE,Erythroblast,0.64248947278397
GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),1/103,0.2277773453985499,0.2791176359486992,0,0,3.971188475390156,5.874923343943355,RYR3,Erythroblast,0.64248947278397
GO_Biological_Process_2021,protein processing (GO:0016485),1/106,0.2335846623503299,0.2826447638471077,0,0,3.857142857142857,5.6090983677319475,KEL,Erythroblast,0.6315556772929499
GO_Biological_Process_2021,regulation of cell cycle process (GO:0010564),1/106,0.2335846623503299,0.2826447638471077,0,0,3.857142857142857,5.6090983677319475,PLK1,Erythroblast,0.6315556772929499
GO_Biological_Process_2021,cellular response to peptide hormone stimulus (GO:0071375),1/106,0.2335846623503299,0.2826447638471077,0,0,3.857142857142857,5.6090983677319475,PKLR,Erythroblast,0.6315556772929499
GO_Biological_Process_2021,protein localization to nucleus (GO:0034504),1/106,0.2335846623503299,0.2826447638471077,0,0,3.857142857142857,5.6090983677319475,PLK1,Erythroblast,0.6315556772929499
GO_Biological_Process_2021,response to calcium ion (GO:0051592),1/107,0.2355109070084182,0.2840850315789045,0,0,3.8205621871390063,5.524525481436682,RYR3,Erythroblast,0.6279889749729552
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.2853385392129614,0,0,2.2110433604336044,3.18053102486219,PLK1;GATA1,Erythroblast,0.6247218387200065
GO_Biological_Process_2021,lipid transport (GO:0006869),1/109,0.239349173739861,0.2860333779058401,0,0,3.749433106575964,5.361058744932435,SLC10A4,Erythroblast,0.6209680674126086
GO_Biological_Process_2021,modulation of chemical synaptic transmission (GO:0050804),1/109,0.239349173739861,0.2860333779058401,0,0,3.749433106575964,5.361058744932435,NMU,Erythroblast,0.6209680674126086
GO_Biological_Process_2021,protein-containing complex subunit organization (GO:0043933),1/112,0.2450711886958998,0.2919675272735103,0,0,3.647545504688362,5.129202360192396,ADD2,Erythroblast,0.6107077427090284
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),2/381,0.2465612635256485,0.2924235787722287,0,0,2.15160510114336,3.012558657024939,PLK1;GATA1,Erythroblast,0.6080751530383309
GO_Biological_Process_2021,positive regulation of metabolic process (GO:0009893),1/113,0.2469691364760274,0.2924235787722287,0,0,3.614795918367347,5.055262825364014,PTH2R,Erythroblast,0.6073573167632206
GO_Biological_Process_2021,calcium ion transport (GO:0006816),1/115,0.2507510141385882,0.2950911324923629,0,0,3.5510204081632653,4.9121080927455,RYR3,Erythroblast,0.6007573018413346
GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),1/115,0.2507510141385882,0.2950911324923629,0,0,3.5510204081632653,4.9121080927455,TFR2,Erythroblast,0.6007573018413346
GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),1/116,0.2526349665899778,0.2961065536778892,0,0,3.5199645075421473,4.8428011439058265,ALOX12B,Erythroblast,0.5975065399797567
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),4/1025,0.2531480899318741,0.2961065536778892,0,0,1.6121449559255632,2.2147335064279132,ST6GALNAC1;GAD1;PLK1;ALOX12B,Erythroblast,0.596625345129507
GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),1/120,0.2601244621662815,0.3033475601093193,0,0,3.4009603841536613,4.579716458908873,ANK1,Erythroblast,0.5848188047272944
GO_Biological_Process_2021,protein homooligomerization (GO:0051260),1/121,0.2619853133921213,0.3045973824378278,0,0,3.372448979591837,4.517283552621874,RYR3,Erythroblast,0.5817230540677998
GO_Biological_Process_2021,potassium ion transport (GO:0006813),1/122,0.2638415777635164,0.3058343814315836,0,0,3.3444088379153314,4.456111874258477,KCNH2,Erythroblast,0.5786567646257991
GO_Biological_Process_2021,cellular response to insulin stimulus (GO:0032869),1/129,0.2767079241059198,0.3197881997152246,0,0,3.1603954081632653,4.060453122404681,PKLR,Erythroblast,0.5579784037567757
GO_Biological_Process_2021,G2/M transition of mitotic cell cycle (GO:0000086),1/130,0.2785278903472666,0.3199754930775146,0,0,3.135738016136687,4.008216604624779,PLK1,Erythroblast,0.5551313103019286
GO_Biological_Process_2021,protein glycosylation (GO:0006486),1/130,0.2785278903472666,0.3199754930775146,0,0,3.135738016136687,4.008216604624779,ST6GALNAC1,Erythroblast,0.5551313103019286
GO_Biological_Process_2021,cell cycle G2/M phase transition (GO:0044839),1/131,0.2803433684983951,0.3211054606539481,0,0,3.111459968602826,3.956968446025251,PLK1,Erythroblast,0.5523097126477655
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3263447080764272,0,0,3.0408163265306123,3.80890385676326,GATA1,Erythroblast,0.5439940297149167
GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3294707173088824,0,0,2.99546485260771,3.714691124222948,PTH2R,Erythroblast,0.5385707850387818
GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3305324731533249,0,0,2.9732893157262907,3.668866926816198,PTH2R,Erythroblast,0.5358942544628899
GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),1/139,0.2947069182263764,0.3335978605143147,0,0,2.929902395740905,3.579678317757992,KCNH2,Erythroblast,0.5306096689947516
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3396158052388157,0,0,2.8467950560505892,3.410594866305226,TFR2,Erythroblast,0.5203052911363482
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3396158052388157,0,0,2.8467950560505892,3.410594866305226,RHAG,Erythroblast,0.5203052911363482
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3484438012655799,0,0,2.749271137026239,3.215201203875706,PLK1,Erythroblast,0.5078961191737069
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3513148059119738,0,0,2.712094233666621,3.141596466170354,RYR3,Erythroblast,0.5030717563895143
GO_Biological_Process_2021,peptidyl-serine phosphorylation (GO:0018105),1/156,0.3243029619756543,0.3617946338803542,0,0,2.6063199473337724,2.934917292064671,PLK1,Erythroblast,0.4890490847411261
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),2/468,0.3272907950685003,0.3640756394710119,0,0,1.742131616595136,1.9457976416065603,GATA1;KLF1,Erythroblast,0.48506620889050567
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.3760234651305533,0,0,2.4621702339472376,2.6600168495918335,PTH2R,Erythroblast,0.46919202564454415
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),2/482,0.3401543782991926,0.3760234651305533,0,0,1.6901041666666667,1.8225334796372663,TFR2;ALOX12B,Erythroblast,0.46832393464331673
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.3760234651305533,0,0,2.4471243042671613,2.6317886779390967,ALOX12B,Erythroblast,0.4670671197091842
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",4/1183,0.3428517320675613,0.3760234651305533,0,0,1.384445181989158,1.481989303783668,KCNH2;TFR2;GATA1;KLF1,Erythroblast,0.4648936521619021
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),2/485,0.3429022272693128,0.3760234651305533,0,0,1.6793478260869563,1.797422644350721,PLK1;GATA1,Erythroblast,0.46482969398207885
GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3766593973096932,0,0,2.4175730172308443,2.5766088705447237,DLGAP5,Erythroblast,0.46286379212748074
GO_Biological_Process_2021,peptidyl-serine modification (GO:0018209),1/169,0.3461106816465725,0.3773975229253588,0,0,2.403061224489796,2.5496399471999527,PLK1,Erythroblast,0.4607849973294511
GO_Biological_Process_2021,cation transport (GO:0006812),1/174,0.3543133002736421,0.3852533349454249,0,0,2.333018756635602,2.4206789693623425,RHAG,Erythroblast,0.45061254473982715
GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),1/177,0.359186378521905,0.3894548935658858,0,0,2.2929035250463823,2.3477357103628296,CDC20,Erythroblast,0.44468014150624274
GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.3901116183624863,0,0,2.279833967485299,2.3241173885161555,PTH2R,Erythroblast,0.44273020383203454
GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),1/185,0.3720057294778557,0.4011011496604814,0,0,2.192324755989352,2.1678716160963645,ANK1,Erythroblast,0.4294503712432232
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),3/908,0.3977118667386928,0.4276233441814357,0,0,1.3432467379804869,1.2385104166535874,TFR2;GATA1;DLGAP5,Erythroblast,0.40043145054722185
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),1/212,0.4134429066373548,0.4433026721167193,0,0,1.909178837411742,1.6862551884518755,PTH2R,Erythroblast,0.3835844547796231
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",3/948,0.4248826431220218,0.4543066488783945,0,0,1.283687943262411,1.0987627875578752,PLK1;DEPDC1;GATA1,Erythroblast,0.3717310099090599
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.4895301996286769,0,0,1.655076845553036,1.2884811006593149,GAD1,Erythroblast,0.33809924509335265
GO_Biological_Process_2021,cellular component assembly (GO:0022607),1/261,0.4819092749521712,0.5124434714367441,0,0,1.5455259026687598,1.1282329953702568,ADD2,Erythroblast,0.31703471507296654
GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5179111795799431,0,0,1.510204081632653,1.0781219104526054,ADD2,Erythroblast,0.3100391544580995
GO_Biological_Process_2021,protein deubiquitination (GO:0016579),1/267,0.4897346646287026,0.5179111795799431,0,0,1.510204081632653,1.0781219104526054,CDC20,Erythroblast,0.3100391544580995
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5259703071261578,0,0,1.4709576138147566,1.0233666205889618,ALOX12B,Erythroblast,0.30214499188263844
GO_Biological_Process_2021,protein modification by small protein removal (GO:0070646),1/276,0.50125602230015,0.5272066065609207,0,0,1.4601113172541744,1.0084087773272885,CDC20,Erythroblast,0.29994039654430615
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),2/684,0.5139408816832591,0.5390792943742881,0,0,1.1771749755620724,0.7835830337156338,PLK1;GATA1,Erythroblast,0.2890868347700152
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5626283090558428,0,0,1.314486450317832,0.8152139890333826,GAD1,Erythroblast,0.2693393582885023
GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),1/314,0.5471545986718139,0.5692767522569276,0,0,1.2803677381495728,0.7720923294539072,UBE2C,Erythroblast,0.26188994631047774
GO_Biological_Process_2021,cilium assembly (GO:0060271),1/314,0.5471545986718139,0.5692767522569276,0,0,1.2803677381495728,0.7720923294539072,PLK1,Erythroblast,0.26188994631047774
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5777798928316686,0,0,1.2440106477373558,0.7270814983759607,RYR3,Erythroblast,0.2538302089398956
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),2/742,0.5583209845238664,0.5777798928316686,0,0,1.0816441441441442,0.6304051823091851,PLK1;GATA1,Erythroblast,0.25311604886163686
GO_Biological_Process_2021,protein transport (GO:0015031),1/369,0.6063398885560332,0.6257946443385796,0,0,1.0859582963620231,0.5433207667028247,TFR2,Erythroblast,0.21728386041430361
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6393390566768609,0,0,1.042628017264347,0.4965325169788531,ALOX12B,Erythroblast,0.20682480102083725
GO_Biological_Process_2021,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6532076500752498,0,0,1.0,0.4521084323403523,PLK1,Erythroblast,0.19634819738734471
GO_Biological_Process_2021,organelle organization (GO:0006996),1/420,0.6544076492323022,0.6700301130070787,0,0,0.9512931664312504,0.4033718992390181,ANK1,Erythroblast,0.18415163293091988
GO_Biological_Process_2021,organelle assembly (GO:0070925),1/425,0.658798168385351,0.672740986763877,0,0,0.939834424335772,0.3922286762298742,DLGAP5,Erythroblast,0.18124761694193237
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.663134010332821,0.6753818680434536,0,0,0.928642785785643,0.3814661952932429,KLF1,Erythroblast,0.17839869773857764
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.6912187085983104,0.7021326882077574,0,0,0.8589500595054437,0.3172093937483807,DEPDC1,Erythroblast,0.16038451570993173
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7249387374153446,0,0,0.8021026592455164,0.2684686706444305,PLK1,Erythroblast,0.1453610219101508
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.7563719190869089,0,0,0.726642950758285,0.2091870484536521,ALOX12B,Erythroblast,0.12502533841998253
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7504933808556635,0.7563719190869089,0,0,0.7252747252747253,0.2081715773755284,DEPDC1,Erythroblast,0.1246531337611999
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7637244288854065,0,0,0.7301532033426184,0.200604530418796,ALOX12B;KLF1,Erythroblast,0.11931939791106433
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),4/2206,0.8166523886858273,0.8187735637213749,0,0,0.7008648264423647,0.1419543867132323,TFR2;PLK1;GATA1;KLF1,Erythroblast,0.08796276329696344
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",4/2244,0.8272634931131488,0.8272634931131488,0,0,0.6875,0.130372014787288,KCNH2;DEPDC1;GATA1;KLF1,Erythroblast,0.08235614053342308
GO_Biological_Process_2021,"complement activation, lectin pathway (GO:0001867)",2/10,0.00027212309342677823,0.0961061630348609,0,0,103.86458333333331,852.6509585567859,MFAP4;MASP1,Fibro-MSC,3.5652346007331377
GO_Biological_Process_2021,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),2/16,0.0007187392304892979,0.0961061630348609,0,0,59.333333333333336,429.45537567816734,SFRP2;CLU,Fibro-MSC,3.14342864967499
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),5/300,0.0008957269205494731,0.0961061630348609,0,0,7.4030131826742,51.953420899616845,MFAP5;COMP;MIA;HAS1;HAPLN1,Fibro-MSC,3.047824373122375
GO_Biological_Process_2021,retinol metabolic process (GO:0042572),2/21,0.0012477930702112,0.0961061630348609,0,0,43.708333333333336,292.25047477799524,CYP27C1;RBP4,Fibro-MSC,2.9038574306125264
GO_Biological_Process_2021,negative regulation of biomineral tissue development (GO:0070168),2/22,0.001370383663162,0.0961061630348609,0,0,41.520833333333336,273.7329252658829,ECM1;ASPN,Fibro-MSC,2.8631578273928713
GO_Biological_Process_2021,extracellular matrix assembly (GO:0085029),2/24,0.0016321249773357,0.0961061630348609,0,0,37.74242424242424,242.22606459531664,MFAP4;HAS1,Fibro-MSC,2.7872465889099036
GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),2/26,0.0019157650058532,0.0961061630348609,0,0,34.59375,216.47517339281177,SFRP2;CLU,Fibro-MSC,2.7176577640050135
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),4/216,0.002065697356164,0.0961061630348609,0,0,8.095980311730926,50.05167712719815,MFAP5;COMP;MIA;HAPLN1,Fibro-MSC,2.6849333063284138
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),4/217,0.002100649710268,0.0961061630348609,0,0,8.057562767911818,49.678972510470935,MFAP5;COMP;MIA;HAPLN1,Fibro-MSC,2.677646361483123
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),5/379,0.0025046631439755,0.0961061630348609,0,0,5.815805109922757,34.83435225893759,RBP4;SFRP2;OGN;PDPN;NOX4,Fibro-MSC,2.601250674806674
GO_Biological_Process_2021,respiratory tube development (GO:0030323),2/30,0.0025478771667966,0.0961061630348609,0,0,29.645833333333332,177.0595839464994,RBP4;PDPN,Fibro-MSC,2.5938215131766835
GO_Biological_Process_2021,negative regulation of response to DNA damage stimulus (GO:2001021),2/31,0.0027192556482504,0.0961061630348609,0,0,28.62212643678161,169.08226656127547,SFRP2;CLU,Fibro-MSC,2.565549960707733
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),7/764,0.0027580135087266,0.0961061630348609,0,0,4.127400079874659,24.32377823939587,BTC;SFRP2;PDPN;SIX3;NOX4;CLU;CRLF1,Fibro-MSC,2.559403610984298
GO_Biological_Process_2021,primary alcohol metabolic process (GO:0034308),2/33,0.0030778471463162,0.0978869478626455,0,0,26.772849462365592,154.84144163978604,CYP27C1;RBP4,Fibro-MSC,2.511752952132796
GO_Biological_Process_2021,respiratory system development (GO:0060541),2/35,0.0034573756419477,0.0978869478626455,0,0,25.147727272727273,142.5183432834292,RBP4;PDPN,Fibro-MSC,2.461253432039241
GO_Biological_Process_2021,lung development (GO:0030324),2/35,0.0034573756419477,0.0978869478626455,0,0,25.147727272727273,142.5183432834292,RBP4;PDPN,Fibro-MSC,2.461253432039241
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),3/134,0.0045804125784184,0.1179610200823132,0,0,9.65681338314114,52.01127050341143,NOX4;CRLF1;THBS4,Fibro-MSC,2.3390954013715843
GO_Biological_Process_2021,visual system development (GO:0150063),2/41,0.0047194951697385,0.1179610200823132,0,0,21.272435897435894,113.93630347986566,RBP4;SIX3,Fibro-MSC,2.3261044540613445
GO_Biological_Process_2021,positive regulation of protein tyrosine kinase activity (GO:0061098),2/42,0.0049475924537835,0.1179610200823132,0,0,20.739583333333332,110.1034239545967,BTC;NOX4,Fibro-MSC,2.3056060815494894
GO_Biological_Process_2021,embryonic organ morphogenesis (GO:0048562),2/44,0.0054187658916089,0.1227350474449437,0,0,19.75,103.05327189846057,MFAP5;RBP4,Fibro-MSC,2.266099611522887
GO_Biological_Process_2021,regulation of cellular component movement (GO:0051270),2/50,0.0069502994651568,0.1487848872770361,0,0,17.276041666666668,85.84414194819459,BTC;PDPN,Fibro-MSC,2.157996482710139
GO_Biological_Process_2021,skeletal system development (GO:0001501),3/158,0.0072257561149995,0.1487848872770361,0,0,8.151681537405628,40.18863284587075,COMP;RBP4;HAPLN1,Fibro-MSC,2.1411167009049183
GO_Biological_Process_2021,sensory organ development (GO:0007423),2/56,0.0086546685435214,0.1500719661057384,0,0,15.351851851851851,72.91602120992282,RBP4;SIX3,Fibro-MSC,2.0627495600792987
GO_Biological_Process_2021,eye development (GO:0001654),2/58,0.0092602829393189,0.1500719661057384,0,0,14.802083333333334,69.30366021141536,RBP4;SIX3,Fibro-MSC,2.033375743652011
GO_Biological_Process_2021,negative regulation of hydrolase activity (GO:0051346),2/58,0.0092602829393189,0.1500719661057384,0,0,14.802083333333334,69.30366021141536,ECM1;SERPINA5,Fibro-MSC,2.033375743652011
GO_Biological_Process_2021,negative regulation of peptidase activity (GO:0010466),2/63,0.0108545013893802,0.1500719661057384,0,0,13.585382513661202,61.44906812714711,ECM1;SERPINA5,Fibro-MSC,1.9643901214324337
GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),2/64,0.0111869000374274,0.1500719661057384,0,0,13.365591397849462,60.051760195429935,SFRP2;CLU,Fibro-MSC,1.9512902426187388
GO_Biological_Process_2021,negative regulation of cardiac muscle cell proliferation (GO:0060044),1/5,0.0124387771927725,0.1500719661057384,0,0,101.76530612244898,446.4379351400606,RBP4,Fibro-MSC,1.9052223113279663
GO_Biological_Process_2021,female genitalia development (GO:0030540),1/5,0.0124387771927725,0.1500719661057384,0,0,101.76530612244898,446.4379351400606,RBP4,Fibro-MSC,1.9052223113279663
GO_Biological_Process_2021,forebrain regionalization (GO:0021871),1/5,0.0124387771927725,0.1500719661057384,0,0,101.76530612244898,446.4379351400606,SIX3,Fibro-MSC,1.9052223113279663
GO_Biological_Process_2021,negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569),1/5,0.0124387771927725,0.1500719661057384,0,0,101.76530612244898,446.4379351400606,CILP,Fibro-MSC,1.9052223113279663
GO_Biological_Process_2021,lymph node development (GO:0048535),1/5,0.0124387771927725,0.1500719661057384,0,0,101.76530612244898,446.4379351400606,PDPN,Fibro-MSC,1.9052223113279663
GO_Biological_Process_2021,regulation of neutrophil activation (GO:1902563),1/5,0.0124387771927725,0.1500719661057384,0,0,101.76530612244898,446.4379351400606,PLA2G2A,Fibro-MSC,1.9052223113279663
GO_Biological_Process_2021,defense response to Gram-positive bacterium (GO:0050830),2/70,0.013274200561286,0.1500719661057384,0,0,12.182598039215684,52.65237170003471,PLA2G2A;DEFB1,Fibro-MSC,1.8769916248436092
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),3/203,0.0142323787832344,0.1500719661057384,0,0,6.303191489361702,26.80265596371328,ECM1;SFRP2;THBS4,Fibro-MSC,1.8467225063744226
GO_Biological_Process_2021,negative regulation of cardiac muscle tissue growth (GO:0055022),1/6,0.0149082847993736,0.1500719661057384,0,0,81.40816326530613,342.3895623444841,RBP4,Fibro-MSC,1.8265723193247598
GO_Biological_Process_2021,regulation of tooth mineralization (GO:0070170),1/6,0.0149082847993736,0.1500719661057384,0,0,81.40816326530613,342.3895623444841,ASPN,Fibro-MSC,1.8265723193247598
GO_Biological_Process_2021,negative regulation of fibroblast migration (GO:0010764),1/6,0.0149082847993736,0.1500719661057384,0,0,81.40816326530613,342.3895623444841,HAS1,Fibro-MSC,1.8265723193247598
GO_Biological_Process_2021,negative regulation of SMAD protein signal transduction (GO:0060392),1/6,0.0149082847993736,0.1500719661057384,0,0,81.40816326530613,342.3895623444841,CILP,Fibro-MSC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of tau-protein kinase activity (GO:1902949),1/6,0.0149082847993736,0.1500719661057384,0,0,81.40816326530613,342.3895623444841,CLU,Fibro-MSC,1.8265723193247598
GO_Biological_Process_2021,embryonic camera-type eye morphogenesis (GO:0048596),1/6,0.0149082847993736,0.1500719661057384,0,0,81.40816326530613,342.3895623444841,SIX3,Fibro-MSC,1.8265723193247598
GO_Biological_Process_2021,regulation of epithelial to mesenchymal transition (GO:0010717),2/76,0.0155171628224907,0.1500719661057384,0,0,11.19144144144144,46.62140287744705,SFRP2;PDPN,Fibro-MSC,1.8091876827669675
GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),2/77,0.0159057771109684,0.1500719661057384,0,0,11.041666666666666,45.72434655376785,ECM1;THBS4,Fibro-MSC,1.7984451076467942
GO_Biological_Process_2021,heart trabecula formation (GO:0060347),1/7,0.0173717414502839,0.1500719661057384,0,0,67.83673469387755,274.9362107684438,RBP4,Fibro-MSC,1.7601566430186848
GO_Biological_Process_2021,hyaluronan biosynthetic process (GO:0030213),1/7,0.0173717414502839,0.1500719661057384,0,0,67.83673469387755,274.9362107684438,HAS1,Fibro-MSC,1.7601566430186848
GO_Biological_Process_2021,cellular response to platelet-derived growth factor stimulus (GO:0036120),1/7,0.0173717414502839,0.1500719661057384,0,0,67.83673469387755,274.9362107684438,HAS1,Fibro-MSC,1.7601566430186848
GO_Biological_Process_2021,definitive hemopoiesis (GO:0060216),1/7,0.0173717414502839,0.1500719661057384,0,0,67.83673469387755,274.9362107684438,MFAP5,Fibro-MSC,1.7601566430186848
GO_Biological_Process_2021,pituitary gland development (GO:0021983),1/7,0.0173717414502839,0.1500719661057384,0,0,67.83673469387755,274.9362107684438,SIX3,Fibro-MSC,1.7601566430186848
GO_Biological_Process_2021,proximal/distal pattern formation (GO:0009954),1/8,0.0198291614511851,0.1500719661057384,0,0,58.142857142857146,227.9549801512961,SIX3,Fibro-MSC,1.702695651141308
GO_Biological_Process_2021,regulation of stem cell division (GO:2000035),1/8,0.0198291614511851,0.1500719661057384,0,0,58.142857142857146,227.9549801512961,SFRP2,Fibro-MSC,1.702695651141308
GO_Biological_Process_2021,folic acid transport (GO:0015884),1/8,0.0198291614511851,0.1500719661057384,0,0,58.142857142857146,227.9549801512961,PDPN,Fibro-MSC,1.702695651141308
GO_Biological_Process_2021,positive regulation of extracellular matrix disassembly (GO:0090091),1/8,0.0198291614511851,0.1500719661057384,0,0,58.142857142857146,227.9549801512961,PDPN,Fibro-MSC,1.702695651141308
GO_Biological_Process_2021,positive regulation of homotypic cell-cell adhesion (GO:0034112),1/8,0.0198291614511851,0.1500719661057384,0,0,58.142857142857146,227.9549801512961,PDPN,Fibro-MSC,1.702695651141308
GO_Biological_Process_2021,lens fiber cell differentiation (GO:0070306),1/8,0.0198291614511851,0.1500719661057384,0,0,58.142857142857146,227.9549801512961,SIX3,Fibro-MSC,1.702695651141308
GO_Biological_Process_2021,cellular response to UV-B (GO:0071493),1/8,0.0198291614511851,0.1500719661057384,0,0,58.142857142857146,227.9549801512961,MFAP4,Fibro-MSC,1.702695651141308
GO_Biological_Process_2021,lymphatic endothelial cell differentiation (GO:0060836),1/8,0.0198291614511851,0.1500719661057384,0,0,58.142857142857146,227.9549801512961,PDPN,Fibro-MSC,1.702695651141308
GO_Biological_Process_2021,elastic fiber assembly (GO:0048251),1/8,0.0198291614511851,0.1500719661057384,0,0,58.142857142857146,227.9549801512961,MFAP4,Fibro-MSC,1.702695651141308
GO_Biological_Process_2021,myoblast migration (GO:0051451),1/8,0.0198291614511851,0.1500719661057384,0,0,58.142857142857146,227.9549801512961,THBS4,Fibro-MSC,1.702695651141308
GO_Biological_Process_2021,retinoid metabolic process (GO:0001523),2/92,0.0222223839756269,0.1500719661057384,0,0,9.194444444444445,35.00007985571613,CYP27C1;RBP4,Fibro-MSC,1.6532093525993499
GO_Biological_Process_2021,regulation of endothelial cell proliferation (GO:0001936),2/92,0.0222223839756269,0.1500719661057384,0,0,9.194444444444445,35.00007985571613,ECM1;THBS4,Fibro-MSC,1.6532093525993499
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),2/92,0.0222223839756269,0.1500719661057384,0,0,9.194444444444445,35.00007985571613,SFRP2;THBS4,Fibro-MSC,1.6532093525993499
GO_Biological_Process_2021,epithelial cell apoptotic process (GO:1904019),1/9,0.0222805591236868,0.1500719661057384,0,0,50.87244897959184,193.52086993316271,SIX3,Fibro-MSC,1.652073914876897
GO_Biological_Process_2021,actin-mediated cell contraction (GO:0070252),1/9,0.0222805591236868,0.1500719661057384,0,0,50.87244897959184,193.52086993316271,PDPN,Fibro-MSC,1.652073914876897
GO_Biological_Process_2021,response to misfolded protein (GO:0051788),1/9,0.0222805591236868,0.1500719661057384,0,0,50.87244897959184,193.52086993316271,CLU,Fibro-MSC,1.652073914876897
GO_Biological_Process_2021,positive regulation of protein polyubiquitination (GO:1902916),1/9,0.0222805591236868,0.1500719661057384,0,0,50.87244897959184,193.52086993316271,SPSB4,Fibro-MSC,1.652073914876897
GO_Biological_Process_2021,hemopoiesis (GO:0030097),2/94,0.0231314233527167,0.1500719661057384,0,0,8.993659420289855,33.87518721331595,MFAP5;SFRP2,Fibro-MSC,1.6357976428363092
GO_Biological_Process_2021,glycosaminoglycan biosynthetic process (GO:0006024),2/97,0.024523395696302,0.1500719661057384,0,0,8.708333333333334,32.29161197321332,HAS1;OGN,Fibro-MSC,1.6104193942653626
GO_Biological_Process_2021,regulation of tau-protein kinase activity (GO:1902947),1/10,0.024725948817258,0.1500719661057384,0,0,45.21768707482993,167.3010120823387,CLU,Fibro-MSC,1.606847034080906
GO_Biological_Process_2021,regulation of actin filament-based movement (GO:1903115),1/10,0.024725948817258,0.1500719661057384,0,0,45.21768707482993,167.3010120823387,PDPN,Fibro-MSC,1.606847034080906
GO_Biological_Process_2021,UV protection (GO:0009650),1/10,0.024725948817258,0.1500719661057384,0,0,45.21768707482993,167.3010120823387,MFAP4,Fibro-MSC,1.606847034080906
GO_Biological_Process_2021,muscle cell migration (GO:0014812),1/10,0.024725948817258,0.1500719661057384,0,0,45.21768707482993,167.3010120823387,THBS4,Fibro-MSC,1.606847034080906
GO_Biological_Process_2021,myelin maintenance (GO:0043217),1/10,0.024725948817258,0.1500719661057384,0,0,45.21768707482993,167.3010120823387,CLU,Fibro-MSC,1.606847034080906
GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),3/258,0.0266503572098972,0.1500719661057384,0,0,4.92991239048811,17.870699352489467,SFRP2;PLA2G2A;PDPN,Fibro-MSC,1.5742969655024164
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),2/102,0.0269177264019109,0.1500719661057384,0,0,8.270833333333334,29.898816321570965,ECM1;SFRP2,Fibro-MSC,1.5699616254585989
GO_Biological_Process_2021,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),1/11,0.0271653448579923,0.1500719661057384,0,0,40.69387755102041,146.73452100035948,BTC,Fibro-MSC,1.5659847773237099
GO_Biological_Process_2021,hematopoietic stem cell proliferation (GO:0071425),1/11,0.0271653448579923,0.1500719661057384,0,0,40.69387755102041,146.73452100035948,SFRP2,Fibro-MSC,1.5659847773237099
GO_Biological_Process_2021,cell proliferation in forebrain (GO:0021846),1/11,0.0271653448579923,0.1500719661057384,0,0,40.69387755102041,146.73452100035948,SIX3,Fibro-MSC,1.5659847773237099
GO_Biological_Process_2021,somite development (GO:0061053),1/11,0.0271653448579923,0.1500719661057384,0,0,40.69387755102041,146.73452100035948,SFRP2,Fibro-MSC,1.5659847773237099
GO_Biological_Process_2021,central nervous system myelination (GO:0022010),1/11,0.0271653448579923,0.1500719661057384,0,0,40.69387755102041,146.73452100035948,CLU,Fibro-MSC,1.5659847773237099
GO_Biological_Process_2021,"synaptic transmission, GABAergic (GO:0051932)",1/11,0.0271653448579923,0.1500719661057384,0,0,40.69387755102041,146.73452100035948,GABRA4,Fibro-MSC,1.5659847773237099
GO_Biological_Process_2021,regulation of lamellipodium morphogenesis (GO:2000392),1/11,0.0271653448579923,0.1500719661057384,0,0,40.69387755102041,146.73452100035948,PDPN,Fibro-MSC,1.5659847773237099
GO_Biological_Process_2021,embryonic eye morphogenesis (GO:0048048),1/11,0.0271653448579923,0.1500719661057384,0,0,40.69387755102041,146.73452100035948,MFAP5,Fibro-MSC,1.5659847773237099
GO_Biological_Process_2021,central nervous system development (GO:0007417),3/268,0.029372975170435,0.1539709777898937,0,0,4.741469289441991,16.726387517431146,SIX3;ZIC1;HAPLN1,Fibro-MSC,1.532052061830539
GO_Biological_Process_2021,epithelial cell-cell adhesion (GO:0090136),1/12,0.029598761568907,0.1539709777898937,0,0,36.99257884972171,130.2147194065139,THBS4,Fibro-MSC,1.5287264597194943
GO_Biological_Process_2021,homocysteine metabolic process (GO:0050667),1/12,0.029598761568907,0.1539709777898937,0,0,36.99257884972171,130.2147194065139,NOX4,Fibro-MSC,1.5287264597194943
GO_Biological_Process_2021,keratan sulfate catabolic process (GO:0042340),1/12,0.029598761568907,0.1539709777898937,0,0,36.99257884972171,130.2147194065139,OGN,Fibro-MSC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of amyloid fibril formation (GO:1905907),1/12,0.029598761568907,0.1539709777898937,0,0,36.99257884972171,130.2147194065139,CLU,Fibro-MSC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),2/108,0.029910476921657,0.1539709777898937,0,0,7.800314465408805,27.37556602865933,CILP;ASPN,Fibro-MSC,1.5241766621009911
GO_Biological_Process_2021,response to UV-B (GO:0010224),1/13,0.032026213248763,0.1559823922191936,0,0,33.90816326530612,116.6847899929619,MFAP4,Fibro-MSC,1.4944944088974865
GO_Biological_Process_2021,homeostasis of number of cells (GO:0048872),1/13,0.032026213248763,0.1559823922191936,0,0,33.90816326530612,116.6847899929619,PLA2G2A,Fibro-MSC,1.4944944088974865
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),2/116,0.0340965412337713,0.1559823922191936,0,0,7.25,24.49455514200503,ECM1;SFRP2,Fibro-MSC,1.467289673772098
GO_Biological_Process_2021,negative regulation of bone mineralization (GO:0030502),1/14,0.0344477141698711,0.1559823922191936,0,0,31.298273155416013,105.4223689491126,ECM1,Fibro-MSC,1.4628395910668823
GO_Biological_Process_2021,regulation of response to endoplasmic reticulum stress (GO:1905897),1/14,0.0344477141698711,0.1559823922191936,0,0,31.298273155416013,105.4223689491126,CLU,Fibro-MSC,1.4628395910668823
GO_Biological_Process_2021,branching involved in blood vessel morphogenesis (GO:0001569),1/14,0.0344477141698711,0.1559823922191936,0,0,31.298273155416013,105.4223689491126,SFRP2,Fibro-MSC,1.4628395910668823
GO_Biological_Process_2021,heart process (GO:0003015),1/14,0.0344477141698711,0.1559823922191936,0,0,31.298273155416013,105.4223689491126,NOX4,Fibro-MSC,1.4628395910668823
GO_Biological_Process_2021,cardiac left ventricle morphogenesis (GO:0003214),1/14,0.0344477141698711,0.1559823922191936,0,0,31.298273155416013,105.4223689491126,SFRP2,Fibro-MSC,1.4628395910668823
GO_Biological_Process_2021,retinal metabolic process (GO:0042574),1/14,0.0344477141698711,0.1559823922191936,0,0,31.298273155416013,105.4223689491126,CYP27C1,Fibro-MSC,1.4628395910668823
GO_Biological_Process_2021,low-density lipoprotein particle remodeling (GO:0034374),1/14,0.0344477141698711,0.1559823922191936,0,0,31.298273155416013,105.4223689491126,PLA2G2A,Fibro-MSC,1.4628395910668823
GO_Biological_Process_2021,regulation of lamellipodium organization (GO:1902743),1/14,0.0344477141698711,0.1559823922191936,0,0,31.298273155416013,105.4223689491126,PDPN,Fibro-MSC,1.4628395910668823
GO_Biological_Process_2021,positive regulation of protein-containing complex assembly (GO:0031334),2/118,0.0351769550093681,0.1559823922191936,0,0,7.124281609195402,23.8475644827565,TPPP3;CLU,Fibro-MSC,1.4537417566881954
GO_Biological_Process_2021,regulation of amyloid fibril formation (GO:1905906),1/15,0.0368632785936063,0.1559823922191936,0,0,29.06122448979592,95.91771596133704,CLU,Fibro-MSC,1.4334060415588732
GO_Biological_Process_2021,interleukin-27-mediated signaling pathway (GO:0070106),1/15,0.0368632785936063,0.1559823922191936,0,0,29.06122448979592,95.91771596133704,CRLF1,Fibro-MSC,1.4334060415588732
GO_Biological_Process_2021,regulation of extracellular matrix disassembly (GO:0010715),1/15,0.0368632785936063,0.1559823922191936,0,0,29.06122448979592,95.91771596133704,PDPN,Fibro-MSC,1.4334060415588732
GO_Biological_Process_2021,superoxide anion generation (GO:0042554),1/15,0.0368632785936063,0.1559823922191936,0,0,29.06122448979592,95.91771596133704,NOX4,Fibro-MSC,1.4334060415588732
GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),2/123,0.0379356146383277,0.1559823922191936,0,0,6.828168044077135,22.34084340876857,ECM1;THBS4,Fibro-MSC,1.420952875040757
GO_Biological_Process_2021,platelet degranulation (GO:0002576),2/125,0.0390617280151273,0.1559823922191936,0,0,6.716463414634147,21.77888563484535,ECM1;CLU,Fibro-MSC,1.408248548277182
GO_Biological_Process_2021,epiboly involved in wound healing (GO:0090505),1/16,0.0392729207344652,0.1559823922191936,0,0,27.122448979591837,87.80133530116419,PDPN,Fibro-MSC,1.405906798966597
GO_Biological_Process_2021,regulation of amyloid-beta clearance (GO:1900221),1/16,0.0392729207344652,0.1559823922191936,0,0,27.122448979591837,87.80133530116419,CLU,Fibro-MSC,1.405906798966597
GO_Biological_Process_2021,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/16,0.0392729207344652,0.1559823922191936,0,0,27.122448979591837,87.80133530116419,CLU,Fibro-MSC,1.405906798966597
GO_Biological_Process_2021,regulation of leukocyte activation (GO:0002694),1/16,0.0392729207344652,0.1559823922191936,0,0,27.122448979591837,87.80133530116419,PLA2G2A,Fibro-MSC,1.405906798966597
GO_Biological_Process_2021,mesenchyme development (GO:0060485),1/16,0.0392729207344652,0.1559823922191936,0,0,27.122448979591837,87.80133530116419,SFRP2,Fibro-MSC,1.405906798966597
GO_Biological_Process_2021,innate immune response (GO:0045087),3/302,0.0396921142190312,0.1559823922191936,0,0,4.195047320856757,13.53575120214285,MFAP4;DEFB1;MASP1,Fibro-MSC,1.4012957675779878
GO_Biological_Process_2021,reverse cholesterol transport (GO:0043691),1/17,0.0416766547912334,0.1559823922191936,0,0,25.426020408163264,80.79916728086499,CLU,Fibro-MSC,1.3801071472903907
GO_Biological_Process_2021,regulation of neuroblast proliferation (GO:1902692),1/17,0.0416766547912334,0.1559823922191936,0,0,25.426020408163264,80.79916728086499,SIX3,Fibro-MSC,1.3801071472903907
GO_Biological_Process_2021,modified amino acid transport (GO:0072337),1/17,0.0416766547912334,0.1559823922191936,0,0,25.426020408163264,80.79916728086499,PDPN,Fibro-MSC,1.3801071472903907
GO_Biological_Process_2021,negative regulation of amyloid-beta formation (GO:1902430),1/17,0.0416766547912334,0.1559823922191936,0,0,25.426020408163264,80.79916728086499,CLU,Fibro-MSC,1.3801071472903907
GO_Biological_Process_2021,epithelial structure maintenance (GO:0010669),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,RBP4,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of amyloid-beta formation (GO:1902004),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,CLU,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,SFRP2,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,fluid transport (GO:0042044),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,PDPN,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,release of cytochrome c from mitochondria (GO:0001836),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,CLU,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of extracellular matrix organization (GO:1903055),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,PDPN,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of macrophage derived foam cell differentiation (GO:0010744),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,PLA2G2A,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,maintenance of gastrointestinal epithelium (GO:0030277),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,RBP4,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,water transport (GO:0006833),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,PDPN,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,PLA2G2A,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,phosphatidylinositol acyl-chain remodeling (GO:0036149),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,PLA2G2A,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,regulation of platelet aggregation (GO:0090330),1/18,0.0440744949316926,0.1559823922191936,0,0,23.92917166866747,74.70385911458476,PDPN,Fibro-MSC,1.3558126557645607
GO_Biological_Process_2021,heart trabecula morphogenesis (GO:0061384),1/19,0.0464664552952436,0.1594644261268588,0,0,22.598639455782312,69.35578082800635,RBP4,Fibro-MSC,1.3328604565168853
GO_Biological_Process_2021,positive regulation of neutrophil chemotaxis (GO:0090023),1/19,0.0464664552952436,0.1594644261268588,0,0,22.598639455782312,69.35578082800635,THBS4,Fibro-MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),1/19,0.0464664552952436,0.1594644261268588,0,0,22.598639455782312,69.35578082800635,CILP,Fibro-MSC,1.3328604565168853
GO_Biological_Process_2021,negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/19,0.0464664552952436,0.1594644261268588,0,0,22.598639455782312,69.35578082800635,CLU,Fibro-MSC,1.3328604565168853
GO_Biological_Process_2021,protein targeting to lysosome (GO:0006622),1/20,0.0488525499820277,0.1611424665542287,0,0,21.40816326530612,64.63014669364038,CLU,Fibro-MSC,1.3111127622579986
GO_Biological_Process_2021,eye morphogenesis (GO:0048592),1/20,0.0488525499820277,0.1611424665542287,0,0,21.40816326530612,64.63014669364038,MFAP5,Fibro-MSC,1.3111127622579986
GO_Biological_Process_2021,regulation of tissue remodeling (GO:0034103),1/20,0.0488525499820277,0.1611424665542287,0,0,21.40816326530612,64.63014669364038,THBS4,Fibro-MSC,1.3111127622579986
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),2/143,0.0497512691479657,0.1611424665542287,0,0,5.8537234042553195,17.565380826397597,MASP1;LRP1B,Fibro-MSC,1.3031958359850326
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),2/143,0.0497512691479657,0.1611424665542287,0,0,5.8537234042553195,17.565380826397597,PDPN;LRP1B,Fibro-MSC,1.3031958359850326
GO_Biological_Process_2021,negative regulation of cell migration (GO:0030336),2/144,0.0503731921946642,0.1611424665542287,0,0,5.812206572769953,17.368594502988177,SFRP2;HAS1,Fibro-MSC,1.2978005266368353
GO_Biological_Process_2021,epithelial cell development (GO:0002064),1/21,0.0512327930672156,0.1611424665542287,0,0,20.336734693877553,60.42807445408675,SIX3,Fibro-MSC,1.2904519669693806
GO_Biological_Process_2021,regulation of cardiac muscle cell proliferation (GO:0060043),1/21,0.0512327930672156,0.1611424665542287,0,0,20.336734693877553,60.42807445408675,RBP4,Fibro-MSC,1.2904519669693806
GO_Biological_Process_2021,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.0512327930672156,0.1611424665542287,0,0,20.336734693877553,60.42807445408675,DEFB1,Fibro-MSC,1.2904519669693806
GO_Biological_Process_2021,innate immune response in mucosa (GO:0002227),1/21,0.0512327930672156,0.1611424665542287,0,0,20.336734693877553,60.42807445408675,DEFB1,Fibro-MSC,1.2904519669693806
GO_Biological_Process_2021,regulation of fibroblast migration (GO:0010762),1/21,0.0512327930672156,0.1611424665542287,0,0,20.336734693877553,60.42807445408675,HAS1,Fibro-MSC,1.2904519669693806
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),4/566,0.0525874539436757,0.1611424665542287,0,0,2.999845273092991,8.835377403898873,SFRP2;PDPN;NOX4;CLU,Fibro-MSC,1.279117855331805
GO_Biological_Process_2021,positive regulation of amyloid precursor protein catabolic process (GO:1902993),1/22,0.0536071985992547,0.1611424665542287,0,0,19.367346938775512,56.67024999786951,CLU,Fibro-MSC,1.2707768875084013
GO_Biological_Process_2021,positive regulation of granulocyte chemotaxis (GO:0071624),1/22,0.0536071985992547,0.1611424665542287,0,0,19.367346938775512,56.67024999786951,THBS4,Fibro-MSC,1.2707768875084013
GO_Biological_Process_2021,positive regulation of neutrophil migration (GO:1902624),1/22,0.0536071985992547,0.1611424665542287,0,0,19.367346938775512,56.67024999786951,THBS4,Fibro-MSC,1.2707768875084013
GO_Biological_Process_2021,chaperone-mediated protein complex assembly (GO:0051131),1/22,0.0536071985992547,0.1611424665542287,0,0,19.367346938775512,56.67024999786951,CLU,Fibro-MSC,1.2707768875084013
GO_Biological_Process_2021,microglial cell activation (GO:0001774),1/22,0.0536071985992547,0.1611424665542287,0,0,19.367346938775512,56.67024999786951,CLU,Fibro-MSC,1.2707768875084013
GO_Biological_Process_2021,phosphatidylserine acyl-chain remodeling (GO:0036150),1/22,0.0536071985992547,0.1611424665542287,0,0,19.367346938775512,56.67024999786951,PLA2G2A,Fibro-MSC,1.2707768875084013
GO_Biological_Process_2021,brain development (GO:0007420),2/150,0.0541636617411515,0.1611424665542287,0,0,5.574887387387387,16.25495026487543,SIX3;ZIC1,Fibro-MSC,1.2662919827974375
GO_Biological_Process_2021,regulation of SMAD protein signal transduction (GO:0060390),1/23,0.0559757805878795,0.1611424665542287,0,0,18.4860853432282,53.29235549319145,CILP,Fibro-MSC,1.2519998414265567
GO_Biological_Process_2021,hyaluronan metabolic process (GO:0030212),1/23,0.0559757805878795,0.1611424665542287,0,0,18.4860853432282,53.29235549319145,HAS1,Fibro-MSC,1.2519998414265567
GO_Biological_Process_2021,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.0559757805878795,0.1611424665542287,0,0,18.4860853432282,53.29235549319145,SIX3,Fibro-MSC,1.2519998414265567
GO_Biological_Process_2021,regulation of peptidase activity (GO:0052547),1/23,0.0559757805878795,0.1611424665542287,0,0,18.4860853432282,53.29235549319145,ECM1,Fibro-MSC,1.2519998414265567
GO_Biological_Process_2021,ear morphogenesis (GO:0042471),1/23,0.0559757805878795,0.1611424665542287,0,0,18.4860853432282,53.29235549319145,ZIC1,Fibro-MSC,1.2519998414265567
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),2/154,0.0567455048100272,0.1611424665542287,0,0,5.427083333333333,15.571272642043729,NOX4;CLU,Fibro-MSC,1.2460685361352464
GO_Biological_Process_2021,negative regulation of neuron differentiation (GO:0045665),1/24,0.0583385530130099,0.1611424665542287,0,0,17.68145519077196,50.24171555062859,SIX3,Fibro-MSC,1.2340443470047993
GO_Biological_Process_2021,negative regulation of ossification (GO:0030279),1/24,0.0583385530130099,0.1611424665542287,0,0,17.68145519077196,50.24171555062859,ECM1,Fibro-MSC,1.2340443470047993
GO_Biological_Process_2021,inner ear morphogenesis (GO:0042472),1/24,0.0583385530130099,0.1611424665542287,0,0,17.68145519077196,50.24171555062859,ZIC1,Fibro-MSC,1.2340443470047993
GO_Biological_Process_2021,sulfur amino acid metabolic process (GO:0000096),1/24,0.0583385530130099,0.1611424665542287,0,0,17.68145519077196,50.24171555062859,NOX4,Fibro-MSC,1.2340443470047993
GO_Biological_Process_2021,"wound healing, spreading of cells (GO:0044319)",1/24,0.0583385530130099,0.1611424665542287,0,0,17.68145519077196,50.24171555062859,PDPN,Fibro-MSC,1.2340443470047993
GO_Biological_Process_2021,dorsal/ventral pattern formation (GO:0009953),1/24,0.0583385530130099,0.1611424665542287,0,0,17.68145519077196,50.24171555062859,SIX3,Fibro-MSC,1.2340443470047993
GO_Biological_Process_2021,endocrine system development (GO:0035270),1/24,0.0583385530130099,0.1611424665542287,0,0,17.68145519077196,50.24171555062859,SIX3,Fibro-MSC,1.2340443470047993
GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),2/158,0.0593699722530508,0.1617357353550085,0,0,5.2868589743589745,14.929913680908546,CILP;HAS1,Fibro-MSC,1.2264331540442923
GO_Biological_Process_2021,cAMP-mediated signaling (GO:0019933),1/25,0.0606955298241754,0.1617357353550085,0,0,16.943877551020407,47.47480020477031,DEFB1,Fibro-MSC,1.2168432931781568
GO_Biological_Process_2021,cellular polysaccharide biosynthetic process (GO:0033692),1/25,0.0606955298241754,0.1617357353550085,0,0,16.943877551020407,47.47480020477031,HAS1,Fibro-MSC,1.2168432931781568
GO_Biological_Process_2021,negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/25,0.0606955298241754,0.1617357353550085,0,0,16.943877551020407,47.47480020477031,CLU,Fibro-MSC,1.2168432931781568
GO_Biological_Process_2021,regulation of neutrophil chemotaxis (GO:0090022),1/25,0.0606955298241754,0.1617357353550085,0,0,16.943877551020407,47.47480020477031,THBS4,Fibro-MSC,1.2168432931781568
GO_Biological_Process_2021,phosphatidylglycerol metabolic process (GO:0046471),1/25,0.0606955298241754,0.1617357353550085,0,0,16.943877551020407,47.47480020477031,PLA2G2A,Fibro-MSC,1.2168432931781568
GO_Biological_Process_2021,regulation of biomineral tissue development (GO:0070167),1/26,0.0630467249540435,0.1650876670761949,0,0,16.26530612244898,44.95534064809558,ECM1,Fibro-MSC,1.2003374685092782
GO_Biological_Process_2021,retinoic acid metabolic process (GO:0042573),1/26,0.0630467249540435,0.1650876670761949,0,0,16.26530612244898,44.95534064809558,CYP27C1,Fibro-MSC,1.2003374685092782
GO_Biological_Process_2021,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/26,0.0630467249540435,0.1650876670761949,0,0,16.26530612244898,44.95534064809558,PLA2G2A,Fibro-MSC,1.2003374685092782
GO_Biological_Process_2021,negative regulation of catalytic activity (GO:0043086),1/27,0.0653921522588676,0.1654896367221621,0,0,15.638932496075354,42.652889831563165,SERPINA5,Fibro-MSC,1.184474368421492
GO_Biological_Process_2021,positive regulation of cellular component movement (GO:0051272),1/27,0.0653921522588676,0.1654896367221621,0,0,15.638932496075354,42.652889831563165,PDPN,Fibro-MSC,1.184474368421492
GO_Biological_Process_2021,regulation of epidermal growth factor-activated receptor activity (GO:0007176),1/27,0.0653921522588676,0.1654896367221621,0,0,15.638932496075354,42.652889831563165,BTC,Fibro-MSC,1.184474368421492
GO_Biological_Process_2021,positive regulation of nitric oxide biosynthetic process (GO:0045429),1/27,0.0653921522588676,0.1654896367221621,0,0,15.638932496075354,42.652889831563165,CLU,Fibro-MSC,1.184474368421492
GO_Biological_Process_2021,positive regulation of nuclear division (GO:0051785),1/27,0.0653921522588676,0.1654896367221621,0,0,15.638932496075354,42.652889831563165,BTC,Fibro-MSC,1.184474368421492
GO_Biological_Process_2021,microtubule polymerization or depolymerization (GO:0031109),1/27,0.0653921522588676,0.1654896367221621,0,0,15.638932496075354,42.652889831563165,TPPP3,Fibro-MSC,1.184474368421492
GO_Biological_Process_2021,amide transport (GO:0042886),1/28,0.0677318256109869,0.1658514432528489,0,0,15.058956916099774,40.54171043527237,PDPN,Fibro-MSC,1.1692072184717057
GO_Biological_Process_2021,keratan sulfate biosynthetic process (GO:0018146),1/28,0.0677318256109869,0.1658514432528489,0,0,15.058956916099774,40.54171043527237,OGN,Fibro-MSC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of nitric oxide metabolic process (GO:1904407),1/28,0.0677318256109869,0.1658514432528489,0,0,15.058956916099774,40.54171043527237,CLU,Fibro-MSC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of protein import into nucleus (GO:0042307),1/28,0.0677318256109869,0.1658514432528489,0,0,15.058956916099774,40.54171043527237,ZIC1,Fibro-MSC,1.1692072184717057
GO_Biological_Process_2021,regulation of immunoglobulin production (GO:0002637),1/28,0.0677318256109869,0.1658514432528489,0,0,15.058956916099774,40.54171043527237,RBP4,Fibro-MSC,1.1692072184717057
GO_Biological_Process_2021,mucosal immune response (GO:0002385),1/28,0.0677318256109869,0.1658514432528489,0,0,15.058956916099774,40.54171043527237,DEFB1,Fibro-MSC,1.1692072184717057
GO_Biological_Process_2021,negative regulation of epithelial to mesenchymal transition (GO:0010719),1/29,0.0700657588372089,0.1688036642037757,0,0,14.520408163265309,38.5999069065122,SFRP2,Fibro-MSC,1.1544941700666143
GO_Biological_Process_2021,limb development (GO:0060173),1/29,0.0700657588372089,0.1688036642037757,0,0,14.520408163265309,38.5999069065122,COMP,Fibro-MSC,1.1544941700666143
GO_Biological_Process_2021,dicarboxylic acid transport (GO:0006835),1/29,0.0700657588372089,0.1688036642037757,0,0,14.520408163265309,38.5999069065122,PDPN,Fibro-MSC,1.1544941700666143
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),4/625,0.0704280188399859,0.1688036642037757,0,0,2.7065742491073306,7.180985632016276,BTC;SFRP2;PDPN;CRLF1,Fibro-MSC,1.1522545282619854
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),2/176,0.0716793261504705,0.1699195153688359,0,0,4.735632183908046,12.48100918849243,PLA2G2A;DEFB1,Fibro-MSC,1.144606086081811
GO_Biological_Process_2021,positive regulation of protein import (GO:1904591),1/30,0.0723939657090184,0.1699195153688359,0,0,14.019000703729768,36.80874147674154,ZIC1,Fibro-MSC,1.1402976322627019
GO_Biological_Process_2021,microtubule polymerization (GO:0046785),1/30,0.0723939657090184,0.1699195153688359,0,0,14.019000703729768,36.80874147674154,TPPP3,Fibro-MSC,1.1402976322627019
GO_Biological_Process_2021,phosphatidylcholine acyl-chain remodeling (GO:0036151),1/30,0.0723939657090184,0.1699195153688359,0,0,14.019000703729768,36.80874147674154,PLA2G2A,Fibro-MSC,1.1402976322627019
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),2/180,0.0745195887056104,0.1700831978954287,0,0,4.628277153558052,12.018216055401329,ECM1;CLU,Fibro-MSC,1.1277295507615273
GO_Biological_Process_2021,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/31,0.0747164600026276,0.1700831978954287,0,0,13.551020408163266,35.15209038871121,SFRP2,Fibro-MSC,1.126583712764908
GO_Biological_Process_2021,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/31,0.0747164600026276,0.1700831978954287,0,0,13.551020408163266,35.15209038871121,CLU,Fibro-MSC,1.126583712764908
GO_Biological_Process_2021,regulation of macrophage derived foam cell differentiation (GO:0010743),1/31,0.0747164600026276,0.1700831978954287,0,0,13.551020408163266,35.15209038871121,PLA2G2A,Fibro-MSC,1.126583712764908
GO_Biological_Process_2021,vitamin transport (GO:0051180),1/31,0.0747164600026276,0.1700831978954287,0,0,13.551020408163266,35.15209038871121,PDPN,Fibro-MSC,1.126583712764908
GO_Biological_Process_2021,phosphatidylethanolamine metabolic process (GO:0046337),1/31,0.0747164600026276,0.1700831978954287,0,0,13.551020408163266,35.15209038871121,PLA2G2A,Fibro-MSC,1.126583712764908
GO_Biological_Process_2021,ERBB2 signaling pathway (GO:0038128),1/32,0.0770332554327668,0.1727527955992247,0,0,13.113232389730086,33.61600807740255,BTC,Fibro-MSC,1.1133217484244988
GO_Biological_Process_2021,regulation of cell morphogenesis (GO:0022604),1/32,0.0770332554327668,0.1727527955992247,0,0,13.113232389730086,33.61600807740255,PDPN,Fibro-MSC,1.1133217484244988
GO_Biological_Process_2021,superoxide metabolic process (GO:0006801),1/32,0.0770332554327668,0.1727527955992247,0,0,13.113232389730086,33.61600807740255,NOX4,Fibro-MSC,1.1133217484244988
GO_Biological_Process_2021,apoptotic mitochondrial changes (GO:0008637),1/33,0.0793443657059371,0.1744125270283988,0,0,12.70280612244898,32.18837516559274,CLU,Fibro-MSC,1.1004839073426347
GO_Biological_Process_2021,signal transduction by p53 class mediator (GO:0072331),1/33,0.0793443657059371,0.1744125270283988,0,0,12.70280612244898,32.18837516559274,ZNF385B,Fibro-MSC,1.1004839073426347
GO_Biological_Process_2021,keratan sulfate metabolic process (GO:0042339),1/33,0.0793443657059371,0.1744125270283988,0,0,12.70280612244898,32.18837516559274,OGN,Fibro-MSC,1.1004839073426347
GO_Biological_Process_2021,negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.0793443657059371,0.1744125270283988,0,0,12.70280612244898,32.18837516559274,OGN,Fibro-MSC,1.1004839073426347
GO_Biological_Process_2021,regulation of amyloid-beta formation (GO:1902003),1/34,0.0816498044624026,0.1744125270283988,0,0,12.317254174397032,30.85861216573232,CLU,Fibro-MSC,1.0880448509885652
GO_Biological_Process_2021,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),1/34,0.0816498044624026,0.1744125270283988,0,0,12.317254174397032,30.85861216573232,BTC,Fibro-MSC,1.0880448509885652
GO_Biological_Process_2021,regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.0816498044624026,0.1744125270283988,0,0,12.317254174397032,30.85861216573232,SFRP2,Fibro-MSC,1.0880448509885652
GO_Biological_Process_2021,negative regulation of mitochondrion organization (GO:0010823),1/34,0.0816498044624026,0.1744125270283988,0,0,12.317254174397032,30.85861216573232,CLU,Fibro-MSC,1.0880448509885652
GO_Biological_Process_2021,striated muscle tissue development (GO:0014706),1/34,0.0816498044624026,0.1744125270283988,0,0,12.317254174397032,30.85861216573232,RBP4,Fibro-MSC,1.0880448509885652
GO_Biological_Process_2021,phosphatidylserine metabolic process (GO:0006658),1/34,0.0816498044624026,0.1744125270283988,0,0,12.317254174397032,30.85861216573232,PLA2G2A,Fibro-MSC,1.0880448509885652
GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),2/191,0.0825129134198004,0.1744125270283988,0,0,4.356481481481482,10.868552054472469,SFRP2;SIX3,Fibro-MSC,1.083478078261104
GO_Biological_Process_2021,positive regulation of immunoglobulin production (GO:0002639),1/35,0.0839495853612937,0.1744125270283988,0,0,11.95438175270108,29.61744503578088,RBP4,Fibro-MSC,1.0759814445616303
GO_Biological_Process_2021,regulation of postsynaptic membrane potential (GO:0060078),1/35,0.0839495853612937,0.1744125270283988,0,0,11.95438175270108,29.61744503578088,GABRA4,Fibro-MSC,1.0759814445616303
GO_Biological_Process_2021,embryonic skeletal system development (GO:0048706),1/35,0.0839495853612937,0.1744125270283988,0,0,11.95438175270108,29.61744503578088,RBP4,Fibro-MSC,1.0759814445616303
GO_Biological_Process_2021,regulation of protein polymerization (GO:0032271),1/35,0.0839495853612937,0.1744125270283988,0,0,11.95438175270108,29.61744503578088,TPPP3,Fibro-MSC,1.0759814445616303
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),2/194,0.0847375162198589,0.1744125270283988,0,0,4.287760416666667,10.58303673172677,SFRP2;CILP,Fibro-MSC,1.0719242699529004
GO_Biological_Process_2021,positive regulation of mitotic nuclear division (GO:0045840),1/36,0.0862437219743075,0.1744125270283988,0,0,11.612244897959185,28.456712045041098,BTC,Fibro-MSC,1.0642725091375862
GO_Biological_Process_2021,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),1/36,0.0862437219743075,0.1744125270283988,0,0,11.612244897959185,28.456712045041098,ZNF385B,Fibro-MSC,1.0642725091375862
GO_Biological_Process_2021,macrophage activation (GO:0042116),1/36,0.0862437219743075,0.1744125270283988,0,0,11.612244897959185,28.456712045041098,CLU,Fibro-MSC,1.0642725091375862
GO_Biological_Process_2021,cyclic-nucleotide-mediated signaling (GO:0019935),1/36,0.0862437219743075,0.1744125270283988,0,0,11.612244897959185,28.456712045041098,DEFB1,Fibro-MSC,1.0642725091375862
GO_Biological_Process_2021,regulation of ossification (GO:0030278),1/36,0.0862437219743075,0.1744125270283988,0,0,11.612244897959185,28.456712045041098,ECM1,Fibro-MSC,1.0642725091375862
GO_Biological_Process_2021,regulation of protein import into nucleus (GO:0042306),1/36,0.0862437219743075,0.1744125270283988,0,0,11.612244897959185,28.456712045041098,ZIC1,Fibro-MSC,1.0642725091375862
GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),2/198,0.0877321663879582,0.1766340949944226,0,0,4.199404761904762,10.219111519148855,ZIC1;CLU,Fibro-MSC,1.0568411463883935
GO_Biological_Process_2021,positive regulation of signaling receptor activity (GO:2000273),1/37,0.0885322278902676,0.1774561913021737,0,0,11.289115646258503,27.36920368672352,BTC,Fibro-MSC,1.0528986067362665
GO_Biological_Process_2021,positive regulation of insulin secretion (GO:0032024),1/38,0.0908151166313484,0.1804352975175476,0,0,10.983452840595698,26.34852930034076,RBP4,Fibro-MSC,1.0418418549683985
GO_Biological_Process_2021,positive regulation of production of molecular mediator of immune response (GO:0002702),1/38,0.0908151166313484,0.1804352975175476,0,0,10.983452840595698,26.34852930034076,RBP4,Fibro-MSC,1.0418418549683985
GO_Biological_Process_2021,regulation of protein tyrosine kinase activity (GO:0061097),1/39,0.0930924017046572,0.1833515564009118,0,0,10.693877551020408,25.38900533231373,NOX4,Fibro-MSC,1.0310857651239858
GO_Biological_Process_2021,regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.0930924017046572,0.1833515564009118,0,0,10.693877551020408,25.38900533231373,CLU,Fibro-MSC,1.0310857651239858
GO_Biological_Process_2021,negative regulation of ERBB signaling pathway (GO:1901185),1/40,0.0953640965755271,0.1846151100372385,0,0,10.419152276295131,24.485561288951835,BTC,Fibro-MSC,1.0206151011238414
GO_Biological_Process_2021,sulfur compound catabolic process (GO:0044273),1/40,0.0953640965755271,0.1846151100372385,0,0,10.419152276295131,24.485561288951835,OGN,Fibro-MSC,1.0206151011238414
GO_Biological_Process_2021,organic hydroxy compound transport (GO:0015850),1/40,0.0953640965755271,0.1846151100372385,0,0,10.419152276295131,24.485561288951835,RBP4,Fibro-MSC,1.0206151011238414
GO_Biological_Process_2021,regulation of nitric oxide biosynthetic process (GO:0045428),1/40,0.0953640965755271,0.1846151100372385,0,0,10.419152276295131,24.485561288951835,CLU,Fibro-MSC,1.0206151011238414
GO_Biological_Process_2021,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.0976302146847681,0.1874003697127117,0,0,10.158163265306122,23.633660200289185,CLU,Fibro-MSC,1.0104157556925017
GO_Biological_Process_2021,gluconeogenesis (GO:0006094),1/41,0.0976302146847681,0.1874003697127117,0,0,10.158163265306122,23.633660200289185,RBP4,Fibro-MSC,1.0104157556925017
GO_Biological_Process_2021,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),1/42,0.0998907694703361,0.1901282292859759,0,0,9.909905425584869,22.829231064333683,CLU,Fibro-MSC,1.00047464143678
GO_Biological_Process_2021,positive regulation of epithelial to mesenchymal transition (GO:0010718),1/42,0.0998907694703361,0.1901282292859759,0,0,9.909905425584869,22.829231064333683,PDPN,Fibro-MSC,1.00047464143678
GO_Biological_Process_2021,regulation of cell-substrate adhesion (GO:0010810),1/43,0.1021457742794159,0.1914617199860093,0,0,9.673469387755102,22.068611238785657,PDPN,Fibro-MSC,0.9907795952096249
GO_Biological_Process_2021,negative regulation of proteolysis (GO:0045861),1/43,0.1021457742794159,0.1914617199860093,0,0,9.673469387755102,22.068611238785657,ECM1,Fibro-MSC,0.9907795952096249
GO_Biological_Process_2021,positive regulation of peptide hormone secretion (GO:0090277),1/43,0.1021457742794159,0.1914617199860093,0,0,9.673469387755102,22.068611238785657,RBP4,Fibro-MSC,0.9907795952096249
GO_Biological_Process_2021,antibacterial humoral response (GO:0019731),1/44,0.1043952424647777,0.1914617199860093,0,0,9.448030374940672,21.34849709415977,DEFB1,Fibro-MSC,0.9813192926974915
GO_Biological_Process_2021,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/44,0.1043952424647777,0.1914617199860093,0,0,9.448030374940672,21.34849709415977,BTC,Fibro-MSC,0.9813192926974915
GO_Biological_Process_2021,branching morphogenesis of an epithelial tube (GO:0048754),1/44,0.1043952424647777,0.1914617199860093,0,0,9.448030374940672,21.34849709415977,SFRP2,Fibro-MSC,0.9813192926974915
GO_Biological_Process_2021,hexose biosynthetic process (GO:0019319),1/44,0.1043952424647777,0.1914617199860093,0,0,9.448030374940672,21.34849709415977,RBP4,Fibro-MSC,0.9813192926974915
GO_Biological_Process_2021,cardiac ventricle morphogenesis (GO:0003208),1/44,0.1043952424647777,0.1914617199860093,0,0,9.448030374940672,21.34849709415977,SFRP2,Fibro-MSC,0.9813192926974915
GO_Biological_Process_2021,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.1043952424647777,0.1914617199860093,0,0,9.448030374940672,21.34849709415977,CLU,Fibro-MSC,0.9813192926974915
GO_Biological_Process_2021,microtubule bundle formation (GO:0001578),1/45,0.1066391873529346,0.1947885156083847,0,0,9.232838589981448,20.665901611884028,TPPP3,Fibro-MSC,0.9720831731354668
GO_Biological_Process_2021,alpha-amino acid metabolic process (GO:1901605),1/46,0.1088776222085674,0.1972862514419242,0,0,9.02721088435374,20.01811780873028,NOX4,Fibro-MSC,0.9630613723103648
GO_Biological_Process_2021,positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.1088776222085674,0.1972862514419242,0,0,9.02721088435374,20.01811780873028,ZIC1,Fibro-MSC,0.9630613723103648
GO_Biological_Process_2021,epidermal growth factor receptor signaling pathway (GO:0007173),1/47,0.1111105603036554,0.1997344595934759,0,0,8.830523513753327,19.4026870705364,BTC,Fibro-MSC,0.9542446623584087
GO_Biological_Process_2021,positive regulation of neuron death (GO:1901216),1/47,0.1111105603036554,0.1997344595934759,0,0,8.830523513753327,19.4026870705364,CLU,Fibro-MSC,0.9542446623584087
GO_Biological_Process_2021,positive regulation of endocytosis (GO:0045807),1/48,0.1133380148369131,0.202134333547723,0,0,8.642205818497612,18.81737166641443,CLU,Fibro-MSC,0.9456243984787533
GO_Biological_Process_2021,phosphatidic acid biosynthetic process (GO:0006654),1/48,0.1133380148369131,0.202134333547723,0,0,8.642205818497612,18.81737166641443,PLA2G2A,Fibro-MSC,0.9456243984787533
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),4/742,0.1138085215723413,0.2021774912638064,0,0,2.2636974195828916,4.919552976765135,COMP;SFRP2;PDPN;CLU,Fibro-MSC,0.943825218316277
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),3/474,0.1149270413547105,0.2029018587483527,0,0,2.6397885892397346,5.711071147622478,BTC;SFRP2;CRLF1,Fibro-MSC,0.9395777734927033
GO_Biological_Process_2021,regulation of smooth muscle cell proliferation (GO:0048660),1/49,0.1155599990222406,0.2029018587483527,0,0,8.46173469387755,18.260130793597916,OGN,Fibro-MSC,0.9371924705024297
GO_Biological_Process_2021,aminoglycan biosynthetic process (GO:0006023),1/49,0.1155599990222406,0.2029018587483527,0,0,8.46173469387755,18.260130793597916,HAS1,Fibro-MSC,0.9371924705024297
GO_Biological_Process_2021,amino acid transport (GO:0006865),1/50,0.1177765260040411,0.2036365125184374,0,0,8.28862973760933,17.7290996615035,PDPN,Fibro-MSC,0.928941259997044
GO_Biological_Process_2021,regulation of complement activation (GO:0030449),1/50,0.1177765260040411,0.2036365125184374,0,0,8.28862973760933,17.7290996615035,CLU,Fibro-MSC,0.928941259997044
GO_Biological_Process_2021,chloride transmembrane transport (GO:1902476),1/50,0.1177765260040411,0.2036365125184374,0,0,8.28862973760933,17.7290996615035,GABRA4,Fibro-MSC,0.928941259997044
GO_Biological_Process_2021,phosphatidic acid metabolic process (GO:0046473),1/50,0.1177765260040411,0.2036365125184374,0,0,8.28862973760933,17.7290996615035,PLA2G2A,Fibro-MSC,0.928941259997044
GO_Biological_Process_2021,regulation of smoothened signaling pathway (GO:0008589),1/51,0.1199876089220907,0.2043398001567936,0,0,8.122448979591837,17.22257115519733,ZIC1,Fibro-MSC,0.9208636010741894
GO_Biological_Process_2021,regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.1199876089220907,0.2043398001567936,0,0,8.122448979591837,17.22257115519733,PDPN,Fibro-MSC,0.9208636010741894
GO_Biological_Process_2021,positive regulation of fat cell differentiation (GO:0045600),1/51,0.1199876089220907,0.2043398001567936,0,0,8.122448979591837,17.22257115519733,SFRP2,Fibro-MSC,0.9208636010741894
GO_Biological_Process_2021,cholesterol transport (GO:0030301),1/51,0.1199876089220907,0.2043398001567936,0,0,8.122448979591837,17.22257115519733,CLU,Fibro-MSC,0.9208636010741894
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),3/485,0.1208716599427582,0.2050743893410842,0,0,2.578087754921868,5.447566347932984,COMP;PDPN;CRLF1,Fibro-MSC,0.9176755136408634
GO_Biological_Process_2021,negative regulation of protein metabolic process (GO:0051248),1/52,0.1221932608707862,0.2057752683065656,0,0,7.962785114045619,16.738979733033663,CLU,Fibro-MSC,0.9129527453809976
GO_Biological_Process_2021,negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.1221932608707862,0.2057752683065656,0,0,7.962785114045619,16.738979733033663,CLU,Fibro-MSC,0.9129527453809976
GO_Biological_Process_2021,cardiac muscle tissue development (GO:0048738),1/53,0.1243934949128716,0.2079345136366452,0,0,7.809262166405024,16.276887238960814,RBP4,Fibro-MSC,0.9052023302345248
GO_Biological_Process_2021,regulation of immune effector process (GO:0002697),1/53,0.1243934949128716,0.2079345136366452,0,0,7.809262166405024,16.276887238960814,CLU,Fibro-MSC,0.9052023302345248
GO_Biological_Process_2021,glycosaminoglycan metabolic process (GO:0030203),1/54,0.1265883240687765,0.2100531531251126,0,0,7.661532537543319,15.834970375184442,HAS1,Fibro-MSC,0.8976063498190403
GO_Biological_Process_2021,regulation of humoral immune response (GO:0002920),1/54,0.1265883240687765,0.2100531531251126,0,0,7.661532537543319,15.834970375184442,CLU,Fibro-MSC,0.8976063498190403
GO_Biological_Process_2021,glycosaminoglycan catabolic process (GO:0006027),1/56,0.1309618198144747,0.2157298340943892,0,0,7.382189239332097,15.00687933540933,OGN,Fibro-MSC,0.8828552987007785
GO_Biological_Process_2021,Rho protein signal transduction (GO:0007266),1/56,0.1309618198144747,0.2157298340943892,0,0,7.382189239332097,15.00687933540933,PDPN,Fibro-MSC,0.8828552987007785
GO_Biological_Process_2021,regulation of bone mineralization (GO:0030500),1/57,0.1331405122852093,0.2169519858460425,0,0,7.25,14.618539131965724,ECM1,Fibro-MSC,0.8756897763447542
GO_Biological_Process_2021,renal system development (GO:0072001),1/57,0.1331405122852093,0.2169519858460425,0,0,7.25,14.618539131965724,RBP4,Fibro-MSC,0.8756897763447542
GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),1/57,0.1331405122852093,0.2169519858460425,0,0,7.25,14.618539131965724,BTC,Fibro-MSC,0.8756897763447542
GO_Biological_Process_2021,chordate embryonic development (GO:0043009),1/58,0.1353138517398134,0.2197031356205573,0,0,7.122448979591836,14.246025949065045,RBP4,Fibro-MSC,0.8686577434892403
GO_Biological_Process_2021,protein polymerization (GO:0051258),1/59,0.1374818510452552,0.2216344431441302,0,0,6.9992962702322306,13.8884471557023,TPPP3,Fibro-MSC,0.8617546291873563
GO_Biological_Process_2021,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/59,0.1374818510452552,0.2216344431441302,0,0,6.9992962702322306,13.8884471557023,CRLF1,Fibro-MSC,0.8617546291873563
GO_Biological_Process_2021,negative regulation of response to stimulus (GO:0048585),1/61,0.1418018805927374,0.227788127335142,0,0,6.76530612244898,13.214837540593155,CLU,Fibro-MSC,0.848318009451734
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),2/267,0.1436652916283004,0.2288109937568727,0,0,3.095125786163522,6.005376764494242,SFRP2;CILP,Fibro-MSC,0.8426481412255155
GO_Biological_Process_2021,glucose metabolic process (GO:0006006),1/62,0.1439539364695556,0.2288109937568727,0,0,6.654064904650385,12.897320592663672,RBP4,Fibro-MSC,0.8417764546925935
GO_Biological_Process_2021,response to retinoic acid (GO:0032526),1/62,0.1439539364695556,0.2288109937568727,0,0,6.654064904650385,12.897320592663672,RBP4,Fibro-MSC,0.8417764546925935
GO_Biological_Process_2021,negative regulation of endopeptidase activity (GO:0010951),1/63,0.1461007034145454,0.231411254009752,0,0,6.54641211323239,12.591756250239603,SERPINA5,Fibro-MSC,0.8353476931121088
GO_Biological_Process_2021,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.1482421941802595,0.2331726179293666,0,0,6.442176870748299,12.297522293260638,DEFB1,Fibro-MSC,0.8290281655096747
GO_Biological_Process_2021,diterpenoid metabolic process (GO:0016101),1/64,0.1482421941802595,0.2331726179293666,0,0,6.442176870748299,12.297522293260638,RBP4,Fibro-MSC,0.8290281655096747
GO_Biological_Process_2021,inorganic anion transmembrane transport (GO:0098661),1/65,0.1503784214913892,0.2357142731335616,0,0,6.341198979591836,12.01403781811508,GABRA4,Fibro-MSC,0.8228144782361342
GO_Biological_Process_2021,ERBB signaling pathway (GO:0038127),1/66,0.1525093979756266,0.2365984838457496,0,0,6.243328100470958,11.740759916332207,BTC,Fibro-MSC,0.8167033932798328
GO_Biological_Process_2021,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.2365984838457496,0,0,6.243328100470958,11.740759916332207,CLU,Fibro-MSC,0.8167033932798328
GO_Biological_Process_2021,embryonic organ development (GO:0048568),1/66,0.1525093979756266,0.2365984838457496,0,0,6.243328100470958,11.740759916332207,RBP4,Fibro-MSC,0.8167033932798328
GO_Biological_Process_2021,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/67,0.1546351363099914,0.2390775315645943,0,0,6.148423005565863,11.477180657220888,BTC,Fibro-MSC,0.8106918184915987
GO_Biological_Process_2021,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/68,0.1567556490806558,0.239091949607869,0,0,6.0563508985683825,11.222824361971773,CRLF1,Fibro-MSC,0.8047767993307415
GO_Biological_Process_2021,canonical Wnt signaling pathway (GO:0060070),1/68,0.1567556490806558,0.239091949607869,0,0,6.0563508985683825,11.222824361971773,SFRP2,Fibro-MSC,0.8047767993307415
GO_Biological_Process_2021,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/68,0.1567556490806558,0.239091949607869,0,0,6.0563508985683825,11.222824361971773,ASPN,Fibro-MSC,0.8047767993307415
GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.1567556490806558,0.239091949607869,0,0,6.0563508985683825,11.222824361971773,ZIC1,Fibro-MSC,0.8047767993307415
GO_Biological_Process_2021,positive regulation of protein polymerization (GO:0032273),1/69,0.158870948881139,0.2415051672589127,0,0,5.966986794717887,10.977245117600177,TPPP3,Fibro-MSC,0.7989555105590889
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),2/286,0.160174195271258,0.242671941330702,0,0,2.885269953051643,5.284352690216861,SFRP2;CLU,Fibro-MSC,0.7954074492629319
GO_Biological_Process_2021,carbohydrate homeostasis (GO:0033500),1/70,0.1609810482853106,0.243081382910819,0,0,5.880212954747116,10.740024519792764,RBP4,Fibro-MSC,0.7932252488723367
GO_Biological_Process_2021,gland development (GO:0048732),1/71,0.16308595979881,0.2438215834615873,0,0,5.795918367346939,10.51076961698872,SIX3,Fibro-MSC,0.7875834261109624
GO_Biological_Process_2021,negative regulation of neuron apoptotic process (GO:0043524),1/71,0.16308595979881,0.2438215834615873,0,0,5.795918367346939,10.51076961698872,CRLF1,Fibro-MSC,0.7875834261109624
GO_Biological_Process_2021,regulation of endopeptidase activity (GO:0052548),1/71,0.16308595979881,0.2438215834615873,0,0,5.795918367346939,10.51076961698872,SERPINA5,Fibro-MSC,0.7875834261109624
GO_Biological_Process_2021,negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.1651856959101235,0.2445396086512614,0,0,5.713998275366484,10.28911103101624,SFRP2,Fibro-MSC,0.78202756268309
GO_Biological_Process_2021,negative regulation of supramolecular fiber organization (GO:1902904),1/72,0.1651856959101235,0.2445396086512614,0,0,5.713998275366484,10.28911103101624,CLU,Fibro-MSC,0.78202756268309
GO_Biological_Process_2021,positive regulation of protein secretion (GO:0050714),1/72,0.1651856959101235,0.2445396086512614,0,0,5.713998275366484,10.28911103101624,RBP4,Fibro-MSC,0.78202756268309
GO_Biological_Process_2021,regulation of hydrolase activity (GO:0051336),1/73,0.1672802691231711,0.2460323438727159,0,0,5.634353741496598,10.074701240888364,SERPINA5,Fibro-MSC,0.7765552814899175
GO_Biological_Process_2021,defense response to Gram-negative bacterium (GO:0050829),1/73,0.1672802691231711,0.2460323438727159,0,0,5.634353741496598,10.074701240888364,DEFB1,Fibro-MSC,0.7765552814899175
GO_Biological_Process_2021,regulation of cell division (GO:0051302),1/76,0.1735331353639065,0.251956763845672,0,0,5.408163265306122,9.4717853003048,SFRP2,Fibro-MSC,0.7606175863963804
GO_Biological_Process_2021,positive regulation of growth (GO:0045927),1/76,0.1735331353639065,0.251956763845672,0,0,5.408163265306122,9.4717853003048,SFRP2,Fibro-MSC,0.7606175863963804
GO_Biological_Process_2021,chloride transport (GO:0006821),1/76,0.1735331353639065,0.251956763845672,0,0,5.408163265306122,9.4717853003048,GABRA4,Fibro-MSC,0.7606175863963804
GO_Biological_Process_2021,phospholipid metabolic process (GO:0006644),1/76,0.1735331353639065,0.251956763845672,0,0,5.408163265306122,9.4717853003048,PLA2G2A,Fibro-MSC,0.7606175863963804
GO_Biological_Process_2021,cellular response to UV (GO:0034644),1/77,0.1756071809118701,0.2525398506446893,0,0,5.336734693877551,9.283280446293812,MFAP4,Fibro-MSC,0.7554577289388229
GO_Biological_Process_2021,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.1756071809118701,0.2525398506446893,0,0,5.336734693877551,9.283280446293812,CLU,Fibro-MSC,0.7554577289388229
GO_Biological_Process_2021,phosphatidylcholine metabolic process (GO:0046470),1/77,0.1756071809118701,0.2525398506446893,0,0,5.336734693877551,9.283280446293812,PLA2G2A,Fibro-MSC,0.7554577289388229
GO_Biological_Process_2021,negative regulation of apoptotic signaling pathway (GO:2001234),1/78,0.1776761254379788,0.2533995030837303,0,0,5.267161410018553,9.10056411919043,CLU,Fibro-MSC,0.7503709249641564
GO_Biological_Process_2021,negative regulation of blood vessel morphogenesis (GO:2000181),1/78,0.1776761254379788,0.2533995030837303,0,0,5.267161410018553,9.10056411919043,THBS4,Fibro-MSC,0.7503709249641564
GO_Biological_Process_2021,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/79,0.1797399811935544,0.2533995030837303,0,0,5.199372056514914,8.923391206941128,CLU,Fibro-MSC,0.745355308086215
GO_Biological_Process_2021,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.1797399811935544,0.2533995030837303,0,0,5.199372056514914,8.923391206941128,CLU,Fibro-MSC,0.745355308086215
GO_Biological_Process_2021,regulation of neuron differentiation (GO:0045664),1/79,0.1797399811935544,0.2533995030837303,0,0,5.199372056514914,8.923391206941128,SIX3,Fibro-MSC,0.745355308086215
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),2/310,0.181502535739734,0.2533995030837303,0,0,2.6571969696969697,4.53446850958879,SFRP2;CLU,Fibro-MSC,0.7411173031343081
GO_Biological_Process_2021,negative regulation of cellular component organization (GO:0051129),1/80,0.181798760490535,0.2533995030837303,0,0,5.133298889175924,8.751529842637671,CLU,Fibro-MSC,0.7404090821369118
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2533995030837303,0,0,5.133298889175924,8.751529842637671,SFRP2,Fibro-MSC,0.7404090821369118
GO_Biological_Process_2021,glycerophospholipid metabolic process (GO:0006650),1/80,0.181798760490535,0.2533995030837303,0,0,5.133298889175924,8.751529842637671,PLA2G2A,Fibro-MSC,0.7404090821369118
GO_Biological_Process_2021,regulation of fat cell differentiation (GO:0045598),1/80,0.181798760490535,0.2533995030837303,0,0,5.133298889175924,8.751529842637671,SFRP2,Fibro-MSC,0.7404090821369118
GO_Biological_Process_2021,positive regulation of cellular amide metabolic process (GO:0034250),1/81,0.1838524754991919,0.2546947137649356,0,0,5.0688775510204085,8.584760541358477,CLU,Fibro-MSC,0.7355305181562768
GO_Biological_Process_2021,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.1838524754991919,0.2546947137649356,0,0,5.0688775510204085,8.584760541358477,CLU,Fibro-MSC,0.7355305181562768
GO_Biological_Process_2021,positive regulation of protein ubiquitination (GO:0031398),1/82,0.1859011384602527,0.2567476089100441,0,0,5.00604686318972,8.422875391899517,SPSB4,Fibro-MSC,0.7307179505966239
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),2/322,0.1923280195400404,0.263971823793519,0,0,2.5559895833333335,4.213684115542283,SFRP2;CILP,Fibro-MSC,0.7159574404356035
GO_Biological_Process_2021,negative regulation of cellular amide metabolic process (GO:0034249),1/86,0.1940455128548384,0.263971823793519,0,0,4.769507803121249,7.820383303288144,CLU,Fibro-MSC,0.7120963955156414
GO_Biological_Process_2021,glucose homeostasis (GO:0042593),1/86,0.1940455128548384,0.263971823793519,0,0,4.769507803121249,7.820383303288144,RBP4,Fibro-MSC,0.7120963955156414
GO_Biological_Process_2021,positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.1940455128548384,0.263971823793519,0,0,4.769507803121249,7.820383303288144,CLU,Fibro-MSC,0.7120963955156414
GO_Biological_Process_2021,regulation of neuron death (GO:1901214),1/86,0.1940455128548384,0.263971823793519,0,0,4.769507803121249,7.820383303288144,CLU,Fibro-MSC,0.7120963955156414
GO_Biological_Process_2021,negative regulation of angiogenesis (GO:0016525),1/87,0.196069097589664,0.2659260515213108,0,0,4.713811105837684,7.6801565438185,THBS4,Fibro-MSC,0.7075908500030543
GO_Biological_Process_2021,positive regulation of inflammatory response (GO:0050729),1/89,0.2001013407742902,0.2697794862224806,0,0,4.6062152133580705,7.411084001248333,PLA2G2A,Fibro-MSC,0.6987500013741589
GO_Biological_Process_2021,protein import (GO:0017038),1/89,0.2001013407742902,0.2697794862224806,0,0,4.6062152133580705,7.411084001248333,CLU,Fibro-MSC,0.6987500013741589
GO_Biological_Process_2021,positive regulation of supramolecular fiber organization (GO:1902905),1/91,0.2041137620931186,0.2743725051281386,0,0,4.503401360544218,7.156255051106618,CLU,Fibro-MSC,0.6901277125812961
GO_Biological_Process_2021,positive regulation of cellular component biogenesis (GO:0044089),1/92,0.2061125694363157,0.2754247609281742,0,0,4.453689167974883,7.03385741012878,CLU,Fibro-MSC,0.6858955226779435
GO_Biological_Process_2021,Wnt signaling pathway (GO:0016055),1/92,0.2061125694363157,0.2754247609281742,0,0,4.453689167974883,7.03385741012878,SFRP2,Fibro-MSC,0.6858955226779435
GO_Biological_Process_2021,regulation of epithelial cell proliferation (GO:0050678),1/93,0.2081064570390282,0.2756497808148531,0,0,4.40505767524401,6.914643337844717,SFRP2,Fibro-MSC,0.6817144444740324
GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.2081064570390282,0.2756497808148531,0,0,4.40505767524401,6.914643337844717,SFRP2,Fibro-MSC,0.6817144444740324
GO_Biological_Process_2021,visual perception (GO:0007601),1/93,0.2081064570390282,0.2756497808148531,0,0,4.40505767524401,6.914643337844717,SIX3,Fibro-MSC,0.6817144444740324
GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),1/94,0.2100954368002021,0.2774729821297129,0,0,4.357472021066491,6.79849904676328,CLU,Fibro-MSC,0.6775833802166729
GO_Biological_Process_2021,regulation of cell cycle phase transition (GO:1901987),1/95,0.2120795205832498,0.278469631374528,0,0,4.310898827616153,6.685315939697291,SIX3,Fibro-MSC,0.6735012670190429
GO_Biological_Process_2021,sensory perception of light stimulus (GO:0050953),1/95,0.2120795205832498,0.278469631374528,0,0,4.310898827616153,6.685315939697291,SIX3,Fibro-MSC,0.6735012670190429
GO_Biological_Process_2021,positive regulation of defense response (GO:0031349),1/98,0.2180025137484037,0.282966013547355,0,0,4.176940879444562,6.362519703204576,PLA2G2A,Fibro-MSC,0.6615384985937142
GO_Biological_Process_2021,negative regulation of neuron death (GO:1901215),1/98,0.2180025137484037,0.282966013547355,0,0,4.176940879444562,6.362519703204576,CRLF1,Fibro-MSC,0.6615384985937142
GO_Biological_Process_2021,regulation of neuron apoptotic process (GO:0043523),1/98,0.2180025137484037,0.282966013547355,0,0,4.176940879444562,6.362519703204576,CRLF1,Fibro-MSC,0.6615384985937142
GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.2180025137484037,0.282966013547355,0,0,4.176940879444562,6.362519703204576,SFRP2,Fibro-MSC,0.6615384985937142
GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),2/351,0.2188220798658953,0.2832182919407159,0,0,2.3401384909264564,3.5558317785950937,MFAP4;TPPP3,Fibro-MSC,0.6599088583892734
GO_Biological_Process_2021,response to UV (GO:0009411),1/99,0.2199671313012003,0.2833847622193428,0,0,4.134110787172012,6.26018948804807,MFAP4,Fibro-MSC,0.6576422090003602
GO_Biological_Process_2021,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1/100,0.2219269115603851,0.2833847622193428,0,0,4.092145949288806,6.1603458876211565,ASPN,Fibro-MSC,0.6537900306498672
GO_Biological_Process_2021,organic acid transport (GO:0015849),1/100,0.2219269115603851,0.2833847622193428,0,0,4.092145949288806,6.1603458876211565,PDPN,Fibro-MSC,0.6537900306498672
GO_Biological_Process_2021,epithelial cell differentiation (GO:0030855),1/101,0.2238818662412048,0.2833847622193428,0,0,4.051020408163265,6.062906014187368,SIX3,Fibro-MSC,0.6499810815451941
GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),1/101,0.2238818662412048,0.2833847622193428,0,0,4.051020408163265,6.062906014187368,BTC,Fibro-MSC,0.6499810815451941
GO_Biological_Process_2021,cellular response to chemical stress (GO:0062197),1/101,0.2238818662412048,0.2833847622193428,0,0,4.051020408163265,6.062906014187368,NOX4,Fibro-MSC,0.6499810815451941
GO_Biological_Process_2021,positive regulation of cell growth (GO:0030307),1/102,0.2258320069783284,0.2833847622193428,0,0,4.010709234188725,5.967790506031058,SFRP2,Fibro-MSC,0.6462145058611213
GO_Biological_Process_2021,regulation of cell death (GO:0010941),1/102,0.2258320069783284,0.2833847622193428,0,0,4.010709234188725,5.967790506031058,CLU,Fibro-MSC,0.6462145058611213
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2833847622193428,0,0,4.010709234188725,5.967790506031058,DEFB1,Fibro-MSC,0.6462145058611213
GO_Biological_Process_2021,intrinsic apoptotic signaling pathway (GO:0097193),1/102,0.2258320069783284,0.2833847622193428,0,0,4.010709234188725,5.967790506031058,ZNF385B,Fibro-MSC,0.6462145058611213
GO_Biological_Process_2021,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/102,0.2258320069783284,0.2833847622193428,0,0,4.010709234188725,5.967790506031058,CLU,Fibro-MSC,0.6462145058611213
GO_Biological_Process_2021,regulation of insulin secretion (GO:0050796),1/104,0.2297178930745814,0.2874646562507884,0,0,3.932435109966317,5.78423168094792,RBP4,Fibro-MSC,0.6388051756325536
GO_Biological_Process_2021,regulation of cell cycle process (GO:0010564),1/106,0.2335846623503299,0.291498214999172,0,0,3.857142857142857,5.6090983677319475,SIX3,Fibro-MSC,0.6315556772929499
GO_Biological_Process_2021,protein transport (GO:0015031),2/369,0.2354374823833979,0.2930032404386793,0,0,2.2233197093551316,3.215609236148146,CLU;LRP1B,Fibro-MSC,0.6281243949487266
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.2944987792077106,0,0,2.2110433604336044,3.18053102486219,SFRP2;THBS4,Fibro-MSC,0.6247218387200065
GO_Biological_Process_2021,response to endoplasmic reticulum stress (GO:0034976),1/110,0.241261218690496,0.2986101969038107,0,0,3.714847406852649,5.282048795926194,THBS4,Fibro-MSC,0.6175124827423236
GO_Biological_Process_2021,regulation of Wnt signaling pathway (GO:0030111),1/111,0.2431685532271013,0.3001508300051141,0,0,3.6808905380333954,5.20478084558139,SFRP2,Fibro-MSC,0.6140925891155178
GO_Biological_Process_2021,phosphatidylinositol metabolic process (GO:0046488),1/112,0.2450711886958998,0.3014296009626974,0,0,3.647545504688362,5.129202360192396,PLA2G2A,Fibro-MSC,0.6107077427090284
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),2/381,0.2465612635256485,0.3014296009626974,0,0,2.15160510114336,3.012558657024939,COMP;PDPN,Fibro-MSC,0.6080751530383309
GO_Biological_Process_2021,sulfur compound biosynthetic process (GO:0044272),1/113,0.2469691364760274,0.3014296009626974,0,0,3.614795918367347,5.055262825364014,OGN,Fibro-MSC,0.6073573167632206
GO_Biological_Process_2021,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.3014296009626974,0,0,3.582625970742279,4.982913653406146,SFRP2,Fibro-MSC,0.6040407011916724
GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.3014296009626974,0,0,3.582625970742279,4.982913653406146,CLU,Fibro-MSC,0.6040407011916724
GO_Biological_Process_2021,response to lipid (GO:0033993),1/114,0.2488624078588274,0.3014296009626974,0,0,3.582625970742279,4.982913653406146,RBP4,Fibro-MSC,0.6040407011916724
GO_Biological_Process_2021,cellular response to transforming growth factor beta stimulus (GO:0071560),1/114,0.2488624078588274,0.3014296009626974,0,0,3.582625970742279,4.982913653406146,CILP,Fibro-MSC,0.6040407011916724
GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),1/115,0.2507510141385882,0.3029072250794146,0,0,3.5510204081632653,4.9121080927455,CLU,Fibro-MSC,0.6007573018413346
GO_Biological_Process_2021,regulation of protein-containing complex assembly (GO:0043254),1/116,0.2526349665899778,0.3043713826203723,0,0,3.5199645075421473,4.8428011439058265,CLU,Fibro-MSC,0.5975065399797567
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),1/124,0.2675403902734135,0.3206238010419479,0,0,3.2896963663514187,4.337414433160371,CLU,Fibro-MSC,0.5726106437410472
GO_Biological_Process_2021,non-canonical Wnt signaling pathway (GO:0035567),1/124,0.2675403902734135,0.3206238010419479,0,0,3.2896963663514187,4.337414433160371,SFRP2,Fibro-MSC,0.5726106437410472
GO_Biological_Process_2021,cellular response to oxidative stress (GO:0034599),1/125,0.2693829605231016,0.3213113822825054,0,0,3.263001974983542,4.279822783786303,NOX4,Fibro-MSC,0.5696298784899082
GO_Biological_Process_2021,negative regulation of cell growth (GO:0030308),1/126,0.2712209880572274,0.3213113822825054,0,0,3.236734693877551,4.223360488574632,SFRP2,Fibro-MSC,0.5666767062328689
GO_Biological_Process_2021,negative regulation of growth (GO:0045926),1/126,0.2712209880572274,0.3213113822825054,0,0,3.236734693877551,4.223360488574632,SFRP2,Fibro-MSC,0.5666767062328689
GO_Biological_Process_2021,circulatory system development (GO:0072359),1/126,0.2712209880572274,0.3213113822825054,0,0,3.236734693877551,4.223360488574632,RBP4,Fibro-MSC,0.5666767062328689
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),2/408,0.2716606168083876,0.3213113822825054,0,0,2.0057471264367814,2.6138931132295458,SFRP2;PDPN,Fibro-MSC,0.5659733175722854
GO_Biological_Process_2021,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.2785278903472666,0.3285758706440411,0,0,3.135738016136687,4.008216604624779,SFRP2,Fibro-MSC,0.5551313103019286
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),4/1079,0.2833172179011324,0.3332494545502703,0,0,1.5267947421638015,1.925575356569311,SFRP2;DLX4;CILP;CLU,Fibro-MSC,0.5477270315076967
GO_Biological_Process_2021,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3332494545502703,0,0,3.0640074211502784,3.857336278341556,BTC,Fibro-MSC,0.546741450090894
GO_Biological_Process_2021,organic substance transport (GO:0071702),1/136,0.289353816496661,0.3387009789999675,0,0,2.99546485260771,3.714691124222948,LRP1B,Fibro-MSC,0.5385707850387818
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.344077922568424,0,0,2.929902395740905,3.579678317757992,PLA2G2A,Fibro-MSC,0.5306096689947516
GO_Biological_Process_2021,Ras protein signal transduction (GO:0007265),1/142,0.3000204969826995,0.3493811957150717,0,0,2.8671298306556667,3.4517504575709377,PDPN,Fibro-MSC,0.522849073872343
GO_Biological_Process_2021,monocarboxylic acid metabolic process (GO:0032787),1/143,0.3017829564686885,0.350532510975169,0,0,2.8467950560505892,3.410594866305226,CYP27C1,Fibro-MSC,0.5203052911363482
GO_Biological_Process_2021,nervous system development (GO:0007399),2/447,0.3078904676985005,0.356711974085475,0,0,1.826310861423221,2.1514146195112085,ZIC1;HAPLN1,Fibro-MSC,0.5116037566636256
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.3087894082520855,0.356840821270905,0,0,2.7682415431926195,3.252948903166252,BDKRB1,Fibro-MSC,0.5103376047629952
GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3570309463113664,0,0,2.749271137026239,3.215201203875706,ZIC1,Fibro-MSC,0.5078961191737069
GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),1/148,0.3105302270346101,0.3570309463113664,0,0,2.749271137026239,3.215201203875706,BDKRB1,Fibro-MSC,0.5078961191737069
GO_Biological_Process_2021,negative regulation of protein phosphorylation (GO:0001933),1/152,0.3174506378807152,0.3640636429366177,0,0,2.6759021489390458,3.0704182805545575,SFRP2,Fibro-MSC,0.4983237959237088
GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.3191700762858281,0.3651112236300003,0,0,2.6581632653061225,3.0357052873752,SFRP2,Fibro-MSC,0.4959778325880012
GO_Biological_Process_2021,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/155,0.3225962281219006,0.3681009857411107,0,0,2.6233766233766236,2.9679671260643183,CLU,Fibro-MSC,0.4913407148001928
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),2/464,0.3236043277850015,0.368323518810567,0,0,1.7575757575757576,1.982956235178162,SFRP2;SIX3,Fibro-MSC,0.48998567889976286
GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3778106506119985,0,0,2.524234693877551,2.7773973646136283,BTC,Fibro-MSC,0.4778511096570981
GO_Biological_Process_2021,heart development (GO:0007507),1/164,0.3378059691212722,0.3825652600298408,0,0,2.4774007762614247,2.6886824434754057,RBP4,Fibro-MSC,0.4713326805982654
GO_Biological_Process_2021,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/165,0.3394751386404204,0.3834968523793278,0,0,2.4621702339472376,2.6600168495918335,SFRP2,Fibro-MSC,0.46919202564454415
GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.388157834946999,0,0,2.4175730172308443,2.5766088705447237,CLU,Fibro-MSC,0.46286379212748074
GO_Biological_Process_2021,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.3494039111808349,0.3927542723695241,0,0,2.3745498199279713,2.4969025061029213,ECM1,Fibro-MSC,0.4566722378913039
GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.3510444250368044,0.3936215954001792,0,0,2.360544217687075,2.4711180018684864,PLA2G2A,Fibro-MSC,0.45463791963821665
GO_Biological_Process_2021,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.359186378521905,0.401756615976353,0,0,2.2929035250463823,2.3477357103628296,PLA2G2A,Fibro-MSC,0.44468014150624274
GO_Biological_Process_2021,protein stabilization (GO:0050821),1/179,0.3624150547196057,0.4043695068669492,0,0,2.266911258885577,2.300835957547096,CLU,Fibro-MSC,0.4407937700298507
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.405166104025555,0,0,2.2541329380914377,2.2778849681371156,CLU,Fibro-MSC,0.4388706874182523
GO_Biological_Process_2021,negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.3814549819175133,0.4235272225701802,0,0,2.122448979591837,2.045536603225051,SFRP2,Fibro-MSC,0.41855670871419515
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4276665724904881,0,0,2.089140319340171,1.988001678572607,CLU,Fibro-MSC,0.4132695879859197
GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),1/201,0.3968950010648283,0.4374407168679075,0,0,2.0153061224489797,1.8623111638641865,SPSB4,Fibro-MSC,0.40132437104403956
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),2/546,0.3979281971141292,0.4374407168679075,0,0,1.4863664215686274,1.3696624285648409,BTC;ECM1,Fibro-MSC,0.40019528574129115
GO_Biological_Process_2021,generation of neurons (GO:0048699),1/202,0.398418067592006,0.4374407168679075,0,0,2.0051781906792567,1.8452720554356252,SIX3,Fibro-MSC,0.39966097527446726
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/547,0.3988146050031916,0.4374407168679075,0,0,1.4835626911314983,1.3637777909312412,SFRP2;SIX3,Fibro-MSC,0.3992289457561903
GO_Biological_Process_2021,proteasomal protein catabolic process (GO:0010498),1/205,0.4029646862685204,0.4409251277285984,0,0,1.975390156062425,1.7954446526222323,SPSB4,Fibro-MSC,0.3947330115033212
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),1/206,0.4044727291727134,0.4415087863017811,0,0,1.9656545545047288,1.7792534267442264,PLA2G2A,Fibro-MSC,0.39311075456855427
GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4420855736851265,0,0,1.9560134733505052,1.7632653144438126,BTC,Fibro-MSC,0.3914985283218076
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4491358194405797,0,0,1.909178837411742,1.6862551884518755,PLA2G2A,Fibro-MSC,0.3835844547796231
GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4512697532918411,0,0,1.8910606496119575,1.656759537391559,SFRP2,Fibro-MSC,0.3804856946694876
GO_Biological_Process_2021,regulation of cell growth (GO:0001558),1/217,0.4208167942393084,0.4549642190701831,0,0,1.8645124716553287,1.613843141672166,SFRP2,Fibro-MSC,0.375906936392536
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",3/948,0.4248826431220218,0.4582662793673234,0,0,1.283687943262411,1.0987627875578752,SFRP2;DLX4;SIX3,Fibro-MSC,0.3717310099090599
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4590799112959922,0,0,1.8302411873840445,1.5589816483293069,PDPN,Fibro-MSC,0.3699278171231457
GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.462648064858772,0,0,1.805344559348403,1.519514184420898,ECM1,Fibro-MSC,0.36553500108915365
GO_Biological_Process_2021,inflammatory response (GO:0006954),1/230,0.4395663655385589,0.4707412850803007,0,0,1.7575082434720612,1.4446130242039086,NOX4,Fibro-MSC,0.35697554604801474
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.4508075224789805,0.4816410558560806,0,0,1.697494187548437,1.352418759111272,PLA2G2A,Fibro-MSC,0.34600884563424106
GO_Biological_Process_2021,membrane organization (GO:0061024),1/242,0.4563449373288627,0.4864100155528819,0,0,1.6689812854602422,1.3093263562491473,BTC,Fibro-MSC,0.3407067631514444
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.488190538059234,0,0,1.655076845553036,1.2884811006593149,GABRA4,Fibro-MSC,0.33809924509335265
GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.4618276248188864,0.4899482764472027,0,0,1.641399416909621,1.2680853834334544,CLU,Fibro-MSC,0.33552009275365935
GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.4988209831230193,0,0,1.5952380952380951,1.2000608149186214,SFRP2,Fibro-MSC,0.32670971902140344
GO_Biological_Process_2021,cellular component assembly (GO:0022607),1/261,0.4819092749521712,0.5088692343900549,0,0,1.5455259026687598,1.1282329953702568,HAS1,Fibro-MSC,0.31703471507296654
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.5186505465435983,0,0,1.498781602193116,1.0620843946744252,PDPN,Fibro-MSC,0.30775490655057164
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.524174560793087,0,0,1.4709576138147566,1.0233666205889618,PLA2G2A,Fibro-MSC,0.30214499188263844
GO_Biological_Process_2021,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.5602852663981011,0,0,1.32774699283687,0.8321996277505203,BTC,Fibro-MSC,0.2722052530518486
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.562692267807725,0,0,1.314486450317832,0.8152139890333826,GABRA4,Fibro-MSC,0.2693393582885023
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.5551458962416416,0.5794495184273356,0,0,1.2519132653061225,0.7367814077584223,SPSB4,Fibro-MSC,0.25559286623594474
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),1/345,0.5815093765862647,0.6041829073247199,0,0,1.1631466540104414,0.6305745813190116,PDPN,Fibro-MSC,0.23544327806907975
GO_Biological_Process_2021,post-translational protein modification (GO:0043687),1/345,0.5815093765862647,0.6041829073247199,0,0,1.1631466540104414,0.6305745813190116,SPSB4,Fibro-MSC,0.23544327806907975
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.5909956578792304,0.612633942835907,0,0,1.1329710354396716,0.5958822738188654,SPSB4,Fibro-MSC,0.22841570992418872
GO_Biological_Process_2021,gene expression (GO:0010467),1/356,0.5930749260701463,0.6133857112095349,0,0,1.126473124461052,0.5885084653208599,NOX4,Fibro-MSC,0.2268904366133749
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6409274626328191,0,0,1.042628017264347,0.4965325169788531,CLU,Fibro-MSC,0.20682480102083725
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),1/409,0.644552703427983,0.6635963060292643,0,0,0.9774909963985594,0.4293127610136149,SPSB4,Fibro-MSC,0.19074156570833578
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.663134010332821,0.6811784731990203,0,0,0.928642785785643,0.3814661952932429,DLX4,Fibro-MSC,0.17839869773857764
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),1/468,0.6943679720033368,0.7116486228902976,0,0,0.8514180832932745,0.3105575044475373,DLX4,Fibro-MSC,0.15841031937391015
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),1/482,0.7051444771556823,0.7194379462872164,0,0,0.8260426831855403,0.2885801301950252,CLU,Fibro-MSC,0.1517218912312197
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7194379462872164,0,0,0.8260426831855403,0.2885801301950252,CRLF1,Fibro-MSC,0.1517218912312197
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),1/511,0.7262961571675228,0.7393531667345795,0,0,0.7779111644657863,0.2487739813280452,ZIC1,Fibro-MSC,0.13888625368433627
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.7475188869047282,0,0,0.7565820221218258,0.231944503707841,SPSB4,Fibro-MSC,0.13314117322745964
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),1/621,0.7938341129137421,0.8044896043622487,0,0,0.6362738643844634,0.1469033967904298,CRLF1,Fibro-MSC,0.10027024237534503
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",2/1183,0.8038594904607679,0.8128311365596603,0,0,0.6621860005644934,0.1445755914280007,SFRP2;ZIC1,Fibro-MSC,0.09481985653812466
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),4/2206,0.8166523886858273,0.8239276883623159,0,0,0.7008648264423647,0.1419543867132323,SFRP2;DLX4;SIX3;ZIC1,Fibro-MSC,0.08796276329696344
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8303452396499437,0,0,0.5757014372366809,0.1108560647358729,DLX4,Fibro-MSC,0.0836269880293983
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",4/2244,0.8272634931131488,0.8309320673619877,0,0,0.6875,0.130372014787288,SFRP2;DLX4;SIX3;ZIC1,Fibro-MSC,0.08235614053342308
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),1/908,0.9023188918982462,0.9043151726325344,0,0,0.4284814256463335,0.0440424414337815,SFRP2,Fibro-MSC,0.044639949690669034
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),1/1025,0.9281942108891912,0.9281942108891912,0,0,0.3771922831632653,0.0281062148400667,SPSB4,Fibro-MSC,0.032361144586154744
KEGG_2021_Human,defense response to Gram-negative bacterium (GO:0050829),6/73,2.6831768558410273e-08,1.20206323141678e-05,0,0,40.4674355495251,705.4962917433171,CTSG;AZU1;RNASE3;LYZ;RNASE2;ELANE,GMP,7.5713507007963825
KEGG_2021_Human,defense response to bacterium (GO:0042742),7/176,2.632691296200134e-07,5.8972285034883e-05,0,0,19.054217696435945,288.6730943350905,CTSG;AZU1;RNASE3;LYZ;RNASE2;MPO;ELANE,GMP,6.579600062358726
KEGG_2021_Human,neutrophil degranulation (GO:0043312),9/481,2.6057990177154847e-06,0.000262730156848352,0,0,9.058598594460522,116.47338816676236,CTSG;PRTN3;AZU1;RNASE3;LYZ;RNASE2;MPO;CD33;ELANE,GMP,5.584059083966164
KEGG_2021_Human,neutrophil activation involved in immune response (GO:0002283),9/485,2.788268216461996e-06,0.000262730156848352,0,0,8.980631276901004,114.86308108315392,CTSG;PRTN3;AZU1;RNASE3;LYZ;RNASE2;MPO;CD33;ELANE,GMP,5.554665451762476
KEGG_2021_Human,neutrophil mediated immunity (GO:0002446),9/488,2.932256214825357e-06,0.000262730156848352,0,0,8.923010336575182,113.67681735773836,CTSG;PRTN3;AZU1;RNASE3;LYZ;RNASE2;MPO;CD33;ELANE,GMP,5.532798084568666
KEGG_2021_Human,proteolysis (GO:0006508),6/287,7.748561793803869e-05,0.0057855928060402,0,0,9.544969265609836,90.34712593704772,CPA3;PRSS57;CTSG;PRTN3;AZU1;ELANE,GMP,4.110778899168209
KEGG_2021_Human,induction of bacterial agglutination (GO:0043152),2/6,9.128927051395768e-05,0.0058425133128932,0,0,207.77083333333337,1932.5756890799971,RNASE3;RNASE2,GMP,4.039580263324499
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),8/621,0.00014018101446836373,0.0068774121486271,0,0,6.008545016701624,53.311272370313645,FLT3;F13A1;CTSG;PRTN3;FCGR1A;PRLR;EREG;CRLF2,GMP,3.853310801418973
KEGG_2021_Human,positive regulation of protein tyrosine kinase activity (GO:0061098),3/42,0.00015756854407171077,0.0068774121486271,0,0,32.58756137479542,285.32528155294955,FCGR1A;AREG;EREG,GMP,3.8025304778337556
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),7/474,0.0001662278374910961,0.0068774121486271,0,0,6.7915442458044915,59.10104487886197,FLT3;PRTN3;PRLR;AREG;ELANE;EREG;CRLF2,GMP,3.7792962449537546
KEGG_2021_Human,antibacterial humoral response (GO:0019731),3/44,0.0001811421903351466,0.0068774121486271,0,0,30.994810586403737,267.0583626754283,CTSG;RNASE3;RNASE2,GMP,3.74198038515947
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),7/482,0.0001842163968382279,0.0068774121486271,0,0,6.674418604651163,57.39599148842437,FLT3;F13A1;CTSG;PRTN3;PRLR;EREG;CRLF2,GMP,3.734671716487508
KEGG_2021_Human,cellular macromolecule catabolic process (GO:0044265),3/53,0.000315376219123607,0.0106260442644659,0,0,25.404255319148938,204.80261014345277,NEU4;RNASE3;RNASE2,GMP,3.501171057655084
KEGG_2021_Human,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),2/11,0.000332063883264561,0.0106260442644659,0,0,92.31944444444444,739.4956618223716,AREG;EREG,GMP,3.478778357620151
KEGG_2021_Human,angiotensin maturation (GO:0002003),2/12,0.0003978405023918531,0.0111395340669718,0,0,83.08333333333333,650.4975835514635,CPA3;CTSG,GMP,3.4002910053496507
KEGG_2021_Human,regulation of angiotensin levels in blood (GO:0002002),2/12,0.0003978405023918531,0.0111395340669718,0,0,83.08333333333333,650.4975835514635,CPA3;CTSG,GMP,3.4002910053496507
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),8/764,0.0005660791215212328,0.0149178497906771,0,0,4.835978835978836,36.15753387701381,FLT3;CDCA7;PRTN3;PRLR;AREG;CD33;EREG;CRLF2,GMP,3.2471228627365543
KEGG_2021_Human,defense response to Gram-positive bacterium (GO:0050830),3/70,0.0007152738836628206,0.0178023722156079,0,0,18.94220387424579,137.19544727387992,RNASE3;LYZ;RNASE2,GMP,3.145527631782337
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),7/625,0.0008747234504077011,0.0194873707998296,0,0,5.092345902009483,35.858277051349106,FLT3;PRTN3;AZU1;PRLR;AREG;EREG;CRLF2,GMP,3.058129230344244
KEGG_2021_Human,positive regulation of interleukin-6 production (GO:0032755),3/76,0.0009089746531003116,0.0194873707998296,0,0,17.38006412124745,121.71594945135638,C1QTNF4;RAB7B;EREG,GMP,3.041448226978414
KEGG_2021_Human,negative regulation of interleukin-8 production (GO:0032717),2/18,0.000913470506242016,0.0194873707998296,0,0,51.911458333333336,363.2898548418271,CD33;ELANE,GMP,3.039305470405725
KEGG_2021_Human,innate immune response in mucosa (GO:0002227),2/21,0.0012477930702112,0.0254096043388467,0,0,43.708333333333336,292.25047477799524,RNASE3;RNASE2,GMP,2.9038574306125264
KEGG_2021_Human,positive regulation of cytokine production (GO:0001819),5/335,0.001461927138891,0.0284757981836174,0,0,6.606060606060606,43.124362021157026,C1QTNF4;RAB7B;ELANE;EREG;CRLF2,GMP,2.8350742716778194
KEGG_2021_Human,dendritic cell differentiation (GO:0097028),2/24,0.0016321249773357,0.0304663329102678,0,0,37.74242424242424,242.22606459531664,FLT3;PRTN3,GMP,2.7872465889099036
KEGG_2021_Human,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),2/25,0.0017712212130127,0.0317402841371881,0,0,36.09963768115942,228.73040961874747,CEMIP;AZU1,GMP,2.751727195110795
KEGG_2021_Human,regulation of epidermal growth factor-activated receptor activity (GO:0007176),2/27,0.0020657293545543,0.0355941058015518,0,0,33.208333333333336,205.3029465636782,AREG;EREG,GMP,2.684926579003782
KEGG_2021_Human,mucosal immune response (GO:0002385),2/28,0.0022210873543451,0.0368535975832076,0,0,31.92948717948718,195.08145262248803,RNASE3;RNASE2,GMP,2.6534343605132076
KEGG_2021_Human,positive regulation of protein serine/threonine kinase activity (GO:0071902),3/106,0.0023667454978385,0.0378679279654161,0,0,12.299318322660609,74.36462396066707,CEMIP;FLT3;ELANE,GMP,2.625848440350125
KEGG_2021_Human,regulation of interleukin-6 production (GO:0032675),3/110,0.0026292225152408,0.0406169547182034,0,0,11.83714456154305,70.32527008978302,C1QTNF4;RAB7B;EREG,GMP,2.5801726573124935
KEGG_2021_Human,positive regulation of kinase activity (GO:0033674),3/114,0.00290902931217,0.0434415043950723,0,0,11.40828062104658,66.623626679358,FLT3;AZU1;EREG,GMP,2.536251902661656
KEGG_2021_Human,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),2/34,0.0032650074009337,0.0471846230844621,0,0,25.934895833333332,148.46413612460563,AREG;EREG,GMP,2.4861158299536776
KEGG_2021_Human,regulation of tumor necrosis factor production (GO:0032680),3/124,0.0036867515545537,0.0516145217637525,0,0,10.460172322841569,58.60844537950275,C1QTNF4;AZU1;CD33,GMP,2.433356127954467
KEGG_2021_Human,positive regulation of signaling receptor activity (GO:2000273),2/37,0.0038576315924392,0.0523702713155385,0,0,23.708333333333332,131.76384828572083,AREG;EREG,GMP,2.4136792502562754
KEGG_2021_Human,regulation of peptidyl-threonine phosphorylation (GO:0010799),2/39,0.0042784069542198,0.056374303396779,0,0,22.42454954954955,122.3074073504305,CEMIP;AZU1,GMP,2.368717908505425
KEGG_2021_Human,negative regulation of ERBB signaling pathway (GO:1901185),2/40,0.0044964248068071,0.0575542375271315,0,0,21.833333333333332,117.99765363023796,AREG;EREG,GMP,2.3471326648462743
KEGG_2021_Human,nucleobase-containing compound catabolic process (GO:0034655),2/41,0.0047194951697385,0.0587314954456356,0,0,21.272435897435894,113.93630347986566,RNASE3;RNASE2,GMP,2.3261044540613445
KEGG_2021_Human,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),2/44,0.0054187658916089,0.0656110032281305,0,0,19.75,103.05327189846057,AREG;EREG,GMP,2.266099611522887
KEGG_2021_Human,positive regulation of smooth muscle cell proliferation (GO:0048661),2/46,0.0059097422436154,0.0696727506615714,0,0,18.85037878787879,96.72417883948356,ELANE;EREG,GMP,2.2284314606782503
KEGG_2021_Human,epidermal growth factor receptor signaling pathway (GO:0007173),2/47,0.0061625935135597,0.0707908177967884,0,0,18.430555555555557,93.79784429037068,AREG;EREG,GMP,2.210236477513525
KEGG_2021_Human,regulation of smooth muscle cell proliferation (GO:0048660),2/49,0.0066828970303688,0.0716899446534811,0,0,17.64450354609929,88.36726791367238,ELANE;EREG,GMP,2.175035230405133
KEGG_2021_Human,RNA catabolic process (GO:0006401),2/49,0.0066828970303688,0.0716899446534811,0,0,17.64450354609929,88.36726791367238,RNASE3;RNASE2,GMP,2.175035230405133
KEGG_2021_Human,positive regulation of protein kinase activity (GO:0045860),3/154,0.0067341648445892,0.0716899446534811,0,0,8.369310976468931,41.85125407551329,AZU1;FCGR1A;EREG,GMP,2.171716256789745
KEGG_2021_Human,MAPK cascade (GO:0000165),4/303,0.006880954509151,0.0716899446534811,0,0,5.714992002326596,28.45493317732783,FLT3;ABHD17C;AREG;EREG,GMP,2.1623513133191365
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),5/485,0.0070959676294594,0.0722498522272236,0,0,4.506944444444445,22.30139137962044,CTSG;AZU1;PRLR;MPO;NTSR1,GMP,2.148988374345894
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),3/161,0.0076080983625269,0.0757428459202687,0,0,7.99569081605171,39.00731366496807,FLT3;AREG;EREG,GMP,2.118723881188083
KEGG_2021_Human,glycoprotein metabolic process (GO:0009100),2/55,0.0083588302127531,0.0814077377242046,0,0,15.642295597484276,74.83957451132376,NEU4;GAL3ST2,GMP,2.077854496208505
KEGG_2021_Human,regulation of phagocytosis (GO:0050764),2/58,0.0092602829393189,0.0882682288684022,0,0,14.802083333333334,69.30366021141536,PRTN3;AZU1,GMP,2.033375743652011
KEGG_2021_Human,protein catabolic process (GO:0030163),2/64,0.0111869000374274,0.0933421797224474,0,0,13.365591397849462,60.051760195429935,NEU4;ELANE,GMP,1.9512902426187388
KEGG_2021_Human,ERBB signaling pathway (GO:0038127),2/66,0.0118650634107129,0.0933421797224474,0,0,12.946614583333334,57.4073222604629,AREG;EREG,GMP,1.9257299364311244
KEGG_2021_Human,extracellular matrix disassembly (GO:0022617),2/66,0.0118650634107129,0.0933421797224474,0,0,12.946614583333334,57.4073222604629,CTSG;ELANE,GMP,1.9257299364311244
KEGG_2021_Human,cellular component disassembly (GO:0022411),2/66,0.0118650634107129,0.0933421797224474,0,0,12.946614583333334,57.4073222604629,CTSG;ELANE,GMP,1.9257299364311244
KEGG_2021_Human,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2/67,0.012210781302115,0.0933421797224474,0,0,12.746794871794872,56.15518906635068,AREG;EREG,GMP,1.9132565470017566
KEGG_2021_Human,camera-type eye photoreceptor cell differentiation (GO:0060219),1/5,0.0124387771927725,0.0933421797224474,0,0,101.76530612244898,446.4379351400606,PROM1,GMP,1.9052223113279663
KEGG_2021_Human,late endosome to Golgi transport (GO:0034499),1/5,0.0124387771927725,0.0933421797224474,0,0,101.76530612244898,446.4379351400606,RAB7B,GMP,1.9052223113279663
KEGG_2021_Human,positive regulation of protein kinase C activity (GO:1900020),1/5,0.0124387771927725,0.0933421797224474,0,0,101.76530612244898,446.4379351400606,CEMIP,GMP,1.9052223113279663
KEGG_2021_Human,mature conventional dendritic cell differentiation (GO:0097029),1/5,0.0124387771927725,0.0933421797224474,0,0,101.76530612244898,446.4379351400606,PRTN3,GMP,1.9052223113279663
KEGG_2021_Human,regulation of protein kinase C activity (GO:1900019),1/5,0.0124387771927725,0.0933421797224474,0,0,101.76530612244898,446.4379351400606,CEMIP,GMP,1.9052223113279663
KEGG_2021_Human,positive regulation of MAP kinase activity (GO:0043406),2/69,0.0129153730394233,0.0933421797224474,0,0,12.36504975124378,53.77976800231812,FLT3;ELANE,GMP,1.888893045423814
KEGG_2021_Human,peptidyl-tyrosine phosphorylation (GO:0018108),2/69,0.0129153730394233,0.0933421797224474,0,0,12.36504975124378,53.77976800231812,FLT3;PRLR,GMP,1.888893045423814
KEGG_2021_Human,activation of Janus kinase activity (GO:0042976),1/6,0.0149082847993736,0.0933421797224474,0,0,81.40816326530613,342.3895623444841,PRLR,GMP,1.8265723193247598
KEGG_2021_Human,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.0149082847993736,0.0933421797224474,0,0,81.40816326530613,342.3895623444841,PRLR,GMP,1.8265723193247598
KEGG_2021_Human,aromatic amino acid transport (GO:0015801),1/6,0.0149082847993736,0.0933421797224474,0,0,81.40816326530613,342.3895623444841,SLC16A10,GMP,1.8265723193247598
KEGG_2021_Human,glomerular epithelial cell differentiation (GO:0072311),1/6,0.0149082847993736,0.0933421797224474,0,0,81.40816326530613,342.3895623444841,PROM1,GMP,1.8265723193247598
KEGG_2021_Human,positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),1/6,0.0149082847993736,0.0933421797224474,0,0,81.40816326530613,342.3895623444841,PROM1,GMP,1.8265723193247598
KEGG_2021_Human,renal filtration cell differentiation (GO:0061318),1/6,0.0149082847993736,0.0933421797224474,0,0,81.40816326530613,342.3895623444841,PROM1,GMP,1.8265723193247598
KEGG_2021_Human,neutrophil extravasation (GO:0072672),1/6,0.0149082847993736,0.0933421797224474,0,0,81.40816326530613,342.3895623444841,PRTN3,GMP,1.8265723193247598
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),3/207,0.0149903872851396,0.0933421797224474,0,0,6.178347934918649,25.95119984420915,FLT3;AREG;EREG,GMP,1.8241871467630404
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),4/381,0.0149918909588685,0.0933421797224474,0,0,4.514588859416445,18.962383016483383,AZU1;PRLR;MPO;NTSR1,GMP,1.8241435852165644
KEGG_2021_Human,positive regulation of tumor necrosis factor production (GO:0032760),2/77,0.0159057771109684,0.0933421797224474,0,0,11.041666666666666,45.72434655376785,C1QTNF4;AZU1,GMP,1.7984451076467942
KEGG_2021_Human,regulation of smooth muscle cell differentiation (GO:0051150),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,EREG,GMP,1.7601566430186848
KEGG_2021_Human,ganglioside catabolic process (GO:0006689),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,NEU4,GMP,1.7601566430186848
KEGG_2021_Human,glial cell migration (GO:0008347),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,AZU1,GMP,1.7601566430186848
KEGG_2021_Human,regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,KCNE5,GMP,1.7601566430186848
KEGG_2021_Human,positive regulation of interleukin-5 production (GO:0032754),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,CRLF2,GMP,1.7601566430186848
KEGG_2021_Human,hyaluronan biosynthetic process (GO:0030213),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,CEMIP,GMP,1.7601566430186848
KEGG_2021_Human,cellular ion homeostasis (GO:0006873),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,P2RY2,GMP,1.7601566430186848
KEGG_2021_Human,positive regulation of mast cell activation (GO:0033005),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,CRLF2,GMP,1.7601566430186848
KEGG_2021_Human,keratinocyte proliferation (GO:0043616),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,EREG,GMP,1.7601566430186848
KEGG_2021_Human,lymphoid progenitor cell differentiation (GO:0002320),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,FLT3,GMP,1.7601566430186848
KEGG_2021_Human,thyroid hormone transport (GO:0070327),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,SLC16A10,GMP,1.7601566430186848
KEGG_2021_Human,modulation by symbiont of host apoptotic process (GO:0052150),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,CTSG,GMP,1.7601566430186848
KEGG_2021_Human,regulation of potassium ion export across plasma membrane (GO:1903764),1/7,0.0173717414502839,0.0933421797224474,0,0,67.83673469387755,274.9362107684438,KCNE5,GMP,1.7601566430186848
KEGG_2021_Human,regulation of interleukin-8 production (GO:0032677),2/81,0.0175016586979588,0.0933421797224474,0,0,10.48048523206751,42.398379802278754,CD33;ELANE,GMP,1.7569207896432026
KEGG_2021_Human,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/81,0.0175016586979588,0.0933421797224474,0,0,10.48048523206751,42.398379802278754,C1QTNF4;AZU1,GMP,1.7569207896432026
KEGG_2021_Human,regulation of interleukin-1 beta production (GO:0032651),2/83,0.0183241429417302,0.0955211218293648,0,0,10.22067901234568,40.877971632620635,AZU1;CD33,GMP,1.7369763290678308
KEGG_2021_Human,atrial cardiac muscle cell to AV node cell signaling (GO:0086026),1/8,0.0198291614511851,0.0955211218293648,0,0,58.142857142857146,227.9549801512961,KCNE5,GMP,1.702695651141308
KEGG_2021_Human,negative regulation of muscle cell differentiation (GO:0051148),1/8,0.0198291614511851,0.0955211218293648,0,0,58.142857142857146,227.9549801512961,EREG,GMP,1.702695651141308
KEGG_2021_Human,positive regulation of MHC class II biosynthetic process (GO:0045348),1/8,0.0198291614511851,0.0955211218293648,0,0,58.142857142857146,227.9549801512961,AZU1,GMP,1.702695651141308
KEGG_2021_Human,lens fiber cell differentiation (GO:0070306),1/8,0.0198291614511851,0.0955211218293648,0,0,58.142857142857146,227.9549801512961,CRYGD,GMP,1.702695651141308
KEGG_2021_Human,macromolecule depalmitoylation (GO:0098734),1/8,0.0198291614511851,0.0955211218293648,0,0,58.142857142857146,227.9549801512961,ABHD17C,GMP,1.702695651141308
KEGG_2021_Human,protein depalmitoylation (GO:0002084),1/8,0.0198291614511851,0.0955211218293648,0,0,58.142857142857146,227.9549801512961,ABHD17C,GMP,1.702695651141308
KEGG_2021_Human,negative regulation by symbiont of host apoptotic process (GO:0033668),1/8,0.0198291614511851,0.0955211218293648,0,0,58.142857142857146,227.9549801512961,CTSG,GMP,1.702695651141308
KEGG_2021_Human,negative regulation by symbiont of host programmed cell death (GO:0052041),1/8,0.0198291614511851,0.0955211218293648,0,0,58.142857142857146,227.9549801512961,CTSG,GMP,1.702695651141308
KEGG_2021_Human,hormone transport (GO:0009914),1/9,0.0222805591236868,0.1018539845654253,0,0,50.87244897959184,193.52086993316271,SLC16A10,GMP,1.652073914876897
KEGG_2021_Human,positive regulation of megakaryocyte differentiation (GO:0045654),1/9,0.0222805591236868,0.1018539845654253,0,0,50.87244897959184,193.52086993316271,RAB7B,GMP,1.652073914876897
KEGG_2021_Human,negative regulation of smooth muscle cell differentiation (GO:0051151),1/9,0.0222805591236868,0.1018539845654253,0,0,50.87244897959184,193.52086993316271,EREG,GMP,1.652073914876897
KEGG_2021_Human,oligosaccharide catabolic process (GO:0009313),1/9,0.0222805591236868,0.1018539845654253,0,0,50.87244897959184,193.52086993316271,NEU4,GMP,1.652073914876897
KEGG_2021_Human,regulation of nephron tubule epithelial cell differentiation (GO:0072182),1/9,0.0222805591236868,0.1018539845654253,0,0,50.87244897959184,193.52086993316271,PROM1,GMP,1.652073914876897
KEGG_2021_Human,regulation of MAP kinase activity (GO:0043405),2/97,0.024523395696302,0.1045021233031283,0,0,8.708333333333334,32.29161197321332,FLT3;ELANE,GMP,1.6104193942653626
KEGG_2021_Human,negative regulation of delayed rectifier potassium channel activity (GO:1902260),1/10,0.024725948817258,0.1045021233031283,0,0,45.21768707482993,167.3010120823387,KCNE5,GMP,1.606847034080906
KEGG_2021_Human,glycosphingolipid catabolic process (GO:0046479),1/10,0.024725948817258,0.1045021233031283,0,0,45.21768707482993,167.3010120823387,NEU4,GMP,1.606847034080906
KEGG_2021_Human,lactation (GO:0007595),1/10,0.024725948817258,0.1045021233031283,0,0,45.21768707482993,167.3010120823387,PRLR,GMP,1.606847034080906
KEGG_2021_Human,negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),1/10,0.024725948817258,0.1045021233031283,0,0,45.21768707482993,167.3010120823387,RAB7B,GMP,1.606847034080906
KEGG_2021_Human,regulation of mast cell activation (GO:0033003),1/10,0.024725948817258,0.1045021233031283,0,0,45.21768707482993,167.3010120823387,CRLF2,GMP,1.606847034080906
KEGG_2021_Human,monocyte activation (GO:0042117),1/10,0.024725948817258,0.1045021233031283,0,0,45.21768707482993,167.3010120823387,AZU1,GMP,1.606847034080906
KEGG_2021_Human,phagosome-lysosome fusion (GO:0090385),1/10,0.024725948817258,0.1045021233031283,0,0,45.21768707482993,167.3010120823387,RAB7B,GMP,1.606847034080906
KEGG_2021_Human,regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/11,0.0271653448579923,0.1058267347511356,0,0,40.69387755102041,146.73452100035948,RAB7B,GMP,1.5659847773237099
KEGG_2021_Human,positive regulation of keratinocyte proliferation (GO:0010838),1/11,0.0271653448579923,0.1058267347511356,0,0,40.69387755102041,146.73452100035948,AREG,GMP,1.5659847773237099
KEGG_2021_Human,cell-cell junction maintenance (GO:0045217),1/11,0.0271653448579923,0.1058267347511356,0,0,40.69387755102041,146.73452100035948,PRTN3,GMP,1.5659847773237099
KEGG_2021_Human,induction of positive chemotaxis (GO:0050930),1/11,0.0271653448579923,0.1058267347511356,0,0,40.69387755102041,146.73452100035948,AZU1,GMP,1.5659847773237099
KEGG_2021_Human,negative regulation of potassium ion transmembrane transport (GO:1901380),1/11,0.0271653448579923,0.1058267347511356,0,0,40.69387755102041,146.73452100035948,KCNE5,GMP,1.5659847773237099
KEGG_2021_Human,lipoprotein catabolic process (GO:0042159),1/11,0.0271653448579923,0.1058267347511356,0,0,40.69387755102041,146.73452100035948,ABHD17C,GMP,1.5659847773237099
KEGG_2021_Human,negative regulation of voltage-gated potassium channel activity (GO:1903817),1/11,0.0271653448579923,0.1058267347511356,0,0,40.69387755102041,146.73452100035948,KCNE5,GMP,1.5659847773237099
KEGG_2021_Human,protein kinase C signaling (GO:0070528),1/11,0.0271653448579923,0.1058267347511356,0,0,40.69387755102041,146.73452100035948,AZU1,GMP,1.5659847773237099
KEGG_2021_Human,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),1/11,0.0271653448579923,0.1058267347511356,0,0,40.69387755102041,146.73452100035948,AZU1,GMP,1.5659847773237099
KEGG_2021_Human,eye photoreceptor cell differentiation (GO:0001754),1/12,0.029598761568907,0.109588803164218,0,0,36.99257884972171,130.2147194065139,PROM1,GMP,1.5287264597194943
KEGG_2021_Human,glomerular visceral epithelial cell differentiation (GO:0072112),1/12,0.029598761568907,0.109588803164218,0,0,36.99257884972171,130.2147194065139,PROM1,GMP,1.5287264597194943
KEGG_2021_Human,macrophage chemotaxis (GO:0048246),1/12,0.029598761568907,0.109588803164218,0,0,36.99257884972171,130.2147194065139,AZU1,GMP,1.5287264597194943
KEGG_2021_Human,regulation of MHC class II biosynthetic process (GO:0045346),1/12,0.029598761568907,0.109588803164218,0,0,36.99257884972171,130.2147194065139,AZU1,GMP,1.5287264597194943
KEGG_2021_Human,phagolysosome assembly (GO:0001845),1/12,0.029598761568907,0.109588803164218,0,0,36.99257884972171,130.2147194065139,RAB7B,GMP,1.5287264597194943
KEGG_2021_Human,mRNA transcription (GO:0009299),1/12,0.029598761568907,0.109588803164218,0,0,36.99257884972171,130.2147194065139,EREG,GMP,1.5287264597194943
KEGG_2021_Human,regulation of protein kinase activity (GO:0045859),2/110,0.0309363405009925,0.1120917463706706,0,0,7.655092592592593,26.607752397672005,AZU1;EREG,GMP,1.5095310608442127
KEGG_2021_Human,regulation of receptor signaling pathway via STAT (GO:1904892),1/13,0.032026213248763,0.1120917463706706,0,0,33.90816326530612,116.6847899929619,CRLF2,GMP,1.4944944088974865
KEGG_2021_Human,atrial cardiac muscle cell action potential (GO:0086014),1/13,0.032026213248763,0.1120917463706706,0,0,33.90816326530612,116.6847899929619,KCNE5,GMP,1.4944944088974865
KEGG_2021_Human,negative regulation of locomotion (GO:0040013),1/13,0.032026213248763,0.1120917463706706,0,0,33.90816326530612,116.6847899929619,ELANE,GMP,1.4944944088974865
KEGG_2021_Human,negative regulation of potassium ion transport (GO:0043267),1/13,0.032026213248763,0.1120917463706706,0,0,33.90816326530612,116.6847899929619,KCNE5,GMP,1.4944944088974865
KEGG_2021_Human,regulation of interleukin-5 production (GO:0032674),1/13,0.032026213248763,0.1120917463706706,0,0,33.90816326530612,116.6847899929619,CRLF2,GMP,1.4944944088974865
KEGG_2021_Human,regulation of membrane repolarization (GO:0060306),1/13,0.032026213248763,0.1120917463706706,0,0,33.90816326530612,116.6847899929619,KCNE5,GMP,1.4944944088974865
KEGG_2021_Human,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),1/14,0.0344477141698711,0.1160344056248291,0,0,31.298273155416013,105.4223689491126,PRLR,GMP,1.4628395910668823
KEGG_2021_Human,cell junction maintenance (GO:0034331),1/14,0.0344477141698711,0.1160344056248291,0,0,31.298273155416013,105.4223689491126,PRTN3,GMP,1.4628395910668823
KEGG_2021_Human,low-density lipoprotein particle remodeling (GO:0034374),1/14,0.0344477141698711,0.1160344056248291,0,0,31.298273155416013,105.4223689491126,MPO,GMP,1.4628395910668823
KEGG_2021_Human,membrane repolarization during action potential (GO:0086011),1/14,0.0344477141698711,0.1160344056248291,0,0,31.298273155416013,105.4223689491126,KCNE5,GMP,1.4628395910668823
KEGG_2021_Human,potassium ion export across plasma membrane (GO:0097623),1/14,0.0344477141698711,0.1160344056248291,0,0,31.298273155416013,105.4223689491126,KCNE5,GMP,1.4628395910668823
KEGG_2021_Human,cellular response to ATP (GO:0071318),1/15,0.0368632785936063,0.1223314726661898,0,0,29.06122448979592,95.91771596133704,P2RY2,GMP,1.4334060415588732
KEGG_2021_Human,macrophage migration (GO:1905517),1/15,0.0368632785936063,0.1223314726661898,0,0,29.06122448979592,95.91771596133704,AZU1,GMP,1.4334060415588732
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),5/742,0.0372014474377122,0.1225459445006992,0,0,2.8965777174732397,9.533817938899622,FLT3;AZU1;PRLR;MPO;NTSR1,GMP,1.4294401622153592
KEGG_2021_Human,defense response to symbiont (GO:0140546),2/124,0.038497072428768,0.1239032992185945,0,0,6.771857923497268,22.05711333941876,AZU1;RNASE2,GMP,1.4145722958518654
KEGG_2021_Human,extracellular matrix organization (GO:0030198),3/300,0.0390400715124679,0.1239032992185945,0,0,4.223726627981947,13.698249489225711,COL23A1;CTSG;ELANE,GMP,1.4084893954766124
KEGG_2021_Human,body fluid secretion (GO:0007589),1/16,0.0392729207344652,0.1239032992185945,0,0,27.122448979591837,87.80133530116419,PRLR,GMP,1.405906798966597
KEGG_2021_Human,ceramide catabolic process (GO:0046514),1/16,0.0392729207344652,0.1239032992185945,0,0,27.122448979591837,87.80133530116419,NEU4,GMP,1.405906798966597
KEGG_2021_Human,regulation of leukocyte activation (GO:0002694),1/16,0.0392729207344652,0.1239032992185945,0,0,27.122448979591837,87.80133530116419,CD33,GMP,1.405906798966597
KEGG_2021_Human,membrane repolarization (GO:0086009),1/16,0.0392729207344652,0.1239032992185945,0,0,27.122448979591837,87.80133530116419,KCNE5,GMP,1.405906798966597
KEGG_2021_Human,positive regulation of macromolecule biosynthetic process (GO:0010557),2/129,0.0413519534712599,0.1247763165192328,0,0,6.5036089238845145,20.718128222258283,AZU1;EREG,GMP,1.383503969503222
KEGG_2021_Human,negative regulation of chemokine production (GO:0032682),1/17,0.0416766547912334,0.1247763165192328,0,0,25.426020408163264,80.79916728086499,ELANE,GMP,1.3801071472903907
KEGG_2021_Human,gliogenesis (GO:0042063),1/17,0.0416766547912334,0.1247763165192328,0,0,25.426020408163264,80.79916728086499,AZU1,GMP,1.3801071472903907
KEGG_2021_Human,positive regulation of DNA replication (GO:0045740),1/17,0.0416766547912334,0.1247763165192328,0,0,25.426020408163264,80.79916728086499,EREG,GMP,1.3801071472903907
KEGG_2021_Human,negative regulation of phagocytosis (GO:0050765),1/17,0.0416766547912334,0.1247763165192328,0,0,25.426020408163264,80.79916728086499,PRTN3,GMP,1.3801071472903907
KEGG_2021_Human,positive regulation of positive chemotaxis (GO:0050927),1/17,0.0416766547912334,0.1247763165192328,0,0,25.426020408163264,80.79916728086499,AZU1,GMP,1.3801071472903907
KEGG_2021_Human,RNA metabolic process (GO:0016070),2/133,0.043691853040543,0.1247763165192328,0,0,6.303753180661578,19.734489511742076,RNASE3;RNASE2,GMP,1.3595995357844428
KEGG_2021_Human,defense response to virus (GO:0051607),2/133,0.043691853040543,0.1247763165192328,0,0,6.303753180661578,19.734489511742076,AZU1;RNASE2,GMP,1.3595995357844428
KEGG_2021_Human,negative regulation of cation transmembrane transport (GO:1904063),1/18,0.0440744949316926,0.1247763165192328,0,0,23.92917166866747,74.70385911458476,KCNE5,GMP,1.3558126557645607
KEGG_2021_Human,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/18,0.0440744949316926,0.1247763165192328,0,0,23.92917166866747,74.70385911458476,KCNE5,GMP,1.3558126557645607
KEGG_2021_Human,glycoprotein catabolic process (GO:0006516),1/18,0.0440744949316926,0.1247763165192328,0,0,23.92917166866747,74.70385911458476,NEU4,GMP,1.3558126557645607
KEGG_2021_Human,hyaluronan catabolic process (GO:0030214),1/18,0.0440744949316926,0.1247763165192328,0,0,23.92917166866747,74.70385911458476,CEMIP,GMP,1.3558126557645607
KEGG_2021_Human,regulation of delayed rectifier potassium channel activity (GO:1902259),1/18,0.0440744949316926,0.1247763165192328,0,0,23.92917166866747,74.70385911458476,KCNE5,GMP,1.3558126557645607
KEGG_2021_Human,positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/18,0.0440744949316926,0.1247763165192328,0,0,23.92917166866747,74.70385911458476,CD33,GMP,1.3558126557645607
KEGG_2021_Human,ventricular cardiac muscle cell action potential (GO:0086005),1/18,0.0440744949316926,0.1247763165192328,0,0,23.92917166866747,74.70385911458476,KCNE5,GMP,1.3558126557645607
KEGG_2021_Human,prostanoid metabolic process (GO:0006692),1/18,0.0440744949316926,0.1247763165192328,0,0,23.92917166866747,74.70385911458476,CYP2S1,GMP,1.3558126557645607
KEGG_2021_Human,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/134,0.0442844516217812,0.1247763165192328,0,0,6.255681818181818,19.49972118549308,FLT3;FCGR1A,GMP,1.3537487288592545
KEGG_2021_Human,epoxygenase P450 pathway (GO:0019373),1/19,0.0464664552952436,0.1254034456160792,0,0,22.598639455782312,69.35578082800635,CYP2S1,GMP,1.3328604565168853
KEGG_2021_Human,negative regulation of calcium ion transport (GO:0051926),1/19,0.0464664552952436,0.1254034456160792,0,0,22.598639455782312,69.35578082800635,CD33,GMP,1.3328604565168853
KEGG_2021_Human,response to ATP (GO:0033198),1/19,0.0464664552952436,0.1254034456160792,0,0,22.598639455782312,69.35578082800635,P2RY2,GMP,1.3328604565168853
KEGG_2021_Human,carbohydrate derivative catabolic process (GO:1901136),1/19,0.0464664552952436,0.1254034456160792,0,0,22.598639455782312,69.35578082800635,NEU4,GMP,1.3328604565168853
KEGG_2021_Human,positive regulation of leukocyte activation (GO:0002696),1/19,0.0464664552952436,0.1254034456160792,0,0,22.598639455782312,69.35578082800635,CRLF2,GMP,1.3328604565168853
KEGG_2021_Human,interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.0464664552952436,0.1254034456160792,0,0,22.598639455782312,69.35578082800635,CRLF2,GMP,1.3328604565168853
KEGG_2021_Human,cellular response to interleukin-7 (GO:0098761),1/19,0.0464664552952436,0.1254034456160792,0,0,22.598639455782312,69.35578082800635,CRLF2,GMP,1.3328604565168853
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),3/323,0.0468728629064742,0.1257427699526972,0,0,3.9155585106382977,11.982847874596391,CRYGD;P2RY2;CTSG,GMP,1.3290785197780062
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),4/546,0.0471837441916468,0.1258233178443915,0,0,3.1137493983635487,9.50847474832882,C1QTNF4;FLT3;AREG;EREG,GMP,1.3262075993289288
KEGG_2021_Human,negative regulation of dephosphorylation (GO:0035305),1/20,0.0488525499820277,0.1272438511159793,0,0,21.40816326530612,64.63014669364038,PPP1R27,GMP,1.3111127622579986
KEGG_2021_Human,ganglioside metabolic process (GO:0001573),1/20,0.0488525499820277,0.1272438511159793,0,0,21.40816326530612,64.63014669364038,NEU4,GMP,1.3111127622579986
KEGG_2021_Human,growth hormone receptor signaling pathway (GO:0060396),1/20,0.0488525499820277,0.1272438511159793,0,0,21.40816326530612,64.63014669364038,PRLR,GMP,1.3111127622579986
KEGG_2021_Human,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1/20,0.0488525499820277,0.1272438511159793,0,0,21.40816326530612,64.63014669364038,CLDN10,GMP,1.3111127622579986
KEGG_2021_Human,purinergic nucleotide receptor signaling pathway (GO:0035590),1/21,0.0512327930672156,0.1311559502520719,0,0,20.336734693877553,60.42807445408675,CTSG,GMP,1.2904519669693806
KEGG_2021_Human,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.0512327930672156,0.1311559502520719,0,0,20.336734693877553,60.42807445408675,AZU1,GMP,1.2904519669693806
KEGG_2021_Human,hydrogen peroxide catabolic process (GO:0042744),1/21,0.0512327930672156,0.1311559502520719,0,0,20.336734693877553,60.42807445408675,MPO,GMP,1.2904519669693806
KEGG_2021_Human,exogenous drug catabolic process (GO:0042738),1/22,0.0536071985992547,0.1349214886093603,0,0,19.367346938775512,56.67024999786951,CYP2S1,GMP,1.2707768875084013
KEGG_2021_Human,regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.0536071985992547,0.1349214886093603,0,0,19.367346938775512,56.67024999786951,KCNE5,GMP,1.2707768875084013
KEGG_2021_Human,microglial cell activation (GO:0001774),1/22,0.0536071985992547,0.1349214886093603,0,0,19.367346938775512,56.67024999786951,AZU1,GMP,1.2707768875084013
KEGG_2021_Human,regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/23,0.0559757805878795,0.1370336049364482,0,0,18.4860853432282,53.29235549319145,RAB7B,GMP,1.2519998414265567
KEGG_2021_Human,hyaluronan metabolic process (GO:0030212),1/23,0.0559757805878795,0.1370336049364482,0,0,18.4860853432282,53.29235549319145,CEMIP,GMP,1.2519998414265567
KEGG_2021_Human,membrane protein ectodomain proteolysis (GO:0006509),1/23,0.0559757805878795,0.1370336049364482,0,0,18.4860853432282,53.29235549319145,PRTN3,GMP,1.2519998414265567
KEGG_2021_Human,drug catabolic process (GO:0042737),1/23,0.0559757805878795,0.1370336049364482,0,0,18.4860853432282,53.29235549319145,CYP2S1,GMP,1.2519998414265567
KEGG_2021_Human,protein deacylation (GO:0035601),1/23,0.0559757805878795,0.1370336049364482,0,0,18.4860853432282,53.29235549319145,ABHD17C,GMP,1.2519998414265567
KEGG_2021_Human,positive regulation of protein targeting to membrane (GO:0090314),1/24,0.0583385530130099,0.1405143642463895,0,0,17.68145519077196,50.24171555062859,CEMIP,GMP,1.2340443470047993
KEGG_2021_Human,mammary gland development (GO:0030879),1/24,0.0583385530130099,0.1405143642463895,0,0,17.68145519077196,50.24171555062859,PRLR,GMP,1.2340443470047993
KEGG_2021_Human,regulation of keratinocyte proliferation (GO:0010837),1/24,0.0583385530130099,0.1405143642463895,0,0,17.68145519077196,50.24171555062859,AREG,GMP,1.2340443470047993
KEGG_2021_Human,negative regulation of ion transport (GO:0043271),1/25,0.0606955298241754,0.1454096115573827,0,0,16.943877551020407,47.47480020477031,CD33,GMP,1.2168432931781568
KEGG_2021_Human,regulation of synapse organization (GO:0050807),1/26,0.0630467249540435,0.1478792292115785,0,0,16.26530612244898,44.95534064809558,ABHD17C,GMP,1.2003374685092782
KEGG_2021_Human,negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.0630467249540435,0.1478792292115785,0,0,16.26530612244898,44.95534064809558,CD33,GMP,1.2003374685092782
KEGG_2021_Human,retinoic acid metabolic process (GO:0042573),1/26,0.0630467249540435,0.1478792292115785,0,0,16.26530612244898,44.95534064809558,CYP2S1,GMP,1.2003374685092782
KEGG_2021_Human,mononuclear cell differentiation (GO:1903131),1/26,0.0630467249540435,0.1478792292115785,0,0,16.26530612244898,44.95534064809558,FLT3,GMP,1.2003374685092782
KEGG_2021_Human,acute inflammatory response (GO:0002526),1/27,0.0653921522588676,0.1494771323828676,0,0,15.638932496075354,42.652889831563165,ELANE,GMP,1.184474368421492
KEGG_2021_Human,positive regulation of calcium ion transmembrane transport (GO:1904427),1/27,0.0653921522588676,0.1494771323828676,0,0,15.638932496075354,42.652889831563165,CEMIP,GMP,1.184474368421492
KEGG_2021_Human,positive regulation of nuclear division (GO:0051785),1/27,0.0653921522588676,0.1494771323828676,0,0,15.638932496075354,42.652889831563165,EREG,GMP,1.184474368421492
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),3/371,0.065510771195163,0.1494771323828676,0,0,3.396507863089732,9.257320432758746,CEMIP;AZU1;EREG,GMP,1.1836872880076514
KEGG_2021_Human,positive regulation of fibroblast proliferation (GO:0048146),1/28,0.0677318256109869,0.1494771323828676,0,0,15.058956916099774,40.54171043527237,EREG,GMP,1.1692072184717057
KEGG_2021_Human,carbohydrate derivative biosynthetic process (GO:1901137),1/28,0.0677318256109869,0.1494771323828676,0,0,15.058956916099774,40.54171043527237,GAL3ST2,GMP,1.1692072184717057
KEGG_2021_Human,negative regulation of phosphatase activity (GO:0010923),1/28,0.0677318256109869,0.1494771323828676,0,0,15.058956916099774,40.54171043527237,PPP1R27,GMP,1.1692072184717057
KEGG_2021_Human,RNA phosphodiester bond hydrolysis (GO:0090501),1/28,0.0677318256109869,0.1494771323828676,0,0,15.058956916099774,40.54171043527237,RNASE2,GMP,1.1692072184717057
KEGG_2021_Human,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/28,0.0677318256109869,0.1494771323828676,0,0,15.058956916099774,40.54171043527237,FLT3,GMP,1.1692072184717057
KEGG_2021_Human,macromolecule catabolic process (GO:0009057),1/28,0.0677318256109869,0.1494771323828676,0,0,15.058956916099774,40.54171043527237,ELANE,GMP,1.1692072184717057
KEGG_2021_Human,regulation of phosphatase activity (GO:0010921),1/28,0.0677318256109869,0.1494771323828676,0,0,15.058956916099774,40.54171043527237,PPP1R27,GMP,1.1692072184717057
KEGG_2021_Human,regulation of postsynapse organization (GO:0099175),1/28,0.0677318256109869,0.1494771323828676,0,0,15.058956916099774,40.54171043527237,ABHD17C,GMP,1.1692072184717057
KEGG_2021_Human,regulation of protein targeting to membrane (GO:0090313),1/29,0.0700657588372089,0.1531193168735102,0,0,14.520408163265309,38.5999069065122,CEMIP,GMP,1.1544941700666143
KEGG_2021_Human,hydrogen peroxide metabolic process (GO:0042743),1/29,0.0700657588372089,0.1531193168735102,0,0,14.520408163265309,38.5999069065122,MPO,GMP,1.1544941700666143
KEGG_2021_Human,negative regulation of interleukin-1 production (GO:0032692),1/30,0.0723939657090184,0.1537085148703329,0,0,14.019000703729768,36.80874147674154,CD33,GMP,1.1402976322627019
KEGG_2021_Human,regulation of cation transmembrane transport (GO:1904062),1/30,0.0723939657090184,0.1537085148703329,0,0,14.019000703729768,36.80874147674154,KCNE5,GMP,1.1402976322627019
KEGG_2021_Human,positive regulation of lipid kinase activity (GO:0090218),1/30,0.0723939657090184,0.1537085148703329,0,0,14.019000703729768,36.80874147674154,FLT3,GMP,1.1402976322627019
KEGG_2021_Human,ion homeostasis (GO:0050801),1/30,0.0723939657090184,0.1537085148703329,0,0,14.019000703729768,36.80874147674154,P2RY2,GMP,1.1402976322627019
KEGG_2021_Human,positive regulation of phosphate metabolic process (GO:0045937),1/30,0.0723939657090184,0.1537085148703329,0,0,14.019000703729768,36.80874147674154,EREG,GMP,1.1402976322627019
KEGG_2021_Human,plasma membrane invagination (GO:0099024),1/30,0.0723939657090184,0.1537085148703329,0,0,14.019000703729768,36.80874147674154,FCGR1A,GMP,1.1402976322627019
KEGG_2021_Human,regulation of immune response (GO:0050776),2/179,0.0738061123878065,0.1547573920801773,0,0,4.654661016949152,12.131506903576025,FCGR1A;CD33,GMP,1.1319076697979504
KEGG_2021_Human,cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.0747164600026276,0.1547573920801773,0,0,13.551020408163266,35.15209038871121,KCNE5,GMP,1.126583712764908
KEGG_2021_Human,peptide cross-linking (GO:0018149),1/31,0.0747164600026276,0.1547573920801773,0,0,13.551020408163266,35.15209038871121,F13A1,GMP,1.126583712764908
KEGG_2021_Human,prostaglandin metabolic process (GO:0006693),1/31,0.0747164600026276,0.1547573920801773,0,0,13.551020408163266,35.15209038871121,CYP2S1,GMP,1.126583712764908
KEGG_2021_Human,regulation of potassium ion transport (GO:0043266),1/31,0.0747164600026276,0.1547573920801773,0,0,13.551020408163266,35.15209038871121,KCNE5,GMP,1.126583712764908
KEGG_2021_Human,negative regulation of cytokine production (GO:0001818),2/182,0.0759532712589317,0.1547573920801773,0,0,4.576388888888889,11.79626923326343,CD33;ELANE,GMP,1.1194535166121444
KEGG_2021_Human,ERBB2 signaling pathway (GO:0038128),1/32,0.0770332554327668,0.1547573920801773,0,0,13.113232389730086,33.61600807740255,EREG,GMP,1.1133217484244988
KEGG_2021_Human,negative regulation of chemotaxis (GO:0050922),1/32,0.0770332554327668,0.1547573920801773,0,0,13.113232389730086,33.61600807740255,ELANE,GMP,1.1133217484244988
KEGG_2021_Human,hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.0770332554327668,0.1547573920801773,0,0,13.113232389730086,33.61600807740255,FLT3,GMP,1.1133217484244988
KEGG_2021_Human,regulation of chemotaxis (GO:0050920),1/32,0.0770332554327668,0.1547573920801773,0,0,13.113232389730086,33.61600807740255,ELANE,GMP,1.1133217484244988
KEGG_2021_Human,positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.0770332554327668,0.1547573920801773,0,0,13.113232389730086,33.61600807740255,CRLF2,GMP,1.1133217484244988
KEGG_2021_Human,metal ion export (GO:0070839),1/32,0.0770332554327668,0.1547573920801773,0,0,13.113232389730086,33.61600807740255,KCNE5,GMP,1.1133217484244988
KEGG_2021_Human,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),1/33,0.0793443657059371,0.1586887314118742,0,0,12.70280612244898,32.18837516559274,PRLR,GMP,1.1004839073426347
KEGG_2021_Human,positive regulation of calcium ion transport into cytosol (GO:0010524),1/34,0.0816498044624026,0.1604347035050717,0,0,12.317254174397032,30.85861216573232,CEMIP,GMP,1.0880448509885652
KEGG_2021_Human,cardiac muscle contraction (GO:0060048),1/34,0.0816498044624026,0.1604347035050717,0,0,12.317254174397032,30.85861216573232,KCNE5,GMP,1.0880448509885652
KEGG_2021_Human,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/34,0.0816498044624026,0.1604347035050717,0,0,12.317254174397032,30.85861216573232,CEMIP,GMP,1.0880448509885652
KEGG_2021_Human,organic cyclic compound biosynthetic process (GO:1901362),1/34,0.0816498044624026,0.1604347035050717,0,0,12.317254174397032,30.85861216573232,PRLR,GMP,1.0880448509885652
KEGG_2021_Human,regulation of blood circulation (GO:1903522),1/35,0.0839495853612937,0.1628113170643273,0,0,11.95438175270108,29.61744503578088,KCNE5,GMP,1.0759814445616303
KEGG_2021_Human,regulation of ion transmembrane transport (GO:0034765),1/35,0.0839495853612937,0.1628113170643273,0,0,11.95438175270108,29.61744503578088,KCNE5,GMP,1.0759814445616303
KEGG_2021_Human,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/35,0.0839495853612937,0.1628113170643273,0,0,11.95438175270108,29.61744503578088,FLT3,GMP,1.0759814445616303
KEGG_2021_Human,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/36,0.0862437219743075,0.1630261073607164,0,0,11.612244897959185,28.456712045041098,C1QTNF4,GMP,1.0642725091375862
KEGG_2021_Human,positive regulation of innate immune response (GO:0045089),1/36,0.0862437219743075,0.1630261073607164,0,0,11.612244897959185,28.456712045041098,EREG,GMP,1.0642725091375862
KEGG_2021_Human,retina homeostasis (GO:0001895),1/36,0.0862437219743075,0.1630261073607164,0,0,11.612244897959185,28.456712045041098,LYZ,GMP,1.0642725091375862
KEGG_2021_Human,positive regulation of mitotic nuclear division (GO:0045840),1/36,0.0862437219743075,0.1630261073607164,0,0,11.612244897959185,28.456712045041098,EREG,GMP,1.0642725091375862
KEGG_2021_Human,negative regulation of toll-like receptor signaling pathway (GO:0034122),1/36,0.0862437219743075,0.1630261073607164,0,0,11.612244897959185,28.456712045041098,RAB7B,GMP,1.0642725091375862
KEGG_2021_Human,macrophage activation (GO:0042116),1/36,0.0862437219743075,0.1630261073607164,0,0,11.612244897959185,28.456712045041098,AZU1,GMP,1.0642725091375862
KEGG_2021_Human,regulation of transport (GO:0051049),1/37,0.0885322278902676,0.1652601587284996,0,0,11.289115646258503,27.36920368672352,CLDN10,GMP,1.0528986067362665
KEGG_2021_Human,positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.0885322278902676,0.1652601587284996,0,0,11.289115646258503,27.36920368672352,RAB7B,GMP,1.0528986067362665
KEGG_2021_Human,"phagocytosis, engulfment (GO:0006911)",1/37,0.0885322278902676,0.1652601587284996,0,0,11.289115646258503,27.36920368672352,FCGR1A,GMP,1.0528986067362665
KEGG_2021_Human,positive regulation of potassium ion transport (GO:0043268),1/38,0.0908151166313484,0.1681205464910914,0,0,10.983452840595698,26.34852930034076,KCNE5,GMP,1.0418418549683985
KEGG_2021_Human,lymphocyte proliferation (GO:0046651),1/38,0.0908151166313484,0.1681205464910914,0,0,10.983452840595698,26.34852930034076,FLT3,GMP,1.0418418549683985
KEGG_2021_Human,regulation of protein tyrosine kinase activity (GO:0061097),1/39,0.0930924017046572,0.1688477569380018,0,0,10.693877551020408,25.38900533231373,FCGR1A,GMP,1.0310857651239858
KEGG_2021_Human,regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.0930924017046572,0.1688477569380018,0,0,10.693877551020408,25.38900533231373,KCNE5,GMP,1.0310857651239858
KEGG_2021_Human,regulation of ion transmembrane transporter activity (GO:0032412),1/39,0.0930924017046572,0.1688477569380018,0,0,10.693877551020408,25.38900533231373,KCNE5,GMP,1.0310857651239858
KEGG_2021_Human,membrane protein proteolysis (GO:0033619),1/39,0.0930924017046572,0.1688477569380018,0,0,10.693877551020408,25.38900533231373,PRTN3,GMP,1.0310857651239858
KEGG_2021_Human,phospholipid dephosphorylation (GO:0046839),1/39,0.0930924017046572,0.1688477569380018,0,0,10.693877551020408,25.38900533231373,PLPPR3,GMP,1.0310857651239858
KEGG_2021_Human,carboxylic acid metabolic process (GO:0019752),1/40,0.0953640965755271,0.17227062607192,0,0,10.419152276295131,24.485561288951835,CYP2S1,GMP,1.0206151011238414
KEGG_2021_Human,positive regulation of cation transmembrane transport (GO:1904064),1/41,0.0976302146847681,0.1735648261062545,0,0,10.158163265306122,23.633660200289185,KCNE5,GMP,1.0104157556925017
KEGG_2021_Human,heart contraction (GO:0060047),1/41,0.0976302146847681,0.1735648261062545,0,0,10.158163265306122,23.633660200289185,KCNE5,GMP,1.0104157556925017
KEGG_2021_Human,carbohydrate catabolic process (GO:0016052),1/41,0.0976302146847681,0.1735648261062545,0,0,10.158163265306122,23.633660200289185,NEU4,GMP,1.0104157556925017
KEGG_2021_Human,keratinocyte differentiation (GO:0030216),1/41,0.0976302146847681,0.1735648261062545,0,0,10.158163265306122,23.633660200289185,EREG,GMP,1.0104157556925017
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),2/212,0.0984576089228105,0.1743439082901942,0,0,3.9166666666666665,9.079339326341122,FCGR1A;ELANE,GMP,1.0067507154273545
KEGG_2021_Human,regulation of chemokine production (GO:0032642),1/42,0.0998907694703361,0.1761852941838999,0,0,9.909905425584869,22.829231064333683,ELANE,GMP,1.00047464143678
KEGG_2021_Human,lipid modification (GO:0030258),1/43,0.1021457742794159,0.1794561054006993,0,0,9.673469387755102,22.068611238785657,PLPPR3,GMP,0.9907795952096249
KEGG_2021_Human,positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.1043952424647777,0.182691674313361,0,0,9.448030374940672,21.34849709415977,KCNE5,GMP,0.9813192926974915
KEGG_2021_Human,action potential (GO:0001508),1/45,0.1066391873529346,0.1851719222252509,0,0,9.232838589981448,20.665901611884028,KCNE5,GMP,0.9720831731354668
KEGG_2021_Human,positive regulation of response to biotic stimulus (GO:0002833),1/45,0.1066391873529346,0.1851719222252509,0,0,9.232838589981448,20.665901611884028,EREG,GMP,0.9720831731354668
KEGG_2021_Human,regulation of fibroblast proliferation (GO:0048145),1/46,0.1088776222085674,0.1876045182670701,0,0,9.02721088435374,20.01811780873028,EREG,GMP,0.9630613723103648
KEGG_2021_Human,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.1088776222085674,0.1876045182670701,0,0,9.02721088435374,20.01811780873028,CD33,GMP,0.9630613723103648
KEGG_2021_Human,glycosphingolipid metabolic process (GO:0006687),1/47,0.1111105603036554,0.190718509639991,0,0,8.830523513753327,19.4026870705364,NEU4,GMP,0.9542446623584087
KEGG_2021_Human,inflammatory response (GO:0006954),2/230,0.1127586124121412,0.1928086196970964,0,0,3.6041666666666665,7.866115081211615,AZU1;LYZ,GMP,0.9478502771198579
KEGG_2021_Human,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.1133380148369131,0.1930624739427265,0,0,8.642205818497612,18.81737166641443,CD33,GMP,0.9456243984787533
KEGG_2021_Human,oligosaccharide metabolic process (GO:0009311),1/49,0.1155599990222406,0.1961018165225902,0,0,8.46173469387755,18.260130793597916,NEU4,GMP,0.9371924705024297
KEGG_2021_Human,amino acid transport (GO:0006865),1/50,0.1177765260040411,0.1983604648489113,0,0,8.28862973760933,17.7290996615035,SLC16A10,GMP,0.928941259997044
KEGG_2021_Human,regulation of cellular component movement (GO:0051270),1/50,0.1177765260040411,0.1983604648489113,0,0,8.28862973760933,17.7290996615035,EREG,GMP,0.928941259997044
KEGG_2021_Human,negative regulation of transport (GO:0051051),1/51,0.1199876089220907,0.2013275235846317,0,0,8.122448979591837,17.22257115519733,PRTN3,GMP,0.9208636010741894
KEGG_2021_Human,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.1221932608707862,0.201914078699154,0,0,7.962785114045619,16.738979733033663,CEMIP,GMP,0.9129527453809976
KEGG_2021_Human,glycolipid metabolic process (GO:0006664),1/52,0.1221932608707862,0.201914078699154,0,0,7.962785114045619,16.738979733033663,NEU4,GMP,0.9129527453809976
KEGG_2021_Human,membrane organization (GO:0061024),2/242,0.122577893374113,0.201914078699154,0,0,3.421875,7.182545007938849,AREG;EREG,GMP,0.9115878467125743
KEGG_2021_Human,epidermal cell differentiation (GO:0009913),1/53,0.1243934949128716,0.201914078699154,0,0,7.809262166405024,16.276887238960814,EREG,GMP,0.9052023302345248
KEGG_2021_Human,positive regulation of chemokine production (GO:0032722),1/53,0.1243934949128716,0.201914078699154,0,0,7.809262166405024,16.276887238960814,AZU1,GMP,0.9052023302345248
KEGG_2021_Human,bicellular tight junction assembly (GO:0070830),1/53,0.1243934949128716,0.201914078699154,0,0,7.809262166405024,16.276887238960814,CLDN10,GMP,0.9052023302345248
KEGG_2021_Human,regulation of DNA replication (GO:0006275),1/53,0.1243934949128716,0.201914078699154,0,0,7.809262166405024,16.276887238960814,EREG,GMP,0.9052023302345248
KEGG_2021_Human,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.1243934949128716,0.201914078699154,0,0,7.809262166405024,16.276887238960814,C1QTNF4,GMP,0.9052023302345248
KEGG_2021_Human,positive regulation of phagocytosis (GO:0050766),1/53,0.1243934949128716,0.201914078699154,0,0,7.809262166405024,16.276887238960814,AZU1,GMP,0.9052023302345248
KEGG_2021_Human,striated muscle contraction (GO:0006941),1/54,0.1265883240687765,0.2032672730566733,0,0,7.661532537543319,15.834970375184442,KCNE5,GMP,0.8976063498190403
KEGG_2021_Human,regulation of megakaryocyte differentiation (GO:0045652),1/54,0.1265883240687765,0.2032672730566733,0,0,7.661532537543319,15.834970375184442,RAB7B,GMP,0.8976063498190403
KEGG_2021_Human,regulation of potassium ion transmembrane transport (GO:1901379),1/54,0.1265883240687765,0.2032672730566733,0,0,7.661532537543319,15.834970375184442,KCNE5,GMP,0.8976063498190403
KEGG_2021_Human,glycosaminoglycan catabolic process (GO:0006027),1/56,0.1309618198144747,0.2073176511550695,0,0,7.382189239332097,15.00687933540933,CEMIP,GMP,0.8828552987007785
KEGG_2021_Human,positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.1309618198144747,0.2073176511550695,0,0,7.382189239332097,15.00687933540933,AZU1,GMP,0.8828552987007785
KEGG_2021_Human,tight junction assembly (GO:0120192),1/56,0.1309618198144747,0.2073176511550695,0,0,7.382189239332097,15.00687933540933,CLDN10,GMP,0.8828552987007785
KEGG_2021_Human,peptidyl-tyrosine modification (GO:0018212),1/56,0.1309618198144747,0.2073176511550695,0,0,7.382189239332097,15.00687933540933,FLT3,GMP,0.8828552987007785
KEGG_2021_Human,positive regulation of phosphorylation (GO:0042327),2/253,0.1317582069542016,0.2078290923476438,0,0,3.270086321381142,6.627767796360294,FLT3;EREG,GMP,0.880222323941479
KEGG_2021_Human,arachidonic acid metabolic process (GO:0019369),1/57,0.1331405122852093,0.2078290923476438,0,0,7.25,14.618539131965724,CYP2S1,GMP,0.8756897763447542
KEGG_2021_Human,icosanoid metabolic process (GO:0006690),1/57,0.1331405122852093,0.2078290923476438,0,0,7.25,14.618539131965724,CYP2S1,GMP,0.8756897763447542
KEGG_2021_Human,regulation of mitotic nuclear division (GO:0007088),1/57,0.1331405122852093,0.2078290923476438,0,0,7.25,14.618539131965724,EREG,GMP,0.8756897763447542
KEGG_2021_Human,regulation of calcium ion transport (GO:0051924),1/58,0.1353138517398134,0.2097598808977039,0,0,7.122448979591836,14.246025949065045,CD33,GMP,0.8686577434892403
KEGG_2021_Human,negative regulation of hydrolase activity (GO:0051346),1/58,0.1353138517398134,0.2097598808977039,0,0,7.122448979591836,14.246025949065045,PPP1R27,GMP,0.8686577434892403
KEGG_2021_Human,response to reactive oxygen species (GO:0000302),1/59,0.1374818510452552,0.2116559081383997,0,0,6.9992962702322306,13.8884471557023,CRYGD,GMP,0.8617546291873563
KEGG_2021_Human,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/59,0.1374818510452552,0.2116559081383997,0,0,6.9992962702322306,13.8884471557023,FLT3,GMP,0.8617546291873563
KEGG_2021_Human,apical junction assembly (GO:0043297),1/60,0.1396445230534406,0.2142491312600732,0,0,6.88031822898651,13.544974303558986,CLDN10,GMP,0.8549760929333525
KEGG_2021_Human,B cell differentiation (GO:0030183),1/61,0.1418018805927374,0.2146003774744798,0,0,6.76530612244898,13.214837540593155,FLT3,GMP,0.848318009451734
KEGG_2021_Human,response to light stimulus (GO:0009416),1/61,0.1418018805927374,0.2146003774744798,0,0,6.76530612244898,13.214837540593155,ELANE,GMP,0.848318009451734
KEGG_2021_Human,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2146003774744798,0,0,6.76530612244898,13.214837540593155,ELANE,GMP,0.848318009451734
KEGG_2021_Human,positive regulation of interleukin-1 production (GO:0032732),1/62,0.1439539364695556,0.2146003774744798,0,0,6.654064904650385,12.897320592663672,AZU1,GMP,0.8417764546925935
KEGG_2021_Human,amyloid fibril formation (GO:1990000),1/63,0.1461007034145454,0.2146003774744798,0,0,6.54641211323239,12.591756250239603,LYZ,GMP,0.8353476931121088
KEGG_2021_Human,negative regulation of endopeptidase activity (GO:0010951),1/63,0.1461007034145454,0.2146003774744798,0,0,6.54641211323239,12.591756250239603,SERPINI2,GMP,0.8353476931121088
KEGG_2021_Human,negative regulation of peptidase activity (GO:0010466),1/63,0.1461007034145454,0.2146003774744798,0,0,6.54641211323239,12.591756250239603,SERPINI2,GMP,0.8353476931121088
KEGG_2021_Human,cellular response to reactive oxygen species (GO:0034614),1/63,0.1461007034145454,0.2146003774744798,0,0,6.54641211323239,12.591756250239603,CRYGD,GMP,0.8353476931121088
KEGG_2021_Human,neuropeptide signaling pathway (GO:0007218),1/63,0.1461007034145454,0.2146003774744798,0,0,6.54641211323239,12.591756250239603,NTSR1,GMP,0.8353476931121088
KEGG_2021_Human,COPII vesicle coating (GO:0048208),1/63,0.1461007034145454,0.2146003774744798,0,0,6.54641211323239,12.591756250239603,AREG,GMP,0.8353476931121088
KEGG_2021_Human,organonitrogen compound catabolic process (GO:1901565),1/63,0.1461007034145454,0.2146003774744798,0,0,6.54641211323239,12.591756250239603,ELANE,GMP,0.8353476931121088
KEGG_2021_Human,vesicle coating (GO:0006901),1/63,0.1461007034145454,0.2146003774744798,0,0,6.54641211323239,12.591756250239603,AREG,GMP,0.8353476931121088
KEGG_2021_Human,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/63,0.1461007034145454,0.2146003774744798,0,0,6.54641211323239,12.591756250239603,AREG,GMP,0.8353476931121088
KEGG_2021_Human,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.1482421941802595,0.2163273713119097,0,0,6.442176870748299,12.297522293260638,RNASE3,GMP,0.8290281655096747
KEGG_2021_Human,regulation of innate immune response (GO:0045088),1/64,0.1482421941802595,0.2163273713119097,0,0,6.442176870748299,12.297522293260638,EREG,GMP,0.8290281655096747
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),2/274,0.1497038344955427,0.2177510319935167,0,0,3.014399509803922,5.724635176902424,FLT3;ELANE,GMP,0.8247670755492156
KEGG_2021_Human,steroid biosynthetic process (GO:0006694),1/65,0.1503784214913892,0.2180243780846031,0,0,6.341198979591836,12.01403781811508,PRLR,GMP,0.8228144782361342
KEGG_2021_Human,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/68,0.1567556490806558,0.2258087806692406,0,0,6.0563508985683825,11.222824361971773,FLT3,GMP,0.8047767993307415
KEGG_2021_Human,interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.1567556490806558,0.2258087806692406,0,0,6.0563508985683825,11.222824361971773,FCGR1A,GMP,0.8047767993307415
KEGG_2021_Human,cell chemotaxis (GO:0060326),1/69,0.158870948881139,0.2273935626158156,0,0,5.966986794717887,10.977245117600177,AZU1,GMP,0.7989555105590889
KEGG_2021_Human,positive regulation of protein transport (GO:0051222),1/69,0.158870948881139,0.2273935626158156,0,0,5.966986794717887,10.977245117600177,CD33,GMP,0.7989555105590889
KEGG_2021_Human,COPII-coated vesicle budding (GO:0090114),1/70,0.1609810482853106,0.2289508242279973,0,0,5.880212954747116,10.740024519792764,AREG,GMP,0.7932252488723367
KEGG_2021_Human,wound healing (GO:0042060),1/70,0.1609810482853106,0.2289508242279973,0,0,5.880212954747116,10.740024519792764,EREG,GMP,0.7932252488723367
KEGG_2021_Human,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/71,0.16308595979881,0.2297563207228519,0,0,5.795918367346939,10.51076961698872,FCGR1A,GMP,0.7875834261109624
KEGG_2021_Human,regulation of endopeptidase activity (GO:0052548),1/71,0.16308595979881,0.2297563207228519,0,0,5.795918367346939,10.51076961698872,SERPINI2,GMP,0.7875834261109624
KEGG_2021_Human,myeloid leukocyte differentiation (GO:0002573),1/71,0.16308595979881,0.2297563207228519,0,0,5.795918367346939,10.51076961698872,PRTN3,GMP,0.7875834261109624
KEGG_2021_Human,Fc-gamma receptor signaling pathway (GO:0038094),1/72,0.1651856959101235,0.2298235769184328,0,0,5.713998275366484,10.28911103101624,FCGR1A,GMP,0.78202756268309
KEGG_2021_Human,negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.1651856959101235,0.2298235769184328,0,0,5.713998275366484,10.28911103101624,EREG,GMP,0.78202756268309
KEGG_2021_Human,positive regulation of protein secretion (GO:0050714),1/72,0.1651856959101235,0.2298235769184328,0,0,5.713998275366484,10.28911103101624,CD33,GMP,0.78202756268309
KEGG_2021_Human,positive regulation of secretion by cell (GO:1903532),1/72,0.1651856959101235,0.2298235769184328,0,0,5.713998275366484,10.28911103101624,CD33,GMP,0.78202756268309
KEGG_2021_Human,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",1/73,0.1672802691231711,0.2320172153782682,0,0,5.634353741496598,10.074701240888364,FCGR1A,GMP,0.7765552814899175
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),3/566,0.1678713329989042,0.2321183863688552,0,0,2.197989493972261,3.922438566092192,PRTN3;CD33;EREG,GMP,0.7750234609992368
KEGG_2021_Human,Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/74,0.1693696918266344,0.2334696059640992,0,0,5.556891249650545,9.867213018330611,FCGR1A,GMP,0.7711643026835198
KEGG_2021_Human,positive regulation of immune response (GO:0050778),1/75,0.1714539764404576,0.2348971909642966,0,0,5.4815223386651954,9.666337985731484,EREG,GMP,0.7658524380723842
KEGG_2021_Human,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.1714539764404576,0.2348971909642966,0,0,5.4815223386651954,9.666337985731484,RNASE2,GMP,0.7658524380723842
KEGG_2021_Human,phospholipid metabolic process (GO:0006644),1/76,0.1735331353639065,0.2370208678141162,0,0,5.408163265306122,9.4717853003048,PLPPR3,GMP,0.7606175863963804
KEGG_2021_Human,innate immune response (GO:0045087),2/302,0.1743414000182094,0.2374010553439448,0,0,2.7291666666666665,4.767144127673996,RNASE3;RNASE2,GMP,0.7585994708102503
KEGG_2021_Human,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.1756071809118701,0.2376798098142532,0,0,5.336734693877551,9.283280446293812,FLT3,GMP,0.7554577289388229
KEGG_2021_Human,neutrophil migration (GO:1990266),1/77,0.1756071809118701,0.2376798098142532,0,0,5.336734693877551,9.283280446293812,PRTN3,GMP,0.7554577289388229
KEGG_2021_Human,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),1/78,0.1776761254379788,0.2397557355307666,0,0,5.267161410018553,9.10056411919043,FCGR1A,GMP,0.7503709249641564
KEGG_2021_Human,regulation of ion transport (GO:0043269),1/79,0.1797399811935544,0.2416790643909782,0,0,5.199372056514914,8.923391206941128,CLDN10,GMP,0.745355308086215
KEGG_2021_Human,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2416790643909782,0,0,5.133298889175924,8.751529842637671,AZU1,GMP,0.7404090821369118
KEGG_2021_Human,skin development (GO:0043588),1/80,0.181798760490535,0.2416790643909782,0,0,5.133298889175924,8.751529842637671,EREG,GMP,0.7404090821369118
KEGG_2021_Human,lipid biosynthetic process (GO:0008610),1/80,0.181798760490535,0.2416790643909782,0,0,5.133298889175924,8.751529842637671,PRLR,GMP,0.7404090821369118
KEGG_2021_Human,regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.181798760490535,0.2416790643909782,0,0,5.133298889175924,8.751529842637671,C1QTNF4,GMP,0.7404090821369118
KEGG_2021_Human,cell-cell junction organization (GO:0045216),1/82,0.1859011384602527,0.2464015089650686,0,0,5.00604686318972,8.422875391899517,PRTN3,GMP,0.7307179505966239
KEGG_2021_Human,glycoprotein biosynthetic process (GO:0009101),1/83,0.1879447615357932,0.2483753780768005,0,0,4.944748631159781,8.265677319811374,GAL3ST2,GMP,0.7259697745939766
KEGG_2021_Human,lymphocyte differentiation (GO:0030098),1/84,0.1899833569114356,0.250331011459774,0,0,4.884927464961889,8.112979399077096,FLT3,GMP,0.7212844428267129
KEGG_2021_Human,negative regulation of defense response (GO:0031348),1/85,0.1920169366451308,0.2515309579444989,0,0,4.826530612244898,7.964604221414354,ELANE,GMP,0.716660463134361
KEGG_2021_Human,B cell activation (GO:0042113),1/85,0.1920169366451308,0.2515309579444989,0,0,4.826530612244898,7.964604221414354,FLT3,GMP,0.716660463134361
KEGG_2021_Human,"retrograde transport, endosome to Golgi (GO:0042147)",1/88,0.1980877029036425,0.2579746828512554,0,0,4.659394792399718,7.5437717166037235,RAB7B,GMP,0.703142484213379
KEGG_2021_Human,sensory perception of mechanical stimulus (GO:0050954),1/88,0.1980877029036425,0.2579746828512554,0,0,4.659394792399718,7.5437717166037235,CEMIP,GMP,0.703142484213379
KEGG_2021_Human,regulation of cation channel activity (GO:2001257),1/89,0.2001013407742902,0.2590907533724914,0,0,4.6062152133580705,7.411084001248333,KCNE5,GMP,0.6987500013741589
KEGG_2021_Human,collagen fibril organization (GO:0030199),1/89,0.2001013407742902,0.2590907533724914,0,0,4.6062152133580705,7.411084001248333,COL23A1,GMP,0.6987500013741589
KEGG_2021_Human,sensory perception of sound (GO:0007605),1/91,0.2041137620931186,0.2627671420049343,0,0,4.503401360544218,7.156255051106618,CEMIP,GMP,0.6901277125812961
KEGG_2021_Human,positive regulation of transport (GO:0051050),1/91,0.2041137620931186,0.2627671420049343,0,0,4.503401360544218,7.156255051106618,AZU1,GMP,0.6901277125812961
KEGG_2021_Human,retinoid metabolic process (GO:0001523),1/92,0.2061125694363157,0.2645800318265601,0,0,4.453689167974883,7.03385741012878,CYP2S1,GMP,0.6858955226779435
KEGG_2021_Human,regulation of epithelial cell proliferation (GO:0050678),1/93,0.2081064570390282,0.2648627635042176,0,0,4.40505767524401,6.914643337844717,EREG,GMP,0.6817144444740324
KEGG_2021_Human,regulation of heart contraction (GO:0008016),1/93,0.2081064570390282,0.2648627635042176,0,0,4.40505767524401,6.914643337844717,KCNE5,GMP,0.6817144444740324
KEGG_2021_Human,visual perception (GO:0007601),1/93,0.2081064570390282,0.2648627635042176,0,0,4.40505767524401,6.914643337844717,CRYGD,GMP,0.6817144444740324
KEGG_2021_Human,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2658834906398038,0,0,4.357472021066491,6.79849904676328,FLT3,GMP,0.6775833802166729
KEGG_2021_Human,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.2658834906398038,0,0,4.357472021066491,6.79849904676328,FLT3,GMP,0.6775833802166729
KEGG_2021_Human,sensory perception of light stimulus (GO:0050953),1/95,0.2120795205832498,0.2668865877002694,0,0,4.310898827616153,6.685315939697291,CRYGD,GMP,0.6735012670190429
KEGG_2021_Human,mRNA metabolic process (GO:0016071),1/95,0.2120795205832498,0.2668865877002694,0,0,4.310898827616153,6.685315939697291,EREG,GMP,0.6735012670190429
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),2/345,0.2133084926466024,0.2676812456741677,0,0,2.381802721088435,3.6799229289674416,PRLR;EREG,GMP,0.6709918532419347
KEGG_2021_Human,positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.2160330472811356,0.2688411255054131,0,0,4.220663265306122,6.46742313757927,PRLR,GMP,0.6654798083211632
KEGG_2021_Human,glycosaminoglycan biosynthetic process (GO:0006024),1/97,0.2160330472811356,0.2688411255054131,0,0,4.220663265306122,6.46742313757927,CEMIP,GMP,0.6654798083211632
KEGG_2021_Human,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2688411255054131,0,0,4.220663265306122,6.46742313757927,ELANE,GMP,0.6654798083211632
KEGG_2021_Human,positive regulation of defense response (GO:0031349),1/98,0.2180025137484037,0.2705405156766894,0,0,4.176940879444562,6.362519703204576,EREG,GMP,0.6615384985937142
KEGG_2021_Human,supramolecular fiber organization (GO:0097435),2/351,0.2188220798658953,0.2708074358561357,0,0,2.3401384909264564,3.5558317785950937,COL23A1;LYZ,GMP,0.6599088583892734
KEGG_2021_Human,response to UV (GO:0009411),1/99,0.2199671313012003,0.2714745862890846,0,0,4.134110787172012,6.26018948804807,ELANE,GMP,0.6576422090003602
KEGG_2021_Human,organic acid transport (GO:0015849),1/100,0.2219269115603851,0.2731408142281663,0,0,4.092145949288806,6.1603458876211565,SLC16A10,GMP,0.6537900306498672
KEGG_2021_Human,epithelial cell differentiation (GO:0030855),1/101,0.2238818662412048,0.2732944852208713,0,0,4.051020408163265,6.062906014187368,CRYGD,GMP,0.6499810815451941
KEGG_2021_Human,positive regulation of cell cycle process (GO:0090068),1/101,0.2238818662412048,0.2732944852208713,0,0,4.051020408163265,6.062906014187368,EREG,GMP,0.6499810815451941
KEGG_2021_Human,positive regulation of protein localization to membrane (GO:1905477),1/101,0.2238818662412048,0.2732944852208713,0,0,4.051020408163265,6.062906014187368,CEMIP,GMP,0.6499810815451941
KEGG_2021_Human,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2749259215388346,0,0,4.010709234188725,5.967790506031058,AZU1,GMP,0.6462145058611213
KEGG_2021_Human,cellular response to organonitrogen compound (GO:0071417),1/103,0.2277773453985499,0.2765426849283207,0,0,3.971188475390156,5.874923343943355,P2RY2,GMP,0.64248947278397
KEGG_2021_Human,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2773951916372304,0,0,3.932435109966317,5.78423168094792,ELANE,GMP,0.6388051756325536
KEGG_2021_Human,steroid metabolic process (GO:0008202),1/104,0.2297178930745814,0.2773951916372304,0,0,3.932435109966317,5.78423168094792,PRLR,GMP,0.6388051756325536
KEGG_2021_Human,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.2335846623503299,0.2813062600348059,0,0,3.857142857142857,5.6090983677319475,FLT3,GMP,0.6315556772929499
KEGG_2021_Human,cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.2431685532271013,0.2920630344389849,0,0,3.6808905380333954,5.20478084558139,ELANE,GMP,0.6140925891155178
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),2/379,0.24470533557908,0.2931229688219995,0,0,2.163240495137047,3.045194735705852,CD33;EREG,GMP,0.6113565611455968
KEGG_2021_Human,positive regulation of metabolic process (GO:0009893),1/113,0.2469691364760274,0.2950457950433607,0,0,3.614795918367347,5.055262825364014,PRLR,GMP,0.6073573167632206
KEGG_2021_Human,activation of protein kinase activity (GO:0032147),1/114,0.2488624078588274,0.2965169114913689,0,0,3.582625970742279,4.982913653406146,PRLR,GMP,0.6040407011916724
KEGG_2021_Human,cellular response to molecule of bacterial origin (GO:0071219),1/115,0.2507510141385882,0.2979746799312666,0,0,3.5510204081632653,4.9121080927455,CTSG,GMP,0.6007573018413346
KEGG_2021_Human,sphingolipid metabolic process (GO:0006665),1/116,0.2526349665899778,0.299419219662196,0,0,3.5199645075421473,4.8428011439058265,NEU4,GMP,0.5975065399797567
KEGG_2021_Human,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.3030666273501175,0,0,3.4594453165881736,4.708511372057024,ELANE,GMP,0.5911006880374128
KEGG_2021_Human,cellular response to lipopolysaccharide (GO:0071222),1/120,0.2601244621662815,0.3066730501328792,0,0,3.4009603841536613,4.579716458908873,CTSG,GMP,0.5848188047272944
KEGG_2021_Human,cellular response to interferon-gamma (GO:0071346),1/121,0.2619853133921213,0.3080562215214445,0,0,3.372448979591837,4.517283552621874,FCGR1A,GMP,0.5817230540677998
KEGG_2021_Human,positive regulation of epithelial cell proliferation (GO:0050679),1/123,0.2656932663769877,0.3107848128900536,0,0,3.316828370692539,4.396166676729281,AREG,GMP,0.5756194520344882
KEGG_2021_Human,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.3107848128900536,0,0,3.316828370692539,4.396166676729281,FLT3,GMP,0.5756194520344882
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),2/404,0.2679393411370432,0.3110401193668802,0,0,2.026119402985074,2.6683884405969245,FLT3;PRLR,GMP,0.5719635148936996
KEGG_2021_Human,cellular response to oxidative stress (GO:0034599),1/125,0.2693829605231016,0.3110401193668802,0,0,3.263001974983542,4.279822783786303,CRYGD,GMP,0.5696298784899082
KEGG_2021_Human,regulation of phosphorylation (GO:0042325),1/125,0.2693829605231016,0.3110401193668802,0,0,3.263001974983542,4.279822783786303,EREG,GMP,0.5696298784899082
KEGG_2021_Human,platelet degranulation (GO:0002576),1/125,0.2693829605231016,0.3110401193668802,0,0,3.263001974983542,4.279822783786303,F13A1,GMP,0.5696298784899082
KEGG_2021_Human,regulation of protein secretion (GO:0050708),1/125,0.2693829605231016,0.3110401193668802,0,0,3.263001974983542,4.279822783786303,CD33,GMP,0.5696298784899082
KEGG_2021_Human,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3261909870179947,0,0,3.0640074211502784,3.857336278341556,AZU1,GMP,0.546741450090894
KEGG_2021_Human,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3261909870179947,0,0,3.0640074211502784,3.857336278341556,EREG,GMP,0.546741450090894
KEGG_2021_Human,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3306900759961839,0,0,2.99546485260771,3.714691124222948,FCGR1A,GMP,0.5385707850387818
KEGG_2021_Human,cellular calcium ion homeostasis (GO:0006874),1/136,0.289353816496661,0.3306900759961839,0,0,2.99546485260771,3.714691124222948,ELANE,GMP,0.5385707850387818
KEGG_2021_Human,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3318877395266546,0,0,2.9732893157262907,3.668866926816198,FCGR1A,GMP,0.5358942544628899
KEGG_2021_Human,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3342498718111814,0,0,2.929902395740905,3.579678317757992,EREG,GMP,0.5306096689947516
KEGG_2021_Human,potassium ion transmembrane transport (GO:0071805),1/139,0.2947069182263764,0.3342498718111814,0,0,2.929902395740905,3.579678317757992,KCNE5,GMP,0.5306096689947516
KEGG_2021_Human,enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.2964824884084789,0.3354145323409054,0,0,2.9086771399207163,3.5362740390257685,FLT3,GMP,0.5280009529309525
KEGG_2021_Human,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3388440212981766,0,0,2.8467950560505892,3.410594866305226,FCGR1A,GMP,0.5203052911363482
KEGG_2021_Human,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3388440212981766,0,0,2.8467950560505892,3.410594866305226,SLC16A10,GMP,0.5203052911363482
KEGG_2021_Human,monocarboxylic acid metabolic process (GO:0032787),1/143,0.3017829564686885,0.3388440212981766,0,0,2.8467950560505892,3.410594866305226,CYP2S1,GMP,0.5203052911363482
KEGG_2021_Human,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3469265379339284,0,0,2.749271137026239,3.215201203875706,CEMIP,GMP,0.5078961191737069
KEGG_2021_Human,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3469265379339284,0,0,2.749271137026239,3.215201203875706,FLT3,GMP,0.5078961191737069
KEGG_2021_Human,positive regulation of hydrolase activity (GO:0051345),1/149,0.3122667490151626,0.3473371483512741,0,0,2.7305570876999448,3.1780885451938787,PRTN3,GMP,0.5054742581266645
KEGG_2021_Human,response to cytokine (GO:0034097),1/150,0.3139989845586295,0.3473371483512741,0,0,2.712094233666621,3.141596466170354,FLT3,GMP,0.5030717563895143
KEGG_2021_Human,regulation of cytokine production (GO:0001817),1/150,0.3139989845586295,0.3473371483512741,0,0,2.712094233666621,3.141596466170354,EREG,GMP,0.5030717563895143
KEGG_2021_Human,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3473371483512741,0,0,2.712094233666621,3.141596466170354,P2RY2,GMP,0.5030717563895143
KEGG_2021_Human,dephosphorylation (GO:0016311),1/153,0.3191700762858281,0.352187670384362,0,0,2.6581632653061225,3.0357052873752,PLPPR3,GMP,0.4959778325880012
KEGG_2021_Human,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/155,0.3225962281219006,0.3550936368516252,0,0,2.6233766233766236,2.9679671260643183,RAB7B,GMP,0.4913407148001928
KEGG_2021_Human,organonitrogen compound biosynthetic process (GO:1901566),1/158,0.3277037968552589,0.3598316200763627,0,0,2.5728584427401535,2.8703970097526006,GAL3ST2,GMP,0.48451852674781976
KEGG_2021_Human,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.3599274813534914,0,0,2.556445362955309,2.8389038953772054,CTSG,GMP,0.4822791499015975
KEGG_2021_Human,protein autophosphorylation (GO:0046777),1/159,0.329397918202972,0.3599274813534914,0,0,2.556445362955309,2.8389038953772054,FLT3,GMP,0.4822791499015975
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),2/482,0.3401543782991926,0.3707765486083657,0,0,1.6901041666666667,1.8225334796372663,AZU1;EREG,GMP,0.46832393464331673
KEGG_2021_Human,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.3709485503829178,0,0,2.4471243042671613,2.6317886779390967,FLT3,GMP,0.4670671197091842
KEGG_2021_Human,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3736492976209972,0,0,2.4175730172308443,2.5766088705447237,PRLR,GMP,0.46286379212748074
KEGG_2021_Human,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.3477593333218013,0.3763192785704517,0,0,2.388721168940949,2.523073857975914,CLDN10,GMP,0.45872120538836164
KEGG_2021_Human,protein phosphorylation (GO:0006468),2/496,0.3529487892748932,0.3810145966148244,0,0,1.641025641025641,1.709017116633574,FLT3;CTSG,GMP,0.4522883035321021
KEGG_2021_Human,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.3885567693454975,0,0,2.279833967485299,2.3241173885161555,FCGR1A,GMP,0.44273020383203454
KEGG_2021_Human,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.3901494911309167,0,0,2.2541329380914377,2.2778849681371156,EREG,GMP,0.4388706874182523
KEGG_2021_Human,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.3901494911309167,0,0,2.2541329380914377,2.2778849681371156,F13A1,GMP,0.4388706874182523
KEGG_2021_Human,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),1/185,0.3720057294778557,0.3977531427352729,0,0,2.192324755989352,2.1678716160963645,AREG,GMP,0.4294503712432232
KEGG_2021_Human,regulation of GTPase activity (GO:0043087),1/189,0.3783208179838206,0.4035422058494087,0,0,2.1452453321754232,2.085205747179162,PRTN3,GMP,0.42213975998471215
KEGG_2021_Human,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4108907175209719,0,0,2.089140319340171,1.988001678572607,FLT3,GMP,0.4132695879859197
KEGG_2021_Human,regulation of inflammatory response (GO:0050727),1/206,0.4044727291727134,0.4293928499274304,0,0,1.9656545545047288,1.7792534267442264,ELANE,GMP,0.39311075456855427
KEGG_2021_Human,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4378780666041015,0,0,1.909178837411742,1.6862551884518755,PLPPR3,GMP,0.3835844547796231
KEGG_2021_Human,positive regulation of GTPase activity (GO:0043547),1/214,0.416403436812339,0.4399734426696412,0,0,1.8910606496119575,1.656759537391559,PRTN3,GMP,0.3804856946694876
KEGG_2021_Human,extracellular structure organization (GO:0043062),1/216,0.41934932166703,0.4420435202513634,0,0,1.8732795443758896,1.627975467192003,COL23A1,GMP,0.3774240551539837
KEGG_2021_Human,external encapsulating structure organization (GO:0045229),1/217,0.4208167942393084,0.4425491169465028,0,0,1.8645124716553287,1.613843141672166,COL23A1,GMP,0.375906936392536
KEGG_2021_Human,cellular response to lipid (GO:0071396),1/219,0.4237408440429794,0.4445805576844375,0,0,1.8472196217936716,1.5860841457604238,CTSG,GMP,0.372899672681652
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4455463648698626,0,0,1.8302411873840445,1.5589816483293069,CEMIP,GMP,0.3699278171231457
KEGG_2021_Human,"transcription, DNA-templated (GO:0006351)",1/221,0.4266504252883283,0.4455463648698626,0,0,1.8302411873840445,1.5589816483293069,EREG,GMP,0.3699278171231457
KEGG_2021_Human,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.4783109389985559,0,0,1.655076845553036,1.2884811006593149,NTSR1,GMP,0.33809924509335265
KEGG_2021_Human,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.4618276248188864,0.4800435636168471,0,0,1.641399416909621,1.2680853834334544,RAB7B,GMP,0.33552009275365935
KEGG_2021_Human,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.4873557630773628,0,0,1.6016749329213755,1.2094704650298027,CRLF2,GMP,0.32794816113488356
KEGG_2021_Human,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5067000687151473,0,0,1.510204081632653,1.0781219104526054,AREG,GMP,0.3100391544580995
KEGG_2021_Human,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.5081984989275734,0,0,1.498781602193116,1.0620843946744252,CEMIP,GMP,0.30775490655057164
KEGG_2021_Human,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5539230005755434,0,0,1.314486450317832,0.8152139890333826,NTSR1,GMP,0.2693393582885023
KEGG_2021_Human,cellular macromolecule biosynthetic process (GO:0034645),1/314,0.5471545986718139,0.5622138995526895,0,0,1.2803677381495728,0.7720923294539072,GAL3ST2,GMP,0.26188994631047774
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6367541380924617,0,0,1.042628017264347,0.4965325169788531,AZU1,GMP,0.20682480102083725
KEGG_2021_Human,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6508122308176335,0,0,1.0,0.4521084323403523,CTSG,GMP,0.19634819738734471
KEGG_2021_Human,regulation of cell migration (GO:0030334),1/408,0.643643262264238,0.6568386822195413,0,0,0.9799428370856942,0.4317732474155183,CEMIP,GMP,0.19135477263518083
KEGG_2021_Human,cellular protein metabolic process (GO:0044267),1/417,0.6517468120762254,0.6635967541139749,0,0,0.9583006279434853,0.41024765313154,CTSG,GMP,0.1859210844420885
KEGG_2021_Human,negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.6912187085983104,0.7020976344444956,0,0,0.8589500595054437,0.3172093937483807,EREG,GMP,0.16038451570993173
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",2/948,0.6926945411260426,0.7020976344444956,0,0,0.8370331219168429,0.3073302326128318,ELANE;EREG,GMP,0.15945823486666727
KEGG_2021_Human,cellular protein modification process (GO:0006464),2/1025,0.7337546800798972,0.742036335611273,0,0,0.7708944281524927,0.2386539053000475,F13A1;CTSG,GMP,0.13444911569132442
KEGG_2021_Human,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7504933808556635,0.7572545824849938,0,0,0.7252747252747253,0.2081715773755284,EREG,GMP,0.1246531337611999
KEGG_2021_Human,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8304070258869889,0,0,0.5757014372366809,0.1108560647358729,ELANE,GMP,0.0836269880293983
KEGG_2021_Human,regulation of gene expression (GO:0010468),1/1079,0.9377418517471742,0.9419469721585964,0,0,0.3572753776835409,0.0229658682151355,AZU1,GMP,0.027916700844649738
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),1/2206,0.9971209346049892,0.9974129150066312,0,0,0.1642371234207968,0.00047353141012936674,ELANE,GMP,0.0012521656136179045
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",1/2244,0.9974129150066312,0.9974129150066312,0,0,0.1611089375562976,0.00041734259811053735,EREG,GMP,0.001125012616753463
KEGG_2021_Human,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),2/11,0.000332063883264561,0.0889931207149023,0,0,92.31944444444444,739.4956618223716,EPGN;AREG,HSC,3.478778357620151
KEGG_2021_Human,regulation of epidermal growth factor-activated receptor activity (GO:0007176),2/27,0.0020657293545543,0.1225164923335815,0,0,33.208333333333336,205.3029465636782,EPGN;AREG,HSC,2.684926579003782
KEGG_2021_Human,membrane organization (GO:0061024),4/242,0.0031132320867603,0.1225164923335815,0,0,7.202046035805626,41.57088553166817,EPGN;CHMP1B;AVP;AREG,HSC,2.5067885021115073
KEGG_2021_Human,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),2/34,0.0032650074009337,0.1225164923335815,0,0,25.934895833333332,148.46413612460563,EPGN;AREG,HSC,2.4861158299536776
KEGG_2021_Human,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),2/36,0.0036549257227984,0.1225164923335815,0,0,24.40686274509804,136.96349152286243,CDH9;CDH7,HSC,2.437121444562911
KEGG_2021_Human,positive regulation of signaling receptor activity (GO:2000273),2/37,0.0038576315924392,0.1225164923335815,0,0,23.708333333333332,131.76384828572083,EPGN;AREG,HSC,2.4136792502562754
KEGG_2021_Human,negative regulation of ERBB signaling pathway (GO:1901185),2/40,0.0044964248068071,0.1225164923335815,0,0,21.833333333333332,117.99765363023796,EPGN;AREG,HSC,2.3471326648462743
KEGG_2021_Human,positive regulation of protein tyrosine kinase activity (GO:0061098),2/42,0.0049475924537835,0.1225164923335815,0,0,20.739583333333332,110.1034239545967,EPGN;AREG,HSC,2.3056060815494894
KEGG_2021_Human,spermatid development (GO:0007286),2/43,0.0051806911627924,0.1225164923335815,0,0,20.232723577235777,106.48111760263689,SPINK2;CCDC42,HSC,2.2856122965939503
KEGG_2021_Human,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),2/44,0.0054187658916089,0.1225164923335815,0,0,19.75,103.05327189846057,EPGN;AREG,HSC,2.266099611522887
KEGG_2021_Human,epidermal growth factor receptor signaling pathway (GO:0007173),2/47,0.0061625935135597,0.1225164923335815,0,0,18.430555555555557,93.79784429037068,EPGN;AREG,HSC,2.210236477513525
KEGG_2021_Human,adherens junction organization (GO:0034332),2/49,0.0066828970303688,0.1225164923335815,0,0,17.64450354609929,88.36726791367238,CDH9;CDH7,HSC,2.175035230405133
KEGG_2021_Human,MAPK cascade (GO:0000165),4/303,0.006880954509151,0.1225164923335815,0,0,5.714992002326596,28.45493317732783,EPGN;PRKG2;AVP;AREG,HSC,2.1623513133191365
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),3/161,0.0076080983625269,0.1225164923335815,0,0,7.99569081605171,39.00731366496807,P2RY12;EPGN;AREG,HSC,2.118723881188083
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),4/323,0.0085789373051947,0.1225164923335815,0,0,5.351233474172005,25.46355140169845,P2RY12;CRYGD;CRHBP;CXCL3,HSC,2.066566505982727
KEGG_2021_Human,negative regulation of endopeptidase activity (GO:0010951),2/63,0.0108545013893802,0.1225164923335815,0,0,13.585382513661202,61.44906812714711,SPINK2;SPOCK3,HSC,1.9643901214324337
KEGG_2021_Human,diterpenoid metabolic process (GO:0016101),2/64,0.0111869000374274,0.1225164923335815,0,0,13.365591397849462,60.051760195429935,ALDH1A1;GPC5,HSC,1.9512902426187388
KEGG_2021_Human,ERBB signaling pathway (GO:0038127),2/66,0.0118650634107129,0.1225164923335815,0,0,12.946614583333334,57.4073222604629,EPGN;AREG,HSC,1.9257299364311244
KEGG_2021_Human,cell-cell junction assembly (GO:0007043),2/66,0.0118650634107129,0.1225164923335815,0,0,12.946614583333334,57.4073222604629,CDH9;CDH7,HSC,1.9257299364311244
KEGG_2021_Human,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2/67,0.012210781302115,0.1225164923335815,0,0,12.746794871794872,56.15518906635068,EPGN;AREG,HSC,1.9132565470017566
KEGG_2021_Human,regulation of glial cell migration (GO:1903975),1/5,0.0124387771927725,0.1225164923335815,0,0,101.76530612244898,446.4379351400606,P2RY12,HSC,1.9052223113279663
KEGG_2021_Human,fructose catabolic process (GO:0006001),1/5,0.0124387771927725,0.1225164923335815,0,0,101.76530612244898,446.4379351400606,ALDH1A1,HSC,1.9052223113279663
KEGG_2021_Human,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),1/5,0.0124387771927725,0.1225164923335815,0,0,101.76530612244898,446.4379351400606,ALDH1A1,HSC,1.9052223113279663
KEGG_2021_Human,gamma-aminobutyric acid metabolic process (GO:0009448),1/5,0.0124387771927725,0.1225164923335815,0,0,101.76530612244898,446.4379351400606,ALDH1A1,HSC,1.9052223113279663
KEGG_2021_Human,response to cocaine (GO:0042220),1/5,0.0124387771927725,0.1225164923335815,0,0,101.76530612244898,446.4379351400606,CRHBP,HSC,1.9052223113279663
KEGG_2021_Human,negative regulation of serine-type peptidase activity (GO:1902572),1/6,0.0149082847993736,0.1225164923335815,0,0,81.40816326530613,342.3895623444841,SPINK2,HSC,1.8265723193247598
KEGG_2021_Human,regulation of serine-type endopeptidase activity (GO:1900003),1/6,0.0149082847993736,0.1225164923335815,0,0,81.40816326530613,342.3895623444841,SPINK2,HSC,1.8265723193247598
KEGG_2021_Human,positive regulation of microglial cell migration (GO:1904141),1/6,0.0149082847993736,0.1225164923335815,0,0,81.40816326530613,342.3895623444841,P2RY12,HSC,1.8265723193247598
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),3/207,0.0149903872851396,0.1225164923335815,0,0,6.178347934918649,25.95119984420915,P2RY12;EPGN;AREG,HSC,1.8241871467630404
KEGG_2021_Human,amino sugar catabolic process (GO:0046348),1/7,0.0173717414502839,0.1225164923335815,0,0,67.83673469387755,274.9362107684438,ALDH1A1,HSC,1.7601566430186848
KEGG_2021_Human,"substrate-dependent cell migration, cell extension (GO:0006930)",1/7,0.0173717414502839,0.1225164923335815,0,0,67.83673469387755,274.9362107684438,P2RY12,HSC,1.7601566430186848
KEGG_2021_Human,"synaptic transmission, dopaminergic (GO:0001963)",1/7,0.0173717414502839,0.1225164923335815,0,0,67.83673469387755,274.9362107684438,CRHBP,HSC,1.7601566430186848
KEGG_2021_Human,aspartate transmembrane transport (GO:0015810),1/7,0.0173717414502839,0.1225164923335815,0,0,67.83673469387755,274.9362107684438,SLC1A6,HSC,1.7601566430186848
KEGG_2021_Human,glial cell migration (GO:0008347),1/7,0.0173717414502839,0.1225164923335815,0,0,67.83673469387755,274.9362107684438,P2RY12,HSC,1.7601566430186848
KEGG_2021_Human,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/7,0.0173717414502839,0.1225164923335815,0,0,67.83673469387755,274.9362107684438,ALDH1A1,HSC,1.7601566430186848
KEGG_2021_Human,regulation of microglial cell migration (GO:1904139),1/7,0.0173717414502839,0.1225164923335815,0,0,67.83673469387755,274.9362107684438,P2RY12,HSC,1.7601566430186848
KEGG_2021_Human,hemostasis (GO:0007599),1/7,0.0173717414502839,0.1225164923335815,0,0,67.83673469387755,274.9362107684438,P2RY12,HSC,1.7601566430186848
KEGG_2021_Human,cellular amino acid biosynthetic process (GO:0008652),1/7,0.0173717414502839,0.1225164923335815,0,0,67.83673469387755,274.9362107684438,ALDH1A1,HSC,1.7601566430186848
KEGG_2021_Human,cell-cell junction organization (GO:0045216),2/82,0.0179108739546233,0.1230798517907452,0,0,10.348958333333334,41.62710426921145,CDH9;CDH7,HSC,1.746883222391611
KEGG_2021_Human,lens fiber cell differentiation (GO:0070306),1/8,0.0198291614511851,0.1235864016027351,0,0,58.142857142857146,227.9549801512961,CRYGD,HSC,1.702695651141308
KEGG_2021_Human,cellular response to potassium ion (GO:0035865),1/8,0.0198291614511851,0.1235864016027351,0,0,58.142857142857146,227.9549801512961,CRHBP,HSC,1.702695651141308
KEGG_2021_Human,positive regulation of glial cell migration (GO:1903977),1/8,0.0198291614511851,0.1235864016027351,0,0,58.142857142857146,227.9549801512961,P2RY12,HSC,1.702695651141308
KEGG_2021_Human,response to potassium ion (GO:0035864),1/8,0.0198291614511851,0.1235864016027351,0,0,58.142857142857146,227.9549801512961,CRHBP,HSC,1.702695651141308
KEGG_2021_Human,retinoid metabolic process (GO:0001523),2/92,0.0222223839756269,0.1335495799981862,0,0,9.194444444444445,35.00007985571613,ALDH1A1;GPC5,HSC,1.6532093525993499
KEGG_2021_Human,ESCRT complex disassembly (GO:1904896),1/10,0.024725948817258,0.1335495799981862,0,0,45.21768707482993,167.3010120823387,CHMP1B,HSC,1.606847034080906
KEGG_2021_Human,ESCRT III complex disassembly (GO:1904903),1/10,0.024725948817258,0.1335495799981862,0,0,45.21768707482993,167.3010120823387,CHMP1B,HSC,1.606847034080906
KEGG_2021_Human,L-glutamate transmembrane transport (GO:0015813),1/10,0.024725948817258,0.1335495799981862,0,0,45.21768707482993,167.3010120823387,SLC1A6,HSC,1.606847034080906
KEGG_2021_Human,regulation of macrophage migration (GO:1905521),1/10,0.024725948817258,0.1335495799981862,0,0,45.21768707482993,167.3010120823387,P2RY12,HSC,1.606847034080906
KEGG_2021_Human,cell junction assembly (GO:0034329),2/102,0.0269177264019109,0.1335495799981862,0,0,8.270833333333334,29.898816321570965,CDH9;CDH7,HSC,1.5699616254585989
KEGG_2021_Human,tetrahydrobiopterin metabolic process (GO:0046146),1/11,0.0271653448579923,0.1335495799981862,0,0,40.69387755102041,146.73452100035948,PRKG2,HSC,1.5659847773237099
KEGG_2021_Human,positive regulation of integrin activation (GO:0033625),1/11,0.0271653448579923,0.1335495799981862,0,0,40.69387755102041,146.73452100035948,P2RY12,HSC,1.5659847773237099
KEGG_2021_Human,positive regulation of keratinocyte proliferation (GO:0010838),1/11,0.0271653448579923,0.1335495799981862,0,0,40.69387755102041,146.73452100035948,AREG,HSC,1.5659847773237099
KEGG_2021_Human,regulation of pH (GO:0006885),1/11,0.0271653448579923,0.1335495799981862,0,0,40.69387755102041,146.73452100035948,ATP6V0A4,HSC,1.5659847773237099
KEGG_2021_Human,protein kinase C signaling (GO:0070528),1/11,0.0271653448579923,0.1335495799981862,0,0,40.69387755102041,146.73452100035948,AVP,HSC,1.5659847773237099
KEGG_2021_Human,cellular response to organonitrogen compound (GO:0071417),2/103,0.0274075630593292,0.1335495799981862,0,0,8.188531353135314,29.45362550083794,P2RY12;CRHBP,HSC,1.56212957799338
KEGG_2021_Human,ethanol oxidation (GO:0006069),1/12,0.029598761568907,0.1344486118723237,0,0,36.99257884972171,130.2147194065139,ALDH1A1,HSC,1.5287264597194943
KEGG_2021_Human,angiotensin maturation (GO:0002003),1/12,0.029598761568907,0.1344486118723237,0,0,36.99257884972171,130.2147194065139,REN,HSC,1.5287264597194943
KEGG_2021_Human,neurotransmitter uptake (GO:0001504),1/12,0.029598761568907,0.1344486118723237,0,0,36.99257884972171,130.2147194065139,SLC1A6,HSC,1.5287264597194943
KEGG_2021_Human,regulation of angiotensin levels in blood (GO:0002002),1/12,0.029598761568907,0.1344486118723237,0,0,36.99257884972171,130.2147194065139,REN,HSC,1.5287264597194943
KEGG_2021_Human,regulation of response to stress (GO:0080134),1/13,0.032026213248763,0.1362384944550554,0,0,33.90816326530612,116.6847899929619,CRHBP,HSC,1.4944944088974865
KEGG_2021_Human,pteridine-containing compound metabolic process (GO:0042558),1/13,0.032026213248763,0.1362384944550554,0,0,33.90816326530612,116.6847899929619,PRKG2,HSC,1.4944944088974865
KEGG_2021_Human,positive regulation of ruffle assembly (GO:1900029),1/13,0.032026213248763,0.1362384944550554,0,0,33.90816326530612,116.6847899929619,P2RY12,HSC,1.4944944088974865
KEGG_2021_Human,negative regulation of locomotion (GO:0040013),1/13,0.032026213248763,0.1362384944550554,0,0,33.90816326530612,116.6847899929619,SPOCK3,HSC,1.4944944088974865
KEGG_2021_Human,substrate-dependent cell migration (GO:0006929),1/14,0.0344477141698711,0.1420305753465456,0,0,31.298273155416013,105.4223689491126,P2RY12,HSC,1.4628395910668823
KEGG_2021_Human,C4-dicarboxylate transport (GO:0015740),1/14,0.0344477141698711,0.1420305753465456,0,0,31.298273155416013,105.4223689491126,SLC1A6,HSC,1.4628395910668823
KEGG_2021_Human,negative regulation of cellular component movement (GO:0051271),1/15,0.0368632785936063,0.1431791110592245,0,0,29.06122448979592,95.91771596133704,SPOCK3,HSC,1.4334060415588732
KEGG_2021_Human,macrophage migration (GO:1905517),1/15,0.0368632785936063,0.1431791110592245,0,0,29.06122448979592,95.91771596133704,P2RY12,HSC,1.4334060415588732
KEGG_2021_Human,cellular response to ATP (GO:0071318),1/15,0.0368632785936063,0.1431791110592245,0,0,29.06122448979592,95.91771596133704,P2RY12,HSC,1.4334060415588732
KEGG_2021_Human,cellular response to estrogen stimulus (GO:0071391),1/15,0.0368632785936063,0.1431791110592245,0,0,29.06122448979592,95.91771596133704,CRHBP,HSC,1.4334060415588732
KEGG_2021_Human,positive regulation of epithelial cell proliferation (GO:0050679),2/123,0.0379356146383277,0.1452392103295975,0,0,6.828168044077135,22.34084340876857,EPGN;AREG,HSC,1.420952875040757
KEGG_2021_Human,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/16,0.0392729207344652,0.1482414472793899,0,0,27.122448979591837,87.80133530116419,AVP,HSC,1.405906798966597
KEGG_2021_Human,midbody abscission (GO:0061952),1/17,0.0416766547912334,0.1482501192753011,0,0,25.426020408163264,80.79916728086499,CHMP1B,HSC,1.3801071472903907
KEGG_2021_Human,acidic amino acid transport (GO:0015800),1/18,0.0440744949316926,0.1482501192753011,0,0,23.92917166866747,74.70385911458476,SLC1A6,HSC,1.3558126557645607
KEGG_2021_Human,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.0440744949316926,0.1482501192753011,0,0,23.92917166866747,74.70385911458476,P2RY12,HSC,1.3558126557645607
KEGG_2021_Human,fluid transport (GO:0042044),1/18,0.0440744949316926,0.1482501192753011,0,0,23.92917166866747,74.70385911458476,AVP,HSC,1.3558126557645607
KEGG_2021_Human,response to axon injury (GO:0048678),1/18,0.0440744949316926,0.1482501192753011,0,0,23.92917166866747,74.70385911458476,P2RY12,HSC,1.3558126557645607
KEGG_2021_Human,water transport (GO:0006833),1/18,0.0440744949316926,0.1482501192753011,0,0,23.92917166866747,74.70385911458476,AVP,HSC,1.3558126557645607
KEGG_2021_Human,negative regulation of peptide hormone secretion (GO:0090278),1/18,0.0440744949316926,0.1482501192753011,0,0,23.92917166866747,74.70385911458476,CRHBP,HSC,1.3558126557645607
KEGG_2021_Human,cellular response to alkaloid (GO:0071312),1/18,0.0440744949316926,0.1482501192753011,0,0,23.92917166866747,74.70385911458476,CRHBP,HSC,1.3558126557645607
KEGG_2021_Human,ethanol metabolic process (GO:0006067),1/19,0.0464664552952436,0.1482501192753011,0,0,22.598639455782312,69.35578082800635,ALDH1A1,HSC,1.3328604565168853
KEGG_2021_Human,regulation of mitotic spindle assembly (GO:1901673),1/19,0.0464664552952436,0.1482501192753011,0,0,22.598639455782312,69.35578082800635,CHMP1B,HSC,1.3328604565168853
KEGG_2021_Human,response to ATP (GO:0033198),1/19,0.0464664552952436,0.1482501192753011,0,0,22.598639455782312,69.35578082800635,P2RY12,HSC,1.3328604565168853
KEGG_2021_Human,diol metabolic process (GO:0034311),1/19,0.0464664552952436,0.1482501192753011,0,0,22.598639455782312,69.35578082800635,PRKG2,HSC,1.3328604565168853
KEGG_2021_Human,positive regulation of macrophage migration (GO:1905523),1/19,0.0464664552952436,0.1482501192753011,0,0,22.598639455782312,69.35578082800635,P2RY12,HSC,1.3328604565168853
KEGG_2021_Human,mitotic cytokinetic process (GO:1902410),1/20,0.0488525499820277,0.1540292164139228,0,0,21.40816326530612,64.63014669364038,CHMP1B,HSC,1.3111127622579986
KEGG_2021_Human,vacuolar acidification (GO:0007035),1/21,0.0512327930672156,0.1578205579541813,0,0,20.336734693877553,60.42807445408675,ATP6V0A4,HSC,1.2904519669693806
KEGG_2021_Human,cellular response to estradiol stimulus (GO:0071392),1/21,0.0512327930672156,0.1578205579541813,0,0,20.336734693877553,60.42807445408675,CRHBP,HSC,1.2904519669693806
KEGG_2021_Human,regulation of centrosome cycle (GO:0046605),1/22,0.0536071985992547,0.1630995656924562,0,0,19.367346938775512,56.67024999786951,CHMP1B,HSC,1.2707768875084013
KEGG_2021_Human,cellular response to organic cyclic compound (GO:0071407),2/150,0.0541636617411515,0.1630995656924562,0,0,5.574887387387387,16.25495026487543,P2RY12;CRHBP,HSC,1.2662919827974375
KEGG_2021_Human,ERK1 and ERK2 cascade (GO:0070371),1/23,0.0559757805878795,0.1666834355283523,0,0,18.4860853432282,53.29235549319145,AVP,HSC,1.2519998414265567
KEGG_2021_Human,regulation of ruffle assembly (GO:1900027),1/24,0.0583385530130099,0.1681154000805018,0,0,17.68145519077196,50.24171555062859,P2RY12,HSC,1.2340443470047993
KEGG_2021_Human,amino acid import across plasma membrane (GO:0089718),1/24,0.0583385530130099,0.1681154000805018,0,0,17.68145519077196,50.24171555062859,SLC1A6,HSC,1.2340443470047993
KEGG_2021_Human,regulation of keratinocyte proliferation (GO:0010837),1/24,0.0583385530130099,0.1681154000805018,0,0,17.68145519077196,50.24171555062859,AREG,HSC,1.2340443470047993
KEGG_2021_Human,regulation of spindle assembly (GO:0090169),1/25,0.0606955298241754,0.1706191112064588,0,0,16.943877551020407,47.47480020477031,CHMP1B,HSC,1.2168432931781568
KEGG_2021_Human,endosome transport via multivesicular body sorting pathway (GO:0032509),1/25,0.0606955298241754,0.1706191112064588,0,0,16.943877551020407,47.47480020477031,CHMP1B,HSC,1.2168432931781568
KEGG_2021_Human,negative regulation of signaling receptor activity (GO:2000272),1/26,0.0630467249540435,0.1706191112064588,0,0,16.26530612244898,44.95534064809558,CRHBP,HSC,1.2003374685092782
KEGG_2021_Human,lamellipodium assembly (GO:0030032),1/26,0.0630467249540435,0.1706191112064588,0,0,16.26530612244898,44.95534064809558,P2RY12,HSC,1.2003374685092782
KEGG_2021_Human,cellular response to drug (GO:0035690),1/26,0.0630467249540435,0.1706191112064588,0,0,16.26530612244898,44.95534064809558,CRHBP,HSC,1.2003374685092782
KEGG_2021_Human,L-alpha-amino acid transmembrane transport (GO:1902475),1/27,0.0653921522588676,0.1706191112064588,0,0,15.638932496075354,42.652889831563165,SLC1A6,HSC,1.184474368421492
KEGG_2021_Human,positive regulation of nuclear division (GO:0051785),1/27,0.0653921522588676,0.1706191112064588,0,0,15.638932496075354,42.652889831563165,EPGN,HSC,1.184474368421492
KEGG_2021_Human,monovalent inorganic cation homeostasis (GO:0055067),1/27,0.0653921522588676,0.1706191112064588,0,0,15.638932496075354,42.652889831563165,ATP6V0A4,HSC,1.184474368421492
KEGG_2021_Human,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/170,0.067488533240135,0.1706191112064588,0,0,4.90625,13.226256844780602,CDH9;CDH7,HSC,1.1707700104811887
KEGG_2021_Human,L-amino acid transport (GO:0015807),1/28,0.0677318256109869,0.1706191112064588,0,0,15.058956916099774,40.54171043527237,SLC1A6,HSC,1.1692072184717057
KEGG_2021_Human,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/28,0.0677318256109869,0.1706191112064588,0,0,15.058956916099774,40.54171043527237,P2RY12,HSC,1.1692072184717057
KEGG_2021_Human,phagosome acidification (GO:0090383),1/28,0.0677318256109869,0.1706191112064588,0,0,15.058956916099774,40.54171043527237,ATP6V0A4,HSC,1.1692072184717057
KEGG_2021_Human,lamellipodium organization (GO:0097581),1/29,0.0700657588372089,0.1706191112064588,0,0,14.520408163265309,38.5999069065122,P2RY12,HSC,1.1544941700666143
KEGG_2021_Human,dicarboxylic acid transport (GO:0006835),1/29,0.0700657588372089,0.1706191112064588,0,0,14.520408163265309,38.5999069065122,SLC1A6,HSC,1.1544941700666143
KEGG_2021_Human,negative regulation of Notch signaling pathway (GO:0045746),1/30,0.0723939657090184,0.1706191112064588,0,0,14.019000703729768,36.80874147674154,DLK1,HSC,1.1402976322627019
KEGG_2021_Human,positive regulation of lipid kinase activity (GO:0090218),1/30,0.0723939657090184,0.1706191112064588,0,0,14.019000703729768,36.80874147674154,P2RY12,HSC,1.1402976322627019
KEGG_2021_Human,cell projection organization (GO:0030030),1/30,0.0723939657090184,0.1706191112064588,0,0,14.019000703729768,36.80874147674154,P2RY12,HSC,1.1402976322627019
KEGG_2021_Human,multivesicular body assembly (GO:0036258),1/30,0.0723939657090184,0.1706191112064588,0,0,14.019000703729768,36.80874147674154,CHMP1B,HSC,1.1402976322627019
KEGG_2021_Human,regulation of protein localization to membrane (GO:1905475),1/30,0.0723939657090184,0.1706191112064588,0,0,14.019000703729768,36.80874147674154,GPC5,HSC,1.1402976322627019
KEGG_2021_Human,aminoglycan catabolic process (GO:0006026),1/31,0.0747164600026276,0.1706191112064588,0,0,13.551020408163266,35.15209038871121,GPC5,HSC,1.126583712764908
KEGG_2021_Human,renal water homeostasis (GO:0003091),1/31,0.0747164600026276,0.1706191112064588,0,0,13.551020408163266,35.15209038871121,AVP,HSC,1.126583712764908
KEGG_2021_Human,positive regulation of locomotion (GO:0040017),1/31,0.0747164600026276,0.1706191112064588,0,0,13.551020408163266,35.15209038871121,P2RY12,HSC,1.126583712764908
KEGG_2021_Human,multivesicular body organization (GO:0036257),1/31,0.0747164600026276,0.1706191112064588,0,0,13.551020408163266,35.15209038871121,CHMP1B,HSC,1.126583712764908
KEGG_2021_Human,cellular response to cAMP (GO:0071320),1/31,0.0747164600026276,0.1706191112064588,0,0,13.551020408163266,35.15209038871121,CRHBP,HSC,1.126583712764908
KEGG_2021_Human,activation of phospholipase C activity (GO:0007202),1/32,0.0770332554327668,0.1706191112064588,0,0,13.113232389730086,33.61600807740255,P2RY12,HSC,1.1133217484244988
KEGG_2021_Human,regulation of centrosome duplication (GO:0010824),1/32,0.0770332554327668,0.1706191112064588,0,0,13.113232389730086,33.61600807740255,CHMP1B,HSC,1.1133217484244988
KEGG_2021_Human,regulation of chemotaxis (GO:0050920),1/32,0.0770332554327668,0.1706191112064588,0,0,13.113232389730086,33.61600807740255,P2RY12,HSC,1.1133217484244988
KEGG_2021_Human,regulation of NMDA receptor activity (GO:2000310),1/32,0.0770332554327668,0.1706191112064588,0,0,13.113232389730086,33.61600807740255,CRHBP,HSC,1.1133217484244988
KEGG_2021_Human,regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.0816498044624026,0.1771534557230451,0,0,12.317254174397032,30.85861216573232,P2RY12,HSC,1.0880448509885652
KEGG_2021_Human,negative regulation of mitochondrion organization (GO:0010823),1/34,0.0816498044624026,0.1771534557230451,0,0,12.317254174397032,30.85861216573232,AVP,HSC,1.0880448509885652
KEGG_2021_Human,regulation of mitotic spindle organization (GO:0060236),1/35,0.0839495853612937,0.1771534557230451,0,0,11.95438175270108,29.61744503578088,CHMP1B,HSC,1.0759814445616303
KEGG_2021_Human,response to estrogen (GO:0043627),1/35,0.0839495853612937,0.1771534557230451,0,0,11.95438175270108,29.61744503578088,CRHBP,HSC,1.0759814445616303
KEGG_2021_Human,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/35,0.0839495853612937,0.1771534557230451,0,0,11.95438175270108,29.61744503578088,P2RY12,HSC,1.0759814445616303
KEGG_2021_Human,intracellular pH reduction (GO:0051452),1/35,0.0839495853612937,0.1771534557230451,0,0,11.95438175270108,29.61744503578088,ATP6V0A4,HSC,1.0759814445616303
KEGG_2021_Human,transferrin transport (GO:0033572),1/36,0.0862437219743075,0.1777947499162648,0,0,11.612244897959185,28.456712045041098,ATP6V0A4,HSC,1.0642725091375862
KEGG_2021_Human,platelet aggregation (GO:0070527),1/36,0.0862437219743075,0.1777947499162648,0,0,11.612244897959185,28.456712045041098,P2RY12,HSC,1.0642725091375862
KEGG_2021_Human,positive regulation of mitotic nuclear division (GO:0045840),1/36,0.0862437219743075,0.1777947499162648,0,0,11.612244897959185,28.456712045041098,EPGN,HSC,1.0642725091375862
KEGG_2021_Human,proton transmembrane transport (GO:1902600),1/37,0.0885322278902676,0.1797472505650889,0,0,11.289115646258503,27.36920368672352,ATP6V0A4,HSC,1.0528986067362665
KEGG_2021_Human,phagosome maturation (GO:0090382),1/37,0.0885322278902676,0.1797472505650889,0,0,11.289115646258503,27.36920368672352,ATP6V0A4,HSC,1.0528986067362665
KEGG_2021_Human,response to cAMP (GO:0051591),1/38,0.0908151166313484,0.1816302332626969,0,0,10.983452840595698,26.34852930034076,CRHBP,HSC,1.0418418549683985
KEGG_2021_Human,response to estradiol (GO:0032355),1/38,0.0908151166313484,0.1816302332626969,0,0,10.983452840595698,26.34852930034076,CRHBP,HSC,1.0418418549683985
KEGG_2021_Human,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.0976302146847681,0.1923889524670431,0,0,10.158163265306122,23.633660200289185,AVP,HSC,1.0104157556925017
KEGG_2021_Human,import into cell (GO:0098657),1/41,0.0976302146847681,0.1923889524670431,0,0,10.158163265306122,23.633660200289185,SLC1A6,HSC,1.0104157556925017
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),2/214,0.100019348409027,0.1956582873986805,0,0,3.879323899371069,8.931722866735825,CRHBP;ALDH1A1,HSC,0.9999159790553556
KEGG_2021_Human,positive regulation of phospholipase C activity (GO:0010863),1/43,0.1021457742794159,0.1983700543977062,0,0,9.673469387755102,22.068611238785657,P2RY12,HSC,0.9907795952096249
KEGG_2021_Human,cellular response to lipid (GO:0071396),2/219,0.1039543502969196,0.1998423212897173,0,0,3.788978494623656,8.577502457974575,CRHBP;CXCL3,HSC,0.9831573315329525
KEGG_2021_Human,homotypic cell-cell adhesion (GO:0034109),1/44,0.1043952424647777,0.1998423212897173,0,0,9.448030374940672,21.34849709415977,P2RY12,HSC,0.9813192926974915
KEGG_2021_Human,amino acid transmembrane transport (GO:0003333),1/45,0.1066391873529346,0.2012626916238485,0,0,9.232838589981448,20.665901611884028,SLC1A6,HSC,0.9720831731354668
KEGG_2021_Human,positive regulation of chemotaxis (GO:0050921),1/45,0.1066391873529346,0.2012626916238485,0,0,9.232838589981448,20.665901611884028,P2RY12,HSC,0.9720831731354668
KEGG_2021_Human,regulation of cellular protein localization (GO:1903827),1/46,0.1088776222085674,0.2040503688943782,0,0,9.02721088435374,20.01811780873028,GPC5,HSC,0.9630613723103648
KEGG_2021_Human,negative regulation of cold-induced thermogenesis (GO:0120163),1/47,0.1111105603036554,0.2067890983429144,0,0,8.830523513753327,19.4026870705364,ALDH1A1,HSC,0.9542446623584087
KEGG_2021_Human,inflammatory response (GO:0006954),2/230,0.1127586124121412,0.2080451231252925,0,0,3.6041666666666665,7.866115081211615,CRHBP;CXCL3,HSC,0.9478502771198579
KEGG_2021_Human,nucleus organization (GO:0006997),1/48,0.1133380148369131,0.2080451231252925,0,0,8.642205818497612,18.81737166641443,CHMP1B,HSC,0.9456243984787533
KEGG_2021_Human,aminoglycan biosynthetic process (GO:0006023),1/49,0.1155599990222406,0.2106808145439489,0,0,8.46173469387755,18.260130793597916,GPC5,HSC,0.9371924705024297
KEGG_2021_Human,iron ion transport (GO:0006826),1/50,0.1177765260040411,0.2132710065478582,0,0,8.28862973760933,17.7290996615035,ATP6V0A4,HSC,0.928941259997044
KEGG_2021_Human,mitotic metaphase plate congression (GO:0007080),1/51,0.1199876089220907,0.2158166388665793,0,0,8.122448979591837,17.22257115519733,CHMP1B,HSC,0.9208636010741894
KEGG_2021_Human,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.1243934949128716,0.2222497109109973,0,0,7.809262166405024,16.276887238960814,AVP,HSC,0.9052023302345248
KEGG_2021_Human,glycosaminoglycan metabolic process (GO:0030203),1/54,0.1265883240687765,0.2246733168902787,0,0,7.661532537543319,15.834970375184442,GPC5,HSC,0.8976063498190403
KEGG_2021_Human,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/55,0.1287777613922166,0.2264372110340595,0,0,7.519274376417234,15.412009607623004,AVP,HSC,0.8901591287349465
KEGG_2021_Human,chemokine-mediated signaling pathway (GO:0070098),1/56,0.1309618198144747,0.2264372110340595,0,0,7.382189239332097,15.00687933540933,CXCL3,HSC,0.8828552987007785
KEGG_2021_Human,glycosaminoglycan catabolic process (GO:0006027),1/56,0.1309618198144747,0.2264372110340595,0,0,7.382189239332097,15.00687933540933,GPC5,HSC,0.8828552987007785
KEGG_2021_Human,negative regulation of metabolic process (GO:0009892),1/56,0.1309618198144747,0.2264372110340595,0,0,7.382189239332097,15.00687933540933,ALDH1A1,HSC,0.8828552987007785
KEGG_2021_Human,renal system development (GO:0072001),1/57,0.1331405122852093,0.2272717024995929,0,0,7.25,14.618539131965724,REN,HSC,0.8756897763447542
KEGG_2021_Human,regulation of mitotic nuclear division (GO:0007088),1/57,0.1331405122852093,0.2272717024995929,0,0,7.25,14.618539131965724,EPGN,HSC,0.8756897763447542
KEGG_2021_Human,regulation of neurotransmitter receptor activity (GO:0099601),1/58,0.1353138517398134,0.2295196978877848,0,0,7.122448979591836,14.246025949065045,CRHBP,HSC,0.8686577434892403
KEGG_2021_Human,response to reactive oxygen species (GO:0000302),1/59,0.1374818510452552,0.2317304155982918,0,0,6.9992962702322306,13.8884471557023,CRYGD,HSC,0.8617546291873563
KEGG_2021_Human,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.1396445230534406,0.2324517526603856,0,0,6.88031822898651,13.544974303558986,P2RY12,HSC,0.8549760929333525
KEGG_2021_Human,cellular response to chemokine (GO:1990869),1/60,0.1396445230534406,0.2324517526603856,0,0,6.88031822898651,13.544974303558986,CXCL3,HSC,0.8549760929333525
KEGG_2021_Human,negative regulation of signal transduction (GO:0009968),2/267,0.1436652916283004,0.2344610090724441,0,0,3.095125786163522,6.005376764494242,CRHBP;DLK1,HSC,0.8426481412255155
KEGG_2021_Human,cellular response to reactive oxygen species (GO:0034614),1/63,0.1461007034145454,0.2344610090724441,0,0,6.54641211323239,12.591756250239603,CRYGD,HSC,0.8353476931121088
KEGG_2021_Human,COPII vesicle coating (GO:0048208),1/63,0.1461007034145454,0.2344610090724441,0,0,6.54641211323239,12.591756250239603,AREG,HSC,0.8353476931121088
KEGG_2021_Human,vesicle coating (GO:0006901),1/63,0.1461007034145454,0.2344610090724441,0,0,6.54641211323239,12.591756250239603,AREG,HSC,0.8353476931121088
KEGG_2021_Human,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/63,0.1461007034145454,0.2344610090724441,0,0,6.54641211323239,12.591756250239603,AREG,HSC,0.8353476931121088
KEGG_2021_Human,negative regulation of peptidase activity (GO:0010466),1/63,0.1461007034145454,0.2344610090724441,0,0,6.54641211323239,12.591756250239603,SPOCK3,HSC,0.8353476931121088
KEGG_2021_Human,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.1482421941802595,0.2364815954780331,0,0,6.442176870748299,12.297522293260638,CXCL3,HSC,0.8290281655096747
KEGG_2021_Human,anion transmembrane transport (GO:0098656),1/67,0.1546351363099914,0.2452202161602231,0,0,6.148423005565863,11.477180657220888,SLC1A6,HSC,0.8106918184915987
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),3/546,0.1557845334346044,0.2455897350616117,0,0,2.281297754790173,4.241574534432652,P2RY12;EPGN;AREG,HSC,0.807475662051351
KEGG_2021_Human,positive regulation of MAP kinase activity (GO:0043406),1/69,0.158870948881139,0.2465309768026471,0,0,5.966986794717887,10.977245117600177,EPGN,HSC,0.7989555105590889
KEGG_2021_Human,cellular response to calcium ion (GO:0071277),1/69,0.158870948881139,0.2465309768026471,0,0,5.966986794717887,10.977245117600177,CRHBP,HSC,0.7989555105590889
KEGG_2021_Human,kidney development (GO:0001822),1/70,0.1609810482853106,0.2465309768026471,0,0,5.880212954747116,10.740024519792764,REN,HSC,0.7932252488723367
KEGG_2021_Human,neutrophil chemotaxis (GO:0030593),1/70,0.1609810482853106,0.2465309768026471,0,0,5.880212954747116,10.740024519792764,CXCL3,HSC,0.7932252488723367
KEGG_2021_Human,COPII-coated vesicle budding (GO:0090114),1/70,0.1609810482853106,0.2465309768026471,0,0,5.880212954747116,10.740024519792764,AREG,HSC,0.7932252488723367
KEGG_2021_Human,regulation of endopeptidase activity (GO:0052548),1/71,0.16308595979881,0.2483354387845517,0,0,5.795918367346939,10.51076961698872,SPOCK3,HSC,0.7875834261109624
KEGG_2021_Human,neurotransmitter transport (GO:0006836),1/73,0.1672802691231711,0.2504531403631835,0,0,5.634353741496598,10.074701240888364,SLC1A6,HSC,0.7765552814899175
KEGG_2021_Human,granulocyte chemotaxis (GO:0071621),1/73,0.1672802691231711,0.2504531403631835,0,0,5.634353741496598,10.074701240888364,CXCL3,HSC,0.7765552814899175
KEGG_2021_Human,insulin receptor signaling pathway (GO:0008286),1/73,0.1672802691231711,0.2504531403631835,0,0,5.634353741496598,10.074701240888364,ATP6V0A4,HSC,0.7765552814899175
KEGG_2021_Human,regulation of peptide hormone secretion (GO:0090276),1/74,0.1693696918266344,0.2521726522752113,0,0,5.556891249650545,9.867213018330611,CRHBP,HSC,0.7711643026835198
KEGG_2021_Human,cellular response to hormone stimulus (GO:0032870),1/76,0.1735331353639065,0.2569440899310881,0,0,5.408163265306122,9.4717853003048,CRHBP,HSC,0.7606175863963804
KEGG_2021_Human,neutrophil migration (GO:1990266),1/77,0.1756071809118701,0.2585863982658307,0,0,5.336734693877551,9.283280446293812,CXCL3,HSC,0.7554577289388229
KEGG_2021_Human,negative regulation of apoptotic signaling pathway (GO:2001234),1/78,0.1776761254379788,0.2591385241323742,0,0,5.267161410018553,9.10056411919043,AVP,HSC,0.7503709249641564
KEGG_2021_Human,chemical synaptic transmission (GO:0007268),2/306,0.1779160016431225,0.2591385241323742,0,0,2.6927083333333335,4.648809448291678,CRHBP;SLC1A6,HSC,0.7497849900117082
KEGG_2021_Human,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2633625287106129,0,0,5.133298889175924,8.751529842637671,P2RY12,HSC,0.7404090821369118
KEGG_2021_Human,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.1838524754991919,0.2649057173859325,0,0,5.0688775510204085,8.584760541358477,P2RY12,HSC,0.7355305181562768
KEGG_2021_Human,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1/83,0.1879447615357932,0.2679212558063435,0,0,4.944748631159781,8.265677319811374,P2RY12,HSC,0.7259697745939766
KEGG_2021_Human,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.2679212558063435,0,0,4.944748631159781,8.265677319811374,DLK1,HSC,0.7259697745939766
KEGG_2021_Human,sensory perception of mechanical stimulus (GO:0050954),1/88,0.1980877029036425,0.2793081214974468,0,0,4.659394792399718,7.5437717166037235,ATP6V0A4,HSC,0.703142484213379
KEGG_2021_Human,regulation of cation channel activity (GO:2001257),1/89,0.2001013407742902,0.2793081214974468,0,0,4.6062152133580705,7.411084001248333,CRHBP,HSC,0.6987500013741589
KEGG_2021_Human,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),1/89,0.2001013407742902,0.2793081214974468,0,0,4.6062152133580705,7.411084001248333,AVP,HSC,0.6987500013741589
KEGG_2021_Human,second-messenger-mediated signaling (GO:0019932),1/89,0.2001013407742902,0.2793081214974468,0,0,4.6062152133580705,7.411084001248333,P2RY12,HSC,0.6987500013741589
KEGG_2021_Human,sensory perception of sound (GO:0007605),1/91,0.2041137620931186,0.2834325815593564,0,0,4.503401360544218,7.156255051106618,ATP6V0A4,HSC,0.6901277125812961
KEGG_2021_Human,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.2081064570390282,0.2845537269717324,0,0,4.40505767524401,6.914643337844717,AVP,HSC,0.6817144444740324
KEGG_2021_Human,visual perception (GO:0007601),1/93,0.2081064570390282,0.2845537269717324,0,0,4.40505767524401,6.914643337844717,CRYGD,HSC,0.6817144444740324
KEGG_2021_Human,regulation of epithelial cell proliferation (GO:0050678),1/93,0.2081064570390282,0.2845537269717324,0,0,4.40505767524401,6.914643337844717,EPGN,HSC,0.6817144444740324
KEGG_2021_Human,sensory perception of light stimulus (GO:0050953),1/95,0.2120795205832498,0.2885142716564007,0,0,4.310898827616153,6.685315939697291,CRYGD,HSC,0.6735012670190429
KEGG_2021_Human,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2909389782479615,0,0,4.220663265306122,6.46742313757927,EPGN,HSC,0.6654798083211632
KEGG_2021_Human,glycosaminoglycan biosynthetic process (GO:0006024),1/97,0.2160330472811356,0.2909389782479615,0,0,4.220663265306122,6.46742313757927,GPC5,HSC,0.6654798083211632
KEGG_2021_Human,regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.2180025137484037,0.292123368422861,0,0,4.176940879444562,6.362519703204576,AVP,HSC,0.6615384985937142
KEGG_2021_Human,epithelial cell differentiation (GO:0030855),1/101,0.2238818662412048,0.2966812640695687,0,0,4.051020408163265,6.062906014187368,CRYGD,HSC,0.6499810815451941
KEGG_2021_Human,positive regulation of cell cycle process (GO:0090068),1/101,0.2238818662412048,0.2966812640695687,0,0,4.051020408163265,6.062906014187368,EPGN,HSC,0.6499810815451941
KEGG_2021_Human,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2966812640695687,0,0,4.010709234188725,5.967790506031058,P2RY12,HSC,0.6462145058611213
KEGG_2021_Human,mitotic sister chromatid segregation (GO:0000070),1/102,0.2258320069783284,0.2966812640695687,0,0,4.010709234188725,5.967790506031058,CHMP1B,HSC,0.6462145058611213
KEGG_2021_Human,cellular response to peptide hormone stimulus (GO:0071375),1/106,0.2335846623503299,0.3034467455685389,0,0,3.857142857142857,5.6090983677319475,CRHBP,HSC,0.6315556772929499
KEGG_2021_Human,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.3034467455685389,0,0,3.857142857142857,5.6090983677319475,EPGN,HSC,0.6315556772929499
KEGG_2021_Human,protein transport (GO:0015031),2/369,0.2354374823833979,0.3034467455685389,0,0,2.2233197093551316,3.215609236148146,CHMP1B;ATP6V0A4,HSC,0.6281243949487266
KEGG_2021_Human,response to calcium ion (GO:0051592),1/107,0.2355109070084182,0.3034467455685389,0,0,3.8205621871390063,5.524525481436682,CRHBP,HSC,0.6279889749729552
KEGG_2021_Human,response to tumor necrosis factor (GO:0034612),1/110,0.241261218690496,0.3093684526748945,0,0,3.714847406852649,5.282048795926194,CRHBP,HSC,0.6175124827423236
KEGG_2021_Human,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.3175958347912655,0,0,3.582625970742279,4.982913653406146,SPOCK3,HSC,0.6040407011916724
KEGG_2021_Human,cellular response to molecule of bacterial origin (GO:0071219),1/115,0.2507510141385882,0.3184894397589651,0,0,3.5510204081632653,4.9121080927455,CXCL3,HSC,0.6007573018413346
KEGG_2021_Human,ion transport (GO:0006811),1/116,0.2526349665899778,0.3193687313495946,0,0,3.5199645075421473,4.8428011439058265,SLC1A6,HSC,0.5975065399797567
KEGG_2021_Human,regulation of cellular response to stress (GO:0080135),1/118,0.2563889548341396,0.3225926755659596,0,0,3.4594453165881736,4.708511372057024,CRHBP,HSC,0.5911006880374128
KEGG_2021_Human,cellular response to lipopolysaccharide (GO:0071222),1/120,0.2601244621662815,0.3257633451428198,0,0,3.4009603841536613,4.579716458908873,CXCL3,HSC,0.5848188047272944
KEGG_2021_Human,cellular response to oxidative stress (GO:0034599),1/125,0.2693829605231016,0.3357889926520522,0,0,3.263001974983542,4.279822783786303,CRYGD,HSC,0.5696298784899082
KEGG_2021_Human,cellular response to insulin stimulus (GO:0032869),1/129,0.2767079241059198,0.3424104340048965,0,0,3.1603954081632653,4.060453122404681,ATP6V0A4,HSC,0.5579784037567757
KEGG_2021_Human,regulation of response to external stimulus (GO:0032101),1/130,0.2785278903472666,0.3424104340048965,0,0,3.135738016136687,4.008216604624779,P2RY12,HSC,0.5551313103019286
KEGG_2021_Human,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.2785278903472666,0.3424104340048965,0,0,3.135738016136687,4.008216604624779,GPC5,HSC,0.5551313103019286
KEGG_2021_Human,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.3430685970665292,0,0,3.111459968602826,3.956968446025251,CRHBP,HSC,0.5523097126477655
KEGG_2021_Human,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.345916010177768,0,0,3.0640074211502784,3.857336278341556,SPOCK3,HSC,0.546741450090894
KEGG_2021_Human,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3493100127076808,0,0,2.99546485260771,3.714691124222948,AVP,HSC,0.5385707850387818
KEGG_2021_Human,organic substance transport (GO:0071702),1/136,0.289353816496661,0.3493100127076808,0,0,2.99546485260771,3.714691124222948,CHMP1B,HSC,0.5385707850387818
KEGG_2021_Human,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3498933403858241,0,0,2.9732893157262907,3.668866926816198,AVP,HSC,0.5358942544628899
KEGG_2021_Human,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3525957771637004,0,0,2.929902395740905,3.579678317757992,P2RY12,HSC,0.5306096689947516
KEGG_2021_Human,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3578665147504802,0,0,2.8467950560505892,3.410594866305226,CLEC9A,HSC,0.5203052911363482
KEGG_2021_Human,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3578665147504802,0,0,2.8467950560505892,3.410594866305226,CHMP1B,HSC,0.5203052911363482
KEGG_2021_Human,regulation of cytokine production (GO:0001817),1/150,0.3139989845586295,0.3707124575405846,0,0,2.712094233666621,3.141596466170354,CLEC9A,HSC,0.5030717563895143
KEGG_2021_Human,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.3191700762858281,0.375164826511412,0,0,2.6581632653061225,3.0357052873752,GPC5,HSC,0.4959778325880012
KEGG_2021_Human,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.385496253617452,0,0,2.556445362955309,2.8389038953772054,CXCL3,HSC,0.4822791499015975
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),2/474,0.3328115296392732,0.3877977823622835,0,0,1.7194562146892656,1.8917094920733264,EPGN;AREG,HSC,0.47780163679243126
KEGG_2021_Human,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.3923844184844444,0,0,2.4621702339472376,2.6600168495918335,P2RY12,HSC,0.46919202564454415
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),2/482,0.3401543782991926,0.3923844184844444,0,0,1.6901041666666667,1.8225334796372663,AVP;CLEC9A,HSC,0.46832393464331673
KEGG_2021_Human,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.3923844184844444,0,0,2.4471243042671613,2.6317886779390967,REN,HSC,0.4670671197091842
KEGG_2021_Human,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.4132270404150529,0,0,2.279833967485299,2.3241173885161555,AVP,HSC,0.44273020383203454
KEGG_2021_Human,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.4151415899928743,0,0,2.2541329380914377,2.2778849681371156,CRHBP,HSC,0.4388706874182523
KEGG_2021_Human,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),1/185,0.3720057294778557,0.4224471843223108,0,0,2.192324755989352,2.1678716160963645,AREG,HSC,0.4294503712432232
KEGG_2021_Human,cellular response to tumor necrosis factor (GO:0071356),1/194,0.3861272144560919,0.4366333057984499,0,0,2.089140319340171,1.988001678572607,CRHBP,HSC,0.4132695879859197
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),1/212,0.4134429066373548,0.4655575587345004,0,0,1.909178837411742,1.6862551884518755,AVP,HSC,0.3835844547796231
KEGG_2021_Human,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.5147989447305886,0,0,1.655076845553036,1.2884811006593149,SLC1A6,HSC,0.33809924509335265
KEGG_2021_Human,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.4618276248188864,0.5157075143810899,0,0,1.641399416909621,1.2680853834334544,BEX1,HSC,0.33552009275365935
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),2/625,0.4660144680358849,0.5182235578158388,0,0,1.2926029962546817,0.9869522795970046,EPGN;AREG,HSC,0.33160059985375573
KEGG_2021_Human,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.5219269338308687,0,0,1.5952380952380951,1.2000608149186214,GPC5,HSC,0.32670971902140344
KEGG_2021_Human,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5401188893847421,0,0,1.510204081632653,1.0781219104526054,AREG,HSC,0.3100391544580995
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5455363803044366,0,0,1.4709576138147566,1.0233666205889618,EPGN,HSC,0.30214499188263844
KEGG_2021_Human,inorganic cation transmembrane transport (GO:0098662),1/274,0.4987179596066677,0.5455363803044366,0,0,1.4709576138147566,1.0233666205889618,ATP6V0A4,HSC,0.30214499188263844
KEGG_2021_Human,plasma membrane bounded cell projection assembly (GO:0120031),1/278,0.5037814900878317,0.5488351192826784,0,0,1.4494216459146836,0.9937418248041268,P2RY12,HSC,0.2977577933690553
KEGG_2021_Human,proteolysis (GO:0006508),1/287,0.51499186851511,0.558776602275504,0,0,1.4031682603111175,0.9311483055746664,REN,HSC,0.28819962821492023
KEGG_2021_Human,positive regulation of cytokine production (GO:0001819),1/335,0.5707160845076258,0.6167415751937246,0,0,1.1985824269827692,0.6722410367689661,CLEC9A,HSC,0.2435798875448389
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),2/764,0.5744134768292987,0.6182442240572371,0,0,1.0492125984251968,0.5816895490313783,EPGN;AREG,HSC,0.24077537927422193
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),1/345,0.5815093765862647,0.6233780517004758,0,0,1.1631466540104414,0.6305745813190116,CLEC9A,HSC,0.23544327806907975
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6495451697567721,0,0,1.0799779371207945,0.5367673309131087,AVP,HSC,0.21585171499242045
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.6574590837228226,0,0,1.0510204081632653,0.5054679174936134,AVP,HSC,0.20886552310647807
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6579448196361232,0,0,1.042628017264347,0.4965325169788531,AVP,HSC,0.20682480102083725
KEGG_2021_Human,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6713560083511766,0,0,1.0,0.4521084323403523,PRKG2,HSC,0.19634819738734471
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.6726092049191331,0,0,0.989871879272801,0.4417939051458828,ATP6V0A4,HSC,0.19383180708628664
KEGG_2021_Human,organelle organization (GO:0006996),1/420,0.6544076492323022,0.6850830077900664,0,0,0.9512931664312504,0.4033718992390181,CHMP1B,HSC,0.18415163293091988
KEGG_2021_Human,organelle assembly (GO:0070925),1/425,0.658798168385351,0.6869957553590431,0,0,0.939834424335772,0.3922286762298742,CHMP1B,HSC,0.18124761694193237
KEGG_2021_Human,regulation of intracellular signal transduction (GO:1902531),1/437,0.6691136001848389,0.695048235850918,0,0,0.9134057292641828,0.3670077257341264,REN,HSC,0.1745001427028418
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7291711115733157,0,0,0.8260426831855403,0.2885801301950252,CRHBP,HSC,0.1517218912312197
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7291711115733157,0,0,0.8207960870298533,0.2841203737887477,AVP,HSC,0.15033199168778996
KEGG_2021_Human,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7347392908900207,0,0,0.8021026592455164,0.2684686706444305,PRKG2,HSC,0.1453610219101508
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),1/621,0.7938341129137421,0.8120135200797055,0,0,0.6362738643844634,0.1469033967904298,CXCL3,HSC,0.10027024237534503
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8654736112433736,0,0,0.5290423861852434,0.0863986224716518,AVP,HSC,0.07092521499844862
KEGG_2021_Human,positive regulation of transcription by RNA polymerase II (GO:0045944),1/908,0.9023188918982462,0.9159903902603408,0,0,0.4284814256463335,0.0440424414337815,BEX1,HSC,0.044639949690669034
KEGG_2021_Human,cellular protein modification process (GO:0006464),1/1025,0.9281942108891912,0.9387020698803896,0,0,0.3771922831632653,0.0281062148400667,PRKG2,HSC,0.032361144586154744
KEGG_2021_Human,regulation of gene expression (GO:0010468),1/1079,0.9377418517471742,0.9447925423618146,0,0,0.3572753776835409,0.0229658682151355,AVP,HSC,0.027916700844649738
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1183,0.952754544972228,0.9563229140545212,0,0,0.3240443385476018,0.0156830878086274,BEX1,HSC,0.021018970814361417
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),1/2206,0.9971209346049892,0.9971209346049892,0,0,0.1642371234207968,0.00047353141012936674,BEX1,HSC,0.0012521656136179045
GO_Biological_Process_2021,hydrogen peroxide catabolic process (GO:0042744),6/21,9.434074612996658e-12,3.037772025384924e-09,0,0,181.22727272727272,4600.761139969045,PRDX2;HBM;HBB;HBA1;HBD;HBQ1,Late Erythroid,11.02530069329229
GO_Biological_Process_2021,hydrogen peroxide metabolic process (GO:0042743),6/29,8.135058370227632e-11,1.3097443976066488e-08,0,0,118.14426877470356,2744.7575553262473,PRDX2;HBM;HBB;HBD;HBQ1;HBA1,Late Erythroid,10.089639326589836
GO_Biological_Process_2021,heme biosynthetic process (GO:0006783),4/22,2.4450393495949793e-07,2.6243422352319445e-05,0,0,96.28985507246377,1465.9200692928152,ALAS2;FECH;UROD;HMBS,Late Erythroid,6.611714147102958
GO_Biological_Process_2021,porphyrin-containing compound biosynthetic process (GO:0006779),4/24,3.538707538969472e-07,2.8486595688704247e-05,0,0,86.65217391304348,1287.1603411426952,ALAS2;FECH;UROD;HMBS,Late Erythroid,6.451155328704732
GO_Biological_Process_2021,bicarbonate transport (GO:0015701),4/35,1.7088008382944347e-06,0.0001100467739861616,0,0,55.873772791023846,741.9879852387336,CA1;HBB;RHAG;HBA1,Late Erythroid,5.767308551597607
GO_Biological_Process_2021,gas transport (GO:0015669),3/12,3.183301843206519e-06,0.00017083719891874984,0,0,141.4255319148936,1790.1066225817303,HBB;RHAG;HBA1,Late Erythroid,5.497122179279147
GO_Biological_Process_2021,erythrocyte differentiation (GO:0030218),4/46,5.219023612482669e-06,0.0002400750861742028,0,0,41.21739130434783,501.3353830213611,ALAS2;AHSP;GATA1;KLF1,Late Erythroid,5.282410738257065
GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),4/52,8.563425546229254e-06,0.00034467787823572746,0,0,36.05434782608695,420.6825006129661,ALAS2;AHSP;GATA1;KLF1,Late Erythroid,5.067352473847294
GO_Biological_Process_2021,hemoglobin metabolic process (GO:0020027),2/5,6.0956786529959696e-05,0.0021808983625163,0,0,277.0416666666667,2688.78505476905,ALAS2;AHSP,Late Erythroid,4.214977935846465
GO_Biological_Process_2021,organic anion transport (GO:0015711),4/99,0.00010922478751602677,0.003517038158016,0,0,18.17391304347826,165.78429812678354,CA1;HBB;RHAG;HBA1,Late Erythroid,3.96167879148639
GO_Biological_Process_2021,oxygen transport (GO:0015671),2/7,0.00012760097078443218,0.0037352284175079,0,0,166.20833333333334,1490.3240703269437,HBB;HBA1,Late Erythroid,3.8941460215026447
GO_Biological_Process_2021,microtubule cytoskeleton organization involved in mitosis (GO:1902850),4/128,0.00029350113438598394,0.0076668567845766,0,0,13.903225806451612,113.08368135915453,CDC20;CCNB1;BIRC5;DLGAP5,Late Erythroid,3.532390215858884
GO_Biological_Process_2021,erythrocyte development (GO:0048821),2/11,0.000332063883264561,0.0076668567845766,0,0,92.31944444444444,739.4956618223716,ALAS2;GATA1,Late Erythroid,3.478778357620151
GO_Biological_Process_2021,regulation of cyclin-dependent protein kinase activity (GO:1904029),3/54,0.0003333415993294188,0.0076668567845766,0,0,24.90488110137672,199.39701474295643,CCNB2;CCNB1;CCNE1,Late Erythroid,3.4771104852237307
GO_Biological_Process_2021,mitotic nuclear membrane disassembly (GO:0007077),2/12,0.0003978405023918531,0.0085403094513451,0,0,83.08333333333333,650.4975835514635,CCNB2;CCNB1,Late Erythroid,3.4002910053496507
GO_Biological_Process_2021,nuclear membrane disassembly (GO:0051081),2/14,0.0005467878206419364,0.0110041048904189,0,0,69.22916666666667,520.0114050756229,CCNB2;CCNB1,Late Erythroid,3.2621811676355046
GO_Biological_Process_2021,mitotic spindle organization (GO:0007052),4/157,0.0006355022741194353,0.0120371607215563,0,0,11.251491901108269,82.82329952539243,CDC20;CCNB1;BIRC5;DLGAP5,Late Erythroid,3.196882891001783
GO_Biological_Process_2021,positive regulation of stem cell proliferation (GO:2000648),2/17,0.0008132713373134499,0.0142948279361744,0,0,55.375,393.96243373102385,CCNE1;EPCAM,Late Erythroid,3.089764533572175
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),5/296,0.0008434836359854469,0.0142948279361744,0,0,7.506300114547537,53.129367444385565,CCNB2;CCNB1;PCLAF;BIRC5;DLGAP5,Late Erythroid,3.073923338528513
GO_Biological_Process_2021,myeloid cell development (GO:0061515),2/20,0.0011307590059983,0.0173740756940076,0,0,46.138888888888886,313.0461870363529,ALAS2;GATA1,Late Erythroid,2.9466299446036754
GO_Biological_Process_2021,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),3/82,0.0011330918930874,0.0173740756940076,0,0,16.055211419337464,108.89937140961504,CCNB2;CCNB1;CCNE1,Late Erythroid,2.9457348676807733
GO_Biological_Process_2021,regulation of mitotic metaphase/anaphase transition (GO:0030071),2/26,0.0019157650058532,0.0280398332674889,0,0,34.59375,216.47517339281177,CCNB1;DLGAP5,Late Erythroid,2.7176577640050135
GO_Biological_Process_2021,regulation of protein serine/threonine kinase activity (GO:0071900),3/111,0.0026975348454772,0.0377654878366812,0,0,11.72695035460993,69.36980081998614,CCNB2;CCNB1;CCNE1,Late Erythroid,2.5690329365984437
GO_Biological_Process_2021,cardiac muscle contraction (GO:0060048),2/34,0.0032650074009337,0.0438055159625279,0,0,25.934895833333332,148.46413612460563,KCNH2;MYL4,Late Erythroid,2.4861158299536776
GO_Biological_Process_2021,platelet aggregation (GO:0070527),2/36,0.0036549257227984,0.0470754433096436,0,0,24.40686274509804,136.96349152286243,HBB;GATA1,Late Erythroid,2.437121444562911
GO_Biological_Process_2021,heart contraction (GO:0060047),2/41,0.0047194951697385,0.0584491324867623,0,0,21.272435897435894,113.93630347986566,KCNH2;MYL4,Late Erythroid,2.3261044540613445
GO_Biological_Process_2021,homotypic cell-cell adhesion (GO:0034109),2/44,0.0054187658916089,0.0646238006332628,0,0,19.75,103.05327189846057,HBB;GATA1,Late Erythroid,2.266099611522887
GO_Biological_Process_2021,response to hydrogen peroxide (GO:0042542),2/49,0.0066828970303688,0.0768533158492418,0,0,17.64450354609929,88.36726791367238,HBB;HBA1,Late Erythroid,2.175035230405133
GO_Biological_Process_2021,mitotic nuclear membrane organization (GO:0101024),2/51,0.0072225026271421,0.077521528197992,0,0,16.922619047619047,83.43788300609687,CCNB2;CCNB1,Late Erythroid,2.1413122915117184
GO_Biological_Process_2021,mitotic nuclear membrane reassembly (GO:0007084),2/51,0.0072225026271421,0.077521528197992,0,0,16.922619047619047,83.43788300609687,CCNB2;CCNB1,Late Erythroid,2.1413122915117184
GO_Biological_Process_2021,striated muscle contraction (GO:0006941),2/54,0.0080676700842631,0.081180930222898,0,0,15.943910256410255,76.8479024006269,MYL4;KCNH2,Late Erythroid,2.0932518699428635
GO_Biological_Process_2021,nuclear membrane reassembly (GO:0031468),2/54,0.0080676700842631,0.081180930222898,0,0,15.943910256410255,76.8479024006269,CCNB2;CCNB1,Late Erythroid,2.0932518699428635
GO_Biological_Process_2021,positive regulation of mitotic cell cycle phase transition (GO:1901992),2/58,0.0092602829393189,0.0890063612460612,0,0,14.802083333333334,69.30366021141536,CCNB1;DLGAP5,Late Erythroid,2.033375743652011
GO_Biological_Process_2021,response to reactive oxygen species (GO:0000302),2/59,0.0095700107879558,0.0890063612460612,0,0,14.541666666666666,67.6059670933825,HBB;HBA1,Late Erythroid,2.019087572657113
GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),3/178,0.009999859714763,0.0890063612460612,0,0,7.212765957446808,33.21611593091175,CDC20;CCNB1;DLGAP5,Late Erythroid,2.000006092553167
GO_Biological_Process_2021,response to light stimulus (GO:0009416),2/61,0.0102031878981958,0.0890063612460612,0,0,14.04731638418079,64.40771918587598,FECH;PCLAF,Late Erythroid,1.9912641154648159
GO_Biological_Process_2021,positive regulation of cell death (GO:0010942),2/66,0.0118650634107129,0.0890063612460612,0,0,12.946614583333334,57.4073222604629,HBB;HBA1,Late Erythroid,1.9257299364311244
GO_Biological_Process_2021,positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),1/5,0.0124387771927725,0.0890063612460612,0,0,101.76530612244898,446.4379351400606,CCNB1,Late Erythroid,1.9052223113279663
GO_Biological_Process_2021,regulation of glycoprotein metabolic process (GO:1903018),1/5,0.0124387771927725,0.0890063612460612,0,0,101.76530612244898,446.4379351400606,GATA1,Late Erythroid,1.9052223113279663
GO_Biological_Process_2021,membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),1/5,0.0124387771927725,0.0890063612460612,0,0,101.76530612244898,446.4379351400606,KCNH2,Late Erythroid,1.9052223113279663
GO_Biological_Process_2021,transsulfuration (GO:0019346),1/5,0.0124387771927725,0.0890063612460612,0,0,101.76530612244898,446.4379351400606,TST,Late Erythroid,1.9052223113279663
GO_Biological_Process_2021,carbon dioxide transport (GO:0015670),1/5,0.0124387771927725,0.0890063612460612,0,0,101.76530612244898,446.4379351400606,RHAG,Late Erythroid,1.9052223113279663
GO_Biological_Process_2021,homoserine metabolic process (GO:0009092),1/5,0.0124387771927725,0.0890063612460612,0,0,101.76530612244898,446.4379351400606,TST,Late Erythroid,1.9052223113279663
GO_Biological_Process_2021,RNA import into mitochondrion (GO:0035927),1/5,0.0124387771927725,0.0890063612460612,0,0,101.76530612244898,446.4379351400606,TST,Late Erythroid,1.9052223113279663
GO_Biological_Process_2021,rRNA transport (GO:0051029),1/5,0.0124387771927725,0.0890063612460612,0,0,101.76530612244898,446.4379351400606,TST,Late Erythroid,1.9052223113279663
GO_Biological_Process_2021,regulation of mitotic sister chromatid segregation (GO:0033047),1/6,0.0149082847993736,0.0960093541079662,0,0,81.40816326530613,342.3895623444841,CCNB1,Late Erythroid,1.8265723193247598
GO_Biological_Process_2021,regulation of mitotic spindle checkpoint (GO:1903504),1/6,0.0149082847993736,0.0960093541079662,0,0,81.40816326530613,342.3895623444841,CCNB1,Late Erythroid,1.8265723193247598
GO_Biological_Process_2021,oxygen homeostasis (GO:0032364),1/6,0.0149082847993736,0.0960093541079662,0,0,81.40816326530613,342.3895623444841,ALAS2,Late Erythroid,1.8265723193247598
GO_Biological_Process_2021,protein K27-linked ubiquitination (GO:0044314),1/6,0.0149082847993736,0.0960093541079662,0,0,81.40816326530613,342.3895623444841,UBE2T,Late Erythroid,1.8265723193247598
GO_Biological_Process_2021,protein K29-linked ubiquitination (GO:0035519),1/6,0.0149082847993736,0.0960093541079662,0,0,81.40816326530613,342.3895623444841,UBE2T,Late Erythroid,1.8265723193247598
GO_Biological_Process_2021,mitotic cell cycle phase transition (GO:0044772),3/209,0.0153778461568471,0.0970914992647993,0,0,6.117744267713283,25.54052619027468,CCNB2;CCNB1;CCNE1,Late Erythroid,1.8131044881821832
GO_Biological_Process_2021,ammonium transport (GO:0015696),1/7,0.0173717414502839,0.0981351008244111,0,0,67.83673469387755,274.9362107684438,RHAG,Late Erythroid,1.7601566430186848
GO_Biological_Process_2021,gas homeostasis (GO:0033483),1/7,0.0173717414502839,0.0981351008244111,0,0,67.83673469387755,274.9362107684438,ALAS2,Late Erythroid,1.7601566430186848
GO_Biological_Process_2021,positive regulation of synaptic plasticity (GO:0031915),1/7,0.0173717414502839,0.0981351008244111,0,0,67.83673469387755,274.9362107684438,CDC20,Late Erythroid,1.7601566430186848
GO_Biological_Process_2021,regulation of potassium ion export across plasma membrane (GO:1903764),1/7,0.0173717414502839,0.0981351008244111,0,0,67.83673469387755,274.9362107684438,KCNH2,Late Erythroid,1.7601566430186848
GO_Biological_Process_2021,cellular ion homeostasis (GO:0006873),1/7,0.0173717414502839,0.0981351008244111,0,0,67.83673469387755,274.9362107684438,RHAG,Late Erythroid,1.7601566430186848
GO_Biological_Process_2021,cellular nitrogen compound catabolic process (GO:0044270),1/7,0.0173717414502839,0.0981351008244111,0,0,67.83673469387755,274.9362107684438,TST,Late Erythroid,1.7601566430186848
GO_Biological_Process_2021,anaphase-promoting complex-dependent catabolic process (GO:0031145),2/84,0.0187414436957378,0.1013490474171683,0,0,10.095528455284551,40.15009805248223,CDC20;CCNB1,Late Erythroid,1.7271969574747794
GO_Biological_Process_2021,ammonium transmembrane transport (GO:0072488),1/8,0.0198291614511851,0.1013490474171683,0,0,58.142857142857146,227.9549801512961,RHAG,Late Erythroid,1.702695651141308
GO_Biological_Process_2021,positive regulation of chromosome segregation (GO:0051984),1/8,0.0198291614511851,0.1013490474171683,0,0,58.142857142857146,227.9549801512961,CCNB1,Late Erythroid,1.702695651141308
GO_Biological_Process_2021,cysteine metabolic process (GO:0006534),1/8,0.0198291614511851,0.1013490474171683,0,0,58.142857142857146,227.9549801512961,TST,Late Erythroid,1.702695651141308
GO_Biological_Process_2021,ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/8,0.0198291614511851,0.1013490474171683,0,0,58.142857142857146,227.9549801512961,KCNH2,Late Erythroid,1.702695651141308
GO_Biological_Process_2021,positive regulation of muscle contraction (GO:0045933),1/8,0.0198291614511851,0.1013490474171683,0,0,58.142857142857146,227.9549801512961,NMU,Late Erythroid,1.702695651141308
GO_Biological_Process_2021,kinetochore assembly (GO:0051382),1/9,0.0222805591236868,0.103975942577205,0,0,50.87244897959184,193.52086993316271,DLGAP5,Late Erythroid,1.652073914876897
GO_Biological_Process_2021,positive regulation of smooth muscle contraction (GO:0045987),1/9,0.0222805591236868,0.103975942577205,0,0,50.87244897959184,193.52086993316271,NMU,Late Erythroid,1.652073914876897
GO_Biological_Process_2021,positive regulation of synapse maturation (GO:0090129),1/9,0.0222805591236868,0.103975942577205,0,0,50.87244897959184,193.52086993316271,CDC20,Late Erythroid,1.652073914876897
GO_Biological_Process_2021,one-carbon compound transport (GO:0019755),1/9,0.0222805591236868,0.103975942577205,0,0,50.87244897959184,193.52086993316271,RHAG,Late Erythroid,1.652073914876897
GO_Biological_Process_2021,organic acid catabolic process (GO:0016054),1/9,0.0222805591236868,0.103975942577205,0,0,50.87244897959184,193.52086993316271,TST,Late Erythroid,1.652073914876897
GO_Biological_Process_2021,protein K6-linked ubiquitination (GO:0085020),1/9,0.0222805591236868,0.103975942577205,0,0,50.87244897959184,193.52086993316271,UBE2T,Late Erythroid,1.652073914876897
GO_Biological_Process_2021,regulation of cell cycle phase transition (GO:1901987),2/95,0.0235916467130086,0.1047340793976712,0,0,8.896505376344086,33.333983109146935,CDC20;CCNB1,Late Erythroid,1.6272417440057543
GO_Biological_Process_2021,regulation of glycoprotein biosynthetic process (GO:0010559),1/10,0.024725948817258,0.1047340793976712,0,0,45.21768707482993,167.3010120823387,GATA1,Late Erythroid,1.606847034080906
GO_Biological_Process_2021,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),1/10,0.024725948817258,0.1047340793976712,0,0,45.21768707482993,167.3010120823387,EPCAM,Late Erythroid,1.606847034080906
GO_Biological_Process_2021,sulfur amino acid catabolic process (GO:0000098),1/10,0.024725948817258,0.1047340793976712,0,0,45.21768707482993,167.3010120823387,TST,Late Erythroid,1.606847034080906
GO_Biological_Process_2021,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),1/10,0.024725948817258,0.1047340793976712,0,0,45.21768707482993,167.3010120823387,CCNB1,Late Erythroid,1.606847034080906
GO_Biological_Process_2021,removal of superoxide radicals (GO:0019430),1/10,0.024725948817258,0.1047340793976712,0,0,45.21768707482993,167.3010120823387,PRDX2,Late Erythroid,1.606847034080906
GO_Biological_Process_2021,defense response to tumor cell (GO:0002357),1/10,0.024725948817258,0.1047340793976712,0,0,45.21768707482993,167.3010120823387,PRDX2,Late Erythroid,1.606847034080906
GO_Biological_Process_2021,regulation of cell death (GO:0010941),2/102,0.0269177264019109,0.1047340793976712,0,0,8.270833333333334,29.898816321570965,HBB;HBA1,Late Erythroid,1.5699616254585989
GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),2/102,0.0269177264019109,0.1047340793976712,0,0,8.270833333333334,29.898816321570965,CCNB1;DLGAP5,Late Erythroid,1.5699616254585989
GO_Biological_Process_2021,cellular response to superoxide (GO:0071451),1/11,0.0271653448579923,0.1047340793976712,0,0,40.69387755102041,146.73452100035948,PRDX2,Late Erythroid,1.5659847773237099
GO_Biological_Process_2021,regulation of synapse maturation (GO:0090128),1/11,0.0271653448579923,0.1047340793976712,0,0,40.69387755102041,146.73452100035948,CDC20,Late Erythroid,1.5659847773237099
GO_Biological_Process_2021,cardiac muscle cell membrane repolarization (GO:0099622),1/11,0.0271653448579923,0.1047340793976712,0,0,40.69387755102041,146.73452100035948,KCNH2,Late Erythroid,1.5659847773237099
GO_Biological_Process_2021,negative regulation of potassium ion transmembrane transport (GO:1901380),1/11,0.0271653448579923,0.1047340793976712,0,0,40.69387755102041,146.73452100035948,KCNH2,Late Erythroid,1.5659847773237099
GO_Biological_Process_2021,regulation of hemopoiesis (GO:1903706),1/12,0.029598761568907,0.1047340793976712,0,0,36.99257884972171,130.2147194065139,GFI1B,Late Erythroid,1.5287264597194943
GO_Biological_Process_2021,cellular response to thyroid hormone stimulus (GO:0097067),1/12,0.029598761568907,0.1047340793976712,0,0,36.99257884972171,130.2147194065139,GATA1,Late Erythroid,1.5287264597194943
GO_Biological_Process_2021,megakaryocyte differentiation (GO:0030219),1/12,0.029598761568907,0.1047340793976712,0,0,36.99257884972171,130.2147194065139,GATA1,Late Erythroid,1.5287264597194943
GO_Biological_Process_2021,positive regulation of ubiquitin protein ligase activity (GO:1904668),1/12,0.029598761568907,0.1047340793976712,0,0,36.99257884972171,130.2147194065139,CDC20,Late Erythroid,1.5287264597194943
GO_Biological_Process_2021,homocysteine metabolic process (GO:0050667),1/12,0.029598761568907,0.1047340793976712,0,0,36.99257884972171,130.2147194065139,TST,Late Erythroid,1.5287264597194943
GO_Biological_Process_2021,inorganic ion transmembrane transport (GO:0098660),1/12,0.029598761568907,0.1047340793976712,0,0,36.99257884972171,130.2147194065139,RHAG,Late Erythroid,1.5287264597194943
GO_Biological_Process_2021,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/12,0.029598761568907,0.1047340793976712,0,0,36.99257884972171,130.2147194065139,DLGAP5,Late Erythroid,1.5287264597194943
GO_Biological_Process_2021,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/12,0.029598761568907,0.1047340793976712,0,0,36.99257884972171,130.2147194065139,DLGAP5,Late Erythroid,1.5287264597194943
GO_Biological_Process_2021,positive regulation of mitotic sister chromatid separation (GO:1901970),1/12,0.029598761568907,0.1047340793976712,0,0,36.99257884972171,130.2147194065139,DLGAP5,Late Erythroid,1.5287264597194943
GO_Biological_Process_2021,kinetochore organization (GO:0051383),1/13,0.032026213248763,0.1074212569385593,0,0,33.90816326530612,116.6847899929619,DLGAP5,Late Erythroid,1.4944944088974865
GO_Biological_Process_2021,regulation of membrane repolarization (GO:0060306),1/13,0.032026213248763,0.1074212569385593,0,0,33.90816326530612,116.6847899929619,KCNH2,Late Erythroid,1.4944944088974865
GO_Biological_Process_2021,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/13,0.032026213248763,0.1074212569385593,0,0,33.90816326530612,116.6847899929619,CCNB1,Late Erythroid,1.4944944088974865
GO_Biological_Process_2021,response to thyroid hormone (GO:0097066),1/13,0.032026213248763,0.1074212569385593,0,0,33.90816326530612,116.6847899929619,GATA1,Late Erythroid,1.4944944088974865
GO_Biological_Process_2021,negative regulation of potassium ion transport (GO:0043267),1/13,0.032026213248763,0.1074212569385593,0,0,33.90816326530612,116.6847899929619,KCNH2,Late Erythroid,1.4944944088974865
GO_Biological_Process_2021,membrane repolarization during action potential (GO:0086011),1/14,0.0344477141698711,0.1120420602292779,0,0,31.298273155416013,105.4223689491126,KCNH2,Late Erythroid,1.4628395910668823
GO_Biological_Process_2021,renal absorption (GO:0070293),1/14,0.0344477141698711,0.1120420602292779,0,0,31.298273155416013,105.4223689491126,HBB,Late Erythroid,1.4628395910668823
GO_Biological_Process_2021,potassium ion export across plasma membrane (GO:0097623),1/14,0.0344477141698711,0.1120420602292779,0,0,31.298273155416013,105.4223689491126,KCNH2,Late Erythroid,1.4628395910668823
GO_Biological_Process_2021,membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,0.0368632785936063,0.1186997570714123,0,0,29.06122448979592,95.91771596133704,KCNH2,Late Erythroid,1.4334060415588732
GO_Biological_Process_2021,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.0392729207344652,0.1215950045817096,0,0,27.122448979591837,87.80133530116419,GATA1,Late Erythroid,1.405906798966597
GO_Biological_Process_2021,membrane repolarization (GO:0086009),1/16,0.0392729207344652,0.1215950045817096,0,0,27.122448979591837,87.80133530116419,KCNH2,Late Erythroid,1.405906798966597
GO_Biological_Process_2021,heme catabolic process (GO:0042167),1/16,0.0392729207344652,0.1215950045817096,0,0,27.122448979591837,87.80133530116419,BLVRB,Late Erythroid,1.405906798966597
GO_Biological_Process_2021,porphyrin-containing compound catabolic process (GO:0006787),1/16,0.0392729207344652,0.1215950045817096,0,0,27.122448979591837,87.80133530116419,BLVRB,Late Erythroid,1.405906798966597
GO_Biological_Process_2021,regulation of stem cell proliferation (GO:0072091),1/17,0.0416766547912334,0.12618884347918,0,0,25.426020408163264,80.79916728086499,EPCAM,Late Erythroid,1.3801071472903907
GO_Biological_Process_2021,positive regulation of transcription of Notch receptor target (GO:0007221),1/17,0.0416766547912334,0.12618884347918,0,0,25.426020408163264,80.79916728086499,DLGAP5,Late Erythroid,1.3801071472903907
GO_Biological_Process_2021,G2/M transition of mitotic cell cycle (GO:0000086),2/130,0.0419323175536405,0.12618884347918,0,0,6.452473958333333,20.46530163526616,CCNB2;CCNB1,Late Erythroid,1.3774511339488533
GO_Biological_Process_2021,cell cycle G2/M phase transition (GO:0044839),2/131,0.0425157677463691,0.1267141729286164,0,0,6.4021317829457365,20.217165618082923,CCNB2;CCNB1,Late Erythroid,1.3714499740612387
GO_Biological_Process_2021,negative regulation of cation transmembrane transport (GO:1904063),1/18,0.0440744949316926,0.1267141729286164,0,0,23.92917166866747,74.70385911458476,KCNH2,Late Erythroid,1.3558126557645607
GO_Biological_Process_2021,leukocyte tethering or rolling (GO:0050901),1/18,0.0440744949316926,0.1267141729286164,0,0,23.92917166866747,74.70385911458476,ADD2,Late Erythroid,1.3558126557645607
GO_Biological_Process_2021,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/18,0.0440744949316926,0.1267141729286164,0,0,23.92917166866747,74.70385911458476,KCNH2,Late Erythroid,1.3558126557645607
GO_Biological_Process_2021,ventricular cardiac muscle cell action potential (GO:0086005),1/18,0.0440744949316926,0.1267141729286164,0,0,23.92917166866747,74.70385911458476,KCNH2,Late Erythroid,1.3558126557645607
GO_Biological_Process_2021,actin filament capping (GO:0051693),1/19,0.0464664552952436,0.1289844707333487,0,0,22.598639455782312,69.35578082800635,ADD2,Late Erythroid,1.3328604565168853
GO_Biological_Process_2021,leukocyte adhesion to vascular endothelial cell (GO:0061756),1/19,0.0464664552952436,0.1289844707333487,0,0,22.598639455782312,69.35578082800635,ADD2,Late Erythroid,1.3328604565168853
GO_Biological_Process_2021,barbed-end actin filament capping (GO:0051016),1/19,0.0464664552952436,0.1289844707333487,0,0,22.598639455782312,69.35578082800635,ADD2,Late Erythroid,1.3328604565168853
GO_Biological_Process_2021,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),1/19,0.0464664552952436,0.1289844707333487,0,0,22.598639455782312,69.35578082800635,EPCAM,Late Erythroid,1.3328604565168853
GO_Biological_Process_2021,regulation of smooth muscle contraction (GO:0006940),1/20,0.0488525499820277,0.1319756749411474,0,0,21.40816326530612,64.63014669364038,NMU,Late Erythroid,1.3111127622579986
GO_Biological_Process_2021,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),1/20,0.0488525499820277,0.1319756749411474,0,0,21.40816326530612,64.63014669364038,CCNB1,Late Erythroid,1.3111127622579986
GO_Biological_Process_2021,granulocyte differentiation (GO:0030851),1/20,0.0488525499820277,0.1319756749411474,0,0,21.40816326530612,64.63014669364038,GATA1,Late Erythroid,1.3111127622579986
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),2/143,0.0497512691479657,0.1319756749411474,0,0,5.8537234042553195,17.565380826397597,HBB;HBA1,Late Erythroid,1.3031958359850326
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),2/143,0.0497512691479657,0.1319756749411474,0,0,5.8537234042553195,17.565380826397597,HBB;RHAG,Late Erythroid,1.3031958359850326
GO_Biological_Process_2021,spindle assembly checkpoint signaling (GO:0071173),1/21,0.0512327930672156,0.1319756749411474,0,0,20.336734693877553,60.42807445408675,CDC20,Late Erythroid,1.2904519669693806
GO_Biological_Process_2021,regulation of ubiquitin protein ligase activity (GO:1904666),1/21,0.0512327930672156,0.1319756749411474,0,0,20.336734693877553,60.42807445408675,CDC20,Late Erythroid,1.2904519669693806
GO_Biological_Process_2021,mitotic spindle assembly checkpoint signaling (GO:0007094),1/21,0.0512327930672156,0.1319756749411474,0,0,20.336734693877553,60.42807445408675,CDC20,Late Erythroid,1.2904519669693806
GO_Biological_Process_2021,mitotic spindle checkpoint signaling (GO:0071174),1/21,0.0512327930672156,0.1319756749411474,0,0,20.336734693877553,60.42807445408675,CDC20,Late Erythroid,1.2904519669693806
GO_Biological_Process_2021,regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.0536071985992547,0.1359174641650396,0,0,19.367346938775512,56.67024999786951,KCNH2,Late Erythroid,1.2707768875084013
GO_Biological_Process_2021,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),1/22,0.0536071985992547,0.1359174641650396,0,0,19.367346938775512,56.67024999786951,CDC20,Late Erythroid,1.2707768875084013
GO_Biological_Process_2021,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.0559757805878795,0.1386477026869015,0,0,18.4860853432282,53.29235549319145,GATA1,Late Erythroid,1.2519998414265567
GO_Biological_Process_2021,positive regulation of cell cycle G2/M phase transition (GO:1902751),1/23,0.0559757805878795,0.1386477026869015,0,0,18.4860853432282,53.29235549319145,CCNB1,Late Erythroid,1.2519998414265567
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.0559757805878795,0.1386477026869015,0,0,18.4860853432282,53.29235549319145,GATA1,Late Erythroid,1.2519998414265567
GO_Biological_Process_2021,sulfur amino acid metabolic process (GO:0000096),1/24,0.0583385530130099,0.1401866721655911,0,0,17.68145519077196,50.24171555062859,TST,Late Erythroid,1.2340443470047993
GO_Biological_Process_2021,glucose catabolic process to pyruvate (GO:0061718),1/24,0.0583385530130099,0.1401866721655911,0,0,17.68145519077196,50.24171555062859,PKLR,Late Erythroid,1.2340443470047993
GO_Biological_Process_2021,canonical glycolysis (GO:0061621),1/24,0.0583385530130099,0.1401866721655911,0,0,17.68145519077196,50.24171555062859,PKLR,Late Erythroid,1.2340443470047993
GO_Biological_Process_2021,potassium ion homeostasis (GO:0055075),1/24,0.0583385530130099,0.1401866721655911,0,0,17.68145519077196,50.24171555062859,KCNH2,Late Erythroid,1.2340443470047993
GO_Biological_Process_2021,glycolytic process through glucose-6-phosphate (GO:0061620),1/25,0.0606955298241754,0.1447700785435887,0,0,16.943877551020407,47.47480020477031,PKLR,Late Erythroid,1.2168432931781568
GO_Biological_Process_2021,membrane depolarization during action potential (GO:0086010),1/26,0.0630467249540435,0.1472466645269606,0,0,16.26530612244898,44.95534064809558,KCNH2,Late Erythroid,1.2003374685092782
GO_Biological_Process_2021,cellular response to drug (GO:0035690),1/26,0.0630467249540435,0.1472466645269606,0,0,16.26530612244898,44.95534064809558,KCNH2,Late Erythroid,1.2003374685092782
GO_Biological_Process_2021,positive regulation of nitric oxide biosynthetic process (GO:0045429),1/27,0.0653921522588676,0.1472466645269606,0,0,15.638932496075354,42.652889831563165,HBB,Late Erythroid,1.184474368421492
GO_Biological_Process_2021,regulation of transcription regulatory region DNA binding (GO:2000677),1/27,0.0653921522588676,0.1472466645269606,0,0,15.638932496075354,42.652889831563165,GATA1,Late Erythroid,1.184474368421492
GO_Biological_Process_2021,positive regulation of erythrocyte differentiation (GO:0045648),1/27,0.0653921522588676,0.1472466645269606,0,0,15.638932496075354,42.652889831563165,GATA1,Late Erythroid,1.184474368421492
GO_Biological_Process_2021,mitotic chromosome condensation (GO:0007076),1/27,0.0653921522588676,0.1472466645269606,0,0,15.638932496075354,42.652889831563165,CCNB1,Late Erythroid,1.184474368421492
GO_Biological_Process_2021,monovalent inorganic cation homeostasis (GO:0055067),1/27,0.0653921522588676,0.1472466645269606,0,0,15.638932496075354,42.652889831563165,KCNH2,Late Erythroid,1.184474368421492
GO_Biological_Process_2021,positive regulation of mitotic cell cycle (GO:0045931),1/27,0.0653921522588676,0.1472466645269606,0,0,15.638932496075354,42.652889831563165,CCNB1,Late Erythroid,1.184474368421492
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.0677318256109869,0.1483649513383522,0,0,15.058956916099774,40.54171043527237,GATA1,Late Erythroid,1.1692072184717057
GO_Biological_Process_2021,positive regulation of nitric oxide metabolic process (GO:1904407),1/28,0.0677318256109869,0.1483649513383522,0,0,15.058956916099774,40.54171043527237,HBB,Late Erythroid,1.1692072184717057
GO_Biological_Process_2021,positive regulation of cell communication (GO:0010647),1/28,0.0677318256109869,0.1483649513383522,0,0,15.058956916099774,40.54171043527237,NMU,Late Erythroid,1.1692072184717057
GO_Biological_Process_2021,regulation of multicellular organismal development (GO:2000026),1/28,0.0677318256109869,0.1483649513383522,0,0,15.058956916099774,40.54171043527237,GFI1B,Late Erythroid,1.1692072184717057
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),3/381,0.0697677490315496,0.1501842520958639,0,0,3.3049645390070923,8.799743799293005,PRDX2;BIRC5;GATA1,Late Erythroid,1.1563452887586665
GO_Biological_Process_2021,glycolytic process (GO:0006096),1/29,0.0700657588372089,0.1501842520958639,0,0,14.520408163265309,38.5999069065122,PKLR,Late Erythroid,1.1544941700666143
GO_Biological_Process_2021,protein K11-linked ubiquitination (GO:0070979),1/29,0.0700657588372089,0.1501842520958639,0,0,14.520408163265309,38.5999069065122,UBE2T,Late Erythroid,1.1544941700666143
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),4/625,0.0704280188399859,0.1501842520958639,0,0,2.7065742491073306,7.180985632016276,EPCAM;HBB;BIRC5;HBA1,Late Erythroid,1.1522545282619854
GO_Biological_Process_2021,ion homeostasis (GO:0050801),1/30,0.0723939657090184,0.1513125793763905,0,0,14.019000703729768,36.80874147674154,RHAG,Late Erythroid,1.1402976322627019
GO_Biological_Process_2021,regulation of cation transmembrane transport (GO:1904062),1/30,0.0723939657090184,0.1513125793763905,0,0,14.019000703729768,36.80874147674154,KCNH2,Late Erythroid,1.1402976322627019
GO_Biological_Process_2021,cardiac muscle cell action potential (GO:0086001),1/30,0.0723939657090184,0.1513125793763905,0,0,14.019000703729768,36.80874147674154,KCNH2,Late Erythroid,1.1402976322627019
GO_Biological_Process_2021,negative regulation of DNA binding (GO:0043392),1/31,0.0747164600026276,0.1513125793763905,0,0,13.551020408163266,35.15209038871121,GATA1,Late Erythroid,1.126583712764908
GO_Biological_Process_2021,positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/31,0.0747164600026276,0.1513125793763905,0,0,13.551020408163266,35.15209038871121,CDC20,Late Erythroid,1.126583712764908
GO_Biological_Process_2021,peptide cross-linking (GO:0018149),1/31,0.0747164600026276,0.1513125793763905,0,0,13.551020408163266,35.15209038871121,EPB42,Late Erythroid,1.126583712764908
GO_Biological_Process_2021,cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.0747164600026276,0.1513125793763905,0,0,13.551020408163266,35.15209038871121,KCNH2,Late Erythroid,1.126583712764908
GO_Biological_Process_2021,regulation of potassium ion transport (GO:0043266),1/31,0.0747164600026276,0.1513125793763905,0,0,13.551020408163266,35.15209038871121,KCNH2,Late Erythroid,1.126583712764908
GO_Biological_Process_2021,superoxide metabolic process (GO:0006801),1/32,0.0770332554327668,0.1521761242291468,0,0,13.113232389730086,33.61600807740255,PRDX2,Late Erythroid,1.1133217484244988
GO_Biological_Process_2021,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/32,0.0770332554327668,0.1521761242291468,0,0,13.113232389730086,33.61600807740255,CCNE1,Late Erythroid,1.1133217484244988
GO_Biological_Process_2021,membrane depolarization (GO:0051899),1/32,0.0770332554327668,0.1521761242291468,0,0,13.113232389730086,33.61600807740255,KCNH2,Late Erythroid,1.1133217484244988
GO_Biological_Process_2021,metal ion export (GO:0070839),1/32,0.0770332554327668,0.1521761242291468,0,0,13.113232389730086,33.61600807740255,KCNH2,Late Erythroid,1.1133217484244988
GO_Biological_Process_2021,actin filament bundle assembly (GO:0051017),1/33,0.0793443657059371,0.1548417318624954,0,0,12.70280612244898,32.18837516559274,ADD2,Late Erythroid,1.1004839073426347
GO_Biological_Process_2021,actin filament bundle organization (GO:0061572),1/33,0.0793443657059371,0.1548417318624954,0,0,12.70280612244898,32.18837516559274,ADD2,Late Erythroid,1.1004839073426347
GO_Biological_Process_2021,regulation of mitotic cell cycle phase transition (GO:1901990),2/188,0.0803070740494964,0.1557763725538425,0,0,4.42741935483871,11.165498097498467,CDC20;CCNB1,Late Erythroid,1.0952461971205107
GO_Biological_Process_2021,negative regulation of cell cycle G1/S phase transition (GO:1902807),1/35,0.0839495853612937,0.1609033719424797,0,0,11.95438175270108,29.61744503578088,GFI1B,Late Erythroid,1.0759814445616303
GO_Biological_Process_2021,regulation of ion transmembrane transport (GO:0034765),1/35,0.0839495853612937,0.1609033719424797,0,0,11.95438175270108,29.61744503578088,KCNH2,Late Erythroid,1.0759814445616303
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),2/194,0.0847375162198589,0.1614525456970093,0,0,4.287760416666667,10.58303673172677,PRDX2;BIRC5,Late Erythroid,1.0719242699529004
GO_Biological_Process_2021,positive regulation of mitotic nuclear division (GO:0045840),1/36,0.0862437219743075,0.1633557557395708,0,0,11.612244897959185,28.456712045041098,DLGAP5,Late Erythroid,1.0642725091375862
GO_Biological_Process_2021,positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.0885322278902676,0.1638355021877367,0,0,11.289115646258503,27.36920368672352,GATA1,Late Erythroid,1.0528986067362665
GO_Biological_Process_2021,centromere complex assembly (GO:0034508),1/37,0.0885322278902676,0.1638355021877367,0,0,11.289115646258503,27.36920368672352,DLGAP5,Late Erythroid,1.0528986067362665
GO_Biological_Process_2021,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/37,0.0885322278902676,0.1638355021877367,0,0,11.289115646258503,27.36920368672352,GFI1B,Late Erythroid,1.0528986067362665
GO_Biological_Process_2021,regulation of erythrocyte differentiation (GO:0045646),1/37,0.0885322278902676,0.1638355021877367,0,0,11.289115646258503,27.36920368672352,GATA1,Late Erythroid,1.0528986067362665
GO_Biological_Process_2021,actin-myosin filament sliding (GO:0033275),1/38,0.0908151166313484,0.1642835255915405,0,0,10.983452840595698,26.34852930034076,MYL4,Late Erythroid,1.0418418549683985
GO_Biological_Process_2021,positive regulation of potassium ion transport (GO:0043268),1/38,0.0908151166313484,0.1642835255915405,0,0,10.983452840595698,26.34852930034076,KCNH2,Late Erythroid,1.0418418549683985
GO_Biological_Process_2021,positive regulation of signaling (GO:0023056),1/38,0.0908151166313484,0.1642835255915405,0,0,10.983452840595698,26.34852930034076,NMU,Late Erythroid,1.0418418549683985
GO_Biological_Process_2021,muscle filament sliding (GO:0030049),1/38,0.0908151166313484,0.1642835255915405,0,0,10.983452840595698,26.34852930034076,MYL4,Late Erythroid,1.0418418549683985
GO_Biological_Process_2021,protein monoubiquitination (GO:0006513),1/39,0.0930924017046572,0.1656118969552465,0,0,10.693877551020408,25.38900533231373,UBE2T,Late Erythroid,1.0310857651239858
GO_Biological_Process_2021,regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.0930924017046572,0.1656118969552465,0,0,10.693877551020408,25.38900533231373,KCNH2,Late Erythroid,1.0310857651239858
GO_Biological_Process_2021,regulation of exit from mitosis (GO:0007096),1/39,0.0930924017046572,0.1656118969552465,0,0,10.693877551020408,25.38900533231373,CDC20,Late Erythroid,1.0310857651239858
GO_Biological_Process_2021,stem cell differentiation (GO:0048863),1/40,0.0953640965755271,0.1668871690071725,0,0,10.419152276295131,24.485561288951835,EPCAM,Late Erythroid,1.0206151011238414
GO_Biological_Process_2021,sulfur compound catabolic process (GO:0044273),1/40,0.0953640965755271,0.1668871690071725,0,0,10.419152276295131,24.485561288951835,TST,Late Erythroid,1.0206151011238414
GO_Biological_Process_2021,regulation of nitric oxide biosynthetic process (GO:0045428),1/40,0.0953640965755271,0.1668871690071725,0,0,10.419152276295131,24.485561288951835,HBB,Late Erythroid,1.0206151011238414
GO_Biological_Process_2021,negative regulation of cell-cell adhesion (GO:0022408),1/41,0.0976302146847681,0.1672177081302944,0,0,10.158163265306122,23.633660200289185,EPCAM,Late Erythroid,1.0104157556925017
GO_Biological_Process_2021,positive regulation of cation transmembrane transport (GO:1904064),1/41,0.0976302146847681,0.1672177081302944,0,0,10.158163265306122,23.633660200289185,KCNH2,Late Erythroid,1.0104157556925017
GO_Biological_Process_2021,regulation of cell development (GO:0060284),1/41,0.0976302146847681,0.1672177081302944,0,0,10.158163265306122,23.633660200289185,HES6,Late Erythroid,1.0104157556925017
GO_Biological_Process_2021,carbohydrate catabolic process (GO:0016052),1/41,0.0976302146847681,0.1672177081302944,0,0,10.158163265306122,23.633660200289185,PKLR,Late Erythroid,1.0104157556925017
GO_Biological_Process_2021,positive regulation of ATPase activity (GO:0032781),1/42,0.0998907694703361,0.1675251446325429,0,0,9.909905425584869,22.829231064333683,MYL4,Late Erythroid,1.00047464143678
GO_Biological_Process_2021,translesion synthesis (GO:0019985),1/42,0.0998907694703361,0.1675251446325429,0,0,9.909905425584869,22.829231064333683,PCLAF,Late Erythroid,1.00047464143678
GO_Biological_Process_2021,regulation of nervous system development (GO:0051960),1/42,0.0998907694703361,0.1675251446325429,0,0,9.909905425584869,22.829231064333683,HES6,Late Erythroid,1.00047464143678
GO_Biological_Process_2021,potassium ion import across plasma membrane (GO:1990573),1/42,0.0998907694703361,0.1675251446325429,0,0,9.909905425584869,22.829231064333683,KCNH2,Late Erythroid,1.00047464143678
GO_Biological_Process_2021,male gonad development (GO:0008584),1/43,0.1021457742794159,0.1686714836819073,0,0,9.673469387755102,22.068611238785657,GATA1,Late Erythroid,0.9907795952096249
GO_Biological_Process_2021,development of primary male sexual characteristics (GO:0046546),1/43,0.1021457742794159,0.1686714836819073,0,0,9.673469387755102,22.068611238785657,GATA1,Late Erythroid,0.9907795952096249
GO_Biological_Process_2021,DNA synthesis involved in DNA repair (GO:0000731),1/43,0.1021457742794159,0.1686714836819073,0,0,9.673469387755102,22.068611238785657,PCLAF,Late Erythroid,0.9907795952096249
GO_Biological_Process_2021,positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.1043952424647777,0.1689209450937609,0,0,9.448030374940672,21.34849709415977,KCNH2,Late Erythroid,0.9813192926974915
GO_Biological_Process_2021,metal ion homeostasis (GO:0055065),1/44,0.1043952424647777,0.1689209450937609,0,0,9.448030374940672,21.34849709415977,KCNH2,Late Erythroid,0.9813192926974915
GO_Biological_Process_2021,cation transmembrane transport (GO:0098655),1/44,0.1043952424647777,0.1689209450937609,0,0,9.448030374940672,21.34849709415977,RHAG,Late Erythroid,0.9813192926974915
GO_Biological_Process_2021,protein K63-linked ubiquitination (GO:0070534),1/44,0.1043952424647777,0.1689209450937609,0,0,9.448030374940672,21.34849709415977,UBE2T,Late Erythroid,0.9813192926974915
GO_Biological_Process_2021,action potential (GO:0001508),1/45,0.1066391873529346,0.17083491705296,0,0,9.232838589981448,20.665901611884028,KCNH2,Late Erythroid,0.9720831731354668
GO_Biological_Process_2021,chromosome condensation (GO:0030261),1/45,0.1066391873529346,0.17083491705296,0,0,9.232838589981448,20.665901611884028,CCNB1,Late Erythroid,0.9720831731354668
GO_Biological_Process_2021,postreplication repair (GO:0006301),1/46,0.1088776222085674,0.1727024352273828,0,0,9.02721088435374,20.01811780873028,PCLAF,Late Erythroid,0.9630613723103648
GO_Biological_Process_2021,interleukin-12-mediated signaling pathway (GO:0035722),1/46,0.1088776222085674,0.1727024352273828,0,0,9.02721088435374,20.01811780873028,CA1,Late Erythroid,0.9630613723103648
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),3/468,0.1117338860370088,0.1763642710976316,0,0,2.6746739876458476,5.861909800062403,HES6;GATA1;KLF1,Late Erythroid,0.9518150964717812
GO_Biological_Process_2021,cellular response to interleukin-12 (GO:0071349),1/48,0.1133380148369131,0.1780236135487123,0,0,8.642205818497612,18.81737166641443,CA1,Late Erythroid,0.9456243984787533
GO_Biological_Process_2021,gonad development (GO:0008406),1/51,0.1199876089220907,0.1866473916565856,0,0,8.122448979591837,17.22257115519733,GATA1,Late Erythroid,0.9208636010741894
GO_Biological_Process_2021,mitotic metaphase plate congression (GO:0007080),1/51,0.1199876089220907,0.1866473916565856,0,0,8.122448979591837,17.22257115519733,CCNB1,Late Erythroid,0.9208636010741894
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),3/485,0.1208716599427582,0.1871186274113854,0,0,2.578087754921868,5.447566347932984,PRDX2;BIRC5;GATA1,Late Erythroid,0.9176755136408634
GO_Biological_Process_2021,regulation of megakaryocyte differentiation (GO:0045652),1/54,0.1265883240687765,0.1941020969054573,0,0,7.661532537543319,15.834970375184442,GATA1,Late Erythroid,0.8976063498190403
GO_Biological_Process_2021,regulation of potassium ion transmembrane transport (GO:1901379),1/54,0.1265883240687765,0.1941020969054573,0,0,7.661532537543319,15.834970375184442,KCNH2,Late Erythroid,0.8976063498190403
GO_Biological_Process_2021,pyruvate metabolic process (GO:0006090),1/55,0.1287777613922166,0.1955964111711969,0,0,7.519274376417234,15.412009607623004,PKLR,Late Erythroid,0.8901591287349465
GO_Biological_Process_2021,interstrand cross-link repair (GO:0036297),1/55,0.1287777613922166,0.1955964111711969,0,0,7.519274376417234,15.412009607623004,UBE2T,Late Erythroid,0.8901591287349465
GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/56,0.1309618198144747,0.1979798402829148,0,0,7.382189239332097,15.00687933540933,CCNB1,Late Erythroid,0.8828552987007785
GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),1/57,0.1331405122852093,0.1994011393294762,0,0,7.25,14.618539131965724,CCNB1,Late Erythroid,0.8756897763447542
GO_Biological_Process_2021,protein K48-linked ubiquitination (GO:0070936),1/57,0.1331405122852093,0.1994011393294762,0,0,7.25,14.618539131965724,UBE2T,Late Erythroid,0.8756897763447542
GO_Biological_Process_2021,positive regulation of protein binding (GO:0032092),1/58,0.1353138517398134,0.1999453430926512,0,0,7.122448979591836,14.246025949065045,ADD2,Late Erythroid,0.8686577434892403
GO_Biological_Process_2021,cellular iron ion homeostasis (GO:0006879),1/58,0.1353138517398134,0.1999453430926512,0,0,7.122448979591836,14.246025949065045,ALAS2,Late Erythroid,0.8686577434892403
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.1353667229633477,0.1999453430926512,0,0,2.442871502764282,4.885175568190959,KCNH2;GATA1;KLF1,Late Erythroid,0.8684880846140173
GO_Biological_Process_2021,Notch signaling pathway (GO:0007219),1/60,0.1396445230534406,0.2053220841242369,0,0,6.88031822898651,13.544974303558986,DLGAP5,Late Erythroid,0.8549760929333525
GO_Biological_Process_2021,iron ion homeostasis (GO:0055072),1/61,0.1418018805927374,0.2066072649360246,0,0,6.76530612244898,13.214837540593155,ALAS2,Late Erythroid,0.848318009451734
GO_Biological_Process_2021,"regulation of DNA-templated transcription, initiation (GO:2000142)",1/61,0.1418018805927374,0.2066072649360246,0,0,6.76530612244898,13.214837540593155,CCNB1,Late Erythroid,0.848318009451734
GO_Biological_Process_2021,regulation of neurogenesis (GO:0050767),1/62,0.1439539364695556,0.2081611792012549,0,0,6.654064904650385,12.897320592663672,HES6,Late Erythroid,0.8417764546925935
GO_Biological_Process_2021,anterior/posterior pattern specification (GO:0009952),1/63,0.1461007034145454,0.2081611792012549,0,0,6.54641211323239,12.591756250239603,HES6,Late Erythroid,0.8353476931121088
GO_Biological_Process_2021,neuropeptide signaling pathway (GO:0007218),1/63,0.1461007034145454,0.2081611792012549,0,0,6.54641211323239,12.591756250239603,NMU,Late Erythroid,0.8353476931121088
GO_Biological_Process_2021,organonitrogen compound catabolic process (GO:1901565),1/63,0.1461007034145454,0.2081611792012549,0,0,6.54641211323239,12.591756250239603,TST,Late Erythroid,0.8353476931121088
GO_Biological_Process_2021,cell cycle G1/S phase transition (GO:0044843),1/63,0.1461007034145454,0.2081611792012549,0,0,6.54641211323239,12.591756250239603,CCNE1,Late Erythroid,0.8353476931121088
GO_Biological_Process_2021,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/64,0.1482421941802595,0.210281878969355,0,0,6.442176870748299,12.297522293260638,CCNB1,Late Erythroid,0.8290281655096747
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),2/274,0.1497038344955427,0.2105297900879449,0,0,3.014399509803922,5.724635176902424,KCNH2;RHAG,Late Erythroid,0.8247670755492156
GO_Biological_Process_2021,mitotic G1 DNA damage checkpoint signaling (GO:0031571),1/65,0.1503784214913892,0.2105297900879449,0,0,6.341198979591836,12.01403781811508,CCNB1,Late Erythroid,0.8228144782361342
GO_Biological_Process_2021,protein autoubiquitination (GO:0051865),1/65,0.1503784214913892,0.2105297900879449,0,0,6.341198979591836,12.01403781811508,UBE2T,Late Erythroid,0.8228144782361342
GO_Biological_Process_2021,positive regulation of cell cycle (GO:0045787),1/66,0.1525093979756266,0.2125888577842069,0,0,6.243328100470958,11.740759916332207,CCNB1,Late Erythroid,0.8167033932798328
GO_Biological_Process_2021,regulation of myeloid cell differentiation (GO:0045637),1/68,0.1567556490806558,0.217566030189531,0,0,6.0563508985683825,11.222824361971773,GATA1,Late Erythroid,0.8047767993307415
GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.16308595979881,0.224417431859901,0,0,5.795918367346939,10.51076961698872,GFI1B,Late Erythroid,0.7875834261109624
GO_Biological_Process_2021,regulation of hematopoietic stem cell differentiation (GO:1902036),1/71,0.16308595979881,0.224417431859901,0,0,5.795918367346939,10.51076961698872,GATA1,Late Erythroid,0.7875834261109624
GO_Biological_Process_2021,positive regulation of synaptic transmission (GO:0050806),1/73,0.1672802691231711,0.2292095602453663,0,0,5.634353741496598,10.074701240888364,NMU,Late Erythroid,0.7765552814899175
GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",1/74,0.1693696918266344,0.2310891557973572,0,0,5.556891249650545,9.867213018330611,CCNB1,Late Erythroid,0.7711643026835198
GO_Biological_Process_2021,regulation of hematopoietic progenitor cell differentiation (GO:1901532),1/75,0.1714539764404576,0.2329459089191027,0,0,5.4815223386651954,9.666337985731484,GATA1,Late Erythroid,0.7658524380723842
GO_Biological_Process_2021,cellular response to hormone stimulus (GO:0032870),1/76,0.1735331353639065,0.2337977806994891,0,0,5.408163265306122,9.4717853003048,GATA1,Late Erythroid,0.7606175863963804
GO_Biological_Process_2021,RNA transport (GO:0050658),1/76,0.1735331353639065,0.2337977806994891,0,0,5.408163265306122,9.4717853003048,TST,Late Erythroid,0.7606175863963804
GO_Biological_Process_2021,inorganic cation import across plasma membrane (GO:0098659),1/77,0.1756071809118701,0.235606301056759,0,0,5.336734693877551,9.283280446293812,KCNH2,Late Erythroid,0.7554577289388229
GO_Biological_Process_2021,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/79,0.1797399811935544,0.2401505142918029,0,0,5.199372056514914,8.923391206941128,CDC20,Late Erythroid,0.745355308086215
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.2418975242890589,0,0,5.133298889175924,8.751529842637671,GATA1,Late Erythroid,0.7404090821369118
GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),2/314,0.1851004260524556,0.2452771077732128,0,0,2.6225961538461537,4.423944044737091,ALAS2;PCLAF,Late Erythroid,0.7325925816143702
GO_Biological_Process_2021,regulation of osteoblast differentiation (GO:0045667),1/83,0.1879447615357932,0.2480254639939566,0,0,4.944748631159781,8.265677319811374,HEMGN,Late Erythroid,0.7259697745939766
GO_Biological_Process_2021,response to insulin (GO:0032868),1/84,0.1899833569114356,0.2496924119407439,0,0,4.884927464961889,8.112979399077096,PKLR,Late Erythroid,0.7212844428267129
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),2/321,0.1914223619241526,0.2503216744928427,0,0,2.5641327063740857,4.239211303475318,CDC20;CCNB1,Late Erythroid,0.7180073293962443
GO_Biological_Process_2021,G1/S transition of mitotic cell cycle (GO:0000082),1/85,0.1920169366451308,0.2503216744928427,0,0,4.826530612244898,7.964604221414354,CCNE1,Late Erythroid,0.716660463134361
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",8/2244,0.193124009270605,0.2507497217142533,0,0,1.5089871368941137,2.481412794468422,KCNH2;HES6;GFI1B;CCNE1;DEPDC1;BIRC5;GATA1;KLF1,Late Erythroid,0.7141637311633254
GO_Biological_Process_2021,sensory perception of mechanical stimulus (GO:0050954),1/88,0.1980877029036425,0.2561616077709755,0,0,4.659394792399718,7.5437717166037235,BIRC5,Late Erythroid,0.703142484213379
GO_Biological_Process_2021,positive regulation of binding (GO:0051099),1/90,0.2021100231923967,0.260317709871807,0,0,4.55423068103646,7.281955543769811,ADD2,Late Erythroid,0.6944121480917811
GO_Biological_Process_2021,sensory perception of sound (GO:0007605),1/91,0.2041137620931186,0.2608120293412071,0,0,4.503401360544218,7.156255051106618,BIRC5,Late Erythroid,0.6901277125812961
GO_Biological_Process_2021,regulation of stem cell differentiation (GO:2000736),1/91,0.2041137620931186,0.2608120293412071,0,0,4.503401360544218,7.156255051106618,GATA1,Late Erythroid,0.6901277125812961
GO_Biological_Process_2021,negative regulation of mitotic cell cycle phase transition (GO:1901991),1/92,0.2061125694363157,0.2612923124350144,0,0,4.453689167974883,7.03385741012878,GFI1B,Late Erythroid,0.6858955226779435
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2612923124350144,0,0,4.453689167974883,7.03385741012878,GATA1,Late Erythroid,0.6858955226779435
GO_Biological_Process_2021,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.265296982939863,0,0,4.357472021066491,6.79849904676328,AHSP,Late Erythroid,0.6775833802166729
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",4/948,0.21159142351009,0.266142337383785,0,0,1.7507369196757554,2.7190662035683872,GFI1B;DEPDC1;BIRC5;GATA1,Late Erythroid,0.6745019396506919
GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.2140587201245348,0.2681980851365766,0,0,4.26530612244898,6.5749903239841245,ALAS2,Late Erythroid,0.6694670755856718
GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),2/350,0.2179021682137168,0.2719554192434761,0,0,2.3469827586206895,3.5761189553619586,UBE2T;PCLAF,Late Erythroid,0.6617384483284671
GO_Biological_Process_2021,response to UV (GO:0009411),1/99,0.2199671313012003,0.2734726497258166,0,0,4.134110787172012,6.26018948804807,PCLAF,Late Erythroid,0.6576422090003602
GO_Biological_Process_2021,epithelial cell differentiation (GO:0030855),1/101,0.2238818662412048,0.2751525226323205,0,0,4.051020408163265,6.062906014187368,TST,Late Erythroid,0.6499810815451941
GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),1/101,0.2238818662412048,0.2751525226323205,0,0,4.051020408163265,6.062906014187368,CCNB1,Late Erythroid,0.6499810815451941
GO_Biological_Process_2021,cellular response to chemical stress (GO:0062197),1/101,0.2238818662412048,0.2751525226323205,0,0,4.051020408163265,6.062906014187368,PRDX2,Late Erythroid,0.6499810815451941
GO_Biological_Process_2021,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.2836215932246649,0,0,3.894427001569859,5.6956456810845415,CCNB1,Late Erythroid,0.6351608308934773
GO_Biological_Process_2021,cellular response to peptide hormone stimulus (GO:0071375),1/106,0.2335846623503299,0.2849025048363872,0,0,3.857142857142857,5.6090983677319475,PKLR,Late Erythroid,0.6315556772929499
GO_Biological_Process_2021,DNA replication (GO:0006260),1/108,0.2374324069826741,0.2885027737676267,0,0,3.7846652679763495,5.441865346754643,PCLAF,Late Erythroid,0.6244600047865677
GO_Biological_Process_2021,modulation of chemical synaptic transmission (GO:0050804),1/109,0.239349173739861,0.2897384734745686,0,0,3.749433106575964,5.361058744932435,NMU,Late Erythroid,0.6209680674126086
GO_Biological_Process_2021,protein-containing complex subunit organization (GO:0043933),1/112,0.2450711886958998,0.295554017828014,0,0,3.647545504688362,5.129202360192396,ADD2,Late Erythroid,0.6107077427090284
GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.299006325860233,0,0,3.582625970742279,4.982913653406146,CDC20,Late Erythroid,0.6040407011916724
GO_Biological_Process_2021,regulation of protein binding (GO:0043393),1/118,0.2563889548341396,0.3069042507680035,0,0,3.4594453165881736,4.708511372057024,ADD2,Late Erythroid,0.5911006880374128
GO_Biological_Process_2021,epithelium development (GO:0060429),1/122,0.2638415777635164,0.3127880187052816,0,0,3.3444088379153314,4.456111874258477,TST,Late Erythroid,0.5786567646257991
GO_Biological_Process_2021,potassium ion transport (GO:0006813),1/122,0.2638415777635164,0.3127880187052816,0,0,3.3444088379153314,4.456111874258477,KCNH2,Late Erythroid,0.5786567646257991
GO_Biological_Process_2021,phosphorylation (GO:0016310),2/400,0.2642184505833435,0.3127880187052816,0,0,2.046901172529313,2.7243825855585304,CCNE1;BIRC5,Late Erythroid,0.5780368585354551
GO_Biological_Process_2021,cellular response to oxidative stress (GO:0034599),1/125,0.2693829605231016,0.3177337483092993,0,0,3.263001974983542,4.279822783786303,PRDX2,Late Erythroid,0.5696298784899082
GO_Biological_Process_2021,cellular response to insulin stimulus (GO:0032869),1/129,0.2767079241059198,0.3239998238622043,0,0,3.1603954081632653,4.060453122404681,PKLR,Late Erythroid,0.5579784037567757
GO_Biological_Process_2021,muscle contraction (GO:0006936),1/129,0.2767079241059198,0.3239998238622043,0,0,3.1603954081632653,4.060453122404681,MYL4,Late Erythroid,0.5579784037567757
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),3/742,0.2833046813486276,0.3305221282400656,0,0,1.6593153485158207,2.092782192966935,PRDX2;BIRC5;GATA1,Late Erythroid,0.5477462491044153
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3321865719702777,0,0,3.0408163265306123,3.80890385676326,GATA1,Late Erythroid,0.5439940297149167
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),2/430,0.2921183511246394,0.3383529102954456,0,0,1.900506230529595,2.3387558342335666,HES6;KLF1,Late Erythroid,0.5344411594186865
GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),1/139,0.2947069182263764,0.3401276977379685,0,0,2.929902395740905,3.579678317757992,KCNH2,Late Erythroid,0.5306096689947516
GO_Biological_Process_2021,negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.3017829564686885,0.3470503999389918,0,0,2.8467950560505892,3.410594866305226,HES6,Late Erythroid,0.5203052911363482
GO_Biological_Process_2021,regulation of G2/M transition of mitotic cell cycle (GO:0010389),1/149,0.3122667490151626,0.3578288013625706,0,0,2.7305570876999448,3.1780885451938787,CCNB1,Late Erythroid,0.5054742581266645
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),2/464,0.3236043277850015,0.368994889597741,0,0,1.7575757575757576,1.982956235178162,DEPDC1;BIRC5,Late Erythroid,0.48998567889976286
GO_Biological_Process_2021,regulation of cell differentiation (GO:0045595),1/156,0.3243029619756543,0.368994889597741,0,0,2.6063199473337724,2.934917292064671,HEMGN,Late Erythroid,0.4890490847411261
GO_Biological_Process_2021,organonitrogen compound biosynthetic process (GO:1901566),1/158,0.3277037968552589,0.3715514879837794,0,0,2.5728584427401535,2.8703970097526006,ALAS2,Late Erythroid,0.48451852674781976
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),2/474,0.3328115296392732,0.3760186405047227,0,0,1.7194562146892656,1.8917094920733264,EPCAM;BIRC5,Late Erythroid,0.47780163679243126
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",4/1183,0.3428517320675613,0.3860078941459955,0,0,1.384445181989158,1.481989303783668,KCNH2;EPCAM;GATA1;KLF1,Late Erythroid,0.4648936521619021
GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3864650128595223,0,0,2.4175730172308443,2.5766088705447237,DLGAP5,Late Erythroid,0.46286379212748074
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),2/496,0.3529487892748932,0.3946163546754014,0,0,1.641025641025641,1.709017116633574,CCNE1;BIRC5,Late Erythroid,0.4522883035321021
GO_Biological_Process_2021,cation transport (GO:0006812),1/174,0.3543133002736421,0.3947712203740925,0,0,2.333018756635602,2.4206789693623425,RHAG,Late Erythroid,0.45061254473982715
GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),1/177,0.359186378521905,0.3988207375312186,0,0,2.2929035250463823,2.3477357103628296,CDC20,Late Erythroid,0.44468014150624274
GO_Biological_Process_2021,protein stabilization (GO:0050821),1/179,0.3624150547196057,0.4010228440539967,0,0,2.266911258885577,2.300835957547096,AHSP,Late Erythroid,0.4407937700298507
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.4014230744576876,0,0,2.2541329380914377,2.2778849681371156,HBB,Late Erythroid,0.4388706874182523
GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),1/185,0.3720057294778557,0.408825409187268,0,0,2.192324755989352,2.1678716160963645,SPTB,Late Erythroid,0.4294503712432232
GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),1/201,0.3968950010648283,0.4321470851772231,0,0,2.0153061224489797,1.8623111638641865,CDC20,Late Erythroid,0.40132437104403956
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),3/908,0.3977118667386928,0.4321470851772231,0,0,1.3432467379804869,1.2385104166535874,EPCAM;GATA1;DLGAP5,Late Erythroid,0.40043145054722185
GO_Biological_Process_2021,generation of neurons (GO:0048699),1/202,0.398418067592006,0.4321470851772231,0,0,2.0051781906792567,1.8452720554356252,HES6,Late Erythroid,0.39966097527446726
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/547,0.3988146050031916,0.4321470851772231,0,0,1.4835626911314983,1.3637777909312412,DEPDC1;BIRC5,Late Erythroid,0.3992289457561903
GO_Biological_Process_2021,axon guidance (GO:0007411),1/203,0.3999373645428959,0.4321470851772231,0,0,1.9951505354617096,1.8284503867148747,SPTB,Late Erythroid,0.398008019580524
GO_Biological_Process_2021,axonogenesis (GO:0007409),1/240,0.4535831041409784,0.4884741121518229,0,0,1.6831184356587825,1.3306343458644796,SPTB,Late Erythroid,0.34334313117644527
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),2/621,0.4626694381715867,0.4965985303041696,0,0,1.3012250942380184,1.0029093993298663,CA1;BIRC5,Late Erythroid,0.33472918706115434
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),3/1025,0.4760222919123325,0.5092331494876114,0,0,1.1821626348003498,0.8775082045072261,EPB42;CCNE1;BIRC5,Late Erythroid,0.3223727089857482
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),6/2206,0.478857675442218,0.5105701042794509,0,0,1.100206611570248,0.8101391784721939,HES6;GFI1B;CCNB1;EPCAM;GATA1;KLF1,Late Erythroid,0.31979354703381785
GO_Biological_Process_2021,cellular component assembly (GO:0022607),1/261,0.4819092749521712,0.5121280083650136,0,0,1.5455259026687598,1.1282329953702568,ADD2,Late Erythroid,0.31703471507296654
GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5170313508539089,0,0,1.510204081632653,1.0781219104526054,ADD2,Late Erythroid,0.3100391544580995
GO_Biological_Process_2021,protein deubiquitination (GO:0016579),1/267,0.4897346646287026,0.5170313508539089,0,0,1.510204081632653,1.0781219104526054,CDC20,Late Erythroid,0.3100391544580995
GO_Biological_Process_2021,protein modification by small protein removal (GO:0070646),1/276,0.50125602230015,0.5270734370950171,0,0,1.4601113172541744,1.0084087773272885,CDC20,Late Erythroid,0.29994039654430615
GO_Biological_Process_2021,DNA metabolic process (GO:0006259),1/277,0.5025203266713362,0.5270734370950171,0,0,1.4547471162377994,1.0010394055052982,UBE2T,Late Erythroid,0.29884636657880626
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),2/684,0.5139408816832591,0.53730183085068,0,0,1.1771749755620724,0.7835830337156338,GFI1B;GATA1,Late Erythroid,0.2890868347700152
GO_Biological_Process_2021,DNA repair (GO:0006281),1/298,0.5283567775332543,0.5505853798242973,0,0,1.3504432075860646,0.8615604955292901,UBE2T,Late Erythroid,0.2770727172622369
GO_Biological_Process_2021,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.5549948137651602,0,0,1.32774699283687,0.8321996277505203,SPTB,Late Erythroid,0.2722052530518486
GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),1/314,0.5471545986718139,0.5665073336730678,0,0,1.2803677381495728,0.7720923294539072,UBE2T,Late Erythroid,0.26188994631047774
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),2/764,0.5744134768292987,0.5928241651892121,0,0,1.0492125984251968,0.5816895490313783,EPCAM;BIRC5,Late Erythroid,0.24077537927422193
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.5909956578792304,0.6079891432495597,0,0,1.1329710354396716,0.5958822738188654,CDC20,Late Erythroid,0.22841570992418872
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6238418541458532,0,0,1.0799779371207945,0.5367673309131087,GATA1,Late Erythroid,0.21585171499242045
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),1/409,0.644552703427983,0.6588760968374937,0,0,0.9774909963985594,0.4293127610136149,UBE2T,Late Erythroid,0.19074156570833578
GO_Biological_Process_2021,organelle assembly (GO:0070925),1/425,0.658798168385351,0.6713069943673514,0,0,0.939834424335772,0.3922286762298742,DLGAP5,Late Erythroid,0.18124761694193237
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),1/481,0.7043872370804651,0.7140142190066971,0,0,0.8278061224489796,0.2900856337670249,HBB,Late Erythroid,0.15218852169360617
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7140142190066971,0,0,0.8260426831855403,0.2885801301950252,BIRC5,Late Erythroid,0.1517218912312197
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),1/485,0.7074048097353064,0.7140575195447293,0,0,0.8207960870298533,0.2841203737887477,HBB,Late Erythroid,0.15033199168778996
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),1/488,0.7096481586491704,0.7140834596407278,0,0,0.815614130662532,0.2797442143304909,HBB,Late Erythroid,0.14895691977455572
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.7382605570764775,0,0,0.7565820221218258,0.231944503707841,UBE2T,Late Erythroid,0.13314117322745964
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7597673074922179,0,0,0.7301532033426184,0.200604530418796,HES6;KLF1,Late Erythroid,0.11931939791106433
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),30/481,3.324893863039629e-36,8.897439023807244e-34,0,0,64.85254988913526,5297.910224429333,ORM1;ITGAM;CRISP3;RETN;ABCA13;FCAR;HK3;C3AR1;S100A12;PGLYRP1;CAMP;CD177;ANXA3;ARG1;CYBB;MMP8;OLFM4;MMP9;OSCAR;CEACAM3;CHIT1;CEACAM1;CLEC4D;VNN1;TCN1;SLCO4C1;LCN2;CEACAM8;S100A8;LTF,Late Myeloid,35.47822221364867
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),30/485,4.2789992138901894e-36,8.897439023807244e-34,0,0,64.26923076923077,5234.04400570314,ORM1;ITGAM;CRISP3;RETN;ABCA13;FCAR;HK3;C3AR1;S100A12;PGLYRP1;CAMP;CD177;ANXA3;ARG1;CYBB;MMP8;OLFM4;MMP9;OSCAR;CEACAM3;CHIT1;CEACAM1;CLEC4D;VNN1;TCN1;SLCO4C1;LCN2;CEACAM8;S100A8;LTF,Late Myeloid,35.36865779330181
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),30/488,5.16292399834076e-36,8.897439023807244e-34,0,0,63.838427947598255,5186.971875443829,ORM1;ITGAM;CRISP3;RETN;ABCA13;FCAR;HK3;C3AR1;S100A12;PGLYRP1;CAMP;CD177;ANXA3;ARG1;CYBB;MMP8;OLFM4;MMP9;OSCAR;CEACAM3;CHIT1;CEACAM1;CLEC4D;VNN1;TCN1;SLCO4C1;LCN2;CEACAM8;S100A8;LTF,Late Myeloid,35.28710426800801
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),8/176,1.2010545756607834e-08,1.5523630390415624e-06,0,0,22.428571428571427,409.0406399037062,ANXA3;LCN2;S100A12;NLRC4;PGLYRP1;S100A8;CAMP;LTF,Late Myeloid,7.920437257901164
GO_Biological_Process_2021,innate immune response (GO:0045087),9/302,5.273976796831145e-08,5.453292007923403e-06,0,0,14.726795971031382,246.79011611413068,CLEC4D;VNN1;CRISP3;LCN2;S100A12;CYBB;PGLYRP1;CAMP;LTF,Late Myeloid,7.277861785242312
GO_Biological_Process_2021,defense response to fungus (GO:0050832),4/24,3.538707538969472e-07,3.049186329412028e-05,0,0,86.65217391304348,1287.1603411426952,CLEC4D;S100A12;S100A8;LTF,Late Myeloid,6.451155328704732
GO_Biological_Process_2021,iron coordination entity transport (GO:1901678),3/7,5.109076037011196e-07,3.773417587335412e-05,0,0,318.28723404255317,4611.051692443593,FLVCR1;LCN2;LTF,Late Myeloid,6.291657633781106
GO_Biological_Process_2021,regulation of neuroinflammatory response (GO:0150077),3/19,1.3849289100030806e-05,0.0008950103080894909,0,0,79.52393617021276,889.6562746439253,CD200R1;MMP8;MMP9,Late Myeloid,4.858572518863624
GO_Biological_Process_2021,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),4/64,1.9659499977716905e-05,0.0011293290542755,0,0,28.82608695652174,312.3868594993703,S100A12;PGLYRP1;CAMP;LTF,Late Myeloid,4.706427532265834
GO_Biological_Process_2021,inflammatory response (GO:0006954),6/230,2.2560286923808732e-05,0.0011663668339609,0,0,12.008522727272728,128.48302033929846,ORM1;VNN1;C3AR1;CYBB;NLRC4;S100A8,Late Myeloid,4.646655381256317
GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),6/246,3.29105445676067e-05,0.0015467955946775,0,0,11.198863636363637,115.59150619287536,IL18RAP;ANXA3;S100A12;NLRC4;S100A8;LTF,Late Myeloid,4.482664931417267
GO_Biological_Process_2021,positive regulation of NF-kappaB transcription factor activity (GO:0051092),5/155,4.190950460849395e-05,0.0018056011568826,0,0,14.666666666666666,147.83996944144806,IL18RAP;S100A12;NLRC4;S100A8;LTF,Late Myeloid,4.377687472715881
GO_Biological_Process_2021,regulation of neutrophil degranulation (GO:0043313),2/5,6.0956786529959696e-05,0.0024242045104607,0,0,277.0416666666667,2688.78505476905,ITGAM;CD177,Late Myeloid,4.214977935846465
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),5/206,0.0001605354097534528,0.0059283433458953,0,0,10.917081260364842,95.3824955022904,CD200R1;S100A12;MMP8;MMP9;S100A8,Late Myeloid,3.7944291591195953
GO_Biological_Process_2021,positive regulation of reactive oxygen species metabolic process (GO:2000379),3/49,0.0002497855682645102,0.0086092759195167,0,0,27.618871415356153,229.09599013803128,ITGAM;MMP8;CD177,Late Myeloid,3.6024326572514935
GO_Biological_Process_2021,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),2/12,0.0003978405023918531,0.0128552212335367,0,0,83.08333333333333,650.4975835514635,ITGAM;CD177,Late Myeloid,3.4002910053496507
GO_Biological_Process_2021,positive regulation of leukocyte degranulation (GO:0043302),2/14,0.0005467878206419364,0.0148783843827305,0,0,69.22916666666667,520.0114050756229,ITGAM;CD177,Late Myeloid,3.2621811676355046
GO_Biological_Process_2021,positive regulation of superoxide anion generation (GO:0032930),2/14,0.0005467878206419364,0.0148783843827305,0,0,69.22916666666667,520.0114050756229,ITGAM;CD177,Late Myeloid,3.2621811676355046
GO_Biological_Process_2021,detection of bacterium (GO:0016045),2/14,0.0005467878206419364,0.0148783843827305,0,0,69.22916666666667,520.0114050756229,NLRC4;PGLYRP1,Late Myeloid,3.2621811676355046
GO_Biological_Process_2021,regulation of superoxide anion generation (GO:0032928),2/15,0.0006299020654549659,0.0162829683920108,0,0,63.90064102564103,470.9442866528224,ITGAM;CD177,Late Myeloid,3.200726967591985
GO_Biological_Process_2021,regulation of interleukin-1 production (GO:0032652),2/16,0.0007187392304892979,0.0175197401311339,0,0,59.333333333333336,429.45537567816734,ORM1;CEACAM1,Late Myeloid,3.14342864967499
GO_Biological_Process_2021,myeloid leukocyte differentiation (GO:0002573),3/71,0.0007455208566439991,0.0175197401311339,0,0,18.66270337922403,134.39810435842293,CEBPE;MMP9;OSCAR,Late Myeloid,3.1275402022462693
GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),4/170,0.0008555920003709937,0.0192322201822523,0,0,10.363541121005762,73.2051208766897,CEACAM1;ITGAM;CEACAM8;CD177,Late Myeloid,3.067733284655648
GO_Biological_Process_2021,neutrophil migration (GO:1990266),3/77,0.0009441676964961806,0.0203389457953552,0,0,17.14433582518689,119.41384383677423,S100A12;S100A8;CD177,Late Myeloid,3.024950862487107
GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),4/182,0.0011021628390365,0.0227927275112749,0,0,9.659013190034196,65.78252399693514,CD200R1;CEACAM1;ORM1;MMP8,Late Myeloid,2.957754235910311
GO_Biological_Process_2021,innate immune response in mucosa (GO:0002227),2/21,0.0012477930702112,0.0248118852807385,0,0,43.708333333333336,292.25047477799524,CAMP;LTF,Late Myeloid,2.9038574306125264
GO_Biological_Process_2021,positive regulation of inflammatory response (GO:0050729),3/89,0.0014352931477222,0.0274832058286075,0,0,14.743196437407224,96.51465720793364,S100A12;MMP8;S100A8,Late Myeloid,2.8430593885216617
GO_Biological_Process_2021,mucosal immune response (GO:0002385),2/28,0.0022210873543451,0.0410107915070149,0,0,31.92948717948718,195.08145262248803,CAMP;LTF,Late Myeloid,2.6534343605132076
GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),3/110,0.0026292225152408,0.0468618390048491,0,0,11.83714456154305,70.32527008978302,CD200R1;ORM1;MMP8,Late Myeloid,2.5801726573124935
GO_Biological_Process_2021,negative regulation of interleukin-6 production (GO:0032715),2/31,0.0027192556482504,0.0468618390048491,0,0,28.62212643678161,169.08226656127547,ORM1;CD200R1,Late Myeloid,2.565549960707733
GO_Biological_Process_2021,endodermal cell differentiation (GO:0035987),2/32,0.0028959211173454,0.0482964908925028,0,0,27.666666666666668,161.69650653172428,MMP8;MMP9,Late Myeloid,2.5382132721600397
GO_Biological_Process_2021,positive regulation of DNA binding (GO:0043388),2/34,0.0032650074009337,0.052750275821336,0,0,25.934895833333332,148.46413612460563,MMP8;MMP9,Late Myeloid,2.4861158299536776
GO_Biological_Process_2021,endoderm formation (GO:0001706),2/36,0.0036549257227984,0.0560603104030673,0,0,24.40686274509804,136.96349152286243,MMP8;MMP9,Late Myeloid,2.437121444562911
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),3/124,0.0036867515545537,0.0560603104030673,0,0,10.460172322841569,58.60844537950275,ORM1;MMP8;LTF,Late Myeloid,2.433356127954467
GO_Biological_Process_2021,organic substance transport (GO:0071702),3/136,0.0047734885794893,0.0705112455884568,0,0,9.51063829787234,50.83129816395182,TCN1;FLVCR1;ABCA13,Late Myeloid,2.3211641121418585
GO_Biological_Process_2021,antibacterial humoral response (GO:0019731),2/44,0.0054187658916089,0.0778194990544958,0,0,19.75,103.05327189846057,CAMP;LTF,Late Myeloid,2.266099611522887
GO_Biological_Process_2021,negative regulation of T cell activation (GO:0050868),2/45,0.0056617913266769,0.07911205718627,0,0,19.289728682170544,99.80534454493326,CEACAM1;ARG1,Late Myeloid,2.2470461412130196
GO_Biological_Process_2021,regulation of DNA binding (GO:0051101),2/47,0.0061625935135597,0.0838437064871149,0,0,18.430555555555557,93.79784429037068,MMP8;MMP9,Late Myeloid,2.210236477513525
GO_Biological_Process_2021,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),2/48,0.0064203200925442,0.0851103971242407,0,0,18.028985507246375,91.01549863791358,ORM1;LTF,Late Myeloid,2.192443319133604
GO_Biological_Process_2021,regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/52,0.007499481830469,0.0913975509782297,0,0,16.583333333333332,81.14094572244915,MMP9;S100A8,Late Myeloid,2.12496874273393
GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),2/52,0.007499481830469,0.0913975509782297,0,0,16.583333333333332,81.14094572244915,CEBPE;FLVCR1,Late Myeloid,2.12496874273393
GO_Biological_Process_2021,positive regulation of interleukin-1 beta production (GO:0032731),2/56,0.0086546685435214,0.0913975509782297,0,0,15.351851851851851,72.91602120992282,ORM1;NLRC4,Late Myeloid,2.0627495600792987
GO_Biological_Process_2021,cellular iron ion homeostasis (GO:0006879),2/58,0.0092602829393189,0.0913975509782297,0,0,14.802083333333334,69.30366021141536,FLVCR1;LCN2,Late Myeloid,2.033375743652011
GO_Biological_Process_2021,iron ion homeostasis (GO:0055072),2/61,0.0102031878981958,0.0913975509782297,0,0,14.04731638418079,64.40771918587598,FLVCR1;LCN2,Late Myeloid,1.9912641154648159
GO_Biological_Process_2021,positive regulation of interleukin-1 production (GO:0032732),2/62,0.0105265894654256,0.0913975509782297,0,0,13.8125,62.9000654557375,ORM1;NLRC4,Late Myeloid,1.977712314119832
GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),2/64,0.0111869000374274,0.0913975509782297,0,0,13.365591397849462,60.051760195429935,VNN1;MMP9,Late Myeloid,1.9512902426187388
GO_Biological_Process_2021,extracellular matrix disassembly (GO:0022617),2/66,0.0118650634107129,0.0913975509782297,0,0,12.946614583333334,57.4073222604629,MMP8;MMP9,Late Myeloid,1.9257299364311244
GO_Biological_Process_2021,cellular component disassembly (GO:0022411),2/66,0.0118650634107129,0.0913975509782297,0,0,12.946614583333334,57.4073222604629,MMP8;MMP9,Late Myeloid,1.9257299364311244
GO_Biological_Process_2021,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2/67,0.012210781302115,0.0913975509782297,0,0,12.746794871794872,56.15518906635068,CEACAM1;MMP9,Late Myeloid,1.9132565470017566
GO_Biological_Process_2021,quinone catabolic process (GO:1901662),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,CYP4F3,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,MMP9,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,antifungal humoral response (GO:0019732),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,LTF,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,histone citrullination (GO:0036414),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,PADI4,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,insulin metabolic process (GO:1901142),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,CEACAM1,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,negative regulation of T cell migration (GO:2000405),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,CD200R1,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,leukotriene B4 metabolic process (GO:0036102),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,CYP4F3,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,regulation of hippocampal neuron apoptotic process (GO:0110089),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,ITGAM,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,regulation of homophilic cell adhesion (GO:1903385),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,CEACAM1,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,chronic inflammatory response (GO:0002544),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,VNN1,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,menaquinone metabolic process (GO:0009233),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,CYP4F3,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,regulation of microglial cell mediated cytotoxicity (GO:1904149),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,ITGAM,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,peptidyl-cysteine S-nitrosylation (GO:0018119),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,S100A8,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,protein citrullination (GO:0018101),1/5,0.0124387771927725,0.0913975509782297,0,0,101.76530612244898,446.4379351400606,PADI4,Late Myeloid,1.9052223113279663
GO_Biological_Process_2021,neutrophil chemotaxis (GO:0030593),2/70,0.013274200561286,0.0913975509782297,0,0,12.182598039215684,52.65237170003471,S100A12;S100A8,Late Myeloid,1.8769916248436092
GO_Biological_Process_2021,defense response to Gram-positive bacterium (GO:0050830),2/70,0.013274200561286,0.0913975509782297,0,0,12.182598039215684,52.65237170003471,PGLYRP1;CAMP,Late Myeloid,1.8769916248436092
GO_Biological_Process_2021,granulocyte chemotaxis (GO:0071621),2/73,0.0143765335552059,0.0913975509782297,0,0,11.666079812206572,49.48935398933624,S100A12;S100A8,Late Myeloid,1.8423458176616205
GO_Biological_Process_2021,defense response to Gram-negative bacterium (GO:0050829),2/73,0.0143765335552059,0.0913975509782297,0,0,11.666079812206572,49.48935398933624,CAMP;LTF,Late Myeloid,1.8423458176616205
GO_Biological_Process_2021,regulation of blood vessel remodeling (GO:0060312),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,CEACAM1,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,positive regulation of microglial cell activation (GO:1903980),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,MMP8,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,positive regulation of osteoblast proliferation (GO:0033690),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,LTF,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,regulation of hepatocyte proliferation (GO:2000345),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,CEACAM1,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,chitin catabolic process (GO:0006032),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,CHIT1,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,chitin metabolic process (GO:0006030),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,CHIT1,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,positive regulation of receptor binding (GO:1900122),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,MMP9,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,neutrophil extravasation (GO:0072672),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,CD177,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,cobalamin transport (GO:0015889),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,TCN1,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,positive regulation of sterol transport (GO:0032373),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,ABCA13,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,positive regulation of T cell differentiation in thymus (GO:0033089),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,VNN1,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,regulation of neutrophil extravasation (GO:2000389),1/6,0.0149082847993736,0.0913975509782297,0,0,81.40816326530613,342.3895623444841,OLFM4,Late Myeloid,1.8265723193247598
GO_Biological_Process_2021,positive regulation of immune response (GO:0050778),2/75,0.0151327357621299,0.0913975509782297,0,0,11.345319634703197,47.54704276850611,ITGAM;CD177,Late Myeloid,1.820082551223806
GO_Biological_Process_2021,water-soluble vitamin metabolic process (GO:0006767),2/76,0.0155171628224907,0.0913975509782297,0,0,11.19144144144144,46.62140287744705,VNN1;TCN1,Late Myeloid,1.8091876827669675
GO_Biological_Process_2021,positive regulation of tumor necrosis factor production (GO:0032760),2/77,0.0159057771109684,0.0913975509782297,0,0,11.041666666666666,45.72434655376785,ORM1;MMP8,Late Myeloid,1.7984451076467942
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),3/216,0.0167785010572714,0.0913975509782297,0,0,5.914593946658676,24.176830822166,ITGAM;MMP8;MMP9,Late Myeloid,1.775246840386538
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),3/217,0.0169842657929789,0.0913975509782297,0,0,5.886657387154504,23.99088324962961,ITGAM;MMP8;MMP9,Late Myeloid,1.7699532223559038
GO_Biological_Process_2021,gap junction assembly (GO:0016264),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,GJB6,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,arginine catabolic process (GO:0006527),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,ARG1,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,ARG1,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,heme transport (GO:0015886),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,FLVCR1,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,regulation of dopamine metabolic process (GO:0042053),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,ITGAM,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,interleukin-18-mediated signaling pathway (GO:0035655),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,IL18RAP,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,negative regulation of response to interferon-gamma (GO:0060331),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,ARG1,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,iron import into cell (GO:0033212),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,LTF,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,sinoatrial node development (GO:0003163),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,GJB6,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,cellular response to interleukin-18 (GO:0071351),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,IL18RAP,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,CEACAM1,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,regulation of necrotic cell death (GO:0010939),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,OLFM4,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,pantothenate metabolic process (GO:0015939),1/7,0.0173717414502839,0.0913975509782297,0,0,67.83673469387755,274.9362107684438,VNN1,Late Myeloid,1.7601566430186848
GO_Biological_Process_2021,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),2/81,0.0175016586979588,0.0913975509782297,0,0,10.48048523206751,42.398379802278754,NLRC4;S100A8,Late Myeloid,1.7569207896432026
GO_Biological_Process_2021,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/81,0.0175016586979588,0.0913975509782297,0,0,10.48048523206751,42.398379802278754,ORM1;MMP8,Late Myeloid,1.7569207896432026
GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),2/83,0.0183241429417302,0.0933088725439592,0,0,10.22067901234568,40.877971632620635,ORM1;NLRC4,Late Myeloid,1.7369763290678308
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),5/621,0.0190565584570887,0.0933088725439592,0,0,3.4873737373737375,13.811199519498388,CEACAM1;ITGAM;IL18RAP;LCN2;MMP9,Late Myeloid,1.719955528569201
GO_Biological_Process_2021,regulation of neuron death (GO:1901214),2/86,0.0195880530452788,0.0933088725439592,0,0,9.854166666666666,38.754815869716495,CD200R1;ITGAM,Late Myeloid,1.7080087285643422
GO_Biological_Process_2021,negative regulation of macrophage migration (GO:1905522),1/8,0.0198291614511851,0.0933088725439592,0,0,58.142857142857146,227.9549801512961,CD200R1,Late Myeloid,1.702695651141308
GO_Biological_Process_2021,positive regulation of isomerase activity (GO:0010912),1/8,0.0198291614511851,0.0933088725439592,0,0,58.142857142857146,227.9549801512961,ITGAM,Late Myeloid,1.702695651141308
GO_Biological_Process_2021,negative regulation of T cell mediated cytotoxicity (GO:0001915),1/8,0.0198291614511851,0.0933088725439592,0,0,58.142857142857146,227.9549801512961,CEACAM1,Late Myeloid,1.702695651141308
GO_Biological_Process_2021,leukocyte aggregation (GO:0070486),1/8,0.0198291614511851,0.0933088725439592,0,0,58.142857142857146,227.9549801512961,S100A8,Late Myeloid,1.702695651141308
GO_Biological_Process_2021,vitamin K metabolic process (GO:0042373),1/8,0.0198291614511851,0.0933088725439592,0,0,58.142857142857146,227.9549801512961,CYP4F3,Late Myeloid,1.702695651141308
GO_Biological_Process_2021,regulation of osteoclast development (GO:2001204),1/8,0.0198291614511851,0.0933088725439592,0,0,58.142857142857146,227.9549801512961,LTF,Late Myeloid,1.702695651141308
GO_Biological_Process_2021,regulation of endothelial cell migration (GO:0010594),2/89,0.0208876608034354,0.0933088725439592,0,0,9.512931034482758,36.80169347929862,CEACAM1;ANXA3,Late Myeloid,1.6801101936742149
GO_Biological_Process_2021,positive regulation of binding (GO:0051099),2/90,0.0213286953840061,0.0933088725439592,0,0,9.40435606060606,36.18515879365064,MMP8;MMP9,Late Myeloid,1.6710357083037395
GO_Biological_Process_2021,toll-like receptor signaling pathway (GO:0002224),2/91,0.0217736102157896,0.0933088725439592,0,0,9.298220973782772,35.5848177883064,ITGAM;S100A8,Late Myeloid,1.6620695559472094
GO_Biological_Process_2021,regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),1/9,0.0222805591236868,0.0933088725439592,0,0,50.87244897959184,193.52086993316271,LTF,Late Myeloid,1.652073914876897
GO_Biological_Process_2021,glucosamine-containing compound catabolic process (GO:1901072),1/9,0.0222805591236868,0.0933088725439592,0,0,50.87244897959184,193.52086993316271,CHIT1,Late Myeloid,1.652073914876897
GO_Biological_Process_2021,negative regulation of leukocyte degranulation (GO:0043301),1/9,0.0222805591236868,0.0933088725439592,0,0,50.87244897959184,193.52086993316271,CEACAM1,Late Myeloid,1.652073914876897
GO_Biological_Process_2021,regulation of cellular extravasation (GO:0002691),1/9,0.0222805591236868,0.0933088725439592,0,0,50.87244897959184,193.52086993316271,OLFM4,Late Myeloid,1.652073914876897
GO_Biological_Process_2021,negative regulation of platelet aggregation (GO:0090331),1/9,0.0222805591236868,0.0933088725439592,0,0,50.87244897959184,193.52086993316271,CEACAM1,Late Myeloid,1.652073914876897
GO_Biological_Process_2021,regulation of endothelial cell differentiation (GO:0045601),1/9,0.0222805591236868,0.0933088725439592,0,0,50.87244897959184,193.52086993316271,CEACAM1,Late Myeloid,1.652073914876897
GO_Biological_Process_2021,synapse pruning (GO:0098883),1/9,0.0222805591236868,0.0933088725439592,0,0,50.87244897959184,193.52086993316271,ITGAM,Late Myeloid,1.652073914876897
GO_Biological_Process_2021,ornithine metabolic process (GO:0006591),1/9,0.0222805591236868,0.0933088725439592,0,0,50.87244897959184,193.52086993316271,ARG1,Late Myeloid,1.652073914876897
GO_Biological_Process_2021,peptidyl-cysteine modification (GO:0018198),1/9,0.0222805591236868,0.0933088725439592,0,0,50.87244897959184,193.52086993316271,S100A8,Late Myeloid,1.652073914876897
GO_Biological_Process_2021,positive regulation of epithelial cell migration (GO:0010634),2/94,0.0231314233527167,0.0933088725439592,0,0,8.993659420289855,33.87518721331595,ANXA3;MMP9,Late Myeloid,1.6357976428363092
GO_Biological_Process_2021,regulation of vesicle-mediated transport (GO:0060627),2/96,0.0240556444712905,0.0933088725439592,0,0,8.801418439716311,32.80628046281635,OLFM4;CD177,Late Myeloid,1.6187830034849287
GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),2/96,0.0240556444712905,0.0933088725439592,0,0,8.801418439716311,32.80628046281635,FLVCR1;LCN2,Late Myeloid,1.6187830034849287
GO_Biological_Process_2021,regulation of receptor binding (GO:1900120),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,MMP9,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,fructose 6-phosphate metabolic process (GO:0006002),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,HK3,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,arginine metabolic process (GO:0006525),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,ARG1,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,granulocyte migration (GO:0097530),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,CD177,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,negative regulation of leukocyte migration (GO:0002686),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,CD200R1,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,LTF,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,positive regulation of keratinocyte migration (GO:0051549),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,MMP9,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,regulation of granulocyte differentiation (GO:0030852),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,CEACAM1,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,regulation of macrophage migration (GO:1905521),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,CD200R1,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,LTF,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,urea cycle (GO:0000050),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,ARG1,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,positive regulation of vasculogenesis (GO:2001214),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,CEACAM1,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,regulation of neutrophil migration (GO:1902622),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,OLFM4,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,ectoderm development (GO:0007398),1/10,0.024725948817258,0.0933088725439592,0,0,45.21768707482993,167.3010120823387,ITGAM,Late Myeloid,1.606847034080906
GO_Biological_Process_2021,positive regulation of defense response (GO:0031349),2/98,0.0249948795228368,0.0936402370529468,0,0,8.6171875,31.789531066243494,S100A12;S100A8,Late Myeloid,1.6021489522377872
GO_Biological_Process_2021,negative regulation of homotypic cell-cell adhesion (GO:0034111),1/11,0.0271653448579923,0.0968585054591866,0,0,40.69387755102041,146.73452100035948,CEACAM1,Late Myeloid,1.5659847773237099
GO_Biological_Process_2021,negative regulation of lymphocyte migration (GO:2000402),1/11,0.0271653448579923,0.0968585054591866,0,0,40.69387755102041,146.73452100035948,CD200R1,Late Myeloid,1.5659847773237099
GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/11,0.0271653448579923,0.0968585054591866,0,0,40.69387755102041,146.73452100035948,MMP9,Late Myeloid,1.5659847773237099
GO_Biological_Process_2021,cell-cell junction maintenance (GO:0045217),1/11,0.0271653448579923,0.0968585054591866,0,0,40.69387755102041,146.73452100035948,CD177,Late Myeloid,1.5659847773237099
GO_Biological_Process_2021,cellular response to UV-A (GO:0071492),1/11,0.0271653448579923,0.0968585054591866,0,0,40.69387755102041,146.73452100035948,MMP9,Late Myeloid,1.5659847773237099
GO_Biological_Process_2021,complement receptor mediated signaling pathway (GO:0002430),1/11,0.0271653448579923,0.0968585054591866,0,0,40.69387755102041,146.73452100035948,C3AR1,Late Myeloid,1.5659847773237099
GO_Biological_Process_2021,organophosphate catabolic process (GO:0046434),1/11,0.0271653448579923,0.0968585054591866,0,0,40.69387755102041,146.73452100035948,PLBD1,Late Myeloid,1.5659847773237099
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),2/106,0.0288986461861609,0.0987261918137094,0,0,7.951121794871795,28.178461808105727,S100A12;LTF,Late Myeloid,1.5391225021448902
GO_Biological_Process_2021,fat-soluble vitamin catabolic process (GO:0042363),1/12,0.029598761568907,0.0987261918137094,0,0,36.99257884972171,130.2147194065139,CYP4F3,Late Myeloid,1.5287264597194943
GO_Biological_Process_2021,negative regulation of fatty acid biosynthetic process (GO:0045717),1/12,0.029598761568907,0.0987261918137094,0,0,36.99257884972171,130.2147194065139,CEACAM1,Late Myeloid,1.5287264597194943
GO_Biological_Process_2021,positive regulation of neuroinflammatory response (GO:0150078),1/12,0.029598761568907,0.0987261918137094,0,0,36.99257884972171,130.2147194065139,MMP8,Late Myeloid,1.5287264597194943
GO_Biological_Process_2021,negative regulation of vascular permeability (GO:0043116),1/12,0.029598761568907,0.0987261918137094,0,0,36.99257884972171,130.2147194065139,CEACAM1,Late Myeloid,1.5287264597194943
GO_Biological_Process_2021,positive regulation of protein maturation (GO:1903319),1/12,0.029598761568907,0.0987261918137094,0,0,36.99257884972171,130.2147194065139,NLRC4,Late Myeloid,1.5287264597194943
GO_Biological_Process_2021,regulation of keratinocyte migration (GO:0051547),1/12,0.029598761568907,0.0987261918137094,0,0,36.99257884972171,130.2147194065139,MMP9,Late Myeloid,1.5287264597194943
GO_Biological_Process_2021,organic hydroxy compound catabolic process (GO:1901616),1/12,0.029598761568907,0.0987261918137094,0,0,36.99257884972171,130.2147194065139,CYP4F3,Late Myeloid,1.5287264597194943
GO_Biological_Process_2021,modulation by host of viral process (GO:0044788),1/12,0.029598761568907,0.0987261918137094,0,0,36.99257884972171,130.2147194065139,LTF,Late Myeloid,1.5287264597194943
GO_Biological_Process_2021,negative regulation by host of viral process (GO:0044793),1/12,0.029598761568907,0.0987261918137094,0,0,36.99257884972171,130.2147194065139,LTF,Late Myeloid,1.5287264597194943
GO_Biological_Process_2021,lipid transport (GO:0006869),2/109,0.0304216645881743,0.1008205166159368,0,0,7.72702492211838,26.987409356009476,CEACAM1;ABCA13,Late Myeloid,1.5168170262567133
GO_Biological_Process_2021,phosphatidylinositol metabolic process (GO:0046488),2/112,0.031976077624072,0.1028419394385744,0,0,7.515151515151516,25.872917364872013,PLBD1;BMX,Late Myeloid,1.4951748104677034
GO_Biological_Process_2021,regulation of T cell differentiation in thymus (GO:0033081),1/13,0.032026213248763,0.1028419394385744,0,0,33.90816326530612,116.6847899929619,VNN1,Late Myeloid,1.4944944088974865
GO_Biological_Process_2021,antifungal innate immune response (GO:0061760),1/13,0.032026213248763,0.1028419394385744,0,0,33.90816326530612,116.6847899929619,CLEC4D,Late Myeloid,1.4944944088974865
GO_Biological_Process_2021,negative regulation of locomotion (GO:0040013),1/13,0.032026213248763,0.1028419394385744,0,0,33.90816326530612,116.6847899929619,CCDC125,Late Myeloid,1.4944944088974865
GO_Biological_Process_2021,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),1/13,0.032026213248763,0.1028419394385744,0,0,33.90816326530612,116.6847899929619,MMP8,Late Myeloid,1.4944944088974865
GO_Biological_Process_2021,activation of cysteine-type endopeptidase activity (GO:0097202),1/14,0.0344477141698711,0.1041489369931192,0,0,31.298273155416013,105.4223689491126,NLRC4,Late Myeloid,1.4628395910668823
GO_Biological_Process_2021,regulation of vasculogenesis (GO:2001212),1/14,0.0344477141698711,0.1041489369931192,0,0,31.298273155416013,105.4223689491126,CEACAM1,Late Myeloid,1.4628395910668823
GO_Biological_Process_2021,bone morphogenesis (GO:0060349),1/14,0.0344477141698711,0.1041489369931192,0,0,31.298273155416013,105.4223689491126,LTF,Late Myeloid,1.4628395910668823
GO_Biological_Process_2021,response to UV-A (GO:0070141),1/14,0.0344477141698711,0.1041489369931192,0,0,31.298273155416013,105.4223689491126,MMP9,Late Myeloid,1.4628395910668823
GO_Biological_Process_2021,negative regulation of neuroinflammatory response (GO:0150079),1/14,0.0344477141698711,0.1041489369931192,0,0,31.298273155416013,105.4223689491126,CD200R1,Late Myeloid,1.4628395910668823
GO_Biological_Process_2021,cell junction maintenance (GO:0034331),1/14,0.0344477141698711,0.1041489369931192,0,0,31.298273155416013,105.4223689491126,CD177,Late Myeloid,1.4628395910668823
GO_Biological_Process_2021,sodium-independent organic anion transport (GO:0043252),1/14,0.0344477141698711,0.1041489369931192,0,0,31.298273155416013,105.4223689491126,SLCO4C1,Late Myeloid,1.4628395910668823
GO_Biological_Process_2021,negative regulation of T cell mediated immunity (GO:0002710),1/14,0.0344477141698711,0.1041489369931192,0,0,31.298273155416013,105.4223689491126,CEACAM1,Late Myeloid,1.4628395910668823
GO_Biological_Process_2021,ceramide transport (GO:0035627),1/14,0.0344477141698711,0.1041489369931192,0,0,31.298273155416013,105.4223689491126,ABCA13,Late Myeloid,1.4628395910668823
GO_Biological_Process_2021,regulation of integrin-mediated signaling pathway (GO:2001044),1/14,0.0344477141698711,0.1041489369931192,0,0,31.298273155416013,105.4223689491126,CD177,Late Myeloid,1.4628395910668823
GO_Biological_Process_2021,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),2/119,0.0357221395623332,0.106471033703321,0,0,7.063034188034188,23.53392133172277,NLRC4;S100A8,Late Myeloid,1.4470625371214694
GO_Biological_Process_2021,negative regulation of cellular component movement (GO:0051271),1/15,0.0368632785936063,0.106471033703321,0,0,29.06122448979592,95.91771596133704,CCDC125,Late Myeloid,1.4334060415588732
GO_Biological_Process_2021,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),1/15,0.0368632785936063,0.106471033703321,0,0,29.06122448979592,95.91771596133704,CEACAM1,Late Myeloid,1.4334060415588732
GO_Biological_Process_2021,superoxide anion generation (GO:0042554),1/15,0.0368632785936063,0.106471033703321,0,0,29.06122448979592,95.91771596133704,CYBB,Late Myeloid,1.4334060415588732
GO_Biological_Process_2021,macrophage differentiation (GO:0030225),1/15,0.0368632785936063,0.106471033703321,0,0,29.06122448979592,95.91771596133704,MMP9,Late Myeloid,1.4334060415588732
GO_Biological_Process_2021,regulation of microglial cell activation (GO:1903978),1/15,0.0368632785936063,0.106471033703321,0,0,29.06122448979592,95.91771596133704,MMP8,Late Myeloid,1.4334060415588732
GO_Biological_Process_2021,peptidyl-arginine modification (GO:0018195),1/15,0.0368632785936063,0.106471033703321,0,0,29.06122448979592,95.91771596133704,PADI4,Late Myeloid,1.4334060415588732
GO_Biological_Process_2021,peptidyl-tyrosine autophosphorylation (GO:0038083),1/15,0.0368632785936063,0.106471033703321,0,0,29.06122448979592,95.91771596133704,BMX,Late Myeloid,1.4334060415588732
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),3/300,0.0390400715124679,0.1074291006334313,0,0,4.223726627981947,13.698249489225711,ITGAM;MMP8;MMP9,Late Myeloid,1.4084893954766124
GO_Biological_Process_2021,cellular response to oxidative stress (GO:0034599),2/125,0.0390617280151273,0.1074291006334313,0,0,6.716463414634147,21.77888563484535,CYBB;MMP9,Late Myeloid,1.408248548277182
GO_Biological_Process_2021,epiboly involved in wound healing (GO:0090505),1/16,0.0392729207344652,0.1074291006334313,0,0,27.122448979591837,87.80133530116419,CEACAM1,Late Myeloid,1.405906798966597
GO_Biological_Process_2021,regulation of Rac protein signal transduction (GO:0035020),1/16,0.0392729207344652,0.1074291006334313,0,0,27.122448979591837,87.80133530116419,KBTBD6,Late Myeloid,1.405906798966597
GO_Biological_Process_2021,negative regulation of epithelial cell differentiation (GO:0030857),1/16,0.0392729207344652,0.1074291006334313,0,0,27.122448979591837,87.80133530116419,MMP9,Late Myeloid,1.405906798966597
GO_Biological_Process_2021,glutamine family amino acid catabolic process (GO:0009065),1/16,0.0392729207344652,0.1074291006334313,0,0,27.122448979591837,87.80133530116419,ARG1,Late Myeloid,1.405906798966597
GO_Biological_Process_2021,negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),1/16,0.0392729207344652,0.1074291006334313,0,0,27.122448979591837,87.80133530116419,CEACAM1,Late Myeloid,1.405906798966597
GO_Biological_Process_2021,negative regulation of platelet activation (GO:0010544),1/16,0.0392729207344652,0.1074291006334313,0,0,27.122448979591837,87.80133530116419,CEACAM1,Late Myeloid,1.405906798966597
GO_Biological_Process_2021,regulation of ERBB signaling pathway (GO:1901184),1/16,0.0392729207344652,0.1074291006334313,0,0,27.122448979591837,87.80133530116419,CEACAM1,Late Myeloid,1.405906798966597
GO_Biological_Process_2021,killing by host of symbiont cells (GO:0051873),1/16,0.0392729207344652,0.1074291006334313,0,0,27.122448979591837,87.80133530116419,CAMP,Late Myeloid,1.405906798966597
GO_Biological_Process_2021,negative regulation of ATPase activity (GO:0032780),1/17,0.0416766547912334,0.1110661367374624,0,0,25.426020408163264,80.79916728086499,LTF,Late Myeloid,1.3801071472903907
GO_Biological_Process_2021,negative regulation of fatty acid metabolic process (GO:0045922),1/17,0.0416766547912334,0.1110661367374624,0,0,25.426020408163264,80.79916728086499,CEACAM1,Late Myeloid,1.3801071472903907
GO_Biological_Process_2021,negative regulation of interleukin-10 production (GO:0032693),1/17,0.0416766547912334,0.1110661367374624,0,0,25.426020408163264,80.79916728086499,MMP8,Late Myeloid,1.3801071472903907
GO_Biological_Process_2021,positive regulation of macrophage activation (GO:0043032),1/17,0.0416766547912334,0.1110661367374624,0,0,25.426020408163264,80.79916728086499,MMP8,Late Myeloid,1.3801071472903907
GO_Biological_Process_2021,regulation of osteoblast proliferation (GO:0033688),1/17,0.0416766547912334,0.1110661367374624,0,0,25.426020408163264,80.79916728086499,LTF,Late Myeloid,1.3801071472903907
GO_Biological_Process_2021,regulation of cell motility (GO:2000145),2/133,0.043691853040543,0.1133657406949508,0,0,6.303753180661578,19.734489511742076,CEACAM1;CCDC125,Late Myeloid,1.3595995357844428
GO_Biological_Process_2021,negative regulation of biosynthetic process (GO:0009890),1/18,0.0440744949316926,0.1133657406949508,0,0,23.92917166866747,74.70385911458476,CEACAM1,Late Myeloid,1.3558126557645607
GO_Biological_Process_2021,negative regulation of cation transmembrane transport (GO:1904063),1/18,0.0440744949316926,0.1133657406949508,0,0,23.92917166866747,74.70385911458476,MMP9,Late Myeloid,1.3558126557645607
GO_Biological_Process_2021,negative regulation of Rho protein signal transduction (GO:0035024),1/18,0.0440744949316926,0.1133657406949508,0,0,23.92917166866747,74.70385911458476,CCDC125,Late Myeloid,1.3558126557645607
GO_Biological_Process_2021,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,0.0440744949316926,0.1133657406949508,0,0,23.92917166866747,74.70385911458476,VNN1,Late Myeloid,1.3558126557645607
GO_Biological_Process_2021,phosphatidylinositol acyl-chain remodeling (GO:0036149),1/18,0.0440744949316926,0.1133657406949508,0,0,23.92917166866747,74.70385911458476,PLBD1,Late Myeloid,1.3558126557645607
GO_Biological_Process_2021,regulation of platelet aggregation (GO:0090330),1/18,0.0440744949316926,0.1133657406949508,0,0,23.92917166866747,74.70385911458476,CEACAM1,Late Myeloid,1.3558126557645607
GO_Biological_Process_2021,pyroptosis (GO:0070269),1/19,0.0464664552952436,0.1166172688720435,0,0,22.598639455782312,69.35578082800635,NLRC4,Late Myeloid,1.3328604565168853
GO_Biological_Process_2021,positive regulation of leukocyte activation (GO:0002696),1/19,0.0464664552952436,0.1166172688720435,0,0,22.598639455782312,69.35578082800635,CLEC4D,Late Myeloid,1.3328604565168853
GO_Biological_Process_2021,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/19,0.0464664552952436,0.1166172688720435,0,0,22.598639455782312,69.35578082800635,VNN1,Late Myeloid,1.3328604565168853
GO_Biological_Process_2021,regulation of epithelial cell differentiation (GO:0030856),1/19,0.0464664552952436,0.1166172688720435,0,0,22.598639455782312,69.35578082800635,CEACAM1,Late Myeloid,1.3328604565168853
GO_Biological_Process_2021,negative regulation of T cell receptor signaling pathway (GO:0050860),1/19,0.0464664552952436,0.1166172688720435,0,0,22.598639455782312,69.35578082800635,CEACAM1,Late Myeloid,1.3328604565168853
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),4/546,0.0471837441916468,0.1169294830588349,0,0,3.1137493983635487,9.50847474832882,S100A12;MMP8;S100A8;LTF,Late Myeloid,1.3262075993289288
GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),2/139,0.0472922793944307,0.1169294830588349,0,0,6.025851581508515,18.3873330672393,CEACAM1;CD177,Late Myeloid,1.3252097533441285
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),2/139,0.0472922793944307,0.1169294830588349,0,0,6.025851581508515,18.3873330672393,S100A12;S100A8,Late Myeloid,1.3252097533441285
GO_Biological_Process_2021,regulation of T cell migration (GO:2000404),1/20,0.0488525499820277,0.1169294830588349,0,0,21.40816326530612,64.63014669364038,CD200R1,Late Myeloid,1.3111127622579986
GO_Biological_Process_2021,regulation of tissue remodeling (GO:0034103),1/20,0.0488525499820277,0.1169294830588349,0,0,21.40816326530612,64.63014669364038,CEACAM1,Late Myeloid,1.3111127622579986
GO_Biological_Process_2021,granulocyte differentiation (GO:0030851),1/20,0.0488525499820277,0.1169294830588349,0,0,21.40816326530612,64.63014669364038,CEBPE,Late Myeloid,1.3111127622579986
GO_Biological_Process_2021,negative regulation of osteoclast differentiation (GO:0045671),1/20,0.0488525499820277,0.1169294830588349,0,0,21.40816326530612,64.63014669364038,LTF,Late Myeloid,1.3111127622579986
GO_Biological_Process_2021,positive regulation of protein processing (GO:0010954),1/20,0.0488525499820277,0.1169294830588349,0,0,21.40816326530612,64.63014669364038,NLRC4,Late Myeloid,1.3111127622579986
GO_Biological_Process_2021,toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.0488525499820277,0.1169294830588349,0,0,21.40816326530612,64.63014669364038,ITGAM,Late Myeloid,1.3111127622579986
GO_Biological_Process_2021,mesoderm development (GO:0007498),1/20,0.0488525499820277,0.1169294830588349,0,0,21.40816326530612,64.63014669364038,BMX,Late Myeloid,1.3111127622579986
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),2/143,0.0497512691479657,0.1185318255737249,0,0,5.8537234042553195,17.565380826397597,TCN1;FLVCR1,Late Myeloid,1.3031958359850326
GO_Biological_Process_2021,purinergic nucleotide receptor signaling pathway (GO:0035590),1/21,0.0512327930672156,0.1193124054763534,0,0,20.336734693877553,60.42807445408675,C3AR1,Late Myeloid,1.2904519669693806
GO_Biological_Process_2021,negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,0.0512327930672156,0.1193124054763534,0,0,20.336734693877553,60.42807445408675,MMP9,Late Myeloid,1.2904519669693806
GO_Biological_Process_2021,cobalamin metabolic process (GO:0009235),1/21,0.0512327930672156,0.1193124054763534,0,0,20.336734693877553,60.42807445408675,TCN1,Late Myeloid,1.2904519669693806
GO_Biological_Process_2021,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),1/21,0.0512327930672156,0.1193124054763534,0,0,20.336734693877553,60.42807445408675,LTF,Late Myeloid,1.2904519669693806
GO_Biological_Process_2021,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),1/21,0.0512327930672156,0.1193124054763534,0,0,20.336734693877553,60.42807445408675,MMP9,Late Myeloid,1.2904519669693806
GO_Biological_Process_2021,negative regulation of lipid biosynthetic process (GO:0051055),1/22,0.0536071985992547,0.122092165972752,0,0,19.367346938775512,56.67024999786951,CEACAM1,Late Myeloid,1.2707768875084013
GO_Biological_Process_2021,heme biosynthetic process (GO:0006783),1/22,0.0536071985992547,0.122092165972752,0,0,19.367346938775512,56.67024999786951,FLVCR1,Late Myeloid,1.2707768875084013
GO_Biological_Process_2021,tetrapyrrole metabolic process (GO:0033013),1/22,0.0536071985992547,0.122092165972752,0,0,19.367346938775512,56.67024999786951,TCN1,Late Myeloid,1.2707768875084013
GO_Biological_Process_2021,microglial cell activation (GO:0001774),1/22,0.0536071985992547,0.122092165972752,0,0,19.367346938775512,56.67024999786951,ITGAM,Late Myeloid,1.2707768875084013
GO_Biological_Process_2021,osteoclast differentiation (GO:0030316),1/22,0.0536071985992547,0.122092165972752,0,0,19.367346938775512,56.67024999786951,OSCAR,Late Myeloid,1.2707768875084013
GO_Biological_Process_2021,regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/23,0.0559757805878795,0.1251495099905649,0,0,18.4860853432282,53.29235549319145,LTF,Late Myeloid,1.2519998414265567
GO_Biological_Process_2021,glucose 6-phosphate metabolic process (GO:0051156),1/23,0.0559757805878795,0.1251495099905649,0,0,18.4860853432282,53.29235549319145,HK3,Late Myeloid,1.2519998414265567
GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity (GO:2000116),1/23,0.0559757805878795,0.1251495099905649,0,0,18.4860853432282,53.29235549319145,LTF,Late Myeloid,1.2519998414265567
GO_Biological_Process_2021,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/23,0.0559757805878795,0.1251495099905649,0,0,18.4860853432282,53.29235549319145,ARG1,Late Myeloid,1.2519998414265567
GO_Biological_Process_2021,glucose catabolic process to pyruvate (GO:0061718),1/24,0.0583385530130099,0.1251495099905649,0,0,17.68145519077196,50.24171555062859,HK3,Late Myeloid,1.2340443470047993
GO_Biological_Process_2021,negative regulation of lipid metabolic process (GO:0045833),1/24,0.0583385530130099,0.1251495099905649,0,0,17.68145519077196,50.24171555062859,CEACAM1,Late Myeloid,1.2340443470047993
GO_Biological_Process_2021,canonical glycolysis (GO:0061621),1/24,0.0583385530130099,0.1251495099905649,0,0,17.68145519077196,50.24171555062859,HK3,Late Myeloid,1.2340443470047993
GO_Biological_Process_2021,immune response-activating cell surface receptor signaling pathway (GO:0002429),1/24,0.0583385530130099,0.1251495099905649,0,0,17.68145519077196,50.24171555062859,C3AR1,Late Myeloid,1.2340443470047993
GO_Biological_Process_2021,positive regulation of neuron apoptotic process (GO:0043525),1/24,0.0583385530130099,0.1251495099905649,0,0,17.68145519077196,50.24171555062859,ITGAM,Late Myeloid,1.2340443470047993
GO_Biological_Process_2021,leukotriene metabolic process (GO:0006691),1/24,0.0583385530130099,0.1251495099905649,0,0,17.68145519077196,50.24171555062859,CYP4F3,Late Myeloid,1.2340443470047993
GO_Biological_Process_2021,positive regulation of protein targeting to membrane (GO:0090314),1/24,0.0583385530130099,0.1251495099905649,0,0,17.68145519077196,50.24171555062859,ITGAM,Late Myeloid,1.2340443470047993
GO_Biological_Process_2021,"wound healing, spreading of cells (GO:0044319)",1/24,0.0583385530130099,0.1251495099905649,0,0,17.68145519077196,50.24171555062859,CEACAM1,Late Myeloid,1.2340443470047993
GO_Biological_Process_2021,phospholipid catabolic process (GO:0009395),1/24,0.0583385530130099,0.1251495099905649,0,0,17.68145519077196,50.24171555062859,PLBD1,Late Myeloid,1.2340443470047993
GO_Biological_Process_2021,porphyrin-containing compound biosynthetic process (GO:0006779),1/24,0.0583385530130099,0.1251495099905649,0,0,17.68145519077196,50.24171555062859,FLVCR1,Late Myeloid,1.2340443470047993
GO_Biological_Process_2021,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/25,0.0606955298241754,0.1265306004802366,0,0,16.943877551020407,47.47480020477031,CEACAM1,Late Myeloid,1.2168432931781568
GO_Biological_Process_2021,positive regulation of ERBB signaling pathway (GO:1901186),1/25,0.0606955298241754,0.1265306004802366,0,0,16.943877551020407,47.47480020477031,MMP9,Late Myeloid,1.2168432931781568
GO_Biological_Process_2021,glycolytic process through glucose-6-phosphate (GO:0061620),1/25,0.0606955298241754,0.1265306004802366,0,0,16.943877551020407,47.47480020477031,HK3,Late Myeloid,1.2168432931781568
GO_Biological_Process_2021,cardiac conduction system development (GO:0003161),1/25,0.0606955298241754,0.1265306004802366,0,0,16.943877551020407,47.47480020477031,GJB6,Late Myeloid,1.2168432931781568
GO_Biological_Process_2021,regulation of cholesterol transport (GO:0032374),1/25,0.0606955298241754,0.1265306004802366,0,0,16.943877551020407,47.47480020477031,ABCA13,Late Myeloid,1.2168432931781568
GO_Biological_Process_2021,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/25,0.0606955298241754,0.1265306004802366,0,0,16.943877551020407,47.47480020477031,MMP9,Late Myeloid,1.2168432931781568
GO_Biological_Process_2021,regulation of protein processing (GO:0070613),1/25,0.0606955298241754,0.1265306004802366,0,0,16.943877551020407,47.47480020477031,NLRC4,Late Myeloid,1.2168432931781568
GO_Biological_Process_2021,negative regulation of cell development (GO:0010721),1/26,0.0630467249540435,0.130380627204962,0,0,16.26530612244898,44.95534064809558,LTF,Late Myeloid,1.2003374685092782
GO_Biological_Process_2021,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/26,0.0630467249540435,0.130380627204962,0,0,16.26530612244898,44.95534064809558,PLBD1,Late Myeloid,1.2003374685092782
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),2/166,0.0647425290365929,0.1310377624722269,0,0,5.0269308943089435,13.760403766207606,CEACAM1;MMP8,Late Myeloid,1.1888103397622347
GO_Biological_Process_2021,acute inflammatory response (GO:0002526),1/27,0.0653921522588676,0.1310377624722269,0,0,15.638932496075354,42.652889831563165,VNN1,Late Myeloid,1.184474368421492
GO_Biological_Process_2021,negative regulation of cation channel activity (GO:2001258),1/27,0.0653921522588676,0.1310377624722269,0,0,15.638932496075354,42.652889831563165,MMP9,Late Myeloid,1.184474368421492
GO_Biological_Process_2021,cellular lipid catabolic process (GO:0044242),1/27,0.0653921522588676,0.1310377624722269,0,0,15.638932496075354,42.652889831563165,PLBD1,Late Myeloid,1.184474368421492
GO_Biological_Process_2021,cellular response to cadmium ion (GO:0071276),1/27,0.0653921522588676,0.1310377624722269,0,0,15.638932496075354,42.652889831563165,MMP9,Late Myeloid,1.184474368421492
GO_Biological_Process_2021,positive regulation of nitric oxide biosynthetic process (GO:0045429),1/27,0.0653921522588676,0.1310377624722269,0,0,15.638932496075354,42.652889831563165,MMP8,Late Myeloid,1.184474368421492
GO_Biological_Process_2021,positive regulation of toll-like receptor signaling pathway (GO:0034123),1/27,0.0653921522588676,0.1310377624722269,0,0,15.638932496075354,42.652889831563165,LTF,Late Myeloid,1.184474368421492
GO_Biological_Process_2021,monocarboxylic acid catabolic process (GO:0072329),1/27,0.0653921522588676,0.1310377624722269,0,0,15.638932496075354,42.652889831563165,CYP4F3,Late Myeloid,1.184474368421492
GO_Biological_Process_2021,regulation of reactive oxygen species biosynthetic process (GO:1903426),1/28,0.0677318256109869,0.1316441873717301,0,0,15.058956916099774,40.54171043527237,MMP8,Late Myeloid,1.1692072184717057
GO_Biological_Process_2021,amide transport (GO:0042886),1/28,0.0677318256109869,0.1316441873717301,0,0,15.058956916099774,40.54171043527237,ABCA13,Late Myeloid,1.1692072184717057
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),1/28,0.0677318256109869,0.1316441873717301,0,0,15.058956916099774,40.54171043527237,C3AR1,Late Myeloid,1.1692072184717057
GO_Biological_Process_2021,bile acid and bile salt transport (GO:0015721),1/28,0.0677318256109869,0.1316441873717301,0,0,15.058956916099774,40.54171043527237,CEACAM1,Late Myeloid,1.1692072184717057
GO_Biological_Process_2021,negative regulation of oxidative stress-induced cell death (GO:1903202),1/28,0.0677318256109869,0.1316441873717301,0,0,15.058956916099774,40.54171043527237,VNN1,Late Myeloid,1.1692072184717057
GO_Biological_Process_2021,positive regulation of nitric oxide metabolic process (GO:1904407),1/28,0.0677318256109869,0.1316441873717301,0,0,15.058956916099774,40.54171043527237,MMP8,Late Myeloid,1.1692072184717057
GO_Biological_Process_2021,leukocyte cell-cell adhesion (GO:0007159),1/28,0.0677318256109869,0.1316441873717301,0,0,15.058956916099774,40.54171043527237,CD177,Late Myeloid,1.1692072184717057
GO_Biological_Process_2021,protein localization to cell surface (GO:0034394),1/28,0.0677318256109869,0.1316441873717301,0,0,15.058956916099774,40.54171043527237,CD177,Late Myeloid,1.1692072184717057
GO_Biological_Process_2021,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),2/171,0.0681810821272572,0.1320210466658876,0,0,4.876972386587771,13.097539204308813,S100A12;LTF,Late Myeloid,1.166336110203534
GO_Biological_Process_2021,regulation of protein targeting to membrane (GO:0090313),1/29,0.0700657588372089,0.1322043697767774,0,0,14.520408163265309,38.5999069065122,ITGAM,Late Myeloid,1.1544941700666143
GO_Biological_Process_2021,regulation of T cell mediated cytotoxicity (GO:0001914),1/29,0.0700657588372089,0.1322043697767774,0,0,14.520408163265309,38.5999069065122,CEACAM1,Late Myeloid,1.1544941700666143
GO_Biological_Process_2021,glycolytic process (GO:0006096),1/29,0.0700657588372089,0.1322043697767774,0,0,14.520408163265309,38.5999069065122,HK3,Late Myeloid,1.1544941700666143
GO_Biological_Process_2021,response to cadmium ion (GO:0046686),1/29,0.0700657588372089,0.1322043697767774,0,0,14.520408163265309,38.5999069065122,MMP9,Late Myeloid,1.1544941700666143
GO_Biological_Process_2021,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.0700657588372089,0.1322043697767774,0,0,14.520408163265309,38.5999069065122,CEACAM1,Late Myeloid,1.1544941700666143
GO_Biological_Process_2021,regulation of fatty acid biosynthetic process (GO:0042304),1/29,0.0700657588372089,0.1322043697767774,0,0,14.520408163265309,38.5999069065122,CEACAM1,Late Myeloid,1.1544941700666143
GO_Biological_Process_2021,lipid catabolic process (GO:0016042),1/29,0.0700657588372089,0.1322043697767774,0,0,14.520408163265309,38.5999069065122,CYP4F3,Late Myeloid,1.1544941700666143
GO_Biological_Process_2021,negative regulation of interleukin-1 production (GO:0032692),1/30,0.0723939657090184,0.1336702866841518,0,0,14.019000703729768,36.80874147674154,CEACAM1,Late Myeloid,1.1402976322627019
GO_Biological_Process_2021,heterotypic cell-cell adhesion (GO:0034113),1/30,0.0723939657090184,0.1336702866841518,0,0,14.019000703729768,36.80874147674154,CD200R1,Late Myeloid,1.1402976322627019
GO_Biological_Process_2021,maintenance of blood-brain barrier (GO:0035633),1/30,0.0723939657090184,0.1336702866841518,0,0,14.019000703729768,36.80874147674154,GJB6,Late Myeloid,1.1402976322627019
GO_Biological_Process_2021,regulation of macrophage activation (GO:0043030),1/30,0.0723939657090184,0.1336702866841518,0,0,14.019000703729768,36.80874147674154,MMP8,Late Myeloid,1.1402976322627019
GO_Biological_Process_2021,phosphatidylcholine acyl-chain remodeling (GO:0036151),1/30,0.0723939657090184,0.1336702866841518,0,0,14.019000703729768,36.80874147674154,PLBD1,Late Myeloid,1.1402976322627019
GO_Biological_Process_2021,plasma membrane invagination (GO:0099024),1/30,0.0723939657090184,0.1336702866841518,0,0,14.019000703729768,36.80874147674154,ITGAM,Late Myeloid,1.1402976322627019
GO_Biological_Process_2021,regulation of immune response (GO:0050776),2/179,0.0738061123878065,0.1357927405853949,0,0,4.654661016949152,12.131506903576025,CD200R1;OSCAR,Late Myeloid,1.1319076697979504
GO_Biological_Process_2021,aminoglycan catabolic process (GO:0006026),1/31,0.0747164600026276,0.1360155275399946,0,0,13.551020408163266,35.15209038871121,CHIT1,Late Myeloid,1.126583712764908
GO_Biological_Process_2021,negative regulation of response to biotic stimulus (GO:0002832),1/31,0.0747164600026276,0.1360155275399946,0,0,13.551020408163266,35.15209038871121,LTF,Late Myeloid,1.126583712764908
GO_Biological_Process_2021,vitamin transport (GO:0051180),1/31,0.0747164600026276,0.1360155275399946,0,0,13.551020408163266,35.15209038871121,TCN1,Late Myeloid,1.126583712764908
GO_Biological_Process_2021,superoxide metabolic process (GO:0006801),1/32,0.0770332554327668,0.1397410282762823,0,0,13.113232389730086,33.61600807740255,CYBB,Late Myeloid,1.1133217484244988
GO_Biological_Process_2021,regulation of sprouting angiogenesis (GO:1903670),1/33,0.0793443657059371,0.1429304427525069,0,0,12.70280612244898,32.18837516559274,CEACAM1,Late Myeloid,1.1004839073426347
GO_Biological_Process_2021,positive regulation of cholesterol transport (GO:0032376),1/33,0.0793443657059371,0.1429304427525069,0,0,12.70280612244898,32.18837516559274,ABCA13,Late Myeloid,1.1004839073426347
GO_Biological_Process_2021,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),1/34,0.0816498044624026,0.1460655671524641,0,0,12.317254174397032,30.85861216573232,MMP9,Late Myeloid,1.0880448509885652
GO_Biological_Process_2021,B cell receptor signaling pathway (GO:0050853),1/34,0.0816498044624026,0.1460655671524641,0,0,12.317254174397032,30.85861216573232,BMX,Late Myeloid,1.0880448509885652
GO_Biological_Process_2021,regulation of T cell receptor signaling pathway (GO:0050856),1/35,0.0839495853612937,0.1481294731460371,0,0,11.95438175270108,29.61744503578088,CEACAM1,Late Myeloid,1.0759814445616303
GO_Biological_Process_2021,negative regulation of Ras protein signal transduction (GO:0046580),1/35,0.0839495853612937,0.1481294731460371,0,0,11.95438175270108,29.61744503578088,CCDC125,Late Myeloid,1.0759814445616303
GO_Biological_Process_2021,negative regulation of T cell proliferation (GO:0042130),1/35,0.0839495853612937,0.1481294731460371,0,0,11.95438175270108,29.61744503578088,ARG1,Late Myeloid,1.0759814445616303
GO_Biological_Process_2021,regulation of lipid biosynthetic process (GO:0046890),1/35,0.0839495853612937,0.1481294731460371,0,0,11.95438175270108,29.61744503578088,CEACAM1,Late Myeloid,1.0759814445616303
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),2/194,0.0847375162198589,0.1490112104954662,0,0,4.287760416666667,10.58303673172677,NLRC4;OLFM4,Late Myeloid,1.0719242699529004
GO_Biological_Process_2021,positive regulation of bone mineralization (GO:0030501),1/36,0.0862437219743075,0.1491237600692877,0,0,11.612244897959185,28.456712045041098,LTF,Late Myeloid,1.0642725091375862
GO_Biological_Process_2021,retina homeostasis (GO:0001895),1/36,0.0862437219743075,0.1491237600692877,0,0,11.612244897959185,28.456712045041098,LTF,Late Myeloid,1.0642725091375862
GO_Biological_Process_2021,macrophage activation (GO:0042116),1/36,0.0862437219743075,0.1491237600692877,0,0,11.612244897959185,28.456712045041098,ITGAM,Late Myeloid,1.0642725091375862
GO_Biological_Process_2021,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/36,0.0862437219743075,0.1491237600692877,0,0,11.612244897959185,28.456712045041098,OLFM4,Late Myeloid,1.0642725091375862
GO_Biological_Process_2021,transition metal ion transport (GO:0000041),1/36,0.0862437219743075,0.1491237600692877,0,0,11.612244897959185,28.456712045041098,LTF,Late Myeloid,1.0642725091375862
GO_Biological_Process_2021,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),1/37,0.0885322278902676,0.1520636605291308,0,0,11.289115646258503,27.36920368672352,MMP9,Late Myeloid,1.0528986067362665
GO_Biological_Process_2021,"phagocytosis, engulfment (GO:0006911)",1/37,0.0885322278902676,0.1520636605291308,0,0,11.289115646258503,27.36920368672352,ITGAM,Late Myeloid,1.0528986067362665
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),2/203,0.0915200219539462,0.1566750044708285,0,0,4.093905472636816,9.789336578359592,CEACAM1;ANXA3,Late Myeloid,1.0384838843718929
GO_Biological_Process_2021,negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.0930924017046572,0.1583183278990388,0,0,10.693877551020408,25.38900533231373,ARG1,Late Myeloid,1.0310857651239858
GO_Biological_Process_2021,response to peptide (GO:1901652),1/39,0.0930924017046572,0.1583183278990388,0,0,10.693877551020408,25.38900533231373,MMP9,Late Myeloid,1.0310857651239858
GO_Biological_Process_2021,bone development (GO:0060348),1/40,0.0953640965755271,0.1595574043027428,0,0,10.419152276295131,24.485561288951835,LTF,Late Myeloid,1.0206151011238414
GO_Biological_Process_2021,carboxylic acid metabolic process (GO:0019752),1/40,0.0953640965755271,0.1595574043027428,0,0,10.419152276295131,24.485561288951835,CYP4F3,Late Myeloid,1.0206151011238414
GO_Biological_Process_2021,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/40,0.0953640965755271,0.1595574043027428,0,0,10.419152276295131,24.485561288951835,S100A8,Late Myeloid,1.0206151011238414
GO_Biological_Process_2021,organic hydroxy compound transport (GO:0015850),1/40,0.0953640965755271,0.1595574043027428,0,0,10.419152276295131,24.485561288951835,CEACAM1,Late Myeloid,1.0206151011238414
GO_Biological_Process_2021,regulation of nitric oxide biosynthetic process (GO:0045428),1/40,0.0953640965755271,0.1595574043027428,0,0,10.419152276295131,24.485561288951835,MMP8,Late Myeloid,1.0206151011238414
GO_Biological_Process_2021,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.0976302146847681,0.161778272410337,0,0,10.158163265306122,23.633660200289185,MMP9,Late Myeloid,1.0104157556925017
GO_Biological_Process_2021,carbohydrate catabolic process (GO:0016052),1/41,0.0976302146847681,0.161778272410337,0,0,10.158163265306122,23.633660200289185,HK3,Late Myeloid,1.0104157556925017
GO_Biological_Process_2021,visual system development (GO:0150063),1/41,0.0976302146847681,0.161778272410337,0,0,10.158163265306122,23.633660200289185,ITGAM,Late Myeloid,1.0104157556925017
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),2/212,0.0984576089228105,0.1626280633006168,0,0,3.9166666666666665,9.079339326341122,HK3;PLBD1,Late Myeloid,1.0067507154273545
GO_Biological_Process_2021,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.0998907694703361,0.1634288854941891,0,0,9.909905425584869,22.829231064333683,CEACAM8,Late Myeloid,1.00047464143678
GO_Biological_Process_2021,skeletal system morphogenesis (GO:0048705),1/42,0.0998907694703361,0.1634288854941891,0,0,9.909905425584869,22.829231064333683,LTF,Late Myeloid,1.00047464143678
GO_Biological_Process_2021,monocyte chemotaxis (GO:0002548),1/42,0.0998907694703361,0.1634288854941891,0,0,9.909905425584869,22.829231064333683,S100A12,Late Myeloid,1.00047464143678
GO_Biological_Process_2021,regulation of cell-cell adhesion (GO:0022407),1/43,0.1021457742794159,0.1648846046851742,0,0,9.673469387755102,22.068611238785657,CEACAM1,Late Myeloid,0.9907795952096249
GO_Biological_Process_2021,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/43,0.1021457742794159,0.1648846046851742,0,0,9.673469387755102,22.068611238785657,ITGAM,Late Myeloid,0.9907795952096249
GO_Biological_Process_2021,cellular glucose homeostasis (GO:0001678),1/43,0.1021457742794159,0.1648846046851742,0,0,9.673469387755102,22.068611238785657,HK3,Late Myeloid,0.9907795952096249
GO_Biological_Process_2021,positive regulation of T cell differentiation (GO:0045582),1/43,0.1021457742794159,0.1648846046851742,0,0,9.673469387755102,22.068611238785657,VNN1,Late Myeloid,0.9907795952096249
GO_Biological_Process_2021,regulation of cell growth (GO:0001558),2/217,0.1023751607426323,0.1648846046851742,0,0,3.824612403100775,8.716716836108898,CEACAM1;S100A8,Late Myeloid,0.9898054033308324
GO_Biological_Process_2021,positive regulation of biosynthetic process (GO:0009891),1/44,0.1043952424647777,0.1665812973897842,0,0,9.448030374940672,21.34849709415977,MMP8,Late Myeloid,0.9813192926974915
GO_Biological_Process_2021,response to amyloid-beta (GO:1904645),1/44,0.1043952424647777,0.1665812973897842,0,0,9.448030374940672,21.34849709415977,MMP9,Late Myeloid,0.9813192926974915
GO_Biological_Process_2021,positive regulation of osteoblast differentiation (GO:0045669),1/44,0.1043952424647777,0.1665812973897842,0,0,9.448030374940672,21.34849709415977,LTF,Late Myeloid,0.9813192926974915
GO_Biological_Process_2021,zymogen activation (GO:0031638),1/45,0.1066391873529346,0.1696383380352837,0,0,9.232838589981448,20.665901611884028,NLRC4,Late Myeloid,0.9720831731354668
GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),2/224,0.1079318309204139,0.1710934063277488,0,0,3.702702702702702,8.2431620580209,S100A12;LTF,Late Myeloid,0.9668504556467957
GO_Biological_Process_2021,erythrocyte differentiation (GO:0030218),1/46,0.1088776222085674,0.1710934063277488,0,0,9.02721088435374,20.01811780873028,FLVCR1,Late Myeloid,0.9630613723103648
GO_Biological_Process_2021,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.1088776222085674,0.1710934063277488,0,0,9.02721088435374,20.01811780873028,ORM1,Late Myeloid,0.9630613723103648
GO_Biological_Process_2021,positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.1088776222085674,0.1710934063277488,0,0,9.02721088435374,20.01811780873028,MMP9,Late Myeloid,0.9630613723103648
GO_Biological_Process_2021,positive regulation of neuron death (GO:1901216),1/47,0.1111105603036554,0.1740732111423936,0,0,8.830523513753327,19.4026870705364,ITGAM,Late Myeloid,0.9542446623584087
GO_Biological_Process_2021,positive regulation of endocytosis (GO:0045807),1/48,0.1133380148369131,0.1764932339478436,0,0,8.642205818497612,18.81737166641443,ABCA13,Late Myeloid,0.9456243984787533
GO_Biological_Process_2021,regulation of interleukin-10 production (GO:0032653),1/48,0.1133380148369131,0.1764932339478436,0,0,8.642205818497612,18.81737166641443,MMP8,Late Myeloid,0.9456243984787533
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),4/742,0.1138085215723413,0.1766937106693708,0,0,2.2636974195828916,4.919552976765135,NLRC4;OLFM4;MMP9;LTF,Late Myeloid,0.943825218316277
GO_Biological_Process_2021,receptor internalization (GO:0031623),1/49,0.1155599990222406,0.1788758068697557,0,0,8.46173469387755,18.260130793597916,CEACAM1,Late Myeloid,0.9371924705024297
GO_Biological_Process_2021,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/50,0.1177765260040411,0.1806838692702945,0,0,8.28862973760933,17.7290996615035,OLFM4,Late Myeloid,0.928941259997044
GO_Biological_Process_2021,regulation of complement activation (GO:0030449),1/50,0.1177765260040411,0.1806838692702945,0,0,8.28862973760933,17.7290996615035,C3AR1,Late Myeloid,0.928941259997044
GO_Biological_Process_2021,iron ion transport (GO:0006826),1/50,0.1177765260040411,0.1806838692702945,0,0,8.28862973760933,17.7290996615035,LTF,Late Myeloid,0.928941259997044
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),3/482,0.1192389583091006,0.1819166973980085,0,0,2.5946342113445566,5.517815916066961,ITGAM;LCN2;MMP9,Late Myeloid,0.92358182668994
GO_Biological_Process_2021,regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.1199876089220907,0.1819166973980085,0,0,8.122448979591837,17.22257115519733,OLFM4,Late Myeloid,0.9208636010741894
GO_Biological_Process_2021,blood circulation (GO:0008015),1/51,0.1199876089220907,0.1819166973980085,0,0,8.122448979591837,17.22257115519733,C3AR1,Late Myeloid,0.9208636010741894
GO_Biological_Process_2021,regulation of epithelial cell migration (GO:0010632),1/51,0.1199876089220907,0.1819166973980085,0,0,8.122448979591837,17.22257115519733,CEACAM1,Late Myeloid,0.9208636010741894
GO_Biological_Process_2021,negative regulation of cellular biosynthetic process (GO:0031327),1/52,0.1221932608707862,0.1841805127410976,0,0,7.962785114045619,16.738979733033663,CEACAM1,Late Myeloid,0.9129527453809976
GO_Biological_Process_2021,amide biosynthetic process (GO:0043604),1/52,0.1221932608707862,0.1841805127410976,0,0,7.962785114045619,16.738979733033663,ARG1,Late Myeloid,0.9129527453809976
GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.1243934949128716,0.1853355529393505,0,0,7.809262166405024,16.276887238960814,LTF,Late Myeloid,0.9052023302345248
GO_Biological_Process_2021,cardiac muscle tissue development (GO:0048738),1/53,0.1243934949128716,0.1853355529393505,0,0,7.809262166405024,16.276887238960814,GJB6,Late Myeloid,0.9052023302345248
GO_Biological_Process_2021,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.1243934949128716,0.1853355529393505,0,0,7.809262166405024,16.276887238960814,MMP8,Late Myeloid,0.9052023302345248
GO_Biological_Process_2021,regulation of immune effector process (GO:0002697),1/53,0.1243934949128716,0.1853355529393505,0,0,7.809262166405024,16.276887238960814,C3AR1,Late Myeloid,0.9052023302345248
GO_Biological_Process_2021,regulation of humoral immune response (GO:0002920),1/54,0.1265883240687765,0.1869890386958784,0,0,7.661532537543319,15.834970375184442,C3AR1,Late Myeloid,0.8976063498190403
GO_Biological_Process_2021,negative regulation of viral genome replication (GO:0045071),1/54,0.1265883240687765,0.1869890386958784,0,0,7.661532537543319,15.834970375184442,LTF,Late Myeloid,0.8976063498190403
GO_Biological_Process_2021,unsaturated fatty acid metabolic process (GO:0033559),1/54,0.1265883240687765,0.1869890386958784,0,0,7.661532537543319,15.834970375184442,CYP4F3,Late Myeloid,0.8976063498190403
GO_Biological_Process_2021,pyruvate metabolic process (GO:0006090),1/55,0.1287777613922166,0.1886065230588555,0,0,7.519274376417234,15.412009607623004,HK3,Late Myeloid,0.8901591287349465
GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/55,0.1287777613922166,0.1886065230588555,0,0,7.519274376417234,15.412009607623004,MMP9,Late Myeloid,0.8901591287349465
GO_Biological_Process_2021,negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/55,0.1287777613922166,0.1886065230588555,0,0,7.519274376417234,15.412009607623004,ARG1,Late Myeloid,0.8901591287349465
GO_Biological_Process_2021,mitochondrial transport (GO:0006839),1/56,0.1309618198144747,0.1912634487121,0,0,7.382189239332097,15.00687933540933,FLVCR1,Late Myeloid,0.8828552987007785
GO_Biological_Process_2021,arachidonic acid metabolic process (GO:0019369),1/57,0.1331405122852093,0.1917371722881705,0,0,7.25,14.618539131965724,CYP4F3,Late Myeloid,0.8756897763447542
GO_Biological_Process_2021,icosanoid metabolic process (GO:0006690),1/57,0.1331405122852093,0.1917371722881705,0,0,7.25,14.618539131965724,CYP4F3,Late Myeloid,0.8756897763447542
GO_Biological_Process_2021,positive regulation of proteolysis (GO:0045862),1/57,0.1331405122852093,0.1917371722881705,0,0,7.25,14.618539131965724,NLRC4,Late Myeloid,0.8756897763447542
GO_Biological_Process_2021,monocarboxylic acid transport (GO:0015718),1/57,0.1331405122852093,0.1917371722881705,0,0,7.25,14.618539131965724,CEACAM1,Late Myeloid,0.8756897763447542
GO_Biological_Process_2021,protein K48-linked ubiquitination (GO:0070936),1/57,0.1331405122852093,0.1917371722881705,0,0,7.25,14.618539131965724,KBTBD6,Late Myeloid,0.8756897763447542
GO_Biological_Process_2021,positive regulation of mitochondrion organization (GO:0010822),1/58,0.1353138517398134,0.1927197282354919,0,0,7.122448979591836,14.246025949065045,MMP9,Late Myeloid,0.8686577434892403
GO_Biological_Process_2021,positive regulation of protein binding (GO:0032092),1/58,0.1353138517398134,0.1927197282354919,0,0,7.122448979591836,14.246025949065045,MMP9,Late Myeloid,0.8686577434892403
GO_Biological_Process_2021,nucleosome assembly (GO:0006334),1/58,0.1353138517398134,0.1927197282354919,0,0,7.122448979591836,14.246025949065045,PADI4,Late Myeloid,0.8686577434892403
GO_Biological_Process_2021,regulation of phagocytosis (GO:0050764),1/58,0.1353138517398134,0.1927197282354919,0,0,7.122448979591836,14.246025949065045,OLFM4,Late Myeloid,0.8686577434892403
GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),2/258,0.1359834100026853,0.1931412718994184,0,0,3.2054036458333335,6.395493110208526,CEACAM1;LTF,Late Myeloid,0.8665140723928182
GO_Biological_Process_2021,positive regulation of apoptotic signaling pathway (GO:2001235),1/59,0.1374818510452552,0.194202505438243,0,0,6.9992962702322306,13.8884471557023,S100A8,Late Myeloid,0.8617546291873563
GO_Biological_Process_2021,response to reactive oxygen species (GO:0000302),1/59,0.1374818510452552,0.194202505438243,0,0,6.9992962702322306,13.8884471557023,MMP9,Late Myeloid,0.8617546291873563
GO_Biological_Process_2021,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/60,0.1396445230534406,0.1967199411951738,0,0,6.88031822898651,13.544974303558986,CEACAM1,Late Myeloid,0.8549760929333525
GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.1986763476055426,0,0,6.76530612244898,13.214837540593155,CD177,Late Myeloid,0.848318009451734
GO_Biological_Process_2021,pattern recognition receptor signaling pathway (GO:0002221),1/61,0.1418018805927374,0.1986763476055426,0,0,6.76530612244898,13.214837540593155,S100A8,Late Myeloid,0.848318009451734
GO_Biological_Process_2021,positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/62,0.1439539364695556,0.2006042726543404,0,0,6.654064904650385,12.897320592663672,NLRC4,Late Myeloid,0.8417764546925935
GO_Biological_Process_2021,negative regulation of kinase activity (GO:0033673),1/62,0.1439539364695556,0.2006042726543404,0,0,6.654064904650385,12.897320592663672,CEACAM1,Late Myeloid,0.8417764546925935
GO_Biological_Process_2021,amyloid fibril formation (GO:1990000),1/63,0.1461007034145454,0.201962737073048,0,0,6.54641211323239,12.591756250239603,LTF,Late Myeloid,0.8353476931121088
GO_Biological_Process_2021,negative regulation of endopeptidase activity (GO:0010951),1/63,0.1461007034145454,0.201962737073048,0,0,6.54641211323239,12.591756250239603,LTF,Late Myeloid,0.8353476931121088
GO_Biological_Process_2021,cellular response to reactive oxygen species (GO:0034614),1/63,0.1461007034145454,0.201962737073048,0,0,6.54641211323239,12.591756250239603,MMP9,Late Myeloid,0.8353476931121088
GO_Biological_Process_2021,protein catabolic process (GO:0030163),1/64,0.1482421941802595,0.2043765717098512,0,0,6.442176870748299,12.297522293260638,CEACAM1,Late Myeloid,0.8290281655096747
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),2/274,0.1497038344955427,0.2058427724313712,0,0,3.014399509803922,5.724635176902424,S100A12;MMP8,Late Myeloid,0.8247670755492156
GO_Biological_Process_2021,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.2085908961730132,0,0,6.243328100470958,11.740759916332207,ITGAM,Late Myeloid,0.8167033932798328
GO_Biological_Process_2021,cell-cell junction assembly (GO:0007043),1/66,0.1525093979756266,0.2085908961730132,0,0,6.243328100470958,11.740759916332207,GJB6,Late Myeloid,0.8167033932798328
GO_Biological_Process_2021,regulation of viral genome replication (GO:0045069),1/67,0.1546351363099914,0.2103851722954357,0,0,6.148423005565863,11.477180657220888,LTF,Late Myeloid,0.8106918184915987
GO_Biological_Process_2021,vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/67,0.1546351363099914,0.2103851722954357,0,0,6.148423005565863,11.477180657220888,CYBB,Late Myeloid,0.8106918184915987
GO_Biological_Process_2021,positive regulation of MAP kinase activity (GO:0043406),1/69,0.158870948881139,0.2150164412867772,0,0,5.966986794717887,10.977245117600177,S100A12,Late Myeloid,0.7989555105590889
GO_Biological_Process_2021,peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.158870948881139,0.2150164412867772,0,0,5.966986794717887,10.977245117600177,BMX,Late Myeloid,0.7989555105590889
GO_Biological_Process_2021,positive regulation of cell-substrate adhesion (GO:0010811),1/70,0.1609810482853106,0.2162712302053994,0,0,5.880212954747116,10.740024519792764,OLFM4,Late Myeloid,0.7932252488723367
GO_Biological_Process_2021,negative regulation of viral process (GO:0048525),1/70,0.1609810482853106,0.2162712302053994,0,0,5.880212954747116,10.740024519792764,LTF,Late Myeloid,0.7932252488723367
GO_Biological_Process_2021,proteolysis (GO:0006508),2/287,0.1610530437699783,0.2162712302053994,0,0,2.875,5.249811823566885,MMP8;MMP9,Late Myeloid,0.7930310629584509
GO_Biological_Process_2021,negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.1651856959101235,0.2211864428048068,0,0,5.713998275366484,10.28911103101624,CEACAM1,Late Myeloid,0.78202756268309
GO_Biological_Process_2021,regulation of Rho protein signal transduction (GO:0035023),1/73,0.1672802691231711,0.2211864428048068,0,0,5.634353741496598,10.074701240888364,CCDC125,Late Myeloid,0.7765552814899175
GO_Biological_Process_2021,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",1/73,0.1672802691231711,0.2211864428048068,0,0,5.634353741496598,10.074701240888364,CYBB,Late Myeloid,0.7765552814899175
GO_Biological_Process_2021,response to molecule of bacterial origin (GO:0002237),1/73,0.1672802691231711,0.2211864428048068,0,0,5.634353741496598,10.074701240888364,S100A8,Late Myeloid,0.7765552814899175
GO_Biological_Process_2021,positive regulation of JNK cascade (GO:0046330),1/73,0.1672802691231711,0.2211864428048068,0,0,5.634353741496598,10.074701240888364,MMP8,Late Myeloid,0.7765552814899175
GO_Biological_Process_2021,chromatin assembly (GO:0031497),1/73,0.1672802691231711,0.2211864428048068,0,0,5.634353741496598,10.074701240888364,PADI4,Late Myeloid,0.7765552814899175
GO_Biological_Process_2021,integrin-mediated signaling pathway (GO:0007229),1/75,0.1714539764404576,0.2261268005605015,0,0,5.4815223386651954,9.666337985731484,CEACAM1,Late Myeloid,0.7658524380723842
GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),1/76,0.1735331353639065,0.2265571489473224,0,0,5.408163265306122,9.4717853003048,ARG1,Late Myeloid,0.7606175863963804
GO_Biological_Process_2021,positive regulation of growth (GO:0045927),1/76,0.1735331353639065,0.2265571489473224,0,0,5.408163265306122,9.4717853003048,S100A8,Late Myeloid,0.7606175863963804
GO_Biological_Process_2021,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.2265571489473224,0,0,5.408163265306122,9.4717853003048,MMP8,Late Myeloid,0.7606175863963804
GO_Biological_Process_2021,phospholipid metabolic process (GO:0006644),1/76,0.1735331353639065,0.2265571489473224,0,0,5.408163265306122,9.4717853003048,PLBD1,Late Myeloid,0.7606175863963804
GO_Biological_Process_2021,cellular response to UV (GO:0034644),1/77,0.1756071809118701,0.2281128455563739,0,0,5.336734693877551,9.283280446293812,MMP9,Late Myeloid,0.7554577289388229
GO_Biological_Process_2021,phosphatidylcholine metabolic process (GO:0046470),1/77,0.1756071809118701,0.2281128455563739,0,0,5.336734693877551,9.283280446293812,PLBD1,Late Myeloid,0.7554577289388229
GO_Biological_Process_2021,negative regulation of apoptotic signaling pathway (GO:2001234),1/78,0.1776761254379788,0.2290737078589403,0,0,5.267161410018553,9.10056411919043,MMP9,Late Myeloid,0.7503709249641564
GO_Biological_Process_2021,protein modification process (GO:0036211),1/78,0.1776761254379788,0.2290737078589403,0,0,5.267161410018553,9.10056411919043,PADI4,Late Myeloid,0.7503709249641564
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),1/78,0.1776761254379788,0.2290737078589403,0,0,5.267161410018553,9.10056411919043,CYBB,Late Myeloid,0.7503709249641564
GO_Biological_Process_2021,regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.181798760490535,0.2332257051454258,0,0,5.133298889175924,8.751529842637671,MMP8,Late Myeloid,0.7404090821369118
GO_Biological_Process_2021,regulation of organelle organization (GO:0033043),1/80,0.181798760490535,0.2332257051454258,0,0,5.133298889175924,8.751529842637671,S100A8,Late Myeloid,0.7404090821369118
GO_Biological_Process_2021,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.1838524754991919,0.2352765589927778,0,0,5.0688775510204085,8.584760541358477,C3AR1,Late Myeloid,0.7355305181562768
GO_Biological_Process_2021,cell-cell junction organization (GO:0045216),1/82,0.1859011384602527,0.2367263265614548,0,0,5.00604686318972,8.422875391899517,CD177,Late Myeloid,0.7307179505966239
GO_Biological_Process_2021,ephrin receptor signaling pathway (GO:0048013),1/82,0.1859011384602527,0.2367263265614548,0,0,5.00604686318972,8.422875391899517,MMP9,Late Myeloid,0.7307179505966239
GO_Biological_Process_2021,long-chain fatty acid metabolic process (GO:0001676),1/83,0.1879447615357932,0.2381554943970713,0,0,4.944748631159781,8.265677319811374,CYP4F3,Late Myeloid,0.7259697745939766
GO_Biological_Process_2021,regulation of osteoblast differentiation (GO:0045667),1/83,0.1879447615357932,0.2381554943970713,0,0,4.944748631159781,8.265677319811374,LTF,Late Myeloid,0.7259697745939766
GO_Biological_Process_2021,response to insulin (GO:0032868),1/84,0.1899833569114356,0.2401501113036973,0,0,4.884927464961889,8.112979399077096,CEACAM1,Late Myeloid,0.7212844428267129
GO_Biological_Process_2021,regulation of Ras protein signal transduction (GO:0046578),1/86,0.1940455128548384,0.2434988595775521,0,0,4.769507803121249,7.820383303288144,KBTBD6,Late Myeloid,0.7120963955156414
GO_Biological_Process_2021,glucose homeostasis (GO:0042593),1/86,0.1940455128548384,0.2434988595775521,0,0,4.769507803121249,7.820383303288144,HK3,Late Myeloid,0.7120963955156414
GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),1/86,0.1940455128548384,0.2434988595775521,0,0,4.769507803121249,7.820383303288144,ANXA3,Late Myeloid,0.7120963955156414
GO_Biological_Process_2021,regulation of cation channel activity (GO:2001257),1/89,0.2001013407742902,0.2504900561266539,0,0,4.6062152133580705,7.411084001248333,MMP9,Late Myeloid,0.6987500013741589
GO_Biological_Process_2021,cellular amino acid catabolic process (GO:0009063),1/90,0.2021100231923967,0.2511800047847815,0,0,4.55423068103646,7.281955543769811,ARG1,Late Myeloid,0.6944121480917811
GO_Biological_Process_2021,negative regulation of protein kinase activity (GO:0006469),1/90,0.2021100231923967,0.2511800047847815,0,0,4.55423068103646,7.281955543769811,CEACAM1,Late Myeloid,0.6944121480917811
GO_Biological_Process_2021,protein complex oligomerization (GO:0051259),1/90,0.2021100231923967,0.2511800047847815,0,0,4.55423068103646,7.281955543769811,NLRC4,Late Myeloid,0.6944121480917811
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),2/335,0.2041536136242794,0.2531113147332194,0,0,2.4545795795795797,3.9000386874614623,ORM1;MMP8,Late Myeloid,0.6900429284365769
GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),1/94,0.2100954368002021,0.2586174781564392,0,0,4.357472021066491,6.79849904676328,CD200R1,Late Myeloid,0.6775833802166729
GO_Biological_Process_2021,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2586174781564392,0,0,4.357472021066491,6.79849904676328,CEBPE,Late Myeloid,0.6775833802166729
GO_Biological_Process_2021,nucleosome organization (GO:0034728),1/94,0.2100954368002021,0.2586174781564392,0,0,4.357472021066491,6.79849904676328,PADI4,Late Myeloid,0.6775833802166729
GO_Biological_Process_2021,positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.2160330472811356,0.2646660792520073,0,0,4.220663265306122,6.46742313757927,LCN2,Late Myeloid,0.6654798083211632
GO_Biological_Process_2021,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2646660792520073,0,0,4.220663265306122,6.46742313757927,S100A12,Late Myeloid,0.6654798083211632
GO_Biological_Process_2021,negative regulation of neuron death (GO:1901215),1/98,0.2180025137484037,0.2664475168036045,0,0,4.176940879444562,6.362519703204576,CD200R1,Late Myeloid,0.6615384985937142
GO_Biological_Process_2021,positive regulation of stress-activated MAPK cascade (GO:0032874),1/99,0.2199671313012003,0.2675835456064013,0,0,4.134110787172012,6.26018948804807,MMP8,Late Myeloid,0.6576422090003602
GO_Biological_Process_2021,organic anion transport (GO:0015711),1/99,0.2199671313012003,0.2675835456064013,0,0,4.134110787172012,6.26018948804807,SLCO4C1,Late Myeloid,0.6576422090003602
GO_Biological_Process_2021,organic acid transport (GO:0015849),1/100,0.2219269115603851,0.2693338339829087,0,0,4.092145949288806,6.1603458876211565,CEACAM1,Late Myeloid,0.6537900306498672
GO_Biological_Process_2021,cellular response to chemical stress (GO:0062197),1/101,0.2238818662412048,0.2704367402960348,0,0,4.051020408163265,6.062906014187368,CYBB,Late Myeloid,0.6499810815451941
GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),1/101,0.2238818662412048,0.2704367402960348,0,0,4.051020408163265,6.062906014187368,ITGAM,Late Myeloid,0.6499810815451941
GO_Biological_Process_2021,positive regulation of cell growth (GO:0030307),1/102,0.2258320069783284,0.2708936139392013,0,0,4.010709234188725,5.967790506031058,S100A8,Late Myeloid,0.6462145058611213
GO_Biological_Process_2021,regulation of cell death (GO:0010941),1/102,0.2258320069783284,0.2708936139392013,0,0,4.010709234188725,5.967790506031058,OLFM4,Late Myeloid,0.6462145058611213
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.2708936139392013,0,0,4.010709234188725,5.967790506031058,ANXA3,Late Myeloid,0.6462145058611213
GO_Biological_Process_2021,chromatin remodeling (GO:0006338),1/103,0.2277773453985499,0.272594647155209,0,0,3.971188475390156,5.874923343943355,PADI4,Late Myeloid,0.64248947278397
GO_Biological_Process_2021,activation of GTPase activity (GO:0090630),1/105,0.2316536615468536,0.2759560899071965,0,0,3.894427001569859,5.6956456810845415,CCDC125,Late Myeloid,0.6351608308934773
GO_Biological_Process_2021,regulation of JNK cascade (GO:0046328),1/105,0.2316536615468536,0.2759560899071965,0,0,3.894427001569859,5.6956456810845415,MMP8,Late Myeloid,0.6351608308934773
GO_Biological_Process_2021,cellular response to peptide hormone stimulus (GO:0071375),1/106,0.2335846623503299,0.2763461566021065,0,0,3.857142857142857,5.6090983677319475,CEACAM1,Late Myeloid,0.6315556772929499
GO_Biological_Process_2021,chromosome organization (GO:0051276),1/106,0.2335846623503299,0.2763461566021065,0,0,3.857142857142857,5.6090983677319475,PADI4,Late Myeloid,0.6315556772929499
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.2335846623503299,0.2763461566021065,0,0,3.857142857142857,5.6090983677319475,CEACAM1,Late Myeloid,0.6315556772929499
GO_Biological_Process_2021,regulation of protein kinase activity (GO:0045859),1/110,0.241261218690496,0.2847763700068184,0,0,3.714847406852649,5.282048795926194,CEACAM1,Late Myeloid,0.6175124827423236
GO_Biological_Process_2021,regulation of protein serine/threonine kinase activity (GO:0071900),1/111,0.2431685532271013,0.2863738998141489,0,0,3.6808905380333954,5.20478084558139,LTF,Late Myeloid,0.6140925891155178
GO_Biological_Process_2021,regulation of cytoskeleton organization (GO:0051493),1/112,0.2450711886958998,0.2879586467176823,0,0,3.647545504688362,5.129202360192396,S100A8,Late Myeloid,0.6107077427090284
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),2/381,0.2465612635256485,0.2888756641586112,0,0,2.15160510114336,3.012558657024939,MMP9;LTF,Late Myeloid,0.6080751530383309
GO_Biological_Process_2021,positive regulation of metabolic process (GO:0009893),1/113,0.2469691364760274,0.2888756641586112,0,0,3.614795918367347,5.055262825364014,LCN2,Late Myeloid,0.6073573167632206
GO_Biological_Process_2021,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.2891277862090197,0,0,3.582625970742279,4.982913653406146,CCDC125,Late Myeloid,0.6040407011916724
GO_Biological_Process_2021,response to lipid (GO:0033993),1/114,0.2488624078588274,0.2891277862090197,0,0,3.582625970742279,4.982913653406146,S100A8,Late Myeloid,0.6040407011916724
GO_Biological_Process_2021,histone modification (GO:0016570),1/114,0.2488624078588274,0.2891277862090197,0,0,3.582625970742279,4.982913653406146,PADI4,Late Myeloid,0.6040407011916724
GO_Biological_Process_2021,cellular amide metabolic process (GO:0043603),1/115,0.2507510141385882,0.2893711480126119,0,0,3.5510204081632653,4.9121080927455,VNN1,Late Myeloid,0.6007573018413346
GO_Biological_Process_2021,cellular response to lectin (GO:1990858),1/115,0.2507510141385882,0.2893711480126119,0,0,3.5510204081632653,4.9121080927455,CLEC4D,Late Myeloid,0.6007573018413346
GO_Biological_Process_2021,stimulatory C-type lectin receptor signaling pathway (GO:0002223),1/115,0.2507510141385882,0.2893711480126119,0,0,3.5510204081632653,4.9121080927455,CLEC4D,Late Myeloid,0.6007573018413346
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.2908959414855647,0,0,3.5199645075421473,4.8428011439058265,ANXA3,Late Myeloid,0.5975065399797567
GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.2945624214427781,0,0,3.4594453165881736,4.708511372057024,LTF,Late Myeloid,0.5911006880374128
GO_Biological_Process_2021,innate immune response activating cell surface receptor signaling pathway (GO:0002220),1/119,0.2582590130323782,0.2960530149395555,0,0,3.429955032860602,4.6434466139665425,CLEC4D,Late Myeloid,0.5879445130148351
GO_Biological_Process_2021,protein homooligomerization (GO:0051260),1/121,0.2619853133921213,0.2996601925303689,0,0,3.372448979591837,4.517283552621874,NLRC4,Late Myeloid,0.5817230540677998
GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.2656932663769877,0.3032305048938249,0,0,3.316828370692539,4.396166676729281,CEACAM1,Late Myeloid,0.5756194520344882
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),2/404,0.2679393411370432,0.3051203510305095,0,0,2.026119402985074,2.6683884405969245,CYBB;MMP9,Late Myeloid,0.5719635148936996
GO_Biological_Process_2021,platelet degranulation (GO:0002576),1/125,0.2693829605231016,0.306090089209766,0,0,3.263001974983542,4.279822783786303,ORM1,Late Myeloid,0.5696298784899082
GO_Biological_Process_2021,phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.2712209880572274,0.3073272185775413,0,0,3.236734693877551,4.223360488574632,BMX,Late Myeloid,0.5666767062328689
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),2/408,0.2716606168083876,0.3073272185775413,0,0,2.0057471264367814,2.6138931132295458,CEACAM1;MMP9,Late Myeloid,0.5659733175722854
GO_Biological_Process_2021,cellular response to insulin stimulus (GO:0032869),1/129,0.2767079241059198,0.3123537047221846,0,0,3.1603954081632653,4.060453122404681,CEACAM1,Late Myeloid,0.5579784037567757
GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.3157680207269505,0,0,3.111459968602826,3.956968446025251,MMP9,Late Myeloid,0.5523097126477655
GO_Biological_Process_2021,chromatin organization (GO:0006325),1/142,0.3000204969826995,0.3369801047393347,0,0,2.8671298306556667,3.4517504575709377,PADI4,Late Myeloid,0.522849073872343
GO_Biological_Process_2021,protein-DNA complex assembly (GO:0065004),1/143,0.3017829564686885,0.3369801047393347,0,0,2.8467950560505892,3.410594866305226,PADI4,Late Myeloid,0.5203052911363482
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3369801047393347,0,0,2.8467950560505892,3.410594866305226,ITGAM,Late Myeloid,0.5203052911363482
GO_Biological_Process_2021,monocarboxylic acid metabolic process (GO:0032787),1/143,0.3017829564686885,0.3369801047393347,0,0,2.8467950560505892,3.410594866305226,VNN1,Late Myeloid,0.5203052911363482
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.3087894082520855,0.3440606122119143,0,0,2.7682415431926195,3.252948903166252,C3AR1,Late Myeloid,0.5103376047629952
GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3445152948002005,0,0,2.749271137026239,3.215201203875706,ITGAM,Late Myeloid,0.5078961191737069
GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),1/148,0.3105302270346101,0.3445152948002005,0,0,2.749271137026239,3.215201203875706,C3AR1,Late Myeloid,0.5078961191737069
GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),1/150,0.3139989845586295,0.3476177195220802,0,0,2.712094233666621,3.141596466170354,LTF,Late Myeloid,0.5030717563895143
GO_Biological_Process_2021,negative regulation of protein phosphorylation (GO:0001933),1/152,0.3174506378807152,0.3506879909921577,0,0,2.6759021489390458,3.0704182805545575,CEACAM1,Late Myeloid,0.4983237959237088
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),1/154,0.3208852696222714,0.3537264059588791,0,0,2.640656262505002,3.0015590720273457,LTF,Late Myeloid,0.493650218923809
GO_Biological_Process_2021,organonitrogen compound biosynthetic process (GO:1901566),1/158,0.3277037968552589,0.3604741765407848,0,0,2.5728584427401535,2.8703970097526006,ARG1,Late Myeloid,0.48451852674781976
GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.3608023807435097,0,0,2.556445362955309,2.8389038953772054,S100A8,Late Myeloid,0.4822791499015975
GO_Biological_Process_2021,protein autophosphorylation (GO:0046777),1/159,0.329397918202972,0.3608023807435097,0,0,2.556445362955309,2.8389038953772054,BMX,Late Myeloid,0.4822791499015975
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),2/485,0.3429022272693128,0.3748001088757605,0,0,1.6793478260869563,1.797422644350721,MMP9;LTF,Late Myeloid,0.46482969398207885
GO_Biological_Process_2021,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.359186378521905,0.3917707968266347,0,0,2.2929035250463823,2.3477357103628296,BMX,Late Myeloid,0.44468014150624274
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.3953783666451168,0,0,2.2541329380914377,2.2778849681371156,MMP8,Late Myeloid,0.4388706874182523
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.3953783666451168,0,0,2.2541329380914377,2.2778849681371156,ORM1,Late Myeloid,0.4388706874182523
GO_Biological_Process_2021,antigen receptor-mediated signaling pathway (GO:0050851),1/185,0.3720057294778557,0.4032011784906738,0,0,2.192324755989352,2.1678716160963645,BMX,Late Myeloid,0.4294503712432232
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.417631317727614,0,0,2.089140319340171,1.988001678572607,MMP8,Late Myeloid,0.4132695879859197
GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),1/198,0.3923030921692546,0.4225431221906347,0,0,2.0463068476121413,1.914771355908193,CD177,Late Myeloid,0.4063782687077012
GO_Biological_Process_2021,negative regulation of intracellular signal transduction (GO:1902532),1/198,0.3923030921692546,0.4225431221906347,0,0,2.0463068476121413,1.914771355908193,MMP9,Late Myeloid,0.4063782687077012
GO_Biological_Process_2021,proteasomal protein catabolic process (GO:0010498),1/205,0.4029646862685204,0.4331242054071207,0,0,1.975390156062425,1.7954446526222323,KBTBD6,Late Myeloid,0.3947330115033212
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),1/212,0.4134429066373548,0.4434646944637188,0,0,1.909178837411742,1.6862551884518755,CD200R1,Late Myeloid,0.3835844547796231
GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),1/214,0.416403436812339,0.4447945802313621,0,0,1.8910606496119575,1.656759537391559,CCDC125,Late Myeloid,0.3804856946694876
GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),1/214,0.416403436812339,0.4447945802313621,0,0,1.8910606496119575,1.656759537391559,MMP9,Late Myeloid,0.3804856946694876
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4548005564413726,0,0,1.8302411873840445,1.5589816483293069,MMP9,Late Myeloid,0.3699278171231457
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.4508075224789805,0.4795627348181747,0,0,1.697494187548437,1.352418759111272,CEACAM1,Late Myeloid,0.34600884563424106
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),1/253,0.4712922312950381,0.5003246069394963,0,0,1.5952380952380951,1.2000608149186214,MMP9,Late Myeloid,0.32670971902140344
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),3/1025,0.4760222919123325,0.5043105018825326,0,0,1.1821626348003498,0.8775082045072261,KBTBD6;PADI4;BMX,Late Myeloid,0.3223727089857482
GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),1/266,0.4884385252284191,0.5164063753437478,0,0,1.5159799768964188,1.086262808220724,MMP9,Late Myeloid,0.3111900887192418
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5167200441082433,0,0,1.510204081632653,1.0781219104526054,LTF,Late Myeloid,0.3100391544580995
GO_Biological_Process_2021,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5170290462942967,0,0,1.504471451501949,1.0700627976731167,ITGAM,Late Myeloid,0.3088941088615854
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.5173334185919854,0,0,1.498781602193116,1.0620843946744252,MMP9,Late Myeloid,0.30775490655057164
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.5387691950011025,0,0,1.4081632653061225,0.937839142501346,NLRC4,Late Myeloid,0.289240867544339
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5677844242495722,0,0,1.2972062611452349,0.7932686422257892,NLRC4,Late Myeloid,0.2655801196036423
GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),1/314,0.5471545986718139,0.5714725808350057,0,0,1.2803677381495728,0.7720923294539072,KBTBD6,Late Myeloid,0.26188994631047774
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.5551458962416416,0.5786500571712272,0,0,1.2519132653061225,0.7367814077584223,KBTBD6,Late Myeloid,0.25559286623594474
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5786615282307295,0,0,1.2479496471485791,0.7319104885681406,MMP8,Late Myeloid,0.2547095446988111
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5786700314247257,0,0,1.2440106477373558,0.7270814983759607,MMP9,Late Myeloid,0.2538302089398956
GO_Biological_Process_2021,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.5844583039109944,0,0,1.2208810353409656,0.6989624697257846,CD177,Late Myeloid,0.24863646405532092
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),1/345,0.5815093765862647,0.6000805343215545,0,0,1.1631466540104414,0.6305745813190116,LCN2,Late Myeloid,0.23544327806907975
GO_Biological_Process_2021,post-translational protein modification (GO:0043687),1/345,0.5815093765862647,0.6000805343215545,0,0,1.1631466540104414,0.6305745813190116,KBTBD6,Late Myeloid,0.23544327806907975
GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),1/351,0.5878572192841084,0.6054226740435937,0,0,1.1428571428571428,0.6071670684764225,LTF,Late Myeloid,0.23072814400359865
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.5909956578792304,0.6074448411999246,0,0,1.1329710354396716,0.5958822738188654,KBTBD6,Late Myeloid,0.22841570992418872
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6240340562353933,0,0,1.0799779371207945,0.5367673309131087,MMP9,Late Myeloid,0.21585171499242045
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6358788263131708,0,0,1.042628017264347,0.4965325169788531,MMP8,Late Myeloid,0.20682480102083725
GO_Biological_Process_2021,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6501174584438959,0,0,1.0,0.4521084323403523,BMX,Late Myeloid,0.19634819738734471
GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),1/417,0.6517468120762254,0.6646017787838433,0,0,0.9583006279434853,0.41024765313154,PADI4,Late Myeloid,0.1859210844420885
GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),1/437,0.6691136001848389,0.6809679749912632,0,0,0.9134057292641828,0.3670077257341264,CEACAM1,Late Myeloid,0.1745001427028418
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),1/474,0.6990329319013457,0.7100196970392844,0,0,0.8403589765716012,0.300896771210595,LTF,Late Myeloid,0.1555023638735803
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),1/482,0.7051444771556823,0.7148229307637014,0,0,0.8260426831855403,0.2885801301950252,MMP8,Late Myeloid,0.1517218912312197
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7239500810148869,0,0,0.8021026592455164,0.2684686706444305,BMX,Late Myeloid,0.1453610219101508
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7671869101044466,0,0,0.7301532033426184,0.200604530418796,MMP8;LTF,Late Myeloid,0.11931939791106433
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),1/625,0.7959537647207185,0.8021600318920302,0,0,0.6320643642072213,0.1442460501716775,S100A8,Late Myeloid,0.09911215878223603
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),1/908,0.9023188918982462,0.9075853445746952,0,0,0.4284814256463335,0.0440424414337815,CEBPE,Late Myeloid,0.044639949690669034
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1183,0.952754544972228,0.9564545626226056,0,0,0.3240443385476018,0.0156830878086274,CEBPE,Late Myeloid,0.021018970814361417
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),1/2206,0.9971209346049892,0.9974129150066312,0,0,0.1642371234207968,0.00047353141012936674,CEBPE,Late Myeloid,0.0012521656136179045
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",1/2244,0.9974129150066312,0.9974129150066312,0,0,0.1611089375562976,0.00041734259811053735,CEBPE,Late Myeloid,0.001125012616753463
GO_Biological_Process_2021,cellular response to ATP (GO:0071318),2/15,0.0006299020654549659,0.1694925747319151,0,0,63.90064102564103,470.9442866528224,P2RY12;RYR3,MEP,3.200726967591985
GO_Biological_Process_2021,response to ATP (GO:0033198),2/19,0.0010193089566942,0.1694925747319151,0,0,48.85539215686274,336.54673838088314,P2RY12;RYR3,MEP,2.9916941596143727
GO_Biological_Process_2021,platelet aggregation (GO:0070527),2/36,0.0036549257227984,0.1694925747319151,0,0,24.40686274509804,136.96349152286243,P2RY12;GATA1,MEP,2.437121444562911
GO_Biological_Process_2021,ceramide biosynthetic process (GO:0046513),2/42,0.0049475924537835,0.1694925747319151,0,0,20.739583333333332,110.1034239545967,ALOX12B;ST8SIA6,MEP,2.3056060815494894
GO_Biological_Process_2021,homotypic cell-cell adhesion (GO:0034109),2/44,0.0054187658916089,0.1694925747319151,0,0,19.75,103.05327189846057,P2RY12;GATA1,MEP,2.266099611522887
GO_Biological_Process_2021,regulation of megakaryocyte differentiation (GO:0045652),2/54,0.0080676700842631,0.1694925747319151,0,0,15.943910256410255,76.8479024006269,ITGA2B;GATA1,MEP,2.0932518699428635
GO_Biological_Process_2021,regulation of glial cell migration (GO:1903975),1/5,0.0124387771927725,0.1694925747319151,0,0,101.76530612244898,446.4379351400606,P2RY12,MEP,1.9052223113279663
GO_Biological_Process_2021,regulation of glycoprotein metabolic process (GO:1903018),1/5,0.0124387771927725,0.1694925747319151,0,0,101.76530612244898,446.4379351400606,GATA1,MEP,1.9052223113279663
GO_Biological_Process_2021,regulation of integrin biosynthetic process (GO:0045113),1/5,0.0124387771927725,0.1694925747319151,0,0,101.76530612244898,446.4379351400606,TMEFF2,MEP,1.9052223113279663
GO_Biological_Process_2021,gamma-aminobutyric acid metabolic process (GO:0009448),1/5,0.0124387771927725,0.1694925747319151,0,0,101.76530612244898,446.4379351400606,GAD1,MEP,1.9052223113279663
GO_Biological_Process_2021,glutamate catabolic process (GO:0006538),1/5,0.0124387771927725,0.1694925747319151,0,0,101.76530612244898,446.4379351400606,GAD1,MEP,1.9052223113279663
GO_Biological_Process_2021,catechol-containing compound biosynthetic process (GO:0009713),1/5,0.0124387771927725,0.1694925747319151,0,0,101.76530612244898,446.4379351400606,PNMT,MEP,1.9052223113279663
GO_Biological_Process_2021,regulation of myeloid cell differentiation (GO:0045637),2/68,0.0125608922452035,0.1694925747319151,0,0,12.553030303030305,54.94671101969335,ITGA2B;GATA1,MEP,1.9009795100092206
GO_Biological_Process_2021,regulation of hematopoietic stem cell differentiation (GO:1902036),2/71,0.0136373517747766,0.1694925747319151,0,0,12.005434782608695,51.56265564232933,GATA2;GATA1,MEP,1.8652699567516449
GO_Biological_Process_2021,cellular response to iron ion (GO:0071281),1/6,0.0149082847993736,0.1694925747319151,0,0,81.40816326530613,342.3895623444841,TFR2,MEP,1.8265723193247598
GO_Biological_Process_2021,cellular response to magnesium ion (GO:0071286),1/6,0.0149082847993736,0.1694925747319151,0,0,81.40816326530613,342.3895623444841,RYR3,MEP,1.8265723193247598
GO_Biological_Process_2021,negative regulation of fat cell proliferation (GO:0070345),1/6,0.0149082847993736,0.1694925747319151,0,0,81.40816326530613,342.3895623444841,GATA2,MEP,1.8265723193247598
GO_Biological_Process_2021,positive regulation of microglial cell migration (GO:1904141),1/6,0.0149082847993736,0.1694925747319151,0,0,81.40816326530613,342.3895623444841,P2RY12,MEP,1.8265723193247598
GO_Biological_Process_2021,regulation of hematopoietic progenitor cell differentiation (GO:1901532),2/75,0.0151327357621299,0.1694925747319151,0,0,11.345319634703197,47.54704276850611,GATA2;GATA1,MEP,1.820082551223806
GO_Biological_Process_2021,regulation of fat cell proliferation (GO:0070344),1/7,0.0173717414502839,0.1694925747319151,0,0,67.83673469387755,274.9362107684438,GATA2,MEP,1.7601566430186848
GO_Biological_Process_2021,iron import into cell (GO:0033212),1/7,0.0173717414502839,0.1694925747319151,0,0,67.83673469387755,274.9362107684438,TFR2,MEP,1.7601566430186848
GO_Biological_Process_2021,"substrate-dependent cell migration, cell extension (GO:0006930)",1/7,0.0173717414502839,0.1694925747319151,0,0,67.83673469387755,274.9362107684438,P2RY12,MEP,1.7601566430186848
GO_Biological_Process_2021,glial cell migration (GO:0008347),1/7,0.0173717414502839,0.1694925747319151,0,0,67.83673469387755,274.9362107684438,P2RY12,MEP,1.7601566430186848
GO_Biological_Process_2021,regulation of microglial cell migration (GO:1904139),1/7,0.0173717414502839,0.1694925747319151,0,0,67.83673469387755,274.9362107684438,P2RY12,MEP,1.7601566430186848
GO_Biological_Process_2021,response to caffeine (GO:0031000),1/7,0.0173717414502839,0.1694925747319151,0,0,67.83673469387755,274.9362107684438,RYR3,MEP,1.7601566430186848
GO_Biological_Process_2021,hemostasis (GO:0007599),1/7,0.0173717414502839,0.1694925747319151,0,0,67.83673469387755,274.9362107684438,P2RY12,MEP,1.7601566430186848
GO_Biological_Process_2021,vascular wound healing (GO:0061042),1/7,0.0173717414502839,0.1694925747319151,0,0,67.83673469387755,274.9362107684438,GATA2,MEP,1.7601566430186848
GO_Biological_Process_2021,cellular amino acid biosynthetic process (GO:0008652),1/7,0.0173717414502839,0.1694925747319151,0,0,67.83673469387755,274.9362107684438,GAD1,MEP,1.7601566430186848
GO_Biological_Process_2021,cellular response to caffeine (GO:0071313),1/7,0.0173717414502839,0.1694925747319151,0,0,67.83673469387755,274.9362107684438,RYR3,MEP,1.7601566430186848
GO_Biological_Process_2021,positive regulation of peptide secretion (GO:0002793),1/8,0.0198291614511851,0.1694925747319151,0,0,58.142857142857146,227.9549801512961,TFR2,MEP,1.702695651141308
GO_Biological_Process_2021,positive regulation of glial cell migration (GO:1903977),1/8,0.0198291614511851,0.1694925747319151,0,0,58.142857142857146,227.9549801512961,P2RY12,MEP,1.702695651141308
GO_Biological_Process_2021,negative regulation of neural precursor cell proliferation (GO:2000178),1/8,0.0198291614511851,0.1694925747319151,0,0,58.142857142857146,227.9549801512961,GATA2,MEP,1.702695651141308
GO_Biological_Process_2021,cellular amino acid catabolic process (GO:0009063),2/90,0.0213286953840061,0.1694925747319151,0,0,9.40435606060606,36.18515879365064,GAD1;SLC25A21,MEP,1.6710357083037395
GO_Biological_Process_2021,regulation of stem cell differentiation (GO:2000736),2/91,0.0217736102157896,0.1694925747319151,0,0,9.298220973782772,35.5848177883064,GATA2;GATA1,MEP,1.6620695559472094
GO_Biological_Process_2021,positive regulation of transport (GO:0051050),2/91,0.0217736102157896,0.1694925747319151,0,0,9.298220973782772,35.5848177883064,TFR2;GATA2,MEP,1.6620695559472094
GO_Biological_Process_2021,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),1/9,0.0222805591236868,0.1694925747319151,0,0,50.87244897959184,193.52086993316271,GATA2,MEP,1.652073914876897
GO_Biological_Process_2021,maintenance of apical/basal cell polarity (GO:0035090),1/9,0.0222805591236868,0.1694925747319151,0,0,50.87244897959184,193.52086993316271,ANK1,MEP,1.652073914876897
GO_Biological_Process_2021,maintenance of epithelial cell apical/basal polarity (GO:0045199),1/9,0.0222805591236868,0.1694925747319151,0,0,50.87244897959184,193.52086993316271,ANK1,MEP,1.652073914876897
GO_Biological_Process_2021,one-carbon compound transport (GO:0019755),1/9,0.0222805591236868,0.1694925747319151,0,0,50.87244897959184,193.52086993316271,SLC14A1,MEP,1.652073914876897
GO_Biological_Process_2021,hepoxilin biosynthetic process (GO:0051122),1/9,0.0222805591236868,0.1694925747319151,0,0,50.87244897959184,193.52086993316271,ALOX12B,MEP,1.652073914876897
GO_Biological_Process_2021,hepoxilin metabolic process (GO:0051121),1/9,0.0222805591236868,0.1694925747319151,0,0,50.87244897959184,193.52086993316271,ALOX12B,MEP,1.652073914876897
GO_Biological_Process_2021,response to magnesium ion (GO:0032026),1/9,0.0222805591236868,0.1694925747319151,0,0,50.87244897959184,193.52086993316271,RYR3,MEP,1.652073914876897
GO_Biological_Process_2021,regulation of glycoprotein biosynthetic process (GO:0010559),1/10,0.024725948817258,0.1694925747319151,0,0,45.21768707482993,167.3010120823387,GATA1,MEP,1.606847034080906
GO_Biological_Process_2021,cellular response to purine-containing compound (GO:0071415),1/10,0.024725948817258,0.1694925747319151,0,0,45.21768707482993,167.3010120823387,RYR3,MEP,1.606847034080906
GO_Biological_Process_2021,regulation of macrophage migration (GO:1905521),1/10,0.024725948817258,0.1694925747319151,0,0,45.21768707482993,167.3010120823387,P2RY12,MEP,1.606847034080906
GO_Biological_Process_2021,actin filament depolymerization (GO:0030042),1/11,0.0271653448579923,0.1694925747319151,0,0,40.69387755102041,146.73452100035948,MICAL2,MEP,1.5659847773237099
GO_Biological_Process_2021,erythrocyte development (GO:0048821),1/11,0.0271653448579923,0.1694925747319151,0,0,40.69387755102041,146.73452100035948,GATA1,MEP,1.5659847773237099
GO_Biological_Process_2021,lipoprotein biosynthetic process (GO:0042158),1/11,0.0271653448579923,0.1694925747319151,0,0,40.69387755102041,146.73452100035948,ALOX12B,MEP,1.5659847773237099
GO_Biological_Process_2021,angiogenesis involved in wound healing (GO:0060055),1/11,0.0271653448579923,0.1694925747319151,0,0,40.69387755102041,146.73452100035948,GATA2,MEP,1.5659847773237099
GO_Biological_Process_2021,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),1/11,0.0271653448579923,0.1694925747319151,0,0,40.69387755102041,146.73452100035948,EPGN,MEP,1.5659847773237099
GO_Biological_Process_2021,vasoconstriction (GO:0042310),1/11,0.0271653448579923,0.1694925747319151,0,0,40.69387755102041,146.73452100035948,KEL,MEP,1.5659847773237099
GO_Biological_Process_2021,positive regulation of integrin activation (GO:0033625),1/11,0.0271653448579923,0.1694925747319151,0,0,40.69387755102041,146.73452100035948,P2RY12,MEP,1.5659847773237099
GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),2/103,0.0274075630593292,0.1694925747319151,0,0,8.188531353135314,29.45362550083794,P2RY12;RYR3,MEP,1.56212957799338
GO_Biological_Process_2021,cellular response to thyroid hormone stimulus (GO:0097067),1/12,0.029598761568907,0.1694925747319151,0,0,36.99257884972171,130.2147194065139,GATA1,MEP,1.5287264597194943
GO_Biological_Process_2021,lysine catabolic process (GO:0006554),1/12,0.029598761568907,0.1694925747319151,0,0,36.99257884972171,130.2147194065139,SLC25A21,MEP,1.5287264597194943
GO_Biological_Process_2021,lysine metabolic process (GO:0006553),1/12,0.029598761568907,0.1694925747319151,0,0,36.99257884972171,130.2147194065139,SLC25A21,MEP,1.5287264597194943
GO_Biological_Process_2021,positive regulation of protein maturation (GO:1903319),1/12,0.029598761568907,0.1694925747319151,0,0,36.99257884972171,130.2147194065139,TFR2,MEP,1.5287264597194943
GO_Biological_Process_2021,megakaryocyte differentiation (GO:0030219),1/12,0.029598761568907,0.1694925747319151,0,0,36.99257884972171,130.2147194065139,GATA1,MEP,1.5287264597194943
GO_Biological_Process_2021,catecholamine biosynthetic process (GO:0042423),1/12,0.029598761568907,0.1694925747319151,0,0,36.99257884972171,130.2147194065139,PNMT,MEP,1.5287264597194943
GO_Biological_Process_2021,motile cilium assembly (GO:0044458),1/12,0.029598761568907,0.1694925747319151,0,0,36.99257884972171,130.2147194065139,DNAAF3,MEP,1.5287264597194943
GO_Biological_Process_2021,lipid oxidation (GO:0034440),1/13,0.032026213248763,0.1694925747319151,0,0,33.90816326530612,116.6847899929619,ALOX12B,MEP,1.4944944088974865
GO_Biological_Process_2021,positive regulation of ruffle assembly (GO:1900029),1/13,0.032026213248763,0.1694925747319151,0,0,33.90816326530612,116.6847899929619,P2RY12,MEP,1.4944944088974865
GO_Biological_Process_2021,negative regulation of macromolecule biosynthetic process (GO:0010558),1/13,0.032026213248763,0.1694925747319151,0,0,33.90816326530612,116.6847899929619,TMEFF2,MEP,1.4944944088974865
GO_Biological_Process_2021,response to iron ion (GO:0010039),1/13,0.032026213248763,0.1694925747319151,0,0,33.90816326530612,116.6847899929619,TFR2,MEP,1.4944944088974865
GO_Biological_Process_2021,response to thyroid hormone (GO:0097066),1/13,0.032026213248763,0.1694925747319151,0,0,33.90816326530612,116.6847899929619,GATA1,MEP,1.4944944088974865
GO_Biological_Process_2021,substrate-dependent cell migration (GO:0006929),1/14,0.0344477141698711,0.1732036504186672,0,0,31.298273155416013,105.4223689491126,P2RY12,MEP,1.4628395910668823
GO_Biological_Process_2021,dicarboxylic acid catabolic process (GO:0043649),1/14,0.0344477141698711,0.1732036504186672,0,0,31.298273155416013,105.4223689491126,GAD1,MEP,1.4628395910668823
GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),2/120,0.0362706169091182,0.1732036504186672,0,0,7.002824858757062,23.22660056193845,MICAL2;ANK1,MEP,1.4404450576550938
GO_Biological_Process_2021,lipoxygenase pathway (GO:0019372),1/15,0.0368632785936063,0.1732036504186672,0,0,29.06122448979592,95.91771596133704,ALOX12B,MEP,1.4334060415588732
GO_Biological_Process_2021,macrophage migration (GO:1905517),1/15,0.0368632785936063,0.1732036504186672,0,0,29.06122448979592,95.91771596133704,P2RY12,MEP,1.4334060415588732
GO_Biological_Process_2021,ganglioside biosynthetic process (GO:0001574),1/15,0.0368632785936063,0.1732036504186672,0,0,29.06122448979592,95.91771596133704,ST8SIA6,MEP,1.4334060415588732
GO_Biological_Process_2021,positive regulation of secretion (GO:0051047),1/15,0.0368632785936063,0.1732036504186672,0,0,29.06122448979592,95.91771596133704,ALOX12B,MEP,1.4334060415588732
GO_Biological_Process_2021,catecholamine metabolic process (GO:0006584),1/15,0.0368632785936063,0.1732036504186672,0,0,29.06122448979592,95.91771596133704,PNMT,MEP,1.4334060415588732
GO_Biological_Process_2021,epiboly involved in wound healing (GO:0090505),1/16,0.0392729207344652,0.1732036504186672,0,0,27.122448979591837,87.80133530116419,TMEFF2,MEP,1.405906798966597
GO_Biological_Process_2021,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.0392729207344652,0.1732036504186672,0,0,27.122448979591837,87.80133530116419,GATA1,MEP,1.405906798966597
GO_Biological_Process_2021,glutamine family amino acid catabolic process (GO:0009065),1/16,0.0392729207344652,0.1732036504186672,0,0,27.122448979591837,87.80133530116419,GAD1,MEP,1.405906798966597
GO_Biological_Process_2021,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/16,0.0392729207344652,0.1732036504186672,0,0,27.122448979591837,87.80133530116419,GATA2,MEP,1.405906798966597
GO_Biological_Process_2021,glycosphingolipid biosynthetic process (GO:0006688),1/16,0.0392729207344652,0.1732036504186672,0,0,27.122448979591837,87.80133530116419,ST8SIA6,MEP,1.405906798966597
GO_Biological_Process_2021,cellular biogenic amine biosynthetic process (GO:0042401),1/17,0.0416766547912334,0.1750549707689328,0,0,25.426020408163264,80.79916728086499,PNMT,MEP,1.3801071472903907
GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),2/131,0.0425157677463691,0.1750549707689328,0,0,6.4021317829457365,20.217165618082923,TFR2;RYR3,MEP,1.3714499740612387
GO_Biological_Process_2021,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.0440744949316926,0.1750549707689328,0,0,23.92917166866747,74.70385911458476,P2RY12,MEP,1.3558126557645607
GO_Biological_Process_2021,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/18,0.0440744949316926,0.1750549707689328,0,0,23.92917166866747,74.70385911458476,GATA2,MEP,1.3558126557645607
GO_Biological_Process_2021,response to axon injury (GO:0048678),1/18,0.0440744949316926,0.1750549707689328,0,0,23.92917166866747,74.70385911458476,P2RY12,MEP,1.3558126557645607
GO_Biological_Process_2021,cellular response to alkaloid (GO:0071312),1/18,0.0440744949316926,0.1750549707689328,0,0,23.92917166866747,74.70385911458476,RYR3,MEP,1.3558126557645607
GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),2/136,0.0454786698217006,0.1750549707689328,0,0,6.161691542288557,19.042780777221537,DPP10;ANK1,MEP,1.3421922462170102
GO_Biological_Process_2021,activin receptor signaling pathway (GO:0032924),1/19,0.0464664552952436,0.1750549707689328,0,0,22.598639455782312,69.35578082800635,AMHR2,MEP,1.3328604565168853
GO_Biological_Process_2021,establishment of skin barrier (GO:0061436),1/19,0.0464664552952436,0.1750549707689328,0,0,22.598639455782312,69.35578082800635,ALOX12B,MEP,1.3328604565168853
GO_Biological_Process_2021,aspartate family amino acid catabolic process (GO:0009068),1/19,0.0464664552952436,0.1750549707689328,0,0,22.598639455782312,69.35578082800635,SLC25A21,MEP,1.3328604565168853
GO_Biological_Process_2021,regulation of water loss via skin (GO:0033561),1/19,0.0464664552952436,0.1750549707689328,0,0,22.598639455782312,69.35578082800635,ALOX12B,MEP,1.3328604565168853
GO_Biological_Process_2021,positive regulation of macrophage migration (GO:1905523),1/19,0.0464664552952436,0.1750549707689328,0,0,22.598639455782312,69.35578082800635,P2RY12,MEP,1.3328604565168853
GO_Biological_Process_2021,N-glycan processing (GO:0006491),1/19,0.0464664552952436,0.1750549707689328,0,0,22.598639455782312,69.35578082800635,ST8SIA6,MEP,1.3328604565168853
GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),2/140,0.0479026862337682,0.1750549707689328,0,0,5.981884057971015,18.176455370515885,DPP10;ANK1,MEP,1.319640132017756
GO_Biological_Process_2021,ganglioside metabolic process (GO:0001573),1/20,0.0488525499820277,0.1750549707689328,0,0,21.40816326530612,64.63014669364038,ST8SIA6,MEP,1.3111127622579986
GO_Biological_Process_2021,granulocyte differentiation (GO:0030851),1/20,0.0488525499820277,0.1750549707689328,0,0,21.40816326530612,64.63014669364038,GATA1,MEP,1.3111127622579986
GO_Biological_Process_2021,positive regulation of hormone secretion (GO:0046887),1/20,0.0488525499820277,0.1750549707689328,0,0,21.40816326530612,64.63014669364038,TFR2,MEP,1.3111127622579986
GO_Biological_Process_2021,myeloid cell development (GO:0061515),1/20,0.0488525499820277,0.1750549707689328,0,0,21.40816326530612,64.63014669364038,GATA1,MEP,1.3111127622579986
GO_Biological_Process_2021,linoleic acid metabolic process (GO:0043651),1/21,0.0512327930672156,0.1816915547950738,0,0,20.336734693877553,60.42807445408675,ALOX12B,MEP,1.2904519669693806
GO_Biological_Process_2021,membrane lipid metabolic process (GO:0006643),1/22,0.0536071985992547,0.1862714779610469,0,0,19.367346938775512,56.67024999786951,ALOX12B,MEP,1.2707768875084013
GO_Biological_Process_2021,glutamate metabolic process (GO:0006536),1/22,0.0536071985992547,0.1862714779610469,0,0,19.367346938775512,56.67024999786951,GAD1,MEP,1.2707768875084013
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),2/150,0.0541636617411515,0.1863229963895612,0,0,5.574887387387387,16.25495026487543,P2RY12;RYR3,MEP,1.2662919827974375
GO_Biological_Process_2021,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.0559757805878795,0.1869482380799082,0,0,18.4860853432282,53.29235549319145,GATA1,MEP,1.2519998414265567
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.0559757805878795,0.1869482380799082,0,0,18.4860853432282,53.29235549319145,GATA1,MEP,1.2519998414265567
GO_Biological_Process_2021,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.0559757805878795,0.1869482380799082,0,0,18.4860853432282,53.29235549319145,GATA2,MEP,1.2519998414265567
GO_Biological_Process_2021,negative regulation of stress fiber assembly (GO:0051497),1/24,0.0583385530130099,0.1875557218362189,0,0,17.68145519077196,50.24171555062859,TMEFF2,MEP,1.2340443470047993
GO_Biological_Process_2021,regulation of ruffle assembly (GO:1900027),1/24,0.0583385530130099,0.1875557218362189,0,0,17.68145519077196,50.24171555062859,P2RY12,MEP,1.2340443470047993
GO_Biological_Process_2021,carbohydrate biosynthetic process (GO:0016051),1/24,0.0583385530130099,0.1875557218362189,0,0,17.68145519077196,50.24171555062859,ST8SIA6,MEP,1.2340443470047993
GO_Biological_Process_2021,"wound healing, spreading of cells (GO:0044319)",1/24,0.0583385530130099,0.1875557218362189,0,0,17.68145519077196,50.24171555062859,TMEFF2,MEP,1.2340443470047993
GO_Biological_Process_2021,negative regulation of sequestering of calcium ion (GO:0051283),1/25,0.0606955298241754,0.1894288456112154,0,0,16.943877551020407,47.47480020477031,RYR3,MEP,1.2168432931781568
GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),2/161,0.0613656526664216,0.1894288456112154,0,0,5.186320754716981,14.474528542436865,P2RY12;EPGN,MEP,1.212074642397333
GO_Biological_Process_2021,lamellipodium assembly (GO:0030032),1/26,0.0630467249540435,0.1894288456112154,0,0,16.26530612244898,44.95534064809558,P2RY12,MEP,1.2003374685092782
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),2/165,0.0640621553999463,0.1894288456112154,0,0,5.058026584867076,13.898958782878776,P2RY12;PTH2R,MEP,1.1933984533937798
GO_Biological_Process_2021,positive regulation of nuclear division (GO:0051785),1/27,0.0653921522588676,0.1894288456112154,0,0,15.638932496075354,42.652889831563165,EPGN,MEP,1.184474368421492
GO_Biological_Process_2021,negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.0653921522588676,0.1894288456112154,0,0,15.638932496075354,42.652889831563165,GATA2,MEP,1.184474368421492
GO_Biological_Process_2021,regulation of transcription regulatory region DNA binding (GO:2000677),1/27,0.0653921522588676,0.1894288456112154,0,0,15.638932496075354,42.652889831563165,GATA1,MEP,1.184474368421492
GO_Biological_Process_2021,positive regulation of erythrocyte differentiation (GO:0045648),1/27,0.0653921522588676,0.1894288456112154,0,0,15.638932496075354,42.652889831563165,GATA1,MEP,1.184474368421492
GO_Biological_Process_2021,release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.0653921522588676,0.1894288456112154,0,0,15.638932496075354,42.652889831563165,RYR3,MEP,1.184474368421492
GO_Biological_Process_2021,regulation of epidermal growth factor-activated receptor activity (GO:0007176),1/27,0.0653921522588676,0.1894288456112154,0,0,15.638932496075354,42.652889831563165,EPGN,MEP,1.184474368421492
GO_Biological_Process_2021,negative regulation of actin filament bundle assembly (GO:0032232),1/27,0.0653921522588676,0.1894288456112154,0,0,15.638932496075354,42.652889831563165,TMEFF2,MEP,1.184474368421492
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.0677318256109869,0.1894288456112154,0,0,15.058956916099774,40.54171043527237,GATA1,MEP,1.1692072184717057
GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/28,0.0677318256109869,0.1894288456112154,0,0,15.058956916099774,40.54171043527237,P2RY12,MEP,1.1692072184717057
GO_Biological_Process_2021,amide transport (GO:0042886),1/28,0.0677318256109869,0.1894288456112154,0,0,15.058956916099774,40.54171043527237,SLC14A1,MEP,1.1692072184717057
GO_Biological_Process_2021,carbohydrate derivative biosynthetic process (GO:1901137),1/28,0.0677318256109869,0.1894288456112154,0,0,15.058956916099774,40.54171043527237,ST8SIA6,MEP,1.1692072184717057
GO_Biological_Process_2021,protein depolymerization (GO:0051261),1/28,0.0677318256109869,0.1894288456112154,0,0,15.058956916099774,40.54171043527237,MICAL2,MEP,1.1692072184717057
GO_Biological_Process_2021,lamellipodium organization (GO:0097581),1/29,0.0700657588372089,0.1915655707992486,0,0,14.520408163265309,38.5999069065122,P2RY12,MEP,1.1544941700666143
GO_Biological_Process_2021,transition metal ion homeostasis (GO:0055076),1/29,0.0700657588372089,0.1915655707992486,0,0,14.520408163265309,38.5999069065122,TFR2,MEP,1.1544941700666143
GO_Biological_Process_2021,long-chain fatty acid biosynthetic process (GO:0042759),1/30,0.0723939657090184,0.1915655707992486,0,0,14.019000703729768,36.80874147674154,ALOX12B,MEP,1.1402976322627019
GO_Biological_Process_2021,regulation of cation transmembrane transport (GO:1904062),1/30,0.0723939657090184,0.1915655707992486,0,0,14.019000703729768,36.80874147674154,DPP10,MEP,1.1402976322627019
GO_Biological_Process_2021,negative regulation of Notch signaling pathway (GO:0045746),1/30,0.0723939657090184,0.1915655707992486,0,0,14.019000703729768,36.80874147674154,GATA2,MEP,1.1402976322627019
GO_Biological_Process_2021,positive regulation of lipid kinase activity (GO:0090218),1/30,0.0723939657090184,0.1915655707992486,0,0,14.019000703729768,36.80874147674154,P2RY12,MEP,1.1402976322627019
GO_Biological_Process_2021,cell projection organization (GO:0030030),1/30,0.0723939657090184,0.1915655707992486,0,0,14.019000703729768,36.80874147674154,P2RY12,MEP,1.1402976322627019
GO_Biological_Process_2021,negative regulation of DNA binding (GO:0043392),1/31,0.0747164600026276,0.1920249265860275,0,0,13.551020408163266,35.15209038871121,GATA1,MEP,1.126583712764908
GO_Biological_Process_2021,positive regulation of locomotion (GO:0040017),1/31,0.0747164600026276,0.1920249265860275,0,0,13.551020408163266,35.15209038871121,P2RY12,MEP,1.126583712764908
GO_Biological_Process_2021,regulation of potassium ion transport (GO:0043266),1/31,0.0747164600026276,0.1920249265860275,0,0,13.551020408163266,35.15209038871121,DPP10,MEP,1.126583712764908
GO_Biological_Process_2021,activation of phospholipase C activity (GO:0007202),1/32,0.0770332554327668,0.1920249265860275,0,0,13.113232389730086,33.61600807740255,P2RY12,MEP,1.1133217484244988
GO_Biological_Process_2021,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/32,0.0770332554327668,0.1920249265860275,0,0,13.113232389730086,33.61600807740255,ANK1,MEP,1.1133217484244988
GO_Biological_Process_2021,axonemal dynein complex assembly (GO:0070286),1/32,0.0770332554327668,0.1920249265860275,0,0,13.113232389730086,33.61600807740255,DNAAF3,MEP,1.1133217484244988
GO_Biological_Process_2021,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/32,0.0770332554327668,0.1920249265860275,0,0,13.113232389730086,33.61600807740255,GATA2,MEP,1.1133217484244988
GO_Biological_Process_2021,regulation of chemotaxis (GO:0050920),1/32,0.0770332554327668,0.1920249265860275,0,0,13.113232389730086,33.61600807740255,P2RY12,MEP,1.1133217484244988
GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),2/185,0.078120393358315,0.1933339231313695,0,0,4.5006830601092895,11.474510084124317,ANK1;SPTBN2,MEP,1.1072355785829093
GO_Biological_Process_2021,phosphatidylcholine biosynthetic process (GO:0006656),1/33,0.0793443657059371,0.194960441448874,0,0,12.70280612244898,32.18837516559274,PCYT1B,MEP,1.1004839073426347
GO_Biological_Process_2021,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.0816498044624026,0.1950523106601839,0,0,12.317254174397032,30.85861216573232,GATA2,MEP,1.0880448509885652
GO_Biological_Process_2021,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),1/34,0.0816498044624026,0.1950523106601839,0,0,12.317254174397032,30.85861216573232,EPGN,MEP,1.0880448509885652
GO_Biological_Process_2021,axoneme assembly (GO:0035082),1/34,0.0816498044624026,0.1950523106601839,0,0,12.317254174397032,30.85861216573232,DNAAF3,MEP,1.0880448509885652
GO_Biological_Process_2021,regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.0816498044624026,0.1950523106601839,0,0,12.317254174397032,30.85861216573232,P2RY12,MEP,1.0880448509885652
GO_Biological_Process_2021,blood vessel diameter maintenance (GO:0097746),1/35,0.0839495853612937,0.196475763967959,0,0,11.95438175270108,29.61744503578088,KEL,MEP,1.0759814445616303
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/35,0.0839495853612937,0.196475763967959,0,0,11.95438175270108,29.61744503578088,P2RY12,MEP,1.0759814445616303
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),2/195,0.0854831524975729,0.196475763967959,0,0,4.265328151986183,10.490301477724982,DPP10;ANK1,MEP,1.0681194700473418
GO_Biological_Process_2021,negative regulation of fat cell differentiation (GO:0045599),1/36,0.0862437219743075,0.196475763967959,0,0,11.612244897959185,28.456712045041098,GATA2,MEP,1.0642725091375862
GO_Biological_Process_2021,transferrin transport (GO:0033572),1/36,0.0862437219743075,0.196475763967959,0,0,11.612244897959185,28.456712045041098,TFR2,MEP,1.0642725091375862
GO_Biological_Process_2021,transition metal ion transport (GO:0000041),1/36,0.0862437219743075,0.196475763967959,0,0,11.612244897959185,28.456712045041098,TFR2,MEP,1.0642725091375862
GO_Biological_Process_2021,positive regulation of mitotic nuclear division (GO:0045840),1/36,0.0862437219743075,0.196475763967959,0,0,11.612244897959185,28.456712045041098,EPGN,MEP,1.0642725091375862
GO_Biological_Process_2021,positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.0885322278902676,0.1964844283500134,0,0,11.289115646258503,27.36920368672352,GATA1,MEP,1.0528986067362665
GO_Biological_Process_2021,negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.0885322278902676,0.1964844283500134,0,0,11.289115646258503,27.36920368672352,GATA2,MEP,1.0528986067362665
GO_Biological_Process_2021,positive regulation of signaling receptor activity (GO:2000273),1/37,0.0885322278902676,0.1964844283500134,0,0,11.289115646258503,27.36920368672352,EPGN,MEP,1.0528986067362665
GO_Biological_Process_2021,regulation of erythrocyte differentiation (GO:0045646),1/37,0.0885322278902676,0.1964844283500134,0,0,11.289115646258503,27.36920368672352,GATA1,MEP,1.0528986067362665
GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),2/207,0.0945848472510804,0.2076281596327933,0,0,4.013211382113822,9.464187818681536,P2RY12;EPGN,MEP,1.0241784331789758
GO_Biological_Process_2021,negative regulation of ERBB signaling pathway (GO:1901185),1/40,0.0953640965755271,0.2076281596327933,0,0,10.419152276295131,24.485561288951835,EPGN,MEP,1.0206151011238414
GO_Biological_Process_2021,glycolipid biosynthetic process (GO:0009247),1/40,0.0953640965755271,0.2076281596327933,0,0,10.419152276295131,24.485561288951835,ST8SIA6,MEP,1.0206151011238414
GO_Biological_Process_2021,response to growth factor (GO:0070848),1/41,0.0976302146847681,0.2079180257521839,0,0,10.158163265306122,23.633660200289185,AMHR2,MEP,1.0104157556925017
GO_Biological_Process_2021,carboxylic acid transmembrane transport (GO:1905039),1/41,0.0976302146847681,0.2079180257521839,0,0,10.158163265306122,23.633660200289185,SLC25A21,MEP,1.0104157556925017
GO_Biological_Process_2021,positive regulation of protein tyrosine kinase activity (GO:0061098),1/42,0.0998907694703361,0.2079180257521839,0,0,9.909905425584869,22.829231064333683,EPGN,MEP,1.00047464143678
GO_Biological_Process_2021,calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.0998907694703361,0.2079180257521839,0,0,9.909905425584869,22.829231064333683,RYR3,MEP,1.00047464143678
GO_Biological_Process_2021,signal release from synapse (GO:0099643),1/43,0.1021457742794159,0.2079180257521839,0,0,9.673469387755102,22.068611238785657,GAD1,MEP,0.9907795952096249
GO_Biological_Process_2021,positive regulation of peptide hormone secretion (GO:0090277),1/43,0.1021457742794159,0.2079180257521839,0,0,9.673469387755102,22.068611238785657,TFR2,MEP,0.9907795952096249
GO_Biological_Process_2021,positive regulation of phospholipase C activity (GO:0010863),1/43,0.1021457742794159,0.2079180257521839,0,0,9.673469387755102,22.068611238785657,P2RY12,MEP,0.9907795952096249
GO_Biological_Process_2021,lipid modification (GO:0030258),1/43,0.1021457742794159,0.2079180257521839,0,0,9.673469387755102,22.068611238785657,ALOX12B,MEP,0.9907795952096249
GO_Biological_Process_2021,male gonad development (GO:0008584),1/43,0.1021457742794159,0.2079180257521839,0,0,9.673469387755102,22.068611238785657,GATA1,MEP,0.9907795952096249
GO_Biological_Process_2021,heart looping (GO:0001947),1/43,0.1021457742794159,0.2079180257521839,0,0,9.673469387755102,22.068611238785657,MICAL2,MEP,0.9907795952096249
GO_Biological_Process_2021,development of primary male sexual characteristics (GO:0046546),1/43,0.1021457742794159,0.2079180257521839,0,0,9.673469387755102,22.068611238785657,GATA1,MEP,0.9907795952096249
GO_Biological_Process_2021,neurotransmitter secretion (GO:0007269),1/44,0.1043952424647777,0.2087904849295554,0,0,9.448030374940672,21.34849709415977,GAD1,MEP,0.9813192926974915
GO_Biological_Process_2021,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/44,0.1043952424647777,0.2087904849295554,0,0,9.448030374940672,21.34849709415977,EPGN,MEP,0.9813192926974915
GO_Biological_Process_2021,regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.1043952424647777,0.2087904849295554,0,0,9.448030374940672,21.34849709415977,GATA2,MEP,0.9813192926974915
GO_Biological_Process_2021,positive regulation of chemotaxis (GO:0050921),1/45,0.1066391873529346,0.2108268991345375,0,0,9.232838589981448,20.665901611884028,P2RY12,MEP,0.9720831731354668
GO_Biological_Process_2021,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.1066391873529346,0.2108268991345375,0,0,9.232838589981448,20.665901611884028,GATA2,MEP,0.9720831731354668
GO_Biological_Process_2021,erythrocyte differentiation (GO:0030218),1/46,0.1088776222085674,0.2128062615894727,0,0,9.02721088435374,20.01811780873028,GATA1,MEP,0.9630613723103648
GO_Biological_Process_2021,establishment of protein localization to extracellular region (GO:0035592),1/46,0.1088776222085674,0.2128062615894727,0,0,9.02721088435374,20.01811780873028,TVP23A,MEP,0.9630613723103648
GO_Biological_Process_2021,epidermal growth factor receptor signaling pathway (GO:0007173),1/47,0.1111105603036554,0.2135309091869133,0,0,8.830523513753327,19.4026870705364,EPGN,MEP,0.9542446623584087
GO_Biological_Process_2021,determination of heart left/right asymmetry (GO:0061371),1/47,0.1111105603036554,0.2135309091869133,0,0,8.830523513753327,19.4026870705364,MICAL2,MEP,0.9542446623584087
GO_Biological_Process_2021,embryonic heart tube morphogenesis (GO:0003143),1/47,0.1111105603036554,0.2135309091869133,0,0,8.830523513753327,19.4026870705364,MICAL2,MEP,0.9542446623584087
GO_Biological_Process_2021,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.1133380148369131,0.2142213027686709,0,0,8.642205818497612,18.81737166641443,GATA2,MEP,0.9456243984787533
GO_Biological_Process_2021,substrate adhesion-dependent cell spreading (GO:0034446),1/48,0.1133380148369131,0.2142213027686709,0,0,8.642205818497612,18.81737166641443,TMEFF2,MEP,0.9456243984787533
GO_Biological_Process_2021,positive regulation of endocytosis (GO:0045807),1/48,0.1133380148369131,0.2142213027686709,0,0,8.642205818497612,18.81737166641443,TFR2,MEP,0.9456243984787533
GO_Biological_Process_2021,oligosaccharide metabolic process (GO:0009311),1/49,0.1155599990222406,0.2172275391456327,0,0,8.46173469387755,18.260130793597916,ST8SIA6,MEP,0.9371924705024297
GO_Biological_Process_2021,iron ion transport (GO:0006826),1/50,0.1177765260040411,0.2177952421738366,0,0,8.28862973760933,17.7290996615035,TFR2,MEP,0.928941259997044
GO_Biological_Process_2021,actin polymerization or depolymerization (GO:0008154),1/50,0.1177765260040411,0.2177952421738366,0,0,8.28862973760933,17.7290996615035,MICAL2,MEP,0.928941259997044
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),3/482,0.1192389583091006,0.2177952421738366,0,0,2.5946342113445566,5.517815916066961,TFR2;ALOX12B;GATA2,MEP,0.92358182668994
GO_Biological_Process_2021,gonad development (GO:0008406),1/51,0.1199876089220907,0.2177952421738366,0,0,8.122448979591837,17.22257115519733,GATA1,MEP,0.9208636010741894
GO_Biological_Process_2021,amide biosynthetic process (GO:0043604),1/52,0.1221932608707862,0.2177952421738366,0,0,7.962785114045619,16.738979733033663,ALOX12B,MEP,0.9129527453809976
GO_Biological_Process_2021,positive regulation of protein localization to cell periphery (GO:1904377),1/52,0.1221932608707862,0.2177952421738366,0,0,7.962785114045619,16.738979733033663,DPP10,MEP,0.9129527453809976
GO_Biological_Process_2021,positive regulation of protein localization to plasma membrane (GO:1903078),1/52,0.1221932608707862,0.2177952421738366,0,0,7.962785114045619,16.738979733033663,DPP10,MEP,0.9129527453809976
GO_Biological_Process_2021,glycolipid metabolic process (GO:0006664),1/52,0.1221932608707862,0.2177952421738366,0,0,7.962785114045619,16.738979733033663,ST8SIA6,MEP,0.9129527453809976
GO_Biological_Process_2021,protein homotetramerization (GO:0051289),1/52,0.1221932608707862,0.2177952421738366,0,0,7.962785114045619,16.738979733033663,RYR3,MEP,0.9129527453809976
GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),1/52,0.1221932608707862,0.2177952421738366,0,0,7.962785114045619,16.738979733033663,GATA1,MEP,0.9129527453809976
GO_Biological_Process_2021,positive regulation of phagocytosis (GO:0050766),1/53,0.1243934949128716,0.2205740322166384,0,0,7.809262166405024,16.276887238960814,GATA2,MEP,0.9052023302345248
GO_Biological_Process_2021,unsaturated fatty acid metabolic process (GO:0033559),1/54,0.1265883240687765,0.2214977495946126,0,0,7.661532537543319,15.834970375184442,ALOX12B,MEP,0.8976063498190403
GO_Biological_Process_2021,regulation of potassium ion transmembrane transport (GO:1901379),1/54,0.1265883240687765,0.2214977495946126,0,0,7.661532537543319,15.834970375184442,DPP10,MEP,0.8976063498190403
GO_Biological_Process_2021,ceramide metabolic process (GO:0006672),1/55,0.1287777613922166,0.2214977495946126,0,0,7.519274376417234,15.412009607623004,ALOX12B,MEP,0.8901591287349465
GO_Biological_Process_2021,regulation of blood vessel endothelial cell migration (GO:0043535),1/55,0.1287777613922166,0.2214977495946126,0,0,7.519274376417234,15.412009607623004,GATA2,MEP,0.8901591287349465
GO_Biological_Process_2021,regulation of cardiac conduction (GO:1903779),1/55,0.1287777613922166,0.2214977495946126,0,0,7.519274376417234,15.412009607623004,RYR3,MEP,0.8901591287349465
GO_Biological_Process_2021,glycoprotein metabolic process (GO:0009100),1/55,0.1287777613922166,0.2214977495946126,0,0,7.519274376417234,15.412009607623004,ST8SIA6,MEP,0.8901591287349465
GO_Biological_Process_2021,arachidonic acid metabolic process (GO:0019369),1/57,0.1331405122852093,0.225617419833064,0,0,7.25,14.618539131965724,ALOX12B,MEP,0.8756897763447542
GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),1/57,0.1331405122852093,0.225617419833064,0,0,7.25,14.618539131965724,EPGN,MEP,0.8756897763447542
GO_Biological_Process_2021,icosanoid metabolic process (GO:0006690),1/57,0.1331405122852093,0.225617419833064,0,0,7.25,14.618539131965724,ALOX12B,MEP,0.8756897763447542
GO_Biological_Process_2021,membrane lipid biosynthetic process (GO:0046467),1/58,0.1353138517398134,0.2259609951383293,0,0,7.122448979591836,14.246025949065045,ST8SIA6,MEP,0.8686577434892403
GO_Biological_Process_2021,regulation of phagocytosis (GO:0050764),1/58,0.1353138517398134,0.2259609951383293,0,0,7.122448979591836,14.246025949065045,GATA2,MEP,0.8686577434892403
GO_Biological_Process_2021,cellular iron ion homeostasis (GO:0006879),1/58,0.1353138517398134,0.2259609951383293,0,0,7.122448979591836,14.246025949065045,TFR2,MEP,0.8686577434892403
GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.1396445230534406,0.232066260533254,0,0,6.88031822898651,13.544974303558986,P2RY12,MEP,0.8549760929333525
GO_Biological_Process_2021,iron ion homeostasis (GO:0055072),1/61,0.1418018805927374,0.2322849853519127,0,0,6.76530612244898,13.214837540593155,TFR2,MEP,0.848318009451734
GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.2322849853519127,0,0,6.76530612244898,13.214837540593155,TFR2,MEP,0.848318009451734
GO_Biological_Process_2021,protein lipidation (GO:0006497),1/61,0.1418018805927374,0.2322849853519127,0,0,6.76530612244898,13.214837540593155,ALOX12B,MEP,0.848318009451734
GO_Biological_Process_2021,protein secretion (GO:0009306),1/64,0.1482421941802595,0.2416839563886696,0,0,6.442176870748299,12.297522293260638,TVP23A,MEP,0.8290281655096747
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),2/274,0.1497038344955427,0.2428646807184877,0,0,3.014399509803922,5.724635176902424,EPGN;ALOX12B,MEP,0.8247670755492156
GO_Biological_Process_2021,BMP signaling pathway (GO:0030509),1/65,0.1503784214913892,0.2428646807184877,0,0,6.341198979591836,12.01403781811508,AMHR2,MEP,0.8228144782361342
GO_Biological_Process_2021,ERBB signaling pathway (GO:0038127),1/66,0.1525093979756266,0.2451552939421288,0,0,6.243328100470958,11.740759916332207,EPGN,MEP,0.8167033932798328
GO_Biological_Process_2021,anion transmembrane transport (GO:0098656),1/67,0.1546351363099914,0.2462707726418382,0,0,6.148423005565863,11.477180657220888,SLC25A21,MEP,0.8106918184915987
GO_Biological_Process_2021,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/67,0.1546351363099914,0.2462707726418382,0,0,6.148423005565863,11.477180657220888,EPGN,MEP,0.8106918184915987
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),3/546,0.1557845334346044,0.2469579700530135,0,0,2.281297754790173,4.241574534432652,P2RY12;EPGN;ALOX12B,MEP,0.807475662051351
GO_Biological_Process_2021,positive regulation of MAP kinase activity (GO:0043406),1/69,0.158870948881139,0.2495507142242549,0,0,5.966986794717887,10.977245117600177,EPGN,MEP,0.7989555105590889
GO_Biological_Process_2021,cellular response to calcium ion (GO:0071277),1/69,0.158870948881139,0.2495507142242549,0,0,5.966986794717887,10.977245117600177,RYR3,MEP,0.7989555105590889
GO_Biological_Process_2021,proteolysis (GO:0006508),2/287,0.1610530437699783,0.2515765478510792,0,0,2.875,5.249811823566885,KEL;CPB1,MEP,0.7930310629584509
GO_Biological_Process_2021,protein tetramerization (GO:0051262),1/71,0.16308595979881,0.2515765478510792,0,0,5.795918367346939,10.51076961698872,RYR3,MEP,0.7875834261109624
GO_Biological_Process_2021,response to metal ion (GO:0010038),1/71,0.16308595979881,0.2515765478510792,0,0,5.795918367346939,10.51076961698872,TFR2,MEP,0.7875834261109624
GO_Biological_Process_2021,cellular response to BMP stimulus (GO:0071773),1/71,0.16308595979881,0.2515765478510792,0,0,5.795918367346939,10.51076961698872,AMHR2,MEP,0.7875834261109624
GO_Biological_Process_2021,cell morphogenesis involved in differentiation (GO:0000904),1/72,0.1651856959101235,0.2536780330048326,0,0,5.713998275366484,10.28911103101624,TMEFF2,MEP,0.78202756268309
GO_Biological_Process_2021,neurotransmitter transport (GO:0006836),1/73,0.1672802691231711,0.2555402367910625,0,0,5.634353741496598,10.074701240888364,GAD1,MEP,0.7765552814899175
GO_Biological_Process_2021,sphingolipid biosynthetic process (GO:0030148),1/74,0.1693696918266344,0.2555402367910625,0,0,5.556891249650545,9.867213018330611,ALOX12B,MEP,0.7711643026835198
GO_Biological_Process_2021,regulation of stress fiber assembly (GO:0051492),1/74,0.1693696918266344,0.2555402367910625,0,0,5.556891249650545,9.867213018330611,TMEFF2,MEP,0.7711643026835198
GO_Biological_Process_2021,regulation of peptide hormone secretion (GO:0090276),1/74,0.1693696918266344,0.2555402367910625,0,0,5.556891249650545,9.867213018330611,TFR2,MEP,0.7711643026835198
GO_Biological_Process_2021,integrin-mediated signaling pathway (GO:0007229),1/75,0.1714539764404576,0.2575553183210367,0,0,5.4815223386651954,9.666337985731484,ITGA2B,MEP,0.7658524380723842
GO_Biological_Process_2021,cellular response to hormone stimulus (GO:0032870),1/76,0.1735331353639065,0.2592655374836194,0,0,5.408163265306122,9.4717853003048,GATA1,MEP,0.7606175863963804
GO_Biological_Process_2021,MAPK cascade (GO:0000165),2/303,0.1752338998526144,0.2592655374836194,0,0,2.7199612403100777,4.737175959955004,EPGN;SPTBN2,MEP,0.7563818736544428
GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1756071809118701,0.2592655374836194,0,0,5.336734693877551,9.283280446293812,GATA2,MEP,0.7554577289388229
GO_Biological_Process_2021,phosphatidylcholine metabolic process (GO:0046470),1/77,0.1756071809118701,0.2592655374836194,0,0,5.336734693877551,9.283280446293812,PCYT1B,MEP,0.7554577289388229
GO_Biological_Process_2021,regulation of fat cell differentiation (GO:0045598),1/80,0.181798760490535,0.2616685088231968,0,0,5.133298889175924,8.751529842637671,GATA2,MEP,0.7404090821369118
GO_Biological_Process_2021,skin development (GO:0043588),1/80,0.181798760490535,0.2616685088231968,0,0,5.133298889175924,8.751529842637671,ALOX12B,MEP,0.7404090821369118
GO_Biological_Process_2021,negative regulation of cellular component organization (GO:0051129),1/80,0.181798760490535,0.2616685088231968,0,0,5.133298889175924,8.751529842637671,TMEFF2,MEP,0.7404090821369118
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2616685088231968,0,0,5.133298889175924,8.751529842637671,P2RY12,MEP,0.7404090821369118
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.2616685088231968,0,0,5.133298889175924,8.751529842637671,GATA1,MEP,0.7404090821369118
GO_Biological_Process_2021,regulation of protein localization to plasma membrane (GO:1903076),1/80,0.181798760490535,0.2616685088231968,0,0,5.133298889175924,8.751529842637671,DPP10,MEP,0.7404090821369118
GO_Biological_Process_2021,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.1838524754991919,0.2635218815488418,0,0,5.0688775510204085,8.584760541358477,P2RY12,MEP,0.7355305181562768
GO_Biological_Process_2021,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1/83,0.1879447615357932,0.2649713031488232,0,0,4.944748631159781,8.265677319811374,P2RY12,MEP,0.7259697745939766
GO_Biological_Process_2021,long-chain fatty acid metabolic process (GO:0001676),1/83,0.1879447615357932,0.2649713031488232,0,0,4.944748631159781,8.265677319811374,ALOX12B,MEP,0.7259697745939766
GO_Biological_Process_2021,glycoprotein biosynthetic process (GO:0009101),1/83,0.1879447615357932,0.2649713031488232,0,0,4.944748631159781,8.265677319811374,ST8SIA6,MEP,0.7259697745939766
GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.2649713031488232,0,0,4.944748631159781,8.265677319811374,GATA2,MEP,0.7259697745939766
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),4/908,0.1908851520255107,0.2680183359052069,0,0,1.8320507887649096,3.0340287711400475,TFR2;MICAL2;GATA2;GATA1,MEP,0.7192278518272621
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),2/323,0.1932342825020938,0.2702137934175621,0,0,2.5478971962616823,4.188365716592005,P2RY12;RYR3,MEP,0.7139158210847405
GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),1/86,0.1940455128548384,0.2702496211419612,0,0,4.769507803121249,7.820383303288144,GATA2,MEP,0.7120963955156414
GO_Biological_Process_2021,calcium ion transmembrane transport (GO:0070588),1/87,0.196069097589664,0.271966812785663,0,0,4.713811105837684,7.6801565438185,RYR3,MEP,0.7075908500030543
GO_Biological_Process_2021,metal ion transport (GO:0030001),1/88,0.1980877029036425,0.2736633325255141,0,0,4.659394792399718,7.5437717166037235,RYR3,MEP,0.703142484213379
GO_Biological_Process_2021,transforming growth factor beta receptor signaling pathway (GO:0007179),1/89,0.2001013407742902,0.2742424750054018,0,0,4.6062152133580705,7.411084001248333,AMHR2,MEP,0.6987500013741589
GO_Biological_Process_2021,second-messenger-mediated signaling (GO:0019932),1/89,0.2001013407742902,0.2742424750054018,0,0,4.6062152133580705,7.411084001248333,P2RY12,MEP,0.6987500013741589
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2813600154210025,0,0,4.453689167974883,7.03385741012878,GATA1,MEP,0.6858955226779435
GO_Biological_Process_2021,regulation of heart contraction (GO:0008016),1/93,0.2081064570390282,0.2818449654386838,0,0,4.40505767524401,6.914643337844717,RYR3,MEP,0.6817144444740324
GO_Biological_Process_2021,regulation of epithelial cell proliferation (GO:0050678),1/93,0.2081064570390282,0.2818449654386838,0,0,4.40505767524401,6.914643337844717,EPGN,MEP,0.6817144444740324
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),2/345,0.2133084926466024,0.2869319238019716,0,0,2.381802721088435,3.6799229289674416,ALOX12B;PTH2R,MEP,0.6709918532419347
GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.2140587201245348,0.2869319238019716,0,0,4.26530612244898,6.5749903239841245,TFR2,MEP,0.6694670755856718
GO_Biological_Process_2021,protein maturation (GO:0051604),1/97,0.2160330472811356,0.2869319238019716,0,0,4.220663265306122,6.46742313757927,KEL,MEP,0.6654798083211632
GO_Biological_Process_2021,positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.2160330472811356,0.2869319238019716,0,0,4.220663265306122,6.46742313757927,PTH2R,MEP,0.6654798083211632
GO_Biological_Process_2021,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2869319238019716,0,0,4.220663265306122,6.46742313757927,EPGN,MEP,0.6654798083211632
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,0.2180025137484037,0.2884340951132726,0,0,4.176940879444562,6.362519703204576,SPTBN2,MEP,0.6615384985937142
GO_Biological_Process_2021,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),1/100,0.2219269115603851,0.2920534225584397,0,0,4.092145949288806,6.1603458876211565,SPTBN2,MEP,0.6537900306498672
GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),1/101,0.2238818662412048,0.2920534225584397,0,0,4.051020408163265,6.062906014187368,EPGN,MEP,0.6499810815451941
GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),1/101,0.2238818662412048,0.2920534225584397,0,0,4.051020408163265,6.062906014187368,DPP10,MEP,0.6499810815451941
GO_Biological_Process_2021,protein O-linked glycosylation (GO:0006493),1/102,0.2258320069783284,0.2920534225584397,0,0,4.010709234188725,5.967790506031058,ST8SIA6,MEP,0.6462145058611213
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2920534225584397,0,0,4.010709234188725,5.967790506031058,P2RY12,MEP,0.6462145058611213
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.2920534225584397,0,0,4.010709234188725,5.967790506031058,GATA2,MEP,0.6462145058611213
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/103,0.2277773453985499,0.2934659431352103,0,0,3.971188475390156,5.874923343943355,SPTBN2,MEP,0.64248947278397
GO_Biological_Process_2021,protein processing (GO:0016485),1/106,0.2335846623503299,0.298710497578117,0,0,3.857142857142857,5.6090983677319475,KEL,MEP,0.6315556772929499
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.298710497578117,0,0,3.857142857142857,5.6090983677319475,EPGN,MEP,0.6315556772929499
GO_Biological_Process_2021,protein transport (GO:0015031),2/369,0.2354374823833979,0.2989511144313501,0,0,2.2233197093551316,3.215609236148146,TFR2;TVP23A,MEP,0.6281243949487266
GO_Biological_Process_2021,response to calcium ion (GO:0051592),1/107,0.2355109070084182,0.2989511144313501,0,0,3.8205621871390063,5.524525481436682,RYR3,MEP,0.6279889749729552
GO_Biological_Process_2021,Fc-epsilon receptor signaling pathway (GO:0038095),1/111,0.2431685532271013,0.3075366996695693,0,0,3.6808905380333954,5.20478084558139,FCER1A,MEP,0.6140925891155178
GO_Biological_Process_2021,Fc receptor signaling pathway (GO:0038093),1/112,0.2450711886958998,0.3077135792811474,0,0,3.647545504688362,5.129202360192396,FCER1A,MEP,0.6107077427090284
GO_Biological_Process_2021,positive regulation of metabolic process (GO:0009893),1/113,0.2469691364760274,0.3077135792811474,0,0,3.614795918367347,5.055262825364014,PTH2R,MEP,0.6073573167632206
GO_Biological_Process_2021,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.3077135792811474,0,0,3.582625970742279,4.982913653406146,TMEFF2,MEP,0.6040407011916724
GO_Biological_Process_2021,cellular response to transforming growth factor beta stimulus (GO:0071560),1/114,0.2488624078588274,0.3077135792811474,0,0,3.582625970742279,4.982913653406146,AMHR2,MEP,0.6040407011916724
GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.3077135792811474,0,0,3.582625970742279,4.982913653406146,TFR2,MEP,0.6040407011916724
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),2/384,0.2493463820044915,0.3077135792811474,0,0,2.1343804537521813,2.9644671728961822,ALOX12B;GATA2,MEP,0.6031969289771376
GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),1/115,0.2507510141385882,0.3077135792811474,0,0,3.5510204081632653,4.9121080927455,TFR2,MEP,0.6007573018413346
GO_Biological_Process_2021,calcium ion transport (GO:0006816),1/115,0.2507510141385882,0.3077135792811474,0,0,3.5510204081632653,4.9121080927455,RYR3,MEP,0.6007573018413346
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.3077135792811474,0,0,3.5199645075421473,4.8428011439058265,GATA2,MEP,0.5975065399797567
GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),1/116,0.2526349665899778,0.3077135792811474,0,0,3.5199645075421473,4.8428011439058265,ALOX12B,MEP,0.5975065399797567
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),4/1025,0.2531480899318741,0.3077135792811474,0,0,1.6121449559255632,2.2147335064279132,AMHR2;GAD1;ALOX12B;ST8SIA6,MEP,0.596625345129507
GO_Biological_Process_2021,protein homooligomerization (GO:0051260),1/121,0.2619853133921213,0.3173343232636962,0,0,3.372448979591837,4.517283552621874,RYR3,MEP,0.5817230540677998
GO_Biological_Process_2021,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.3195751176002929,0,0,3.316828370692539,4.396166676729281,AMHR2,MEP,0.5756194520344882
GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),1/123,0.2656932663769877,0.3195751176002929,0,0,3.316828370692539,4.396166676729281,EPGN,MEP,0.5756194520344882
GO_Biological_Process_2021,fatty acid metabolic process (GO:0006631),1/124,0.2675403902734135,0.3206755897353806,0,0,3.2896963663514187,4.337414433160371,ALOX12B,MEP,0.5726106437410472
GO_Biological_Process_2021,platelet degranulation (GO:0002576),1/125,0.2693829605231016,0.3217629806248158,0,0,3.263001974983542,4.279822783786303,ITGA2B,MEP,0.5696298784899082
GO_Biological_Process_2021,circulatory system development (GO:0072359),1/126,0.2712209880572274,0.3228374390715786,0,0,3.236734693877551,4.223360488574632,MICAL2,MEP,0.5666767062328689
GO_Biological_Process_2021,regulation of response to external stimulus (GO:0032101),1/130,0.2785278903472666,0.3292563377301021,0,0,3.135738016136687,4.008216604624779,P2RY12,MEP,0.5551313103019286
GO_Biological_Process_2021,protein glycosylation (GO:0006486),1/130,0.2785278903472666,0.3292563377301021,0,0,3.135738016136687,4.008216604624779,ST8SIA6,MEP,0.5551313103019286
GO_Biological_Process_2021,organelle organization (GO:0006996),2/420,0.2828230936231133,0.3331888500217499,0,0,1.946969696969697,2.4588936191845474,MICAL2;ANK1,MEP,0.5484851315667836
GO_Biological_Process_2021,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1/133,0.2839609038772722,0.3333875458490841,0,0,3.0640074211502784,3.857336278341556,AMHR2,MEP,0.546741450090894
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3343621294408228,0,0,3.0408163265306123,3.80890385676326,GATA1,MEP,0.5439940297149167
GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3374159758469538,0,0,2.99546485260771,3.714691124222948,PTH2R,MEP,0.5385707850387818
GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3383549053004908,0,0,2.9732893157262907,3.668866926816198,PTH2R,MEP,0.5358942544628899
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.341344039965904,0,0,2.929902395740905,3.579678317757992,P2RY12,MEP,0.5306096689947516
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3483669027692244,0,0,2.8467950560505892,3.410594866305226,TFR2,MEP,0.5203052911363482
GO_Biological_Process_2021,negative regulation of cell migration (GO:0030336),1/144,0.3035410668561185,0.3492245050117216,0,0,2.826744683887541,3.370153465117457,TMEFF2,MEP,0.5177825437898177
GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),1/158,0.3277037968552589,0.3745186249774387,0,0,2.5728584427401535,2.8703970097526006,AMHR2,MEP,0.48451852674781976
GO_Biological_Process_2021,organonitrogen compound biosynthetic process (GO:1901566),1/158,0.3277037968552589,0.3745186249774387,0,0,2.5728584427401535,2.8703970097526006,PCYT1B,MEP,0.48451852674781976
GO_Biological_Process_2021,heart development (GO:0007507),1/164,0.3378059691212722,0.3847856072109856,0,0,2.4774007762614247,2.6886824434754057,MICAL2,MEP,0.4713326805982654
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.3873010678090389,0,0,2.4471243042671613,2.6317886779390967,ALOX12B,MEP,0.4670671197091842
GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3897813602238774,0,0,2.4175730172308443,2.5766088705447237,DNAAF3,MEP,0.46286379212748074
GO_Biological_Process_2021,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.359186378521905,0.4051151285624109,0,0,2.2929035250463823,2.3477357103628296,PCYT1B,MEP,0.44468014150624274
GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.4056082802318079,0,0,2.279833967485299,2.3241173885161555,PTH2R,MEP,0.44273020383203454
GO_Biological_Process_2021,regulation of immune response (GO:0050776),1/179,0.3624150547196057,0.4060937420962357,0,0,2.266911258885577,2.300835957547096,FCER1A,MEP,0.4407937700298507
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.4065715998137231,0,0,2.2541329380914377,2.2778849681371156,ITGA2B,MEP,0.4388706874182523
GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.424661856891989,0,0,2.122448979591837,2.045536603225051,GATA2,MEP,0.41855670871419515
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.4284766508803084,0,0,2.089140319340171,1.988001678572607,GATA2,MEP,0.4132695879859197
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),1/203,0.3999373645428959,0.4409565814190904,0,0,1.9951505354617096,1.8284503867148747,GATA2,MEP,0.398008019580524
GO_Biological_Process_2021,axon guidance (GO:0007411),1/203,0.3999373645428959,0.4409565814190904,0,0,1.9951505354617096,1.8284503867148747,SPTBN2,MEP,0.398008019580524
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),1/212,0.4134429066373548,0.4543909261445689,0,0,1.909178837411742,1.6862551884518755,PTH2R,MEP,0.3835844547796231
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),1/216,0.41934932166703,0.4594145434823514,0,0,1.8732795443758896,1.627975467192003,ITGA2B,MEP,0.3774240551539837
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),1/217,0.4208167942393084,0.4595586578359432,0,0,1.8645124716553287,1.613843141672166,ITGA2B,MEP,0.375906936392536
GO_Biological_Process_2021,axonogenesis (GO:0007409),1/240,0.4535831041409784,0.4937740121028373,0,0,1.6831184356587825,1.3306343458644796,SPTBN2,MEP,0.34334313117644527
GO_Biological_Process_2021,membrane organization (GO:0061024),1/242,0.4563449373288627,0.4952134335682295,0,0,1.6689812854602422,1.3093263562491473,EPGN,MEP,0.3407067631514444
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.4966290016893137,0,0,1.655076845553036,1.2884811006593149,GAD1,MEP,0.33809924509335265
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),2/625,0.4660144680358849,0.5025359780700452,0,0,1.2926029962546817,0.9869522795970046,EPGN;GATA2,MEP,0.33160059985375573
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5264647644758553,0,0,1.510204081632653,1.0781219104526054,GATA2,MEP,0.3100391544580995
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),1/274,0.4987179596066677,0.5344516451859617,0,0,1.4709576138147566,1.0233666205889618,RYR3,MEP,0.30214499188263844
GO_Biological_Process_2021,plasma membrane bounded cell projection assembly (GO:0120031),1/278,0.5037814900878317,0.5382013434478699,0,0,1.4494216459146836,0.9937418248041268,P2RY12,MEP,0.2977577933690553
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),1/300,0.5307476794848257,0.5652544945596906,0,0,1.341273633199099,0.8496546643160489,ITGA2B,MEP,0.2751118959639202
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5710499187481007,0,0,1.314486450317832,0.8152139890333826,GAD1,MEP,0.2693393582885023
GO_Biological_Process_2021,cilium assembly (GO:0060271),1/314,0.5471545986718139,0.5791420982864739,0,0,1.2803677381495728,0.7720923294539072,DNAAF3,MEP,0.26188994631047774
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5869908044199745,0,0,1.2479496471485791,0.7319104885681406,GATA2,MEP,0.2547095446988111
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",3/1183,0.5741266920581598,0.6039742570887063,0,0,1.015326361341507,0.5634098665849442,TFR2;GATA2;GATA1,MEP,0.24099226162550894
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6380179302134003,0,0,1.0799779371207945,0.5367673309131087,GATA1,MEP,0.21585171499242045
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),1/379,0.6162544539128882,0.6443511615380959,0,0,1.056689342403628,0.5115383719098227,GATA2,MEP,0.2102399288866402
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.6444347925120313,0,0,1.0510204081632653,0.5054679174936134,GATA1,MEP,0.20886552310647807
GO_Biological_Process_2021,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6612752241702261,0,0,1.0,0.4521084323403523,AMHR2,MEP,0.19634819738734471
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),1/408,0.643643262264238,0.6669074765629454,0,0,0.9799428370856942,0.4317732474155183,TMEFF2,MEP,0.19135477263518083
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),1/468,0.6943679720033368,0.7173050521596032,0,0,0.8514180832932745,0.3105575044475373,GATA1,MEP,0.15841031937391015
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),1/474,0.6990329319013457,0.7199620615989908,0,0,0.8403589765716012,0.300896771210595,EPGN,MEP,0.1555023638735803
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7264097150714788,0,0,0.8207960870298533,0.2841203737887477,GATA1,MEP,0.15033199168778996
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.732585204482827,0,0,0.8021026592455164,0.2684686706444305,AMHR2,MEP,0.1453610219101508
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),1/511,0.7262961571675228,0.7413824274944446,0,0,0.7779111644657863,0.2487739813280452,GATA1,MEP,0.13888625368433627
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7732543011163402,0,0,0.7301532033426184,0.200604530418796,ALOX12B;GATA2,MEP,0.11931939791106433
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8370121386613745,0,0,0.5757014372366809,0.1108560647358729,GATA1,MEP,0.0836269880293983
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8593187945172354,0,0,0.5290423861852434,0.0863986224716518,GATA1,MEP,0.07092521499844862
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),1/764,0.8577067842472734,0.8652525917333198,0,0,0.5131997753229732,0.0787725634671716,EPGN,MEP,0.06666115474745983
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",1/948,0.912055183209665,0.9173888392518268,0,0,0.4095209361463698,0.0376983608425212,GATA1,MEP,0.039978884217174375
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),3/2206,0.924809545507298,0.9275057832493018,0,0,0.5142021035145498,0.0401938720592393,TFR2;GATA2;GATA1,MEP,0.03394769628973127
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",2/2244,0.9810359386268036,0.9810359386268036,0,0,0.3290960451977401,0.006300933896412,GATA2;GATA1,MEP,0.008315082669573565
GO_Biological_Process_2021,defense response to Gram-negative bacterium (GO:0050829),4/73,3.312541129342562e-05,0.0150720621385086,0,0,25.054820415879018,258.4457305274999,AZU1;RNASE3;RNASE2;ELANE,MPP,4.479838720712305
GO_Biological_Process_2021,induction of bacterial agglutination (GO:0043152),2/6,9.128927051395768e-05,0.0207683090419253,0,0,207.77083333333337,1932.5756890799971,RNASE3;RNASE2,MPP,4.039580263324499
GO_Biological_Process_2021,protein kinase C signaling (GO:0070528),2/11,0.000332063883264561,0.0468389720646027,0,0,92.31944444444444,739.4956618223716,AVP;AZU1,MPP,3.478778357620151
GO_Biological_Process_2021,regulation of phagocytosis (GO:0050764),3/58,0.00041177118298551824,0.0468389720646027,0,0,23.088974854932303,179.97954590931704,PRTN3;AZU1;GATA2,MPP,3.3853440499187784
GO_Biological_Process_2021,DNA unwinding involved in DNA replication (GO:0006268),2/16,0.0007187392304892979,0.0632698226813445,0,0,59.333333333333336,429.45537567816734,HMGA1;MCM2,MPP,3.14342864967499
GO_Biological_Process_2021,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),2/18,0.000913470506242016,0.0632698226813445,0,0,51.911458333333336,363.2898548418271,GNA15;RGS10,MPP,3.039305470405725
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),4/176,0.0009733818874053012,0.0632698226813445,0,0,9.998988877654195,69.34032881835857,AZU1;RNASE3;RNASE2;ELANE,MPP,3.011716739326452
GO_Biological_Process_2021,innate immune response in mucosa (GO:0002227),2/21,0.0012477930702112,0.0692805074154123,0,0,43.708333333333336,292.25047477799524,RNASE3;RNASE2,MPP,2.9038574306125264
GO_Biological_Process_2021,microglial cell activation (GO:0001774),2/22,0.001370383663162,0.0692805074154123,0,0,41.520833333333336,273.7329252658829,AZU1;AIF1,MPP,2.8631578273928713
GO_Biological_Process_2021,positive regulation of transport (GO:0051050),3/91,0.0015300336428855,0.0693496899153773,0,0,14.406673114119922,93.39076222450518,MLC1;AZU1;GATA2,MPP,2.8152990196667855
GO_Biological_Process_2021,nucleobase-containing small molecule interconversion (GO:0015949),2/27,0.0020657293545543,0.0693496899153773,0,0,33.208333333333336,205.3029465636782,RRM2;TYMS,MPP,2.684926579003782
GO_Biological_Process_2021,mucosal immune response (GO:0002385),2/28,0.0022210873543451,0.0693496899153773,0,0,31.92948717948718,195.08145262248803,RNASE3;RNASE2,MPP,2.6534343605132076
GO_Biological_Process_2021,DNA replication (GO:0006260),3/108,0.0024958414919694,0.0693496899153773,0,0,12.063829787234043,72.30009219407567,PCLAF;NT5M;MCM2,MPP,2.6027829996582548
GO_Biological_Process_2021,CENP-A containing chromatin organization (GO:0061641),2/30,0.0025478771667966,0.0693496899153773,0,0,29.645833333333332,177.0595839464994,CENPW;CENPM,MPP,2.5938215131766835
GO_Biological_Process_2021,CENP-A containing nucleosome assembly (GO:0034080),2/30,0.0025478771667966,0.0693496899153773,0,0,29.645833333333332,177.0595839464994,CENPW;CENPM,MPP,2.5938215131766835
GO_Biological_Process_2021,negative regulation of chemotaxis (GO:0050922),2/32,0.0028959211173454,0.0693496899153773,0,0,27.666666666666668,161.69650653172428,AIF1;ELANE,MPP,2.5382132721600397
GO_Biological_Process_2021,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),2/32,0.0028959211173454,0.0693496899153773,0,0,27.666666666666668,161.69650653172428,RRM2;TYMS,MPP,2.5382132721600397
GO_Biological_Process_2021,regulation of chemotaxis (GO:0050920),2/32,0.0028959211173454,0.0693496899153773,0,0,27.666666666666668,161.69650653172428,AIF1;ELANE,MPP,2.5382132721600397
GO_Biological_Process_2021,chromatin remodeling at centromere (GO:0031055),2/32,0.0028959211173454,0.0693496899153773,0,0,27.666666666666668,161.69650653172428,CENPW;CENPM,MPP,2.5382132721600397
GO_Biological_Process_2021,macrophage activation (GO:0042116),2/36,0.0036549257227984,0.0791900573272991,0,0,24.40686274509804,136.96349152286243,AZU1;AIF1,MPP,2.437121444562911
GO_Biological_Process_2021,platelet aggregation (GO:0070527),2/36,0.0036549257227984,0.0791900573272991,0,0,24.40686274509804,136.96349152286243,GATA1;FERMT3,MPP,2.437121444562911
GO_Biological_Process_2021,centromere complex assembly (GO:0034508),2/37,0.0038576315924392,0.0797828352072657,0,0,23.708333333333332,131.76384828572083,CENPW;CENPM,MPP,2.4136792502562754
GO_Biological_Process_2021,histone exchange (GO:0043486),2/38,0.0040654672914765,0.0804255485922525,0,0,23.04861111111111,126.88782669928548,CENPW;CENPM,MPP,2.390889528680986
GO_Biological_Process_2021,DNA replication-independent nucleosome assembly (GO:0006336),2/39,0.0042784069542198,0.0811114651737511,0,0,22.42454954954955,122.3074073504305,CENPW;CENPM,MPP,2.368717908505425
GO_Biological_Process_2021,nucleobase-containing compound catabolic process (GO:0034655),2/41,0.0047194951697385,0.0858948120892421,0,0,21.272435897435894,113.93630347986566,RNASE3;RNASE2,MPP,2.3261044540613445
GO_Biological_Process_2021,regulation of chemokine production (GO:0032642),2/42,0.0049475924537835,0.0865828679412122,0,0,20.739583333333332,110.1034239545967,AIF1;ELANE,MPP,2.3056060815494894
GO_Biological_Process_2021,antibacterial humoral response (GO:0019731),2/44,0.0054187658916089,0.0880549457386461,0,0,19.75,103.05327189846057,RNASE3;RNASE2,MPP,2.266099611522887
GO_Biological_Process_2021,homotypic cell-cell adhesion (GO:0034109),2/44,0.0054187658916089,0.0880549457386461,0,0,19.75,103.05327189846057,GATA1;FERMT3,MPP,2.266099611522887
GO_Biological_Process_2021,proteolysis (GO:0006508),4/287,0.0056959581367739,0.0885451099483232,0,0,6.043017360577662,31.23030437987747,PRSS57;PRTN3;AZU1;ELANE,MPP,2.2444332112663723
GO_Biological_Process_2021,positive regulation of smooth muscle cell proliferation (GO:0048661),2/46,0.0059097422436154,0.0885451099483232,0,0,18.85037878787879,96.72417883948356,AIF1;ELANE,MPP,2.2284314606782503
GO_Biological_Process_2021,regulation of smooth muscle cell proliferation (GO:0048660),2/49,0.0066828970303688,0.0885451099483232,0,0,17.64450354609929,88.36726791367238,AIF1;ELANE,MPP,2.175035230405133
GO_Biological_Process_2021,RNA catabolic process (GO:0006401),2/49,0.0066828970303688,0.0885451099483232,0,0,17.64450354609929,88.36726791367238,RNASE3;RNASE2,MPP,2.175035230405133
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),5/481,0.006857817428032,0.0885451099483232,0,0,4.545751633986928,22.648598599483577,PRTN3;AZU1;RNASE3;RNASE2;ELANE,MPP,2.163814081054509
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),5/485,0.0070959676294594,0.0885451099483232,0,0,4.506944444444445,22.30139137962044,PRTN3;AZU1;RNASE3;RNASE2;ELANE,MPP,2.148988374345894
GO_Biological_Process_2021,DNA duplex unwinding (GO:0032508),2/51,0.0072225026271421,0.0885451099483232,0,0,16.922619047619047,83.43788300609687,HMGA1;MCM2,MPP,2.1413122915117184
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),5/488,0.0072783553709236,0.0885451099483232,0,0,4.478260869565218,22.045808102039476,PRTN3;AZU1;RNASE3;RNASE2;ELANE,MPP,2.1379667434923895
GO_Biological_Process_2021,positive regulation of chemokine production (GO:0032722),2/53,0.0077812124839393,0.0885451099483232,0,0,16.25735294117647,78.94640668269977,AZU1;AIF1,MPP,2.108952725111067
GO_Biological_Process_2021,cellular macromolecule catabolic process (GO:0044265),2/53,0.0077812124839393,0.0885451099483232,0,0,16.25735294117647,78.94640668269977,RNASE3;RNASE2,MPP,2.108952725111067
GO_Biological_Process_2021,positive regulation of phagocytosis (GO:0050766),2/53,0.0077812124839393,0.0885451099483232,0,0,16.25735294117647,78.94640668269977,AZU1;GATA2,MPP,2.108952725111067
GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),4/314,0.0077841854899624,0.0885451099483232,0,0,5.5091164095371665,26.75040227125582,PCLAF;NT5M;TYMS;MCM2,MPP,2.108786823779362
GO_Biological_Process_2021,regulation of megakaryocyte differentiation (GO:0045652),2/54,0.0080676700842631,0.0895314606912131,0,0,15.943910256410255,76.8479024006269,ITGA2B;GATA1,MPP,2.0932518699428635
GO_Biological_Process_2021,positive regulation of mitotic cell cycle phase transition (GO:1901992),2/58,0.0092602829393189,0.1003197318426224,0,0,14.802083333333334,69.30366021141536,UBE2C;AIF1,MPP,2.033375743652011
GO_Biological_Process_2021,protein polymerization (GO:0051258),2/59,0.0095700107879558,0.1012640676399974,0,0,14.541666666666666,67.6059670933825,UBE2C;AIF1,MPP,2.019087572657113
GO_Biological_Process_2021,response to light stimulus (GO:0009416),2/61,0.0102031878981958,0.1055102384927072,0,0,14.04731638418079,64.40771918587598,PCLAF;ELANE,MPP,1.9912641154648159
GO_Biological_Process_2021,pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),1/5,0.0124387771927725,0.1076115501023148,0,0,101.76530612244898,446.4379351400606,TYMS,MPP,1.9052223113279663
GO_Biological_Process_2021,caveolin-mediated endocytosis (GO:0072584),1/5,0.0124387771927725,0.1076115501023148,0,0,101.76530612244898,446.4379351400606,MLC1,MPP,1.9052223113279663
GO_Biological_Process_2021,regulation of glycoprotein metabolic process (GO:1903018),1/5,0.0124387771927725,0.1076115501023148,0,0,101.76530612244898,446.4379351400606,GATA1,MPP,1.9052223113279663
GO_Biological_Process_2021,mature conventional dendritic cell differentiation (GO:0097029),1/5,0.0124387771927725,0.1076115501023148,0,0,101.76530612244898,446.4379351400606,PRTN3,MPP,1.9052223113279663
GO_Biological_Process_2021,deoxyribonucleotide metabolic process (GO:0009262),1/5,0.0124387771927725,0.1076115501023148,0,0,101.76530612244898,446.4379351400606,RRM2,MPP,1.9052223113279663
GO_Biological_Process_2021,regulation of myeloid cell differentiation (GO:0045637),2/68,0.0125608922452035,0.1076115501023148,0,0,12.553030303030305,54.94671101969335,ITGA2B;GATA1,MPP,1.9009795100092206
GO_Biological_Process_2021,defense response to Gram-positive bacterium (GO:0050830),2/70,0.013274200561286,0.1076115501023148,0,0,12.182598039215684,52.65237170003471,RNASE3;RNASE2,MPP,1.8769916248436092
GO_Biological_Process_2021,regulation of hematopoietic stem cell differentiation (GO:1902036),2/71,0.0136373517747766,0.1076115501023148,0,0,12.005434782608695,51.56265564232933,GATA2;GATA1,MPP,1.8652699567516449
GO_Biological_Process_2021,mitotic nuclear division (GO:0140014),2/74,0.0147525184670075,0.1076115501023148,0,0,11.50347222222222,48.50256694786101,UBE2C;ZWINT,MPP,1.8311338330445346
GO_Biological_Process_2021,regulation of serine-type endopeptidase activity (GO:1900003),1/6,0.0149082847993736,0.1076115501023148,0,0,81.40816326530613,342.3895623444841,SPINK2,MPP,1.8265723193247598
GO_Biological_Process_2021,free ubiquitin chain polymerization (GO:0010994),1/6,0.0149082847993736,0.1076115501023148,0,0,81.40816326530613,342.3895623444841,UBE2C,MPP,1.8265723193247598
GO_Biological_Process_2021,negative regulation of fat cell proliferation (GO:0070345),1/6,0.0149082847993736,0.1076115501023148,0,0,81.40816326530613,342.3895623444841,GATA2,MPP,1.8265723193247598
GO_Biological_Process_2021,ruffle assembly (GO:0097178),1/6,0.0149082847993736,0.1076115501023148,0,0,81.40816326530613,342.3895623444841,AIF1,MPP,1.8265723193247598
GO_Biological_Process_2021,negative regulation of serine-type peptidase activity (GO:1902572),1/6,0.0149082847993736,0.1076115501023148,0,0,81.40816326530613,342.3895623444841,SPINK2,MPP,1.8265723193247598
GO_Biological_Process_2021,neutrophil extravasation (GO:0072672),1/6,0.0149082847993736,0.1076115501023148,0,0,81.40816326530613,342.3895623444841,PRTN3,MPP,1.8265723193247598
GO_Biological_Process_2021,nuclear cell cycle DNA replication initiation (GO:1902315),1/6,0.0149082847993736,0.1076115501023148,0,0,81.40816326530613,342.3895623444841,MCM2,MPP,1.8265723193247598
GO_Biological_Process_2021,mitotic DNA replication initiation (GO:1902975),1/6,0.0149082847993736,0.1076115501023148,0,0,81.40816326530613,342.3895623444841,MCM2,MPP,1.8265723193247598
GO_Biological_Process_2021,integrin-mediated signaling pathway (GO:0007229),2/75,0.0151327357621299,0.1076115501023148,0,0,11.345319634703197,47.54704276850611,ITGA2B;FERMT3,MPP,1.820082551223806
GO_Biological_Process_2021,regulation of hematopoietic progenitor cell differentiation (GO:1901532),2/75,0.0151327357621299,0.1076115501023148,0,0,11.345319634703197,47.54704276850611,GATA2;GATA1,MPP,1.820082551223806
GO_Biological_Process_2021,positive regulation of interleukin-6 production (GO:0032755),2/76,0.0155171628224907,0.1076115501023148,0,0,11.19144144144144,46.62140287744705,C1QTNF4;AIF1,MPP,1.8091876827669675
GO_Biological_Process_2021,positive regulation of tumor necrosis factor production (GO:0032760),2/77,0.0159057771109684,0.1076115501023148,0,0,11.041666666666666,45.72434655376785,C1QTNF4;AZU1,MPP,1.7984451076467942
GO_Biological_Process_2021,glial cell migration (GO:0008347),1/7,0.0173717414502839,0.1076115501023148,0,0,67.83673469387755,274.9362107684438,AZU1,MPP,1.7601566430186848
GO_Biological_Process_2021,regulation of fat cell proliferation (GO:0070344),1/7,0.0173717414502839,0.1076115501023148,0,0,67.83673469387755,274.9362107684438,GATA2,MPP,1.7601566430186848
GO_Biological_Process_2021,creatine metabolic process (GO:0006600),1/7,0.0173717414502839,0.1076115501023148,0,0,67.83673469387755,274.9362107684438,GAMT,MPP,1.7601566430186848
GO_Biological_Process_2021,vascular wound healing (GO:0061042),1/7,0.0173717414502839,0.1076115501023148,0,0,67.83673469387755,274.9362107684438,GATA2,MPP,1.7601566430186848
GO_Biological_Process_2021,parallel actin filament bundle assembly (GO:0030046),1/7,0.0173717414502839,0.1076115501023148,0,0,67.83673469387755,274.9362107684438,AIF1,MPP,1.7601566430186848
GO_Biological_Process_2021,zinc ion import across plasma membrane (GO:0071578),1/7,0.0173717414502839,0.1076115501023148,0,0,67.83673469387755,274.9362107684438,SLC39A4,MPP,1.7601566430186848
GO_Biological_Process_2021,phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),1/7,0.0173717414502839,0.1076115501023148,0,0,67.83673469387755,274.9362107684438,GNA15,MPP,1.7601566430186848
GO_Biological_Process_2021,polyamine biosynthetic process (GO:0006596),1/7,0.0173717414502839,0.1076115501023148,0,0,67.83673469387755,274.9362107684438,SMOX,MPP,1.7601566430186848
GO_Biological_Process_2021,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/81,0.0175016586979588,0.1076115501023148,0,0,10.48048523206751,42.398379802278754,C1QTNF4;AZU1,MPP,1.7569207896432026
GO_Biological_Process_2021,G1/S transition of mitotic cell cycle (GO:0000082),2/85,0.0191627543313976,0.111386030373941,0,0,9.973393574297187,39.44264488506008,RRM2;TYMS,MPP,1.717542068067663
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),5/625,0.0195349467399156,0.111386030373941,0,0,3.46415770609319,13.633366819342184,MLC1;PRTN3;AZU1;GATA2;AIF1,MPP,1.7091877684981829
GO_Biological_Process_2021,negative regulation of neural precursor cell proliferation (GO:2000178),1/8,0.0198291614511851,0.111386030373941,0,0,58.142857142857146,227.9549801512961,GATA2,MPP,1.702695651141308
GO_Biological_Process_2021,positive regulation of MHC class II biosynthetic process (GO:0045348),1/8,0.0198291614511851,0.111386030373941,0,0,58.142857142857146,227.9549801512961,AZU1,MPP,1.702695651141308
GO_Biological_Process_2021,integrin activation (GO:0033622),1/8,0.0198291614511851,0.111386030373941,0,0,58.142857142857146,227.9549801512961,FERMT3,MPP,1.702695651141308
GO_Biological_Process_2021,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),1/8,0.0198291614511851,0.111386030373941,0,0,58.142857142857146,227.9549801512961,UBE2C,MPP,1.702695651141308
GO_Biological_Process_2021,pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),1/8,0.0198291614511851,0.111386030373941,0,0,58.142857142857146,227.9549801512961,MCM2,MPP,1.702695651141308
GO_Biological_Process_2021,regulation of stem cell differentiation (GO:2000736),2/91,0.0217736102157896,0.115650214509422,0,0,9.298220973782772,35.5848177883064,GATA2;GATA1,MPP,1.6620695559472094
GO_Biological_Process_2021,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),1/9,0.0222805591236868,0.115650214509422,0,0,50.87244897959184,193.52086993316271,GATA2,MPP,1.652073914876897
GO_Biological_Process_2021,kinetochore assembly (GO:0051382),1/9,0.0222805591236868,0.115650214509422,0,0,50.87244897959184,193.52086993316271,CENPW,MPP,1.652073914876897
GO_Biological_Process_2021,tetrahydrofolate interconversion (GO:0035999),1/9,0.0222805591236868,0.115650214509422,0,0,50.87244897959184,193.52086993316271,TYMS,MPP,1.652073914876897
GO_Biological_Process_2021,regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/10,0.024725948817258,0.115650214509422,0,0,45.21768707482993,167.3010120823387,FERMT3,MPP,1.606847034080906
GO_Biological_Process_2021,cellular biogenic amine catabolic process (GO:0042402),1/10,0.024725948817258,0.115650214509422,0,0,45.21768707482993,167.3010120823387,SMOX,MPP,1.606847034080906
GO_Biological_Process_2021,regulation of glycoprotein biosynthetic process (GO:0010559),1/10,0.024725948817258,0.115650214509422,0,0,45.21768707482993,167.3010120823387,GATA1,MPP,1.606847034080906
GO_Biological_Process_2021,mitotic DNA replication (GO:1902969),1/10,0.024725948817258,0.115650214509422,0,0,45.21768707482993,167.3010120823387,MCM2,MPP,1.606847034080906
GO_Biological_Process_2021,monocyte activation (GO:0042117),1/10,0.024725948817258,0.115650214509422,0,0,45.21768707482993,167.3010120823387,AZU1,MPP,1.606847034080906
GO_Biological_Process_2021,response to UV (GO:0009411),2/99,0.0254700751762328,0.115650214509422,0,0,8.527920962199312,31.299610767204847,PCLAF;ELANE,MPP,1.5939697731920623
GO_Biological_Process_2021,erythrocyte development (GO:0048821),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,GATA1,MPP,1.5659847773237099
GO_Biological_Process_2021,pyrimidine nucleoside catabolic process (GO:0046135),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,NT5M,MPP,1.5659847773237099
GO_Biological_Process_2021,pyrimidine nucleoside salvage (GO:0043097),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,TK1,MPP,1.5659847773237099
GO_Biological_Process_2021,pyrimidine-containing compound salvage (GO:0008655),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,TK1,MPP,1.5659847773237099
GO_Biological_Process_2021,angiogenesis involved in wound healing (GO:0060055),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,GATA2,MPP,1.5659847773237099
GO_Biological_Process_2021,cell-cell junction maintenance (GO:0045217),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,PRTN3,MPP,1.5659847773237099
GO_Biological_Process_2021,induction of positive chemotaxis (GO:0050930),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,AZU1,MPP,1.5659847773237099
GO_Biological_Process_2021,cellular response to cholesterol (GO:0071397),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,MLC1,MPP,1.5659847773237099
GO_Biological_Process_2021,tetrahydrofolate metabolic process (GO:0046653),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,TYMS,MPP,1.5659847773237099
GO_Biological_Process_2021,nuclear DNA replication (GO:0033260),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,MCM2,MPP,1.5659847773237099
GO_Biological_Process_2021,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),1/11,0.0271653448579923,0.115650214509422,0,0,40.69387755102041,146.73452100035948,AZU1,MPP,1.5659847773237099
GO_Biological_Process_2021,actin crosslink formation (GO:0051764),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,AIF1,MPP,1.5287264597194943
GO_Biological_Process_2021,exit from mitosis (GO:0010458),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,UBE2C,MPP,1.5287264597194943
GO_Biological_Process_2021,positive regulation of cellular senescence (GO:2000774),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,HMGA1,MPP,1.5287264597194943
GO_Biological_Process_2021,cell cycle checkpoint signaling (GO:0000075),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,ZWINT,MPP,1.5287264597194943
GO_Biological_Process_2021,cellular response to thyroid hormone stimulus (GO:0097067),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,GATA1,MPP,1.5287264597194943
GO_Biological_Process_2021,macrophage chemotaxis (GO:0048246),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,AZU1,MPP,1.5287264597194943
GO_Biological_Process_2021,megakaryocyte differentiation (GO:0030219),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,GATA1,MPP,1.5287264597194943
GO_Biological_Process_2021,nucleoside catabolic process (GO:0009164),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,NT5M,MPP,1.5287264597194943
GO_Biological_Process_2021,regulation of MHC class II biosynthetic process (GO:0045346),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,AZU1,MPP,1.5287264597194943
GO_Biological_Process_2021,nucleoside salvage (GO:0043174),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,TK1,MPP,1.5287264597194943
GO_Biological_Process_2021,positive regulation of ubiquitin protein ligase activity (GO:1904668),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,UBE2C,MPP,1.5287264597194943
GO_Biological_Process_2021,double-strand break repair via break-induced replication (GO:0000727),1/12,0.029598761568907,0.115650214509422,0,0,36.99257884972171,130.2147194065139,MCM2,MPP,1.5287264597194943
GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),2/110,0.0309363405009925,0.115650214509422,0,0,7.655092592592593,26.607752397672005,C1QTNF4;AIF1,MPP,1.5095310608442127
GO_Biological_Process_2021,cellular divalent inorganic cation homeostasis (GO:0072503),2/111,0.0314544847807964,0.115650214509422,0,0,7.584480122324159,26.23633758944092,SLC39A4;ELANE,MPP,1.5023174240917434
GO_Biological_Process_2021,regulation of response to stress (GO:0080134),1/13,0.032026213248763,0.115650214509422,0,0,33.90816326530612,116.6847899929619,MLC1,MPP,1.4944944088974865
GO_Biological_Process_2021,positive regulation of cell aging (GO:0090343),1/13,0.032026213248763,0.115650214509422,0,0,33.90816326530612,116.6847899929619,HMGA1,MPP,1.4944944088974865
GO_Biological_Process_2021,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),1/13,0.032026213248763,0.115650214509422,0,0,33.90816326530612,116.6847899929619,NT5M,MPP,1.4944944088974865
GO_Biological_Process_2021,negative regulation of chromatin organization (GO:1905268),1/13,0.032026213248763,0.115650214509422,0,0,33.90816326530612,116.6847899929619,HMGA1,MPP,1.4944944088974865
GO_Biological_Process_2021,negative regulation of chromatin silencing (GO:0031936),1/13,0.032026213248763,0.115650214509422,0,0,33.90816326530612,116.6847899929619,HMGA1,MPP,1.4944944088974865
GO_Biological_Process_2021,negative regulation of gene silencing (GO:0060969),1/13,0.032026213248763,0.115650214509422,0,0,33.90816326530612,116.6847899929619,HMGA1,MPP,1.4944944088974865
GO_Biological_Process_2021,negative regulation of locomotion (GO:0040013),1/13,0.032026213248763,0.115650214509422,0,0,33.90816326530612,116.6847899929619,ELANE,MPP,1.4944944088974865
GO_Biological_Process_2021,response to thyroid hormone (GO:0097066),1/13,0.032026213248763,0.115650214509422,0,0,33.90816326530612,116.6847899929619,GATA1,MPP,1.4944944088974865
GO_Biological_Process_2021,kinetochore organization (GO:0051383),1/13,0.032026213248763,0.115650214509422,0,0,33.90816326530612,116.6847899929619,CENPW,MPP,1.4944944088974865
GO_Biological_Process_2021,polyamine metabolic process (GO:0006595),1/13,0.032026213248763,0.115650214509422,0,0,33.90816326530612,116.6847899929619,SMOX,MPP,1.4944944088974865
GO_Biological_Process_2021,pyrimidine nucleoside biosynthetic process (GO:0046134),1/14,0.0344477141698711,0.120566999594549,0,0,31.298273155416013,105.4223689491126,TK1,MPP,1.4628395910668823
GO_Biological_Process_2021,cell junction maintenance (GO:0034331),1/14,0.0344477141698711,0.120566999594549,0,0,31.298273155416013,105.4223689491126,PRTN3,MPP,1.4628395910668823
GO_Biological_Process_2021,positive regulation of lymphocyte migration (GO:2000403),1/14,0.0344477141698711,0.120566999594549,0,0,31.298273155416013,105.4223689491126,AIF1,MPP,1.4628395910668823
GO_Biological_Process_2021,negative regulation of smooth muscle cell migration (GO:0014912),1/14,0.0344477141698711,0.120566999594549,0,0,31.298273155416013,105.4223689491126,AIF1,MPP,1.4628395910668823
GO_Biological_Process_2021,pyrimidine nucleoside metabolic process (GO:0006213),1/15,0.0368632785936063,0.1207826619745938,0,0,29.06122448979592,95.91771596133704,NT5M,MPP,1.4334060415588732
GO_Biological_Process_2021,glucan catabolic process (GO:0009251),1/15,0.0368632785936063,0.1207826619745938,0,0,29.06122448979592,95.91771596133704,PHKG1,MPP,1.4334060415588732
GO_Biological_Process_2021,glycogen catabolic process (GO:0005980),1/15,0.0368632785936063,0.1207826619745938,0,0,29.06122448979592,95.91771596133704,PHKG1,MPP,1.4334060415588732
GO_Biological_Process_2021,macrophage migration (GO:1905517),1/15,0.0368632785936063,0.1207826619745938,0,0,29.06122448979592,95.91771596133704,AZU1,MPP,1.4334060415588732
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),2/124,0.038497072428768,0.1207826619745938,0,0,6.771857923497268,22.05711333941876,C1QTNF4;AZU1,MPP,1.4145722958518654
GO_Biological_Process_2021,defense response to symbiont (GO:0140546),2/124,0.038497072428768,0.1207826619745938,0,0,6.771857923497268,22.05711333941876,AZU1;RNASE2,MPP,1.4145722958518654
GO_Biological_Process_2021,platelet degranulation (GO:0002576),2/125,0.0390617280151273,0.1207826619745938,0,0,6.716463414634147,21.77888563484535,ITGA2B;FERMT3,MPP,1.408248548277182
GO_Biological_Process_2021,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/16,0.0392729207344652,0.1207826619745938,0,0,27.122448979591837,87.80133530116419,GATA2,MPP,1.405906798966597
GO_Biological_Process_2021,response to organophosphorus (GO:0046683),1/16,0.0392729207344652,0.1207826619745938,0,0,27.122448979591837,87.80133530116419,TYMS,MPP,1.405906798966597
GO_Biological_Process_2021,regulation of chromatin silencing (GO:0031935),1/16,0.0392729207344652,0.1207826619745938,0,0,27.122448979591837,87.80133530116419,HMGA1,MPP,1.405906798966597
GO_Biological_Process_2021,cellular polysaccharide catabolic process (GO:0044247),1/16,0.0392729207344652,0.1207826619745938,0,0,27.122448979591837,87.80133530116419,PHKG1,MPP,1.405906798966597
GO_Biological_Process_2021,negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/16,0.0392729207344652,0.1207826619745938,0,0,27.122448979591837,87.80133530116419,AVP,MPP,1.405906798966597
GO_Biological_Process_2021,negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.0392729207344652,0.1207826619745938,0,0,27.122448979591837,87.80133530116419,GATA1,MPP,1.405906798966597
GO_Biological_Process_2021,cellular response to sterol (GO:0036315),1/16,0.0392729207344652,0.1207826619745938,0,0,27.122448979591837,87.80133530116419,MLC1,MPP,1.405906798966597
GO_Biological_Process_2021,nuclear transport (GO:0051169),1/16,0.0392729207344652,0.1207826619745938,0,0,27.122448979591837,87.80133530116419,HMGA1,MPP,1.405906798966597
GO_Biological_Process_2021,regulation of mitotic sister chromatid separation (GO:0010965),1/16,0.0392729207344652,0.1207826619745938,0,0,27.122448979591837,87.80133530116419,UBE2C,MPP,1.405906798966597
GO_Biological_Process_2021,microtubule cytoskeleton organization involved in mitosis (GO:1902850),2/128,0.0407746939326368,0.1207826619745938,0,0,6.555555555555555,20.975769396496517,CENPM;ZWINT,MPP,1.3896092902230834
GO_Biological_Process_2021,DNA-dependent DNA replication (GO:0006261),2/129,0.0413519534712599,0.1207826619745938,0,0,6.5036089238845145,20.718128222258283,HMGA1;MCM2,MPP,1.383503969503222
GO_Biological_Process_2021,negative regulation of chemokine production (GO:0032682),1/17,0.0416766547912334,0.1207826619745938,0,0,25.426020408163264,80.79916728086499,ELANE,MPP,1.3801071472903907
GO_Biological_Process_2021,pyrimidine-containing compound catabolic process (GO:0072529),1/17,0.0416766547912334,0.1207826619745938,0,0,25.426020408163264,80.79916728086499,NT5M,MPP,1.3801071472903907
GO_Biological_Process_2021,gliogenesis (GO:0042063),1/17,0.0416766547912334,0.1207826619745938,0,0,25.426020408163264,80.79916728086499,AZU1,MPP,1.3801071472903907
GO_Biological_Process_2021,cellular biogenic amine biosynthetic process (GO:0042401),1/17,0.0416766547912334,0.1207826619745938,0,0,25.426020408163264,80.79916728086499,SMOX,MPP,1.3801071472903907
GO_Biological_Process_2021,negative regulation of phagocytosis (GO:0050765),1/17,0.0416766547912334,0.1207826619745938,0,0,25.426020408163264,80.79916728086499,PRTN3,MPP,1.3801071472903907
GO_Biological_Process_2021,ruffle organization (GO:0031529),1/17,0.0416766547912334,0.1207826619745938,0,0,25.426020408163264,80.79916728086499,AIF1,MPP,1.3801071472903907
GO_Biological_Process_2021,positive regulation of positive chemotaxis (GO:0050927),1/17,0.0416766547912334,0.1207826619745938,0,0,25.426020408163264,80.79916728086499,AZU1,MPP,1.3801071472903907
GO_Biological_Process_2021,positive regulation of smooth muscle cell migration (GO:0014911),1/17,0.0416766547912334,0.1207826619745938,0,0,25.426020408163264,80.79916728086499,AIF1,MPP,1.3801071472903907
GO_Biological_Process_2021,DNA biosynthetic process (GO:0071897),1/17,0.0416766547912334,0.1207826619745938,0,0,25.426020408163264,80.79916728086499,TYMS,MPP,1.3801071472903907
GO_Biological_Process_2021,RNA metabolic process (GO:0016070),2/133,0.043691853040543,0.1208065975537359,0,0,6.303753180661578,19.734489511742076,RNASE3;RNASE2,MPP,1.3595995357844428
GO_Biological_Process_2021,defense response to virus (GO:0051607),2/133,0.043691853040543,0.1208065975537359,0,0,6.303753180661578,19.734489511742076,AZU1;RNASE2,MPP,1.3595995357844428
GO_Biological_Process_2021,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/18,0.0440744949316926,0.1208065975537359,0,0,23.92917166866747,74.70385911458476,GATA2,MPP,1.3558126557645607
GO_Biological_Process_2021,fluid transport (GO:0042044),1/18,0.0440744949316926,0.1208065975537359,0,0,23.92917166866747,74.70385911458476,AVP,MPP,1.3558126557645607
GO_Biological_Process_2021,negative regulation of interleukin-8 production (GO:0032717),1/18,0.0440744949316926,0.1208065975537359,0,0,23.92917166866747,74.70385911458476,ELANE,MPP,1.3558126557645607
GO_Biological_Process_2021,chromatin disassembly (GO:0031498),1/18,0.0440744949316926,0.1208065975537359,0,0,23.92917166866747,74.70385911458476,HMGA1,MPP,1.3558126557645607
GO_Biological_Process_2021,nucleosome disassembly (GO:0006337),1/18,0.0440744949316926,0.1208065975537359,0,0,23.92917166866747,74.70385911458476,HMGA1,MPP,1.3558126557645607
GO_Biological_Process_2021,nucleotide biosynthetic process (GO:0009165),1/18,0.0440744949316926,0.1208065975537359,0,0,23.92917166866747,74.70385911458476,RRM2,MPP,1.3558126557645607
GO_Biological_Process_2021,water transport (GO:0006833),1/18,0.0440744949316926,0.1208065975537359,0,0,23.92917166866747,74.70385911458476,AVP,MPP,1.3558126557645607
GO_Biological_Process_2021,Rac protein signal transduction (GO:0016601),1/19,0.0464664552952436,0.1251019950256559,0,0,22.598639455782312,69.35578082800635,AIF1,MPP,1.3328604565168853
GO_Biological_Process_2021,response to cholesterol (GO:0070723),1/19,0.0464664552952436,0.1251019950256559,0,0,22.598639455782312,69.35578082800635,MLC1,MPP,1.3328604565168853
GO_Biological_Process_2021,positive regulation of monocyte chemotaxis (GO:0090026),1/19,0.0464664552952436,0.1251019950256559,0,0,22.598639455782312,69.35578082800635,AIF1,MPP,1.3328604565168853
GO_Biological_Process_2021,protein-DNA complex disassembly (GO:0032986),1/20,0.0488525499820277,0.1270166299532721,0,0,21.40816326530612,64.63014669364038,HMGA1,MPP,1.3111127622579986
GO_Biological_Process_2021,regulation of T cell migration (GO:2000404),1/20,0.0488525499820277,0.1270166299532721,0,0,21.40816326530612,64.63014669364038,AIF1,MPP,1.3111127622579986
GO_Biological_Process_2021,granulocyte differentiation (GO:0030851),1/20,0.0488525499820277,0.1270166299532721,0,0,21.40816326530612,64.63014669364038,GATA1,MPP,1.3111127622579986
GO_Biological_Process_2021,cellular modified amino acid biosynthetic process (GO:0042398),1/20,0.0488525499820277,0.1270166299532721,0,0,21.40816326530612,64.63014669364038,GAMT,MPP,1.3111127622579986
GO_Biological_Process_2021,nucleobase-containing compound biosynthetic process (GO:0034654),1/20,0.0488525499820277,0.1270166299532721,0,0,21.40816326530612,64.63014669364038,TYMS,MPP,1.3111127622579986
GO_Biological_Process_2021,myeloid cell development (GO:0061515),1/20,0.0488525499820277,0.1270166299532721,0,0,21.40816326530612,64.63014669364038,GATA1,MPP,1.3111127622579986
GO_Biological_Process_2021,acetylcholine receptor signaling pathway (GO:0095500),1/21,0.0512327930672156,0.1274163832762432,0,0,20.336734693877553,60.42807445408675,RGS10,MPP,1.2904519669693806
GO_Biological_Process_2021,regulation of ubiquitin protein ligase activity (GO:1904666),1/21,0.0512327930672156,0.1274163832762432,0,0,20.336734693877553,60.42807445408675,UBE2C,MPP,1.2904519669693806
GO_Biological_Process_2021,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.0512327930672156,0.1274163832762432,0,0,20.336734693877553,60.42807445408675,AZU1,MPP,1.2904519669693806
GO_Biological_Process_2021,spindle assembly checkpoint signaling (GO:0071173),1/21,0.0512327930672156,0.1274163832762432,0,0,20.336734693877553,60.42807445408675,ZWINT,MPP,1.2904519669693806
GO_Biological_Process_2021,mitotic spindle assembly checkpoint signaling (GO:0007094),1/21,0.0512327930672156,0.1274163832762432,0,0,20.336734693877553,60.42807445408675,ZWINT,MPP,1.2904519669693806
GO_Biological_Process_2021,mitotic spindle checkpoint signaling (GO:0071174),1/21,0.0512327930672156,0.1274163832762432,0,0,20.336734693877553,60.42807445408675,ZWINT,MPP,1.2904519669693806
GO_Biological_Process_2021,zinc ion transport (GO:0006829),1/21,0.0512327930672156,0.1274163832762432,0,0,20.336734693877553,60.42807445408675,SLC39A4,MPP,1.2904519669693806
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),3/335,0.0512465893176978,0.1274163832762432,0,0,3.7717251986670086,11.206196171777655,C1QTNF4;AIF1;ELANE,MPP,1.2903350334876962
GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),2/149,0.0535249876216422,0.1311358890465641,0,0,5.613095238095238,16.432935090777736,RGS10;PRTN3,MPP,1.271443424469827
GO_Biological_Process_2021,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),1/22,0.0536071985992547,0.1311358890465641,0,0,19.367346938775512,56.67024999786951,ZWINT,MPP,1.2707768875084013
GO_Biological_Process_2021,zinc ion transmembrane transport (GO:0071577),1/22,0.0536071985992547,0.1311358890465641,0,0,19.367346938775512,56.67024999786951,SLC39A4,MPP,1.2707768875084013
GO_Biological_Process_2021,ERK1 and ERK2 cascade (GO:0070371),1/23,0.0559757805878795,0.131963627810804,0,0,18.4860853432282,53.29235549319145,AVP,MPP,1.2519998414265567
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.0559757805878795,0.131963627810804,0,0,18.4860853432282,53.29235549319145,GATA1,MPP,1.2519998414265567
GO_Biological_Process_2021,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.0559757805878795,0.131963627810804,0,0,18.4860853432282,53.29235549319145,GATA1,MPP,1.2519998414265567
GO_Biological_Process_2021,membrane protein ectodomain proteolysis (GO:0006509),1/23,0.0559757805878795,0.131963627810804,0,0,18.4860853432282,53.29235549319145,PRTN3,MPP,1.2519998414265567
GO_Biological_Process_2021,regulation of mononuclear cell migration (GO:0071675),1/23,0.0559757805878795,0.131963627810804,0,0,18.4860853432282,53.29235549319145,AIF1,MPP,1.2519998414265567
GO_Biological_Process_2021,mitotic cell cycle checkpoint signaling (GO:0007093),1/23,0.0559757805878795,0.131963627810804,0,0,18.4860853432282,53.29235549319145,ZWINT,MPP,1.2519998414265567
GO_Biological_Process_2021,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.0559757805878795,0.131963627810804,0,0,18.4860853432282,53.29235549319145,GATA2,MPP,1.2519998414265567
GO_Biological_Process_2021,heterochromatin assembly (GO:0031507),1/24,0.0583385530130099,0.1361232903636899,0,0,17.68145519077196,50.24171555062859,HMGA1,MPP,1.2340443470047993
GO_Biological_Process_2021,dendritic cell differentiation (GO:0097028),1/24,0.0583385530130099,0.1361232903636899,0,0,17.68145519077196,50.24171555062859,PRTN3,MPP,1.2340443470047993
GO_Biological_Process_2021,mitotic spindle organization (GO:0007052),2/157,0.058709917979055,0.1362908810228063,0,0,5.321236559139785,15.086485770152208,CENPM;ZWINT,MPP,1.231288526354898
GO_Biological_Process_2021,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/25,0.0606955298241754,0.1394771013636354,0,0,16.943877551020407,47.47480020477031,AZU1,MPP,1.2168432931781568
GO_Biological_Process_2021,positive regulation of T cell migration (GO:2000406),1/25,0.0606955298241754,0.1394771013636354,0,0,16.943877551020407,47.47480020477031,AIF1,MPP,1.2168432931781568
GO_Biological_Process_2021,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/26,0.0630467249540435,0.1427177107168647,0,0,16.26530612244898,44.95534064809558,AIF1,MPP,1.2003374685092782
GO_Biological_Process_2021,regulation of mitotic metaphase/anaphase transition (GO:0030071),1/26,0.0630467249540435,0.1427177107168647,0,0,16.26530612244898,44.95534064809558,UBE2C,MPP,1.2003374685092782
GO_Biological_Process_2021,regulation of monocyte chemotaxis (GO:0090025),1/26,0.0630467249540435,0.1427177107168647,0,0,16.26530612244898,44.95534064809558,AIF1,MPP,1.2003374685092782
GO_Biological_Process_2021,acute inflammatory response (GO:0002526),1/27,0.0653921522588676,0.1433394448976699,0,0,15.638932496075354,42.652889831563165,ELANE,MPP,1.184474368421492
GO_Biological_Process_2021,negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.0653921522588676,0.1433394448976699,0,0,15.638932496075354,42.652889831563165,GATA2,MPP,1.184474368421492
GO_Biological_Process_2021,regulation of transcription regulatory region DNA binding (GO:2000677),1/27,0.0653921522588676,0.1433394448976699,0,0,15.638932496075354,42.652889831563165,GATA1,MPP,1.184474368421492
GO_Biological_Process_2021,positive regulation of erythrocyte differentiation (GO:0045648),1/27,0.0653921522588676,0.1433394448976699,0,0,15.638932496075354,42.652889831563165,GATA1,MPP,1.184474368421492
GO_Biological_Process_2021,cellular senescence (GO:0090398),1/27,0.0653921522588676,0.1433394448976699,0,0,15.638932496075354,42.652889831563165,HMGA1,MPP,1.184474368421492
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),3/371,0.065510771195163,0.1433394448976699,0,0,3.396507863089732,9.257320432758746,AZU1;AVP;GATA1,MPP,1.1836872880076514
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),1/28,0.0677318256109869,0.1433394448976699,0,0,15.058956916099774,40.54171043527237,GNA15,MPP,1.1692072184717057
GO_Biological_Process_2021,glycogen metabolic process (GO:0005977),1/28,0.0677318256109869,0.1433394448976699,0,0,15.058956916099774,40.54171043527237,PHKG1,MPP,1.1692072184717057
GO_Biological_Process_2021,carbohydrate derivative biosynthetic process (GO:1901137),1/28,0.0677318256109869,0.1433394448976699,0,0,15.058956916099774,40.54171043527237,RRM2,MPP,1.1692072184717057
GO_Biological_Process_2021,RNA phosphodiester bond hydrolysis (GO:0090501),1/28,0.0677318256109869,0.1433394448976699,0,0,15.058956916099774,40.54171043527237,RNASE2,MPP,1.1692072184717057
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.0677318256109869,0.1433394448976699,0,0,15.058956916099774,40.54171043527237,GATA1,MPP,1.1692072184717057
GO_Biological_Process_2021,leukocyte cell-cell adhesion (GO:0007159),1/28,0.0677318256109869,0.1433394448976699,0,0,15.058956916099774,40.54171043527237,FERMT3,MPP,1.1692072184717057
GO_Biological_Process_2021,cellular zinc ion homeostasis (GO:0006882),1/28,0.0677318256109869,0.1433394448976699,0,0,15.058956916099774,40.54171043527237,SLC39A4,MPP,1.1692072184717057
GO_Biological_Process_2021,macromolecule catabolic process (GO:0009057),1/28,0.0677318256109869,0.1433394448976699,0,0,15.058956916099774,40.54171043527237,ELANE,MPP,1.1692072184717057
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),3/379,0.068906376040614,0.1449087285042276,0,0,3.3228836577636938,8.888735598390964,HMGA1;GATA2;AIF1,MPP,1.1617405901223166
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),3/381,0.0697677490315496,0.1449087285042276,0,0,3.3049645390070923,8.799743799293005,AZU1;AVP;GATA1,MPP,1.1563452887586665
GO_Biological_Process_2021,actin filament polymerization (GO:0030041),1/29,0.0700657588372089,0.1449087285042276,0,0,14.520408163265309,38.5999069065122,AIF1,MPP,1.1544941700666143
GO_Biological_Process_2021,positive regulation of leukocyte migration (GO:0002687),1/29,0.0700657588372089,0.1449087285042276,0,0,14.520408163265309,38.5999069065122,AIF1,MPP,1.1544941700666143
GO_Biological_Process_2021,protein K11-linked ubiquitination (GO:0070979),1/29,0.0700657588372089,0.1449087285042276,0,0,14.520408163265309,38.5999069065122,UBE2C,MPP,1.1544941700666143
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),3/384,0.0710690821644848,0.1463186985739393,0,0,3.27843859943039,8.668528964802487,AZU1;AVP;GATA2,MPP,1.148319293302099
GO_Biological_Process_2021,negative regulation of Notch signaling pathway (GO:0045746),1/30,0.0723939657090184,0.1470502428464436,0,0,14.019000703729768,36.80874147674154,GATA2,MPP,1.1402976322627019
GO_Biological_Process_2021,zinc ion homeostasis (GO:0055069),1/30,0.0723939657090184,0.1470502428464436,0,0,14.019000703729768,36.80874147674154,SLC39A4,MPP,1.1402976322627019
GO_Biological_Process_2021,plasma membrane invagination (GO:0099024),1/30,0.0723939657090184,0.1470502428464436,0,0,14.019000703729768,36.80874147674154,AIF1,MPP,1.1402976322627019
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),2/180,0.0745195887056104,0.1471687848536605,0,0,4.628277153558052,12.018216055401329,ITGA2B;FERMT3,MPP,1.1277295507615273
GO_Biological_Process_2021,negative regulation of DNA binding (GO:0043392),1/31,0.0747164600026276,0.1471687848536605,0,0,13.551020408163266,35.15209038871121,GATA1,MPP,1.126583712764908
GO_Biological_Process_2021,renal water homeostasis (GO:0003091),1/31,0.0747164600026276,0.1471687848536605,0,0,13.551020408163266,35.15209038871121,AVP,MPP,1.126583712764908
GO_Biological_Process_2021,regulation of cellular senescence (GO:2000772),1/31,0.0747164600026276,0.1471687848536605,0,0,13.551020408163266,35.15209038871121,HMGA1,MPP,1.126583712764908
GO_Biological_Process_2021,positive regulation of locomotion (GO:0040017),1/31,0.0747164600026276,0.1471687848536605,0,0,13.551020408163266,35.15209038871121,AIF1,MPP,1.126583712764908
GO_Biological_Process_2021,positive regulation of mononuclear cell migration (GO:0071677),1/31,0.0747164600026276,0.1471687848536605,0,0,13.551020408163266,35.15209038871121,AIF1,MPP,1.126583712764908
GO_Biological_Process_2021,positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/31,0.0747164600026276,0.1471687848536605,0,0,13.551020408163266,35.15209038871121,UBE2C,MPP,1.126583712764908
GO_Biological_Process_2021,activation of phospholipase C activity (GO:0007202),1/32,0.0770332554327668,0.1497868855637133,0,0,13.113232389730086,33.61600807740255,GNA15,MPP,1.1133217484244988
GO_Biological_Process_2021,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/32,0.0770332554327668,0.1497868855637133,0,0,13.113232389730086,33.61600807740255,GATA2,MPP,1.1133217484244988
GO_Biological_Process_2021,hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.0770332554327668,0.1497868855637133,0,0,13.113232389730086,33.61600807740255,PLD4,MPP,1.1133217484244988
GO_Biological_Process_2021,actin filament bundle assembly (GO:0051017),1/33,0.0793443657059371,0.1523277907012716,0,0,12.70280612244898,32.18837516559274,AIF1,MPP,1.1004839073426347
GO_Biological_Process_2021,actin filament bundle organization (GO:0061572),1/33,0.0793443657059371,0.1523277907012716,0,0,12.70280612244898,32.18837516559274,AIF1,MPP,1.1004839073426347
GO_Biological_Process_2021,negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.0793443657059371,0.1523277907012716,0,0,12.70280612244898,32.18837516559274,AIF1,MPP,1.1004839073426347
GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),2/189,0.0810402447075638,0.1535151282247652,0,0,4.403520499108734,11.065207700859313,RGS10;PRTN3,MPP,1.0912992562585337
GO_Biological_Process_2021,regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.0816498044624026,0.1535151282247652,0,0,12.317254174397032,30.85861216573232,FERMT3,MPP,1.0880448509885652
GO_Biological_Process_2021,negative regulation of mitochondrion organization (GO:0010823),1/34,0.0816498044624026,0.1535151282247652,0,0,12.317254174397032,30.85861216573232,AVP,MPP,1.0880448509885652
GO_Biological_Process_2021,sister chromatid segregation (GO:0000819),1/34,0.0816498044624026,0.1535151282247652,0,0,12.317254174397032,30.85861216573232,ZWINT,MPP,1.0880448509885652
GO_Biological_Process_2021,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.0816498044624026,0.1535151282247652,0,0,12.317254174397032,30.85861216573232,GATA2,MPP,1.0880448509885652
GO_Biological_Process_2021,positive regulation of cell cycle G1/S phase transition (GO:1902808),1/35,0.0839495853612937,0.1571895528369904,0,0,11.95438175270108,29.61744503578088,AIF1,MPP,1.0759814445616303
GO_Biological_Process_2021,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/36,0.0862437219743075,0.1601669122379998,0,0,11.612244897959185,28.456712045041098,C1QTNF4,MPP,1.0642725091375862
GO_Biological_Process_2021,negative regulation of fat cell differentiation (GO:0045599),1/36,0.0862437219743075,0.1601669122379998,0,0,11.612244897959185,28.456712045041098,GATA2,MPP,1.0642725091375862
GO_Biological_Process_2021,negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.0885322278902676,0.1617757577914529,0,0,11.289115646258503,27.36920368672352,GATA2,MPP,1.0528986067362665
GO_Biological_Process_2021,regulation of erythrocyte differentiation (GO:0045646),1/37,0.0885322278902676,0.1617757577914529,0,0,11.289115646258503,27.36920368672352,GATA1,MPP,1.0528986067362665
GO_Biological_Process_2021,positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.0885322278902676,0.1617757577914529,0,0,11.289115646258503,27.36920368672352,GATA1,MPP,1.0528986067362665
GO_Biological_Process_2021,"phagocytosis, engulfment (GO:0006911)",1/37,0.0885322278902676,0.1617757577914529,0,0,11.289115646258503,27.36920368672352,AIF1,MPP,1.0528986067362665
GO_Biological_Process_2021,negative regulation of G0 to G1 transition (GO:0070317),1/38,0.0908151166313484,0.1646250122201735,0,0,10.983452840595698,26.34852930034076,RRM2,MPP,1.0418418549683985
GO_Biological_Process_2021,DNA replication initiation (GO:0006270),1/38,0.0908151166313484,0.1646250122201735,0,0,10.983452840595698,26.34852930034076,MCM2,MPP,1.0418418549683985
GO_Biological_Process_2021,positive regulation of intracellular transport (GO:0032388),1/39,0.0930924017046572,0.1654571983422618,0,0,10.693877551020408,25.38900533231373,MLC1,MPP,1.0310857651239858
GO_Biological_Process_2021,regulation of exit from mitosis (GO:0007096),1/39,0.0930924017046572,0.1654571983422618,0,0,10.693877551020408,25.38900533231373,UBE2C,MPP,1.0310857651239858
GO_Biological_Process_2021,regulation of intracellular transport (GO:0032386),1/39,0.0930924017046572,0.1654571983422618,0,0,10.693877551020408,25.38900533231373,MLC1,MPP,1.0310857651239858
GO_Biological_Process_2021,membrane protein proteolysis (GO:0033619),1/39,0.0930924017046572,0.1654571983422618,0,0,10.693877551020408,25.38900533231373,PRTN3,MPP,1.0310857651239858
GO_Biological_Process_2021,regulation of peptidyl-threonine phosphorylation (GO:0010799),1/39,0.0930924017046572,0.1654571983422618,0,0,10.693877551020408,25.38900533231373,AZU1,MPP,1.0310857651239858
GO_Biological_Process_2021,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.0976302146847681,0.1721773165952307,0,0,10.158163265306122,23.633660200289185,AVP,MPP,1.0104157556925017
GO_Biological_Process_2021,regulation of G0 to G1 transition (GO:0070316),1/41,0.0976302146847681,0.1721773165952307,0,0,10.158163265306122,23.633660200289185,RRM2,MPP,1.0104157556925017
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),2/212,0.0984576089228105,0.1729660697292618,0,0,3.9166666666666665,9.079339326341122,AVP;ELANE,MPP,1.0067507154273545
GO_Biological_Process_2021,translesion synthesis (GO:0019985),1/42,0.0998907694703361,0.1734191317057248,0,0,9.909905425584869,22.829231064333683,PCLAF,MPP,1.00047464143678
GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),2/214,0.100019348409027,0.1734191317057248,0,0,3.879323899371069,8.931722866735825,RGS10;PRTN3,MPP,0.9999159790553556
GO_Biological_Process_2021,regulation of cell-cell adhesion (GO:0022407),1/43,0.1021457742794159,0.1734191317057248,0,0,9.673469387755102,22.068611238785657,FERMT3,MPP,0.9907795952096249
GO_Biological_Process_2021,regulation of cytokine production involved in inflammatory response (GO:1900015),1/43,0.1021457742794159,0.1734191317057248,0,0,9.673469387755102,22.068611238785657,PLD4,MPP,0.9907795952096249
GO_Biological_Process_2021,spermatid development (GO:0007286),1/43,0.1021457742794159,0.1734191317057248,0,0,9.673469387755102,22.068611238785657,SPINK2,MPP,0.9907795952096249
GO_Biological_Process_2021,positive regulation of phospholipase C activity (GO:0010863),1/43,0.1021457742794159,0.1734191317057248,0,0,9.673469387755102,22.068611238785657,GNA15,MPP,0.9907795952096249
GO_Biological_Process_2021,male gonad development (GO:0008584),1/43,0.1021457742794159,0.1734191317057248,0,0,9.673469387755102,22.068611238785657,GATA1,MPP,0.9907795952096249
GO_Biological_Process_2021,development of primary male sexual characteristics (GO:0046546),1/43,0.1021457742794159,0.1734191317057248,0,0,9.673469387755102,22.068611238785657,GATA1,MPP,0.9907795952096249
GO_Biological_Process_2021,DNA synthesis involved in DNA repair (GO:0000731),1/43,0.1021457742794159,0.1734191317057248,0,0,9.673469387755102,22.068611238785657,PCLAF,MPP,0.9907795952096249
GO_Biological_Process_2021,regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.1043952424647777,0.1765793134627281,0,0,9.448030374940672,21.34849709415977,GATA2,MPP,0.9813192926974915
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),2/221,0.1055403360927836,0.1777319789215578,0,0,3.7539954337899544,8.441467129790793,AIF1;FERMT3,MPP,0.97658152714763
GO_Biological_Process_2021,action potential (GO:0001508),1/45,0.1066391873529346,0.1777319789215578,0,0,9.232838589981448,20.665901611884028,GNA15,MPP,0.9720831731354668
GO_Biological_Process_2021,positive regulation of chemotaxis (GO:0050921),1/45,0.1066391873529346,0.1777319789215578,0,0,9.232838589981448,20.665901611884028,AIF1,MPP,0.9720831731354668
GO_Biological_Process_2021,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.1066391873529346,0.1777319789215578,0,0,9.232838589981448,20.665901611884028,GATA2,MPP,0.9720831731354668
GO_Biological_Process_2021,erythrocyte differentiation (GO:0030218),1/46,0.1088776222085674,0.1794902829887615,0,0,9.02721088435374,20.01811780873028,GATA1,MPP,0.9630613723103648
GO_Biological_Process_2021,positive regulation of response to stimulus (GO:0048584),1/46,0.1088776222085674,0.1794902829887615,0,0,9.02721088435374,20.01811780873028,HMGA1,MPP,0.9630613723103648
GO_Biological_Process_2021,postreplication repair (GO:0006301),1/46,0.1088776222085674,0.1794902829887615,0,0,9.02721088435374,20.01811780873028,PCLAF,MPP,0.9630613723103648
GO_Biological_Process_2021,polyol metabolic process (GO:0019751),1/47,0.1111105603036554,0.1822218966459204,0,0,8.830523513753327,19.4026870705364,PLD4,MPP,0.9542446623584087
GO_Biological_Process_2021,inflammatory response (GO:0006954),2/230,0.1127586124121412,0.1822218966459204,0,0,3.6041666666666665,7.866115081211615,AZU1;AIF1,MPP,0.9478502771198579
GO_Biological_Process_2021,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.1133380148369131,0.1822218966459204,0,0,8.642205818497612,18.81737166641443,GATA2,MPP,0.9456243984787533
GO_Biological_Process_2021,negative regulation of mitotic cell cycle (GO:0045930),1/48,0.1133380148369131,0.1822218966459204,0,0,8.642205818497612,18.81737166641443,ZWINT,MPP,0.9456243984787533
GO_Biological_Process_2021,inositol phosphate metabolic process (GO:0043647),1/48,0.1133380148369131,0.1822218966459204,0,0,8.642205818497612,18.81737166641443,PLD4,MPP,0.9456243984787533
GO_Biological_Process_2021,cellular response to alcohol (GO:0097306),1/48,0.1133380148369131,0.1822218966459204,0,0,8.642205818497612,18.81737166641443,MLC1,MPP,0.9456243984787533
GO_Biological_Process_2021,substrate adhesion-dependent cell spreading (GO:0034446),1/48,0.1133380148369131,0.1822218966459204,0,0,8.642205818497612,18.81737166641443,FERMT3,MPP,0.9456243984787533
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),4/742,0.1138085215723413,0.1823340750542793,0,0,2.2636974195828916,4.919552976765135,BEX2;AZU1;AVP;GATA1,MPP,0.943825218316277
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),3/474,0.1149270413547105,0.1834800133908536,0,0,2.6397885892397346,5.711071147622478,PRTN3;AIF1;ELANE,MPP,0.9395777734927033
GO_Biological_Process_2021,actin polymerization or depolymerization (GO:0008154),1/50,0.1177765260040411,0.1873717459155199,0,0,8.28862973760933,17.7290996615035,AIF1,MPP,0.928941259997044
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),3/482,0.1192389583091006,0.1889078271956792,0,0,2.5946342113445566,5.517815916066961,AZU1;AVP;GATA2,MPP,0.92358182668994
GO_Biological_Process_2021,gonad development (GO:0008406),1/51,0.1199876089220907,0.1889078271956792,0,0,8.122448979591837,17.22257115519733,GATA1,MPP,0.9208636010741894
GO_Biological_Process_2021,negative regulation of transport (GO:0051051),1/51,0.1199876089220907,0.1889078271956792,0,0,8.122448979591837,17.22257115519733,PRTN3,MPP,0.9208636010741894
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),3/485,0.1208716599427582,0.1896434664619138,0,0,2.578087754921868,5.447566347932984,AZU1;AVP;GATA1,MPP,0.9176755136408634
GO_Biological_Process_2021,protein homotetramerization (GO:0051289),1/52,0.1221932608707862,0.1904038825212593,0,0,7.962785114045619,16.738979733033663,TK1,MPP,0.9129527453809976
GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),1/52,0.1221932608707862,0.1904038825212593,0,0,7.962785114045619,16.738979733033663,GATA1,MPP,0.9129527453809976
GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.1243934949128716,0.1925137421270633,0,0,7.809262166405024,16.276887238960814,AVP,MPP,0.9052023302345248
GO_Biological_Process_2021,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.1243934949128716,0.1925137421270633,0,0,7.809262166405024,16.276887238960814,C1QTNF4,MPP,0.9052023302345248
GO_Biological_Process_2021,positive regulation of leukocyte chemotaxis (GO:0002690),1/54,0.1265883240687765,0.1952463981399773,0,0,7.661532537543319,15.834970375184442,AIF1,MPP,0.8976063498190403
GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/55,0.1287777613922166,0.197285796072251,0,0,7.519274376417234,15.412009607623004,AVP,MPP,0.8901591287349465
GO_Biological_Process_2021,regulation of blood vessel endothelial cell migration (GO:0043535),1/55,0.1287777613922166,0.197285796072251,0,0,7.519274376417234,15.412009607623004,GATA2,MPP,0.8901591287349465
GO_Biological_Process_2021,positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.1309618198144747,0.1993544478786766,0,0,7.382189239332097,15.00687933540933,AZU1,MPP,0.8828552987007785
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),5/1079,0.1310043514631303,0.1993544478786766,0,0,1.952824332712601,3.969163767270571,HMGA1;AZU1;AVP;GATA2;AIF1,MPP,0.8827142785042424
GO_Biological_Process_2021,"positive regulation of gene expression, epigenetic (GO:0045815)",1/57,0.1331405122852093,0.2012589139195024,0,0,7.25,14.618539131965724,HMGA1,MPP,0.8756897763447542
GO_Biological_Process_2021,protein K48-linked ubiquitination (GO:0070936),1/57,0.1331405122852093,0.2012589139195024,0,0,7.25,14.618539131965724,UBE2C,MPP,0.8756897763447542
GO_Biological_Process_2021,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2136419061910447,0,0,6.76530612244898,13.214837540593155,ELANE,MPP,0.848318009451734
GO_Biological_Process_2021,positive regulation of interleukin-1 production (GO:0032732),1/62,0.1439539364695556,0.2161684524542833,0,0,6.654064904650385,12.897320592663672,AZU1,MPP,0.8417764546925935
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),2/269,0.1453850943051252,0.2165336158098311,0,0,3.071629213483146,5.923235274252741,AIF1;FERMT3,MPP,0.837480117499467
GO_Biological_Process_2021,negative regulation of endopeptidase activity (GO:0010951),1/63,0.1461007034145454,0.2165336158098311,0,0,6.54641211323239,12.591756250239603,SPINK2,MPP,0.8353476931121088
GO_Biological_Process_2021,organonitrogen compound catabolic process (GO:1901565),1/63,0.1461007034145454,0.2165336158098311,0,0,6.54641211323239,12.591756250239603,ELANE,MPP,0.8353476931121088
GO_Biological_Process_2021,monocarboxylic acid biosynthetic process (GO:0072330),1/63,0.1461007034145454,0.2165336158098311,0,0,6.54641211323239,12.591756250239603,GAMT,MPP,0.8353476931121088
GO_Biological_Process_2021,negative regulation of cell cycle process (GO:0010948),1/64,0.1482421941802595,0.2168816667267463,0,0,6.442176870748299,12.297522293260638,RRM2,MPP,0.8290281655096747
GO_Biological_Process_2021,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.1482421941802595,0.2168816667267463,0,0,6.442176870748299,12.297522293260638,RNASE3,MPP,0.8290281655096747
GO_Biological_Process_2021,pre-replicative complex assembly (GO:0036388),1/64,0.1482421941802595,0.2168816667267463,0,0,6.442176870748299,12.297522293260638,MCM2,MPP,0.8290281655096747
GO_Biological_Process_2021,protein catabolic process (GO:0030163),1/64,0.1482421941802595,0.2168816667267463,0,0,6.442176870748299,12.297522293260638,ELANE,MPP,0.8290281655096747
GO_Biological_Process_2021,DNA metabolic process (GO:0006259),2/277,0.1523078472737738,0.2202913526314607,0,0,2.981060606060606,5.609913359099665,TYMS;MCM2,MPP,0.8172777201708421
GO_Biological_Process_2021,extracellular matrix disassembly (GO:0022617),1/66,0.1525093979756266,0.2202913526314607,0,0,6.243328100470958,11.740759916332207,ELANE,MPP,0.8167033932798328
GO_Biological_Process_2021,cellular component disassembly (GO:0022411),1/66,0.1525093979756266,0.2202913526314607,0,0,6.243328100470958,11.740759916332207,ELANE,MPP,0.8167033932798328
GO_Biological_Process_2021,positive regulation of T cell proliferation (GO:0042102),1/66,0.1525093979756266,0.2202913526314607,0,0,6.243328100470958,11.740759916332207,AIF1,MPP,0.8167033932798328
GO_Biological_Process_2021,cell chemotaxis (GO:0060326),1/69,0.158870948881139,0.2280324345139377,0,0,5.966986794717887,10.977245117600177,AZU1,MPP,0.7989555105590889
GO_Biological_Process_2021,positive regulation of MAP kinase activity (GO:0043406),1/69,0.158870948881139,0.2280324345139377,0,0,5.966986794717887,10.977245117600177,ELANE,MPP,0.7989555105590889
GO_Biological_Process_2021,protein tetramerization (GO:0051262),1/71,0.16308595979881,0.2318878490889331,0,0,5.795918367346939,10.51076961698872,TK1,MPP,0.7875834261109624
GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.16308595979881,0.2318878490889331,0,0,5.795918367346939,10.51076961698872,AIF1,MPP,0.7875834261109624
GO_Biological_Process_2021,myeloid leukocyte differentiation (GO:0002573),1/71,0.16308595979881,0.2318878490889331,0,0,5.795918367346939,10.51076961698872,PRTN3,MPP,0.7875834261109624
GO_Biological_Process_2021,cell morphogenesis involved in differentiation (GO:0000904),1/72,0.1651856959101235,0.2341417185018885,0,0,5.713998275366484,10.28911103101624,FERMT3,MPP,0.78202756268309
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),2/296,0.1690031560036776,0.238808807396501,0,0,2.7857142857142856,4.952548406897344,BEX2;PCLAF,MPP,0.7721051851958874
GO_Biological_Process_2021,positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.1714539764404576,0.2400355670166406,0,0,5.4815223386651954,9.666337985731484,AIF1,MPP,0.7658524380723842
GO_Biological_Process_2021,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.1714539764404576,0.2400355670166406,0,0,5.4815223386651954,9.666337985731484,RNASE2,MPP,0.7658524380723842
GO_Biological_Process_2021,positive regulation of T cell activation (GO:0050870),1/75,0.1714539764404576,0.2400355670166406,0,0,5.4815223386651954,9.666337985731484,AIF1,MPP,0.7658524380723842
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),2/300,0.1725587566609558,0.2406664678159665,0,0,2.7477628635346756,4.8278673881252745,ITGA2B;ELANE,MPP,0.7630629971198796
GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),1/76,0.1735331353639065,0.2406664678159665,0,0,5.408163265306122,9.4717853003048,AIF1,MPP,0.7606175863963804
GO_Biological_Process_2021,cellular response to hormone stimulus (GO:0032870),1/76,0.1735331353639065,0.2406664678159665,0,0,5.408163265306122,9.4717853003048,GATA1,MPP,0.7606175863963804
GO_Biological_Process_2021,innate immune response (GO:0045087),2/302,0.1743414000182094,0.2406664678159665,0,0,2.7291666666666665,4.767144127673996,RNASE3;RNASE2,MPP,0.7585994708102503
GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1756071809118701,0.2406664678159665,0,0,5.336734693877551,9.283280446293812,GATA2,MPP,0.7554577289388229
GO_Biological_Process_2021,inorganic cation import across plasma membrane (GO:0098659),1/77,0.1756071809118701,0.2406664678159665,0,0,5.336734693877551,9.283280446293812,SLC39A4,MPP,0.7554577289388229
GO_Biological_Process_2021,neutrophil migration (GO:1990266),1/77,0.1756071809118701,0.2406664678159665,0,0,5.336734693877551,9.283280446293812,PRTN3,MPP,0.7554577289388229
GO_Biological_Process_2021,negative regulation of apoptotic signaling pathway (GO:2001234),1/78,0.1776761254379788,0.2427706819047458,0,0,5.267161410018553,9.10056411919043,AVP,MPP,0.7503709249641564
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2447291006603356,0,0,5.133298889175924,8.751529842637671,AZU1,MPP,0.7404090821369118
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.2447291006603356,0,0,5.133298889175924,8.751529842637671,GATA1,MPP,0.7404090821369118
GO_Biological_Process_2021,response to interferon-gamma (GO:0034341),1/80,0.181798760490535,0.2447291006603356,0,0,5.133298889175924,8.751529842637671,AIF1,MPP,0.7404090821369118
GO_Biological_Process_2021,regulation of fat cell differentiation (GO:0045598),1/80,0.181798760490535,0.2447291006603356,0,0,5.133298889175924,8.751529842637671,GATA2,MPP,0.7404090821369118
GO_Biological_Process_2021,regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.181798760490535,0.2447291006603356,0,0,5.133298889175924,8.751529842637671,C1QTNF4,MPP,0.7404090821369118
GO_Biological_Process_2021,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2460378716239186,0,0,5.0688775510204085,8.584760541358477,ELANE,MPP,0.7355305181562768
GO_Biological_Process_2021,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.1838524754991919,0.2460378716239186,0,0,5.0688775510204085,8.584760541358477,GNA15,MPP,0.7355305181562768
GO_Biological_Process_2021,cell-cell junction organization (GO:0045216),1/82,0.1859011384602527,0.2480499061566421,0,0,5.00604686318972,8.422875391899517,PRTN3,MPP,0.7307179505966239
GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.2493144795882971,0,0,4.944748631159781,8.265677319811374,AZU1,MPP,0.7259697745939766
GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.2493144795882971,0,0,4.944748631159781,8.265677319811374,GATA2,MPP,0.7259697745939766
GO_Biological_Process_2021,anaphase-promoting complex-dependent catabolic process (GO:0031145),1/84,0.1899833569114356,0.251286126147393,0,0,4.884927464961889,8.112979399077096,UBE2C,MPP,0.7212844428267129
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),4/908,0.1908851520255107,0.2517470845553837,0,0,1.8320507887649096,3.0340287711400475,BEX1;HMGA1;GATA2;GATA1,MPP,0.7192278518272621
GO_Biological_Process_2021,negative regulation of defense response (GO:0031348),1/85,0.1920169366451308,0.2521880371490444,0,0,4.826530612244898,7.964604221414354,ELANE,MPP,0.716660463134361
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),2/322,0.1923280195400404,0.2521880371490444,0,0,2.5559895833333335,4.213684115542283,TYMS;GATA2,MPP,0.7159574404356035
GO_Biological_Process_2021,negative regulation of cellular amide metabolic process (GO:0034249),1/86,0.1940455128548384,0.2529819723465659,0,0,4.769507803121249,7.820383303288144,TYMS,MPP,0.7120963955156414
GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),1/86,0.1940455128548384,0.2529819723465659,0,0,4.769507803121249,7.820383303288144,GATA2,MPP,0.7120963955156414
GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),1/89,0.2001013407742902,0.2601317430065773,0,0,4.6062152133580705,7.411084001248333,AVP,MPP,0.6987500013741589
GO_Biological_Process_2021,negative regulation of translation (GO:0017148),1/90,0.2021100231923967,0.2619944745086625,0,0,4.55423068103646,7.281955543769811,TYMS,MPP,0.6944121480917811
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2664239178793286,0,0,4.453689167974883,7.03385741012878,GATA1,MPP,0.6858955226779435
GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.2081064570390282,0.268239200999314,0,0,4.40505767524401,6.914643337844717,AVP,MPP,0.6817144444740324
GO_Biological_Process_2021,negative regulation of cellular protein metabolic process (GO:0032269),1/94,0.2100954368002021,0.2685208532137414,0,0,4.357472021066491,6.79849904676328,TYMS,MPP,0.6775833802166729
GO_Biological_Process_2021,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2685208532137414,0,0,4.357472021066491,6.79849904676328,PLD4,MPP,0.6775833802166729
GO_Biological_Process_2021,nucleosome organization (GO:0034728),1/94,0.2100954368002021,0.2685208532137414,0,0,4.357472021066491,6.79849904676328,HMGA1,MPP,0.6775833802166729
GO_Biological_Process_2021,regulation of cell cycle phase transition (GO:1901987),1/95,0.2120795205832498,0.2702974281943379,0,0,4.310898827616153,6.685315939697291,UBE2C,MPP,0.6735012670190429
GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.2140587201245348,0.2715332500356814,0,0,4.26530612244898,6.5749903239841245,SLC39A4,MPP,0.6694670755856718
GO_Biological_Process_2021,protein maturation (GO:0051604),1/97,0.2160330472811356,0.2715332500356814,0,0,4.220663265306122,6.46742313757927,TSPAN32,MPP,0.6654798083211632
GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2715332500356814,0,0,4.220663265306122,6.46742313757927,ELANE,MPP,0.6654798083211632
GO_Biological_Process_2021,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2715332500356814,0,0,4.220663265306122,6.46742313757927,ELANE,MPP,0.6654798083211632
GO_Biological_Process_2021,double-strand break repair via homologous recombination (GO:0000724),1/97,0.2160330472811356,0.2715332500356814,0,0,4.220663265306122,6.46742313757927,MCM2,MPP,0.6654798083211632
GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.2180025137484037,0.2732538395468972,0,0,4.176940879444562,6.362519703204576,AVP,MPP,0.6615384985937142
GO_Biological_Process_2021,cell-matrix adhesion (GO:0007160),1/100,0.2219269115603851,0.2774086394504814,0,0,4.092145949288806,6.1603458876211565,FERMT3,MPP,0.6537900306498672
GO_Biological_Process_2021,cellular response to chemical stress (GO:0062197),1/101,0.2238818662412048,0.279085614081502,0,0,4.051020408163265,6.062906014187368,AIF1,MPP,0.6499810815451941
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2792216390628789,0,0,4.010709234188725,5.967790506031058,AZU1,MPP,0.6462145058611213
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.2792216390628789,0,0,4.010709234188725,5.967790506031058,GATA2,MPP,0.6462145058611213
GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),1/102,0.2258320069783284,0.2792216390628789,0,0,4.010709234188725,5.967790506031058,ZWINT,MPP,0.6462145058611213
GO_Biological_Process_2021,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2832564806204188,0,0,3.932435109966317,5.78423168094792,ELANE,MPP,0.6388051756325536
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2864717557126687,0,0,3.857142857142857,5.6090983677319475,ELANE,MPP,0.6315556772929499
GO_Biological_Process_2021,chromosome organization (GO:0051276),1/106,0.2335846623503299,0.2864717557126687,0,0,3.857142857142857,5.6090983677319475,CENPW,MPP,0.6315556772929499
GO_Biological_Process_2021,regulation of protein kinase activity (GO:0045859),1/110,0.241261218690496,0.2950910067316551,0,0,3.714847406852649,5.282048795926194,AZU1,MPP,0.6175124827423236
GO_Biological_Process_2021,Fc-epsilon receptor signaling pathway (GO:0038095),1/111,0.2431685532271013,0.2966265193520941,0,0,3.6808905380333954,5.20478084558139,FCER1A,MPP,0.6140925891155178
GO_Biological_Process_2021,Fc receptor signaling pathway (GO:0038093),1/112,0.2450711886958998,0.2981481038947444,0,0,3.647545504688362,5.129202360192396,FCER1A,MPP,0.6107077427090284
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.3019530548687106,0,0,3.582625970742279,4.982913653406146,AZU1,MPP,0.6040407011916724
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.3057151856341487,0,0,3.5199645075421473,4.8428011439058265,GATA2,MPP,0.5975065399797567
GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.3094349454894788,0,0,3.4594453165881736,4.708511372057024,ELANE,MPP,0.5911006880374128
GO_Biological_Process_2021,cellular response to interferon-gamma (GO:0071346),1/121,0.2619853133921213,0.3145206268955546,0,0,3.372448979591837,4.517283552621874,AIF1,MPP,0.5817230540677998
GO_Biological_Process_2021,protein homooligomerization (GO:0051260),1/121,0.2619853133921213,0.3145206268955546,0,0,3.372448979591837,4.517283552621874,TK1,MPP,0.5817230540677998
GO_Biological_Process_2021,cellular response to oxidative stress (GO:0034599),1/125,0.2693829605231016,0.3225506501000296,0,0,3.263001974983542,4.279822783786303,AIF1,MPP,0.5696298784899082
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),2/408,0.2716606168083876,0.3244240961884944,0,0,2.0057471264367814,2.6138931132295458,AIF1;FERMT3,MPP,0.5659733175722854
GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.3287261239378421,0,0,3.1603954081632653,4.060453122404681,AZU1,MPP,0.5579784037567757
GO_Biological_Process_2021,muscle contraction (GO:0006936),1/129,0.2767079241059198,0.3287261239378421,0,0,3.1603954081632653,4.060453122404681,GAMT,MPP,0.5579784037567757
GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.336464091833747,0,0,3.0640074211502784,3.857336278341556,AZU1,MPP,0.546741450090894
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3377198886688227,0,0,3.0408163265306123,3.80890385676326,GATA1,MPP,0.5439940297149167
GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.3393195528504658,0,0,2.99546485260771,3.714691124222948,TSPAN32,MPP,0.5385707850387818
GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3393195528504658,0,0,2.99546485260771,3.714691124222948,AVP,MPP,0.5385707850387818
GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),1/136,0.289353816496661,0.3393195528504658,0,0,2.99546485260771,3.714691124222948,ELANE,MPP,0.5385707850387818
GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3405395367210954,0,0,2.9732893157262907,3.668866926816198,AVP,MPP,0.5358942544628899
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3438247379307725,0,0,2.929902395740905,3.579678317757992,AIF1,MPP,0.5306096689947516
GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),1/140,0.2964824884084789,0.3450115913704805,0,0,2.9086771399207163,3.5362740390257685,TSPAN32,MPP,0.5280009529309525
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),3/764,0.2984210193557987,0.3463815403236949,0,0,1.6095003774428942,1.9462882878583572,HMGA1;PRTN3;AIF1,MPP,0.5251705904864272
GO_Biological_Process_2021,Ras protein signal transduction (GO:0007265),1/142,0.3000204969826995,0.347351974878189,0,0,2.8671298306556667,3.4517504575709377,AIF1,MPP,0.522849073872343
GO_Biological_Process_2021,protein-DNA complex assembly (GO:0065004),1/143,0.3017829564686885,0.3476234055525399,0,0,2.8467950560505892,3.410594866305226,MCM2,MPP,0.5203052911363482
GO_Biological_Process_2021,monocarboxylic acid metabolic process (GO:0032787),1/143,0.3017829564686885,0.3476234055525399,0,0,2.8467950560505892,3.410594866305226,GAMT,MPP,0.5203052911363482
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.3087894082520855,0.3547959109967145,0,0,2.7682415431926195,3.252948903166252,GNA15,MPP,0.5103376047629952
GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),1/150,0.3139989845586295,0.3598728916226106,0,0,2.712094233666621,3.141596466170354,PLD4,MPP,0.5030717563895143
GO_Biological_Process_2021,actin filament organization (GO:0007015),1/152,0.3174506378807152,0.3629146739591091,0,0,2.6759021489390458,3.0704182805545575,AIF1,MPP,0.4983237959237088
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),1/154,0.3208852696222714,0.3659217986920639,0,0,2.640656262505002,3.0015590720273457,AZU1,MPP,0.493650218923809
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),2/468,0.3272907950685003,0.3722932793904191,0,0,1.742131616595136,1.9457976416065603,HMGA1;GATA1,MPP,0.48506620889050567
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.3850006023038125,0,0,2.4621702339472376,2.6600168495918335,GNA15,MPP,0.46919202564454415
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),2/482,0.3401543782991926,0.3850006023038125,0,0,1.6901041666666667,1.8225334796372663,PRTN3;AIF1,MPP,0.46832393464331673
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",4/1183,0.3428517320675613,0.3870906652375692,0,0,1.384445181989158,1.481989303783668,BEX1;HMGA1;GATA2;GATA1,MPP,0.4648936521619021
GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3879414988643127,0,0,2.4175730172308443,2.5766088705447237,CENPW,MPP,0.46286379212748074
GO_Biological_Process_2021,regulation of translation (GO:0006417),1/178,0.3608027143922477,0.4033543858684833,0,0,2.279833967485299,2.3241173885161555,TYMS,MPP,0.44273020383203454
GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.4033543858684833,0,0,2.279833967485299,2.3241173885161555,AVP,MPP,0.44273020383203454
GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),1/178,0.3608027143922477,0.4033543858684833,0,0,2.279833967485299,2.3241173885161555,UBE2C,MPP,0.44273020383203454
GO_Biological_Process_2021,regulation of immune response (GO:0050776),1/179,0.3624150547196057,0.4041638477877956,0,0,2.266911258885577,2.300835957547096,FCER1A,MPP,0.4407937700298507
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),2/511,0.3665685304553946,0.407533732775199,0,0,1.591437459070072,1.5971185548456277,HMGA1;GATA1,MPP,0.43584482152384213
GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.407533732775199,0,0,2.2289998872477166,2.2329492942532405,ELANE,MPP,0.4350639775318079
GO_Biological_Process_2021,regulation of mitotic cell cycle phase transition (GO:1901990),1/188,0.3767479051184041,0.4170810141821749,0,0,2.1568263669104004,2.105448610107896,UBE2C,MPP,0.4239491538721143
GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.4212670310011373,0,0,2.122448979591837,2.045536603225051,GATA2,MPP,0.41855670871419515
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.4243668661292797,0,0,2.089140319340171,1.988001678572607,GATA2,MPP,0.4132695879859197
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4243668661292797,0,0,2.089140319340171,1.988001678572607,BEX2,MPP,0.4132695879859197
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.4250433765414927,0,0,2.0782663580896275,1.969329769675335,TSPAN32,MPP,0.4115300469974289
GO_Biological_Process_2021,regulation of macromolecule metabolic process (GO:0060255),1/200,0.3953681557510544,0.4324339203527158,0,0,2.025535842477695,1.8795714928238216,AIF1,MPP,0.40299831311675843
GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),1/201,0.3968950010648283,0.4330628908501125,0,0,2.0153061224489797,1.8623111638641865,UBE2C,MPP,0.40132437104403956
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/547,0.3988146050031916,0.434116376259455,0,0,1.4835626911314983,1.3637777909312412,HMGA1;TYMS,MPP,0.3992289457561903
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),1/203,0.3999373645428959,0.4342995247422855,0,0,1.9951505354617096,1.8284503867148747,GATA2,MPP,0.398008019580524
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),1/206,0.4044727291727134,0.4381787899371062,0,0,1.9656545545047288,1.7792534267442264,ELANE,MPP,0.39311075456855427
GO_Biological_Process_2021,mitotic cell cycle phase transition (GO:0044772),1/209,0.4089744952578169,0.4420033143522724,0,0,1.937009419152276,1.731884932549588,UBE2C,MPP,0.3883037749123832
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4457737500473849,0,0,1.909178837411742,1.6862551884518755,PLD4,MPP,0.3835844547796231
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),2/566,0.4155454754335446,0.4469815397689428,0,0,1.43218085106383,1.2576885523498746,HMGA1;PRTN3,MPP,0.38138144203835345
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),1/216,0.41934932166703,0.4500092956568365,0,0,1.8732795443758896,1.627975467192003,ITGA2B,MPP,0.3774240551539837
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),1/217,0.4208167942393084,0.450521509126789,0,0,1.8645124716553287,1.613843141672166,ITGA2B,MPP,0.375906936392536
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",3/948,0.4248826431220218,0.4538065789214082,0,0,1.283687943262411,1.0987627875578752,HMGA1;GATA1;ELANE,MPP,0.3717310099090599
GO_Biological_Process_2021,apoptotic process (GO:0006915),1/231,0.4409837467017168,0.4699007136985508,0,0,1.749778172138421,1.4326260836369302,MCM2,MPP,0.35557741698984124
GO_Biological_Process_2021,membrane organization (GO:0061024),1/242,0.4563449373288627,0.4851330525341881,0,0,1.6689812854602422,1.3093263562491473,AVP,MPP,0.3407067631514444
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.4869169123328102,0,0,1.655076845553036,1.2884811006593149,NRGN,MPP,0.33809924509335265
GO_Biological_Process_2021,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.4618276248188864,0.48867806812231,0,0,1.641399416909621,1.2680853834334544,BEX1,MPP,0.33552009275365935
GO_Biological_Process_2021,cellular component assembly (GO:0022607),1/261,0.4819092749521712,0.5087441301699256,0,0,1.5455259026687598,1.1282329953702568,AIF1,MPP,0.31703471507296654
GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5146172572888215,0,0,1.510204081632653,1.0781219104526054,FERMT3,MPP,0.3100391544580995
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5146172572888215,0,0,1.510204081632653,1.0781219104526054,GATA2,MPP,0.3100391544580995
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5216475209678938,0,0,1.4709576138147566,1.0233666205889618,ELANE,MPP,0.30214499188263844
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),1/274,0.4987179596066677,0.5216475209678938,0,0,1.4709576138147566,1.0233666205889618,SLC39A4,MPP,0.30214499188263844
GO_Biological_Process_2021,plasma membrane bounded cell projection assembly (GO:0120031),1/278,0.5037814900878317,0.5257352706191821,0,0,1.4494216459146836,0.9937418248041268,AIF1,MPP,0.2977577933690553
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),2/684,0.5139408816832591,0.5351100713178099,0,0,1.1771749755620724,0.7835830337156338,GATA1;ELANE,MPP,0.2890868347700152
GO_Biological_Process_2021,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.5550499055672017,0,0,1.32774699283687,0.8321996277505203,AVP,MPP,0.2722052530518486
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5574520515829118,0,0,1.314486450317832,0.8152139890333826,NRGN,MPP,0.2693393582885023
GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),1/314,0.5471545986718139,0.5658075963538076,0,0,1.2803677381495728,0.7720923294539072,UBE2C,MPP,0.26188994631047774
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.5551458962416416,0.572769575487408,0,0,1.2519132653061225,0.7367814077584223,UBE2C,MPP,0.25559286623594474
GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),1/350,0.5868058377702841,0.6040648329988217,0,0,1.1461902812701013,0.6109896633619631,PCLAF,MPP,0.23150557427863594
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.5909956578792304,0.6070045696050786,0,0,1.1329710354396716,0.5958822738188654,UBE2C,MPP,0.22841570992418872
GO_Biological_Process_2021,gene expression (GO:0010467),1/356,0.5930749260701463,0.6077682237881005,0,0,1.126473124461052,0.5885084653208599,TSPAN32,MPP,0.2268904366133749
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),1/409,0.644552703427983,0.659037033842095,0,0,0.9774909963985594,0.4293127610136149,UBE2C,MPP,0.19074156570833578
GO_Biological_Process_2021,organelle organization (GO:0006996),1/420,0.6544076492323022,0.6676131847549271,0,0,0.9512931664312504,0.4033718992390181,CENPW,MPP,0.18415163293091988
GO_Biological_Process_2021,organelle assembly (GO:0070925),1/425,0.658798168385351,0.6692017388288674,0,0,0.939834424335772,0.3922286762298742,CENPW,MPP,0.18124761694193237
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),5/2206,0.6589063274622694,0.6692017388288674,0,0,0.8960068655661568,0.3737906767782196,BEX1;HMGA1;GATA2;GATA1;ELANE,MPP,0.1811763219125431
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.663134010332821,0.6719954893127696,0,0,0.928642785785643,0.3814661952932429,HMGA1,MPP,0.17839869773857764
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",5/2244,0.6741952652975136,0.6816863238008193,0,0,0.8789141978065604,0.3464991772661544,RRM2;HMGA1;TYMS;GATA2;GATA1,MPP,0.1712143017444203
GO_Biological_Process_2021,nervous system development (GO:0007399),1/447,0.677475806229693,0.6834844608303997,0,0,0.8924681980415484,0.3475105496336908,NRGN,MPP,0.16910620954367267
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.6912187085983104,0.6958064433898921,0,0,0.8589500595054437,0.3172093937483807,HMGA1,MPP,0.16038451570993173
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.7392171284864528,0,0,0.7565820221218258,0.231944503707841,UBE2C,MPP,0.13314117322745964
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.7515021118730189,0,0,0.726642950758285,0.2091870484536521,C1QTNF4,MPP,0.12502533841998253
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),1/621,0.7938341129137421,0.7938341129137421,0,0,0.6362738643844634,0.1469033967904298,PRTN3,MPP,0.10027024237534503
KEGG_2021_Human,inflammatory response (GO:0006954),10/230,2.2846038918861327e-10,1.3045088222669818e-07,0,0,22.420454545454547,497.7264292140973,TMIGD3;CSF1R;CCL8;CCL3L1;CCL4;CCL3;CD14;FOLR2;CCL18;AIF1,Macrophages,9.641189087708105
KEGG_2021_Human,monocyte chemotaxis (GO:0002548),6/42,8.766373567479813e-10,2.502799653515487e-07,0,0,75.43181818181819,1573.12511546846,CCL8;CCL3L1;CCL4;CCL3;CCL18;FOLR2,Macrophages,9.057180026399575
KEGG_2021_Human,response to interferon-gamma (GO:0034341),6/80,4.67433033089022e-08,6.991159550406177e-06,0,0,36.62653562653563,618.2044550939977,CCL8;CCL3L1;CCL4;CCL3;CCL18;AIF1,Macrophages,7.3302805996430696
KEGG_2021_Human,lymphocyte migration (GO:0072676),5/40,4.8974847988834866e-08,6.991159550406177e-06,0,0,63.22222222222222,1064.1538508775088,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,7.3100269033212335
KEGG_2021_Human,lymphocyte chemotaxis (GO:0048247),5/44,8.0226634383705e-08,9.16188164661911e-06,0,0,56.72649572649573,926.8207607933768,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,7.095681426658831
KEGG_2021_Human,chemokine-mediated signaling pathway (GO:0070098),5/56,2.759038080443561e-07,2.385640788844257e-05,0,0,43.35294117647059,654.7687287629624,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,6.559242305315531
KEGG_2021_Human,cell junction disassembly (GO:0150146),3/6,2.9246034188983885e-07,2.385640788844257e-05,0,0,424.40425531914894,6385.135183118324,C1QB;C1QA;C1QC,Macrophages,6.533933016645414
KEGG_2021_Human,cellular response to chemokine (GO:1990869),5/60,3.915355339243013e-07,2.7945848733847005e-05,0,0,40.19191919191919,592.9590027029255,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,6.407228817291998
KEGG_2021_Human,cellular response to interferon-gamma (GO:0071346),6/121,5.533086889350138e-07,3.510436237576587e-05,0,0,23.5197628458498,338.8574501410103,CCL8;CCL3L1;CCL4;CCL3;CCL18;AIF1,Macrophages,6.257032509748073
KEGG_2021_Human,neutrophil chemotaxis (GO:0030593),5/70,8.51548432464697e-07,4.862341549373421e-05,0,0,33.99145299145299,475.07166684012833,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,6.069790646169976
KEGG_2021_Human,granulocyte chemotaxis (GO:0071621),5/73,1.0508789438099845e-06,5.366850138326043e-05,0,0,32.48692810457516,447.2112725834527,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,5.978447309721848
KEGG_2021_Human,synapse pruning (GO:0098883),3/9,1.2218748125786088e-06,5.366850138326043e-05,0,0,212.17021276595744,2888.7237871380835,C1QB;C1QA;C1QC,Macrophages,5.912973287539758
KEGG_2021_Human,"complement activation, classical pathway (GO:0006958)",3/9,1.2218748125786088e-06,5.366850138326043e-05,0,0,212.17021276595744,2888.7237871380835,C1QB;C1QA;C1QC,Macrophages,5.912973287539758
KEGG_2021_Human,neutrophil migration (GO:1990266),5/77,1.3720031205746515e-06,5.5958127274866145e-05,0,0,30.675925925925927,414.1016480799777,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,5.8626449008400465
KEGG_2021_Human,response to interleukin-1 (GO:0070555),5/86,2.3779117449844017e-06,8.535313257947318e-05,0,0,27.255144032921812,352.9347061163162,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,5.623804268042617
KEGG_2021_Human,humoral immune response mediated by circulating immunoglobulin (GO:0002455),3/11,2.3916814733302462e-06,8.535313257947318e-05,0,0,159.11170212765958,2059.464527197914,C1QB;C1QA;C1QC,Macrophages,5.621296660631103
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),9/482,2.6504214905940406e-06,8.902298065465865e-05,0,0,9.038983138245758,116.06770126298235,CSF1R;CCL8;CCL3L1;CCL4;CCL3;F13A1;HMOX1;CCL18;AIF1,Macrophages,5.5766850556921375
KEGG_2021_Human,positive regulation of ERK1 and ERK2 cascade (GO:0070374),6/172,4.3051563053862945e-06,0.00013656912502086523,0,0,16.251916757940855,200.803760964731,CSF1R;CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,5.366011076188386
KEGG_2021_Human,response to tumor necrosis factor (GO:0034612),5/110,7.989164282813401e-06,0.00021877726406037128,0,0,21.0,246.48591238003183,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,5.097498648263631
KEGG_2021_Human,eosinophil chemotaxis (GO:0048245),3/16,8.046099028490012e-06,0.00021877726406037128,0,0,97.89034369885434,1148.2853674678522,CCL8;CCL4;CCL3,Macrophages,5.09441462659174
KEGG_2021_Human,eosinophil migration (GO:0072677),3/16,8.046099028490012e-06,0.00021877726406037128,0,0,97.89034369885434,1148.2853674678522,CCL8;CCL4;CCL3,Macrophages,5.09441462659174
KEGG_2021_Human,regulation of ERK1 and ERK2 cascade (GO:0070372),6/238,2.734289301191869e-05,0.0007073041784044699,0,0,11.589733542319747,121.77395520326633,CSF1R;CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,4.563155536855161
KEGG_2021_Human,receptor-mediated endocytosis (GO:0006898),5/143,2.8490360951493538e-05,0.0007073041784044699,0,0,15.951690821256038,166.94951464681884,MSR1;CD163;DAB2;STAB1;MRC1,Macrophages,4.545302048540486
KEGG_2021_Human,positive regulation of hydrolase activity (GO:0051345),5/149,3.469891233977438e-05,0.0008255449560837988,0,0,15.282407407407408,156.93201905371728,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,4.459684138241904
KEGG_2021_Human,cellular response to interleukin-1 (GO:0071347),5/155,4.190950460849395e-05,0.0009572130852580018,0,0,14.666666666666666,147.83996944144806,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,4.377687472715881
KEGG_2021_Human,transition metal ion homeostasis (GO:0055076),3/29,5.1313052371625945e-05,0.0011269135732384,0,0,48.91325695581015,483.1438947992733,SLC40A1;HMOX1;FTL,Macrophages,4.289772150444491
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),6/274,5.997983710065591e-05,0.0012430830395931,0,0,10.014586160108548,97.35682039154874,CSF1R;CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,4.22199471807603
KEGG_2021_Human,positive regulation of natural killer cell chemotaxis (GO:2000503),2/5,6.0956786529959696e-05,0.0012430830395931,0,0,277.0416666666667,2688.78505476905,CCL4;CCL3,Macrophages,4.214977935846465
KEGG_2021_Human,regulation of GTPase activity (GO:0043087),5/189,0.00010726051414887444,0.0021119225372071,0,0,11.93599033816425,109.09793534153432,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,3.9695601255951782
KEGG_2021_Human,cellular response to tumor necrosis factor (GO:0071356),5/194,0.00012124827565673686,0.0023077588466665,0,0,11.617283950617283,104.76083586304996,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,3.916324429039836
KEGG_2021_Human,regulation of natural killer cell chemotaxis (GO:2000501),2/7,0.00012760097078443218,0.0023503275586422,0,0,166.20833333333334,1490.3240703269437,CCL4;CCL3,Macrophages,3.8941460215026447
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),8/621,0.00014018101446836373,0.0025013549769198,0,0,6.008545016701624,53.311272370313645,CSF1R;CCL8;CCL3L1;CCL4;CCL3;F13A1;HMOX1;CCL18,Macrophages,3.853310801418973
KEGG_2021_Human,regulation of chemokine production (GO:0032642),3/42,0.00015756854407171077,0.0027264132928771,0,0,32.58756137479542,285.32528155294955,CSF1R;HMOX1;AIF1,Macrophages,3.8025304778337556
KEGG_2021_Human,positive regulation of GTPase activity (GO:0043547),5/214,0.00019169029203686572,0.0032192693162661,0,0,10.494949494949497,89.83287982934151,CCL8;CCL3L1;CCL4;CCL3;CCL18,Macrophages,3.7173998809747197
KEGG_2021_Human,positive regulation of ion transport (GO:0043270),3/50,0.00026526273964070014,0.0042073617870788,0,0,27.02987777274785,222.5853605029436,CCL4;CCL3;SCN1B,Macrophages,3.576323749282245
KEGG_2021_Human,regulation of complement activation (GO:0030449),3/50,0.00026526273964070014,0.0042073617870788,0,0,27.02987777274785,222.5853605029436,C1QB;C1QA;C1QC,Macrophages,3.576323749282245
KEGG_2021_Human,positive regulation of chemokine production (GO:0032722),3/53,0.000315376219123607,0.0047389426610415,0,0,25.404255319148938,204.80261014345277,CSF1R;HMOX1;AIF1,Macrophages,3.501171057655084
KEGG_2021_Human,regulation of immune effector process (GO:0002697),3/53,0.000315376219123607,0.0047389426610415,0,0,25.404255319148938,204.80261014345277,C1QB;C1QA;C1QC,Macrophages,3.501171057655084
KEGG_2021_Human,positive regulation of leukocyte chemotaxis (GO:0002690),3/54,0.0003333415993294188,0.0047584513304274,0,0,24.90488110137672,199.39701474295643,CSF1R;PLA2G7;AIF1,Macrophages,3.4771104852237307
KEGG_2021_Human,regulation of humoral immune response (GO:0002920),3/54,0.0003333415993294188,0.0047584513304274,0,0,24.90488110137672,199.39701474295643,C1QB;C1QA;C1QC,Macrophages,3.4771104852237307
KEGG_2021_Human,cellular iron ion homeostasis (GO:0006879),3/58,0.00041177118298551824,0.0057346669630422,0,0,23.088974854932303,179.97954590931704,SLC40A1;HMOX1;FTL,Macrophages,3.3853440499187784
KEGG_2021_Human,positive regulation of calcium-mediated signaling (GO:0050850),2/13,0.00046942457388711873,0.0062000274759276,0,0,75.52651515151516,578.8354329773197,CCL4;CCL3,Macrophages,3.3284341792789096
KEGG_2021_Human,negative regulation by host of viral transcription (GO:0043922),2/13,0.00046942457388711873,0.0062000274759276,0,0,75.52651515151516,578.8354329773197,CCL4;CCL3,Macrophages,3.3284341792789096
KEGG_2021_Human,iron ion homeostasis (GO:0055072),3/61,0.0004777604359734098,0.0062000274759276,0,0,21.891415994130593,167.39054801840658,SLC40A1;HMOX1;FTL,Macrophages,3.320789817645709
KEGG_2021_Human,positive regulation of cell migration (GO:0030335),5/269,0.0005480378555617464,0.0069539914561279,0,0,8.285353535353535,62.21609667226863,SHTN1;CSF1R;DAB2;CCL3;AIF1,Macrophages,3.261189441709513
KEGG_2021_Human,heme catabolic process (GO:0042167),2/16,0.0007187392304892979,0.0087319170342423,0,0,59.333333333333336,429.45537567816734,SLCO2B1;HMOX1,Macrophages,3.14342864967499
KEGG_2021_Human,porphyrin-containing compound catabolic process (GO:0006787),2/16,0.0007187392304892979,0.0087319170342423,0,0,59.333333333333336,429.45537567816734,SLCO2B1;HMOX1,Macrophages,3.14342864967499
KEGG_2021_Human,ruffle organization (GO:0031529),2/17,0.0008132713373134499,0.0096745402834579,0,0,55.375,393.96243373102385,CSF1R;AIF1,Macrophages,3.089764533572175
KEGG_2021_Human,positive regulation of lymphocyte chemotaxis (GO:0140131),2/18,0.000913470506242016,0.0106447277360039,0,0,51.911458333333336,363.2898548418271,CCL4;CCL3,Macrophages,3.039305470405725
KEGG_2021_Human,positive regulation of macrophage migration (GO:1905523),2/19,0.0010193089566942,0.0114122630249494,0,0,48.85539215686274,336.54673838088314,CSF1R;CCL3,Macrophages,2.9916941596143727
KEGG_2021_Human,positive regulation of monocyte chemotaxis (GO:0090026),2/19,0.0010193089566942,0.0114122630249494,0,0,48.85539215686274,336.54673838088314,AIF1;PLA2G7,Macrophages,2.9916941596143727
KEGG_2021_Human,lipopolysaccharide-mediated signaling pathway (GO:0031663),2/20,0.0011307590059983,0.0124166037004816,0,0,46.138888888888886,313.0461870363529,CCL3;CD14,Macrophages,2.9466299446036754
KEGG_2021_Human,microglial cell activation (GO:0001774),2/22,0.001370383663162,0.0147639447484057,0,0,41.520833333333336,273.7329252658829,C1QA;AIF1,Macrophages,2.8631578273928713
KEGG_2021_Human,regulation of mononuclear cell migration (GO:0071675),2/23,0.0014985033958486,0.0158452859079556,0,0,39.541666666666664,257.15086234948103,CSF1R;AIF1,Macrophages,2.8243422685363964
KEGG_2021_Human,cellular transition metal ion homeostasis (GO:0046916),3/96,0.001783802806518,0.0185191164094875,0,0,13.628689087165409,86.25607933742052,SLC40A1;HMOX1;FTL,Macrophages,2.7486531571205104
KEGG_2021_Human,regulation of monocyte chemotaxis (GO:0090025),2/26,0.0019157650058532,0.0195339610418254,0,0,34.59375,216.47517339281177,AIF1;PLA2G7,Macrophages,2.7176577640050135
KEGG_2021_Human,regulation of calcium-mediated signaling (GO:0050848),2/28,0.0022210873543451,0.0220973000040543,0,0,31.92948717948718,195.08145262248803,CCL4;CCL3,Macrophages,2.6534343605132076
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),4/221,0.0022445593699389,0.0220973000040543,0,0,7.907433380084152,48.22938179957882,CSF1R;DAB2;CCL3;AIF1,Macrophages,2.6488689027613925
KEGG_2021_Human,negative regulation of myeloid leukocyte differentiation (GO:0002762),2/29,0.0023818121959682,0.0230510976931845,0,0,30.74537037037037,185.6987673947897,CCL3;C1QC,Macrophages,2.623092485284041
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),5/379,0.0025046631439755,0.0238360442535002,0,0,5.815805109922757,34.83435225893759,TMIGD3;FABP3;CCL3L1;HMOX1;AIF1,Macrophages,2.601250674806674
KEGG_2021_Human,plasma membrane invagination (GO:0099024),2/30,0.0025478771667966,0.0238498010203422,0,0,29.645833333333332,177.0595839464994,MSR1;AIF1,Macrophages,2.5938215131766835
KEGG_2021_Human,positive regulation of locomotion (GO:0040017),2/31,0.0027192556482504,0.0242608589867343,0,0,28.62212643678161,169.08226656127547,CSF1R;AIF1,Macrophages,2.565549960707733
KEGG_2021_Human,positive regulation of mononuclear cell migration (GO:0071677),2/31,0.0027192556482504,0.0242608589867343,0,0,28.62212643678161,169.08226656127547,AIF1;PLA2G7,Macrophages,2.565549960707733
KEGG_2021_Human,peptide cross-linking (GO:0018149),2/31,0.0027192556482504,0.0242608589867343,0,0,28.62212643678161,169.08226656127547,FCGR3A;F13A1,Macrophages,2.565549960707733
KEGG_2021_Human,modulation by host of symbiont process (GO:0051851),2/32,0.0028959211173454,0.0254395532000652,0,0,27.666666666666668,161.69650653172428,CCL4;CCL3,Macrophages,2.5382132721600397
KEGG_2021_Human,negative regulation of smooth muscle cell proliferation (GO:0048662),2/33,0.0030778471463162,0.0266280412204028,0,0,26.772849462365592,154.84144163978604,HMOX1;AIF1,Macrophages,2.511752952132796
KEGG_2021_Human,cellular response to lipopolysaccharide (GO:0071222),3/120,0.0033620370494817,0.0286525844067773,0,0,10.819967266775777,61.62196656098476,CCL3;CD14;CD68,Macrophages,2.473397504966506
KEGG_2021_Human,regulation of cell migration (GO:0030334),5/408,0.0034370574105232,0.028861173256011,0,0,5.3893024538185825,30.574265046313705,TMIGD3;CSF1R;DAB2;CCL3;AIF1,Macrophages,2.463813213610463
KEGG_2021_Human,macrophage activation (GO:0042116),2/36,0.0036549257227984,0.0302458346046072,0,0,24.40686274509804,136.96349152286243,C1QA;AIF1,Macrophages,2.437121444562911
KEGG_2021_Human,synapse organization (GO:0050808),3/126,0.0038560473771467,0.0305931616567055,0,0,10.289050337311885,57.18770048343562,C1QB;C1QA;C1QC,Macrophages,2.41385763879748
KEGG_2021_Human,positive regulation of calcium ion transport (GO:0051928),2/37,0.0038576315924392,0.0305931616567055,0,0,23.708333333333332,131.76384828572083,CCL4;CCL3,Macrophages,2.4136792502562754
KEGG_2021_Human,"phagocytosis, engulfment (GO:0006911)",2/37,0.0038576315924392,0.0305931616567055,0,0,23.708333333333332,131.76384828572083,MSR1;AIF1,Macrophages,2.4136792502562754
KEGG_2021_Human,positive regulation of response to external stimulus (GO:0032103),3/139,0.0050722381718543,0.0396746300839567,0,0,9.299436795994994,49.137973919606814,CCL3;PLA2G7;AIF1,Macrophages,2.294800361929647
KEGG_2021_Human,positive regulation of smooth muscle cell proliferation (GO:0048661),2/46,0.0059097422436154,0.0456008489338434,0,0,18.85037878787879,96.72417883948356,HMOX1;AIF1,Macrophages,2.2284314606782503
KEGG_2021_Human,positive regulation of neuron death (GO:1901216),2/47,0.0061625935135597,0.0469178786165679,0,0,18.430555555555557,93.79784429037068,C1QA;CCL3,Macrophages,2.210236477513525
KEGG_2021_Human,regulation of smooth muscle cell proliferation (GO:0048660),2/49,0.0066828970303688,0.0502096605834291,0,0,17.64450354609929,88.36726791367238,HMOX1;AIF1,Macrophages,2.175035230405133
KEGG_2021_Human,inositol lipid-mediated signaling (GO:0048017),2/51,0.0072225026271421,0.0528724230781814,0,0,16.922619047619047,83.43788300609687,CSF1R;ADAP2,Macrophages,2.1413122915117184
KEGG_2021_Human,cholesterol transport (GO:0030301),2/51,0.0072225026271421,0.0528724230781814,0,0,16.922619047619047,83.43788300609687,MSR1;APOC1,Macrophages,2.1413122915117184
KEGG_2021_Human,triglyceride metabolic process (GO:0006641),2/55,0.0083588302127531,0.0604163550820512,0,0,15.642295597484276,74.83957451132376,FABP3;APOC1,Macrophages,2.077854496208505
KEGG_2021_Human,glycosaminoglycan catabolic process (GO:0006027),2/56,0.0086546685435214,0.0617726967293841,0,0,15.351851851851851,72.91602120992282,FUCA1;LYVE1,Macrophages,2.0627495600792987
KEGG_2021_Human,regulation of calcium ion transport (GO:0051924),2/58,0.0092602829393189,0.0652792784981622,0,0,14.802083333333334,69.30366021141536,CCL4;CCL3,Macrophages,2.033375743652011
KEGG_2021_Human,positive regulation of cytokine production (GO:0001819),4/335,0.0097191113097967,0.0676782019255358,0,0,5.1540785498489425,23.88225325042697,CSF1R;HMOX1;CD14;AIF1,Macrophages,2.0123734440136594
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),6/764,0.0115877898422174,0.0789171308563679,0,0,3.4526265291436795,15.391130056301876,TMIGD3;CSF1R;FABP3;CCL3L1;FOLR2;AIF1,Macrophages,1.9359993898225176
KEGG_2021_Human,regulation of sterol transport (GO:0032371),1/5,0.0124387771927725,0.0789171308563679,0,0,101.76530612244898,446.4379351400606,APOC1,Macrophages,1.9052223113279663
KEGG_2021_Human,negative regulation of macrophage differentiation (GO:0045650),1/5,0.0124387771927725,0.0789171308563679,0,0,101.76530612244898,446.4379351400606,C1QC,Macrophages,1.9052223113279663
KEGG_2021_Human,response to macrophage colony-stimulating factor (GO:0036005),1/5,0.0124387771927725,0.0789171308563679,0,0,101.76530612244898,446.4379351400606,CSF1R,Macrophages,1.9052223113279663
KEGG_2021_Human,positive regulation of macrophage proliferation (GO:0120041),1/5,0.0124387771927725,0.0789171308563679,0,0,101.76530612244898,446.4379351400606,CSF1R,Macrophages,1.9052223113279663
KEGG_2021_Human,intracellular sequestering of iron ion (GO:0006880),1/5,0.0124387771927725,0.0789171308563679,0,0,101.76530612244898,446.4379351400606,FTL,Macrophages,1.9052223113279663
KEGG_2021_Human,cellular response to macrophage colony-stimulating factor stimulus (GO:0036006),1/5,0.0124387771927725,0.0789171308563679,0,0,101.76530612244898,446.4379351400606,CSF1R,Macrophages,1.9052223113279663
KEGG_2021_Human,mammary gland duct morphogenesis (GO:0060603),1/5,0.0124387771927725,0.0789171308563679,0,0,101.76530612244898,446.4379351400606,CSF1R,Macrophages,1.9052223113279663
KEGG_2021_Human,endoplasmic reticulum organization (GO:0007029),2/73,0.0143765335552059,0.0793130723534486,0,0,11.666079812206572,49.48935398933624,SHTN1;HMOX1,Macrophages,1.8423458176616205
KEGG_2021_Human,positive regulation of cholesterol storage (GO:0010886),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,MSR1,Macrophages,1.8265723193247598
KEGG_2021_Human,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,CCL3,Macrophages,1.8265723193247598
KEGG_2021_Human,glycoside metabolic process (GO:0016137),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,FUCA1,Macrophages,1.8265723193247598
KEGG_2021_Human,glycosyl compound catabolic process (GO:1901658),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,FUCA1,Macrophages,1.8265723193247598
KEGG_2021_Human,negative regulation of lipoprotein lipase activity (GO:0051005),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,APOC1,Macrophages,1.8265723193247598
KEGG_2021_Human,negative regulation of lipoprotein particle clearance (GO:0010985),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,APOC1,Macrophages,1.8265723193247598
KEGG_2021_Human,response to lipoteichoic acid (GO:0070391),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,CD14,Macrophages,1.8265723193247598
KEGG_2021_Human,positive regulation of microglial cell activation (GO:1903980),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,CCL3,Macrophages,1.8265723193247598
KEGG_2021_Human,positive regulation of microglial cell migration (GO:1904141),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,CCL3,Macrophages,1.8265723193247598
KEGG_2021_Human,ruffle assembly (GO:0097178),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,AIF1,Macrophages,1.8265723193247598
KEGG_2021_Human,cellular response to bacterial lipopeptide (GO:0071221),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,CD14,Macrophages,1.8265723193247598
KEGG_2021_Human,cellular response to lipoteichoic acid (GO:0071223),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,CD14,Macrophages,1.8265723193247598
KEGG_2021_Human,regulation of macrophage proliferation (GO:0120040),1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,CSF1R,Macrophages,1.8265723193247598
KEGG_2021_Human,"positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)",1/6,0.0149082847993736,0.0793130723534486,0,0,81.40816326530613,342.3895623444841,DAB2,Macrophages,1.8265723193247598
KEGG_2021_Human,regulation of T cell proliferation (GO:0042129),2/76,0.0155171628224907,0.0793130723534486,0,0,11.19144144144144,46.62140287744705,VSIG4;AIF1,Macrophages,1.8091876827669675
KEGG_2021_Human,water-soluble vitamin metabolic process (GO:0006767),2/76,0.0155171628224907,0.0793130723534486,0,0,11.19144144144144,46.62140287744705,ACP5;FOLR2,Macrophages,1.8091876827669675
KEGG_2021_Human,positive regulation of tumor necrosis factor production (GO:0032760),2/77,0.0159057771109684,0.0793130723534486,0,0,11.041666666666666,45.72434655376785,CCL3;CD14,Macrophages,1.7984451076467942
KEGG_2021_Human,glycerophospholipid metabolic process (GO:0006650),2/80,0.0170965192165363,0.0793130723534486,0,0,10.615384615384617,43.19273030214829,CSF1R;PLA2G7,Macrophages,1.7670923012410087
KEGG_2021_Human,flavin-containing compound metabolic process (GO:0042726),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,ACP5,Macrophages,1.7601566430186848
KEGG_2021_Human,glial cell migration (GO:0008347),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,CCL3,Macrophages,1.7601566430186848
KEGG_2021_Human,regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,SCN1B,Macrophages,1.7601566430186848
KEGG_2021_Human,release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,CCL3,Macrophages,1.7601566430186848
KEGG_2021_Human,response to host defenses (GO:0052200),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,MRC1,Macrophages,1.7601566430186848
KEGG_2021_Human,negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,CD14,Macrophages,1.7601566430186848
KEGG_2021_Human,Cdc42 protein signal transduction (GO:0032488),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,SHTN1,Macrophages,1.7601566430186848
KEGG_2021_Human,riboflavin metabolic process (GO:0006771),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,ACP5,Macrophages,1.7601566430186848
KEGG_2021_Human,positive regulation of phospholipid biosynthetic process (GO:0071073),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,FABP3,Macrophages,1.7601566430186848
KEGG_2021_Human,"substrate-dependent cell migration, cell extension (GO:0006930)",1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,SHTN1,Macrophages,1.7601566430186848
KEGG_2021_Human,chylomicron remnant clearance (GO:0034382),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,APOC1,Macrophages,1.7601566430186848
KEGG_2021_Human,creatine metabolic process (GO:0006600),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,GATM,Macrophages,1.7601566430186848
KEGG_2021_Human,regulation of microglial cell migration (GO:1904139),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,CCL3,Macrophages,1.7601566430186848
KEGG_2021_Human,parallel actin filament bundle assembly (GO:0030046),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,AIF1,Macrophages,1.7601566430186848
KEGG_2021_Human,modulation by symbiont of host defense response (GO:0052031),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,MRC1,Macrophages,1.7601566430186848
KEGG_2021_Human,negative regulation by host of viral genome replication (GO:0044828),1/7,0.0173717414502839,0.0793130723534486,0,0,67.83673469387755,274.9362107684438,CCL8,Macrophages,1.7601566430186848
KEGG_2021_Human,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/81,0.0175016586979588,0.0793130723534486,0,0,10.48048523206751,42.398379802278754,CCL3;CD14,Macrophages,1.7569207896432026
KEGG_2021_Human,folic acid transport (GO:0015884),1/8,0.0198291614511851,0.0851312119445616,0,0,58.142857142857146,227.9549801512961,FOLR2,Macrophages,1.702695651141308
KEGG_2021_Human,regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,0.0198291614511851,0.0851312119445616,0,0,58.142857142857146,227.9549801512961,HMOX1,Macrophages,1.702695651141308
KEGG_2021_Human,positive regulation of early endosome to late endosome transport (GO:2000643),1/8,0.0198291614511851,0.0851312119445616,0,0,58.142857142857146,227.9549801512961,DAB2,Macrophages,1.702695651141308
KEGG_2021_Human,glycoside catabolic process (GO:0016139),1/8,0.0198291614511851,0.0851312119445616,0,0,58.142857142857146,227.9549801512961,FUCA1,Macrophages,1.702695651141308
KEGG_2021_Human,positive regulation of glial cell migration (GO:1903977),1/8,0.0198291614511851,0.0851312119445616,0,0,58.142857142857146,227.9549801512961,CCL3,Macrophages,1.702695651141308
KEGG_2021_Human,regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),1/8,0.0198291614511851,0.0851312119445616,0,0,58.142857142857146,227.9549801512961,CD14,Macrophages,1.702695651141308
KEGG_2021_Human,platelet activating factor metabolic process (GO:0046469),1/8,0.0198291614511851,0.0851312119445616,0,0,58.142857142857146,227.9549801512961,PLA2G7,Macrophages,1.702695651141308
KEGG_2021_Human,metal ion transport (GO:0030001),2/88,0.0204505278871254,0.0871436673399151,0,0,9.624031007751938,37.43504172973695,CCL8;CCL3,Macrophages,1.6892954771184148
KEGG_2021_Human,positive regulation of inflammatory response (GO:0050729),2/89,0.0208876608034354,0.0883470690278638,0,0,9.512931034482758,36.80169347929862,CCL3;PLA2G7,Macrophages,1.6801101936742149
KEGG_2021_Human,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),1/9,0.0222805591236868,0.0902283635434408,0,0,50.87244897959184,193.52086993316271,HMOX1,Macrophages,1.652073914876897
KEGG_2021_Human,positive regulation of cholesterol esterification (GO:0010873),1/9,0.0222805591236868,0.0902283635434408,0,0,50.87244897959184,193.52086993316271,APOC1,Macrophages,1.652073914876897
KEGG_2021_Human,"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",1/9,0.0222805591236868,0.0902283635434408,0,0,50.87244897959184,193.52086993316271,DAB2,Macrophages,1.652073914876897
KEGG_2021_Human,bone resorption (GO:0045453),1/9,0.0222805591236868,0.0902283635434408,0,0,50.87244897959184,193.52086993316271,ACP5,Macrophages,1.652073914876897
KEGG_2021_Human,negative regulation of lipase activity (GO:0060192),1/9,0.0222805591236868,0.0902283635434408,0,0,50.87244897959184,193.52086993316271,APOC1,Macrophages,1.652073914876897
KEGG_2021_Human,regulation of dendritic cell antigen processing and presentation (GO:0002604),1/9,0.0222805591236868,0.0902283635434408,0,0,50.87244897959184,193.52086993316271,CD68,Macrophages,1.652073914876897
KEGG_2021_Human,calcium ion homeostasis (GO:0055074),2/97,0.024523395696302,0.0928849787806207,0,0,8.708333333333334,32.29161197321332,CCL8;CCL3,Macrophages,1.6104193942653626
KEGG_2021_Human,granulocyte migration (GO:0097530),1/10,0.024725948817258,0.0928849787806207,0,0,45.21768707482993,167.3010120823387,CCL3,Macrophages,1.606847034080906
KEGG_2021_Human,negative regulation of leukocyte migration (GO:0002686),1/10,0.024725948817258,0.0928849787806207,0,0,45.21768707482993,167.3010120823387,HMOX1,Macrophages,1.606847034080906
KEGG_2021_Human,sarcoplasmic reticulum calcium ion transport (GO:0070296),1/10,0.024725948817258,0.0928849787806207,0,0,45.21768707482993,167.3010120823387,CCL3,Macrophages,1.606847034080906
KEGG_2021_Human,iron ion transmembrane transport (GO:0034755),1/10,0.024725948817258,0.0928849787806207,0,0,45.21768707482993,167.3010120823387,SLC40A1,Macrophages,1.606847034080906
KEGG_2021_Human,regulation of granulocyte differentiation (GO:0030852),1/10,0.024725948817258,0.0928849787806207,0,0,45.21768707482993,167.3010120823387,C1QC,Macrophages,1.606847034080906
KEGG_2021_Human,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),1/10,0.024725948817258,0.0928849787806207,0,0,45.21768707482993,167.3010120823387,CD68,Macrophages,1.606847034080906
KEGG_2021_Human,neuron remodeling (GO:0016322),1/10,0.024725948817258,0.0928849787806207,0,0,45.21768707482993,167.3010120823387,C1QA,Macrophages,1.606847034080906
KEGG_2021_Human,membrane lipid catabolic process (GO:0046466),1/10,0.024725948817258,0.0928849787806207,0,0,45.21768707482993,167.3010120823387,FUCA1,Macrophages,1.606847034080906
KEGG_2021_Human,modulation by symbiont of host process (GO:0044003),1/10,0.024725948817258,0.0928849787806207,0,0,45.21768707482993,167.3010120823387,MRC1,Macrophages,1.606847034080906
KEGG_2021_Human,phosphatidylcholine catabolic process (GO:0034638),1/10,0.024725948817258,0.0928849787806207,0,0,45.21768707482993,167.3010120823387,PLA2G7,Macrophages,1.606847034080906
KEGG_2021_Human,positive regulation of defense response (GO:0031349),2/98,0.0249948795228368,0.0932815438401297,0,0,8.6171875,31.789531066243494,CCL3;PLA2G7,Macrophages,1.6021489522377872
KEGG_2021_Human,cell-matrix adhesion (GO:0007160),2/100,0.025948961945953,0.0955926275557369,0,0,8.44047619047619,30.82144266223132,OTOA;LYVE1,Macrophages,1.5858800108468012
KEGG_2021_Human,organic acid transport (GO:0015849),2/100,0.025948961945953,0.0955926275557369,0,0,8.44047619047619,30.82144266223132,SLCO2B1;FOLR2,Macrophages,1.5858800108468012
KEGG_2021_Human,negative regulation of cholesterol transport (GO:0032375),1/11,0.0271653448579923,0.0957494562587262,0,0,40.69387755102041,146.73452100035948,APOC1,Macrophages,1.5659847773237099
KEGG_2021_Human,positive regulation of cytoplasmic transport (GO:1903651),1/11,0.0271653448579923,0.0957494562587262,0,0,40.69387755102041,146.73452100035948,DAB2,Macrophages,1.5659847773237099
KEGG_2021_Human,response to sterol (GO:0036314),1/11,0.0271653448579923,0.0957494562587262,0,0,40.69387755102041,146.73452100035948,CCL3,Macrophages,1.5659847773237099
KEGG_2021_Human,cell-cell junction maintenance (GO:0045217),1/11,0.0271653448579923,0.0957494562587262,0,0,40.69387755102041,146.73452100035948,CSF1R,Macrophages,1.5659847773237099
KEGG_2021_Human,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),1/11,0.0271653448579923,0.0957494562587262,0,0,40.69387755102041,146.73452100035948,DAB2,Macrophages,1.5659847773237099
KEGG_2021_Human,T cell chemotaxis (GO:0010818),1/11,0.0271653448579923,0.0957494562587262,0,0,40.69387755102041,146.73452100035948,CCL3,Macrophages,1.5659847773237099
KEGG_2021_Human,monocyte differentiation (GO:0030224),1/11,0.0271653448579923,0.0957494562587262,0,0,40.69387755102041,146.73452100035948,CSF1R,Macrophages,1.5659847773237099
KEGG_2021_Human,cellular metal ion homeostasis (GO:0006875),2/104,0.0279010087799889,0.096576530604834,0,0,8.107843137254902,29.018720027145317,CCL8;CCL3,Macrophages,1.5543800942295387
KEGG_2021_Human,actin crosslink formation (GO:0051764),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,AIF1,Macrophages,1.5287264597194943
KEGG_2021_Human,regulation of sensory perception (GO:0051931),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,CCL3,Macrophages,1.5287264597194943
KEGG_2021_Human,negative regulation of complement activation (GO:0045916),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,VSIG4,Macrophages,1.5287264597194943
KEGG_2021_Human,negative regulation of fatty acid biosynthetic process (GO:0045717),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,APOC1,Macrophages,1.5287264597194943
KEGG_2021_Human,regulation of cholesterol esterification (GO:0010872),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,APOC1,Macrophages,1.5287264597194943
KEGG_2021_Human,positive regulation of leukocyte proliferation (GO:0070665),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,CSF1R,Macrophages,1.5287264597194943
KEGG_2021_Human,positive regulation of neuroinflammatory response (GO:0150078),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,CCL3,Macrophages,1.5287264597194943
KEGG_2021_Human,macrophage chemotaxis (GO:0048246),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,CCL3,Macrophages,1.5287264597194943
KEGG_2021_Human,very-low-density lipoprotein particle assembly (GO:0034379),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,APOC1,Macrophages,1.5287264597194943
KEGG_2021_Human,phospholipid efflux (GO:0033700),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,APOC1,Macrophages,1.5287264597194943
KEGG_2021_Human,phospholipid homeostasis (GO:0055091),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,FABP3,Macrophages,1.5287264597194943
KEGG_2021_Human,negative regulation by host of viral process (GO:0044793),1/12,0.029598761568907,0.096576530604834,0,0,36.99257884972171,130.2147194065139,CCL8,Macrophages,1.5287264597194943
KEGG_2021_Human,lipid transport (GO:0006869),2/109,0.0304216645881743,0.0982425519037376,0,0,7.72702492211838,26.987409356009476,FABP3;SLCO2B1,Macrophages,1.5168170262567133
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),4/474,0.030453470555099,0.0982425519037376,0,0,3.604070305272895,12.583810832834969,CSF1R;HMOX1;FOLR2;AIF1,Macrophages,1.5163632069049728
KEGG_2021_Human,cellular divalent inorganic cation homeostasis (GO:0072503),2/111,0.0314544847807964,0.0988424361356604,0,0,7.584480122324159,26.23633758944092,CCL8;CCL3,Macrophages,1.5023174240917434
KEGG_2021_Human,neutrophil degranulation (GO:0043312),4/481,0.0318938223451042,0.0988424361356604,0,0,3.549904293136451,12.230637711209717,FUCA1;CD14;CD68;FTL,Macrophages,1.4962934292076782
KEGG_2021_Human,positive regulation of calcium ion import (GO:0090280),1/13,0.032026213248763,0.0988424361356604,0,0,33.90816326530612,116.6847899929619,CCL3,Macrophages,1.4944944088974865
KEGG_2021_Human,positive regulation of neuron migration (GO:2001224),1/13,0.032026213248763,0.0988424361356604,0,0,33.90816326530612,116.6847899929619,SHTN1,Macrophages,1.4944944088974865
KEGG_2021_Human,lipid oxidation (GO:0034440),1/13,0.032026213248763,0.0988424361356604,0,0,33.90816326530612,116.6847899929619,PLA2G7,Macrophages,1.4944944088974865
KEGG_2021_Human,positive regulation of sodium ion transport (GO:0010765),1/13,0.032026213248763,0.0988424361356604,0,0,33.90816326530612,116.6847899929619,SCN1B,Macrophages,1.4944944088974865
KEGG_2021_Human,positive regulation of steroid metabolic process (GO:0045940),1/13,0.032026213248763,0.0988424361356604,0,0,33.90816326530612,116.6847899929619,APOC1,Macrophages,1.4944944088974865
KEGG_2021_Human,neutrophil activation involved in immune response (GO:0002283),4/485,0.0327347557645973,0.0988424361356604,0,0,3.5196601283557807,12.03483687212892,FUCA1;CD14;CD68;FTL,Macrophages,1.4849908950194666
KEGG_2021_Human,neutrophil mediated immunity (GO:0002446),4/488,0.0333740074148611,0.0988424361356604,0,0,3.497305066475027,11.890759946354155,FUCA1;CD14;CD68;FTL,Macrophages,1.476591641901793
KEGG_2021_Human,calcium ion transport (GO:0006816),2/115,0.033561350657856,0.0988424361356604,0,0,7.31452802359882,24.82828874550635,CCL8;CCL3,Macrophages,1.4741605695522084
KEGG_2021_Human,cellular response to molecule of bacterial origin (GO:0071219),2/115,0.033561350657856,0.0988424361356604,0,0,7.31452802359882,24.82828874550635,CD14;CD68,Macrophages,1.4741605695522084
KEGG_2021_Human,negative regulation of bone mineralization (GO:0030502),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,CCL3,Macrophages,1.4628395910668823
KEGG_2021_Human,regulation of sensory perception of pain (GO:0051930),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,CCL3,Macrophages,1.4628395910668823
KEGG_2021_Human,ether lipid metabolic process (GO:0046485),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,PLA2G7,Macrophages,1.4628395910668823
KEGG_2021_Human,cell junction maintenance (GO:0034331),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,CSF1R,Macrophages,1.4628395910668823
KEGG_2021_Human,positive regulation of lymphocyte migration (GO:2000403),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,AIF1,Macrophages,1.4628395910668823
KEGG_2021_Human,positive regulation of macrophage chemotaxis (GO:0010759),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,CSF1R,Macrophages,1.4628395910668823
KEGG_2021_Human,negative regulation of smooth muscle cell migration (GO:0014912),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,AIF1,Macrophages,1.4628395910668823
KEGG_2021_Human,sodium-independent organic anion transport (GO:0043252),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,SLCO2B1,Macrophages,1.4628395910668823
KEGG_2021_Human,low-density lipoprotein particle remodeling (GO:0034374),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,PLA2G7,Macrophages,1.4628395910668823
KEGG_2021_Human,substrate-dependent cell migration (GO:0006929),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,SHTN1,Macrophages,1.4628395910668823
KEGG_2021_Human,positive regulation of SMAD protein signal transduction (GO:0060391),1/14,0.0344477141698711,0.0988424361356604,0,0,31.298273155416013,105.4223689491126,DAB2,Macrophages,1.4628395910668823
KEGG_2021_Human,negative regulation of androgen receptor signaling pathway (GO:0060766),1/15,0.0368632785936063,0.1016856622074841,0,0,29.06122448979592,95.91771596133704,DAB2,Macrophages,1.4334060415588732
KEGG_2021_Human,regulation of clathrin-dependent endocytosis (GO:2000369),1/15,0.0368632785936063,0.1016856622074841,0,0,29.06122448979592,95.91771596133704,DAB2,Macrophages,1.4334060415588732
KEGG_2021_Human,macrophage differentiation (GO:0030225),1/15,0.0368632785936063,0.1016856622074841,0,0,29.06122448979592,95.91771596133704,CSF1R,Macrophages,1.4334060415588732
KEGG_2021_Human,macrophage migration (GO:1905517),1/15,0.0368632785936063,0.1016856622074841,0,0,29.06122448979592,95.91771596133704,CCL3,Macrophages,1.4334060415588732
KEGG_2021_Human,mammary gland epithelium development (GO:0061180),1/15,0.0368632785936063,0.1016856622074841,0,0,29.06122448979592,95.91771596133704,CSF1R,Macrophages,1.4334060415588732
KEGG_2021_Human,regulation of macrophage differentiation (GO:0045649),1/15,0.0368632785936063,0.1016856622074841,0,0,29.06122448979592,95.91771596133704,C1QC,Macrophages,1.4334060415588732
KEGG_2021_Human,regulation of microglial cell activation (GO:1903978),1/15,0.0368632785936063,0.1016856622074841,0,0,29.06122448979592,95.91771596133704,CCL3,Macrophages,1.4334060415588732
KEGG_2021_Human,modulation by host of viral genome replication (GO:0044827),1/15,0.0368632785936063,0.1016856622074841,0,0,29.06122448979592,95.91771596133704,CCL8,Macrophages,1.4334060415588732
KEGG_2021_Human,cellular response to organic substance (GO:0071310),2/123,0.0379356146383277,0.1041405574927169,0,0,6.828168044077135,22.34084340876857,CSF1R;CCL3,Macrophages,1.420952875040757
KEGG_2021_Human,regulation of tumor necrosis factor production (GO:0032680),2/124,0.038497072428768,0.1043015708808355,0,0,6.771857923497268,22.05711333941876,CCL3;CD14,Macrophages,1.4145722958518654
KEGG_2021_Human,cellular response to oxidative stress (GO:0034599),2/125,0.0390617280151273,0.1043015708808355,0,0,6.716463414634147,21.77888563484535,HMOX1;AIF1,Macrophages,1.408248548277182
KEGG_2021_Human,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/16,0.0392729207344652,0.1043015708808355,0,0,27.122448979591837,87.80133530116419,HMOX1,Macrophages,1.405906798966597
KEGG_2021_Human,regulation of cholesterol storage (GO:0010885),1/16,0.0392729207344652,0.1043015708808355,0,0,27.122448979591837,87.80133530116419,MSR1,Macrophages,1.405906798966597
KEGG_2021_Human,regulation of establishment of cell polarity (GO:2000114),1/16,0.0392729207344652,0.1043015708808355,0,0,27.122448979591837,87.80133530116419,SHTN1,Macrophages,1.405906798966597
KEGG_2021_Human,regulation of fatty acid oxidation (GO:0046320),1/16,0.0392729207344652,0.1043015708808355,0,0,27.122448979591837,87.80133530116419,FABP3,Macrophages,1.405906798966597
KEGG_2021_Human,necroptotic process (GO:0070266),1/16,0.0392729207344652,0.1043015708808355,0,0,27.122448979591837,87.80133530116419,CD14,Macrophages,1.405906798966597
KEGG_2021_Human,negative regulation of fatty acid metabolic process (GO:0045922),1/17,0.0416766547912334,0.1070916451319,0,0,25.426020408163264,80.79916728086499,APOC1,Macrophages,1.3801071472903907
KEGG_2021_Human,positive regulation of macrophage activation (GO:0043032),1/17,0.0416766547912334,0.1070916451319,0,0,25.426020408163264,80.79916728086499,CCL3,Macrophages,1.3801071472903907
KEGG_2021_Human,regulation of leukocyte migration (GO:0002685),1/17,0.0416766547912334,0.1070916451319,0,0,25.426020408163264,80.79916728086499,HMOX1,Macrophages,1.3801071472903907
KEGG_2021_Human,membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,0.0416766547912334,0.1070916451319,0,0,25.426020408163264,80.79916728086499,SCN1B,Macrophages,1.3801071472903907
KEGG_2021_Human,positive regulation of smooth muscle cell migration (GO:0014911),1/17,0.0416766547912334,0.1070916451319,0,0,25.426020408163264,80.79916728086499,AIF1,Macrophages,1.3801071472903907
KEGG_2021_Human,modified amino acid transport (GO:0072337),1/17,0.0416766547912334,0.1070916451319,0,0,25.426020408163264,80.79916728086499,FOLR2,Macrophages,1.3801071472903907
KEGG_2021_Human,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,HMOX1,Macrophages,1.3558126557645607
KEGG_2021_Human,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,SCN1B,Macrophages,1.3558126557645607
KEGG_2021_Human,negative regulation of lipid catabolic process (GO:0050995),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,APOC1,Macrophages,1.3558126557645607
KEGG_2021_Human,high-density lipoprotein particle remodeling (GO:0034375),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,APOC1,Macrophages,1.3558126557645607
KEGG_2021_Human,hyaluronan catabolic process (GO:0030214),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,LYVE1,Macrophages,1.3558126557645607
KEGG_2021_Human,positive regulation of macrophage derived foam cell differentiation (GO:0010744),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,MSR1,Macrophages,1.3558126557645607
KEGG_2021_Human,regulation of early endosome to late endosome transport (GO:2000641),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,DAB2,Macrophages,1.3558126557645607
KEGG_2021_Human,regulation of establishment or maintenance of cell polarity (GO:0032878),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,SHTN1,Macrophages,1.3558126557645607
KEGG_2021_Human,regulation of fatty acid metabolic process (GO:0019217),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,FABP3,Macrophages,1.3558126557645607
KEGG_2021_Human,neuron maturation (GO:0042551),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,C1QA,Macrophages,1.3558126557645607
KEGG_2021_Human,T cell migration (GO:0072678),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,CCL3,Macrophages,1.3558126557645607
KEGG_2021_Human,regulation of membrane depolarization (GO:0003254),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,SCN1B,Macrophages,1.3558126557645607
KEGG_2021_Human,programmed necrotic cell death (GO:0097300),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,CD14,Macrophages,1.3558126557645607
KEGG_2021_Human,endothelial cell proliferation (GO:0001935),1/18,0.0440744949316926,0.1070916451319,0,0,23.92917166866747,74.70385911458476,HMOX1,Macrophages,1.3558126557645607
KEGG_2021_Human,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),2/136,0.0454786698217006,0.1087391228425578,0,0,6.161691542288557,19.042780777221537,CD163;FCGR3A,Macrophages,1.3421922462170102
KEGG_2021_Human,cellular calcium ion homeostasis (GO:0006874),2/136,0.0454786698217006,0.1087391228425578,0,0,6.161691542288557,19.042780777221537,CCL8;CCL3,Macrophages,1.3421922462170102
KEGG_2021_Human,regulation of inflammatory response to antigenic stimulus (GO:0002861),2/137,0.0460802533373535,0.1087391228425578,0,0,6.1157407407407405,18.820401760879264,CD163;FCGR3A,Macrophages,1.3364851419391792
KEGG_2021_Human,Rac protein signal transduction (GO:0016601),1/19,0.0464664552952436,0.1087391228425578,0,0,22.598639455782312,69.35578082800635,AIF1,Macrophages,1.3328604565168853
KEGG_2021_Human,folic acid metabolic process (GO:0046655),1/19,0.0464664552952436,0.1087391228425578,0,0,22.598639455782312,69.35578082800635,FOLR2,Macrophages,1.3328604565168853
KEGG_2021_Human,negative regulation of immune system process (GO:0002683),1/19,0.0464664552952436,0.1087391228425578,0,0,22.598639455782312,69.35578082800635,HMOX1,Macrophages,1.3328604565168853
KEGG_2021_Human,response to cholesterol (GO:0070723),1/19,0.0464664552952436,0.1087391228425578,0,0,22.598639455782312,69.35578082800635,CCL3,Macrophages,1.3328604565168853
KEGG_2021_Human,carbohydrate derivative catabolic process (GO:1901136),1/19,0.0464664552952436,0.1087391228425578,0,0,22.598639455782312,69.35578082800635,FUCA1,Macrophages,1.3328604565168853
KEGG_2021_Human,cardiac muscle cell contraction (GO:0086003),1/19,0.0464664552952436,0.1087391228425578,0,0,22.598639455782312,69.35578082800635,SCN1B,Macrophages,1.3328604565168853
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),4/546,0.0471837441916468,0.109967011973185,0,0,3.1137493983635487,9.50847474832882,CCL4;CCL3;HMOX1;CD14,Macrophages,1.3262075993289288
KEGG_2021_Human,fatty acid transport (GO:0015908),1/20,0.0488525499820277,0.1104507302932367,0,0,21.40816326530612,64.63014669364038,FABP3,Macrophages,1.3111127622579986
KEGG_2021_Human,folic acid-containing compound metabolic process (GO:0006760),1/20,0.0488525499820277,0.1104507302932367,0,0,21.40816326530612,64.63014669364038,FOLR2,Macrophages,1.3111127622579986
KEGG_2021_Human,regulation of T cell migration (GO:2000404),1/20,0.0488525499820277,0.1104507302932367,0,0,21.40816326530612,64.63014669364038,AIF1,Macrophages,1.3111127622579986
KEGG_2021_Human,negative regulation of osteoclast differentiation (GO:0045671),1/20,0.0488525499820277,0.1104507302932367,0,0,21.40816326530612,64.63014669364038,CCL3,Macrophages,1.3111127622579986
KEGG_2021_Human,cellular modified amino acid biosynthetic process (GO:0042398),1/20,0.0488525499820277,0.1104507302932367,0,0,21.40816326530612,64.63014669364038,GATM,Macrophages,1.3111127622579986
KEGG_2021_Human,regulation of granulocyte chemotaxis (GO:0071622),1/20,0.0488525499820277,0.1104507302932367,0,0,21.40816326530612,64.63014669364038,CSF1R,Macrophages,1.3111127622579986
KEGG_2021_Human,toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.0488525499820277,0.1104507302932367,0,0,21.40816326530612,64.63014669364038,CD14,Macrophages,1.3111127622579986
KEGG_2021_Human,Ras protein signal transduction (GO:0007265),2/142,0.049132198764417,0.1104507302932367,0,0,5.895833333333333,17.765564841290935,SHTN1;AIF1,Macrophages,1.3086337998813415
KEGG_2021_Human,protein localization to organelle (GO:0033365),2/142,0.049132198764417,0.1104507302932367,0,0,5.895833333333333,17.765564841290935,HMOX1;CD68,Macrophages,1.3086337998813415
KEGG_2021_Human,negative regulation of cell migration (GO:0030336),2/144,0.0503731921946642,0.1116562016846569,0,0,5.812206572769953,17.368594502988177,TMIGD3;HMOX1,Macrophages,1.2978005266368353
KEGG_2021_Human,positive regulation of lipid storage (GO:0010884),1/21,0.0512327930672156,0.1116562016846569,0,0,20.336734693877553,60.42807445408675,MSR1,Macrophages,1.2904519669693806
KEGG_2021_Human,negative regulation of protein localization to cell periphery (GO:1904376),1/21,0.0512327930672156,0.1116562016846569,0,0,20.336734693877553,60.42807445408675,DAB2,Macrophages,1.2904519669693806
KEGG_2021_Human,negative regulation of protein localization to plasma membrane (GO:1903077),1/21,0.0512327930672156,0.1116562016846569,0,0,20.336734693877553,60.42807445408675,DAB2,Macrophages,1.2904519669693806
KEGG_2021_Human,intracellular lipid transport (GO:0032365),1/21,0.0512327930672156,0.1116562016846569,0,0,20.336734693877553,60.42807445408675,FABP3,Macrophages,1.2904519669693806
KEGG_2021_Human,sterol transport (GO:0015918),1/21,0.0512327930672156,0.1116562016846569,0,0,20.336734693877553,60.42807445408675,MSR1,Macrophages,1.2904519669693806
KEGG_2021_Human,regulation of lipid catabolic process (GO:0050994),1/21,0.0512327930672156,0.1116562016846569,0,0,20.336734693877553,60.42807445408675,APOC1,Macrophages,1.2904519669693806
KEGG_2021_Human,regulation of lipoprotein lipase activity (GO:0051004),1/21,0.0512327930672156,0.1116562016846569,0,0,20.336734693877553,60.42807445408675,APOC1,Macrophages,1.2904519669693806
KEGG_2021_Human,negative regulation of biomineral tissue development (GO:0070168),1/22,0.0536071985992547,0.1137907449820612,0,0,19.367346938775512,56.67024999786951,CCL3,Macrophages,1.2707768875084013
KEGG_2021_Human,positive regulation of axon extension (GO:0045773),1/22,0.0536071985992547,0.1137907449820612,0,0,19.367346938775512,56.67024999786951,SHTN1,Macrophages,1.2707768875084013
KEGG_2021_Human,regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.0536071985992547,0.1137907449820612,0,0,19.367346938775512,56.67024999786951,SCN1B,Macrophages,1.2707768875084013
KEGG_2021_Human,negative regulation of interleukin-2 production (GO:0032703),1/22,0.0536071985992547,0.1137907449820612,0,0,19.367346938775512,56.67024999786951,VSIG4,Macrophages,1.2707768875084013
KEGG_2021_Human,negative regulation of lipid biosynthetic process (GO:0051055),1/22,0.0536071985992547,0.1137907449820612,0,0,19.367346938775512,56.67024999786951,APOC1,Macrophages,1.2707768875084013
KEGG_2021_Human,regulation of macrophage chemotaxis (GO:0010758),1/22,0.0536071985992547,0.1137907449820612,0,0,19.367346938775512,56.67024999786951,CSF1R,Macrophages,1.2707768875084013
KEGG_2021_Human,osteoclast differentiation (GO:0030316),1/22,0.0536071985992547,0.1137907449820612,0,0,19.367346938775512,56.67024999786951,CSF1R,Macrophages,1.2707768875084013
KEGG_2021_Human,regulation of SMAD protein signal transduction (GO:0060390),1/23,0.0559757805878795,0.1170775484090813,0,0,18.4860853432282,53.29235549319145,DAB2,Macrophages,1.2519998414265567
KEGG_2021_Human,response to nutrient levels (GO:0031667),1/23,0.0559757805878795,0.1170775484090813,0,0,18.4860853432282,53.29235549319145,CD68,Macrophages,1.2519998414265567
KEGG_2021_Human,hyaluronan metabolic process (GO:0030212),1/23,0.0559757805878795,0.1170775484090813,0,0,18.4860853432282,53.29235549319145,LYVE1,Macrophages,1.2519998414265567
KEGG_2021_Human,triglyceride catabolic process (GO:0019433),1/23,0.0559757805878795,0.1170775484090813,0,0,18.4860853432282,53.29235549319145,FABP3,Macrophages,1.2519998414265567
KEGG_2021_Human,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/24,0.0583385530130099,0.118968977751531,0,0,17.68145519077196,50.24171555062859,DAB2,Macrophages,1.2340443470047993
KEGG_2021_Human,negative regulation of lipid metabolic process (GO:0045833),1/24,0.0583385530130099,0.118968977751531,0,0,17.68145519077196,50.24171555062859,APOC1,Macrophages,1.2340443470047993
KEGG_2021_Human,negative regulation of ossification (GO:0030279),1/24,0.0583385530130099,0.118968977751531,0,0,17.68145519077196,50.24171555062859,CCL3,Macrophages,1.2340443470047993
KEGG_2021_Human,positive regulation of neuron apoptotic process (GO:0043525),1/24,0.0583385530130099,0.118968977751531,0,0,17.68145519077196,50.24171555062859,CCL3,Macrophages,1.2340443470047993
KEGG_2021_Human,cholesterol efflux (GO:0033344),1/24,0.0583385530130099,0.118968977751531,0,0,17.68145519077196,50.24171555062859,APOC1,Macrophages,1.2340443470047993
KEGG_2021_Human,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/24,0.0583385530130099,0.118968977751531,0,0,17.68145519077196,50.24171555062859,DAB2,Macrophages,1.2340443470047993
KEGG_2021_Human,protein kinase B signaling (GO:0043491),1/24,0.0583385530130099,0.118968977751531,0,0,17.68145519077196,50.24171555062859,CCL3,Macrophages,1.2340443470047993
KEGG_2021_Human,response to lipopolysaccharide (GO:0032496),2/159,0.060032623780291,0.1216040264196637,0,0,5.25291932059448,14.77576411894998,CD14;CD68,Macrophages,1.2216126749949432
KEGG_2021_Human,negative regulation of endocytosis (GO:0045806),1/25,0.0606955298241754,0.1216040264196637,0,0,16.943877551020407,47.47480020477031,APOC1,Macrophages,1.2168432931781568
KEGG_2021_Human,regulation of calcium ion import (GO:0090279),1/25,0.0606955298241754,0.1216040264196637,0,0,16.943877551020407,47.47480020477031,CCL3,Macrophages,1.2168432931781568
KEGG_2021_Human,regulation of cholesterol transport (GO:0032374),1/25,0.0606955298241754,0.1216040264196637,0,0,16.943877551020407,47.47480020477031,APOC1,Macrophages,1.2168432931781568
KEGG_2021_Human,positive regulation of T cell migration (GO:2000406),1/25,0.0606955298241754,0.1216040264196637,0,0,16.943877551020407,47.47480020477031,AIF1,Macrophages,1.2168432931781568
KEGG_2021_Human,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/26,0.0630467249540435,0.1241368274095133,0,0,16.26530612244898,44.95534064809558,AIF1,Macrophages,1.2003374685092782
KEGG_2021_Human,negative regulation of protein localization to membrane (GO:1905476),1/26,0.0630467249540435,0.1241368274095133,0,0,16.26530612244898,44.95534064809558,DAB2,Macrophages,1.2003374685092782
KEGG_2021_Human,negative regulation of receptor-mediated endocytosis (GO:0048261),1/26,0.0630467249540435,0.1241368274095133,0,0,16.26530612244898,44.95534064809558,APOC1,Macrophages,1.2003374685092782
KEGG_2021_Human,membrane depolarization during action potential (GO:0086010),1/26,0.0630467249540435,0.1241368274095133,0,0,16.26530612244898,44.95534064809558,SCN1B,Macrophages,1.2003374685092782
KEGG_2021_Human,mononuclear cell differentiation (GO:1903131),1/26,0.0630467249540435,0.1241368274095133,0,0,16.26530612244898,44.95534064809558,CSF1R,Macrophages,1.2003374685092782
KEGG_2021_Human,positive regulation of cellular component movement (GO:0051272),1/27,0.0653921522588676,0.1278730100678541,0,0,15.638932496075354,42.652889831563165,CSF1R,Macrophages,1.184474368421492
KEGG_2021_Human,regulation of vasculature development (GO:1901342),1/27,0.0653921522588676,0.1278730100678541,0,0,15.638932496075354,42.652889831563165,HMOX1,Macrophages,1.184474368421492
KEGG_2021_Human,regulation of sodium ion transmembrane transport (GO:1902305),1/28,0.0677318256109869,0.1297814510868239,0,0,15.058956916099774,40.54171043527237,SCN1B,Macrophages,1.1692072184717057
KEGG_2021_Human,amide transport (GO:0042886),1/28,0.0677318256109869,0.1297814510868239,0,0,15.058956916099774,40.54171043527237,FOLR2,Macrophages,1.1692072184717057
KEGG_2021_Human,glycerophospholipid catabolic process (GO:0046475),1/28,0.0677318256109869,0.1297814510868239,0,0,15.058956916099774,40.54171043527237,PLA2G7,Macrophages,1.1692072184717057
KEGG_2021_Human,bile acid and bile salt transport (GO:0015721),1/28,0.0677318256109869,0.1297814510868239,0,0,15.058956916099774,40.54171043527237,SLCO2B1,Macrophages,1.1692072184717057
KEGG_2021_Human,RNA phosphodiester bond hydrolysis (GO:0090501),1/28,0.0677318256109869,0.1297814510868239,0,0,15.058956916099774,40.54171043527237,RNASE1,Macrophages,1.1692072184717057
KEGG_2021_Human,regulation of neuron migration (GO:2001222),1/28,0.0677318256109869,0.1297814510868239,0,0,15.058956916099774,40.54171043527237,SHTN1,Macrophages,1.1692072184717057
KEGG_2021_Human,actin filament polymerization (GO:0030041),1/29,0.0700657588372089,0.1320381131882716,0,0,14.520408163265309,38.5999069065122,AIF1,Macrophages,1.1544941700666143
KEGG_2021_Human,positive regulation of leukocyte migration (GO:0002687),1/29,0.0700657588372089,0.1320381131882716,0,0,14.520408163265309,38.5999069065122,AIF1,Macrophages,1.1544941700666143
KEGG_2021_Human,regulation of fatty acid biosynthetic process (GO:0042304),1/29,0.0700657588372089,0.1320381131882716,0,0,14.520408163265309,38.5999069065122,APOC1,Macrophages,1.1544941700666143
KEGG_2021_Human,dicarboxylic acid transport (GO:0006835),1/29,0.0700657588372089,0.1320381131882716,0,0,14.520408163265309,38.5999069065122,FOLR2,Macrophages,1.1544941700666143
KEGG_2021_Human,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/29,0.0700657588372089,0.1320381131882716,0,0,14.520408163265309,38.5999069065122,CD14,Macrophages,1.1544941700666143
KEGG_2021_Human,defense response to bacterium (GO:0042742),2/176,0.0716793261504705,0.1346345237892062,0,0,4.735632183908046,12.48100918849243,STAB1;MPEG1,Macrophages,1.144606086081811
KEGG_2021_Human,response to alcohol (GO:0097305),1/30,0.0723939657090184,0.1346480599995098,0,0,14.019000703729768,36.80874147674154,CCL3,Macrophages,1.1402976322627019
KEGG_2021_Human,cardiac muscle cell action potential (GO:0086001),1/30,0.0723939657090184,0.1346480599995098,0,0,14.019000703729768,36.80874147674154,SCN1B,Macrophages,1.1402976322627019
KEGG_2021_Human,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/30,0.0723939657090184,0.1346480599995098,0,0,14.019000703729768,36.80874147674154,CD14,Macrophages,1.1402976322627019
KEGG_2021_Human,negative regulation of immune response (GO:0050777),2/178,0.073094899664538,0.1355103497027637,0,0,4.681344696969697,12.246382216533686,CD163;FCGR3A,Macrophages,1.1361129257073213
KEGG_2021_Human,aminoglycan catabolic process (GO:0006026),1/31,0.0747164600026276,0.136303829589458,0,0,13.551020408163266,35.15209038871121,FUCA1,Macrophages,1.126583712764908
KEGG_2021_Human,cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.0747164600026276,0.136303829589458,0,0,13.551020408163266,35.15209038871121,SCN1B,Macrophages,1.126583712764908
KEGG_2021_Human,regulation of macrophage derived foam cell differentiation (GO:0010743),1/31,0.0747164600026276,0.136303829589458,0,0,13.551020408163266,35.15209038871121,MSR1,Macrophages,1.126583712764908
KEGG_2021_Human,vitamin transport (GO:0051180),1/31,0.0747164600026276,0.136303829589458,0,0,13.551020408163266,35.15209038871121,FOLR2,Macrophages,1.126583712764908
KEGG_2021_Human,MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/31,0.0747164600026276,0.136303829589458,0,0,13.551020408163266,35.15209038871121,CD14,Macrophages,1.126583712764908
KEGG_2021_Human,negative regulation of chemotaxis (GO:0050922),1/32,0.0770332554327668,0.1370280026545479,0,0,13.113232389730086,33.61600807740255,AIF1,Macrophages,1.1133217484244988
KEGG_2021_Human,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),1/32,0.0770332554327668,0.1370280026545479,0,0,13.113232389730086,33.61600807740255,DAB2,Macrophages,1.1133217484244988
KEGG_2021_Human,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/32,0.0770332554327668,0.1370280026545479,0,0,13.113232389730086,33.61600807740255,HMOX1,Macrophages,1.1133217484244988
KEGG_2021_Human,hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.0770332554327668,0.1370280026545479,0,0,13.113232389730086,33.61600807740255,CSF1R,Macrophages,1.1133217484244988
KEGG_2021_Human,regulation of chemotaxis (GO:0050920),1/32,0.0770332554327668,0.1370280026545479,0,0,13.113232389730086,33.61600807740255,AIF1,Macrophages,1.1133217484244988
KEGG_2021_Human,long-chain fatty acid transport (GO:0015909),1/32,0.0770332554327668,0.1370280026545479,0,0,13.113232389730086,33.61600807740255,FABP3,Macrophages,1.1133217484244988
KEGG_2021_Human,membrane depolarization (GO:0051899),1/32,0.0770332554327668,0.1370280026545479,0,0,13.113232389730086,33.61600807740255,SCN1B,Macrophages,1.1133217484244988
KEGG_2021_Human,metal ion export (GO:0070839),1/32,0.0770332554327668,0.1370280026545479,0,0,13.113232389730086,33.61600807740255,SLC40A1,Macrophages,1.1133217484244988
KEGG_2021_Human,actin filament bundle assembly (GO:0051017),1/33,0.0793443657059371,0.1402651170838702,0,0,12.70280612244898,32.18837516559274,AIF1,Macrophages,1.1004839073426347
KEGG_2021_Human,actin filament bundle organization (GO:0061572),1/33,0.0793443657059371,0.1402651170838702,0,0,12.70280612244898,32.18837516559274,AIF1,Macrophages,1.1004839073426347
KEGG_2021_Human,epithelial tube morphogenesis (GO:0060562),1/34,0.0816498044624026,0.1425750408196693,0,0,12.317254174397032,30.85861216573232,CSF1R,Macrophages,1.0880448509885652
KEGG_2021_Human,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/34,0.0816498044624026,0.1425750408196693,0,0,12.317254174397032,30.85861216573232,HMOX1,Macrophages,1.0880448509885652
KEGG_2021_Human,cardiac muscle contraction (GO:0060048),1/34,0.0816498044624026,0.1425750408196693,0,0,12.317254174397032,30.85861216573232,SCN1B,Macrophages,1.0880448509885652
KEGG_2021_Human,protein insertion into membrane (GO:0051205),1/34,0.0816498044624026,0.1425750408196693,0,0,12.317254174397032,30.85861216573232,HMOX1,Macrophages,1.0880448509885652
KEGG_2021_Human,acylglycerol catabolic process (GO:0046464),1/35,0.0839495853612937,0.1443831724135504,0,0,11.95438175270108,29.61744503578088,FABP3,Macrophages,1.0759814445616303
KEGG_2021_Human,positive regulation of cell cycle G1/S phase transition (GO:1902808),1/35,0.0839495853612937,0.1443831724135504,0,0,11.95438175270108,29.61744503578088,AIF1,Macrophages,1.0759814445616303
KEGG_2021_Human,regulation of blood circulation (GO:1903522),1/35,0.0839495853612937,0.1443831724135504,0,0,11.95438175270108,29.61744503578088,TMIGD3,Macrophages,1.0759814445616303
KEGG_2021_Human,positive regulation of lipid biosynthetic process (GO:0046889),1/35,0.0839495853612937,0.1443831724135504,0,0,11.95438175270108,29.61744503578088,FABP3,Macrophages,1.0759814445616303
KEGG_2021_Human,negative regulation of T cell proliferation (GO:0042130),1/35,0.0839495853612937,0.1443831724135504,0,0,11.95438175270108,29.61744503578088,VSIG4,Macrophages,1.0759814445616303
KEGG_2021_Human,negative regulation of macromolecule metabolic process (GO:0010605),2/194,0.0847375162198589,0.1452659741809134,0,0,4.287760416666667,10.58303673172677,MSR1;CCL3,Macrophages,1.0719242699529004
KEGG_2021_Human,activation of adenylate cyclase activity (GO:0007190),1/36,0.0862437219743075,0.1452659741809134,0,0,11.612244897959185,28.456712045041098,TMIGD3,Macrophages,1.0642725091375862
KEGG_2021_Human,regulation of sodium ion transport (GO:0002028),1/36,0.0862437219743075,0.1452659741809134,0,0,11.612244897959185,28.456712045041098,SCN1B,Macrophages,1.0642725091375862
KEGG_2021_Human,regulation of androgen receptor signaling pathway (GO:0060765),1/36,0.0862437219743075,0.1452659741809134,0,0,11.612244897959185,28.456712045041098,DAB2,Macrophages,1.0642725091375862
KEGG_2021_Human,cellular response to heat (GO:0034605),1/36,0.0862437219743075,0.1452659741809134,0,0,11.612244897959185,28.456712045041098,HMOX1,Macrophages,1.0642725091375862
KEGG_2021_Human,negative regulation of toll-like receptor signaling pathway (GO:0034122),1/36,0.0862437219743075,0.1452659741809134,0,0,11.612244897959185,28.456712045041098,CD14,Macrophages,1.0642725091375862
KEGG_2021_Human,regulation of osteoclast differentiation (GO:0045670),1/36,0.0862437219743075,0.1452659741809134,0,0,11.612244897959185,28.456712045041098,CCL3,Macrophages,1.0642725091375862
KEGG_2021_Human,regulation of actin cytoskeleton reorganization (GO:2000249),1/37,0.0885322278902676,0.1482460472883954,0,0,11.289115646258503,27.36920368672352,CSF1R,Macrophages,1.0528986067362665
KEGG_2021_Human,protein insertion into ER membrane (GO:0045048),1/37,0.0885322278902676,0.1482460472883954,0,0,11.289115646258503,27.36920368672352,HMOX1,Macrophages,1.0528986067362665
KEGG_2021_Human,regulation of axon extension (GO:0030516),1/38,0.0908151166313484,0.1511820163163265,0,0,10.983452840595698,26.34852930034076,SHTN1,Macrophages,1.0418418549683985
KEGG_2021_Human,negative regulation of innate immune response (GO:0045824),1/38,0.0908151166313484,0.1511820163163265,0,0,10.983452840595698,26.34852930034076,VSIG4,Macrophages,1.0418418549683985
KEGG_2021_Human,regulation of angiogenesis (GO:0045765),2/203,0.0915200219539462,0.1519125945805328,0,0,4.093905472636816,9.789336578359592,STAB1;HMOX1,Macrophages,1.0384838843718929
KEGG_2021_Human,regulation of protein tyrosine kinase activity (GO:0061097),1/39,0.0930924017046572,0.1523087718434363,0,0,10.693877551020408,25.38900533231373,CSF1R,Macrophages,1.0310857651239858
KEGG_2021_Human,regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.0930924017046572,0.1523087718434363,0,0,10.693877551020408,25.38900533231373,APOC1,Macrophages,1.0310857651239858
KEGG_2021_Human,negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.0930924017046572,0.1523087718434363,0,0,10.693877551020408,25.38900533231373,VSIG4,Macrophages,1.0310857651239858
KEGG_2021_Human,regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.0930924017046572,0.1523087718434363,0,0,10.693877551020408,25.38900533231373,SCN1B,Macrophages,1.0310857651239858
KEGG_2021_Human,regulation of ion transmembrane transporter activity (GO:0032412),1/39,0.0930924017046572,0.1523087718434363,0,0,10.693877551020408,25.38900533231373,SCN1B,Macrophages,1.0310857651239858
KEGG_2021_Human,regulation of inflammatory response (GO:0050727),2/206,0.0938158179234975,0.1530538058123345,0,0,4.033088235294118,9.543987931843056,CCL3;PLA2G7,Macrophages,1.0277239307283335
KEGG_2021_Human,regulation of sodium ion transmembrane transporter activity (GO:2000649),1/40,0.0953640965755271,0.1546957362063238,0,0,10.419152276295131,24.485561288951835,SCN1B,Macrophages,1.0206151011238414
KEGG_2021_Human,organic hydroxy compound transport (GO:0015850),1/40,0.0953640965755271,0.1546957362063238,0,0,10.419152276295131,24.485561288951835,SLCO2B1,Macrophages,1.0206151011238414
KEGG_2021_Human,acylglycerol metabolic process (GO:0006639),1/41,0.0976302146847681,0.1565922825421422,0,0,10.158163265306122,23.633660200289185,APOC1,Macrophages,1.0104157556925017
KEGG_2021_Human,heart contraction (GO:0060047),1/41,0.0976302146847681,0.1565922825421422,0,0,10.158163265306122,23.633660200289185,SCN1B,Macrophages,1.0104157556925017
KEGG_2021_Human,hexose metabolic process (GO:0019318),1/41,0.0976302146847681,0.1565922825421422,0,0,10.158163265306122,23.633660200289185,FUCA1,Macrophages,1.0104157556925017
KEGG_2021_Human,visual system development (GO:0150063),1/41,0.0976302146847681,0.1565922825421422,0,0,10.158163265306122,23.633660200289185,C1QA,Macrophages,1.0104157556925017
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),2/212,0.0984576089228105,0.1574770159521704,0,0,3.9166666666666665,9.079339326341122,CD163;FCGR3A,Macrophages,1.0067507154273545
KEGG_2021_Human,positive regulation of epithelial to mesenchymal transition (GO:0010718),1/42,0.0998907694703361,0.1582023488685718,0,0,9.909905425584869,22.829231064333683,DAB2,Macrophages,1.00047464143678
KEGG_2021_Human,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/42,0.0998907694703361,0.1582023488685718,0,0,9.909905425584869,22.829231064333683,HMOX1,Macrophages,1.00047464143678
KEGG_2021_Human,positive regulation of protein tyrosine kinase activity (GO:0061098),1/42,0.0998907694703361,0.1582023488685718,0,0,9.909905425584869,22.829231064333683,CSF1R,Macrophages,1.00047464143678
KEGG_2021_Human,positive regulation of protein modification process (GO:0031401),2/214,0.100019348409027,0.1582023488685718,0,0,3.879323899371069,8.931722866735825,CSF1R;DAB2,Macrophages,0.9999159790553556
KEGG_2021_Human,positive regulation of axonogenesis (GO:0050772),1/43,0.1021457742794159,0.1602341678943585,0,0,9.673469387755102,22.068611238785657,SHTN1,Macrophages,0.9907795952096249
KEGG_2021_Human,anion transport (GO:0006820),1/43,0.1021457742794159,0.1602341678943585,0,0,9.673469387755102,22.068611238785657,SLCO2B1,Macrophages,0.9907795952096249
KEGG_2021_Human,lipid modification (GO:0030258),1/43,0.1021457742794159,0.1602341678943585,0,0,9.673469387755102,22.068611238785657,PLA2G7,Macrophages,0.9907795952096249
KEGG_2021_Human,cellular response to lipid (GO:0071396),2/219,0.1039543502969196,0.162624476765866,0,0,3.788978494623656,8.577502457974575,CD14;CD68,Macrophages,0.9831573315329525
KEGG_2021_Human,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.1043952424647777,0.1628679875611696,0,0,9.448030374940672,21.34849709415977,DAB2,Macrophages,0.9813192926974915
KEGG_2021_Human,positive regulation of chemotaxis (GO:0050921),1/45,0.1066391873529346,0.1650161950637552,0,0,9.232838589981448,20.665901611884028,AIF1,Macrophages,0.9720831731354668
KEGG_2021_Human,negative regulation of T cell activation (GO:0050868),1/45,0.1066391873529346,0.1650161950637552,0,0,9.232838589981448,20.665901611884028,VSIG4,Macrophages,0.9720831731354668
KEGG_2021_Human,zymogen activation (GO:0031638),1/45,0.1066391873529346,0.1650161950637552,0,0,9.232838589981448,20.665901611884028,CD5L,Macrophages,0.9720831731354668
KEGG_2021_Human,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/47,0.1111105603036554,0.1714706214415872,0,0,8.830523513753327,19.4026870705364,DAB2,Macrophages,0.9542446623584087
KEGG_2021_Human,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.1133380148369131,0.1735013578334514,0,0,8.642205818497612,18.81737166641443,HMOX1,Macrophages,0.9456243984787533
KEGG_2021_Human,positive regulation of endocytosis (GO:0045807),1/48,0.1133380148369131,0.1735013578334514,0,0,8.642205818497612,18.81737166641443,DAB2,Macrophages,0.9456243984787533
KEGG_2021_Human,regulation of interleukin-2 production (GO:0032663),1/48,0.1133380148369131,0.1735013578334514,0,0,8.642205818497612,18.81737166641443,VSIG4,Macrophages,0.9456243984787533
KEGG_2021_Human,negative regulation of catabolic process (GO:0009895),1/49,0.1155599990222406,0.1754913814938814,0,0,8.46173469387755,18.260130793597916,APOC1,Macrophages,0.9371924705024297
KEGG_2021_Human,response to hydrogen peroxide (GO:0042542),1/49,0.1155599990222406,0.1754913814938814,0,0,8.46173469387755,18.260130793597916,HMOX1,Macrophages,0.9371924705024297
KEGG_2021_Human,cellular defense response (GO:0006968),1/49,0.1155599990222406,0.1754913814938814,0,0,8.46173469387755,18.260130793597916,CD5L,Macrophages,0.9371924705024297
KEGG_2021_Human,actin polymerization or depolymerization (GO:0008154),1/50,0.1177765260040411,0.1779111014505488,0,0,8.28862973760933,17.7290996615035,AIF1,Macrophages,0.928941259997044
KEGG_2021_Human,iron ion transport (GO:0006826),1/50,0.1177765260040411,0.1779111014505488,0,0,8.28862973760933,17.7290996615035,SLC40A1,Macrophages,0.928941259997044
KEGG_2021_Human,axonogenesis (GO:0007409),2/240,0.1209266562339864,0.1821732427081434,0,0,3.450980392156863,7.290441318878535,SHTN1;SCN1B,Macrophages,0.9174779557207333
KEGG_2021_Human,negative regulation of cellular biosynthetic process (GO:0031327),1/52,0.1221932608707862,0.1821732427081434,0,0,7.962785114045619,16.738979733033663,APOC1,Macrophages,0.9129527453809976
KEGG_2021_Human,positive regulation of developmental growth (GO:0048639),1/52,0.1221932608707862,0.1821732427081434,0,0,7.962785114045619,16.738979733033663,SHTN1,Macrophages,0.9129527453809976
KEGG_2021_Human,glycolipid metabolic process (GO:0006664),1/52,0.1221932608707862,0.1821732427081434,0,0,7.962785114045619,16.738979733033663,FUCA1,Macrophages,0.9129527453809976
KEGG_2021_Human,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.1221932608707862,0.1821732427081434,0,0,7.962785114045619,16.738979733033663,SHTN1,Macrophages,0.9129527453809976
KEGG_2021_Human,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.1243934949128716,0.1849705354042961,0,0,7.809262166405024,16.276887238960814,CD14,Macrophages,0.9052023302345248
KEGG_2021_Human,glycosaminoglycan metabolic process (GO:0030203),1/54,0.1265883240687765,0.1872588938944854,0,0,7.661532537543319,15.834970375184442,FUCA1,Macrophages,0.8976063498190403
KEGG_2021_Human,striated muscle contraction (GO:0006941),1/54,0.1265883240687765,0.1872588938944854,0,0,7.661532537543319,15.834970375184442,SCN1B,Macrophages,0.8976063498190403
KEGG_2021_Human,negative regulation of metabolic process (GO:0009892),1/56,0.1309618198144747,0.1917415361899104,0,0,7.382189239332097,15.00687933540933,APOC1,Macrophages,0.8828552987007785
KEGG_2021_Human,positive regulation of interleukin-1 beta production (GO:0032731),1/56,0.1309618198144747,0.1917415361899104,0,0,7.382189239332097,15.00687933540933,CCL3,Macrophages,0.8828552987007785
KEGG_2021_Human,Rho protein signal transduction (GO:0007266),1/56,0.1309618198144747,0.1917415361899104,0,0,7.382189239332097,15.00687933540933,SHTN1,Macrophages,0.8828552987007785
KEGG_2021_Human,peptidyl-tyrosine modification (GO:0018212),1/56,0.1309618198144747,0.1917415361899104,0,0,7.382189239332097,15.00687933540933,CSF1R,Macrophages,0.8828552987007785
KEGG_2021_Human,positive regulation of phosphorylation (GO:0042327),2/253,0.1317582069542016,0.1924141590047292,0,0,3.270086321381142,6.627767796360294,CSF1R;DAB2,Macrophages,0.880222323941479
KEGG_2021_Human,regulation of bone mineralization (GO:0030500),1/57,0.1331405122852093,0.1924638797844418,0,0,7.25,14.618539131965724,CCL3,Macrophages,0.8756897763447542
KEGG_2021_Human,positive regulation of interferon-gamma production (GO:0032729),1/57,0.1331405122852093,0.1924638797844418,0,0,7.25,14.618539131965724,CD14,Macrophages,0.8756897763447542
KEGG_2021_Human,dicarboxylic acid metabolic process (GO:0043648),1/57,0.1331405122852093,0.1924638797844418,0,0,7.25,14.618539131965724,FOLR2,Macrophages,0.8756897763447542
KEGG_2021_Human,monocarboxylic acid transport (GO:0015718),1/57,0.1331405122852093,0.1924638797844418,0,0,7.25,14.618539131965724,SLCO2B1,Macrophages,0.8756897763447542
KEGG_2021_Human,positive regulation of mitotic cell cycle phase transition (GO:1901992),1/58,0.1353138517398134,0.1946201746685982,0,0,7.122448979591836,14.246025949065045,AIF1,Macrophages,0.8686577434892403
KEGG_2021_Human,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/58,0.1353138517398134,0.1946201746685982,0,0,7.122448979591836,14.246025949065045,DAB2,Macrophages,0.8686577434892403
KEGG_2021_Human,positive regulation of cell differentiation (GO:0045597),2/258,0.1359834100026853,0.1950917766621439,0,0,3.2054036458333335,6.395493110208526,MSR1;DAB2,Macrophages,0.8665140723928182
KEGG_2021_Human,protein polymerization (GO:0051258),1/59,0.1374818510452552,0.195278947628957,0,0,6.9992962702322306,13.8884471557023,AIF1,Macrophages,0.8617546291873563
KEGG_2021_Human,response to reactive oxygen species (GO:0000302),1/59,0.1374818510452552,0.195278947628957,0,0,6.9992962702322306,13.8884471557023,HMOX1,Macrophages,0.8617546291873563
KEGG_2021_Human,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/59,0.1374818510452552,0.195278947628957,0,0,6.9992962702322306,13.8884471557023,CSF1R,Macrophages,0.8617546291873563
KEGG_2021_Human,phospholipid transport (GO:0015914),1/59,0.1374818510452552,0.195278947628957,0,0,6.9992962702322306,13.8884471557023,APOC1,Macrophages,0.8617546291873563
KEGG_2021_Human,response to organic cyclic compound (GO:0014070),1/60,0.1396445230534406,0.1978586170310536,0,0,6.88031822898651,13.544974303558986,CCL3,Macrophages,0.8549760929333525
KEGG_2021_Human,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.198940721912661,0,0,6.76530612244898,13.214837540593155,CD14,Macrophages,0.848318009451734
KEGG_2021_Human,"regulation of DNA-templated transcription, initiation (GO:2000142)",1/61,0.1418018805927374,0.198940721912661,0,0,6.76530612244898,13.214837540593155,CSF1R,Macrophages,0.848318009451734
KEGG_2021_Human,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.198940721912661,0,0,6.76530612244898,13.214837540593155,DAB2,Macrophages,0.848318009451734
KEGG_2021_Human,pattern recognition receptor signaling pathway (GO:0002221),1/61,0.1418018805927374,0.198940721912661,0,0,6.76530612244898,13.214837540593155,CD14,Macrophages,0.848318009451734
KEGG_2021_Human,regulation of protein phosphorylation (GO:0001932),2/266,0.1428070813555834,0.199859910426564,0,0,3.1070075757575757,6.047046555927847,CSF1R;DAB2,Macrophages,0.8452502567236859
KEGG_2021_Human,positive regulation of interleukin-1 production (GO:0032732),1/62,0.1439539364695556,0.2004821895710153,0,0,6.654064904650385,12.897320592663672,CCL3,Macrophages,0.8417764546925935
KEGG_2021_Human,I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/62,0.1439539364695556,0.2004821895710153,0,0,6.654064904650385,12.897320592663672,CD14,Macrophages,0.8417764546925935
KEGG_2021_Human,organonitrogen compound catabolic process (GO:1901565),1/63,0.1461007034145454,0.2024842273051102,0,0,6.54641211323239,12.591756250239603,PLA2G7,Macrophages,0.8353476931121088
KEGG_2021_Human,monocarboxylic acid biosynthetic process (GO:0072330),1/63,0.1461007034145454,0.2024842273051102,0,0,6.54641211323239,12.591756250239603,GATM,Macrophages,0.8353476931121088
KEGG_2021_Human,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/64,0.1482421941802595,0.2044596446302614,0,0,6.442176870748299,12.297522293260638,CSF1R,Macrophages,0.8290281655096747
KEGG_2021_Human,lipid homeostasis (GO:0055088),1/64,0.1482421941802595,0.2044596446302614,0,0,6.442176870748299,12.297522293260638,FABP3,Macrophages,0.8290281655096747
KEGG_2021_Human,inorganic cation transmembrane transport (GO:0098662),2/274,0.1497038344955427,0.2059780469806142,0,0,3.014399509803922,5.724635176902424,SLC40A1;SCN1B,Macrophages,0.8247670755492156
KEGG_2021_Human,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.208332215894935,0,0,6.243328100470958,11.740759916332207,C1QA,Macrophages,0.8167033932798328
KEGG_2021_Human,cellular response to nutrient levels (GO:0031669),1/66,0.1525093979756266,0.208332215894935,0,0,6.243328100470958,11.740759916332207,CD68,Macrophages,0.8167033932798328
KEGG_2021_Human,positive regulation of T cell proliferation (GO:0042102),1/66,0.1525093979756266,0.208332215894935,0,0,6.243328100470958,11.740759916332207,AIF1,Macrophages,0.8167033932798328
KEGG_2021_Human,plasma membrane bounded cell projection assembly (GO:0120031),2/278,0.1531779174072652,0.2087460401898531,0,0,2.970108695652174,5.572384797626887,SHTN1;AIF1,Macrophages,0.8148038393993969
KEGG_2021_Human,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/68,0.1567556490806558,0.2131130372025107,0,0,6.0563508985683825,11.222824361971773,CSF1R,Macrophages,0.8047767993307415
KEGG_2021_Human,negative regulation of cellular catabolic process (GO:0031330),1/69,0.158870948881139,0.2144570019175659,0,0,5.966986794717887,10.977245117600177,APOC1,Macrophages,0.7989555105590889
KEGG_2021_Human,cellular response to decreased oxygen levels (GO:0036294),1/69,0.158870948881139,0.2144570019175659,0,0,5.966986794717887,10.977245117600177,HMOX1,Macrophages,0.7989555105590889
KEGG_2021_Human,peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.158870948881139,0.2144570019175659,0,0,5.966986794717887,10.977245117600177,CSF1R,Macrophages,0.7989555105590889
KEGG_2021_Human,defense response to Gram-positive bacterium (GO:0050830),1/70,0.1609810482853106,0.2162827731080291,0,0,5.880212954747116,10.740024519792764,MPEG1,Macrophages,0.7932252488723367
KEGG_2021_Human,wound healing (GO:0042060),1/70,0.1609810482853106,0.2162827731080291,0,0,5.880212954747116,10.740024519792764,HMOX1,Macrophages,0.7932252488723367
KEGG_2021_Human,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/71,0.16308595979881,0.2165629838258617,0,0,5.795918367346939,10.51076961698872,FCGR3A,Macrophages,0.7875834261109624
KEGG_2021_Human,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.16308595979881,0.2165629838258617,0,0,5.795918367346939,10.51076961698872,AIF1,Macrophages,0.7875834261109624
KEGG_2021_Human,cholesterol homeostasis (GO:0042632),1/71,0.16308595979881,0.2165629838258617,0,0,5.795918367346939,10.51076961698872,FABP3,Macrophages,0.7875834261109624
KEGG_2021_Human,phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.16308595979881,0.2165629838258617,0,0,5.795918367346939,10.51076961698872,CSF1R,Macrophages,0.7875834261109624
KEGG_2021_Human,myeloid leukocyte differentiation (GO:0002573),1/71,0.16308595979881,0.2165629838258617,0,0,5.795918367346939,10.51076961698872,CSF1R,Macrophages,0.7875834261109624
KEGG_2021_Human,Fc-gamma receptor signaling pathway (GO:0038094),1/72,0.1651856959101235,0.2178314835212022,0,0,5.713998275366484,10.28911103101624,FCGR3A,Macrophages,0.78202756268309
KEGG_2021_Human,cell junction organization (GO:0034330),1/72,0.1651856959101235,0.2178314835212022,0,0,5.713998275366484,10.28911103101624,C1QA,Macrophages,0.78202756268309
KEGG_2021_Human,sterol homeostasis (GO:0055092),1/72,0.1651856959101235,0.2178314835212022,0,0,5.713998275366484,10.28911103101624,FABP3,Macrophages,0.78202756268309
KEGG_2021_Human,response to molecule of bacterial origin (GO:0002237),1/73,0.1672802691231711,0.2195793877455878,0,0,5.634353741496598,10.074701240888364,CD14,Macrophages,0.7765552814899175
KEGG_2021_Human,defense response to Gram-negative bacterium (GO:0050829),1/73,0.1672802691231711,0.2195793877455878,0,0,5.634353741496598,10.074701240888364,MPEG1,Macrophages,0.7765552814899175
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),3/566,0.1678713329989042,0.2198498420696658,0,0,2.197989493972261,3.922438566092192,TMIGD3;FABP3;CCL3L1,Macrophages,0.7750234609992368
KEGG_2021_Human,Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/74,0.1693696918266344,0.2207993014452244,0,0,5.556891249650545,9.867213018330611,FCGR3A,Macrophages,0.7711643026835198
KEGG_2021_Human,negative regulation of protein binding (GO:0032091),1/74,0.1693696918266344,0.2207993014452244,0,0,5.556891249650545,9.867213018330611,DAB2,Macrophages,0.7711643026835198
KEGG_2021_Human,positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.1714539764404576,0.2214937116459305,0,0,5.4815223386651954,9.666337985731484,AIF1,Macrophages,0.7658524380723842
KEGG_2021_Human,integrin-mediated signaling pathway (GO:0007229),1/75,0.1714539764404576,0.2214937116459305,0,0,5.4815223386651954,9.666337985731484,DAB2,Macrophages,0.7658524380723842
KEGG_2021_Human,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.1714539764404576,0.2214937116459305,0,0,5.4815223386651954,9.666337985731484,RNASE1,Macrophages,0.7658524380723842
KEGG_2021_Human,positive regulation of T cell activation (GO:0050870),1/75,0.1714539764404576,0.2214937116459305,0,0,5.4815223386651954,9.666337985731484,AIF1,Macrophages,0.7658524380723842
KEGG_2021_Human,establishment of protein localization to organelle (GO:0072594),1/76,0.1735331353639065,0.2221691037954947,0,0,5.408163265306122,9.4717853003048,CD68,Macrophages,0.7606175863963804
KEGG_2021_Human,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.2221691037954947,0,0,5.408163265306122,9.4717853003048,AIF1,Macrophages,0.7606175863963804
KEGG_2021_Human,cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.1735331353639065,0.2221691037954947,0,0,5.408163265306122,9.4717853003048,SHTN1,Macrophages,0.7606175863963804
KEGG_2021_Human,regulation of epithelial to mesenchymal transition (GO:0010717),1/76,0.1735331353639065,0.2221691037954947,0,0,5.408163265306122,9.4717853003048,DAB2,Macrophages,0.7606175863963804
KEGG_2021_Human,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1756071809118701,0.2233222723845831,0,0,5.336734693877551,9.283280446293812,HMOX1,Macrophages,0.7554577289388229
KEGG_2021_Human,positive regulation of type I interferon production (GO:0032481),1/77,0.1756071809118701,0.2233222723845831,0,0,5.336734693877551,9.283280446293812,CD14,Macrophages,0.7554577289388229
KEGG_2021_Human,phosphatidylcholine metabolic process (GO:0046470),1/77,0.1756071809118701,0.2233222723845831,0,0,5.336734693877551,9.283280446293812,PLA2G7,Macrophages,0.7554577289388229
KEGG_2021_Human,negative regulation of blood vessel morphogenesis (GO:2000181),1/78,0.1776761254379788,0.2254512613890798,0,0,5.267161410018553,9.10056411919043,STAB1,Macrophages,0.7503709249641564
KEGG_2021_Human,axon development (GO:0061564),1/79,0.1797399811935544,0.2260606371399109,0,0,5.199372056514914,8.923391206941128,SHTN1,Macrophages,0.745355308086215
KEGG_2021_Human,negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/79,0.1797399811935544,0.2260606371399109,0,0,5.199372056514914,8.923391206941128,TMIGD3,Macrophages,0.745355308086215
KEGG_2021_Human,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/79,0.1797399811935544,0.2260606371399109,0,0,5.199372056514914,8.923391206941128,DAB2,Macrophages,0.745355308086215
KEGG_2021_Human,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.1797399811935544,0.2260606371399109,0,0,5.199372056514914,8.923391206941128,DAB2,Macrophages,0.745355308086215
KEGG_2021_Human,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.2271489983371892,0,0,5.133298889175924,8.751529842637671,HMOX1,Macrophages,0.7404090821369118
KEGG_2021_Human,regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.181798760490535,0.2271489983371892,0,0,5.133298889175924,8.751529842637671,CD14,Macrophages,0.7404090821369118
KEGG_2021_Human,regulation of protein localization to plasma membrane (GO:1903076),1/80,0.181798760490535,0.2271489983371892,0,0,5.133298889175924,8.751529842637671,DAB2,Macrophages,0.7404090821369118
KEGG_2021_Human,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2292134574454991,0,0,5.0688775510204085,8.584760541358477,CD14,Macrophages,0.7355305181562768
KEGG_2021_Human,cell-cell junction organization (GO:0045216),1/82,0.1859011384602527,0.2312626362980485,0,0,5.00604686318972,8.422875391899517,CSF1R,Macrophages,0.7307179505966239
KEGG_2021_Human,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.2332966496455172,0,0,4.944748631159781,8.265677319811374,CCL3,Macrophages,0.7259697745939766
KEGG_2021_Human,vascular transport (GO:0010232),1/84,0.1899833569114356,0.2353156112720818,0,0,4.884927464961889,8.112979399077096,SLCO2B1,Macrophages,0.7212844428267129
KEGG_2021_Human,negative regulation of gene expression (GO:0010629),2/322,0.1923280195400404,0.2372590746040958,0,0,2.5559895833333335,4.213684115542283,MSR1;CCL3,Macrophages,0.7159574404356035
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),2/323,0.1932342825020938,0.2372590746040958,0,0,2.5478971962616823,4.188365716592005,CD14;CD68,Macrophages,0.7139158210847405
KEGG_2021_Human,positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.1940455128548384,0.2372590746040958,0,0,4.769507803121249,7.820383303288144,DAB2,Macrophages,0.7120963955156414
KEGG_2021_Human,regulation of interferon-gamma production (GO:0032649),1/86,0.1940455128548384,0.2372590746040958,0,0,4.769507803121249,7.820383303288144,CD14,Macrophages,0.7120963955156414
KEGG_2021_Human,transport across blood-brain barrier (GO:0150104),1/86,0.1940455128548384,0.2372590746040958,0,0,4.769507803121249,7.820383303288144,SLCO2B1,Macrophages,0.7120963955156414
KEGG_2021_Human,regulation of neuron death (GO:1901214),1/86,0.1940455128548384,0.2372590746040958,0,0,4.769507803121249,7.820383303288144,C1QA,Macrophages,0.7120963955156414
KEGG_2021_Human,negative regulation of angiogenesis (GO:0016525),1/87,0.196069097589664,0.2382030951568046,0,0,4.713811105837684,7.6801565438185,STAB1,Macrophages,0.7075908500030543
KEGG_2021_Human,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.196069097589664,0.2382030951568046,0,0,4.713811105837684,7.6801565438185,HMOX1,Macrophages,0.7075908500030543
KEGG_2021_Human,sodium ion transmembrane transport (GO:0035725),1/87,0.196069097589664,0.2382030951568046,0,0,4.713811105837684,7.6801565438185,SCN1B,Macrophages,0.7075908500030543
KEGG_2021_Human,negative regulation of binding (GO:0051100),1/88,0.1980877029036425,0.2396357592330082,0,0,4.659394792399718,7.5437717166037235,DAB2,Macrophages,0.703142484213379
KEGG_2021_Human,positive regulation of neuron projection development (GO:0010976),1/88,0.1980877029036425,0.2396357592330082,0,0,4.659394792399718,7.5437717166037235,SCN1B,Macrophages,0.703142484213379
KEGG_2021_Human,regulation of type I interferon production (GO:0032479),1/89,0.2001013407742902,0.2405428749097257,0,0,4.6062152133580705,7.411084001248333,CD14,Macrophages,0.6987500013741589
KEGG_2021_Human,second-messenger-mediated signaling (GO:0019932),1/89,0.2001013407742902,0.2405428749097257,0,0,4.6062152133580705,7.411084001248333,CCL3,Macrophages,0.6987500013741589
KEGG_2021_Human,post-Golgi vesicle-mediated transport (GO:0006892),1/89,0.2001013407742902,0.2405428749097257,0,0,4.6062152133580705,7.411084001248333,FTL,Macrophages,0.6987500013741589
KEGG_2021_Human,sodium ion transport (GO:0006814),1/90,0.2021100231923967,0.2424471076530641,0,0,4.55423068103646,7.281955543769811,SCN1B,Macrophages,0.6944121480917811
KEGG_2021_Human,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.2041137620931186,0.2433172404074545,0,0,4.503401360544218,7.156255051106618,CSF1R,Macrophages,0.6901277125812961
KEGG_2021_Human,toll-like receptor signaling pathway (GO:0002224),1/91,0.2041137620931186,0.2433172404074545,0,0,4.503401360544218,7.156255051106618,CD14,Macrophages,0.6901277125812961
KEGG_2021_Human,positive regulation of transport (GO:0051050),1/91,0.2041137620931186,0.2433172404074545,0,0,4.503401360544218,7.156255051106618,DAB2,Macrophages,0.6901277125812961
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),3/625,0.2050267003954304,0.2438963456787308,0,0,1.9834439351440103,3.142995135240803,CSF1R;FOLR2;AIF1,Macrophages,0.6881895775817527
KEGG_2021_Human,regulation of lipid metabolic process (GO:0019216),1/92,0.2061125694363157,0.2441706994774612,0,0,4.453689167974883,7.03385741012878,APOC1,Macrophages,0.6858955226779435
KEGG_2021_Human,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),1/92,0.2061125694363157,0.2441706994774612,0,0,4.453689167974883,7.03385741012878,DAB2,Macrophages,0.6858955226779435
KEGG_2021_Human,regulation of heart contraction (GO:0008016),1/93,0.2081064570390282,0.2460223332697414,0,0,4.40505767524401,6.914643337844717,TMIGD3,Macrophages,0.6817144444740324
KEGG_2021_Human,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2473494730163204,0,0,4.357472021066491,6.79849904676328,CSF1R,Macrophages,0.6775833802166729
KEGG_2021_Human,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.2473494730163204,0,0,4.357472021066491,6.79849904676328,CSF1R,Macrophages,0.6775833802166729
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),2/345,0.2133084926466024,0.2506155335415843,0,0,2.381802721088435,3.6799229289674416,DAB2;GATM,Macrophages,0.6709918532419347
KEGG_2021_Human,positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.2160330472811356,0.2532954209394834,0,0,4.220663265306122,6.46742313757927,GATM,Macrophages,0.6654798083211632
KEGG_2021_Human,regulation of neuron apoptotic process (GO:0043523),1/98,0.2180025137484037,0.2550808101441363,0,0,4.176940879444562,6.362519703204576,CCL3,Macrophages,0.6615384985937142
KEGG_2021_Human,organic anion transport (GO:0015711),1/99,0.2199671313012003,0.2568532351185795,0,0,4.134110787172012,6.26018948804807,SLCO2B1,Macrophages,0.6576422090003602
KEGG_2021_Human,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),1/100,0.2219269115603851,0.25861278877751,0,0,4.092145949288806,6.1603458876211565,DAB2,Macrophages,0.6537900306498672
KEGG_2021_Human,epithelial cell differentiation (GO:0030855),1/101,0.2238818662412048,0.259830377284,0,0,4.051020408163265,6.062906014187368,DAB2,Macrophages,0.6499810815451941
KEGG_2021_Human,cellular response to chemical stress (GO:0062197),1/101,0.2238818662412048,0.259830377284,0,0,4.051020408163265,6.062906014187368,AIF1,Macrophages,0.6499810815451941
KEGG_2021_Human,positive regulation of cell growth (GO:0030307),1/102,0.2258320069783284,0.2599799919044869,0,0,4.010709234188725,5.967790506031058,SHTN1,Macrophages,0.6462145058611213
KEGG_2021_Human,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2599799919044869,0,0,4.010709234188725,5.967790506031058,CCL3,Macrophages,0.6462145058611213
KEGG_2021_Human,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.2599799919044869,0,0,4.010709234188725,5.967790506031058,HMOX1,Macrophages,0.6462145058611213
KEGG_2021_Human,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/102,0.2258320069783284,0.2599799919044869,0,0,4.010709234188725,5.967790506031058,DAB2,Macrophages,0.6462145058611213
KEGG_2021_Human,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.2661453536081558,0,0,3.894427001569859,5.6956456810845415,APOC1,Macrophages,0.6351608308934773
KEGG_2021_Human,protein processing (GO:0016485),1/106,0.2335846623503299,0.2667536844040767,0,0,3.857142857142857,5.6090983677319475,CD5L,Macrophages,0.6315556772929499
KEGG_2021_Human,small GTPase mediated signal transduction (GO:0007264),1/106,0.2335846623503299,0.2667536844040767,0,0,3.857142857142857,5.6090983677319475,SHTN1,Macrophages,0.6315556772929499
KEGG_2021_Human,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2667536844040767,0,0,3.857142857142857,5.6090983677319475,CSF1R,Macrophages,0.6315556772929499
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.2704434974138919,0,0,2.2110433604336044,3.18053102486219,CSF1R;DAB2,Macrophages,0.6247218387200065
KEGG_2021_Human,regulation of interleukin-6 production (GO:0032675),1/110,0.241261218690496,0.2744226212595085,0,0,3.714847406852649,5.282048795926194,AIF1,Macrophages,0.6175124827423236
KEGG_2021_Human,regulation of protein serine/threonine kinase activity (GO:0071900),1/111,0.2431685532271013,0.2760422343790752,0,0,3.6808905380333954,5.20478084558139,CSF1R,Macrophages,0.6140925891155178
KEGG_2021_Human,phosphatidylinositol metabolic process (GO:0046488),1/112,0.2450711886958998,0.2776500967169817,0,0,3.647545504688362,5.129202360192396,CSF1R,Macrophages,0.6107077427090284
KEGG_2021_Human,positive regulation of metabolic process (GO:0009893),1/113,0.2469691364760274,0.2792462909461616,0,0,3.614795918367347,5.055262825364014,GATM,Macrophages,0.6073573167632206
KEGG_2021_Human,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.2797252655263592,0,0,3.582625970742279,4.982913653406146,TMIGD3,Macrophages,0.6040407011916724
KEGG_2021_Human,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.2797252655263592,0,0,3.582625970742279,4.982913653406146,DAB2,Macrophages,0.6040407011916724
KEGG_2021_Human,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.2797252655263592,0,0,3.582625970742279,4.982913653406146,CSF1R,Macrophages,0.6040407011916724
KEGG_2021_Human,cellular amide metabolic process (GO:0043603),1/115,0.2507510141385882,0.2812943596721687,0,0,3.5510204081632653,4.9121080927455,FOLR2,Macrophages,0.6007573018413346
KEGG_2021_Human,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.2828520900448575,0,0,3.5199645075421473,4.8428011439058265,HMOX1,Macrophages,0.5975065399797567
KEGG_2021_Human,positive regulation of cell projection organization (GO:0031346),1/117,0.2545142764118688,0.284398535873145,0,0,3.4894440534834623,4.774949480472317,SCN1B,Macrophages,0.5942878518616017
KEGG_2021_Human,regulation of protein binding (GO:0043393),1/118,0.2563889548341396,0.2859337758013549,0,0,3.4594453165881736,4.708511372057024,DAB2,Macrophages,0.5911006880374128
KEGG_2021_Human,cytoskeleton organization (GO:0007010),1/120,0.2601244621662815,0.2895342454131516,0,0,3.4009603841536613,4.579716458908873,CCL3,Macrophages,0.5848188047272944
KEGG_2021_Human,regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.2656932663769877,0.2951573056444747,0,0,3.316828370692539,4.396166676729281,HMOX1,Macrophages,0.5756194520344882
KEGG_2021_Human,defense response to symbiont (GO:0140546),1/124,0.2675403902734135,0.2966321608662506,0,0,3.2896963663514187,4.337414433160371,RNASE1,Macrophages,0.5726106437410472
KEGG_2021_Human,platelet degranulation (GO:0002576),1/125,0.2693829605231016,0.2980962605788586,0,0,3.263001974983542,4.279822783786303,F13A1,Macrophages,0.5696298784899082
KEGG_2021_Human,circulatory system development (GO:0072359),1/126,0.2712209880572274,0.2995496792662995,0,0,3.236734693877551,4.223360488574632,ADAP2,Macrophages,0.5666767062328689
KEGG_2021_Human,plasma membrane bounded cell projection organization (GO:0120036),1/128,0.274883458910421,0.3030086004591706,0,0,3.1854411055760887,4.113704308580095,CSF1R,Macrophages,0.5608513930050725
KEGG_2021_Human,cellular response to hypoxia (GO:0071456),1/131,0.2803433684983951,0.3084317214115291,0,0,3.111459968602826,3.956968446025251,HMOX1,Macrophages,0.5523097126477655
KEGG_2021_Human,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3106162377661349,0,0,3.0640074211502784,3.857336278341556,CSF1R,Macrophages,0.546741450090894
KEGG_2021_Human,RNA metabolic process (GO:0016070),1/133,0.2839609038772722,0.3106162377661349,0,0,3.0640074211502784,3.857336278341556,RNASE1,Macrophages,0.546741450090894
KEGG_2021_Human,defense response to virus (GO:0051607),1/133,0.2839609038772722,0.3106162377661349,0,0,3.0640074211502784,3.857336278341556,RNASE1,Macrophages,0.546741450090894
KEGG_2021_Human,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3119897956653736,0,0,3.0408163265306123,3.80890385676326,CSF1R,Macrophages,0.5439940297149167
KEGG_2021_Human,organic substance transport (GO:0071702),1/136,0.289353816496661,0.3153073076709798,0,0,2.99546485260771,3.714691124222948,SLCO2B1,Macrophages,0.5385707850387818
KEGG_2021_Human,neuron projection morphogenesis (GO:0048812),1/140,0.2964824884084789,0.3218469598502689,0,0,2.9086771399207163,3.5362740390257685,SHTN1,Macrophages,0.5280009529309525
KEGG_2021_Human,enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.2964824884084789,0.3218469598502689,0,0,2.9086771399207163,3.5362740390257685,CSF1R,Macrophages,0.5280009529309525
KEGG_2021_Human,negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.3017829564686885,0.326359977544737,0,0,2.8467950560505892,3.410594866305226,TMIGD3,Macrophages,0.5203052911363482
KEGG_2021_Human,monocarboxylic acid metabolic process (GO:0032787),1/143,0.3017829564686885,0.326359977544737,0,0,2.8467950560505892,3.410594866305226,GATM,Macrophages,0.5203052911363482
KEGG_2021_Human,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3351848008256377,0,0,2.749271137026239,3.215201203875706,CSF1R,Macrophages,0.5078961191737069
KEGG_2021_Human,response to cytokine (GO:0034097),1/150,0.3139989845586295,0.3376523920583379,0,0,2.712094233666621,3.141596466170354,CSF1R,Macrophages,0.5030717563895143
KEGG_2021_Human,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3376523920583379,0,0,2.712094233666621,3.141596466170354,CCL3,Macrophages,0.5030717563895143
KEGG_2021_Human,actin filament organization (GO:0007015),1/152,0.3174506378807152,0.3407223951689631,0,0,2.6759021489390458,3.0704182805545575,AIF1,Macrophages,0.4983237959237088
KEGG_2021_Human,positive regulation of protein kinase activity (GO:0045860),1/154,0.3208852696222714,0.3437626434414952,0,0,2.640656262505002,3.0015590720273457,CSF1R,Macrophages,0.493650218923809
KEGG_2021_Human,protein autophosphorylation (GO:0046777),1/159,0.329397918202972,0.3522213694642266,0,0,2.556445362955309,2.8389038953772054,CSF1R,Macrophages,0.4822791499015975
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3551658629625177,0,0,2.524234693877551,2.7773973646136283,CCL3,Macrophages,0.4778511096570981
KEGG_2021_Human,heart development (GO:0007507),1/164,0.3378059691212722,0.3598641947168777,0,0,2.4774007762614247,2.6886824434754057,ADAP2,Macrophages,0.4713326805982654
KEGG_2021_Human,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/165,0.3394751386404204,0.3602979631295168,0,0,2.4621702339472376,2.6600168495918335,DAB2,Macrophages,0.46919202564454415
KEGG_2021_Human,regulation of neuron projection development (GO:0010975),1/165,0.3394751386404204,0.3602979631295168,0,0,2.4621702339472376,2.6600168495918335,SCN1B,Macrophages,0.46919202564454415
KEGG_2021_Human,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.3494039111808349,0.3694622838597347,0,0,2.3745498199279713,2.4969025061029213,HMOX1,Macrophages,0.4566722378913039
KEGG_2021_Human,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.3694622838597347,0,0,2.3745498199279713,2.4969025061029213,SHTN1,Macrophages,0.4566722378913039
KEGG_2021_Human,regulation of immune response (GO:0050776),1/179,0.3624150547196057,0.3825120078463861,0,0,2.266911258885577,2.300835957547096,FCGR3A,Macrophages,0.4407937700298507
KEGG_2021_Human,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.3827944136581859,0,0,2.2541329380914377,2.2778849681371156,FABP3,Macrophages,0.4388706874182523
KEGG_2021_Human,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.3827944136581859,0,0,2.2541329380914377,2.2778849681371156,F13A1,Macrophages,0.4388706874182523
KEGG_2021_Human,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.3854545983354954,0,0,2.2289998872477166,2.2329492942532405,VSIG4,Macrophages,0.4350639775318079
KEGG_2021_Human,negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.3814549819175133,0.3996528342658717,0,0,2.122448979591837,2.045536603225051,DAB2,Macrophages,0.41855670871419515
KEGG_2021_Human,regulation of macromolecule metabolic process (GO:0060255),1/200,0.3953681557510544,0.4134710932854434,0,0,2.025535842477695,1.8795714928238216,AIF1,Macrophages,0.40299831311675843
KEGG_2021_Human,axon guidance (GO:0007411),1/203,0.3999373645428959,0.41748489059231,0,0,1.9951505354617096,1.8284503867148747,SCN1B,Macrophages,0.398008019580524
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4230162212616225,0,0,1.9560134733505052,1.7632653144438126,CCL3,Macrophages,0.3914985283218076
KEGG_2021_Human,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.4482587365529114,0,0,1.805344559348403,1.519514184420898,HMOX1,Macrophages,0.36553500108915365
KEGG_2021_Human,apoptotic process (GO:0006915),1/231,0.4409837467017168,0.4578213079394187,0,0,1.749778172138421,1.4326260836369302,CD14,Macrophages,0.35557741698984124
KEGG_2021_Human,membrane organization (GO:0061024),1/242,0.4563449373288627,0.4729091818780047,0,0,1.6689812854602422,1.3093263562491473,DAB2,Macrophages,0.3407067631514444
KEGG_2021_Human,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.4875142465026572,0,0,1.5952380952380951,1.2000608149186214,DAB2,Macrophages,0.32670971902140344
KEGG_2021_Human,cellular component assembly (GO:0022607),1/261,0.4819092749521712,0.4975952911350629,0,0,1.5455259026687598,1.1282329953702568,AIF1,Macrophages,0.31703471507296654
KEGG_2021_Human,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5060952190438985,0,0,1.504471451501949,1.0700627976731167,C1QA,Macrophages,0.3088941088615854
KEGG_2021_Human,regulation of gene expression (GO:0010468),3/1079,0.5107084384516999,0.5254315646052624,0,0,1.1196314165941628,0.7523435208329574,MSR1;CCL3;AIF1,Macrophages,0.2918269662236996
KEGG_2021_Human,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.548726663303605,0,0,1.32774699283687,0.8321996277505203,CCL3,Macrophages,0.2722052530518486
KEGG_2021_Human,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5561613357193789,0,0,1.2972062611452349,0.7932686422257892,CCL3,Macrophages,0.2655801196036423
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.6326104857101883,0,0,1.0510204081632653,0.5054679174936134,DAB2,Macrophages,0.20886552310647807
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6344530643679629,0,0,1.042628017264347,0.4965325169788531,CCL3,Macrophages,0.20682480102083725
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.6525537265608367,0,0,0.989871879272801,0.4417939051458828,CSF1R,Macrophages,0.19383180708628664
KEGG_2021_Human,organelle organization (GO:0006996),1/420,0.6544076492323022,0.6660726697177265,0,0,0.9512931664312504,0.4033718992390181,CCL3,Macrophages,0.18415163293091988
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),1/482,0.7051444771556823,0.7164368264339761,0,0,0.8260426831855403,0.2885801301950252,CCL3,Macrophages,0.1517218912312197
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7174567430885611,0,0,0.8207960870298533,0.2841203737887477,DAB2,Macrophages,0.15033199168778996
KEGG_2021_Human,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7244292583666155,0,0,0.8021026592455164,0.2684686706444305,CSF1R,Macrophages,0.1453610219101508
KEGG_2021_Human,cellular protein modification process (GO:0006464),2/1025,0.7337546800798972,0.7415467651780908,0,0,0.7708944281524927,0.2386539053000475,FCGR3A;F13A1,Macrophages,0.13444911569132442
KEGG_2021_Human,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8321328923316603,0,0,0.5757014372366809,0.1108560647358729,DAB2,Macrophages,0.0836269880293983
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8553184383719704,0,0,0.5290423861852434,0.0863986224716518,DAB2,Macrophages,0.07092521499844862
KEGG_2021_Human,positive regulation of transcription by RNA polymerase II (GO:0045944),1/908,0.9023188918982462,0.9070846606934834,0,0,0.4284814256463335,0.0440424414337815,DAB2,Macrophages,0.044639949690669034
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",1/948,0.912055183209665,0.9152610010768344,0,0,0.4095209361463698,0.0376983608425212,DAB2,Macrophages,0.039978884217174375
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1183,0.952754544972228,0.9544260441739336,0,0,0.3240443385476018,0.0156830878086274,DAB2,Macrophages,0.021018970814361417
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),2/2206,0.9792407454532416,0.9792407454532416,0,0,0.3354885057471264,0.0070377963929841,CSF1R;DAB2,Macrophages,0.009110524163636814
GO_Biological_Process_2021,B cell activation (GO:0042113),6/85,6.739206916543919e-08,2.2508951101256687e-05,0,0,34.29976985040276,566.3831299482074,FCRL1;CD79A;CD70;BANK1;MS4A1;CD22,Mature B,7.171391209107793
GO_Biological_Process_2021,regulation of B cell proliferation (GO:0030888),4/46,5.219023612482669e-06,0.0007286664624956522,0,0,41.21739130434783,501.3353830213611,BLK;FCRL3;TNFRSF13C;CD22,Mature B,5.282410738257065
GO_Biological_Process_2021,antigen receptor-mediated signaling pathway (GO:0050851),6/185,6.544908345769332e-06,0.0007286664624956522,0,0,15.061706449974606,179.78892641736596,BLK;CD79A;MS4A1;HLA-DQA2;HLA-DQA1;HLA-DQB1,Mature B,5.1840964308863855
GO_Biological_Process_2021,regulation of B cell receptor signaling pathway (GO:0050855),3/23,2.5134148576039852e-05,0.0020987014060993,0,0,63.6063829787234,673.6732113483868,BLK;FCRL3;CD22,Mature B,4.59973582199312
GO_Biological_Process_2021,regulation of B cell activation (GO:0050864),3/28,4.6085838596253206e-05,0.0030785340182297,0,0,50.87234042553192,507.9605655722774,BANK1;FCRL3;CD22,Mature B,4.336432505507012
GO_Biological_Process_2021,negative regulation of immunoglobulin production (GO:0002638),2/5,6.0956786529959696e-05,0.0033059537710077,0,0,277.0416666666667,2688.78505476905,FCRL3;CD22,Mature B,4.214977935846465
GO_Biological_Process_2021,B cell proliferation (GO:0042100),3/32,6.928645627860575e-05,0.0033059537710077,0,0,43.84666177549523,419.9309284926422,CD79A;CD70;MS4A1,Mature B,4.159351650500962
GO_Biological_Process_2021,B cell receptor signaling pathway (GO:0050853),3/34,8.329713391830358e-05,0.0033878462612957,0,0,41.01372683596431,385.24589055488593,BLK;CD79A;MS4A1,Mature B,4.079369941508931
GO_Biological_Process_2021,negative regulation of B cell receptor signaling pathway (GO:0050859),2/6,9.128927051395768e-05,0.0033878462612957,0,0,207.77083333333337,1932.5756890799971,FCRL3;CD22,Mature B,4.039580263324499
GO_Biological_Process_2021,lymphocyte proliferation (GO:0046651),3/38,0.00011660554961914327,0.0038946253572793,0,0,36.319148936170215,328.93213337279053,CD79A;CD70;MS4A1,Mature B,3.9332807796660614
GO_Biological_Process_2021,positive regulation of dendritic cell chemotaxis (GO:2000510),2/8,0.0001698630098259154,0.0047278537734879,0,0,138.5,1202.2517804391236,CCR7;CCR6,Mature B,3.7699011848597213
GO_Biological_Process_2021,regulation of dendritic cell chemotaxis (GO:2000508),2/8,0.0001698630098259154,0.0047278537734879,0,0,138.5,1202.2517804391236,CCR7;CCR6,Mature B,3.7699011848597213
GO_Biological_Process_2021,negative regulation of production of molecular mediator of immune response (GO:0002701),2/9,0.00021804660985203623,0.005602120591583,0,0,118.70833333333331,1000.8064198202924,FCRL3;CD22,Mature B,3.6614506612675517
GO_Biological_Process_2021,regulation of dendritic cell apoptotic process (GO:2000668),2/11,0.000332063883264561,0.0079220955007402,0,0,92.31944444444444,739.4956618223716,BLK;CCR7,Mature B,3.478778357620151
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),4/147,0.0004961294316551132,0.0106249076856696,0,0,12.04439039221648,91.6418365827904,CD52;CXCR5;CCR7;CCR6,Mature B,3.304405008750408
GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),4/148,0.0005089776136847754,0.0106249076856696,0,0,11.960144927536232,90.69505302025782,CD52;CXCR5;CCR7;CCR6,Mature B,3.293301318777142
GO_Biological_Process_2021,interferon-gamma-mediated signaling pathway (GO:0060333),3/68,0.0006571555344566322,0.0126346791043908,0,0,19.527004909983635,143.08588265054038,HLA-DQA2;HLA-DQA1;HLA-DQB1,Mature B,3.1823318301935126
GO_Biological_Process_2021,cell chemotaxis (GO:0060326),3/69,0.0006858216610371124,0.0126346791043908,0,0,19.230174081237912,140.08975927188362,CXCR5;CCR7;CCR6,Mature B,3.163788802218554
GO_Biological_Process_2021,dendritic cell chemotaxis (GO:0002407),2/16,0.0007187392304892979,0.0126346791043908,0,0,59.333333333333336,429.45537567816734,CCR7;CCR6,Mature B,3.14342864967499
GO_Biological_Process_2021,positive regulation of T cell activation (GO:0050870),3/75,0.0008746267241459595,0.0138681431402196,0,0,17.622340425531913,124.09147007242574,CD70;CCR7;TNFRSF13C,Mature B,3.058177256957078
GO_Biological_Process_2021,positive regulation of lymphocyte proliferation (GO:0050671),3/75,0.0008746267241459595,0.0138681431402196,0,0,17.622340425531913,124.09147007242574,CD70;FCRL3;TNFRSF13C,Mature B,3.058177256957078
GO_Biological_Process_2021,dendritic cell migration (GO:0036336),2/18,0.000913470506242016,0.0138681431402196,0,0,51.911458333333336,363.2898548418271,CCR7;CCR6,Mature B,3.039305470405725
GO_Biological_Process_2021,negative regulation of B cell activation (GO:0050869),2/22,0.001370383663162,0.0199003540650482,0,0,41.520833333333336,273.7329252658829,BLK;BANK1,Mature B,2.8631578273928713
GO_Biological_Process_2021,second-messenger-mediated signaling (GO:0019932),3/89,0.0014352931477222,0.0199744963058013,0,0,14.743196437407224,96.51465720793364,CXCR5;CCR7;CCR6,Mature B,2.8430593885216617
GO_Biological_Process_2021,dendritic cell differentiation (GO:0097028),2/24,0.0016321249773357,0.0218051896972059,0,0,37.74242424242424,242.22606459531664,BLK;CCR7,Mature B,2.7872465889099036
GO_Biological_Process_2021,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),2/25,0.0017712212130127,0.0227533801979327,0,0,36.09963768115942,228.73040961874747,FCRL3;CD22,Mature B,2.751727195110795
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),3/98,0.0018922236540246,0.023182599260977,0,0,13.340425531914894,83.64450283646559,HLA-DQA2;HLA-DQA1;HLA-DQB1,Mature B,2.723027532855894
GO_Biological_Process_2021,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),3/100,0.0020046761378758,0.023182599260977,0,0,13.064049133581928,81.15743654844592,HLA-DQA2;HLA-DQA1;HLA-DQB1,Mature B,2.6979557791007505
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),3/102,0.0021212129826486,0.023182599260977,0,0,12.798839458413926,78.78667603753651,CXCR5;CCR7;CCR6,Mature B,2.673415723494172
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen (GO:0002478),3/103,0.002181029234164,0.023182599260977,0,0,12.670212765957446,77.64253659479164,HLA-DQA2;HLA-DQA1;HLA-DQB1,Mature B,2.661338513169113
GO_Biological_Process_2021,regulation of immunoglobulin production (GO:0002637),2/28,0.0022210873543451,0.023182599260977,0,0,31.92948717948718,195.08145262248803,FCRL3;CD22,Mature B,2.6534343605132076
GO_Biological_Process_2021,response to ketone (GO:1901654),2/28,0.0022210873543451,0.023182599260977,0,0,31.92948717948718,195.08145262248803,ABCB4;CCR7,Mature B,2.6534343605132076
GO_Biological_Process_2021,positive regulation of B cell proliferation (GO:0030890),2/30,0.0025478771667966,0.0257876052639416,0,0,29.645833333333332,177.0595839464994,FCRL3;TNFRSF13C,Mature B,2.5938215131766835
GO_Biological_Process_2021,positive regulation of mononuclear cell migration (GO:0071677),2/31,0.0027192556482504,0.0267126878386954,0,0,28.62212643678161,169.08226656127547,CCR7;CCR6,Mature B,2.565549960707733
GO_Biological_Process_2021,positive regulation of interleukin-12 production (GO:0032735),2/34,0.0032650074009337,0.0311574991974821,0,0,25.934895833333332,148.46413612460563,CCR7;SCIMP,Mature B,2.4861158299536776
GO_Biological_Process_2021,cellular response to interferon-gamma (GO:0071346),3/121,0.0034414938802973,0.0319294154449808,0,0,10.727731698521456,60.84608111150705,HLA-DQA2;HLA-DQA1;HLA-DQB1,Mature B,2.46325299837684
GO_Biological_Process_2021,positive regulation of production of molecular mediator of immune response (GO:0002702),2/38,0.0040654672914765,0.0366990831176527,0,0,23.04861111111111,126.88782669928548,SCIMP;CD244,Mature B,2.390889528680986
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),6/621,0.0043552416698362,0.0382802820454031,0,0,4.287139689578714,23.30649979183367,FCER2;CD70;TNFRSF13C;HLA-DQA2;HLA-DQA1;HLA-DQB1,Mature B,2.360987741238573
GO_Biological_Process_2021,cellular defense response (GO:0006968),2/49,0.0066828970303688,0.0572330155934153,0,0,17.64450354609929,88.36726791367238,FCMR;CCR6,Mature B,2.175035230405133
GO_Biological_Process_2021,regulation of interleukin-12 production (GO:0032655),2/51,0.0072225026271421,0.0588634766441426,0,0,16.922619047619047,83.43788300609687,CCR7;SCIMP,Mature B,2.1413122915117184
GO_Biological_Process_2021,T cell receptor signaling pathway (GO:0050852),3/158,0.0072257561149995,0.0588634766441426,0,0,8.151681537405628,40.18863284587075,HLA-DQA2;HLA-DQA1;HLA-DQB1,Mature B,2.1411167009049183
GO_Biological_Process_2021,positive regulation of B cell activation (GO:0050871),2/53,0.0077812124839393,0.061879165943708,0,0,16.25735294117647,78.94640668269977,FCRL3;TNFRSF13C,Mature B,2.108952725111067
GO_Biological_Process_2021,positive regulation of leukocyte chemotaxis (GO:0002690),2/54,0.0080676700842631,0.0626651583289278,0,0,15.943910256410255,76.8479024006269,CCR7;CCR6,Mature B,2.0932518699428635
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),4/335,0.0097191113097967,0.0737768903970934,0,0,5.1540785498489425,23.88225325042697,CCR7;SCIMP;LY9;CD244,Mature B,2.0123734440136594
GO_Biological_Process_2021,B cell differentiation (GO:0030183),2/61,0.0102031878981958,0.0757303279554982,0,0,14.04731638418079,64.40771918587598,CD79A;MS4A1,Mature B,1.9912641154648159
GO_Biological_Process_2021,positive regulation of T cell proliferation (GO:0042102),2/66,0.0118650634107129,0.0783877657053967,0,0,12.946614583333334,57.4073222604629,CD70;TNFRSF13C,Mature B,1.9257299364311244
GO_Biological_Process_2021,establishment of T cell polarity (GO:0001768),1/5,0.0124387771927725,0.0783877657053967,0,0,101.76530612244898,446.4379351400606,CCR7,Mature B,1.9052223113279663
GO_Biological_Process_2021,mature conventional dendritic cell differentiation (GO:0097029),1/5,0.0124387771927725,0.0783877657053967,0,0,101.76530612244898,446.4379351400606,CCR7,Mature B,1.9052223113279663
GO_Biological_Process_2021,bile acid secretion (GO:0032782),1/5,0.0124387771927725,0.0783877657053967,0,0,101.76530612244898,446.4379351400606,ABCB4,Mature B,1.9052223113279663
GO_Biological_Process_2021,cannabinoid signaling pathway (GO:0038171),1/5,0.0124387771927725,0.0783877657053967,0,0,101.76530612244898,446.4379351400606,CNR2,Mature B,1.9052223113279663
GO_Biological_Process_2021,response to prostaglandin (GO:0034694),1/5,0.0124387771927725,0.0783877657053967,0,0,101.76530612244898,446.4379351400606,CCR7,Mature B,1.9052223113279663
GO_Biological_Process_2021,positive regulation of leukocyte mediated immunity (GO:0002705),1/5,0.0124387771927725,0.0783877657053967,0,0,101.76530612244898,446.4379351400606,SCIMP,Mature B,1.9052223113279663
GO_Biological_Process_2021,regulation of dendritic cell cytokine production (GO:0002730),1/5,0.0124387771927725,0.0783877657053967,0,0,101.76530612244898,446.4379351400606,SCIMP,Mature B,1.9052223113279663
GO_Biological_Process_2021,positive regulation of antigen processing and presentation (GO:0002579),1/6,0.0149082847993736,0.0816289692293572,0,0,81.40816326530613,342.3895623444841,CCR7,Mature B,1.8265723193247598
GO_Biological_Process_2021,establishment of lymphocyte polarity (GO:0001767),1/6,0.0149082847993736,0.0816289692293572,0,0,81.40816326530613,342.3895623444841,CCR7,Mature B,1.8265723193247598
GO_Biological_Process_2021,galactolipid biosynthetic process (GO:0019375),1/6,0.0149082847993736,0.0816289692293572,0,0,81.40816326530613,342.3895623444841,UGT8,Mature B,1.8265723193247598
GO_Biological_Process_2021,galactosylceramide biosynthetic process (GO:0006682),1/6,0.0149082847993736,0.0816289692293572,0,0,81.40816326530613,342.3895623444841,UGT8,Mature B,1.8265723193247598
GO_Biological_Process_2021,T-helper 17 cell lineage commitment (GO:0072540),1/6,0.0149082847993736,0.0816289692293572,0,0,81.40816326530613,342.3895623444841,LY9,Mature B,1.8265723193247598
GO_Biological_Process_2021,positive regulation of dendritic cell antigen processing and presentation (GO:0002606),1/6,0.0149082847993736,0.0816289692293572,0,0,81.40816326530613,342.3895623444841,CCR7,Mature B,1.8265723193247598
GO_Biological_Process_2021,positive regulation of sterol transport (GO:0032373),1/6,0.0149082847993736,0.0816289692293572,0,0,81.40816326530613,342.3895623444841,ABCB4,Mature B,1.8265723193247598
GO_Biological_Process_2021,positive regulation of killing of cells of other organism (GO:0051712),1/6,0.0149082847993736,0.0816289692293572,0,0,81.40816326530613,342.3895623444841,FCER2,Mature B,1.8265723193247598
GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),2/76,0.0155171628224907,0.0835924577856758,0,0,11.19144144144144,46.62140287744705,CD70;TNFRSF13C,Mature B,1.8091876827669675
GO_Biological_Process_2021,regulation of inositol phosphate biosynthetic process (GO:0010919),1/7,0.0173717414502839,0.0840892991941281,0,0,67.83673469387755,274.9362107684438,CD244,Mature B,1.7601566430186848
GO_Biological_Process_2021,negative regulation of dendritic cell apoptotic process (GO:2000669),1/7,0.0173717414502839,0.0840892991941281,0,0,67.83673469387755,274.9362107684438,CCR7,Mature B,1.7601566430186848
GO_Biological_Process_2021,T-helper 17 cell differentiation (GO:0072539),1/7,0.0173717414502839,0.0840892991941281,0,0,67.83673469387755,274.9362107684438,LY9,Mature B,1.7601566430186848
GO_Biological_Process_2021,glycosylceramide biosynthetic process (GO:0046476),1/7,0.0173717414502839,0.0840892991941281,0,0,67.83673469387755,274.9362107684438,UGT8,Mature B,1.7601566430186848
GO_Biological_Process_2021,positive regulation of humoral immune response (GO:0002922),1/7,0.0173717414502839,0.0840892991941281,0,0,67.83673469387755,274.9362107684438,CCR7,Mature B,1.7601566430186848
GO_Biological_Process_2021,positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),1/7,0.0173717414502839,0.0840892991941281,0,0,67.83673469387755,274.9362107684438,SCIMP,Mature B,1.7601566430186848
GO_Biological_Process_2021,regulation of phospholipid transport (GO:2001138),1/7,0.0173717414502839,0.0840892991941281,0,0,67.83673469387755,274.9362107684438,ABCB4,Mature B,1.7601566430186848
GO_Biological_Process_2021,lymphocyte differentiation (GO:0030098),2/84,0.0187414436957378,0.0860122068142315,0,0,10.095528455284551,40.15009805248223,CD79A;MS4A1,Mature B,1.7271969574747794
GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),2/86,0.0195880530452788,0.0860122068142315,0,0,9.854166666666666,38.754815869716495,CCR7;CD244,Mature B,1.7080087285643422
GO_Biological_Process_2021,store-operated calcium entry (GO:0002115),1/8,0.0198291614511851,0.0860122068142315,0,0,58.142857142857146,227.9549801512961,MS4A1,Mature B,1.702695651141308
GO_Biological_Process_2021,galactosylceramide metabolic process (GO:0006681),1/8,0.0198291614511851,0.0860122068142315,0,0,58.142857142857146,227.9549801512961,UGT8,Mature B,1.702695651141308
GO_Biological_Process_2021,T-helper cell lineage commitment (GO:0002295),1/8,0.0198291614511851,0.0860122068142315,0,0,58.142857142857146,227.9549801512961,LY9,Mature B,1.702695651141308
GO_Biological_Process_2021,positive regulation of dendritic cell cytokine production (GO:0002732),1/8,0.0198291614511851,0.0860122068142315,0,0,58.142857142857146,227.9549801512961,SCIMP,Mature B,1.702695651141308
GO_Biological_Process_2021,regulation of lymphocyte apoptotic process (GO:0070228),1/8,0.0198291614511851,0.0860122068142315,0,0,58.142857142857146,227.9549801512961,BLK,Mature B,1.702695651141308
GO_Biological_Process_2021,immunological synapse formation (GO:0001771),1/8,0.0198291614511851,0.0860122068142315,0,0,58.142857142857146,227.9549801512961,CCR7,Mature B,1.702695651141308
GO_Biological_Process_2021,acid secretion (GO:0046717),1/9,0.0222805591236868,0.0907525213086755,0,0,50.87244897959184,193.52086993316271,ABCB4,Mature B,1.652073914876897
GO_Biological_Process_2021,regulation of leukocyte degranulation (GO:0043300),1/9,0.0222805591236868,0.0907525213086755,0,0,50.87244897959184,193.52086993316271,BLK,Mature B,1.652073914876897
GO_Biological_Process_2021,negative regulation of leukocyte proliferation (GO:0070664),1/9,0.0222805591236868,0.0907525213086755,0,0,50.87244897959184,193.52086993316271,BLK,Mature B,1.652073914876897
GO_Biological_Process_2021,positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/9,0.0222805591236868,0.0907525213086755,0,0,50.87244897959184,193.52086993316271,CD244,Mature B,1.652073914876897
GO_Biological_Process_2021,regulation of dendritic cell antigen processing and presentation (GO:0002604),1/9,0.0222805591236868,0.0907525213086755,0,0,50.87244897959184,193.52086993316271,CCR7,Mature B,1.652073914876897
GO_Biological_Process_2021,protein poly-ADP-ribosylation (GO:0070212),1/10,0.024725948817258,0.0945127623184318,0,0,45.21768707482993,167.3010120823387,PARP15,Mature B,1.606847034080906
GO_Biological_Process_2021,positive regulation of stress-activated MAPK cascade (GO:0032874),2/99,0.0254700751762328,0.0945127623184318,0,0,8.527920962199312,31.299610767204847,CCR7;SCIMP,Mature B,1.5939697731920623
GO_Biological_Process_2021,positive regulation of alcohol biosynthetic process (GO:1902932),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,CD244,Mature B,1.5659847773237099
GO_Biological_Process_2021,isotype switching (GO:0045190),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,CCR6,Mature B,1.5659847773237099
GO_Biological_Process_2021,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,FCER2,Mature B,1.5659847773237099
GO_Biological_Process_2021,positive regulation of phospholipid transport (GO:2001140),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,ABCB4,Mature B,1.5659847773237099
GO_Biological_Process_2021,regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,FCRL3,Mature B,1.5659847773237099
GO_Biological_Process_2021,regulation of long-term neuronal synaptic plasticity (GO:0048169),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,NETO1,Mature B,1.5659847773237099
GO_Biological_Process_2021,regulation of lymphocyte migration (GO:2000401),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,CCR6,Mature B,1.5659847773237099
GO_Biological_Process_2021,regulation of mast cell activation involved in immune response (GO:0033006),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,BLK,Mature B,1.5659847773237099
GO_Biological_Process_2021,B cell mediated immunity (GO:0019724),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,CD70,Mature B,1.5659847773237099
GO_Biological_Process_2021,regulation of myeloid leukocyte mediated immunity (GO:0002886),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,BLK,Mature B,1.5659847773237099
GO_Biological_Process_2021,response to prostaglandin E (GO:0034695),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,CCR7,Mature B,1.5659847773237099
GO_Biological_Process_2021,positive regulation of leukocyte apoptotic process (GO:2000108),1/11,0.0271653448579923,0.0945127623184318,0,0,40.69387755102041,146.73452100035948,BLK,Mature B,1.5659847773237099
GO_Biological_Process_2021,regulation of pseudopodium assembly (GO:0031272),1/12,0.029598761568907,0.0959804501360676,0,0,36.99257884972171,130.2147194065139,CCR7,Mature B,1.5287264597194943
GO_Biological_Process_2021,protein mono-ADP-ribosylation (GO:0140289),1/12,0.029598761568907,0.0959804501360676,0,0,36.99257884972171,130.2147194065139,PARP15,Mature B,1.5287264597194943
GO_Biological_Process_2021,negative regulation of B cell proliferation (GO:0030889),1/12,0.029598761568907,0.0959804501360676,0,0,36.99257884972171,130.2147194065139,BLK,Mature B,1.5287264597194943
GO_Biological_Process_2021,positive regulation of pseudopodium assembly (GO:0031274),1/12,0.029598761568907,0.0959804501360676,0,0,36.99257884972171,130.2147194065139,CCR7,Mature B,1.5287264597194943
GO_Biological_Process_2021,toll-like receptor 3 signaling pathway (GO:0034138),1/12,0.029598761568907,0.0959804501360676,0,0,36.99257884972171,130.2147194065139,SCIMP,Mature B,1.5287264597194943
GO_Biological_Process_2021,regulation of B cell apoptotic process (GO:0002902),1/12,0.029598761568907,0.0959804501360676,0,0,36.99257884972171,130.2147194065139,BLK,Mature B,1.5287264597194943
GO_Biological_Process_2021,negative regulation of leukocyte apoptotic process (GO:2000107),1/12,0.029598761568907,0.0959804501360676,0,0,36.99257884972171,130.2147194065139,CCR7,Mature B,1.5287264597194943
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),3/274,0.0310750535699626,0.0972432293189713,0,0,4.63507890398053,16.089980771839137,FCRL3;CCR7;SCIMP,Mature B,1.5075881140099185
GO_Biological_Process_2021,regulation of homotypic cell-cell adhesion (GO:0034110),1/13,0.032026213248763,0.0972432293189713,0,0,33.90816326530612,116.6847899929619,BLK,Mature B,1.4944944088974865
GO_Biological_Process_2021,lymphocyte mediated immunity (GO:0002449),1/13,0.032026213248763,0.0972432293189713,0,0,33.90816326530612,116.6847899929619,CD70,Mature B,1.4944944088974865
GO_Biological_Process_2021,positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,0.032026213248763,0.0972432293189713,0,0,33.90816326530612,116.6847899929619,CD244,Mature B,1.4944944088974865
GO_Biological_Process_2021,regulation of antigen receptor-mediated signaling pathway (GO:0050854),1/13,0.032026213248763,0.0972432293189713,0,0,33.90816326530612,116.6847899929619,BLK,Mature B,1.4944944088974865
GO_Biological_Process_2021,response to nitric oxide (GO:0071731),1/13,0.032026213248763,0.0972432293189713,0,0,33.90816326530612,116.6847899929619,CCR7,Mature B,1.4944944088974865
GO_Biological_Process_2021,positive regulation of lipid transport (GO:0032370),1/13,0.032026213248763,0.0972432293189713,0,0,33.90816326530612,116.6847899929619,ABCB4,Mature B,1.4944944088974865
GO_Biological_Process_2021,tumor necrosis factor-mediated signaling pathway (GO:0033209),2/116,0.0340965412337713,0.0983379190832219,0,0,7.25,24.49455514200503,CD70;TNFRSF13C,Mature B,1.467289673772098
GO_Biological_Process_2021,ceramide transport (GO:0035627),1/14,0.0344477141698711,0.0983379190832219,0,0,31.298273155416013,105.4223689491126,ABCB4,Mature B,1.4628395910668823
GO_Biological_Process_2021,T cell differentiation in thymus (GO:0033077),1/14,0.0344477141698711,0.0983379190832219,0,0,31.298273155416013,105.4223689491126,CCR6,Mature B,1.4628395910668823
GO_Biological_Process_2021,negative regulation of interleukin-12 production (GO:0032695),1/14,0.0344477141698711,0.0983379190832219,0,0,31.298273155416013,105.4223689491126,CCR7,Mature B,1.4628395910668823
GO_Biological_Process_2021,positive regulation of glycoprotein biosynthetic process (GO:0010560),1/14,0.0344477141698711,0.0983379190832219,0,0,31.298273155416013,105.4223689491126,CCR7,Mature B,1.4628395910668823
GO_Biological_Process_2021,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/14,0.0344477141698711,0.0983379190832219,0,0,31.298273155416013,105.4223689491126,FCER2,Mature B,1.4628395910668823
GO_Biological_Process_2021,immune response-regulating cell surface receptor signaling pathway (GO:0002768),1/14,0.0344477141698711,0.0983379190832219,0,0,31.298273155416013,105.4223689491126,BTLA,Mature B,1.4628395910668823
GO_Biological_Process_2021,positive regulation of cell killing (GO:0031343),1/15,0.0368632785936063,0.1026027920855375,0,0,29.06122448979592,95.91771596133704,FCER2,Mature B,1.4334060415588732
GO_Biological_Process_2021,regulation of lymphocyte activation (GO:0051249),1/15,0.0368632785936063,0.1026027920855375,0,0,29.06122448979592,95.91771596133704,FCRL3,Mature B,1.4334060415588732
GO_Biological_Process_2021,calcium ion import into cytosol (GO:1902656),1/15,0.0368632785936063,0.1026027920855375,0,0,29.06122448979592,95.91771596133704,MS4A1,Mature B,1.4334060415588732
GO_Biological_Process_2021,regulation of interleukin-1 production (GO:0032652),1/16,0.0392729207344652,0.1057835123008982,0,0,27.122448979591837,87.80133530116419,CCR7,Mature B,1.405906798966597
GO_Biological_Process_2021,male meiosis I (GO:0007141),1/16,0.0392729207344652,0.1057835123008982,0,0,27.122448979591837,87.80133530116419,SYCP3,Mature B,1.405906798966597
GO_Biological_Process_2021,T cell mediated immunity (GO:0002456),1/16,0.0392729207344652,0.1057835123008982,0,0,27.122448979591837,87.80133530116419,CD70,Mature B,1.405906798966597
GO_Biological_Process_2021,regulation of mast cell degranulation (GO:0043304),1/16,0.0392729207344652,0.1057835123008982,0,0,27.122448979591837,87.80133530116419,BLK,Mature B,1.405906798966597
GO_Biological_Process_2021,plasma membrane bounded cell projection organization (GO:0120036),2/128,0.0407746939326368,0.1089499821880057,0,0,6.555555555555555,20.975769396496517,BLK;CCR7,Mature B,1.3896092902230834
GO_Biological_Process_2021,ruffle organization (GO:0031529),1/17,0.0416766547912334,0.1104762119069205,0,0,25.426020408163264,80.79916728086499,CCR7,Mature B,1.3801071472903907
GO_Biological_Process_2021,protein O-linked mannosylation (GO:0035269),1/18,0.0440744949316926,0.110683318099138,0,0,23.92917166866747,74.70385911458476,LARGE2,Mature B,1.3558126557645607
GO_Biological_Process_2021,positive regulation of nitric-oxide synthase activity (GO:0051000),1/18,0.0440744949316926,0.110683318099138,0,0,23.92917166866747,74.70385911458476,FCER2,Mature B,1.3558126557645607
GO_Biological_Process_2021,positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/18,0.0440744949316926,0.110683318099138,0,0,23.92917166866747,74.70385911458476,FCRL3,Mature B,1.3558126557645607
GO_Biological_Process_2021,T cell migration (GO:0072678),1/18,0.0440744949316926,0.110683318099138,0,0,23.92917166866747,74.70385911458476,CCR6,Mature B,1.3558126557645607
GO_Biological_Process_2021,regulation of B cell differentiation (GO:0045577),1/18,0.0440744949316926,0.110683318099138,0,0,23.92917166866747,74.70385911458476,FCRL3,Mature B,1.3558126557645607
GO_Biological_Process_2021,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),1/18,0.0440744949316926,0.110683318099138,0,0,23.92917166866747,74.70385911458476,SCIMP,Mature B,1.3558126557645607
GO_Biological_Process_2021,regulation of platelet aggregation (GO:0090330),1/18,0.0440744949316926,0.110683318099138,0,0,23.92917166866747,74.70385911458476,BLK,Mature B,1.3558126557645607
GO_Biological_Process_2021,positive regulation of neutrophil chemotaxis (GO:0090023),1/19,0.0464664552952436,0.1141161475633189,0,0,22.598639455782312,69.35578082800635,CCR7,Mature B,1.3328604565168853
GO_Biological_Process_2021,regulation of lymphocyte proliferation (GO:0050670),1/19,0.0464664552952436,0.1141161475633189,0,0,22.598639455782312,69.35578082800635,CD22,Mature B,1.3328604565168853
GO_Biological_Process_2021,pore complex assembly (GO:0046931),1/19,0.0464664552952436,0.1141161475633189,0,0,22.598639455782312,69.35578082800635,TSPAN33,Mature B,1.3328604565168853
GO_Biological_Process_2021,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/20,0.0488525499820277,0.1165482263856948,0,0,21.40816326530612,64.63014669364038,CD70,Mature B,1.3111127622579986
GO_Biological_Process_2021,regulation of T cell migration (GO:2000404),1/20,0.0488525499820277,0.1165482263856948,0,0,21.40816326530612,64.63014669364038,CCR6,Mature B,1.3111127622579986
GO_Biological_Process_2021,regulation of lymphocyte differentiation (GO:0045619),1/20,0.0488525499820277,0.1165482263856948,0,0,21.40816326530612,64.63014669364038,FCRL3,Mature B,1.3111127622579986
GO_Biological_Process_2021,toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.0488525499820277,0.1165482263856948,0,0,21.40816326530612,64.63014669364038,SCIMP,Mature B,1.3111127622579986
GO_Biological_Process_2021,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),1/21,0.0512327930672156,0.1196626075835665,0,0,20.336734693877553,60.42807445408675,SCIMP,Mature B,1.2904519669693806
GO_Biological_Process_2021,calcium ion transport into cytosol (GO:0060402),1/21,0.0512327930672156,0.1196626075835665,0,0,20.336734693877553,60.42807445408675,MS4A1,Mature B,1.2904519669693806
GO_Biological_Process_2021,natural killer cell activation involved in immune response (GO:0002323),1/21,0.0512327930672156,0.1196626075835665,0,0,20.336734693877553,60.42807445408675,CD244,Mature B,1.2904519669693806
GO_Biological_Process_2021,protein mannosylation (GO:0035268),1/22,0.0536071985992547,0.1209784076496695,0,0,19.367346938775512,56.67024999786951,LARGE2,Mature B,1.2707768875084013
GO_Biological_Process_2021,positive regulation of neutrophil migration (GO:1902624),1/22,0.0536071985992547,0.1209784076496695,0,0,19.367346938775512,56.67024999786951,CCR7,Mature B,1.2707768875084013
GO_Biological_Process_2021,positive regulation of granulocyte chemotaxis (GO:0071624),1/22,0.0536071985992547,0.1209784076496695,0,0,19.367346938775512,56.67024999786951,CCR7,Mature B,1.2707768875084013
GO_Biological_Process_2021,negative regulation of lymphocyte activation (GO:0051250),1/22,0.0536071985992547,0.1209784076496695,0,0,19.367346938775512,56.67024999786951,BANK1,Mature B,1.2707768875084013
GO_Biological_Process_2021,regulation of platelet activation (GO:0010543),1/22,0.0536071985992547,0.1209784076496695,0,0,19.367346938775512,56.67024999786951,BLK,Mature B,1.2707768875084013
GO_Biological_Process_2021,positive regulation of interleukin-17 production (GO:0032740),1/23,0.0559757805878795,0.1254759108479983,0,0,18.4860853432282,53.29235549319145,LY9,Mature B,1.2519998414265567
GO_Biological_Process_2021,lipid translocation (GO:0034204),1/24,0.0583385530130099,0.1273534425251328,0,0,17.68145519077196,50.24171555062859,ABCB4,Mature B,1.2340443470047993
GO_Biological_Process_2021,lymphocyte activation involved in immune response (GO:0002285),1/24,0.0583385530130099,0.1273534425251328,0,0,17.68145519077196,50.24171555062859,CD244,Mature B,1.2340443470047993
GO_Biological_Process_2021,regulation of cytokine production involved in immune response (GO:0002718),1/24,0.0583385530130099,0.1273534425251328,0,0,17.68145519077196,50.24171555062859,SCIMP,Mature B,1.2340443470047993
GO_Biological_Process_2021,immune response-activating cell surface receptor signaling pathway (GO:0002429),1/24,0.0583385530130099,0.1273534425251328,0,0,17.68145519077196,50.24171555062859,BLK,Mature B,1.2340443470047993
GO_Biological_Process_2021,negative regulation of sequestering of calcium ion (GO:0051283),1/25,0.0606955298241754,0.1283057402612315,0,0,16.943877551020407,47.47480020477031,CCR7,Mature B,1.2168432931781568
GO_Biological_Process_2021,regulation of calcium ion import (GO:0090279),1/25,0.0606955298241754,0.1283057402612315,0,0,16.943877551020407,47.47480020477031,FCRL3,Mature B,1.2168432931781568
GO_Biological_Process_2021,regulation of neutrophil chemotaxis (GO:0090022),1/25,0.0606955298241754,0.1283057402612315,0,0,16.943877551020407,47.47480020477031,CCR7,Mature B,1.2168432931781568
GO_Biological_Process_2021,regulation of cholesterol transport (GO:0032374),1/25,0.0606955298241754,0.1283057402612315,0,0,16.943877551020407,47.47480020477031,ABCB4,Mature B,1.2168432931781568
GO_Biological_Process_2021,peripheral nervous system development (GO:0007422),1/25,0.0606955298241754,0.1283057402612315,0,0,16.943877551020407,47.47480020477031,UGT8,Mature B,1.2168432931781568
GO_Biological_Process_2021,meiosis I (GO:0007127),1/26,0.0630467249540435,0.1299852230533983,0,0,16.26530612244898,44.95534064809558,SYCP3,Mature B,1.2003374685092782
GO_Biological_Process_2021,positive regulation of filopodium assembly (GO:0051491),1/26,0.0630467249540435,0.1299852230533983,0,0,16.26530612244898,44.95534064809558,CCR7,Mature B,1.2003374685092782
GO_Biological_Process_2021,mononuclear cell differentiation (GO:1903131),1/26,0.0630467249540435,0.1299852230533983,0,0,16.26530612244898,44.95534064809558,BLK,Mature B,1.2003374685092782
GO_Biological_Process_2021,regulation of potassium ion transmembrane transporter activity (GO:1901016),1/26,0.0630467249540435,0.1299852230533983,0,0,16.26530612244898,44.95534064809558,NETO1,Mature B,1.2003374685092782
GO_Biological_Process_2021,positive regulation of cellular component movement (GO:0051272),1/27,0.0653921522588676,0.1323695688149199,0,0,15.638932496075354,42.652889831563165,CCR7,Mature B,1.184474368421492
GO_Biological_Process_2021,regulation of toll-like receptor signaling pathway (GO:0034121),1/27,0.0653921522588676,0.1323695688149199,0,0,15.638932496075354,42.652889831563165,FCRL3,Mature B,1.184474368421492
GO_Biological_Process_2021,release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.0653921522588676,0.1323695688149199,0,0,15.638932496075354,42.652889831563165,CCR7,Mature B,1.184474368421492
GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/28,0.0677318256109869,0.1338605310891693,0,0,15.058956916099774,40.54171043527237,CCR7,Mature B,1.1692072184717057
GO_Biological_Process_2021,regulation of calcium-mediated signaling (GO:0050848),1/28,0.0677318256109869,0.1338605310891693,0,0,15.058956916099774,40.54171043527237,CD22,Mature B,1.1692072184717057
GO_Biological_Process_2021,calcium ion import (GO:0070509),1/28,0.0677318256109869,0.1338605310891693,0,0,15.058956916099774,40.54171043527237,MS4A1,Mature B,1.1692072184717057
GO_Biological_Process_2021,positive regulation of monooxygenase activity (GO:0032770),1/28,0.0677318256109869,0.1338605310891693,0,0,15.058956916099774,40.54171043527237,FCER2,Mature B,1.1692072184717057
GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),2/172,0.0688760185279422,0.1353211187548982,0,0,4.848039215686274,12.970673059288286,CCR7;SCIMP,Mature B,1.1619319658128364
GO_Biological_Process_2021,regulation of neuronal synaptic plasticity (GO:0048168),1/29,0.0700657588372089,0.1360579270443475,0,0,14.520408163265309,38.5999069065122,NETO1,Mature B,1.1544941700666143
GO_Biological_Process_2021,protein ADP-ribosylation (GO:0006471),1/29,0.0700657588372089,0.1360579270443475,0,0,14.520408163265309,38.5999069065122,PARP15,Mature B,1.1544941700666143
GO_Biological_Process_2021,positive regulation of phosphate metabolic process (GO:0045937),1/30,0.0723939657090184,0.1381690545532122,0,0,14.019000703729768,36.80874147674154,CD244,Mature B,1.1402976322627019
GO_Biological_Process_2021,response to alcohol (GO:0097305),1/30,0.0723939657090184,0.1381690545532122,0,0,14.019000703729768,36.80874147674154,CCR7,Mature B,1.1402976322627019
GO_Biological_Process_2021,positive regulation of lipid kinase activity (GO:0090218),1/30,0.0723939657090184,0.1381690545532122,0,0,14.019000703729768,36.80874147674154,CCR7,Mature B,1.1402976322627019
GO_Biological_Process_2021,positive regulation of locomotion (GO:0040017),1/31,0.0747164600026276,0.140990382151851,0,0,13.551020408163266,35.15209038871121,CCR7,Mature B,1.126583712764908
GO_Biological_Process_2021,phospholipid translocation (GO:0045332),1/31,0.0747164600026276,0.140990382151851,0,0,13.551020408163266,35.15209038871121,ABCB4,Mature B,1.126583712764908
GO_Biological_Process_2021,regulation of interleukin-17 production (GO:0032660),1/33,0.0793443657059371,0.1472278785876833,0,0,12.70280612244898,32.18837516559274,LY9,Mature B,1.1004839073426347
GO_Biological_Process_2021,positive regulation of cholesterol transport (GO:0032376),1/33,0.0793443657059371,0.1472278785876833,0,0,12.70280612244898,32.18837516559274,ABCB4,Mature B,1.1004839073426347
GO_Biological_Process_2021,positive regulation of cytokine production involved in immune response (GO:0002720),1/33,0.0793443657059371,0.1472278785876833,0,0,12.70280612244898,32.18837516559274,SCIMP,Mature B,1.1004839073426347
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/35,0.0839495853612937,0.1549124945341001,0,0,11.95438175270108,29.61744503578088,CCR7,Mature B,1.0759814445616303
GO_Biological_Process_2021,cellular response to tumor necrosis factor (GO:0071356),2/194,0.0847375162198589,0.1555073099858949,0,0,4.287760416666667,10.58303673172677,CD70;TNFRSF13C,Mature B,1.0719242699529004
GO_Biological_Process_2021,regulation of mRNA processing (GO:0050684),1/36,0.0862437219743075,0.1574065745323428,0,0,11.612244897959185,28.456712045041098,KHDRBS2,Mature B,1.0642725091375862
GO_Biological_Process_2021,negative regulation of intracellular signal transduction (GO:1902532),2/198,0.0877321663879582,0.1592529542042286,0,0,4.199404761904762,10.219111519148855,BANK1;CD22,Mature B,1.0568411463883935
GO_Biological_Process_2021,positive regulation of cytokinesis (GO:0032467),1/37,0.0885322278902676,0.1598365627856724,0,0,11.289115646258503,27.36920368672352,CXCR5,Mature B,1.0528986067362665
GO_Biological_Process_2021,positive regulation of insulin secretion (GO:0032024),1/38,0.0908151166313484,0.1630766072842494,0,0,10.983452840595698,26.34852930034076,BLK,Mature B,1.0418418549683985
GO_Biological_Process_2021,negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.0930924017046572,0.1653875647306144,0,0,10.693877551020408,25.38900533231373,BLK,Mature B,1.0310857651239858
GO_Biological_Process_2021,regulation of nitric-oxide synthase activity (GO:0050999),1/39,0.0930924017046572,0.1653875647306144,0,0,10.693877551020408,25.38900533231373,FCER2,Mature B,1.0310857651239858
GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),2/207,0.0945848472510804,0.1658937930011774,0,0,4.013211382113822,9.464187818681536,BANK1;CCR7,Mature B,1.0241784331789758
GO_Biological_Process_2021,regulation of sodium ion transmembrane transporter activity (GO:2000649),1/40,0.0953640965755271,0.1658937930011774,0,0,10.419152276295131,24.485561288951835,NETO1,Mature B,1.0206151011238414
GO_Biological_Process_2021,lymphocyte migration (GO:0072676),1/40,0.0953640965755271,0.1658937930011774,0,0,10.419152276295131,24.485561288951835,CCR6,Mature B,1.0206151011238414
GO_Biological_Process_2021,negative regulation of protein kinase B signaling (GO:0051898),1/40,0.0953640965755271,0.1658937930011774,0,0,10.419152276295131,24.485561288951835,BANK1,Mature B,1.0206151011238414
GO_Biological_Process_2021,regulation of filopodium assembly (GO:0051489),1/41,0.0976302146847681,0.1689559155684589,0,0,10.158163265306122,23.633660200289185,CCR7,Mature B,1.0104157556925017
GO_Biological_Process_2021,calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.0998907694703361,0.1713151916339231,0,0,9.909905425584869,22.829231064333683,CCR7,Mature B,1.00047464143678
GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),2/214,0.100019348409027,0.1713151916339231,0,0,3.879323899371069,8.931722866735825,CCR7;RGS7,Mature B,0.9999159790553556
GO_Biological_Process_2021,positive regulation of peptide hormone secretion (GO:0090277),1/43,0.1021457742794159,0.1723065081279036,0,0,9.673469387755102,22.068611238785657,BLK,Mature B,0.9907795952096249
GO_Biological_Process_2021,spermatid development (GO:0007286),1/43,0.1021457742794159,0.1723065081279036,0,0,9.673469387755102,22.068611238785657,SYCP3,Mature B,0.9907795952096249
GO_Biological_Process_2021,natural killer cell activation (GO:0030101),1/43,0.1021457742794159,0.1723065081279036,0,0,9.673469387755102,22.068611238785657,CD244,Mature B,0.9907795952096249
GO_Biological_Process_2021,positive regulation of cell division (GO:0051781),1/44,0.1043952424647777,0.1743400549161788,0,0,9.448030374940672,21.34849709415977,CXCR5,Mature B,0.9813192926974915
GO_Biological_Process_2021,positive regulation of cell-matrix adhesion (GO:0001954),1/44,0.1043952424647777,0.1743400549161788,0,0,9.448030374940672,21.34849709415977,CCR7,Mature B,0.9813192926974915
GO_Biological_Process_2021,positive regulation of response to biotic stimulus (GO:0002833),1/45,0.1066391873529346,0.1772014357008964,0,0,9.232838589981448,20.665901611884028,SCIMP,Mature B,0.9720831731354668
GO_Biological_Process_2021,glycosphingolipid metabolic process (GO:0006687),1/47,0.1111105603036554,0.1837174610961432,0,0,8.830523513753327,19.4026870705364,UGT8,Mature B,0.9542446623584087
GO_Biological_Process_2021,regulation of stress-activated MAPK cascade (GO:0032872),1/49,0.1155599990222406,0.1882782423094067,0,0,8.46173469387755,18.260130793597916,SCIMP,Mature B,0.9371924705024297
GO_Biological_Process_2021,regulation of cellular localization (GO:0060341),1/49,0.1155599990222406,0.1882782423094067,0,0,8.46173469387755,18.260130793597916,BLK,Mature B,0.9371924705024297
GO_Biological_Process_2021,positive regulation of actin filament polymerization (GO:0030838),1/49,0.1155599990222406,0.1882782423094067,0,0,8.46173469387755,18.260130793597916,CCR7,Mature B,0.9371924705024297
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),2/238,0.1192811662769016,0.1933976191091512,0,0,3.4805790960451977,7.400657287256659,CCR7;SCIMP,Mature B,0.9234281232007147
GO_Biological_Process_2021,glycolipid metabolic process (GO:0006664),1/52,0.1221932608707862,0.197162073095858,0,0,7.962785114045619,16.738979733033663,UGT8,Mature B,0.9129527453809976
GO_Biological_Process_2021,regulation of humoral immune response (GO:0002920),1/54,0.1265883240687765,0.2022990442056045,0,0,7.661532537543319,15.834970375184442,CCR7,Mature B,0.8976063498190403
GO_Biological_Process_2021,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/54,0.1265883240687765,0.2022990442056045,0,0,7.661532537543319,15.834970375184442,KHDRBS2,Mature B,0.8976063498190403
GO_Biological_Process_2021,peptidyl-tyrosine modification (GO:0018212),1/56,0.1309618198144747,0.208291656276355,0,0,7.382189239332097,15.00687933540933,BLK,Mature B,0.8828552987007785
GO_Biological_Process_2021,positive regulation of interferon-gamma production (GO:0032729),1/57,0.1331405122852093,0.209759108977641,0,0,7.25,14.618539131965724,CD244,Mature B,0.8756897763447542
GO_Biological_Process_2021,monocarboxylic acid transport (GO:0015718),1/57,0.1331405122852093,0.209759108977641,0,0,7.25,14.618539131965724,ABCB4,Mature B,0.8756897763447542
GO_Biological_Process_2021,regulation of calcium ion transport (GO:0051924),1/58,0.1353138517398134,0.2111907779490547,0,0,7.122448979591836,14.246025949065045,FCRL3,Mature B,0.8686577434892403
GO_Biological_Process_2021,regulation of neurotransmitter receptor activity (GO:0099601),1/58,0.1353138517398134,0.2111907779490547,0,0,7.122448979591836,14.246025949065045,NETO1,Mature B,0.8686577434892403
GO_Biological_Process_2021,phospholipid transport (GO:0015914),1/59,0.1374818510452552,0.213576456972629,0,0,6.9992962702322306,13.8884471557023,ABCB4,Mature B,0.8617546291873563
GO_Biological_Process_2021,Notch signaling pathway (GO:0007219),1/60,0.1396445230534406,0.2149367313357104,0,0,6.88031822898651,13.544974303558986,FCER2,Mature B,0.8549760929333525
GO_Biological_Process_2021,response to organic cyclic compound (GO:0014070),1/60,0.1396445230534406,0.2149367313357104,0,0,6.88031822898651,13.544974303558986,ABCB4,Mature B,0.8549760929333525
GO_Biological_Process_2021,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2162640553332159,0,0,6.76530612244898,13.214837540593155,CD244,Mature B,0.848318009451734
GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.2162640553332159,0,0,6.76530612244898,13.214837540593155,CD22,Mature B,0.848318009451734
GO_Biological_Process_2021,amyloid fibril formation (GO:1990000),1/63,0.1461007034145454,0.2218074315475371,0,0,6.54641211323239,12.591756250239603,TSPAN33,Mature B,0.8353476931121088
GO_Biological_Process_2021,lipid homeostasis (GO:0055088),1/64,0.1482421941802595,0.2240402391683561,0,0,6.442176870748299,12.297522293260638,ABCB4,Mature B,0.8290281655096747
GO_Biological_Process_2021,chemical homeostasis (GO:0048878),1/65,0.1503784214913892,0.2242249677594821,0,0,6.341198979591836,12.01403781811508,ABCB4,Mature B,0.8228144782361342
GO_Biological_Process_2021,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/65,0.1503784214913892,0.2242249677594821,0,0,6.341198979591836,12.01403781811508,CNR2,Mature B,0.8228144782361342
GO_Biological_Process_2021,regulation of cell-matrix adhesion (GO:0001952),1/65,0.1503784214913892,0.2242249677594821,0,0,6.341198979591836,12.01403781811508,CCR7,Mature B,0.8228144782361342
GO_Biological_Process_2021,positive regulation of protein polymerization (GO:0032273),1/69,0.158870948881139,0.2347915793199134,0,0,5.966986794717887,10.977245117600177,CCR7,Mature B,0.7989555105590889
GO_Biological_Process_2021,peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.158870948881139,0.2347915793199134,0,0,5.966986794717887,10.977245117600177,BLK,Mature B,0.7989555105590889
GO_Biological_Process_2021,positive regulation of cell-substrate adhesion (GO:0010811),1/70,0.1609810482853106,0.2358231145933936,0,0,5.880212954747116,10.740024519792764,CCR7,Mature B,0.7932252488723367
GO_Biological_Process_2021,regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/70,0.1609810482853106,0.2358231145933936,0,0,5.880212954747116,10.740024519792764,CCR7,Mature B,0.7932252488723367
GO_Biological_Process_2021,protein tetramerization (GO:0051262),1/71,0.16308595979881,0.2368291764034894,0,0,5.795918367346939,10.51076961698872,MS4A1,Mature B,0.7875834261109624
GO_Biological_Process_2021,myeloid leukocyte differentiation (GO:0002573),1/71,0.16308595979881,0.2368291764034894,0,0,5.795918367346939,10.51076961698872,CCR7,Mature B,0.7875834261109624
GO_Biological_Process_2021,extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.1651856959101235,0.2378104415257813,0,0,5.713998275366484,10.28911103101624,CD70,Mature B,0.78202756268309
GO_Biological_Process_2021,positive regulation of protein secretion (GO:0050714),1/72,0.1651856959101235,0.2378104415257813,0,0,5.713998275366484,10.28911103101624,BLK,Mature B,0.78202756268309
GO_Biological_Process_2021,regulation of actin filament polymerization (GO:0030833),1/73,0.1672802691231711,0.2387675636202527,0,0,5.634353741496598,10.074701240888364,CCR7,Mature B,0.7765552814899175
GO_Biological_Process_2021,positive regulation of JNK cascade (GO:0046330),1/73,0.1672802691231711,0.2387675636202527,0,0,5.634353741496598,10.074701240888364,CCR7,Mature B,0.7765552814899175
GO_Biological_Process_2021,Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/74,0.1693696918266344,0.2407211790216847,0,0,5.556891249650545,9.867213018330611,BLK,Mature B,0.7711643026835198
GO_Biological_Process_2021,positive regulation of immune response (GO:0050778),1/75,0.1714539764404576,0.2426509666572577,0,0,5.4815223386651954,9.666337985731484,CCR7,Mature B,0.7658524380723842
GO_Biological_Process_2021,regulation of RNA splicing (GO:0043484),1/76,0.1735331353639065,0.2435296941661545,0,0,5.408163265306122,9.4717853003048,KHDRBS2,Mature B,0.7606175863963804
GO_Biological_Process_2021,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.2435296941661545,0,0,5.408163265306122,9.4717853003048,SCIMP,Mature B,0.7606175863963804
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2540618661248481,0,0,5.133298889175924,8.751529842637671,CCR7,Mature B,0.7404090821369118
GO_Biological_Process_2021,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2558613617363754,0,0,5.0688775510204085,8.584760541358477,CD244,Mature B,0.7355305181562768
GO_Biological_Process_2021,positive regulation of cytoskeleton organization (GO:0051495),1/82,0.1859011384602527,0.257638922181429,0,0,5.00604686318972,8.422875391899517,CCR7,Mature B,0.7307179505966239
GO_Biological_Process_2021,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1/83,0.1879447615357932,0.2583273677076335,0,0,4.944748631159781,8.265677319811374,CCR7,Mature B,0.7259697745939766
GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.2583273677076335,0,0,4.944748631159781,8.265677319811374,CCR7,Mature B,0.7259697745939766
GO_Biological_Process_2021,regulation of cytokinesis (GO:0032465),1/84,0.1899833569114356,0.2600591852804078,0,0,4.884927464961889,8.112979399077096,CXCR5,Mature B,0.7212844428267129
GO_Biological_Process_2021,collagen fibril organization (GO:0030199),1/89,0.2001013407742902,0.2716823082057437,0,0,4.6062152133580705,7.411084001248333,COL19A1,Mature B,0.6987500013741589
GO_Biological_Process_2021,regulation of cation channel activity (GO:2001257),1/89,0.2001013407742902,0.2716823082057437,0,0,4.6062152133580705,7.411084001248333,NETO1,Mature B,0.6987500013741589
GO_Biological_Process_2021,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.2021100231923967,0.2721965634929859,0,0,4.55423068103646,7.281955543769811,KHDRBS2,Mature B,0.6944121480917811
GO_Biological_Process_2021,protein complex oligomerization (GO:0051259),1/90,0.2021100231923967,0.2721965634929859,0,0,4.55423068103646,7.281955543769811,MS4A1,Mature B,0.6944121480917811
GO_Biological_Process_2021,toll-like receptor signaling pathway (GO:0002224),1/91,0.2041137620931186,0.2726959861564065,0,0,4.503401360544218,7.156255051106618,SCIMP,Mature B,0.6901277125812961
GO_Biological_Process_2021,positive regulation of supramolecular fiber organization (GO:1902905),1/91,0.2041137620931186,0.2726959861564065,0,0,4.503401360544218,7.156255051106618,CCR7,Mature B,0.6901277125812961
GO_Biological_Process_2021,T cell activation (GO:0042110),1/92,0.2061125694363157,0.2731809452052756,0,0,4.453689167974883,7.03385741012878,CCR7,Mature B,0.6858955226779435
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2731809452052756,0,0,4.453689167974883,7.03385741012878,BANK1,Mature B,0.6858955226779435
GO_Biological_Process_2021,regulation of vesicle-mediated transport (GO:0060627),1/96,0.2140587201245348,0.2825913538402949,0,0,4.26530612244898,6.5749903239841245,CD22,Mature B,0.6694670755856718
GO_Biological_Process_2021,protein maturation (GO:0051604),1/97,0.2160330472811356,0.2840749519366114,0,0,4.220663265306122,6.46742313757927,TSPAN33,Mature B,0.6654798083211632
GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),2/351,0.2188220798658953,0.2866140183341531,0,0,2.3401384909264564,3.5558317785950937,TSPAN33;COL19A1,Mature B,0.6599088583892734
GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),1/101,0.2238818662412048,0.292095872361572,0,0,4.051020408163265,6.062906014187368,CXCR5,Mature B,0.6499810815451941
GO_Biological_Process_2021,protein O-linked glycosylation (GO:0006493),1/102,0.2258320069783284,0.2934937366955708,0,0,4.010709234188725,5.967790506031058,LARGE2,Mature B,0.6462145058611213
GO_Biological_Process_2021,regulation of insulin secretion (GO:0050796),1/104,0.2297178930745814,0.2973867297942256,0,0,3.932435109966317,5.78423168094792,BLK,Mature B,0.6388051756325536
GO_Biological_Process_2021,activation of GTPase activity (GO:0090630),1/105,0.2316536615468536,0.2975858575255735,0,0,3.894427001569859,5.6956456810845415,CCR7,Mature B,0.6351608308934773
GO_Biological_Process_2021,regulation of JNK cascade (GO:0046328),1/105,0.2316536615468536,0.2975858575255735,0,0,3.894427001569859,5.6956456810845415,CCR7,Mature B,0.6351608308934773
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.3036575759154551,0,0,2.2110433604336044,3.18053102486219,BANK1;CCR7,Mature B,0.6247218387200065
GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),1/110,0.241261218690496,0.3063925743065615,0,0,3.714847406852649,5.282048795926194,SCIMP,Mature B,0.6175124827423236
GO_Biological_Process_2021,regulation of protein kinase activity (GO:0045859),1/110,0.241261218690496,0.3063925743065615,0,0,3.714847406852649,5.282048795926194,CCR7,Mature B,0.6175124827423236
GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.3136605442447108,0,0,3.582625970742279,4.982913653406146,ABCB4,Mature B,0.6040407011916724
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.3136605442447108,0,0,3.582625970742279,4.982913653406146,CCR7,Mature B,0.6040407011916724
GO_Biological_Process_2021,calcium ion transport (GO:0006816),1/115,0.2507510141385882,0.3148527771514604,0,0,3.5510204081632653,4.9121080927455,MS4A1,Mature B,0.6007573018413346
GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),1/116,0.2526349665899778,0.3160302578316576,0,0,3.5199645075421473,4.8428011439058265,UGT8,Mature B,0.5975065399797567
GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.2563889548341396,0.3195295183380695,0,0,3.4594453165881736,4.708511372057024,CNR2,Mature B,0.5911006880374128
GO_Biological_Process_2021,potassium ion transport (GO:0006813),1/122,0.2638415777635164,0.3275951188587899,0,0,3.3444088379153314,4.456111874258477,KCNH8,Mature B,0.5786567646257991
GO_Biological_Process_2021,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.3286724109996811,0,0,3.316828370692539,4.396166676729281,CCR7,Mature B,0.5756194520344882
GO_Biological_Process_2021,platelet degranulation (GO:0002576),1/125,0.2693829605231016,0.3320070435967377,0,0,3.263001974983542,4.279822783786303,BLK,Mature B,0.5696298784899082
GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.3397810538653574,0,0,3.1603954081632653,4.060453122404681,FCER2,Mature B,0.5579784037567757
GO_Biological_Process_2021,protein glycosylation (GO:0006486),1/130,0.2785278903472666,0.3407630599853005,0,0,3.135738016136687,4.008216604624779,LARGE2,Mature B,0.5551313103019286
GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3448834250727597,0,0,3.0640074211502784,3.857336278341556,CCR7,Mature B,0.546741450090894
GO_Biological_Process_2021,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3448834250727597,0,0,3.0640074211502784,3.857336278341556,CCR7,Mature B,0.546741450090894
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3458146240159572,0,0,3.0408163265306123,3.80890385676326,BANK1,Mature B,0.5439940297149167
GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.3488959375808114,0,0,2.99546485260771,3.714691124222948,TSPAN33,Mature B,0.5385707850387818
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3511530181859289,0,0,2.929902395740905,3.579678317757992,SCIMP,Mature B,0.5306096689947516
GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),1/139,0.2947069182263764,0.3511530181859289,0,0,2.929902395740905,3.579678317757992,CD22,Mature B,0.5306096689947516
GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),1/139,0.2947069182263764,0.3511530181859289,0,0,2.929902395740905,3.579678317757992,KCNH8,Mature B,0.5306096689947516
GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),1/140,0.2964824884084789,0.3511530181859289,0,0,2.9086771399207163,3.5362740390257685,TSPAN33,Mature B,0.5280009529309525
GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.2964824884084789,0.3511530181859289,0,0,2.9086771399207163,3.5362740390257685,BLK,Mature B,0.5280009529309525
GO_Biological_Process_2021,neuron development (GO:0048666),1/143,0.3017829564686885,0.3561678708853072,0,0,2.8467950560505892,3.410594866305226,BLK,Mature B,0.5203052911363482
GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),1/149,0.3122667490151626,0.3654204210542935,0,0,2.7305570876999448,3.1780885451938787,RGS7,Mature B,0.5054742581266645
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3654204210542935,0,0,2.712094233666621,3.141596466170354,ABCB4,Mature B,0.5030717563895143
GO_Biological_Process_2021,response to cytokine (GO:0034097),1/150,0.3139989845586295,0.3654204210542935,0,0,2.712094233666621,3.141596466170354,CCR7,Mature B,0.5030717563895143
GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),1/150,0.3139989845586295,0.3654204210542935,0,0,2.712094233666621,3.141596466170354,CCR7,Mature B,0.5030717563895143
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),1/154,0.3208852696222714,0.3721377779647176,0,0,2.640656262505002,3.0015590720273457,CCR7,Mature B,0.493650218923809
GO_Biological_Process_2021,skeletal system development (GO:0001501),1/158,0.3277037968552589,0.3787303396181884,0,0,2.5728584427401535,2.8703970097526006,COL19A1,Mature B,0.48451852674781976
GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3832634099448777,0,0,2.524234693877551,2.7773973646136283,CCR7,Mature B,0.4778511096570981
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.388876524569513,0,0,2.4621702339472376,2.6600168495918335,CNR2,Mature B,0.46919202564454415
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),2/482,0.3401543782991926,0.388876524569513,0,0,1.6901041666666667,1.8225334796372663,FCER2;CCR7,Mature B,0.46832393464331673
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.388876524569513,0,0,2.4471243042671613,2.6317886779390967,FCRL3,Mature B,0.4670671197091842
GO_Biological_Process_2021,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.3955962926589791,0,0,2.3745498199279713,2.4969025061029213,BLK,Mature B,0.4566722378913039
GO_Biological_Process_2021,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.3494039111808349,0.3955962926589791,0,0,2.3745498199279713,2.4969025061029213,CCR7,Mature B,0.4566722378913039
GO_Biological_Process_2021,regulation of immune response (GO:0050776),1/179,0.3624150547196057,0.4079993914472191,0,0,2.266911258885577,2.300835957547096,CD22,Mature B,0.4407937700298507
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.4079993914472191,0,0,2.2541329380914377,2.2778849681371156,CD244,Mature B,0.4388706874182523
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.4079993914472191,0,0,2.2541329380914377,2.2778849681371156,BLK,Mature B,0.4388706874182523
GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.4102147772151549,0,0,2.2289998872477166,2.2329492942532405,CCR7,Mature B,0.4350639775318079
GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),1/189,0.3783208179838206,0.4211971773553203,0,0,2.1452453321754232,2.085205747179162,RGS7,Mature B,0.42213975998471215
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.4284600984330056,0,0,2.089140319340171,1.988001678572607,PARP15,Mature B,0.4132695879859197
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.4287552756161583,0,0,2.0782663580896275,1.969329769675335,TSPAN33,Mature B,0.4115300469974289
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),2/546,0.3979281971141292,0.4386403228914823,0,0,1.4863664215686274,1.3696624285648409,FCRL3;CCR7,Mature B,0.40019528574129115
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),1/216,0.41934932166703,0.4607324784104869,0,0,1.8732795443758896,1.627975467192003,COL19A1,Mature B,0.3774240551539837
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),1/217,0.4208167942393084,0.4608288828718984,0,0,1.8645124716553287,1.613843141672166,COL19A1,Mature B,0.375906936392536
GO_Biological_Process_2021,cellular response to lipid (GO:0071396),1/219,0.4237408440429794,0.4625145160469122,0,0,1.8472196217936716,1.5860841457604238,ABCB4,Mature B,0.372899672681652
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4641734268609174,0,0,1.8302411873840445,1.5589816483293069,CCR7,Mature B,0.3699278171231457
GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.4673699108806671,0,0,1.805344559348403,1.519514184420898,CCR7,Mature B,0.36553500108915365
GO_Biological_Process_2021,inflammatory response (GO:0006954),1/230,0.4395663655385589,0.4751299873458857,0,0,1.7575082434720612,1.4446130242039086,CCR7,Mature B,0.35697554604801474
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.5063334414091772,0,0,1.6016749329213755,1.2094704650298027,SCIMP,Mature B,0.32794816113488356
GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5256513255591114,0,0,1.510204081632653,1.0781219104526054,TSPAN33,Mature B,0.3100391544580995
GO_Biological_Process_2021,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5256513255591114,0,0,1.504471451501949,1.0700627976731167,UGT8,Mature B,0.3088941088615854
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),1/274,0.4987179596066677,0.5321782699956136,0,0,1.4709576138147566,1.0233666205889618,KCNH8,Mature B,0.30214499188263844
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.5464821125507986,0,0,1.4081632653061225,0.937839142501346,FCER2,Mature B,0.289240867544339
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),1/300,0.5307476794848257,0.5627610315807359,0,0,1.341273633199099,0.8496546643160489,COL19A1,Mature B,0.2751118959639202
GO_Biological_Process_2021,innate immune response (GO:0045087),1/302,0.5331267023920349,0.5634946791105685,0,0,1.3322259136212624,0.8379649939237771,BLK,Mature B,0.2731695646873957
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5854490935059393,0,0,1.2479496471485791,0.7319104885681406,PARP15,Mature B,0.2547095446988111
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5854490935059393,0,0,1.2440106477373558,0.7270814983759607,ABCB4,Mature B,0.2538302089398956
GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),1/350,0.5868058377702841,0.6143985887626171,0,0,1.1461902812701013,0.6109896633619631,BLK,Mature B,0.23150557427863594
GO_Biological_Process_2021,gene expression (GO:0010467),1/356,0.5930749260701463,0.6190219540857153,0,0,1.126473124461052,0.5885084653208599,TSPAN33,Mature B,0.2268904366133749
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.64324424790513,0,0,1.0510204081632653,0.5054679174936134,FCMR,Mature B,0.20886552310647807
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.6638329236924373,0,0,0.989871879272801,0.4417939051458828,BLK,Mature B,0.19383180708628664
GO_Biological_Process_2021,nervous system development (GO:0007399),1/447,0.677475806229693,0.7005477377111995,0,0,0.8924681980415484,0.3475105496336908,UGT8,Mature B,0.16910620954367267
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7292382915172603,0,0,0.8207960870298533,0.2841203737887477,FCMR,Mature B,0.15033199168778996
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7353635240418674,0,0,0.8021026592455164,0.2684686706444305,BLK,Mature B,0.1453610219101508
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),1/625,0.7959537647207185,0.8154863724439264,0,0,0.6320643642072213,0.1442460501716775,CCR7,Mature B,0.09911215878223603
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8425035240387666,0,0,0.5757014372366809,0.1108560647358729,PARP15,Mature B,0.0836269880293983
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8648631798193532,0,0,0.5290423861852434,0.0863986224716518,FCMR,Mature B,0.07092521499844862
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),1/908,0.9023188918982462,0.9160319449666086,0,0,0.4284814256463335,0.0440424414337815,SPIB,Mature B,0.044639949690669034
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",1/948,0.912055183209665,0.9231103975516004,0,0,0.4095209361463698,0.0376983608425212,PARP15,Mature B,0.039978884217174375
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),1/1079,0.9377418517471742,0.9462410226089312,0,0,0.3572753776835409,0.0229658682151355,PARP15,Mature B,0.027916700844649738
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1183,0.952754544972228,0.9584940301829042,0,0,0.3240443385476018,0.0156830878086274,SPIB,Mature B,0.021018970814361417
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),2/2206,0.9792407454532416,0.9821814083525006,0,0,0.3354885057471264,0.0070377963929841,SPIB;PARP15,Mature B,0.009110524163636814
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",1/2244,0.9974129150066312,0.9974129150066312,0,0,0.1611089375562976,0.00041734259811053735,SPIB,Mature B,0.001125012616753463
GO_Biological_Process_2021,regulation of metaphase/anaphase transition of cell cycle (GO:1902099),3/8,8.160167950922518e-07,0.0003925040784393731,0,0,254.61702127659575,3569.432965531479,CENPE;UBE2C;PLK1,Megakaryocyte,6.088300902593167
GO_Biological_Process_2021,regulation of mitotic sister chromatid separation (GO:0010965),3/16,8.046099028490012e-06,0.0019350868163518,0,0,97.89034369885434,1148.2853674678522,CENPE;UBE2C;PLK1,Megakaryocyte,5.09441462659174
GO_Biological_Process_2021,regulation of mitotic metaphase/anaphase transition (GO:0030071),3/26,3.6705035971544355e-05,0.0058850407674376,0,0,55.30157261794635,564.7726520715403,CENPE;UBE2C;PLK1,Megakaryocyte,4.435274345976522
GO_Biological_Process_2021,regulation of mitotic cell cycle phase transition (GO:1901990),5/188,0.00010461863572485712,0.012580390945914,0,0,12.001821493624773,109.9989606578414,CENPE;CENPF;UBE2C;PLK1;HMMR,Megakaryocyte,3.980390947671511
GO_Biological_Process_2021,regulation of protein localization to cell cortex (GO:1904776),2/8,0.0001698630098259154,0.0149829170484042,0,0,138.5,1202.2517804391236,SAPCD2;PLK1,Megakaryocyte,3.7699011848597213
GO_Biological_Process_2021,regulation of animal organ morphogenesis (GO:2000027),2/9,0.00021804660985203623,0.0149829170484042,0,0,118.70833333333331,1000.8064198202924,SAPCD2;WT1,Megakaryocyte,3.6614506612675517
GO_Biological_Process_2021,kinetochore assembly (GO:0051382),2/9,0.00021804660985203623,0.0149829170484042,0,0,118.70833333333331,1000.8064198202924,CENPE;CENPF,Megakaryocyte,3.6614506612675517
GO_Biological_Process_2021,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),2/11,0.000332063883264561,0.0173964801500437,0,0,92.31944444444444,739.4956618223716,EGF;ADRA2A,Megakaryocyte,3.478778357620151
GO_Biological_Process_2021,regulation of megakaryocyte differentiation (GO:0045652),3/54,0.0003333415993294188,0.0173964801500437,0,0,24.90488110137672,199.39701474295643,ITGA2B;GP1BA;PF4,Megakaryocyte,3.4771104852237307
GO_Biological_Process_2021,renal system development (GO:0072001),3/57,0.0003911590889551034,0.0173964801500437,0,0,23.5177304964539,184.5294312848504,CENPF;WT1;REN,Megakaryocyte,3.407646574053549
GO_Biological_Process_2021,positive regulation of ubiquitin protein ligase activity (GO:1904668),2/12,0.0003978405023918531,0.0173964801500437,0,0,83.08333333333333,650.4975835514635,UBE2C;PLK1,Megakaryocyte,3.4002910053496507
GO_Biological_Process_2021,kinetochore organization (GO:0051383),2/13,0.00046942457388711873,0.0188161016699753,0,0,75.52651515151516,578.8354329773197,CENPE;CENPF,Megakaryocyte,3.3284341792789096
GO_Biological_Process_2021,negative regulation of secretion (GO:0051048),2/14,0.0005467878206419364,0.0202311493637516,0,0,69.22916666666667,520.0114050756229,EGF;SPX,Megakaryocyte,3.2621811676355046
GO_Biological_Process_2021,regulation of myeloid cell differentiation (GO:0045637),3/68,0.0006571555344566322,0.0225779865766885,0,0,19.527004909983635,143.08588265054038,ITGA2B;GP1BA;PF4,Megakaryocyte,3.1823318301935126
GO_Biological_Process_2021,kidney development (GO:0001822),3/70,0.0007152738836628206,0.0229364492027877,0,0,18.94220387424579,137.19544727387992,CENPF;WT1;REN,Megakaryocyte,3.145527631782337
GO_Biological_Process_2021,regulation of ubiquitin protein ligase activity (GO:1904666),2/21,0.0012477930702112,0.0302331940183186,0,0,43.708333333333336,292.25047477799524,UBE2C;PLK1,Megakaryocyte,2.9038574306125264
GO_Biological_Process_2021,spindle assembly checkpoint signaling (GO:0071173),2/21,0.0012477930702112,0.0302331940183186,0,0,43.708333333333336,292.25047477799524,CENPF;PLK1,Megakaryocyte,2.9038574306125264
GO_Biological_Process_2021,mitotic spindle assembly checkpoint signaling (GO:0007094),2/21,0.0012477930702112,0.0302331940183186,0,0,43.708333333333336,292.25047477799524,CENPF;PLK1,Megakaryocyte,2.9038574306125264
GO_Biological_Process_2021,mitotic spindle checkpoint signaling (GO:0071174),2/21,0.0012477930702112,0.0302331940183186,0,0,43.708333333333336,292.25047477799524,CENPF;PLK1,Megakaryocyte,2.9038574306125264
GO_Biological_Process_2021,regulation of cell cycle G2/M phase transition (GO:1902749),3/85,0.0012570974643791,0.0302331940183186,0,0,15.465490399584846,103.29323424451243,CENPF;PLK1;HMMR,Megakaryocyte,2.900631049600358
GO_Biological_Process_2021,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),2/22,0.001370383663162,0.0313883115229011,0,0,41.520833333333336,273.7329252658829,CENPF;PLK1,Megakaryocyte,2.8631578273928713
GO_Biological_Process_2021,establishment of mitotic spindle orientation (GO:0000132),2/24,0.0016321249773357,0.0356841870044776,0,0,37.74242424242424,242.22606459531664,SAPCD2;PLK1,Megakaryocyte,2.7872465889099036
GO_Biological_Process_2021,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),2/25,0.0017712212130127,0.0370416262373532,0,0,36.09963768115942,228.73040961874747,EGF;PLK1,Megakaryocyte,2.751727195110795
GO_Biological_Process_2021,regulation of epidermal growth factor-activated receptor activity (GO:0007176),2/27,0.0020657293545543,0.0414006591475266,0,0,33.208333333333336,205.3029465636782,EGF;ADRA2A,Megakaryocyte,2.684926579003782
GO_Biological_Process_2021,establishment of mitotic spindle localization (GO:0040001),2/29,0.0023818121959682,0.0458260666504297,0,0,30.74537037037037,185.6987673947897,SAPCD2;PLK1,Megakaryocyte,2.623092485284041
GO_Biological_Process_2021,establishment of spindle orientation (GO:0051294),2/30,0.0025478771667966,0.0471357275857376,0,0,29.645833333333332,177.0595839464994,SAPCD2;PLK1,Megakaryocyte,2.5938215131766835
GO_Biological_Process_2021,positive regulation of ubiquitin-protein transferase activity (GO:0051443),2/31,0.0027192556482504,0.0484430358077207,0,0,28.62212643678161,169.08226656127547,UBE2C;PLK1,Megakaryocyte,2.565549960707733
GO_Biological_Process_2021,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),2/34,0.0032650074009337,0.0541540882706599,0,0,25.934895833333332,148.46413612460563,EGF;ADRA2A,Megakaryocyte,2.4861158299536776
GO_Biological_Process_2021,sister chromatid segregation (GO:0000819),2/34,0.0032650074009337,0.0541540882706599,0,0,25.934895833333332,148.46413612460563,TOP2A;PLK1,Megakaryocyte,2.4861158299536776
GO_Biological_Process_2021,platelet degranulation (GO:0002576),3/125,0.0037708170170264,0.057985024873852,0,0,10.3739100104639,57.89122705378868,EGF;ITGA2B;PF4,Megakaryocyte,2.4235645416924525
GO_Biological_Process_2021,centromere complex assembly (GO:0034508),2/37,0.0038576315924392,0.057985024873852,0,0,23.708333333333332,131.76384828572083,CENPE;CENPF,Megakaryocyte,2.4136792502562754
GO_Biological_Process_2021,positive regulation of signaling receptor activity (GO:2000273),2/37,0.0038576315924392,0.057985024873852,0,0,23.708333333333332,131.76384828572083,EGF;ADRA2A,Megakaryocyte,2.4136792502562754
GO_Biological_Process_2021,microtubule cytoskeleton organization involved in mitosis (GO:1902850),3/128,0.0040300226589612,0.0587406333018285,0,0,10.12340425531915,55.82028180525176,CENPE;CENPF;PLK1,Megakaryocyte,2.3946925120141884
GO_Biological_Process_2021,regulation of peptidyl-threonine phosphorylation (GO:0010799),2/39,0.0042784069542198,0.0605268748523453,0,0,22.42454954954955,122.3074073504305,EGF;PLK1,Megakaryocyte,2.368717908505425
GO_Biological_Process_2021,positive regulation of protein tyrosine kinase activity (GO:0061098),2/42,0.0049475924537835,0.0679940562934254,0,0,20.739583333333332,110.1034239545967,EGF;ADRA2A,Megakaryocyte,2.3056060815494894
GO_Biological_Process_2021,chromosome condensation (GO:0030261),2/45,0.0056617913266769,0.0736032872468005,0,0,19.289728682170544,99.80534454493326,TOP2A;PLK1,Megakaryocyte,2.2470461412130196
GO_Biological_Process_2021,microtubule bundle formation (GO:0001578),2/45,0.0056617913266769,0.0736032872468005,0,0,19.289728682170544,99.80534454493326,PLK1;KIF20A,Megakaryocyte,2.2470461412130196
GO_Biological_Process_2021,regulation of G2/M transition of mitotic cell cycle (GO:0010389),3/149,0.0061486161723867,0.0760053200005697,0,0,8.658117167006704,44.08304801864367,CENPF;PLK1;HMMR,Megakaryocyte,2.2112226169597906
GO_Biological_Process_2021,regulation of wound healing (GO:0061041),2/47,0.0061625935135597,0.0760053200005697,0,0,18.430555555555557,93.79784429037068,GP1BA;ADRA2A,Megakaryocyte,2.210236477513525
GO_Biological_Process_2021,mitotic cytokinesis (GO:0000281),2/49,0.0066828970303688,0.0803618367901854,0,0,17.64450354609929,88.36726791367238,PLK1;KIF20A,Megakaryocyte,2.175035230405133
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),5/482,0.0069168190120408,0.0811460962144301,0,0,4.535988819007687,22.5610979918269,MYCN;EGF;WT1;ADRA2A;PF4,Megakaryocyte,2.1600935880773298
GO_Biological_Process_2021,mitotic spindle organization (GO:0007052),3/157,0.0071009150987215,0.0813223848210726,0,0,8.205029013539653,40.594640455474256,CENPE;CENPF;PLK1,Megakaryocyte,2.14868567991247
GO_Biological_Process_2021,unsaturated fatty acid metabolic process (GO:0033559),2/54,0.0080676700842631,0.0902453328030367,0,0,15.943910256410255,76.8479024006269,ALOX12;PTGS1,Megakaryocyte,2.0932518699428635
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),3/166,0.0082715898220491,0.0904235160092188,0,0,7.748466257668712,37.153342067959336,EGF;REN;ADRA2A,Megakaryocyte,2.082411009844599
GO_Biological_Process_2021,arachidonic acid metabolic process (GO:0019369),2/57,0.0089551608364968,0.0916474970713822,0,0,15.071969696969695,71.07225417227201,ALOX12;PTGS1,Megakaryocyte,2.0479266097283184
GO_Biological_Process_2021,icosanoid metabolic process (GO:0006690),2/57,0.0089551608364968,0.0916474970713822,0,0,15.071969696969695,71.07225417227201,ALOX12;PTGS1,Megakaryocyte,2.0479266097283184
GO_Biological_Process_2021,positive regulation of proteolysis (GO:0045862),2/57,0.0089551608364968,0.0916474970713822,0,0,15.071969696969695,71.07225417227201,PLK1;ADRA2A,Megakaryocyte,2.0479266097283184
GO_Biological_Process_2021,regulation of calcium ion transport (GO:0051924),2/58,0.0092602829393189,0.0927957519544257,0,0,14.802083333333334,69.30366021141536,EGF;ADRA2A,Megakaryocyte,2.033375743652011
GO_Biological_Process_2021,negative regulation of response to stimulus (GO:0048585),2/61,0.0102031878981958,0.0953782665802003,0,0,14.04731638418079,64.40771918587598,MPIG6B;ADRA2A,Megakaryocyte,1.9912641154648159
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),3/180,0.01030679429305,0.0953782665802003,0,0,7.130544536602957,32.621898711524636,EGF;ITGA2B;PF4,Megakaryocyte,1.9868763916831889
GO_Biological_Process_2021,negative regulation of calcium ion-dependent exocytosis (GO:0045955),1/5,0.0124387771927725,0.0953782665802003,0,0,101.76530612244898,446.4379351400606,ADRA2A,Megakaryocyte,1.9052223113279663
GO_Biological_Process_2021,receptor transactivation (GO:0035624),1/5,0.0124387771927725,0.0953782665802003,0,0,101.76530612244898,446.4379351400606,ADRA2A,Megakaryocyte,1.9052223113279663
GO_Biological_Process_2021,apoptotic chromosome condensation (GO:0030263),1/5,0.0124387771927725,0.0953782665802003,0,0,101.76530612244898,446.4379351400606,TOP2A,Megakaryocyte,1.9052223113279663
GO_Biological_Process_2021,cardiac cell fate commitment (GO:0060911),1/5,0.0124387771927725,0.0953782665802003,0,0,101.76530612244898,446.4379351400606,WT1,Megakaryocyte,1.9052223113279663
GO_Biological_Process_2021,negative regulation of response to food (GO:0032096),1/5,0.0124387771927725,0.0953782665802003,0,0,101.76530612244898,446.4379351400606,SPX,Megakaryocyte,1.9052223113279663
GO_Biological_Process_2021,regulation of heart growth (GO:0060420),1/5,0.0124387771927725,0.0953782665802003,0,0,101.76530612244898,446.4379351400606,WT1,Megakaryocyte,1.9052223113279663
GO_Biological_Process_2021,thorax and anterior abdomen determination (GO:0007356),1/5,0.0124387771927725,0.0953782665802003,0,0,101.76530612244898,446.4379351400606,WT1,Megakaryocyte,1.9052223113279663
GO_Biological_Process_2021,metanephric epithelium development (GO:0072207),1/5,0.0124387771927725,0.0953782665802003,0,0,101.76530612244898,446.4379351400606,WT1,Megakaryocyte,1.9052223113279663
GO_Biological_Process_2021,diaphragm development (GO:0060539),1/5,0.0124387771927725,0.0953782665802003,0,0,101.76530612244898,446.4379351400606,WT1,Megakaryocyte,1.9052223113279663
GO_Biological_Process_2021,"zygotic determination of anterior/posterior axis, embryo (GO:0007354)",1/5,0.0124387771927725,0.0953782665802003,0,0,101.76530612244898,446.4379351400606,WT1,Megakaryocyte,1.9052223113279663
GO_Biological_Process_2021,positive regulation of MAP kinase activity (GO:0043406),2/69,0.0129153730394233,0.0953782665802003,0,0,12.36504975124378,53.77976800231812,EGF;ADRA2A,Megakaryocyte,1.888893045423814
GO_Biological_Process_2021,cytoskeleton-dependent cytokinesis (GO:0061640),2/72,0.0140048037295852,0.0953782665802003,0,0,11.833333333333334,50.50886613536219,PLK1;KIF20A,Megakaryocyte,1.8537229732206628
GO_Biological_Process_2021,mitotic nuclear division (GO:0140014),2/74,0.0147525184670075,0.0953782665802003,0,0,11.50347222222222,48.50256694786101,UBE2C;PLK1,Megakaryocyte,1.8311338330445346
GO_Biological_Process_2021,free ubiquitin chain polymerization (GO:0010994),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,UBE2C,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,glomerular epithelial cell differentiation (GO:0072311),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,WT1,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,renal filtration cell differentiation (GO:0061318),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,WT1,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,positive regulation of gonad development (GO:1905941),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,WT1,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,response to gonadotropin (GO:0034698),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,WT1,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,positive regulation of male gonad development (GO:2000020),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,WT1,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,regulation of epinephrine secretion (GO:0014060),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,ADRA2A,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,lipoxin metabolic process (GO:2001300),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,ALOX12,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,regulation of hyaluronan biosynthetic process (GO:1900125),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,EGF,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,megakaryocyte development (GO:0035855),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,MPIG6B,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,protein localization to nuclear envelope (GO:0090435),1/6,0.0149082847993736,0.0953782665802003,0,0,81.40816326530613,342.3895623444841,PLK1,Megakaryocyte,1.8265723193247598
GO_Biological_Process_2021,integrin-mediated signaling pathway (GO:0007229),2/75,0.0151327357621299,0.0953782665802003,0,0,11.345319634703197,47.54704276850611,MPIG6B;ITGA2B,Megakaryocyte,1.820082551223806
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),4/384,0.0153877459849858,0.0953782665802003,0,0,4.478260869565218,18.69308398095575,MYCN;EGF;WT1;PF4,Megakaryocyte,1.8128249914729373
GO_Biological_Process_2021,regulation of cell division (GO:0051302),2/76,0.0155171628224907,0.0953782665802003,0,0,11.19144144144144,46.62140287744705,PLK1;KIF20A,Megakaryocyte,1.8091876827669675
GO_Biological_Process_2021,cellular response to hormone stimulus (GO:0032870),2/76,0.0155171628224907,0.0953782665802003,0,0,11.19144144144144,46.62140287744705,WT1;ADRA2A,Megakaryocyte,1.8091876827669675
GO_Biological_Process_2021,negative regulation of catecholamine secretion (GO:0033604),1/7,0.0173717414502839,0.0953782665802003,0,0,67.83673469387755,274.9362107684438,ADRA2A,Megakaryocyte,1.7601566430186848
GO_Biological_Process_2021,negative regulation of heart rate (GO:0010459),1/7,0.0173717414502839,0.0953782665802003,0,0,67.83673469387755,274.9362107684438,SPX,Megakaryocyte,1.7601566430186848
GO_Biological_Process_2021,positive regulation of epithelial tube formation (GO:1905278),1/7,0.0173717414502839,0.0953782665802003,0,0,67.83673469387755,274.9362107684438,EGF,Megakaryocyte,1.7601566430186848
GO_Biological_Process_2021,cellular response to gonadotropin stimulus (GO:0071371),1/7,0.0173717414502839,0.0953782665802003,0,0,67.83673469387755,274.9362107684438,WT1,Megakaryocyte,1.7601566430186848
GO_Biological_Process_2021,lipoxin biosynthetic process (GO:2001301),1/7,0.0173717414502839,0.0953782665802003,0,0,67.83673469387755,274.9362107684438,ALOX12,Megakaryocyte,1.7601566430186848
GO_Biological_Process_2021,regulation of male gonad development (GO:2000018),1/7,0.0173717414502839,0.0953782665802003,0,0,67.83673469387755,274.9362107684438,WT1,Megakaryocyte,1.7601566430186848
GO_Biological_Process_2021,regulation of muscle organ development (GO:0048634),1/7,0.0173717414502839,0.0953782665802003,0,0,67.83673469387755,274.9362107684438,CENPF,Megakaryocyte,1.7601566430186848
GO_Biological_Process_2021,DNA ligation (GO:0006266),1/7,0.0173717414502839,0.0953782665802003,0,0,67.83673469387755,274.9362107684438,TOP2A,Megakaryocyte,1.7601566430186848
GO_Biological_Process_2021,regulation of norepinephrine secretion (GO:0014061),1/7,0.0173717414502839,0.0953782665802003,0,0,67.83673469387755,274.9362107684438,ADRA2A,Megakaryocyte,1.7601566430186848
GO_Biological_Process_2021,anaphase-promoting complex-dependent catabolic process (GO:0031145),2/84,0.0187414436957378,0.0953782665802003,0,0,10.095528455284551,40.15009805248223,UBE2C;PLK1,Megakaryocyte,1.7271969574747794
GO_Biological_Process_2021,regulation of cytokinesis (GO:0032465),2/84,0.0187414436957378,0.0953782665802003,0,0,10.095528455284551,40.15009805248223,PLK1;KIF20A,Megakaryocyte,1.7271969574747794
GO_Biological_Process_2021,negative regulation of appetite (GO:0032099),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,SPX,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,regulation of striated muscle tissue development (GO:0016202),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,CENPF,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,negative regulation of chromosome organization (GO:2001251),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,TOP2A,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,negative regulation of muscle cell apoptotic process (GO:0010656),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,ALOX12,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,negative regulation of regulated secretory pathway (GO:1903306),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,ADRA2A,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,kidney epithelium development (GO:0072073),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,WT1,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,kidney mesenchyme development (GO:0072074),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,WT1,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,lipid import into cell (GO:0140354),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,SPX,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,positive regulation of protein localization to early endosome (GO:1902966),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,EGF,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,positive regulation of protein localization to endosome (GO:1905668),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,EGF,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,regulation of protein localization to early endosome (GO:1902965),1/8,0.0198291614511851,0.0953782665802003,0,0,58.142857142857146,227.9549801512961,EGF,Megakaryocyte,1.702695651141308
GO_Biological_Process_2021,positive regulation of blood pressure (GO:0045777),1/9,0.0222805591236868,0.0983206324632417,0,0,50.87244897959184,193.52086993316271,SPX,Megakaryocyte,1.652073914876897
GO_Biological_Process_2021,bone cell development (GO:0098751),1/9,0.0222805591236868,0.0983206324632417,0,0,50.87244897959184,193.52086993316271,MPIG6B,Megakaryocyte,1.652073914876897
GO_Biological_Process_2021,hepoxilin biosynthetic process (GO:0051122),1/9,0.0222805591236868,0.0983206324632417,0,0,50.87244897959184,193.52086993316271,ALOX12,Megakaryocyte,1.652073914876897
GO_Biological_Process_2021,hepoxilin metabolic process (GO:0051121),1/9,0.0222805591236868,0.0983206324632417,0,0,50.87244897959184,193.52086993316271,ALOX12,Megakaryocyte,1.652073914876897
GO_Biological_Process_2021,negative regulation of platelet aggregation (GO:0090331),1/9,0.0222805591236868,0.0983206324632417,0,0,50.87244897959184,193.52086993316271,ALOX12,Megakaryocyte,1.652073914876897
GO_Biological_Process_2021,positive regulation of smooth muscle contraction (GO:0045987),1/9,0.0222805591236868,0.0983206324632417,0,0,50.87244897959184,193.52086993316271,SPX,Megakaryocyte,1.652073914876897
GO_Biological_Process_2021,unsaturated fatty acid biosynthetic process (GO:0006636),1/9,0.0222805591236868,0.0983206324632417,0,0,50.87244897959184,193.52086993316271,ALOX12,Megakaryocyte,1.652073914876897
GO_Biological_Process_2021,DNA topological change (GO:0006265),1/9,0.0222805591236868,0.0983206324632417,0,0,50.87244897959184,193.52086993316271,TOP2A,Megakaryocyte,1.652073914876897
GO_Biological_Process_2021,muscle cell fate commitment (GO:0042693),1/9,0.0222805591236868,0.0983206324632417,0,0,50.87244897959184,193.52086993316271,WT1,Megakaryocyte,1.652073914876897
GO_Biological_Process_2021,regulation of cell cycle phase transition (GO:1901987),2/95,0.0235916467130086,0.1025274256991475,0,0,8.896505376344086,33.333983109146935,UBE2C;PLK1,Megakaryocyte,1.6272417440057543
GO_Biological_Process_2021,regulation of MAP kinase activity (GO:0043405),2/97,0.024523395696302,0.1025274256991475,0,0,8.708333333333334,32.29161197321332,EGF;ADRA2A,Megakaryocyte,1.6104193942653626
GO_Biological_Process_2021,adrenal gland development (GO:0030325),1/10,0.024725948817258,0.1025274256991475,0,0,45.21768707482993,167.3010120823387,WT1,Megakaryocyte,1.606847034080906
GO_Biological_Process_2021,regulation of DNA methylation (GO:0044030),1/10,0.024725948817258,0.1025274256991475,0,0,45.21768707482993,167.3010120823387,WT1,Megakaryocyte,1.606847034080906
GO_Biological_Process_2021,sequestering of actin monomers (GO:0042989),1/10,0.024725948817258,0.1025274256991475,0,0,45.21768707482993,167.3010120823387,TMSB15A,Megakaryocyte,1.606847034080906
GO_Biological_Process_2021,long-chain fatty acid import into cell (GO:0044539),1/10,0.024725948817258,0.1025274256991475,0,0,45.21768707482993,167.3010120823387,SPX,Megakaryocyte,1.606847034080906
GO_Biological_Process_2021,mesenchymal to epithelial transition (GO:0060231),1/10,0.024725948817258,0.1025274256991475,0,0,45.21768707482993,167.3010120823387,WT1,Megakaryocyte,1.606847034080906
GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),2/102,0.0269177264019109,0.1039197395229512,0,0,8.270833333333334,29.898816321570965,CENPE;PLK1,Megakaryocyte,1.5699616254585989
GO_Biological_Process_2021,negative regulation of calcium ion transmembrane transport (GO:1903170),1/11,0.0271653448579923,0.1039197395229512,0,0,40.69387755102041,146.73452100035948,ADRA2A,Megakaryocyte,1.5659847773237099
GO_Biological_Process_2021,negative regulation of homotypic cell-cell adhesion (GO:0034111),1/11,0.0271653448579923,0.1039197395229512,0,0,40.69387755102041,146.73452100035948,ALOX12,Megakaryocyte,1.5659847773237099
GO_Biological_Process_2021,regulation of coagulation (GO:0050818),1/11,0.0271653448579923,0.1039197395229512,0,0,40.69387755102041,146.73452100035948,GP1BA,Megakaryocyte,1.5659847773237099
GO_Biological_Process_2021,positive regulation of macrophage differentiation (GO:0045651),1/11,0.0271653448579923,0.1039197395229512,0,0,40.69387755102041,146.73452100035948,PF4,Megakaryocyte,1.5659847773237099
GO_Biological_Process_2021,inositol phosphate biosynthetic process (GO:0032958),1/11,0.0271653448579923,0.1039197395229512,0,0,40.69387755102041,146.73452100035948,ITPKA,Megakaryocyte,1.5659847773237099
GO_Biological_Process_2021,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/11,0.0271653448579923,0.1039197395229512,0,0,40.69387755102041,146.73452100035948,MYCN,Megakaryocyte,1.5659847773237099
GO_Biological_Process_2021,cyclooxygenase pathway (GO:0019371),1/11,0.0271653448579923,0.1039197395229512,0,0,40.69387755102041,146.73452100035948,PTGS1,Megakaryocyte,1.5659847773237099
GO_Biological_Process_2021,metanephric mesenchyme development (GO:0072075),1/11,0.0271653448579923,0.1039197395229512,0,0,40.69387755102041,146.73452100035948,WT1,Megakaryocyte,1.5659847773237099
GO_Biological_Process_2021,regulation of cell cycle process (GO:0010564),2/106,0.0288986461861609,0.1039197395229512,0,0,7.951121794871795,28.178461808105727,PLK1;KIF20A,Megakaryocyte,1.5391225021448902
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),2/106,0.0288986461861609,0.1039197395229512,0,0,7.951121794871795,28.178461808105727,EGF;ADRA2A,Megakaryocyte,1.5391225021448902
GO_Biological_Process_2021,regulation of sensory perception (GO:0051931),1/12,0.029598761568907,0.1039197395229512,0,0,36.99257884972171,130.2147194065139,SPX,Megakaryocyte,1.5287264597194943
GO_Biological_Process_2021,exit from mitosis (GO:0010458),1/12,0.029598761568907,0.1039197395229512,0,0,36.99257884972171,130.2147194065139,UBE2C,Megakaryocyte,1.5287264597194943
GO_Biological_Process_2021,angiotensin maturation (GO:0002003),1/12,0.029598761568907,0.1039197395229512,0,0,36.99257884972171,130.2147194065139,REN,Megakaryocyte,1.5287264597194943
GO_Biological_Process_2021,regulation of angiotensin levels in blood (GO:0002002),1/12,0.029598761568907,0.1039197395229512,0,0,36.99257884972171,130.2147194065139,REN,Megakaryocyte,1.5287264597194943
GO_Biological_Process_2021,glomerular visceral epithelial cell differentiation (GO:0072112),1/12,0.029598761568907,0.1039197395229512,0,0,36.99257884972171,130.2147194065139,WT1,Megakaryocyte,1.5287264597194943
GO_Biological_Process_2021,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),1/12,0.029598761568907,0.1039197395229512,0,0,36.99257884972171,130.2147194065139,CENPE,Megakaryocyte,1.5287264597194943
GO_Biological_Process_2021,negative regulation of heart contraction (GO:0045822),1/12,0.029598761568907,0.1039197395229512,0,0,36.99257884972171,130.2147194065139,SPX,Megakaryocyte,1.5287264597194943
GO_Biological_Process_2021,megakaryocyte differentiation (GO:0030219),1/12,0.029598761568907,0.1039197395229512,0,0,36.99257884972171,130.2147194065139,MPIG6B,Megakaryocyte,1.5287264597194943
GO_Biological_Process_2021,regulation of MHC class II biosynthetic process (GO:0045346),1/12,0.029598761568907,0.1039197395229512,0,0,36.99257884972171,130.2147194065139,PF4,Megakaryocyte,1.5287264597194943
GO_Biological_Process_2021,mitotic nuclear membrane disassembly (GO:0007077),1/12,0.029598761568907,0.1039197395229512,0,0,36.99257884972171,130.2147194065139,PLK1,Megakaryocyte,1.5287264597194943
GO_Biological_Process_2021,regulation of receptor signaling pathway via STAT (GO:1904892),1/13,0.032026213248763,0.1100329183761072,0,0,33.90816326530612,116.6847899929619,EGF,Megakaryocyte,1.4944944088974865
GO_Biological_Process_2021,negative regulation of macromolecule biosynthetic process (GO:0010558),1/13,0.032026213248763,0.1100329183761072,0,0,33.90816326530612,116.6847899929619,PF4,Megakaryocyte,1.4944944088974865
GO_Biological_Process_2021,lipid oxidation (GO:0034440),1/13,0.032026213248763,0.1100329183761072,0,0,33.90816326530612,116.6847899929619,ALOX12,Megakaryocyte,1.4944944088974865
GO_Biological_Process_2021,regulation of sensory perception of pain (GO:0051930),1/14,0.0344477141698711,0.1142713828669519,0,0,31.298273155416013,105.4223689491126,SPX,Megakaryocyte,1.4628395910668823
GO_Biological_Process_2021,genitalia development (GO:0048806),1/14,0.0344477141698711,0.1142713828669519,0,0,31.298273155416013,105.4223689491126,WT1,Megakaryocyte,1.4628395910668823
GO_Biological_Process_2021,intestinal absorption (GO:0050892),1/14,0.0344477141698711,0.1142713828669519,0,0,31.298273155416013,105.4223689491126,ADRA2A,Megakaryocyte,1.4628395910668823
GO_Biological_Process_2021,nuclear membrane disassembly (GO:0051081),1/14,0.0344477141698711,0.1142713828669519,0,0,31.298273155416013,105.4223689491126,PLK1,Megakaryocyte,1.4628395910668823
GO_Biological_Process_2021,defense response to protozoan (GO:0042832),1/14,0.0344477141698711,0.1142713828669519,0,0,31.298273155416013,105.4223689491126,PF4,Megakaryocyte,1.4628395910668823
GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),2/118,0.0351769550093681,0.1158904379315336,0,0,7.124281609195402,23.8475644827565,ADRA2A;PF4,Megakaryocyte,1.4537417566881954
GO_Biological_Process_2021,regulation of secretion (GO:0051046),1/15,0.0368632785936063,0.1158904379315336,0,0,29.06122448979592,95.91771596133704,EGF,Megakaryocyte,1.4334060415588732
GO_Biological_Process_2021,fibrinolysis (GO:0042730),1/15,0.0368632785936063,0.1158904379315336,0,0,29.06122448979592,95.91771596133704,GP1BA,Megakaryocyte,1.4334060415588732
GO_Biological_Process_2021,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/15,0.0368632785936063,0.1158904379315336,0,0,29.06122448979592,95.91771596133704,ADRA2A,Megakaryocyte,1.4334060415588732
GO_Biological_Process_2021,lipoxygenase pathway (GO:0019372),1/15,0.0368632785936063,0.1158904379315336,0,0,29.06122448979592,95.91771596133704,ALOX12,Megakaryocyte,1.4334060415588732
GO_Biological_Process_2021,superoxide anion generation (GO:0042554),1/15,0.0368632785936063,0.1158904379315336,0,0,29.06122448979592,95.91771596133704,ALOX12,Megakaryocyte,1.4334060415588732
GO_Biological_Process_2021,regulation of macrophage differentiation (GO:0045649),1/15,0.0368632785936063,0.1158904379315336,0,0,29.06122448979592,95.91771596133704,PF4,Megakaryocyte,1.4334060415588732
GO_Biological_Process_2021,prostanoid biosynthetic process (GO:0046457),1/15,0.0368632785936063,0.1158904379315336,0,0,29.06122448979592,95.91771596133704,PTGS1,Megakaryocyte,1.4334060415588732
GO_Biological_Process_2021,regulation of systemic arterial blood pressure (GO:0003073),1/16,0.0392729207344652,0.1188067602092942,0,0,27.122448979591837,87.80133530116419,SPX,Megakaryocyte,1.405906798966597
GO_Biological_Process_2021,resolution of meiotic recombination intermediates (GO:0000712),1/16,0.0392729207344652,0.1188067602092942,0,0,27.122448979591837,87.80133530116419,TOP2A,Megakaryocyte,1.405906798966597
GO_Biological_Process_2021,negative regulation of platelet activation (GO:0010544),1/16,0.0392729207344652,0.1188067602092942,0,0,27.122448979591837,87.80133530116419,ALOX12,Megakaryocyte,1.405906798966597
GO_Biological_Process_2021,regulation of ERBB signaling pathway (GO:1901184),1/16,0.0392729207344652,0.1188067602092942,0,0,27.122448979591837,87.80133530116419,EGF,Megakaryocyte,1.405906798966597
GO_Biological_Process_2021,killing by host of symbiont cells (GO:0051873),1/16,0.0392729207344652,0.1188067602092942,0,0,27.122448979591837,87.80133530116419,PF4,Megakaryocyte,1.405906798966597
GO_Biological_Process_2021,polyol biosynthetic process (GO:0046173),1/16,0.0392729207344652,0.1188067602092942,0,0,27.122448979591837,87.80133530116419,ITPKA,Megakaryocyte,1.405906798966597
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),5/764,0.0413571138631448,0.1211418974979667,0,0,2.8093983311374617,8.949368815489745,SAPCD2;EGF;WT1;ADRA2A;PF4,Megakaryocyte,1.3834497764190727
GO_Biological_Process_2021,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/17,0.0416766547912334,0.1211418974979667,0,0,25.426020408163264,80.79916728086499,ADRA2A,Megakaryocyte,1.3801071472903907
GO_Biological_Process_2021,positive regulation of DNA replication (GO:0045740),1/17,0.0416766547912334,0.1211418974979667,0,0,25.426020408163264,80.79916728086499,EGF,Megakaryocyte,1.3801071472903907
GO_Biological_Process_2021,negative regulation of insulin secretion (GO:0046676),1/17,0.0416766547912334,0.1211418974979667,0,0,25.426020408163264,80.79916728086499,ADRA2A,Megakaryocyte,1.3801071472903907
GO_Biological_Process_2021,mesonephric tubule development (GO:0072164),1/17,0.0416766547912334,0.1211418974979667,0,0,25.426020408163264,80.79916728086499,WT1,Megakaryocyte,1.3801071472903907
GO_Biological_Process_2021,midbody abscission (GO:0061952),1/17,0.0416766547912334,0.1211418974979667,0,0,25.426020408163264,80.79916728086499,KIF20A,Megakaryocyte,1.3801071472903907
GO_Biological_Process_2021,regulation of cell motility (GO:2000145),2/133,0.043691853040543,0.1211418974979667,0,0,6.303753180661578,19.734489511742076,EGF;TMSB15A,Megakaryocyte,1.3595995357844428
GO_Biological_Process_2021,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),1/18,0.0440744949316926,0.1211418974979667,0,0,23.92917166866747,74.70385911458476,TOP2A,Megakaryocyte,1.3558126557645607
GO_Biological_Process_2021,negative regulation of lipid catabolic process (GO:0050995),1/18,0.0440744949316926,0.1211418974979667,0,0,23.92917166866747,74.70385911458476,ADRA2A,Megakaryocyte,1.3558126557645607
GO_Biological_Process_2021,hyaluronan catabolic process (GO:0030214),1/18,0.0440744949316926,0.1211418974979667,0,0,23.92917166866747,74.70385911458476,HMMR,Megakaryocyte,1.3558126557645607
GO_Biological_Process_2021,negative regulation of peptide hormone secretion (GO:0090278),1/18,0.0440744949316926,0.1211418974979667,0,0,23.92917166866747,74.70385911458476,ADRA2A,Megakaryocyte,1.3558126557645607
GO_Biological_Process_2021,positive regulation of macrophage derived foam cell differentiation (GO:0010744),1/18,0.0440744949316926,0.1211418974979667,0,0,23.92917166866747,74.70385911458476,PF4,Megakaryocyte,1.3558126557645607
GO_Biological_Process_2021,DNA conformation change (GO:0071103),1/18,0.0440744949316926,0.1211418974979667,0,0,23.92917166866747,74.70385911458476,TOP2A,Megakaryocyte,1.3558126557645607
GO_Biological_Process_2021,prostanoid metabolic process (GO:0006692),1/18,0.0440744949316926,0.1211418974979667,0,0,23.92917166866747,74.70385911458476,PTGS1,Megakaryocyte,1.3558126557645607
GO_Biological_Process_2021,regulation of platelet aggregation (GO:0090330),1/18,0.0440744949316926,0.1211418974979667,0,0,23.92917166866747,74.70385911458476,ALOX12,Megakaryocyte,1.3558126557645607
GO_Biological_Process_2021,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/18,0.0440744949316926,0.1211418974979667,0,0,23.92917166866747,74.70385911458476,MYCN,Megakaryocyte,1.3558126557645607
GO_Biological_Process_2021,negative regulation of calcium ion transport (GO:0051926),1/19,0.0464664552952436,0.1214693749837619,0,0,22.598639455782312,69.35578082800635,ADRA2A,Megakaryocyte,1.3328604565168853
GO_Biological_Process_2021,establishment of skin barrier (GO:0061436),1/19,0.0464664552952436,0.1214693749837619,0,0,22.598639455782312,69.35578082800635,ALOX12,Megakaryocyte,1.3328604565168853
GO_Biological_Process_2021,regulation of water loss via skin (GO:0033561),1/19,0.0464664552952436,0.1214693749837619,0,0,22.598639455782312,69.35578082800635,ALOX12,Megakaryocyte,1.3328604565168853
GO_Biological_Process_2021,branching involved in ureteric bud morphogenesis (GO:0001658),1/19,0.0464664552952436,0.1214693749837619,0,0,22.598639455782312,69.35578082800635,WT1,Megakaryocyte,1.3328604565168853
GO_Biological_Process_2021,nuclear membrane organization (GO:0071763),1/19,0.0464664552952436,0.1214693749837619,0,0,22.598639455782312,69.35578082800635,PLK1,Megakaryocyte,1.3328604565168853
GO_Biological_Process_2021,regulation of mitotic spindle assembly (GO:1901673),1/19,0.0464664552952436,0.1214693749837619,0,0,22.598639455782312,69.35578082800635,PLK1,Megakaryocyte,1.3328604565168853
GO_Biological_Process_2021,ureteric bud development (GO:0001657),1/19,0.0464664552952436,0.1214693749837619,0,0,22.598639455782312,69.35578082800635,WT1,Megakaryocyte,1.3328604565168853
GO_Biological_Process_2021,ureteric bud morphogenesis (GO:0060675),1/19,0.0464664552952436,0.1214693749837619,0,0,22.598639455782312,69.35578082800635,WT1,Megakaryocyte,1.3328604565168853
GO_Biological_Process_2021,prostaglandin biosynthetic process (GO:0001516),1/19,0.0464664552952436,0.1214693749837619,0,0,22.598639455782312,69.35578082800635,PTGS1,Megakaryocyte,1.3328604565168853
GO_Biological_Process_2021,adrenergic receptor signaling pathway (GO:0071875),1/20,0.0488525499820277,0.123674087059765,0,0,21.40816326530612,64.63014669364038,ADRA2A,Megakaryocyte,1.3111127622579986
GO_Biological_Process_2021,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/20,0.0488525499820277,0.123674087059765,0,0,21.40816326530612,64.63014669364038,PLK1,Megakaryocyte,1.3111127622579986
GO_Biological_Process_2021,positive regulation of nitrogen compound metabolic process (GO:0051173),1/20,0.0488525499820277,0.123674087059765,0,0,21.40816326530612,64.63014669364038,EGF,Megakaryocyte,1.3111127622579986
GO_Biological_Process_2021,mitotic cytokinetic process (GO:1902410),1/20,0.0488525499820277,0.123674087059765,0,0,21.40816326530612,64.63014669364038,KIF20A,Megakaryocyte,1.3111127622579986
GO_Biological_Process_2021,myeloid cell development (GO:0061515),1/20,0.0488525499820277,0.123674087059765,0,0,21.40816326530612,64.63014669364038,MPIG6B,Megakaryocyte,1.3111127622579986
GO_Biological_Process_2021,regulation of protein localization to cell periphery (GO:1904375),1/20,0.0488525499820277,0.123674087059765,0,0,21.40816326530612,64.63014669364038,PLK1,Megakaryocyte,1.3111127622579986
GO_Biological_Process_2021,negative regulation of cell communication (GO:0010648),1/21,0.0512327930672156,0.1257294564557688,0,0,20.336734693877553,60.42807445408675,MPIG6B,Megakaryocyte,1.2904519669693806
GO_Biological_Process_2021,negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,0.0512327930672156,0.1257294564557688,0,0,20.336734693877553,60.42807445408675,ADRA2A,Megakaryocyte,1.2904519669693806
GO_Biological_Process_2021,negative regulation of protein localization to cell periphery (GO:1904376),1/21,0.0512327930672156,0.1257294564557688,0,0,20.336734693877553,60.42807445408675,SAPCD2,Megakaryocyte,1.2904519669693806
GO_Biological_Process_2021,linoleic acid metabolic process (GO:0043651),1/21,0.0512327930672156,0.1257294564557688,0,0,20.336734693877553,60.42807445408675,ALOX12,Megakaryocyte,1.2904519669693806
GO_Biological_Process_2021,regulation of lipid catabolic process (GO:0050994),1/21,0.0512327930672156,0.1257294564557688,0,0,20.336734693877553,60.42807445408675,ADRA2A,Megakaryocyte,1.2904519669693806
GO_Biological_Process_2021,protein localization to chromatin (GO:0071168),1/21,0.0512327930672156,0.1257294564557688,0,0,20.336734693877553,60.42807445408675,PLK1,Megakaryocyte,1.2904519669693806
GO_Biological_Process_2021,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/22,0.0536071985992547,0.1295731785238268,0,0,19.367346938775512,56.67024999786951,PLK1,Megakaryocyte,1.2707768875084013
GO_Biological_Process_2021,negative regulation of myeloid cell differentiation (GO:0045638),1/22,0.0536071985992547,0.1295731785238268,0,0,19.367346938775512,56.67024999786951,PF4,Megakaryocyte,1.2707768875084013
GO_Biological_Process_2021,regulation of membrane protein ectodomain proteolysis (GO:0051043),1/22,0.0536071985992547,0.1295731785238268,0,0,19.367346938775512,56.67024999786951,ADRA2A,Megakaryocyte,1.2707768875084013
GO_Biological_Process_2021,ERK1 and ERK2 cascade (GO:0070371),1/23,0.0559757805878795,0.1313382949403417,0,0,18.4860853432282,53.29235549319145,EGF,Megakaryocyte,1.2519998414265567
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.0559757805878795,0.1313382949403417,0,0,18.4860853432282,53.29235549319145,PF4,Megakaryocyte,1.2519998414265567
GO_Biological_Process_2021,hyaluronan metabolic process (GO:0030212),1/23,0.0559757805878795,0.1313382949403417,0,0,18.4860853432282,53.29235549319145,HMMR,Megakaryocyte,1.2519998414265567
GO_Biological_Process_2021,positive regulation of morphogenesis of an epithelium (GO:1905332),1/23,0.0559757805878795,0.1313382949403417,0,0,18.4860853432282,53.29235549319145,EGF,Megakaryocyte,1.2519998414265567
GO_Biological_Process_2021,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.0559757805878795,0.1313382949403417,0,0,18.4860853432282,53.29235549319145,PF4,Megakaryocyte,1.2519998414265567
GO_Biological_Process_2021,positive regulation of receptor internalization (GO:0002092),1/23,0.0559757805878795,0.1313382949403417,0,0,18.4860853432282,53.29235549319145,EGF,Megakaryocyte,1.2519998414265567
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),2/154,0.0567455048100272,0.1323624716946122,0,0,5.427083333333333,15.571272642043729,CENPE;ADRA2A,Megakaryocyte,1.2460685361352464
GO_Biological_Process_2021,positive regulation of carbohydrate metabolic process (GO:0045913),1/24,0.0583385530130099,0.1323624716946122,0,0,17.68145519077196,50.24171555062859,EGF,Megakaryocyte,1.2340443470047993
GO_Biological_Process_2021,apoptotic nuclear changes (GO:0030262),1/24,0.0583385530130099,0.1323624716946122,0,0,17.68145519077196,50.24171555062859,TOP2A,Megakaryocyte,1.2340443470047993
GO_Biological_Process_2021,negative regulation of lipid metabolic process (GO:0045833),1/24,0.0583385530130099,0.1323624716946122,0,0,17.68145519077196,50.24171555062859,ADRA2A,Megakaryocyte,1.2340443470047993
GO_Biological_Process_2021,cardiac muscle cell differentiation (GO:0055007),1/24,0.0583385530130099,0.1323624716946122,0,0,17.68145519077196,50.24171555062859,WT1,Megakaryocyte,1.2340443470047993
GO_Biological_Process_2021,leukotriene metabolic process (GO:0006691),1/24,0.0583385530130099,0.1323624716946122,0,0,17.68145519077196,50.24171555062859,ALOX12,Megakaryocyte,1.2340443470047993
GO_Biological_Process_2021,endocrine system development (GO:0035270),1/24,0.0583385530130099,0.1323624716946122,0,0,17.68145519077196,50.24171555062859,WT1,Megakaryocyte,1.2340443470047993
GO_Biological_Process_2021,regulation of spindle assembly (GO:0090169),1/25,0.0606955298241754,0.1345370960618818,0,0,16.943877551020407,47.47480020477031,PLK1,Megakaryocyte,1.2168432931781568
GO_Biological_Process_2021,regulation of calcium ion import (GO:0090279),1/25,0.0606955298241754,0.1345370960618818,0,0,16.943877551020407,47.47480020477031,EGF,Megakaryocyte,1.2168432931781568
GO_Biological_Process_2021,negative regulation of ion transport (GO:0043271),1/25,0.0606955298241754,0.1345370960618818,0,0,16.943877551020407,47.47480020477031,ADRA2A,Megakaryocyte,1.2168432931781568
GO_Biological_Process_2021,negative regulation of signaling (GO:0023057),1/25,0.0606955298241754,0.1345370960618818,0,0,16.943877551020407,47.47480020477031,MPIG6B,Megakaryocyte,1.2168432931781568
GO_Biological_Process_2021,negative regulation of actin filament polymerization (GO:0030837),1/25,0.0606955298241754,0.1345370960618818,0,0,16.943877551020407,47.47480020477031,TMSB15A,Megakaryocyte,1.2168432931781568
GO_Biological_Process_2021,metanephros development (GO:0001656),1/26,0.0630467249540435,0.1391076821233713,0,0,16.26530612244898,44.95534064809558,WT1,Megakaryocyte,1.2003374685092782
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),2/165,0.0640621553999463,0.1400474708661042,0,0,5.058026584867076,13.898958782878776,ADRA2A;PF4,Megakaryocyte,1.1933984533937798
GO_Biological_Process_2021,regulation of blood coagulation (GO:0030193),1/27,0.0653921522588676,0.1400474708661042,0,0,15.638932496075354,42.652889831563165,GP1BA,Megakaryocyte,1.184474368421492
GO_Biological_Process_2021,positive regulation of gene silencing by miRNA (GO:2000637),1/27,0.0653921522588676,0.1400474708661042,0,0,15.638932496075354,42.652889831563165,MYCN,Megakaryocyte,1.184474368421492
GO_Biological_Process_2021,camera-type eye development (GO:0043010),1/27,0.0653921522588676,0.1400474708661042,0,0,15.638932496075354,42.652889831563165,WT1,Megakaryocyte,1.184474368421492
GO_Biological_Process_2021,positive regulation of nuclear division (GO:0051785),1/27,0.0653921522588676,0.1400474708661042,0,0,15.638932496075354,42.652889831563165,EGF,Megakaryocyte,1.184474368421492
GO_Biological_Process_2021,mitotic chromosome condensation (GO:0007076),1/27,0.0653921522588676,0.1400474708661042,0,0,15.638932496075354,42.652889831563165,PLK1,Megakaryocyte,1.184474368421492
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),3/371,0.065510771195163,0.1400474708661042,0,0,3.396507863089732,9.257320432758746,CENPE;EGF;PLK1,Megakaryocyte,1.1836872880076514
GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),2/168,0.0661106611264017,0.1407045486805275,0,0,4.965863453815261,13.48939691018369,CENPE;CENPF,Megakaryocyte,1.1797284997424928
GO_Biological_Process_2021,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/28,0.0677318256109869,0.1416478613864552,0,0,15.058956916099774,40.54171043527237,ADRA2A,Megakaryocyte,1.1692072184717057
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.0677318256109869,0.1416478613864552,0,0,15.058956916099774,40.54171043527237,PF4,Megakaryocyte,1.1692072184717057
GO_Biological_Process_2021,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),1/28,0.0677318256109869,0.1416478613864552,0,0,15.058956916099774,40.54171043527237,ADRA2A,Megakaryocyte,1.1692072184717057
GO_Biological_Process_2021,positive regulation of response to wounding (GO:1903036),1/28,0.0677318256109869,0.1416478613864552,0,0,15.058956916099774,40.54171043527237,ADRA2A,Megakaryocyte,1.1692072184717057
GO_Biological_Process_2021,regulation of ubiquitin-protein transferase activity (GO:0051438),1/29,0.0700657588372089,0.1440240598320405,0,0,14.520408163265309,38.5999069065122,PLK1,Megakaryocyte,1.1544941700666143
GO_Biological_Process_2021,regulation of calcium ion transmembrane transporter activity (GO:1901019),1/29,0.0700657588372089,0.1440240598320405,0,0,14.520408163265309,38.5999069065122,ADRA2A,Megakaryocyte,1.1544941700666143
GO_Biological_Process_2021,positive regulation of viral genome replication (GO:0045070),1/29,0.0700657588372089,0.1440240598320405,0,0,14.520408163265309,38.5999069065122,TOP2A,Megakaryocyte,1.1544941700666143
GO_Biological_Process_2021,protein K11-linked ubiquitination (GO:0070979),1/29,0.0700657588372089,0.1440240598320405,0,0,14.520408163265309,38.5999069065122,UBE2C,Megakaryocyte,1.1544941700666143
GO_Biological_Process_2021,negative regulation of Notch signaling pathway (GO:0045746),1/30,0.0723939657090184,0.1466882337194444,0,0,14.019000703729768,36.80874147674154,EGF,Megakaryocyte,1.1402976322627019
GO_Biological_Process_2021,positive regulation of phosphate metabolic process (GO:0045937),1/30,0.0723939657090184,0.1466882337194444,0,0,14.019000703729768,36.80874147674154,EGF,Megakaryocyte,1.1402976322627019
GO_Biological_Process_2021,long-chain fatty acid biosynthetic process (GO:0042759),1/30,0.0723939657090184,0.1466882337194444,0,0,14.019000703729768,36.80874147674154,ALOX12,Megakaryocyte,1.1402976322627019
GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),2/178,0.073094899664538,0.1466882337194444,0,0,4.681344696969697,12.246382216533686,UBE2C;PLK1,Megakaryocyte,1.1361129257073213
GO_Biological_Process_2021,regulation of immune response (GO:0050776),2/179,0.0738061123878065,0.1466882337194444,0,0,4.654661016949152,12.131506903576025,TREML1;FCER1A,Megakaryocyte,1.1319076697979504
GO_Biological_Process_2021,activation of protein kinase B activity (GO:0032148),1/31,0.0747164600026276,0.1466882337194444,0,0,13.551020408163266,35.15209038871121,ADRA2A,Megakaryocyte,1.126583712764908
GO_Biological_Process_2021,regulation of calcium ion-dependent exocytosis (GO:0017158),1/31,0.0747164600026276,0.1466882337194444,0,0,13.551020408163266,35.15209038871121,ADRA2A,Megakaryocyte,1.126583712764908
GO_Biological_Process_2021,cellular response to cAMP (GO:0071320),1/31,0.0747164600026276,0.1466882337194444,0,0,13.551020408163266,35.15209038871121,WT1,Megakaryocyte,1.126583712764908
GO_Biological_Process_2021,regulation of macrophage derived foam cell differentiation (GO:0010743),1/31,0.0747164600026276,0.1466882337194444,0,0,13.551020408163266,35.15209038871121,PF4,Megakaryocyte,1.126583712764908
GO_Biological_Process_2021,prostaglandin metabolic process (GO:0006693),1/31,0.0747164600026276,0.1466882337194444,0,0,13.551020408163266,35.15209038871121,PTGS1,Megakaryocyte,1.126583712764908
GO_Biological_Process_2021,regulation of potassium ion transport (GO:0043266),1/31,0.0747164600026276,0.1466882337194444,0,0,13.551020408163266,35.15209038871121,ADRA2A,Megakaryocyte,1.126583712764908
GO_Biological_Process_2021,ERBB2 signaling pathway (GO:0038128),1/32,0.0770332554327668,0.1488072123018508,0,0,13.113232389730086,33.61600807740255,EGF,Megakaryocyte,1.1133217484244988
GO_Biological_Process_2021,skeletal muscle organ development (GO:0060538),1/32,0.0770332554327668,0.1488072123018508,0,0,13.113232389730086,33.61600807740255,WT1,Megakaryocyte,1.1133217484244988
GO_Biological_Process_2021,long-chain fatty acid transport (GO:0015909),1/32,0.0770332554327668,0.1488072123018508,0,0,13.113232389730086,33.61600807740255,SPX,Megakaryocyte,1.1133217484244988
GO_Biological_Process_2021,superoxide metabolic process (GO:0006801),1/32,0.0770332554327668,0.1488072123018508,0,0,13.113232389730086,33.61600807740255,ALOX12,Megakaryocyte,1.1133217484244988
GO_Biological_Process_2021,vasculogenesis (GO:0001570),1/33,0.0793443657059371,0.1514469837482371,0,0,12.70280612244898,32.18837516559274,WT1,Megakaryocyte,1.1004839073426347
GO_Biological_Process_2021,mitotic G2 DNA damage checkpoint signaling (GO:0007095),1/33,0.0793443657059371,0.1514469837482371,0,0,12.70280612244898,32.18837516559274,PLK1,Megakaryocyte,1.1004839073426347
GO_Biological_Process_2021,regulation of protein localization to cell surface (GO:2000008),1/33,0.0793443657059371,0.1514469837482371,0,0,12.70280612244898,32.18837516559274,EGF,Megakaryocyte,1.1004839073426347
GO_Biological_Process_2021,positive regulation of DNA binding (GO:0043388),1/34,0.0816498044624026,0.153231916857131,0,0,12.317254174397032,30.85861216573232,EGF,Megakaryocyte,1.0880448509885652
GO_Biological_Process_2021,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.0816498044624026,0.153231916857131,0,0,12.317254174397032,30.85861216573232,WT1,Megakaryocyte,1.0880448509885652
GO_Biological_Process_2021,protein destabilization (GO:0031648),1/34,0.0816498044624026,0.153231916857131,0,0,12.317254174397032,30.85861216573232,PLK1,Megakaryocyte,1.0880448509885652
GO_Biological_Process_2021,protein localization to chromosome (GO:0034502),1/34,0.0816498044624026,0.153231916857131,0,0,12.317254174397032,30.85861216573232,PLK1,Megakaryocyte,1.0880448509885652
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),3/408,0.0818723547448704,0.153231916857131,0,0,3.0803782505910164,7.708935801164887,EGF;TMSB15A;ADRA2A,Megakaryocyte,1.086862718612554
GO_Biological_Process_2021,respiratory system development (GO:0060541),1/35,0.0839495853612937,0.1559063728138313,0,0,11.95438175270108,29.61744503578088,WT1,Megakaryocyte,1.0759814445616303
GO_Biological_Process_2021,regulation of mitotic spindle organization (GO:0060236),1/35,0.0839495853612937,0.1559063728138313,0,0,11.95438175270108,29.61744503578088,PLK1,Megakaryocyte,1.0759814445616303
GO_Biological_Process_2021,regulation of receptor internalization (GO:0002090),1/36,0.0862437219743075,0.157730913572783,0,0,11.612244897959185,28.456712045041098,EGF,Megakaryocyte,1.0642725091375862
GO_Biological_Process_2021,positive regulation of mitotic nuclear division (GO:0045840),1/36,0.0862437219743075,0.157730913572783,0,0,11.612244897959185,28.456712045041098,EGF,Megakaryocyte,1.0642725091375862
GO_Biological_Process_2021,positive regulation of myeloid leukocyte differentiation (GO:0002763),1/36,0.0862437219743075,0.157730913572783,0,0,11.612244897959185,28.456712045041098,PF4,Megakaryocyte,1.0642725091375862
GO_Biological_Process_2021,platelet aggregation (GO:0070527),1/36,0.0862437219743075,0.157730913572783,0,0,11.612244897959185,28.456712045041098,GP1BA,Megakaryocyte,1.0642725091375862
GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),2/201,0.0899990393946084,0.1639755225333586,0,0,4.135469011725293,9.958028586222367,UBE2C;PLK1,Megakaryocyte,1.0457621259812002
GO_Biological_Process_2021,response to cAMP (GO:0051591),1/38,0.0908151166313484,0.1642183124048068,0,0,10.983452840595698,26.34852930034076,WT1,Megakaryocyte,1.0418418549683985
GO_Biological_Process_2021,positive regulation of potassium ion transport (GO:0043268),1/38,0.0908151166313484,0.1642183124048068,0,0,10.983452840595698,26.34852930034076,ADRA2A,Megakaryocyte,1.0418418549683985
GO_Biological_Process_2021,negative regulation of protein secretion (GO:0050709),1/39,0.0930924017046572,0.1664589041633462,0,0,10.693877551020408,25.38900533231373,ADRA2A,Megakaryocyte,1.0310857651239858
GO_Biological_Process_2021,regulation of exit from mitosis (GO:0007096),1/39,0.0930924017046572,0.1664589041633462,0,0,10.693877551020408,25.38900533231373,UBE2C,Megakaryocyte,1.0310857651239858
GO_Biological_Process_2021,organophosphate biosynthetic process (GO:0090407),1/39,0.0930924017046572,0.1664589041633462,0,0,10.693877551020408,25.38900533231373,ITPKA,Megakaryocyte,1.0310857651239858
GO_Biological_Process_2021,negative regulation of blood coagulation (GO:0030195),1/40,0.0953640965755271,0.1680224558711669,0,0,10.419152276295131,24.485561288951835,GP1BA,Megakaryocyte,1.0206151011238414
GO_Biological_Process_2021,fatty acid derivative biosynthetic process (GO:1901570),1/40,0.0953640965755271,0.1680224558711669,0,0,10.419152276295131,24.485561288951835,ALOX12,Megakaryocyte,1.0206151011238414
GO_Biological_Process_2021,negative regulation of ERBB signaling pathway (GO:1901185),1/40,0.0953640965755271,0.1680224558711669,0,0,10.419152276295131,24.485561288951835,EGF,Megakaryocyte,1.0206151011238414
GO_Biological_Process_2021,positive regulation of wound healing (GO:0090303),1/40,0.0953640965755271,0.1680224558711669,0,0,10.419152276295131,24.485561288951835,ADRA2A,Megakaryocyte,1.0206151011238414
GO_Biological_Process_2021,mitotic cell cycle phase transition (GO:0044772),2/209,0.0961284696354655,0.1687510726082443,0,0,3.9740338164251208,9.30746441383207,UBE2C;PLK1,Megakaryocyte,1.0171479715978702
GO_Biological_Process_2021,phosphatidylinositol phosphate biosynthetic process (GO:0046854),1/42,0.0998907694703361,0.1747180367826606,0,0,9.909905425584869,22.829231064333683,ITPKA,Megakaryocyte,1.00047464143678
GO_Biological_Process_2021,lipid modification (GO:0030258),1/43,0.1021457742794159,0.1767342353539534,0,0,9.673469387755102,22.068611238785657,ALOX12,Megakaryocyte,0.9907795952096249
GO_Biological_Process_2021,male gonad development (GO:0008584),1/43,0.1021457742794159,0.1767342353539534,0,0,9.673469387755102,22.068611238785657,WT1,Megakaryocyte,0.9907795952096249
GO_Biological_Process_2021,development of primary male sexual characteristics (GO:0046546),1/43,0.1021457742794159,0.1767342353539534,0,0,9.673469387755102,22.068611238785657,WT1,Megakaryocyte,0.9907795952096249
GO_Biological_Process_2021,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/44,0.1043952424647777,0.1780642256225464,0,0,9.448030374940672,21.34849709415977,EGF,Megakaryocyte,0.9813192926974915
GO_Biological_Process_2021,branching morphogenesis of an epithelial tube (GO:0048754),1/44,0.1043952424647777,0.1780642256225464,0,0,9.448030374940672,21.34849709415977,WT1,Megakaryocyte,0.9813192926974915
GO_Biological_Process_2021,homotypic cell-cell adhesion (GO:0034109),1/44,0.1043952424647777,0.1780642256225464,0,0,9.448030374940672,21.34849709415977,GP1BA,Megakaryocyte,0.9813192926974915
GO_Biological_Process_2021,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.1043952424647777,0.1780642256225464,0,0,9.448030374940672,21.34849709415977,EGF,Megakaryocyte,0.9813192926974915
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),2/221,0.1055403360927836,0.1787228192221657,0,0,3.7539954337899544,8.441467129790793,EGF;ADRA2A,Megakaryocyte,0.97658152714763
GO_Biological_Process_2021,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),1/45,0.1066391873529346,0.1787228192221657,0,0,9.232838589981448,20.665901611884028,EGF,Megakaryocyte,0.9720831731354668
GO_Biological_Process_2021,positive regulation of RNA metabolic process (GO:0051254),1/45,0.1066391873529346,0.1787228192221657,0,0,9.232838589981448,20.665901611884028,MYCN,Megakaryocyte,0.9720831731354668
GO_Biological_Process_2021,mitotic G2/M transition checkpoint (GO:0044818),1/45,0.1066391873529346,0.1787228192221657,0,0,9.232838589981448,20.665901611884028,PLK1,Megakaryocyte,0.9720831731354668
GO_Biological_Process_2021,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.1066391873529346,0.1787228192221657,0,0,9.232838589981448,20.665901611884028,WT1,Megakaryocyte,0.9720831731354668
GO_Biological_Process_2021,erythrocyte differentiation (GO:0030218),1/46,0.1088776222085674,0.1812115442294842,0,0,9.02721088435374,20.01811780873028,MPIG6B,Megakaryocyte,0.9630613723103648
GO_Biological_Process_2021,regulation of cellular protein localization (GO:1903827),1/46,0.1088776222085674,0.1812115442294842,0,0,9.02721088435374,20.01811780873028,EGF,Megakaryocyte,0.9630613723103648
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),3/464,0.1096249049131507,0.1817829234899941,0,0,2.69843540868602,5.965406050856904,CENPF;WT1;DEPDC1,Megakaryocyte,0.9600907703256691
GO_Biological_Process_2021,epidermal growth factor receptor signaling pathway (GO:0007173),1/47,0.1111105603036554,0.1817829234899941,0,0,8.830523513753327,19.4026870705364,EGF,Megakaryocyte,0.9542446623584087
GO_Biological_Process_2021,regulation of DNA binding (GO:0051101),1/47,0.1111105603036554,0.1817829234899941,0,0,8.830523513753327,19.4026870705364,EGF,Megakaryocyte,0.9542446623584087
GO_Biological_Process_2021,polyol metabolic process (GO:0019751),1/47,0.1111105603036554,0.1817829234899941,0,0,8.830523513753327,19.4026870705364,ITPKA,Megakaryocyte,0.9542446623584087
GO_Biological_Process_2021,regulation of protein localization to nucleus (GO:1900180),1/47,0.1111105603036554,0.1817829234899941,0,0,8.830523513753327,19.4026870705364,PLK1,Megakaryocyte,0.9542446623584087
GO_Biological_Process_2021,inositol phosphate metabolic process (GO:0043647),1/48,0.1133380148369131,0.184798593683238,0,0,8.642205818497612,18.81737166641443,ITPKA,Megakaryocyte,0.9456243984787533
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),3/474,0.1149270413547105,0.1867564422014046,0,0,2.6397885892397346,5.711071147622478,SAPCD2;EGF;ADRA2A,Megakaryocyte,0.9395777734927033
GO_Biological_Process_2021,negative regulation of catabolic process (GO:0009895),1/49,0.1155599990222406,0.187152725689218,0,0,8.46173469387755,18.260130793597916,ADRA2A,Megakaryocyte,0.9371924705024297
GO_Biological_Process_2021,regulation of cellular component movement (GO:0051270),1/50,0.1177765260040411,0.1888350300264792,0,0,8.28862973760933,17.7290996615035,EGF,Megakaryocyte,0.928941259997044
GO_Biological_Process_2021,positive regulation of ion transport (GO:0043270),1/50,0.1177765260040411,0.1888350300264792,0,0,8.28862973760933,17.7290996615035,ADRA2A,Megakaryocyte,0.928941259997044
GO_Biological_Process_2021,organic hydroxy compound biosynthetic process (GO:1901617),1/50,0.1177765260040411,0.1888350300264792,0,0,8.28862973760933,17.7290996615035,ALOX12,Megakaryocyte,0.928941259997044
GO_Biological_Process_2021,gonad development (GO:0008406),1/51,0.1199876089220907,0.1904753791799526,0,0,8.122448979591837,17.22257115519733,WT1,Megakaryocyte,0.9208636010741894
GO_Biological_Process_2021,negative regulation of transport (GO:0051051),1/51,0.1199876089220907,0.1904753791799526,0,0,8.122448979591837,17.22257115519733,EGF,Megakaryocyte,0.9208636010741894
GO_Biological_Process_2021,mitotic metaphase plate congression (GO:0007080),1/51,0.1199876089220907,0.1904753791799526,0,0,8.122448979591837,17.22257115519733,CENPE,Megakaryocyte,0.9208636010741894
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),3/485,0.1208716599427582,0.1912475935278511,0,0,2.578087754921868,5.447566347932984,WT1;PLK1;ALOX12,Megakaryocyte,0.9176755136408634
GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),1/52,0.1221932608707862,0.1926796297808769,0,0,7.962785114045619,16.738979733033663,MPIG6B,Megakaryocyte,0.9129527453809976
GO_Biological_Process_2021,membrane organization (GO:0061024),2/242,0.122577893374113,0.1926796297808769,0,0,3.421875,7.182545007938849,EGF;KIF20A,Megakaryocyte,0.9115878467125743
GO_Biological_Process_2021,regulation of DNA replication (GO:0006275),1/53,0.1243934949128716,0.1948966483814048,0,0,7.809262166405024,16.276887238960814,EGF,Megakaryocyte,0.9052023302345248
GO_Biological_Process_2021,regulation of proteolysis (GO:0030162),1/54,0.1265883240687765,0.1976915060944204,0,0,7.661532537543319,15.834970375184442,PLK1,Megakaryocyte,0.8976063498190403
GO_Biological_Process_2021,glycosaminoglycan catabolic process (GO:0006027),1/56,0.1309618198144747,0.2018994722139818,0,0,7.382189239332097,15.00687933540933,HMMR,Megakaryocyte,0.8828552987007785
GO_Biological_Process_2021,blood vessel morphogenesis (GO:0048514),1/56,0.1309618198144747,0.2018994722139818,0,0,7.382189239332097,15.00687933540933,WT1,Megakaryocyte,0.8828552987007785
GO_Biological_Process_2021,Rho protein signal transduction (GO:0007266),1/56,0.1309618198144747,0.2018994722139818,0,0,7.382189239332097,15.00687933540933,ADRA2A,Megakaryocyte,0.8828552987007785
GO_Biological_Process_2021,chemokine-mediated signaling pathway (GO:0070098),1/56,0.1309618198144747,0.2018994722139818,0,0,7.382189239332097,15.00687933540933,PF4,Megakaryocyte,0.8828552987007785
GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),1/57,0.1331405122852093,0.2039509121311646,0,0,7.25,14.618539131965724,EGF,Megakaryocyte,0.8756897763447542
GO_Biological_Process_2021,protein K48-linked ubiquitination (GO:0070936),1/57,0.1331405122852093,0.2039509121311646,0,0,7.25,14.618539131965724,UBE2C,Megakaryocyte,0.8756897763447542
GO_Biological_Process_2021,eye development (GO:0001654),1/58,0.1353138517398134,0.2053987184396538,0,0,7.122448979591836,14.246025949065045,WT1,Megakaryocyte,0.8686577434892403
GO_Biological_Process_2021,positive regulation of mitotic cell cycle phase transition (GO:1901992),1/58,0.1353138517398134,0.2053987184396538,0,0,7.122448979591836,14.246025949065045,UBE2C,Megakaryocyte,0.8686577434892403
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.1353667229633477,0.2053987184396538,0,0,2.442871502764282,4.885175568190959,MYCN;EGF;WT1,Megakaryocyte,0.8684880846140173
GO_Biological_Process_2021,protein polymerization (GO:0051258),1/59,0.1374818510452552,0.2066524073523992,0,0,6.9992962702322306,13.8884471557023,UBE2C,Megakaryocyte,0.8617546291873563
GO_Biological_Process_2021,fatty acid oxidation (GO:0019395),1/59,0.1374818510452552,0.2066524073523992,0,0,6.9992962702322306,13.8884471557023,ALOX12,Megakaryocyte,0.8617546291873563
GO_Biological_Process_2021,mitotic DNA damage checkpoint signaling (GO:0044773),1/59,0.1374818510452552,0.2066524073523992,0,0,6.9992962702322306,13.8884471557023,PLK1,Megakaryocyte,0.8617546291873563
GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.1396445230534406,0.2085994272941147,0,0,6.88031822898651,13.544974303558986,ADRA2A,Megakaryocyte,0.8549760929333525
GO_Biological_Process_2021,cellular response to chemokine (GO:1990869),1/60,0.1396445230534406,0.2085994272941147,0,0,6.88031822898651,13.544974303558986,PF4,Megakaryocyte,0.8549760929333525
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),2/267,0.1436652916283004,0.2139411927963236,0,0,3.095125786163522,6.005376764494242,MPIG6B;EGF,Megakaryocyte,0.8426481412255155
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),2/269,0.1453850943051252,0.2155657617864918,0,0,3.071629213483146,5.923235274252741,EGF;ADRA2A,Megakaryocyte,0.837480117499467
GO_Biological_Process_2021,anterior/posterior pattern specification (GO:0009952),1/63,0.1461007034145454,0.2155657617864918,0,0,6.54641211323239,12.591756250239603,WT1,Megakaryocyte,0.8353476931121088
GO_Biological_Process_2021,positive regulation of DNA metabolic process (GO:0051054),1/63,0.1461007034145454,0.2155657617864918,0,0,6.54641211323239,12.591756250239603,WT1,Megakaryocyte,0.8353476931121088
GO_Biological_Process_2021,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.1482421941802595,0.2180565608584246,0,0,6.442176870748299,12.297522293260638,PF4,Megakaryocyte,0.8290281655096747
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),2/274,0.1497038344955427,0.2195351963181587,0,0,3.014399509803922,5.724635176902424,EGF;ADRA2A,Megakaryocyte,0.8247670755492156
GO_Biological_Process_2021,ERBB signaling pathway (GO:0038127),1/66,0.1525093979756266,0.2229696669491685,0,0,6.243328100470958,11.740759916332207,EGF,Megakaryocyte,0.8167033932798328
GO_Biological_Process_2021,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/67,0.1546351363099914,0.2253924259548663,0,0,6.148423005565863,11.477180657220888,EGF,Megakaryocyte,0.8106918184915987
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),3/547,0.1563819881642389,0.227106828939143,0,0,2.2769868585732165,4.224843515564561,CENPF;WT1;DEPDC1,Megakaryocyte,0.80581326976307
GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.1567556490806558,0.227106828939143,0,0,6.0563508985683825,11.222824361971773,PLK1,Megakaryocyte,0.8047767993307415
GO_Biological_Process_2021,carbohydrate homeostasis (GO:0033500),1/70,0.1609810482853106,0.2318319886983066,0,0,5.880212954747116,10.740024519792764,ADRA2A,Megakaryocyte,0.7932252488723367
GO_Biological_Process_2021,neutrophil chemotaxis (GO:0030593),1/70,0.1609810482853106,0.2318319886983066,0,0,5.880212954747116,10.740024519792764,PF4,Megakaryocyte,0.7932252488723367
GO_Biological_Process_2021,fatty acid biosynthetic process (GO:0006633),1/71,0.16308595979881,0.2327725420273817,0,0,5.795918367346939,10.51076961698872,ALOX12,Megakaryocyte,0.7875834261109624
GO_Biological_Process_2021,positive regulation of cellular protein localization (GO:1903829),1/71,0.16308595979881,0.2327725420273817,0,0,5.795918367346939,10.51076961698872,PLK1,Megakaryocyte,0.7875834261109624
GO_Biological_Process_2021,gland development (GO:0048732),1/71,0.16308595979881,0.2327725420273817,0,0,5.795918367346939,10.51076961698872,WT1,Megakaryocyte,0.7875834261109624
GO_Biological_Process_2021,granulocyte chemotaxis (GO:0071621),1/73,0.1672802691231711,0.2380526906752819,0,0,5.634353741496598,10.074701240888364,PF4,Megakaryocyte,0.7765552814899175
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),2/296,0.1690031560036776,0.2396082993194446,0,0,2.7857142857142856,4.952548406897344,CENPF;PLK1,Megakaryocyte,0.7721051851958874
GO_Biological_Process_2021,regulation of peptide hormone secretion (GO:0090276),1/74,0.1693696918266344,0.2396082993194446,0,0,5.556891249650545,9.867213018330611,ADRA2A,Megakaryocyte,0.7711643026835198
GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1756071809118701,0.2455437616820044,0,0,5.336734693877551,9.283280446293812,EGF,Megakaryocyte,0.7554577289388229
GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.1756071809118701,0.2455437616820044,0,0,5.336734693877551,9.283280446293812,EGF,Megakaryocyte,0.7554577289388229
GO_Biological_Process_2021,neutrophil migration (GO:1990266),1/77,0.1756071809118701,0.2455437616820044,0,0,5.336734693877551,9.283280446293812,PF4,Megakaryocyte,0.7554577289388229
GO_Biological_Process_2021,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.1756071809118701,0.2455437616820044,0,0,5.336734693877551,9.283280446293812,PF4,Megakaryocyte,0.7554577289388229
GO_Biological_Process_2021,negative regulation of blood vessel morphogenesis (GO:2000181),1/78,0.1776761254379788,0.2470006252475949,0,0,5.267161410018553,9.10056411919043,PF4,Megakaryocyte,0.7503709249641564
GO_Biological_Process_2021,negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.1776761254379788,0.2470006252475949,0,0,5.267161410018553,9.10056411919043,PLK1,Megakaryocyte,0.7503709249641564
GO_Biological_Process_2021,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/79,0.1797399811935544,0.2484337096382174,0,0,5.199372056514914,8.923391206941128,PLK1,Megakaryocyte,0.745355308086215
GO_Biological_Process_2021,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.1797399811935544,0.2484337096382174,0,0,5.199372056514914,8.923391206941128,PLK1,Megakaryocyte,0.745355308086215
GO_Biological_Process_2021,negative regulation of cell cycle (GO:0045786),1/80,0.181798760490535,0.2491316347462887,0,0,5.133298889175924,8.751529842637671,PLK1,Megakaryocyte,0.7404090821369118
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.2491316347462887,0,0,5.133298889175924,8.751529842637671,PF4,Megakaryocyte,0.7404090821369118
GO_Biological_Process_2021,skin development (GO:0043588),1/80,0.181798760490535,0.2491316347462887,0,0,5.133298889175924,8.751529842637671,ALOX12,Megakaryocyte,0.7404090821369118
GO_Biological_Process_2021,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.1838524754991919,0.2505185289379924,0,0,5.0688775510204085,8.584760541358477,PF4,Megakaryocyte,0.7355305181562768
GO_Biological_Process_2021,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.1838524754991919,0.2505185289379924,0,0,5.0688775510204085,8.584760541358477,ADRA2A,Megakaryocyte,0.7355305181562768
GO_Biological_Process_2021,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.1859011384602527,0.2518829509841733,0,0,5.00604686318972,8.422875391899517,PLK1,Megakaryocyte,0.7307179505966239
GO_Biological_Process_2021,positive regulation of protein ubiquitination (GO:0031398),1/82,0.1859011384602527,0.2518829509841733,0,0,5.00604686318972,8.422875391899517,PLK1,Megakaryocyte,0.7307179505966239
GO_Biological_Process_2021,long-chain fatty acid metabolic process (GO:0001676),1/83,0.1879447615357932,0.2532252949543881,0,0,4.944748631159781,8.265677319811374,ALOX12,Megakaryocyte,0.7259697745939766
GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.2532252949543881,0,0,4.944748631159781,8.265677319811374,EGF,Megakaryocyte,0.7259697745939766
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),2/321,0.1914223619241526,0.2564172848438937,0,0,2.5641327063740857,4.239211303475318,UBE2C;PLK1,Megakaryocyte,0.7180073293962443
GO_Biological_Process_2021,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",1/85,0.1920169366451308,0.2564172848438937,0,0,4.826530612244898,7.964604221414354,CENPE,Megakaryocyte,0.716660463134361
GO_Biological_Process_2021,positive regulation of protein catabolic process (GO:0045732),1/85,0.1920169366451308,0.2564172848438937,0,0,4.826530612244898,7.964604221414354,ADRA2A,Megakaryocyte,0.716660463134361
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),2/323,0.1932342825020938,0.2564172848438937,0,0,2.5478971962616823,4.188365716592005,WT1;PF4,Megakaryocyte,0.7139158210847405
GO_Biological_Process_2021,glucose homeostasis (GO:0042593),1/86,0.1940455128548384,0.2564172848438937,0,0,4.769507803121249,7.820383303288144,ADRA2A,Megakaryocyte,0.7120963955156414
GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),1/86,0.1940455128548384,0.2564172848438937,0,0,4.769507803121249,7.820383303288144,EGF,Megakaryocyte,0.7120963955156414
GO_Biological_Process_2021,positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.1940455128548384,0.2564172848438937,0,0,4.769507803121249,7.820383303288144,PLK1,Megakaryocyte,0.7120963955156414
GO_Biological_Process_2021,negative regulation of angiogenesis (GO:0016525),1/87,0.196069097589664,0.2583814683304887,0,0,4.713811105837684,7.6801565438185,PF4,Megakaryocyte,0.7075908500030543
GO_Biological_Process_2021,regulation of establishment of planar polarity (GO:0090175),1/88,0.1980877029036425,0.2603283745810165,0,0,4.659394792399718,7.5437717166037235,SAPCD2,Megakaryocyte,0.703142484213379
GO_Biological_Process_2021,regulation of endothelial cell migration (GO:0010594),1/89,0.2001013407742902,0.2622581605243422,0,0,4.6062152133580705,7.411084001248333,EGF,Megakaryocyte,0.6987500013741589
GO_Biological_Process_2021,positive regulation of binding (GO:0051099),1/90,0.2021100231923967,0.2641709814009316,0,0,4.55423068103646,7.281955543769811,EGF,Megakaryocyte,0.6944121480917811
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),3/625,0.2050267003954304,0.2672570268027156,0,0,1.9834439351440103,3.142995135240803,SAPCD2;EGF;ADRA2A,Megakaryocyte,0.6881895775817527
GO_Biological_Process_2021,regulation of endothelial cell proliferation (GO:0001936),1/92,0.2061125694363157,0.2679463402672105,0,0,4.453689167974883,7.03385741012878,EGF,Megakaryocyte,0.6858955226779435
GO_Biological_Process_2021,positive regulation of epithelial cell migration (GO:0010634),1/94,0.2100954368002021,0.2723878843689952,0,0,4.357472021066491,6.79849904676328,EGF,Megakaryocyte,0.6775833802166729
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",4/948,0.21159142351009,0.273485923325853,0,0,1.7507369196757554,2.7190662035683872,CENPF;WT1;PLK1;DEPDC1,Megakaryocyte,0.6745019396506919
GO_Biological_Process_2021,ciliary basal body-plasma membrane docking (GO:0097711),1/95,0.2120795205832498,0.273485923325853,0,0,4.310898827616153,6.685315939697291,PLK1,Megakaryocyte,0.6735012670190429
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),2/345,0.2133084926466024,0.2743352539118068,0,0,2.381802721088435,3.6799229289674416,EGF;ADRA2A,Megakaryocyte,0.6709918532419347
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,0.2180025137484037,0.2788808753004845,0,0,4.176940879444562,6.362519703204576,CENPE,Megakaryocyte,0.6615384985937142
GO_Biological_Process_2021,RNA splicing (GO:0008380),1/98,0.2180025137484037,0.2788808753004845,0,0,4.176940879444562,6.362519703204576,WT1,Megakaryocyte,0.6615384985937142
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),2/354,0.2215840331594591,0.2823990594194319,0,0,2.319839015151515,3.495889243162455,UBE2C;PLK1,Megakaryocyte,0.6544615370869727
GO_Biological_Process_2021,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),1/100,0.2219269115603851,0.2823990594194319,0,0,4.092145949288806,6.1603458876211565,CENPE,Megakaryocyte,0.6537900306498672
GO_Biological_Process_2021,epithelial cell differentiation (GO:0030855),1/101,0.2238818662412048,0.2833873096368935,0,0,4.051020408163265,6.062906014187368,WT1,Megakaryocyte,0.6499810815451941
GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),1/101,0.2238818662412048,0.2833873096368935,0,0,4.051020408163265,6.062906014187368,EGF,Megakaryocyte,0.6499810815451941
GO_Biological_Process_2021,positive regulation of cellular protein metabolic process (GO:0032270),1/102,0.2258320069783284,0.2843591501481046,0,0,4.010709234188725,5.967790506031058,PLK1,Megakaryocyte,0.6462145058611213
GO_Biological_Process_2021,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/102,0.2258320069783284,0.2843591501481046,0,0,4.010709234188725,5.967790506031058,PLK1,Megakaryocyte,0.6462145058611213
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/103,0.2277773453985499,0.2853148519184961,0,0,3.971188475390156,5.874923343943355,CENPE,Megakaryocyte,0.64248947278397
GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),1/103,0.2277773453985499,0.2853148519184961,0,0,3.971188475390156,5.874923343943355,WT1,Megakaryocyte,0.64248947278397
GO_Biological_Process_2021,regulation of insulin secretion (GO:0050796),1/104,0.2297178930745814,0.2869981988801914,0,0,3.932435109966317,5.78423168094792,ADRA2A,Megakaryocyte,0.6388051756325536
GO_Biological_Process_2021,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.2880877502320735,0,0,3.894427001569859,5.6956456810845415,EGF,Megakaryocyte,0.6351608308934773
GO_Biological_Process_2021,small GTPase mediated signal transduction (GO:0007264),1/106,0.2335846623503299,0.2880877502320735,0,0,3.857142857142857,5.6090983677319475,ADRA2A,Megakaryocyte,0.6315556772929499
GO_Biological_Process_2021,chromosome organization (GO:0051276),1/106,0.2335846623503299,0.2880877502320735,0,0,3.857142857142857,5.6090983677319475,TOP2A,Megakaryocyte,0.6315556772929499
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.2335846623503299,0.2880877502320735,0,0,3.857142857142857,5.6090983677319475,EGF,Megakaryocyte,0.6315556772929499
GO_Biological_Process_2021,protein localization to nucleus (GO:0034504),1/106,0.2335846623503299,0.2880877502320735,0,0,3.857142857142857,5.6090983677319475,PLK1,Megakaryocyte,0.6315556772929499
GO_Biological_Process_2021,regulation of protein kinase activity (GO:0045859),1/110,0.241261218690496,0.2967944915348557,0,0,3.714847406852649,5.282048795926194,CENPE,Megakaryocyte,0.6175124827423236
GO_Biological_Process_2021,Fc-epsilon receptor signaling pathway (GO:0038095),1/111,0.2431685532271013,0.2983777400567238,0,0,3.6808905380333954,5.20478084558139,FCER1A,Megakaryocyte,0.6140925891155178
GO_Biological_Process_2021,Fc receptor signaling pathway (GO:0038093),1/112,0.2450711886958998,0.2999471800578316,0,0,3.647545504688362,5.129202360192396,FCER1A,Megakaryocyte,0.6107077427090284
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),2/381,0.2465612635256485,0.3010049943041546,0,0,2.15160510114336,3.012558657024939,WT1;PLK1,Megakaryocyte,0.6080751530383309
GO_Biological_Process_2021,activation of protein kinase activity (GO:0032147),1/114,0.2488624078588274,0.3022798438891313,0,0,3.582625970742279,4.982913653406146,ADRA2A,Megakaryocyte,0.6040407011916724
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.3022798438891313,0,0,3.582625970742279,4.982913653406146,CENPE,Megakaryocyte,0.6040407011916724
GO_Biological_Process_2021,cellular response to molecule of bacterial origin (GO:0071219),1/115,0.2507510141385882,0.3038066443341585,0,0,3.5510204081632653,4.9121080927455,PF4,Megakaryocyte,0.6007573018413346
GO_Biological_Process_2021,regulation of protein binding (GO:0043393),1/118,0.2563889548341396,0.3098570032040732,0,0,3.4594453165881736,4.708511372057024,PLK1,Megakaryocyte,0.5911006880374128
GO_Biological_Process_2021,cellular response to lipopolysaccharide (GO:0071222),1/120,0.2601244621662815,0.3135836248169961,0,0,3.4009603841536613,4.579716458908873,PF4,Megakaryocyte,0.5848188047272944
GO_Biological_Process_2021,epithelium development (GO:0060429),1/122,0.2638415777635164,0.3172694972606285,0,0,3.3444088379153314,4.456111874258477,WT1,Megakaryocyte,0.5786567646257991
GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),1/123,0.2656932663769877,0.3179066197197291,0,0,3.316828370692539,4.396166676729281,EGF,Megakaryocyte,0.5756194520344882
GO_Biological_Process_2021,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.3179066197197291,0,0,3.316828370692539,4.396166676729281,ADRA2A,Megakaryocyte,0.5756194520344882
GO_Biological_Process_2021,fatty acid metabolic process (GO:0006631),1/124,0.2675403902734135,0.3181885250134789,0,0,3.2896963663514187,4.337414433160371,ALOX12,Megakaryocyte,0.5726106437410472
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),1/124,0.2675403902734135,0.3181885250134789,0,0,3.2896963663514187,4.337414433160371,PF4,Megakaryocyte,0.5726106437410472
GO_Biological_Process_2021,regulation of phosphorylation (GO:0042325),1/125,0.2693829605231016,0.3181885250134789,0,0,3.263001974983542,4.279822783786303,EGF,Megakaryocyte,0.5696298784899082
GO_Biological_Process_2021,regulation of protein secretion (GO:0050708),1/125,0.2693829605231016,0.3181885250134789,0,0,3.263001974983542,4.279822783786303,ADRA2A,Megakaryocyte,0.5696298784899082
GO_Biological_Process_2021,negative regulation of cell growth (GO:0030308),1/126,0.2712209880572274,0.3181885250134789,0,0,3.236734693877551,4.223360488574632,WT1,Megakaryocyte,0.5666767062328689
GO_Biological_Process_2021,negative regulation of growth (GO:0045926),1/126,0.2712209880572274,0.3181885250134789,0,0,3.236734693877551,4.223360488574632,WT1,Megakaryocyte,0.5666767062328689
GO_Biological_Process_2021,circulatory system development (GO:0072359),1/126,0.2712209880572274,0.3181885250134789,0,0,3.236734693877551,4.223360488574632,WT1,Megakaryocyte,0.5666767062328689
GO_Biological_Process_2021,phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.2712209880572274,0.3181885250134789,0,0,3.236734693877551,4.223360488574632,ITPKA,Megakaryocyte,0.5666767062328689
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),2/409,0.2725909524148647,0.3190176353079073,0,0,2.000716625716626,2.600497358364142,UBE2C;PLK1,Megakaryocyte,0.5644885629602858
GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.322823892185627,0,0,3.1603954081632653,4.060453122404681,EGF,Megakaryocyte,0.5579784037567757
GO_Biological_Process_2021,regulation of response to external stimulus (GO:0032101),1/130,0.2785278903472666,0.322823892185627,0,0,3.135738016136687,4.008216604624779,GP1BA,Megakaryocyte,0.5551313103019286
GO_Biological_Process_2021,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.2785278903472666,0.322823892185627,0,0,3.135738016136687,4.008216604624779,EGF,Megakaryocyte,0.5551313103019286
GO_Biological_Process_2021,G2/M transition of mitotic cell cycle (GO:0000086),1/130,0.2785278903472666,0.322823892185627,0,0,3.135738016136687,4.008216604624779,PLK1,Megakaryocyte,0.5551313103019286
GO_Biological_Process_2021,cell cycle G2/M phase transition (GO:0044839),1/131,0.2803433684983951,0.3241470198262693,0,0,3.111459968602826,3.956968446025251,PLK1,Megakaryocyte,0.5523097126477655
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),3/742,0.2833046813486276,0.3260181383024992,0,0,1.6593153485158207,2.092782192966935,TOP2A;WT1;PLK1,Megakaryocyte,0.5477462491044153
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),4/1079,0.2833172179011324,0.3260181383024992,0,0,1.5267947421638015,1.925575356569311,MYCN;EGF;WT1;PF4,Megakaryocyte,0.5477270315076967
GO_Biological_Process_2021,organelle assembly (GO:0070925),2/425,0.2874718767319864,0.3300094814035452,0,0,1.9234633569739952,2.397847593244936,CENPE;CENPF,Megakaryocyte,0.541404635765748
GO_Biological_Process_2021,organic substance transport (GO:0071702),1/136,0.289353816496661,0.3313790136545093,0,0,2.99546485260771,3.714691124222948,CENPF,Megakaryocyte,0.5385707850387818
GO_Biological_Process_2021,positive regulation of cellular catabolic process (GO:0031331),1/141,0.2982536777952956,0.3407601401889245,0,0,2.8877551020408165,3.4936375609484274,ADRA2A,Megakaryocyte,0.5254141922968343
GO_Biological_Process_2021,Ras protein signal transduction (GO:0007265),1/142,0.3000204969826995,0.3419664906366789,0,0,2.8671298306556667,3.4517504575709377,ADRA2A,Megakaryocyte,0.522849073872343
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3423528350505641,0,0,2.8467950560505892,3.410594866305226,CENPF,Megakaryocyte,0.5203052911363482
GO_Biological_Process_2021,monocarboxylic acid metabolic process (GO:0032787),1/143,0.3017829564686885,0.3423528350505641,0,0,2.8467950560505892,3.410594866305226,ALOX12,Megakaryocyte,0.5203052911363482
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3514471510674057,0,0,2.749271137026239,3.215201203875706,PLK1,Megakaryocyte,0.5078961191737069
GO_Biological_Process_2021,brain development (GO:0007420),1/150,0.3139989845586295,0.3528820363848149,0,0,2.712094233666621,3.141596466170354,CENPF,Megakaryocyte,0.5030717563895143
GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),1/150,0.3139989845586295,0.3528820363848149,0,0,2.712094233666621,3.141596466170354,ADRA2A,Megakaryocyte,0.5030717563895143
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3528820363848149,0,0,2.712094233666621,3.141596466170354,WT1,Megakaryocyte,0.5030717563895143
GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.3191700762858281,0.3578573582598678,0,0,2.6581632653061225,3.0357052873752,EGF,Megakaryocyte,0.4959778325880012
GO_Biological_Process_2021,peptidyl-serine phosphorylation (GO:0018105),1/156,0.3243029619756543,0.3627668016518366,0,0,2.6063199473337724,2.934917292064671,PLK1,Megakaryocyte,0.4890490847411261
GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.3676111337717622,0,0,2.556445362955309,2.8389038953772054,PF4,Megakaryocyte,0.4822791499015975
GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3705187753188829,0,0,2.524234693877551,2.7773973646136283,EGF,Megakaryocyte,0.4778511096570981
GO_Biological_Process_2021,heart development (GO:0007507),1/164,0.3378059691212722,0.3752532820954548,0,0,2.4774007762614247,2.6886824434754057,WT1,Megakaryocyte,0.4713326805982654
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",4/1183,0.3428517320675613,0.3799808366923894,0,0,1.384445181989158,1.481989303783668,MYCN;EGF;WT1;PF4,Megakaryocyte,0.4648936521619021
GO_Biological_Process_2021,peptidyl-serine modification (GO:0018209),1/169,0.3461106816465725,0.3827108916597733,0,0,2.403061224489796,2.5496399471999527,PLK1,Megakaryocyte,0.4607849973294511
GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),1/177,0.359186378521905,0.3962583671308172,0,0,2.2929035250463823,2.3477357103628296,WT1,Megakaryocyte,0.44468014150624274
GO_Biological_Process_2021,RNA processing (GO:0006396),1/179,0.3624150547196057,0.3989053577119687,0,0,2.266911258885577,2.300835957547096,WT1,Megakaryocyte,0.4407937700298507
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.3640234091355428,0.3997608671100368,0,0,2.2541329380914377,2.2778849681371156,EGF,Megakaryocyte,0.4388706874182523
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),2/525,0.3791874550703379,0.4154650703618053,0,0,1.547721478648821,1.5008635790547311,UBE2C;PLK1,Megakaryocyte,0.42114603917112947
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.4221072503485913,0,0,2.089140319340171,1.988001678572607,MYCN,Megakaryocyte,0.4132695879859197
GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),1/198,0.3923030921692546,0.4278861390780306,0,0,2.0463068476121413,1.914771355908193,MPIG6B,Megakaryocyte,0.4063782687077012
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),3/908,0.3977118667386928,0.4320619928033773,0,0,1.3432467379804869,1.2385104166535874,MYCN;WT1;PF4,Megakaryocyte,0.40043145054722185
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),2/546,0.3979281971141292,0.4320619928033773,0,0,1.4863664215686274,1.3696624285648409,EGF;ADRA2A,Megakaryocyte,0.40019528574129115
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),1/203,0.3999373645428959,0.4332654782548039,0,0,1.9951505354617096,1.8284503867148747,PF4,Megakaryocyte,0.398008019580524
GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4388201252677485,0,0,1.9560134733505052,1.7632653144438126,EGF,Megakaryocyte,0.3914985283218076
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4458879777860261,0,0,1.909178837411742,1.6862551884518755,ITPKA,Megakaryocyte,0.3835844547796231
GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4480761814468346,0,0,1.8910606496119575,1.656759537391559,SPX,Megakaryocyte,0.3804856946694876
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),1/216,0.41934932166703,0.4498063956202386,0,0,1.8732795443758896,1.627975467192003,ITGA2B,Megakaryocyte,0.3774240551539837
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),1/217,0.4208167942393084,0.4498063956202386,0,0,1.8645124716553287,1.613843141672166,ITGA2B,Megakaryocyte,0.375906936392536
GO_Biological_Process_2021,regulation of cell growth (GO:0001558),1/217,0.4208167942393084,0.4498063956202386,0,0,1.8645124716553287,1.613843141672166,WT1,Megakaryocyte,0.375906936392536
GO_Biological_Process_2021,cellular response to lipid (GO:0071396),1/219,0.4237408440429794,0.4519275964183439,0,0,1.8472196217936716,1.5860841457604238,PF4,Megakaryocyte,0.372899672681652
GO_Biological_Process_2021,inflammatory response (GO:0006954),1/230,0.4395663655385589,0.4677686323540859,0,0,1.7575082434720612,1.4446130242039086,PF4,Megakaryocyte,0.35697554604801474
GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.4993206239050954,0,0,1.5952380952380951,1.2000608149186214,EGF,Megakaryocyte,0.32670971902140344
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),1/253,0.4712922312950381,0.4993206239050954,0,0,1.5952380952380951,1.2000608149186214,EGF,Megakaryocyte,0.32670971902140344
GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),1/258,0.4779525975371456,0.5052641745392683,0,0,1.563805288652426,1.154469433244659,PF4,Megakaryocyte,0.3206151737830371
GO_Biological_Process_2021,DNA metabolic process (GO:0006259),1/277,0.5025203266713362,0.5300707831774402,0,0,1.4547471162377994,1.0010394055052982,TOP2A,Megakaryocyte,0.29884636657880626
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.5396755746313027,0,0,1.4081632653061225,0.937839142501346,TOP2A,Megakaryocyte,0.289240867544339
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),2/684,0.5139408816832591,0.5396755746313027,0,0,1.1771749755620724,0.7835830337156338,WT1;PLK1,Megakaryocyte,0.2890868347700152
GO_Biological_Process_2021,proteolysis (GO:0006508),1/287,0.51499186851511,0.5396755746313027,0,0,1.4031682603111175,0.9311483055746664,REN,Megakaryocyte,0.28819962821492023
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),1/300,0.5307476794848257,0.5549774648526112,0,0,1.341273633199099,0.8496546643160489,ITGA2B,Megakaryocyte,0.2751118959639202
GO_Biological_Process_2021,innate immune response (GO:0045087),1/302,0.5331267023920349,0.5562558434936415,0,0,1.3322259136212624,0.8379649939237771,TREML1,Megakaryocyte,0.2731695646873957
GO_Biological_Process_2021,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.5562856381955515,0,0,1.32774699283687,0.8321996277505203,EGF,Megakaryocyte,0.2722052530518486
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5636168465839131,0,0,1.2972062611452349,0.7932686422257892,TOP2A,Megakaryocyte,0.2655801196036423
GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),1/314,0.5471545986718139,0.5659814235723495,0,0,1.2803677381495728,0.7720923294539072,UBE2C,Megakaryocyte,0.26188994631047774
GO_Biological_Process_2021,cilium assembly (GO:0060271),1/314,0.5471545986718139,0.5659814235723495,0,0,1.2803677381495728,0.7720923294539072,PLK1,Megakaryocyte,0.26188994631047774
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5741820545830332,0,0,1.2479496471485791,0.7319104885681406,MYCN,Megakaryocyte,0.2547095446988111
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),1/335,0.5707160845076258,0.5878253461416874,0,0,1.1985824269827692,0.6722410367689661,ADRA2A,Megakaryocyte,0.2435798875448389
GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),1/350,0.5868058377702841,0.6031059999305697,0,0,1.1461902812701013,0.6109896633619631,TOP2A,Megakaryocyte,0.23150557427863594
GO_Biological_Process_2021,protein transport (GO:0015031),1/369,0.6063398885560332,0.6218539155553346,0,0,1.0859582963620231,0.5433207667028247,CENPF,Megakaryocyte,0.21728386041430361
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),1/379,0.6162544539128882,0.6306774304938282,0,0,1.056689342403628,0.5115383719098227,WT1,Megakaryocyte,0.2102399288866402
GO_Biological_Process_2021,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6497944114166164,0,0,1.0,0.4521084323403523,PLK1,Megakaryocyte,0.19634819738734471
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.663134010332821,0.6757785147671334,0,0,0.928642785785643,0.3814661952932429,WT1,Megakaryocyte,0.17839869773857764
GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),1/437,0.6691136001848389,0.6804305321118552,0,0,0.9134057292641828,0.3670077257341264,REN,Megakaryocyte,0.1745001427028418
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",5/2244,0.6741952652975136,0.6841517354601351,0,0,0.8789141978065604,0.3464991772661544,CENPF;MYCN;EGF;WT1;DEPDC1,Megakaryocyte,0.1712143017444203
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),1/468,0.6943679720033368,0.7031389358602209,0,0,0.8514180832932745,0.3105575044475373,WT1,Megakaryocyte,0.15841031937391015
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7125514569577378,0,0,0.8260426831855403,0.2885801301950252,PF4,Megakaryocyte,0.1517218912312197
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7215487446229862,0,0,0.8021026592455164,0.2684686706444305,PLK1,Megakaryocyte,0.1453610219101508
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),1/566,0.7624057114769476,0.7671906845615308,0,0,0.700198663536211,0.1899473973942179,WT1,Megakaryocyte,0.11781385888910202
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),1/621,0.7938341129137421,0.7971486603580583,0,0,0.6362738643844634,0.1469033967904298,PF4,Megakaryocyte,0.10027024237534503
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),4/2206,0.8166523886858273,0.8183537478289229,0,0,0.7008648264423647,0.1419543867132323,MYCN;WT1;PLK1;PF4,Megakaryocyte,0.08796276329696344
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),1/1025,0.9281942108891912,0.9281942108891912,0,0,0.3771922831632653,0.0281062148400667,PLK1,Megakaryocyte,0.032361144586154744
KEGG_2021_Human,inflammatory response (GO:0006954),12/230,3.312500420994986e-13,2.103437767331816e-10,0,0,28.58329309512313,821.3667346726558,CCR1;IL1A;IL1RN;CCL3L1;CCL20;IL1B;CCRL2;CCL3;NLRP3;OLR1;FPR3;CD14,Monocyte,12.479844057859426
KEGG_2021_Human,cellular response to lipopolysaccharide (GO:0071222),8/120,5.768451292393498e-10,1.8314832853349358e-07,0,0,33.73809523809524,717.7255907906293,IL10;CD86;IL1A;IL1B;CCL3;NLRP3;CD14;CD68,Monocyte,9.238940770110876
KEGG_2021_Human,cellular response to molecule of bacterial origin (GO:0071219),7/115,1.4070124285811432e-08,2.978176307163419e-06,0,0,29.90826873385013,540.7179349541402,IL10;CD86;IL1A;IL1B;NLRP3;CD14;CD68,Monocyte,7.851702066289228
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),12/621,2.9803542657653235e-08,4.73131239690245e-06,0,0,10.029038112522686,173.7895766503579,CCR1;IL10;CD86;IL1A;IL1RN;SERPINB2;CCL3L1;CCL20;IL1B;CCL3;FCGR1A;PRLR,Monocyte,7.525732109573925
KEGG_2021_Human,response to lipopolysaccharide (GO:0032496),7/159,1.3177575991908014e-07,1.6735521509723177e-05,0,0,21.203488372093023,335.9091432888057,IL10;CD86;IL1A;IL1B;NLRP3;CD14;CD68,Monocyte,6.88016447063407
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),10/482,2.606607767513925e-07,2.7586598872855708e-05,0,0,10.316737288135592,156.4022116610774,CCR1;IL10;CD86;IL1A;IL1RN;CCL3L1;CCL20;IL1B;CCL3;PRLR,Monocyte,6.583924314907649
KEGG_2021_Human,positive regulation of interleukin-2 production (GO:0032743),4/26,4.960429225063624e-07,4.499817939879144e-05,0,0,78.76679841897233,1143.4263718971108,CD86;IL1A;CLEC7A;IL1B,Monocyte,6.304480742459122
KEGG_2021_Human,cellular response to lipid (GO:0071396),7/219,1.1483367272312394e-06,9.114922772397962e-05,0,0,15.156428258007898,207.29743974271116,IL10;CD86;IL1A;IL1B;NLRP3;CD14;CD68,Monocyte,5.93993074492105
KEGG_2021_Human,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),5/81,1.7658975721181e-06,0.00012459388425499926,0,0,29.055555555555557,384.89462845661075,CD86;IL1A;CLEC7A;CCL3;CD14,Monocyte,5.753034490539867
KEGG_2021_Human,cellular response to interleukin-1 (GO:0071347),6/155,2.3577693232323745e-06,0.00014971835202525578,0,0,18.121720561317876,234.81753261346168,IL1A;IL1RN;CCL3L1;CCL20;IL1B;CCL3,Monocyte,5.627498687174709
KEGG_2021_Human,regulation of interleukin-2 production (GO:0032663),4/48,6.2002690053006694e-06,0.00035792461985144775,0,0,39.3399209486166,471.7217614573871,CD86;IL1A;CLEC7A;IL1B,Monocyte,5.207589467762504
KEGG_2021_Human,chemokine-mediated signaling pathway (GO:0070098),4/56,1.153281738315398e-05,0.000610278253191898,0,0,33.274247491638796,378.3386388039555,CCR1;CCL3L1;CCL20;CCL3,Monocyte,4.938064584770356
KEGG_2021_Human,regulation of tumor necrosis factor production (GO:0032680),5/124,1.4316168261955225e-05,0.0006434445675169513,0,0,18.516339869281047,206.5334955959104,IL10;IL1A;CLEC7A;CCL3;CD14,Monocyte,4.844173205866747
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),7/323,1.477958040001514e-05,0.0006434445675169513,0,0,10.114659994112452,112.49791905411092,IL10;CD86;IL1A;IL1B;NLRP3;CD14;CD68,Monocyte,4.830337895612696
KEGG_2021_Human,cellular response to chemokine (GO:1990869),4/60,1.5199477972841366e-05,0.0006434445675169513,0,0,30.89130434782609,342.71583703038743,CCR1;CCL3L1;CCL20;CCL3,Monocyte,4.818171327674149
KEGG_2021_Human,lipopolysaccharide-mediated signaling pathway (GO:0031663),3/20,1.626462332560456e-05,0.000645502238234931,0,0,74.84230287859825,825.2500115945311,IL1B;CCL3;CD14,Monocyte,4.7887559901445425
KEGG_2021_Human,positive regulation of cytokine production (GO:0001819),7/335,1.869512476672057e-05,0.0006983178956980918,0,0,9.738655700510494,106.02715761423524,IL10;CD86;IL1A;CLEC7A;IL1B;NLRP3;CD14,Monocyte,4.728271632124233
KEGG_2021_Human,regulation of ERK1 and ERK2 cascade (GO:0070372),6/238,2.734289301191869e-05,0.0009645965034760204,0,0,11.589733542319747,121.77395520326633,CCR1;MARCO;CCL3L1;CCL20;IL1B;CCL3,Monocyte,4.563155536855161
KEGG_2021_Human,regulation of heterotypic cell-cell adhesion (GO:0034114),3/25,3.252704029670916e-05,0.0010870879257058,0,0,57.81818181818182,597.4606436592223,IL10;IL1RN;IL1B,Monocyte,4.487755452281791
KEGG_2021_Human,positive regulation of tumor necrosis factor production (GO:0032760),4/77,4.088424652163623e-05,0.0012980748270619,0,0,23.677188802858844,239.25244622831585,IL1A;CLEC7A;CCL3;CD14,Monocyte,4.3884440016910355
KEGG_2021_Human,response to interferon-gamma (GO:0034341),4/80,4.751910548580115e-05,0.0013715741810674,0,0,22.73913043478261,226.3539158165837,CCL3L1;CCL20;KYNU;CCL3,Monocyte,4.323131743242287
KEGG_2021_Human,regulation of NIK/NF-kappaB signaling (GO:1901222),4/80,4.751910548580115e-05,0.0013715741810674,0,0,22.73913043478261,226.3539158165837,CD86;IL1B;NLRP3;CD14,Monocyte,4.323131743242287
KEGG_2021_Human,regulation of interleukin-8 production (GO:0032677),4/81,4.98959147333325e-05,0.0013775611241593,0,0,22.442687747035578,222.30764650625184,IL10;CLEC7A;IL1B;CD14,Monocyte,4.3019350111181165
KEGG_2021_Human,response to interleukin-1 (GO:0070555),4/86,6.310381984044947e-05,0.0016696218999452,0,0,21.068928950159066,203.75190754771063,CCL3L1;CCL20;IL1B;CCL3,Monocyte,4.19994435097111
KEGG_2021_Human,positive regulation of ERK1 and ERK2 cascade (GO:0070374),5/172,6.875254637079586e-05,0.0017463146778182,0,0,13.162341982701264,126.16100557387368,CCR1;MARCO;CCL3L1;CCL20;CCL3,Monocyte,4.162711212344154
KEGG_2021_Human,regulation of immune response (GO:0050776),5/179,8.302771912954982e-05,0.0020277923710486,0,0,12.628352490421456,118.66024363795388,CD300LB;CD300E;CD300C;FCGR1A;SIGLEC7,Monocyte,4.080776892500167
KEGG_2021_Human,regulation of immature T cell proliferation in thymus (GO:0033084),2/6,9.128927051395768e-05,0.0020703102420129,0,0,207.77083333333337,1932.5756890799971,IL1A;IL1B,Monocyte,4.039580263324499
KEGG_2021_Human,positive regulation of T-helper 2 cell differentiation (GO:0045630),2/6,9.128927051395768e-05,0.0020703102420129,0,0,207.77083333333337,1932.5756890799971,CD86;NLRP3,Monocyte,4.039580263324499
KEGG_2021_Human,calcium-mediated signaling (GO:0019722),4/102,0.0001226260480091412,0.0026850876029587,0,0,17.614906832298136,158.64638771191477,CCR1;CCL20;CCRL2;CCL3,Monocyte,3.9114172679492665
KEGG_2021_Human,lymphocyte migration (GO:0072676),3/40,0.00013608554044552048,0.0028804772727635,0,0,34.35250143760782,305.8137622456798,CCL3L1;CCL20;CCL3,Monocyte,3.8661880176205408
KEGG_2021_Human,monocyte chemotaxis (GO:0002548),3/42,0.00015756854407171077,0.0029961947566515,0,0,32.58756137479542,285.32528155294955,CCL3L1;CCL20;CCL3,Monocyte,3.8025304778337556
KEGG_2021_Human,regulation of inflammatory response (GO:0050727),5/206,0.0001605354097534528,0.0029961947566515,0,0,10.917081260364842,95.3824955022904,IL10;IL1B;CCL3;NLRP3;PLA2G7,Monocyte,3.7944291591195953
KEGG_2021_Human,regulation of interleukin-6 production (GO:0032675),4/110,0.00016416405485274464,0.0029961947566515,0,0,16.278917145200985,141.86497243916284,IL10;IL1A;CLEC7A;IL1B,Monocyte,3.7847219293605328
KEGG_2021_Human,regulation of T-helper 2 cell differentiation (GO:0045628),2/8,0.0001698630098259154,0.0029961947566515,0,0,138.5,1202.2517804391236,CD86;NLRP3,Monocyte,3.7699011848597213
KEGG_2021_Human,benzene-containing compound metabolic process (GO:0042537),2/8,0.0001698630098259154,0.0029961947566515,0,0,138.5,1202.2517804391236,KYNU;KMO,Monocyte,3.7699011848597213
KEGG_2021_Human,positive regulation of monocyte chemotactic protein-1 production (GO:0071639),2/8,0.0001698630098259154,0.0029961947566515,0,0,138.5,1202.2517804391236,CLEC7A;IL1B,Monocyte,3.7699011848597213
KEGG_2021_Human,lymphocyte chemotaxis (GO:0048247),3/44,0.0001811421903351466,0.003108791644941,0,0,30.994810586403737,267.0583626754283,CCL3L1;CCL20;CCL3,Monocyte,3.74198038515947
KEGG_2021_Human,calcium ion transport (GO:0006816),4/115,0.00019479030705295337,0.003255048552069,0,0,15.54171562867215,132.78199845970988,CCR1;CATSPER1;SLC24A4;CCL3,Monocyte,3.7104326578175195
KEGG_2021_Human,kynurenine metabolic process (GO:0070189),2/9,0.00021804660985203623,0.0035502460834882,0,0,118.70833333333331,1000.8064198202924,KYNU;KMO,Monocyte,3.6614506612675517
KEGG_2021_Human,cellular response to interferon-gamma (GO:0071346),4/121,0.00023674726676064357,0.0037583628598252,0,0,14.740245261984391,123.05919361950455,CCL3L1;CCL20;CCL3;FCGR1A,Monocyte,3.6257150262111613
KEGG_2021_Human,negative regulation of heterotypic cell-cell adhesion (GO:0034115),2/10,0.00027212309342677823,0.0040185619610698,0,0,103.86458333333331,852.6509585567859,IL10;IL1RN,Monocyte,3.5652346007331377
KEGG_2021_Human,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),2/10,0.00027212309342677823,0.0040185619610698,0,0,103.86458333333331,852.6509585567859,IL10;IL1RN,Monocyte,3.5652346007331377
KEGG_2021_Human,indolalkylamine catabolic process (GO:0046218),2/10,0.00027212309342677823,0.0040185619610698,0,0,103.86458333333331,852.6509585567859,KYNU;KMO,Monocyte,3.5652346007331377
KEGG_2021_Human,positive regulation of NIK/NF-kappaB signaling (GO:1901224),3/53,0.000315376219123607,0.0043929284556874,0,0,25.404255319148938,204.80261014345277,CD86;IL1B;CD14,Monocyte,3.501171057655084
KEGG_2021_Human,response to corticosteroid (GO:0031960),2/11,0.000332063883264561,0.0043929284556874,0,0,92.31944444444444,739.4956618223716,IL10;IL1RN,Monocyte,3.478778357620151
KEGG_2021_Human,tryptophan catabolic process (GO:0006569),2/11,0.000332063883264561,0.0043929284556874,0,0,92.31944444444444,739.4956618223716,KYNU;KMO,Monocyte,3.478778357620151
KEGG_2021_Human,regulation of monocyte chemotactic protein-1 production (GO:0071637),2/11,0.000332063883264561,0.0043929284556874,0,0,92.31944444444444,739.4956618223716,CLEC7A;IL1B,Monocyte,3.478778357620151
KEGG_2021_Human,tryptophan metabolic process (GO:0006568),2/11,0.000332063883264561,0.0043929284556874,0,0,92.31944444444444,739.4956618223716,KYNU;KMO,Monocyte,3.478778357620151
KEGG_2021_Human,positive regulation of interleukin-1 beta production (GO:0032731),3/56,0.0003712232496723555,0.0048107502763662,0,0,23.962665596146127,189.274072690484,CLEC7A;CCL3;NLRP3,Monocyte,3.430364831784506
KEGG_2021_Human,positive regulation of interferon-gamma production (GO:0032729),3/57,0.0003911590889551034,0.0049535042944868,0,0,23.5177304964539,184.5294312848504,CLEC7A;IL1B;CD14,Monocyte,3.407646574053549
KEGG_2021_Human,positive regulation of neuroinflammatory response (GO:0150078),2/12,0.0003978405023918531,0.0049535042944868,0,0,83.08333333333333,650.4975835514635,IL1B;CCL3,Monocyte,3.4002910053496507
KEGG_2021_Human,response to organic cyclic compound (GO:0014070),3/60,0.000455062391672894,0.0055159613971475,0,0,22.27659574468085,171.42009780807578,IL1B;KYNU;CCL3,Monocyte,3.3419290549876433
KEGG_2021_Human,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),2/13,0.00046942457388711873,0.0055159613971475,0,0,75.52651515151516,578.8354329773197,CLEC7A;IL1B,Monocyte,3.3284341792789096
KEGG_2021_Human,positive regulation of calcium-mediated signaling (GO:0050850),2/13,0.00046942457388711873,0.0055159613971475,0,0,75.52651515151516,578.8354329773197,CLEC7A;CCL3,Monocyte,3.3284341792789096
KEGG_2021_Human,positive regulation of interleukin-8 production (GO:0032757),3/61,0.0004777604359734098,0.0055159613971475,0,0,21.891415994130593,167.39054801840658,CLEC7A;IL1B;CD14,Monocyte,3.320789817645709
KEGG_2021_Human,positive regulation of interleukin-1 production (GO:0032732),3/62,0.0005011725952207779,0.0056829392493784,0,0,21.519293184276957,163.51564073611056,CLEC7A;CCL3;NLRP3,Monocyte,3.300012684824315
KEGG_2021_Human,negative regulation of bone mineralization (GO:0030502),2/14,0.0005467878206419364,0.005884919764536,0,0,69.22916666666667,520.0114050756229,CCR1;CCL3,Monocyte,3.2621811676355046
KEGG_2021_Human,positive regulation of T-helper cell differentiation (GO:0045624),2/14,0.0005467878206419364,0.005884919764536,0,0,69.22916666666667,520.0114050756229,CD86;NLRP3,Monocyte,3.2621811676355046
KEGG_2021_Human,positive regulation of type 2 immune response (GO:0002830),2/14,0.0005467878206419364,0.005884919764536,0,0,69.22916666666667,520.0114050756229,CD86;NLRP3,Monocyte,3.2621811676355046
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),5/274,0.0005957168046908393,0.0063046695163113,0,0,8.129285419248244,60.36600188662742,CCR1;MARCO;CCL3L1;CCL20;CCL3,Monocyte,3.2249601486311157
KEGG_2021_Human,positive regulation of heterotypic cell-cell adhesion (GO:0034116),2/15,0.0006299020654549659,0.0065571772387525,0,0,63.90064102564103,470.9442866528224,IL10;IL1B,Monocyte,3.200726967591985
KEGG_2021_Human,cell chemotaxis (GO:0060326),3/69,0.0006858216610371124,0.0070241412057833,0,0,19.230174081237912,140.08975927188362,CCR1;CCL20;CCRL2,Monocyte,3.163788802218554
KEGG_2021_Human,neutrophil chemotaxis (GO:0030593),3/70,0.0007152738836628206,0.007131240802511,0,0,18.94220387424579,137.19544727387992,CCL3L1;CCL20;CCL3,Monocyte,3.145527631782337
KEGG_2021_Human,aromatic amino acid family catabolic process (GO:0009074),2/16,0.0007187392304892979,0.007131240802511,0,0,59.333333333333336,429.45537567816734,KYNU;KMO,Monocyte,3.14342864967499
KEGG_2021_Human,granulocyte chemotaxis (GO:0071621),3/73,0.0008084332971786784,0.0077781082380069,0,0,18.127659574468087,129.07641173230985,CCL3L1;CCL20;CCL3,Monocyte,3.0923558073744988
KEGG_2021_Human,response to molecule of bacterial origin (GO:0002237),3/73,0.0008084332971786784,0.0077781082380069,0,0,18.127659574468087,129.07641173230985,IL10;IL1B;CD14,Monocyte,3.0923558073744988
KEGG_2021_Human,regulation of T cell proliferation (GO:0042129),3/76,0.0009089746531003116,0.0082864824494811,0,0,17.38006412124745,121.71594945135638,IL10;CD86;IL1B,Monocyte,3.041448226978414
KEGG_2021_Human,positive regulation of interleukin-6 production (GO:0032755),3/76,0.0009089746531003116,0.0082864824494811,0,0,17.38006412124745,121.71594945135638,IL1A;CLEC7A;IL1B,Monocyte,3.041448226978414
KEGG_2021_Human,positive regulation of interleukin-4 production (GO:0032753),2/18,0.000913470506242016,0.0082864824494811,0,0,51.911458333333336,363.2898548418271,CD86;NLRP3,Monocyte,3.039305470405725
KEGG_2021_Human,T cell migration (GO:0072678),2/18,0.000913470506242016,0.0082864824494811,0,0,51.911458333333336,363.2898548418271,CCL20;CCL3,Monocyte,3.039305470405725
KEGG_2021_Human,neutrophil migration (GO:1990266),3/77,0.0009441676964961806,0.0084443167221841,0,0,17.14433582518689,119.41384383677423,CCL3L1;CCL20;CCL3,Monocyte,3.024950862487107
KEGG_2021_Human,positive regulation of monocyte chemotaxis (GO:0090026),2/19,0.0010193089566942,0.0089897387152896,0,0,48.85539215686274,336.54673838088314,CCR1;PLA2G7,Monocyte,2.9916941596143727
KEGG_2021_Human,regulation of interleukin-1 beta production (GO:0032651),3/83,0.0011735239744728,0.0102080510108256,0,0,15.85372340425532,106.97686877010656,CLEC7A;CCL3;NLRP3,Monocyte,2.9305080335686804
KEGG_2021_Human,purinergic nucleotide receptor signaling pathway (GO:0035590),2/21,0.0012477930702112,0.010564647994455,0,0,43.708333333333336,292.25047477799524,IL1B;NLRP3,Monocyte,2.9038574306125264
KEGG_2021_Human,positive regulation of T cell cytokine production (GO:0002726),2/21,0.0012477930702112,0.010564647994455,0,0,43.708333333333336,292.25047477799524,IL1B;NLRP3,Monocyte,2.9038574306125264
KEGG_2021_Human,regulation of interferon-gamma production (GO:0032649),3/86,0.0013002540770145,0.0108639649855822,0,0,15.27839015637016,101.52789088565108,CLEC7A;IL1B;CD14,Monocyte,2.8859717757979877
KEGG_2021_Human,negative regulation of biomineral tissue development (GO:0070168),2/22,0.001370383663162,0.0111563285398445,0,0,41.520833333333336,273.7329252658829,CCR1;CCL3,Monocyte,2.8631578273928713
KEGG_2021_Human,regulation of membrane protein ectodomain proteolysis (GO:0051043),2/22,0.001370383663162,0.0111563285398445,0,0,41.520833333333336,273.7329252658829,IL10;IL1B,Monocyte,2.8631578273928713
KEGG_2021_Human,metal ion transport (GO:0030001),3/88,0.0013893445250705,0.0111675161192376,0,0,14.917396745932416,98.14040765115747,CCR1;CATSPER1;CCL3,Monocyte,2.8571900459948085
KEGG_2021_Human,positive regulation of inflammatory response (GO:0050729),3/89,0.0014352931477222,0.0112519894914028,0,0,14.743196437407224,96.51465720793364,IL1B;CCL3;PLA2G7,Monocyte,2.8430593885216617
KEGG_2021_Human,second-messenger-mediated signaling (GO:0019932),3/89,0.0014352931477222,0.0112519894914028,0,0,14.743196437407224,96.51465720793364,CCR1;CCRL2;CCL3,Monocyte,2.8430593885216617
KEGG_2021_Human,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),2/23,0.0014985033958486,0.0113279720995704,0,0,39.541666666666664,257.15086234948103,IL1A;IL1B,Monocyte,2.8243422685363964
KEGG_2021_Human,negative regulation of signal transduction in absence of ligand (GO:1901099),2/23,0.0014985033958486,0.0113279720995704,0,0,39.541666666666664,257.15086234948103,IL1A;IL1B,Monocyte,2.8243422685363964
KEGG_2021_Human,regulation of interleukin-4 production (GO:0032673),2/23,0.0014985033958486,0.0113279720995704,0,0,39.541666666666664,257.15086234948103,CD86;NLRP3,Monocyte,2.8243422685363964
KEGG_2021_Human,negative regulation of ossification (GO:0030279),2/24,0.0016321249773357,0.01191263632883,0,0,37.74242424242424,242.22606459531664,CCR1;CCL3,Monocyte,2.7872465889099036
KEGG_2021_Human,regulation of monooxygenase activity (GO:0032768),2/24,0.0016321249773357,0.01191263632883,0,0,37.74242424242424,242.22606459531664,IL1A;IL1B,Monocyte,2.7872465889099036
KEGG_2021_Human,protein kinase B signaling (GO:0043491),2/24,0.0016321249773357,0.01191263632883,0,0,37.74242424242424,242.22606459531664,IL1B;CCL3,Monocyte,2.7872465889099036
KEGG_2021_Human,interleukin-1-mediated signaling pathway (GO:0070498),3/94,0.0016793598271121,0.0121181078433662,0,0,13.92962356792144,89.00113745221904,IL1A;IL1RN;IL1B,Monocyte,2.774856240022537
KEGG_2021_Human,positive regulation of vascular endothelial growth factor production (GO:0010575),2/25,0.0017712212130127,0.0126373648344166,0,0,36.09963768115942,228.73040961874747,IL1A;IL1B,Monocyte,2.751727195110795
KEGG_2021_Human,calcium ion homeostasis (GO:0055074),3/97,0.001837512611877,0.0129646723171326,0,0,13.483023992756904,84.93418557118899,CCR1;SLC24A4;CCL3,Monocyte,2.735769671427555
KEGG_2021_Human,positive regulation of defense response (GO:0031349),3/98,0.0018922236540246,0.0131773741235725,0,0,13.340425531914894,83.64450283646559,IL1B;CCL3;PLA2G7,Monocyte,2.723027532855894
KEGG_2021_Human,regulation of monocyte chemotaxis (GO:0090025),2/26,0.0019157650058532,0.0131773741235725,0,0,34.59375,216.47517339281177,CCR1;PLA2G7,Monocyte,2.7176577640050135
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),4/212,0.0019299146354208,0.0131773741235725,0,0,8.253344481605351,51.585709880853,IL10;CD163;NLRP3;FCGR1A,Monocyte,2.714461900414819
KEGG_2021_Human,regulation of vascular endothelial growth factor production (GO:0010574),2/27,0.0020657293545543,0.0135230736097114,0,0,33.208333333333336,205.3029465636782,IL1A;IL1B,Monocyte,2.684926579003782
KEGG_2021_Human,response to glucocorticoid (GO:0051384),2/27,0.0020657293545543,0.0135230736097114,0,0,33.208333333333336,205.3029465636782,IL10;IL1RN,Monocyte,2.684926579003782
KEGG_2021_Human,positive regulation of nitric oxide biosynthetic process (GO:0045429),2/27,0.0020657293545543,0.0135230736097114,0,0,33.208333333333336,205.3029465636782,CLEC7A;IL1B,Monocyte,2.684926579003782
KEGG_2021_Human,positive regulation of nuclear division (GO:0051785),2/27,0.0020657293545543,0.0135230736097114,0,0,33.208333333333336,205.3029465636782,IL1A;IL1B,Monocyte,2.684926579003782
KEGG_2021_Human,regulation of calcium-mediated signaling (GO:0050848),2/28,0.0022210873543451,0.0138378174748664,0,0,31.92948717948718,195.08145262248803,CLEC7A;CCL3,Monocyte,2.6534343605132076
KEGG_2021_Human,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),2/28,0.0022210873543451,0.0138378174748664,0,0,31.92948717948718,195.08145262248803,IL1A;IL1B,Monocyte,2.6534343605132076
KEGG_2021_Human,positive regulation of nitric oxide metabolic process (GO:1904407),2/28,0.0022210873543451,0.0138378174748664,0,0,31.92948717948718,195.08145262248803,CLEC7A;IL1B,Monocyte,2.6534343605132076
KEGG_2021_Human,regulation of immunoglobulin production (GO:0002637),2/28,0.0022210873543451,0.0138378174748664,0,0,31.92948717948718,195.08145262248803,CD86;IL10,Monocyte,2.6534343605132076
KEGG_2021_Human,cellular metal ion homeostasis (GO:0006875),3/104,0.0022418858798504,0.0138378174748664,0,0,12.544133136717926,76.5247046664134,CCR1;SLC24A4;CCL3,Monocyte,2.6493864983479414
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),4/221,0.0022445593699389,0.0138378174748664,0,0,7.907433380084152,48.22938179957882,CCR1;CLEC7A;IL1B;CCL3,Monocyte,2.6488689027613925
KEGG_2021_Human,alpha-amino acid catabolic process (GO:1901606),2/30,0.0025478771667966,0.0152632264237345,0,0,29.645833333333332,177.0595839464994,KYNU;KMO,Monocyte,2.5938215131766835
KEGG_2021_Human,negative regulation of interleukin-1 production (GO:0032692),2/30,0.0025478771667966,0.0152632264237345,0,0,29.645833333333332,177.0595839464994,IL10;NLRP3,Monocyte,2.5938215131766835
KEGG_2021_Human,plasma membrane invagination (GO:0099024),2/30,0.0025478771667966,0.0152632264237345,0,0,29.645833333333332,177.0595839464994,MARCO;FCGR1A,Monocyte,2.5938215131766835
KEGG_2021_Human,response to tumor necrosis factor (GO:0034612),3/110,0.0026292225152408,0.0154862829723129,0,0,11.83714456154305,70.32527008978302,CCL3L1;CCL20;CCL3,Monocyte,2.5801726573124935
KEGG_2021_Human,apoptotic process (GO:0006915),4/231,0.0026338874976532,0.0154862829723129,0,0,7.555257613484007,44.87289914494664,IL1A;IL1B;NLRP3;CD14,Monocyte,2.579402779181324
KEGG_2021_Human,cellular divalent inorganic cation homeostasis (GO:0072503),3/111,0.0026975348454772,0.0156975212421729,0,0,11.72695035460993,69.36980081998614,CCR1;SLC24A4;CCL3,Monocyte,2.5690329365984437
KEGG_2021_Human,positive regulation of mononuclear cell migration (GO:0071677),2/31,0.0027192556482504,0.0156975212421729,0,0,28.62212643678161,169.08226656127547,CCR1;PLA2G7,Monocyte,2.565549960707733
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),7/764,0.0027580135087266,0.0157778250274004,0,0,4.127400079874659,24.32377823939587,IL10;CD86;IL1A;CCL3L1;CLEC7A;IL1B;PRLR,Monocyte,2.559403610984298
KEGG_2021_Human,positive regulation of immune effector process (GO:0002699),2/32,0.0028959211173454,0.0164188384778066,0,0,27.666666666666668,161.69650653172428,IL10;IL1B,Monocyte,2.5382132721600397
KEGG_2021_Human,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),2/33,0.0030778471463162,0.0172958667071754,0,0,26.772849462365592,154.84144163978604,IL10;PRLR,Monocyte,2.511752952132796
KEGG_2021_Human,positive regulation of DNA-binding transcription factor activity (GO:0051091),4/246,0.0033014024401746,0.0183893907851833,0,0,7.081566654689184,40.45987900324554,IL10;CLEC7A;IL1B;NLRP3,Monocyte,2.4813015320483554
KEGG_2021_Human,positive regulation of immunoglobulin production (GO:0002639),2/35,0.0034573756419477,0.0189261511434208,0,0,25.147727272727273,142.5183432834292,CD86;IL10,Monocyte,2.461253432039241
KEGG_2021_Human,negative regulation of T cell proliferation (GO:0042130),2/35,0.0034573756419477,0.0189261511434208,0,0,25.147727272727273,142.5183432834292,CD86;IL10,Monocyte,2.461253432039241
KEGG_2021_Human,positive regulation of mitotic nuclear division (GO:0045840),2/36,0.0036549257227984,0.019668456220144,0,0,24.40686274509804,136.96349152286243,IL1A;IL1B,Monocyte,2.437121444562911
KEGG_2021_Human,regulation of osteoclast differentiation (GO:0045670),2/36,0.0036549257227984,0.019668456220144,0,0,24.40686274509804,136.96349152286243,CCR1;CCL3,Monocyte,2.437121444562911
KEGG_2021_Human,positive regulation of calcium ion transport (GO:0051928),2/37,0.0038576315924392,0.0204133005099908,0,0,23.708333333333332,131.76384828572083,CCR1;CCL3,Monocyte,2.4136792502562754
KEGG_2021_Human,"phagocytosis, engulfment (GO:0006911)",2/37,0.0038576315924392,0.0204133005099908,0,0,23.708333333333332,131.76384828572083,MARCO;FCGR1A,Monocyte,2.4136792502562754
KEGG_2021_Human,positive regulation of production of molecular mediator of immune response (GO:0002702),2/38,0.0040654672914765,0.0213353035544427,0,0,23.04861111111111,126.88782669928548,CD86;IL10,Monocyte,2.390889528680986
KEGG_2021_Human,negative regulation of lymphocyte proliferation (GO:0050672),2/39,0.0042784069542198,0.0220877106986146,0,0,22.42454954954955,122.3074073504305,CD86;IL10,Monocyte,2.368717908505425
KEGG_2021_Human,regulation of nitric-oxide synthase activity (GO:0050999),2/39,0.0042784069542198,0.0220877106986146,0,0,22.42454954954955,122.3074073504305,IL1A;IL1B,Monocyte,2.368717908505425
KEGG_2021_Human,regulation of nitric oxide biosynthetic process (GO:0045428),2/40,0.0044964248068071,0.0230260463896979,0,0,21.833333333333332,117.99765363023796,CLEC7A;IL1B,Monocyte,2.3471326648462743
KEGG_2021_Human,positive regulation of cell migration (GO:0030335),4/269,0.0045359913163442,0.0230428358870289,0,0,6.459392945036916,34.85302161654024,CCR1;CLEC7A;IL1B;CCL3,Monocyte,2.343327785523308
KEGG_2021_Human,negative regulation of cell-cell adhesion (GO:0022408),2/41,0.0047194951697385,0.0236809784998104,0,0,21.272435897435894,113.93630347986566,IL10;IL1RN,Monocyte,2.3261044540613445
KEGG_2021_Human,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),3/136,0.0047734885794893,0.0236809784998104,0,0,9.51063829787234,50.83129816395182,IL10;CD163;FCGR1A,Monocyte,2.3211641121418585
KEGG_2021_Human,cellular calcium ion homeostasis (GO:0006874),3/136,0.0047734885794893,0.0236809784998104,0,0,9.51063829787234,50.83129816395182,CCR1;SLC24A4;CCL3,Monocyte,2.3211641121418585
KEGG_2021_Human,regulation of inflammatory response to antigenic stimulus (GO:0002861),3/137,0.0048718493218606,0.0239815838711747,0,0,9.439187043505877,50.256890616051635,IL10;CD163;FCGR1A,Monocyte,2.3123061521683725
KEGG_2021_Human,positive regulation of response to external stimulus (GO:0032103),3/139,0.0050722381718543,0.0247759326086732,0,0,9.299436795994994,49.137973919606814,IL1B;CCL3;PLA2G7,Monocyte,2.294800361929647
KEGG_2021_Human,receptor-mediated endocytosis (GO:0006898),3/143,0.0054878045288024,0.0266011898915235,0,0,9.03191489361702,47.013167330286905,MARCO;CD163;FCGR1A,Monocyte,2.2606013662470708
KEGG_2021_Human,negative regulation of T cell activation (GO:0050868),2/45,0.0056617913266769,0.027236647669999,0,0,19.289728682170544,99.80534454493326,CD86;IL10,Monocyte,2.2470461412130196
KEGG_2021_Human,interleukin-12-mediated signaling pathway (GO:0035722),2/46,0.0059097422436154,0.0280694094787961,0,0,18.85037878787879,96.72417883948356,IL10;SERPINB2,Monocyte,2.2284314606782503
KEGG_2021_Human,positive regulation of cytosolic calcium ion concentration (GO:0007204),3/147,0.0059233084569428,0.0280694094787961,0,0,8.779255319148936,45.02757253551548,CCR1;CCRL2;FPR3,Monocyte,2.22743565083701
KEGG_2021_Human,regulation of cytosolic calcium ion concentration (GO:0051480),3/148,0.0060353294659236,0.0283568614573218,0,0,8.718268525311812,44.55144049537493,CCR1;CCRL2;FPR3,Monocyte,2.2192990169788867
KEGG_2021_Human,positive regulation of hydrolase activity (GO:0051345),3/149,0.0061486161723867,0.0283568614573218,0,0,8.658117167006704,44.08304801864367,CCL3L1;CCL20;CCL3,Monocyte,2.2112226169597906
KEGG_2021_Human,positive regulation of cell-cell adhesion (GO:0022409),2/47,0.0061625935135597,0.0283568614573218,0,0,18.430555555555557,93.79784429037068,IL10;IL1B,Monocyte,2.210236477513525
KEGG_2021_Human,positive regulation of neuron death (GO:1901216),2/47,0.0061625935135597,0.0283568614573218,0,0,18.430555555555557,93.79784429037068,C1QA;CCL3,Monocyte,2.210236477513525
KEGG_2021_Human,cellular response to interleukin-12 (GO:0071349),2/48,0.0064203200925442,0.029330239271695,0,0,18.028985507246375,91.01549863791358,IL10;SERPINB2,Monocyte,2.192443319133604
KEGG_2021_Human,innate immune response (GO:0045087),4/302,0.0068024792155626,0.0306488900026016,0,0,5.7344616282462795,28.617648071431297,CLEC7A;KYNU;CD300LB;CD300E,Monocyte,2.167332776498629
KEGG_2021_Human,positive regulation of NF-kappaB transcription factor activity (GO:0051092),3/155,0.0068551228506196,0.0306488900026016,0,0,8.313829787234043,41.42581056937343,CLEC7A;IL1B;NLRP3,Monocyte,2.1639847578156624
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),5/482,0.0069168190120408,0.0306488900026016,0,0,4.535988819007687,22.5610979918269,IL10;IL1A;CLEC7A;IL1B;CCL3,Monocyte,2.1600935880773298
KEGG_2021_Human,positive regulation of ion transport (GO:0043270),2/50,0.0069502994651568,0.0306488900026016,0,0,17.276041666666668,85.84414194819459,CCR1;CCL3,Monocyte,2.157996482710139
KEGG_2021_Human,regulation of complement activation (GO:0030449),2/50,0.0069502994651568,0.0306488900026016,0,0,17.276041666666668,85.84414194819459,C1QA;IL1B,Monocyte,2.157996482710139
KEGG_2021_Human,regulation of interleukin-12 production (GO:0032655),2/51,0.0072225026271421,0.0316295804705879,0,0,16.922619047619047,83.43788300609687,IL10;CLEC7A,Monocyte,2.1413122915117184
KEGG_2021_Human,positive regulation of chemokine production (GO:0032722),2/53,0.0077812124839393,0.0336127205938875,0,0,16.25735294117647,78.94640668269977,CLEC7A;IL1B,Monocyte,2.108952725111067
KEGG_2021_Human,positive regulation of phagocytosis (GO:0050766),2/53,0.0077812124839393,0.0336127205938875,0,0,16.25735294117647,78.94640668269977,CLEC7A;IL1B,Monocyte,2.108952725111067
KEGG_2021_Human,positive regulation of leukocyte chemotaxis (GO:0002690),2/54,0.0080676700842631,0.0346146655642372,0,0,15.943910256410255,76.8479024006269,CCR1;PLA2G7,Monocyte,2.0932518699428635
KEGG_2021_Human,regulation of bone mineralization (GO:0030500),2/57,0.0089551608364968,0.0379101808745031,0,0,15.071969696969695,71.07225417227201,CCR1;CCL3,Monocyte,2.0479266097283184
KEGG_2021_Human,regulation of mitotic nuclear division (GO:0007088),2/57,0.0089551608364968,0.0379101808745031,0,0,15.071969696969695,71.07225417227201,IL1A;IL1B,Monocyte,2.0479266097283184
KEGG_2021_Human,regulation of calcium ion transport (GO:0051924),2/58,0.0092602829393189,0.0386860504372865,0,0,14.802083333333334,69.30366021141536,CCR1;CCL3,Monocyte,2.033375743652011
KEGG_2021_Human,regulation of phagocytosis (GO:0050764),2/58,0.0092602829393189,0.0386860504372865,0,0,14.802083333333334,69.30366021141536,CLEC7A;IL1B,Monocyte,2.033375743652011
KEGG_2021_Human,negative regulation of immune response (GO:0050777),3/178,0.009999859714763,0.0415026857442781,0,0,7.212765957446808,33.21611593091175,IL10;CD163;FCGR1A,Monocyte,2.000006092553167
KEGG_2021_Human,positive regulation of cysteine-type endopeptidase activity (GO:2001056),2/62,0.0105265894654256,0.0434050929256188,0,0,13.8125,62.9000654557375,CLEC7A;NLRP3,Monocyte,1.977712314119832
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),4/345,0.0107415239006722,0.0440055979156571,0,0,5.000382506693867,22.66992569587075,IL10;IL1A;IL1B;PRLR,Monocyte,1.9689341008800065
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),5/546,0.0114820673240434,0.0448785427125599,0,0,3.986239474224687,17.806407455609126,CD86;CLEC7A;IL1B;CCL3;CD14,Monocyte,1.9399799110152702
KEGG_2021_Human,regulation of GTPase activity (GO:0043087),3/189,0.0117556913396771,0.0448785427125599,0,0,6.782429649965683,30.13716854116709,CCL3L1;CCL20;CCL3,Monocyte,1.9297518253924517
KEGG_2021_Human,positive regulation of T cell proliferation (GO:0042102),2/66,0.0118650634107129,0.0448785427125599,0,0,12.946614583333334,57.4073222604629,CD86;IL1B,Monocyte,1.9257299364311244
KEGG_2021_Human,activation of protein kinase C activity (GO:1990051),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,CD86,Monocyte,1.9052223113279663
KEGG_2021_Human,regulation of T-helper 1 cell cytokine production (GO:2000554),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,IL1B,Monocyte,1.9052223113279663
KEGG_2021_Human,negative regulation of hydrogen peroxide-induced neuron death (GO:1903208),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,IL10,Monocyte,1.9052223113279663
KEGG_2021_Human,negative regulation of interferon-alpha production (GO:0032687),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,IL10,Monocyte,1.9052223113279663
KEGG_2021_Human,positive regulation of glial cell proliferation (GO:0060252),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,IL1B,Monocyte,1.9052223113279663
KEGG_2021_Human,regulation of cell maturation (GO:1903429),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,CLEC7A,Monocyte,1.9052223113279663
KEGG_2021_Human,positive regulation of heat generation (GO:0031652),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,IL1B,Monocyte,1.9052223113279663
KEGG_2021_Human,response to salt stress (GO:0009651),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,KMO,Monocyte,1.9052223113279663
KEGG_2021_Human,positive regulation of leukocyte mediated immunity (GO:0002705),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,CLEC7A,Monocyte,1.9052223113279663
KEGG_2021_Human,regulation of dendritic cell cytokine production (GO:0002730),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,CLEC7A,Monocyte,1.9052223113279663
KEGG_2021_Human,positive regulation of natural killer cell chemotaxis (GO:2000503),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,CCL3,Monocyte,1.9052223113279663
KEGG_2021_Human,regulation of fever generation (GO:0031620),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,IL1B,Monocyte,1.9052223113279663
KEGG_2021_Human,positive regulation of prostaglandin biosynthetic process (GO:0031394),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,IL1B,Monocyte,1.9052223113279663
KEGG_2021_Human,positive regulation of prostaglandin secretion (GO:0032308),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,IL1B,Monocyte,1.9052223113279663
KEGG_2021_Human,positive regulation of T-helper 1 cell cytokine production (GO:2000556),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,IL1B,Monocyte,1.9052223113279663
KEGG_2021_Human,tryptophan catabolic process to kynurenine (GO:0019441),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,KYNU,Monocyte,1.9052223113279663
KEGG_2021_Human,protein localization to axon (GO:0099612),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,EPB41L3,Monocyte,1.9052223113279663
KEGG_2021_Human,endothelial cell apoptotic process (GO:0072577),1/5,0.0124387771927725,0.0448785427125599,0,0,101.76530612244898,446.4379351400606,IL10,Monocyte,1.9052223113279663
KEGG_2021_Human,cellular response to tumor necrosis factor (GO:0071356),3/194,0.0126088864195478,0.0452352704882085,0,0,6.603208198730088,28.878163305605018,CCL3L1;CCL20;CCL3,Monocyte,1.899323267368311
KEGG_2021_Human,positive regulation of secretion by cell (GO:1903532),2/72,0.0140048037295852,0.0485317535805682,0,0,11.833333333333334,50.50886613536219,IL1A;IL1B,Monocyte,1.8537229732206628
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),4/379,0.014731626177976,0.0485317535805682,0,0,4.539130434782609,19.14495667998926,IL10;IL1A;CCL3L1;IL1B,Monocyte,1.8317493101064308
KEGG_2021_Human,activation of Janus kinase activity (GO:0042976),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,PRLR,Monocyte,1.8265723193247598
KEGG_2021_Human,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,PRLR,Monocyte,1.8265723193247598
KEGG_2021_Human,regulation of adiponectin secretion (GO:0070163),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,IL1B,Monocyte,1.8265723193247598
KEGG_2021_Human,regulation of type 2 immune response (GO:0002828),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,NLRP3,Monocyte,1.8265723193247598
KEGG_2021_Human,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,CCL3,Monocyte,1.8265723193247598
KEGG_2021_Human,positive regulation of fever generation (GO:0031622),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,IL1B,Monocyte,1.8265723193247598
KEGG_2021_Human,positive regulation of histone phosphorylation (GO:0033129),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,IL1B,Monocyte,1.8265723193247598
KEGG_2021_Human,response to lipoteichoic acid (GO:0070391),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,CD14,Monocyte,1.8265723193247598
KEGG_2021_Human,positive regulation of killing of cells of other organism (GO:0051712),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,CLEC7A,Monocyte,1.8265723193247598
KEGG_2021_Human,cell junction disassembly (GO:0150146),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,C1QA,Monocyte,1.8265723193247598
KEGG_2021_Human,positive regulation of microglial cell activation (GO:1903980),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,CCL3,Monocyte,1.8265723193247598
KEGG_2021_Human,positive regulation of microglial cell migration (GO:1904141),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,CCL3,Monocyte,1.8265723193247598
KEGG_2021_Human,cellular response to bacterial lipopeptide (GO:0071221),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,CD14,Monocyte,1.8265723193247598
KEGG_2021_Human,cellular response to lipoteichoic acid (GO:0071223),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,CD14,Monocyte,1.8265723193247598
KEGG_2021_Human,regulation of immunoglobulin mediated immune response (GO:0002889),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,IL10,Monocyte,1.8265723193247598
KEGG_2021_Human,regulation of interleukin-1-mediated signaling pathway (GO:2000659),1/6,0.0149082847993736,0.0485317535805682,0,0,81.40816326530613,342.3895623444841,IL1RN,Monocyte,1.8265723193247598
KEGG_2021_Human,positive regulation of immune response (GO:0050778),2/75,0.0151327357621299,0.0485317535805682,0,0,11.345319634703197,47.54704276850611,IL10;NLRP3,Monocyte,1.820082551223806
KEGG_2021_Human,positive regulation of lymphocyte proliferation (GO:0050671),2/75,0.0151327357621299,0.0485317535805682,0,0,11.345319634703197,47.54704276850611,CD86;IL1B,Monocyte,1.820082551223806
KEGG_2021_Human,positive regulation of T cell activation (GO:0050870),2/75,0.0151327357621299,0.0485317535805682,0,0,11.345319634703197,47.54704276850611,CD86;IL1B,Monocyte,1.820082551223806
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),4/384,0.0153877459849858,0.0491016015098793,0,0,4.478260869565218,18.69308398095575,IL1A;CLEC7A;IL1B;CCL3,Monocyte,1.8128249914729373
KEGG_2021_Human,positive regulation of GTPase activity (GO:0043547),3/214,0.0163712299817738,0.0501411628224105,0,0,5.971261470202682,24.55519908720985,CCL3L1;CCL20;CCL3,Monocyte,1.785918690519014
KEGG_2021_Human,negative regulation of NF-kappaB transcription factor activity (GO:0032088),2/79,0.0166954776383478,0.0501411628224105,0,0,10.75378787878788,44.01113934918422,IL10;NLRP3,Monocyte,1.7774011517679502
KEGG_2021_Human,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),2/80,0.0170965192165363,0.0501411628224105,0,0,10.615384615384617,43.19273030214829,IL1A;IL1B,Monocyte,1.7670923012410087
KEGG_2021_Human,glial cell migration (GO:0008347),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,CCL3,Monocyte,1.7601566430186848
KEGG_2021_Human,regulation of calcidiol 1-monooxygenase activity (GO:0060558),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,IL1B,Monocyte,1.7601566430186848
KEGG_2021_Human,release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,CCL3,Monocyte,1.7601566430186848
KEGG_2021_Human,positive regulation of gliogenesis (GO:0014015),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,IL1B,Monocyte,1.7601566430186848
KEGG_2021_Human,positive regulation of humoral immune response (GO:0002922),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,IL1B,Monocyte,1.7601566430186848
KEGG_2021_Human,positive regulation of icosanoid secretion (GO:0032305),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,IL1B,Monocyte,1.7601566430186848
KEGG_2021_Human,negative regulation of membrane protein ectodomain proteolysis (GO:0051045),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,IL10,Monocyte,1.7601566430186848
KEGG_2021_Human,positive regulation of interleukin-23 production (GO:0032747),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,CLEC7A,Monocyte,1.7601566430186848
KEGG_2021_Human,negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,CD14,Monocyte,1.7601566430186848
KEGG_2021_Human,hyaluronan biosynthetic process (GO:0030213),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,IL1B,Monocyte,1.7601566430186848
KEGG_2021_Human,positive regulation of lymphocyte apoptotic process (GO:0070230),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,IL10,Monocyte,1.7601566430186848
KEGG_2021_Human,positive regulation of respiratory burst (GO:0060267),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,CLEC7A,Monocyte,1.7601566430186848
KEGG_2021_Human,nicotinamide nucleotide biosynthetic process (GO:0019359),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,KYNU,Monocyte,1.7601566430186848
KEGG_2021_Human,regulation of microglial cell migration (GO:1904139),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,CCL3,Monocyte,1.7601566430186848
KEGG_2021_Human,positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,IL1B,Monocyte,1.7601566430186848
KEGG_2021_Human,regulation of natural killer cell chemotaxis (GO:2000501),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,CCL3,Monocyte,1.7601566430186848
KEGG_2021_Human,regulation of prostaglandin biosynthetic process (GO:0031392),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,IL1B,Monocyte,1.7601566430186848
KEGG_2021_Human,negative regulation of acute inflammatory response (GO:0002674),1/7,0.0173717414502839,0.0501411628224105,0,0,67.83673469387755,274.9362107684438,NLRP3,Monocyte,1.7601566430186848
KEGG_2021_Human,regulation of cell migration (GO:0030334),4/408,0.0187942434702196,0.053809903938045,0,0,4.207059836418424,16.719716783347426,CCR1;CLEC7A;IL1B;CCL3,Monocyte,1.7259751513719126
KEGG_2021_Human,negative regulation of defense response (GO:0031348),2/85,0.0191627543313976,0.053809903938045,0,0,9.973393574297187,39.44264488506008,IL10;NLRP3,Monocyte,1.717542068067663
KEGG_2021_Human,B cell activation (GO:0042113),2/85,0.0191627543313976,0.053809903938045,0,0,9.973393574297187,39.44264488506008,IL10;CD86,Monocyte,1.717542068067663
KEGG_2021_Human,regulation of response to wounding (GO:1903034),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,IL10,Monocyte,1.702695651141308
KEGG_2021_Human,regulation of RNA biosynthetic process (GO:2001141),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,IL1B,Monocyte,1.702695651141308
KEGG_2021_Human,positive regulation of dendritic cell cytokine production (GO:0002732),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,CLEC7A,Monocyte,1.702695651141308
KEGG_2021_Human,positive regulation of glial cell migration (GO:1903977),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,CCL3,Monocyte,1.702695651141308
KEGG_2021_Human,regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,IL10,Monocyte,1.702695651141308
KEGG_2021_Human,leukocyte aggregation (GO:0070486),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,IL1B,Monocyte,1.702695651141308
KEGG_2021_Human,regulation of interleukin-18 production (GO:0032661),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,IL10,Monocyte,1.702695651141308
KEGG_2021_Human,cytoplasmic sequestering of NF-kappaB (GO:0007253),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,IL10,Monocyte,1.702695651141308
KEGG_2021_Human,positive regulation of T-helper 2 cell cytokine production (GO:2000553),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,NLRP3,Monocyte,1.702695651141308
KEGG_2021_Human,regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,CD14,Monocyte,1.702695651141308
KEGG_2021_Human,platelet activating factor metabolic process (GO:0046469),1/8,0.0198291614511851,0.053809903938045,0,0,58.142857142857146,227.9549801512961,PLA2G7,Monocyte,1.702695651141308
KEGG_2021_Human,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),2/89,0.0208876608034354,0.0559215614369214,0,0,9.512931034482758,36.80169347929862,CLEC7A;NLRP3,Monocyte,1.6801101936742149
KEGG_2021_Human,cellular amino acid catabolic process (GO:0009063),2/90,0.0213286953840061,0.0559215614369214,0,0,9.40435606060606,36.18515879365064,KYNU;KMO,Monocyte,1.6710357083037395
KEGG_2021_Human,positive regulation of transport (GO:0051050),2/91,0.0217736102157896,0.0559215614369214,0,0,9.298220973782772,35.5848177883064,CLEC7A;IL1B,Monocyte,1.6620695559472094
KEGG_2021_Human,epithelial cell apoptotic process (GO:1904019),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,IL10,Monocyte,1.652073914876897
KEGG_2021_Human,regulation of respiratory burst (GO:0060263),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,CLEC7A,Monocyte,1.652073914876897
KEGG_2021_Human,positive regulation of B cell differentiation (GO:0045579),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,IL10,Monocyte,1.652073914876897
KEGG_2021_Human,regulation of cell adhesion molecule production (GO:0060353),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,IL1B,Monocyte,1.652073914876897
KEGG_2021_Human,regulation of complement-dependent cytotoxicity (GO:1903659),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,IL10,Monocyte,1.652073914876897
KEGG_2021_Human,response to vitamin (GO:0033273),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,KYNU,Monocyte,1.652073914876897
KEGG_2021_Human,CD40 signaling pathway (GO:0023035),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,CD86,Monocyte,1.652073914876897
KEGG_2021_Human,regulation of dendritic cell antigen processing and presentation (GO:0002604),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,CD68,Monocyte,1.652073914876897
KEGG_2021_Human,negative regulation of production of molecular mediator of immune response (GO:0002701),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,IL10,Monocyte,1.652073914876897
KEGG_2021_Human,regulation of endothelial cell development (GO:1901550),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,IL1B,Monocyte,1.652073914876897
KEGG_2021_Human,regulation of gap junction assembly (GO:1903596),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,IL1B,Monocyte,1.652073914876897
KEGG_2021_Human,regulation of glial cell proliferation (GO:0060251),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,IL1B,Monocyte,1.652073914876897
KEGG_2021_Human,lipoprotein metabolic process (GO:0042157),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,OLR1,Monocyte,1.652073914876897
KEGG_2021_Human,synapse pruning (GO:0098883),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,C1QA,Monocyte,1.652073914876897
KEGG_2021_Human,regulation of interleukin-23 production (GO:0032667),1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,CLEC7A,Monocyte,1.652073914876897
KEGG_2021_Human,"complement activation, classical pathway (GO:0006958)",1/9,0.0222805591236868,0.0559215614369214,0,0,50.87244897959184,193.52086993316271,C1QA,Monocyte,1.652073914876897
KEGG_2021_Human,regulation of T-helper 17 type immune response (GO:2000316),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,CLEC7A,Monocyte,1.606847034080906
KEGG_2021_Human,aromatic amino acid family metabolic process (GO:0009072),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,KYNU,Monocyte,1.606847034080906
KEGG_2021_Human,negative regulation of hormone secretion (GO:0046888),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,IL1B,Monocyte,1.606847034080906
KEGG_2021_Human,granulocyte migration (GO:0097530),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,CCL3,Monocyte,1.606847034080906
KEGG_2021_Human,sarcoplasmic reticulum calcium ion transport (GO:0070296),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,CCL3,Monocyte,1.606847034080906
KEGG_2021_Human,negative regulation of receptor binding (GO:1900121),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,IL10,Monocyte,1.606847034080906
KEGG_2021_Human,lactation (GO:0007595),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,PRLR,Monocyte,1.606847034080906
KEGG_2021_Human,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,CD68,Monocyte,1.606847034080906
KEGG_2021_Human,lipid droplet formation (GO:0140042),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,CDS1,Monocyte,1.606847034080906
KEGG_2021_Human,negative regulation of transmembrane transport (GO:0034763),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,IL1B,Monocyte,1.606847034080906
KEGG_2021_Human,regulation of histone phosphorylation (GO:0033127),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,IL1B,Monocyte,1.606847034080906
KEGG_2021_Human,neuron remodeling (GO:0016322),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,C1QA,Monocyte,1.606847034080906
KEGG_2021_Human,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,IL1B,Monocyte,1.606847034080906
KEGG_2021_Human,dicarboxylic acid biosynthetic process (GO:0043650),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,KYNU,Monocyte,1.606847034080906
KEGG_2021_Human,phosphatidylcholine catabolic process (GO:0034638),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,PLA2G7,Monocyte,1.606847034080906
KEGG_2021_Human,myelin assembly (GO:0032288),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,EPB41L3,Monocyte,1.606847034080906
KEGG_2021_Human,myelin maintenance (GO:0043217),1/10,0.024725948817258,0.0581517685146624,0,0,45.21768707482993,167.3010120823387,EPB41L3,Monocyte,1.606847034080906
KEGG_2021_Human,positive regulation of cell cycle process (GO:0090068),2/101,0.0264315192050235,0.0618279354294809,0,0,8.35479797979798,30.35463590957481,IL1A;IL1B,Monocyte,1.577877874197194
KEGG_2021_Human,positive regulation of vasculature development (GO:1904018),2/102,0.0269177264019109,0.0618279354294809,0,0,8.270833333333334,29.898816321570965,IL1A;IL1B,Monocyte,1.5699616254585989
KEGG_2021_Human,regulation of T cell mediated immunity (GO:0002709),1/11,0.0271653448579923,0.0618279354294809,0,0,40.69387755102041,146.73452100035948,IL1B,Monocyte,1.5659847773237099
KEGG_2021_Human,regulation of T-helper 2 cell cytokine production (GO:2000551),1/11,0.0271653448579923,0.0618279354294809,0,0,40.69387755102041,146.73452100035948,NLRP3,Monocyte,1.5659847773237099
KEGG_2021_Human,response to sterol (GO:0036314),1/11,0.0271653448579923,0.0618279354294809,0,0,40.69387755102041,146.73452100035948,CCL3,Monocyte,1.5659847773237099
KEGG_2021_Human,humoral immune response mediated by circulating immunoglobulin (GO:0002455),1/11,0.0271653448579923,0.0618279354294809,0,0,40.69387755102041,146.73452100035948,C1QA,Monocyte,1.5659847773237099
KEGG_2021_Human,negative regulation of oxidative stress-induced neuron death (GO:1903204),1/11,0.0271653448579923,0.0618279354294809,0,0,40.69387755102041,146.73452100035948,IL10,Monocyte,1.5659847773237099
KEGG_2021_Human,T cell chemotaxis (GO:0010818),1/11,0.0271653448579923,0.0618279354294809,0,0,40.69387755102041,146.73452100035948,CCL3,Monocyte,1.5659847773237099
KEGG_2021_Human,complement receptor mediated signaling pathway (GO:0002430),1/11,0.0271653448579923,0.0618279354294809,0,0,40.69387755102041,146.73452100035948,FPR3,Monocyte,1.5659847773237099
KEGG_2021_Human,negative regulation of B cell proliferation (GO:0030889),1/12,0.029598761568907,0.0654885491158745,0,0,36.99257884972171,130.2147194065139,IL10,Monocyte,1.5287264597194943
KEGG_2021_Human,regulation of sensory perception (GO:0051931),1/12,0.029598761568907,0.0654885491158745,0,0,36.99257884972171,130.2147194065139,CCL3,Monocyte,1.5287264597194943
KEGG_2021_Human,regulation of B cell apoptotic process (GO:0002902),1/12,0.029598761568907,0.0654885491158745,0,0,36.99257884972171,130.2147194065139,IL10,Monocyte,1.5287264597194943
KEGG_2021_Human,negative regulation of glucose transmembrane transport (GO:0010829),1/12,0.029598761568907,0.0654885491158745,0,0,36.99257884972171,130.2147194065139,IL1B,Monocyte,1.5287264597194943
KEGG_2021_Human,macrophage chemotaxis (GO:0048246),1/12,0.029598761568907,0.0654885491158745,0,0,36.99257884972171,130.2147194065139,CCL3,Monocyte,1.5287264597194943
KEGG_2021_Human,regulation of MHC class II biosynthetic process (GO:0045346),1/12,0.029598761568907,0.0654885491158745,0,0,36.99257884972171,130.2147194065139,IL10,Monocyte,1.5287264597194943
KEGG_2021_Human,positive regulation of T-helper 1 type immune response (GO:0002827),1/12,0.029598761568907,0.0654885491158745,0,0,36.99257884972171,130.2147194065139,IL1B,Monocyte,1.5287264597194943
KEGG_2021_Human,positive regulation of T-helper 17 type immune response (GO:2000318),1/12,0.029598761568907,0.0654885491158745,0,0,36.99257884972171,130.2147194065139,CLEC7A,Monocyte,1.5287264597194943
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),4/474,0.030453470555099,0.0671456729253052,0,0,3.604070305272895,12.583810832834969,CD86;CLEC7A;IL1B;PRLR,Monocyte,1.5163632069049728
KEGG_2021_Human,regulation of response to stress (GO:0080134),1/13,0.032026213248763,0.0689377810608967,0,0,33.90816326530612,116.6847899929619,IL10,Monocyte,1.4944944088974865
KEGG_2021_Human,positive regulation of calcium ion import (GO:0090280),1/13,0.032026213248763,0.0689377810608967,0,0,33.90816326530612,116.6847899929619,CCL3,Monocyte,1.4944944088974865
KEGG_2021_Human,antifungal innate immune response (GO:0061760),1/13,0.032026213248763,0.0689377810608967,0,0,33.90816326530612,116.6847899929619,CLEC7A,Monocyte,1.4944944088974865
KEGG_2021_Human,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/13,0.032026213248763,0.0689377810608967,0,0,33.90816326530612,116.6847899929619,IL10,Monocyte,1.4944944088974865
KEGG_2021_Human,negative regulation of macromolecule biosynthetic process (GO:0010558),1/13,0.032026213248763,0.0689377810608967,0,0,33.90816326530612,116.6847899929619,IL10,Monocyte,1.4944944088974865
KEGG_2021_Human,lipid oxidation (GO:0034440),1/13,0.032026213248763,0.0689377810608967,0,0,33.90816326530612,116.6847899929619,PLA2G7,Monocyte,1.4944944088974865
KEGG_2021_Human,negative regulation by host of viral transcription (GO:0043922),1/13,0.032026213248763,0.0689377810608967,0,0,33.90816326530612,116.6847899929619,CCL3,Monocyte,1.4944944088974865
KEGG_2021_Human,positive regulation of metabolic process (GO:0009893),2/113,0.032501099312465,0.0697236421061327,0,0,7.447072072072072,25.51725368040207,CLEC7A;PRLR,Monocyte,1.4881019492591823
KEGG_2021_Human,activation of protein kinase activity (GO:0032147),2/114,0.0330295301793541,0.0703353649449137,0,0,7.380208333333333,25.169117576656426,CD86;PRLR,Monocyte,1.4810976037825534
KEGG_2021_Human,cellular response to lectin (GO:1990858),2/115,0.033561350657856,0.0703353649449137,0,0,7.31452802359882,24.82828874550635,CLEC7A;CLEC10A,Monocyte,1.4741605695522084
KEGG_2021_Human,stimulatory C-type lectin receptor signaling pathway (GO:0002223),2/115,0.033561350657856,0.0703353649449137,0,0,7.31452802359882,24.82828874550635,CLEC7A;CLEC10A,Monocyte,1.4741605695522084
KEGG_2021_Human,positive regulation of protein metabolic process (GO:0051247),2/115,0.033561350657856,0.0703353649449137,0,0,7.31452802359882,24.82828874550635,CD86;IL1B,Monocyte,1.4741605695522084
KEGG_2021_Human,positive regulation of angiogenesis (GO:0045766),2/116,0.0340965412337713,0.0703353649449137,0,0,7.25,24.49455514200503,IL1A;IL1B,Monocyte,1.467289673772098
KEGG_2021_Human,regulation of sensory perception of pain (GO:0051930),1/14,0.0344477141698711,0.0703353649449137,0,0,31.298273155416013,105.4223689491126,CCL3,Monocyte,1.4628395910668823
KEGG_2021_Human,ether lipid metabolic process (GO:0046485),1/14,0.0344477141698711,0.0703353649449137,0,0,31.298273155416013,105.4223689491126,PLA2G7,Monocyte,1.4628395910668823
KEGG_2021_Human,negative regulation of interleukin-12 production (GO:0032695),1/14,0.0344477141698711,0.0703353649449137,0,0,31.298273155416013,105.4223689491126,IL10,Monocyte,1.4628395910668823
KEGG_2021_Human,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),1/14,0.0344477141698711,0.0703353649449137,0,0,31.298273155416013,105.4223689491126,PRLR,Monocyte,1.4628395910668823
KEGG_2021_Human,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),1/14,0.0344477141698711,0.0703353649449137,0,0,31.298273155416013,105.4223689491126,IL1B,Monocyte,1.4628395910668823
KEGG_2021_Human,positive regulation of lymphocyte migration (GO:2000403),1/14,0.0344477141698711,0.0703353649449137,0,0,31.298273155416013,105.4223689491126,CCL20,Monocyte,1.4628395910668823
KEGG_2021_Human,low-density lipoprotein particle remodeling (GO:0034374),1/14,0.0344477141698711,0.0703353649449137,0,0,31.298273155416013,105.4223689491126,PLA2G7,Monocyte,1.4628395910668823
KEGG_2021_Human,positive regulation of superoxide anion generation (GO:0032930),1/14,0.0344477141698711,0.0703353649449137,0,0,31.298273155416013,105.4223689491126,CLEC7A,Monocyte,1.4628395910668823
KEGG_2021_Human,cytoplasmic sequestering of transcription factor (GO:0042994),1/14,0.0344477141698711,0.0703353649449137,0,0,31.298273155416013,105.4223689491126,IL10,Monocyte,1.4628395910668823
KEGG_2021_Human,defense response to protozoan (GO:0042832),1/14,0.0344477141698711,0.0703353649449137,0,0,31.298273155416013,105.4223689491126,CLEC7A,Monocyte,1.4628395910668823
KEGG_2021_Human,negative regulation of response to external stimulus (GO:0032102),2/118,0.0351769550093681,0.0715941231761178,0,0,7.124281609195402,23.8475644827565,IL10;NLRP3,Monocyte,1.4537417566881954
KEGG_2021_Human,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),2/119,0.0357221395623332,0.0720251750982769,0,0,7.063034188034188,23.53392133172277,CLEC7A;NLRP3,Monocyte,1.4470625371214694
KEGG_2021_Human,innate immune response activating cell surface receptor signaling pathway (GO:0002220),2/119,0.0357221395623332,0.0720251750982769,0,0,7.063034188034188,23.53392133172277,CLEC7A;CLEC10A,Monocyte,1.4470625371214694
KEGG_2021_Human,cytoskeleton organization (GO:0007010),2/120,0.0362706169091182,0.0720251750982769,0,0,7.002824858757062,23.22660056193845,EPB41L3;CCL3,Monocyte,1.4404450576550938
KEGG_2021_Human,positive regulation of acute inflammatory response (GO:0002675),1/15,0.0368632785936063,0.0720251750982769,0,0,29.06122448979592,95.91771596133704,IL1B,Monocyte,1.4334060415588732
KEGG_2021_Human,positive regulation of cell killing (GO:0031343),1/15,0.0368632785936063,0.0720251750982769,0,0,29.06122448979592,95.91771596133704,CLEC7A,Monocyte,1.4334060415588732
KEGG_2021_Human,regulation of superoxide anion generation (GO:0032928),1/15,0.0368632785936063,0.0720251750982769,0,0,29.06122448979592,95.91771596133704,CLEC7A,Monocyte,1.4334060415588732
KEGG_2021_Human,fibrinolysis (GO:0042730),1/15,0.0368632785936063,0.0720251750982769,0,0,29.06122448979592,95.91771596133704,SERPINB2,Monocyte,1.4334060415588732
KEGG_2021_Human,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/15,0.0368632785936063,0.0720251750982769,0,0,29.06122448979592,95.91771596133704,IL1B,Monocyte,1.4334060415588732
KEGG_2021_Human,positive regulation of osteoclast differentiation (GO:0045672),1/15,0.0368632785936063,0.0720251750982769,0,0,29.06122448979592,95.91771596133704,CCR1,Monocyte,1.4334060415588732
KEGG_2021_Human,positive regulation of protein export from nucleus (GO:0046827),1/15,0.0368632785936063,0.0720251750982769,0,0,29.06122448979592,95.91771596133704,IL1B,Monocyte,1.4334060415588732
KEGG_2021_Human,macrophage migration (GO:1905517),1/15,0.0368632785936063,0.0720251750982769,0,0,29.06122448979592,95.91771596133704,CCL3,Monocyte,1.4334060415588732
KEGG_2021_Human,regulation of lymphocyte activation (GO:0051249),1/15,0.0368632785936063,0.0720251750982769,0,0,29.06122448979592,95.91771596133704,CLEC7A,Monocyte,1.4334060415588732
KEGG_2021_Human,regulation of microglial cell activation (GO:1903978),1/15,0.0368632785936063,0.0720251750982769,0,0,29.06122448979592,95.91771596133704,CCL3,Monocyte,1.4334060415588732
KEGG_2021_Human,potassium ion transport (GO:0006813),2/122,0.0373773734873947,0.0728056201364897,0,0,6.885416666666667,22.63022834568748,SLC24A4;KCNK13,Monocyte,1.4273912198113348
KEGG_2021_Human,cellular response to organic substance (GO:0071310),2/123,0.0379356146383277,0.0736670192517984,0,0,6.828168044077135,22.34084340876857,IL1B;CCL3,Monocyte,1.420952875040757
KEGG_2021_Human,regulation of protein secretion (GO:0050708),2/125,0.0390617280151273,0.0742211448404328,0,0,6.716463414634147,21.77888563484535,IL1A;IL1B,Monocyte,1.408248548277182
KEGG_2021_Human,body fluid secretion (GO:0007589),1/16,0.0392729207344652,0.0742211448404328,0,0,27.122448979591837,87.80133530116419,PRLR,Monocyte,1.405906798966597
KEGG_2021_Human,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),1/16,0.0392729207344652,0.0742211448404328,0,0,27.122448979591837,87.80133530116419,IL1B,Monocyte,1.405906798966597
KEGG_2021_Human,regulation of interleukin-1 production (GO:0032652),1/16,0.0392729207344652,0.0742211448404328,0,0,27.122448979591837,87.80133530116419,IL10,Monocyte,1.405906798966597
KEGG_2021_Human,regulation of isotype switching (GO:0045191),1/16,0.0392729207344652,0.0742211448404328,0,0,27.122448979591837,87.80133530116419,IL10,Monocyte,1.405906798966597
KEGG_2021_Human,dendritic cell chemotaxis (GO:0002407),1/16,0.0392729207344652,0.0742211448404328,0,0,27.122448979591837,87.80133530116419,CCR1,Monocyte,1.405906798966597
KEGG_2021_Human,necroptotic process (GO:0070266),1/16,0.0392729207344652,0.0742211448404328,0,0,27.122448979591837,87.80133530116419,CD14,Monocyte,1.405906798966597
KEGG_2021_Human,eosinophil chemotaxis (GO:0048245),1/16,0.0392729207344652,0.0742211448404328,0,0,27.122448979591837,87.80133530116419,CCL3,Monocyte,1.405906798966597
KEGG_2021_Human,eosinophil migration (GO:0072677),1/16,0.0392729207344652,0.0742211448404328,0,0,27.122448979591837,87.80133530116419,CCL3,Monocyte,1.405906798966597
KEGG_2021_Human,negative regulation of chemokine production (GO:0032682),1/17,0.0416766547912334,0.0769321970710269,0,0,25.426020408163264,80.79916728086499,IL10,Monocyte,1.3801071472903907
KEGG_2021_Human,negative regulation of cytokine production involved in immune response (GO:0002719),1/17,0.0416766547912334,0.0769321970710269,0,0,25.426020408163264,80.79916728086499,IL10,Monocyte,1.3801071472903907
KEGG_2021_Human,positive regulation of cytokine production involved in inflammatory response (GO:1900017),1/17,0.0416766547912334,0.0769321970710269,0,0,25.426020408163264,80.79916728086499,CLEC7A,Monocyte,1.3801071472903907
KEGG_2021_Human,regulation of cell killing (GO:0031341),1/17,0.0416766547912334,0.0769321970710269,0,0,25.426020408163264,80.79916728086499,IL10,Monocyte,1.3801071472903907
KEGG_2021_Human,positive regulation of macrophage activation (GO:0043032),1/17,0.0416766547912334,0.0769321970710269,0,0,25.426020408163264,80.79916728086499,CCL3,Monocyte,1.3801071472903907
KEGG_2021_Human,regulation of establishment of endothelial barrier (GO:1903140),1/17,0.0416766547912334,0.0769321970710269,0,0,25.426020408163264,80.79916728086499,IL1B,Monocyte,1.3801071472903907
KEGG_2021_Human,stabilization of membrane potential (GO:0030322),1/17,0.0416766547912334,0.0769321970710269,0,0,25.426020408163264,80.79916728086499,KCNK13,Monocyte,1.3801071472903907
KEGG_2021_Human,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),1/17,0.0416766547912334,0.0769321970710269,0,0,25.426020408163264,80.79916728086499,IL10,Monocyte,1.3801071472903907
KEGG_2021_Human,negative regulation of interleukin-8 production (GO:0032717),1/18,0.0440744949316926,0.0799637265189281,0,0,23.92917166866747,74.70385911458476,IL10,Monocyte,1.3558126557645607
KEGG_2021_Human,negative regulation of lipid catabolic process (GO:0050995),1/18,0.0440744949316926,0.0799637265189281,0,0,23.92917166866747,74.70385911458476,IL1B,Monocyte,1.3558126557645607
KEGG_2021_Human,positive regulation of lymphocyte chemotaxis (GO:0140131),1/18,0.0440744949316926,0.0799637265189281,0,0,23.92917166866747,74.70385911458476,CCL3,Monocyte,1.3558126557645607
KEGG_2021_Human,neuron maturation (GO:0042551),1/18,0.0440744949316926,0.0799637265189281,0,0,23.92917166866747,74.70385911458476,C1QA,Monocyte,1.3558126557645607
KEGG_2021_Human,dendritic cell migration (GO:0036336),1/18,0.0440744949316926,0.0799637265189281,0,0,23.92917166866747,74.70385911458476,CCR1,Monocyte,1.3558126557645607
KEGG_2021_Human,programmed necrotic cell death (GO:0097300),1/18,0.0440744949316926,0.0799637265189281,0,0,23.92917166866747,74.70385911458476,CD14,Monocyte,1.3558126557645607
KEGG_2021_Human,response to cholesterol (GO:0070723),1/19,0.0464664552952436,0.0827406623960478,0,0,22.598639455782312,69.35578082800635,CCL3,Monocyte,1.3328604565168853
KEGG_2021_Human,negative regulation of nervous system development (GO:0051961),1/19,0.0464664552952436,0.0827406623960478,0,0,22.598639455782312,69.35578082800635,IL1B,Monocyte,1.3328604565168853
KEGG_2021_Human,positive regulation of leukocyte activation (GO:0002696),1/19,0.0464664552952436,0.0827406623960478,0,0,22.598639455782312,69.35578082800635,CLEC7A,Monocyte,1.3328604565168853
KEGG_2021_Human,positive regulation of macrophage migration (GO:1905523),1/19,0.0464664552952436,0.0827406623960478,0,0,22.598639455782312,69.35578082800635,CCL3,Monocyte,1.3328604565168853
KEGG_2021_Human,regulation of glucose transmembrane transport (GO:0010827),1/19,0.0464664552952436,0.0827406623960478,0,0,22.598639455782312,69.35578082800635,IL1B,Monocyte,1.3328604565168853
KEGG_2021_Human,regulation of neuroinflammatory response (GO:0150077),1/19,0.0464664552952436,0.0827406623960478,0,0,22.598639455782312,69.35578082800635,IL1B,Monocyte,1.3328604565168853
KEGG_2021_Human,negative regulation of gene expression (GO:0010629),3/322,0.0465171912998253,0.0827406623960478,0,0,3.9280330821049825,12.05094361134169,CCR1;IL10;CCL3,Monocyte,1.332386515779621
KEGG_2021_Human,potassium ion transmembrane transport (GO:0071805),2/139,0.0472922793944307,0.0838843503225238,0,0,6.025851581508515,18.3873330672393,SLC24A4;KCNK13,Monocyte,1.3252097533441285
KEGG_2021_Human,regulation of T cell migration (GO:2000404),1/20,0.0488525499820277,0.0852235418642517,0,0,21.40816326530612,64.63014669364038,CCL20,Monocyte,1.3111127622579986
KEGG_2021_Human,regulation of acute inflammatory response (GO:0002673),1/20,0.0488525499820277,0.0852235418642517,0,0,21.40816326530612,64.63014669364038,NLRP3,Monocyte,1.3111127622579986
KEGG_2021_Human,growth hormone receptor signaling pathway (GO:0060396),1/20,0.0488525499820277,0.0852235418642517,0,0,21.40816326530612,64.63014669364038,PRLR,Monocyte,1.3111127622579986
KEGG_2021_Human,negative regulation of osteoclast differentiation (GO:0045671),1/20,0.0488525499820277,0.0852235418642517,0,0,21.40816326530612,64.63014669364038,CCL3,Monocyte,1.3111127622579986
KEGG_2021_Human,positive regulation of peptidyl-lysine acetylation (GO:2000758),1/20,0.0488525499820277,0.0852235418642517,0,0,21.40816326530612,64.63014669364038,IL1B,Monocyte,1.3111127622579986
KEGG_2021_Human,toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.0488525499820277,0.0852235418642517,0,0,21.40816326530612,64.63014669364038,CD14,Monocyte,1.3111127622579986
KEGG_2021_Human,regulation of gene expression (GO:0010468),6/1079,0.0512007807086264,0.0876895514762315,0,0,2.399008726594934,7.129855132155819,CCR1;IL10;IL1A;CLEC7A;IL1B;CCL3,Monocyte,1.2907234168588677
KEGG_2021_Human,negative regulation of cell communication (GO:0010648),1/21,0.0512327930672156,0.0876895514762315,0,0,20.336734693877553,60.42807445408675,IL1B,Monocyte,1.2904519669693806
KEGG_2021_Human,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.0512327930672156,0.0876895514762315,0,0,20.336734693877553,60.42807445408675,CCL20,Monocyte,1.2904519669693806
KEGG_2021_Human,response to progesterone (GO:0032570),1/21,0.0512327930672156,0.0876895514762315,0,0,20.336734693877553,60.42807445408675,CATSPER1,Monocyte,1.2904519669693806
KEGG_2021_Human,regulation of lipid catabolic process (GO:0050994),1/21,0.0512327930672156,0.0876895514762315,0,0,20.336734693877553,60.42807445408675,IL1B,Monocyte,1.2904519669693806
KEGG_2021_Human,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),1/21,0.0512327930672156,0.0876895514762315,0,0,20.336734693877553,60.42807445408675,IL10,Monocyte,1.2904519669693806
KEGG_2021_Human,NAD biosynthetic process (GO:0009435),1/21,0.0512327930672156,0.0876895514762315,0,0,20.336734693877553,60.42807445408675,KYNU,Monocyte,1.2904519669693806
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),4/566,0.0525874539436757,0.0897662184253604,0,0,2.999845273092991,8.835377403898873,IL10;IL1A;CCL3L1;IL1B,Monocyte,1.279117855331805
KEGG_2021_Human,negative regulation of B cell activation (GO:0050869),1/22,0.0536071985992547,0.0905334338045925,0,0,19.367346938775512,56.67024999786951,IL10,Monocyte,1.2707768875084013
KEGG_2021_Human,positive regulation of lipid catabolic process (GO:0050996),1/22,0.0536071985992547,0.0905334338045925,0,0,19.367346938775512,56.67024999786951,IL1B,Monocyte,1.2707768875084013
KEGG_2021_Human,lipid droplet organization (GO:0034389),1/22,0.0536071985992547,0.0905334338045925,0,0,19.367346938775512,56.67024999786951,CDS1,Monocyte,1.2707768875084013
KEGG_2021_Human,microglial cell activation (GO:0001774),1/22,0.0536071985992547,0.0905334338045925,0,0,19.367346938775512,56.67024999786951,C1QA,Monocyte,1.2707768875084013
KEGG_2021_Human,response to cytokine (GO:0034097),2/150,0.0541636617411515,0.0907491430227736,0,0,5.574887387387387,16.25495026487543,IL1B;KYNU,Monocyte,1.2662919827974375
KEGG_2021_Human,regulation of cytokine production (GO:0001817),2/150,0.0541636617411515,0.0907491430227736,0,0,5.574887387387387,16.25495026487543,IL10;IL1A,Monocyte,1.2662919827974375
KEGG_2021_Human,cellular response to organic cyclic compound (GO:0071407),2/150,0.0541636617411515,0.0907491430227736,0,0,5.574887387387387,16.25495026487543,IL1B;CCL3,Monocyte,1.2662919827974375
KEGG_2021_Human,response to copper ion (GO:0046688),1/23,0.0559757805878795,0.0925641163367278,0,0,18.4860853432282,53.29235549319145,IL1A,Monocyte,1.2519998414265567
KEGG_2021_Human,positive regulation of histone acetylation (GO:0035066),1/23,0.0559757805878795,0.0925641163367278,0,0,18.4860853432282,53.29235549319145,IL1B,Monocyte,1.2519998414265567
KEGG_2021_Human,response to nutrient levels (GO:0031667),1/23,0.0559757805878795,0.0925641163367278,0,0,18.4860853432282,53.29235549319145,CD68,Monocyte,1.2519998414265567
KEGG_2021_Human,hyaluronan metabolic process (GO:0030212),1/23,0.0559757805878795,0.0925641163367278,0,0,18.4860853432282,53.29235549319145,IL1B,Monocyte,1.2519998414265567
KEGG_2021_Human,regulation of protein export from nucleus (GO:0046825),1/23,0.0559757805878795,0.0925641163367278,0,0,18.4860853432282,53.29235549319145,IL1B,Monocyte,1.2519998414265567
KEGG_2021_Human,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),1/24,0.0583385530130099,0.0940227948306125,0,0,17.68145519077196,50.24171555062859,IL1B,Monocyte,1.2340443470047993
KEGG_2021_Human,negative regulation of lipid metabolic process (GO:0045833),1/24,0.0583385530130099,0.0940227948306125,0,0,17.68145519077196,50.24171555062859,IL1B,Monocyte,1.2340443470047993
KEGG_2021_Human,negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/24,0.0583385530130099,0.0940227948306125,0,0,17.68145519077196,50.24171555062859,NLRP3,Monocyte,1.2340443470047993
KEGG_2021_Human,regulation of cytokine production involved in immune response (GO:0002718),1/24,0.0583385530130099,0.0940227948306125,0,0,17.68145519077196,50.24171555062859,IL10,Monocyte,1.2340443470047993
KEGG_2021_Human,immune response-activating cell surface receptor signaling pathway (GO:0002429),1/24,0.0583385530130099,0.0940227948306125,0,0,17.68145519077196,50.24171555062859,FPR3,Monocyte,1.2340443470047993
KEGG_2021_Human,positive regulation of neuron apoptotic process (GO:0043525),1/24,0.0583385530130099,0.0940227948306125,0,0,17.68145519077196,50.24171555062859,CCL3,Monocyte,1.2340443470047993
KEGG_2021_Human,negative regulation of synaptic transmission (GO:0050805),1/24,0.0583385530130099,0.0940227948306125,0,0,17.68145519077196,50.24171555062859,IL1B,Monocyte,1.2340443470047993
KEGG_2021_Human,positive regulation of p38MAPK cascade (GO:1900745),1/24,0.0583385530130099,0.0940227948306125,0,0,17.68145519077196,50.24171555062859,IL1B,Monocyte,1.2340443470047993
KEGG_2021_Human,mammary gland development (GO:0030879),1/24,0.0583385530130099,0.0940227948306125,0,0,17.68145519077196,50.24171555062859,PRLR,Monocyte,1.2340443470047993
KEGG_2021_Human,defense response to fungus (GO:0050832),1/24,0.0583385530130099,0.0940227948306125,0,0,17.68145519077196,50.24171555062859,CLEC7A,Monocyte,1.2340443470047993
KEGG_2021_Human,negative regulation of cell junction assembly (GO:1901889),1/25,0.0606955298241754,0.0963541535958784,0,0,16.943877551020407,47.47480020477031,IL1B,Monocyte,1.2168432931781568
KEGG_2021_Human,regulation of calcium ion import (GO:0090279),1/25,0.0606955298241754,0.0963541535958784,0,0,16.943877551020407,47.47480020477031,CCL3,Monocyte,1.2168432931781568
KEGG_2021_Human,positive regulation of lipid metabolic process (GO:0045834),1/25,0.0606955298241754,0.0963541535958784,0,0,16.943877551020407,47.47480020477031,IL1B,Monocyte,1.2168432931781568
KEGG_2021_Human,negative regulation of signaling (GO:0023057),1/25,0.0606955298241754,0.0963541535958784,0,0,16.943877551020407,47.47480020477031,IL1B,Monocyte,1.2168432931781568
KEGG_2021_Human,regulation of interferon-alpha production (GO:0032647),1/25,0.0606955298241754,0.0963541535958784,0,0,16.943877551020407,47.47480020477031,IL10,Monocyte,1.2168432931781568
KEGG_2021_Human,positive regulation of T cell migration (GO:2000406),1/25,0.0606955298241754,0.0963541535958784,0,0,16.943877551020407,47.47480020477031,CCL20,Monocyte,1.2168432931781568
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),2/161,0.0613656526664216,0.0971750360178996,0,0,5.186320754716981,14.474528542436865,CD86;CCL3,Monocyte,1.212074642397333
KEGG_2021_Human,negative regulation of cell development (GO:0010721),1/26,0.0630467249540435,0.0990957186777664,0,0,16.26530612244898,44.95534064809558,IL1B,Monocyte,1.2003374685092782
KEGG_2021_Human,negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.0630467249540435,0.0990957186777664,0,0,16.26530612244898,44.95534064809558,NLRP3,Monocyte,1.2003374685092782
KEGG_2021_Human,cellular response to drug (GO:0035690),1/26,0.0630467249540435,0.0990957186777664,0,0,16.26530612244898,44.95534064809558,IL1B,Monocyte,1.2003374685092782
KEGG_2021_Human,negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.0653921522588676,0.1022759031634998,0,0,15.638932496075354,42.652889831563165,IL10,Monocyte,1.184474368421492
KEGG_2021_Human,negative regulation of insulin receptor signaling pathway (GO:0046627),1/27,0.0653921522588676,0.1022759031634998,0,0,15.638932496075354,42.652889831563165,IL1B,Monocyte,1.184474368421492
KEGG_2021_Human,negative regulation of cellular response to insulin stimulus (GO:1900077),1/28,0.0677318256109869,0.1038881866255475,0,0,15.058956916099774,40.54171043527237,IL1B,Monocyte,1.1692072184717057
KEGG_2021_Human,regulation of B cell activation (GO:0050864),1/28,0.0677318256109869,0.1038881866255475,0,0,15.058956916099774,40.54171043527237,IL10,Monocyte,1.1692072184717057
KEGG_2021_Human,regulation of calcineurin-NFAT signaling cascade (GO:0070884),1/28,0.0677318256109869,0.1038881866255475,0,0,15.058956916099774,40.54171043527237,CLEC7A,Monocyte,1.1692072184717057
KEGG_2021_Human,glycerophospholipid catabolic process (GO:0046475),1/28,0.0677318256109869,0.1038881866255475,0,0,15.058956916099774,40.54171043527237,PLA2G7,Monocyte,1.1692072184717057
KEGG_2021_Human,response to ketone (GO:1901654),1/28,0.0677318256109869,0.1038881866255475,0,0,15.058956916099774,40.54171043527237,CATSPER1,Monocyte,1.1692072184717057
KEGG_2021_Human,positive regulation of monooxygenase activity (GO:0032770),1/28,0.0677318256109869,0.1038881866255475,0,0,15.058956916099774,40.54171043527237,IL1B,Monocyte,1.1692072184717057
KEGG_2021_Human,leukocyte cell-cell adhesion (GO:0007159),1/28,0.0677318256109869,0.1038881866255475,0,0,15.058956916099774,40.54171043527237,OLR1,Monocyte,1.1692072184717057
KEGG_2021_Human,positive regulation of response to wounding (GO:1903036),1/28,0.0677318256109869,0.1038881866255475,0,0,15.058956916099774,40.54171043527237,CLEC7A,Monocyte,1.1692072184717057
KEGG_2021_Human,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.0700657588372089,0.1069513386096819,0,0,14.520408163265309,38.5999069065122,CCL3,Monocyte,1.1544941700666143
KEGG_2021_Human,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/29,0.0700657588372089,0.1069513386096819,0,0,14.520408163265309,38.5999069065122,CD14,Monocyte,1.1544941700666143
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),4/625,0.0704280188399859,0.107246503509331,0,0,2.7065742491073306,7.180985632016276,CD86;CLEC7A;IL1B;PRLR,Monocyte,1.1522545282619854
KEGG_2021_Human,protein N-linked glycosylation via asparagine (GO:0018279),1/30,0.0723939657090184,0.1094527814886349,0,0,14.019000703729768,36.80874147674154,ASGR2,Monocyte,1.1402976322627019
KEGG_2021_Human,response to alcohol (GO:0097305),1/30,0.0723939657090184,0.1094527814886349,0,0,14.019000703729768,36.80874147674154,CCL3,Monocyte,1.1402976322627019
KEGG_2021_Human,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/30,0.0723939657090184,0.1094527814886349,0,0,14.019000703729768,36.80874147674154,CD14,Monocyte,1.1402976322627019
KEGG_2021_Human,positive regulation of cellular biosynthetic process (GO:0031328),2/180,0.0745195887056104,0.1118984719378975,0,0,4.628277153558052,12.018216055401329,CLEC7A;IL1B,Monocyte,1.1277295507615273
KEGG_2021_Human,negative regulation of interleukin-6 production (GO:0032715),1/31,0.0747164600026276,0.1118984719378975,0,0,13.551020408163266,35.15209038871121,IL10,Monocyte,1.126583712764908
KEGG_2021_Human,peptidyl-asparagine modification (GO:0018196),1/31,0.0747164600026276,0.1118984719378975,0,0,13.551020408163266,35.15209038871121,ASGR2,Monocyte,1.126583712764908
KEGG_2021_Human,MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/31,0.0747164600026276,0.1118984719378975,0,0,13.551020408163266,35.15209038871121,CD14,Monocyte,1.126583712764908
KEGG_2021_Human,activation of phospholipase C activity (GO:0007202),1/32,0.0770332554327668,0.1140235832163332,0,0,13.113232389730086,33.61600807740255,CD86,Monocyte,1.1133217484244988
KEGG_2021_Human,B cell proliferation (GO:0042100),1/32,0.0770332554327668,0.1140235832163332,0,0,13.113232389730086,33.61600807740255,IL10,Monocyte,1.1133217484244988
KEGG_2021_Human,positive regulation of interleukin-10 production (GO:0032733),1/32,0.0770332554327668,0.1140235832163332,0,0,13.113232389730086,33.61600807740255,CLEC7A,Monocyte,1.1133217484244988
KEGG_2021_Human,positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.0770332554327668,0.1140235832163332,0,0,13.113232389730086,33.61600807740255,IL10,Monocyte,1.1133217484244988
KEGG_2021_Human,modulation by host of symbiont process (GO:0051851),1/32,0.0770332554327668,0.1140235832163332,0,0,13.113232389730086,33.61600807740255,CCL3,Monocyte,1.1133217484244988
KEGG_2021_Human,positive regulation of cytokine production involved in immune response (GO:0002720),1/33,0.0793443657059371,0.1163595201461202,0,0,12.70280612244898,32.18837516559274,CLEC7A,Monocyte,1.1004839073426347
KEGG_2021_Human,positive regulation of histone modification (GO:0031058),1/33,0.0793443657059371,0.1163595201461202,0,0,12.70280612244898,32.18837516559274,IL1B,Monocyte,1.1004839073426347
KEGG_2021_Human,negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.0793443657059371,0.1163595201461202,0,0,12.70280612244898,32.18837516559274,IL10,Monocyte,1.1004839073426347
KEGG_2021_Human,regulation of histone acetylation (GO:0035065),1/33,0.0793443657059371,0.1163595201461202,0,0,12.70280612244898,32.18837516559274,IL1B,Monocyte,1.1004839073426347
KEGG_2021_Human,positive regulation of interleukin-12 production (GO:0032735),1/34,0.0816498044624026,0.1186444527085255,0,0,12.317254174397032,30.85861216573232,CLEC7A,Monocyte,1.0880448509885652
KEGG_2021_Human,response to steroid hormone (GO:0048545),1/34,0.0816498044624026,0.1186444527085255,0,0,12.317254174397032,30.85861216573232,CATSPER1,Monocyte,1.0880448509885652
KEGG_2021_Human,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.0816498044624026,0.1186444527085255,0,0,12.317254174397032,30.85861216573232,IL10,Monocyte,1.0880448509885652
KEGG_2021_Human,organic cyclic compound biosynthetic process (GO:1901362),1/34,0.0816498044624026,0.1186444527085255,0,0,12.317254174397032,30.85861216573232,PRLR,Monocyte,1.0880448509885652
KEGG_2021_Human,negative regulation of neurogenesis (GO:0050768),1/35,0.0839495853612937,0.1214304936319397,0,0,11.95438175270108,29.61744503578088,IL1B,Monocyte,1.0759814445616303
KEGG_2021_Human,positive regulation of lymphocyte activation (GO:0051251),1/35,0.0839495853612937,0.1214304936319397,0,0,11.95438175270108,29.61744503578088,CLEC7A,Monocyte,1.0759814445616303
KEGG_2021_Human,negative regulation of macromolecule metabolic process (GO:0010605),2/194,0.0847375162198589,0.1222916427263873,0,0,4.287760416666667,10.58303673172677,CCR1;CCL3,Monocyte,1.0719242699529004
KEGG_2021_Human,positive regulation of myeloid leukocyte differentiation (GO:0002763),1/36,0.0862437219743075,0.1230668841655849,0,0,11.612244897959185,28.456712045041098,CCR1,Monocyte,1.0642725091375862
KEGG_2021_Human,cellular response to heat (GO:0034605),1/36,0.0862437219743075,0.1230668841655849,0,0,11.612244897959185,28.456712045041098,IL1A,Monocyte,1.0642725091375862
KEGG_2021_Human,negative regulation of toll-like receptor signaling pathway (GO:0034122),1/36,0.0862437219743075,0.1230668841655849,0,0,11.612244897959185,28.456712045041098,CD14,Monocyte,1.0642725091375862
KEGG_2021_Human,macrophage activation (GO:0042116),1/36,0.0862437219743075,0.1230668841655849,0,0,11.612244897959185,28.456712045041098,C1QA,Monocyte,1.0642725091375862
KEGG_2021_Human,positive regulation of T cell mediated immunity (GO:0002711),1/36,0.0862437219743075,0.1230668841655849,0,0,11.612244897959185,28.456712045041098,IL1B,Monocyte,1.0642725091375862
KEGG_2021_Human,negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.0885322278902676,0.1252070483526057,0,0,11.289115646258503,27.36920368672352,IL10,Monocyte,1.0528986067362665
KEGG_2021_Human,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),1/37,0.0885322278902676,0.1252070483526057,0,0,11.289115646258503,27.36920368672352,IL10,Monocyte,1.0528986067362665
KEGG_2021_Human,positive regulation of signaling receptor activity (GO:2000273),1/37,0.0885322278902676,0.1252070483526057,0,0,11.289115646258503,27.36920368672352,IL10,Monocyte,1.0528986067362665
KEGG_2021_Human,regulation of p38MAPK cascade (GO:1900744),1/37,0.0885322278902676,0.1252070483526057,0,0,11.289115646258503,27.36920368672352,IL1B,Monocyte,1.0528986067362665
KEGG_2021_Human,positive regulation of cell development (GO:0010720),1/38,0.0908151166313484,0.1278660733057789,0,0,10.983452840595698,26.34852930034076,CLEC7A,Monocyte,1.0418418549683985
KEGG_2021_Human,lymphocyte proliferation (GO:0046651),1/38,0.0908151166313484,0.1278660733057789,0,0,10.983452840595698,26.34852930034076,IL10,Monocyte,1.0418418549683985
KEGG_2021_Human,regulation of angiogenesis (GO:0045765),2/203,0.0915200219539462,0.1285734821698138,0,0,4.093905472636816,9.789336578359592,IL1A;IL1B,Monocyte,1.0384838843718929
KEGG_2021_Human,regulation of protein tyrosine kinase activity (GO:0061097),1/39,0.0930924017046572,0.130206332780743,0,0,10.693877551020408,25.38900533231373,FCGR1A,Monocyte,1.0310857651239858
KEGG_2021_Human,negative regulation of protein secretion (GO:0050709),1/39,0.0930924017046572,0.130206332780743,0,0,10.693877551020408,25.38900533231373,IL1B,Monocyte,1.0310857651239858
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),2/207,0.0945848472510804,0.1320030285811782,0,0,4.013211382113822,9.464187818681536,CD86;CCL3,Monocyte,1.0241784331789758
KEGG_2021_Human,negative regulation of blood coagulation (GO:0030195),1/40,0.0953640965755271,0.1322187801865933,0,0,10.419152276295131,24.485561288951835,SERPINB2,Monocyte,1.0206151011238414
KEGG_2021_Human,response to organonitrogen compound (GO:0010243),1/40,0.0953640965755271,0.1322187801865933,0,0,10.419152276295131,24.485561288951835,KYNU,Monocyte,1.0206151011238414
KEGG_2021_Human,positive regulation of wound healing (GO:0090303),1/40,0.0953640965755271,0.1322187801865933,0,0,10.419152276295131,24.485561288951835,CLEC7A,Monocyte,1.0206151011238414
KEGG_2021_Human,regulation of cell development (GO:0060284),1/41,0.0976302146847681,0.1344797968000602,0,0,10.158163265306122,23.633660200289185,IL1B,Monocyte,1.0104157556925017
KEGG_2021_Human,cortical cytoskeleton organization (GO:0030865),1/41,0.0976302146847681,0.1344797968000602,0,0,10.158163265306122,23.633660200289185,EPB41L3,Monocyte,1.0104157556925017
KEGG_2021_Human,visual system development (GO:0150063),1/41,0.0976302146847681,0.1344797968000602,0,0,10.158163265306122,23.633660200289185,C1QA,Monocyte,1.0104157556925017
KEGG_2021_Human,positive regulation of epithelial to mesenchymal transition (GO:0010718),1/42,0.0998907694703361,0.135710013332761,0,0,9.909905425584869,22.829231064333683,IL1B,Monocyte,1.00047464143678
KEGG_2021_Human,regulation of DNA recombination (GO:0000018),1/42,0.0998907694703361,0.135710013332761,0,0,9.909905425584869,22.829231064333683,IL10,Monocyte,1.00047464143678
KEGG_2021_Human,negative regulation of protein catabolic process (GO:0042177),1/42,0.0998907694703361,0.135710013332761,0,0,9.909905425584869,22.829231064333683,IL10,Monocyte,1.00047464143678
KEGG_2021_Human,positive regulation of protein tyrosine kinase activity (GO:0061098),1/42,0.0998907694703361,0.135710013332761,0,0,9.909905425584869,22.829231064333683,FCGR1A,Monocyte,1.00047464143678
KEGG_2021_Human,regulation of nervous system development (GO:0051960),1/42,0.0998907694703361,0.135710013332761,0,0,9.909905425584869,22.829231064333683,IL1B,Monocyte,1.00047464143678
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),2/214,0.100019348409027,0.135710013332761,0,0,3.879323899371069,8.931722866735825,IL10;IL1B,Monocyte,0.9999159790553556
KEGG_2021_Human,positive regulation of protein modification process (GO:0031401),2/214,0.100019348409027,0.135710013332761,0,0,3.879323899371069,8.931722866735825,MARCO;IL1B,Monocyte,0.9999159790553556
KEGG_2021_Human,regulation of cytokine production involved in inflammatory response (GO:1900015),1/43,0.1021457742794159,0.1371301620875879,0,0,9.673469387755102,22.068611238785657,CLEC7A,Monocyte,0.9907795952096249
KEGG_2021_Human,negative regulation of proteolysis (GO:0045861),1/43,0.1021457742794159,0.1371301620875879,0,0,9.673469387755102,22.068611238785657,IL10,Monocyte,0.9907795952096249
KEGG_2021_Human,positive regulation of phospholipase C activity (GO:0010863),1/43,0.1021457742794159,0.1371301620875879,0,0,9.673469387755102,22.068611238785657,CD86,Monocyte,0.9907795952096249
KEGG_2021_Human,lipid modification (GO:0030258),1/43,0.1021457742794159,0.1371301620875879,0,0,9.673469387755102,22.068611238785657,PLA2G7,Monocyte,0.9907795952096249
KEGG_2021_Human,negative regulation of type I interferon production (GO:0032480),1/43,0.1021457742794159,0.1371301620875879,0,0,9.673469387755102,22.068611238785657,IL10,Monocyte,0.9907795952096249
KEGG_2021_Human,regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.1043952424647777,0.1398543860023921,0,0,9.448030374940672,21.34849709415977,IL10,Monocyte,0.9813192926974915
KEGG_2021_Human,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),1/45,0.1066391873529346,0.1416650292240868,0,0,9.232838589981448,20.665901611884028,IL10,Monocyte,0.9720831731354668
KEGG_2021_Human,regulation of insulin receptor signaling pathway (GO:0046626),1/45,0.1066391873529346,0.1416650292240868,0,0,9.232838589981448,20.665901611884028,IL1B,Monocyte,0.9720831731354668
KEGG_2021_Human,positive regulation of RNA metabolic process (GO:0051254),1/45,0.1066391873529346,0.1416650292240868,0,0,9.232838589981448,20.665901611884028,IL1B,Monocyte,0.9720831731354668
KEGG_2021_Human,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.1066391873529346,0.1416650292240868,0,0,9.232838589981448,20.665901611884028,IL10,Monocyte,0.9720831731354668
KEGG_2021_Human,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),2/224,0.1079318309204139,0.1428456407075213,0,0,3.702702702702702,8.2431620580209,CLEC7A;IL1B,Monocyte,0.9668504556467957
KEGG_2021_Human,alpha-amino acid metabolic process (GO:1901605),1/46,0.1088776222085674,0.1428456407075213,0,0,9.02721088435374,20.01811780873028,KMO,Monocyte,0.9630613723103648
KEGG_2021_Human,regulation of B cell proliferation (GO:0030888),1/46,0.1088776222085674,0.1428456407075213,0,0,9.02721088435374,20.01811780873028,IL10,Monocyte,0.9630613723103648
KEGG_2021_Human,positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.1088776222085674,0.1428456407075213,0,0,9.02721088435374,20.01811780873028,IL1B,Monocyte,0.9630613723103648
KEGG_2021_Human,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.1088776222085674,0.1428456407075213,0,0,9.02721088435374,20.01811780873028,IL10,Monocyte,0.9630613723103648
KEGG_2021_Human,positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.1088776222085674,0.1428456407075213,0,0,9.02721088435374,20.01811780873028,IL10,Monocyte,0.9630613723103648
KEGG_2021_Human,regulation of wound healing (GO:0061041),1/47,0.1111105603036554,0.145474651119219,0,0,8.830523513753327,19.4026870705364,CLEC7A,Monocyte,0.9542446623584087
KEGG_2021_Human,negative regulation of MAP kinase activity (GO:0043407),1/48,0.1133380148369131,0.1468768151457955,0,0,8.642205818497612,18.81737166641443,IL1B,Monocyte,0.9456243984787533
KEGG_2021_Human,negative regulation of mitotic cell cycle (GO:0045930),1/48,0.1133380148369131,0.1468768151457955,0,0,8.642205818497612,18.81737166641443,IL10,Monocyte,0.9456243984787533
KEGG_2021_Human,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.1133380148369131,0.1468768151457955,0,0,8.642205818497612,18.81737166641443,IL10,Monocyte,0.9456243984787533
KEGG_2021_Human,regulation of interleukin-10 production (GO:0032653),1/48,0.1133380148369131,0.1468768151457955,0,0,8.642205818497612,18.81737166641443,CLEC7A,Monocyte,0.9456243984787533
KEGG_2021_Human,myelination (GO:0042552),1/48,0.1133380148369131,0.1468768151457955,0,0,8.642205818497612,18.81737166641443,EPB41L3,Monocyte,0.9456243984787533
KEGG_2021_Human,negative regulation of catabolic process (GO:0009895),1/49,0.1155599990222406,0.1485437234395198,0,0,8.46173469387755,18.260130793597916,IL1B,Monocyte,0.9371924705024297
KEGG_2021_Human,cellular defense response (GO:0006968),1/49,0.1155599990222406,0.1485437234395198,0,0,8.46173469387755,18.260130793597916,CD300C,Monocyte,0.9371924705024297
KEGG_2021_Human,cellular response to mechanical stimulus (GO:0071260),1/49,0.1155599990222406,0.1485437234395198,0,0,8.46173469387755,18.260130793597916,IL1B,Monocyte,0.9371924705024297
KEGG_2021_Human,positive regulation of reactive oxygen species metabolic process (GO:2000379),1/49,0.1155599990222406,0.1485437234395198,0,0,8.46173469387755,18.260130793597916,CLEC7A,Monocyte,0.9371924705024297
KEGG_2021_Human,neutrophil degranulation (GO:0043312),3/481,0.1186966169654727,0.1522673773193439,0,0,2.6001958515089467,5.541497039756371,OLR1;CD14;CD68,Monocyte,0.9255616589237978
KEGG_2021_Human,positive regulation of fat cell differentiation (GO:0045600),1/51,0.1199876089220907,0.1533040878582044,0,0,8.122448979591837,17.22257115519733,CDS1,Monocyte,0.9208636010741894
KEGG_2021_Human,blood circulation (GO:0008015),1/51,0.1199876089220907,0.1533040878582044,0,0,8.122448979591837,17.22257115519733,OLR1,Monocyte,0.9208636010741894
KEGG_2021_Human,neutrophil activation involved in immune response (GO:0002283),3/485,0.1208716599427582,0.1541235021358464,0,0,2.578087754921868,5.447566347932984,OLR1;CD14;CD68,Monocyte,0.9176755136408634
KEGG_2021_Human,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.1221932608707862,0.155496434174247,0,0,7.962785114045619,16.738979733033663,EPB41L3,Monocyte,0.9129527453809976
KEGG_2021_Human,neutrophil mediated immunity (GO:0002446),3/488,0.1225128127530552,0.1555912721963802,0,0,2.561745996929151,5.3784873208449016,OLR1;CD14;CD68,Monocyte,0.9118184891201561
KEGG_2021_Human,regulation of immune effector process (GO:0002697),1/53,0.1243934949128716,0.1576644097199072,0,0,7.809262166405024,16.276887238960814,C1QA,Monocyte,0.9052023302345248
KEGG_2021_Human,regulation of humoral immune response (GO:0002920),1/54,0.1265883240687765,0.1601266649077152,0,0,7.661532537543319,15.834970375184442,C1QA,Monocyte,0.8976063498190403
KEGG_2021_Human,negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/55,0.1287777613922166,0.1625723230299355,0,0,7.519274376417234,15.412009607623004,IL1RN,Monocyte,0.8901591287349465
KEGG_2021_Human,negative regulation of metabolic process (GO:0009892),1/56,0.1309618198144747,0.1650014991710147,0,0,7.382189239332097,15.00687933540933,IL1B,Monocyte,0.8828552987007785
KEGG_2021_Human,positive regulation of phosphorylation (GO:0042327),2/253,0.1317582069542016,0.1656761612196397,0,0,3.270086321381142,6.627767796360294,MARCO;IL1B,Monocyte,0.880222323941479
KEGG_2021_Human,positive regulation of proteolysis (GO:0045862),1/57,0.1331405122852093,0.1670834492116757,0,0,7.25,14.618539131965724,IL1B,Monocyte,0.8756897763447542
KEGG_2021_Human,positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.1353667229633477,0.169542148090189,0,0,2.442871502764282,4.885175568190959,IL10;CD86;IL1B,Monocyte,0.8684880846140173
KEGG_2021_Human,positive regulation of cell differentiation (GO:0045597),2/258,0.1359834100026853,0.1699792625033566,0,0,3.2054036458333335,6.395493110208526,CDS1;IL1B,Monocyte,0.8665140723928182
KEGG_2021_Human,negative regulation of autophagy (GO:0010507),1/59,0.1374818510452552,0.1715146864709961,0,0,6.9992962702322306,13.8884471557023,IL10,Monocyte,0.8617546291873563
KEGG_2021_Human,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.1396445230534406,0.1738711218410486,0,0,6.88031822898651,13.544974303558986,MARCO,Monocyte,0.8549760929333525
KEGG_2021_Human,B cell differentiation (GO:0030183),1/61,0.1418018805927374,0.1758675667507583,0,0,6.76530612244898,13.214837540593155,IL10,Monocyte,0.848318009451734
KEGG_2021_Human,pattern recognition receptor signaling pathway (GO:0002221),1/61,0.1418018805927374,0.1758675667507583,0,0,6.76530612244898,13.214837540593155,CD14,Monocyte,0.848318009451734
KEGG_2021_Human,regulation of protein phosphorylation (GO:0001932),2/266,0.1428070813555834,0.1767689993387826,0,0,3.1070075757575757,6.047046555927847,MARCO;IL1B,Monocyte,0.8452502567236859
KEGG_2021_Human,negative regulation of signal transduction (GO:0009968),2/267,0.1436652916283004,0.1771526156166043,0,0,3.095125786163522,6.005376764494242,IL10;IL1B,Monocyte,0.8426481412255155
KEGG_2021_Human,I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/62,0.1439539364695556,0.1771526156166043,0,0,6.654064904650385,12.897320592663672,CD14,Monocyte,0.8417764546925935
KEGG_2021_Human,regulation of neurogenesis (GO:0050767),1/62,0.1439539364695556,0.1771526156166043,0,0,6.654064904650385,12.897320592663672,IL1B,Monocyte,0.8417764546925935
KEGG_2021_Human,negative regulation of endopeptidase activity (GO:0010951),1/63,0.1461007034145454,0.1787551958925555,0,0,6.54641211323239,12.591756250239603,SERPINB2,Monocyte,0.8353476931121088
KEGG_2021_Human,negative regulation of peptidase activity (GO:0010466),1/63,0.1461007034145454,0.1787551958925555,0,0,6.54641211323239,12.591756250239603,SERPINB2,Monocyte,0.8353476931121088
KEGG_2021_Human,organonitrogen compound catabolic process (GO:1901565),1/63,0.1461007034145454,0.1787551958925555,0,0,6.54641211323239,12.591756250239603,PLA2G7,Monocyte,0.8353476931121088
KEGG_2021_Human,plasma membrane organization (GO:0007009),1/64,0.1482421941802595,0.1810265255855093,0,0,6.442176870748299,12.297522293260638,EPB41L3,Monocyte,0.8290281655096747
KEGG_2021_Human,inorganic cation transmembrane transport (GO:0098662),2/274,0.1497038344955427,0.1824605276481183,0,0,3.014399509803922,5.724635176902424,SLC24A4;KCNK13,Monocyte,0.8247670755492156
KEGG_2021_Human,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/65,0.1503784214913892,0.182581831065071,0,0,6.341198979591836,12.01403781811508,CCR1,Monocyte,0.8228144782361342
KEGG_2021_Human,steroid biosynthetic process (GO:0006694),1/65,0.1503784214913892,0.182581831065071,0,0,6.341198979591836,12.01403781811508,PRLR,Monocyte,0.8228144782361342
KEGG_2021_Human,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.1841130564914884,0,0,6.243328100470958,11.740759916332207,C1QA,Monocyte,0.8167033932798328
KEGG_2021_Human,cell-cell junction assembly (GO:0007043),1/66,0.1525093979756266,0.1841130564914884,0,0,6.243328100470958,11.740759916332207,EPB41L3,Monocyte,0.8167033932798328
KEGG_2021_Human,cellular response to nutrient levels (GO:0031669),1/66,0.1525093979756266,0.1841130564914884,0,0,6.243328100470958,11.740759916332207,CD68,Monocyte,0.8167033932798328
KEGG_2021_Human,protein N-linked glycosylation (GO:0006487),1/67,0.1546351363099914,0.1859721809788723,0,0,6.148423005565863,11.477180657220888,ASGR2,Monocyte,0.8106918184915987
KEGG_2021_Human,positive regulation of catabolic process (GO:0009896),1/67,0.1546351363099914,0.1859721809788723,0,0,6.148423005565863,11.477180657220888,IL1B,Monocyte,0.8106918184915987
KEGG_2021_Human,interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.1567556490806558,0.1881660437924697,0,0,6.0563508985683825,11.222824361971773,FCGR1A,Monocyte,0.8047767993307415
KEGG_2021_Human,negative regulation of cellular catabolic process (GO:0031330),1/69,0.158870948881139,0.1896297980066227,0,0,5.966986794717887,10.977245117600177,IL10,Monocyte,0.7989555105590889
KEGG_2021_Human,positive regulation of protein transport (GO:0051222),1/69,0.158870948881139,0.1896297980066227,0,0,5.966986794717887,10.977245117600177,IL1A,Monocyte,0.7989555105590889
KEGG_2021_Human,peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.158870948881139,0.1896297980066227,0,0,5.966986794717887,10.977245117600177,PRLR,Monocyte,0.7989555105590889
KEGG_2021_Human,defense response to Gram-positive bacterium (GO:0050830),1/70,0.1609810482853106,0.1917879280697415,0,0,5.880212954747116,10.740024519792764,MPEG1,Monocyte,0.7932252488723367
KEGG_2021_Human,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/71,0.16308595979881,0.1932081799855305,0,0,5.795918367346939,10.51076961698872,FCGR1A,Monocyte,0.7875834261109624
KEGG_2021_Human,response to metal ion (GO:0010038),1/71,0.16308595979881,0.1932081799855305,0,0,5.795918367346939,10.51076961698872,IL1A,Monocyte,0.7875834261109624
KEGG_2021_Human,regulation of endopeptidase activity (GO:0052548),1/71,0.16308595979881,0.1932081799855305,0,0,5.795918367346939,10.51076961698872,SERPINB2,Monocyte,0.7875834261109624
KEGG_2021_Human,Fc-gamma receptor signaling pathway (GO:0038094),1/72,0.1651856959101235,0.1946065248662866,0,0,5.713998275366484,10.28911103101624,FCGR1A,Monocyte,0.78202756268309
KEGG_2021_Human,cell junction organization (GO:0034330),1/72,0.1651856959101235,0.1946065248662866,0,0,5.713998275366484,10.28911103101624,C1QA,Monocyte,0.78202756268309
KEGG_2021_Human,positive regulation of protein secretion (GO:0050714),1/72,0.1651856959101235,0.1946065248662866,0,0,5.713998275366484,10.28911103101624,IL1A,Monocyte,0.78202756268309
KEGG_2021_Human,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",1/73,0.1672802691231711,0.1959833411313905,0,0,5.634353741496598,10.074701240888364,FCGR1A,Monocyte,0.7765552814899175
KEGG_2021_Human,positive regulation of JNK cascade (GO:0046330),1/73,0.1672802691231711,0.1959833411313905,0,0,5.634353741496598,10.074701240888364,IL1B,Monocyte,0.7765552814899175
KEGG_2021_Human,defense response to Gram-negative bacterium (GO:0050829),1/73,0.1672802691231711,0.1959833411313905,0,0,5.634353741496598,10.074701240888364,MPEG1,Monocyte,0.7765552814899175
KEGG_2021_Human,Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/74,0.1693696918266344,0.1977017542461634,0,0,5.556891249650545,9.867213018330611,FCGR1A,Monocyte,0.7711643026835198
KEGG_2021_Human,regulation of peptide hormone secretion (GO:0090276),1/74,0.1693696918266344,0.1977017542461634,0,0,5.556891249650545,9.867213018330611,IL1B,Monocyte,0.7711643026835198
KEGG_2021_Human,actomyosin structure organization (GO:0031032),1/76,0.1735331353639065,0.2014507147277525,0,0,5.408163265306122,9.4717853003048,EPB41L3,Monocyte,0.7606175863963804
KEGG_2021_Human,establishment of protein localization to organelle (GO:0072594),1/76,0.1735331353639065,0.2014507147277525,0,0,5.408163265306122,9.4717853003048,CD68,Monocyte,0.7606175863963804
KEGG_2021_Human,regulation of epithelial to mesenchymal transition (GO:0010717),1/76,0.1735331353639065,0.2014507147277525,0,0,5.408163265306122,9.4717853003048,IL1B,Monocyte,0.7606175863963804
KEGG_2021_Human,MAPK cascade (GO:0000165),2/303,0.1752338998526144,0.2027464725073409,0,0,2.7199612403100777,4.737175959955004,IL1B;CCL3,Monocyte,0.7563818736544428
KEGG_2021_Human,positive regulation of type I interferon production (GO:0032481),1/77,0.1756071809118701,0.2027464725073409,0,0,5.336734693877551,9.283280446293812,CD14,Monocyte,0.7554577289388229
KEGG_2021_Human,phosphatidylcholine metabolic process (GO:0046470),1/77,0.1756071809118701,0.2027464725073409,0,0,5.336734693877551,9.283280446293812,PLA2G7,Monocyte,0.7554577289388229
KEGG_2021_Human,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),1/78,0.1776761254379788,0.204391919661443,0,0,5.267161410018553,9.10056411919043,FCGR1A,Monocyte,0.7503709249641564
KEGG_2021_Human,negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.1776761254379788,0.204391919661443,0,0,5.267161410018553,9.10056411919043,IL1B,Monocyte,0.7503709249641564
KEGG_2021_Human,negative regulation of cell cycle (GO:0045786),1/80,0.181798760490535,0.2076298793372117,0,0,5.133298889175924,8.751529842637671,IL10,Monocyte,0.7404090821369118
KEGG_2021_Human,glycerophospholipid metabolic process (GO:0006650),1/80,0.181798760490535,0.2076298793372117,0,0,5.133298889175924,8.751529842637671,PLA2G7,Monocyte,0.7404090821369118
KEGG_2021_Human,regulation of fat cell differentiation (GO:0045598),1/80,0.181798760490535,0.2076298793372117,0,0,5.133298889175924,8.751529842637671,CDS1,Monocyte,0.7404090821369118
KEGG_2021_Human,lipid biosynthetic process (GO:0008610),1/80,0.181798760490535,0.2076298793372117,0,0,5.133298889175924,8.751529842637671,PRLR,Monocyte,0.7404090821369118
KEGG_2021_Human,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.1838524754991919,0.2095984235942314,0,0,5.0688775510204085,8.584760541358477,FPR3,Monocyte,0.7355305181562768
KEGG_2021_Human,lymphocyte differentiation (GO:0030098),1/84,0.1899833569114356,0.2161996982773505,0,0,4.884927464961889,8.112979399077096,IL10,Monocyte,0.7212844428267129
KEGG_2021_Human,positive regulation of protein catabolic process (GO:0045732),1/85,0.1920169366451308,0.2181229960101218,0,0,4.826530612244898,7.964604221414354,IL1B,Monocyte,0.716660463134361
KEGG_2021_Human,regulation of neuron death (GO:1901214),1/86,0.1940455128548384,0.2200337511836115,0,0,4.769507803121249,7.820383303288144,C1QA,Monocyte,0.7120963955156414
KEGG_2021_Human,calcium ion transmembrane transport (GO:0070588),1/87,0.196069097589664,0.2215371476324495,0,0,4.713811105837684,7.6801565438185,SLC24A4,Monocyte,0.7075908500030543
KEGG_2021_Human,sodium ion transmembrane transport (GO:0035725),1/87,0.196069097589664,0.2215371476324495,0,0,4.713811105837684,7.6801565438185,SLC24A4,Monocyte,0.7075908500030543
KEGG_2021_Human,regulation of type I interferon production (GO:0032479),1/89,0.2001013407742902,0.2256915655269526,0,0,4.6062152133580705,7.411084001248333,CD14,Monocyte,0.6987500013741589
KEGG_2021_Human,sodium ion transport (GO:0006814),1/90,0.2021100231923967,0.2275529516439219,0,0,4.55423068103646,7.281955543769811,SLC24A4,Monocyte,0.6944121480917811
KEGG_2021_Human,toll-like receptor signaling pathway (GO:0002224),1/91,0.2041137620931186,0.2294021927949209,0,0,4.503401360544218,7.156255051106618,CD14,Monocyte,0.6901277125812961
KEGG_2021_Human,positive regulation of cellular component biogenesis (GO:0044089),1/92,0.2061125694363157,0.2304251436479938,0,0,4.453689167974883,7.03385741012878,CLEC7A,Monocyte,0.6858955226779435
KEGG_2021_Human,T cell activation (GO:0042110),1/92,0.2061125694363157,0.2304251436479938,0,0,4.453689167974883,7.03385741012878,CLEC7A,Monocyte,0.6858955226779435
KEGG_2021_Human,regulation of lipid metabolic process (GO:0019216),1/92,0.2061125694363157,0.2304251436479938,0,0,4.453689167974883,7.03385741012878,IL1B,Monocyte,0.6858955226779435
KEGG_2021_Human,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2340536883651374,0,0,4.357472021066491,6.79849904676328,IL10,Monocyte,0.6775833802166729
KEGG_2021_Human,negative regulation of MAPK cascade (GO:0043409),1/94,0.2100954368002021,0.2340536883651374,0,0,4.357472021066491,6.79849904676328,IL1B,Monocyte,0.6775833802166729
KEGG_2021_Human,positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.2160330472811356,0.2394083508263893,0,0,4.220663265306122,6.46742313757927,PRLR,Monocyte,0.6654798083211632
KEGG_2021_Human,glycosaminoglycan biosynthetic process (GO:0006024),1/97,0.2160330472811356,0.2394083508263893,0,0,4.220663265306122,6.46742313757927,IL1B,Monocyte,0.6654798083211632
KEGG_2021_Human,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2394083508263893,0,0,4.220663265306122,6.46742313757927,IL1B,Monocyte,0.6654798083211632
KEGG_2021_Human,regulation of neuron apoptotic process (GO:0043523),1/98,0.2180025137484037,0.2411700282756731,0,0,4.176940879444562,6.362519703204576,CCL3,Monocyte,0.6615384985937142
KEGG_2021_Human,sensory perception of chemical stimulus (GO:0007606),1/99,0.2199671313012003,0.242498486764344,0,0,4.134110787172012,6.26018948804807,SLC24A4,Monocyte,0.6576422090003602
KEGG_2021_Human,positive regulation of stress-activated MAPK cascade (GO:0032874),1/99,0.2199671313012003,0.242498486764344,0,0,4.134110787172012,6.26018948804807,IL1B,Monocyte,0.6576422090003602
KEGG_2021_Human,steroid metabolic process (GO:0008202),1/104,0.2297178930745814,0.2523717337411059,0,0,3.932435109966317,5.78423168094792,PRLR,Monocyte,0.6388051756325536
KEGG_2021_Human,regulation of insulin secretion (GO:0050796),1/104,0.2297178930745814,0.2523717337411059,0,0,3.932435109966317,5.78423168094792,IL1B,Monocyte,0.6388051756325536
KEGG_2021_Human,regulation of JNK cascade (GO:0046328),1/105,0.2316536615468536,0.2540588516101071,0,0,3.894427001569859,5.6956456810845415,IL1B,Monocyte,0.6351608308934773
KEGG_2021_Human,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2557349320559646,0,0,3.857142857142857,5.6090983677319475,IL1B,Monocyte,0.6315556772929499
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.2593437308396011,0,0,2.2110433604336044,3.18053102486219,MARCO;IL1B,Monocyte,0.6247218387200065
KEGG_2021_Human,modulation of chemical synaptic transmission (GO:0050804),1/109,0.239349173739861,0.2611455761594703,0,0,3.749433106575964,5.361058744932435,IL1B,Monocyte,0.6209680674126086
KEGG_2021_Human,sensory perception of smell (GO:0007608),1/111,0.2431685532271013,0.26485768661957,0,0,3.6808905380333954,5.20478084558139,SLC24A4,Monocyte,0.6140925891155178
KEGG_2021_Human,phosphatidylinositol metabolic process (GO:0046488),1/112,0.2450711886958998,0.2664729534621513,0,0,3.647545504688362,5.129202360192396,CDS1,Monocyte,0.6107077427090284
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),2/381,0.2465612635256485,0.2676348757927979,0,0,2.15160510114336,3.012558657024939,IL10;PRLR,Monocyte,0.6080751530383309
KEGG_2021_Human,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.2692123151454096,0,0,3.582625970742279,4.982913653406146,CLEC7A,Monocyte,0.6040407011916724
KEGG_2021_Human,response to lipid (GO:0033993),1/114,0.2488624078588274,0.2692123151454096,0,0,3.582625970742279,4.982913653406146,IL1B,Monocyte,0.6040407011916724
KEGG_2021_Human,regulation of protein-containing complex assembly (GO:0043254),1/116,0.2526349665899778,0.2723653714509948,0,0,3.5199645075421473,4.8428011439058265,CLEC7A,Monocyte,0.5975065399797567
KEGG_2021_Human,ion transport (GO:0006811),1/116,0.2526349665899778,0.2723653714509948,0,0,3.5199645075421473,4.8428011439058265,SLC24A4,Monocyte,0.5975065399797567
KEGG_2021_Human,positive regulation of protein-containing complex assembly (GO:0031334),1/118,0.2563889548341396,0.2759440446096248,0,0,3.4594453165881736,4.708511372057024,CLEC7A,Monocyte,0.5911006880374128
KEGG_2021_Human,synapse organization (GO:0050808),1/126,0.2712209880572274,0.2909211611762489,0,0,3.236734693877551,4.223360488574632,C1QA,Monocyte,0.5666767062328689
KEGG_2021_Human,phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.2712209880572274,0.2909211611762489,0,0,3.236734693877551,4.223360488574632,CDS1,Monocyte,0.5666767062328689
KEGG_2021_Human,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.2963061244641806,0,0,3.1603954081632653,4.060453122404681,IL1B,Monocyte,0.5579784037567757
KEGG_2021_Human,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3054873636819122,0,0,3.0408163265306123,3.80890385676326,FCGR1A,Monocyte,0.5439940297149167
KEGG_2021_Human,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.3088061739082012,0,0,2.99546485260771,3.714691124222948,EPB41L3,Monocyte,0.5385707850387818
KEGG_2021_Human,neuron projection morphogenesis (GO:0048812),1/140,0.2964824884084789,0.3153540705852329,0,0,2.9086771399207163,3.5362740390257685,EPB41L3,Monocyte,0.5280009529309525
KEGG_2021_Human,protein localization to cell periphery (GO:1990778),1/140,0.2964824884084789,0.3153540705852329,0,0,2.9086771399207163,3.5362740390257685,EPB41L3,Monocyte,0.5280009529309525
KEGG_2021_Human,positive regulation of cellular catabolic process (GO:0031331),1/141,0.2982536777952956,0.3165653113901202,0,0,2.8877551020408165,3.4936375609484274,IL1B,Monocyte,0.5254141922968343
KEGG_2021_Human,regulation of intracellular signal transduction (GO:1902531),2/437,0.2986183016105228,0.3165653113901202,0,0,1.8692528735632183,2.259158656282815,CLEC7A;IL1B,Monocyte,0.5248835789121016
KEGG_2021_Human,protein localization to organelle (GO:0033365),1/142,0.3000204969826995,0.3175216926400237,0,0,2.8671298306556667,3.4517504575709377,CD68,Monocyte,0.522849073872343
KEGG_2021_Human,negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.3017829564686885,0.3183258760093309,0,0,2.8467950560505892,3.410594866305226,NLRP3,Monocyte,0.5203052911363482
KEGG_2021_Human,monocarboxylic acid metabolic process (GO:0032787),1/143,0.3017829564686885,0.3183258760093309,0,0,2.8467950560505892,3.410594866305226,KYNU,Monocyte,0.5203052911363482
KEGG_2021_Human,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3270094430629807,0,0,2.749271137026239,3.215201203875706,IL1B,Monocyte,0.5078961191737069
KEGG_2021_Human,positive regulation of protein kinase activity (GO:0045860),1/154,0.3208852696222714,0.3373545467055337,0,0,2.640656262505002,3.0015590720273457,FCGR1A,Monocyte,0.493650218923809
KEGG_2021_Human,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.3563086165895322,0,0,2.4621702339472376,2.6600168495918335,MARCO,Monocyte,0.46919202564454415
KEGG_2021_Human,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.3574653750853774,0,0,2.4471243042671613,2.6317886779390967,IL1B,Monocyte,0.4670671197091842
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",4/1183,0.3428517320675613,0.3581297932829171,0,0,1.384445181989158,1.481989303783668,IL10;CD86;IL1B;NLRP3,Monocyte,0.4648936521619021
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),2/485,0.3429022272693128,0.3581297932829171,0,0,1.6793478260869563,1.797422644350721,IL10;PRLR,Monocyte,0.46482969398207885
KEGG_2021_Human,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3591638684157086,0,0,2.4175730172308443,2.5766088705447237,PRLR,Monocyte,0.46286379212748074
KEGG_2021_Human,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.3494039111808349,0.3631284510635518,0,0,2.3745498199279713,2.4969025061029213,CLEC7A,Monocyte,0.4566722378913039
KEGG_2021_Human,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.3631284510635518,0,0,2.3745498199279713,2.4969025061029213,EPB41L3,Monocyte,0.4566722378913039
KEGG_2021_Human,defense response to bacterium (GO:0042742),1/176,0.3575660373570176,0.3710039766694546,0,0,2.306122448979592,2.3716975343886144,MPEG1,Monocyte,0.4466437384468818
KEGG_2021_Human,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.359186378521905,0.3720772436564594,0,0,2.2929035250463823,2.3477357103628296,CDS1,Monocyte,0.44468014150624274
KEGG_2021_Human,regulation of mitotic cell cycle (GO:0007346),1/178,0.3608027143922477,0.3731428723763474,0,0,2.279833967485299,2.3241173885161555,IL10,Monocyte,0.44273020383203454
KEGG_2021_Human,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.3791705792120899,0,0,2.2289998872477166,2.2329492942532405,IL10,Monocyte,0.4350639775318079
KEGG_2021_Human,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.3996344933748283,0,0,2.0782663580896275,1.969329769675335,EPB41L3,Monocyte,0.4115300469974289
KEGG_2021_Human,negative regulation of intracellular signal transduction (GO:1902532),1/198,0.3923030921692546,0.4037479149553917,0,0,2.0463068476121413,1.914771355908193,NLRP3,Monocyte,0.4063782687077012
KEGG_2021_Human,regulation of macromolecule metabolic process (GO:0060255),1/200,0.3953681557510544,0.4062439788056951,0,0,2.025535842477695,1.8795714928238216,IL10,Monocyte,0.40299831311675843
KEGG_2021_Human,generation of neurons (GO:0048699),1/202,0.398418067592006,0.4087164344441418,0,0,2.0051781906792567,1.8452720554356252,IL1B,Monocyte,0.39966097527446726
KEGG_2021_Human,regulation of autophagy (GO:0010506),1/231,0.4409837467017168,0.451652708315468,0,0,1.749778172138421,1.4326260836369302,IL10,Monocyte,0.35557741698984124
KEGG_2021_Human,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.480544890611996,0,0,1.6016749329213755,1.2094704650298027,IL1B,Monocyte,0.32794816113488356
KEGG_2021_Human,protein deubiquitination (GO:0016579),1/267,0.4897346646287026,0.4999702765903957,0,0,1.510204081632653,1.0781219104526054,NLRP3,Monocyte,0.3100391544580995
KEGG_2021_Human,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.500485580779554,0,0,1.504471451501949,1.0700627976731167,C1QA,Monocyte,0.3088941088615854
KEGG_2021_Human,protein modification by small protein removal (GO:0070646),1/276,0.50125602230015,0.5100922662830052,0,0,1.4601113172541744,1.0084087773272885,NLRP3,Monocyte,0.29994039654430615
KEGG_2021_Human,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.521978770881455,0,0,1.4081632653061225,0.937839142501346,CLEC7A,Monocyte,0.289240867544339
KEGG_2021_Human,proteolysis (GO:0006508),1/287,0.51499186851511,0.5223959049634103,0,0,1.4031682603111175,0.9311483055746664,OLR1,Monocyte,0.28819962821492023
KEGG_2021_Human,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5494473269070064,0,0,1.2972062611452349,0.7932686422257892,CCL3,Monocyte,0.2655801196036423
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),2/742,0.5583209845238664,0.5645443075997693,0,0,1.0816441441441442,0.6304051823091851,IL10;PRLR,Monocyte,0.25311604886163686
KEGG_2021_Human,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.5694906731348991,0,0,1.2208810353409656,0.6989624697257846,EPB41L3,Monocyte,0.24863646405532092
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.6450618663025979,0,0,0.989871879272801,0.4417939051458828,PRLR,Monocyte,0.19383180708628664
KEGG_2021_Human,organelle organization (GO:0006996),1/420,0.6544076492323022,0.6585560336965324,0,0,0.9512931664312504,0.4033718992390181,CCL3,Monocyte,0.18415163293091988
KEGG_2021_Human,organelle assembly (GO:0070925),1/425,0.658798168385351,0.6619253748808511,0,0,0.939834424335772,0.3922286762298742,CDS1,Monocyte,0.18124761694193237
KEGG_2021_Human,positive regulation of transcription by RNA polymerase II (GO:0045944),2/908,0.6694431207036386,0.6715582648448825,0,0,0.8758278145695364,0.3514776504163603,IL10;NLRP3,Monocyte,0.17428631695508484
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",3/2244,0.9302128294243438,0.931680042089051,0,0,0.5044005810475947,0.036489281349511,IL10;CD86;IL1B,Monocyte,0.03141767502685046
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),1/2206,0.9971209346049892,0.9971209346049892,0,0,0.1642371234207968,0.00047353141012936674,NLRP3,Monocyte,0.0012521656136179045
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),15/481,4.3620418595117584e-13,1.020617767164476e-10,0,0,17.919068056407113,509.98860999528455,MGAM;SERPINA1;CR1;SLC11A1;C5AR1;FPR1;FPR2;LILRB3;SIRPB1;MMP25;FCGR2A;FCGR3B;ADGRE3;CXCR2;ITGAX,Neutrophil,12.36031017111226
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),15/485,4.915070642085154e-13,1.020617767164476e-10,0,0,17.762917933130698,503.4241874867491,MGAM;SERPINA1;CR1;SLC11A1;C5AR1;FPR1;FPR2;LILRB3;SIRPB1;MMP25;FCGR2A;FCGR3B;ADGRE3;CXCR2;ITGAX,Neutrophil,12.308470235869017
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),15/488,5.3716724587604e-13,1.020617767164476e-10,0,0,17.647538508003624,498.58649763543247,MGAM;SERPINA1;CR1;SLC11A1;C5AR1;FPR1;FPR2;LILRB3;SIRPB1;MMP25;FCGR2A;FCGR3B;ADGRE3;CXCR2;ITGAX,Neutrophil,12.269890476585925
GO_Biological_Process_2021,inflammatory response (GO:0006954),9/230,5.002635637635646e-09,7.128755783630795e-07,0,0,19.59618143692749,374.5477129978672,IL1RN;MMP25;SLC11A1;C5AR1;CXCR2;FPR1;PROK2;FPR2;MEFV,Neutrophil,8.300801127403771
GO_Biological_Process_2021,complement receptor mediated signaling pathway (GO:0002430),4/11,1.1255388293226212e-08,1.283114265427788e-06,0,0,247.7391304347826,4534.225334112145,CR1;C5AR1;FPR1;FPR2,Neutrophil,7.948639517927195
GO_Biological_Process_2021,immune response-activating cell surface receptor signaling pathway (GO:0002429),4/24,3.538707538969472e-07,3.3617721620209985e-05,0,0,86.65217391304348,1287.1603411426952,CR1;C5AR1;FPR1;FPR2,Neutrophil,6.451155328704732
GO_Biological_Process_2021,innate immune response (GO:0045087),7/302,9.561909372105728e-06,0.0007786126203000378,0,0,10.84627512810406,125.35824487609356,CR1;SLC11A1;CLEC4E;MEFV;TREM1;SIRPB1;APOBEC3A,Neutrophil,5.019455376869147
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),5/147,3.252323044018875e-05,0.0021278355508968,0,0,15.49921752738654,160.1620313639072,C5AR1;CXCR2;FPR1;PROK2;FPR2,Neutrophil,4.487806323696984
GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),5/148,3.359740343521294e-05,0.0021278355508968,0,0,15.39005439005439,158.53390095708875,C5AR1;CXCR2;FPR1;PROK2;FPR2,Neutrophil,4.473694285626042
GO_Biological_Process_2021,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),4/81,4.98959147333325e-05,0.0028440671397999,0,0,22.442687747035578,222.30764650625184,C5AR1;CXCR2;FPR1;FPR2,Neutrophil,4.3019350111181165
GO_Biological_Process_2021,second-messenger-mediated signaling (GO:0019932),4/89,7.21571171107513e-05,0.0037390506139207,0,0,20.32225063938619,193.80648896314605,LRRK2;CXCR2;FPR1;FPR2,Neutrophil,4.141720826462557
GO_Biological_Process_2021,regulation of immune response (GO:0050776),5/179,8.302771912954982e-05,0.0039438166586536,0,0,12.628352490421456,118.66024363795388,FCGR2A;FCGR3B;JAML;PILRA;TREM1,Neutrophil,4.080776892500167
GO_Biological_Process_2021,macrophage activation (GO:0042116),3/36,9.903955378900077e-05,0.0043425035122869,0,0,38.524177949709866,355.1925837792589,SLC11A1;C5AR1;FPR2,Neutrophil,4.004191324981987
GO_Biological_Process_2021,pantothenate metabolic process (GO:0015939),2/7,0.00012760097078443218,0.0051951823819375,0,0,166.20833333333334,1490.3240703269437,VNN2;VNN3,Neutrophil,3.8941460215026447
GO_Biological_Process_2021,positive regulation of phagocytosis (GO:0050766),3/53,0.000315376219123607,0.011984296326697,0,0,25.404255319148938,204.80261014345277,SLC11A1;FPR2;SIRPB1,Neutrophil,3.501171057655084
GO_Biological_Process_2021,regulation of phagocytosis (GO:0050764),3/58,0.00041177118298551824,0.014669348393859,0,0,23.088974854932303,179.97954590931704,SLC11A1;FPR2;SIRPB1,Neutrophil,3.3853440499187784
GO_Biological_Process_2021,manganese ion transport (GO:0006828),2/14,0.0005467878206419364,0.0183334739862296,0,0,69.22916666666667,520.0114050756229,SLC11A1;ATP2C2,Neutrophil,3.2621811676355046
GO_Biological_Process_2021,cellular response to fatty acid (GO:0071398),2/17,0.0008132713373134499,0.0257535923482592,0,0,55.375,393.96243373102385,DGAT2;FFAR2,Neutrophil,3.089764533572175
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),7/625,0.0008747234504077011,0.026241703512231,0,0,5.092345902009483,35.858277051349106,CR1;SLC11A1;CXCR2;ITGAX;PROK2;FPR2;SIRPB1,Neutrophil,3.058129230344244
GO_Biological_Process_2021,microglial cell activation (GO:0001774),2/22,0.001370383663162,0.039055934400117,0,0,41.520833333333336,273.7329252658829,C5AR1;FPR2,Neutrophil,2.8631578273928713
GO_Biological_Process_2021,positive regulation of transport (GO:0051050),3/91,0.0015300336428855,0.041529484592609,0,0,14.406673114119922,93.39076222450518,SLC11A1;FPR2;SIRPB1,Neutrophil,2.8152990196667855
GO_Biological_Process_2021,long-chain fatty-acyl-CoA metabolic process (GO:0035336),2/24,0.0016321249773357,0.0422868744127905,0,0,37.74242424242424,242.22606459531664,DGAT2;ACSL1,Neutrophil,2.7872465889099036
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),3/102,0.0021212129826486,0.052569191309119,0,0,12.798839458413926,78.78667603753651,LRRK2;CXCR2;FPR2,Neutrophil,2.673415723494172
GO_Biological_Process_2021,positive regulation of endopeptidase activity (GO:0010950),2/30,0.0025478771667966,0.0605120827114199,0,0,29.645833333333332,177.0595839464994,CR1;MEFV,Neutrophil,2.5938215131766835
GO_Biological_Process_2021,transition metal ion transport (GO:0000041),2/36,0.0036549257227984,0.083332306479804,0,0,24.40686274509804,136.96349152286243,SLC11A1;ATP2C2,Neutrophil,2.437121444562911
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),6/621,0.0043552416698362,0.0932671344802608,0,0,4.287139689578714,23.30649979183367,IL1RN;CSF3R;IL1R2;CXCR2;FPR1;ITGAX,Neutrophil,2.360987741238573
GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),4/267,0.0044179168964334,0.0932671344802608,0,0,6.5091750702595474,35.29331342753395,SERPINA1;LRRK2;MEFV;F5,Neutrophil,2.3547824577176053
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),5/474,0.0064546964501927,0.1042304487017037,0,0,4.615257048092869,23.274497983277463,CR1;C5AR1;CXCR2;ITGAX;PROK2,Neutrophil,2.1901241768067132
GO_Biological_Process_2021,cellular defense response (GO:0006968),2/49,0.0066828970303688,0.1042304487017037,0,0,17.64450354609929,88.36726791367238,C5AR1;CXCR2,Neutrophil,2.175035230405133
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),5/482,0.0069168190120408,0.1042304487017037,0,0,4.535988819007687,22.5610979918269,IL1RN;CSF3R;IL1R2;FPR1;ITGAX,Neutrophil,2.1600935880773298
GO_Biological_Process_2021,regulation of complement activation (GO:0030449),2/50,0.0069502994651568,0.1042304487017037,0,0,17.276041666666668,85.84414194819459,CR1;C5AR1,Neutrophil,2.157996482710139
GO_Biological_Process_2021,sensory perception (GO:0007600),2/51,0.0072225026271421,0.1042304487017037,0,0,16.922619047619047,83.43788300609687,C5AR1;PROK2,Neutrophil,2.1413122915117184
GO_Biological_Process_2021,regulation of immune effector process (GO:0002697),2/53,0.0077812124839393,0.1042304487017037,0,0,16.25735294117647,78.94640668269977,CR1;C5AR1,Neutrophil,2.108952725111067
GO_Biological_Process_2021,regulation of humoral immune response (GO:0002920),2/54,0.0080676700842631,0.1042304487017037,0,0,15.943910256410255,76.8479024006269,CR1;C5AR1,Neutrophil,2.0932518699428635
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),3/165,0.0081362517216861,0.1042304487017037,0,0,7.796690307328605,37.51319597515579,ADGRE3;FPR1;FPR2,Neutrophil,2.08957562355039
GO_Biological_Process_2021,pattern recognition receptor signaling pathway (GO:0002221),2/61,0.0102031878981958,0.1042304487017037,0,0,14.04731638418079,64.40771918587598,FFAR2;CLEC4E,Neutrophil,1.9912641154648159
GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),3/182,0.0106191782545143,0.1042304487017037,0,0,7.05016046594556,32.04363951820088,CR1;SLC11A1;MEFV,Neutrophil,1.9739090890302413
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),4/345,0.0107415239006722,0.1042304487017037,0,0,5.000382506693867,22.66992569587075,ACSL1;SLC11A1;ITGAX;G0S2,Neutrophil,1.9689341008800065
GO_Biological_Process_2021,negative regulation of endopeptidase activity (GO:0010951),2/63,0.0108545013893802,0.1042304487017037,0,0,13.585382513661202,61.44906812714711,SERPINA1;CR1,Neutrophil,1.9643901214324337
GO_Biological_Process_2021,COPII vesicle coating (GO:0048208),2/63,0.0108545013893802,0.1042304487017037,0,0,13.585382513661202,61.44906812714711,SERPINA1;F5,Neutrophil,1.9643901214324337
GO_Biological_Process_2021,vesicle coating (GO:0006901),2/63,0.0108545013893802,0.1042304487017037,0,0,13.585382513661202,61.44906812714711,SERPINA1;F5,Neutrophil,1.9643901214324337
GO_Biological_Process_2021,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",2/63,0.0108545013893802,0.1042304487017037,0,0,13.585382513661202,61.44906812714711,SERPINA1;F5,Neutrophil,1.9643901214324337
GO_Biological_Process_2021,negative regulation of B cell differentiation (GO:0045578),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,CR1,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,amine transport (GO:0015837),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,AQP9,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,positive regulation of dopamine receptor signaling pathway (GO:0060161),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,LRRK2,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,regulation of vascular associated smooth muscle contraction (GO:0003056),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,DOCK4,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,negative regulation of immunoglobulin production (GO:0002638),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,CR1,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,cadmium ion transmembrane transport (GO:0070574),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,SLC11A1,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,cadmium ion transport (GO:0015691),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,SLC11A1,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,regulation of cell maturation (GO:1903429),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,LRRK2,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,regulation of endothelial tube morphogenesis (GO:1901509),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,ITGAX,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,intracellular distribution of mitochondria (GO:0048312),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,LRRK2,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,kidney morphogenesis (GO:0060993),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,LRRK2,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,negative regulation of smooth muscle contraction (GO:0045986),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,DOCK4,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,regulation of morphogenesis of a branching structure (GO:0060688),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,LRRK2,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,monocyte extravasation (GO:0035696),1/5,0.0124387771927725,0.1042304487017037,0,0,101.76530612244898,446.4379351400606,JAML,Neutrophil,1.9052223113279663
GO_Biological_Process_2021,cell chemotaxis (GO:0060326),2/69,0.0129153730394233,0.1042304487017037,0,0,12.36504975124378,53.77976800231812,DOCK4;CXCR2,Neutrophil,1.888893045423814
GO_Biological_Process_2021,neutrophil chemotaxis (GO:0030593),2/70,0.013274200561286,0.1042304487017037,0,0,12.182598039215684,52.65237170003471,JAML;CXCR2,Neutrophil,1.8769916248436092
GO_Biological_Process_2021,COPII-coated vesicle budding (GO:0090114),2/70,0.013274200561286,0.1042304487017037,0,0,12.182598039215684,52.65237170003471,SERPINA1;F5,Neutrophil,1.8769916248436092
GO_Biological_Process_2021,wound healing (GO:0042060),2/70,0.013274200561286,0.1042304487017037,0,0,12.182598039215684,52.65237170003471,JAML;SLC11A1,Neutrophil,1.8769916248436092
GO_Biological_Process_2021,extrinsic apoptotic signaling pathway (GO:0097191),2/72,0.0140048037295852,0.1042304487017037,0,0,11.833333333333334,50.50886613536219,BCL2A1;G0S2,Neutrophil,1.8537229732206628
GO_Biological_Process_2021,granulocyte chemotaxis (GO:0071621),2/73,0.0143765335552059,0.1042304487017037,0,0,11.666079812206572,49.48935398933624,JAML;CXCR2,Neutrophil,1.8423458176616205
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),3/206,0.0147987734204783,0.1042304487017037,0,0,6.209097578870139,26.160238086750542,FFAR2;FPR2;MEFV,Neutrophil,1.8297742791181009
GO_Biological_Process_2021,positive regulation of antigen processing and presentation (GO:0002579),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,SLC11A1,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,"regulation of retrograde transport, endosome to Golgi (GO:1905279)",1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,LRRK2,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,regulation of serine-type endopeptidase activity (GO:1900003),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,CR1,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,purine nucleobase transport (GO:0006863),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,AQP9,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,positive regulation of dendritic cell antigen processing and presentation (GO:0002606),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,SLC11A1,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,negative regulation of establishment of protein localization to mitochondrion (GO:1903748),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,LRRK2,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,negative regulation of excitatory postsynaptic potential (GO:0090394),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,LRRK2,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,response to manganese ion (GO:0010042),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,LRRK2,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,negative regulation of serine-type peptidase activity (GO:1902572),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,CR1,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,leukocyte chemotaxis involved in inflammatory response (GO:0002232),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,FFAR2,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,cellular triglyceride homeostasis (GO:0035356),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,DGAT2,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,regulation of interleukin-1-mediated signaling pathway (GO:2000659),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,IL1RN,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,macromolecule biosynthetic process (GO:0009059),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,SLC11A1,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,telencephalon cell migration (GO:0022029),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,LRRK2,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,neutrophil extravasation (GO:0072672),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,JAML,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,regulation of long-chain fatty acid import across plasma membrane (GO:0010746),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,ACSL1,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,regulation of protein autoubiquitination (GO:1902498),1/6,0.0149082847993736,0.1042304487017037,0,0,81.40816326530613,342.3895623444841,LRRK2,Neutrophil,1.8265723193247598
GO_Biological_Process_2021,water-soluble vitamin metabolic process (GO:0006767),2/76,0.0155171628224907,0.1042304487017037,0,0,11.19144144144144,46.62140287744705,VNN2;VNN3,Neutrophil,1.8091876827669675
GO_Biological_Process_2021,neutrophil migration (GO:1990266),2/77,0.0159057771109684,0.1042304487017037,0,0,11.041666666666666,45.72434655376785,JAML;CXCR2,Neutrophil,1.7984451076467942
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),3/212,0.0159696302578282,0.1042304487017037,0,0,6.029013539651838,24.942429757967023,FCGR2A;FPR2;MEFV,Neutrophil,1.7967051388924395
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),3/216,0.0167785010572714,0.1042304487017037,0,0,5.914593946658676,24.176830822166,MMP25;LAMB3;ITGAX,Neutrophil,1.775246840386538
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),3/217,0.0169842657929789,0.1042304487017037,0,0,5.886657387154504,23.99088324962961,MMP25;LAMB3;ITGAX,Neutrophil,1.7699532223559038
GO_Biological_Process_2021,response to interferon-gamma (GO:0034341),2/80,0.0170965192165363,0.1042304487017037,0,0,10.615384615384617,43.19273030214829,SLC11A1;MEFV,Neutrophil,1.7670923012410087
GO_Biological_Process_2021,acylglycerol acyl-chain remodeling (GO:0036155),1/7,0.0173717414502839,0.1042304487017037,0,0,67.83673469387755,274.9362107684438,DGAT2,Neutrophil,1.7601566430186848
GO_Biological_Process_2021,gamma-delta T cell activation (GO:0046629),1/7,0.0173717414502839,0.1042304487017037,0,0,67.83673469387755,274.9362107684438,JAML,Neutrophil,1.7601566430186848
GO_Biological_Process_2021,glycerol transport (GO:0015793),1/7,0.0173717414502839,0.1042304487017037,0,0,67.83673469387755,274.9362107684438,AQP9,Neutrophil,1.7601566430186848
GO_Biological_Process_2021,negative regulation of NLRP3 inflammasome complex assembly (GO:1900226),1/7,0.0173717414502839,0.1042304487017037,0,0,67.83673469387755,274.9362107684438,MEFV,Neutrophil,1.7601566430186848
GO_Biological_Process_2021,"complement activation, alternative pathway (GO:0006957)",1/7,0.0173717414502839,0.1042304487017037,0,0,67.83673469387755,274.9362107684438,CR1,Neutrophil,1.7601566430186848
GO_Biological_Process_2021,TRAIL-activated apoptotic signaling pathway (GO:0036462),1/7,0.0173717414502839,0.1042304487017037,0,0,67.83673469387755,274.9362107684438,TNFRSF10C,Neutrophil,1.7601566430186848
GO_Biological_Process_2021,monoacylglycerol biosynthetic process (GO:0006640),1/7,0.0173717414502839,0.1042304487017037,0,0,67.83673469387755,274.9362107684438,DGAT2,Neutrophil,1.7601566430186848
GO_Biological_Process_2021,mRNA transcription by RNA polymerase II (GO:0042789),1/7,0.0173717414502839,0.1042304487017037,0,0,67.83673469387755,274.9362107684438,C5AR1,Neutrophil,1.7601566430186848
GO_Biological_Process_2021,protein localization to endoplasmic reticulum exit site (GO:0070973),1/7,0.0173717414502839,0.1042304487017037,0,0,67.83673469387755,274.9362107684438,LRRK2,Neutrophil,1.7601566430186848
GO_Biological_Process_2021,negative regulation of defense response (GO:0031348),2/85,0.0191627543313976,0.1056319815623879,0,0,9.973393574297187,39.44264488506008,FPR2;MEFV,Neutrophil,1.717542068067663
GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),2/86,0.0195880530452788,0.1056319815623879,0,0,9.854166666666666,38.754815869716495,CR1;SLC11A1,Neutrophil,1.7080087285643422
GO_Biological_Process_2021,actin filament reorganization (GO:0090527),1/8,0.0198291614511851,0.1056319815623879,0,0,58.142857142857146,227.9549801512961,CASS4,Neutrophil,1.702695651141308
GO_Biological_Process_2021,"negative regulation of complement activation, classical pathway (GO:0045959)",1/8,0.0198291614511851,0.1056319815623879,0,0,58.142857142857146,227.9549801512961,CR1,Neutrophil,1.702695651141308
GO_Biological_Process_2021,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/8,0.0198291614511851,0.1056319815623879,0,0,58.142857142857146,227.9549801512961,JAML,Neutrophil,1.702695651141308
GO_Biological_Process_2021,regulation of dopamine receptor signaling pathway (GO:0060159),1/8,0.0198291614511851,0.1056319815623879,0,0,58.142857142857146,227.9549801512961,LRRK2,Neutrophil,1.702695651141308
GO_Biological_Process_2021,positive regulation of muscle contraction (GO:0045933),1/8,0.0198291614511851,0.1056319815623879,0,0,58.142857142857146,227.9549801512961,PROK2,Neutrophil,1.702695651141308
GO_Biological_Process_2021,negative regulation of response to reactive oxygen species (GO:1901032),1/8,0.0198291614511851,0.1056319815623879,0,0,58.142857142857146,227.9549801512961,LRRK2,Neutrophil,1.702695651141308
GO_Biological_Process_2021,lipid import into cell (GO:0140354),1/8,0.0198291614511851,0.1056319815623879,0,0,58.142857142857146,227.9549801512961,ACSL1,Neutrophil,1.702695651141308
GO_Biological_Process_2021,positive regulation of vascular associated smooth muscle cell migration (GO:1904754),1/8,0.0198291614511851,0.1056319815623879,0,0,58.142857142857146,227.9549801512961,DOCK4,Neutrophil,1.702695651141308
GO_Biological_Process_2021,diacylglycerol biosynthetic process (GO:0006651),1/8,0.0198291614511851,0.1056319815623879,0,0,58.142857142857146,227.9549801512961,DGAT2,Neutrophil,1.702695651141308
GO_Biological_Process_2021,water homeostasis (GO:0030104),1/8,0.0198291614511851,0.1056319815623879,0,0,58.142857142857146,227.9549801512961,AQP9,Neutrophil,1.702695651141308
GO_Biological_Process_2021,positive regulation of autophagy (GO:0010508),2/90,0.0213286953840061,0.1094820577629437,0,0,9.40435606060606,36.18515879365064,LRRK2;MEFV,Neutrophil,1.6710357083037395
GO_Biological_Process_2021,regulation of T-helper 1 type immune response (GO:0002825),1/9,0.0222805591236868,0.1094820577629437,0,0,50.87244897959184,193.52086993316271,SLC11A1,Neutrophil,1.652073914876897
GO_Biological_Process_2021,basement membrane assembly (GO:0070831),1/9,0.0222805591236868,0.1094820577629437,0,0,50.87244897959184,193.52086993316271,LAMB3,Neutrophil,1.652073914876897
GO_Biological_Process_2021,"regulation of complement activation, classical pathway (GO:0030450)",1/9,0.0222805591236868,0.1094820577629437,0,0,50.87244897959184,193.52086993316271,CR1,Neutrophil,1.652073914876897
GO_Biological_Process_2021,regulation of dendritic cell antigen processing and presentation (GO:0002604),1/9,0.0222805591236868,0.1094820577629437,0,0,50.87244897959184,193.52086993316271,SLC11A1,Neutrophil,1.652073914876897
GO_Biological_Process_2021,negative regulation of production of molecular mediator of immune response (GO:0002701),1/9,0.0222805591236868,0.1094820577629437,0,0,50.87244897959184,193.52086993316271,CR1,Neutrophil,1.652073914876897
GO_Biological_Process_2021,regulation of ER to Golgi vesicle-mediated transport (GO:0060628),1/9,0.0222805591236868,0.1094820577629437,0,0,50.87244897959184,193.52086993316271,LRRK2,Neutrophil,1.652073914876897
GO_Biological_Process_2021,positive regulation of smooth muscle contraction (GO:0045987),1/9,0.0222805591236868,0.1094820577629437,0,0,50.87244897959184,193.52086993316271,PROK2,Neutrophil,1.652073914876897
GO_Biological_Process_2021,DNA cytosine deamination (GO:0070383),1/9,0.0222805591236868,0.1094820577629437,0,0,50.87244897959184,193.52086993316271,APOBEC3A,Neutrophil,1.652073914876897
GO_Biological_Process_2021,interleukin-1-mediated signaling pathway (GO:0070498),2/94,0.0231314233527167,0.110974730912103,0,0,8.993659420289855,33.87518721331595,IL1RN;IL1R2,Neutrophil,1.6357976428363092
GO_Biological_Process_2021,positive regulation of cold-induced thermogenesis (GO:0120162),2/97,0.024523395696302,0.110974730912103,0,0,8.708333333333334,32.29161197321332,ACSL1;G0S2,Neutrophil,1.6104193942653626
GO_Biological_Process_2021,regulation of tau-protein kinase activity (GO:1902947),1/10,0.024725948817258,0.110974730912103,0,0,45.21768707482993,167.3010120823387,C5AR1,Neutrophil,1.606847034080906
GO_Biological_Process_2021,negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/10,0.024725948817258,0.110974730912103,0,0,45.21768707482993,167.3010120823387,IL1RN,Neutrophil,1.606847034080906
GO_Biological_Process_2021,negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),1/10,0.024725948817258,0.110974730912103,0,0,45.21768707482993,167.3010120823387,CR1,Neutrophil,1.606847034080906
GO_Biological_Process_2021,granulocyte activation (GO:0036230),1/10,0.024725948817258,0.110974730912103,0,0,45.21768707482993,167.3010120823387,CXCR2,Neutrophil,1.606847034080906
GO_Biological_Process_2021,response to dopamine (GO:1903350),1/10,0.024725948817258,0.110974730912103,0,0,45.21768707482993,167.3010120823387,LRRK2,Neutrophil,1.606847034080906
GO_Biological_Process_2021,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/10,0.024725948817258,0.110974730912103,0,0,45.21768707482993,167.3010120823387,IL1RN,Neutrophil,1.606847034080906
GO_Biological_Process_2021,cellular response to dopamine (GO:1903351),1/10,0.024725948817258,0.110974730912103,0,0,45.21768707482993,167.3010120823387,LRRK2,Neutrophil,1.606847034080906
GO_Biological_Process_2021,long-chain fatty acid import into cell (GO:0044539),1/10,0.024725948817258,0.110974730912103,0,0,45.21768707482993,167.3010120823387,ACSL1,Neutrophil,1.606847034080906
GO_Biological_Process_2021,regulation of hydrogen peroxide-induced cell death (GO:1903205),1/10,0.024725948817258,0.110974730912103,0,0,45.21768707482993,167.3010120823387,LRRK2,Neutrophil,1.606847034080906
GO_Biological_Process_2021,fatty acid homeostasis (GO:0055089),1/11,0.0271653448579923,0.1155540788735497,0,0,40.69387755102041,146.73452100035948,DGAT2,Neutrophil,1.5659847773237099
GO_Biological_Process_2021,response to corticosteroid (GO:0031960),1/11,0.0271653448579923,0.1155540788735497,0,0,40.69387755102041,146.73452100035948,IL1RN,Neutrophil,1.5659847773237099
GO_Biological_Process_2021,regulation of cytoplasmic transport (GO:1903649),1/11,0.0271653448579923,0.1155540788735497,0,0,40.69387755102041,146.73452100035948,LRRK2,Neutrophil,1.5659847773237099
GO_Biological_Process_2021,negative regulation of protein maturation (GO:1903318),1/11,0.0271653448579923,0.1155540788735497,0,0,40.69387755102041,146.73452100035948,LRRK2,Neutrophil,1.5659847773237099
GO_Biological_Process_2021,positive regulation of myelination (GO:0031643),1/11,0.0271653448579923,0.1155540788735497,0,0,40.69387755102041,146.73452100035948,ITGAX,Neutrophil,1.5659847773237099
GO_Biological_Process_2021,cytidine to uridine editing (GO:0016554),1/11,0.0271653448579923,0.1155540788735497,0,0,40.69387755102041,146.73452100035948,APOBEC3A,Neutrophil,1.5659847773237099
GO_Biological_Process_2021,regulation of mitochondrial depolarization (GO:0051900),1/11,0.0271653448579923,0.1155540788735497,0,0,40.69387755102041,146.73452100035948,LRRK2,Neutrophil,1.5659847773237099
GO_Biological_Process_2021,adipose tissue development (GO:0060612),1/12,0.029598761568907,0.1171617645435905,0,0,36.99257884972171,130.2147194065139,DGAT2,Neutrophil,1.5287264597194943
GO_Biological_Process_2021,negative regulation of complement activation (GO:0045916),1/12,0.029598761568907,0.1171617645435905,0,0,36.99257884972171,130.2147194065139,CR1,Neutrophil,1.5287264597194943
GO_Biological_Process_2021,ATP transport (GO:0015867),1/12,0.029598761568907,0.1171617645435905,0,0,36.99257884972171,130.2147194065139,CR1,Neutrophil,1.5287264597194943
GO_Biological_Process_2021,regulation of vascular associated smooth muscle cell migration (GO:1904752),1/12,0.029598761568907,0.1171617645435905,0,0,36.99257884972171,130.2147194065139,DOCK4,Neutrophil,1.5287264597194943
GO_Biological_Process_2021,hemidesmosome assembly (GO:0031581),1/12,0.029598761568907,0.1171617645435905,0,0,36.99257884972171,130.2147194065139,LAMB3,Neutrophil,1.5287264597194943
GO_Biological_Process_2021,positive regulation of T-helper 1 type immune response (GO:0002827),1/12,0.029598761568907,0.1171617645435905,0,0,36.99257884972171,130.2147194065139,SLC11A1,Neutrophil,1.5287264597194943
GO_Biological_Process_2021,mitochondrion distribution (GO:0048311),1/12,0.029598761568907,0.1171617645435905,0,0,36.99257884972171,130.2147194065139,LRRK2,Neutrophil,1.5287264597194943
GO_Biological_Process_2021,presynapse organization (GO:0099172),1/12,0.029598761568907,0.1171617645435905,0,0,36.99257884972171,130.2147194065139,C5AR1,Neutrophil,1.5287264597194943
GO_Biological_Process_2021,mRNA transcription (GO:0009299),1/12,0.029598761568907,0.1171617645435905,0,0,36.99257884972171,130.2147194065139,C5AR1,Neutrophil,1.5287264597194943
GO_Biological_Process_2021,polyol transport (GO:0015791),1/12,0.029598761568907,0.1171617645435905,0,0,36.99257884972171,130.2147194065139,AQP9,Neutrophil,1.5287264597194943
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),3/274,0.0310750535699626,0.117773816463193,0,0,4.63507890398053,16.089980771839137,LRRK2;C5AR1;FPR2,Neutrophil,1.5075881140099185
GO_Biological_Process_2021,cellular divalent inorganic cation homeostasis (GO:0072503),2/111,0.0314544847807964,0.117773816463193,0,0,7.584480122324159,26.23633758944092,SLC11A1;ATP2C2,Neutrophil,1.5023174240917434
GO_Biological_Process_2021,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),1/13,0.032026213248763,0.117773816463193,0,0,33.90816326530612,116.6847899929619,SLC11A1,Neutrophil,1.4944944088974865
GO_Biological_Process_2021,negative regulation of autophagosome assembly (GO:1902902),1/13,0.032026213248763,0.117773816463193,0,0,33.90816326530612,116.6847899929619,LRRK2,Neutrophil,1.4944944088974865
GO_Biological_Process_2021,alpha-linolenic acid metabolic process (GO:0036109),1/13,0.032026213248763,0.117773816463193,0,0,33.90816326530612,116.6847899929619,ACSL1,Neutrophil,1.4944944088974865
GO_Biological_Process_2021,purine ribonucleoside triphosphate metabolic process (GO:0009205),1/13,0.032026213248763,0.117773816463193,0,0,33.90816326530612,116.6847899929619,LRRK2,Neutrophil,1.4944944088974865
GO_Biological_Process_2021,antifungal innate immune response (GO:0061760),1/13,0.032026213248763,0.117773816463193,0,0,33.90816326530612,116.6847899929619,CLEC4E,Neutrophil,1.4944944088974865
GO_Biological_Process_2021,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/13,0.032026213248763,0.117773816463193,0,0,33.90816326530612,116.6847899929619,LRRK2,Neutrophil,1.4944944088974865
GO_Biological_Process_2021,regulation of lysosomal lumen pH (GO:0035751),1/13,0.032026213248763,0.117773816463193,0,0,33.90816326530612,116.6847899929619,LRRK2,Neutrophil,1.4944944088974865
GO_Biological_Process_2021,DNA deamination (GO:0045006),1/13,0.032026213248763,0.117773816463193,0,0,33.90816326530612,116.6847899929619,APOBEC3A,Neutrophil,1.4944944088974865
GO_Biological_Process_2021,protein localization to mitochondrion (GO:0070585),1/13,0.032026213248763,0.117773816463193,0,0,33.90816326530612,116.6847899929619,LRRK2,Neutrophil,1.4944944088974865
GO_Biological_Process_2021,positive regulation of metabolic process (GO:0009893),2/113,0.032501099312465,0.1187540167186221,0,0,7.447072072072072,25.51725368040207,ACSL1;G0S2,Neutrophil,1.4881019492591823
GO_Biological_Process_2021,cellular amide metabolic process (GO:0043603),2/115,0.033561350657856,0.1190011944050094,0,0,7.31452802359882,24.82828874550635,VNN2;VNN3,Neutrophil,1.4741605695522084
GO_Biological_Process_2021,negative regulation of interleukin-12 production (GO:0032695),1/14,0.0344477141698711,0.1190011944050094,0,0,31.298273155416013,105.4223689491126,MEFV,Neutrophil,1.4628395910668823
GO_Biological_Process_2021,carbohydrate transport (GO:0008643),1/14,0.0344477141698711,0.1190011944050094,0,0,31.298273155416013,105.4223689491126,AQP9,Neutrophil,1.4628395910668823
GO_Biological_Process_2021,immune response-regulating cell surface receptor signaling pathway (GO:0002768),1/14,0.0344477141698711,0.1190011944050094,0,0,31.298273155416013,105.4223689491126,FPR2,Neutrophil,1.4628395910668823
GO_Biological_Process_2021,positive regulation of regulatory T cell differentiation (GO:0045591),1/14,0.0344477141698711,0.1190011944050094,0,0,31.298273155416013,105.4223689491126,CR1,Neutrophil,1.4628395910668823
GO_Biological_Process_2021,positive regulation of superoxide anion generation (GO:0032930),1/14,0.0344477141698711,0.1190011944050094,0,0,31.298273155416013,105.4223689491126,FPR2,Neutrophil,1.4628395910668823
GO_Biological_Process_2021,defense response to protozoan (GO:0042832),1/14,0.0344477141698711,0.1190011944050094,0,0,31.298273155416013,105.4223689491126,SLC11A1,Neutrophil,1.4628395910668823
GO_Biological_Process_2021,positive regulation of transmembrane transport (GO:0034764),1/14,0.0344477141698711,0.1190011944050094,0,0,31.298273155416013,105.4223689491126,ACSL1,Neutrophil,1.4628395910668823
GO_Biological_Process_2021,monoacylglycerol metabolic process (GO:0046462),1/14,0.0344477141698711,0.1190011944050094,0,0,31.298273155416013,105.4223689491126,DGAT2,Neutrophil,1.4628395910668823
GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),2/118,0.0351769550093681,0.1190721532906658,0,0,7.124281609195402,23.8475644827565,FPR2;MEFV,Neutrophil,1.4537417566881954
GO_Biological_Process_2021,innate immune response activating cell surface receptor signaling pathway (GO:0002220),2/119,0.0357221395623332,0.1190721532906658,0,0,7.063034188034188,23.53392133172277,FFAR2;CLEC4E,Neutrophil,1.4470625371214694
GO_Biological_Process_2021,positive regulation of acute inflammatory response (GO:0002675),1/15,0.0368632785936063,0.1190721532906658,0,0,29.06122448979592,95.91771596133704,FFAR2,Neutrophil,1.4334060415588732
GO_Biological_Process_2021,regulation of superoxide anion generation (GO:0032928),1/15,0.0368632785936063,0.1190721532906658,0,0,29.06122448979592,95.91771596133704,FPR2,Neutrophil,1.4334060415588732
GO_Biological_Process_2021,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/15,0.0368632785936063,0.1190721532906658,0,0,29.06122448979592,95.91771596133704,LRRK2,Neutrophil,1.4334060415588732
GO_Biological_Process_2021,glucan catabolic process (GO:0009251),1/15,0.0368632785936063,0.1190721532906658,0,0,29.06122448979592,95.91771596133704,MGAM,Neutrophil,1.4334060415588732
GO_Biological_Process_2021,GTP metabolic process (GO:0046039),1/15,0.0368632785936063,0.1190721532906658,0,0,29.06122448979592,95.91771596133704,LRRK2,Neutrophil,1.4334060415588732
GO_Biological_Process_2021,negative regulation of protein processing (GO:0010955),1/15,0.0368632785936063,0.1190721532906658,0,0,29.06122448979592,95.91771596133704,LRRK2,Neutrophil,1.4334060415588732
GO_Biological_Process_2021,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),1/15,0.0368632785936063,0.1190721532906658,0,0,29.06122448979592,95.91771596133704,APOBEC3A,Neutrophil,1.4334060415588732
GO_Biological_Process_2021,T cell proliferation (GO:0042098),1/15,0.0368632785936063,0.1190721532906658,0,0,29.06122448979592,95.91771596133704,SLC11A1,Neutrophil,1.4334060415588732
GO_Biological_Process_2021,peptidyl-tyrosine autophosphorylation (GO:0038083),1/15,0.0368632785936063,0.1190721532906658,0,0,29.06122448979592,95.91771596133704,AATK,Neutrophil,1.4334060415588732
GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),2/123,0.0379356146383277,0.1190721532906658,0,0,6.828168044077135,22.34084340876857,LRRK2;PROK2,Neutrophil,1.420952875040757
GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),2/123,0.0379356146383277,0.1190721532906658,0,0,6.828168044077135,22.34084340876857,JAML;C5AR1,Neutrophil,1.420952875040757
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),3/300,0.0390400715124679,0.1190721532906658,0,0,4.223726627981947,13.698249489225711,MMP25;LAMB3;ITGAX,Neutrophil,1.4084893954766124
GO_Biological_Process_2021,platelet degranulation (GO:0002576),2/125,0.0390617280151273,0.1190721532906658,0,0,6.716463414634147,21.77888563484535,SERPINA1;F5,Neutrophil,1.408248548277182
GO_Biological_Process_2021,negative regulation of immune effector process (GO:0002698),1/16,0.0392729207344652,0.1190721532906658,0,0,27.122448979591837,87.80133530116419,CR1,Neutrophil,1.405906798966597
GO_Biological_Process_2021,basement membrane organization (GO:0071711),1/16,0.0392729207344652,0.1190721532906658,0,0,27.122448979591837,87.80133530116419,LAMB3,Neutrophil,1.405906798966597
GO_Biological_Process_2021,cellular polysaccharide catabolic process (GO:0044247),1/16,0.0392729207344652,0.1190721532906658,0,0,27.122448979591837,87.80133530116419,MGAM,Neutrophil,1.405906798966597
GO_Biological_Process_2021,regulation of hormone secretion (GO:0046883),1/16,0.0392729207344652,0.1190721532906658,0,0,27.122448979591837,87.80133530116419,FFAR2,Neutrophil,1.405906798966597
GO_Biological_Process_2021,regulation of interleukin-1 production (GO:0032652),1/16,0.0392729207344652,0.1190721532906658,0,0,27.122448979591837,87.80133530116419,MEFV,Neutrophil,1.405906798966597
GO_Biological_Process_2021,neutrophil activation (GO:0042119),1/16,0.0392729207344652,0.1190721532906658,0,0,27.122448979591837,87.80133530116419,CXCR2,Neutrophil,1.405906798966597
GO_Biological_Process_2021,dendritic cell chemotaxis (GO:0002407),1/16,0.0392729207344652,0.1190721532906658,0,0,27.122448979591837,87.80133530116419,CXCR2,Neutrophil,1.405906798966597
GO_Biological_Process_2021,protein localization to endoplasmic reticulum (GO:0070972),1/16,0.0392729207344652,0.1190721532906658,0,0,27.122448979591837,87.80133530116419,LRRK2,Neutrophil,1.405906798966597
GO_Biological_Process_2021,synapse organization (GO:0050808),2/126,0.0396295625933463,0.1195177284561237,0,0,6.661962365591398,21.50601306379386,LRRK2;C5AR1,Neutrophil,1.4019807211138142
GO_Biological_Process_2021,negative regulation of chemokine production (GO:0032682),1/17,0.0416766547912334,0.1225485956637308,0,0,25.426020408163264,80.79916728086499,MEFV,Neutrophil,1.3801071472903907
GO_Biological_Process_2021,positive regulation of smooth muscle cell migration (GO:0014911),1/17,0.0416766547912334,0.1225485956637308,0,0,25.426020408163264,80.79916728086499,DOCK4,Neutrophil,1.3801071472903907
GO_Biological_Process_2021,regulation of neuroblast proliferation (GO:1902692),1/17,0.0416766547912334,0.1225485956637308,0,0,25.426020408163264,80.79916728086499,LRRK2,Neutrophil,1.3801071472903907
GO_Biological_Process_2021,regulation of NLRP3 inflammasome complex assembly (GO:1900225),1/17,0.0416766547912334,0.1225485956637308,0,0,25.426020408163264,80.79916728086499,MEFV,Neutrophil,1.3801071472903907
GO_Biological_Process_2021,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,APOBEC3A,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,fluid transport (GO:0042044),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,AQP9,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,base conversion or substitution editing (GO:0016553),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,APOBEC3A,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,positive regulation of nervous system process (GO:0031646),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,ITGAX,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,ACSL1,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,nitric oxide mediated signal transduction (GO:0007263),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,FPR1,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,regulation of membrane depolarization (GO:0003254),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,LRRK2,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,triglyceride biosynthetic process (GO:0019432),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,DGAT2,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,dendritic cell migration (GO:0036336),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,CXCR2,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,water transport (GO:0006833),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,AQP9,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,endothelial cell proliferation (GO:0001935),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,PROK2,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,positive chemotaxis (GO:0050918),1/18,0.0440744949316926,0.1225485956637308,0,0,23.92917166866747,74.70385911458476,FPR2,Neutrophil,1.3558126557645607
GO_Biological_Process_2021,excitatory postsynaptic potential (GO:0060079),1/19,0.0464664552952436,0.1255254953473406,0,0,22.598639455782312,69.35578082800635,LRRK2,Neutrophil,1.3328604565168853
GO_Biological_Process_2021,regulation of synaptic vesicle exocytosis (GO:2000300),1/19,0.0464664552952436,0.1255254953473406,0,0,22.598639455782312,69.35578082800635,LRRK2,Neutrophil,1.3328604565168853
GO_Biological_Process_2021,negative regulation of cytokine production involved in inflammatory response (GO:1900016),1/19,0.0464664552952436,0.1255254953473406,0,0,22.598639455782312,69.35578082800635,MEFV,Neutrophil,1.3328604565168853
GO_Biological_Process_2021,response to fatty acid (GO:0070542),1/19,0.0464664552952436,0.1255254953473406,0,0,22.598639455782312,69.35578082800635,FFAR2,Neutrophil,1.3328604565168853
GO_Biological_Process_2021,positive regulation of monocyte chemotaxis (GO:0090026),1/19,0.0464664552952436,0.1255254953473406,0,0,22.598639455782312,69.35578082800635,FPR2,Neutrophil,1.3328604565168853
GO_Biological_Process_2021,mitochondrion localization (GO:0051646),1/19,0.0464664552952436,0.1255254953473406,0,0,22.598639455782312,69.35578082800635,LRRK2,Neutrophil,1.3328604565168853
GO_Biological_Process_2021,positive regulation of cellular catabolic process (GO:0031331),2/141,0.0485159985807625,0.1283223663122388,0,0,5.938549160671463,17.96922826755323,LRRK2;MEFV,Neutrophil,1.3141150253231082
GO_Biological_Process_2021,regulation of smooth muscle contraction (GO:0006940),1/20,0.0488525499820277,0.1283223663122388,0,0,21.40816326530612,64.63014669364038,PROK2,Neutrophil,1.3111127622579986
GO_Biological_Process_2021,fatty acid transport (GO:0015908),1/20,0.0488525499820277,0.1283223663122388,0,0,21.40816326530612,64.63014669364038,ACSL1,Neutrophil,1.3111127622579986
GO_Biological_Process_2021,regulation of acute inflammatory response (GO:0002673),1/20,0.0488525499820277,0.1283223663122388,0,0,21.40816326530612,64.63014669364038,FFAR2,Neutrophil,1.3111127622579986
GO_Biological_Process_2021,negative regulation of osteoclast differentiation (GO:0045671),1/20,0.0488525499820277,0.1283223663122388,0,0,21.40816326530612,64.63014669364038,LILRB3,Neutrophil,1.3111127622579986
GO_Biological_Process_2021,regulation of protein kinase A signaling (GO:0010738),1/20,0.0488525499820277,0.1283223663122388,0,0,21.40816326530612,64.63014669364038,LRRK2,Neutrophil,1.3111127622579986
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),2/143,0.0497512691479657,0.1289010155197295,0,0,5.8537234042553195,17.565380826397597,CXCR2;FPR2,Neutrophil,1.3031958359850326
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),2/143,0.0497512691479657,0.1289010155197295,0,0,5.8537234042553195,17.565380826397597,SLC11A1;AQP9,Neutrophil,1.3031958359850326
GO_Biological_Process_2021,monocarboxylic acid metabolic process (GO:0032787),2/143,0.0497512691479657,0.1289010155197295,0,0,5.8537234042553195,17.565380826397597,VNN2;VNN3,Neutrophil,1.3031958359850326
GO_Biological_Process_2021,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/21,0.0512327930672156,0.1292154515412075,0,0,20.336734693877553,60.42807445408675,BCL2A1,Neutrophil,1.2904519669693806
GO_Biological_Process_2021,purinergic nucleotide receptor signaling pathway (GO:0035590),1/21,0.0512327930672156,0.1292154515412075,0,0,20.336734693877553,60.42807445408675,MEFV,Neutrophil,1.2904519669693806
GO_Biological_Process_2021,regulation of transposition (GO:0010528),1/21,0.0512327930672156,0.1292154515412075,0,0,20.336734693877553,60.42807445408675,APOBEC3A,Neutrophil,1.2904519669693806
GO_Biological_Process_2021,sensory perception of pain (GO:0019233),1/21,0.0512327930672156,0.1292154515412075,0,0,20.336734693877553,60.42807445408675,PROK2,Neutrophil,1.2904519669693806
GO_Biological_Process_2021,linoleic acid metabolic process (GO:0043651),1/21,0.0512327930672156,0.1292154515412075,0,0,20.336734693877553,60.42807445408675,ACSL1,Neutrophil,1.2904519669693806
GO_Biological_Process_2021,vacuolar acidification (GO:0007035),1/21,0.0512327930672156,0.1292154515412075,0,0,20.336734693877553,60.42807445408675,SLC11A1,Neutrophil,1.2904519669693806
GO_Biological_Process_2021,fatty-acyl-CoA metabolic process (GO:0035337),1/22,0.0536071985992547,0.1330745137605877,0,0,19.367346938775512,56.67024999786951,DGAT2,Neutrophil,1.2707768875084013
GO_Biological_Process_2021,negative regulation of interleukin-2 production (GO:0032703),1/22,0.0536071985992547,0.1330745137605877,0,0,19.367346938775512,56.67024999786951,CR1,Neutrophil,1.2707768875084013
GO_Biological_Process_2021,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/22,0.0536071985992547,0.1330745137605877,0,0,19.367346938775512,56.67024999786951,LRRK2,Neutrophil,1.2707768875084013
GO_Biological_Process_2021,response to cytokine (GO:0034097),2/150,0.0541636617411515,0.1330745137605877,0,0,5.574887387387387,16.25495026487543,SLC11A1;MEFV,Neutrophil,1.2662919827974375
GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),2/150,0.0541636617411515,0.1330745137605877,0,0,5.574887387387387,16.25495026487543,BTNL8;SLC11A1,Neutrophil,1.2662919827974375
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),2/150,0.0541636617411515,0.1330745137605877,0,0,5.574887387387387,16.25495026487543,LRRK2;AQP9,Neutrophil,1.2662919827974375
GO_Biological_Process_2021,acylglycerol biosynthetic process (GO:0046463),1/23,0.0559757805878795,0.1334987235777879,0,0,18.4860853432282,53.29235549319145,DGAT2,Neutrophil,1.2519998414265567
GO_Biological_Process_2021,negative regulation of GTPase activity (GO:0034260),1/23,0.0559757805878795,0.1334987235777879,0,0,18.4860853432282,53.29235549319145,LRRK2,Neutrophil,1.2519998414265567
GO_Biological_Process_2021,negative regulation of intracellular protein transport (GO:0090317),1/23,0.0559757805878795,0.1334987235777879,0,0,18.4860853432282,53.29235549319145,LRRK2,Neutrophil,1.2519998414265567
GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity (GO:2000116),1/23,0.0559757805878795,0.1334987235777879,0,0,18.4860853432282,53.29235549319145,MEFV,Neutrophil,1.2519998414265567
GO_Biological_Process_2021,positive regulation of morphogenesis of an epithelium (GO:1905332),1/23,0.0559757805878795,0.1334987235777879,0,0,18.4860853432282,53.29235549319145,ITGAX,Neutrophil,1.2519998414265567
GO_Biological_Process_2021,diacylglycerol metabolic process (GO:0046339),1/23,0.0559757805878795,0.1334987235777879,0,0,18.4860853432282,53.29235549319145,DGAT2,Neutrophil,1.2519998414265567
GO_Biological_Process_2021,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.0559757805878795,0.1334987235777879,0,0,18.4860853432282,53.29235549319145,LRRK2,Neutrophil,1.2519998414265567
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),2/154,0.0567455048100272,0.1346274300300229,0,0,5.427083333333333,15.571272642043729,SLC11A1;CASS4,Neutrophil,1.2460685361352464
GO_Biological_Process_2021,cellular response to interleukin-1 (GO:0071347),2/155,0.0573976675935087,0.1346274300300229,0,0,5.391339869281046,15.407110195493528,IL1RN;IL1R2,Neutrophil,1.2411057551952243
GO_Biological_Process_2021,extracellular matrix assembly (GO:0085029),1/24,0.0583385530130099,0.1346274300300229,0,0,17.68145519077196,50.24171555062859,LAMB3,Neutrophil,1.2340443470047993
GO_Biological_Process_2021,regulation of cytokine production involved in immune response (GO:0002718),1/24,0.0583385530130099,0.1346274300300229,0,0,17.68145519077196,50.24171555062859,FFAR2,Neutrophil,1.2340443470047993
GO_Biological_Process_2021,cellular response to catecholamine stimulus (GO:0071870),1/24,0.0583385530130099,0.1346274300300229,0,0,17.68145519077196,50.24171555062859,LRRK2,Neutrophil,1.2340443470047993
GO_Biological_Process_2021,negative regulation of synaptic transmission (GO:0050805),1/24,0.0583385530130099,0.1346274300300229,0,0,17.68145519077196,50.24171555062859,LRRK2,Neutrophil,1.2340443470047993
GO_Biological_Process_2021,neuromuscular junction development (GO:0007528),1/24,0.0583385530130099,0.1346274300300229,0,0,17.68145519077196,50.24171555062859,LRRK2,Neutrophil,1.2340443470047993
GO_Biological_Process_2021,defense response to fungus (GO:0050832),1/24,0.0583385530130099,0.1346274300300229,0,0,17.68145519077196,50.24171555062859,CLEC4E,Neutrophil,1.2340443470047993
GO_Biological_Process_2021,protein autophosphorylation (GO:0046777),2/159,0.060032623780291,0.1367448695643477,0,0,5.25291932059448,14.77576411894998,LRRK2;AATK,Neutrophil,1.2216126749949432
GO_Biological_Process_2021,negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/25,0.0606955298241754,0.1367448695643477,0,0,16.943877551020407,47.47480020477031,LRRK2,Neutrophil,1.2168432931781568
GO_Biological_Process_2021,regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.0606955298241754,0.1367448695643477,0,0,16.943877551020407,47.47480020477031,IL1RN,Neutrophil,1.2168432931781568
GO_Biological_Process_2021,"chemical synaptic transmission, postsynaptic (GO:0099565)",1/25,0.0606955298241754,0.1367448695643477,0,0,16.943877551020407,47.47480020477031,LRRK2,Neutrophil,1.2168432931781568
GO_Biological_Process_2021,regulation of mitochondrial fission (GO:0090140),1/25,0.0606955298241754,0.1367448695643477,0,0,16.943877551020407,47.47480020477031,LRRK2,Neutrophil,1.2168432931781568
GO_Biological_Process_2021,regulation of protein processing (GO:0070613),1/25,0.0606955298241754,0.1367448695643477,0,0,16.943877551020407,47.47480020477031,LRRK2,Neutrophil,1.2168432931781568
GO_Biological_Process_2021,regulation of regulatory T cell differentiation (GO:0045589),1/26,0.0630467249540435,0.13875147962859,0,0,16.26530612244898,44.95534064809558,CR1,Neutrophil,1.2003374685092782
GO_Biological_Process_2021,negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.0630467249540435,0.13875147962859,0,0,16.26530612244898,44.95534064809558,MEFV,Neutrophil,1.2003374685092782
GO_Biological_Process_2021,negative regulation of macroautophagy (GO:0016242),1/26,0.0630467249540435,0.13875147962859,0,0,16.26530612244898,44.95534064809558,LRRK2,Neutrophil,1.2003374685092782
GO_Biological_Process_2021,negative regulation of transposition (GO:0010529),1/26,0.0630467249540435,0.13875147962859,0,0,16.26530612244898,44.95534064809558,APOBEC3A,Neutrophil,1.2003374685092782
GO_Biological_Process_2021,regulation of monocyte chemotaxis (GO:0090025),1/26,0.0630467249540435,0.13875147962859,0,0,16.26530612244898,44.95534064809558,FPR2,Neutrophil,1.2003374685092782
GO_Biological_Process_2021,regulation of myelination (GO:0031641),1/26,0.0630467249540435,0.13875147962859,0,0,16.26530612244898,44.95534064809558,ITGAX,Neutrophil,1.2003374685092782
GO_Biological_Process_2021,regulation of vasculature development (GO:1901342),1/27,0.0653921522588676,0.1422653694181471,0,0,15.638932496075354,42.652889831563165,PROK2,Neutrophil,1.184474368421492
GO_Biological_Process_2021,response to glucocorticoid (GO:0051384),1/27,0.0653921522588676,0.1422653694181471,0,0,15.638932496075354,42.652889831563165,IL1RN,Neutrophil,1.184474368421492
GO_Biological_Process_2021,modulation of excitatory postsynaptic potential (GO:0098815),1/27,0.0653921522588676,0.1422653694181471,0,0,15.638932496075354,42.652889831563165,LRRK2,Neutrophil,1.184474368421492
GO_Biological_Process_2021,regulation of calcium-mediated signaling (GO:0050848),1/28,0.0677318256109869,0.1435209687667752,0,0,15.058956916099774,40.54171043527237,LRRK2,Neutrophil,1.1692072184717057
GO_Biological_Process_2021,negative regulation of oxidative stress-induced cell death (GO:1903202),1/28,0.0677318256109869,0.1435209687667752,0,0,15.058956916099774,40.54171043527237,LRRK2,Neutrophil,1.1692072184717057
GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/28,0.0677318256109869,0.1435209687667752,0,0,15.058956916099774,40.54171043527237,FPR2,Neutrophil,1.1692072184717057
GO_Biological_Process_2021,regulation of immunoglobulin production (GO:0002637),1/28,0.0677318256109869,0.1435209687667752,0,0,15.058956916099774,40.54171043527237,CR1,Neutrophil,1.1692072184717057
GO_Biological_Process_2021,T cell activation involved in immune response (GO:0002286),1/28,0.0677318256109869,0.1435209687667752,0,0,15.058956916099774,40.54171043527237,SLC11A1,Neutrophil,1.1692072184717057
GO_Biological_Process_2021,mucosal immune response (GO:0002385),1/28,0.0677318256109869,0.1435209687667752,0,0,15.058956916099774,40.54171043527237,FFAR2,Neutrophil,1.1692072184717057
GO_Biological_Process_2021,regulation of postsynapse organization (GO:0099175),1/28,0.0677318256109869,0.1435209687667752,0,0,15.058956916099774,40.54171043527237,LRRK2,Neutrophil,1.1692072184717057
GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),2/172,0.0688760185279422,0.1452272092262148,0,0,4.848039215686274,12.970673059288286,C5AR1;FPR2,Neutrophil,1.1619319658128364
GO_Biological_Process_2021,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/29,0.0700657588372089,0.1452272092262148,0,0,14.520408163265309,38.5999069065122,G0S2,Neutrophil,1.1544941700666143
GO_Biological_Process_2021,negative regulation of interferon-gamma production (GO:0032689),1/29,0.0700657588372089,0.1452272092262148,0,0,14.520408163265309,38.5999069065122,CR1,Neutrophil,1.1544941700666143
GO_Biological_Process_2021,negative regulation of mRNA catabolic process (GO:1902373),1/29,0.0700657588372089,0.1452272092262148,0,0,14.520408163265309,38.5999069065122,SLC11A1,Neutrophil,1.1544941700666143
GO_Biological_Process_2021,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.0700657588372089,0.1452272092262148,0,0,14.520408163265309,38.5999069065122,LILRB3,Neutrophil,1.1544941700666143
GO_Biological_Process_2021,transition metal ion homeostasis (GO:0055076),1/29,0.0700657588372089,0.1452272092262148,0,0,14.520408163265309,38.5999069065122,SLC11A1,Neutrophil,1.1544941700666143
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),2/176,0.0716793261504705,0.1473734301933588,0,0,4.735632183908046,12.48100918849243,SLC11A1;FPR2,Neutrophil,1.144606086081811
GO_Biological_Process_2021,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/30,0.0723939657090184,0.1473734301933588,0,0,14.019000703729768,36.80874147674154,TNFRSF10C,Neutrophil,1.1402976322627019
GO_Biological_Process_2021,fatty-acyl-CoA biosynthetic process (GO:0046949),1/30,0.0723939657090184,0.1473734301933588,0,0,14.019000703729768,36.80874147674154,ACSL1,Neutrophil,1.1402976322627019
GO_Biological_Process_2021,negative regulation of interleukin-1 production (GO:0032692),1/30,0.0723939657090184,0.1473734301933588,0,0,14.019000703729768,36.80874147674154,MEFV,Neutrophil,1.1402976322627019
GO_Biological_Process_2021,heterotypic cell-cell adhesion (GO:0034113),1/30,0.0723939657090184,0.1473734301933588,0,0,14.019000703729768,36.80874147674154,ITGAX,Neutrophil,1.1402976322627019
GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),2/178,0.073094899664538,0.1482707929138316,0,0,4.681344696969697,12.246382216533686,FCGR2A;CR1,Neutrophil,1.1361129257073213
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),2/180,0.0745195887056104,0.1489104272779641,0,0,4.628277153558052,12.018216055401329,SERPINA1;F5,Neutrophil,1.1277295507615273
GO_Biological_Process_2021,positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/31,0.0747164600026276,0.1489104272779641,0,0,13.551020408163266,35.15209038871121,SIRPB1,Neutrophil,1.126583712764908
GO_Biological_Process_2021,cellular response to cAMP (GO:0071320),1/31,0.0747164600026276,0.1489104272779641,0,0,13.551020408163266,35.15209038871121,AQP9,Neutrophil,1.126583712764908
GO_Biological_Process_2021,positive regulation of mononuclear cell migration (GO:0071677),1/31,0.0747164600026276,0.1489104272779641,0,0,13.551020408163266,35.15209038871121,FPR2,Neutrophil,1.126583712764908
GO_Biological_Process_2021,triglyceride homeostasis (GO:0070328),1/31,0.0747164600026276,0.1489104272779641,0,0,13.551020408163266,35.15209038871121,DGAT2,Neutrophil,1.126583712764908
GO_Biological_Process_2021,activation of phospholipase C activity (GO:0007202),1/32,0.0770332554327668,0.1508898817755227,0,0,13.113232389730086,33.61600807740255,C5AR1,Neutrophil,1.1133217484244988
GO_Biological_Process_2021,regulation of dendritic spine morphogenesis (GO:0061001),1/32,0.0770332554327668,0.1508898817755227,0,0,13.113232389730086,33.61600807740255,LRRK2,Neutrophil,1.1133217484244988
GO_Biological_Process_2021,long-chain fatty acid transport (GO:0015909),1/32,0.0770332554327668,0.1508898817755227,0,0,13.113232389730086,33.61600807740255,ACSL1,Neutrophil,1.1133217484244988
GO_Biological_Process_2021,metal ion export (GO:0070839),1/32,0.0770332554327668,0.1508898817755227,0,0,13.113232389730086,33.61600807740255,SLC11A1,Neutrophil,1.1133217484244988
GO_Biological_Process_2021,endodermal cell differentiation (GO:0035987),1/32,0.0770332554327668,0.1508898817755227,0,0,13.113232389730086,33.61600807740255,LAMB3,Neutrophil,1.1133217484244988
GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),2/185,0.078120393358315,0.1522770654962429,0,0,4.5006830601092895,11.474510084124317,SERPINA1;F5,Neutrophil,1.1072355785829093
GO_Biological_Process_2021,positive regulation of cytokine production involved in immune response (GO:0002720),1/33,0.0793443657059371,0.1522770654962429,0,0,12.70280612244898,32.18837516559274,FFAR2,Neutrophil,1.1004839073426347
GO_Biological_Process_2021,RNA stabilization (GO:0043489),1/33,0.0793443657059371,0.1522770654962429,0,0,12.70280612244898,32.18837516559274,SLC11A1,Neutrophil,1.1004839073426347
GO_Biological_Process_2021,lytic vacuole organization (GO:0080171),1/33,0.0793443657059371,0.1522770654962429,0,0,12.70280612244898,32.18837516559274,LRRK2,Neutrophil,1.1004839073426347
GO_Biological_Process_2021,regulation of neurotransmitter secretion (GO:0046928),1/33,0.0793443657059371,0.1522770654962429,0,0,12.70280612244898,32.18837516559274,LRRK2,Neutrophil,1.1004839073426347
GO_Biological_Process_2021,very long-chain fatty acid metabolic process (GO:0000038),1/33,0.0793443657059371,0.1522770654962429,0,0,12.70280612244898,32.18837516559274,ACSL1,Neutrophil,1.1004839073426347
GO_Biological_Process_2021,regulation of transmembrane transport (GO:0034762),1/34,0.0816498044624026,0.1553612456361605,0,0,12.317254174397032,30.85861216573232,KCNJ15,Neutrophil,1.0880448509885652
GO_Biological_Process_2021,cell-substrate junction assembly (GO:0007044),1/34,0.0816498044624026,0.1553612456361605,0,0,12.317254174397032,30.85861216573232,LAMB3,Neutrophil,1.0880448509885652
GO_Biological_Process_2021,regulation of regulated secretory pathway (GO:1903305),1/35,0.0839495853612937,0.1553612456361605,0,0,11.95438175270108,29.61744503578088,LRRK2,Neutrophil,1.0759814445616303
GO_Biological_Process_2021,regulation of autophagosome assembly (GO:2000785),1/35,0.0839495853612937,0.1553612456361605,0,0,11.95438175270108,29.61744503578088,LRRK2,Neutrophil,1.0759814445616303
GO_Biological_Process_2021,negative regulation of organelle assembly (GO:1902116),1/35,0.0839495853612937,0.1553612456361605,0,0,11.95438175270108,29.61744503578088,LRRK2,Neutrophil,1.0759814445616303
GO_Biological_Process_2021,positive regulation of lymphocyte activation (GO:0051251),1/35,0.0839495853612937,0.1553612456361605,0,0,11.95438175270108,29.61744503578088,SIRPB1,Neutrophil,1.0759814445616303
GO_Biological_Process_2021,cellular response to amyloid-beta (GO:1904646),1/35,0.0839495853612937,0.1553612456361605,0,0,11.95438175270108,29.61744503578088,FPR2,Neutrophil,1.0759814445616303
GO_Biological_Process_2021,intracellular pH reduction (GO:0051452),1/35,0.0839495853612937,0.1553612456361605,0,0,11.95438175270108,29.61744503578088,SLC11A1,Neutrophil,1.0759814445616303
GO_Biological_Process_2021,negative regulation of T cell proliferation (GO:0042130),1/35,0.0839495853612937,0.1553612456361605,0,0,11.95438175270108,29.61744503578088,CR1,Neutrophil,1.0759814445616303
GO_Biological_Process_2021,regulation of ion transmembrane transport (GO:0034765),1/35,0.0839495853612937,0.1553612456361605,0,0,11.95438175270108,29.61744503578088,KCNJ15,Neutrophil,1.0759814445616303
GO_Biological_Process_2021,regulation of postsynaptic membrane potential (GO:0060078),1/35,0.0839495853612937,0.1553612456361605,0,0,11.95438175270108,29.61744503578088,LRRK2,Neutrophil,1.0759814445616303
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),2/194,0.0847375162198589,0.1563119231240116,0,0,4.287760416666667,10.58303673172677,LRRK2;TNFRSF10C,Neutrophil,1.0719242699529004
GO_Biological_Process_2021,positive regulation of innate immune response (GO:0045089),1/36,0.0862437219743075,0.1570572572695058,0,0,11.612244897959185,28.456712045041098,FPR2,Neutrophil,1.0642725091375862
GO_Biological_Process_2021,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/36,0.0862437219743075,0.1570572572695058,0,0,11.612244897959185,28.456712045041098,CASS4,Neutrophil,1.0642725091375862
GO_Biological_Process_2021,regulation of osteoclast differentiation (GO:0045670),1/36,0.0862437219743075,0.1570572572695058,0,0,11.612244897959185,28.456712045041098,LILRB3,Neutrophil,1.0642725091375862
GO_Biological_Process_2021,endoderm formation (GO:0001706),1/36,0.0862437219743075,0.1570572572695058,0,0,11.612244897959185,28.456712045041098,LAMB3,Neutrophil,1.0642725091375862
GO_Biological_Process_2021,endomembrane system organization (GO:0010256),2/199,0.0884858252339979,0.1596942085362423,0,0,4.177876480541455,10.130986600028606,CR1;LRRK2,Neutrophil,1.0531262944513837
GO_Biological_Process_2021,regulation of transport (GO:0051049),1/37,0.0885322278902676,0.1596942085362423,0,0,11.289115646258503,27.36920368672352,LRRK2,Neutrophil,1.0528986067362665
GO_Biological_Process_2021,regulation of intracellular pH (GO:0051453),1/37,0.0885322278902676,0.1596942085362423,0,0,11.289115646258503,27.36920368672352,LRRK2,Neutrophil,1.0528986067362665
GO_Biological_Process_2021,negative regulation of innate immune response (GO:0045824),1/38,0.0908151166313484,0.1612604874762263,0,0,10.983452840595698,26.34852930034076,CR1,Neutrophil,1.0418418549683985
GO_Biological_Process_2021,response to cAMP (GO:0051591),1/38,0.0908151166313484,0.1612604874762263,0,0,10.983452840595698,26.34852930034076,AQP9,Neutrophil,1.0418418549683985
GO_Biological_Process_2021,positive regulation of potassium ion transport (GO:0043268),1/38,0.0908151166313484,0.1612604874762263,0,0,10.983452840595698,26.34852930034076,KCNJ15,Neutrophil,1.0418418549683985
GO_Biological_Process_2021,positive regulation of production of molecular mediator of immune response (GO:0002702),1/38,0.0908151166313484,0.1612604874762263,0,0,10.983452840595698,26.34852930034076,FFAR2,Neutrophil,1.0418418549683985
GO_Biological_Process_2021,lysosome organization (GO:0007040),1/38,0.0908151166313484,0.1612604874762263,0,0,10.983452840595698,26.34852930034076,LRRK2,Neutrophil,1.0418418549683985
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),2/203,0.0915200219539462,0.1620074922787246,0,0,4.093905472636816,9.789336578359592,ITGAX;PROK2,Neutrophil,1.0384838843718929
GO_Biological_Process_2021,regulation of protein targeting to mitochondrion (GO:1903214),1/39,0.0930924017046572,0.1622711589347236,0,0,10.693877551020408,25.38900533231373,LRRK2,Neutrophil,1.0310857651239858
GO_Biological_Process_2021,regulation of protein tyrosine kinase activity (GO:0061097),1/39,0.0930924017046572,0.1622711589347236,0,0,10.693877551020408,25.38900533231373,CASS4,Neutrophil,1.0310857651239858
GO_Biological_Process_2021,regulation of T cell differentiation (GO:0045580),1/39,0.0930924017046572,0.1622711589347236,0,0,10.693877551020408,25.38900533231373,CR1,Neutrophil,1.0310857651239858
GO_Biological_Process_2021,negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.0930924017046572,0.1622711589347236,0,0,10.693877551020408,25.38900533231373,CR1,Neutrophil,1.0310857651239858
GO_Biological_Process_2021,regulation of intracellular transport (GO:0032386),1/39,0.0930924017046572,0.1622711589347236,0,0,10.693877551020408,25.38900533231373,LRRK2,Neutrophil,1.0310857651239858
GO_Biological_Process_2021,organic hydroxy compound transport (GO:0015850),1/40,0.0953640965755271,0.1657241922196661,0,0,10.419152276295131,24.485561288951835,AQP9,Neutrophil,1.0206151011238414
GO_Biological_Process_2021,acylglycerol metabolic process (GO:0006639),1/41,0.0976302146847681,0.1676181396696321,0,0,10.158163265306122,23.633660200289185,DGAT2,Neutrophil,1.0104157556925017
GO_Biological_Process_2021,negative regulation of cell-cell adhesion (GO:0022408),1/41,0.0976302146847681,0.1676181396696321,0,0,10.158163265306122,23.633660200289185,IL1RN,Neutrophil,1.0104157556925017
GO_Biological_Process_2021,positive regulation of cation transmembrane transport (GO:1904064),1/41,0.0976302146847681,0.1676181396696321,0,0,10.158163265306122,23.633660200289185,KCNJ15,Neutrophil,1.0104157556925017
GO_Biological_Process_2021,regulation of mitochondrial membrane potential (GO:0051881),1/41,0.0976302146847681,0.1676181396696321,0,0,10.158163265306122,23.633660200289185,LRRK2,Neutrophil,1.0104157556925017
GO_Biological_Process_2021,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.0998907694703361,0.1691721916710545,0,0,9.909905425584869,22.829231064333683,JAML,Neutrophil,1.00047464143678
GO_Biological_Process_2021,regulation of chemokine production (GO:0032642),1/42,0.0998907694703361,0.1691721916710545,0,0,9.909905425584869,22.829231064333683,FFAR2,Neutrophil,1.00047464143678
GO_Biological_Process_2021,positive regulation of protein tyrosine kinase activity (GO:0061098),1/42,0.0998907694703361,0.1691721916710545,0,0,9.909905425584869,22.829231064333683,CASS4,Neutrophil,1.00047464143678
GO_Biological_Process_2021,potassium ion import across plasma membrane (GO:1990573),1/42,0.0998907694703361,0.1691721916710545,0,0,9.909905425584869,22.829231064333683,KCNJ15,Neutrophil,1.00047464143678
GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),2/214,0.100019348409027,0.1691721916710545,0,0,3.879323899371069,8.931722866735825,LRRK2;FPR2,Neutrophil,0.9999159790553556
GO_Biological_Process_2021,regulation of cytokine production involved in inflammatory response (GO:1900015),1/43,0.1021457742794159,0.1707422033409591,0,0,9.673469387755102,22.068611238785657,MEFV,Neutrophil,0.9907795952096249
GO_Biological_Process_2021,negative regulation of proteolysis (GO:0045861),1/43,0.1021457742794159,0.1707422033409591,0,0,9.673469387755102,22.068611238785657,LRRK2,Neutrophil,0.9907795952096249
GO_Biological_Process_2021,positive regulation of phospholipase C activity (GO:0010863),1/43,0.1021457742794159,0.1707422033409591,0,0,9.673469387755102,22.068611238785657,C5AR1,Neutrophil,0.9907795952096249
GO_Biological_Process_2021,positive regulation of T cell differentiation (GO:0045582),1/43,0.1021457742794159,0.1707422033409591,0,0,9.673469387755102,22.068611238785657,CR1,Neutrophil,0.9907795952096249
GO_Biological_Process_2021,response to amyloid-beta (GO:1904645),1/44,0.1043952424647777,0.1729804889678003,0,0,9.448030374940672,21.34849709415977,FPR2,Neutrophil,0.9813192926974915
GO_Biological_Process_2021,positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.1043952424647777,0.1729804889678003,0,0,9.448030374940672,21.34849709415977,KCNJ15,Neutrophil,0.9813192926974915
GO_Biological_Process_2021,mRNA stabilization (GO:0048255),1/44,0.1043952424647777,0.1729804889678003,0,0,9.448030374940672,21.34849709415977,SLC11A1,Neutrophil,0.9813192926974915
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),2/221,0.1055403360927836,0.1743709900663382,0,0,3.7539954337899544,8.441467129790793,CASS4;ITGAX,Neutrophil,0.97658152714763
GO_Biological_Process_2021,negative regulation of T cell activation (GO:0050868),1/45,0.1066391873529346,0.1751709993981924,0,0,9.232838589981448,20.665901611884028,CR1,Neutrophil,0.9720831731354668
GO_Biological_Process_2021,positive regulation of response to biotic stimulus (GO:0002833),1/45,0.1066391873529346,0.1751709993981924,0,0,9.232838589981448,20.665901611884028,FPR2,Neutrophil,0.9720831731354668
GO_Biological_Process_2021,"regulation of synaptic transmission, glutamatergic (GO:0051966)",1/46,0.1088776222085674,0.1783340363761018,0,0,9.02721088435374,20.01811780873028,LRRK2,Neutrophil,0.9630613723103648
GO_Biological_Process_2021,regulation of T cell activation (GO:0050863),1/47,0.1111105603036554,0.1814699695503829,0,0,8.830523513753327,19.4026870705364,SIRPB1,Neutrophil,0.9542446623584087
GO_Biological_Process_2021,substrate adhesion-dependent cell spreading (GO:0034446),1/48,0.1133380148369131,0.1828647034138951,0,0,8.642205818497612,18.81737166641443,LAMB3,Neutrophil,0.9456243984787533
GO_Biological_Process_2021,regulation of interleukin-2 production (GO:0032663),1/48,0.1133380148369131,0.1828647034138951,0,0,8.642205818497612,18.81737166641443,CR1,Neutrophil,0.9456243984787533
GO_Biological_Process_2021,cognition (GO:0050890),1/48,0.1133380148369131,0.1828647034138951,0,0,8.642205818497612,18.81737166641443,C5AR1,Neutrophil,0.9456243984787533
GO_Biological_Process_2021,regulation of mitochondrion organization (GO:0010821),1/48,0.1133380148369131,0.1828647034138951,0,0,8.642205818497612,18.81737166641443,LRRK2,Neutrophil,0.9456243984787533
GO_Biological_Process_2021,regulation of autophagy (GO:0010506),2/231,0.1135686052781033,0.1828647034138951,0,0,3.5882459970887917,7.805684373606142,LRRK2;MEFV,Neutrophil,0.9447417076995079
GO_Biological_Process_2021,receptor internalization (GO:0031623),1/49,0.1155599990222406,0.1845075614640817,0,0,8.46173469387755,18.260130793597916,CXCR2,Neutrophil,0.9371924705024297
GO_Biological_Process_2021,regulation of cellular localization (GO:0060341),1/49,0.1155599990222406,0.1845075614640817,0,0,8.46173469387755,18.260130793597916,LRRK2,Neutrophil,0.9371924705024297
GO_Biological_Process_2021,positive regulation of reactive oxygen species metabolic process (GO:2000379),1/49,0.1155599990222406,0.1845075614640817,0,0,8.46173469387755,18.260130793597916,FPR2,Neutrophil,0.9371924705024297
GO_Biological_Process_2021,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/50,0.1177765260040411,0.1869989410092017,0,0,8.28862973760933,17.7290996615035,CASS4,Neutrophil,0.928941259997044
GO_Biological_Process_2021,iron ion transport (GO:0006826),1/50,0.1177765260040411,0.1869989410092017,0,0,8.28862973760933,17.7290996615035,SLC11A1,Neutrophil,0.928941259997044
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),2/238,0.1192811662769016,0.1878926843010762,0,0,3.4805790960451977,7.400657287256659,C5AR1;FPR2,Neutrophil,0.9234281232007147
GO_Biological_Process_2021,regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.1199876089220907,0.1878926843010762,0,0,8.122448979591837,17.22257115519733,CASS4,Neutrophil,0.9208636010741894
GO_Biological_Process_2021,blood circulation (GO:0008015),1/51,0.1199876089220907,0.1878926843010762,0,0,8.122448979591837,17.22257115519733,F5,Neutrophil,0.9208636010741894
GO_Biological_Process_2021,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/51,0.1199876089220907,0.1878926843010762,0,0,8.122448979591837,17.22257115519733,BCL2A1,Neutrophil,0.9208636010741894
GO_Biological_Process_2021,regulation of interleukin-12 production (GO:0032655),1/51,0.1199876089220907,0.1878926843010762,0,0,8.122448979591837,17.22257115519733,MEFV,Neutrophil,0.9208636010741894
GO_Biological_Process_2021,negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.1221932608707862,0.1903009800446671,0,0,7.962785114045619,16.738979733033663,MEFV,Neutrophil,0.9129527453809976
GO_Biological_Process_2021,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.1221932608707862,0.1903009800446671,0,0,7.962785114045619,16.738979733033663,LRRK2,Neutrophil,0.9129527453809976
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),4/764,0.1230654595125794,0.191137089706186,0,0,2.1956521739130435,4.5999766581612365,CR1;CXCR2;ITGAX;PROK2,Neutrophil,0.9098638223570947
GO_Biological_Process_2021,positive regulation of chemokine production (GO:0032722),1/53,0.1243934949128716,0.1926747067943936,0,0,7.809262166405024,16.276887238960814,FFAR2,Neutrophil,0.9052023302345248
GO_Biological_Process_2021,positive regulation of leukocyte chemotaxis (GO:0002690),1/54,0.1265883240687765,0.193445964394645,0,0,7.661532537543319,15.834970375184442,FPR2,Neutrophil,0.8976063498190403
GO_Biological_Process_2021,inorganic anion transport (GO:0015698),1/54,0.1265883240687765,0.193445964394645,0,0,7.661532537543319,15.834970375184442,SLC11A1,Neutrophil,0.8976063498190403
GO_Biological_Process_2021,negative regulation of viral genome replication (GO:0045071),1/54,0.1265883240687765,0.193445964394645,0,0,7.661532537543319,15.834970375184442,APOBEC3A,Neutrophil,0.8976063498190403
GO_Biological_Process_2021,unsaturated fatty acid metabolic process (GO:0033559),1/54,0.1265883240687765,0.193445964394645,0,0,7.661532537543319,15.834970375184442,ACSL1,Neutrophil,0.8976063498190403
GO_Biological_Process_2021,regulation of potassium ion transmembrane transport (GO:1901379),1/54,0.1265883240687765,0.193445964394645,0,0,7.661532537543319,15.834970375184442,KCNJ15,Neutrophil,0.8976063498190403
GO_Biological_Process_2021,negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/55,0.1287777613922166,0.1957421973161693,0,0,7.519274376417234,15.412009607623004,IL1RN,Neutrophil,0.8901591287349465
GO_Biological_Process_2021,triglyceride metabolic process (GO:0006641),1/55,0.1287777613922166,0.1957421973161693,0,0,7.519274376417234,15.412009607623004,DGAT2,Neutrophil,0.8901591287349465
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),2/253,0.1317582069542016,0.1997398350103588,0,0,3.270086321381142,6.627767796360294,LRRK2;FPR2,Neutrophil,0.880222323941479
GO_Biological_Process_2021,carboxylic acid transport (GO:0046942),1/57,0.1331405122852093,0.2002377097693121,0,0,7.25,14.618539131965724,AQP9,Neutrophil,0.8756897763447542
GO_Biological_Process_2021,positive regulation of interferon-gamma production (GO:0032729),1/57,0.1331405122852093,0.2002377097693121,0,0,7.25,14.618539131965724,SLC11A1,Neutrophil,0.8756897763447542
GO_Biological_Process_2021,cellular response to peptide (GO:1901653),1/57,0.1331405122852093,0.2002377097693121,0,0,7.25,14.618539131965724,FPR2,Neutrophil,0.8756897763447542
GO_Biological_Process_2021,fat cell differentiation (GO:0045444),1/58,0.1353138517398134,0.2008564986762856,0,0,7.122448979591836,14.246025949065045,FFAR2,Neutrophil,0.8686577434892403
GO_Biological_Process_2021,receptor metabolic process (GO:0043112),1/58,0.1353138517398134,0.2008564986762856,0,0,7.122448979591836,14.246025949065045,CXCR2,Neutrophil,0.8686577434892403
GO_Biological_Process_2021,negative regulation of hydrolase activity (GO:0051346),1/58,0.1353138517398134,0.2008564986762856,0,0,7.122448979591836,14.246025949065045,LRRK2,Neutrophil,0.8686577434892403
GO_Biological_Process_2021,cellular iron ion homeostasis (GO:0006879),1/58,0.1353138517398134,0.2008564986762856,0,0,7.122448979591836,14.246025949065045,SLC11A1,Neutrophil,0.8686577434892403
GO_Biological_Process_2021,positive regulation of protein binding (GO:0032092),1/58,0.1353138517398134,0.2008564986762856,0,0,7.122448979591836,14.246025949065045,LRRK2,Neutrophil,0.8686577434892403
GO_Biological_Process_2021,negative regulation of autophagy (GO:0010507),1/59,0.1374818510452552,0.2030172411808172,0,0,6.9992962702322306,13.8884471557023,LRRK2,Neutrophil,0.8617546291873563
GO_Biological_Process_2021,positive regulation of apoptotic signaling pathway (GO:2001235),1/59,0.1374818510452552,0.2030172411808172,0,0,6.9992962702322306,13.8884471557023,G0S2,Neutrophil,0.8617546291873563
GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.1396445230534406,0.2046205093585119,0,0,6.88031822898651,13.544974303558986,FPR2,Neutrophil,0.8549760929333525
GO_Biological_Process_2021,response to organic cyclic compound (GO:0014070),1/60,0.1396445230534406,0.2046205093585119,0,0,6.88031822898651,13.544974303558986,LRRK2,Neutrophil,0.8549760929333525
GO_Biological_Process_2021,peptidyl-threonine phosphorylation (GO:0018107),1/60,0.1396445230534406,0.2046205093585119,0,0,6.88031822898651,13.544974303558986,LRRK2,Neutrophil,0.8549760929333525
GO_Biological_Process_2021,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2067188540610238,0,0,6.76530612244898,13.214837540593155,FFAR2,Neutrophil,0.848318009451734
GO_Biological_Process_2021,iron ion homeostasis (GO:0055072),1/61,0.1418018805927374,0.2067188540610238,0,0,6.76530612244898,13.214837540593155,SLC11A1,Neutrophil,0.848318009451734
GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),2/266,0.1428070813555834,0.2076531540119452,0,0,3.1070075757575757,6.047046555927847,LRRK2;FPR2,Neutrophil,0.8452502567236859
GO_Biological_Process_2021,positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/62,0.1439539364695556,0.2087881521314166,0,0,6.654064904650385,12.897320592663672,MEFV,Neutrophil,0.8417764546925935
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),2/269,0.1453850943051252,0.2102964670360881,0,0,3.071629213483146,5.923235274252741,CASS4;ITGAX,Neutrophil,0.837480117499467
GO_Biological_Process_2021,actin cytoskeleton reorganization (GO:0031532),1/63,0.1461007034145454,0.2102964670360881,0,0,6.54641211323239,12.591756250239603,CASS4,Neutrophil,0.8353476931121088
GO_Biological_Process_2021,negative regulation of peptidase activity (GO:0010466),1/63,0.1461007034145454,0.2102964670360881,0,0,6.54641211323239,12.591756250239603,SERPINA1,Neutrophil,0.8353476931121088
GO_Biological_Process_2021,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/64,0.1482421941802595,0.2107183308796707,0,0,6.442176870748299,12.297522293260638,LRRK2,Neutrophil,0.8290281655096747
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway (GO:2001236),1/64,0.1482421941802595,0.2107183308796707,0,0,6.442176870748299,12.297522293260638,G0S2,Neutrophil,0.8290281655096747
GO_Biological_Process_2021,lipid homeostasis (GO:0055088),1/64,0.1482421941802595,0.2107183308796707,0,0,6.442176870748299,12.297522293260638,DGAT2,Neutrophil,0.8290281655096747
GO_Biological_Process_2021,regulation of innate immune response (GO:0045088),1/64,0.1482421941802595,0.2107183308796707,0,0,6.442176870748299,12.297522293260638,FPR2,Neutrophil,0.8290281655096747
GO_Biological_Process_2021,plasma membrane organization (GO:0007009),1/64,0.1482421941802595,0.2107183308796707,0,0,6.442176870748299,12.297522293260638,CR1,Neutrophil,0.8290281655096747
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),2/274,0.1497038344955427,0.2121675748764649,0,0,3.014399509803922,5.724635176902424,SLC11A1;ATP2C2,Neutrophil,0.8247670755492156
GO_Biological_Process_2021,regulation of cellular catabolic process (GO:0031329),1/65,0.1503784214913892,0.2121675748764649,0,0,6.341198979591836,12.01403781811508,LRRK2,Neutrophil,0.8228144782361342
GO_Biological_Process_2021,chemical homeostasis (GO:0048878),1/65,0.1503784214913892,0.2121675748764649,0,0,6.341198979591836,12.01403781811508,AQP9,Neutrophil,0.8228144782361342
GO_Biological_Process_2021,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.2141141794239093,0,0,6.243328100470958,11.740759916332207,LRRK2,Neutrophil,0.8167033932798328
GO_Biological_Process_2021,cellular response to nutrient levels (GO:0031669),1/66,0.1525093979756266,0.2141141794239093,0,0,6.243328100470958,11.740759916332207,LRRK2,Neutrophil,0.8167033932798328
GO_Biological_Process_2021,regulation of viral genome replication (GO:0045069),1/67,0.1546351363099914,0.2160343816095468,0,0,6.148423005565863,11.477180657220888,APOBEC3A,Neutrophil,0.8106918184915987
GO_Biological_Process_2021,peptidyl-threonine modification (GO:0018210),1/67,0.1546351363099914,0.2160343816095468,0,0,6.148423005565863,11.477180657220888,LRRK2,Neutrophil,0.8106918184915987
GO_Biological_Process_2021,canonical Wnt signaling pathway (GO:0060070),1/68,0.1567556490806558,0.2184614180341658,0,0,6.0563508985683825,11.222824361971773,LRRK2,Neutrophil,0.8047767993307415
GO_Biological_Process_2021,positive regulation of MAP kinase activity (GO:0043406),1/69,0.158870948881139,0.2203319729008498,0,0,5.966986794717887,10.977245117600177,LRRK2,Neutrophil,0.7989555105590889
GO_Biological_Process_2021,peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.158870948881139,0.2203319729008498,0,0,5.966986794717887,10.977245117600177,AATK,Neutrophil,0.7989555105590889
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),2/286,0.160174195271258,0.221106500054523,0,0,2.885269953051643,5.284352690216861,LRRK2;TNFRSF10C,Neutrophil,0.7954074492629319
GO_Biological_Process_2021,positive regulation of cell-substrate adhesion (GO:0010811),1/70,0.1609810482853106,0.221106500054523,0,0,5.880212954747116,10.740024519792764,CASS4,Neutrophil,0.7932252488723367
GO_Biological_Process_2021,carbohydrate homeostasis (GO:0033500),1/70,0.1609810482853106,0.221106500054523,0,0,5.880212954747116,10.740024519792764,FFAR2,Neutrophil,0.7932252488723367
GO_Biological_Process_2021,negative regulation of viral process (GO:0048525),1/70,0.1609810482853106,0.221106500054523,0,0,5.880212954747116,10.740024519792764,APOBEC3A,Neutrophil,0.7932252488723367
GO_Biological_Process_2021,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/71,0.16308595979881,0.22185918158788,0,0,5.795918367346939,10.51076961698872,FCGR2A,Neutrophil,0.7875834261109624
GO_Biological_Process_2021,response to metal ion (GO:0010038),1/71,0.16308595979881,0.22185918158788,0,0,5.795918367346939,10.51076961698872,AQP9,Neutrophil,0.7875834261109624
GO_Biological_Process_2021,regulation of endopeptidase activity (GO:0052548),1/71,0.16308595979881,0.22185918158788,0,0,5.795918367346939,10.51076961698872,SERPINA1,Neutrophil,0.7875834261109624
GO_Biological_Process_2021,cholesterol homeostasis (GO:0042632),1/71,0.16308595979881,0.22185918158788,0,0,5.795918367346939,10.51076961698872,DGAT2,Neutrophil,0.7875834261109624
GO_Biological_Process_2021,Fc-gamma receptor signaling pathway (GO:0038094),1/72,0.1651856959101235,0.2231181200681764,0,0,5.713998275366484,10.28911103101624,FCGR2A,Neutrophil,0.78202756268309
GO_Biological_Process_2021,cell morphogenesis involved in differentiation (GO:0000904),1/72,0.1651856959101235,0.2231181200681764,0,0,5.713998275366484,10.28911103101624,LAMB3,Neutrophil,0.78202756268309
GO_Biological_Process_2021,sterol homeostasis (GO:0055092),1/72,0.1651856959101235,0.2231181200681764,0,0,5.713998275366484,10.28911103101624,DGAT2,Neutrophil,0.78202756268309
GO_Biological_Process_2021,response to molecule of bacterial origin (GO:0002237),1/73,0.1672802691231711,0.2243523609416647,0,0,5.634353741496598,10.074701240888364,SLC11A1,Neutrophil,0.7765552814899175
GO_Biological_Process_2021,defense response to Gram-negative bacterium (GO:0050829),1/73,0.1672802691231711,0.2243523609416647,0,0,5.634353741496598,10.074701240888364,SLC11A1,Neutrophil,0.7765552814899175
GO_Biological_Process_2021,endoplasmic reticulum organization (GO:0007029),1/73,0.1672802691231711,0.2243523609416647,0,0,5.634353741496598,10.074701240888364,LRRK2,Neutrophil,0.7765552814899175
GO_Biological_Process_2021,Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/74,0.1693696918266344,0.2255624400494898,0,0,5.556891249650545,9.867213018330611,FCGR2A,Neutrophil,0.7711643026835198
GO_Biological_Process_2021,negative regulation of protein binding (GO:0032091),1/74,0.1693696918266344,0.2255624400494898,0,0,5.556891249650545,9.867213018330611,LRRK2,Neutrophil,0.7711643026835198
GO_Biological_Process_2021,regulation of peptide hormone secretion (GO:0090276),1/74,0.1693696918266344,0.2255624400494898,0,0,5.556891249650545,9.867213018330611,FFAR2,Neutrophil,0.7711643026835198
GO_Biological_Process_2021,positive regulation of immune response (GO:0050778),1/75,0.1714539764404576,0.2272762013280484,0,0,5.4815223386651954,9.666337985731484,FPR2,Neutrophil,0.7658524380723842
GO_Biological_Process_2021,positive regulation of T cell activation (GO:0050870),1/75,0.1714539764404576,0.2272762013280484,0,0,5.4815223386651954,9.666337985731484,SIRPB1,Neutrophil,0.7658524380723842
GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),1/76,0.1735331353639065,0.2294985780914773,0,0,5.408163265306122,9.4717853003048,CR1,Neutrophil,0.7606175863963804
GO_Biological_Process_2021,purine ribonucleotide metabolic process (GO:0009150),1/77,0.1756071809118701,0.2306361592621335,0,0,5.336734693877551,9.283280446293812,LRRK2,Neutrophil,0.7554577289388229
GO_Biological_Process_2021,inorganic cation import across plasma membrane (GO:0098659),1/77,0.1756071809118701,0.2306361592621335,0,0,5.336734693877551,9.283280446293812,KCNJ15,Neutrophil,0.7554577289388229
GO_Biological_Process_2021,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/77,0.1756071809118701,0.2306361592621335,0,0,5.336734693877551,9.283280446293812,LRRK2,Neutrophil,0.7554577289388229
GO_Biological_Process_2021,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),1/79,0.1797399811935544,0.2339081947039407,0,0,5.199372056514914,8.923391206941128,LRRK2,Neutrophil,0.745355308086215
GO_Biological_Process_2021,regulation of ion transport (GO:0043269),1/79,0.1797399811935544,0.2339081947039407,0,0,5.199372056514914,8.923391206941128,KCNJ15,Neutrophil,0.745355308086215
GO_Biological_Process_2021,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.1797399811935544,0.2339081947039407,0,0,5.199372056514914,8.923391206941128,LRRK2,Neutrophil,0.745355308086215
GO_Biological_Process_2021,regulation of neuron differentiation (GO:0045664),1/79,0.1797399811935544,0.2339081947039407,0,0,5.199372056514914,8.923391206941128,LRRK2,Neutrophil,0.745355308086215
GO_Biological_Process_2021,lipid biosynthetic process (GO:0008610),1/80,0.181798760490535,0.2360485045093507,0,0,5.133298889175924,8.751529842637671,ACSL1,Neutrophil,0.7404090821369118
GO_Biological_Process_2021,negative regulation of protein modification process (GO:0031400),1/81,0.1838524754991919,0.2376324513254862,0,0,5.0688775510204085,8.584760541358477,LRRK2,Neutrophil,0.7355305181562768
GO_Biological_Process_2021,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2376324513254862,0,0,5.0688775510204085,8.584760541358477,FFAR2,Neutrophil,0.7355305181562768
GO_Biological_Process_2021,positive regulation of protein ubiquitination (GO:0031398),1/82,0.1859011384602527,0.2397367622677467,0,0,5.00604686318972,8.422875391899517,LRRK2,Neutrophil,0.7307179505966239
GO_Biological_Process_2021,epidermis development (GO:0008544),1/83,0.1879447615357932,0.2407382338773082,0,0,4.944748631159781,8.265677319811374,LAMB3,Neutrophil,0.7259697745939766
GO_Biological_Process_2021,long-chain fatty acid metabolic process (GO:0001676),1/83,0.1879447615357932,0.2407382338773082,0,0,4.944748631159781,8.265677319811374,ACSL1,Neutrophil,0.7259697745939766
GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.2407382338773082,0,0,4.944748631159781,8.265677319811374,MEFV,Neutrophil,0.7259697745939766
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),2/323,0.1932342825020938,0.245790982949462,0,0,2.5478971962616823,4.188365716592005,AQP9;FFAR2,Neutrophil,0.7139158210847405
GO_Biological_Process_2021,glucose homeostasis (GO:0042593),1/86,0.1940455128548384,0.245790982949462,0,0,4.769507803121249,7.820383303288144,FFAR2,Neutrophil,0.7120963955156414
GO_Biological_Process_2021,negative regulation of phosphorylation (GO:0042326),1/86,0.1940455128548384,0.245790982949462,0,0,4.769507803121249,7.820383303288144,LRRK2,Neutrophil,0.7120963955156414
GO_Biological_Process_2021,positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.1940455128548384,0.245790982949462,0,0,4.769507803121249,7.820383303288144,LRRK2,Neutrophil,0.7120963955156414
GO_Biological_Process_2021,regulation of neuron death (GO:1901214),1/86,0.1940455128548384,0.245790982949462,0,0,4.769507803121249,7.820383303288144,LRRK2,Neutrophil,0.7120963955156414
GO_Biological_Process_2021,calcium ion transmembrane transport (GO:0070588),1/87,0.196069097589664,0.247803515800684,0,0,4.713811105837684,7.6801565438185,ATP2C2,Neutrophil,0.7075908500030543
GO_Biological_Process_2021,negative regulation of binding (GO:0051100),1/88,0.1980877029036425,0.2492494274946495,0,0,4.659394792399718,7.5437717166037235,LRRK2,Neutrophil,0.703142484213379
GO_Biological_Process_2021,metal ion transport (GO:0030001),1/88,0.1980877029036425,0.2492494274946495,0,0,4.659394792399718,7.5437717166037235,SLC11A1,Neutrophil,0.703142484213379
GO_Biological_Process_2021,collagen fibril organization (GO:0030199),1/89,0.2001013407742902,0.2512285555976772,0,0,4.6062152133580705,7.411084001248333,LAMB3,Neutrophil,0.6987500013741589
GO_Biological_Process_2021,positive regulation of binding (GO:0051099),1/90,0.2021100231923967,0.2531927763069586,0,0,4.55423068103646,7.281955543769811,LRRK2,Neutrophil,0.6944121480917811
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),2/335,0.2041536136242794,0.2551920170303493,0,0,2.4545795795795797,3.9000386874614623,SLC11A1;FFAR2,Neutrophil,0.6900429284365769
GO_Biological_Process_2021,T cell activation (GO:0042110),1/92,0.2061125694363157,0.2565156431849344,0,0,4.453689167974883,7.03385741012878,JAML,Neutrophil,0.6858955226779435
GO_Biological_Process_2021,Wnt signaling pathway (GO:0016055),1/92,0.2061125694363157,0.2565156431849344,0,0,4.453689167974883,7.03385741012878,LRRK2,Neutrophil,0.6858955226779435
GO_Biological_Process_2021,regulation of epithelial cell proliferation (GO:0050678),1/93,0.2081064570390282,0.2584328551465056,0,0,4.40505767524401,6.914643337844717,C5AR1,Neutrophil,0.6817144444740324
GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),1/94,0.2100954368002021,0.2603356499480765,0,0,4.357472021066491,6.79849904676328,LRRK2,Neutrophil,0.6775833802166729
GO_Biological_Process_2021,post-translational protein modification (GO:0043687),2/345,0.2133084926466024,0.2635280139762091,0,0,2.381802721088435,3.6799229289674416,SERPINA1;F5,Neutrophil,0.6709918532419347
GO_Biological_Process_2021,regulation of vesicle-mediated transport (GO:0060627),1/96,0.2140587201245348,0.2635280139762091,0,0,4.26530612244898,6.5749903239841245,LRRK2,Neutrophil,0.6694670755856718
GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.2140587201245348,0.2635280139762091,0,0,4.26530612244898,6.5749903239841245,SLC11A1,Neutrophil,0.6694670755856718
GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2648147031188114,0,0,4.220663265306122,6.46742313757927,ATP2C2,Neutrophil,0.6654798083211632
GO_Biological_Process_2021,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2648147031188114,0,0,4.220663265306122,6.46742313757927,LRRK2,Neutrophil,0.6654798083211632
GO_Biological_Process_2021,positive regulation of defense response (GO:0031349),1/98,0.2180025137484037,0.2660844386222487,0,0,4.176940879444562,6.362519703204576,FPR2,Neutrophil,0.6615384985937142
GO_Biological_Process_2021,negative regulation of neuron death (GO:1901215),1/98,0.2180025137484037,0.2660844386222487,0,0,4.176940879444562,6.362519703204576,LRRK2,Neutrophil,0.6615384985937142
GO_Biological_Process_2021,sensory perception of chemical stimulus (GO:0007606),1/99,0.2199671313012003,0.2673374516880259,0,0,4.134110787172012,6.26018948804807,C5AR1,Neutrophil,0.6576422090003602
GO_Biological_Process_2021,organic anion transport (GO:0015711),1/99,0.2199671313012003,0.2673374516880259,0,0,4.134110787172012,6.26018948804807,AQP9,Neutrophil,0.6576422090003602
GO_Biological_Process_2021,organic acid transport (GO:0015849),1/100,0.2219269115603851,0.2691454033817437,0,0,4.092145949288806,6.1603458876211565,ACSL1,Neutrophil,0.6537900306498672
GO_Biological_Process_2021,cellular response to chemical stress (GO:0062197),1/101,0.2238818662412048,0.2709398381262989,0,0,4.051020408163265,6.062906014187368,LRRK2,Neutrophil,0.6499810815451941
GO_Biological_Process_2021,regulation of cell death (GO:0010941),1/102,0.2258320069783284,0.2709984083739941,0,0,4.010709234188725,5.967790506031058,LRRK2,Neutrophil,0.6462145058611213
GO_Biological_Process_2021,intrinsic apoptotic signaling pathway (GO:0097193),1/102,0.2258320069783284,0.2709984083739941,0,0,4.010709234188725,5.967790506031058,BCL2A1,Neutrophil,0.6462145058611213
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.2709984083739941,0,0,4.010709234188725,5.967790506031058,ITGAX,Neutrophil,0.6462145058611213
GO_Biological_Process_2021,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/102,0.2258320069783284,0.2709984083739941,0,0,4.010709234188725,5.967790506031058,LRRK2,Neutrophil,0.6462145058611213
GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),1/103,0.2277773453985499,0.2727585858764147,0,0,3.971188475390156,5.874923343943355,AQP9,Neutrophil,0.64248947278397
GO_Biological_Process_2021,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2745056583910092,0,0,3.932435109966317,5.78423168094792,ATP2C2,Neutrophil,0.6388051756325536
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2785423797901423,0,0,3.857142857142857,5.6090983677319475,LRRK2,Neutrophil,0.6315556772929499
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.2823693171211373,0,0,2.2110433604336044,3.18053102486219,LRRK2;FPR2,Neutrophil,0.6247218387200065
GO_Biological_Process_2021,regulation of protein ubiquitination (GO:0031396),1/109,0.239349173739861,0.2830477780741096,0,0,3.749433106575964,5.361058744932435,LRRK2,Neutrophil,0.6209680674126086
GO_Biological_Process_2021,lipid transport (GO:0006869),1/109,0.239349173739861,0.2830477780741096,0,0,3.749433106575964,5.361058744932435,ACSL1,Neutrophil,0.6209680674126086
GO_Biological_Process_2021,modulation of chemical synaptic transmission (GO:0050804),1/109,0.239349173739861,0.2830477780741096,0,0,3.749433106575964,5.361058744932435,LRRK2,Neutrophil,0.6209680674126086
GO_Biological_Process_2021,regulation of protein kinase activity (GO:0045859),1/110,0.241261218690496,0.2847182083925109,0,0,3.714847406852649,5.282048795926194,C5AR1,Neutrophil,0.6175124827423236
GO_Biological_Process_2021,regulation of Wnt signaling pathway (GO:0030111),1/111,0.2431685532271013,0.2863761887178672,0,0,3.6808905380333954,5.20478084558139,LRRK2,Neutrophil,0.6140925891155178
GO_Biological_Process_2021,regulation of macroautophagy (GO:0016241),1/112,0.2450711886958998,0.2880218093951812,0,0,3.647545504688362,5.129202360192396,LRRK2,Neutrophil,0.6107077427090284
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),2/381,0.2465612635256485,0.2891767905547729,0,0,2.15160510114336,3.012558657024939,BCL2A1;PROK2,Neutrophil,0.6080751530383309
GO_Biological_Process_2021,activation of protein kinase activity (GO:0032147),1/114,0.2488624078588274,0.2905042236971449,0,0,3.582625970742279,4.982913653406146,SLC11A1,Neutrophil,0.6040407011916724
GO_Biological_Process_2021,response to lipid (GO:0033993),1/114,0.2488624078588274,0.2905042236971449,0,0,3.582625970742279,4.982913653406146,SLC11A1,Neutrophil,0.6040407011916724
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),2/384,0.2493463820044915,0.2905042236971449,0,0,2.1343804537521813,2.9644671728961822,SLC11A1;ITGAX,Neutrophil,0.6031969289771376
GO_Biological_Process_2021,calcium ion transport (GO:0006816),1/115,0.2507510141385882,0.2905042236971449,0,0,3.5510204081632653,4.9121080927455,ATP2C2,Neutrophil,0.6007573018413346
GO_Biological_Process_2021,cellular response to lectin (GO:1990858),1/115,0.2507510141385882,0.2905042236971449,0,0,3.5510204081632653,4.9121080927455,CLEC4E,Neutrophil,0.6007573018413346
GO_Biological_Process_2021,stimulatory C-type lectin receptor signaling pathway (GO:0002223),1/115,0.2507510141385882,0.2905042236971449,0,0,3.5510204081632653,4.9121080927455,CLEC4E,Neutrophil,0.6007573018413346
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.2920931662399338,0,0,3.5199645075421473,4.8428011439058265,ITGAX,Neutrophil,0.5975065399797567
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),4/1025,0.2531480899318741,0.2920939499213932,0,0,1.6121449559255632,2.2147335064279132,SERPINA1;LRRK2;AATK;F5,Neutrophil,0.596625345129507
GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.2563889548341396,0.294640532773104,0,0,3.4594453165881736,4.708511372057024,ADGRE3,Neutrophil,0.5911006880374128
GO_Biological_Process_2021,regulation of protein binding (GO:0043393),1/118,0.2563889548341396,0.294640532773104,0,0,3.4594453165881736,4.708511372057024,LRRK2,Neutrophil,0.5911006880374128
GO_Biological_Process_2021,potassium ion transport (GO:0006813),1/122,0.2638415777635164,0.3024187084990076,0,0,3.3444088379153314,4.456111874258477,KCNJ15,Neutrophil,0.5786567646257991
GO_Biological_Process_2021,phosphorylation (GO:0016310),2/400,0.2642184505833435,0.3024187084990076,0,0,2.046901172529313,2.7243825855585304,LRRK2;AATK,Neutrophil,0.5780368585354551
GO_Biological_Process_2021,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.3034973183063788,0,0,3.316828370692539,4.396166676729281,LRRK2,Neutrophil,0.5756194520344882
GO_Biological_Process_2021,fatty acid metabolic process (GO:0006631),1/124,0.2675403902734135,0.3043872703709495,0,0,3.2896963663514187,4.337414433160371,ACSL1,Neutrophil,0.5726106437410472
GO_Biological_Process_2021,defense response to symbiont (GO:0140546),1/124,0.2675403902734135,0.3043872703709495,0,0,3.2896963663514187,4.337414433160371,APOBEC3A,Neutrophil,0.5726106437410472
GO_Biological_Process_2021,cellular response to oxidative stress (GO:0034599),1/125,0.2693829605231016,0.3058730826656732,0,0,3.263001974983542,4.279822783786303,LRRK2,Neutrophil,0.5696298784899082
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),2/408,0.2716606168083876,0.3078460269995645,0,0,2.0057471264367814,2.6138931132295458,CASS4;ITGAX,Neutrophil,0.5659733175722854
GO_Biological_Process_2021,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.2785278903472666,0.3143780148474098,0,0,3.135738016136687,4.008216604624779,LRRK2,Neutrophil,0.5551313103019286
GO_Biological_Process_2021,Golgi organization (GO:0007030),1/130,0.2785278903472666,0.3143780148474098,0,0,3.135738016136687,4.008216604624779,LRRK2,Neutrophil,0.5551313103019286
GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),2/417,0.2800329921032276,0.3151789349981957,0,0,1.9613453815261044,2.4964942594636463,SERPINA1;F5,Neutrophil,0.552790799213849
GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.3151789349981957,0,0,3.111459968602826,3.956968446025251,LRRK2,Neutrophil,0.5523097126477655
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),3/742,0.2833046813486276,0.3172707548205216,0,0,1.6593153485158207,2.092782192966935,BCL2A1;TNFRSF10C;PROK2,Neutrophil,0.5477462491044153
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),4/1079,0.2833172179011324,0.3172707548205216,0,0,1.5267947421638015,1.925575356569311,BTNL8;SLC11A1;ITGAX;MEFV,Neutrophil,0.5477270315076967
GO_Biological_Process_2021,defense response to virus (GO:0051607),1/133,0.2839609038772722,0.3173680690393042,0,0,3.0640074211502784,3.857336278341556,APOBEC3A,Neutrophil,0.546741450090894
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3187571431512145,0,0,3.0408163265306123,3.80890385676326,CASS4,Neutrophil,0.5439940297149167
GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3208787459204217,0,0,2.99546485260771,3.714691124222948,FCGR2A,Neutrophil,0.5385707850387818
GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),1/136,0.289353816496661,0.3208787459204217,0,0,2.99546485260771,3.714691124222948,ATP2C2,Neutrophil,0.5385707850387818
GO_Biological_Process_2021,organic substance transport (GO:0071702),1/136,0.289353816496661,0.3208787459204217,0,0,2.99546485260771,3.714691124222948,AQP9,Neutrophil,0.5385707850387818
GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3222354912073765,0,0,2.9732893157262907,3.668866926816198,FCGR2A,Neutrophil,0.5358942544628899
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3249186525900088,0,0,2.929902395740905,3.579678317757992,FPR2,Neutrophil,0.5306096689947516
GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),1/139,0.2947069182263764,0.3249186525900088,0,0,2.929902395740905,3.579678317757992,KCNJ15,Neutrophil,0.5306096689947516
GO_Biological_Process_2021,neuron projection morphogenesis (GO:0048812),1/140,0.2964824884084789,0.3256166057665375,0,0,2.9086771399207163,3.5362740390257685,LRRK2,Neutrophil,0.5280009529309525
GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.2964824884084789,0.3256166057665375,0,0,2.9086771399207163,3.5362740390257685,CASS4,Neutrophil,0.5280009529309525
GO_Biological_Process_2021,protein localization to organelle (GO:0033365),1/142,0.3000204969826995,0.3288686216925745,0,0,2.8671298306556667,3.4517504575709377,LRRK2,Neutrophil,0.522849073872343
GO_Biological_Process_2021,regulation of mRNA stability (GO:0043488),1/146,0.307044282279795,0.335921767561388,0,0,2.7874736101337088,3.291346538126983,SLC11A1,Neutrophil,0.5127989855557247
GO_Biological_Process_2021,brain development (GO:0007420),1/150,0.3139989845586295,0.3428724544031012,0,0,2.712094233666621,3.141596466170354,AATK,Neutrophil,0.5030717563895143
GO_Biological_Process_2021,actin filament organization (GO:0007015),1/152,0.3174506378807152,0.3453184419694803,0,0,2.6759021489390458,3.0704182805545575,CASS4,Neutrophil,0.4983237959237088
GO_Biological_Process_2021,negative regulation of protein phosphorylation (GO:0001933),1/152,0.3174506378807152,0.3453184419694803,0,0,2.6759021489390458,3.0704182805545575,LRRK2,Neutrophil,0.4983237959237088
GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.3191700762858281,0.3465275113960419,0,0,2.6581632653061225,3.0357052873752,LRRK2,Neutrophil,0.4959778325880012
GO_Biological_Process_2021,peptidyl-serine phosphorylation (GO:0018105),1/156,0.3243029619756543,0.3514309663994733,0,0,2.6063199473337724,2.934917292064671,LRRK2,Neutrophil,0.4890490847411261
GO_Biological_Process_2021,cellular response to starvation (GO:0009267),1/158,0.3277037968552589,0.3537711443323817,0,0,2.5728584427401535,2.8703970097526006,LRRK2,Neutrophil,0.48451852674781976
GO_Biological_Process_2021,T cell receptor signaling pathway (GO:0050852),1/158,0.3277037968552589,0.3537711443323817,0,0,2.5728584427401535,2.8703970097526006,BTNL8,Neutrophil,0.48451852674781976
GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.3549278135646391,0,0,2.556445362955309,2.8389038953772054,SLC11A1,Neutrophil,0.4822791499015975
GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3578886095576108,0,0,2.524234693877551,2.7773973646136283,CASS4,Neutrophil,0.4778511096570981
GO_Biological_Process_2021,regulation of neuron projection development (GO:0010975),1/165,0.3394751386404204,0.3644083409134457,0,0,2.4621702339472376,2.6600168495918335,LRRK2,Neutrophil,0.46919202564454415
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),2/482,0.3401543782991926,0.3644511196062778,0,0,1.6901041666666667,1.8225334796372663,SLC11A1;ITGAX,Neutrophil,0.46832393464331673
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),2/485,0.3429022272693128,0.3667059466107097,0,0,1.6793478260869563,1.797422644350721,BCL2A1;PROK2,Neutrophil,0.46482969398207885
GO_Biological_Process_2021,peptidyl-serine modification (GO:0018209),1/169,0.3461106816465725,0.3694439860272403,0,0,2.403061224489796,2.5496399471999527,LRRK2,Neutrophil,0.4607849973294511
GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.3477593333218013,0.3705099439129472,0,0,2.388721168940949,2.523073857975914,JAML,Neutrophil,0.45872120538836164
GO_Biological_Process_2021,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.3715675921139476,0,0,2.3745498199279713,2.4969025061029213,LRRK2,Neutrophil,0.4566722378913039
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),2/496,0.3529487892748932,0.374638379677261,0,0,1.641025641025641,1.709017116633574,LRRK2;AATK,Neutrophil,0.4522883035321021
GO_Biological_Process_2021,cation transport (GO:0006812),1/174,0.3543133002736421,0.3753876973159405,0,0,2.333018756635602,2.4206789693623425,KCNJ15,Neutrophil,0.45061254473982715
GO_Biological_Process_2021,mitochondrion organization (GO:0007005),1/175,0.3559416811668189,0.3764132806402352,0,0,2.319493314567206,2.396009637948729,LRRK2,Neutrophil,0.4486211526513072
GO_Biological_Process_2021,antigen receptor-mediated signaling pathway (GO:0050851),1/185,0.3720057294778557,0.3926727144488477,0,0,2.192324755989352,2.1678716160963645,BTNL8,Neutrophil,0.4294503712432232
GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),1/189,0.3783208179838206,0.3986004921456151,0,0,2.1452453321754232,2.085205747179162,LRRK2,Neutrophil,0.42213975998471215
GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),1/198,0.3923030921692546,0.4125696725765224,0,0,2.0463068476121413,1.914771355908193,LRRK2,Neutrophil,0.4063782687077012
GO_Biological_Process_2021,regulation of macromolecule metabolic process (GO:0060255),1/200,0.3953681557510544,0.415027345816024,0,0,2.025535842477695,1.8795714928238216,MEFV,Neutrophil,0.40299831311675843
GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4253803533316176,0,0,1.9560134733505052,1.7632653144438126,CASS4,Neutrophil,0.3914985283218076
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4324081775840224,0,0,1.909178837411742,1.6862551884518755,LRRK2,Neutrophil,0.3835844547796231
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),2/566,0.4155454754335446,0.4338112106174367,0,0,1.43218085106383,1.2576885523498746,CR1;APOBEC3A,Neutrophil,0.38138144203835345
GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4339121736435709,0,0,1.8910606496119575,1.656759537391559,SLC11A1,Neutrophil,0.3804856946694876
GO_Biological_Process_2021,cellular response to lipid (GO:0071396),1/219,0.4237408440429794,0.4407523377819312,0,0,1.8472196217936716,1.5860841457604238,FFAR2,Neutrophil,0.372899672681652
GO_Biological_Process_2021,membrane organization (GO:0061024),1/242,0.4563449373288627,0.4738007546037373,0,0,1.6689812854602422,1.3093263562491473,CR1,Neutrophil,0.3407067631514444
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.4870392982961438,0,0,1.6016749329213755,1.2094704650298027,LRRK2,Neutrophil,0.32794816113488356
GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.4875436875465912,0,0,1.5952380952380951,1.2000608149186214,LRRK2,Neutrophil,0.32670971902140344
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5057042732578995,0,0,1.510204081632653,1.0781219104526054,LRRK2,Neutrophil,0.3100391544580995
GO_Biological_Process_2021,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5061224661207371,0,0,1.504471451501949,1.0700627976731167,AATK,Neutrophil,0.3088941088615854
GO_Biological_Process_2021,proteolysis (GO:0006508),1/287,0.51499186851511,0.5298652798801673,0,0,1.4031682603111175,0.9311483055746664,MMP25,Neutrophil,0.28819962821492023
GO_Biological_Process_2021,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.54875263607131,0,0,1.32774699283687,0.8321996277505203,LRRK2,Neutrophil,0.2722052530518486
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5561858612227243,0,0,1.2972062611452349,0.7932686422257892,TNFRSF10C,Neutrophil,0.2655801196036423
GO_Biological_Process_2021,transcription by RNA polymerase II (GO:0006366),1/320,0.5540128017436795,0.5669430825743219,0,0,1.255901733734246,0.7416947278731473,C5AR1,Neutrophil,0.2564801997798679
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5682390976771259,0,0,1.2479496471485791,0.7319104885681406,SLC11A1,Neutrophil,0.2547095446988111
GO_Biological_Process_2021,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.5752102067501172,0,0,1.2208810353409656,0.6989624697257846,LRRK2,Neutrophil,0.24863646405532092
GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),1/350,0.5868058377702841,0.5972845134447534,0,0,1.1461902812701013,0.6109896633619631,BCL2A1,Neutrophil,0.23150557427863594
GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),1/351,0.5878572192841084,0.5972880837646022,0,0,1.1428571428571428,0.6071670684764225,LAMB3,Neutrophil,0.23072814400359865
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.6490927121620279,0,0,0.989871879272801,0.4417939051458828,CASS4,Neutrophil,0.19383180708628664
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),1/409,0.644552703427983,0.6525666802023984,0,0,0.9774909963985594,0.4293127610136149,MEFV,Neutrophil,0.19074156570833578
GO_Biological_Process_2021,organelle organization (GO:0006996),1/420,0.6544076492323022,0.6613694327347736,0,0,0.9512931664312504,0.4033718992390181,LRRK2,Neutrophil,0.18415163293091988
GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),1/437,0.6691136001848389,0.67503495947851,0,0,0.9134057292641828,0.3670077257341264,LRRK2,Neutrophil,0.1745001427028418
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.7411690084513921,0,0,0.7565820221218258,0.231944503707841,MEFV,Neutrophil,0.13314117322745964
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.7538179216252877,0,0,0.726642950758285,0.2091870484536521,CASS4,Neutrophil,0.12502533841998253
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),1/908,0.9023188918982462,0.9054960710950712,0,0,0.4284814256463335,0.0440424414337815,SLC11A1,Neutrophil,0.044639949690669034
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1183,0.952754544972228,0.9544289817823728,0,0,0.3240443385476018,0.0156830878086274,SLC11A1,Neutrophil,0.021018970814361417
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),1/2206,0.9971209346049892,0.9971209346049892,0,0,0.1642371234207968,0.00047353141012936674,SLC11A1,Neutrophil,0.0012521656136179045
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),7/300,9.157617210590753e-06,0.0034249488367609,0,0,10.92142233510596,126.69859641142828,VIT;IBSP;ITGA10;COL12A1;ITGA8;KLK4;NPNT,Osteo-MSC,5.038217513986156
GO_Biological_Process_2021,skeletal system development (GO:0001501),5/158,4.592416598080171e-05,0.0085878190384099,0,0,14.376906318082789,143.60400317721937,EXTL1;DLX5;DLX6;BMP7;FGFR3,Osteo-MSC,4.337958722082026
GO_Biological_Process_2021,positive regulation of osteoblast differentiation (GO:0045669),3/44,0.0001811421903351466,0.0135915720141102,0,0,30.994810586403737,267.0583626754283,NPNT;BMP7;TP63,Osteo-MSC,3.74198038515947
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),5/216,0.00020015431168576712,0.0135915720141102,0,0,10.39441811479726,88.5232503874961,VIT;IBSP;ITGA10;ITGA8;NPNT,Osteo-MSC,3.698635049969732
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),5/217,0.00020449186137451637,0.0135915720141102,0,0,10.344863731656185,87.87943513377891,VIT;IBSP;ITGA10;ITGA8;NPNT,Osteo-MSC,3.689323971913233
GO_Biological_Process_2021,endochondral ossification (GO:0001958),2/9,0.00021804660985203623,0.0135915720141102,0,0,118.70833333333331,1000.8064198202924,DLX5;FGFR3,Osteo-MSC,3.6614506612675517
GO_Biological_Process_2021,endochondral bone morphogenesis (GO:0060350),2/13,0.00046942457388711873,0.0250806843762546,0,0,75.52651515151516,578.8354329773197,DLX5;FGFR3,Osteo-MSC,3.3284341792789096
GO_Biological_Process_2021,mesonephric tubule development (GO:0072164),2/17,0.0008132713373134499,0.0380204350194037,0,0,55.375,393.96243373102385,NPNT;BMP7,Osteo-MSC,3.089764533572175
GO_Biological_Process_2021,ureteric bud development (GO:0001657),2/19,0.0010193089566942,0.0394532046630591,0,0,48.85539215686274,336.54673838088314,NPNT;BMP7,Osteo-MSC,2.9916941596143727
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),3/80,0.0010548985204026,0.0394532046630591,0,0,16.473887814313347,112.9171456129886,VIT;IBSP;NPNT,Osteo-MSC,2.9767893168107804
GO_Biological_Process_2021,regulation of osteoblast differentiation (GO:0045667),3/83,0.0011735239744728,0.0398998151320777,0,0,15.85372340425532,106.97686877010656,NPNT;BMP7;TP63,Osteo-MSC,2.9305080335686804
GO_Biological_Process_2021,cell-matrix adhesion (GO:0007160),3/100,0.0020046761378758,0.0594294445079481,0,0,13.064049133581928,81.15743654844592,ITGA10;ITGA8;NPNT,Osteo-MSC,2.6979557791007505
GO_Biological_Process_2021,calcium-ion regulated exocytosis (GO:0017156),2/27,0.0020657293545543,0.0594294445079481,0,0,33.208333333333336,205.3029465636782,SCIN;SYT12,Osteo-MSC,2.684926579003782
GO_Biological_Process_2021,regulation of dendrite morphogenesis (GO:0048814),2/32,0.0028959211173454,0.0773624641347993,0,0,27.666666666666668,161.69650653172428,PTPRD;HECW1,Osteo-MSC,2.5382132721600397
GO_Biological_Process_2021,regulation of dendrite development (GO:0050773),2/39,0.0042784069542198,0.1066749467252146,0,0,22.42454954954955,122.3074073504305,HECW1;BMP7,Osteo-MSC,2.368717908505425
GO_Biological_Process_2021,regulation of cell-substrate adhesion (GO:0010810),2/43,0.0051806911627924,0.1210986559302724,0,0,20.232723577235777,106.48111760263689,VIT;NPNT,Osteo-MSC,2.2856122965939503
GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),3/158,0.0072257561149995,0.1472440431433211,0,0,8.151681537405628,40.18863284587075,IBSP;DLX5;BMP7,Osteo-MSC,2.1411167009049183
GO_Biological_Process_2021,BMP signaling pathway (GO:0030509),2/65,0.0115237618661231,0.1472440431433211,0,0,13.15277777777778,58.70537343689256,DLX5;BMP7,Osteo-MSC,1.9384057248186684
GO_Biological_Process_2021,protein side chain deglutamylation (GO:0035610),1/5,0.0124387771927725,0.1472440431433211,0,0,101.76530612244898,446.4379351400606,AGBL4,Osteo-MSC,1.9052223113279663
GO_Biological_Process_2021,regulation of glomerular mesangial cell proliferation (GO:0072124),1/5,0.0124387771927725,0.1472440431433211,0,0,101.76530612244898,446.4379351400606,BMP7,Osteo-MSC,1.9052223113279663
GO_Biological_Process_2021,tight junction organization (GO:0120193),1/5,0.0124387771927725,0.1472440431433211,0,0,101.76530612244898,446.4379351400606,CLDN11,Osteo-MSC,1.9052223113279663
GO_Biological_Process_2021,C-terminal protein deglutamylation (GO:0035609),1/5,0.0124387771927725,0.1472440431433211,0,0,101.76530612244898,446.4379351400606,AGBL4,Osteo-MSC,1.9052223113279663
GO_Biological_Process_2021,carbon dioxide transport (GO:0015670),1/5,0.0124387771927725,0.1472440431433211,0,0,101.76530612244898,446.4379351400606,CA2,Osteo-MSC,1.9052223113279663
GO_Biological_Process_2021,cell-cell adhesion mediated by integrin (GO:0033631),1/5,0.0124387771927725,0.1472440431433211,0,0,101.76530612244898,446.4379351400606,NPNT,Osteo-MSC,1.9052223113279663
GO_Biological_Process_2021,cellular response to decreased oxygen levels (GO:0036294),2/69,0.0129153730394233,0.1472440431433211,0,0,12.36504975124378,53.77976800231812,ANGPT4;BMP7,Osteo-MSC,1.888893045423814
GO_Biological_Process_2021,kidney development (GO:0001822),2/70,0.013274200561286,0.1472440431433211,0,0,12.182598039215684,52.65237170003471,ITGA8;BMP7,Osteo-MSC,1.8769916248436092
GO_Biological_Process_2021,positive regulation of cell-substrate adhesion (GO:0010811),2/70,0.013274200561286,0.1472440431433211,0,0,12.182598039215684,52.65237170003471,VIT;NPNT,Osteo-MSC,1.8769916248436092
GO_Biological_Process_2021,cellular response to BMP stimulus (GO:0071773),2/71,0.0136373517747766,0.1472440431433211,0,0,12.005434782608695,51.56265564232933,DLX5;BMP7,Osteo-MSC,1.8652699567516449
GO_Biological_Process_2021,regulation of response to reactive oxygen species (GO:1901031),1/6,0.0149082847993736,0.1472440431433211,0,0,81.40816326530613,342.3895623444841,BMP7,Osteo-MSC,1.8265723193247598
GO_Biological_Process_2021,regulation of superoxide metabolic process (GO:0090322),1/6,0.0149082847993736,0.1472440431433211,0,0,81.40816326530613,342.3895623444841,BMP7,Osteo-MSC,1.8265723193247598
GO_Biological_Process_2021,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,0.0149082847993736,0.1472440431433211,0,0,81.40816326530613,342.3895623444841,PTPRD,Osteo-MSC,1.8265723193247598
GO_Biological_Process_2021,negative regulation of actin filament depolymerization (GO:0030835),1/6,0.0149082847993736,0.1472440431433211,0,0,81.40816326530613,342.3895623444841,SCIN,Osteo-MSC,1.8265723193247598
GO_Biological_Process_2021,regulation of cell division (GO:0051302),2/76,0.0155171628224907,0.1472440431433211,0,0,11.19144144144144,46.62140287744705,INSC;TP63,Osteo-MSC,1.8091876827669675
GO_Biological_Process_2021,negative regulation of blood vessel morphogenesis (GO:2000181),2/78,0.0162985561731684,0.1472440431433211,0,0,10.895833333333334,44.85464558420347,ANGPT4;ISM1,Osteo-MSC,1.7878508663812431
GO_Biological_Process_2021,regulation of ion transport (GO:0043269),2/79,0.0166954776383478,0.1472440431433211,0,0,10.75378787878788,44.01113934918422,SYT12;CA2,Osteo-MSC,1.7774011517679502
GO_Biological_Process_2021,angiotensin-activated signaling pathway (GO:0038166),1/7,0.0173717414502839,0.1472440431433211,0,0,67.83673469387755,274.9362107684438,CA2,Osteo-MSC,1.7601566430186848
GO_Biological_Process_2021,synaptic vesicle docking (GO:0016081),1/7,0.0173717414502839,0.1472440431433211,0,0,67.83673469387755,274.9362107684438,UNC13C,Osteo-MSC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of fibroblast apoptotic process (GO:2000271),1/7,0.0173717414502839,0.1472440431433211,0,0,67.83673469387755,274.9362107684438,TP63,Osteo-MSC,1.7601566430186848
GO_Biological_Process_2021,pericardium morphogenesis (GO:0003344),1/7,0.0173717414502839,0.1472440431433211,0,0,67.83673469387755,274.9362107684438,BMP7,Osteo-MSC,1.7601566430186848
GO_Biological_Process_2021,negative regulation of striated muscle cell apoptotic process (GO:0010664),1/8,0.0198291614511851,0.1472440431433211,0,0,58.142857142857146,227.9549801512961,BMP7,Osteo-MSC,1.702695651141308
GO_Biological_Process_2021,leukocyte aggregation (GO:0070486),1/8,0.0198291614511851,0.1472440431433211,0,0,58.142857142857146,227.9549801512961,BMP7,Osteo-MSC,1.702695651141308
GO_Biological_Process_2021,regulation of anion transport (GO:0044070),1/8,0.0198291614511851,0.1472440431433211,0,0,58.142857142857146,227.9549801512961,CA2,Osteo-MSC,1.702695651141308
GO_Biological_Process_2021,commissural neuron axon guidance (GO:0071679),1/8,0.0198291614511851,0.1472440431433211,0,0,58.142857142857146,227.9549801512961,NCAM1,Osteo-MSC,1.702695651141308
GO_Biological_Process_2021,negative regulation of mitotic nuclear division (GO:0045839),1/8,0.0198291614511851,0.1472440431433211,0,0,58.142857142857146,227.9549801512961,BMP7,Osteo-MSC,1.702695651141308
GO_Biological_Process_2021,negative regulation of muscle cell apoptotic process (GO:0010656),1/8,0.0198291614511851,0.1472440431433211,0,0,58.142857142857146,227.9549801512961,BMP7,Osteo-MSC,1.702695651141308
GO_Biological_Process_2021,protein deglutamylation (GO:0035608),1/8,0.0198291614511851,0.1472440431433211,0,0,58.142857142857146,227.9549801512961,AGBL4,Osteo-MSC,1.702695651141308
GO_Biological_Process_2021,cellular response to angiotensin (GO:1904385),1/8,0.0198291614511851,0.1472440431433211,0,0,58.142857142857146,227.9549801512961,CA2,Osteo-MSC,1.702695651141308
GO_Biological_Process_2021,negative regulation of angiogenesis (GO:0016525),2/87,0.0200173181098975,0.1472440431433211,0,0,9.737745098039216,38.08585452607372,ANGPT4;ISM1,Osteo-MSC,1.6985941090791523
GO_Biological_Process_2021,regulation of fibroblast apoptotic process (GO:2000269),1/9,0.0222805591236868,0.1472440431433211,0,0,50.87244897959184,193.52086993316271,TP63,Osteo-MSC,1.652073914876897
GO_Biological_Process_2021,mesodermal cell differentiation (GO:0048333),1/9,0.0222805591236868,0.1472440431433211,0,0,50.87244897959184,193.52086993316271,ITGA8,Osteo-MSC,1.652073914876897
GO_Biological_Process_2021,one-carbon compound transport (GO:0019755),1/9,0.0222805591236868,0.1472440431433211,0,0,50.87244897959184,193.52086993316271,CA2,Osteo-MSC,1.652073914876897
GO_Biological_Process_2021,regulation of cellular response to oxidative stress (GO:1900407),1/9,0.0222805591236868,0.1472440431433211,0,0,50.87244897959184,193.52086993316271,BMP7,Osteo-MSC,1.652073914876897
GO_Biological_Process_2021,pericardium development (GO:0060039),1/9,0.0222805591236868,0.1472440431433211,0,0,50.87244897959184,193.52086993316271,BMP7,Osteo-MSC,1.652073914876897
GO_Biological_Process_2021,positive regulation of megakaryocyte differentiation (GO:0045654),1/9,0.0222805591236868,0.1472440431433211,0,0,50.87244897959184,193.52086993316271,SCIN,Osteo-MSC,1.652073914876897
GO_Biological_Process_2021,sequestering of actin monomers (GO:0042989),1/10,0.024725948817258,0.1472440431433211,0,0,45.21768707482993,167.3010120823387,SCIN,Osteo-MSC,1.606847034080906
GO_Biological_Process_2021,negative regulation of sodium ion transmembrane transport (GO:1902306),1/10,0.024725948817258,0.1472440431433211,0,0,45.21768707482993,167.3010120823387,HECW1,Osteo-MSC,1.606847034080906
GO_Biological_Process_2021,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,0.024725948817258,0.1472440431433211,0,0,45.21768707482993,167.3010120823387,HECW1,Osteo-MSC,1.606847034080906
GO_Biological_Process_2021,apical protein localization (GO:0045176),1/10,0.024725948817258,0.1472440431433211,0,0,45.21768707482993,167.3010120823387,INSC,Osteo-MSC,1.606847034080906
GO_Biological_Process_2021,presynaptic membrane assembly (GO:0097105),1/10,0.024725948817258,0.1472440431433211,0,0,45.21768707482993,167.3010120823387,PTPRD,Osteo-MSC,1.606847034080906
GO_Biological_Process_2021,morphogenesis of an epithelial sheet (GO:0002011),1/10,0.024725948817258,0.1472440431433211,0,0,45.21768707482993,167.3010120823387,BMP7,Osteo-MSC,1.606847034080906
GO_Biological_Process_2021,positive regulation of lipase activity (GO:0060193),1/10,0.024725948817258,0.1472440431433211,0,0,45.21768707482993,167.3010120823387,FGFR3,Osteo-MSC,1.606847034080906
GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),3/258,0.0266503572098972,0.1472440431433211,0,0,4.92991239048811,17.870699352489467,NPNT;BMP7;TP63,Osteo-MSC,1.5742969655024164
GO_Biological_Process_2021,positive regulation of actin nucleation (GO:0051127),1/11,0.0271653448579923,0.1472440431433211,0,0,40.69387755102041,146.73452100035948,SCIN,Osteo-MSC,1.5659847773237099
GO_Biological_Process_2021,positive regulation of dendrite development (GO:1900006),1/11,0.0271653448579923,0.1472440431433211,0,0,40.69387755102041,146.73452100035948,BMP7,Osteo-MSC,1.5659847773237099
GO_Biological_Process_2021,mesonephros development (GO:0001823),1/11,0.0271653448579923,0.1472440431433211,0,0,40.69387755102041,146.73452100035948,BMP7,Osteo-MSC,1.5659847773237099
GO_Biological_Process_2021,presynaptic membrane organization (GO:0097090),1/11,0.0271653448579923,0.1472440431433211,0,0,40.69387755102041,146.73452100035948,PTPRD,Osteo-MSC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of nuclear division (GO:0051784),1/11,0.0271653448579923,0.1472440431433211,0,0,40.69387755102041,146.73452100035948,BMP7,Osteo-MSC,1.5659847773237099
GO_Biological_Process_2021,regulation of phospholipase activity (GO:0010517),1/11,0.0271653448579923,0.1472440431433211,0,0,40.69387755102041,146.73452100035948,FGFR3,Osteo-MSC,1.5659847773237099
GO_Biological_Process_2021,inhibitory synapse assembly (GO:1904862),1/11,0.0271653448579923,0.1472440431433211,0,0,40.69387755102041,146.73452100035948,CBLN4,Osteo-MSC,1.5659847773237099
GO_Biological_Process_2021,regulation of actin nucleation (GO:0051125),1/12,0.029598761568907,0.1516429702297432,0,0,36.99257884972171,130.2147194065139,SCIN,Osteo-MSC,1.5287264597194943
GO_Biological_Process_2021,gas transport (GO:0015669),1/12,0.029598761568907,0.1516429702297432,0,0,36.99257884972171,130.2147194065139,CA2,Osteo-MSC,1.5287264597194943
GO_Biological_Process_2021,C-terminal protein amino acid modification (GO:0018410),1/12,0.029598761568907,0.1516429702297432,0,0,36.99257884972171,130.2147194065139,AGBL4,Osteo-MSC,1.5287264597194943
GO_Biological_Process_2021,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),1/12,0.029598761568907,0.1516429702297432,0,0,36.99257884972171,130.2147194065139,UNC13C,Osteo-MSC,1.5287264597194943
GO_Biological_Process_2021,spinal cord development (GO:0021510),1/13,0.032026213248763,0.1618622129059104,0,0,33.90816326530612,116.6847899929619,VIT,Osteo-MSC,1.4944944088974865
GO_Biological_Process_2021,positive regulation of brown fat cell differentiation (GO:0090336),1/14,0.0344477141698711,0.1631326222614141,0,0,31.298273155416013,105.4223689491126,BMP7,Osteo-MSC,1.4628395910668823
GO_Biological_Process_2021,synaptic membrane adhesion (GO:0099560),1/14,0.0344477141698711,0.1631326222614141,0,0,31.298273155416013,105.4223689491126,PTPRD,Osteo-MSC,1.4628395910668823
GO_Biological_Process_2021,bone morphogenesis (GO:0060349),1/14,0.0344477141698711,0.1631326222614141,0,0,31.298273155416013,105.4223689491126,FGFR3,Osteo-MSC,1.4628395910668823
GO_Biological_Process_2021,positive regulation of transmembrane transport (GO:0034764),1/14,0.0344477141698711,0.1631326222614141,0,0,31.298273155416013,105.4223689491126,CA2,Osteo-MSC,1.4628395910668823
GO_Biological_Process_2021,regulation of secretion (GO:0051046),1/15,0.0368632785936063,0.1631326222614141,0,0,29.06122448979592,95.91771596133704,SCIN,Osteo-MSC,1.4334060415588732
GO_Biological_Process_2021,steroid hormone mediated signaling pathway (GO:0043401),1/15,0.0368632785936063,0.1631326222614141,0,0,29.06122448979592,95.91771596133704,BMP7,Osteo-MSC,1.4334060415588732
GO_Biological_Process_2021,positive regulation of secretion (GO:0051047),1/15,0.0368632785936063,0.1631326222614141,0,0,29.06122448979592,95.91771596133704,SCIN,Osteo-MSC,1.4334060415588732
GO_Biological_Process_2021,positive regulation of heterotypic cell-cell adhesion (GO:0034116),1/15,0.0368632785936063,0.1631326222614141,0,0,29.06122448979592,95.91771596133704,BMP7,Osteo-MSC,1.4334060415588732
GO_Biological_Process_2021,non-canonical Wnt signaling pathway (GO:0035567),2/124,0.038497072428768,0.1631326222614141,0,0,6.771857923497268,22.05711333941876,ARHGEF19;FZD8,Osteo-MSC,1.4145722958518654
GO_Biological_Process_2021,regulation of systemic arterial blood pressure (GO:0003073),1/16,0.0392729207344652,0.1631326222614141,0,0,27.122448979591837,87.80133530116419,KLK1,Osteo-MSC,1.405906798966597
GO_Biological_Process_2021,mesenchyme development (GO:0060485),1/16,0.0392729207344652,0.1631326222614141,0,0,27.122448979591837,87.80133530116419,BMP7,Osteo-MSC,1.405906798966597
GO_Biological_Process_2021,oligodendrocyte development (GO:0014003),1/16,0.0392729207344652,0.1631326222614141,0,0,27.122448979591837,87.80133530116419,ZNF488,Osteo-MSC,1.405906798966597
GO_Biological_Process_2021,synapse organization (GO:0050808),2/126,0.0396295625933463,0.1631326222614141,0,0,6.661962365591398,21.50601306379386,PTPRD;UNC13C,Osteo-MSC,1.4019807211138142
GO_Biological_Process_2021,pharyngeal system development (GO:0060037),1/17,0.0416766547912334,0.1631326222614141,0,0,25.426020408163264,80.79916728086499,BMP7,Osteo-MSC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),3/310,0.0423559096851941,0.1631326222614141,0,0,4.084066809896735,12.912378899302078,SCIN;ARHGEF19;TP63,Osteo-MSC,1.3730859864049756
GO_Biological_Process_2021,cellular response to hypoxia (GO:0071456),2/131,0.0425157677463691,0.1631326222614141,0,0,6.4021317829457365,20.217165618082923,ANGPT4;BMP7,Osteo-MSC,1.3714499740612387
GO_Biological_Process_2021,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),2/133,0.043691853040543,0.1631326222614141,0,0,6.303753180661578,19.734489511742076,DLX5;BMP7,Osteo-MSC,1.3595995357844428
GO_Biological_Process_2021,"synaptic transmission, glutamatergic (GO:0035249)",1/18,0.0440744949316926,0.1631326222614141,0,0,23.92917166866747,74.70385911458476,UNC13C,Osteo-MSC,1.3558126557645607
GO_Biological_Process_2021,regulation of brown fat cell differentiation (GO:0090335),1/18,0.0440744949316926,0.1631326222614141,0,0,23.92917166866747,74.70385911458476,BMP7,Osteo-MSC,1.3558126557645607
GO_Biological_Process_2021,regulation of cartilage development (GO:0061035),1/18,0.0440744949316926,0.1631326222614141,0,0,23.92917166866747,74.70385911458476,SCIN,Osteo-MSC,1.3558126557645607
GO_Biological_Process_2021,presynapse assembly (GO:0099054),1/18,0.0440744949316926,0.1631326222614141,0,0,23.92917166866747,74.70385911458476,PTPRD,Osteo-MSC,1.3558126557645607
GO_Biological_Process_2021,regulation of presynapse assembly (GO:1905606),1/18,0.0440744949316926,0.1631326222614141,0,0,23.92917166866747,74.70385911458476,PTPRD,Osteo-MSC,1.3558126557645607
GO_Biological_Process_2021,regulation of presynapse organization (GO:0099174),1/18,0.0440744949316926,0.1631326222614141,0,0,23.92917166866747,74.70385911458476,PTPRD,Osteo-MSC,1.3558126557645607
GO_Biological_Process_2021,endothelial cell proliferation (GO:0001935),1/18,0.0440744949316926,0.1631326222614141,0,0,23.92917166866747,74.70385911458476,ANGPT4,Osteo-MSC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),2/134,0.0442844516217812,0.1631326222614141,0,0,6.255681818181818,19.49972118549308,ANGPT4;FGFR3,Osteo-MSC,1.3537487288592545
GO_Biological_Process_2021,actin filament capping (GO:0051693),1/19,0.0464664552952436,0.1631326222614141,0,0,22.598639455782312,69.35578082800635,SCIN,Osteo-MSC,1.3328604565168853
GO_Biological_Process_2021,establishment of skin barrier (GO:0061436),1/19,0.0464664552952436,0.1631326222614141,0,0,22.598639455782312,69.35578082800635,TP63,Osteo-MSC,1.3328604565168853
GO_Biological_Process_2021,barbed-end actin filament capping (GO:0051016),1/19,0.0464664552952436,0.1631326222614141,0,0,22.598639455782312,69.35578082800635,SCIN,Osteo-MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of water loss via skin (GO:0033561),1/19,0.0464664552952436,0.1631326222614141,0,0,22.598639455782312,69.35578082800635,TP63,Osteo-MSC,1.3328604565168853
GO_Biological_Process_2021,branching involved in ureteric bud morphogenesis (GO:0001658),1/19,0.0464664552952436,0.1631326222614141,0,0,22.598639455782312,69.35578082800635,NPNT,Osteo-MSC,1.3328604565168853
GO_Biological_Process_2021,heart trabecula morphogenesis (GO:0061384),1/19,0.0464664552952436,0.1631326222614141,0,0,22.598639455782312,69.35578082800635,BMP7,Osteo-MSC,1.3328604565168853
GO_Biological_Process_2021,ureteric bud morphogenesis (GO:0060675),1/19,0.0464664552952436,0.1631326222614141,0,0,22.598639455782312,69.35578082800635,NPNT,Osteo-MSC,1.3328604565168853
GO_Biological_Process_2021,neuron projection morphogenesis (GO:0048812),2/140,0.0479026862337682,0.1631326222614141,0,0,5.981884057971015,18.176455370515885,SLITRK4;BMP7,Osteo-MSC,1.319640132017756
GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),2/140,0.0479026862337682,0.1631326222614141,0,0,5.981884057971015,18.176455370515885,PTPRD;FGFR3,Osteo-MSC,1.319640132017756
GO_Biological_Process_2021,positive regulation of dendrite morphogenesis (GO:0050775),1/20,0.0488525499820277,0.1631326222614141,0,0,21.40816326530612,64.63014669364038,PTPRD,Osteo-MSC,1.3111127622579986
GO_Biological_Process_2021,mesoderm formation (GO:0001707),1/20,0.0488525499820277,0.1631326222614141,0,0,21.40816326530612,64.63014669364038,ITGA8,Osteo-MSC,1.3111127622579986
GO_Biological_Process_2021,oligodendrocyte differentiation (GO:0048709),1/20,0.0488525499820277,0.1631326222614141,0,0,21.40816326530612,64.63014669364038,ZNF488,Osteo-MSC,1.3111127622579986
GO_Biological_Process_2021,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1/20,0.0488525499820277,0.1631326222614141,0,0,21.40816326530612,64.63014669364038,CLDN11,Osteo-MSC,1.3111127622579986
GO_Biological_Process_2021,actin nucleation (GO:0045010),1/21,0.0512327930672156,0.1651815914408503,0,0,20.336734693877553,60.42807445408675,SCIN,Osteo-MSC,1.2904519669693806
GO_Biological_Process_2021,cellular response to steroid hormone stimulus (GO:0071383),1/21,0.0512327930672156,0.1651815914408503,0,0,20.336734693877553,60.42807445408675,BMP7,Osteo-MSC,1.2904519669693806
GO_Biological_Process_2021,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,0.0512327930672156,0.1651815914408503,0,0,20.336734693877553,60.42807445408675,DLX5,Osteo-MSC,1.2904519669693806
GO_Biological_Process_2021,negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,0.0512327930672156,0.1651815914408503,0,0,20.336734693877553,60.42807445408675,HECW1,Osteo-MSC,1.2904519669693806
GO_Biological_Process_2021,cell projection assembly (GO:0030031),1/22,0.0536071985992547,0.1699075616620448,0,0,19.367346938775512,56.67024999786951,SCIN,Osteo-MSC,1.2707768875084013
GO_Biological_Process_2021,negative regulation of phosphate metabolic process (GO:0045936),1/22,0.0536071985992547,0.1699075616620448,0,0,19.367346938775512,56.67024999786951,BMP7,Osteo-MSC,1.2707768875084013
GO_Biological_Process_2021,establishment of mitotic spindle orientation (GO:0000132),1/24,0.0583385530130099,0.1759566034424655,0,0,17.68145519077196,50.24171555062859,INSC,Osteo-MSC,1.2340443470047993
GO_Biological_Process_2021,positive regulation of phospholipase activity (GO:0010518),1/24,0.0583385530130099,0.1759566034424655,0,0,17.68145519077196,50.24171555062859,FGFR3,Osteo-MSC,1.2340443470047993
GO_Biological_Process_2021,neuromuscular junction development (GO:0007528),1/24,0.0583385530130099,0.1759566034424655,0,0,17.68145519077196,50.24171555062859,UNC13C,Osteo-MSC,1.2340443470047993
GO_Biological_Process_2021,peptidyl-glutamic acid modification (GO:0018200),1/24,0.0583385530130099,0.1759566034424655,0,0,17.68145519077196,50.24171555062859,AGBL4,Osteo-MSC,1.2340443470047993
GO_Biological_Process_2021,negative regulation of neuron differentiation (GO:0045665),1/24,0.0583385530130099,0.1759566034424655,0,0,17.68145519077196,50.24171555062859,BMP7,Osteo-MSC,1.2340443470047993
GO_Biological_Process_2021,negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/24,0.0583385530130099,0.1759566034424655,0,0,17.68145519077196,50.24171555062859,BMP7,Osteo-MSC,1.2340443470047993
GO_Biological_Process_2021,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/25,0.0606955298241754,0.17596623233442,0,0,16.943877551020407,47.47480020477031,BMP7,Osteo-MSC,1.2168432931781568
GO_Biological_Process_2021,regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.0606955298241754,0.17596623233442,0,0,16.943877551020407,47.47480020477031,BMP7,Osteo-MSC,1.2168432931781568
GO_Biological_Process_2021,regulation of dopamine secretion (GO:0014059),1/25,0.0606955298241754,0.17596623233442,0,0,16.943877551020407,47.47480020477031,SYT12,Osteo-MSC,1.2168432931781568
GO_Biological_Process_2021,negative regulation of actin filament polymerization (GO:0030837),1/25,0.0606955298241754,0.17596623233442,0,0,16.943877551020407,47.47480020477031,SCIN,Osteo-MSC,1.2168432931781568
GO_Biological_Process_2021,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/26,0.0630467249540435,0.17596623233442,0,0,16.26530612244898,44.95534064809558,TP63,Osteo-MSC,1.2003374685092782
GO_Biological_Process_2021,regulation of synapse organization (GO:0050807),1/26,0.0630467249540435,0.17596623233442,0,0,16.26530612244898,44.95534064809558,SLITRK4,Osteo-MSC,1.2003374685092782
GO_Biological_Process_2021,glial cell development (GO:0021782),1/26,0.0630467249540435,0.17596623233442,0,0,16.26530612244898,44.95534064809558,ZNF488,Osteo-MSC,1.2003374685092782
GO_Biological_Process_2021,metanephros development (GO:0001656),1/26,0.0630467249540435,0.17596623233442,0,0,16.26530612244898,44.95534064809558,BMP7,Osteo-MSC,1.2003374685092782
GO_Biological_Process_2021,regulation of chondrocyte differentiation (GO:0032330),1/26,0.0630467249540435,0.17596623233442,0,0,16.26530612244898,44.95534064809558,SCIN,Osteo-MSC,1.2003374685092782
GO_Biological_Process_2021,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/26,0.0630467249540435,0.17596623233442,0,0,16.26530612244898,44.95534064809558,TP63,Osteo-MSC,1.2003374685092782
GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/170,0.067488533240135,0.1849029399891175,0,0,4.90625,13.226256844780602,CLDN11;PTPRD,Osteo-MSC,1.1707700104811887
GO_Biological_Process_2021,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),1/28,0.0677318256109869,0.1849029399891175,0,0,15.058956916099774,40.54171043527237,FGFR3,Osteo-MSC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of synapse assembly (GO:0051965),1/28,0.0677318256109869,0.1849029399891175,0,0,15.058956916099774,40.54171043527237,PTPRD,Osteo-MSC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),2/172,0.0688760185279422,0.1866639922423942,0,0,4.848039215686274,12.970673059288286,NPNT;FGFR3,Osteo-MSC,1.1619319658128364
GO_Biological_Process_2021,establishment of mitotic spindle localization (GO:0040001),1/29,0.0700657588372089,0.1877292763061102,0,0,14.520408163265309,38.5999069065122,INSC,Osteo-MSC,1.1544941700666143
GO_Biological_Process_2021,neuron differentiation (GO:0030182),2/174,0.0702729911306294,0.1877292763061102,0,0,4.791182170542636,12.722350612514177,PTPRD;FZD8,Osteo-MSC,1.1532115605672306
GO_Biological_Process_2021,establishment of spindle orientation (GO:0051294),1/30,0.0723939657090184,0.1880232164942561,0,0,14.019000703729768,36.80874147674154,INSC,Osteo-MSC,1.1402976322627019
GO_Biological_Process_2021,regulation of catecholamine secretion (GO:0050433),1/30,0.0723939657090184,0.1880232164942561,0,0,14.019000703729768,36.80874147674154,SYT12,Osteo-MSC,1.1402976322627019
GO_Biological_Process_2021,positive regulation of lipid kinase activity (GO:0090218),1/30,0.0723939657090184,0.1880232164942561,0,0,14.019000703729768,36.80874147674154,FGFR3,Osteo-MSC,1.1402976322627019
GO_Biological_Process_2021,cell projection organization (GO:0030030),1/30,0.0723939657090184,0.1880232164942561,0,0,14.019000703729768,36.80874147674154,SCIN,Osteo-MSC,1.1402976322627019
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),2/180,0.0745195887056104,0.1888105137904239,0,0,4.628277153558052,12.018216055401329,SCIN;SYT12,Osteo-MSC,1.1277295507615273
GO_Biological_Process_2021,regulation of calcium ion-dependent exocytosis (GO:0017158),1/31,0.0747164600026276,0.1888105137904239,0,0,13.551020408163266,35.15209038871121,SYT12,Osteo-MSC,1.126583712764908
GO_Biological_Process_2021,regulation of cellular pH (GO:0030641),1/31,0.0747164600026276,0.1888105137904239,0,0,13.551020408163266,35.15209038871121,CA2,Osteo-MSC,1.126583712764908
GO_Biological_Process_2021,regulation of developmental growth (GO:0048638),1/31,0.0747164600026276,0.1888105137904239,0,0,13.551020408163266,35.15209038871121,FGFR3,Osteo-MSC,1.126583712764908
GO_Biological_Process_2021,negative regulation of developmental growth (GO:0048640),1/32,0.0770332554327668,0.1907975995487073,0,0,13.113232389730086,33.61600807740255,FGFR3,Osteo-MSC,1.1133217484244988
GO_Biological_Process_2021,chondrocyte differentiation (GO:0002062),1/32,0.0770332554327668,0.1907975995487073,0,0,13.113232389730086,33.61600807740255,FGFR3,Osteo-MSC,1.1133217484244988
GO_Biological_Process_2021,endodermal cell differentiation (GO:0035987),1/32,0.0770332554327668,0.1907975995487073,0,0,13.113232389730086,33.61600807740255,COL12A1,Osteo-MSC,1.1133217484244988
GO_Biological_Process_2021,negative regulation of blood vessel endothelial cell migration (GO:0043537),1/34,0.0816498044624026,0.1982923822658348,0,0,12.317254174397032,30.85861216573232,ANGPT4,Osteo-MSC,1.0880448509885652
GO_Biological_Process_2021,striated muscle tissue development (GO:0014706),1/34,0.0816498044624026,0.1982923822658348,0,0,12.317254174397032,30.85861216573232,BMP7,Osteo-MSC,1.0880448509885652
GO_Biological_Process_2021,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/34,0.0816498044624026,0.1982923822658348,0,0,12.317254174397032,30.85861216573232,TP63,Osteo-MSC,1.0880448509885652
GO_Biological_Process_2021,negative regulation of Wnt signaling pathway (GO:0030178),2/191,0.0825129134198004,0.1987161071210371,0,0,4.356481481481482,10.868552054472469,WIF1;HECW1,Osteo-MSC,1.083478078261104
GO_Biological_Process_2021,regulation of regulated secretory pathway (GO:1903305),1/35,0.0839495853612937,0.1987161071210371,0,0,11.95438175270108,29.61744503578088,SYT12,Osteo-MSC,1.0759814445616303
GO_Biological_Process_2021,bicarbonate transport (GO:0015701),1/35,0.0839495853612937,0.1987161071210371,0,0,11.95438175270108,29.61744503578088,CA2,Osteo-MSC,1.0759814445616303
GO_Biological_Process_2021,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/35,0.0839495853612937,0.1987161071210371,0,0,11.95438175270108,29.61744503578088,FGFR3,Osteo-MSC,1.0759814445616303
GO_Biological_Process_2021,positive regulation of bone mineralization (GO:0030501),1/36,0.0862437219743075,0.2003425591204412,0,0,11.612244897959185,28.456712045041098,BMP7,Osteo-MSC,1.0642725091375862
GO_Biological_Process_2021,membrane assembly (GO:0071709),1/36,0.0862437219743075,0.2003425591204412,0,0,11.612244897959185,28.456712045041098,PTPRD,Osteo-MSC,1.0642725091375862
GO_Biological_Process_2021,endoderm formation (GO:0001706),1/36,0.0862437219743075,0.2003425591204412,0,0,11.612244897959185,28.456712045041098,COL12A1,Osteo-MSC,1.0642725091375862
GO_Biological_Process_2021,positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.0885322278902676,0.2031352958954607,0,0,11.289115646258503,27.36920368672352,SCIN,Osteo-MSC,1.0528986067362665
GO_Biological_Process_2021,regulation of intracellular pH (GO:0051453),1/37,0.0885322278902676,0.2031352958954607,0,0,11.289115646258503,27.36920368672352,CA2,Osteo-MSC,1.0528986067362665
GO_Biological_Process_2021,generation of neurons (GO:0048699),2/202,0.0907585666054427,0.2058475976977232,0,0,4.114583333333333,9.87315836367001,PTPRD;FZD8,Osteo-MSC,1.042112371758702
GO_Biological_Process_2021,negative regulation of endothelial cell migration (GO:0010596),1/38,0.0908151166313484,0.2058475976977232,0,0,10.983452840595698,26.34852930034076,ANGPT4,Osteo-MSC,1.0418418549683985
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),2/203,0.0915200219539462,0.2061957121131077,0,0,4.093905472636816,9.789336578359592,ANGPT4;ISM1,Osteo-MSC,1.0384838843718929
GO_Biological_Process_2021,regulation of peptidyl-threonine phosphorylation (GO:0010799),1/39,0.0930924017046572,0.208482384655939,0,0,10.693877551020408,25.38900533231373,BMP7,Osteo-MSC,1.0310857651239858
GO_Biological_Process_2021,positive regulation of ossification (GO:0045778),1/40,0.0953640965755271,0.2085741059605097,0,0,10.419152276295131,24.485561288951835,BMP7,Osteo-MSC,1.0206151011238414
GO_Biological_Process_2021,regulation of sodium ion transmembrane transporter activity (GO:2000649),1/40,0.0953640965755271,0.2085741059605097,0,0,10.419152276295131,24.485561288951835,HECW1,Osteo-MSC,1.0206151011238414
GO_Biological_Process_2021,synaptic vesicle exocytosis (GO:0016079),1/40,0.0953640965755271,0.2085741059605097,0,0,10.419152276295131,24.485561288951835,UNC13C,Osteo-MSC,1.0206151011238414
GO_Biological_Process_2021,bone development (GO:0060348),1/40,0.0953640965755271,0.2085741059605097,0,0,10.419152276295131,24.485561288951835,FGFR3,Osteo-MSC,1.0206151011238414
GO_Biological_Process_2021,positive regulation of biomineral tissue development (GO:0070169),1/41,0.0976302146847681,0.211061851399441,0,0,10.158163265306122,23.633660200289185,BMP7,Osteo-MSC,1.0104157556925017
GO_Biological_Process_2021,response to growth factor (GO:0070848),1/41,0.0976302146847681,0.211061851399441,0,0,10.158163265306122,23.633660200289185,IBSP,Osteo-MSC,1.0104157556925017
GO_Biological_Process_2021,skeletal system morphogenesis (GO:0048705),1/42,0.0998907694703361,0.2134808444680326,0,0,9.909905425584869,22.829231064333683,FGFR3,Osteo-MSC,1.00047464143678
GO_Biological_Process_2021,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.0998907694703361,0.2134808444680326,0,0,9.909905425584869,22.829231064333683,PTPRD,Osteo-MSC,1.00047464143678
GO_Biological_Process_2021,nervous system development (GO:0007399),3/447,0.1008432425551151,0.2142918904296196,0,0,2.8041978148361126,6.433357037369621,SCIN;DLX5;DLX6,Osteo-MSC,0.9963531982876066
GO_Biological_Process_2021,branching morphogenesis of an epithelial tube (GO:0048754),1/44,0.1043952424647777,0.2205865575244456,0,0,9.448030374940672,21.34849709415977,NPNT,Osteo-MSC,0.9813192926974915
GO_Biological_Process_2021,positive regulation of nervous system development (GO:0051962),1/45,0.1066391873529346,0.2215725337222087,0,0,9.232838589981448,20.665901611884028,PTPRD,Osteo-MSC,0.9720831731354668
GO_Biological_Process_2021,positive regulation of Notch signaling pathway (GO:0045747),1/45,0.1066391873529346,0.2215725337222087,0,0,9.232838589981448,20.665901611884028,TP63,Osteo-MSC,0.9720831731354668
GO_Biological_Process_2021,zymogen activation (GO:0031638),1/45,0.1066391873529346,0.2215725337222087,0,0,9.232838589981448,20.665901611884028,KLK1,Osteo-MSC,0.9720831731354668
GO_Biological_Process_2021,epithelial to mesenchymal transition (GO:0001837),1/47,0.1111105603036554,0.2252083971854797,0,0,8.830523513753327,19.4026870705364,BMP7,Osteo-MSC,0.9542446623584087
GO_Biological_Process_2021,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),1/47,0.1111105603036554,0.2252083971854797,0,0,8.830523513753327,19.4026870705364,BMP7,Osteo-MSC,0.9542446623584087
GO_Biological_Process_2021,regulation of synapse assembly (GO:0051963),1/47,0.1111105603036554,0.2252083971854797,0,0,8.830523513753327,19.4026870705364,PTPRD,Osteo-MSC,0.9542446623584087
GO_Biological_Process_2021,positive regulation of cell-cell adhesion (GO:0022409),1/47,0.1111105603036554,0.2252083971854797,0,0,8.830523513753327,19.4026870705364,BMP7,Osteo-MSC,0.9542446623584087
GO_Biological_Process_2021,positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.1133380148369131,0.2252083971854797,0,0,8.642205818497612,18.81737166641443,ANGPT4,Osteo-MSC,0.9456243984787533
GO_Biological_Process_2021,substrate adhesion-dependent cell spreading (GO:0034446),1/48,0.1133380148369131,0.2252083971854797,0,0,8.642205818497612,18.81737166641443,ITGA8,Osteo-MSC,0.9456243984787533
GO_Biological_Process_2021,negative regulation of MAP kinase activity (GO:0043407),1/48,0.1133380148369131,0.2252083971854797,0,0,8.642205818497612,18.81737166641443,BMP7,Osteo-MSC,0.9456243984787533
GO_Biological_Process_2021,negative regulation of mitotic cell cycle (GO:0045930),1/48,0.1133380148369131,0.2252083971854797,0,0,8.642205818497612,18.81737166641443,BMP7,Osteo-MSC,0.9456243984787533
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),4/742,0.1138085215723413,0.2252083971854797,0,0,2.2636974195828916,4.919552976765135,ANGPT4;SCIN;ARHGEF19;TP63,Osteo-MSC,0.943825218316277
GO_Biological_Process_2021,aminoglycan biosynthetic process (GO:0006023),1/49,0.1155599990222406,0.2262797886613508,0,0,8.46173469387755,18.260130793597916,HS3ST1,Osteo-MSC,0.9371924705024297
GO_Biological_Process_2021,positive regulation of actin filament polymerization (GO:0030838),1/49,0.1155599990222406,0.2262797886613508,0,0,8.46173469387755,18.260130793597916,SCIN,Osteo-MSC,0.9371924705024297
GO_Biological_Process_2021,actin polymerization or depolymerization (GO:0008154),1/50,0.1177765260040411,0.2282301591995407,0,0,8.28862973760933,17.7290996615035,SCIN,Osteo-MSC,0.928941259997044
GO_Biological_Process_2021,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/50,0.1177765260040411,0.2282301591995407,0,0,8.28862973760933,17.7290996615035,PTPRD,Osteo-MSC,0.928941259997044
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),2/238,0.1192811662769016,0.2289559476370507,0,0,3.4805790960451977,7.400657287256659,NPNT;FGFR3,Osteo-MSC,0.9234281232007147
GO_Biological_Process_2021,mesenchymal cell differentiation (GO:0048762),1/51,0.1199876089220907,0.2289559476370507,0,0,8.122448979591837,17.22257115519733,BMP7,Osteo-MSC,0.9208636010741894
GO_Biological_Process_2021,positive regulation of fat cell differentiation (GO:0045600),1/51,0.1199876089220907,0.2289559476370507,0,0,8.122448979591837,17.22257115519733,BMP7,Osteo-MSC,0.9208636010741894
GO_Biological_Process_2021,axonogenesis (GO:0007409),2/240,0.1209266562339864,0.2295764945761975,0,0,3.450980392156863,7.290441318878535,SLITRK4;NCAM1,Osteo-MSC,0.9174779557207333
GO_Biological_Process_2021,cartilage development (GO:0051216),1/52,0.1221932608707862,0.2296496460586636,0,0,7.962785114045619,16.738979733033663,FGFR3,Osteo-MSC,0.9129527453809976
GO_Biological_Process_2021,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.1221932608707862,0.2296496460586636,0,0,7.962785114045619,16.738979733033663,BMP7,Osteo-MSC,0.9129527453809976
GO_Biological_Process_2021,IRE1-mediated unfolded protein response (GO:0036498),1/53,0.1243934949128716,0.2303127084030396,0,0,7.809262166405024,16.276887238960814,EXTL1,Osteo-MSC,0.9052023302345248
GO_Biological_Process_2021,bicellular tight junction assembly (GO:0070830),1/53,0.1243934949128716,0.2303127084030396,0,0,7.809262166405024,16.276887238960814,CLDN11,Osteo-MSC,0.9052023302345248
GO_Biological_Process_2021,cardiac muscle tissue development (GO:0048738),1/53,0.1243934949128716,0.2303127084030396,0,0,7.809262166405024,16.276887238960814,BMP7,Osteo-MSC,0.9052023302345248
GO_Biological_Process_2021,regulation of megakaryocyte differentiation (GO:0045652),1/54,0.1265883240687765,0.2320785941260902,0,0,7.661532537543319,15.834970375184442,SCIN,Osteo-MSC,0.8976063498190403
GO_Biological_Process_2021,glycosaminoglycan metabolic process (GO:0030203),1/54,0.1265883240687765,0.2320785941260902,0,0,7.661532537543319,15.834970375184442,HS3ST1,Osteo-MSC,0.8976063498190403
GO_Biological_Process_2021,regulation of blood vessel endothelial cell migration (GO:0043535),1/55,0.1287777613922166,0.2348799603522088,0,0,7.519274376417234,15.412009607623004,ANGPT4,Osteo-MSC,0.8901591287349465
GO_Biological_Process_2021,tight junction assembly (GO:0120192),1/56,0.1309618198144747,0.2348799603522088,0,0,7.382189239332097,15.00687933540933,CLDN11,Osteo-MSC,0.8828552987007785
GO_Biological_Process_2021,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/56,0.1309618198144747,0.2348799603522088,0,0,7.382189239332097,15.00687933540933,TP63,Osteo-MSC,0.8828552987007785
GO_Biological_Process_2021,peptidyl-tyrosine modification (GO:0018212),1/56,0.1309618198144747,0.2348799603522088,0,0,7.382189239332097,15.00687933540933,FGFR3,Osteo-MSC,0.8828552987007785
GO_Biological_Process_2021,positive regulation of cell junction assembly (GO:1901890),1/57,0.1331405122852093,0.2348799603522088,0,0,7.25,14.618539131965724,PTPRD,Osteo-MSC,0.8756897763447542
GO_Biological_Process_2021,regulation of bone mineralization (GO:0030500),1/57,0.1331405122852093,0.2348799603522088,0,0,7.25,14.618539131965724,BMP7,Osteo-MSC,0.8756897763447542
GO_Biological_Process_2021,renal system development (GO:0072001),1/57,0.1331405122852093,0.2348799603522088,0,0,7.25,14.618539131965724,ITGA8,Osteo-MSC,0.8756897763447542
GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),1/57,0.1331405122852093,0.2348799603522088,0,0,7.25,14.618539131965724,BMP7,Osteo-MSC,0.8756897763447542
GO_Biological_Process_2021,chordate embryonic development (GO:0043009),1/58,0.1353138517398134,0.2354751366897305,0,0,7.122448979591836,14.246025949065045,BMP7,Osteo-MSC,0.8686577434892403
GO_Biological_Process_2021,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/58,0.1353138517398134,0.2354751366897305,0,0,7.122448979591836,14.246025949065045,BMP7,Osteo-MSC,0.8686577434892403
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.1353667229633477,0.2354751366897305,0,0,2.442871502764282,4.885175568190959,DLX5;BMP7;TP63,Osteo-MSC,0.8684880846140173
GO_Biological_Process_2021,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/59,0.1374818510452552,0.2380472791246548,0,0,6.9992962702322306,13.8884471557023,FGFR3,Osteo-MSC,0.8617546291873563
GO_Biological_Process_2021,apical junction assembly (GO:0043297),1/60,0.1396445230534406,0.2406776572441788,0,0,6.88031822898651,13.544974303558986,CLDN11,Osteo-MSC,0.8549760929333525
GO_Biological_Process_2021,central nervous system development (GO:0007417),2/268,0.1445246328363994,0.2479459297285017,0,0,3.0833333333333335,5.964108059214085,VIT;SCIN,Osteo-MSC,0.8400581252728833
GO_Biological_Process_2021,negative regulation of endopeptidase activity (GO:0010951),1/63,0.1461007034145454,0.2483711958047271,0,0,6.54641211323239,12.591756250239603,SERPINA11,Osteo-MSC,0.8353476931121088
GO_Biological_Process_2021,negative regulation of peptidase activity (GO:0010466),1/63,0.1461007034145454,0.2483711958047271,0,0,6.54641211323239,12.591756250239603,SERPINA11,Osteo-MSC,0.8353476931121088
GO_Biological_Process_2021,negative regulation of cell cycle process (GO:0010948),1/64,0.1482421941802595,0.2508714055358239,0,0,6.442176870748299,12.297522293260638,BMP7,Osteo-MSC,0.8290281655096747
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),2/274,0.1497038344955427,0.2522037572132116,0,0,3.014399509803922,5.724635176902424,NPNT;FGFR3,Osteo-MSC,0.8247670755492156
GO_Biological_Process_2021,extracellular matrix disassembly (GO:0022617),1/66,0.1525093979756266,0.2535045104128194,0,0,6.243328100470958,11.740759916332207,KLK4,Osteo-MSC,0.8167033932798328
GO_Biological_Process_2021,cell-cell junction assembly (GO:0007043),1/66,0.1525093979756266,0.2535045104128194,0,0,6.243328100470958,11.740759916332207,CLDN11,Osteo-MSC,0.8167033932798328
GO_Biological_Process_2021,cellular component disassembly (GO:0022411),1/66,0.1525093979756266,0.2535045104128194,0,0,6.243328100470958,11.740759916332207,KLK4,Osteo-MSC,0.8167033932798328
GO_Biological_Process_2021,positive regulation of catabolic process (GO:0009896),1/67,0.1546351363099914,0.2559006238050301,0,0,6.148423005565863,11.477180657220888,HECW1,Osteo-MSC,0.8106918184915987
GO_Biological_Process_2021,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/68,0.1567556490806558,0.256011409415569,0,0,6.0563508985683825,11.222824361971773,FGFR3,Osteo-MSC,0.8047767993307415
GO_Biological_Process_2021,canonical Wnt signaling pathway (GO:0060070),1/68,0.1567556490806558,0.256011409415569,0,0,6.0563508985683825,11.222824361971773,FZD8,Osteo-MSC,0.8047767993307415
GO_Biological_Process_2021,interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.1567556490806558,0.256011409415569,0,0,6.0563508985683825,11.222824361971773,NCAM1,Osteo-MSC,0.8047767993307415
GO_Biological_Process_2021,synapse assembly (GO:0007416),1/69,0.158870948881139,0.2561109262135603,0,0,5.966986794717887,10.977245117600177,CBLN4,Osteo-MSC,0.7989555105590889
GO_Biological_Process_2021,peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.158870948881139,0.2561109262135603,0,0,5.966986794717887,10.977245117600177,FGFR3,Osteo-MSC,0.7989555105590889
GO_Biological_Process_2021,cellular response to calcium ion (GO:0071277),1/69,0.158870948881139,0.2561109262135603,0,0,5.966986794717887,10.977245117600177,SYT12,Osteo-MSC,0.7989555105590889
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),2/286,0.160174195271258,0.2571036439118047,0,0,2.885269953051643,5.284352690216861,SCIN;ARHGEF19,Osteo-MSC,0.7954074492629319
GO_Biological_Process_2021,regulation of endopeptidase activity (GO:0052548),1/71,0.16308595979881,0.2606587562596366,0,0,5.795918367346939,10.51076961698872,SERPINA11,Osteo-MSC,0.7875834261109624
GO_Biological_Process_2021,positive regulation of neurogenesis (GO:0050769),1/72,0.1651856959101235,0.2606727859509967,0,0,5.713998275366484,10.28911103101624,PTPRD,Osteo-MSC,0.78202756268309
GO_Biological_Process_2021,extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.1651856959101235,0.2606727859509967,0,0,5.713998275366484,10.28911103101624,FGFR3,Osteo-MSC,0.78202756268309
GO_Biological_Process_2021,cell morphogenesis involved in differentiation (GO:0000904),1/72,0.1651856959101235,0.2606727859509967,0,0,5.713998275366484,10.28911103101624,ITGA8,Osteo-MSC,0.78202756268309
GO_Biological_Process_2021,regulation of actin filament-based process (GO:0032970),1/73,0.1672802691231711,0.2628689943364117,0,0,5.634353741496598,10.074701240888364,ARHGEF19,Osteo-MSC,0.7765552814899175
GO_Biological_Process_2021,fibroblast growth factor receptor signaling pathway (GO:0008543),1/75,0.1714539764404576,0.2669568800711797,0,0,5.4815223386651954,9.666337985731484,FGFR3,Osteo-MSC,0.7658524380723842
GO_Biological_Process_2021,integrin-mediated signaling pathway (GO:0007229),1/75,0.1714539764404576,0.2669568800711797,0,0,5.4815223386651954,9.666337985731484,ITGA10,Osteo-MSC,0.7658524380723842
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",5/1183,0.1720230163025516,0.2669568800711797,0,0,1.7706093189964158,3.116497260687803,DLX5;HNF4G;LMO7;BMP7;TP63,Osteo-MSC,0.7644134415549481
GO_Biological_Process_2021,cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.1735331353639065,0.2681875728351283,0,0,5.408163265306122,9.4717853003048,SLITRK4,Osteo-MSC,0.7606175863963804
GO_Biological_Process_2021,MAPK cascade (GO:0000165),2/303,0.1752338998526144,0.2691683838567189,0,0,2.7199612403100777,4.737175959955004,NCAM1;FGFR3,Osteo-MSC,0.7563818736544428
GO_Biological_Process_2021,negative regulation of developmental process (GO:0051093),1/77,0.1756071809118701,0.2691683838567189,0,0,5.336734693877551,9.283280446293812,FGFR3,Osteo-MSC,0.7554577289388229
GO_Biological_Process_2021,negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.1776761254379788,0.2708873961094027,0,0,5.267161410018553,9.10056411919043,BMP7,Osteo-MSC,0.7503709249641564
GO_Biological_Process_2021,axon development (GO:0061564),1/79,0.1797399811935544,0.2708873961094027,0,0,5.199372056514914,8.923391206941128,SLITRK4,Osteo-MSC,0.745355308086215
GO_Biological_Process_2021,regulation of neuron differentiation (GO:0045664),1/79,0.1797399811935544,0.2708873961094027,0,0,5.199372056514914,8.923391206941128,BMP7,Osteo-MSC,0.745355308086215
GO_Biological_Process_2021,negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/79,0.1797399811935544,0.2708873961094027,0,0,5.199372056514914,8.923391206941128,BMP7,Osteo-MSC,0.745355308086215
GO_Biological_Process_2021,skin development (GO:0043588),1/80,0.181798760490535,0.2708873961094027,0,0,5.133298889175924,8.751529842637671,TP63,Osteo-MSC,0.7404090821369118
GO_Biological_Process_2021,negative regulation of cell cycle (GO:0045786),1/80,0.181798760490535,0.2708873961094027,0,0,5.133298889175924,8.751529842637671,BMP7,Osteo-MSC,0.7404090821369118
GO_Biological_Process_2021,regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.181798760490535,0.2708873961094027,0,0,5.133298889175924,8.751529842637671,BMP7,Osteo-MSC,0.7404090821369118
GO_Biological_Process_2021,protein polyubiquitination (GO:0000209),2/314,0.1851004260524556,0.2747125370778508,0,0,2.6225961538461537,4.423944044737091,HECW1;LMO7,Osteo-MSC,0.7325925816143702
GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.2778313866181291,0,0,4.944748631159781,8.265677319811374,TP63,Osteo-MSC,0.7259697745939766
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),4/908,0.1908851520255107,0.2805247433799959,0,0,1.8320507887649096,3.0340287711400475,DLX5;HNF4G;LMO7;TP63,Osteo-MSC,0.7192278518272621
GO_Biological_Process_2021,positive regulation of protein catabolic process (GO:0045732),1/85,0.1920169366451308,0.2805247433799959,0,0,4.826530612244898,7.964604221414354,HECW1,Osteo-MSC,0.716660463134361
GO_Biological_Process_2021,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",1/85,0.1920169366451308,0.2805247433799959,0,0,4.826530612244898,7.964604221414354,ARHGEF19,Osteo-MSC,0.716660463134361
GO_Biological_Process_2021,positive regulation of endothelial cell migration (GO:0010595),1/86,0.1940455128548384,0.2812907822004247,0,0,4.769507803121249,7.820383303288144,ANGPT4,Osteo-MSC,0.7120963955156414
GO_Biological_Process_2021,negative regulation of phosphorylation (GO:0042326),1/86,0.1940455128548384,0.2812907822004247,0,0,4.769507803121249,7.820383303288144,BMP7,Osteo-MSC,0.7120963955156414
GO_Biological_Process_2021,positive regulation of neuron projection development (GO:0010976),1/88,0.1980877029036425,0.2849415418690857,0,0,4.659394792399718,7.5437717166037235,BMP7,Osteo-MSC,0.703142484213379
GO_Biological_Process_2021,regulation of establishment of planar polarity (GO:0090175),1/88,0.1980877029036425,0.2849415418690857,0,0,4.659394792399718,7.5437717166037235,ARHGEF19,Osteo-MSC,0.703142484213379
GO_Biological_Process_2021,collagen fibril organization (GO:0030199),1/89,0.2001013407742902,0.285640845227422,0,0,4.6062152133580705,7.411084001248333,COL12A1,Osteo-MSC,0.6987500013741589
GO_Biological_Process_2021,regulation of endothelial cell migration (GO:0010594),1/89,0.2001013407742902,0.285640845227422,0,0,4.6062152133580705,7.411084001248333,ANGPT4,Osteo-MSC,0.6987500013741589
GO_Biological_Process_2021,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.2041137620931186,0.2865654311122011,0,0,4.503401360544218,7.156255051106618,ARHGEF19,Osteo-MSC,0.6901277125812961
GO_Biological_Process_2021,positive regulation of transport (GO:0051050),1/91,0.2041137620931186,0.2865654311122011,0,0,4.503401360544218,7.156255051106618,SCIN,Osteo-MSC,0.6901277125812961
GO_Biological_Process_2021,cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.2061125694363157,0.2865654311122011,0,0,4.453689167974883,7.03385741012878,FGFR3,Osteo-MSC,0.6858955226779435
GO_Biological_Process_2021,positive regulation of cellular component biogenesis (GO:0044089),1/92,0.2061125694363157,0.2865654311122011,0,0,4.453689167974883,7.03385741012878,BMP7,Osteo-MSC,0.6858955226779435
GO_Biological_Process_2021,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),1/92,0.2061125694363157,0.2865654311122011,0,0,4.453689167974883,7.03385741012878,BMP7,Osteo-MSC,0.6858955226779435
GO_Biological_Process_2021,Wnt signaling pathway (GO:0016055),1/92,0.2061125694363157,0.2865654311122011,0,0,4.453689167974883,7.03385741012878,FZD8,Osteo-MSC,0.6858955226779435
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2865654311122011,0,0,4.453689167974883,7.03385741012878,ANGPT4,Osteo-MSC,0.6858955226779435
GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),1/94,0.2100954368002021,0.287823052612731,0,0,4.357472021066491,6.79849904676328,BMP7,Osteo-MSC,0.6775833802166729
GO_Biological_Process_2021,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.287823052612731,0,0,4.357472021066491,6.79849904676328,FGFR3,Osteo-MSC,0.6775833802166729
GO_Biological_Process_2021,positive regulation of epithelial cell migration (GO:0010634),1/94,0.2100954368002021,0.287823052612731,0,0,4.357472021066491,6.79849904676328,ANGPT4,Osteo-MSC,0.6775833802166729
GO_Biological_Process_2021,negative regulation of MAPK cascade (GO:0043409),1/94,0.2100954368002021,0.287823052612731,0,0,4.357472021066491,6.79849904676328,BMP7,Osteo-MSC,0.6775833802166729
GO_Biological_Process_2021,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2938049443023444,0,0,4.220663265306122,6.46742313757927,BMP7,Osteo-MSC,0.6654798083211632
GO_Biological_Process_2021,glycosaminoglycan biosynthetic process (GO:0006024),1/97,0.2160330472811356,0.2938049443023444,0,0,4.220663265306122,6.46742313757927,HS3ST1,Osteo-MSC,0.6654798083211632
GO_Biological_Process_2021,organic anion transport (GO:0015711),1/99,0.2199671313012003,0.2980714025603221,0,0,4.134110787172012,6.26018948804807,CA2,Osteo-MSC,0.6576422090003602
GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),1/101,0.2238818662412048,0.3016470378924815,0,0,4.051020408163265,6.062906014187368,TP63,Osteo-MSC,0.6499810815451941
GO_Biological_Process_2021,regulation of cell death (GO:0010941),1/102,0.2258320069783284,0.3016470378924815,0,0,4.010709234188725,5.967790506031058,BMP7,Osteo-MSC,0.6462145058611213
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.3016470378924815,0,0,4.010709234188725,5.967790506031058,ANGPT4,Osteo-MSC,0.6462145058611213
GO_Biological_Process_2021,regulation of protein catabolic process (GO:0042176),1/102,0.2258320069783284,0.3016470378924815,0,0,4.010709234188725,5.967790506031058,HECW1,Osteo-MSC,0.6462145058611213
GO_Biological_Process_2021,activation of GTPase activity (GO:0090630),1/105,0.2316536615468536,0.3083219552260614,0,0,3.894427001569859,5.6956456810845415,ARHGEF19,Osteo-MSC,0.6351608308934773
GO_Biological_Process_2021,protein processing (GO:0016485),1/106,0.2335846623503299,0.3086949248022028,0,0,3.857142857142857,5.6090983677319475,KLK1,Osteo-MSC,0.6315556772929499
GO_Biological_Process_2021,protein localization to nucleus (GO:0034504),1/106,0.2335846623503299,0.3086949248022028,0,0,3.857142857142857,5.6090983677319475,BMP7,Osteo-MSC,0.6315556772929499
GO_Biological_Process_2021,response to calcium ion (GO:0051592),1/107,0.2355109070084182,0.3101446451448888,0,0,3.8205621871390063,5.524525481436682,SYT12,Osteo-MSC,0.6279889749729552
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.3113901734994352,0,0,2.2110433604336044,3.18053102486219,ANGPT4;BMP7,Osteo-MSC,0.6247218387200065
GO_Biological_Process_2021,response to tumor necrosis factor (GO:0034612),1/110,0.241261218690496,0.3154954398260333,0,0,3.714847406852649,5.282048795926194,NPNT,Osteo-MSC,0.6175124827423236
GO_Biological_Process_2021,regulation of Wnt signaling pathway (GO:0030111),1/111,0.2431685532271013,0.3168816686652818,0,0,3.6808905380333954,5.20478084558139,WIF1,Osteo-MSC,0.6140925891155178
GO_Biological_Process_2021,regulation of cytoskeleton organization (GO:0051493),1/112,0.2450711886958998,0.3182521686537032,0,0,3.647545504688362,5.129202360192396,ARHGEF19,Osteo-MSC,0.6107077427090284
GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.3209466915144878,0,0,3.582625970742279,4.982913653406146,BMP7,Osteo-MSC,0.6040407011916724
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.3209466915144878,0,0,3.582625970742279,4.982913653406146,FGFR3,Osteo-MSC,0.6040407011916724
GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),1/115,0.2507510141385882,0.3222710628447835,0,0,3.5510204081632653,4.9121080927455,HECW1,Osteo-MSC,0.6007573018413346
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.3235804024131908,0,0,3.5199645075421473,4.8428011439058265,ANGPT4,Osteo-MSC,0.5975065399797567
GO_Biological_Process_2021,positive regulation of cell projection organization (GO:0031346),1/117,0.2545142764118688,0.3248748784233411,0,0,3.4894440534834623,4.774949480472317,PTPRD,Osteo-MSC,0.5942878518616017
GO_Biological_Process_2021,cellular response to interferon-gamma (GO:0071346),1/121,0.2619853133921213,0.3332738340430387,0,0,3.372448979591837,4.517283552621874,NCAM1,Osteo-MSC,0.5817230540677998
GO_Biological_Process_2021,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.3357070325168697,0,0,3.316828370692539,4.396166676729281,IBSP,Osteo-MSC,0.5756194520344882
GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.2656932663769877,0.3357070325168697,0,0,3.316828370692539,4.396166676729281,HECW1,Osteo-MSC,0.5756194520344882
GO_Biological_Process_2021,defense response to symbiont (GO:0140546),1/124,0.2675403902734135,0.3369027136776318,0,0,3.2896963663514187,4.337414433160371,AGBL4,Osteo-MSC,0.5726106437410472
GO_Biological_Process_2021,regulation of phosphorylation (GO:0042325),1/125,0.2693829605231016,0.3380846551531544,0,0,3.263001974983542,4.279822783786303,BMP7,Osteo-MSC,0.5696298784899082
GO_Biological_Process_2021,negative regulation of growth (GO:0045926),1/126,0.2712209880572274,0.3392530084729199,0,0,3.236734693877551,4.223360488574632,FGFR3,Osteo-MSC,0.5666767062328689
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),2/409,0.2725909524148647,0.3398300540105313,0,0,2.000716625716626,2.600497358364142,HECW1;LMO7,Osteo-MSC,0.5644885629602858
GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.3483336206591355,0,0,3.111459968602826,3.956968446025251,SYT12,Osteo-MSC,0.5523097126477655
GO_Biological_Process_2021,defense response to virus (GO:0051607),1/133,0.2839609038772722,0.3504995975250819,0,0,3.0640074211502784,3.857336278341556,AGBL4,Osteo-MSC,0.546741450090894
GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3504995975250819,0,0,3.0640074211502784,3.857336278341556,IBSP,Osteo-MSC,0.546741450090894
GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),1/139,0.2947069182263764,0.3613783193989009,0,0,2.929902395740905,3.579678317757992,SLITRK4,Osteo-MSC,0.5306096689947516
GO_Biological_Process_2021,protein dephosphorylation (GO:0006470),1/139,0.2947069182263764,0.3613783193989009,0,0,2.929902395740905,3.579678317757992,PTPRD,Osteo-MSC,0.5306096689947516
GO_Biological_Process_2021,transcription initiation from RNA polymerase II promoter (GO:0006367),1/140,0.2964824884084789,0.3623674858325854,0,0,2.9086771399207163,3.5362740390257685,HNF4G,Osteo-MSC,0.5280009529309525
GO_Biological_Process_2021,regulation of small GTPase mediated signal transduction (GO:0051056),1/141,0.2982536777952956,0.3626079376699205,0,0,2.8877551020408165,3.4936375609484274,ARHGEF19,Osteo-MSC,0.5254141922968343
GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),2/437,0.2986183016105228,0.3626079376699205,0,0,1.8692528735632183,2.259158656282815,ARHGEF19;TP63,Osteo-MSC,0.5248835789121016
GO_Biological_Process_2021,protein localization to organelle (GO:0033365),1/142,0.3000204969826995,0.3631316047622318,0,0,2.8671298306556667,3.4517504575709377,BMP7,Osteo-MSC,0.522849073872343
GO_Biological_Process_2021,negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.3017829564686885,0.3640865345783532,0,0,2.8467950560505892,3.410594866305226,BMP7,Osteo-MSC,0.5203052911363482
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3722381567658467,0,0,2.749271137026239,3.215201203875706,FGFR3,Osteo-MSC,0.5078961191737069
GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3722381567658467,0,0,2.749271137026239,3.215201203875706,TP63,Osteo-MSC,0.5078961191737069
GO_Biological_Process_2021,actin filament organization (GO:0007015),1/152,0.3174506378807152,0.3793180145922923,0,0,2.6759021489390458,3.0704182805545575,SCIN,Osteo-MSC,0.4983237959237088
GO_Biological_Process_2021,dephosphorylation (GO:0016311),1/153,0.3191700762858281,0.3801579889519099,0,0,2.6581632653061225,3.0357052873752,PTPRD,Osteo-MSC,0.4959778325880012
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),2/464,0.3236043277850015,0.3826161128671758,0,0,1.7575757575757576,1.982956235178162,BMP7;TP63,Osteo-MSC,0.48998567889976286
GO_Biological_Process_2021,regulation of signal transduction by p53 class mediator (GO:1901796),1/156,0.3243029619756543,0.3826161128671758,0,0,2.6063199473337724,2.934917292064671,TP63,Osteo-MSC,0.4890490847411261
GO_Biological_Process_2021,regulation of cell differentiation (GO:0045595),1/156,0.3243029619756543,0.3826161128671758,0,0,2.6063199473337724,2.934917292064671,SCIN,Osteo-MSC,0.4890490847411261
GO_Biological_Process_2021,protein autophosphorylation (GO:0046777),1/159,0.329397918202972,0.3874050987670174,0,0,2.556445362955309,2.8389038953772054,FGFR3,Osteo-MSC,0.4822791499015975
GO_Biological_Process_2021,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3901483813810131,0,0,2.524234693877551,2.7773973646136283,FGFR3,Osteo-MSC,0.4778511096570981
GO_Biological_Process_2021,heart development (GO:0007507),1/164,0.3378059691212722,0.3948107264104869,0,0,2.4774007762614247,2.6886824434754057,BMP7,Osteo-MSC,0.4713326805982654
GO_Biological_Process_2021,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/165,0.3394751386404204,0.395525550939306,0,0,2.4621702339472376,2.6600168495918335,HECW1,Osteo-MSC,0.46919202564454415
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.3962311462358795,0,0,2.4471243042671613,2.6317886779390967,FGFR3,Osteo-MSC,0.4670671197091842
GO_Biological_Process_2021,"DNA-templated transcription, initiation (GO:0006352)",1/168,0.3444579462443567,0.3988460430197815,0,0,2.4175730172308443,2.5766088705447237,HNF4G,Osteo-MSC,0.46286379212748074
GO_Biological_Process_2021,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.403324267844544,0,0,2.3745498199279713,2.4969025061029213,BMP7,Osteo-MSC,0.4566722378913039
GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),1/177,0.359186378521905,0.4133406325144383,0,0,2.2929035250463823,2.3477357103628296,BMP7,Osteo-MSC,0.44468014150624274
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),2/525,0.3791874550703379,0.4350187367984858,0,0,1.547721478648821,1.5008635790547311,HECW1;LMO7,Osteo-MSC,0.42114603917112947
GO_Biological_Process_2021,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.4362818447619266,0,0,2.122448979591837,2.045536603225051,BMP7,Osteo-MSC,0.41855670871419515
GO_Biological_Process_2021,cellular response to tumor necrosis factor (GO:0071356),1/194,0.3861272144560919,0.4389409671932473,0,0,2.089140319340171,1.988001678572607,NPNT,Osteo-MSC,0.4132695879859197
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4389409671932473,0,0,2.089140319340171,1.988001678572607,TP63,Osteo-MSC,0.4132695879859197
GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),1/198,0.3923030921692546,0.443266937979762,0,0,2.0463068476121413,1.914771355908193,NCAM1,Osteo-MSC,0.4063782687077012
GO_Biological_Process_2021,negative regulation of intracellular signal transduction (GO:1902532),1/198,0.3923030921692546,0.443266937979762,0,0,2.0463068476121413,1.914771355908193,BMP7,Osteo-MSC,0.4063782687077012
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/547,0.3988146050031916,0.4491789019190482,0,0,1.4835626911314983,1.3637777909312412,BMP7;TP63,Osteo-MSC,0.3992289457561903
GO_Biological_Process_2021,axon guidance (GO:0007411),1/203,0.3999373645428959,0.4491789019190482,0,0,1.9951505354617096,1.8284503867148747,NCAM1,Osteo-MSC,0.398008019580524
GO_Biological_Process_2021,proteasomal protein catabolic process (GO:0010498),1/205,0.4029646862685204,0.4512239301330139,0,0,1.975390156062425,1.7954446526222323,HECW1,Osteo-MSC,0.3947330115033212
GO_Biological_Process_2021,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4532400375356774,0,0,1.9560134733505052,1.7632653144438126,FGFR3,Osteo-MSC,0.3914985283218076
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4602013306022938,0,0,1.909178837411742,1.6862551884518755,PTPRD,Osteo-MSC,0.3835844547796231
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),2/566,0.4155454754335446,0.4607540987213456,0,0,1.43218085106383,1.2576885523498746,SCIN;BMP7,Osteo-MSC,0.38138144203835345
GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),1/214,0.416403436812339,0.4607540987213456,0,0,1.8910606496119575,1.656759537391559,ARHGEF19,Osteo-MSC,0.3804856946694876
GO_Biological_Process_2021,apoptotic process (GO:0006915),1/231,0.4409837467017168,0.4865130420839,0,0,1.749778172138421,1.4326260836369302,TP63,Osteo-MSC,0.35557741698984124
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.5050023976480289,0,0,1.655076845553036,1.2884811006593149,UNC13C,Osteo-MSC,0.33809924509335265
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),2/625,0.4660144680358849,0.5111126423619382,0,0,1.2926029962546817,0.9869522795970046,IBSP;FGFR3,Osteo-MSC,0.33160059985375573
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.5123932979777449,0,0,1.6016749329213755,1.2094704650298027,TP63,Osteo-MSC,0.32794816113488356
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),1/253,0.4712922312950381,0.5123932979777449,0,0,1.5952380952380951,1.2000608149186214,FGFR3,Osteo-MSC,0.32670971902140344
GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.5123932979777449,0,0,1.5952380952380951,1.2000608149186214,HECW1,Osteo-MSC,0.32670971902140344
GO_Biological_Process_2021,cellular component assembly (GO:0022607),1/261,0.4819092749521712,0.5224175908177161,0,0,1.5455259026687598,1.1282329953702568,SCIN,Osteo-MSC,0.31703471507296654
GO_Biological_Process_2021,regulation of protein phosphorylation (GO:0001932),1/266,0.4884385252284191,0.5278408200897257,0,0,1.5159799768964188,1.086262808220724,BMP7,Osteo-MSC,0.3111900887192418
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5278408200897257,0,0,1.510204081632653,1.0781219104526054,WIF1,Osteo-MSC,0.3100391544580995
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",6/2244,0.4960895197517082,0.5331536792733875,0,0,1.079210333902023,0.7565252409314136,DLX5;DLX6;HNF4G;BMP7;ZNF488;TP63,Osteo-MSC,0.30443994765052834
GO_Biological_Process_2021,proteolysis (GO:0006508),1/287,0.51499186851511,0.5518824035090292,0,0,1.4031682603111175,0.9311483055746664,KLK4,Osteo-MSC,0.28819962821492023
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),1/296,0.5259539383992272,0.5620193513180314,0,0,1.359737115185057,0.8736877155004001,BMP7,Osteo-MSC,0.2790522884983112
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5730930311586485,0,0,1.314486450317832,0.8152139890333826,UNC13C,Osteo-MSC,0.2693393582885023
GO_Biological_Process_2021,transcription by RNA polymerase II (GO:0006366),1/320,0.5540128017436795,0.5881715727885948,0,0,1.255901733734246,0.7416947278731473,HNF4G,Osteo-MSC,0.2564801997798679
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.5551458962416416,0.5881715727885948,0,0,1.2519132653061225,0.7367814077584223,HECW1,Osteo-MSC,0.25559286623594474
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),2/764,0.5744134768292987,0.6068662156332137,0,0,1.0492125984251968,0.5816895490313783,SCIN;FGFR3,Osteo-MSC,0.24077537927422193
GO_Biological_Process_2021,post-translational protein modification (GO:0043687),1/345,0.5815093765862647,0.6126324136429943,0,0,1.1631466540104414,0.6305745813190116,LMO7,Osteo-MSC,0.23544327806907975
GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),1/351,0.5878572192841084,0.6175803371130801,0,0,1.1428571428571428,0.6071670684764225,COL12A1,Osteo-MSC,0.23072814400359865
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.5909956578792304,0.6191383082544318,0,0,1.1329710354396716,0.5958822738188654,HECW1,Osteo-MSC,0.22841570992418872
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),1/379,0.6162544539128882,0.6437965524117882,0,0,1.056689342403628,0.5115383719098227,SCIN,Osteo-MSC,0.2102399288866402
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.644038204410142,0,0,1.0510204081632653,0.5054679174936134,ANGPT4,Osteo-MSC,0.20886552310647807
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6452741990423845,0,0,1.042628017264347,0.4965325169788531,BMP7,Osteo-MSC,0.20682480102083725
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.6630291052335731,0,0,0.989871879272801,0.4417939051458828,FGFR3,Osteo-MSC,0.19383180708628664
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),5/2206,0.6589063274622694,0.6807485261626761,0,0,0.8960068655661568,0.3737906767782196,DLX5;DLX6;HNF4G;LMO7;TP63,Osteo-MSC,0.1811763219125431
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.663134010332821,0.6832289803429065,0,0,0.928642785785643,0.3814661952932429,ZNF488,Osteo-MSC,0.17839869773857764
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",2/948,0.6926945411260426,0.7114893740527342,0,0,0.8370331219168429,0.3073302326128318,BMP7;TP63,Osteo-MSC,0.15945823486666727
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),1/468,0.6943679720033368,0.7114893740527342,0,0,0.8514180832932745,0.3105575044475373,ZNF488,Osteo-MSC,0.15841031937391015
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),1/474,0.6990329319013457,0.7143123402489162,0,0,0.8403589765716012,0.300896771210595,FGFR3,Osteo-MSC,0.1555023638735803
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),1/482,0.7051444771556823,0.7166413979788727,0,0,0.8260426831855403,0.2885801301950252,BMP7,Osteo-MSC,0.1517218912312197
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7166413979788727,0,0,0.8260426831855403,0.2885801301950252,NPNT,Osteo-MSC,0.1517218912312197
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7169902407615301,0,0,0.8207960870298533,0.2841203737887477,ANGPT4,Osteo-MSC,0.15033199168778996
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7232839969840507,0,0,0.8021026592455164,0.2684686706444305,FGFR3,Osteo-MSC,0.1453610219101508
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),2/1025,0.7337546800798972,0.7396880063339125,0,0,0.7708944281524927,0.2386539053000475,PTPRD;LMO7,Osteo-MSC,0.13444911569132442
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.7538819129598908,0,0,0.726642950758285,0.2091870484536521,FGFR3,Osteo-MSC,0.12502533841998253
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7618042171637788,0,0,0.7301532033426184,0.200604530418796,BMP7;ZNF488,Osteo-MSC,0.11931939791106433
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),1/621,0.7938341129137421,0.7938341129137421,0,0,0.6362738643844634,0.1469033967904298,NCAM1,Osteo-MSC,0.10027024237534503
KEGG_2021_Human,phosphate ion homeostasis (GO:0055062),3/10,1.7424677736230126e-06,0.0004334872662170099,0,0,181.8510638297872,2411.382965740782,SFRP4;ENPP1;FGF23,Osteoblast,5.7588352452914275
KEGG_2021_Human,skeletal system development (GO:0001501),6/158,2.6351809496474767e-06,0.0004334872662170099,0,0,17.761363636363637,228.17240066622728,BMP3;MMP16;COL13A1;BGLAP;COL11A2;BMP8B,Osteoblast,5.579189557781517
KEGG_2021_Human,extracellular structure organization (GO:0043062),6/216,1.5824032163970238e-05,0.0013360111708656,0,0,12.818181818181818,141.6919350743239,MMP16;COL13A1;IBSP;COL22A1;COL11A2;SPP1,Osteoblast,4.800682842997869
KEGG_2021_Human,external encapsulating structure organization (GO:0045229),6/217,1.6243296910220135e-05,0.0013360111708656,0,0,12.756785868160277,140.6796688616016,MMP16;COL13A1;IBSP;COL22A1;COL11A2;SPP1,Osteoblast,4.789325817176341
KEGG_2021_Human,negative regulation of ossification (GO:0030279),3/24,2.867422295491e-05,0.001886763870433,0,0,60.57446808510638,633.5793754459056,LRP4;ENPP1;FGF23,Osteoblast,4.542508342248569
KEGG_2021_Human,trivalent inorganic anion homeostasis (GO:0072506),2/5,6.0956786529959696e-05,0.0033424637947261,0,0,277.0416666666667,2688.78505476905,SFRP4;FGF23,Osteoblast,4.214977935846465
KEGG_2021_Human,extracellular matrix organization (GO:0030198),6/300,9.885304072455858e-05,0.0046460929140542,0,0,9.116883116883116,84.07476786976937,MMP16;COL13A1;IBSP;COL22A1;COL11A2;SPP1,Osteoblast,4.005009967224501
KEGG_2021_Human,bone development (GO:0060348),3/40,0.00013608554044552048,0.005596517850822,0,0,34.35250143760782,305.8137622456798,SFRP4;BGLAP;IFITM5,Osteoblast,3.8661880176205408
KEGG_2021_Human,response to vitamin (GO:0033273),2/9,0.00021804660985203623,0.006598272206852,0,0,118.70833333333331,1000.8064198202924,BGLAP;SPP1,Osteoblast,3.6614506612675517
KEGG_2021_Human,response to vitamin D (GO:0033280),2/9,0.00021804660985203623,0.006598272206852,0,0,118.70833333333331,1000.8064198202924,BGLAP;SPP1,Osteoblast,3.6614506612675517
KEGG_2021_Human,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),3/47,0.0002206109248491568,0.006598272206852,0,0,28.87717601547389,243.12011931420915,BMP3;BMP8A;BMP8B,Osteoblast,3.6563729847143955
KEGG_2021_Human,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),3/58,0.00041177118298551824,0.0112893932668529,0,0,23.088974854932303,179.97954590931704,BMP3;BMP8A;BMP8B,Osteoblast,3.3853440499187784
KEGG_2021_Human,negative regulation of bone mineralization (GO:0030502),2/14,0.0005467878206419364,0.0119928795327464,0,0,69.22916666666667,520.0114050756229,ENPP1;FGF23,Osteoblast,3.2621811676355046
KEGG_2021_Human,steroid catabolic process (GO:0006706),2/14,0.0005467878206419364,0.0119928795327464,0,0,69.22916666666667,520.0114050756229,SPP1;FGF23,Osteoblast,3.2621811676355046
KEGG_2021_Human,bone morphogenesis (GO:0060349),2/14,0.0005467878206419364,0.0119928795327464,0,0,69.22916666666667,520.0114050756229,SFRP4;IFITM5,Osteoblast,3.2621811676355046
KEGG_2021_Human,negative regulation of biomineral tissue development (GO:0070168),2/22,0.001370383663162,0.02777714385886,0,0,41.520833333333336,273.7329252658829,ENPP1;FGF23,Osteoblast,2.8631578273928713
KEGG_2021_Human,collagen fibril organization (GO:0030199),3/89,0.0014352931477222,0.02777714385886,0,0,14.743196437407224,96.51465720793364,COL13A1;COL22A1;COL11A2,Osteoblast,2.8430593885216617
KEGG_2021_Human,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),3/92,0.0015788398918981,0.0288576846908044,0,0,14.244083193879993,91.88950579800434,BMP3;BMP8A;BMP8B,Osteoblast,2.801661908997864
KEGG_2021_Human,proteoglycan metabolic process (GO:0006029),2/26,0.0019157650058532,0.0331729835224068,0,0,34.59375,216.47517339281177,CHST13;HS3ST4,Osteoblast,2.7176577640050135
KEGG_2021_Human,regulation of ossification (GO:0030278),2/36,0.0036549257227984,0.060123528140034,0,0,24.40686274509804,136.96349152286243,LRP4;ENPP1,Osteoblast,2.437121444562911
KEGG_2021_Human,skeletal system morphogenesis (GO:0048705),2/42,0.0049475924537835,0.0775122817759423,0,0,20.739583333333332,110.1034239545967,SFRP4;IFITM5,Osteoblast,2.3056060815494894
KEGG_2021_Human,adherens junction organization (GO:0034332),2/49,0.0066828970303688,0.0994195010450704,0,0,17.64450354609929,88.36726791367238,CADM1;CDH15,Osteoblast,2.175035230405133
KEGG_2021_Human,chloride transmembrane transport (GO:1902476),2/50,0.0069502994651568,0.0994195010450704,0,0,17.276041666666668,85.84414194819459,GABRB1;ANO5,Osteoblast,2.157996482710139
KEGG_2021_Human,inorganic anion transport (GO:0015698),2/54,0.0080676700842631,0.1105943107384408,0,0,15.943910256410255,76.8479024006269,ENPP1;ANO5,Osteoblast,2.0932518699428635
KEGG_2021_Human,regulation of bone mineralization (GO:0030500),2/57,0.0089551608364968,0.1144525283761386,0,0,15.071969696969695,71.07225417227201,ENPP1;FGF23,Osteoblast,2.0479266097283184
KEGG_2021_Human,response to organic cyclic compound (GO:0014070),2/60,0.0098843204040546,0.1144525283761386,0,0,14.290229885057473,65.97521300057967,BGLAP;SPP1,Osteoblast,2.0050531852188076
KEGG_2021_Human,BMP signaling pathway (GO:0030509),2/65,0.0115237618661231,0.1144525283761386,0,0,13.15277777777778,58.70537343689256,BMP8A;BMP8B,Osteoblast,1.9384057248186684
KEGG_2021_Human,inorganic anion transmembrane transport (GO:0098661),2/65,0.0115237618661231,0.1144525283761386,0,0,13.15277777777778,58.70537343689256,GABRB1;ANO5,Osteoblast,1.9384057248186684
KEGG_2021_Human,negative regulation of Wnt signaling pathway (GO:0030178),3/191,0.0120928119559138,0.1144525283761386,0,0,6.709597102761431,29.623837767279053,SFRP4;WIF1;LRP4,Osteoblast,1.917472700384869
KEGG_2021_Human,cellular response to testosterone stimulus (GO:0071394),1/5,0.0124387771927725,0.1144525283761386,0,0,101.76530612244898,446.4379351400606,SPP1,Osteoblast,1.9052223113279663
KEGG_2021_Human,receptor-mediated virion attachment to host cell (GO:0046813),1/5,0.0124387771927725,0.1144525283761386,0,0,101.76530612244898,446.4379351400606,LRRC15,Osteoblast,1.9052223113279663
KEGG_2021_Human,nucleoside triphosphate catabolic process (GO:0009143),1/5,0.0124387771927725,0.1144525283761386,0,0,101.76530612244898,446.4379351400606,ENPP1,Osteoblast,1.9052223113279663
KEGG_2021_Human,positive regulation of hippo signaling (GO:0035332),1/5,0.0124387771927725,0.1144525283761386,0,0,101.76530612244898,446.4379351400606,FRMD1,Osteoblast,1.9052223113279663
KEGG_2021_Human,proline transmembrane transport (GO:0035524),1/5,0.0124387771927725,0.1144525283761386,0,0,101.76530612244898,446.4379351400606,SLC36A2,Osteoblast,1.9052223113279663
KEGG_2021_Human,cellular response to BMP stimulus (GO:0071773),2/71,0.0136373517747766,0.1144525283761386,0,0,12.005434782608695,51.56265564232933,BMP8A;BMP8B,Osteoblast,1.8652699567516449
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),4/371,0.01371944672388,0.1144525283761386,0,0,4.63997156734984,19.9005642186198,BMP3;BMP8A;BMP8B;FGF23,Osteoblast,1.862663402449304
KEGG_2021_Human,negative regulation of anion transport (GO:1903792),1/6,0.0149082847993736,0.1144525283761386,0,0,81.40816326530613,342.3895623444841,SFRP4,Osteoblast,1.8265723193247598
KEGG_2021_Human,cellular trivalent inorganic anion homeostasis (GO:0072502),1/6,0.0149082847993736,0.1144525283761386,0,0,81.40816326530613,342.3895623444841,ENPP1,Osteoblast,1.8265723193247598
KEGG_2021_Human,regulation of keratinocyte apoptotic process (GO:1902172),1/6,0.0149082847993736,0.1144525283761386,0,0,81.40816326530613,342.3895623444841,SFRP4,Osteoblast,1.8265723193247598
KEGG_2021_Human,negative regulation of glycogen biosynthetic process (GO:0045719),1/6,0.0149082847993736,0.1144525283761386,0,0,81.40816326530613,342.3895623444841,ENPP1,Osteoblast,1.8265723193247598
KEGG_2021_Human,response to testosterone (GO:0033574),1/6,0.0149082847993736,0.1144525283761386,0,0,81.40816326530613,342.3895623444841,SPP1,Osteoblast,1.8265723193247598
KEGG_2021_Human,cellular phosphate ion homeostasis (GO:0030643),1/6,0.0149082847993736,0.1144525283761386,0,0,81.40816326530613,342.3895623444841,ENPP1,Osteoblast,1.8265723193247598
KEGG_2021_Human,chloride transport (GO:0006821),2/76,0.0155171628224907,0.1144525283761386,0,0,11.19144144144144,46.62140287744705,GABRB1;ANO5,Osteoblast,1.8091876827669675
KEGG_2021_Human,cellular response to histamine (GO:0071420),1/7,0.0173717414502839,0.1144525283761386,0,0,67.83673469387755,274.9362107684438,GABRB1,Osteoblast,1.7601566430186848
KEGG_2021_Human,L-alanine transport (GO:0015808),1/7,0.0173717414502839,0.1144525283761386,0,0,67.83673469387755,274.9362107684438,SLC36A2,Osteoblast,1.7601566430186848
KEGG_2021_Human,flavin-containing compound metabolic process (GO:0042726),1/7,0.0173717414502839,0.1144525283761386,0,0,67.83673469387755,274.9362107684438,ENPP1,Osteoblast,1.7601566430186848
KEGG_2021_Human,negative regulation of glycogen metabolic process (GO:0070874),1/7,0.0173717414502839,0.1144525283761386,0,0,67.83673469387755,274.9362107684438,ENPP1,Osteoblast,1.7601566430186848
KEGG_2021_Human,riboflavin metabolic process (GO:0006771),1/7,0.0173717414502839,0.1144525283761386,0,0,67.83673469387755,274.9362107684438,ENPP1,Osteoblast,1.7601566430186848
KEGG_2021_Human,endothelial cell morphogenesis (GO:0001886),1/7,0.0173717414502839,0.1144525283761386,0,0,67.83673469387755,274.9362107684438,COL22A1,Osteoblast,1.7601566430186848
KEGG_2021_Human,cell-cell junction organization (GO:0045216),2/82,0.0179108739546233,0.1144525283761386,0,0,10.348958333333334,41.62710426921145,CADM1;CDH15,Osteoblast,1.746883222391611
KEGG_2021_Human,regulation of cell migration (GO:0030334),4/408,0.0187942434702196,0.1144525283761386,0,0,4.207059836418424,16.719716783347426,LRRC15;SEMA3D;SRGAP3;FGF23,Osteoblast,1.7259751513719126
KEGG_2021_Human,positive regulation of oligodendrocyte differentiation (GO:0048714),1/8,0.0198291614511851,0.1144525283761386,0,0,58.142857142857146,227.9549801512961,PTPRZ1,Osteoblast,1.702695651141308
KEGG_2021_Human,T cell mediated cytotoxicity (GO:0001913),1/8,0.0198291614511851,0.1144525283761386,0,0,58.142857142857146,227.9549801512961,CADM1,Osteoblast,1.702695651141308
KEGG_2021_Human,regulation of anion transport (GO:0044070),1/8,0.0198291614511851,0.1144525283761386,0,0,58.142857142857146,227.9549801512961,FGF23,Osteoblast,1.702695651141308
KEGG_2021_Human,commissural neuron axon guidance (GO:0071679),1/8,0.0198291614511851,0.1144525283761386,0,0,58.142857142857146,227.9549801512961,NCAM1,Osteoblast,1.702695651141308
KEGG_2021_Human,negative regulation of glucose import (GO:0046325),1/8,0.0198291614511851,0.1144525283761386,0,0,58.142857142857146,227.9549801512961,ENPP1,Osteoblast,1.702695651141308
KEGG_2021_Human,regulation of myeloid leukocyte differentiation (GO:0002761),1/8,0.0198291614511851,0.1144525283761386,0,0,58.142857142857146,227.9549801512961,BGLAP,Osteoblast,1.702695651141308
KEGG_2021_Human,Wnt signaling pathway (GO:0016055),2/92,0.0222223839756269,0.1162119594411128,0,0,9.194444444444445,35.00007985571613,SFRP4;CPE,Osteoblast,1.6532093525993499
KEGG_2021_Human,postsynaptic membrane assembly (GO:0097104),1/9,0.0222805591236868,0.1162119594411128,0,0,50.87244897959184,193.52086993316271,LRP4,Osteoblast,1.652073914876897
KEGG_2021_Human,endochondral ossification (GO:0001958),1/9,0.0222805591236868,0.1162119594411128,0,0,50.87244897959184,193.52086993316271,COL13A1,Osteoblast,1.652073914876897
KEGG_2021_Human,protein maturation (GO:0051604),2/97,0.024523395696302,0.1162119594411128,0,0,8.708333333333334,32.29161197321332,MMP16;CPE,Osteoblast,1.6104193942653626
KEGG_2021_Human,glycosaminoglycan biosynthetic process (GO:0006024),2/97,0.024523395696302,0.1162119594411128,0,0,8.708333333333334,32.29161197321332,OMD;CHST13,Osteoblast,1.6104193942653626
KEGG_2021_Human,alanine transport (GO:0032328),1/10,0.024725948817258,0.1162119594411128,0,0,45.21768707482993,167.3010120823387,SLC36A2,Osteoblast,1.606847034080906
KEGG_2021_Human,positive regulation of epidermis development (GO:0045684),1/10,0.024725948817258,0.1162119594411128,0,0,45.21768707482993,167.3010120823387,SFRP4,Osteoblast,1.606847034080906
KEGG_2021_Human,negative regulation of hormone secretion (GO:0046888),1/10,0.024725948817258,0.1162119594411128,0,0,45.21768707482993,167.3010120823387,FGF23,Osteoblast,1.606847034080906
KEGG_2021_Human,glycine transport (GO:0015816),1/10,0.024725948817258,0.1162119594411128,0,0,45.21768707482993,167.3010120823387,SLC36A2,Osteoblast,1.606847034080906
KEGG_2021_Human,hematopoietic stem cell differentiation (GO:0060218),1/10,0.024725948817258,0.1162119594411128,0,0,45.21768707482993,167.3010120823387,SP7,Osteoblast,1.606847034080906
KEGG_2021_Human,response to histamine (GO:0034776),1/10,0.024725948817258,0.1162119594411128,0,0,45.21768707482993,167.3010120823387,GABRB1,Osteoblast,1.606847034080906
KEGG_2021_Human,presynaptic membrane assembly (GO:0097105),1/10,0.024725948817258,0.1162119594411128,0,0,45.21768707482993,167.3010120823387,LRP4,Osteoblast,1.606847034080906
KEGG_2021_Human,negative regulation of protein autophosphorylation (GO:0031953),1/10,0.024725948817258,0.1162119594411128,0,0,45.21768707482993,167.3010120823387,ENPP1,Osteoblast,1.606847034080906
KEGG_2021_Human,positive regulation of bone resorption (GO:0045780),1/11,0.0271653448579923,0.1217249069521304,0,0,40.69387755102041,146.73452100035948,SPP1,Osteoblast,1.5659847773237099
KEGG_2021_Human,postsynapse assembly (GO:0099068),1/11,0.0271653448579923,0.1217249069521304,0,0,40.69387755102041,146.73452100035948,LRP4,Osteoblast,1.5659847773237099
KEGG_2021_Human,presynaptic membrane organization (GO:0097090),1/11,0.0271653448579923,0.1217249069521304,0,0,40.69387755102041,146.73452100035948,LRP4,Osteoblast,1.5659847773237099
KEGG_2021_Human,protein processing (GO:0016485),2/106,0.0288986461861609,0.1217249069521304,0,0,7.951121794871795,28.178461808105727,MMP16;CPE,Osteoblast,1.5391225021448902
KEGG_2021_Human,negative regulation of signal transduction (GO:0009968),3/267,0.0290942849381526,0.1217249069521304,0,0,4.759671179883946,16.83597323857966,SFRP4;WIF1;ENPP1,Osteoblast,1.5361923121681382
KEGG_2021_Human,keratan sulfate catabolic process (GO:0042340),1/12,0.029598761568907,0.1217249069521304,0,0,36.99257884972171,130.2147194065139,OMD,Osteoblast,1.5287264597194943
KEGG_2021_Human,fat-soluble vitamin catabolic process (GO:0042363),1/12,0.029598761568907,0.1217249069521304,0,0,36.99257884972171,130.2147194065139,FGF23,Osteoblast,1.5287264597194943
KEGG_2021_Human,melanocyte differentiation (GO:0030318),1/12,0.029598761568907,0.1217249069521304,0,0,36.99257884972171,130.2147194065139,ENPP1,Osteoblast,1.5287264597194943
KEGG_2021_Human,negative regulation of glucose transmembrane transport (GO:0010829),1/12,0.029598761568907,0.1217249069521304,0,0,36.99257884972171,130.2147194065139,ENPP1,Osteoblast,1.5287264597194943
KEGG_2021_Human,organic hydroxy compound catabolic process (GO:1901616),1/12,0.029598761568907,0.1217249069521304,0,0,36.99257884972171,130.2147194065139,FGF23,Osteoblast,1.5287264597194943
KEGG_2021_Human,regulation of Wnt signaling pathway (GO:0030111),2/111,0.0314544847807964,0.1269472790222052,0,0,7.584480122324159,26.23633758944092,SFRP4;WIF1,Osteoblast,1.5023174240917434
KEGG_2021_Human,positive regulation of lipid transport (GO:0032370),1/13,0.032026213248763,0.1269472790222052,0,0,33.90816326530612,116.6847899929619,SPP1,Osteoblast,1.4944944088974865
KEGG_2021_Human,endochondral bone morphogenesis (GO:0060350),1/13,0.032026213248763,0.1269472790222052,0,0,33.90816326530612,116.6847899929619,COL13A1,Osteoblast,1.4944944088974865
KEGG_2021_Human,sulfur compound biosynthetic process (GO:0044272),2/113,0.032501099312465,0.1272959723071546,0,0,7.447072072072072,25.51725368040207,OMD;CHST13,Osteoblast,1.4881019492591823
KEGG_2021_Human,response to lipid (GO:0033993),2/114,0.0330295301793541,0.127340426538063,0,0,7.380208333333333,25.169117576656426,BGLAP;SPP1,Osteoblast,1.4810976037825534
KEGG_2021_Human,ion transport (GO:0006811),2/116,0.0340965412337713,0.127340426538063,0,0,7.25,24.49455514200503,GABRB1;SLC36A2,Osteoblast,1.467289673772098
KEGG_2021_Human,nucleoside phosphate catabolic process (GO:1901292),1/14,0.0344477141698711,0.127340426538063,0,0,31.298273155416013,105.4223689491126,ENPP1,Osteoblast,1.4628395910668823
KEGG_2021_Human,nucleoside triphosphate metabolic process (GO:0009141),1/14,0.0344477141698711,0.127340426538063,0,0,31.298273155416013,105.4223689491126,ENPP1,Osteoblast,1.4628395910668823
KEGG_2021_Human,cardiac left ventricle morphogenesis (GO:0003214),1/14,0.0344477141698711,0.127340426538063,0,0,31.298273155416013,105.4223689491126,CPE,Osteoblast,1.4628395910668823
KEGG_2021_Human,T cell proliferation (GO:0042098),1/15,0.0368632785936063,0.1318262897532226,0,0,29.06122448979592,95.91771596133704,CADM1,Osteoblast,1.4334060415588732
KEGG_2021_Human,regulation of non-canonical Wnt signaling pathway (GO:2000050),1/15,0.0368632785936063,0.1318262897532226,0,0,29.06122448979592,95.91771596133704,SFRP4,Osteoblast,1.4334060415588732
KEGG_2021_Human,vitamin D metabolic process (GO:0042359),1/15,0.0368632785936063,0.1318262897532226,0,0,29.06122448979592,95.91771596133704,FGF23,Osteoblast,1.4334060415588732
KEGG_2021_Human,regulation of hormone secretion (GO:0046883),1/16,0.0392729207344652,0.1374552225706283,0,0,27.122448979591837,87.80133530116419,FGF23,Osteoblast,1.405906798966597
KEGG_2021_Human,T cell mediated immunity (GO:0002456),1/16,0.0392729207344652,0.1374552225706283,0,0,27.122448979591837,87.80133530116419,CADM1,Osteoblast,1.405906798966597
KEGG_2021_Human,epithelial cell morphogenesis (GO:0003382),1/17,0.0416766547912334,0.1399144839419981,0,0,25.426020408163264,80.79916728086499,COL22A1,Osteoblast,1.3801071472903907
KEGG_2021_Human,positive regulation of stem cell differentiation (GO:2000738),1/17,0.0416766547912334,0.1399144839419981,0,0,25.426020408163264,80.79916728086499,SP7,Osteoblast,1.3801071472903907
KEGG_2021_Human,negative regulation of insulin secretion (GO:0046676),1/17,0.0416766547912334,0.1399144839419981,0,0,25.426020408163264,80.79916728086499,BMP8A,Osteoblast,1.3801071472903907
KEGG_2021_Human,regulation of cellular response to growth factor stimulus (GO:0090287),1/17,0.0416766547912334,0.1399144839419981,0,0,25.426020408163264,80.79916728086499,SFRP4,Osteoblast,1.3801071472903907
KEGG_2021_Human,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),2/133,0.043691853040543,0.1421618512992832,0,0,6.303753180661578,19.734489511742076,BMP8A;BMP8B,Osteoblast,1.3595995357844428
KEGG_2021_Human,positive regulation of glial cell differentiation (GO:0045687),1/18,0.0440744949316926,0.1421618512992832,0,0,23.92917166866747,74.70385911458476,PTPRZ1,Osteoblast,1.3558126557645607
KEGG_2021_Human,presynapse assembly (GO:0099054),1/18,0.0440744949316926,0.1421618512992832,0,0,23.92917166866747,74.70385911458476,LRP4,Osteoblast,1.3558126557645607
KEGG_2021_Human,negative regulation of peptide hormone secretion (GO:0090278),1/18,0.0440744949316926,0.1421618512992832,0,0,23.92917166866747,74.70385911458476,BMP8A,Osteoblast,1.3558126557645607
KEGG_2021_Human,purine ribonucleoside bisphosphate metabolic process (GO:0034035),1/19,0.0464664552952436,0.142843973890796,0,0,22.598639455782312,69.35578082800635,ENPP1,Osteoblast,1.3328604565168853
KEGG_2021_Human,postsynaptic membrane organization (GO:0001941),1/19,0.0464664552952436,0.142843973890796,0,0,22.598639455782312,69.35578082800635,LRP4,Osteoblast,1.3328604565168853
KEGG_2021_Human,regulation of oligodendrocyte differentiation (GO:0048713),1/19,0.0464664552952436,0.142843973890796,0,0,22.598639455782312,69.35578082800635,PTPRZ1,Osteoblast,1.3328604565168853
KEGG_2021_Human,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/20,0.0488525499820277,0.142843973890796,0,0,21.40816326530612,64.63014669364038,CADM1,Osteoblast,1.3111127622579986
KEGG_2021_Human,negative regulation of axon extension involved in axon guidance (GO:0048843),1/20,0.0488525499820277,0.142843973890796,0,0,21.40816326530612,64.63014669364038,SEMA3D,Osteoblast,1.3111127622579986
KEGG_2021_Human,regulation of hippo signaling (GO:0035330),1/20,0.0488525499820277,0.142843973890796,0,0,21.40816326530612,64.63014669364038,FRMD1,Osteoblast,1.3111127622579986
KEGG_2021_Human,positive regulation of epidermal cell differentiation (GO:0045606),1/20,0.0488525499820277,0.142843973890796,0,0,21.40816326530612,64.63014669364038,SFRP4,Osteoblast,1.3111127622579986
KEGG_2021_Human,positive regulation of epithelial cell differentiation (GO:0030858),1/20,0.0488525499820277,0.142843973890796,0,0,21.40816326530612,64.63014669364038,SFRP4,Osteoblast,1.3111127622579986
KEGG_2021_Human,oligodendrocyte differentiation (GO:0048709),1/20,0.0488525499820277,0.142843973890796,0,0,21.40816326530612,64.63014669364038,PTPRZ1,Osteoblast,1.3111127622579986
KEGG_2021_Human,positive regulation of hormone secretion (GO:0046887),1/20,0.0488525499820277,0.142843973890796,0,0,21.40816326530612,64.63014669364038,SPP1,Osteoblast,1.3111127622579986
KEGG_2021_Human,negative regulation of cell communication (GO:0010648),1/21,0.0512327930672156,0.142843973890796,0,0,20.336734693877553,60.42807445408675,FGF23,Osteoblast,1.2904519669693806
KEGG_2021_Human,androgen metabolic process (GO:0008209),1/21,0.0512327930672156,0.142843973890796,0,0,20.336734693877553,60.42807445408675,SPP1,Osteoblast,1.2904519669693806
KEGG_2021_Human,chondroitin sulfate biosynthetic process (GO:0030206),1/21,0.0512327930672156,0.142843973890796,0,0,20.336734693877553,60.42807445408675,CHST13,Osteoblast,1.2904519669693806
KEGG_2021_Human,heparan sulfate proteoglycan metabolic process (GO:0030201),1/21,0.0512327930672156,0.142843973890796,0,0,20.336734693877553,60.42807445408675,HS3ST4,Osteoblast,1.2904519669693806
KEGG_2021_Human,negative regulation of protein localization to cell periphery (GO:1904376),1/21,0.0512327930672156,0.142843973890796,0,0,20.336734693877553,60.42807445408675,LRRC15,Osteoblast,1.2904519669693806
KEGG_2021_Human,negative regulation of protein localization to plasma membrane (GO:1903077),1/21,0.0512327930672156,0.142843973890796,0,0,20.336734693877553,60.42807445408675,LRRC15,Osteoblast,1.2904519669693806
KEGG_2021_Human,cellular response to organic cyclic compound (GO:0071407),2/150,0.0541636617411515,0.1485163855920351,0,0,5.574887387387387,16.25495026487543,GABRB1;SPP1,Osteoblast,1.2662919827974375
KEGG_2021_Human,positive regulation of natural killer cell mediated immunity (GO:0002717),1/23,0.0559757805878795,0.1485163855920351,0,0,18.4860853432282,53.29235549319145,CADM1,Osteoblast,1.2519998414265567
KEGG_2021_Human,negative regulation of smoothened signaling pathway (GO:0045879),1/23,0.0559757805878795,0.1485163855920351,0,0,18.4860853432282,53.29235549319145,ENPP1,Osteoblast,1.2519998414265567
KEGG_2021_Human,positive regulation of receptor internalization (GO:0002092),1/23,0.0559757805878795,0.1485163855920351,0,0,18.4860853432282,53.29235549319145,SFRP4,Osteoblast,1.2519998414265567
KEGG_2021_Human,positive regulation of epithelial cell apoptotic process (GO:1904037),1/23,0.0559757805878795,0.1485163855920351,0,0,18.4860853432282,53.29235549319145,SFRP4,Osteoblast,1.2519998414265567
KEGG_2021_Human,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.0559757805878795,0.1485163855920351,0,0,18.4860853432282,53.29235549319145,PTPRZ1,Osteoblast,1.2519998414265567
KEGG_2021_Human,supramolecular fiber organization (GO:0097435),3/351,0.0573776228581519,0.1510179033626558,0,0,3.595377842993397,10.275952639346544,COL13A1;COL22A1;COL11A2,Osteoblast,1.2412574484387946
KEGG_2021_Human,neuromuscular junction development (GO:0007528),1/24,0.0583385530130099,0.1511290074116557,0,0,17.68145519077196,50.24171555062859,LRP4,Osteoblast,1.2340443470047993
KEGG_2021_Human,regulation of axon extension involved in axon guidance (GO:0048841),1/24,0.0583385530130099,0.1511290074116557,0,0,17.68145519077196,50.24171555062859,SEMA3D,Osteoblast,1.2340443470047993
KEGG_2021_Human,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),1/25,0.0606955298241754,0.1515902763674468,0,0,16.943877551020407,47.47480020477031,ENPP1,Osteoblast,1.2168432931781568
KEGG_2021_Human,negative regulation of signaling (GO:0023057),1/25,0.0606955298241754,0.1515902763674468,0,0,16.943877551020407,47.47480020477031,FGF23,Osteoblast,1.2168432931781568
KEGG_2021_Human,regulation of epidermal cell differentiation (GO:0045604),1/25,0.0606955298241754,0.1515902763674468,0,0,16.943877551020407,47.47480020477031,SFRP4,Osteoblast,1.2168432931781568
KEGG_2021_Human,regulation of glycogen biosynthetic process (GO:0005979),1/26,0.0630467249540435,0.1515902763674468,0,0,16.26530612244898,44.95534064809558,ENPP1,Osteoblast,1.2003374685092782
KEGG_2021_Human,regulation of biomineral tissue development (GO:0070167),1/26,0.0630467249540435,0.1515902763674468,0,0,16.26530612244898,44.95534064809558,ENPP1,Osteoblast,1.2003374685092782
KEGG_2021_Human,regulation of myelination (GO:0031641),1/26,0.0630467249540435,0.1515902763674468,0,0,16.26530612244898,44.95534064809558,PTPRZ1,Osteoblast,1.2003374685092782
KEGG_2021_Human,negative regulation of protein localization to membrane (GO:1905476),1/26,0.0630467249540435,0.1515902763674468,0,0,16.26530612244898,44.95534064809558,LRRC15,Osteoblast,1.2003374685092782
KEGG_2021_Human,endothelial cell development (GO:0001885),1/26,0.0630467249540435,0.1515902763674468,0,0,16.26530612244898,44.95534064809558,COL22A1,Osteoblast,1.2003374685092782
KEGG_2021_Human,negative regulation of canonical Wnt signaling pathway (GO:0090090),2/165,0.0640621553999463,0.1515902763674468,0,0,5.058026584867076,13.898958782878776,SFRP4;LRP4,Osteoblast,1.1933984533937798
KEGG_2021_Human,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),1/27,0.0653921522588676,0.1515902763674468,0,0,15.638932496075354,42.652889831563165,CHST13,Osteoblast,1.184474368421492
KEGG_2021_Human,negative regulation of insulin receptor signaling pathway (GO:0046627),1/27,0.0653921522588676,0.1515902763674468,0,0,15.638932496075354,42.652889831563165,ENPP1,Osteoblast,1.184474368421492
KEGG_2021_Human,positive regulation of muscle cell differentiation (GO:0051149),1/27,0.0653921522588676,0.1515902763674468,0,0,15.638932496075354,42.652889831563165,CDH15,Osteoblast,1.184474368421492
KEGG_2021_Human,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),2/170,0.067488533240135,0.1515902763674468,0,0,4.90625,13.226256844780602,CADM1;CDH15,Osteoblast,1.1707700104811887
KEGG_2021_Human,negative regulation of axonogenesis (GO:0050771),1/28,0.0677318256109869,0.1515902763674468,0,0,15.058956916099774,40.54171043527237,LRP4,Osteoblast,1.1692072184717057
KEGG_2021_Human,keratan sulfate biosynthetic process (GO:0018146),1/28,0.0677318256109869,0.1515902763674468,0,0,15.058956916099774,40.54171043527237,OMD,Osteoblast,1.1692072184717057
KEGG_2021_Human,L-amino acid transport (GO:0015807),1/28,0.0677318256109869,0.1515902763674468,0,0,15.058956916099774,40.54171043527237,SLC36A2,Osteoblast,1.1692072184717057
KEGG_2021_Human,negative regulation of cellular response to insulin stimulus (GO:1900077),1/28,0.0677318256109869,0.1515902763674468,0,0,15.058956916099774,40.54171043527237,ENPP1,Osteoblast,1.1692072184717057
KEGG_2021_Human,receptor clustering (GO:0043113),1/28,0.0677318256109869,0.1515902763674468,0,0,15.058956916099774,40.54171043527237,LRP4,Osteoblast,1.1692072184717057
KEGG_2021_Human,neutral amino acid transport (GO:0015804),1/28,0.0677318256109869,0.1515902763674468,0,0,15.058956916099774,40.54171043527237,SLC36A2,Osteoblast,1.1692072184717057
KEGG_2021_Human,positive regulation of monooxygenase activity (GO:0032770),1/28,0.0677318256109869,0.1515902763674468,0,0,15.058956916099774,40.54171043527237,FGF23,Osteoblast,1.1692072184717057
KEGG_2021_Human,limb development (GO:0060173),1/29,0.0700657588372089,0.1547089574324948,0,0,14.520408163265309,38.5999069065122,LRP4,Osteoblast,1.1544941700666143
KEGG_2021_Human,glial cell differentiation (GO:0010001),1/29,0.0700657588372089,0.1547089574324948,0,0,14.520408163265309,38.5999069065122,PTPRZ1,Osteoblast,1.1544941700666143
KEGG_2021_Human,chondroitin sulfate metabolic process (GO:0030204),1/30,0.0723939657090184,0.157732547803093,0,0,14.019000703729768,36.80874147674154,CHST13,Osteoblast,1.1402976322627019
KEGG_2021_Human,regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/30,0.0723939657090184,0.157732547803093,0,0,14.019000703729768,36.80874147674154,CADM1,Osteoblast,1.1402976322627019
KEGG_2021_Human,negative regulation of axon extension (GO:0030517),1/31,0.0747164600026276,0.1585917118765451,0,0,13.551020408163266,35.15209038871121,SEMA3D,Osteoblast,1.126583712764908
KEGG_2021_Human,proteoglycan biosynthetic process (GO:0030166),1/31,0.0747164600026276,0.1585917118765451,0,0,13.551020408163266,35.15209038871121,CHST13,Osteoblast,1.126583712764908
KEGG_2021_Human,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/31,0.0747164600026276,0.1585917118765451,0,0,13.551020408163266,35.15209038871121,SFRP4,Osteoblast,1.126583712764908
KEGG_2021_Human,negative regulation of osteoblast differentiation (GO:0045668),1/31,0.0747164600026276,0.1585917118765451,0,0,13.551020408163266,35.15209038871121,FGF23,Osteoblast,1.126583712764908
KEGG_2021_Human,negative regulation of chemotaxis (GO:0050922),1/32,0.0770332554327668,0.1604046901100018,0,0,13.113232389730086,33.61600807740255,SEMA3D,Osteoblast,1.1133217484244988
KEGG_2021_Human,hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.0770332554327668,0.1604046901100018,0,0,13.113232389730086,33.61600807740255,SP7,Osteoblast,1.1133217484244988
KEGG_2021_Human,regulation of NMDA receptor activity (GO:2000310),1/32,0.0770332554327668,0.1604046901100018,0,0,13.113232389730086,33.61600807740255,GRIA1,Osteoblast,1.1133217484244988
KEGG_2021_Human,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),2/185,0.078120393358315,0.1611376315879834,0,0,4.5006830601092895,11.474510084124317,GRIA1;BGLAP,Osteoblast,1.1072355785829093
KEGG_2021_Human,keratan sulfate metabolic process (GO:0042339),1/33,0.0793443657059371,0.1611376315879834,0,0,12.70280612244898,32.18837516559274,OMD,Osteoblast,1.1004839073426347
KEGG_2021_Human,phosphatidylcholine biosynthetic process (GO:0006656),1/33,0.0793443657059371,0.1611376315879834,0,0,12.70280612244898,32.18837516559274,SLC44A5,Osteoblast,1.1004839073426347
KEGG_2021_Human,negative chemotaxis (GO:0050919),1/33,0.0793443657059371,0.1611376315879834,0,0,12.70280612244898,32.18837516559274,SEMA3D,Osteoblast,1.1004839073426347
KEGG_2021_Human,negative regulation of cell differentiation (GO:0045596),2/191,0.0825129134198004,0.1630700260318804,0,0,4.356481481481482,10.868552054472469,ENPP1;FGF23,Osteoblast,1.083478078261104
KEGG_2021_Human,regulation of muscle cell differentiation (GO:0051147),1/35,0.0839495853612937,0.1630700260318804,0,0,11.95438175270108,29.61744503578088,CDH15,Osteoblast,1.0759814445616303
KEGG_2021_Human,oxoacid metabolic process (GO:0043436),1/35,0.0839495853612937,0.1630700260318804,0,0,11.95438175270108,29.61744503578088,ENPP1,Osteoblast,1.0759814445616303
KEGG_2021_Human,peptidyl-tyrosine dephosphorylation (GO:0035335),1/35,0.0839495853612937,0.1630700260318804,0,0,11.95438175270108,29.61744503578088,PTPRZ1,Osteoblast,1.0759814445616303
KEGG_2021_Human,negative regulation of neurogenesis (GO:0050768),1/35,0.0839495853612937,0.1630700260318804,0,0,11.95438175270108,29.61744503578088,LRP4,Osteoblast,1.0759814445616303
KEGG_2021_Human,semaphorin-plexin signaling pathway (GO:0071526),1/35,0.0839495853612937,0.1630700260318804,0,0,11.95438175270108,29.61744503578088,SEMA3D,Osteoblast,1.0759814445616303
KEGG_2021_Human,cellular protein metabolic process (GO:0044267),3/417,0.0860988143705088,0.1630700260318804,0,0,3.012025901942646,7.386269548006634,SPP1;CPE;FGF23,Osteoblast,1.0650028289864255
KEGG_2021_Human,regulation of receptor internalization (GO:0002090),1/36,0.0862437219743075,0.1630700260318804,0,0,11.612244897959185,28.456712045041098,SFRP4,Osteoblast,1.0642725091375862
KEGG_2021_Human,negative regulation of fat cell differentiation (GO:0045599),1/36,0.0862437219743075,0.1630700260318804,0,0,11.612244897959185,28.456712045041098,ENPP1,Osteoblast,1.0642725091375862
KEGG_2021_Human,membrane assembly (GO:0071709),1/36,0.0862437219743075,0.1630700260318804,0,0,11.612244897959185,28.456712045041098,LRP4,Osteoblast,1.0642725091375862
KEGG_2021_Human,dendrite morphogenesis (GO:0048813),1/36,0.0862437219743075,0.1630700260318804,0,0,11.612244897959185,28.456712045041098,LRP4,Osteoblast,1.0642725091375862
KEGG_2021_Human,regulation of osteoclast differentiation (GO:0045670),1/36,0.0862437219743075,0.1630700260318804,0,0,11.612244897959185,28.456712045041098,BGLAP,Osteoblast,1.0642725091375862
KEGG_2021_Human,regulation of glucose import (GO:0046324),1/37,0.0885322278902676,0.1636354099769554,0,0,11.289115646258503,27.36920368672352,ENPP1,Osteoblast,1.0528986067362665
KEGG_2021_Human,proton transmembrane transport (GO:1902600),1/37,0.0885322278902676,0.1636354099769554,0,0,11.289115646258503,27.36920368672352,SLC36A2,Osteoblast,1.0528986067362665
KEGG_2021_Human,neural crest cell migration (GO:0001755),1/37,0.0885322278902676,0.1636354099769554,0,0,11.289115646258503,27.36920368672352,SEMA3D,Osteoblast,1.0528986067362665
KEGG_2021_Human,regulation of protein autophosphorylation (GO:0031952),1/37,0.0885322278902676,0.1636354099769554,0,0,11.289115646258503,27.36920368672352,ENPP1,Osteoblast,1.0528986067362665
KEGG_2021_Human,connective tissue development (GO:0061448),1/38,0.0908151166313484,0.1669171696743779,0,0,10.983452840595698,26.34852930034076,COL11A2,Osteoblast,1.0418418549683985
KEGG_2021_Human,axon guidance (GO:0007411),2/203,0.0915200219539462,0.1672782623491572,0,0,4.093905472636816,9.789336578359592,SEMA3D;NCAM1,Osteoblast,1.0384838843718929
KEGG_2021_Human,negative regulation of secretion by cell (GO:1903531),1/39,0.0930924017046572,0.1673628424089193,0,0,10.693877551020408,25.38900533231373,FGF23,Osteoblast,1.0310857651239858
KEGG_2021_Human,cellular response to ketone (GO:1901655),1/39,0.0930924017046572,0.1673628424089193,0,0,10.693877551020408,25.38900533231373,SPP1,Osteoblast,1.0310857651239858
KEGG_2021_Human,negative regulation of protein secretion (GO:0050709),1/39,0.0930924017046572,0.1673628424089193,0,0,10.693877551020408,25.38900533231373,BMP8A,Osteoblast,1.0310857651239858
KEGG_2021_Human,stem cell differentiation (GO:0048863),1/40,0.0953640965755271,0.169593447423505,0,0,10.419152276295131,24.485561288951835,SP7,Osteoblast,1.0206151011238414
KEGG_2021_Human,sulfur compound catabolic process (GO:0044273),1/40,0.0953640965755271,0.169593447423505,0,0,10.419152276295131,24.485561288951835,OMD,Osteoblast,1.0206151011238414
KEGG_2021_Human,response to growth factor (GO:0070848),1/41,0.0976302146847681,0.1717665274400466,0,0,10.158163265306122,23.633660200289185,IBSP,Osteoblast,1.0104157556925017
KEGG_2021_Human,carboxylic acid transmembrane transport (GO:1905039),1/41,0.0976302146847681,0.1717665274400466,0,0,10.158163265306122,23.633660200289185,SLC36A2,Osteoblast,1.0104157556925017
KEGG_2021_Human,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.0998907694703361,0.1738839320409554,0,0,9.909905425584869,22.829231064333683,CADM1,Osteoblast,1.00047464143678
KEGG_2021_Human,regulation of nervous system development (GO:0051960),1/42,0.0998907694703361,0.1738839320409554,0,0,9.909905425584869,22.829231064333683,PTPRZ1,Osteoblast,1.00047464143678
KEGG_2021_Human,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/43,0.1021457742794159,0.1768734723048833,0,0,9.673469387755102,22.068611238785657,CADM1,Osteoblast,0.9907795952096249
KEGG_2021_Human,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.1043952424647777,0.1780928560361193,0,0,9.448030374940672,21.34849709415977,SFRP4,Osteoblast,0.9813192926974915
KEGG_2021_Human,cardiac ventricle morphogenesis (GO:0003208),1/44,0.1043952424647777,0.1780928560361193,0,0,9.448030374940672,21.34849709415977,CPE,Osteoblast,0.9813192926974915
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),2/221,0.1055403360927836,0.1780928560361193,0,0,3.7539954337899544,8.441467129790793,LRRC15;SEMA3D,Osteoblast,0.97658152714763
KEGG_2021_Human,positive regulation of Notch signaling pathway (GO:0045747),1/45,0.1066391873529346,0.1780928560361193,0,0,9.232838589981448,20.665901611884028,ENHO,Osteoblast,0.9720831731354668
KEGG_2021_Human,amino acid transmembrane transport (GO:0003333),1/45,0.1066391873529346,0.1780928560361193,0,0,9.232838589981448,20.665901611884028,SLC36A2,Osteoblast,0.9720831731354668
KEGG_2021_Human,regulation of insulin receptor signaling pathway (GO:0046626),1/45,0.1066391873529346,0.1780928560361193,0,0,9.232838589981448,20.665901611884028,ENPP1,Osteoblast,0.9720831731354668
KEGG_2021_Human,neural crest cell development (GO:0014032),1/45,0.1066391873529346,0.1780928560361193,0,0,9.232838589981448,20.665901611884028,SEMA3D,Osteoblast,0.9720831731354668
KEGG_2021_Human,amino acid transport (GO:0006865),1/50,0.1177765260040411,0.1956993790673208,0,0,8.28862973760933,17.7290996615035,SLC36A2,Osteoblast,0.928941259997044
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),3/482,0.1192389583091006,0.1971337551944427,0,0,2.5946342113445566,5.517815916066961,SFRP4;CADM1;FGF23,Osteoblast,0.92358182668994
KEGG_2021_Human,regulation of axonogenesis (GO:0050770),1/51,0.1199876089220907,0.1973796166768393,0,0,8.122448979591837,17.22257115519733,LRP4,Osteoblast,0.9208636010741894
KEGG_2021_Human,axonogenesis (GO:0007409),2/240,0.1209266562339864,0.1979346761242862,0,0,3.450980392156863,7.290441318878535,SEMA3D;NCAM1,Osteoblast,0.9174779557207333
KEGG_2021_Human,ameboidal-type cell migration (GO:0001667),1/52,0.1221932608707862,0.1980373538250673,0,0,7.962785114045619,16.738979733033663,SEMA3D,Osteoblast,0.9129527453809976
KEGG_2021_Human,cartilage development (GO:0051216),1/52,0.1221932608707862,0.1980373538250673,0,0,7.962785114045619,16.738979733033663,COL11A2,Osteoblast,0.9129527453809976
KEGG_2021_Human,anterograde trans-synaptic signaling (GO:0098916),2/244,0.1242347823719992,0.2003590362764105,0,0,3.3932506887052343,7.076902888304532,GRIA1;GABRB1,Osteoblast,0.9057567964507174
KEGG_2021_Human,glycosaminoglycan catabolic process (GO:0006027),1/56,0.1309618198144747,0.210177749848596,0,0,7.382189239332097,15.00687933540933,OMD,Osteoblast,0.8828552987007785
KEGG_2021_Human,regulation of canonical Wnt signaling pathway (GO:0060828),2/253,0.1317582069542016,0.2104293693588948,0,0,3.270086321381142,6.627767796360294,SFRP4;LRP4,Osteoblast,0.880222323941479
KEGG_2021_Human,renal system development (GO:0072001),1/57,0.1331405122852093,0.2105924449126628,0,0,7.25,14.618539131965724,LRP4,Osteoblast,0.8756897763447542
KEGG_2021_Human,carboxylic acid transport (GO:0046942),1/57,0.1331405122852093,0.2105924449126628,0,0,7.25,14.618539131965724,SLC36A2,Osteoblast,0.8756897763447542
KEGG_2021_Human,regulation of neurotransmitter receptor activity (GO:0099601),1/58,0.1353138517398134,0.2119917010590411,0,0,7.122448979591836,14.246025949065045,GRIA1,Osteoblast,0.8686577434892403
KEGG_2021_Human,negative regulation of neuron projection development (GO:0010977),1/58,0.1353138517398134,0.2119917010590411,0,0,7.122448979591836,14.246025949065045,LRP4,Osteoblast,0.8686577434892403
KEGG_2021_Human,positive regulation of cell differentiation (GO:0045597),2/258,0.1359834100026853,0.2120310042221965,0,0,3.2054036458333335,6.395493110208526,SP7;CDH15,Osteoblast,0.8665140723928182
KEGG_2021_Human,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/60,0.1396445230534406,0.2167124909650092,0,0,6.88031822898651,13.544974303558986,CADM1,Osteoblast,0.8549760929333525
KEGG_2021_Human,positive regulation of cell migration (GO:0030335),2/269,0.1453850943051252,0.2215075180801172,0,0,3.071629213483146,5.923235274252741,LRRC15;SEMA3D,Osteoblast,0.837480117499467
KEGG_2021_Human,neuropeptide signaling pathway (GO:0007218),1/63,0.1461007034145454,0.2215075180801172,0,0,6.54641211323239,12.591756250239603,CPE,Osteoblast,0.8353476931121088
KEGG_2021_Human,COPII vesicle coating (GO:0048208),1/63,0.1461007034145454,0.2215075180801172,0,0,6.54641211323239,12.591756250239603,GRIA1,Osteoblast,0.8353476931121088
KEGG_2021_Human,vesicle coating (GO:0006901),1/63,0.1461007034145454,0.2215075180801172,0,0,6.54641211323239,12.591756250239603,GRIA1,Osteoblast,0.8353476931121088
KEGG_2021_Human,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/63,0.1461007034145454,0.2215075180801172,0,0,6.54641211323239,12.591756250239603,GRIA1,Osteoblast,0.8353476931121088
KEGG_2021_Human,extracellular matrix disassembly (GO:0022617),1/66,0.1525093979756266,0.2280708724271871,0,0,6.243328100470958,11.740759916332207,MMP16,Osteoblast,0.8167033932798328
KEGG_2021_Human,cellular component disassembly (GO:0022411),1/66,0.1525093979756266,0.2280708724271871,0,0,6.243328100470958,11.740759916332207,MMP16,Osteoblast,0.8167033932798328
KEGG_2021_Human,embryonic organ development (GO:0048568),1/66,0.1525093979756266,0.2280708724271871,0,0,6.243328100470958,11.740759916332207,COL13A1,Osteoblast,0.8167033932798328
KEGG_2021_Human,canonical Wnt signaling pathway (GO:0060070),1/68,0.1567556490806558,0.2323090475114224,0,0,6.0563508985683825,11.222824361971773,SFRP4,Osteoblast,0.8047767993307415
KEGG_2021_Human,interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.1567556490806558,0.2323090475114224,0,0,6.0563508985683825,11.222824361971773,NCAM1,Osteoblast,0.8047767993307415
KEGG_2021_Human,kidney development (GO:0001822),1/70,0.1609810482853106,0.2354953395569905,0,0,5.880212954747116,10.740024519792764,LRP4,Osteoblast,0.7932252488723367
KEGG_2021_Human,COPII-coated vesicle budding (GO:0090114),1/70,0.1609810482853106,0.2354953395569905,0,0,5.880212954747116,10.740024519792764,GRIA1,Osteoblast,0.7932252488723367
KEGG_2021_Human,proteolysis (GO:0006508),2/287,0.1610530437699783,0.2354953395569905,0,0,2.875,5.249811823566885,MMP16;CPE,Osteoblast,0.7930310629584509
KEGG_2021_Human,nucleic acid metabolic process (GO:0090304),1/71,0.16308595979881,0.2363668756555441,0,0,5.795918367346939,10.51076961698872,ENPP1,Osteoblast,0.7875834261109624
KEGG_2021_Human,negative regulation of neuron apoptotic process (GO:0043524),1/71,0.16308595979881,0.2363668756555441,0,0,5.795918367346939,10.51076961698872,PTPRZ1,Osteoblast,0.7875834261109624
KEGG_2021_Human,cell junction organization (GO:0034330),1/72,0.1651856959101235,0.2383600612036432,0,0,5.713998275366484,10.28911103101624,LRP4,Osteoblast,0.78202756268309
KEGG_2021_Human,fibroblast growth factor receptor signaling pathway (GO:0008543),1/75,0.1714539764404576,0.2448083157627341,0,0,5.4815223386651954,9.666337985731484,FGF23,Osteoblast,0.7658524380723842
KEGG_2021_Human,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.1714539764404576,0.2448083157627341,0,0,5.4815223386651954,9.666337985731484,ENPP1,Osteoblast,0.7658524380723842
KEGG_2021_Human,regulation of BMP signaling pathway (GO:0030510),1/76,0.1735331353639065,0.2448083157627341,0,0,5.408163265306122,9.4717853003048,SFRP4,Osteoblast,0.7606175863963804
KEGG_2021_Human,water-soluble vitamin metabolic process (GO:0006767),1/76,0.1735331353639065,0.2448083157627341,0,0,5.408163265306122,9.4717853003048,ENPP1,Osteoblast,0.7606175863963804
KEGG_2021_Human,cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.1735331353639065,0.2448083157627341,0,0,5.408163265306122,9.4717853003048,LRP4,Osteoblast,0.7606175863963804
KEGG_2021_Human,MAPK cascade (GO:0000165),2/303,0.1752338998526144,0.2448083157627341,0,0,2.7199612403100777,4.737175959955004,NCAM1;FGF23,Osteoblast,0.7563818736544428
KEGG_2021_Human,purine ribonucleotide metabolic process (GO:0009150),1/77,0.1756071809118701,0.2448083157627341,0,0,5.336734693877551,9.283280446293812,ENPP1,Osteoblast,0.7554577289388229
KEGG_2021_Human,phosphatidylcholine metabolic process (GO:0046470),1/77,0.1756071809118701,0.2448083157627341,0,0,5.336734693877551,9.283280446293812,SLC44A5,Osteoblast,0.7554577289388229
KEGG_2021_Human,protein modification process (GO:0036211),1/78,0.1776761254379788,0.2459427081537282,0,0,5.267161410018553,9.10056411919043,CPE,Osteoblast,0.7503709249641564
KEGG_2021_Human,chemical synaptic transmission (GO:0007268),2/306,0.1779160016431225,0.2459427081537282,0,0,2.6927083333333335,4.648809448291678,GRIA1;GABRB1,Osteoblast,0.7497849900117082
KEGG_2021_Human,regulation of fat cell differentiation (GO:0045598),1/80,0.181798760490535,0.2481817103791951,0,0,5.133298889175924,8.751529842637671,ENPP1,Osteoblast,0.7404090821369118
KEGG_2021_Human,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2481817103791951,0,0,5.133298889175924,8.751529842637671,IBSP,Osteoblast,0.7404090821369118
KEGG_2021_Human,regulation of protein localization to plasma membrane (GO:1903076),1/80,0.181798760490535,0.2481817103791951,0,0,5.133298889175924,8.751529842637671,LRRC15,Osteoblast,0.7404090821369118
KEGG_2021_Human,glycoprotein biosynthetic process (GO:0009101),1/83,0.1879447615357932,0.2523829654909223,0,0,4.944748631159781,8.265677319811374,CHST13,Osteoblast,0.7259697745939766
KEGG_2021_Human,peptide metabolic process (GO:0006518),1/83,0.1879447615357932,0.2523829654909223,0,0,4.944748631159781,8.265677319811374,CPE,Osteoblast,0.7259697745939766
KEGG_2021_Human,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.2523829654909223,0,0,4.944748631159781,8.265677319811374,ENHO,Osteoblast,0.7259697745939766
KEGG_2021_Human,regulation of osteoblast differentiation (GO:0045667),1/83,0.1879447615357932,0.2523829654909223,0,0,4.944748631159781,8.265677319811374,FGF23,Osteoblast,0.7259697745939766
KEGG_2021_Human,response to insulin (GO:0032868),1/84,0.1899833569114356,0.2540834326173264,0,0,4.884927464961889,8.112979399077096,ENPP1,Osteoblast,0.7212844428267129
KEGG_2021_Human,sensory perception of mechanical stimulus (GO:0050954),1/88,0.1980877029036425,0.2638496123696291,0,0,4.659394792399718,7.5437717166037235,COL11A2,Osteoblast,0.703142484213379
KEGG_2021_Human,regulation of cation channel activity (GO:2001257),1/89,0.2001013407742902,0.2654570206239576,0,0,4.6062152133580705,7.411084001248333,GRIA1,Osteoblast,0.6987500013741589
KEGG_2021_Human,sensory perception of sound (GO:0007605),1/91,0.2041137620931186,0.2686137109145441,0,0,4.503401360544218,7.156255051106618,COL11A2,Osteoblast,0.6901277125812961
KEGG_2021_Human,regulation of stem cell differentiation (GO:2000736),1/91,0.2041137620931186,0.2686137109145441,0,0,4.503401360544218,7.156255051106618,SP7,Osteoblast,0.6901277125812961
KEGG_2021_Human,cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.2061125694363157,0.2701634874284776,0,0,4.453689167974883,7.03385741012878,FGF23,Osteoblast,0.6858955226779435
KEGG_2021_Human,post-translational protein modification (GO:0043687),2/345,0.2133084926466024,0.2784860876219531,0,0,2.381802721088435,3.6799229289674416,SPP1;FGF23,Osteoblast,0.6709918532419347
KEGG_2021_Human,regulation of neuron apoptotic process (GO:0043523),1/98,0.2180025137484037,0.2823733347371056,0,0,4.176940879444562,6.362519703204576,PTPRZ1,Osteoblast,0.6615384985937142
KEGG_2021_Human,negative regulation of neuron death (GO:1901215),1/98,0.2180025137484037,0.2823733347371056,0,0,4.176940879444562,6.362519703204576,PTPRZ1,Osteoblast,0.6615384985937142
KEGG_2021_Human,organic acid transport (GO:0015849),1/100,0.2219269115603851,0.2852107574350262,0,0,4.092145949288806,6.1603458876211565,SLC36A2,Osteoblast,0.6537900306498672
KEGG_2021_Human,cell-matrix adhesion (GO:0007160),1/100,0.2219269115603851,0.2852107574350262,0,0,4.092145949288806,6.1603458876211565,COL13A1,Osteoblast,0.6537900306498672
KEGG_2021_Human,cellular response to organonitrogen compound (GO:0071417),1/103,0.2277773453985499,0.2915904538370541,0,0,3.971188475390156,5.874923343943355,GABRB1,Osteoblast,0.64248947278397
KEGG_2021_Human,regulation of insulin secretion (GO:0050796),1/104,0.2297178930745814,0.2929348326416174,0,0,3.932435109966317,5.78423168094792,BMP8A,Osteoblast,0.6388051756325536
KEGG_2021_Human,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.2942627592622194,0,0,3.894427001569859,5.6956456810845415,SFRP4,Osteoblast,0.6351608308934773
KEGG_2021_Human,cellular response to peptide hormone stimulus (GO:0071375),1/106,0.2335846623503299,0.2955744381279174,0,0,3.857142857142857,5.6090983677319475,ENPP1,Osteoblast,0.6315556772929499
KEGG_2021_Human,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.3119199987812841,0,0,3.582625970742279,4.982913653406146,SRGAP3,Osteoblast,0.6040407011916724
KEGG_2021_Human,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.3119199987812841,0,0,3.582625970742279,4.982913653406146,LRP4,Osteoblast,0.6040407011916724
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),2/384,0.2493463820044915,0.3119199987812841,0,0,2.1343804537521813,2.9644671728961822,SFRP4;FGF23,Osteoblast,0.6031969289771376
KEGG_2021_Human,cellular amide metabolic process (GO:0043603),1/115,0.2507510141385882,0.3124889532257406,0,0,3.5510204081632653,4.9121080927455,CPE,Osteoblast,0.6007573018413346
KEGG_2021_Human,cellular protein modification process (GO:0006464),4/1025,0.2531480899318741,0.3142857418399494,0,0,1.6121449559255632,2.2147335064279132,PTPRZ1;SPP1;CPE;FGF23,Osteoblast,0.596625345129507
KEGG_2021_Human,cellular response to interferon-gamma (GO:0071346),1/121,0.2619853133921213,0.3240344665639396,0,0,3.372448979591837,4.517283552621874,NCAM1,Osteoblast,0.5817230540677998
KEGG_2021_Human,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.3273898301049774,0,0,3.316828370692539,4.396166676729281,IBSP,Osteoblast,0.5756194520344882
KEGG_2021_Human,non-canonical Wnt signaling pathway (GO:0035567),1/124,0.2675403902734135,0.328435777611765,0,0,3.2896963663514187,4.337414433160371,SFRP4,Osteoblast,0.5726106437410472
KEGG_2021_Human,negative regulation of cell growth (GO:0030308),1/126,0.2712209880572274,0.3292682843941986,0,0,3.236734693877551,4.223360488574632,ENPP1,Osteoblast,0.5666767062328689
KEGG_2021_Human,synapse organization (GO:0050808),1/126,0.2712209880572274,0.3292682843941986,0,0,3.236734693877551,4.223360488574632,LRP4,Osteoblast,0.5666767062328689
KEGG_2021_Human,negative regulation of growth (GO:0045926),1/126,0.2712209880572274,0.3292682843941986,0,0,3.236734693877551,4.223360488574632,ENPP1,Osteoblast,0.5666767062328689
KEGG_2021_Human,cellular response to insulin stimulus (GO:0032869),1/129,0.2767079241059198,0.3346945111428221,0,0,3.1603954081632653,4.060453122404681,ENPP1,Osteoblast,0.5579784037567757
KEGG_2021_Human,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.2785278903472666,0.3356618165723469,0,0,3.135738016136687,4.008216604624779,SFRP4,Osteoblast,0.5551313103019286
KEGG_2021_Human,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3397204995477184,0,0,3.0640074211502784,3.857336278341556,IBSP,Osteoblast,0.546741450090894
KEGG_2021_Human,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3397204995477184,0,0,3.0640074211502784,3.857336278341556,FGF23,Osteoblast,0.546741450090894
KEGG_2021_Human,protein dephosphorylation (GO:0006470),1/139,0.2947069182263764,0.3512991887553545,0,0,2.929902395740905,3.579678317757992,PTPRZ1,Osteoblast,0.5306096689947516
KEGG_2021_Human,neuron projection morphogenesis (GO:0048812),1/140,0.2964824884084789,0.3521398508533919,0,0,2.9086771399207163,3.5362740390257685,LRP4,Osteoblast,0.5280009529309525
KEGG_2021_Human,regulation of small GTPase mediated signal transduction (GO:0051056),1/141,0.2982536777952956,0.3529692805563031,0,0,2.8877551020408165,3.4936375609484274,SRGAP3,Osteoblast,0.5254141922968343
KEGG_2021_Human,negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.3017829564686885,0.354594973850709,0,0,2.8467950560505892,3.410594866305226,SFRP4,Osteoblast,0.5203052911363482
KEGG_2021_Human,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.354594973850709,0,0,2.8467950560505892,3.410594866305226,SLC36A2,Osteoblast,0.5203052911363482
KEGG_2021_Human,negative regulation of cell migration (GO:0030336),1/144,0.3035410668561185,0.3553914982052064,0,0,2.826744683887541,3.370153465117457,SRGAP3,Osteoblast,0.5177825437898177
KEGG_2021_Human,regulation of cytokine production (GO:0001817),1/150,0.3139989845586295,0.3663321486517344,0,0,2.712094233666621,3.141596466170354,CADM1,Osteoblast,0.5030717563895143
KEGG_2021_Human,negative regulation of protein phosphorylation (GO:0001933),1/152,0.3174506378807152,0.3684454564843419,0,0,2.6759021489390458,3.0704182805545575,ENPP1,Osteoblast,0.4983237959237088
KEGG_2021_Human,dephosphorylation (GO:0016311),1/153,0.3191700762858281,0.3684454564843419,0,0,2.6581632653061225,3.0357052873752,PTPRZ1,Osteoblast,0.4959778325880012
KEGG_2021_Human,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.3191700762858281,0.3684454564843419,0,0,2.6581632653061225,3.0357052873752,SFRP4,Osteoblast,0.4959778325880012
KEGG_2021_Human,cellular response to growth factor stimulus (GO:0071363),1/158,0.3277037968552589,0.3756604500535894,0,0,2.5728584427401535,2.8703970097526006,IBSP,Osteoblast,0.48451852674781976
KEGG_2021_Human,organonitrogen compound biosynthetic process (GO:1901566),1/158,0.3277037968552589,0.3756604500535894,0,0,2.5728584427401535,2.8703970097526006,SLC44A5,Osteoblast,0.48451852674781976
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3801476416213488,0,0,2.524234693877551,2.7773973646136283,FGF23,Osteoblast,0.4778511096570981
KEGG_2021_Human,cation transport (GO:0006812),1/174,0.3543133002736421,0.4033532034257032,0,0,2.333018756635602,2.4206789693623425,SLC36A2,Osteoblast,0.45061254473982715
KEGG_2021_Human,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.359186378521905,0.407490753564506,0,0,2.2929035250463823,2.3477357103628296,SLC44A5,Osteoblast,0.44468014150624274
KEGG_2021_Human,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.4383014041470693,0,0,2.0782663580896275,1.969329769675335,CPE,Osteoblast,0.4115300469974289
KEGG_2021_Human,regulation of signal transduction (GO:0009966),1/198,0.3923030921692546,0.4420127305605643,0,0,2.0463068476121413,1.914771355908193,NCAM1,Osteoblast,0.4063782687077012
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),2/546,0.3979281971141292,0.4468203988073328,0,0,1.4863664215686274,1.3696624285648409,FGF23;FRMD1,Osteoblast,0.40019528574129115
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4543076388463993,0,0,1.9560134733505052,1.7632653144438126,FGF23,Osteoblast,0.3914985283218076
KEGG_2021_Human,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4597205728565756,0,0,1.909178837411742,1.6862551884518755,ENPP1,Osteoblast,0.3835844547796231
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),2/566,0.4155454754335446,0.4597205728565756,0,0,1.43218085106383,1.2576885523498746,SFRP4;ENPP1,Osteoblast,0.38138144203835345
KEGG_2021_Human,positive regulation of protein modification process (GO:0031401),1/214,0.416403436812339,0.4597205728565756,0,0,1.8910606496119575,1.656759537391559,FGF23,Osteoblast,0.3804856946694876
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4597205728565756,0,0,1.8910606496119575,1.656759537391559,LRP4,Osteoblast,0.3804856946694876
KEGG_2021_Human,regulation of cell growth (GO:0001558),1/217,0.4208167942393084,0.4630392150659949,0,0,1.8645124716553287,1.613843141672166,ENPP1,Osteoblast,0.375906936392536
KEGG_2021_Human,cellular response to lipid (GO:0071396),1/219,0.4237408440429794,0.4647024589671341,0,0,1.8472196217936716,1.5860841457604238,SPP1,Osteoblast,0.372899672681652
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),2/621,0.4626694381715867,0.5057084556759203,0,0,1.3012250942380184,1.0029093993298663,PTPRZ1;NCAM1,Osteoblast,0.33472918706115434
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),2/625,0.4660144680358849,0.507678013191411,0,0,1.2926029962546817,0.9869522795970046,IBSP;FGF23,Osteoblast,0.33160059985375573
KEGG_2021_Human,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.5100498161054854,0,0,1.6016749329213755,1.2094704650298027,ENHO,Osteoblast,0.32794816113488356
KEGG_2021_Human,positive regulation of phosphorylation (GO:0042327),1/253,0.4712922312950381,0.5100498161054854,0,0,1.5952380952380951,1.2000608149186214,FGF23,Osteoblast,0.32670971902140344
KEGG_2021_Human,regulation of protein phosphorylation (GO:0001932),1/266,0.4884385252284191,0.5262152301194841,0,0,1.5159799768964188,1.086262808220724,FGF23,Osteoblast,0.3111900887192418
KEGG_2021_Human,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5262152301194841,0,0,1.510204081632653,1.0781219104526054,GRIA1,Osteoblast,0.3100391544580995
KEGG_2021_Human,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5262152301194841,0,0,1.504471451501949,1.0700627976731167,PTPRZ1,Osteoblast,0.3088941088615854
KEGG_2021_Human,inorganic cation transmembrane transport (GO:0098662),1/274,0.4987179596066677,0.5327214568525769,0,0,1.4709576138147566,1.0233666205889618,SLC36A2,Osteoblast,0.30214499188263844
KEGG_2021_Human,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.5470116186963238,0,0,1.4081632653061225,0.937839142501346,SFRP4,Osteoblast,0.289240867544339
KEGG_2021_Human,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.575776697670094,0,0,1.2972062611452349,0.7932686422257892,SFRP4,Osteoblast,0.2655801196036423
KEGG_2021_Human,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.5967590925346692,0,0,1.2208810353409656,0.6989624697257846,CPE,Osteoblast,0.24863646405532092
KEGG_2021_Human,positive regulation of cytokine production (GO:0001819),1/335,0.5707160845076258,0.6018127942404131,0,0,1.1985824269827692,0.6722410367689661,CADM1,Osteoblast,0.2435798875448389
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),2/764,0.5744134768292987,0.6037764660601893,0,0,1.0492125984251968,0.5816895490313783,SFRP4;FGF23,Osteoblast,0.24077537927422193
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),1/345,0.5815093765862647,0.6092884869327423,0,0,1.1631466540104414,0.6305745813190116,CADM1,Osteoblast,0.23544327806907975
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),1/379,0.6162544539128882,0.6436435407534611,0,0,1.056689342403628,0.5115383719098227,SFRP4,Osteoblast,0.2102399288866402
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.666311038714938,0,0,0.989871879272801,0.4417939051458828,FGF23,Osteoblast,0.19383180708628664
KEGG_2021_Human,regulation of intracellular signal transduction (GO:1902531),1/437,0.6691136001848389,0.69444282164294,0,0,0.9134057292641828,0.3670077257341264,SRGAP3,Osteoblast,0.1745001427028418
KEGG_2021_Human,nervous system development (GO:0007399),1/447,0.677475806229693,0.7009105039294623,0,0,0.8924681980415484,0.3475105496336908,PTPRZ1,Osteoblast,0.16910620954367267
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),1/474,0.6990329319013457,0.7209461899546794,0,0,0.8403589765716012,0.300896771210595,FGF23,Osteoblast,0.1555023638735803
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7249766655756859,0,0,0.8260426831855403,0.2885801301950252,PTPRZ1,Osteoblast,0.1517218912312197
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7250348361461552,0,0,0.8207960870298533,0.2841203737887477,PTPRZ1,Osteoblast,0.15033199168778996
KEGG_2021_Human,positive regulation of nucleic acid-templated transcription (GO:1903508),1/511,0.7262961571675228,0.742085204062469,0,0,0.7779111644657863,0.2487739813280452,SPP1,Osteoblast,0.13888625368433627
KEGG_2021_Human,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7504933808556635,0.7644344343700102,0,0,0.7252747252747253,0.2081715773755284,ENPP1,Osteoblast,0.1246531337611999
KEGG_2021_Human,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7714921116201843,0,0,0.7301532033426184,0.200604530418796,SFRP4;FGF23,Osteoblast,0.11931939791106433
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",2/1183,0.8038594904607679,0.8137531457279774,0,0,0.6621860005644934,0.1445755914280007,SPP1;SP7,Osteoblast,0.09481985653812466
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.857142605531263,0,0,0.5290423861852434,0.0863986224716518,SFRP4,Osteoblast,0.07092521499844862
KEGG_2021_Human,positive regulation of transcription by RNA polymerase II (GO:0045944),1/908,0.9023188918982462,0.9078376618792752,0,0,0.4284814256463335,0.0440424414337815,SP7,Osteoblast,0.044639949690669034
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",2/2244,0.9810359386268036,0.9840269018543244,0,0,0.3290960451977401,0.006300933896412,SPP1;SP7,Osteoblast,0.008315082669573565
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),1/2206,0.9971209346049892,0.9971209346049892,0,0,0.1642371234207968,0.00047353141012936674,SP7,Osteoblast,0.0012521656136179045
KEGG_2021_Human,bicellular tight junction assembly (GO:0070830),3/53,0.000315376219123607,0.0335229295199031,0,0,25.404255319148938,204.80261014345277,CLDN3;CLDN14;CRB3,Plasma Cell,3.501171057655084
KEGG_2021_Human,tight junction assembly (GO:0120192),3/56,0.0003712232496723555,0.0335229295199031,0,0,23.962665596146127,189.274072690484,CLDN3;CLDN14;CRB3,Plasma Cell,3.430364831784506
KEGG_2021_Human,apical junction assembly (GO:0043297),3/60,0.000455062391672894,0.0335229295199031,0,0,22.27659574468085,171.42009780807578,CLDN3;CLDN14;CRB3,Plasma Cell,3.3419290549876433
KEGG_2021_Human,regulation of cell junction assembly (GO:1901888),2/27,0.0020657293545543,0.1141315468391276,0,0,33.208333333333336,205.3029465636782,CLDN3;CRB3,Plasma Cell,2.684926579003782
KEGG_2021_Human,negative regulation of lymphocyte proliferation (GO:0050672),2/39,0.0042784069542198,0.157962545205804,0,0,22.42454954954955,122.3074073504305,PLA2G2D;TNFRSF13B,Plasma Cell,2.368717908505425
KEGG_2021_Human,positive regulation of cell junction assembly (GO:1901890),2/57,0.0089551608364968,0.157962545205804,0,0,15.071969696969695,71.07225417227201,CLDN3;CRB3,Plasma Cell,2.0479266097283184
KEGG_2021_Human,positive regulation of bicellular tight junction assembly (GO:1903348),1/5,0.0124387771927725,0.157962545205804,0,0,101.76530612244898,446.4379351400606,CLDN3,Plasma Cell,1.9052223113279663
KEGG_2021_Human,negative regulation of collateral sprouting (GO:0048671),1/5,0.0124387771927725,0.157962545205804,0,0,101.76530612244898,446.4379351400606,DCC,Plasma Cell,1.9052223113279663
KEGG_2021_Human,determination of pancreatic left/right asymmetry (GO:0035469),1/5,0.0124387771927725,0.157962545205804,0,0,101.76530612244898,446.4379351400606,DNAAF1,Plasma Cell,1.9052223113279663
KEGG_2021_Human,positive regulation of metallopeptidase activity (GO:1905050),1/5,0.0124387771927725,0.157962545205804,0,0,101.76530612244898,446.4379351400606,CLDN3,Plasma Cell,1.9052223113279663
KEGG_2021_Human,determination of liver left/right asymmetry (GO:0071910),1/6,0.0149082847993736,0.157962545205804,0,0,81.40816326530613,342.3895623444841,DNAAF1,Plasma Cell,1.8265723193247598
KEGG_2021_Human,IMP biosynthetic process (GO:0006188),1/6,0.0149082847993736,0.157962545205804,0,0,81.40816326530613,342.3895623444841,AMPD1,Plasma Cell,1.8265723193247598
KEGG_2021_Human,left/right pattern formation (GO:0060972),1/7,0.0173717414502839,0.157962545205804,0,0,67.83673469387755,274.9362107684438,DNAAF1,Plasma Cell,1.7601566430186848
KEGG_2021_Human,positive regulation of respiratory burst (GO:0060267),1/7,0.0173717414502839,0.157962545205804,0,0,67.83673469387755,274.9362107684438,JCHAIN,Plasma Cell,1.7601566430186848
KEGG_2021_Human,glutathione catabolic process (GO:0006751),1/7,0.0173717414502839,0.157962545205804,0,0,67.83673469387755,274.9362107684438,DPEP1,Plasma Cell,1.7601566430186848
KEGG_2021_Human,regulation of metallopeptidase activity (GO:1905048),1/7,0.0173717414502839,0.157962545205804,0,0,67.83673469387755,274.9362107684438,CLDN3,Plasma Cell,1.7601566430186848
KEGG_2021_Human,determination of digestive tract left/right asymmetry (GO:0071907),1/7,0.0173717414502839,0.157962545205804,0,0,67.83673469387755,274.9362107684438,DNAAF1,Plasma Cell,1.7601566430186848
KEGG_2021_Human,regulation of cilium beat frequency (GO:0003356),1/7,0.0173717414502839,0.157962545205804,0,0,67.83673469387755,274.9362107684438,DNAAF1,Plasma Cell,1.7601566430186848
KEGG_2021_Human,regulation of collateral sprouting (GO:0048670),1/8,0.0198291614511851,0.157962545205804,0,0,58.142857142857146,227.9549801512961,DCC,Plasma Cell,1.702695651141308
KEGG_2021_Human,positive regulation of cellular component biogenesis (GO:0044089),2/92,0.0222223839756269,0.157962545205804,0,0,9.194444444444445,35.00007985571613,CLDN3;CRB3,Plasma Cell,1.6532093525993499
KEGG_2021_Human,"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/9,0.0222805591236868,0.157962545205804,0,0,50.87244897959184,193.52086993316271,DERL3,Plasma Cell,1.652073914876897
KEGG_2021_Human,epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),1/9,0.0222805591236868,0.157962545205804,0,0,50.87244897959184,193.52086993316271,DNAAF1,Plasma Cell,1.652073914876897
KEGG_2021_Human,regulation of respiratory burst (GO:0060263),1/9,0.0222805591236868,0.157962545205804,0,0,50.87244897959184,193.52086993316271,JCHAIN,Plasma Cell,1.652073914876897
KEGG_2021_Human,cellular response to nitric oxide (GO:0071732),1/9,0.0222805591236868,0.157962545205804,0,0,50.87244897959184,193.52086993316271,DPEP1,Plasma Cell,1.652073914876897
KEGG_2021_Human,cellular response to reactive nitrogen species (GO:1902170),1/9,0.0222805591236868,0.157962545205804,0,0,50.87244897959184,193.52086993316271,DPEP1,Plasma Cell,1.652073914876897
KEGG_2021_Human,glomerular filtration (GO:0003094),1/9,0.0222805591236868,0.157962545205804,0,0,50.87244897959184,193.52086993316271,JCHAIN,Plasma Cell,1.652073914876897
KEGG_2021_Human,"complement activation, classical pathway (GO:0006958)",1/9,0.0222805591236868,0.157962545205804,0,0,50.87244897959184,193.52086993316271,IGLL5,Plasma Cell,1.652073914876897
KEGG_2021_Human,IMP metabolic process (GO:0046040),1/9,0.0222805591236868,0.157962545205804,0,0,50.87244897959184,193.52086993316271,AMPD1,Plasma Cell,1.652073914876897
KEGG_2021_Human,B cell homeostasis (GO:0001782),1/10,0.024725948817258,0.157962545205804,0,0,45.21768707482993,167.3010120823387,TNFRSF13B,Plasma Cell,1.606847034080906
KEGG_2021_Human,renal filtration (GO:0097205),1/10,0.024725948817258,0.157962545205804,0,0,45.21768707482993,167.3010120823387,JCHAIN,Plasma Cell,1.606847034080906
KEGG_2021_Human,regulation of cilium movement (GO:0003352),1/10,0.024725948817258,0.157962545205804,0,0,45.21768707482993,167.3010120823387,DNAAF1,Plasma Cell,1.606847034080906
KEGG_2021_Human,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),1/10,0.024725948817258,0.157962545205804,0,0,45.21768707482993,167.3010120823387,DERL3,Plasma Cell,1.606847034080906
KEGG_2021_Human,humoral immune response mediated by circulating immunoglobulin (GO:0002455),1/11,0.0271653448579923,0.157962545205804,0,0,40.69387755102041,146.73452100035948,IGLL5,Plasma Cell,1.5659847773237099
KEGG_2021_Human,negative regulation of B cell proliferation (GO:0030889),1/12,0.029598761568907,0.157962545205804,0,0,36.99257884972171,130.2147194065139,TNFRSF13B,Plasma Cell,1.5287264597194943
KEGG_2021_Human,homocysteine metabolic process (GO:0050667),1/12,0.029598761568907,0.157962545205804,0,0,36.99257884972171,130.2147194065139,DPEP1,Plasma Cell,1.5287264597194943
KEGG_2021_Human,motile cilium assembly (GO:0044458),1/12,0.029598761568907,0.157962545205804,0,0,36.99257884972171,130.2147194065139,DNAAF1,Plasma Cell,1.5287264597194943
KEGG_2021_Human,protein-containing complex subunit organization (GO:0043933),2/112,0.031976077624072,0.157962545205804,0,0,7.515151515151516,25.872917364872013,CLDN14;JCHAIN,Plasma Cell,1.4951748104677034
KEGG_2021_Human,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/13,0.032026213248763,0.157962545205804,0,0,33.90816326530612,116.6847899929619,DERL3,Plasma Cell,1.4944944088974865
KEGG_2021_Human,purine-containing compound salvage (GO:0043101),1/13,0.032026213248763,0.157962545205804,0,0,33.90816326530612,116.6847899929619,AMPD1,Plasma Cell,1.4944944088974865
KEGG_2021_Human,AMP metabolic process (GO:0046033),1/13,0.032026213248763,0.157962545205804,0,0,33.90816326530612,116.6847899929619,AMPD1,Plasma Cell,1.4944944088974865
KEGG_2021_Human,response to nitric oxide (GO:0071731),1/13,0.032026213248763,0.157962545205804,0,0,33.90816326530612,116.6847899929619,DPEP1,Plasma Cell,1.4944944088974865
KEGG_2021_Human,cellular component maintenance (GO:0043954),1/13,0.032026213248763,0.157962545205804,0,0,33.90816326530612,116.6847899929619,CLDN3,Plasma Cell,1.4944944088974865
KEGG_2021_Human,inner dynein arm assembly (GO:0036159),1/13,0.032026213248763,0.157962545205804,0,0,33.90816326530612,116.6847899929619,DNAAF1,Plasma Cell,1.4944944088974865
KEGG_2021_Human,negative regulation of cell motility (GO:2000146),2/114,0.0330295301793541,0.157962545205804,0,0,7.380208333333333,25.169117576656426,CLDN3;DPEP1,Plasma Cell,1.4810976037825534
KEGG_2021_Human,positive regulation of cellular component organization (GO:0051130),2/114,0.0330295301793541,0.157962545205804,0,0,7.380208333333333,25.169117576656426,CLDN3;CRB3,Plasma Cell,1.4810976037825534
KEGG_2021_Human,tumor necrosis factor-mediated signaling pathway (GO:0033209),2/116,0.0340965412337713,0.157962545205804,0,0,7.25,24.49455514200503,TNFRSF13B;TNFRSF17,Plasma Cell,1.467289673772098
KEGG_2021_Human,pancreas development (GO:0031016),1/14,0.0344477141698711,0.157962545205804,0,0,31.298273155416013,105.4223689491126,DNAAF1,Plasma Cell,1.4628395910668823
KEGG_2021_Human,cell junction maintenance (GO:0034331),1/14,0.0344477141698711,0.157962545205804,0,0,31.298273155416013,105.4223689491126,CLDN3,Plasma Cell,1.4628395910668823
KEGG_2021_Human,aflatoxin metabolic process (GO:0046222),1/15,0.0368632785936063,0.157962545205804,0,0,29.06122448979592,95.91771596133704,DPEP1,Plasma Cell,1.4334060415588732
KEGG_2021_Human,organic heteropentacyclic compound metabolic process (GO:1901376),1/15,0.0368632785936063,0.157962545205804,0,0,29.06122448979592,95.91771596133704,DPEP1,Plasma Cell,1.4334060415588732
KEGG_2021_Human,mycotoxin metabolic process (GO:0043385),1/15,0.0368632785936063,0.157962545205804,0,0,29.06122448979592,95.91771596133704,DPEP1,Plasma Cell,1.4334060415588732
KEGG_2021_Human,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),1/16,0.0392729207344652,0.157962545205804,0,0,27.122448979591837,87.80133530116419,AMPD1,Plasma Cell,1.405906798966597
KEGG_2021_Human,epithelial cell morphogenesis (GO:0003382),1/17,0.0416766547912334,0.157962545205804,0,0,25.426020408163264,80.79916728086499,CLDN3,Plasma Cell,1.3801071472903907
KEGG_2021_Human,cellular modified amino acid catabolic process (GO:0042219),1/17,0.0416766547912334,0.157962545205804,0,0,25.426020408163264,80.79916728086499,DPEP1,Plasma Cell,1.3801071472903907
KEGG_2021_Human,outer dynein arm assembly (GO:0036158),1/18,0.0440744949316926,0.157962545205804,0,0,23.92917166866747,74.70385911458476,DNAAF1,Plasma Cell,1.3558126557645607
KEGG_2021_Human,phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,0.0440744949316926,0.157962545205804,0,0,23.92917166866747,74.70385911458476,PLA2G2D,Plasma Cell,1.3558126557645607
KEGG_2021_Human,phosphatidylinositol acyl-chain remodeling (GO:0036149),1/18,0.0440744949316926,0.157962545205804,0,0,23.92917166866747,74.70385911458476,PLA2G2D,Plasma Cell,1.3558126557645607
KEGG_2021_Human,regulation of inflammatory response to antigenic stimulus (GO:0002861),2/137,0.0460802533373535,0.157962545205804,0,0,6.1157407407407405,18.820401760879264,PLA2G2D;DPEP1,Plasma Cell,1.3364851419391792
KEGG_2021_Human,regulation of bicellular tight junction assembly (GO:2000810),1/19,0.0464664552952436,0.157962545205804,0,0,22.598639455782312,69.35578082800635,CLDN3,Plasma Cell,1.3328604565168853
KEGG_2021_Human,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),1/20,0.0488525499820277,0.157962545205804,0,0,21.40816326530612,64.63014669364038,DNAAF1,Plasma Cell,1.3111127622579986
KEGG_2021_Human,skeletal muscle contraction (GO:0003009),1/20,0.0488525499820277,0.157962545205804,0,0,21.40816326530612,64.63014669364038,JSRP1,Plasma Cell,1.3111127622579986
KEGG_2021_Human,purine ribonucleoside monophosphate metabolic process (GO:0009167),1/20,0.0488525499820277,0.157962545205804,0,0,21.40816326530612,64.63014669364038,AMPD1,Plasma Cell,1.3111127622579986
KEGG_2021_Human,regulation of acute inflammatory response (GO:0002673),1/20,0.0488525499820277,0.157962545205804,0,0,21.40816326530612,64.63014669364038,PLA2G2D,Plasma Cell,1.3111127622579986
KEGG_2021_Human,nucleobase-containing compound biosynthetic process (GO:0034654),1/20,0.0488525499820277,0.157962545205804,0,0,21.40816326530612,64.63014669364038,AMPD1,Plasma Cell,1.3111127622579986
KEGG_2021_Human,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1/20,0.0488525499820277,0.157962545205804,0,0,21.40816326530612,64.63014669364038,CLDN14,Plasma Cell,1.3111127622579986
KEGG_2021_Human,natural killer cell mediated immunity (GO:0002228),1/20,0.0488525499820277,0.157962545205804,0,0,21.40816326530612,64.63014669364038,SLAMF7,Plasma Cell,1.3111127622579986
KEGG_2021_Human,negative regulation of cell migration (GO:0030336),2/144,0.0503731921946642,0.157962545205804,0,0,5.812206572769953,17.368594502988177,CLDN3;DPEP1,Plasma Cell,1.2978005266368353
KEGG_2021_Human,epithelial cell development (GO:0002064),1/21,0.0512327930672156,0.157962545205804,0,0,20.336734693877553,60.42807445408675,CLDN3,Plasma Cell,1.2904519669693806
KEGG_2021_Human,negative regulation of response to wounding (GO:1903035),1/21,0.0512327930672156,0.157962545205804,0,0,20.336734693877553,60.42807445408675,CLDN3,Plasma Cell,1.2904519669693806
KEGG_2021_Human,cellular response to inorganic substance (GO:0071241),1/21,0.0512327930672156,0.157962545205804,0,0,20.336734693877553,60.42807445408675,DPEP1,Plasma Cell,1.2904519669693806
KEGG_2021_Human,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/21,0.0512327930672156,0.157962545205804,0,0,20.336734693877553,60.42807445408675,DCC,Plasma Cell,1.2904519669693806
KEGG_2021_Human,negative regulation of B cell activation (GO:0050869),1/22,0.0536071985992547,0.157962545205804,0,0,19.367346938775512,56.67024999786951,TNFRSF13B,Plasma Cell,1.2707768875084013
KEGG_2021_Human,positive regulation of peptidase activity (GO:0010952),1/22,0.0536071985992547,0.157962545205804,0,0,19.367346938775512,56.67024999786951,CLDN3,Plasma Cell,1.2707768875084013
KEGG_2021_Human,phosphatidylserine acyl-chain remodeling (GO:0036150),1/22,0.0536071985992547,0.157962545205804,0,0,19.367346938775512,56.67024999786951,PLA2G2D,Plasma Cell,1.2707768875084013
KEGG_2021_Human,natural killer cell mediated cytotoxicity (GO:0042267),1/22,0.0536071985992547,0.157962545205804,0,0,19.367346938775512,56.67024999786951,SLAMF7,Plasma Cell,1.2707768875084013
KEGG_2021_Human,leukotriene metabolic process (GO:0006691),1/24,0.0583385530130099,0.1652849461227327,0,0,17.68145519077196,50.24171555062859,DPEP1,Plasma Cell,1.2340443470047993
KEGG_2021_Human,sulfur amino acid metabolic process (GO:0000096),1/24,0.0583385530130099,0.1652849461227327,0,0,17.68145519077196,50.24171555062859,DPEP1,Plasma Cell,1.2340443470047993
KEGG_2021_Human,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),1/25,0.0606955298241754,0.1652849461227327,0,0,16.943877551020407,47.47480020477031,JSRP1,Plasma Cell,1.2168432931781568
KEGG_2021_Human,peptide catabolic process (GO:0043171),1/25,0.0606955298241754,0.1652849461227327,0,0,16.943877551020407,47.47480020477031,DPEP1,Plasma Cell,1.2168432931781568
KEGG_2021_Human,phosphatidylglycerol metabolic process (GO:0046471),1/25,0.0606955298241754,0.1652849461227327,0,0,16.943877551020407,47.47480020477031,PLA2G2D,Plasma Cell,1.2168432931781568
KEGG_2021_Human,purine-containing compound biosynthetic process (GO:0072522),1/26,0.0630467249540435,0.1652849461227327,0,0,16.26530612244898,44.95534064809558,AMPD1,Plasma Cell,1.2003374685092782
KEGG_2021_Human,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/26,0.0630467249540435,0.1652849461227327,0,0,16.26530612244898,44.95534064809558,PLA2G2D,Plasma Cell,1.2003374685092782
KEGG_2021_Human,cellular response to drug (GO:0035690),1/26,0.0630467249540435,0.1652849461227327,0,0,16.26530612244898,44.95534064809558,DPEP1,Plasma Cell,1.2003374685092782
KEGG_2021_Human,negative regulation of axonogenesis (GO:0050771),1/28,0.0677318256109869,0.1652849461227327,0,0,15.058956916099774,40.54171043527237,DCC,Plasma Cell,1.1692072184717057
KEGG_2021_Human,macromolecule catabolic process (GO:0009057),1/28,0.0677318256109869,0.1652849461227327,0,0,15.058956916099774,40.54171043527237,PRSS16,Plasma Cell,1.1692072184717057
KEGG_2021_Human,positive regulation of response to wounding (GO:1903036),1/28,0.0677318256109869,0.1652849461227327,0,0,15.058956916099774,40.54171043527237,CLDN3,Plasma Cell,1.1692072184717057
KEGG_2021_Human,regulation of B cell activation (GO:0050864),1/28,0.0677318256109869,0.1652849461227327,0,0,15.058956916099774,40.54171043527237,IGLL5,Plasma Cell,1.1692072184717057
KEGG_2021_Human,establishment of endothelial barrier (GO:0061028),1/29,0.0700657588372089,0.1652849461227327,0,0,14.520408163265309,38.5999069065122,CLDN3,Plasma Cell,1.1544941700666143
KEGG_2021_Human,negative regulation of wound healing (GO:0061045),1/29,0.0700657588372089,0.1652849461227327,0,0,14.520408163265309,38.5999069065122,CLDN3,Plasma Cell,1.1544941700666143
KEGG_2021_Human,regulation of calcium ion transmembrane transporter activity (GO:1901019),1/29,0.0700657588372089,0.1652849461227327,0,0,14.520408163265309,38.5999069065122,JSRP1,Plasma Cell,1.1544941700666143
KEGG_2021_Human,defense response to bacterium (GO:0042742),2/176,0.0716793261504705,0.1652849461227327,0,0,4.735632183908046,12.48100918849243,IGLL5;JCHAIN,Plasma Cell,1.144606086081811
KEGG_2021_Human,protein N-linked glycosylation via asparagine (GO:0018279),1/30,0.0723939657090184,0.1652849461227327,0,0,14.019000703729768,36.80874147674154,DERL3,Plasma Cell,1.1402976322627019
KEGG_2021_Human,maintenance of blood-brain barrier (GO:0035633),1/30,0.0723939657090184,0.1652849461227327,0,0,14.019000703729768,36.80874147674154,CLDN3,Plasma Cell,1.1402976322627019
KEGG_2021_Human,respiratory tube development (GO:0030323),1/30,0.0723939657090184,0.1652849461227327,0,0,14.019000703729768,36.80874147674154,DNAAF1,Plasma Cell,1.1402976322627019
KEGG_2021_Human,phosphatidylcholine acyl-chain remodeling (GO:0036151),1/30,0.0723939657090184,0.1652849461227327,0,0,14.019000703729768,36.80874147674154,PLA2G2D,Plasma Cell,1.1402976322627019
KEGG_2021_Human,plasma membrane invagination (GO:0099024),1/30,0.0723939657090184,0.1652849461227327,0,0,14.019000703729768,36.80874147674154,IGLL5,Plasma Cell,1.1402976322627019
KEGG_2021_Human,peptidyl-asparagine modification (GO:0018196),1/31,0.0747164600026276,0.1652849461227327,0,0,13.551020408163266,35.15209038871121,DERL3,Plasma Cell,1.126583712764908
KEGG_2021_Human,phosphatidylethanolamine metabolic process (GO:0046337),1/31,0.0747164600026276,0.1652849461227327,0,0,13.551020408163266,35.15209038871121,PLA2G2D,Plasma Cell,1.126583712764908
KEGG_2021_Human,liver development (GO:0001889),1/32,0.0770332554327668,0.1652849461227327,0,0,13.113232389730086,33.61600807740255,DNAAF1,Plasma Cell,1.1133217484244988
KEGG_2021_Human,negative regulation of developmental growth (GO:0048640),1/32,0.0770332554327668,0.1652849461227327,0,0,13.113232389730086,33.61600807740255,DCC,Plasma Cell,1.1133217484244988
KEGG_2021_Human,axonemal dynein complex assembly (GO:0070286),1/32,0.0770332554327668,0.1652849461227327,0,0,13.113232389730086,33.61600807740255,DNAAF1,Plasma Cell,1.1133217484244988
KEGG_2021_Human,regulation of cell morphogenesis (GO:0022604),1/32,0.0770332554327668,0.1652849461227327,0,0,13.113232389730086,33.61600807740255,CLDN3,Plasma Cell,1.1133217484244988
KEGG_2021_Human,hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.0770332554327668,0.1652849461227327,0,0,13.113232389730086,33.61600807740255,TNFRSF13B,Plasma Cell,1.1133217484244988
KEGG_2021_Human,axoneme assembly (GO:0035082),1/34,0.0816498044624026,0.1686623487713266,0,0,12.317254174397032,30.85861216573232,DNAAF1,Plasma Cell,1.0880448509885652
KEGG_2021_Human,B cell receptor signaling pathway (GO:0050853),1/34,0.0816498044624026,0.1686623487713266,0,0,12.317254174397032,30.85861216573232,IGLL5,Plasma Cell,1.0880448509885652
KEGG_2021_Human,phosphatidylserine metabolic process (GO:0006658),1/34,0.0816498044624026,0.1686623487713266,0,0,12.317254174397032,30.85861216573232,PLA2G2D,Plasma Cell,1.0880448509885652
KEGG_2021_Human,negative regulation of T cell proliferation (GO:0042130),1/35,0.0839495853612937,0.1686623487713266,0,0,11.95438175270108,29.61744503578088,PLA2G2D,Plasma Cell,1.0759814445616303
KEGG_2021_Human,lung development (GO:0030324),1/35,0.0839495853612937,0.1686623487713266,0,0,11.95438175270108,29.61744503578088,DNAAF1,Plasma Cell,1.0759814445616303
KEGG_2021_Human,respiratory system development (GO:0060541),1/35,0.0839495853612937,0.1686623487713266,0,0,11.95438175270108,29.61744503578088,DNAAF1,Plasma Cell,1.0759814445616303
KEGG_2021_Human,positive regulation of lymphocyte activation (GO:0051251),1/35,0.0839495853612937,0.1686623487713266,0,0,11.95438175270108,29.61744503578088,IGLL5,Plasma Cell,1.0759814445616303
KEGG_2021_Human,cellular response to tumor necrosis factor (GO:0071356),2/194,0.0847375162198589,0.1687116313926921,0,0,4.287760416666667,10.58303673172677,TNFRSF13B;TNFRSF17,Plasma Cell,1.0719242699529004
KEGG_2021_Human,retina homeostasis (GO:0001895),1/36,0.0862437219743075,0.1701773442528748,0,0,11.612244897959185,28.456712045041098,JCHAIN,Plasma Cell,1.0642725091375862
KEGG_2021_Human,regulation of transport (GO:0051049),1/37,0.0885322278902676,0.1716282663486768,0,0,11.289115646258503,27.36920368672352,CLDN3,Plasma Cell,1.0528986067362665
KEGG_2021_Human,"phagocytosis, engulfment (GO:0006911)",1/37,0.0885322278902676,0.1716282663486768,0,0,11.289115646258503,27.36920368672352,IGLL5,Plasma Cell,1.0528986067362665
KEGG_2021_Human,regulation of dendrite development (GO:0050773),1/39,0.0930924017046572,0.1786056385016229,0,0,10.693877551020408,25.38900533231373,DCC,Plasma Cell,1.0310857651239858
KEGG_2021_Human,sulfur compound catabolic process (GO:0044273),1/40,0.0953640965755271,0.1786056385016229,0,0,10.419152276295131,24.485561288951835,DPEP1,Plasma Cell,1.0206151011238414
KEGG_2021_Human,digestive tract development (GO:0048565),1/40,0.0953640965755271,0.1786056385016229,0,0,10.419152276295131,24.485561288951835,DNAAF1,Plasma Cell,1.0206151011238414
KEGG_2021_Human,positive regulation of wound healing (GO:0090303),1/40,0.0953640965755271,0.1786056385016229,0,0,10.419152276295131,24.485561288951835,CLDN3,Plasma Cell,1.0206151011238414
KEGG_2021_Human,determination of left/right symmetry (GO:0007368),1/42,0.0998907694703361,0.1850345583258272,0,0,9.909905425584869,22.829231064333683,DNAAF1,Plasma Cell,1.00047464143678
KEGG_2021_Human,glutathione metabolic process (GO:0006749),1/43,0.1021457742794159,0.1850345583258272,0,0,9.673469387755102,22.068611238785657,DPEP1,Plasma Cell,0.9907795952096249
KEGG_2021_Human,heart looping (GO:0001947),1/43,0.1021457742794159,0.1850345583258272,0,0,9.673469387755102,22.068611238785657,DNAAF1,Plasma Cell,0.9907795952096249
KEGG_2021_Human,natural killer cell activation (GO:0030101),1/43,0.1021457742794159,0.1850345583258272,0,0,9.673469387755102,22.068611238785657,SLAMF7,Plasma Cell,0.9907795952096249
KEGG_2021_Human,antibacterial humoral response (GO:0019731),1/44,0.1043952424647777,0.1875719397131372,0,0,9.448030374940672,21.34849709415977,JCHAIN,Plasma Cell,0.9813192926974915
KEGG_2021_Human,negative regulation of T cell activation (GO:0050868),1/45,0.1066391873529346,0.1900585516532142,0,0,9.232838589981448,20.665901611884028,PLA2G2D,Plasma Cell,0.9720831731354668
KEGG_2021_Human,alpha-amino acid metabolic process (GO:1901605),1/46,0.1088776222085674,0.1903522002101384,0,0,9.02721088435374,20.01811780873028,DPEP1,Plasma Cell,0.9630613723103648
KEGG_2021_Human,regulation of B cell proliferation (GO:0030888),1/46,0.1088776222085674,0.1903522002101384,0,0,9.02721088435374,20.01811780873028,TNFRSF13B,Plasma Cell,0.9630613723103648
KEGG_2021_Human,regulation of wound healing (GO:0061041),1/47,0.1111105603036554,0.1903522002101384,0,0,8.830523513753327,19.4026870705364,CLDN3,Plasma Cell,0.9542446623584087
KEGG_2021_Human,determination of heart left/right asymmetry (GO:0061371),1/47,0.1111105603036554,0.1903522002101384,0,0,8.830523513753327,19.4026870705364,DNAAF1,Plasma Cell,0.9542446623584087
KEGG_2021_Human,embryonic heart tube morphogenesis (GO:0003143),1/47,0.1111105603036554,0.1903522002101384,0,0,8.830523513753327,19.4026870705364,DNAAF1,Plasma Cell,0.9542446623584087
KEGG_2021_Human,purine ribonucleotide biosynthetic process (GO:0009152),1/48,0.1133380148369131,0.1912038265569297,0,0,8.642205818497612,18.81737166641443,AMPD1,Plasma Cell,0.9456243984787533
KEGG_2021_Human,phosphatidic acid biosynthetic process (GO:0006654),1/48,0.1133380148369131,0.1912038265569297,0,0,8.642205818497612,18.81737166641443,PLA2G2D,Plasma Cell,0.9456243984787533
KEGG_2021_Human,negative regulation of cell projection organization (GO:0031345),1/49,0.1155599990222406,0.1934754529084483,0,0,8.46173469387755,18.260130793597916,DCC,Plasma Cell,0.9371924705024297
KEGG_2021_Human,phosphatidic acid metabolic process (GO:0046473),1/50,0.1177765260040411,0.1957038514803991,0,0,8.28862973760933,17.7290996615035,PLA2G2D,Plasma Cell,0.928941259997044
KEGG_2021_Human,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.1221932608707862,0.2000348937218056,0,0,7.962785114045619,16.738979733033663,JSRP1,Plasma Cell,0.9129527453809976
KEGG_2021_Human,cilium movement (GO:0003341),1/52,0.1221932608707862,0.2000348937218056,0,0,7.962785114045619,16.738979733033663,DNAAF1,Plasma Cell,0.9129527453809976
KEGG_2021_Human,positive regulation of B cell activation (GO:0050871),1/53,0.1243934949128716,0.2006639589470411,0,0,7.809262166405024,16.276887238960814,IGLL5,Plasma Cell,0.9052023302345248
KEGG_2021_Human,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.1243934949128716,0.2006639589470411,0,0,7.809262166405024,16.276887238960814,DPEP1,Plasma Cell,0.9052023302345248
KEGG_2021_Human,striated muscle contraction (GO:0006941),1/54,0.1265883240687765,0.2027247798492724,0,0,7.661532537543319,15.834970375184442,JSRP1,Plasma Cell,0.8976063498190403
KEGG_2021_Human,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/55,0.1287777613922166,0.2047473760264739,0,0,7.519274376417234,15.412009607623004,DPEP1,Plasma Cell,0.8901591287349465
KEGG_2021_Human,icosanoid metabolic process (GO:0006690),1/57,0.1331405122852093,0.2101718086787947,0,0,7.25,14.618539131965724,DPEP1,Plasma Cell,0.8756897763447542
KEGG_2021_Human,negative regulation of neuron projection development (GO:0010977),1/58,0.1353138517398134,0.2120876683297785,0,0,7.122448979591836,14.246025949065045,DCC,Plasma Cell,0.8686577434892403
KEGG_2021_Human,cellular component assembly (GO:0022607),2/261,0.1385333711760542,0.2156047537317462,0,0,3.1677927927927927,6.261598728808151,CLDN14;JCHAIN,Plasma Cell,0.8584455971996626
KEGG_2021_Human,protein-containing complex assembly (GO:0065003),2/267,0.1436652916283004,0.2220281779710098,0,0,3.095125786163522,6.005376764494242,CLDN14;JCHAIN,Plasma Cell,0.8426481412255155
KEGG_2021_Human,actin cytoskeleton reorganization (GO:0031532),1/63,0.1461007034145454,0.2226776238249278,0,0,6.54641211323239,12.591756250239603,CLDN3,Plasma Cell,0.8353476931121088
KEGG_2021_Human,organonitrogen compound catabolic process (GO:1901565),1/63,0.1461007034145454,0.2226776238249278,0,0,6.54641211323239,12.591756250239603,PRSS16,Plasma Cell,0.8353476931121088
KEGG_2021_Human,protein catabolic process (GO:0030163),1/64,0.1482421941802595,0.22439400625916,0,0,6.442176870748299,12.297522293260638,PRSS16,Plasma Cell,0.8290281655096747
KEGG_2021_Human,protein N-linked glycosylation (GO:0006487),1/67,0.1546351363099914,0.2324786743163817,0,0,6.148423005565863,11.477180657220888,DERL3,Plasma Cell,0.8106918184915987
KEGG_2021_Human,cellular response to calcium ion (GO:0071277),1/69,0.158870948881139,0.2372329709644036,0,0,5.966986794717887,10.977245117600177,DPEP1,Plasma Cell,0.7989555105590889
KEGG_2021_Human,extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.1651856959101235,0.2417618463320351,0,0,5.713998275366484,10.28911103101624,DCC,Plasma Cell,0.78202756268309
KEGG_2021_Human,cell junction organization (GO:0034330),1/72,0.1651856959101235,0.2417618463320351,0,0,5.713998275366484,10.28911103101624,CLDN3,Plasma Cell,0.78202756268309
KEGG_2021_Human,cell morphogenesis involved in differentiation (GO:0000904),1/72,0.1651856959101235,0.2417618463320351,0,0,5.713998275366484,10.28911103101624,CLDN3,Plasma Cell,0.78202756268309
KEGG_2021_Human,ubiquitin-dependent ERAD pathway (GO:0030433),1/73,0.1672802691231711,0.2432167070804,0,0,5.634353741496598,10.074701240888364,DERL3,Plasma Cell,0.7765552814899175
KEGG_2021_Human,regulation of T cell proliferation (GO:0042129),1/76,0.1735331353639065,0.2440829369907125,0,0,5.408163265306122,9.4717853003048,PLA2G2D,Plasma Cell,0.7606175863963804
KEGG_2021_Human,cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.1735331353639065,0.2440829369907125,0,0,5.408163265306122,9.4717853003048,DCC,Plasma Cell,0.7606175863963804
KEGG_2021_Human,phospholipid metabolic process (GO:0006644),1/76,0.1735331353639065,0.2440829369907125,0,0,5.408163265306122,9.4717853003048,PLA2G2D,Plasma Cell,0.7606175863963804
KEGG_2021_Human,innate immune response (GO:0045087),2/302,0.1743414000182094,0.2440829369907125,0,0,2.7291666666666665,4.767144127673996,IGLL5;JCHAIN,Plasma Cell,0.7585994708102503
KEGG_2021_Human,purine ribonucleotide metabolic process (GO:0009150),1/77,0.1756071809118701,0.2440829369907125,0,0,5.336734693877551,9.283280446293812,AMPD1,Plasma Cell,0.7554577289388229
KEGG_2021_Human,negative regulation of developmental process (GO:0051093),1/77,0.1756071809118701,0.2440829369907125,0,0,5.336734693877551,9.283280446293812,DCC,Plasma Cell,0.7554577289388229
KEGG_2021_Human,phosphatidylcholine metabolic process (GO:0046470),1/77,0.1756071809118701,0.2440829369907125,0,0,5.336734693877551,9.283280446293812,PLA2G2D,Plasma Cell,0.7554577289388229
KEGG_2021_Human,axon development (GO:0061564),1/79,0.1797399811935544,0.248265849023597,0,0,5.199372056514914,8.923391206941128,DCC,Plasma Cell,0.745355308086215
KEGG_2021_Human,glycerophospholipid metabolic process (GO:0006650),1/80,0.181798760490535,0.2495498513565729,0,0,5.133298889175924,8.751529842637671,PLA2G2D,Plasma Cell,0.7404090821369118
KEGG_2021_Human,peptide metabolic process (GO:0006518),1/83,0.1879447615357932,0.2563937796259895,0,0,4.944748631159781,8.265677319811374,DPEP1,Plasma Cell,0.7259697745939766
KEGG_2021_Human,regulation of neuron death (GO:1901214),1/86,0.1940455128548384,0.2630923824596276,0,0,4.769507803121249,7.820383303288144,DCC,Plasma Cell,0.7120963955156414
KEGG_2021_Human,ERAD pathway (GO:0036503),1/87,0.196069097589664,0.2642150644348521,0,0,4.713811105837684,7.6801565438185,DERL3,Plasma Cell,0.7075908500030543
KEGG_2021_Human,regulation of cation channel activity (GO:2001257),1/89,0.2001013407742902,0.2663999777778201,0,0,4.6062152133580705,7.411084001248333,JSRP1,Plasma Cell,0.6987500013741589
KEGG_2021_Human,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),1/89,0.2001013407742902,0.2663999777778201,0,0,4.6062152133580705,7.411084001248333,DPEP1,Plasma Cell,0.6987500013741589
KEGG_2021_Human,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2780304882206267,0,0,4.357472021066491,6.79849904676328,TNFRSF13B,Plasma Cell,0.6775833802166729
KEGG_2021_Human,regulation of cell death (GO:0010941),1/102,0.2258320069783284,0.2970766282274439,0,0,4.010709234188725,5.967790506031058,DCC,Plasma Cell,0.6462145058611213
KEGG_2021_Human,response to calcium ion (GO:0051592),1/107,0.2355109070084182,0.3079758014725469,0,0,3.8205621871390063,5.524525481436682,DPEP1,Plasma Cell,0.6279889749729552
KEGG_2021_Human,phosphatidylinositol metabolic process (GO:0046488),1/112,0.2450711886958998,0.3185925453046698,0,0,3.647545504688362,5.129202360192396,PLA2G2D,Plasma Cell,0.6107077427090284
KEGG_2021_Human,positive regulation of metabolic process (GO:0009893),1/113,0.2469691364760274,0.3191823342760354,0,0,3.614795918367347,5.055262825364014,JCHAIN,Plasma Cell,0.6073573167632206
KEGG_2021_Human,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.3294299942927026,0,0,3.4594453165881736,4.708511372057024,CLDN3,Plasma Cell,0.5911006880374128
KEGG_2021_Human,regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.2656932663769877,0.3394116293023947,0,0,3.316828370692539,4.396166676729281,CLDN3,Plasma Cell,0.5756194520344882
KEGG_2021_Human,negative regulation of cell growth (GO:0030308),1/126,0.2712209880572274,0.3430685503694495,0,0,3.236734693877551,4.223360488574632,DCC,Plasma Cell,0.5666767062328689
KEGG_2021_Human,regulation of cell migration (GO:0030334),2/408,0.2716606168083876,0.3430685503694495,0,0,2.0057471264367814,2.6138931132295458,CLDN3;DPEP1,Plasma Cell,0.5659733175722854
KEGG_2021_Human,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.3520220706712802,0,0,3.111459968602826,3.956968446025251,DPEP1,Plasma Cell,0.5523097126477655
KEGG_2021_Human,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.3592538957627083,0,0,2.99546485260771,3.714691124222948,CRB3,Plasma Cell,0.5385707850387818
KEGG_2021_Human,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3592538957627083,0,0,2.99546485260771,3.714691124222948,DPEP1,Plasma Cell,0.5385707850387818
KEGG_2021_Human,neuron projection morphogenesis (GO:0048812),1/140,0.2964824884084789,0.364014610768188,0,0,2.9086771399207163,3.5362740390257685,DCC,Plasma Cell,0.5280009529309525
KEGG_2021_Human,protein localization to cell periphery (GO:1990778),1/140,0.2964824884084789,0.364014610768188,0,0,2.9086771399207163,3.5362740390257685,CRB3,Plasma Cell,0.5280009529309525
KEGG_2021_Human,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3684753225391169,0,0,2.8467950560505892,3.410594866305226,JCHAIN,Plasma Cell,0.5203052911363482
KEGG_2021_Human,regulation of neuron projection development (GO:0010975),1/165,0.3394751386404204,0.4122198112062248,0,0,2.4621702339472376,2.6600168495918335,DCC,Plasma Cell,0.46919202564454415
KEGG_2021_Human,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.4159847328961904,0,0,2.4175730172308443,2.5766088705447237,DNAAF1,Plasma Cell,0.46286379212748074
KEGG_2021_Human,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.3477593333218013,0.4176891992615114,0,0,2.388721168940949,2.523073857975914,CLDN14,Plasma Cell,0.45872120538836164
KEGG_2021_Human,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.359186378521905,0.4283087010322613,0,0,2.2929035250463823,2.3477357103628296,PLA2G2D,Plasma Cell,0.44468014150624274
KEGG_2021_Human,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.4283087010322613,0,0,2.279833967485299,2.3241173885161555,DPEP1,Plasma Cell,0.44273020383203454
KEGG_2021_Human,regulation of immune response (GO:0050776),1/179,0.3624150547196057,0.4283087010322613,0,0,2.266911258885577,2.300835957547096,SLAMF7,Plasma Cell,0.4407937700298507
KEGG_2021_Human,antigen receptor-mediated signaling pathway (GO:0050851),1/185,0.3720057294778557,0.4373046075245006,0,0,2.192324755989352,2.1678716160963645,IGLL5,Plasma Cell,0.4294503712432232
KEGG_2021_Human,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.450929476917328,0,0,2.089140319340171,1.988001678572607,CLDN3,Plasma Cell,0.4132695879859197
KEGG_2021_Human,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.450929476917328,0,0,2.0782663580896275,1.969329769675335,CRB3,Plasma Cell,0.4115300469974289
KEGG_2021_Human,axon guidance (GO:0007411),1/203,0.3999373645428959,0.4627547516438743,0,0,1.9951505354617096,1.8284503867148747,DCC,Plasma Cell,0.398008019580524
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),1/212,0.4134429066373548,0.4734242609681628,0,0,1.909178837411742,1.6862551884518755,DPEP1,Plasma Cell,0.3835844547796231
KEGG_2021_Human,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4734242609681628,0,0,1.909178837411742,1.6862551884518755,PLA2G2D,Plasma Cell,0.3835844547796231
KEGG_2021_Human,positive regulation of protein modification process (GO:0031401),1/214,0.416403436812339,0.4743564924511697,0,0,1.8910606496119575,1.656759537391559,CLDN3,Plasma Cell,0.3804856946694876
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4835371486601054,0,0,1.8302411873840445,1.5589816483293069,CLDN3,Plasma Cell,0.3699278171231457
KEGG_2021_Human,cilium organization (GO:0044782),1/228,0.4367210295579323,0.492209131419593,0,0,1.7731727052054302,1.469003836799846,DNAAF1,Plasma Cell,0.359795894863476
KEGG_2021_Human,inflammatory response (GO:0006954),1/230,0.4395663655385589,0.492209131419593,0,0,1.7575082434720612,1.4446130242039086,PLA2G2D,Plasma Cell,0.35697554604801474
KEGG_2021_Human,apoptotic process (GO:0006915),1/231,0.4409837467017168,0.492209131419593,0,0,1.749778172138421,1.4326260836369302,DCC,Plasma Cell,0.35557741698984124
KEGG_2021_Human,axonogenesis (GO:0007409),1/240,0.4535831041409784,0.5037279699254082,0,0,1.6831184356587825,1.3306343458644796,DCC,Plasma Cell,0.34334313117644527
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),2/621,0.4626694381715867,0.5112497291796033,0,0,1.3012250942380184,1.0029093993298663,TNFRSF13B;TNFRSF17,Plasma Cell,0.33472918706115434
KEGG_2021_Human,positive regulation of phosphorylation (GO:0042327),1/253,0.4712922312950381,0.518186980677629,0,0,1.5952380952380951,1.2000608149186214,CLDN3,Plasma Cell,0.32670971902140344
KEGG_2021_Human,regulation of protein phosphorylation (GO:0001932),1/266,0.4884385252284191,0.5331594132164693,0,0,1.5159799768964188,1.086262808220724,CLDN3,Plasma Cell,0.3111900887192418
KEGG_2021_Human,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5331594132164693,0,0,1.510204081632653,1.0781219104526054,DCC,Plasma Cell,0.3100391544580995
KEGG_2021_Human,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.5333437371557606,0,0,1.498781602193116,1.0620843946744252,CLDN3,Plasma Cell,0.30775490655057164
KEGG_2021_Human,plasma membrane bounded cell projection assembly (GO:0120031),1/278,0.5037814900878317,0.5431010210215161,0,0,1.4494216459146836,0.9937418248041268,DNAAF1,Plasma Cell,0.2977577933690553
KEGG_2021_Human,proteolysis (GO:0006508),1/287,0.51499186851511,0.5524912764166957,0,0,1.4031682603111175,0.9311483055746664,PRSS16,Plasma Cell,0.28819962821492023
KEGG_2021_Human,cilium assembly (GO:0060271),1/314,0.5471545986718139,0.5841602237027579,0,0,1.2803677381495728,0.7720923294539072,DNAAF1,Plasma Cell,0.26188994631047774
KEGG_2021_Human,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.5551458962416416,0.5866009608413232,0,0,1.2519132653061225,0.7367814077584223,DERL3,Plasma Cell,0.25559286623594474
KEGG_2021_Human,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5866009608413232,0,0,1.2479496471485791,0.7319104885681406,CLDN3,Plasma Cell,0.2547095446988111
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5866009608413232,0,0,1.2440106477373558,0.7270814983759607,DPEP1,Plasma Cell,0.2538302089398956
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6371740841688107,0,0,1.0799779371207945,0.5367673309131087,CLDN3,Plasma Cell,0.21585171499242045
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),1/379,0.6162544539128882,0.6414268672603783,0,0,1.056689342403628,0.5115383719098227,CLDN3,Plasma Cell,0.2102399288866402
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.6414268672603783,0,0,1.0510204081632653,0.5054679174936134,DPEP1,Plasma Cell,0.20886552310647807
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6414365445026251,0,0,1.042628017264347,0.4965325169788531,CLDN3,Plasma Cell,0.20682480102083725
KEGG_2021_Human,organelle assembly (GO:0070925),1/425,0.658798168385351,0.6771832335495933,0,0,0.939834424335772,0.3922286762298742,DNAAF1,Plasma Cell,0.18124761694193237
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),1/482,0.7051444771556823,0.7204445297304272,0,0,0.8260426831855403,0.2885801301950252,CLDN3,Plasma Cell,0.1517218912312197
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7204445297304272,0,0,0.8207960870298533,0.2841203737887477,DPEP1,Plasma Cell,0.15033199168778996
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),1/566,0.7624057114769476,0.7728975331945203,0,0,0.700198663536211,0.1899473973942179,CLDN3,Plasma Cell,0.11781385888910202
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8570831238720542,0,0,0.5290423861852434,0.0863986224716518,DPEP1,Plasma Cell,0.07092521499844862
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),1/764,0.8577067842472734,0.8616054514483975,0,0,0.5131997753229732,0.0787725634671716,CLDN3,Plasma Cell,0.06666115474745983
KEGG_2021_Human,regulation of gene expression (GO:0010468),1/1079,0.9377418517471742,0.9377418517471742,0,0,0.3572753776835409,0.0229658682151355,CLDN3,Plasma Cell,0.027916700844649738
KEGG_2021_Human,regulation of antigen receptor-mediated signaling pathway (GO:0050854),2/13,0.00046942457388711873,0.0812104512824715,0,0,75.52651515151516,578.8354329773197,GCSAM;PAX5,Pre-B,3.3284341792789096
KEGG_2021_Human,regulation of B cell receptor signaling pathway (GO:0050855),2/23,0.0014985033958486,0.1006524142010828,0,0,39.541666666666664,257.15086234948103,GCSAM;PAX5,Pre-B,2.8243422685363964
KEGG_2021_Human,purine nucleoside bisphosphate metabolic process (GO:0034032),2/31,0.0027192556482504,0.1006524142010828,0,0,28.62212643678161,169.08226656127547,ACSM3;ACSM1,Pre-B,2.565549960707733
KEGG_2021_Human,ribonucleoside bisphosphate metabolic process (GO:0033875),2/31,0.0027192556482504,0.1006524142010828,0,0,28.62212643678161,169.08226656127547,ACSM3;ACSM1,Pre-B,2.565549960707733
KEGG_2021_Human,positive regulation of cellular component organization (GO:0051130),3/114,0.00290902931217,0.1006524142010828,0,0,11.40828062104658,66.623626679358,HRK;TCL1A;ABCB4,Pre-B,2.536251902661656
KEGG_2021_Human,acyl-CoA metabolic process (GO:0006637),2/37,0.0038576315924392,0.1112283775819975,0,0,23.708333333333332,131.76384828572083,ACSM3;ACSM1,Pre-B,2.4136792502562754
KEGG_2021_Human,monocarboxylic acid biosynthetic process (GO:0072330),2/63,0.0108545013893802,0.1415258887586207,0,0,13.585382513661202,61.44906812714711,ACSM3;ACSM1,Pre-B,1.9643901214324337
KEGG_2021_Human,bile acid secretion (GO:0032782),1/5,0.0124387771927725,0.1415258887586207,0,0,101.76530612244898,446.4379351400606,ABCB4,Pre-B,1.9052223113279663
KEGG_2021_Human,fatty acid biosynthetic process (GO:0006633),2/71,0.0136373517747766,0.1415258887586207,0,0,12.005434782608695,51.56265564232933,ACSM3;ACSM1,Pre-B,1.8652699567516449
KEGG_2021_Human,cholesterol homeostasis (GO:0042632),2/71,0.0136373517747766,0.1415258887586207,0,0,12.005434782608695,51.56265564232933,ACSM3;ACSM1,Pre-B,1.8652699567516449
KEGG_2021_Human,sterol homeostasis (GO:0055092),2/72,0.0140048037295852,0.1415258887586207,0,0,11.833333333333334,50.50886613536219,ACSM3;ACSM1,Pre-B,1.8537229732206628
KEGG_2021_Human,regulation of microtubule motor activity (GO:2000574),1/6,0.0149082847993736,0.1415258887586207,0,0,81.40816326530613,342.3895623444841,CFAP73,Pre-B,1.8265723193247598
KEGG_2021_Human,embryonic hindlimb morphogenesis (GO:0035116),1/6,0.0149082847993736,0.1415258887586207,0,0,81.40816326530613,342.3895623444841,AFF3,Pre-B,1.8265723193247598
KEGG_2021_Human,positive regulation of sterol transport (GO:0032373),1/6,0.0149082847993736,0.1415258887586207,0,0,81.40816326530613,342.3895623444841,ABCB4,Pre-B,1.8265723193247598
KEGG_2021_Human,purine ribonucleotide metabolic process (GO:0009150),2/77,0.0159057771109684,0.1415258887586207,0,0,11.041666666666666,45.72434655376785,ACSM3;ACSM1,Pre-B,1.7984451076467942
KEGG_2021_Human,lipid biosynthetic process (GO:0008610),2/80,0.0170965192165363,0.1415258887586207,0,0,10.615384615384617,43.19273030214829,ACSM3;ACSM1,Pre-B,1.7670923012410087
KEGG_2021_Human,hindlimb morphogenesis (GO:0035137),1/7,0.0173717414502839,0.1415258887586207,0,0,67.83673469387755,274.9362107684438,AFF3,Pre-B,1.7601566430186848
KEGG_2021_Human,regulation of phospholipid transport (GO:2001138),1/7,0.0173717414502839,0.1415258887586207,0,0,67.83673469387755,274.9362107684438,ABCB4,Pre-B,1.7601566430186848
KEGG_2021_Human,positive regulation of mitochondrial membrane potential (GO:0010918),1/7,0.0173717414502839,0.1415258887586207,0,0,67.83673469387755,274.9362107684438,TCL1A,Pre-B,1.7601566430186848
KEGG_2021_Human,benzene-containing compound metabolic process (GO:0042537),1/8,0.0198291614511851,0.1415258887586207,0,0,58.142857142857146,227.9549801512961,ACSM1,Pre-B,1.702695651141308
KEGG_2021_Human,positive regulation of cellular component biogenesis (GO:0044089),2/92,0.0222223839756269,0.1415258887586207,0,0,9.194444444444445,35.00007985571613,HRK;TCL1A,Pre-B,1.6532093525993499
KEGG_2021_Human,short-chain fatty acid metabolic process (GO:0046459),1/9,0.0222805591236868,0.1415258887586207,0,0,50.87244897959184,193.52086993316271,ACSM1,Pre-B,1.652073914876897
KEGG_2021_Human,acid secretion (GO:0046717),1/9,0.0222805591236868,0.1415258887586207,0,0,50.87244897959184,193.52086993316271,ABCB4,Pre-B,1.652073914876897
KEGG_2021_Human,positive regulation of membrane potential (GO:0045838),1/9,0.0222805591236868,0.1415258887586207,0,0,50.87244897959184,193.52086993316271,TCL1A,Pre-B,1.652073914876897
KEGG_2021_Human,positive regulation of peptidyl-serine phosphorylation (GO:0033138),2/93,0.0226749954090764,0.1415258887586207,0,0,9.092948717948715,34.43038199107018,TCL1B;TCL1A,Pre-B,1.6444527921978775
KEGG_2021_Human,regulation of peptidyl-serine phosphorylation (GO:0033135),2/98,0.0249948795228368,0.1415258887586207,0,0,8.6171875,31.789531066243494,TCL1B;TCL1A,Pre-B,1.6021489522377872
KEGG_2021_Human,V(D)J recombination (GO:0033151),1/11,0.0271653448579923,0.1415258887586207,0,0,40.69387755102041,146.73452100035948,RAG2,Pre-B,1.5659847773237099
KEGG_2021_Human,negative regulation of lymphocyte migration (GO:2000402),1/11,0.0271653448579923,0.1415258887586207,0,0,40.69387755102041,146.73452100035948,GCSAM,Pre-B,1.5659847773237099
KEGG_2021_Human,positive regulation of phospholipid transport (GO:2001140),1/11,0.0271653448579923,0.1415258887586207,0,0,40.69387755102041,146.73452100035948,ABCB4,Pre-B,1.5659847773237099
KEGG_2021_Human,regulation of lymphocyte migration (GO:2000401),1/11,0.0271653448579923,0.1415258887586207,0,0,40.69387755102041,146.73452100035948,GCSAM,Pre-B,1.5659847773237099
KEGG_2021_Human,positive regulation of protein serine/threonine kinase activity (GO:0071902),2/106,0.0288986461861609,0.1415258887586207,0,0,7.951121794871795,28.178461808105727,TCL1B;TCL1A,Pre-B,1.5391225021448902
KEGG_2021_Human,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),1/12,0.029598761568907,0.1415258887586207,0,0,36.99257884972171,130.2147194065139,RIMS3,Pre-B,1.5287264597194943
KEGG_2021_Human,response to tumor necrosis factor (GO:0034612),2/110,0.0309363405009925,0.1415258887586207,0,0,7.655092592592593,26.607752397672005,TCL1A;AFF3,Pre-B,1.5095310608442127
KEGG_2021_Human,regulation of protein serine/threonine kinase activity (GO:0071900),2/111,0.0314544847807964,0.1415258887586207,0,0,7.584480122324159,26.23633758944092,TCL1B;TCL1A,Pre-B,1.5023174240917434
KEGG_2021_Human,lipid oxidation (GO:0034440),1/13,0.032026213248763,0.1415258887586207,0,0,33.90816326530612,116.6847899929619,ACSM1,Pre-B,1.4944944088974865
KEGG_2021_Human,negative regulation of mononuclear cell migration (GO:0071676),1/13,0.032026213248763,0.1415258887586207,0,0,33.90816326530612,116.6847899929619,GCSAM,Pre-B,1.4944944088974865
KEGG_2021_Human,positive regulation of lipid transport (GO:0032370),1/13,0.032026213248763,0.1415258887586207,0,0,33.90816326530612,116.6847899929619,ABCB4,Pre-B,1.4944944088974865
KEGG_2021_Human,inner dynein arm assembly (GO:0036159),1/13,0.032026213248763,0.1415258887586207,0,0,33.90816326530612,116.6847899929619,CFAP73,Pre-B,1.4944944088974865
KEGG_2021_Human,cellular amide metabolic process (GO:0043603),2/115,0.033561350657856,0.1415258887586207,0,0,7.31452802359882,24.82828874550635,ACSM3;ACSM1,Pre-B,1.4741605695522084
KEGG_2021_Human,regulation of protein-containing complex assembly (GO:0043254),2/116,0.0340965412337713,0.1415258887586207,0,0,7.25,24.49455514200503,HRK;TCL1A,Pre-B,1.467289673772098
KEGG_2021_Human,ceramide transport (GO:0035627),1/14,0.0344477141698711,0.1415258887586207,0,0,31.298273155416013,105.4223689491126,ABCB4,Pre-B,1.4628395910668823
KEGG_2021_Human,T cell differentiation in thymus (GO:0033077),1/14,0.0344477141698711,0.1415258887586207,0,0,31.298273155416013,105.4223689491126,RAG2,Pre-B,1.4628395910668823
KEGG_2021_Human,positive regulation of protein-containing complex assembly (GO:0031334),2/118,0.0351769550093681,0.1415258887586207,0,0,7.124281609195402,23.8475644827565,HRK;TCL1A,Pre-B,1.4537417566881954
KEGG_2021_Human,fatty acid metabolic process (GO:0006631),2/124,0.038497072428768,0.1509825619347219,0,0,6.771857923497268,22.05711333941876,ACSM3;ACSM1,Pre-B,1.4145722958518654
KEGG_2021_Human,apoptotic DNA fragmentation (GO:0006309),1/16,0.0392729207344652,0.1509825619347219,0,0,27.122448979591837,87.80133530116419,CECR2,Pre-B,1.405906798966597
KEGG_2021_Human,positive regulation of dendrite extension (GO:1903861),1/17,0.0416766547912334,0.1567404625844215,0,0,25.426020408163264,80.79916728086499,RASAL1,Pre-B,1.3801071472903907
KEGG_2021_Human,regulation of dendrite extension (GO:1903859),1/18,0.0440744949316926,0.1622316515570815,0,0,23.92917166866747,74.70385911458476,RASAL1,Pre-B,1.3558126557645607
KEGG_2021_Human,regulation of synaptic vesicle exocytosis (GO:2000300),1/19,0.0464664552952436,0.1674728492932739,0,0,22.598639455782312,69.35578082800635,RIMS3,Pre-B,1.3328604565168853
KEGG_2021_Human,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/20,0.0488525499820277,0.1724794111610368,0,0,21.40816326530612,64.63014669364038,BACH2,Pre-B,1.3111127622579986
KEGG_2021_Human,"DNA catabolic process, endonucleolytic (GO:0000737)",1/23,0.0559757805878795,0.1810401148203852,0,0,18.4860853432282,53.29235549319145,CECR2,Pre-B,1.2519998414265567
KEGG_2021_Human,positive regulation of protein kinase activity (GO:0045860),2/154,0.0567455048100272,0.1810401148203852,0,0,5.427083333333333,15.571272642043729,TCL1B;TCL1A,Pre-B,1.2460685361352464
KEGG_2021_Human,lipid translocation (GO:0034204),1/24,0.0583385530130099,0.1810401148203852,0,0,17.68145519077196,50.24171555062859,ABCB4,Pre-B,1.2340443470047993
KEGG_2021_Human,negative regulation of neuron differentiation (GO:0045665),1/24,0.0583385530130099,0.1810401148203852,0,0,17.68145519077196,50.24171555062859,DTX1,Pre-B,1.2340443470047993
KEGG_2021_Human,negative regulation of ossification (GO:0030279),1/24,0.0583385530130099,0.1810401148203852,0,0,17.68145519077196,50.24171555062859,KREMEN2,Pre-B,1.2340443470047993
KEGG_2021_Human,apoptotic nuclear changes (GO:0030262),1/24,0.0583385530130099,0.1810401148203852,0,0,17.68145519077196,50.24171555062859,CECR2,Pre-B,1.2340443470047993
KEGG_2021_Human,regulation of cholesterol transport (GO:0032374),1/25,0.0606955298241754,0.1810401148203852,0,0,16.943877551020407,47.47480020477031,ABCB4,Pre-B,1.2168432931781568
KEGG_2021_Human,positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/25,0.0606955298241754,0.1810401148203852,0,0,16.943877551020407,47.47480020477031,HRK,Pre-B,1.2168432931781568
KEGG_2021_Human,energy derivation by oxidation of organic compounds (GO:0015980),1/25,0.0606955298241754,0.1810401148203852,0,0,16.943877551020407,47.47480020477031,ACSM1,Pre-B,1.2168432931781568
KEGG_2021_Human,calcium-ion regulated exocytosis (GO:0017156),1/27,0.0653921522588676,0.1917430905217644,0,0,15.638932496075354,42.652889831563165,RIMS3,Pre-B,1.184474368421492
KEGG_2021_Human,response to ketone (GO:1901654),1/28,0.0677318256109869,0.1920918988639464,0,0,15.058956916099774,40.54171043527237,ABCB4,Pre-B,1.1692072184717057
KEGG_2021_Human,positive regulation of cell communication (GO:0010647),1/28,0.0677318256109869,0.1920918988639464,0,0,15.058956916099774,40.54171043527237,RIMS3,Pre-B,1.1692072184717057
KEGG_2021_Human,limb development (GO:0060173),1/29,0.0700657588372089,0.1955060690135023,0,0,14.520408163265309,38.5999069065122,KREMEN2,Pre-B,1.1544941700666143
KEGG_2021_Human,phospholipid translocation (GO:0045332),1/31,0.0747164600026276,0.2051737711183267,0,0,13.551020408163266,35.15209038871121,ABCB4,Pre-B,1.126583712764908
KEGG_2021_Human,axonemal dynein complex assembly (GO:0070286),1/32,0.0770332554327668,0.2079784131382896,0,0,13.113232389730086,33.61600807740255,CFAP73,Pre-B,1.1133217484244988
KEGG_2021_Human,regulation of neurotransmitter secretion (GO:0046928),1/33,0.0793443657059371,0.2079784131382896,0,0,12.70280612244898,32.18837516559274,RIMS3,Pre-B,1.1004839073426347
KEGG_2021_Human,positive regulation of cholesterol transport (GO:0032376),1/33,0.0793443657059371,0.2079784131382896,0,0,12.70280612244898,32.18837516559274,ABCB4,Pre-B,1.1004839073426347
KEGG_2021_Human,regulation of regulated secretory pathway (GO:1903305),1/35,0.0839495853612937,0.2162342594428291,0,0,11.95438175270108,29.61744503578088,RIMS3,Pre-B,1.0759814445616303
KEGG_2021_Human,regulation of ossification (GO:0030278),1/36,0.0862437219743075,0.2162342594428291,0,0,11.612244897959185,28.456712045041098,KREMEN2,Pre-B,1.0642725091375862
KEGG_2021_Human,embryonic limb morphogenesis (GO:0030326),1/36,0.0862437219743075,0.2162342594428291,0,0,11.612244897959185,28.456712045041098,AFF3,Pre-B,1.0642725091375862
KEGG_2021_Human,actin-myosin filament sliding (GO:0033275),1/38,0.0908151166313484,0.2182085441281012,0,0,10.983452840595698,26.34852930034076,MYBPC2,Pre-B,1.0418418549683985
KEGG_2021_Human,muscle filament sliding (GO:0030049),1/38,0.0908151166313484,0.2182085441281012,0,0,10.983452840595698,26.34852930034076,MYBPC2,Pre-B,1.0418418549683985
KEGG_2021_Human,positive regulation of signaling (GO:0023056),1/38,0.0908151166313484,0.2182085441281012,0,0,10.983452840595698,26.34852930034076,RIMS3,Pre-B,1.0418418549683985
KEGG_2021_Human,synaptic vesicle exocytosis (GO:0016079),1/40,0.0953640965755271,0.2187481407388373,0,0,10.419152276295131,24.485561288951835,RIMS3,Pre-B,1.0206151011238414
KEGG_2021_Human,nucleocytoplasmic transport (GO:0006913),1/40,0.0953640965755271,0.2187481407388373,0,0,10.419152276295131,24.485561288951835,BACH2,Pre-B,1.0206151011238414
KEGG_2021_Human,regulation of mitochondrial membrane potential (GO:0051881),1/41,0.0976302146847681,0.2187481407388373,0,0,10.158163265306122,23.633660200289185,TCL1A,Pre-B,1.0104157556925017
KEGG_2021_Human,regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.0976302146847681,0.2187481407388373,0,0,10.158163265306122,23.633660200289185,HRK,Pre-B,1.0104157556925017
KEGG_2021_Human,T cell differentiation (GO:0030217),1/41,0.0976302146847681,0.2187481407388373,0,0,10.158163265306122,23.633660200289185,RAG2,Pre-B,1.0104157556925017
KEGG_2021_Human,ATP-dependent chromatin remodeling (GO:0043044),1/42,0.0998907694703361,0.2187481407388373,0,0,9.909905425584869,22.829231064333683,CECR2,Pre-B,1.00047464143678
KEGG_2021_Human,nucleic acid-templated transcription (GO:0097659),1/42,0.0998907694703361,0.2187481407388373,0,0,9.909905425584869,22.829231064333683,DTX1,Pre-B,1.00047464143678
KEGG_2021_Human,homotypic cell-cell adhesion (GO:0034109),1/44,0.1043952424647777,0.2254133104203897,0,0,9.448030374940672,21.34849709415977,MEGF11,Pre-B,0.9813192926974915
KEGG_2021_Human,"transcription, DNA-templated (GO:0006351)",2/221,0.1055403360927836,0.2254133104203897,0,0,3.7539954337899544,8.441467129790793,DTX1;PAX5,Pre-B,0.97658152714763
KEGG_2021_Human,inositol lipid-mediated signaling (GO:0048017),1/51,0.1199876089220907,0.2516599301267383,0,0,8.122448979591837,17.22257115519733,PITPNM2,Pre-B,0.9208636010741894
KEGG_2021_Human,cilium movement (GO:0003341),1/52,0.1221932608707862,0.2516599301267383,0,0,7.962785114045619,16.738979733033663,CFAP73,Pre-B,0.9129527453809976
KEGG_2021_Human,positive regulation of developmental growth (GO:0048639),1/52,0.1221932608707862,0.2516599301267383,0,0,7.962785114045619,16.738979733033663,RASAL1,Pre-B,0.9129527453809976
KEGG_2021_Human,monocarboxylic acid transport (GO:0015718),1/57,0.1331405122852093,0.268427805424947,0,0,7.25,14.618539131965724,ABCB4,Pre-B,0.8756897763447542
KEGG_2021_Human,positive regulation of mitochondrion organization (GO:0010822),1/58,0.1353138517398134,0.268427805424947,0,0,7.122448979591836,14.246025949065045,HRK,Pre-B,0.8686577434892403
KEGG_2021_Human,fatty acid oxidation (GO:0019395),1/59,0.1374818510452552,0.268427805424947,0,0,6.9992962702322306,13.8884471557023,ACSM1,Pre-B,0.8617546291873563
KEGG_2021_Human,phospholipid transport (GO:0015914),1/59,0.1374818510452552,0.268427805424947,0,0,6.9992962702322306,13.8884471557023,ABCB4,Pre-B,0.8617546291873563
KEGG_2021_Human,response to organic cyclic compound (GO:0014070),1/60,0.1396445230534406,0.268427805424947,0,0,6.88031822898651,13.544974303558986,ABCB4,Pre-B,0.8549760929333525
KEGG_2021_Human,Notch signaling pathway (GO:0007219),1/60,0.1396445230534406,0.268427805424947,0,0,6.88031822898651,13.544974303558986,DTX1,Pre-B,0.8549760929333525
KEGG_2021_Human,B cell differentiation (GO:0030183),1/61,0.1418018805927374,0.2695793993686106,0,0,6.76530612244898,13.214837540593155,RAG2,Pre-B,0.848318009451734
KEGG_2021_Human,lipid homeostasis (GO:0055088),1/64,0.1482421941802595,0.2787597781867924,0,0,6.442176870748299,12.297522293260638,ABCB4,Pre-B,0.8290281655096747
KEGG_2021_Human,chemical homeostasis (GO:0048878),1/65,0.1503784214913892,0.279736203419466,0,0,6.341198979591836,12.01403781811508,ABCB4,Pre-B,0.8228144782361342
KEGG_2021_Human,phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.16308595979881,0.2983452222506041,0,0,5.795918367346939,10.51076961698872,PITPNM2,Pre-B,0.7875834261109624
KEGG_2021_Human,cytoskeleton-dependent cytokinesis (GO:0061640),1/72,0.1651856959101235,0.2983452222506041,0,0,5.713998275366484,10.28911103101624,CECR2,Pre-B,0.78202756268309
KEGG_2021_Human,regulation of hydrolase activity (GO:0051336),1/73,0.1672802691231711,0.2983452222506041,0,0,5.634353741496598,10.074701240888364,CFAP73,Pre-B,0.7765552814899175
KEGG_2021_Human,positive regulation of synaptic transmission (GO:0050806),1/73,0.1672802691231711,0.2983452222506041,0,0,5.634353741496598,10.074701240888364,RIMS3,Pre-B,0.7765552814899175
KEGG_2021_Human,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.1756071809118701,0.3068691141187225,0,0,5.336734693877551,9.283280446293812,ROR1,Pre-B,0.7554577289388229
KEGG_2021_Human,import into nucleus (GO:0051170),1/77,0.1756071809118701,0.3068691141187225,0,0,5.336734693877551,9.283280446293812,BACH2,Pre-B,0.7554577289388229
KEGG_2021_Human,regulation of neuron differentiation (GO:0045664),1/79,0.1797399811935544,0.3109501674648491,0,0,5.199372056514914,8.923391206941128,DTX1,Pre-B,0.745355308086215
KEGG_2021_Human,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.3194127888423811,0,0,4.944748631159781,8.265677319811374,DTX1,Pre-B,0.7259697745939766
KEGG_2021_Human,lymphocyte differentiation (GO:0030098),1/84,0.1899833569114356,0.3194127888423811,0,0,4.884927464961889,8.112979399077096,RAG2,Pre-B,0.7212844428267129
KEGG_2021_Human,transcription by RNA polymerase II (GO:0006366),2/320,0.1905173181447624,0.3194127888423811,0,0,2.5723270440251573,4.2649495690392465,DTX1;PAX5,Pre-B,0.7200655405507924
KEGG_2021_Human,B cell activation (GO:0042113),1/85,0.1920169366451308,0.3194127888423811,0,0,4.826530612244898,7.964604221414354,RAG2,Pre-B,0.716660463134361
KEGG_2021_Human,positive regulation of neuron projection development (GO:0010976),1/88,0.1980877029036425,0.323294081154058,0,0,4.659394792399718,7.5437717166037235,ROR1,Pre-B,0.703142484213379
KEGG_2021_Human,sensory perception of mechanical stimulus (GO:0050954),1/88,0.1980877029036425,0.323294081154058,0,0,4.659394792399718,7.5437717166037235,ROR1,Pre-B,0.703142484213379
KEGG_2021_Human,sensory perception of sound (GO:0007605),1/91,0.2041137620931186,0.3300157088047619,0,0,4.503401360544218,7.156255051106618,ROR1,Pre-B,0.6901277125812961
KEGG_2021_Human,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.3365417645040274,0,0,4.357472021066491,6.79849904676328,ROR1,Pre-B,0.6775833802166729
KEGG_2021_Human,positive regulation of cell growth (GO:0030307),1/102,0.2258320069783284,0.3582316432177194,0,0,4.010709234188725,5.967790506031058,RASAL1,Pre-B,0.6462145058611213
KEGG_2021_Human,chromatin remodeling (GO:0006338),1/103,0.2277773453985499,0.3582316432177194,0,0,3.971188475390156,5.874923343943355,CECR2,Pre-B,0.64248947278397
KEGG_2021_Human,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.2335846623503299,0.3640553746541178,0,0,3.857142857142857,5.6090983677319475,ROR1,Pre-B,0.6315556772929499
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),2/371,0.2372893033351311,0.3664372305928846,0,0,2.2110433604336044,3.18053102486219,TCL1B;TCL1A,Pre-B,0.6247218387200065
KEGG_2021_Human,modulation of chemical synaptic transmission (GO:0050804),1/109,0.239349173739861,0.3664372305928846,0,0,3.749433106575964,5.361058744932435,RIMS3,Pre-B,0.6209680674126086
KEGG_2021_Human,phosphatidylinositol metabolic process (GO:0046488),1/112,0.2450711886958998,0.3719062775823743,0,0,3.647545504688362,5.129202360192396,PITPNM2,Pre-B,0.6107077427090284
KEGG_2021_Human,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.3743756222571926,0,0,3.582625970742279,4.982913653406146,ROR1,Pre-B,0.6040407011916724
KEGG_2021_Human,positive regulation of cell projection organization (GO:0031346),1/117,0.2545142764118688,0.3795773260280458,0,0,3.4894440534834623,4.774949480472317,ROR1,Pre-B,0.5942878518616017
KEGG_2021_Human,cytoskeleton organization (GO:0007010),1/120,0.2601244621662815,0.3846284782458693,0,0,3.4009603841536613,4.579716458908873,CECR2,Pre-B,0.5848188047272944
KEGG_2021_Human,phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.2712209880572274,0.397637550287291,0,0,3.236734693877551,4.223360488574632,PITPNM2,Pre-B,0.5666767062328689
KEGG_2021_Human,muscle contraction (GO:0006936),1/129,0.2767079241059198,0.4022728644565053,0,0,3.1603954081632653,4.060453122404681,MYBPC2,Pre-B,0.5579784037567757
KEGG_2021_Human,enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.2964824884084789,0.4274289207888904,0,0,2.9086771399207163,3.5362740390257685,ROR1,Pre-B,0.5280009529309525
KEGG_2021_Human,monocarboxylic acid metabolic process (GO:0032787),1/143,0.3017829564686885,0.4314748055296125,0,0,2.8467950560505892,3.410594866305226,ACSM1,Pre-B,0.5203052911363482
KEGG_2021_Human,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.4380792284567976,0,0,2.749271137026239,3.215201203875706,ROR1,Pre-B,0.5078961191737069
KEGG_2021_Human,response to cytokine (GO:0034097),1/150,0.3139989845586295,0.4380792284567976,0,0,2.712094233666621,3.141596466170354,AFF3,Pre-B,0.5030717563895143
KEGG_2021_Human,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.4380792284567976,0,0,2.712094233666621,3.141596466170354,ABCB4,Pre-B,0.5030717563895143
KEGG_2021_Human,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/155,0.3225962281219006,0.4464731797207104,0,0,2.6233766233766236,2.9679671260643183,ROR1,Pre-B,0.4913407148001928
KEGG_2021_Human,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/165,0.3394751386404204,0.4610722809202854,0,0,2.4621702339472376,2.6600168495918335,KREMEN2,Pre-B,0.46919202564454415
KEGG_2021_Human,regulation of neuron projection development (GO:0010975),1/165,0.3394751386404204,0.4610722809202854,0,0,2.4621702339472376,2.6600168495918335,ROR1,Pre-B,0.46919202564454415
KEGG_2021_Human,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.4610722809202854,0,0,2.4471243042671613,2.6317886779390967,ROR1,Pre-B,0.4670671197091842
KEGG_2021_Human,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.3494039111808349,0.4671591194720551,0,0,2.3745498199279713,2.4969025061029213,ROR1,Pre-B,0.4566722378913039
KEGG_2021_Human,positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.3510444250368044,0.4671591194720551,0,0,2.360544217687075,2.4711180018684864,ROR1,Pre-B,0.45463791963821665
KEGG_2021_Human,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.359186378521905,0.4743453701090807,0,0,2.2929035250463823,2.3477357103628296,PITPNM2,Pre-B,0.44468014150624274
KEGG_2021_Human,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.477091286215522,0,0,2.2541329380914377,2.2778849681371156,RIMS3,Pre-B,0.4388706874182523
KEGG_2021_Human,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.4924754617293269,0,0,2.122448979591837,2.045536603225051,DTX1,Pre-B,0.41855670871419515
KEGG_2021_Human,negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.3814549819175133,0.4924754617293269,0,0,2.122448979591837,2.045536603225051,KREMEN2,Pre-B,0.41855670871419515
KEGG_2021_Human,cellular response to tumor necrosis factor (GO:0071356),1/194,0.3861272144560919,0.4948148748215103,0,0,2.089140319340171,1.988001678572607,TCL1A,Pre-B,0.4132695879859197
KEGG_2021_Human,regulation of signal transduction (GO:0009966),1/198,0.3923030921692546,0.4990326098917724,0,0,2.0463068476121413,1.914771355908193,DTX1,Pre-B,0.4063782687077012
KEGG_2021_Human,regulation of macromolecule metabolic process (GO:0060255),1/200,0.3953681557510544,0.499260517846222,0,0,2.025535842477695,1.8795714928238216,AFF3,Pre-B,0.40299831311675843
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.5220130041198163,0,0,1.8910606496119575,1.656759537391559,KREMEN2,Pre-B,0.3804856946694876
KEGG_2021_Human,cellular response to lipid (GO:0071396),1/219,0.4237408440429794,0.5273896835930608,0,0,1.8472196217936716,1.5860841457604238,ABCB4,Pre-B,0.372899672681652
KEGG_2021_Human,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.5325778086262931,0,0,1.805344559348403,1.519514184420898,ROR1,Pre-B,0.36553500108915365
KEGG_2021_Human,regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.4508075224789805,0.5531184495664088,0,0,1.697494187548437,1.352418759111272,ROR1,Pre-B,0.34600884563424106
KEGG_2021_Human,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.4618276248188864,0.5626491485469531,0,0,1.641399416909621,1.2680853834334544,ROR1,Pre-B,0.33552009275365935
KEGG_2021_Human,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.5662052500975111,0,0,1.5952380952380951,1.2000608149186214,KREMEN2,Pre-B,0.32670971902140344
KEGG_2021_Human,positive regulation of phosphorylation (GO:0042327),1/253,0.4712922312950381,0.5662052500975111,0,0,1.5952380952380951,1.2000608149186214,ROR1,Pre-B,0.32670971902140344
KEGG_2021_Human,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5858467055209291,0,0,1.504471451501949,1.0700627976731167,ADAM23,Pre-B,0.3088941088615854
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5909466233695447,0,0,1.4709576138147566,1.0233666205889618,ROR1,Pre-B,0.30214499188263844
KEGG_2021_Human,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.6046275065783633,0,0,1.4081632653061225,0.937839142501346,HRK,Pre-B,0.289240867544339
KEGG_2021_Human,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.6245671450022147,0,0,1.32774699283687,0.8321996277505203,RASAL1,Pre-B,0.2722052530518486
KEGG_2021_Human,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.6299117581454304,0,0,1.2972062611452349,0.7932686422257892,HRK,Pre-B,0.2655801196036423
KEGG_2021_Human,cellular macromolecule biosynthetic process (GO:0034645),1/314,0.5471545986718139,0.6310516371348254,0,0,1.2803677381495728,0.7720923294539072,DTX1,Pre-B,0.26188994631047774
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.6354574363330847,0,0,1.2440106477373558,0.7270814983759607,ABCB4,Pre-B,0.2538302089398956
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),2/742,0.5583209845238664,0.6354574363330847,0,0,1.0816441441441442,0.6304051823091851,HRK;TCL1A,Pre-B,0.25311604886163686
KEGG_2021_Human,gene expression (GO:0010467),1/356,0.5930749260701463,0.6706010601969629,0,0,1.126473124461052,0.5885084653208599,DTX1,Pre-B,0.2268904366133749
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.6944801854521268,0,0,1.0510204081632653,0.5054679174936134,TCL1A,Pre-B,0.20886552310647807
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.7143032035389398,0,0,0.989871879272801,0.4417939051458828,ROR1,Pre-B,0.19383180708628664
KEGG_2021_Human,protein modification by small protein conjugation (GO:0032446),1/409,0.644552703427983,0.7147924211092376,0,0,0.9774909963985594,0.4293127610136149,DTX1,Pre-B,0.19074156570833578
KEGG_2021_Human,organelle organization (GO:0006996),1/420,0.6544076492323022,0.7210988746317725,0,0,0.9512931664312504,0.4033718992390181,CECR2,Pre-B,0.18415163293091988
KEGG_2021_Human,nervous system development (GO:0007399),1/447,0.677475806229693,0.7417931296059297,0,0,0.8924681980415484,0.3475105496336908,ADAM23,Pre-B,0.16910620954367267
KEGG_2021_Human,negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.6912187085983104,0.7520807332547653,0,0,0.8589500595054437,0.3172093937483807,BCL7A,Pre-B,0.16038451570993173
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),1/474,0.6990329319013457,0.755438469655605,0,0,0.8403589765716012,0.300896771210595,TCL1A,Pre-B,0.1555023638735803
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.755438469655605,0,0,0.8260426831855403,0.2885801301950252,TCL1A,Pre-B,0.1517218912312197
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.755438469655605,0,0,0.8207960870298533,0.2841203737887477,TCL1A,Pre-B,0.15033199168778996
KEGG_2021_Human,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.781119222576078,0,0,0.7565820221218258,0.231944503707841,DTX1,Pre-B,0.13314117322745964
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.7868809387153322,0,0,0.726642950758285,0.2091870484536521,ROR1,Pre-B,0.12502533841998253
KEGG_2021_Human,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7504933808556635,0.7868809387153322,0,0,0.7252747252747253,0.2081715773755284,BCL7A,Pre-B,0.1246531337611999
KEGG_2021_Human,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7918056879286368,0,0,0.7301532033426184,0.200604530418796,AFF3;RAG2,Pre-B,0.11931939791106433
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),1/625,0.7959537647207185,0.8245509059681696,0,0,0.6320643642072213,0.1442460501716775,TCL1A,Pre-B,0.09911215878223603
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",4/2244,0.8272634931131488,0.851884430408183,0,0,0.6875,0.130372014787288,SPIB;BCL7A;PAX5;BACH2,Pre-B,0.08235614053342308
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),1/764,0.8577067842472734,0.8780075365371496,0,0,0.5131997753229732,0.0787725634671716,TCL1A,Pre-B,0.06666115474745983
KEGG_2021_Human,positive regulation of transcription by RNA polymerase II (GO:0045944),1/908,0.9023188918982462,0.9182421664611564,0,0,0.4284814256463335,0.0440424414337815,SPIB,Pre-B,0.044639949690669034
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",1/948,0.912055183209665,0.9227224952939888,0,0,0.4095209361463698,0.0376983608425212,BCL7A,Pre-B,0.039978884217174375
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),3/2206,0.924809545507298,0.9301863451904798,0,0,0.5142021035145498,0.0401938720592393,SPIB;PAX5;BACH2,Pre-B,0.03394769628973127
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1183,0.952754544972228,0.952754544972228,0,0,0.3240443385476018,0.0156830878086274,SPIB,Pre-B,0.021018970814361417
GO_Biological_Process_2021,negative regulation of cytokinesis (GO:0032466),3/6,2.9246034188983885e-07,8.65682611993923e-05,0,0,424.40425531914894,6385.135183118324,AURKB;E2F7;E2F8,Pre-Pro B,6.533933016645414
GO_Biological_Process_2021,negative regulation of cell division (GO:0051782),3/12,3.183301843206519e-06,0.0004711286727945648,0,0,141.4255319148936,1790.1066225817303,AURKB;E2F7;E2F8,Pre-Pro B,5.497122179279147
GO_Biological_Process_2021,negative regulation of cell cycle process (GO:0010948),4/64,1.9659499977716905e-05,0.0019397373311347,0,0,28.82608695652174,312.3868594993703,RRM2;AURKB;E2F7;E2F8,Pre-Pro B,4.706427532265834
GO_Biological_Process_2021,trophoblast giant cell differentiation (GO:0060707),2/5,6.0956786529959696e-05,0.0045036040120219,0,0,277.0416666666667,2688.78505476905,E2F7;E2F8,Pre-Pro B,4.214977935846465
GO_Biological_Process_2021,sister chromatid segregation (GO:0000819),3/34,8.329713391830358e-05,0.0045036040120219,0,0,41.01372683596431,385.24589055488593,TOP2A;KIF18B;NUSAP1,Pre-Pro B,4.079369941508931
GO_Biological_Process_2021,hepatocyte differentiation (GO:0070365),2/6,9.128927051395768e-05,0.0045036040120219,0,0,207.77083333333337,1932.5756890799971,E2F7;E2F8,Pre-Pro B,4.039580263324499
GO_Biological_Process_2021,positive regulation of cell cycle process (GO:0090068),4/101,0.00011803358541059466,0.0045371637763382,0,0,17.797400268937697,160.96932268822695,NUSAP1;AURKB;E2F7;E2F8,Pre-Pro B,3.9279944004638385
GO_Biological_Process_2021,mitotic sister chromatid segregation (GO:0000070),4/102,0.0001226260480091412,0.0045371637763382,0,0,17.614906832298136,158.64638771191477,KIF18B;NUSAP1;NCAPG;CEP55,Pre-Pro B,3.9114172679492665
GO_Biological_Process_2021,chromosome condensation (GO:0030261),3/45,0.00019374001249454243,0.0063718937442649,0,0,30.25531914893617,258.65252491347,TOP2A;NUSAP1;NCAPG,Pre-Pro B,3.7127806765909845
GO_Biological_Process_2021,positive regulation of DNA-dependent DNA replication (GO:2000105),2/11,0.000332063883264561,0.009829090944631,0,0,92.31944444444444,739.4956618223716,E2F7;E2F8,Pre-Pro B,3.478778357620151
GO_Biological_Process_2021,placenta development (GO:0001890),2/15,0.0006299020654549659,0.0169500919431518,0,0,63.90064102564103,470.9442866528224,E2F7;E2F8,Pre-Pro B,3.200726967591985
GO_Biological_Process_2021,cytoskeleton-dependent cytokinesis (GO:0061640),3/72,0.0007765711595735495,0.0191554219361475,0,0,18.39130434782609,131.69318363710184,NUSAP1;AURKB;CEP55,Pre-Pro B,3.10981874238982
GO_Biological_Process_2021,regulation of chromosome segregation (GO:0051983),2/18,0.000913470506242016,0.0207990207575105,0,0,51.911458333333336,363.2898548418271,MKI67;AURKB,Pre-Pro B,3.039305470405725
GO_Biological_Process_2021,regulation of cytokinesis (GO:0032465),3/84,0.0012148566191106,0.0256855399469104,0,0,15.657210401891254,105.10887662312086,AURKB;E2F7;E2F8,Pre-Pro B,2.91547497573114
GO_Biological_Process_2021,mitotic chromosome condensation (GO:0007076),2/27,0.0020657293545543,0.0407637259298724,0,0,33.208333333333336,205.3029465636782,NUSAP1;NCAPG,Pre-Pro B,2.684926579003782
GO_Biological_Process_2021,plasma membrane invagination (GO:0099024),2/30,0.0025478771667966,0.0471357275857376,0,0,29.645833333333332,177.0595839464994,IGLL1;AURKB,Pre-Pro B,2.5938215131766835
GO_Biological_Process_2021,liver development (GO:0001889),2/32,0.0028959211173454,0.0476218139296803,0,0,27.666666666666668,161.69650653172428,E2F7;E2F8,Pre-Pro B,2.5382132721600397
GO_Biological_Process_2021,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),2/32,0.0028959211173454,0.0476218139296803,0,0,27.666666666666668,161.69650653172428,RRM2;E2F7,Pre-Pro B,2.5382132721600397
GO_Biological_Process_2021,mitotic cytokinesis (GO:0000281),2/49,0.0066828970303688,0.1041125011046937,0,0,17.64450354609929,88.36726791367238,NUSAP1;CEP55,Pre-Pro B,2.175035230405133
GO_Biological_Process_2021,sprouting angiogenesis (GO:0002040),2/52,0.007499481830469,0.1109923310909422,0,0,16.583333333333332,81.14094572244915,E2F7;E2F8,Pre-Pro B,2.12496874273393
GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",2/56,0.0086546685435214,0.1117833797670445,0,0,15.351851851851851,72.91602120992282,E2F7;E2F8,Pre-Pro B,2.0627495600792987
GO_Biological_Process_2021,regulation of mitotic nuclear division (GO:0007088),2/57,0.0089551608364968,0.1117833797670445,0,0,15.071969696969695,71.07225417227201,NUSAP1;MKI67,Pre-Pro B,2.0479266097283184
GO_Biological_Process_2021,mitotic G1 DNA damage checkpoint signaling (GO:0031571),2/65,0.0115237618661231,0.1117833797670445,0,0,13.15277777777778,58.70537343689256,E2F7;E2F8,Pre-Pro B,1.9384057248186684
GO_Biological_Process_2021,L-arginine import across plasma membrane (GO:0097638),1/5,0.0124387771927725,0.1117833797670445,0,0,101.76530612244898,446.4379351400606,SLC7A3,Pre-Pro B,1.9052223113279663
GO_Biological_Process_2021,establishment of protein localization to telomere (GO:0070200),1/5,0.0124387771927725,0.1117833797670445,0,0,101.76530612244898,446.4379351400606,TERT,Pre-Pro B,1.9052223113279663
GO_Biological_Process_2021,apoptotic chromosome condensation (GO:0030263),1/5,0.0124387771927725,0.1117833797670445,0,0,101.76530612244898,446.4379351400606,TOP2A,Pre-Pro B,1.9052223113279663
GO_Biological_Process_2021,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),1/5,0.0124387771927725,0.1117833797670445,0,0,101.76530612244898,446.4379351400606,UHRF1,Pre-Pro B,1.9052223113279663
GO_Biological_Process_2021,deoxyribonucleotide metabolic process (GO:0009262),1/5,0.0124387771927725,0.1117833797670445,0,0,101.76530612244898,446.4379351400606,RRM2,Pre-Pro B,1.9052223113279663
GO_Biological_Process_2021,ornithine transport (GO:0015822),1/5,0.0124387771927725,0.1117833797670445,0,0,101.76530612244898,446.4379351400606,SLC7A3,Pre-Pro B,1.9052223113279663
GO_Biological_Process_2021,carbon dioxide transport (GO:0015670),1/5,0.0124387771927725,0.1117833797670445,0,0,101.76530612244898,446.4379351400606,AQP5,Pre-Pro B,1.9052223113279663
GO_Biological_Process_2021,regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),1/5,0.0124387771927725,0.1117833797670445,0,0,101.76530612244898,446.4379351400606,UHRF1,Pre-Pro B,1.9052223113279663
GO_Biological_Process_2021,mitotic nuclear division (GO:0140014),2/74,0.0147525184670075,0.1117833797670445,0,0,11.50347222222222,48.50256694786101,KIF18B;NUSAP1,Pre-Pro B,1.8311338330445346
GO_Biological_Process_2021,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",2/74,0.0147525184670075,0.1117833797670445,0,0,11.50347222222222,48.50256694786101,E2F7;E2F8,Pre-Pro B,1.8311338330445346
GO_Biological_Process_2021,L-arginine transmembrane transport (GO:1903400),1/6,0.0149082847993736,0.1117833797670445,0,0,81.40816326530613,342.3895623444841,SLC7A3,Pre-Pro B,1.8265723193247598
GO_Biological_Process_2021,L-ornithine transmembrane transport (GO:1903352),1/6,0.0149082847993736,0.1117833797670445,0,0,81.40816326530613,342.3895623444841,SLC7A3,Pre-Pro B,1.8265723193247598
GO_Biological_Process_2021,maintenance of DNA methylation (GO:0010216),1/6,0.0149082847993736,0.1117833797670445,0,0,81.40816326530613,342.3895623444841,UHRF1,Pre-Pro B,1.8265723193247598
GO_Biological_Process_2021,histone-serine phosphorylation (GO:0035404),1/6,0.0149082847993736,0.1117833797670445,0,0,81.40816326530613,342.3895623444841,AURKB,Pre-Pro B,1.8265723193247598
GO_Biological_Process_2021,regulation of cell division (GO:0051302),2/76,0.0155171628224907,0.1117833797670445,0,0,11.19144144144144,46.62140287744705,KIF18B;AURKB,Pre-Pro B,1.8091876827669675
GO_Biological_Process_2021,"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",1/7,0.0173717414502839,0.1117833797670445,0,0,67.83673469387755,274.9362107684438,ELOVL2,Pre-Pro B,1.7601566430186848
GO_Biological_Process_2021,"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",1/7,0.0173717414502839,0.1117833797670445,0,0,67.83673469387755,274.9362107684438,ELOVL2,Pre-Pro B,1.7601566430186848
GO_Biological_Process_2021,"fatty acid elongation, saturated fatty acid (GO:0019367)",1/7,0.0173717414502839,0.1117833797670445,0,0,67.83673469387755,274.9362107684438,ELOVL2,Pre-Pro B,1.7601566430186848
GO_Biological_Process_2021,"fatty acid elongation, unsaturated fatty acid (GO:0019368)",1/7,0.0173717414502839,0.1117833797670445,0,0,67.83673469387755,274.9362107684438,ELOVL2,Pre-Pro B,1.7601566430186848
GO_Biological_Process_2021,cleavage furrow formation (GO:0036089),1/7,0.0173717414502839,0.1117833797670445,0,0,67.83673469387755,274.9362107684438,AURKB,Pre-Pro B,1.7601566430186848
GO_Biological_Process_2021,DNA ligation (GO:0006266),1/7,0.0173717414502839,0.1117833797670445,0,0,67.83673469387755,274.9362107684438,TOP2A,Pre-Pro B,1.7601566430186848
GO_Biological_Process_2021,hypotonic response (GO:0006971),1/7,0.0173717414502839,0.1117833797670445,0,0,67.83673469387755,274.9362107684438,AQP5,Pre-Pro B,1.7601566430186848
GO_Biological_Process_2021,cellular hypotonic response (GO:0071476),1/7,0.0173717414502839,0.1117833797670445,0,0,67.83673469387755,274.9362107684438,AQP5,Pre-Pro B,1.7601566430186848
GO_Biological_Process_2021,negative regulation of B cell apoptotic process (GO:0002903),1/8,0.0198291614511851,0.1128736882605921,0,0,58.142857142857146,227.9549801512961,AURKB,Pre-Pro B,1.702695651141308
GO_Biological_Process_2021,negative regulation of chromosome organization (GO:2001251),1/8,0.0198291614511851,0.1128736882605921,0,0,58.142857142857146,227.9549801512961,TOP2A,Pre-Pro B,1.702695651141308
GO_Biological_Process_2021,mitotic spindle elongation (GO:0000022),1/8,0.0198291614511851,0.1128736882605921,0,0,58.142857142857146,227.9549801512961,AURKB,Pre-Pro B,1.702695651141308
GO_Biological_Process_2021,mitotic spindle midzone assembly (GO:0051256),1/8,0.0198291614511851,0.1128736882605921,0,0,58.142857142857146,227.9549801512961,AURKB,Pre-Pro B,1.702695651141308
GO_Biological_Process_2021,positive regulation of isomerase activity (GO:0010912),1/8,0.0198291614511851,0.1128736882605921,0,0,58.142857142857146,227.9549801512961,UHRF1,Pre-Pro B,1.702695651141308
GO_Biological_Process_2021,regulation of protein localization to nucleolus (GO:1904749),1/8,0.0198291614511851,0.1128736882605921,0,0,58.142857142857146,227.9549801512961,TERT,Pre-Pro B,1.702695651141308
GO_Biological_Process_2021,"complement activation, classical pathway (GO:0006958)",1/9,0.0222805591236868,0.1177686696537731,0,0,50.87244897959184,193.52086993316271,IGLL1,Pre-Pro B,1.652073914876897
GO_Biological_Process_2021,one-carbon compound transport (GO:0019755),1/9,0.0222805591236868,0.1177686696537731,0,0,50.87244897959184,193.52086993316271,AQP5,Pre-Pro B,1.652073914876897
GO_Biological_Process_2021,DNA topological change (GO:0006265),1/9,0.0222805591236868,0.1177686696537731,0,0,50.87244897959184,193.52086993316271,TOP2A,Pre-Pro B,1.652073914876897
GO_Biological_Process_2021,intestinal epithelial cell differentiation (GO:0060575),1/9,0.0222805591236868,0.1177686696537731,0,0,50.87244897959184,193.52086993316271,NPY,Pre-Pro B,1.652073914876897
GO_Biological_Process_2021,sequestering of actin monomers (GO:0042989),1/10,0.024725948817258,0.1199816532771866,0,0,45.21768707482993,167.3010120823387,TMSB15A,Pre-Pro B,1.606847034080906
GO_Biological_Process_2021,regulation of hair cycle (GO:0042634),1/10,0.024725948817258,0.1199816532771866,0,0,45.21768707482993,167.3010120823387,TERT,Pre-Pro B,1.606847034080906
GO_Biological_Process_2021,negative regulation of lymphocyte apoptotic process (GO:0070229),1/10,0.024725948817258,0.1199816532771866,0,0,45.21768707482993,167.3010120823387,AURKB,Pre-Pro B,1.606847034080906
GO_Biological_Process_2021,production of siRNA involved in RNA interference (GO:0030422),1/10,0.024725948817258,0.1199816532771866,0,0,45.21768707482993,167.3010120823387,TERT,Pre-Pro B,1.606847034080906
GO_Biological_Process_2021,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),1/10,0.024725948817258,0.1199816532771866,0,0,45.21768707482993,167.3010120823387,NPTX1,Pre-Pro B,1.606847034080906
GO_Biological_Process_2021,epithelial cell differentiation (GO:0030855),2/101,0.0264315192050235,0.1215353733542802,0,0,8.35479797979798,30.35463590957481,E2F7;E2F8,Pre-Pro B,1.577877874197194
GO_Biological_Process_2021,negative regulation of sprouting angiogenesis (GO:1903671),1/11,0.0271653448579923,0.1215353733542802,0,0,40.69387755102041,146.73452100035948,E2F2,Pre-Pro B,1.5659847773237099
GO_Biological_Process_2021,columnar/cuboidal epithelial cell differentiation (GO:0002065),1/11,0.0271653448579923,0.1215353733542802,0,0,40.69387755102041,146.73452100035948,NPY,Pre-Pro B,1.5659847773237099
GO_Biological_Process_2021,humoral immune response mediated by circulating immunoglobulin (GO:0002455),1/11,0.0271653448579923,0.1215353733542802,0,0,40.69387755102041,146.73452100035948,IGLL1,Pre-Pro B,1.5659847773237099
GO_Biological_Process_2021,regulation of cell cycle process (GO:0010564),2/106,0.0288986461861609,0.1215353733542802,0,0,7.951121794871795,28.178461808105727,MKI67;AURKB,Pre-Pro B,1.5391225021448902
GO_Biological_Process_2021,gas transport (GO:0015669),1/12,0.029598761568907,0.1215353733542802,0,0,36.99257884972171,130.2147194065139,AQP5,Pre-Pro B,1.5287264597194943
GO_Biological_Process_2021,negative regulation of gene silencing by miRNA (GO:0060965),1/12,0.029598761568907,0.1215353733542802,0,0,36.99257884972171,130.2147194065139,TERT,Pre-Pro B,1.5287264597194943
GO_Biological_Process_2021,regulation of B cell apoptotic process (GO:0002902),1/12,0.029598761568907,0.1215353733542802,0,0,36.99257884972171,130.2147194065139,AURKB,Pre-Pro B,1.5287264597194943
GO_Biological_Process_2021,replicative senescence (GO:0090399),1/12,0.029598761568907,0.1215353733542802,0,0,36.99257884972171,130.2147194065139,TERT,Pre-Pro B,1.5287264597194943
GO_Biological_Process_2021,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/12,0.029598761568907,0.1215353733542802,0,0,36.99257884972171,130.2147194065139,TERT,Pre-Pro B,1.5287264597194943
GO_Biological_Process_2021,protein localization to condensed chromosome (GO:1903083),1/12,0.029598761568907,0.1215353733542802,0,0,36.99257884972171,130.2147194065139,AURKB,Pre-Pro B,1.5287264597194943
GO_Biological_Process_2021,DNA metabolic process (GO:0006259),3/277,0.0319453076723714,0.1215353733542802,0,0,4.583630998602268,15.784787458078153,TOP2A;TERT;UHRF1,Pre-Pro B,1.4955929247248396
GO_Biological_Process_2021,establishment of protein localization to chromosome (GO:0070199),1/13,0.032026213248763,0.1215353733542802,0,0,33.90816326530612,116.6847899929619,TERT,Pre-Pro B,1.4944944088974865
GO_Biological_Process_2021,alpha-linolenic acid metabolic process (GO:0036109),1/13,0.032026213248763,0.1215353733542802,0,0,33.90816326530612,116.6847899929619,ELOVL2,Pre-Pro B,1.4944944088974865
GO_Biological_Process_2021,fatty acid elongation (GO:0030497),1/13,0.032026213248763,0.1215353733542802,0,0,33.90816326530612,116.6847899929619,ELOVL2,Pre-Pro B,1.4944944088974865
GO_Biological_Process_2021,negative regulation of cellular senescence (GO:2000773),1/13,0.032026213248763,0.1215353733542802,0,0,33.90816326530612,116.6847899929619,TERT,Pre-Pro B,1.4944944088974865
GO_Biological_Process_2021,very long-chain fatty acid biosynthetic process (GO:0042761),1/13,0.032026213248763,0.1215353733542802,0,0,33.90816326530612,116.6847899929619,ELOVL2,Pre-Pro B,1.4944944088974865
GO_Biological_Process_2021,histone modification (GO:0016570),2/114,0.0330295301793541,0.1230759481111418,0,0,7.380208333333333,25.169117576656426,UHRF1;AURKB,Pre-Pro B,1.4810976037825534
GO_Biological_Process_2021,covalent chromatin modification (GO:0016569),1/14,0.0344477141698711,0.1230759481111418,0,0,31.298273155416013,105.4223689491126,AURKB,Pre-Pro B,1.4628395910668823
GO_Biological_Process_2021,regulation of chromatin organization (GO:1902275),1/14,0.0344477141698711,0.1230759481111418,0,0,31.298273155416013,105.4223689491126,MKI67,Pre-Pro B,1.4628395910668823
GO_Biological_Process_2021,protein localization to kinetochore (GO:0034501),1/14,0.0344477141698711,0.1230759481111418,0,0,31.298273155416013,105.4223689491126,AURKB,Pre-Pro B,1.4628395910668823
GO_Biological_Process_2021,regulation of protein binding (GO:0043393),2/118,0.0351769550093681,0.1230759481111418,0,0,7.124281609195402,23.8475644827565,TERT;AURKB,Pre-Pro B,1.4537417566881954
GO_Biological_Process_2021,establishment of spindle localization (GO:0051293),1/15,0.0368632785936063,0.1230759481111418,0,0,29.06122448979592,95.91771596133704,NUSAP1,Pre-Pro B,1.4334060415588732
GO_Biological_Process_2021,central nervous system neuron development (GO:0021954),1/15,0.0368632785936063,0.1230759481111418,0,0,29.06122448979592,95.91771596133704,NPY,Pre-Pro B,1.4334060415588732
GO_Biological_Process_2021,"protein localization to chromosome, telomeric region (GO:0070198)",1/15,0.0368632785936063,0.1230759481111418,0,0,29.06122448979592,95.91771596133704,TERT,Pre-Pro B,1.4334060415588732
GO_Biological_Process_2021,resolution of meiotic recombination intermediates (GO:0000712),1/16,0.0392729207344652,0.1230759481111418,0,0,27.122448979591837,87.80133530116419,TOP2A,Pre-Pro B,1.405906798966597
GO_Biological_Process_2021,microtubule cytoskeleton organization involved in mitosis (GO:1902850),2/128,0.0407746939326368,0.1230759481111418,0,0,6.555555555555555,20.975769396496517,NUSAP1;AURKB,Pre-Pro B,1.3896092902230834
GO_Biological_Process_2021,negative regulation of cell aging (GO:0090344),1/17,0.0416766547912334,0.1230759481111418,0,0,25.426020408163264,80.79916728086499,TERT,Pre-Pro B,1.3801071472903907
GO_Biological_Process_2021,regulation of stem cell proliferation (GO:0072091),1/17,0.0416766547912334,0.1230759481111418,0,0,25.426020408163264,80.79916728086499,TERT,Pre-Pro B,1.3801071472903907
GO_Biological_Process_2021,positive regulation of stem cell proliferation (GO:2000648),1/17,0.0416766547912334,0.1230759481111418,0,0,25.426020408163264,80.79916728086499,TERT,Pre-Pro B,1.3801071472903907
GO_Biological_Process_2021,positive regulation of telomere capping (GO:1904355),1/17,0.0416766547912334,0.1230759481111418,0,0,25.426020408163264,80.79916728086499,AURKB,Pre-Pro B,1.3801071472903907
GO_Biological_Process_2021,midbody abscission (GO:0061952),1/17,0.0416766547912334,0.1230759481111418,0,0,25.426020408163264,80.79916728086499,CEP55,Pre-Pro B,1.3801071472903907
GO_Biological_Process_2021,DNA biosynthetic process (GO:0071897),1/17,0.0416766547912334,0.1230759481111418,0,0,25.426020408163264,80.79916728086499,TERT,Pre-Pro B,1.3801071472903907
GO_Biological_Process_2021,RNA interference (GO:0016246),1/17,0.0416766547912334,0.1230759481111418,0,0,25.426020408163264,80.79916728086499,TERT,Pre-Pro B,1.3801071472903907
GO_Biological_Process_2021,"protein localization to chromosome, centromeric region (GO:0071459)",1/17,0.0416766547912334,0.1230759481111418,0,0,25.426020408163264,80.79916728086499,AURKB,Pre-Pro B,1.3801071472903907
GO_Biological_Process_2021,positive regulation of nitric-oxide synthase activity (GO:0051000),1/18,0.0440744949316926,0.1230759481111418,0,0,23.92917166866747,74.70385911458476,TERT,Pre-Pro B,1.3558126557645607
GO_Biological_Process_2021,regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),1/18,0.0440744949316926,0.1230759481111418,0,0,23.92917166866747,74.70385911458476,TOP2A,Pre-Pro B,1.3558126557645607
GO_Biological_Process_2021,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,0.0440744949316926,0.1230759481111418,0,0,23.92917166866747,74.70385911458476,ELOVL2,Pre-Pro B,1.3558126557645607
GO_Biological_Process_2021,fluid transport (GO:0042044),1/18,0.0440744949316926,0.1230759481111418,0,0,23.92917166866747,74.70385911458476,AQP5,Pre-Pro B,1.3558126557645607
GO_Biological_Process_2021,nucleotide biosynthetic process (GO:0009165),1/18,0.0440744949316926,0.1230759481111418,0,0,23.92917166866747,74.70385911458476,RRM2,Pre-Pro B,1.3558126557645607
GO_Biological_Process_2021,microtubule depolymerization (GO:0007019),1/18,0.0440744949316926,0.1230759481111418,0,0,23.92917166866747,74.70385911458476,KIF18B,Pre-Pro B,1.3558126557645607
GO_Biological_Process_2021,DNA conformation change (GO:0071103),1/18,0.0440744949316926,0.1230759481111418,0,0,23.92917166866747,74.70385911458476,TOP2A,Pre-Pro B,1.3558126557645607
GO_Biological_Process_2021,water transport (GO:0006833),1/18,0.0440744949316926,0.1230759481111418,0,0,23.92917166866747,74.70385911458476,AQP5,Pre-Pro B,1.3558126557645607
GO_Biological_Process_2021,DNA strand elongation (GO:0022616),1/18,0.0440744949316926,0.1230759481111418,0,0,23.92917166866747,74.70385911458476,TERT,Pre-Pro B,1.3558126557645607
GO_Biological_Process_2021,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/18,0.0440744949316926,0.1230759481111418,0,0,23.92917166866747,74.70385911458476,TERT,Pre-Pro B,1.3558126557645607
GO_Biological_Process_2021,negative regulation of RNA metabolic process (GO:0051253),1/19,0.0464664552952436,0.1273525071054825,0,0,22.598639455782312,69.35578082800635,TERT,Pre-Pro B,1.3328604565168853
GO_Biological_Process_2021,regulation of nervous system process (GO:0031644),1/19,0.0464664552952436,0.1273525071054825,0,0,22.598639455782312,69.35578082800635,NPTX1,Pre-Pro B,1.3328604565168853
GO_Biological_Process_2021,nucleobase-containing compound biosynthetic process (GO:0034654),1/20,0.0488525499820277,0.1291103106667876,0,0,21.40816326530612,64.63014669364038,TERT,Pre-Pro B,1.3111127622579986
GO_Biological_Process_2021,mitotic cytokinetic process (GO:1902410),1/20,0.0488525499820277,0.1291103106667876,0,0,21.40816326530612,64.63014669364038,CEP55,Pre-Pro B,1.3111127622579986
GO_Biological_Process_2021,regulation of nuclear division (GO:0051783),1/20,0.0488525499820277,0.1291103106667876,0,0,21.40816326530612,64.63014669364038,MKI67,Pre-Pro B,1.3111127622579986
GO_Biological_Process_2021,production of small RNA involved in gene silencing by RNA (GO:0070918),1/20,0.0488525499820277,0.1291103106667876,0,0,21.40816326530612,64.63014669364038,TERT,Pre-Pro B,1.3111127622579986
GO_Biological_Process_2021,linoleic acid metabolic process (GO:0043651),1/21,0.0512327930672156,0.1330254977885598,0,0,20.336734693877553,60.42807445408675,ELOVL2,Pre-Pro B,1.2904519669693806
GO_Biological_Process_2021,histone ubiquitination (GO:0016574),1/21,0.0512327930672156,0.1330254977885598,0,0,20.336734693877553,60.42807445408675,UHRF1,Pre-Pro B,1.2904519669693806
GO_Biological_Process_2021,cellular response to osmotic stress (GO:0071470),1/22,0.0536071985992547,0.1379802676989514,0,0,19.367346938775512,56.67024999786951,AQP5,Pre-Pro B,1.2707768875084013
GO_Biological_Process_2021,negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.0559757805878795,0.139233874403465,0,0,18.4860853432282,53.29235549319145,TERT,Pre-Pro B,1.2519998414265567
GO_Biological_Process_2021,regulation of telomere capping (GO:1904353),1/23,0.0559757805878795,0.139233874403465,0,0,18.4860853432282,53.29235549319145,AURKB,Pre-Pro B,1.2519998414265567
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.0559757805878795,0.139233874403465,0,0,18.4860853432282,53.29235549319145,TERT,Pre-Pro B,1.2519998414265567
GO_Biological_Process_2021,mitotic cell cycle checkpoint signaling (GO:0007093),1/23,0.0559757805878795,0.139233874403465,0,0,18.4860853432282,53.29235549319145,AURKB,Pre-Pro B,1.2519998414265567
GO_Biological_Process_2021,amino acid import across plasma membrane (GO:0089718),1/24,0.0583385530130099,0.1403919649743979,0,0,17.68145519077196,50.24171555062859,SLC7A3,Pre-Pro B,1.2340443470047993
GO_Biological_Process_2021,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/24,0.0583385530130099,0.1403919649743979,0,0,17.68145519077196,50.24171555062859,ELOVL2,Pre-Pro B,1.2340443470047993
GO_Biological_Process_2021,apoptotic nuclear changes (GO:0030262),1/24,0.0583385530130099,0.1403919649743979,0,0,17.68145519077196,50.24171555062859,TOP2A,Pre-Pro B,1.2340443470047993
GO_Biological_Process_2021,histone monoubiquitination (GO:0010390),1/24,0.0583385530130099,0.1403919649743979,0,0,17.68145519077196,50.24171555062859,UHRF1,Pre-Pro B,1.2340443470047993
GO_Biological_Process_2021,negative regulation of actin filament polymerization (GO:0030837),1/25,0.0606955298241754,0.1448861034512574,0,0,16.943877551020407,47.47480020477031,TMSB15A,Pre-Pro B,1.2168432931781568
GO_Biological_Process_2021,L-alpha-amino acid transmembrane transport (GO:1902475),1/27,0.0653921522588676,0.1492047814087327,0,0,15.638932496075354,42.652889831563165,SLC7A3,Pre-Pro B,1.184474368421492
GO_Biological_Process_2021,positive regulation of nuclear division (GO:0051785),1/27,0.0653921522588676,0.1492047814087327,0,0,15.638932496075354,42.652889831563165,NUSAP1,Pre-Pro B,1.184474368421492
GO_Biological_Process_2021,nucleobase-containing small molecule interconversion (GO:0015949),1/27,0.0653921522588676,0.1492047814087327,0,0,15.638932496075354,42.652889831563165,RRM2,Pre-Pro B,1.184474368421492
GO_Biological_Process_2021,microtubule polymerization or depolymerization (GO:0031109),1/27,0.0653921522588676,0.1492047814087327,0,0,15.638932496075354,42.652889831563165,KIF18B,Pre-Pro B,1.184474368421492
GO_Biological_Process_2021,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.0677318256109869,0.1492047814087327,0,0,15.058956916099774,40.54171043527237,TERT,Pre-Pro B,1.1692072184717057
GO_Biological_Process_2021,L-amino acid transport (GO:0015807),1/28,0.0677318256109869,0.1492047814087327,0,0,15.058956916099774,40.54171043527237,SLC7A3,Pre-Pro B,1.1692072184717057
GO_Biological_Process_2021,regulation of B cell activation (GO:0050864),1/28,0.0677318256109869,0.1492047814087327,0,0,15.058956916099774,40.54171043527237,IGLL1,Pre-Pro B,1.1692072184717057
GO_Biological_Process_2021,carbohydrate derivative biosynthetic process (GO:1901137),1/28,0.0677318256109869,0.1492047814087327,0,0,15.058956916099774,40.54171043527237,RRM2,Pre-Pro B,1.1692072184717057
GO_Biological_Process_2021,protein depolymerization (GO:0051261),1/28,0.0677318256109869,0.1492047814087327,0,0,15.058956916099774,40.54171043527237,KIF18B,Pre-Pro B,1.1692072184717057
GO_Biological_Process_2021,positive regulation of monooxygenase activity (GO:0032770),1/28,0.0677318256109869,0.1492047814087327,0,0,15.058956916099774,40.54171043527237,TERT,Pre-Pro B,1.1692072184717057
GO_Biological_Process_2021,establishment of mitotic spindle localization (GO:0040001),1/29,0.0700657588372089,0.1492047814087327,0,0,14.520408163265309,38.5999069065122,NUSAP1,Pre-Pro B,1.1544941700666143
GO_Biological_Process_2021,telomere maintenance via telomerase (GO:0007004),1/29,0.0700657588372089,0.1492047814087327,0,0,14.520408163265309,38.5999069065122,TERT,Pre-Pro B,1.1544941700666143
GO_Biological_Process_2021,positive regulation of dephosphorylation (GO:0035306),1/29,0.0700657588372089,0.1492047814087327,0,0,14.520408163265309,38.5999069065122,CDCA2,Pre-Pro B,1.1544941700666143
GO_Biological_Process_2021,beta-catenin-TCF complex assembly (GO:1904837),1/29,0.0700657588372089,0.1492047814087327,0,0,14.520408163265309,38.5999069065122,TERT,Pre-Pro B,1.1544941700666143
GO_Biological_Process_2021,positive regulation of viral genome replication (GO:0045070),1/29,0.0700657588372089,0.1492047814087327,0,0,14.520408163265309,38.5999069065122,TOP2A,Pre-Pro B,1.1544941700666143
GO_Biological_Process_2021,fatty-acyl-CoA biosynthetic process (GO:0046949),1/30,0.0723939657090184,0.1519759847508471,0,0,14.019000703729768,36.80874147674154,ELOVL2,Pre-Pro B,1.1402976322627019
GO_Biological_Process_2021,RNA-dependent DNA biosynthetic process (GO:0006278),1/30,0.0723939657090184,0.1519759847508471,0,0,14.019000703729768,36.80874147674154,TERT,Pre-Pro B,1.1402976322627019
GO_Biological_Process_2021,regulation of cellular senescence (GO:2000772),1/31,0.0747164600026276,0.1546578472781662,0,0,13.551020408163266,35.15209038871121,TERT,Pre-Pro B,1.126583712764908
GO_Biological_Process_2021,protein acetylation (GO:0006473),1/31,0.0747164600026276,0.1546578472781662,0,0,13.551020408163266,35.15209038871121,ESCO2,Pre-Pro B,1.126583712764908
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),5/908,0.0754099186412883,0.1550092772070927,0,0,2.343669250645995,6.057954869114585,TERT;UHRF1;E2F2;E2F7;E2F8,Pre-Pro B,1.1225715277657997
GO_Biological_Process_2021,positive regulation of telomere maintenance (GO:0032206),1/32,0.0770332554327668,0.1559247878765881,0,0,13.113232389730086,33.61600807740255,AURKB,Pre-Pro B,1.1133217484244988
GO_Biological_Process_2021,RNA biosynthetic process (GO:0032774),1/32,0.0770332554327668,0.1559247878765881,0,0,13.113232389730086,33.61600807740255,TERT,Pre-Pro B,1.1133217484244988
GO_Biological_Process_2021,signal transduction by p53 class mediator (GO:0072331),1/33,0.0793443657059371,0.1559247878765881,0,0,12.70280612244898,32.18837516559274,E2F7,Pre-Pro B,1.1004839073426347
GO_Biological_Process_2021,regulation of sprouting angiogenesis (GO:1903670),1/33,0.0793443657059371,0.1559247878765881,0,0,12.70280612244898,32.18837516559274,E2F2,Pre-Pro B,1.1004839073426347
GO_Biological_Process_2021,positive regulation of telomere maintenance via telomerase (GO:0032212),1/33,0.0793443657059371,0.1559247878765881,0,0,12.70280612244898,32.18837516559274,AURKB,Pre-Pro B,1.1004839073426347
GO_Biological_Process_2021,very long-chain fatty acid metabolic process (GO:0000038),1/33,0.0793443657059371,0.1559247878765881,0,0,12.70280612244898,32.18837516559274,ELOVL2,Pre-Pro B,1.1004839073426347
GO_Biological_Process_2021,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.0816498044624026,0.1559247878765881,0,0,12.317254174397032,30.85861216573232,TERT,Pre-Pro B,1.0880448509885652
GO_Biological_Process_2021,positive regulation of protein dephosphorylation (GO:0035307),1/34,0.0816498044624026,0.1559247878765881,0,0,12.317254174397032,30.85861216573232,CDCA2,Pre-Pro B,1.0880448509885652
GO_Biological_Process_2021,central nervous system neuron differentiation (GO:0021953),1/34,0.0816498044624026,0.1559247878765881,0,0,12.317254174397032,30.85861216573232,NPY,Pre-Pro B,1.0880448509885652
GO_Biological_Process_2021,B cell receptor signaling pathway (GO:0050853),1/34,0.0816498044624026,0.1559247878765881,0,0,12.317254174397032,30.85861216573232,IGLL1,Pre-Pro B,1.0880448509885652
GO_Biological_Process_2021,positive regulation of telomerase activity (GO:0051973),1/34,0.0816498044624026,0.1559247878765881,0,0,12.317254174397032,30.85861216573232,AURKB,Pre-Pro B,1.0880448509885652
GO_Biological_Process_2021,negative regulation of cell cycle G1/S phase transition (GO:1902807),1/35,0.0839495853612937,0.1582743774964519,0,0,11.95438175270108,29.61744503578088,E2F7,Pre-Pro B,1.0759814445616303
GO_Biological_Process_2021,positive regulation of lymphocyte activation (GO:0051251),1/35,0.0839495853612937,0.1582743774964519,0,0,11.95438175270108,29.61744503578088,IGLL1,Pre-Pro B,1.0759814445616303
GO_Biological_Process_2021,telomere maintenance via telomere lengthening (GO:0010833),1/36,0.0862437219743075,0.159550885652469,0,0,11.612244897959185,28.456712045041098,TERT,Pre-Pro B,1.0642725091375862
GO_Biological_Process_2021,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/36,0.0862437219743075,0.159550885652469,0,0,11.612244897959185,28.456712045041098,AURKB,Pre-Pro B,1.0642725091375862
GO_Biological_Process_2021,positive regulation of mitotic nuclear division (GO:0045840),1/36,0.0862437219743075,0.159550885652469,0,0,11.612244897959185,28.456712045041098,NUSAP1,Pre-Pro B,1.0642725091375862
GO_Biological_Process_2021,positive regulation of cytokinesis (GO:0032467),1/37,0.0885322278902676,0.1607701807087069,0,0,11.289115646258503,27.36920368672352,AURKB,Pre-Pro B,1.0528986067362665
GO_Biological_Process_2021,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/37,0.0885322278902676,0.1607701807087069,0,0,11.289115646258503,27.36920368672352,E2F7,Pre-Pro B,1.0528986067362665
GO_Biological_Process_2021,"phagocytosis, engulfment (GO:0006911)",1/37,0.0885322278902676,0.1607701807087069,0,0,11.289115646258503,27.36920368672352,IGLL1,Pre-Pro B,1.0528986067362665
GO_Biological_Process_2021,modification-dependent protein catabolic process (GO:0019941),2/201,0.0899990393946084,0.1623120038577218,0,0,4.135469011725293,9.958028586222367,UHRF1;AURKB,Pre-Pro B,1.0457621259812002
GO_Biological_Process_2021,negative regulation of G0 to G1 transition (GO:0070317),1/38,0.0908151166313484,0.1623120038577218,0,0,10.983452840595698,26.34852930034076,RRM2,Pre-Pro B,1.0418418549683985
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),4/684,0.0910263264877764,0.1623120038577218,0,0,2.4641943734015346,5.9057042827231845,UHRF1;AURKB;E2F7;E2F8,Pre-Pro B,1.0408329835599175
GO_Biological_Process_2021,protein monoubiquitination (GO:0006513),1/39,0.0930924017046572,0.1630494136365594,0,0,10.693877551020408,25.38900533231373,UHRF1,Pre-Pro B,1.0310857651239858
GO_Biological_Process_2021,odontogenesis (GO:0042476),1/39,0.0930924017046572,0.1630494136365594,0,0,10.693877551020408,25.38900533231373,AQP5,Pre-Pro B,1.0310857651239858
GO_Biological_Process_2021,regulation of nitric-oxide synthase activity (GO:0050999),1/39,0.0930924017046572,0.1630494136365594,0,0,10.693877551020408,25.38900533231373,TERT,Pre-Pro B,1.0310857651239858
GO_Biological_Process_2021,digestive tract development (GO:0048565),1/40,0.0953640965755271,0.166045721096212,0,0,10.419152276295131,24.485561288951835,NPY,Pre-Pro B,1.0206151011238414
GO_Biological_Process_2021,regulation of G0 to G1 transition (GO:0070316),1/41,0.0976302146847681,0.1680147880621591,0,0,10.158163265306122,23.633660200289185,RRM2,Pre-Pro B,1.0104157556925017
GO_Biological_Process_2021,regulation of protein dephosphorylation (GO:0035304),1/41,0.0976302146847681,0.1680147880621591,0,0,10.158163265306122,23.633660200289185,CDCA2,Pre-Pro B,1.0104157556925017
GO_Biological_Process_2021,positive regulation of ATPase activity (GO:0032781),1/42,0.0998907694703361,0.1699291250759741,0,0,9.909905425584869,22.829231064333683,UHRF1,Pre-Pro B,1.00047464143678
GO_Biological_Process_2021,nucleic acid-templated transcription (GO:0097659),1/42,0.0998907694703361,0.1699291250759741,0,0,9.909905425584869,22.829231064333683,TERT,Pre-Pro B,1.00047464143678
GO_Biological_Process_2021,positive regulation of cell division (GO:0051781),1/44,0.1043952424647777,0.174581874404374,0,0,9.448030374940672,21.34849709415977,AURKB,Pre-Pro B,0.9813192926974915
GO_Biological_Process_2021,mitotic spindle assembly (GO:0090307),1/44,0.1043952424647777,0.174581874404374,0,0,9.448030374940672,21.34849709415977,AURKB,Pre-Pro B,0.9813192926974915
GO_Biological_Process_2021,cation transmembrane transport (GO:0098655),1/44,0.1043952424647777,0.174581874404374,0,0,9.448030374940672,21.34849709415977,SLC7A3,Pre-Pro B,0.9813192926974915
GO_Biological_Process_2021,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.1066391873529346,0.1773325812161161,0,0,9.232838589981448,20.665901611884028,TERT,Pre-Pro B,0.9720831731354668
GO_Biological_Process_2021,regulation of telomerase activity (GO:0051972),1/46,0.1088776222085674,0.1800434423113741,0,0,9.02721088435374,20.01811780873028,AURKB,Pre-Pro B,0.9630613723103648
GO_Biological_Process_2021,telomere organization (GO:0032200),1/47,0.1111105603036554,0.1827151436104556,0,0,8.830523513753327,19.4026870705364,TERT,Pre-Pro B,0.9542446623584087
GO_Biological_Process_2021,nucleus organization (GO:0006997),1/48,0.1133380148369131,0.1853483557553938,0,0,8.642205818497612,18.81737166641443,CEP55,Pre-Pro B,0.9456243984787533
GO_Biological_Process_2021,regulation of cellular protein metabolic process (GO:0032268),1/49,0.1155599990222406,0.1879437346735342,0,0,8.46173469387755,18.260130793597916,UHRF1,Pre-Pro B,0.9371924705024297
GO_Biological_Process_2021,amino acid transport (GO:0006865),1/50,0.1177765260040411,0.1905019218426019,0,0,8.28862973760933,17.7290996615035,SLC7A3,Pre-Pro B,0.928941259997044
GO_Biological_Process_2021,mitotic metaphase plate congression (GO:0007080),1/51,0.1199876089220907,0.1930235447877112,0,0,8.122448979591837,17.22257115519733,CEP55,Pre-Pro B,0.9208636010741894
GO_Biological_Process_2021,signal transduction in response to DNA damage (GO:0042770),1/52,0.1221932608707862,0.1934182097206028,0,0,7.962785114045619,16.738979733033663,E2F7,Pre-Pro B,0.9129527453809976
GO_Biological_Process_2021,regulation of telomere maintenance via telomerase (GO:0032210),1/52,0.1221932608707862,0.1934182097206028,0,0,7.962785114045619,16.738979733033663,AURKB,Pre-Pro B,0.9129527453809976
GO_Biological_Process_2021,protein homotetramerization (GO:0051289),1/52,0.1221932608707862,0.1934182097206028,0,0,7.962785114045619,16.738979733033663,AQP5,Pre-Pro B,0.9129527453809976
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),2/244,0.1242347823719992,0.1937919710221579,0,0,3.3932506887052343,7.076902888304532,NPY;NPTX1,Pre-Pro B,0.9057567964507174
GO_Biological_Process_2021,positive regulation of B cell activation (GO:0050871),1/53,0.1243934949128716,0.1937919710221579,0,0,7.809262166405024,16.276887238960814,IGLL1,Pre-Pro B,0.9052023302345248
GO_Biological_Process_2021,regulation of DNA replication (GO:0006275),1/53,0.1243934949128716,0.1937919710221579,0,0,7.809262166405024,16.276887238960814,ESCO2,Pre-Pro B,0.9052023302345248
GO_Biological_Process_2021,unsaturated fatty acid metabolic process (GO:0033559),1/54,0.1265883240687765,0.1961787640018735,0,0,7.661532537543319,15.834970375184442,ELOVL2,Pre-Pro B,0.8976063498190403
GO_Biological_Process_2021,telomere maintenance (GO:0000723),1/56,0.1309618198144747,0.2018994722139818,0,0,7.382189239332097,15.00687933540933,TERT,Pre-Pro B,0.8828552987007785
GO_Biological_Process_2021,positive regulation of protein binding (GO:0032092),1/58,0.1353138517398134,0.2053994877691527,0,0,7.122448979591836,14.246025949065045,TERT,Pre-Pro B,0.8686577434892403
GO_Biological_Process_2021,membrane lipid biosynthetic process (GO:0046467),1/58,0.1353138517398134,0.2053994877691527,0,0,7.122448979591836,14.246025949065045,ELOVL2,Pre-Pro B,0.8686577434892403
GO_Biological_Process_2021,regulation of neurotransmitter receptor activity (GO:0099601),1/58,0.1353138517398134,0.2053994877691527,0,0,7.122448979591836,14.246025949065045,NPTX1,Pre-Pro B,0.8686577434892403
GO_Biological_Process_2021,negative regulation of response to stimulus (GO:0048585),1/61,0.1418018805927374,0.2130627241393415,0,0,6.76530612244898,13.214837540593155,TERT,Pre-Pro B,0.848318009451734
GO_Biological_Process_2021,positive regulation of DNA biosynthetic process (GO:2000573),1/61,0.1418018805927374,0.2130627241393415,0,0,6.76530612244898,13.214837540593155,AURKB,Pre-Pro B,0.848318009451734
GO_Biological_Process_2021,neuropeptide signaling pathway (GO:0007218),1/63,0.1461007034145454,0.2184131727813406,0,0,6.54641211323239,12.591756250239603,NPY,Pre-Pro B,0.8353476931121088
GO_Biological_Process_2021,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/65,0.1503784214913892,0.222560063807256,0,0,6.341198979591836,12.01403781811508,NPY,Pre-Pro B,0.8228144782361342
GO_Biological_Process_2021,protein autoubiquitination (GO:0051865),1/65,0.1503784214913892,0.222560063807256,0,0,6.341198979591836,12.01403781811508,UHRF1,Pre-Pro B,0.8228144782361342
GO_Biological_Process_2021,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),1/66,0.1525093979756266,0.2245909542327636,0,0,6.243328100470958,11.740759916332207,AURKB,Pre-Pro B,0.8167033932798328
GO_Biological_Process_2021,anion transmembrane transport (GO:0098656),1/67,0.1546351363099914,0.2265940611275122,0,0,6.148423005565863,11.477180657220888,SLC7A3,Pre-Pro B,0.8106918184915987
GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.1567556490806558,0.2285698134378036,0,0,6.0563508985683825,11.222824361971773,TERT,Pre-Pro B,0.8047767993307415
GO_Biological_Process_2021,cellular response to decreased oxygen levels (GO:0036294),1/69,0.158870948881139,0.230518631709888,0,0,5.966986794717887,10.977245117600177,TERT,Pre-Pro B,0.7989555105590889
GO_Biological_Process_2021,cellular response to light stimulus (GO:0071482),1/70,0.1609810482853106,0.2320838658675374,0,0,5.880212954747116,10.740024519792764,AURKB,Pre-Pro B,0.7932252488723367
GO_Biological_Process_2021,regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.16308595979881,0.2320838658675374,0,0,5.795918367346939,10.51076961698872,E2F7,Pre-Pro B,0.7875834261109624
GO_Biological_Process_2021,protein tetramerization (GO:0051262),1/71,0.16308595979881,0.2320838658675374,0,0,5.795918367346939,10.51076961698872,AQP5,Pre-Pro B,0.7875834261109624
GO_Biological_Process_2021,fatty acid biosynthetic process (GO:0006633),1/71,0.16308595979881,0.2320838658675374,0,0,5.795918367346939,10.51076961698872,ELOVL2,Pre-Pro B,0.7875834261109624
GO_Biological_Process_2021,sphingolipid biosynthetic process (GO:0030148),1/74,0.1693696918266344,0.2387306132413514,0,0,5.556891249650545,9.867213018330611,ELOVL2,Pre-Pro B,0.7711643026835198
GO_Biological_Process_2021,negative regulation of protein binding (GO:0032091),1/74,0.1693696918266344,0.2387306132413514,0,0,5.556891249650545,9.867213018330611,AURKB,Pre-Pro B,0.7711643026835198
GO_Biological_Process_2021,cellular response to UV (GO:0034644),1/77,0.1756071809118701,0.2463494101891637,0,0,5.336734693877551,9.283280446293812,AURKB,Pre-Pro B,0.7554577289388229
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),2/306,0.1779160016431225,0.2484110211620956,0,0,2.6927083333333335,4.648809448291678,NPY;NPTX1,Pre-Pro B,0.7497849900117082
GO_Biological_Process_2021,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.181798760490535,0.2526405310103209,0,0,5.133298889175924,8.751529842637671,TERT,Pre-Pro B,0.7404090821369118
GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),2/314,0.1851004260524556,0.2560267575304994,0,0,2.6225961538461537,4.423944044737091,FAM111B;TERT,Pre-Pro B,0.7325925816143702
GO_Biological_Process_2021,long-chain fatty acid metabolic process (GO:0001676),1/83,0.1879447615357932,0.2587518577423014,0,0,4.944748631159781,8.265677319811374,ELOVL2,Pre-Pro B,0.7259697745939766
GO_Biological_Process_2021,anaphase-promoting complex-dependent catabolic process (GO:0031145),1/84,0.1899833569114356,0.2591478048192854,0,0,4.884927464961889,8.112979399077096,AURKB,Pre-Pro B,0.7212844428267129
GO_Biological_Process_2021,vascular transport (GO:0010232),1/84,0.1899833569114356,0.2591478048192854,0,0,4.884927464961889,8.112979399077096,SLC7A3,Pre-Pro B,0.7212844428267129
GO_Biological_Process_2021,G1/S transition of mitotic cell cycle (GO:0000082),1/85,0.1920169366451308,0.2595297408536928,0,0,4.826530612244898,7.964604221414354,RRM2,Pre-Pro B,0.716660463134361
GO_Biological_Process_2021,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",1/85,0.1920169366451308,0.2595297408536928,0,0,4.826530612244898,7.964604221414354,KIF15,Pre-Pro B,0.716660463134361
GO_Biological_Process_2021,transport across blood-brain barrier (GO:0150104),1/86,0.1940455128548384,0.2610794172956008,0,0,4.769507803121249,7.820383303288144,SLC7A3,Pre-Pro B,0.7120963955156414
GO_Biological_Process_2021,negative regulation of angiogenesis (GO:0016525),1/87,0.196069097589664,0.2626083841019934,0,0,4.713811105837684,7.6801565438185,E2F2,Pre-Pro B,0.7075908500030543
GO_Biological_Process_2021,negative regulation of binding (GO:0051100),1/88,0.1980877029036425,0.2641169372048567,0,0,4.659394792399718,7.5437717166037235,AURKB,Pre-Pro B,0.703142484213379
GO_Biological_Process_2021,positive regulation of binding (GO:0051099),1/90,0.2021100231923967,0.2682716002912531,0,0,4.55423068103646,7.281955543769811,TERT,Pre-Pro B,0.6944121480917811
GO_Biological_Process_2021,negative regulation of mitotic cell cycle phase transition (GO:1901991),1/92,0.2061125694363157,0.2723630381837029,0,0,4.453689167974883,7.03385741012878,E2F7,Pre-Pro B,0.6858955226779435
GO_Biological_Process_2021,regulation of epithelial cell proliferation (GO:0050678),1/93,0.2081064570390282,0.273775605704677,0,0,4.40505767524401,6.914643337844717,UHRF1,Pre-Pro B,0.6817144444740324
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",4/948,0.21159142351009,0.2771285900840117,0,0,1.7507369196757554,2.7190662035683872,UHRF1;AURKB;E2F7;E2F8,Pre-Pro B,0.6745019396506919
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,0.2180025137484037,0.2842675950199449,0,0,4.176940879444562,6.362519703204576,KIF15,Pre-Pro B,0.6615384985937142
GO_Biological_Process_2021,response to UV (GO:0009411),1/99,0.2199671313012003,0.2843738780167705,0,0,4.134110787172012,6.26018948804807,AURKB,Pre-Pro B,0.6576422090003602
GO_Biological_Process_2021,ubiquitin-dependent protein catabolic process (GO:0006511),2/354,0.2215840331594591,0.2843738780167705,0,0,2.319839015151515,3.495889243162455,UHRF1;AURKB,Pre-Pro B,0.6544615370869727
GO_Biological_Process_2021,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),1/100,0.2219269115603851,0.2843738780167705,0,0,4.092145949288806,6.1603458876211565,KIF15,Pre-Pro B,0.6537900306498672
GO_Biological_Process_2021,organic acid transport (GO:0015849),1/100,0.2219269115603851,0.2843738780167705,0,0,4.092145949288806,6.1603458876211565,SLC7A3,Pre-Pro B,0.6537900306498672
GO_Biological_Process_2021,positive regulation of cellular protein metabolic process (GO:0032270),1/102,0.2258320069783284,0.2881304916620052,0,0,4.010709234188725,5.967790506031058,UHRF1,Pre-Pro B,0.6462145058611213
GO_Biological_Process_2021,antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/103,0.2277773453985499,0.2893652113217629,0,0,3.971188475390156,5.874923343943355,KIF15,Pre-Pro B,0.64248947278397
GO_Biological_Process_2021,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.2930319821276439,0,0,3.894427001569859,5.6956456810845415,UHRF1,Pre-Pro B,0.6351608308934773
GO_Biological_Process_2021,chromosome organization (GO:0051276),1/106,0.2335846623503299,0.2942172768327559,0,0,3.857142857142857,5.6090983677319475,TOP2A,Pre-Pro B,0.6315556772929499
GO_Biological_Process_2021,DNA replication (GO:0006260),1/108,0.2374324069826741,0.2977965782494557,0,0,3.7846652679763495,5.441865346754643,FAM111B,Pre-Pro B,0.6244600047865677
GO_Biological_Process_2021,modulation of chemical synaptic transmission (GO:0050804),1/109,0.239349173739861,0.2989339891434552,0,0,3.749433106575964,5.361058744932435,NPTX1,Pre-Pro B,0.6209680674126086
GO_Biological_Process_2021,regulation of Wnt signaling pathway (GO:0030111),1/111,0.2431685532271013,0.3024281166185798,0,0,3.6808905380333954,5.20478084558139,TERT,Pre-Pro B,0.6140925891155178
GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),1/115,0.2507510141385882,0.3105535572595067,0,0,3.5510204081632653,4.9121080927455,UHRF1,Pre-Pro B,0.6007573018413346
GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),1/116,0.2526349665899778,0.3115831254609727,0,0,3.5199645075421473,4.8428011439058265,ELOVL2,Pre-Pro B,0.5975065399797567
GO_Biological_Process_2021,protein homooligomerization (GO:0051260),1/121,0.2619853133921213,0.3217744927969623,0,0,3.372448979591837,4.517283552621874,AQP5,Pre-Pro B,0.5817230540677998
GO_Biological_Process_2021,plasma membrane bounded cell projection organization (GO:0120036),1/128,0.274883458910421,0.3362210902375397,0,0,3.1854411055760887,4.113704308580095,NPY,Pre-Pro B,0.5608513930050725
GO_Biological_Process_2021,cellular response to hypoxia (GO:0071456),1/131,0.2803433684983951,0.3414882184177982,0,0,3.111459968602826,3.956968446025251,TERT,Pre-Pro B,0.5523097126477655
GO_Biological_Process_2021,organelle organization (GO:0006996),2/420,0.2828230936231133,0.3430711328476432,0,0,1.946969696969697,2.4588936191845474,TERT;CEP55,Pre-Pro B,0.5484851315667836
GO_Biological_Process_2021,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3430711328476432,0,0,3.0640074211502784,3.857336278341556,TMSB15A,Pre-Pro B,0.546741450090894
GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),1/139,0.2947069182263764,0.3546066983536888,0,0,2.929902395740905,3.579678317757992,MKI67,Pre-Pro B,0.5306096689947516
GO_Biological_Process_2021,transcription initiation from RNA polymerase II promoter (GO:0006367),1/140,0.2964824884084789,0.3552988525057075,0,0,2.9086771399207163,3.5362740390257685,E2F2,Pre-Pro B,0.5280009529309525
GO_Biological_Process_2021,neuron development (GO:0048666),1/143,0.3017829564686885,0.3587460044768345,0,0,2.8467950560505892,3.410594866305226,NPY,Pre-Pro B,0.5203052911363482
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3587460044768345,0,0,2.8467950560505892,3.410594866305226,SLC7A3,Pre-Pro B,0.5203052911363482
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3676677888089783,0,0,2.749271137026239,3.215201203875706,AURKB,Pre-Pro B,0.5078961191737069
GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.3191700762858281,0.3763918031099806,0,0,2.6581632653061225,3.0357052873752,TERT,Pre-Pro B,0.4959778325880012
GO_Biological_Process_2021,regulation of signal transduction by p53 class mediator (GO:1901796),1/156,0.3243029619756543,0.3803934269378692,0,0,2.6063199473337724,2.934917292064671,AURKB,Pre-Pro B,0.4890490847411261
GO_Biological_Process_2021,mitotic spindle organization (GO:0007052),1/157,0.3260054815208176,0.3803934269378692,0,0,2.5894819466248036,2.902397750177957,AURKB,Pre-Pro B,0.48677509755712384
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),2/468,0.3272907950685003,0.3803934269378692,0,0,1.742131616595136,1.9457976416065603,ESCO2;ZNF695,Pre-Pro B,0.48506620889050567
GO_Biological_Process_2021,organonitrogen compound biosynthetic process (GO:1901566),1/158,0.3277037968552589,0.3803934269378692,0,0,2.5728584427401535,2.8703970097526006,ELOVL2,Pre-Pro B,0.48451852674781976
GO_Biological_Process_2021,protein autophosphorylation (GO:0046777),1/159,0.329397918202972,0.3808663429221864,0,0,2.556445362955309,2.8389038953772054,AURKB,Pre-Pro B,0.4822791499015975
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",4/1183,0.3428517320675613,0.3948798159221717,0,0,1.384445181989158,1.481989303783668,UHRF1;E2F2;E2F7;E2F8,Pre-Pro B,0.4648936521619021
GO_Biological_Process_2021,"DNA-templated transcription, initiation (GO:0006352)",1/168,0.3444579462443567,0.3951920623578667,0,0,2.4175730172308443,2.5766088705447237,E2F2,Pre-Pro B,0.46286379212748074
GO_Biological_Process_2021,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.3993187556352399,0,0,2.3745498199279713,2.4969025061029213,NPY,Pre-Pro B,0.4566722378913039
GO_Biological_Process_2021,mitochondrion organization (GO:0007005),1/175,0.3559416811668189,0.405225913943763,0,0,2.319493314567206,2.396009637948729,TERT,Pre-Pro B,0.4486211526513072
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),1/176,0.3575660373570176,0.405515505968112,0,0,2.306122448979592,2.3716975343886144,IGLL1,Pre-Pro B,0.4466437384468818
GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),1/178,0.3608027143922477,0.4076244406874249,0,0,2.279833967485299,2.3241173885161555,MKI67,Pre-Pro B,0.44273020383203454
GO_Biological_Process_2021,antigen receptor-mediated signaling pathway (GO:0050851),1/185,0.3720057294778557,0.4186832544693738,0,0,2.192324755989352,2.1678716160963645,IGLL1,Pre-Pro B,0.4294503712432232
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.4329305131780424,0,0,2.089140319340171,1.988001678572607,TERT,Pre-Pro B,0.4132695879859197
GO_Biological_Process_2021,positive regulation of protein modification process (GO:0031401),1/214,0.416403436812339,0.4651147822507636,0,0,1.8910606496119575,1.656759537391559,CDCA2,Pre-Pro B,0.3804856946694876
GO_Biological_Process_2021,membrane organization (GO:0061024),1/242,0.4563449373288627,0.5078124114636968,0,0,1.6689812854602422,1.3093263562491473,CEP55,Pre-Pro B,0.3407067631514444
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.5209934802721087,0,0,1.6016749329213755,1.2094704650298027,TERT,Pre-Pro B,0.32794816113488356
GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5403128822433392,0,0,1.510204081632653,1.0781219104526054,TERT,Pre-Pro B,0.3100391544580995
GO_Biological_Process_2021,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5403128822433392,0,0,1.504471451501949,1.0700627976731167,NPTX1,Pre-Pro B,0.3088941088615854
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.5632316862821183,0,0,1.4081632653061225,0.937839142501346,TOP2A,Pre-Pro B,0.289240867544339
GO_Biological_Process_2021,innate immune response (GO:0045087),1/302,0.5331267023920349,0.5823081325020012,0,0,1.3322259136212624,0.8379649939237771,IGLL1,Pre-Pro B,0.2731695646873957
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5903950225528319,0,0,1.2972062611452349,0.7932686422257892,TOP2A,Pre-Pro B,0.2655801196036423
GO_Biological_Process_2021,transcription by RNA polymerase II (GO:0006366),1/320,0.5540128017436795,0.5987554404155377,0,0,1.255901733734246,0.7416947278731473,E2F2,Pre-Pro B,0.2564801997798679
GO_Biological_Process_2021,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.5551458962416416,0.5987554404155377,0,0,1.2519132653061225,0.7367814077584223,AURKB,Pre-Pro B,0.25559286623594474
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5987554404155377,0,0,1.2479496471485791,0.7319104885681406,TERT,Pre-Pro B,0.2547095446988111
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),2/764,0.5744134768292987,0.6160376418169291,0,0,1.0492125984251968,0.5816895490313783,UHRF1;E2F7,Pre-Pro B,0.24077537927422193
GO_Biological_Process_2021,post-translational protein modification (GO:0043687),1/345,0.5815093765862647,0.6191610628400516,0,0,1.1631466540104414,0.6305745813190116,ESCO2,Pre-Pro B,0.23544327806907975
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),1/345,0.5815093765862647,0.6191610628400516,0,0,1.1631466540104414,0.6305745813190116,TERT,Pre-Pro B,0.23544327806907975
GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),1/350,0.5868058377702841,0.6214490603860574,0,0,1.1461902812701013,0.6109896633619631,TOP2A,Pre-Pro B,0.23150557427863594
GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),1/351,0.5878572192841084,0.6214490603860574,0,0,1.1428571428571428,0.6071670684764225,KIF18B,Pre-Pro B,0.23072814400359865
GO_Biological_Process_2021,negative regulation of cell population proliferation (GO:0008285),1/379,0.6162544539128882,0.6491505991395549,0,0,1.056689342403628,0.5115383719098227,E2F7,Pre-Pro B,0.2102399288866402
GO_Biological_Process_2021,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6678737976589773,0,0,1.0,0.4521084323403523,AURKB,Pre-Pro B,0.19634819738734471
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),1/408,0.643643262264238,0.6717873246995879,0,0,0.9799428370856942,0.4317732474155183,TMSB15A,Pre-Pro B,0.19135477263518083
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),1/409,0.644552703427983,0.6717873246995879,0,0,0.9774909963985594,0.4293127610136149,UHRF1,Pre-Pro B,0.19074156570833578
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),5/2206,0.6589063274622694,0.6843377997502867,0,0,0.8960068655661568,0.3737906767782196,UHRF1;E2F2;AURKB;E2F7;E2F8,Pre-Pro B,0.1811763219125431
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.663134010332821,0.686320514190612,0,0,0.928642785785643,0.3814661952932429,ZNF695,Pre-Pro B,0.17839869773857764
GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),1/437,0.6691136001848389,0.6900962566366282,0,0,0.9134057292641828,0.3670077257341264,AURKB,Pre-Pro B,0.1745001427028418
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",5/2244,0.6741952652975136,0.6929229115557778,0,0,0.8789141978065604,0.3464991772661544,RRM2;E2F2;E2F7;E2F8;ZNF695,Pre-Pro B,0.1712143017444203
GO_Biological_Process_2021,nervous system development (GO:0007399),1/447,0.677475806229693,0.6938852548234917,0,0,0.8924681980415484,0.3475105496336908,NPTX1,Pre-Pro B,0.16910620954367267
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),1/474,0.6990329319013457,0.713495682216546,0,0,0.8403589765716012,0.300896771210595,TERT,Pre-Pro B,0.1555023638735803
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7278429842668029,0,0,0.8021026592455164,0.2684686706444305,AURKB,Pre-Pro B,0.1453610219101508
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.7460495734193248,0,0,0.7565820221218258,0.231944503707841,UHRF1,Pre-Pro B,0.13314117322745964
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7675464949409436,0,0,0.7301532033426184,0.200604530418796,TERT;ZNF695,Pre-Pro B,0.11931939791106433
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),1/566,0.7624057114769476,0.7675921448883554,0,0,0.700198663536211,0.1899473973942179,E2F7,Pre-Pro B,0.11781385888910202
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8522057891231235,0,0,0.5290423861852434,0.0863986224716518,TOP2A,Pre-Pro B,0.07092521499844862
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),1/1025,0.9281942108891912,0.9281942108891912,0,0,0.3771922831632653,0.0281062148400667,AURKB,Pre-Pro B,0.032361144586154744
GO_Biological_Process_2021,V(D)J recombination (GO:0033151),2/11,0.000332063883264561,0.0161302407089371,0,0,92.31944444444444,739.4956618223716,RAG2;RAG1,Pro-B,3.478778357620151
GO_Biological_Process_2021,T cell differentiation in thymus (GO:0033077),2/14,0.0005467878206419364,0.0161302407089371,0,0,69.22916666666667,520.0114050756229,RAG2;RAG1,Pro-B,3.2621811676355046
GO_Biological_Process_2021,T cell differentiation (GO:0030217),2/41,0.0047194951697385,0.092816738338192,0,0,21.272435897435894,113.93630347986566,RAG2;RAG1,Pro-B,2.3261044540613445
GO_Biological_Process_2021,B cell differentiation (GO:0030183),2/61,0.0102031878981958,0.150497021498389,0,0,14.04731638418079,64.40771918587598,RAG2;RAG1,Pro-B,1.9912641154648159
GO_Biological_Process_2021,lymphocyte differentiation (GO:0030098),2/84,0.0187414436957378,0.1602755346621551,0,0,10.095528455284551,40.15009805248223,RAG2;RAG1,Pro-B,1.7271969574747794
GO_Biological_Process_2021,B cell activation (GO:0042113),2/85,0.0191627543313976,0.1602755346621551,0,0,9.973393574297187,39.44264488506008,RAG2;RAG1,Pro-B,1.717542068067663
GO_Biological_Process_2021,adenosine to inosine editing (GO:0006382),1/8,0.0198291614511851,0.1602755346621551,0,0,58.142857142857146,227.9549801512961,ADARB2,Pro-B,1.702695651141308
GO_Biological_Process_2021,intestinal epithelial cell differentiation (GO:0060575),1/9,0.0222805591236868,0.1602755346621551,0,0,50.87244897959184,193.52086993316271,NPY,Pro-B,1.652073914876897
GO_Biological_Process_2021,cellular response to acetylcholine (GO:1905145),1/10,0.024725948817258,0.1602755346621551,0,0,45.21768707482993,167.3010120823387,LY6H,Pro-B,1.606847034080906
GO_Biological_Process_2021,columnar/cuboidal epithelial cell differentiation (GO:0002065),1/11,0.0271653448579923,0.1602755346621551,0,0,40.69387755102041,146.73452100035948,NPY,Pro-B,1.5659847773237099
GO_Biological_Process_2021,central nervous system neuron development (GO:0021954),1/15,0.0368632785936063,0.1977212215475248,0,0,29.06122448979592,95.91771596133704,NPY,Pro-B,1.4334060415588732
GO_Biological_Process_2021,base conversion or substitution editing (GO:0016553),1/18,0.0440744949316926,0.2159096279261229,0,0,23.92917166866747,74.70385911458476,ADARB2,Pro-B,1.3558126557645607
GO_Biological_Process_2021,histone ubiquitination (GO:0016574),1/21,0.0512327930672156,0.2159096279261229,0,0,20.336734693877553,60.42807445408675,RAG1,Pro-B,1.2904519669693806
GO_Biological_Process_2021,acetylcholine receptor signaling pathway (GO:0095500),1/21,0.0512327930672156,0.2159096279261229,0,0,20.336734693877553,60.42807445408675,LY6H,Pro-B,1.2904519669693806
GO_Biological_Process_2021,histone monoubiquitination (GO:0010390),1/24,0.0583385530130099,0.2294649751845058,0,0,17.68145519077196,50.24171555062859,RAG1,Pro-B,1.2340443470047993
GO_Biological_Process_2021,protein localization to Golgi apparatus (GO:0034067),1/28,0.0677318256109869,0.2497611069405141,0,0,15.058956916099774,40.54171043527237,ARL5C,Pro-B,1.1692072184717057
GO_Biological_Process_2021,central nervous system neuron differentiation (GO:0021953),1/34,0.0816498044624026,0.2813240848978051,0,0,12.317254174397032,30.85861216573232,NPY,Pro-B,1.0880448509885652
GO_Biological_Process_2021,protein monoubiquitination (GO:0006513),1/39,0.0930924017046572,0.2813240848978051,0,0,10.693877551020408,25.38900533231373,RAG1,Pro-B,1.0310857651239858
GO_Biological_Process_2021,DNA recombination (GO:0006310),1/39,0.0930924017046572,0.2813240848978051,0,0,10.693877551020408,25.38900533231373,RAG1,Pro-B,1.0310857651239858
GO_Biological_Process_2021,digestive tract development (GO:0048565),1/40,0.0953640965755271,0.2813240848978051,0,0,10.419152276295131,24.485561288951835,NPY,Pro-B,1.0206151011238414
GO_Biological_Process_2021,positive regulation of interferon-gamma production (GO:0032729),1/57,0.1331405122852093,0.3456216534289483,0,0,7.25,14.618539131965724,HMHB1,Pro-B,0.8756897763447542
GO_Biological_Process_2021,double-strand break repair via nonhomologous end joining (GO:0006303),1/62,0.1439539364695556,0.3456216534289483,0,0,6.654064904650385,12.897320592663672,DNTT,Pro-B,0.8417764546925935
GO_Biological_Process_2021,neuropeptide signaling pathway (GO:0007218),1/63,0.1461007034145454,0.3456216534289483,0,0,6.54641211323239,12.591756250239603,NPY,Pro-B,0.8353476931121088
GO_Biological_Process_2021,protein autoubiquitination (GO:0051865),1/65,0.1503784214913892,0.3456216534289483,0,0,6.341198979591836,12.01403781811508,RAG1,Pro-B,0.8228144782361342
GO_Biological_Process_2021,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/65,0.1503784214913892,0.3456216534289483,0,0,6.341198979591836,12.01403781811508,NPY,Pro-B,0.8228144782361342
GO_Biological_Process_2021,DNA metabolic process (GO:0006259),2/277,0.1523078472737738,0.3456216534289483,0,0,2.981060606060606,5.609913359099665,DNTT;RAG1,Pro-B,0.8172777201708421
GO_Biological_Process_2021,nucleic acid metabolic process (GO:0090304),1/71,0.16308595979881,0.3563730232640664,0,0,5.795918367346939,10.51076961698872,DNTT,Pro-B,0.7875834261109624
GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),1/86,0.1940455128548384,0.4088816163726954,0,0,4.769507803121249,7.820383303288144,HMHB1,Pro-B,0.7120963955156414
GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.2081064570390282,0.4219689600117347,0,0,4.40505767524401,6.914643337844717,TCL1B,Pro-B,0.6817144444740324
GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.2180025137484037,0.4219689600117347,0,0,4.176940879444562,6.362519703204576,TCL1B,Pro-B,0.6615384985937142
GO_Biological_Process_2021,gene expression (GO:0010467),2/356,0.2234271100431196,0.4219689600117347,0,0,2.306497175141243,3.456678231445734,RPS4Y2;ADARB2,Pro-B,0.6508641319016764
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.4219689600117347,0,0,3.857142857142857,5.6090983677319475,TCL1B,Pro-B,0.6315556772929499
GO_Biological_Process_2021,response to tumor necrosis factor (GO:0034612),1/110,0.241261218690496,0.4219689600117347,0,0,3.714847406852649,5.282048795926194,HMHB1,Pro-B,0.6175124827423236
GO_Biological_Process_2021,regulation of protein serine/threonine kinase activity (GO:0071900),1/111,0.2431685532271013,0.4219689600117347,0,0,3.6808905380333954,5.20478084558139,TCL1B,Pro-B,0.6140925891155178
GO_Biological_Process_2021,plasma membrane bounded cell projection organization (GO:0120036),1/128,0.274883458910421,0.4633749735918526,0,0,3.1854411055760887,4.113704308580095,NPY,Pro-B,0.5608513930050725
GO_Biological_Process_2021,RNA metabolic process (GO:0016070),1/133,0.2839609038772722,0.4653803702433072,0,0,3.0640074211502784,3.857336278341556,ADARB2,Pro-B,0.546741450090894
GO_Biological_Process_2021,neuron development (GO:0048666),1/143,0.3017829564686885,0.4812214711257465,0,0,2.8467950560505892,3.410594866305226,NPY,Pro-B,0.5203052911363482
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),1/154,0.3208852696222714,0.4982166028345793,0,0,2.640656262505002,3.0015590720273457,TCL1B,Pro-B,0.493650218923809
GO_Biological_Process_2021,peptide biosynthetic process (GO:0043043),1/162,0.3344552195120095,0.4982638044538766,0,0,2.5084294587400175,2.747363087126053,RPS4Y2,Pro-B,0.47566202205377284
GO_Biological_Process_2021,double-strand break repair (GO:0006302),1/164,0.3378059691212722,0.4982638044538766,0,0,2.4774007762614247,2.6886824434754057,DNTT,Pro-B,0.4713326805982654
GO_Biological_Process_2021,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.5028007502358356,0,0,2.3745498199279713,2.4969025061029213,NPY,Pro-B,0.4566722378913039
GO_Biological_Process_2021,RNA processing (GO:0006396),1/179,0.3624150547196057,0.5091068625823032,0,0,2.266911258885577,2.300835957547096,ADARB2,Pro-B,0.4407937700298507
GO_Biological_Process_2021,cellular response to tumor necrosis factor (GO:0071356),1/194,0.3861272144560919,0.5183715819847158,0,0,2.089140319340171,1.988001678572607,HMHB1,Pro-B,0.4132695879859197
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.5183715819847158,0,0,2.0782663580896275,1.969329769675335,ARL5C,Pro-B,0.4115300469974289
GO_Biological_Process_2021,regulation of macromolecule metabolic process (GO:0060255),1/200,0.3953681557510544,0.5183715819847158,0,0,2.025535842477695,1.8795714928238216,HMHB1,Pro-B,0.40299831311675843
GO_Biological_Process_2021,translation (GO:0006412),1/214,0.416403436812339,0.5340826689549566,0,0,1.8910606496119575,1.656759537391559,RPS4Y2,Pro-B,0.3804856946694876
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.5763083454784081,0,0,1.655076845553036,1.2884811006593149,NPY,Pro-B,0.33809924509335265
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),3/1079,0.5107084384516999,0.6277457889302145,0,0,1.1196314165941628,0.7523435208329574,HMHB1;RAG2;RAG1,Pro-B,0.2918269662236996
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.636540506511575,0,0,1.314486450317832,0.8152139890333826,NPY,Pro-B,0.2693393582885023
GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),1/314,0.5471545986718139,0.636540506511575,0,0,1.2803677381495728,0.7720923294539072,RPS4Y2,Pro-B,0.26188994631047774
GO_Biological_Process_2021,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.636540506511575,0,0,1.2208810353409656,0.6989624697257846,ARL5C,Pro-B,0.24863646405532092
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),1/335,0.5707160845076258,0.636540506511575,0,0,1.1985824269827692,0.6722410367689661,HMHB1,Pro-B,0.2435798875448389
GO_Biological_Process_2021,intracellular protein transport (GO:0006886),1/336,0.5718075736459911,0.636540506511575,0,0,1.1949436491014316,0.6679170434332091,ARL5C,Pro-B,0.2427500966679934
GO_Biological_Process_2021,protein transport (GO:0015031),1/369,0.6063398885560332,0.6525857814740867,0,0,1.0859582963620231,0.5433207667028247,ARL5C,Pro-B,0.21728386041430361
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6525857814740867,0,0,1.0799779371207945,0.5367673309131087,TCL1B,Pro-B,0.21585171499242045
GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),1/417,0.6517468120762254,0.6866618198660233,0,0,0.9583006279434853,0.41024765313154,RPS4Y2,Pro-B,0.1859210844420885
GO_Biological_Process_2021,nervous system development (GO:0007399),1/447,0.677475806229693,0.7012468871500331,0,0,0.8924681980415484,0.3475105496336908,LY6H,Pro-B,0.16910620954367267
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7173021405549181,0,0,0.8260426831855403,0.2885801301950252,HMHB1,Pro-B,0.1517218912312197
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.7359678224271717,0,0,0.7565820221218258,0.231944503707841,RAG1,Pro-B,0.13314117322745964
GO_Biological_Process_2021,hydrogen peroxide catabolic process (GO:0042744),4/21,2.004167160639595e-07,7.796210254888023e-05,0,0,101.95907928388746,1572.501325123093,HBM;HBB;HBA1;HBD,RBC,6.698066058295932
GO_Biological_Process_2021,hydrogen peroxide metabolic process (GO:0042743),4/29,7.837266532203001e-07,0.00015243483405134837,0,0,69.30434782608695,974.3640704866168,HBM;HBB;HBD;HBA1,RBC,6.105835383358823
GO_Biological_Process_2021,bicarbonate transport (GO:0015701),4/35,1.7088008382944347e-06,0.00022157450869884503,0,0,55.873772791023846,741.9879852387336,HBB;SLC4A1;RHAG;HBA1,RBC,5.767308551597607
GO_Biological_Process_2021,gas transport (GO:0015669),3/12,3.183301843206519e-06,0.000309576104251834,0,0,141.4255319148936,1790.1066225817303,HBB;RHAG;HBA1,RBC,5.497122179279147
GO_Biological_Process_2021,organic anion transport (GO:0015711),4/99,0.00010922478751602677,0.006204597204393,0,0,18.17391304347826,165.78429812678354,HBB;RHAG;SLC4A1;HBA1,RBC,3.96167879148639
GO_Biological_Process_2021,ammonium transport (GO:0015696),2/7,0.00012760097078443218,0.006204597204393,0,0,166.20833333333334,1490.3240703269437,RHAG;RHCE,RBC,3.8941460215026447
GO_Biological_Process_2021,cellular ion homeostasis (GO:0006873),2/7,0.00012760097078443218,0.006204597204393,0,0,166.20833333333334,1490.3240703269437,RHAG;SLC4A1,RBC,3.8941460215026447
GO_Biological_Process_2021,oxygen transport (GO:0015671),2/7,0.00012760097078443218,0.006204597204393,0,0,166.20833333333334,1490.3240703269437,HBB;HBA1,RBC,3.8941460215026447
GO_Biological_Process_2021,ammonium transmembrane transport (GO:0072488),2/8,0.0001698630098259154,0.0070683442693701,0,0,138.5,1202.2517804391236,RHAG;RHCE,RBC,3.7699011848597213
GO_Biological_Process_2021,erythrocyte differentiation (GO:0030218),3/46,0.0002068927342806532,0.0070683442693701,0,0,29.55022266204849,250.683702096932,ALAS2;TSPO2;DMTN,RBC,3.684254760746667
GO_Biological_Process_2021,response to magnesium ion (GO:0032026),2/9,0.00021804660985203623,0.0070683442693701,0,0,118.70833333333331,1000.8064198202924,SLFN14;SNCA,RBC,3.6614506612675517
GO_Biological_Process_2021,one-carbon compound transport (GO:0019755),2/9,0.00021804660985203623,0.0070683442693701,0,0,118.70833333333331,1000.8064198202924,SLC14A1;RHAG,RBC,3.6614506612675517
GO_Biological_Process_2021,erythrocyte development (GO:0048821),2/11,0.000332063883264561,0.009936373122301,0,0,92.31944444444444,739.4956618223716,ALAS2;DMTN,RBC,3.478778357620151
GO_Biological_Process_2021,positive regulation of cell death (GO:0010942),3/66,0.0006021465740591645,0.0167310726649296,0,0,20.148936170212767,149.404556417174,HBB;HBA1;SNCA,RBC,3.220297780242388
GO_Biological_Process_2021,myeloid cell development (GO:0061515),2/20,0.0011307590059983,0.0293243502222232,0,0,46.138888888888886,313.0461870363529,ALAS2;DMTN,RBC,2.9466299446036754
GO_Biological_Process_2021,heme biosynthetic process (GO:0006783),2/22,0.001370383663162,0.0333174528106261,0,0,41.520833333333336,273.7329252658829,ALAS2;FECH,RBC,2.8631578273928713
GO_Biological_Process_2021,porphyrin-containing compound biosynthetic process (GO:0006779),2/24,0.0016321249773357,0.0373468597755068,0,0,37.74242424242424,242.22606459531664,ALAS2;FECH,RBC,2.7872465889099036
GO_Biological_Process_2021,protein export from nucleus (GO:0006611),2/27,0.0020657293545543,0.0434290447500173,0,0,33.208333333333336,205.3029465636782,STRADB;XPO7,RBC,2.684926579003782
GO_Biological_Process_2021,regulation of cell death (GO:0010941),3/102,0.0021212129826486,0.0434290447500173,0,0,12.798839458413926,78.78667603753651,HBB;HBA1;SNCA,RBC,2.673415723494172
GO_Biological_Process_2021,ion homeostasis (GO:0050801),2/30,0.0025478771667966,0.0495562108941944,0,0,29.645833333333332,177.0595839464994,SLC4A1;RHAG,RBC,2.5938215131766835
GO_Biological_Process_2021,peptide cross-linking (GO:0018149),2/31,0.0027192556482504,0.0503709736747342,0,0,28.62212643678161,169.08226656127547,EPB42;KRT1,RBC,2.565549960707733
GO_Biological_Process_2021,regulation of transmembrane transport (GO:0034762),2/34,0.0032650074009337,0.0577312672256015,0,0,25.934895833333332,148.46413612460563,SLC2A1;SNCA,RBC,2.4861158299536776
GO_Biological_Process_2021,cellular response to metal ion (GO:0071248),3/131,0.0042998450257392,0.072723465870111,0,0,9.884640957446807,53.86315121420032,DMTN;SLFN14;SNCA,RBC,2.3665471969039427
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),3/143,0.0054878045288024,0.0889481650710071,0,0,9.03191489361702,47.013167330286905,HBB;HBA1;SNCA,RBC,2.2606013662470708
GO_Biological_Process_2021,response to hydrogen peroxide (GO:0042542),2/49,0.0066828970303688,0.1017755544174561,0,0,17.64450354609929,88.36726791367238,HBB;HBA1,RBC,2.175035230405133
GO_Biological_Process_2021,innate immune response (GO:0045087),4/302,0.0068024792155626,0.1017755544174561,0,0,5.7344616282462795,28.617648071431297,KRT1;TRIM58;TRIM10;SNCA,RBC,2.167332776498629
GO_Biological_Process_2021,response to reactive oxygen species (GO:0000302),2/59,0.0095700107879558,0.117144676317874,0,0,14.541666666666666,67.6059670933825,HBB;HBA1,RBC,2.019087572657113
GO_Biological_Process_2021,positive regulation of cellular biosynthetic process (GO:0031328),3/180,0.01030679429305,0.117144676317874,0,0,7.130544536602957,32.621898711524636,SLC25A37;HBB;SNCA,RBC,1.9868763916831889
GO_Biological_Process_2021,actin cytoskeleton reorganization (GO:0031532),2/63,0.0108545013893802,0.117144676317874,0,0,13.585382513661202,61.44906812714711,DMTN;PLEK2,RBC,1.9643901214324337
GO_Biological_Process_2021,amyloid fibril formation (GO:1990000),2/63,0.0108545013893802,0.117144676317874,0,0,13.585382513661202,61.44906812714711,TSPAN5;SNCA,RBC,1.9643901214324337
GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),3/185,0.0110980112028504,0.117144676317874,0,0,6.932896890343699,31.20489512099179,SPTA1;SPTB;ANK1,RBC,1.9547548411245153
GO_Biological_Process_2021,regulation of synaptic vesicle recycling (GO:1903421),1/5,0.0124387771927725,0.117144676317874,0,0,101.76530612244898,446.4379351400606,SNCA,RBC,1.9052223113279663
GO_Biological_Process_2021,glucose import across plasma membrane (GO:0098708),1/5,0.0124387771927725,0.117144676317874,0,0,101.76530612244898,446.4379351400606,SLC2A1,RBC,1.9052223113279663
GO_Biological_Process_2021,hemoglobin metabolic process (GO:0020027),1/5,0.0124387771927725,0.117144676317874,0,0,101.76530612244898,446.4379351400606,ALAS2,RBC,1.9052223113279663
GO_Biological_Process_2021,carbon dioxide transport (GO:0015670),1/5,0.0124387771927725,0.117144676317874,0,0,101.76530612244898,446.4379351400606,RHAG,RBC,1.9052223113279663
GO_Biological_Process_2021,disaccharide biosynthetic process (GO:0046351),1/5,0.0124387771927725,0.117144676317874,0,0,101.76530612244898,446.4379351400606,SLC2A1,RBC,1.9052223113279663
GO_Biological_Process_2021,dopamine biosynthetic process (GO:0042416),1/5,0.0124387771927725,0.117144676317874,0,0,101.76530612244898,446.4379351400606,SNCA,RBC,1.9052223113279663
GO_Biological_Process_2021,protein tetramerization (GO:0051262),2/71,0.0136373517747766,0.117144676317874,0,0,12.005434782608695,51.56265564232933,KRT1;SNCA,RBC,1.8652699567516449
GO_Biological_Process_2021,regulation of SNARE complex assembly (GO:0035542),1/6,0.0149082847993736,0.117144676317874,0,0,81.40816326530613,342.3895623444841,SNCA,RBC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of hemoglobin biosynthetic process (GO:0046985),1/6,0.0149082847993736,0.117144676317874,0,0,81.40816326530613,342.3895623444841,SLC25A37,RBC,1.8265723193247598
GO_Biological_Process_2021,hexose import across plasma membrane (GO:0140271),1/6,0.0149082847993736,0.117144676317874,0,0,81.40816326530613,342.3895623444841,SLC2A1,RBC,1.8265723193247598
GO_Biological_Process_2021,response to manganese ion (GO:0010042),1/6,0.0149082847993736,0.117144676317874,0,0,81.40816326530613,342.3895623444841,SLFN14,RBC,1.8265723193247598
GO_Biological_Process_2021,negative regulation of protein targeting to membrane (GO:0090315),1/6,0.0149082847993736,0.117144676317874,0,0,81.40816326530613,342.3895623444841,DMTN,RBC,1.8265723193247598
GO_Biological_Process_2021,cellular response to magnesium ion (GO:0071286),1/6,0.0149082847993736,0.117144676317874,0,0,81.40816326530613,342.3895623444841,SLFN14,RBC,1.8265723193247598
GO_Biological_Process_2021,negative regulation of transporter activity (GO:0032410),1/6,0.0149082847993736,0.117144676317874,0,0,81.40816326530613,342.3895623444841,SNCA,RBC,1.8265723193247598
GO_Biological_Process_2021,oxygen homeostasis (GO:0032364),1/6,0.0149082847993736,0.117144676317874,0,0,81.40816326530613,342.3895623444841,ALAS2,RBC,1.8265723193247598
GO_Biological_Process_2021,gas homeostasis (GO:0033483),1/7,0.0173717414502839,0.117144676317874,0,0,67.83673469387755,274.9362107684438,ALAS2,RBC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of integrin-mediated signaling pathway (GO:2001046),1/7,0.0173717414502839,0.117144676317874,0,0,67.83673469387755,274.9362107684438,DMTN,RBC,1.7601566430186848
GO_Biological_Process_2021,regulation of cGMP-mediated signaling (GO:0010752),1/7,0.0173717414502839,0.117144676317874,0,0,67.83673469387755,274.9362107684438,RUNDC3A,RBC,1.7601566430186848
GO_Biological_Process_2021,regulation of hemoglobin biosynthetic process (GO:0046984),1/7,0.0173717414502839,0.117144676317874,0,0,67.83673469387755,274.9362107684438,SLC25A37,RBC,1.7601566430186848
GO_Biological_Process_2021,regulation of inositol phosphate biosynthetic process (GO:0010919),1/7,0.0173717414502839,0.117144676317874,0,0,67.83673469387755,274.9362107684438,SNCA,RBC,1.7601566430186848
GO_Biological_Process_2021,"synaptic transmission, dopaminergic (GO:0001963)",1/7,0.0173717414502839,0.117144676317874,0,0,67.83673469387755,274.9362107684438,SNCA,RBC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of vesicle fusion (GO:0031340),1/7,0.0173717414502839,0.117144676317874,0,0,67.83673469387755,274.9362107684438,SNCA,RBC,1.7601566430186848
GO_Biological_Process_2021,nuclear export (GO:0051168),2/84,0.0187414436957378,0.117144676317874,0,0,10.095528455284551,40.15009805248223,STRADB;XPO7,RBC,1.7271969574747794
GO_Biological_Process_2021,actin filament reorganization (GO:0090527),1/8,0.0198291614511851,0.117144676317874,0,0,58.142857142857146,227.9549801512961,DMTN,RBC,1.702695651141308
GO_Biological_Process_2021,"negative regulation of complement activation, classical pathway (GO:0045959)",1/8,0.0198291614511851,0.117144676317874,0,0,58.142857142857146,227.9549801512961,CR1L,RBC,1.702695651141308
GO_Biological_Process_2021,positive regulation of fibroblast migration (GO:0010763),1/8,0.0198291614511851,0.117144676317874,0,0,58.142857142857146,227.9549801512961,DMTN,RBC,1.702695651141308
GO_Biological_Process_2021,response to epinephrine (GO:0071871),1/8,0.0198291614511851,0.117144676317874,0,0,58.142857142857146,227.9549801512961,SNCA,RBC,1.702695651141308
GO_Biological_Process_2021,positive regulation of homotypic cell-cell adhesion (GO:0034112),1/8,0.0198291614511851,0.117144676317874,0,0,58.142857142857146,227.9549801512961,DMTN,RBC,1.702695651141308
GO_Biological_Process_2021,regulation of chaperone-mediated autophagy (GO:1904714),1/8,0.0198291614511851,0.117144676317874,0,0,58.142857142857146,227.9549801512961,SNCA,RBC,1.702695651141308
GO_Biological_Process_2021,negative regulation of monooxygenase activity (GO:0032769),1/8,0.0198291614511851,0.117144676317874,0,0,58.142857142857146,227.9549801512961,SNCA,RBC,1.702695651141308
GO_Biological_Process_2021,regulation of dopamine uptake involved in synaptic transmission (GO:0051584),1/8,0.0198291614511851,0.117144676317874,0,0,58.142857142857146,227.9549801512961,SNCA,RBC,1.702695651141308
GO_Biological_Process_2021,cellular response to epinephrine stimulus (GO:0071872),1/8,0.0198291614511851,0.117144676317874,0,0,58.142857142857146,227.9549801512961,SNCA,RBC,1.702695651141308
GO_Biological_Process_2021,dopamine uptake (GO:0090494),1/8,0.0198291614511851,0.117144676317874,0,0,58.142857142857146,227.9549801512961,SNCA,RBC,1.702695651141308
GO_Biological_Process_2021,negative regulation of exocytosis (GO:0045920),1/9,0.0222805591236868,0.117144676317874,0,0,50.87244897959184,193.52086993316271,SNCA,RBC,1.652073914876897
GO_Biological_Process_2021,regulation of transmembrane transporter activity (GO:0022898),1/9,0.0222805591236868,0.117144676317874,0,0,50.87244897959184,193.52086993316271,SNCA,RBC,1.652073914876897
GO_Biological_Process_2021,positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/9,0.0222805591236868,0.117144676317874,0,0,50.87244897959184,193.52086993316271,SNCA,RBC,1.652073914876897
GO_Biological_Process_2021,"regulation of complement activation, classical pathway (GO:0030450)",1/9,0.0222805591236868,0.117144676317874,0,0,50.87244897959184,193.52086993316271,CR1L,RBC,1.652073914876897
GO_Biological_Process_2021,regulation of complement-dependent cytotoxicity (GO:1903659),1/9,0.0222805591236868,0.117144676317874,0,0,50.87244897959184,193.52086993316271,CR1L,RBC,1.652073914876897
GO_Biological_Process_2021,L-ascorbic acid metabolic process (GO:0019852),1/9,0.0222805591236868,0.117144676317874,0,0,50.87244897959184,193.52086993316271,SLC2A1,RBC,1.652073914876897
GO_Biological_Process_2021,maintenance of apical/basal cell polarity (GO:0035090),1/9,0.0222805591236868,0.117144676317874,0,0,50.87244897959184,193.52086993316271,ANK1,RBC,1.652073914876897
GO_Biological_Process_2021,maintenance of epithelial cell apical/basal polarity (GO:0045199),1/9,0.0222805591236868,0.117144676317874,0,0,50.87244897959184,193.52086993316271,ANK1,RBC,1.652073914876897
GO_Biological_Process_2021,positive regulation of coagulation (GO:0050820),1/10,0.024725948817258,0.117144676317874,0,0,45.21768707482993,167.3010120823387,DMTN,RBC,1.606847034080906
GO_Biological_Process_2021,arginine metabolic process (GO:0006525),1/10,0.024725948817258,0.117144676317874,0,0,45.21768707482993,167.3010120823387,ART4,RBC,1.606847034080906
GO_Biological_Process_2021,negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),1/10,0.024725948817258,0.117144676317874,0,0,45.21768707482993,167.3010120823387,CR1L,RBC,1.606847034080906
GO_Biological_Process_2021,positive regulation of hemostasis (GO:1900048),1/10,0.024725948817258,0.117144676317874,0,0,45.21768707482993,167.3010120823387,DMTN,RBC,1.606847034080906
GO_Biological_Process_2021,negative regulation of peptidyl-lysine acetylation (GO:2000757),1/10,0.024725948817258,0.117144676317874,0,0,45.21768707482993,167.3010120823387,SNCA,RBC,1.606847034080906
GO_Biological_Process_2021,iron ion transmembrane transport (GO:0034755),1/10,0.024725948817258,0.117144676317874,0,0,45.21768707482993,167.3010120823387,SLC25A37,RBC,1.606847034080906
GO_Biological_Process_2021,SNARE complex assembly (GO:0035493),1/10,0.024725948817258,0.117144676317874,0,0,45.21768707482993,167.3010120823387,SNCA,RBC,1.606847034080906
GO_Biological_Process_2021,long-chain fatty acid import into cell (GO:0044539),1/10,0.024725948817258,0.117144676317874,0,0,45.21768707482993,167.3010120823387,SLC2A1,RBC,1.606847034080906
GO_Biological_Process_2021,positive regulation of receptor recycling (GO:0001921),1/10,0.024725948817258,0.117144676317874,0,0,45.21768707482993,167.3010120823387,SNCA,RBC,1.606847034080906
GO_Biological_Process_2021,"complement activation, lectin pathway (GO:0001867)",1/10,0.024725948817258,0.117144676317874,0,0,45.21768707482993,167.3010120823387,KRT1,RBC,1.606847034080906
GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation (GO:0033135),2/98,0.0249948795228368,0.117144676317874,0,0,8.6171875,31.789531066243494,DMTN;SNCA,RBC,1.6021489522377872
GO_Biological_Process_2021,positive regulation of alcohol biosynthetic process (GO:1902932),1/11,0.0271653448579923,0.1209533684831924,0,0,40.69387755102041,146.73452100035948,SNCA,RBC,1.5659847773237099
GO_Biological_Process_2021,regulation of biosynthetic process (GO:0009889),1/11,0.0271653448579923,0.1209533684831924,0,0,40.69387755102041,146.73452100035948,SNCA,RBC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/11,0.0271653448579923,0.1209533684831924,0,0,40.69387755102041,146.73452100035948,SNCA,RBC,1.5659847773237099
GO_Biological_Process_2021,regulation of phospholipase activity (GO:0010517),1/11,0.0271653448579923,0.1209533684831924,0,0,40.69387755102041,146.73452100035948,SNCA,RBC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of complement activation (GO:0045916),1/12,0.029598761568907,0.1209533684831924,0,0,36.99257884972171,130.2147194065139,CR1L,RBC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of histone acetylation (GO:0035067),1/12,0.029598761568907,0.1209533684831924,0,0,36.99257884972171,130.2147194065139,SNCA,RBC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of microtubule polymerization (GO:0031115),1/12,0.029598761568907,0.1209533684831924,0,0,36.99257884972171,130.2147194065139,SNCA,RBC,1.5287264597194943
GO_Biological_Process_2021,catecholamine biosynthetic process (GO:0042423),1/12,0.029598761568907,0.1209533684831924,0,0,36.99257884972171,130.2147194065139,SNCA,RBC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of oxidoreductase activity (GO:0051354),1/12,0.029598761568907,0.1209533684831924,0,0,36.99257884972171,130.2147194065139,SNCA,RBC,1.5287264597194943
GO_Biological_Process_2021,inorganic ion transmembrane transport (GO:0098660),1/12,0.029598761568907,0.1209533684831924,0,0,36.99257884972171,130.2147194065139,RHAG,RBC,1.5287264597194943
GO_Biological_Process_2021,protein-containing complex subunit organization (GO:0043933),2/112,0.031976077624072,0.1209533684831924,0,0,7.515151515151516,25.872917364872013,DMTN;SLC2A1,RBC,1.4951748104677034
GO_Biological_Process_2021,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/13,0.032026213248763,0.1209533684831924,0,0,33.90816326530612,116.6847899929619,DMTN,RBC,1.4944944088974865
GO_Biological_Process_2021,positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,0.032026213248763,0.1209533684831924,0,0,33.90816326530612,116.6847899929619,SNCA,RBC,1.4944944088974865
GO_Biological_Process_2021,glucose import (GO:0046323),1/13,0.032026213248763,0.1209533684831924,0,0,33.90816326530612,116.6847899929619,SLC2A1,RBC,1.4944944088974865
GO_Biological_Process_2021,Golgi ribbon formation (GO:0090161),1/13,0.032026213248763,0.1209533684831924,0,0,33.90816326530612,116.6847899929619,FHDC1,RBC,1.4944944088974865
GO_Biological_Process_2021,response to iron ion (GO:0010039),1/13,0.032026213248763,0.1209533684831924,0,0,33.90816326530612,116.6847899929619,SNCA,RBC,1.4944944088974865
GO_Biological_Process_2021,intracellular sterol transport (GO:0032366),1/13,0.032026213248763,0.1209533684831924,0,0,33.90816326530612,116.6847899929619,TSPO2,RBC,1.4944944088974865
GO_Biological_Process_2021,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),1/13,0.032026213248763,0.1209533684831924,0,0,33.90816326530612,116.6847899929619,DMTN,RBC,1.4944944088974865
GO_Biological_Process_2021,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/13,0.032026213248763,0.1209533684831924,0,0,33.90816326530612,116.6847899929619,SNCA,RBC,1.4944944088974865
GO_Biological_Process_2021,protein heterotetramerization (GO:0051290),1/13,0.032026213248763,0.1209533684831924,0,0,33.90816326530612,116.6847899929619,KRT1,RBC,1.4944944088974865
GO_Biological_Process_2021,renal absorption (GO:0070293),1/14,0.0344477141698711,0.1252351477764474,0,0,31.298273155416013,105.4223689491126,HBB,RBC,1.4628395910668823
GO_Biological_Process_2021,regulation of integrin-mediated signaling pathway (GO:2001044),1/14,0.0344477141698711,0.1252351477764474,0,0,31.298273155416013,105.4223689491126,DMTN,RBC,1.4628395910668823
GO_Biological_Process_2021,regulation of lamellipodium organization (GO:1902743),1/14,0.0344477141698711,0.1252351477764474,0,0,31.298273155416013,105.4223689491126,DMTN,RBC,1.4628395910668823
GO_Biological_Process_2021,regulation of lipase activity (GO:0060191),1/14,0.0344477141698711,0.1252351477764474,0,0,31.298273155416013,105.4223689491126,SNCA,RBC,1.4628395910668823
GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),2/120,0.0362706169091182,0.1257878541483584,0,0,7.002824858757062,23.22660056193845,DMTN;ANK1,RBC,1.4404450576550938
GO_Biological_Process_2021,fibrinolysis (GO:0042730),1/15,0.0368632785936063,0.1257878541483584,0,0,29.06122448979592,95.91771596133704,KRT1,RBC,1.4334060415588732
GO_Biological_Process_2021,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",1/15,0.0368632785936063,0.1257878541483584,0,0,29.06122448979592,95.91771596133704,SLFN14,RBC,1.4334060415588732
GO_Biological_Process_2021,intracellular cholesterol transport (GO:0032367),1/15,0.0368632785936063,0.1257878541483584,0,0,29.06122448979592,95.91771596133704,TSPO2,RBC,1.4334060415588732
GO_Biological_Process_2021,stress fiber assembly (GO:0043149),1/15,0.0368632785936063,0.1257878541483584,0,0,29.06122448979592,95.91771596133704,FHDC1,RBC,1.4334060415588732
GO_Biological_Process_2021,contractile actin filament bundle assembly (GO:0030038),1/15,0.0368632785936063,0.1257878541483584,0,0,29.06122448979592,95.91771596133704,FHDC1,RBC,1.4334060415588732
GO_Biological_Process_2021,peptidyl-arginine modification (GO:0018195),1/15,0.0368632785936063,0.1257878541483584,0,0,29.06122448979592,95.91771596133704,ART4,RBC,1.4334060415588732
GO_Biological_Process_2021,negative regulation of cell-substrate junction organization (GO:0150118),1/16,0.0392729207344652,0.1305740697923673,0,0,27.122448979591837,87.80133530116419,DMTN,RBC,1.405906798966597
GO_Biological_Process_2021,negative regulation of focal adhesion assembly (GO:0051895),1/16,0.0392729207344652,0.1305740697923673,0,0,27.122448979591837,87.80133530116419,DMTN,RBC,1.405906798966597
GO_Biological_Process_2021,negative regulation of histone modification (GO:0031057),1/16,0.0392729207344652,0.1305740697923673,0,0,27.122448979591837,87.80133530116419,SNCA,RBC,1.405906798966597
GO_Biological_Process_2021,regulation of receptor recycling (GO:0001919),1/17,0.0416766547912334,0.1328870386376215,0,0,25.426020408163264,80.79916728086499,SNCA,RBC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of blood coagulation (GO:0030194),1/17,0.0416766547912334,0.1328870386376215,0,0,25.426020408163264,80.79916728086499,DMTN,RBC,1.3801071472903907
GO_Biological_Process_2021,regulation of cell killing (GO:0031341),1/17,0.0416766547912334,0.1328870386376215,0,0,25.426020408163264,80.79916728086499,CR1L,RBC,1.3801071472903907
GO_Biological_Process_2021,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1/17,0.0416766547912334,0.1328870386376215,0,0,25.426020408163264,80.79916728086499,DMTN,RBC,1.3801071472903907
GO_Biological_Process_2021,protein heterooligomerization (GO:0051291),1/17,0.0416766547912334,0.1328870386376215,0,0,25.426020408163264,80.79916728086499,KRT1,RBC,1.3801071472903907
GO_Biological_Process_2021,amyloid precursor protein metabolic process (GO:0042982),1/18,0.0440744949316926,0.1339451447533472,0,0,23.92917166866747,74.70385911458476,TMCC2,RBC,1.3558126557645607
GO_Biological_Process_2021,rRNA catabolic process (GO:0016075),1/18,0.0440744949316926,0.1339451447533472,0,0,23.92917166866747,74.70385911458476,SLFN14,RBC,1.3558126557645607
GO_Biological_Process_2021,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,0.0440744949316926,0.1339451447533472,0,0,23.92917166866747,74.70385911458476,ACSL6,RBC,1.3558126557645607
GO_Biological_Process_2021,regulation of platelet aggregation (GO:0090330),1/18,0.0440744949316926,0.1339451447533472,0,0,23.92917166866747,74.70385911458476,DMTN,RBC,1.3558126557645607
GO_Biological_Process_2021,regulation of presynapse assembly (GO:1905606),1/18,0.0440744949316926,0.1339451447533472,0,0,23.92917166866747,74.70385911458476,SNCA,RBC,1.3558126557645607
GO_Biological_Process_2021,regulation of presynapse organization (GO:0099174),1/18,0.0440744949316926,0.1339451447533472,0,0,23.92917166866747,74.70385911458476,SNCA,RBC,1.3558126557645607
GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),2/136,0.0454786698217006,0.1359056474424795,0,0,6.161691542288557,19.042780777221537,TSPAN5;ANK1,RBC,1.3421922462170102
GO_Biological_Process_2021,fatty acid transmembrane transport (GO:1902001),1/19,0.0464664552952436,0.1359056474424795,0,0,22.598639455782312,69.35578082800635,SLC2A1,RBC,1.3328604565168853
GO_Biological_Process_2021,cellular response to copper ion (GO:0071280),1/19,0.0464664552952436,0.1359056474424795,0,0,22.598639455782312,69.35578082800635,SNCA,RBC,1.3328604565168853
GO_Biological_Process_2021,regulation of glucose transmembrane transport (GO:0010827),1/19,0.0464664552952436,0.1359056474424795,0,0,22.598639455782312,69.35578082800635,SLC2A1,RBC,1.3328604565168853
GO_Biological_Process_2021,dopamine metabolic process (GO:0042417),1/19,0.0464664552952436,0.1359056474424795,0,0,22.598639455782312,69.35578082800635,SNCA,RBC,1.3328604565168853
GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),2/140,0.0479026862337682,0.1390607831711631,0,0,5.981884057971015,18.176455370515885,TSPAN5;ANK1,RBC,1.319640132017756
GO_Biological_Process_2021,glucose transmembrane transport (GO:1904659),1/20,0.0488525499820277,0.1407677180963614,0,0,21.40816326530612,64.63014669364038,SLC2A1,RBC,1.3111127622579986
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),2/143,0.0497512691479657,0.1423032624894021,0,0,5.8537234042553195,17.565380826397597,HBB;RHAG,RBC,1.3031958359850326
GO_Biological_Process_2021,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.0512327930672156,0.1433781043391861,0,0,20.336734693877553,60.42807445408675,DMTN,RBC,1.2904519669693806
GO_Biological_Process_2021,negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/21,0.0512327930672156,0.1433781043391861,0,0,20.336734693877553,60.42807445408675,DMTN,RBC,1.2904519669693806
GO_Biological_Process_2021,regulation of fibroblast migration (GO:0010762),1/21,0.0512327930672156,0.1433781043391861,0,0,20.336734693877553,60.42807445408675,DMTN,RBC,1.2904519669693806
GO_Biological_Process_2021,amino acid import (GO:0043090),1/22,0.0536071985992547,0.1468535229233106,0,0,19.367346938775512,56.67024999786951,TSPO2,RBC,1.2707768875084013
GO_Biological_Process_2021,lipid droplet organization (GO:0034389),1/22,0.0536071985992547,0.1468535229233106,0,0,19.367346938775512,56.67024999786951,TSPO2,RBC,1.2707768875084013
GO_Biological_Process_2021,microglial cell activation (GO:0001774),1/22,0.0536071985992547,0.1468535229233106,0,0,19.367346938775512,56.67024999786951,SNCA,RBC,1.2707768875084013
GO_Biological_Process_2021,actin filament organization (GO:0007015),2/152,0.0554491879134877,0.1471255314100346,0,0,5.5,15.907585158720506,SPTA1;DMTN,RBC,1.2561048099706147
GO_Biological_Process_2021,negative regulation of protein phosphorylation (GO:0001933),2/152,0.0554491879134877,0.1471255314100346,0,0,5.5,15.907585158720506,DMTN;SNCA,RBC,1.2561048099706147
GO_Biological_Process_2021,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),1/23,0.0559757805878795,0.1471255314100346,0,0,18.4860853432282,53.29235549319145,SNCA,RBC,1.2519998414265567
GO_Biological_Process_2021,negative regulation of intracellular protein transport (GO:0090317),1/23,0.0559757805878795,0.1471255314100346,0,0,18.4860853432282,53.29235549319145,DMTN,RBC,1.2519998414265567
GO_Biological_Process_2021,response to copper ion (GO:0046688),1/23,0.0559757805878795,0.1471255314100346,0,0,18.4860853432282,53.29235549319145,SNCA,RBC,1.2519998414265567
GO_Biological_Process_2021,hexose transmembrane transport (GO:0008645),1/23,0.0559757805878795,0.1471255314100346,0,0,18.4860853432282,53.29235549319145,SLC2A1,RBC,1.2519998414265567
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),2/154,0.0567455048100272,0.1473616696237719,0,0,5.427083333333333,15.571272642043729,STRADB;SNCA,RBC,1.2460685361352464
GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),3/351,0.0573776228581519,0.1473616696237719,0,0,3.595377842993397,10.275952639346544,SPTA1;TSPAN5;SNCA,RBC,1.2412574484387946
GO_Biological_Process_2021,amino acid import across plasma membrane (GO:0089718),1/24,0.0583385530130099,0.1473616696237719,0,0,17.68145519077196,50.24171555062859,TSPO2,RBC,1.2340443470047993
GO_Biological_Process_2021,cellular response to catecholamine stimulus (GO:0071870),1/24,0.0583385530130099,0.1473616696237719,0,0,17.68145519077196,50.24171555062859,SNCA,RBC,1.2340443470047993
GO_Biological_Process_2021,long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/24,0.0583385530130099,0.1473616696237719,0,0,17.68145519077196,50.24171555062859,ACSL6,RBC,1.2340443470047993
GO_Biological_Process_2021,regulation of monooxygenase activity (GO:0032768),1/24,0.0583385530130099,0.1473616696237719,0,0,17.68145519077196,50.24171555062859,SNCA,RBC,1.2340443470047993
GO_Biological_Process_2021,organonitrogen compound biosynthetic process (GO:1901566),2/158,0.0593699722530508,0.148494094978643,0,0,5.2868589743589745,14.929913680908546,ALAS2;RHCE,RBC,1.2264331540442923
GO_Biological_Process_2021,negative regulation of cell junction assembly (GO:1901889),1/25,0.0606955298241754,0.148494094978643,0,0,16.943877551020407,47.47480020477031,DMTN,RBC,1.2168432931781568
GO_Biological_Process_2021,negative regulation of ion transport (GO:0043271),1/25,0.0606955298241754,0.148494094978643,0,0,16.943877551020407,47.47480020477031,SNCA,RBC,1.2168432931781568
GO_Biological_Process_2021,regulation of dopamine secretion (GO:0014059),1/25,0.0606955298241754,0.148494094978643,0,0,16.943877551020407,47.47480020477031,SNCA,RBC,1.2168432931781568
GO_Biological_Process_2021,divalent inorganic cation homeostasis (GO:0072507),1/25,0.0606955298241754,0.148494094978643,0,0,16.943877551020407,47.47480020477031,SNCA,RBC,1.2168432931781568
GO_Biological_Process_2021,negative regulation of protein localization to membrane (GO:1905476),1/26,0.0630467249540435,0.1523206420880209,0,0,16.26530612244898,44.95534064809558,DMTN,RBC,1.2003374685092782
GO_Biological_Process_2021,lamellipodium assembly (GO:0030032),1/26,0.0630467249540435,0.1523206420880209,0,0,16.26530612244898,44.95534064809558,DMTN,RBC,1.2003374685092782
GO_Biological_Process_2021,positive regulation of calcium ion transmembrane transport (GO:1904427),1/27,0.0653921522588676,0.1523206420880209,0,0,15.638932496075354,42.652889831563165,SNCA,RBC,1.184474368421492
GO_Biological_Process_2021,regulation of blood coagulation (GO:0030193),1/27,0.0653921522588676,0.1523206420880209,0,0,15.638932496075354,42.652889831563165,DMTN,RBC,1.184474368421492
GO_Biological_Process_2021,regulation of vasculature development (GO:1901342),1/27,0.0653921522588676,0.1523206420880209,0,0,15.638932496075354,42.652889831563165,KRT1,RBC,1.184474368421492
GO_Biological_Process_2021,negative regulation of protein polymerization (GO:0032272),1/27,0.0653921522588676,0.1523206420880209,0,0,15.638932496075354,42.652889831563165,SNCA,RBC,1.184474368421492
GO_Biological_Process_2021,positive regulation of nitric oxide biosynthetic process (GO:0045429),1/27,0.0653921522588676,0.1523206420880209,0,0,15.638932496075354,42.652889831563165,HBB,RBC,1.184474368421492
GO_Biological_Process_2021,presynaptic endocytosis (GO:0140238),1/27,0.0653921522588676,0.1523206420880209,0,0,15.638932496075354,42.652889831563165,SNCA,RBC,1.184474368421492
GO_Biological_Process_2021,regulation of reactive oxygen species biosynthetic process (GO:1903426),1/28,0.0677318256109869,0.1531841869922901,0,0,15.058956916099774,40.54171043527237,SNCA,RBC,1.1692072184717057
GO_Biological_Process_2021,amide transport (GO:0042886),1/28,0.0677318256109869,0.1531841869922901,0,0,15.058956916099774,40.54171043527237,SLC14A1,RBC,1.1692072184717057
GO_Biological_Process_2021,RNA phosphodiester bond hydrolysis (GO:0090501),1/28,0.0677318256109869,0.1531841869922901,0,0,15.058956916099774,40.54171043527237,SLFN14,RBC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of nitric oxide metabolic process (GO:1904407),1/28,0.0677318256109869,0.1531841869922901,0,0,15.058956916099774,40.54171043527237,HBB,RBC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of response to wounding (GO:1903036),1/28,0.0677318256109869,0.1531841869922901,0,0,15.058956916099774,40.54171043527237,DMTN,RBC,1.1692072184717057
GO_Biological_Process_2021,regulation of protein targeting to membrane (GO:0090313),1/29,0.0700657588372089,0.1557461725009958,0,0,14.520408163265309,38.5999069065122,DMTN,RBC,1.1544941700666143
GO_Biological_Process_2021,lamellipodium organization (GO:0097581),1/29,0.0700657588372089,0.1557461725009958,0,0,14.520408163265309,38.5999069065122,DMTN,RBC,1.1544941700666143
GO_Biological_Process_2021,protein ADP-ribosylation (GO:0006471),1/29,0.0700657588372089,0.1557461725009958,0,0,14.520408163265309,38.5999069065122,ART4,RBC,1.1544941700666143
GO_Biological_Process_2021,fatty-acyl-CoA biosynthetic process (GO:0046949),1/30,0.0723939657090184,0.1564514036711564,0,0,14.019000703729768,36.80874147674154,ACSL6,RBC,1.1402976322627019
GO_Biological_Process_2021,regulation of catecholamine secretion (GO:0050433),1/30,0.0723939657090184,0.1564514036711564,0,0,14.019000703729768,36.80874147674154,SNCA,RBC,1.1402976322627019
GO_Biological_Process_2021,positive regulation of phosphate metabolic process (GO:0045937),1/30,0.0723939657090184,0.1564514036711564,0,0,14.019000703729768,36.80874147674154,SNCA,RBC,1.1402976322627019
GO_Biological_Process_2021,synaptic vesicle cycle (GO:0099504),1/30,0.0723939657090184,0.1564514036711564,0,0,14.019000703729768,36.80874147674154,SNCA,RBC,1.1402976322627019
GO_Biological_Process_2021,ncRNA catabolic process (GO:0034661),1/30,0.0723939657090184,0.1564514036711564,0,0,14.019000703729768,36.80874147674154,SLFN14,RBC,1.1402976322627019
GO_Biological_Process_2021,purine nucleoside bisphosphate metabolic process (GO:0034032),1/31,0.0747164600026276,0.1571065023839035,0,0,13.551020408163266,35.15209038871121,ACSL6,RBC,1.126583712764908
GO_Biological_Process_2021,regulation of cellular pH (GO:0030641),1/31,0.0747164600026276,0.1571065023839035,0,0,13.551020408163266,35.15209038871121,SLC4A1,RBC,1.126583712764908
GO_Biological_Process_2021,ribonucleoside bisphosphate metabolic process (GO:0033875),1/31,0.0747164600026276,0.1571065023839035,0,0,13.551020408163266,35.15209038871121,ACSL6,RBC,1.126583712764908
GO_Biological_Process_2021,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/31,0.0747164600026276,0.1571065023839035,0,0,13.551020408163266,35.15209038871121,DMTN,RBC,1.126583712764908
GO_Biological_Process_2021,cellular response to cAMP (GO:0071320),1/31,0.0747164600026276,0.1571065023839035,0,0,13.551020408163266,35.15209038871121,DMTN,RBC,1.126583712764908
GO_Biological_Process_2021,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/32,0.0770332554327668,0.1593932785284378,0,0,13.113232389730086,33.61600807740255,ANK1,RBC,1.1133217484244988
GO_Biological_Process_2021,negative regulation of cell-matrix adhesion (GO:0001953),1/32,0.0770332554327668,0.1593932785284378,0,0,13.113232389730086,33.61600807740255,DMTN,RBC,1.1133217484244988
GO_Biological_Process_2021,negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/32,0.0770332554327668,0.1593932785284378,0,0,13.113232389730086,33.61600807740255,SNCA,RBC,1.1133217484244988
GO_Biological_Process_2021,actin filament bundle assembly (GO:0051017),1/33,0.0793443657059371,0.1607549909354663,0,0,12.70280612244898,32.18837516559274,DMTN,RBC,1.1004839073426347
GO_Biological_Process_2021,actin filament bundle organization (GO:0061572),1/33,0.0793443657059371,0.1607549909354663,0,0,12.70280612244898,32.18837516559274,DMTN,RBC,1.1004839073426347
GO_Biological_Process_2021,regulation of histone acetylation (GO:0035065),1/33,0.0793443657059371,0.1607549909354663,0,0,12.70280612244898,32.18837516559274,SNCA,RBC,1.1004839073426347
GO_Biological_Process_2021,very long-chain fatty acid metabolic process (GO:0000038),1/33,0.0793443657059371,0.1607549909354663,0,0,12.70280612244898,32.18837516559274,ACSL6,RBC,1.1004839073426347
GO_Biological_Process_2021,positive regulation of calcium ion transport into cytosol (GO:0010524),1/34,0.0816498044624026,0.1612272788623076,0,0,12.317254174397032,30.85861216573232,SNCA,RBC,1.0880448509885652
GO_Biological_Process_2021,synaptic vesicle recycling (GO:0036465),1/34,0.0816498044624026,0.1612272788623076,0,0,12.317254174397032,30.85861216573232,SNCA,RBC,1.0880448509885652
GO_Biological_Process_2021,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/34,0.0816498044624026,0.1612272788623076,0,0,12.317254174397032,30.85861216573232,SNCA,RBC,1.0880448509885652
GO_Biological_Process_2021,regulation of lamellipodium assembly (GO:0010591),1/34,0.0816498044624026,0.1612272788623076,0,0,12.317254174397032,30.85861216573232,DMTN,RBC,1.0880448509885652
GO_Biological_Process_2021,protein destabilization (GO:0031648),1/34,0.0816498044624026,0.1612272788623076,0,0,12.317254174397032,30.85861216573232,SNCA,RBC,1.0880448509885652
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),2/195,0.0854831524975729,0.165572291583241,0,0,4.265328151986183,10.490301477724982,TSPAN5;ANK1,RBC,1.0681194700473418
GO_Biological_Process_2021,retina homeostasis (GO:0001895),1/36,0.0862437219743075,0.165572291583241,0,0,11.612244897959185,28.456712045041098,KRT1,RBC,1.0642725091375862
GO_Biological_Process_2021,macrophage activation (GO:0042116),1/36,0.0862437219743075,0.165572291583241,0,0,11.612244897959185,28.456712045041098,SNCA,RBC,1.0642725091375862
GO_Biological_Process_2021,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/36,0.0862437219743075,0.165572291583241,0,0,11.612244897959185,28.456712045041098,DMTN,RBC,1.0642725091375862
GO_Biological_Process_2021,platelet aggregation (GO:0070527),1/36,0.0862437219743075,0.165572291583241,0,0,11.612244897959185,28.456712045041098,HBB,RBC,1.0642725091375862
GO_Biological_Process_2021,organelle organization (GO:0006996),3/420,0.0875282858129556,0.165572291583241,0,0,2.9898974437471297,7.28277207572745,TSPO2;DMTN;ANK1,RBC,1.0578515768365675
GO_Biological_Process_2021,acyl-CoA metabolic process (GO:0006637),1/37,0.0885322278902676,0.165572291583241,0,0,11.289115646258503,27.36920368672352,ACSL6,RBC,1.0528986067362665
GO_Biological_Process_2021,regulation of transport (GO:0051049),1/37,0.0885322278902676,0.165572291583241,0,0,11.289115646258503,27.36920368672352,SNCA,RBC,1.0528986067362665
GO_Biological_Process_2021,glutamine family amino acid metabolic process (GO:0009064),1/37,0.0885322278902676,0.165572291583241,0,0,11.289115646258503,27.36920368672352,ART4,RBC,1.0528986067362665
GO_Biological_Process_2021,positive regulation of exocytosis (GO:0045921),1/37,0.0885322278902676,0.165572291583241,0,0,11.289115646258503,27.36920368672352,SNCA,RBC,1.0528986067362665
GO_Biological_Process_2021,regulation of intracellular pH (GO:0051453),1/37,0.0885322278902676,0.165572291583241,0,0,11.289115646258503,27.36920368672352,SLC4A1,RBC,1.0528986067362665
GO_Biological_Process_2021,regulation of macromolecule metabolic process (GO:0060255),2/200,0.0892414542606553,0.1661001230018895,0,0,4.156565656565657,10.043965211617904,TRIM58;TRIM10,RBC,1.0494333611556608
GO_Biological_Process_2021,response to cAMP (GO:0051591),1/38,0.0908151166313484,0.1666371715546913,0,0,10.983452840595698,26.34852930034076,DMTN,RBC,1.0418418549683985
GO_Biological_Process_2021,synaptic vesicle endocytosis (GO:0048488),1/38,0.0908151166313484,0.1666371715546913,0,0,10.983452840595698,26.34852930034076,SNCA,RBC,1.0418418549683985
GO_Biological_Process_2021,positive regulation of signaling (GO:0023056),1/38,0.0908151166313484,0.1666371715546913,0,0,10.983452840595698,26.34852930034076,SNCA,RBC,1.0418418549683985
GO_Biological_Process_2021,axon guidance (GO:0007411),2/203,0.0915200219539462,0.1671019530084687,0,0,4.093905472636816,9.789336578359592,SPTA1;SPTB,RBC,1.0384838843718929
GO_Biological_Process_2021,negative regulation of secretion by cell (GO:1903531),1/39,0.0930924017046572,0.1671019530084687,0,0,10.693877551020408,25.38900533231373,SNCA,RBC,1.0310857651239858
GO_Biological_Process_2021,regulation of peptidyl-threonine phosphorylation (GO:0010799),1/39,0.0930924017046572,0.1671019530084687,0,0,10.693877551020408,25.38900533231373,DMTN,RBC,1.0310857651239858
GO_Biological_Process_2021,negative regulation of blood coagulation (GO:0030195),1/40,0.0953640965755271,0.1671019530084687,0,0,10.419152276295131,24.485561288951835,KRT1,RBC,1.0206151011238414
GO_Biological_Process_2021,negative regulation of cell-substrate adhesion (GO:0010812),1/40,0.0953640965755271,0.1671019530084687,0,0,10.419152276295131,24.485561288951835,DMTN,RBC,1.0206151011238414
GO_Biological_Process_2021,carboxylic acid metabolic process (GO:0019752),1/40,0.0953640965755271,0.1671019530084687,0,0,10.419152276295131,24.485561288951835,SLC2A1,RBC,1.0206151011238414
GO_Biological_Process_2021,synaptic vesicle exocytosis (GO:0016079),1/40,0.0953640965755271,0.1671019530084687,0,0,10.419152276295131,24.485561288951835,SNCA,RBC,1.0206151011238414
GO_Biological_Process_2021,regulation of microtubule polymerization (GO:0031113),1/40,0.0953640965755271,0.1671019530084687,0,0,10.419152276295131,24.485561288951835,SNCA,RBC,1.0206151011238414
GO_Biological_Process_2021,positive regulation of wound healing (GO:0090303),1/40,0.0953640965755271,0.1671019530084687,0,0,10.419152276295131,24.485561288951835,DMTN,RBC,1.0206151011238414
GO_Biological_Process_2021,regulation of nitric oxide biosynthetic process (GO:0045428),1/40,0.0953640965755271,0.1671019530084687,0,0,10.419152276295131,24.485561288951835,HBB,RBC,1.0206151011238414
GO_Biological_Process_2021,import into cell (GO:0098657),1/41,0.0976302146847681,0.1695453281802447,0,0,10.158163265306122,23.633660200289185,TSPO2,RBC,1.0104157556925017
GO_Biological_Process_2021,regulation of filopodium assembly (GO:0051489),1/41,0.0976302146847681,0.1695453281802447,0,0,10.158163265306122,23.633660200289185,DMTN,RBC,1.0104157556925017
GO_Biological_Process_2021,negative regulation of protein catabolic process (GO:0042177),1/42,0.0998907694703361,0.1727000414398256,0,0,9.909905425584869,22.829231064333683,SNCA,RBC,1.00047464143678
GO_Biological_Process_2021,anion transport (GO:0006820),1/43,0.1021457742794159,0.1742750271697052,0,0,9.673469387755102,22.068611238785657,SLC4A1,RBC,0.9907795952096249
GO_Biological_Process_2021,regulation of cell-substrate adhesion (GO:0010810),1/43,0.1021457742794159,0.1742750271697052,0,0,9.673469387755102,22.068611238785657,DMTN,RBC,0.9907795952096249
GO_Biological_Process_2021,signal release from synapse (GO:0099643),1/43,0.1021457742794159,0.1742750271697052,0,0,9.673469387755102,22.068611238785657,SNCA,RBC,0.9907795952096249
GO_Biological_Process_2021,cation transmembrane transport (GO:0098655),1/44,0.1043952424647777,0.1742907696085774,0,0,9.448030374940672,21.34849709415977,RHAG,RBC,0.9813192926974915
GO_Biological_Process_2021,homotypic cell-cell adhesion (GO:0034109),1/44,0.1043952424647777,0.1742907696085774,0,0,9.448030374940672,21.34849709415977,HBB,RBC,0.9813192926974915
GO_Biological_Process_2021,neurotransmitter secretion (GO:0007269),1/44,0.1043952424647777,0.1742907696085774,0,0,9.448030374940672,21.34849709415977,SNCA,RBC,0.9813192926974915
GO_Biological_Process_2021,metal ion homeostasis (GO:0055065),1/44,0.1043952424647777,0.1742907696085774,0,0,9.448030374940672,21.34849709415977,SNCA,RBC,0.9813192926974915
GO_Biological_Process_2021,mRNA catabolic process (GO:0006402),1/44,0.1043952424647777,0.1742907696085774,0,0,9.448030374940672,21.34849709415977,SLFN14,RBC,0.9813192926974915
GO_Biological_Process_2021,amino acid transmembrane transport (GO:0003333),1/45,0.1066391873529346,0.1765218888523046,0,0,9.232838589981448,20.665901611884028,TSPO2,RBC,0.9720831731354668
GO_Biological_Process_2021,positive regulation of Notch signaling pathway (GO:0045747),1/45,0.1066391873529346,0.1765218888523046,0,0,9.232838589981448,20.665901611884028,TSPAN5,RBC,0.9720831731354668
GO_Biological_Process_2021,regulation of synapse assembly (GO:0051963),1/47,0.1111105603036554,0.181605075454294,0,0,8.830523513753327,19.4026870705364,SNCA,RBC,0.9542446623584087
GO_Biological_Process_2021,regulation of wound healing (GO:0061041),1/47,0.1111105603036554,0.181605075454294,0,0,8.830523513753327,19.4026870705364,DMTN,RBC,0.9542446623584087
GO_Biological_Process_2021,positive regulation of neuron death (GO:1901216),1/47,0.1111105603036554,0.181605075454294,0,0,8.830523513753327,19.4026870705364,SNCA,RBC,0.9542446623584087
GO_Biological_Process_2021,positive regulation of endocytosis (GO:0045807),1/48,0.1133380148369131,0.1844706601320468,0,0,8.642205818497612,18.81737166641443,SNCA,RBC,0.9456243984787533
GO_Biological_Process_2021,receptor internalization (GO:0031623),1/49,0.1155599990222406,0.1865263054757328,0,0,8.46173469387755,18.260130793597916,SNCA,RBC,0.9371924705024297
GO_Biological_Process_2021,RNA catabolic process (GO:0006401),1/49,0.1155599990222406,0.1865263054757328,0,0,8.46173469387755,18.260130793597916,SLFN14,RBC,0.9371924705024297
GO_Biological_Process_2021,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/50,0.1177765260040411,0.1885393770188147,0,0,8.28862973760933,17.7290996615035,DMTN,RBC,0.928941259997044
GO_Biological_Process_2021,regulation of complement activation (GO:0030449),1/50,0.1177765260040411,0.1885393770188147,0,0,8.28862973760933,17.7290996615035,CR1L,RBC,0.928941259997044
GO_Biological_Process_2021,regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.1199876089220907,0.1893752130626926,0,0,8.122448979591837,17.22257115519733,DMTN,RBC,0.9208636010741894
GO_Biological_Process_2021,negative regulation of transport (GO:0051051),1/51,0.1199876089220907,0.1893752130626926,0,0,8.122448979591837,17.22257115519733,SNCA,RBC,0.9208636010741894
GO_Biological_Process_2021,cholesterol transport (GO:0030301),1/51,0.1199876089220907,0.1893752130626926,0,0,8.122448979591837,17.22257115519733,TSPO2,RBC,0.9208636010741894
GO_Biological_Process_2021,axonogenesis (GO:0007409),2/240,0.1209266562339864,0.1893752130626926,0,0,3.450980392156863,7.290441318878535,SPTA1;SPTB,RBC,0.9174779557207333
GO_Biological_Process_2021,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.1221932608707862,0.1893752130626926,0,0,7.962785114045619,16.738979733033663,SNCA,RBC,0.9129527453809976
GO_Biological_Process_2021,amide biosynthetic process (GO:0043604),1/52,0.1221932608707862,0.1893752130626926,0,0,7.962785114045619,16.738979733033663,RHCE,RBC,0.9129527453809976
GO_Biological_Process_2021,regulation of exocytosis (GO:0017157),1/52,0.1221932608707862,0.1893752130626926,0,0,7.962785114045619,16.738979733033663,SNCA,RBC,0.9129527453809976
GO_Biological_Process_2021,myeloid cell differentiation (GO:0030099),1/52,0.1221932608707862,0.1893752130626926,0,0,7.962785114045619,16.738979733033663,ALAS2,RBC,0.9129527453809976
GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.1243934949128716,0.1912611443522019,0,0,7.809262166405024,16.276887238960814,SNCA,RBC,0.9052023302345248
GO_Biological_Process_2021,regulation of immune effector process (GO:0002697),1/53,0.1243934949128716,0.1912611443522019,0,0,7.809262166405024,16.276887238960814,CR1L,RBC,0.9052023302345248
GO_Biological_Process_2021,inorganic anion transport (GO:0015698),1/54,0.1265883240687765,0.192354914307633,0,0,7.661532537543319,15.834970375184442,SLC4A1,RBC,0.8976063498190403
GO_Biological_Process_2021,regulation of focal adhesion assembly (GO:0051893),1/54,0.1265883240687765,0.192354914307633,0,0,7.661532537543319,15.834970375184442,DMTN,RBC,0.8976063498190403
GO_Biological_Process_2021,regulation of humoral immune response (GO:0002920),1/54,0.1265883240687765,0.192354914307633,0,0,7.661532537543319,15.834970375184442,CR1L,RBC,0.8976063498190403
GO_Biological_Process_2021,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/55,0.1287777613922166,0.1949204248310205,0,0,7.519274376417234,15.412009607623004,SNCA,RBC,0.8901591287349465
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),2/252,0.1309169770529217,0.1973903258666146,0,0,3.283333333333333,6.675646802845627,DMTN;TSPAN5,RBC,0.8830040313535863
GO_Biological_Process_2021,regulation of reactive oxygen species metabolic process (GO:2000377),1/57,0.1331405122852093,0.1999677964438086,0,0,7.25,14.618539131965724,SNCA,RBC,0.8756897763447542
GO_Biological_Process_2021,receptor metabolic process (GO:0043112),1/58,0.1353138517398134,0.2016746679187258,0,0,7.122448979591836,14.246025949065045,SNCA,RBC,0.8686577434892403
GO_Biological_Process_2021,cellular iron ion homeostasis (GO:0006879),1/58,0.1353138517398134,0.2016746679187258,0,0,7.122448979591836,14.246025949065045,ALAS2,RBC,0.8686577434892403
GO_Biological_Process_2021,negative regulation of autophagy (GO:0010507),1/59,0.1374818510452552,0.2041238170099399,0,0,6.9992962702322306,13.8884471557023,SNCA,RBC,0.8617546291873563
GO_Biological_Process_2021,cellular component assembly (GO:0022607),2/261,0.1385333711760542,0.2049029710550763,0,0,3.1677927927927927,6.261598728808151,DMTN;SLC2A1,RBC,0.8584455971996626
GO_Biological_Process_2021,response to light stimulus (GO:0009416),1/61,0.1418018805927374,0.2073719231224618,0,0,6.76530612244898,13.214837540593155,FECH,RBC,0.848318009451734
GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.2073719231224618,0,0,6.76530612244898,13.214837540593155,SNCA,RBC,0.848318009451734
GO_Biological_Process_2021,iron ion homeostasis (GO:0055072),1/61,0.1418018805927374,0.2073719231224618,0,0,6.76530612244898,13.214837540593155,ALAS2,RBC,0.848318009451734
GO_Biological_Process_2021,protein-containing complex assembly (GO:0065003),2/267,0.1436652916283004,0.2089480645024521,0,0,3.095125786163522,6.005376764494242,DMTN;SLC2A1,RBC,0.8426481412255155
GO_Biological_Process_2021,negative regulation of kinase activity (GO:0033673),1/62,0.1439539364695556,0.2089480645024521,0,0,6.654064904650385,12.897320592663672,SNCA,RBC,0.8417764546925935
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),2/274,0.1497038344955427,0.2164862141961566,0,0,3.014399509803922,5.724635176902424,RHAG;RHCE,RBC,0.8247670755492156
GO_Biological_Process_2021,chemical homeostasis (GO:0048878),1/65,0.1503784214913892,0.2166563183709274,0,0,6.341198979591836,12.01403781811508,SLC4A1,RBC,0.8228144782361342
GO_Biological_Process_2021,plasma membrane bounded cell projection assembly (GO:0120031),2/278,0.1531779174072652,0.2198753131786944,0,0,2.970108695652174,5.572384797626887,DMTN;FHDC1,RBC,0.8148038393993969
GO_Biological_Process_2021,cellular response to calcium ion (GO:0071277),1/69,0.158870948881139,0.2272088202748643,0,0,5.966986794717887,10.977245117600177,DMTN,RBC,0.7989555105590889
GO_Biological_Process_2021,positive regulation of cell-substrate adhesion (GO:0010811),1/70,0.1609810482853106,0.2285460867992183,0,0,5.880212954747116,10.740024519792764,DMTN,RBC,0.7932252488723367
GO_Biological_Process_2021,regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/70,0.1609810482853106,0.2285460867992183,0,0,5.880212954747116,10.740024519792764,DMTN,RBC,0.7932252488723367
GO_Biological_Process_2021,response to metal ion (GO:0010038),1/71,0.16308595979881,0.2306925031335895,0,0,5.795918367346939,10.51076961698872,SNCA,RBC,0.7875834261109624
GO_Biological_Process_2021,cell junction organization (GO:0034330),1/72,0.1651856959101235,0.2311411356440218,0,0,5.713998275366484,10.28911103101624,SNCA,RBC,0.78202756268309
GO_Biological_Process_2021,negative regulation of supramolecular fiber organization (GO:1902904),1/72,0.1651856959101235,0.2311411356440218,0,0,5.713998275366484,10.28911103101624,SNCA,RBC,0.78202756268309
GO_Biological_Process_2021,positive regulation of secretion by cell (GO:1903532),1/72,0.1651856959101235,0.2311411356440218,0,0,5.713998275366484,10.28911103101624,SNCA,RBC,0.78202756268309
GO_Biological_Process_2021,negative regulation of cell adhesion (GO:0007162),1/73,0.1672802691231711,0.2315730415975571,0,0,5.634353741496598,10.074701240888364,DMTN,RBC,0.7765552814899175
GO_Biological_Process_2021,regulation of actin filament-based process (GO:0032970),1/73,0.1672802691231711,0.2315730415975571,0,0,5.634353741496598,10.074701240888364,DMTN,RBC,0.7765552814899175
GO_Biological_Process_2021,response to molecule of bacterial origin (GO:0002237),1/73,0.1672802691231711,0.2315730415975571,0,0,5.634353741496598,10.074701240888364,SNCA,RBC,0.7765552814899175
GO_Biological_Process_2021,regulation of peptide hormone secretion (GO:0090276),1/74,0.1693696918266344,0.233634078441705,0,0,5.556891249650545,9.867213018330611,SLC2A1,RBC,0.7711643026835198
GO_Biological_Process_2021,actomyosin structure organization (GO:0031032),1/76,0.1735331353639065,0.2368575075668759,0,0,5.408163265306122,9.4717853003048,FHDC1,RBC,0.7606175863963804
GO_Biological_Process_2021,chloride transport (GO:0006821),1/76,0.1735331353639065,0.2368575075668759,0,0,5.408163265306122,9.4717853003048,SLC4A1,RBC,0.7606175863963804
GO_Biological_Process_2021,water-soluble vitamin metabolic process (GO:0006767),1/76,0.1735331353639065,0.2368575075668759,0,0,5.408163265306122,9.4717853003048,SLC2A1,RBC,0.7606175863963804
GO_Biological_Process_2021,MAPK cascade (GO:0000165),2/303,0.1752338998526144,0.2380180953822908,0,0,2.7199612403100777,4.737175959955004,SPTA1;SPTB,RBC,0.7563818736544428
GO_Biological_Process_2021,purine ribonucleotide metabolic process (GO:0009150),1/77,0.1756071809118701,0.2380180953822908,0,0,5.336734693877551,9.283280446293812,ACSL6,RBC,0.7554577289388229
GO_Biological_Process_2021,regulation of ion transport (GO:0043269),1/79,0.1797399811935544,0.2427737940426828,0,0,5.199372056514914,8.923391206941128,SNCA,RBC,0.745355308086215
GO_Biological_Process_2021,response to interferon-gamma (GO:0034341),1/80,0.181798760490535,0.2438610959683383,0,0,5.133298889175924,8.751529842637671,SNCA,RBC,0.7404090821369118
GO_Biological_Process_2021,lipid biosynthetic process (GO:0008610),1/80,0.181798760490535,0.2438610959683383,0,0,5.133298889175924,8.751529842637671,ACSL6,RBC,0.7404090821369118
GO_Biological_Process_2021,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),1/81,0.1838524754991919,0.2457684294473734,0,0,5.0688775510204085,8.584760541358477,SNCA,RBC,0.7355305181562768
GO_Biological_Process_2021,long-chain fatty acid metabolic process (GO:0001676),1/83,0.1879447615357932,0.2486752116919169,0,0,4.944748631159781,8.265677319811374,ACSL6,RBC,0.7259697745939766
GO_Biological_Process_2021,peptide metabolic process (GO:0006518),1/83,0.1879447615357932,0.2486752116919169,0,0,4.944748631159781,8.265677319811374,RHCE,RBC,0.7259697745939766
GO_Biological_Process_2021,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.2486752116919169,0,0,4.944748631159781,8.265677319811374,TSPAN5,RBC,0.7259697745939766
GO_Biological_Process_2021,vascular transport (GO:0010232),1/84,0.1899833569114356,0.2505204265713507,0,0,4.884927464961889,8.112979399077096,SLC2A1,RBC,0.7212844428267129
GO_Biological_Process_2021,response to interleukin-1 (GO:0070555),1/86,0.1940455128548384,0.2533010218138663,0,0,4.769507803121249,7.820383303288144,SNCA,RBC,0.7120963955156414
GO_Biological_Process_2021,transport across blood-brain barrier (GO:0150104),1/86,0.1940455128548384,0.2533010218138663,0,0,4.769507803121249,7.820383303288144,SLC2A1,RBC,0.7120963955156414
GO_Biological_Process_2021,regulation of neuron death (GO:1901214),1/86,0.1940455128548384,0.2533010218138663,0,0,4.769507803121249,7.820383303288144,SNCA,RBC,0.7120963955156414
GO_Biological_Process_2021,positive regulation of inflammatory response (GO:0050729),1/89,0.2001013407742902,0.2594647385373297,0,0,4.6062152133580705,7.411084001248333,SNCA,RBC,0.6987500013741589
GO_Biological_Process_2021,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),1/89,0.2001013407742902,0.2594647385373297,0,0,4.6062152133580705,7.411084001248333,SNCA,RBC,0.6987500013741589
GO_Biological_Process_2021,negative regulation of protein kinase activity (GO:0006469),1/90,0.2021100231923967,0.2603337715955044,0,0,4.55423068103646,7.281955543769811,SNCA,RBC,0.6944121480917811
GO_Biological_Process_2021,protein complex oligomerization (GO:0051259),1/90,0.2021100231923967,0.2603337715955044,0,0,4.55423068103646,7.281955543769811,SNCA,RBC,0.6944121480917811
GO_Biological_Process_2021,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.2041137620931186,0.261185044257313,0,0,4.503401360544218,7.156255051106618,DMTN,RBC,0.6901277125812961
GO_Biological_Process_2021,positive regulation of transport (GO:0051050),1/91,0.2041137620931186,0.261185044257313,0,0,4.503401360544218,7.156255051106618,SNCA,RBC,0.6901277125812961
GO_Biological_Process_2021,intracellular protein transport (GO:0006886),2/336,0.205066989906835,0.2615444559795371,0,0,2.4471057884231535,3.877239861741715,STRADB;XPO7,RBC,0.6881042433620284
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2620189199696955,0,0,4.453689167974883,7.03385741012878,DMTN,RBC,0.6858955226779435
GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.2081064570390282,0.2636918950755113,0,0,4.40505767524401,6.914643337844717,SNCA,RBC,0.6817144444740324
GO_Biological_Process_2021,negative regulation of cell death (GO:0060548),1/94,0.2100954368002021,0.265347808166489,0,0,4.357472021066491,6.79849904676328,SNCA,RBC,0.6775833802166729
GO_Biological_Process_2021,mRNA metabolic process (GO:0016071),1/95,0.2120795205832498,0.2669868398281041,0,0,4.310898827616153,6.685315939697291,SLFN14,RBC,0.6735012670190429
GO_Biological_Process_2021,cellular transition metal ion homeostasis (GO:0046916),1/96,0.2140587201245348,0.2686091681562711,0,0,4.26530612244898,6.5749903239841245,ALAS2,RBC,0.6694670755856718
GO_Biological_Process_2021,protein maturation (GO:0051604),1/97,0.2160330472811356,0.2693488954883389,0,0,4.220663265306122,6.46742313757927,TSPAN5,RBC,0.6654798083211632
GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2693488954883389,0,0,4.220663265306122,6.46742313757927,SNCA,RBC,0.6654798083211632
GO_Biological_Process_2021,positive regulation of defense response (GO:0031349),1/98,0.2180025137484037,0.2700731778602836,0,0,4.176940879444562,6.362519703204576,SNCA,RBC,0.6615384985937142
GO_Biological_Process_2021,negative regulation of neuron death (GO:1901215),1/98,0.2180025137484037,0.2700731778602836,0,0,4.176940879444562,6.362519703204576,SNCA,RBC,0.6615384985937142
GO_Biological_Process_2021,cellular response to chemical stress (GO:0062197),1/101,0.2238818662412048,0.2764763364058054,0,0,4.051020408163265,6.062906014187368,SNCA,RBC,0.6499810815451941
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2780020592233219,0,0,4.010709234188725,5.967790506031058,DMTN,RBC,0.6462145058611213
GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),1/103,0.2277773453985499,0.279512262965413,0,0,3.971188475390156,5.874923343943355,DMTN,RBC,0.64248947278397
GO_Biological_Process_2021,regulation of insulin secretion (GO:0050796),1/104,0.2297178930745814,0.2810071081950069,0,0,3.932435109966317,5.78423168094792,SLC2A1,RBC,0.6388051756325536
GO_Biological_Process_2021,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.2824867534223387,0,0,3.894427001569859,5.6956456810845415,SNCA,RBC,0.6351608308934773
GO_Biological_Process_2021,small GTPase mediated signal transduction (GO:0007264),1/106,0.2335846623503299,0.2830667715086552,0,0,3.857142857142857,5.6090983677319475,RUNDC3A,RBC,0.6315556772929499
GO_Biological_Process_2021,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2830667715086552,0,0,3.857142857142857,5.6090983677319475,SNCA,RBC,0.6315556772929499
GO_Biological_Process_2021,response to calcium ion (GO:0051592),1/107,0.2355109070084182,0.284514729274145,0,0,3.8205621871390063,5.524525481436682,DMTN,RBC,0.6279889749729552
GO_Biological_Process_2021,regulation of protein kinase activity (GO:0045859),1/110,0.241261218690496,0.2905591766891732,0,0,3.714847406852649,5.282048795926194,SNCA,RBC,0.6175124827423236
GO_Biological_Process_2021,regulation of protein serine/threonine kinase activity (GO:0071900),1/111,0.2431685532271013,0.2919523679177235,0,0,3.6808905380333954,5.20478084558139,SNCA,RBC,0.6140925891155178
GO_Biological_Process_2021,regulation of cytoskeleton organization (GO:0051493),1/112,0.2450711886958998,0.2933313612390924,0,0,3.647545504688362,5.129202360192396,DMTN,RBC,0.6107077427090284
GO_Biological_Process_2021,activation of protein kinase activity (GO:0032147),1/114,0.2488624078588274,0.2951447459057436,0,0,3.582625970742279,4.982913653406146,STRADB,RBC,0.6040407011916724
GO_Biological_Process_2021,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.2951447459057436,0,0,3.582625970742279,4.982913653406146,SNCA,RBC,0.6040407011916724
GO_Biological_Process_2021,response to lipid (GO:0033993),1/114,0.2488624078588274,0.2951447459057436,0,0,3.582625970742279,4.982913653406146,SNCA,RBC,0.6040407011916724
GO_Biological_Process_2021,cellular amide metabolic process (GO:0043603),1/115,0.2507510141385882,0.2955822560603358,0,0,3.5510204081632653,4.9121080927455,ACSL6,RBC,0.6007573018413346
GO_Biological_Process_2021,positive regulation of protein metabolic process (GO:0051247),1/115,0.2507510141385882,0.2955822560603358,0,0,3.5510204081632653,4.9121080927455,SLC25A37,RBC,0.6007573018413346
GO_Biological_Process_2021,ion transport (GO:0006811),1/116,0.2526349665899778,0.296610261998491,0,0,3.5199645075421473,4.8428011439058265,SLC4A1,RBC,0.5975065399797567
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),4/1025,0.2531480899318741,0.296610261998491,0,0,1.6121449559255632,2.2147335064279132,EPB42;STRADB;KRT1;ART4,RBC,0.596625345129507
GO_Biological_Process_2021,positive regulation of protein-containing complex assembly (GO:0031334),1/118,0.2563889548341396,0.299505415707148,0,0,3.4594453165881736,4.708511372057024,SNCA,RBC,0.5911006880374128
GO_Biological_Process_2021,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),1/119,0.2582590130323782,0.3007866948191471,0,0,3.429955032860602,4.6434466139665425,SNCA,RBC,0.5879445130148351
GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.2656932663769877,0.3085214346885022,0,0,3.316828370692539,4.396166676729281,KRT1,RBC,0.5756194520344882
GO_Biological_Process_2021,fatty acid metabolic process (GO:0006631),1/124,0.2675403902734135,0.3088225869921597,0,0,3.2896963663514187,4.337414433160371,ACSL6,RBC,0.5726106437410472
GO_Biological_Process_2021,defense response to symbiont (GO:0140546),1/124,0.2675403902734135,0.3088225869921597,0,0,3.2896963663514187,4.337414433160371,IFIT1B,RBC,0.5726106437410472
GO_Biological_Process_2021,cellular response to oxidative stress (GO:0034599),1/125,0.2693829605231016,0.3091149606002553,0,0,3.263001974983542,4.279822783786303,SNCA,RBC,0.5696298784899082
GO_Biological_Process_2021,regulation of protein secretion (GO:0050708),1/125,0.2693829605231016,0.3091149606002553,0,0,3.263001974983542,4.279822783786303,SLC2A1,RBC,0.5696298784899082
GO_Biological_Process_2021,synapse organization (GO:0050808),1/126,0.2712209880572274,0.3103087186890043,0,0,3.236734693877551,4.223360488574632,SNCA,RBC,0.5666767062328689
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),2/409,0.2725909524148647,0.3109615263618251,0,0,2.000716625716626,2.600497358364142,TRIM58;TRIM10,RBC,0.5644885629602858
GO_Biological_Process_2021,positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.2767079241059198,0.3147350364830491,0,0,3.1603954081632653,4.060453122404681,SLC25A37,RBC,0.5579784037567757
GO_Biological_Process_2021,Golgi organization (GO:0007030),1/130,0.2785278903472666,0.3158814849710983,0,0,3.135738016136687,4.008216604624779,FHDC1,RBC,0.5551313103019286
GO_Biological_Process_2021,defense response to virus (GO:0051607),1/133,0.2839609038772722,0.3211069523495898,0,0,3.0640074211502784,3.857336278341556,IFIT1B,RBC,0.546741450090894
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3322927280871317,0,0,2.929902395740905,3.579678317757992,SNCA,RBC,0.5306096689947516
GO_Biological_Process_2021,positive regulation of cellular catabolic process (GO:0031331),1/141,0.2982536777952956,0.3353198863074277,0,0,2.8877551020408165,3.4936375609484274,SNCA,RBC,0.5254141922968343
GO_Biological_Process_2021,response to cytokine (GO:0034097),1/150,0.3139989845586295,0.3509931177968588,0,0,2.712094233666621,3.141596466170354,SNCA,RBC,0.5030717563895143
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3509931177968588,0,0,2.712094233666621,3.141596466170354,DMTN,RBC,0.5030717563895143
GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.3671512612634846,0,0,2.556445362955309,2.8389038953772054,SNCA,RBC,0.4822791499015975
GO_Biological_Process_2021,rRNA metabolic process (GO:0016072),1/162,0.3344552195120095,0.3706640466956458,0,0,2.5084294587400175,2.747363087126053,SLFN14,RBC,0.47566202205377284
GO_Biological_Process_2021,peptide biosynthetic process (GO:0043043),1/162,0.3344552195120095,0.3706640466956458,0,0,2.5084294587400175,2.747363087126053,RHCE,RBC,0.47566202205377284
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),2/481,0.3392377168904141,0.3748962269044634,0,0,1.6937195546276966,1.8310026171217704,KRT1;HBB,RBC,0.46949586830577306
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),2/485,0.3429022272693128,0.3778724260843136,0,0,1.6793478260869563,1.797422644350721,KRT1;HBB,RBC,0.46482969398207885
GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3785145228504372,0,0,2.4175730172308443,2.5766088705447237,SNCA,RBC,0.46286379212748074
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),2/488,0.3456467916703843,0.3787509914359986,0,0,1.668724279835391,1.7727489781212855,KRT1;HBB,RBC,0.4613674699295729
GO_Biological_Process_2021,cation transport (GO:0006812),1/174,0.3543133002736421,0.3871569488945134,0,0,2.333018756635602,2.4206789693623425,RHAG,RBC,0.45061254473982715
GO_Biological_Process_2021,regulated exocytosis (GO:0045055),1/180,0.3640234091355428,0.3966529584137987,0,0,2.2541329380914377,2.2778849681371156,SNCA,RBC,0.4388706874182523
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),2/525,0.3791874550703379,0.4120221229674901,0,0,1.547721478648821,1.5008635790547311,TRIM58;TRIM10,RBC,0.42114603917112947
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),1/203,0.3999373645428959,0.4333583142261463,0,0,1.9951505354617096,1.8284503867148747,KRT1,RBC,0.398008019580524
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),1/206,0.4044727291727134,0.4370552545782931,0,0,1.9656545545047288,1.7792534267442264,SNCA,RBC,0.39311075456855427
GO_Biological_Process_2021,cilium organization (GO:0044782),1/228,0.4367210295579323,0.4705941288034229,0,0,1.7731727052054302,1.469003836799846,FHDC1,RBC,0.359795894863476
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.4933348384858946,0,0,1.655076845553036,1.2884811006593149,SNCA,RBC,0.33809924509335265
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),2/625,0.4660144680358849,0.4993929147822569,0,0,1.2926029962546817,0.9869522795970046,HBB;HBA1,RBC,0.33160059985375573
GO_Biological_Process_2021,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5232552679787916,0,0,1.510204081632653,1.0781219104526054,SNCA,RBC,0.3100391544580995
GO_Biological_Process_2021,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5232552679787916,0,0,1.504471451501949,1.0700627976731167,SLC2A1,RBC,0.3088941088615854
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.5232552679787916,0,0,1.498781602193116,1.0620843946744252,DMTN,RBC,0.30775490655057164
GO_Biological_Process_2021,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.5443799914466788,0,0,1.4081632653061225,0.937839142501346,SNCA,RBC,0.289240867544339
GO_Biological_Process_2021,proteolysis (GO:0006508),1/287,0.51499186851511,0.5443799914466788,0,0,1.4031682603111175,0.9311483055746664,CPB1,RBC,0.28819962821492023
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5670010679345153,0,0,1.314486450317832,0.8152139890333826,SNCA,RBC,0.2693393582885023
GO_Biological_Process_2021,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5703845557548397,0,0,1.2972062611452349,0.7932686422257892,SNCA,RBC,0.2655801196036423
GO_Biological_Process_2021,cellular macromolecule biosynthetic process (GO:0034645),1/314,0.5471545986718139,0.5721589754928377,0,0,1.2803677381495728,0.7720923294539072,ALAS2,RBC,0.26188994631047774
GO_Biological_Process_2021,cilium assembly (GO:0060271),1/314,0.5471545986718139,0.5721589754928377,0,0,1.2803677381495728,0.7720923294539072,FHDC1,RBC,0.26188994631047774
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5797593884279972,0,0,1.2479496471485791,0.7319104885681406,SLFN14,RBC,0.2547095446988111
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5797593884279972,0,0,1.2440106477373558,0.7270814983759607,DMTN,RBC,0.2538302089398956
GO_Biological_Process_2021,gene expression (GO:0010467),1/356,0.5930749260701463,0.6152163899767652,0,0,1.126473124461052,0.5885084653208599,TSPAN5,RBC,0.2268904366133749
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6293758021383918,0,0,1.0799779371207945,0.5367673309131087,SNCA,RBC,0.21585171499242045
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.6378854968444995,0,0,1.0510204081632653,0.5054679174936134,SNCA,RBC,0.20886552310647807
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6391944574165712,0,0,1.042628017264347,0.4965325169788531,SNCA,RBC,0.20682480102083725
GO_Biological_Process_2021,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6530736990622057,0,0,1.0,0.4521084323403523,STRADB,RBC,0.19634819738734471
GO_Biological_Process_2021,organelle assembly (GO:0070925),1/425,0.658798168385351,0.6744012828997409,0,0,0.939834424335772,0.3922286762298742,FHDC1,RBC,0.18124761694193237
GO_Biological_Process_2021,nervous system development (GO:0007399),1/447,0.677475806229693,0.6917010200087942,0,0,0.8924681980415484,0.3475105496336908,SLC2A1,RBC,0.16910620954367267
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7203677250969481,0,0,0.8207960870298533,0.2841203737887477,SNCA,RBC,0.15033199168778996
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7267579738199301,0,0,0.8021026592455164,0.2684686706444305,STRADB,RBC,0.1453610219101508
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.75961413672989,0,0,0.726642950758285,0.2091870484536521,RUNDC3A,RBC,0.12502533841998253
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7676609938038254,0,0,0.7301532033426184,0.200604530418796,TRIM58;TRIM10,RBC,0.11931939791106433
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.8312569868162889,0,0,0.5757014372366809,0.1108560647358729,SNCA,RBC,0.0836269880293983
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8537160008627002,0,0,0.5290423861852434,0.0863986224716518,SNCA,RBC,0.07092521499844862
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",1/948,0.912055183209665,0.9144058408983498,0,0,0.4095209361463698,0.0376983608425212,SNCA,RBC,0.039978884217174375
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),1/2206,0.9971209346049892,0.9971209346049892,0,0,0.1642371234207968,0.00047353141012936674,SNCA,RBC,0.0012521656136179045
KEGG_2021_Human,retinoid metabolic process (GO:0001523),6/92,1.0843486507975929e-07,9.53142464051084e-05,0,0,31.496828752642703,505.1183015691571,ALDH1A3;RARRES2;RBP1;SDC3;CYP1B1;APOE,RNAlo MSC,6.9648310565685625
KEGG_2021_Human,platelet degranulation (GO:0002576),6/125,6.702105964892939e-07,0.0002945575571570447,0,0,22.72459893048128,323.04548678669244,CFD;TF;SPARC;RARRES2;SERPING1;GAS6,RNAlo MSC,6.17378870995278
KEGG_2021_Human,regulation of canonical Wnt signaling pathway (GO:0060828),7/253,2.996499695237845e-06,0.0007443022643466834,0,0,13.039137833238795,165.8326118790255,COL1A1;SFRP1;MDK;FRZB;IGFBP4;IGFBP2;APOE,RNAlo MSC,5.523385762137871
KEGG_2021_Human,negative regulation of canonical Wnt signaling pathway (GO:0090090),6/165,3.3870410209177857e-06,0.0007443022643466834,0,0,16.973413379073758,213.789542623436,SFRP1;MDK;FRZB;IGFBP4;IGFBP2;APOE,RNAlo MSC,5.470179543523555
KEGG_2021_Human,regulated exocytosis (GO:0045055),6/180,5.592564428638942e-06,0.0009831728265547262,0,0,15.498432601880875,187.43916943144697,CFD;TF;SPARC;RARRES2;SERPING1;GAS6,RNAlo MSC,5.252389003951728
KEGG_2021_Human,negative regulation of Wnt signaling pathway (GO:0030178),6/191,7.857426943942e-06,0.0010458346383126,0,0,14.568796068796068,171.2423773325197,SFRP1;MDK;FRZB;IGFBP4;IGFBP2;APOE,RNAlo MSC,5.104719648234704
KEGG_2021_Human,cellular protein metabolic process (GO:0044267),8/417,8.328603490544093e-06,0.0010458346383126,0,0,9.100477354756084,106.43749740551364,TF;IGFBP4;IGFBP2;APOE;GAS6;CP;CHRDL1;FSTL1,RNAlo MSC,5.0794278133825665
KEGG_2021_Human,positive regulation of leukocyte chemotaxis (GO:0002690),4/54,9.96677383351584e-06,0.0010950992749575,0,0,34.608695652173914,398.5625163721059,CXCL12;MDK;RARRES2;GAS6,RNAlo MSC,5.001445396657338
KEGG_2021_Human,diterpenoid metabolic process (GO:0016101),4/64,1.9659499977716905e-05,0.001920077831157,0,0,28.82608695652174,312.3868594993703,RARRES2;RBP1;SDC3;APOE,RNAlo MSC,4.706427532265834
KEGG_2021_Human,post-translational protein modification (GO:0043687),7/345,2.2580550649886258e-05,0.001984830402125,0,0,9.445713499380762,101.05422545122356,TF;IGFBP4;APOE;GAS6;CP;CHRDL1;FSTL1,RNAlo MSC,4.646265471565561
KEGG_2021_Human,negative regulation of dendritic cell differentiation (GO:2001199),2/5,6.0956786529959696e-05,0.0041216165661411,0,0,277.0416666666667,2688.78505476905,TMEM176B;TMEM176A,RNAlo MSC,4.214977935846465
KEGG_2021_Human,negative regulation of leukocyte differentiation (GO:1902106),2/5,6.0956786529959696e-05,0.0041216165661411,0,0,277.0416666666667,2688.78505476905,TMEM176B;TMEM176A,RNAlo MSC,4.214977935846465
KEGG_2021_Human,cellular response to vitamin (GO:0071295),2/5,6.0956786529959696e-05,0.0041216165661411,0,0,277.0416666666667,2688.78505476905,SFRP1;GAS6,RNAlo MSC,4.214977935846465
KEGG_2021_Human,positive regulation of supramolecular fiber organization (GO:1902905),4/91,7.869565920366472e-05,0.0049409631742872,0,0,19.85307346326837,187.6100068119366,EFEMP2;STMN2;APOE;PFN2,RNAlo MSC,4.1040492223536065
KEGG_2021_Human,innate immune response (GO:0045087),6/302,0.00010252015509604308,0.0060076810886281,0,0,9.05436117936118,83.16839224982584,IFITM3;CFD;SLPI;RARRES2;LBP;S100B,RNAlo MSC,3.9891907454715554
KEGG_2021_Human,negative regulation of dendritic cell apoptotic process (GO:2000669),2/7,0.00012760097078443218,0.0065977207835009,0,0,166.20833333333334,1490.3240703269437,CXCL12;GAS6,RNAlo MSC,3.8941460215026447
KEGG_2021_Human,regulation of bone remodeling (GO:0046850),2/7,0.00012760097078443218,0.0065977207835009,0,0,166.20833333333334,1490.3240703269437,SFRP1;MDK,RNAlo MSC,3.8941460215026447
KEGG_2021_Human,sequestering of BMP from receptor via BMP binding (GO:0038098),2/8,0.0001698630098259154,0.0082949769798322,0,0,138.5,1202.2517804391236,CHRDL1;FSTL1,RNAlo MSC,3.7699011848597213
KEGG_2021_Human,positive regulation of cell-matrix adhesion (GO:0001954),3/44,0.0001811421903351466,0.0083802097528733,0,0,30.994810586403737,267.0583626754283,EFEMP2;SFRP1;THY1,RNAlo MSC,3.74198038515947
KEGG_2021_Human,regulation of fibroblast apoptotic process (GO:2000269),2/9,0.00021804660985203623,0.0095831485029969,0,0,118.70833333333331,1000.8064198202924,SFRP1;GAS6,RNAlo MSC,3.6614506612675517
KEGG_2021_Human,positive regulation of fat cell differentiation (GO:0045600),3/51,0.00028134681783249164,0.0117763739464171,0,0,26.465425531914892,216.37926602740956,SFRP1;FRZB;RARRES2,RNAlo MSC,3.550757992561188
KEGG_2021_Human,regulation of dendritic cell apoptotic process (GO:2000668),2/11,0.000332063883264561,0.012690615364763,0,0,92.31944444444444,739.4956618223716,CXCL12;GAS6,RNAlo MSC,3.478778357620151
KEGG_2021_Human,positive regulation of cellular extravasation (GO:0002693),2/11,0.000332063883264561,0.012690615364763,0,0,92.31944444444444,739.4956618223716,MDK;THY1,RNAlo MSC,3.478778357620151
KEGG_2021_Human,negative regulation of leukocyte apoptotic process (GO:2000107),2/12,0.0003978405023918531,0.0139116282674371,0,0,83.08333333333333,650.4975835514635,CXCL12;GAS6,RNAlo MSC,3.4002910053496507
KEGG_2021_Human,regulation of dendritic cell differentiation (GO:2001198),2/12,0.0003978405023918531,0.0139116282674371,0,0,83.08333333333333,650.4975835514635,TMEM176B;TMEM176A,RNAlo MSC,3.4002910053496507
KEGG_2021_Human,negative regulation of neuron projection development (GO:0010977),3/58,0.00041177118298551824,0.0139116282674371,0,0,23.088974854932303,179.97954590931704,STMN2;THY1;APOE,RNAlo MSC,3.3853440499187784
KEGG_2021_Human,positive regulation of cell differentiation (GO:0045597),5/258,0.0004532990344698463,0.0139116282674371,0,0,8.650417215634606,66.59920341056167,COL1A1;SFRP1;MDK;FRZB;RARRES2,RNAlo MSC,3.343615205990649
KEGG_2021_Human,response to organic cyclic compound (GO:0014070),3/60,0.000455062391672894,0.0139116282674371,0,0,22.27659574468085,171.42009780807578,GGT5;SFRP1;CYP1B1,RNAlo MSC,3.3419290549876433
KEGG_2021_Human,negative regulation of cell migration (GO:0030336),4/144,0.00045897294625219106,0.0139116282674371,0,0,12.304347826086955,94.57760691938245,SFRP1;CYP1B1;THY1;PFN2,RNAlo MSC,3.3382129128062186
KEGG_2021_Human,regulation of cell migration (GO:0030334),6/408,0.0005169603732444072,0.0145644392225533,0,0,6.630936227951153,50.17990388021586,COL1A1;SFRP1;CXCL12;MDK;CYP1B1;THY1,RNAlo MSC,3.2865427457665275
KEGG_2021_Human,retinal metabolic process (GO:0042574),2/14,0.0005467878206419364,0.0145644392225533,0,0,69.22916666666667,520.0114050756229,ALDH1A3;CYP1B1,RNAlo MSC,3.2621811676355046
KEGG_2021_Human,positive regulation of macrophage chemotaxis (GO:0010759),2/14,0.0005467878206419364,0.0145644392225533,0,0,69.22916666666667,520.0114050756229,MDK;RARRES2,RNAlo MSC,3.2621811676355046
KEGG_2021_Human,sequestering of extracellular ligand from receptor (GO:0035581),2/14,0.0005467878206419364,0.0145644392225533,0,0,69.22916666666667,520.0114050756229,CHRDL1;FSTL1,RNAlo MSC,3.2621811676355046
KEGG_2021_Human,negative regulation of epithelial cell proliferation (GO:0050680),3/72,0.0007765711595735495,0.0195030299790042,0,0,18.39130434782609,131.69318363710184,SFRP1;SPARC;APOE,RNAlo MSC,3.10981874238982
KEGG_2021_Human,negative regulation of supramolecular fiber organization (GO:1902904),3/72,0.0007765711595735495,0.0195030299790042,0,0,18.39130434782609,131.69318363710184,STMN2;APOE;PFN2,RNAlo MSC,3.10981874238982
KEGG_2021_Human,response to molecule of bacterial origin (GO:0002237),3/73,0.0008084332971786784,0.019739246339446,0,0,18.127659574468087,129.07641173230985,GGT5;SLPI;LBP,RNAlo MSC,3.0923558073744988
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),7/625,0.0008747234504077011,0.020363013021233,0,0,5.092345902009483,35.858277051349106,SFRP1;CXCL12;MDK;HP;LBP;GAS6;S100B,RNAlo MSC,3.058129230344244
KEGG_2021_Human,regulation of epithelial to mesenchymal transition (GO:0010717),3/76,0.0009089746531003116,0.020363013021233,0,0,17.38006412124745,121.71594945135638,COL1A1;SFRP1;MDK,RNAlo MSC,3.041448226978414
KEGG_2021_Human,response to interferon-alpha (GO:0035455),2/18,0.000913470506242016,0.020363013021233,0,0,51.911458333333336,363.2898548418271,IFITM3;GAS6,RNAlo MSC,3.039305470405725
KEGG_2021_Human,negative regulation of developmental process (GO:0051093),3/77,0.0009441676964961806,0.020363013021233,0,0,17.14433582518689,119.41384383677423,SFRP1;THY1;GAS6,RNAlo MSC,3.024950862487107
KEGG_2021_Human,defense response to bacterium (GO:0042742),4/176,0.0009733818874053012,0.020363013021233,0,0,9.998988877654195,69.34032881835857,TF;SLPI;RARRES2;LBP,RNAlo MSC,3.011716739326452
KEGG_2021_Human,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),2/19,0.0010193089566942,0.020363013021233,0,0,48.85539215686274,336.54673838088314,IGFBP4;IGFBP2,RNAlo MSC,2.9916941596143727
KEGG_2021_Human,positive regulation of focal adhesion assembly (GO:0051894),2/19,0.0010193089566942,0.020363013021233,0,0,48.85539215686274,336.54673838088314,SFRP1;THY1,RNAlo MSC,2.9916941596143727
KEGG_2021_Human,positive regulation of macrophage migration (GO:1905523),2/19,0.0010193089566942,0.020363013021233,0,0,48.85539215686274,336.54673838088314,MDK;RARRES2,RNAlo MSC,2.9916941596143727
KEGG_2021_Human,regulation of fat cell differentiation (GO:0045598),3/80,0.0010548985204026,0.0206056844318651,0,0,16.473887814313347,112.9171456129886,SFRP1;FRZB;RARRES2,RNAlo MSC,2.9767893168107804
KEGG_2021_Human,regulation of granulocyte chemotaxis (GO:0071622),2/20,0.0011307590059983,0.0211475992823942,0,0,46.138888888888886,313.0461870363529,MDK;RARRES2,RNAlo MSC,2.9466299446036754
KEGG_2021_Human,positive regulation of lymphocyte differentiation (GO:0045621),2/20,0.0011307590059983,0.0211475992823942,0,0,46.138888888888886,313.0461870363529,MDK;GAS6,RNAlo MSC,2.9466299446036754
KEGG_2021_Human,regulation of macrophage chemotaxis (GO:0010758),2/22,0.001370383663162,0.0244246767507396,0,0,41.520833333333336,273.7329252658829,MDK;RARRES2,RNAlo MSC,2.8631578273928713
KEGG_2021_Human,regulation of membrane protein ectodomain proteolysis (GO:0051043),2/22,0.001370383663162,0.0244246767507396,0,0,41.520833333333336,273.7329252658829,APOE;TIMP4,RNAlo MSC,2.8631578273928713
KEGG_2021_Human,positive regulation of neuron projection development (GO:0010976),3/88,0.0013893445250705,0.0244246767507396,0,0,14.917396745932416,98.14040765115747,MDK;STMN2;APOE,RNAlo MSC,2.8571900459948085
KEGG_2021_Human,regulation of mononuclear cell migration (GO:0071675),2/23,0.0014985033958486,0.0253304708644423,0,0,39.541666666666664,257.15086234948103,MDK;RARRES2,RNAlo MSC,2.8243422685363964
KEGG_2021_Human,regulation of supramolecular fiber organization (GO:1902903),2/23,0.0014985033958486,0.0253304708644423,0,0,39.541666666666664,257.15086234948103,EFEMP2;APOE,RNAlo MSC,2.8243422685363964
KEGG_2021_Human,negative regulation of ossification (GO:0030279),2/24,0.0016321249773357,0.0260843246377844,0,0,37.74242424242424,242.22606459531664,SFRP1;MDK,RNAlo MSC,2.7872465889099036
KEGG_2021_Human,extracellular matrix assembly (GO:0085029),2/24,0.0016321249773357,0.0260843246377844,0,0,37.74242424242424,242.22606459531664,EFEMP2;GAS6,RNAlo MSC,2.7872465889099036
KEGG_2021_Human,positive regulation of cell-substrate junction organization (GO:0150117),2/24,0.0016321249773357,0.0260843246377844,0,0,37.74242424242424,242.22606459531664,SFRP1;THY1,RNAlo MSC,2.7872465889099036
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),5/345,0.0016636705220729,0.0261136855161086,0,0,6.408496732026144,41.00623362768128,COL1A1;MDK;LBP;APOE;GAS6,RNAlo MSC,2.7789326784141215
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),4/214,0.001997005570499,0.0302629350442211,0,0,8.173913043478262,50.80991346966578,SFRP1;MDK;GAS6;PFN2,RNAlo MSC,2.699620723695345
KEGG_2021_Human,acute inflammatory response (GO:0002526),2/27,0.0020657293545543,0.0302629350442211,0,0,33.208333333333336,205.3029465636782,HP;LBP,RNAlo MSC,2.684926579003782
KEGG_2021_Human,camera-type eye development (GO:0043010),2/27,0.0020657293545543,0.0302629350442211,0,0,33.208333333333336,205.3029465636782,ALDH1A3;CYP1B1,RNAlo MSC,2.684926579003782
KEGG_2021_Human,negative regulation of protein polymerization (GO:0032272),2/27,0.0020657293545543,0.0302629350442211,0,0,33.208333333333336,205.3029465636782,STMN2;PFN2,RNAlo MSC,2.684926579003782
KEGG_2021_Human,regulation of actin polymerization or depolymerization (GO:0008064),2/29,0.0023818121959682,0.0332319511151765,0,0,30.74537037037037,185.6987673947897,CXCL12;PFN2,RNAlo MSC,2.623092485284041
KEGG_2021_Human,positive regulation of leukocyte migration (GO:0002687),2/29,0.0023818121959682,0.0332319511151765,0,0,30.74537037037037,185.6987673947897,MDK;THY1,RNAlo MSC,2.623092485284041
KEGG_2021_Human,transition metal ion homeostasis (GO:0055076),2/29,0.0023818121959682,0.0332319511151765,0,0,30.74537037037037,185.6987673947897,TF;CP,RNAlo MSC,2.623092485284041
KEGG_2021_Human,aminoglycan catabolic process (GO:0006026),2/31,0.0027192556482504,0.0356750106688378,0,0,28.62212643678161,169.08226656127547,SDC3;CHI3L2,RNAlo MSC,2.565549960707733
KEGG_2021_Human,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),2/31,0.0027192556482504,0.0356750106688378,0,0,28.62212643678161,169.08226656127547,SFRP1;THY1,RNAlo MSC,2.565549960707733
KEGG_2021_Human,positive regulation of leukocyte cell-cell adhesion (GO:1903039),2/31,0.0027192556482504,0.0356750106688378,0,0,28.62212643678161,169.08226656127547,MDK;THY1,RNAlo MSC,2.565549960707733
KEGG_2021_Human,positive regulation of mononuclear cell migration (GO:0071677),2/31,0.0027192556482504,0.0356750106688378,0,0,28.62212643678161,169.08226656127547,CXCL12;GAS6,RNAlo MSC,2.565549960707733
KEGG_2021_Human,negative regulation of cell motility (GO:2000146),3/114,0.00290902931217,0.0370585038463398,0,0,11.40828062104658,66.623626679358,SFRP1;CYP1B1;THY1,RNAlo MSC,2.536251902661656
KEGG_2021_Human,response to lipid (GO:0033993),3/114,0.00290902931217,0.0370585038463398,0,0,11.40828062104658,66.623626679358,GGT5;SLPI;LBP,RNAlo MSC,2.536251902661656
KEGG_2021_Human,positive regulation of cell projection organization (GO:0031346),3/117,0.0031304799763545,0.0393098842745098,0,0,11.106382978723405,64.04572311094852,MDK;STMN2;APOE,RNAlo MSC,2.5043890697694766
KEGG_2021_Human,cytoskeleton organization (GO:0007010),3/120,0.0033620370494817,0.0416229657252741,0,0,10.819967266775777,61.62196656098476,MDK;THY1;APOE,RNAlo MSC,2.473397504966506
KEGG_2021_Human,negative regulation of epithelial cell migration (GO:0010633),2/35,0.0034573756419477,0.0422087942954454,0,0,25.147727272727273,142.5183432834292,APOE;PFN2,RNAlo MSC,2.461253432039241
KEGG_2021_Human,regulation of ossification (GO:0030278),2/36,0.0036549257227984,0.0434145906802677,0,0,24.40686274509804,136.96349152286243,SFRP1;MDK,RNAlo MSC,2.437121444562911
KEGG_2021_Human,transition metal ion transport (GO:0000041),2/36,0.0036549257227984,0.0434145906802677,0,0,24.40686274509804,136.96349152286243,TF;CP,RNAlo MSC,2.437121444562911
KEGG_2021_Human,negative regulation of endothelial cell proliferation (GO:0001937),2/37,0.0038576315924392,0.0446165548651852,0,0,23.708333333333332,131.76384828572083,SPARC;APOE,RNAlo MSC,2.4136792502562754
KEGG_2021_Human,negative regulation of epithelial cell apoptotic process (GO:1904036),2/37,0.0038576315924392,0.0446165548651852,0,0,23.708333333333332,131.76384828572083,MDK;GAS6,RNAlo MSC,2.4136792502562754
KEGG_2021_Human,response to estradiol (GO:0032355),2/38,0.0040654672914765,0.0464096850546473,0,0,23.04861111111111,126.88782669928548,GGT5;SFRP1,RNAlo MSC,2.390889528680986
KEGG_2021_Human,negative regulation of protein secretion (GO:0050709),2/39,0.0042784069542198,0.0470089964094905,0,0,22.42454954954955,122.3074073504305,SFRP1;APOE,RNAlo MSC,2.368717908505425
KEGG_2021_Human,endothelial cell migration (GO:0043542),2/39,0.0042784069542198,0.0470089964094905,0,0,22.42454954954955,122.3074073504305,CYP1B1;FSTL1,RNAlo MSC,2.368717908505425
KEGG_2021_Human,regulation of protein tyrosine kinase activity (GO:0061097),2/39,0.0042784069542198,0.0470089964094905,0,0,22.42454954954955,122.3074073504305,THY1;GAS6,RNAlo MSC,2.368717908505425
KEGG_2021_Human,negative regulation of blood coagulation (GO:0030195),2/40,0.0044964248068071,0.0481994805510181,0,0,21.833333333333332,117.99765363023796,SERPING1;APOE,RNAlo MSC,2.3471326648462743
KEGG_2021_Human,sulfur compound catabolic process (GO:0044273),2/40,0.0044964248068071,0.0481994805510181,0,0,21.833333333333332,117.99765363023796,GGT5;FMOD,RNAlo MSC,2.3471326648462743
KEGG_2021_Human,epithelial cell migration (GO:0010631),2/41,0.0047194951697385,0.0499811596891591,0,0,21.272435897435894,113.93630347986566,CYP1B1;FSTL1,RNAlo MSC,2.3261044540613445
KEGG_2021_Human,positive regulation of epithelial to mesenchymal transition (GO:0010718),2/42,0.0049475924537835,0.051773021034235,0,0,20.739583333333332,110.1034239545967,COL1A1;MDK,RNAlo MSC,2.3056060815494894
KEGG_2021_Human,antibacterial humoral response (GO:0019731),2/44,0.0054187658916089,0.0553848281247012,0,0,19.75,103.05327189846057,TF;SLPI,RNAlo MSC,2.266099611522887
KEGG_2021_Human,positive regulation of stress fiber assembly (GO:0051496),2/44,0.0054187658916089,0.0553848281247012,0,0,19.75,103.05327189846057,SFRP1;PFN2,RNAlo MSC,2.266099611522887
KEGG_2021_Human,receptor-mediated endocytosis (GO:0006898),3/143,0.0054878045288024,0.0554457492047976,0,0,9.03191489361702,47.013167330286905,SPARC;HP;APOE,RNAlo MSC,2.2606013662470708
KEGG_2021_Human,positive regulation of chemotaxis (GO:0050921),2/45,0.0056617913266769,0.0559181413050455,0,0,19.289728682170544,99.80534454493326,MDK;RARRES2,RNAlo MSC,2.2470461412130196
KEGG_2021_Human,zymogen activation (GO:0031638),2/45,0.0056617913266769,0.0559181413050455,0,0,19.289728682170544,99.80534454493326,C1R;HP,RNAlo MSC,2.2470461412130196
KEGG_2021_Human,regulation of fibroblast proliferation (GO:0048145),2/46,0.0059097422436154,0.0570842135399776,0,0,18.85037878787879,96.72417883948356,SFRP1;GAS6,RNAlo MSC,2.2284314606782503
KEGG_2021_Human,negative regulation of tumor necrosis factor production (GO:0032720),2/46,0.0059097422436154,0.0570842135399776,0,0,18.85037878787879,96.72417883948356,LBP;GAS6,RNAlo MSC,2.2284314606782503
KEGG_2021_Human,positive regulation of cell-cell adhesion (GO:0022409),2/47,0.0061625935135597,0.0588795619393367,0,0,18.430555555555557,93.79784429037068,MDK;THY1,RNAlo MSC,2.210236477513525
KEGG_2021_Human,response to cytokine (GO:0034097),3/150,0.0062631723305451,0.0591970804145071,0,0,8.598784194528875,43.62222089301041,IFITM3;GGT5;TIMP4,RNAlo MSC,2.2032056385661116
KEGG_2021_Human,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),2/48,0.0064203200925442,0.0594048564352254,0,0,18.028985507246375,91.01549863791358,LBP;GAS6,RNAlo MSC,2.192443319133604
KEGG_2021_Human,positive regulation of endocytosis (GO:0045807),2/48,0.0064203200925442,0.0594048564352254,0,0,18.028985507246375,91.01549863791358,TF;APOE,RNAlo MSC,2.192443319133604
KEGG_2021_Human,extracellular matrix organization (GO:0030198),4/300,0.0066473197433902,0.0599414947927981,0,0,5.7737955346650995,28.94716382386717,COL1A1;SPARC;CYP1B1;GAS6,RNAlo MSC,2.1773534306812214
KEGG_2021_Human,negative regulation of cell projection organization (GO:0031345),2/49,0.0066828970303688,0.0599414947927981,0,0,17.64450354609929,88.36726791367238,STMN2;APOE,RNAlo MSC,2.175035230405133
KEGG_2021_Human,response to hydrogen peroxide (GO:0042542),2/49,0.0066828970303688,0.0599414947927981,0,0,17.64450354609929,88.36726791367238,HP;CYP1B1,RNAlo MSC,2.175035230405133
KEGG_2021_Human,regulation of complement activation (GO:0030449),2/50,0.0069502994651568,0.0610931322987291,0,0,17.276041666666668,85.84414194819459,C1R;SERPING1,RNAlo MSC,2.157996482710139
KEGG_2021_Human,iron ion transport (GO:0006826),2/50,0.0069502994651568,0.0610931322987291,0,0,17.276041666666668,85.84414194819459,TF;CP,RNAlo MSC,2.157996482710139
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),5/485,0.0070959676294594,0.0616366971772614,0,0,4.506944444444445,22.30139137962044,SFRP1;MDK;APOE;GAS6;FSTL1,RNAlo MSC,2.148988374345894
KEGG_2021_Human,blood circulation (GO:0008015),2/51,0.0072225026271421,0.0616366971772614,0,0,16.922619047619047,83.43788300609687,CXCL12;SERPING1,RNAlo MSC,2.1413122915117184
KEGG_2021_Human,positive regulation of actin filament bundle assembly (GO:0032233),2/51,0.0072225026271421,0.0616366971772614,0,0,16.922619047619047,83.43788300609687,SFRP1;PFN2,RNAlo MSC,2.1413122915117184
KEGG_2021_Human,response to lipopolysaccharide (GO:0032496),3/159,0.0073518981608103,0.0621376777245414,0,0,8.099018003273322,39.78882929168961,GGT5;SLPI;LBP,RNAlo MSC,2.133600517468579
KEGG_2021_Human,negative regulation of BMP signaling pathway (GO:0030514),2/52,0.007499481830469,0.0627813764664982,0,0,16.583333333333332,81.14094572244915,CHRDL1;FSTL1,RNAlo MSC,2.12496874273393
KEGG_2021_Human,regulation of immune effector process (GO:0002697),2/53,0.0077812124839393,0.0645253374847421,0,0,16.25735294117647,78.94640668269977,C1R;SERPING1,RNAlo MSC,2.108952725111067
KEGG_2021_Human,regulation of focal adhesion assembly (GO:0051893),2/54,0.0080676700842631,0.0650160478487464,0,0,15.943910256410255,76.8479024006269,SFRP1;THY1,RNAlo MSC,2.0932518699428635
KEGG_2021_Human,regulation of humoral immune response (GO:0002920),2/54,0.0080676700842631,0.0650160478487464,0,0,15.943910256410255,76.8479024006269,C1R;SERPING1,RNAlo MSC,2.0932518699428635
KEGG_2021_Human,negative regulation of viral genome replication (GO:0045071),2/54,0.0080676700842631,0.0650160478487464,0,0,15.943910256410255,76.8479024006269,IFITM3;SLPI,RNAlo MSC,2.0932518699428635
KEGG_2021_Human,regulation of neuron projection development (GO:0010975),3/165,0.0081362517216861,0.0650160478487464,0,0,7.796690307328605,37.51319597515579,MDK;STMN2;APOE,RNAlo MSC,2.08957562355039
KEGG_2021_Human,glycosaminoglycan catabolic process (GO:0006027),2/56,0.0086546685435214,0.0685356184662642,0,0,15.351851851851851,72.91602120992282,SDC3;FMOD,RNAlo MSC,2.0627495600792987
KEGG_2021_Human,arachidonic acid metabolic process (GO:0019369),2/57,0.0089551608364968,0.0690490032919359,0,0,15.071969696969695,71.07225417227201,CYP1B1;PTGDS,RNAlo MSC,2.0479266097283184
KEGG_2021_Human,positive regulation of cell junction assembly (GO:1901890),2/57,0.0089551608364968,0.0690490032919359,0,0,15.071969696969695,71.07225417227201,SFRP1;THY1,RNAlo MSC,2.0479266097283184
KEGG_2021_Human,icosanoid metabolic process (GO:0006690),2/57,0.0089551608364968,0.0690490032919359,0,0,15.071969696969695,71.07225417227201,GGT5;CYP1B1,RNAlo MSC,2.0479266097283184
KEGG_2021_Human,cellular iron ion homeostasis (GO:0006879),2/58,0.0092602829393189,0.070780771336186,0,0,14.802083333333334,69.30366021141536,TF;CP,RNAlo MSC,2.033375743652011
KEGG_2021_Human,response to reactive oxygen species (GO:0000302),2/59,0.0095700107879558,0.0725175817466651,0,0,14.541666666666666,67.6059670933825,HP;APOE,RNAlo MSC,2.019087572657113
KEGG_2021_Human,iron ion homeostasis (GO:0055072),2/61,0.0102031878981958,0.0736201254980304,0,0,14.04731638418079,64.40771918587598,TF;CP,RNAlo MSC,1.9912641154648159
KEGG_2021_Human,negative regulation of endopeptidase activity (GO:0010951),2/63,0.0108545013893802,0.0736201254980304,0,0,13.585382513661202,61.44906812714711,SERPING1;TIMP4,RNAlo MSC,1.9643901214324337
KEGG_2021_Human,negative regulation of peptidase activity (GO:0010466),2/63,0.0108545013893802,0.0736201254980304,0,0,13.585382513661202,61.44906812714711,SERPING1;TIMP4,RNAlo MSC,1.9643901214324337
KEGG_2021_Human,lipid homeostasis (GO:0055088),2/64,0.0111869000374274,0.0736201254980304,0,0,13.365591397849462,60.051760195429935,RBP1;APOE,RNAlo MSC,1.9512902426187388
KEGG_2021_Human,supramolecular fiber organization (GO:0097435),4/351,0.0113872544583053,0.0736201254980304,0,0,4.912416990352086,21.984346104614293,COL1A1;EFEMP2;STMN2;CYP1B1,RNAlo MSC,1.943580974546083
KEGG_2021_Human,regulation of cell-matrix adhesion (GO:0001952),2/65,0.0115237618661231,0.0736201254980304,0,0,13.15277777777778,58.70537343689256,SFRP1;THY1,RNAlo MSC,1.9384057248186684
KEGG_2021_Human,embryonic organ development (GO:0048568),2/66,0.0118650634107129,0.0736201254980304,0,0,12.946614583333334,57.4073222604629,ALDH1A3;RARRES2,RNAlo MSC,1.9257299364311244
KEGG_2021_Human,regulation of viral genome replication (GO:0045069),2/67,0.012210781302115,0.0736201254980304,0,0,12.746794871794872,56.15518906635068,IFITM3;SLPI,RNAlo MSC,1.9132565470017566
KEGG_2021_Human,negative regulation of B cell differentiation (GO:0045578),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,SFRP1,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,"negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,SERPING1,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,negative regulation of cholesterol biosynthetic process (GO:0045541),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,APOE,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,negative regulation of cholesterol metabolic process (GO:0090206),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,APOE,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,receptor-mediated virion attachment to host cell (GO:0046813),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,GAS6,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,antifungal humoral response (GO:0019732),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,RARRES2,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,"regulation of blood coagulation, intrinsic pathway (GO:2000266)",1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,SERPING1,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,negative regulation of hydrogen peroxide metabolic process (GO:0010727),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,HP,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,CXCL12,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,regulation of circadian sleep/wake cycle (GO:0042749),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,PTGDS,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,negative regulation of regulatory T cell differentiation (GO:0045590),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,MDK,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,cellular response to heparin (GO:0071504),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,SFRP1,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,negative regulation of sterol biosynthetic process (GO:0106119),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,APOE,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,cellular response to vitamin D (GO:0071305),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,SFRP1,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,regulation of inflammatory response to wounding (GO:0106014),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,MDK,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,CXCL12,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,APOE,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,regulation of natural killer cell differentiation (GO:0032823),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,GAS6,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,dorsal/ventral axis specification (GO:0009950),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,SFRP1,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,regulation of respiratory burst involved in inflammatory response (GO:0060264),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,LBP,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,hematopoietic stem cell migration (GO:0035701),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,GAS6,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,positive regulation of neutrophil extravasation (GO:2000391),1/5,0.0124387771927725,0.0736201254980304,0,0,101.76530612244898,446.4379351400606,MDK,RNAlo MSC,1.9052223113279663
KEGG_2021_Human,canonical Wnt signaling pathway (GO:0060070),2/68,0.0125608922452035,0.0736201254980304,0,0,12.553030303030305,54.94671101969335,SFRP1;FRZB,RNAlo MSC,1.9009795100092206
KEGG_2021_Human,negative regulation of cellular catabolic process (GO:0031330),2/69,0.0129153730394233,0.0736201254980304,0,0,12.36504975124378,53.77976800231812,HP;TIMP4,RNAlo MSC,1.888893045423814
KEGG_2021_Human,cellular protein modification process (GO:0006464),7/1025,0.0132474901348472,0.0736201254980304,0,0,3.027459222369443,13.090573731641388,TF;IGFBP4;APOE;GAS6;CP;CHRDL1;FSTL1,RNAlo MSC,1.8778663952243155
KEGG_2021_Human,negative regulation of viral process (GO:0048525),2/70,0.013274200561286,0.0736201254980304,0,0,12.182598039215684,52.65237170003471,IFITM3;SLPI,RNAlo MSC,1.8769916248436092
KEGG_2021_Human,defense response to Gram-positive bacterium (GO:0050830),2/70,0.013274200561286,0.0736201254980304,0,0,12.182598039215684,52.65237170003471,RARRES2;LBP,RNAlo MSC,1.8769916248436092
KEGG_2021_Human,positive regulation of cell-substrate adhesion (GO:0010811),2/70,0.013274200561286,0.0736201254980304,0,0,12.182598039215684,52.65237170003471,SFRP1;MDK,RNAlo MSC,1.8769916248436092
KEGG_2021_Human,sterol metabolic process (GO:0016125),2/70,0.013274200561286,0.0736201254980304,0,0,12.182598039215684,52.65237170003471,CYP1B1;APOE,RNAlo MSC,1.8769916248436092
KEGG_2021_Human,negative regulation of neuron apoptotic process (GO:0043524),2/71,0.0136373517747766,0.0736201254980304,0,0,12.005434782608695,51.56265564232933,MDK;APOE,RNAlo MSC,1.8652699567516449
KEGG_2021_Human,regulation of endopeptidase activity (GO:0052548),2/71,0.0136373517747766,0.0736201254980304,0,0,12.005434782608695,51.56265564232933,SERPING1;TIMP4,RNAlo MSC,1.8652699567516449
KEGG_2021_Human,regulation of angiogenesis (GO:0045765),3/203,0.0142323787832344,0.0736201254980304,0,0,6.303191489361702,26.80265596371328,SFRP1;SPARC;CYP1B1,RNAlo MSC,1.8467225063744226
KEGG_2021_Human,negative regulation of cell adhesion (GO:0007162),2/73,0.0143765335552059,0.0736201254980304,0,0,11.666079812206572,49.48935398933624,MDK;CYP1B1,RNAlo MSC,1.8423458176616205
KEGG_2021_Human,defense response to Gram-negative bacterium (GO:0050829),2/73,0.0143765335552059,0.0736201254980304,0,0,11.666079812206572,49.48935398933624,RARRES2;LBP,RNAlo MSC,1.8423458176616205
KEGG_2021_Human,regulation of stress fiber assembly (GO:0051492),2/74,0.0147525184670075,0.0736201254980304,0,0,11.50347222222222,48.50256694786101,SFRP1;PFN2,RNAlo MSC,1.8311338330445346
KEGG_2021_Human,negative regulation of cardiac muscle cell apoptotic process (GO:0010667),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,MDK,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,negative regulation of cellular extravasation (GO:0002692),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,CXCL12,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,B cell chemotaxis (GO:0035754),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,GAS6,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,regulation of collagen fibril organization (GO:1904026),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,EFEMP2,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,cellular response to iron ion (GO:0071281),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,TF,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,regulation of glomerular filtration (GO:0003093),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,GAS6,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,cellular response to lipoteichoic acid (GO:0071223),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,LBP,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,regulation of hepatocyte proliferation (GO:2000345),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,MDK,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,chitin catabolic process (GO:0006032),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,CHI3L2,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,chitin metabolic process (GO:0006030),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,CHI3L2,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,neurotransmitter-gated ion channel clustering (GO:0072578),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,APOE,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,regulation of neutrophil extravasation (GO:2000389),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,MDK,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,embryonic camera-type eye development (GO:0031076),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,ALDH1A3,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,SFRP1,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,response to heparin (GO:0071503),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,SFRP1,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,response to lipoteichoic acid (GO:0070391),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,LBP,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,retinal cone cell development (GO:0046549),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,THY1,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,retinal cone cell differentiation (GO:0042670),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,THY1,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,leukocyte chemotaxis involved in inflammatory response (GO:0002232),1/6,0.0149082847993736,0.0736201254980304,0,0,81.40816326530613,342.3895623444841,MDK,RNAlo MSC,1.8265723193247598
KEGG_2021_Human,positive regulation of T cell activation (GO:0050870),2/75,0.0151327357621299,0.0743110320386157,0,0,11.345319634703197,47.54704276850611,MDK;THY1,RNAlo MSC,1.820082551223806
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),3/212,0.0159696302578282,0.077120003711109,0,0,6.029013539651838,24.942429757967023,GGT5;MDK;APOE,RNAlo MSC,1.7967051388924395
KEGG_2021_Human,positive regulation of cell adhesion (GO:0045785),2/80,0.0170965192165363,0.077120003711109,0,0,10.615384615384617,43.19273030214829,CXCL12;MDK,RNAlo MSC,1.7670923012410087
KEGG_2021_Human,negative regulation of lymphocyte differentiation (GO:0045620),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,SFRP1,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,negative regulation of membrane protein ectodomain proteolysis (GO:0051045),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,TIMP4,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,negative regulation of ruffle assembly (GO:1900028),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,PFN2,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,cellular response to prostaglandin E stimulus (GO:0071380),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,SFRP1,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,chylomicron remnant clearance (GO:0034382),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,APOE,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,COL1A1,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,"complement activation, alternative pathway (GO:0006957)",1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,CFD,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,detection of molecule of bacterial origin (GO:0032490),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,LBP,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,positive regulation of amyloid-beta clearance (GO:1900223),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,APOE,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,glutathione catabolic process (GO:0006751),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,GGT5,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,positive regulation of fibroblast apoptotic process (GO:2000271),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,SFRP1,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,skin morphogenesis (GO:0043589),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,COL1A1,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,positive regulation of receptor catabolic process (GO:2000646),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,APOE,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,positive regulation of respiratory burst (GO:0060267),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,LBP,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,EFEMP2,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,vascular associated smooth muscle cell development (GO:0097084),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,EFEMP2,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,vitamin A metabolic process (GO:0006776),1/7,0.0173717414502839,0.077120003711109,0,0,67.83673469387755,274.9362107684438,RBP1,RNAlo MSC,1.7601566430186848
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),3/221,0.0178215403858025,0.0787192663272383,0,0,5.777474136248292,23.267895552531773,COL1A1;CXCL12;MDK,RNAlo MSC,1.7490547608972438
KEGG_2021_Human,regulation of actin filament length (GO:0030832),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,CXCL12,RNAlo MSC,1.702695651141308
KEGG_2021_Human,negative regulation of glial cell apoptotic process (GO:0034351),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,GAS6,RNAlo MSC,1.702695651141308
KEGG_2021_Human,regulation of Cdc42 protein signal transduction (GO:0032489),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,APOE,RNAlo MSC,1.702695651141308
KEGG_2021_Human,negative regulation of long-term synaptic potentiation (GO:1900272),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,APOE,RNAlo MSC,1.702695651141308
KEGG_2021_Human,negative regulation of neuron projection regeneration (GO:0070571),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,THY1,RNAlo MSC,1.702695651141308
KEGG_2021_Human,negative regulation of osteoblast proliferation (GO:0033689),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,SFRP1,RNAlo MSC,1.702695651141308
KEGG_2021_Human,regulation of dendritic cell chemotaxis (GO:2000508),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,GAS6,RNAlo MSC,1.702695651141308
KEGG_2021_Human,regulation of dendritic spine maintenance (GO:1902950),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,APOE,RNAlo MSC,1.702695651141308
KEGG_2021_Human,regulation of extent of cell growth (GO:0061387),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,APOE,RNAlo MSC,1.702695651141308
KEGG_2021_Human,cellular response to interferon-alpha (GO:0035457),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,GAS6,RNAlo MSC,1.702695651141308
KEGG_2021_Human,negative regulation of striated muscle cell apoptotic process (GO:0010664),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,MDK,RNAlo MSC,1.702695651141308
KEGG_2021_Human,regulation of nitrogen compound metabolic process (GO:0051171),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,APOE,RNAlo MSC,1.702695651141308
KEGG_2021_Human,elastic fiber assembly (GO:0048251),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,EFEMP2,RNAlo MSC,1.702695651141308
KEGG_2021_Human,fusion of virus membrane with host plasma membrane (GO:0019064),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,GAS6,RNAlo MSC,1.702695651141308
KEGG_2021_Human,positive regulation of dendritic cell chemotaxis (GO:2000510),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,GAS6,RNAlo MSC,1.702695651141308
KEGG_2021_Human,integrin activation (GO:0033622),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,CXCL12,RNAlo MSC,1.702695651141308
KEGG_2021_Human,positive regulation of oligodendrocyte differentiation (GO:0048714),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,MDK,RNAlo MSC,1.702695651141308
KEGG_2021_Human,membrane fusion involved in viral entry into host cell (GO:0039663),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,GAS6,RNAlo MSC,1.702695651141308
KEGG_2021_Human,vascular associated smooth muscle cell differentiation (GO:0035886),1/8,0.0198291614511851,0.0799533619981271,0,0,58.142857142857146,227.9549801512961,EFEMP2,RNAlo MSC,1.702695651141308
KEGG_2021_Human,regulation of endothelial cell migration (GO:0010594),2/89,0.0208876608034354,0.0812639480071398,0,0,9.512931034482758,36.80169347929862,SPARC;APOE,RNAlo MSC,1.6801101936742149
KEGG_2021_Human,collagen fibril organization (GO:0030199),2/89,0.0208876608034354,0.0812639480071398,0,0,9.512931034482758,36.80169347929862,COL1A1;CYP1B1,RNAlo MSC,1.6801101936742149
KEGG_2021_Human,positive regulation of inflammatory response (GO:0050729),2/89,0.0208876608034354,0.0812639480071398,0,0,9.512931034482758,36.80169347929862,MDK;LBP,RNAlo MSC,1.6801101936742149
KEGG_2021_Human,positive regulation of transport (GO:0051050),2/91,0.0217736102157896,0.0812639480071398,0,0,9.298220973782772,35.5848177883064,APOE;GAS6,RNAlo MSC,1.6620695559472094
KEGG_2021_Human,regulation of endothelial cell proliferation (GO:0001936),2/92,0.0222223839756269,0.0812639480071398,0,0,9.194444444444445,35.00007985571613,SPARC;APOE,RNAlo MSC,1.6532093525993499
KEGG_2021_Human,Wnt signaling pathway (GO:0016055),2/92,0.0222223839756269,0.0812639480071398,0,0,9.194444444444445,35.00007985571613,SFRP1;FRZB,RNAlo MSC,1.6532093525993499
KEGG_2021_Human,negative regulation of biomineralization (GO:0110150),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,GAS6,RNAlo MSC,1.652073914876897
KEGG_2021_Human,regulation of actin filament organization (GO:0110053),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,CXCL12,RNAlo MSC,1.652073914876897
KEGG_2021_Human,regulation of cellular extravasation (GO:0002691),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,THY1,RNAlo MSC,1.652073914876897
KEGG_2021_Human,negative regulation of protein activation cascade (GO:2000258),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,SERPING1,RNAlo MSC,1.652073914876897
KEGG_2021_Human,cholesterol catabolic process (GO:0006707),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,APOE,RNAlo MSC,1.652073914876897
KEGG_2021_Human,chylomicron remodeling (GO:0034371),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,APOE,RNAlo MSC,1.652073914876897
KEGG_2021_Human,collagen-activated signaling pathway (GO:0038065),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,COL1A1,RNAlo MSC,1.652073914876897
KEGG_2021_Human,"complement activation, classical pathway (GO:0006958)",1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,C1R,RNAlo MSC,1.652073914876897
KEGG_2021_Human,organic cyclic compound catabolic process (GO:1901361),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,HSD11B1,RNAlo MSC,1.652073914876897
KEGG_2021_Human,positive regulation of cholesterol esterification (GO:0010873),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,APOE,RNAlo MSC,1.652073914876897
KEGG_2021_Human,glucosamine-containing compound catabolic process (GO:1901072),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,CHI3L2,RNAlo MSC,1.652073914876897
KEGG_2021_Human,response to vitamin D (GO:0033280),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,SFRP1,RNAlo MSC,1.652073914876897
KEGG_2021_Human,leukotriene D4 biosynthetic process (GO:1901750),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,GGT5,RNAlo MSC,1.652073914876897
KEGG_2021_Human,leukotriene D4 metabolic process (GO:1901748),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,GGT5,RNAlo MSC,1.652073914876897
KEGG_2021_Human,sterol catabolic process (GO:0016127),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,APOE,RNAlo MSC,1.652073914876897
KEGG_2021_Human,lipoprotein metabolic process (GO:0042157),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,APOE,RNAlo MSC,1.652073914876897
KEGG_2021_Human,very-low-density lipoprotein particle remodeling (GO:0034372),1/9,0.0222805591236868,0.0812639480071398,0,0,50.87244897959184,193.52086993316271,APOE,RNAlo MSC,1.652073914876897
KEGG_2021_Human,positive regulation of peptidyl-serine phosphorylation (GO:0033138),2/93,0.0226749954090764,0.0823608304321412,0,0,9.092948717948715,34.43038199107018,GAS6;PFN2,RNAlo MSC,1.6444527921978775
KEGG_2021_Human,cellular transition metal ion homeostasis (GO:0046916),2/96,0.0240556444712905,0.0848281818554965,0,0,8.801418439716311,32.80628046281635,TF;CP,RNAlo MSC,1.6187830034849287
KEGG_2021_Human,glycosaminoglycan biosynthetic process (GO:0006024),2/97,0.024523395696302,0.0848281818554965,0,0,8.708333333333334,32.29161197321332,SDC3;FMOD,RNAlo MSC,1.6104193942653626
KEGG_2021_Human,negative regulation of cell adhesion mediated by integrin (GO:0033629),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,CYP1B1,RNAlo MSC,1.606847034080906
KEGG_2021_Human,adrenal gland development (GO:0030325),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,MDK,RNAlo MSC,1.606847034080906
KEGG_2021_Human,regulation of epithelial cell apoptotic process (GO:1904035),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,MDK,RNAlo MSC,1.606847034080906
KEGG_2021_Human,cellular response to prostaglandin stimulus (GO:0071379),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,SFRP1,RNAlo MSC,1.606847034080906
KEGG_2021_Human,chylomicron assembly (GO:0034378),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,APOE,RNAlo MSC,1.606847034080906
KEGG_2021_Human,regulation of leukocyte tethering or rolling (GO:1903236),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,CXCL12,RNAlo MSC,1.606847034080906
KEGG_2021_Human,omega-hydroxylase P450 pathway (GO:0097267),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,CYP1B1,RNAlo MSC,1.606847034080906
KEGG_2021_Human,endothelium development (GO:0003158),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,FSTL1,RNAlo MSC,1.606847034080906
KEGG_2021_Human,hematopoietic stem cell differentiation (GO:0060218),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,SFRP1,RNAlo MSC,1.606847034080906
KEGG_2021_Human,smooth muscle tissue development (GO:0048745),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,EFEMP2,RNAlo MSC,1.606847034080906
KEGG_2021_Human,membrane lipid catabolic process (GO:0046466),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,CYP1B1,RNAlo MSC,1.606847034080906
KEGG_2021_Human,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),1/10,0.024725948817258,0.0848281818554965,0,0,45.21768707482993,167.3010120823387,LBP,RNAlo MSC,1.606847034080906
KEGG_2021_Human,negative regulation of neuron death (GO:1901215),2/98,0.0249948795228368,0.0848281818554965,0,0,8.6171875,31.789531066243494,MDK;APOE,RNAlo MSC,1.6021489522377872
KEGG_2021_Human,regulation of neuron apoptotic process (GO:0043523),2/98,0.0249948795228368,0.0848281818554965,0,0,8.6171875,31.789531066243494,MDK;APOE,RNAlo MSC,1.6021489522377872
KEGG_2021_Human,regulation of peptidyl-serine phosphorylation (GO:0033135),2/98,0.0249948795228368,0.0848281818554965,0,0,8.6171875,31.789531066243494,GAS6;PFN2,RNAlo MSC,1.6021489522377872
KEGG_2021_Human,negative regulation of bone remodeling (GO:0046851),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,SFRP1,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,alcohol catabolic process (GO:0046164),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,APOE,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,regulation of cardiac muscle cell apoptotic process (GO:0010665),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,MDK,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,cyclooxygenase pathway (GO:0019371),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,PTGDS,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,embryonic eye morphogenesis (GO:0048048),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,ALDH1A3,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,positive regulation by host of viral process (GO:0044794),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,APOE,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,fatty acid homeostasis (GO:0055089),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,APOE,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,glucocorticoid biosynthetic process (GO:0006704),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,HSD11B1,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,glucocorticoid metabolic process (GO:0008211),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,HSD11B1,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,response to prostaglandin E (GO:0034695),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,SFRP1,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,positive regulation of keratinocyte proliferation (GO:0010838),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,MDK,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,humoral immune response mediated by circulating immunoglobulin (GO:0002455),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,C1R,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,induction of positive chemotaxis (GO:0050930),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,CXCL12,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,SFRP1,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,positive regulation of phospholipid transport (GO:2001140),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,APOE,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,lipoprotein biosynthetic process (GO:0042158),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,APOE,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,lipoprotein catabolic process (GO:0042159),1/11,0.0271653448579923,0.086515717862954,0,0,40.69387755102041,146.73452100035948,APOE,RNAlo MSC,1.5659847773237099
KEGG_2021_Human,steroid metabolic process (GO:0008202),2/104,0.0279010087799889,0.0885378581863185,0,0,8.107843137254902,29.018720027145317,HSD11B1;CYP1B1,RNAlo MSC,1.5543800942295387
KEGG_2021_Human,protein processing (GO:0016485),2/106,0.0288986461861609,0.0892639311036363,0,0,7.951121794871795,28.178461808105727,C1R;HP,RNAlo MSC,1.5391225021448902
KEGG_2021_Human,negative regulation of complement activation (GO:0045916),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,SERPING1,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,regulation of amyloid precursor protein catabolic process (GO:1902991),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,APOE,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,negative regulation of hemostasis (GO:1900047),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,APOE,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,negative regulation of microtubule polymerization (GO:0031115),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,STMN2,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,regulation of cholesterol esterification (GO:0010872),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,APOE,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,negative regulation of oxidoreductase activity (GO:0051354),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,HP,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,regulation of leukocyte cell-cell adhesion (GO:1903037),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,MDK,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,phospholipid efflux (GO:0033700),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,APOE,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,CYP1B1,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,keratan sulfate catabolic process (GO:0042340),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,FMOD,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,positive regulation of protein depolymerization (GO:1901881),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,STMN2,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,modulation by host of viral process (GO:0044788),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,APOE,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,negative regulation of amyloid fibril formation (GO:1905907),1/12,0.029598761568907,0.0892639311036363,0,0,36.99257884972171,130.2147194065139,APOE,RNAlo MSC,1.5287264597194943
KEGG_2021_Human,positive regulation of cell migration (GO:0030335),3/269,0.029653092016225,0.0892639311036363,0,0,4.723404255319149,16.617828303773123,COL1A1;CXCL12;MDK,RNAlo MSC,1.5279300147593886
KEGG_2021_Human,lipid transport (GO:0006869),2/109,0.0304216645881743,0.0904435646479529,0,0,7.72702492211838,26.987409356009476,LBP;APOE,RNAlo MSC,1.5168170262567133
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),4/474,0.030453470555099,0.0904435646479529,0,0,3.604070305272895,12.583810832834969,SFRP1;MDK;GAS6;S100B,RNAlo MSC,1.5163632069049728
KEGG_2021_Human,regulation of interleukin-6 production (GO:0032675),2/110,0.0309363405009925,0.0904435646479529,0,0,7.655092592592593,26.607752397672005,LBP;GAS6,RNAlo MSC,1.5095310608442127
KEGG_2021_Human,regulation of protein kinase activity (GO:0045859),2/110,0.0309363405009925,0.0904435646479529,0,0,7.655092592592593,26.607752397672005,THY1;GAS6,RNAlo MSC,1.5095310608442127
KEGG_2021_Human,response to tumor necrosis factor (GO:0034612),2/110,0.0309363405009925,0.0904435646479529,0,0,7.655092592592593,26.607752397672005,GGT5;SFRP1,RNAlo MSC,1.5095310608442127
KEGG_2021_Human,regulation of Wnt signaling pathway (GO:0030111),2/111,0.0314544847807964,0.0904435646479529,0,0,7.584480122324159,26.23633758944092,SFRP1;FRZB,RNAlo MSC,1.5023174240917434
KEGG_2021_Human,antifungal innate immune response (GO:0061760),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,RARRES2,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,MDK,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,regulation of oxidoreductase activity (GO:0051341),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,HP,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,positive regulation of calcium ion import (GO:0090280),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,CXCL12,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,high-density lipoprotein particle assembly (GO:0034380),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,APOE,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,response to iron ion (GO:0010039),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,TF,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,positive regulation of lipid transport (GO:0032370),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,APOE,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,positive regulation of neuron migration (GO:2001224),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,MDK,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,macrophage activation involved in immune response (GO:0002281),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,LBP,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,positive regulation of steroid metabolic process (GO:0045940),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,APOE,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,triglyceride-rich lipoprotein particle remodeling (GO:0034370),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,APOE,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,positive regulation of vascular endothelial cell proliferation (GO:1905564),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,MDK,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,negative regulation of alcohol biosynthetic process (GO:1902931),1/13,0.032026213248763,0.0904435646479529,0,0,33.90816326530612,116.6847899929619,APOE,RNAlo MSC,1.4944944088974865
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),4/482,0.0321028352334031,0.0904435646479529,0,0,3.5422957977078404,12.181285498368895,SFRP1;CXCL12;LBP;GAS6,RNAlo MSC,1.4934566102167288
KEGG_2021_Human,sulfur compound biosynthetic process (GO:0044272),2/113,0.032501099312465,0.0912730552576892,0,0,7.447072072072072,25.51725368040207,GGT5;FMOD,RNAlo MSC,1.4881019492591823
KEGG_2021_Human,positive regulation of angiogenesis (GO:0045766),2/116,0.0340965412337713,0.0934553727015948,0,0,7.25,24.49455514200503,MDK;CYP1B1,RNAlo MSC,1.467289673772098
KEGG_2021_Human,negative regulation of cell activation (GO:0050866),1/14,0.0344477141698711,0.0934553727015948,0,0,31.298273155416013,105.4223689491126,APOE,RNAlo MSC,1.4628395910668823
KEGG_2021_Human,negative regulation of coagulation (GO:0050819),1/14,0.0344477141698711,0.0934553727015948,0,0,31.298273155416013,105.4223689491126,APOE,RNAlo MSC,1.4628395910668823
KEGG_2021_Human,aorta development (GO:0035904),1/14,0.0344477141698711,0.0934553727015948,0,0,31.298273155416013,105.4223689491126,EFEMP2,RNAlo MSC,1.4628395910668823
KEGG_2021_Human,negative regulation of T cell differentiation (GO:0045581),1/14,0.0344477141698711,0.0934553727015948,0,0,31.298273155416013,105.4223689491126,MDK,RNAlo MSC,1.4628395910668823
KEGG_2021_Human,negative regulation of viral transcription (GO:0032897),1/14,0.0344477141698711,0.0934553727015948,0,0,31.298273155416013,105.4223689491126,IFITM3,RNAlo MSC,1.4628395910668823
KEGG_2021_Human,cGMP-mediated signaling (GO:0019934),1/14,0.0344477141698711,0.0934553727015948,0,0,31.298273155416013,105.4223689491126,APOE,RNAlo MSC,1.4628395910668823
KEGG_2021_Human,endothelial cell differentiation (GO:0045446),1/14,0.0344477141698711,0.0934553727015948,0,0,31.298273155416013,105.4223689491126,FSTL1,RNAlo MSC,1.4628395910668823
KEGG_2021_Human,response to chemokine (GO:1990868),1/14,0.0344477141698711,0.0934553727015948,0,0,31.298273155416013,105.4223689491126,CXCL12,RNAlo MSC,1.4628395910668823
KEGG_2021_Human,positive regulation of lymphocyte migration (GO:2000403),1/14,0.0344477141698711,0.0934553727015948,0,0,31.298273155416013,105.4223689491126,CXCL12,RNAlo MSC,1.4628395910668823
KEGG_2021_Human,steroid catabolic process (GO:0006706),1/14,0.0344477141698711,0.0934553727015948,0,0,31.298273155416013,105.4223689491126,HSD11B1,RNAlo MSC,1.4628395910668823
KEGG_2021_Human,positive regulation of programmed cell death (GO:0043068),3/286,0.0346326750027728,0.0936680656228841,0,0,4.435831892338922,14.917514922023985,SFRP1;FRZB;CYP1B1,RNAlo MSC,1.4605139625632677
KEGG_2021_Human,negative regulation of androgen receptor signaling pathway (GO:0060766),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,SFRP1,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,acute-phase response (GO:0006953),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,LBP,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,regulation of amyloid fibril formation (GO:1905906),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,APOE,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,cellular response to estrogen stimulus (GO:0071391),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,SFRP1,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,regulation of extracellular matrix organization (GO:1903053),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,EFEMP2,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,nitric oxide biosynthetic process (GO:0006809),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,CYP1B1,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,regulation of non-canonical Wnt signaling pathway (GO:2000050),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,SFRP1,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,eye photoreceptor cell development (GO:0042462),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,THY1,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,positive regulation of heterotypic cell-cell adhesion (GO:0034116),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,THY1,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,APOE,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,positive regulation of natural killer cell activation (GO:0032816),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,GAS6,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,positive regulation of protein export from nucleus (GO:0046827),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,GAS6,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,positive regulation of response to cytokine stimulus (GO:0060760),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,GAS6,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,prostanoid biosynthetic process (GO:0046457),1/15,0.0368632785936063,0.0955835453798818,0,0,29.06122448979592,95.91771596133704,PTGDS,RNAlo MSC,1.4334060415588732
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),5/742,0.0372014474377122,0.0961766832286738,0,0,2.8965777174732397,9.533817938899622,SFRP1;FRZB;CYP1B1;GAS6;FSTL1,RNAlo MSC,1.4294401622153592
KEGG_2021_Human,regulation of anatomical structure morphogenesis (GO:0022603),2/123,0.0379356146383277,0.0972169249769389,0,0,6.828168044077135,22.34084340876857,SFRP1;SPARC,RNAlo MSC,1.420952875040757
KEGG_2021_Human,cellular response to organic substance (GO:0071310),2/123,0.0379356146383277,0.0972169249769389,0,0,6.828168044077135,22.34084340876857,SFRP1;CYP1B1,RNAlo MSC,1.420952875040757
KEGG_2021_Human,positive regulation of epithelial cell proliferation (GO:0050679),2/123,0.0379356146383277,0.0972169249769389,0,0,6.828168044077135,22.34084340876857,SFRP1;MDK,RNAlo MSC,1.420952875040757
KEGG_2021_Human,non-canonical Wnt signaling pathway (GO:0035567),2/124,0.038497072428768,0.0977929102708071,0,0,6.771857923497268,22.05711333941876,SFRP1;FRZB,RNAlo MSC,1.4145722958518654
KEGG_2021_Human,regulation of tumor necrosis factor production (GO:0032680),2/124,0.038497072428768,0.0977929102708071,0,0,6.771857923497268,22.05711333941876,LBP;GAS6,RNAlo MSC,1.4145722958518654
KEGG_2021_Human,regulation of amyloid-beta clearance (GO:1900221),1/16,0.0392729207344652,0.0977929102708071,0,0,27.122448979591837,87.80133530116419,APOE,RNAlo MSC,1.405906798966597
KEGG_2021_Human,negative regulation of platelet activation (GO:0010544),1/16,0.0392729207344652,0.0977929102708071,0,0,27.122448979591837,87.80133530116419,APOE,RNAlo MSC,1.405906798966597
KEGG_2021_Human,regulation of hormone secretion (GO:0046883),1/16,0.0392729207344652,0.0977929102708071,0,0,27.122448979591837,87.80133530116419,NMB,RNAlo MSC,1.405906798966597
KEGG_2021_Human,regulation of interleukin-1 production (GO:0032652),1/16,0.0392729207344652,0.0977929102708071,0,0,27.122448979591837,87.80133530116419,GAS6,RNAlo MSC,1.405906798966597
KEGG_2021_Human,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.0392729207344652,0.0977929102708071,0,0,27.122448979591837,87.80133530116419,CXCL12,RNAlo MSC,1.405906798966597
KEGG_2021_Human,nitric oxide metabolic process (GO:0046209),1/16,0.0392729207344652,0.0977929102708071,0,0,27.122448979591837,87.80133530116419,CYP1B1,RNAlo MSC,1.405906798966597
KEGG_2021_Human,oogenesis (GO:0048477),1/16,0.0392729207344652,0.0977929102708071,0,0,27.122448979591837,87.80133530116419,MDK,RNAlo MSC,1.405906798966597
KEGG_2021_Human,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),1/16,0.0392729207344652,0.0977929102708071,0,0,27.122448979591837,87.80133530116419,MDK,RNAlo MSC,1.405906798966597
KEGG_2021_Human,negative regulation of cell growth (GO:0030308),2/126,0.0396295625933463,0.0981250296325391,0,0,6.661962365591398,21.50601306379386,SFRP1;FRZB,RNAlo MSC,1.4019807211138142
KEGG_2021_Human,negative regulation of growth (GO:0045926),2/126,0.0396295625933463,0.0981250296325391,0,0,6.661962365591398,21.50601306379386,SFRP1;FRZB,RNAlo MSC,1.4019807211138142
KEGG_2021_Human,plasma membrane bounded cell projection organization (GO:0120036),2/128,0.0407746939326368,0.0990102150310654,0,0,6.555555555555555,20.975769396496517,STMN2;APOE,RNAlo MSC,1.3896092902230834
KEGG_2021_Human,aorta morphogenesis (GO:0035909),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,EFEMP2,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,negative regulation of insulin secretion (GO:0046676),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,SFRP1,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,regulation of cellular response to growth factor stimulus (GO:0090287),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,FSTL1,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,regulation of cholesterol biosynthetic process (GO:0045540),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,APOE,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,cellular modified amino acid catabolic process (GO:0042219),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,GGT5,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,EFEMP2,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,negative regulation of viral entry into host cell (GO:0046597),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,IFITM3,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,regulation of osteoblast proliferation (GO:0033688),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,SFRP1,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,reverse cholesterol transport (GO:0043691),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,APOE,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,positive regulation of macrophage activation (GO:0043032),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,LBP,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,positive regulation of positive chemotaxis (GO:0050927),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,CXCL12,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,positive regulation of smooth muscle cell migration (GO:0014911),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,MDK,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,muscle tissue morphogenesis (GO:0060415),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,EFEMP2,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,negative regulation of amyloid-beta formation (GO:1902430),1/17,0.0416766547912334,0.0990102150310654,0,0,25.426020408163264,80.79916728086499,APOE,RNAlo MSC,1.3801071472903907
KEGG_2021_Human,positive regulation of canonical Wnt signaling pathway (GO:0090263),2/130,0.0419323175536405,0.0993490758211591,0,0,6.452473958333333,20.46530163526616,COL1A1;SFRP1,RNAlo MSC,1.3774511339488533
KEGG_2021_Human,positive regulation of apoptotic process (GO:0043065),3/310,0.0423559096851941,0.0995924962595317,0,0,4.084066809896735,12.912378899302078,SFRP1;FRZB;CYP1B1,RNAlo MSC,1.3730859864049756
KEGG_2021_Human,regulation of cell adhesion (GO:0030155),2/133,0.043691853040543,0.0995924962595317,0,0,6.303753180661578,19.734489511742076,CXCL12;MDK,RNAlo MSC,1.3595995357844428
KEGG_2021_Human,amyloid precursor protein metabolic process (GO:0042982),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,APOE,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,negative regulation of fibroblast proliferation (GO:0048147),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,SFRP1,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,regulation of B cell differentiation (GO:0045577),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,SFRP1,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,regulation of cartilage development (GO:0061035),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,MDK,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,regulation of catabolic process (GO:0009894),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,RARRES2,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,carbohydrate derivative transport (GO:1901264),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,LBP,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,negative regulation of peptide hormone secretion (GO:0090278),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,SFRP1,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,GAS6,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,nitric oxide mediated signal transduction (GO:0007263),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,APOE,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,positive regulation of cartilage development (GO:0061036),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,MDK,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,regulation of vascular endothelial cell proliferation (GO:1905562),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,MDK,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,positive regulation of extracellular matrix organization (GO:1903055),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,EFEMP2,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,positive regulation of glial cell differentiation (GO:0045687),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,MDK,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,high-density lipoprotein particle remodeling (GO:0034375),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,APOE,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,positive regulation of nitric-oxide synthase activity (GO:0051000),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,APOE,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,microtubule depolymerization (GO:0007019),1/18,0.0440744949316926,0.0995924962595317,0,0,23.92917166866747,74.70385911458476,STMN2,RNAlo MSC,1.3558126557645607
KEGG_2021_Human,negative regulation of T cell receptor signaling pathway (GO:0050860),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,THY1,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,regulation of leukocyte chemotaxis (GO:0002688),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,MDK,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,regulation of oligodendrocyte differentiation (GO:0048713),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,MDK,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,epoxygenase P450 pathway (GO:0019373),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,CYP1B1,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,positive regulation of cellular protein catabolic process (GO:1903364),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,APOE,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,positive regulation of leukocyte activation (GO:0002696),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,LBP,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,positive regulation of monocyte chemotaxis (GO:0090026),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,CXCL12,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,positive regulation of neutrophil chemotaxis (GO:0090023),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,MDK,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,leukotriene biosynthetic process (GO:0019370),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,GGT5,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,long-term memory (GO:0007616),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,APOE,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,"synaptic transmission, cholinergic (GO:0007271)",1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,APOE,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,postsynaptic membrane organization (GO:0001941),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,APOE,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,prostaglandin biosynthetic process (GO:0001516),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,PTGDS,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,myeloid cell activation involved in immune response (GO:0002275),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,LBP,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/19,0.0464664552952436,0.1010990450606909,0,0,22.598639455782312,69.35578082800635,APOE,RNAlo MSC,1.3328604565168853
KEGG_2021_Human,positive regulation of response to external stimulus (GO:0032103),2/139,0.0472922793944307,0.1026417619449498,0,0,6.025851581508515,18.3873330672393,MDK;RARRES2,RNAlo MSC,1.3252097533441285
KEGG_2021_Human,negative regulation of viral life cycle (GO:1903901),1/20,0.0488525499820277,0.103473232371572,0,0,21.40816326530612,64.63014669364038,IFITM3,RNAlo MSC,1.3111127622579986
KEGG_2021_Human,embryonic digestive tract development (GO:0048566),1/20,0.0488525499820277,0.103473232371572,0,0,21.40816326530612,64.63014669364038,RARRES2,RNAlo MSC,1.3111127622579986
KEGG_2021_Human,positive regulation of activated T cell proliferation (GO:0042104),1/20,0.0488525499820277,0.103473232371572,0,0,21.40816326530612,64.63014669364038,IGFBP2,RNAlo MSC,1.3111127622579986
KEGG_2021_Human,eye morphogenesis (GO:0048592),1/20,0.0488525499820277,0.103473232371572,0,0,21.40816326530612,64.63014669364038,ALDH1A3,RNAlo MSC,1.3111127622579986
KEGG_2021_Human,fatty acid transport (GO:0015908),1/20,0.0488525499820277,0.103473232371572,0,0,21.40816326530612,64.63014669364038,APOE,RNAlo MSC,1.3111127622579986
KEGG_2021_Human,regulation of T cell migration (GO:2000404),1/20,0.0488525499820277,0.103473232371572,0,0,21.40816326530612,64.63014669364038,CXCL12,RNAlo MSC,1.3111127622579986
KEGG_2021_Human,regulation of tissue remodeling (GO:0034103),1/20,0.0488525499820277,0.103473232371572,0,0,21.40816326530612,64.63014669364038,MDK,RNAlo MSC,1.3111127622579986
KEGG_2021_Human,positive regulation of hormone secretion (GO:0046887),1/20,0.0488525499820277,0.103473232371572,0,0,21.40816326530612,64.63014669364038,NMB,RNAlo MSC,1.3111127622579986
KEGG_2021_Human,lipopolysaccharide-mediated signaling pathway (GO:0031663),1/20,0.0488525499820277,0.103473232371572,0,0,21.40816326530612,64.63014669364038,LBP,RNAlo MSC,1.3111127622579986
KEGG_2021_Human,toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.0488525499820277,0.103473232371572,0,0,21.40816326530612,64.63014669364038,LBP,RNAlo MSC,1.3111127622579986
KEGG_2021_Human,negative regulation of DNA-binding transcription factor activity (GO:0043433),2/143,0.0497512691479657,0.1046204918207223,0,0,5.8537234042553195,17.565380826397597,CYP1B1;GAS6,RNAlo MSC,1.3031958359850326
KEGG_2021_Human,neuron development (GO:0048666),2/143,0.0497512691479657,0.1046204918207223,0,0,5.8537234042553195,17.565380826397597,STMN2;APOE,RNAlo MSC,1.3031958359850326
KEGG_2021_Human,monocarboxylic acid metabolic process (GO:0032787),2/143,0.0497512691479657,0.1046204918207223,0,0,5.8537234042553195,17.565380826397597,GGT5;ALDH1A3,RNAlo MSC,1.3031958359850326
KEGG_2021_Human,negative regulation of microtubule depolymerization (GO:0007026),1/21,0.0512327930672156,0.105247084136113,0,0,20.336734693877553,60.42807445408675,STMN2,RNAlo MSC,1.2904519669693806
KEGG_2021_Human,regulation of cholesterol metabolic process (GO:0090181),1/21,0.0512327930672156,0.105247084136113,0,0,20.336734693877553,60.42807445408675,APOE,RNAlo MSC,1.2904519669693806
KEGG_2021_Human,regulation of dendritic spine development (GO:0060998),1/21,0.0512327930672156,0.105247084136113,0,0,20.336734693877553,60.42807445408675,APOE,RNAlo MSC,1.2904519669693806
KEGG_2021_Human,cellular response to estradiol stimulus (GO:0071392),1/21,0.0512327930672156,0.105247084136113,0,0,20.336734693877553,60.42807445408675,SFRP1,RNAlo MSC,1.2904519669693806
KEGG_2021_Human,negative regulation of response to wounding (GO:1903035),1/21,0.0512327930672156,0.105247084136113,0,0,20.336734693877553,60.42807445408675,MDK,RNAlo MSC,1.2904519669693806
KEGG_2021_Human,regulation of lipid catabolic process (GO:0050994),1/21,0.0512327930672156,0.105247084136113,0,0,20.336734693877553,60.42807445408675,RARRES2,RNAlo MSC,1.2904519669693806
KEGG_2021_Human,focal adhesion assembly (GO:0048041),1/21,0.0512327930672156,0.105247084136113,0,0,20.336734693877553,60.42807445408675,THY1,RNAlo MSC,1.2904519669693806
KEGG_2021_Human,retinol metabolic process (GO:0042572),1/21,0.0512327930672156,0.105247084136113,0,0,20.336734693877553,60.42807445408675,CYP1B1,RNAlo MSC,1.2904519669693806
KEGG_2021_Human,positive regulation of smoothened signaling pathway (GO:0045880),1/21,0.0512327930672156,0.105247084136113,0,0,20.336734693877553,60.42807445408675,SFRP1,RNAlo MSC,1.2904519669693806
KEGG_2021_Human,positive regulation of cytokine production (GO:0001819),3/335,0.0512465893176978,0.105247084136113,0,0,3.7717251986670086,11.206196171777655,MDK;CYP1B1;LBP,RNAlo MSC,1.2903350334876962
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),4/566,0.0525874539436757,0.1073365092682117,0,0,2.999845273092991,8.835377403898873,SFRP1;MDK;FRZB;CYP1B1,RNAlo MSC,1.279117855331805
KEGG_2021_Human,positive regulation of hydrolase activity (GO:0051345),2/149,0.0535249876216422,0.1073365092682117,0,0,5.613095238095238,16.432935090777736,SFRP1;THY1,RNAlo MSC,1.271443424469827
KEGG_2021_Human,negative regulation of B cell activation (GO:0050869),1/22,0.0536071985992547,0.1073365092682117,0,0,19.367346938775512,56.67024999786951,SFRP1,RNAlo MSC,1.2707768875084013
KEGG_2021_Human,negative regulation of biomineral tissue development (GO:0070168),1/22,0.0536071985992547,0.1073365092682117,0,0,19.367346938775512,56.67024999786951,GAS6,RNAlo MSC,1.2707768875084013
KEGG_2021_Human,cellular response to nerve growth factor stimulus (GO:1990090),1/22,0.0536071985992547,0.1073365092682117,0,0,19.367346938775512,56.67024999786951,STMN2,RNAlo MSC,1.2707768875084013
KEGG_2021_Human,regulation of platelet activation (GO:0010543),1/22,0.0536071985992547,0.1073365092682117,0,0,19.367346938775512,56.67024999786951,APOE,RNAlo MSC,1.2707768875084013
KEGG_2021_Human,positive regulation of dendritic spine development (GO:0060999),1/22,0.0536071985992547,0.1073365092682117,0,0,19.367346938775512,56.67024999786951,APOE,RNAlo MSC,1.2707768875084013
KEGG_2021_Human,positive regulation of granulocyte chemotaxis (GO:0071624),1/22,0.0536071985992547,0.1073365092682117,0,0,19.367346938775512,56.67024999786951,MDK,RNAlo MSC,1.2707768875084013
KEGG_2021_Human,positive regulation of neural precursor cell proliferation (GO:2000179),1/22,0.0536071985992547,0.1073365092682117,0,0,19.367346938775512,56.67024999786951,MDK,RNAlo MSC,1.2707768875084013
KEGG_2021_Human,positive regulation of neutrophil migration (GO:1902624),1/22,0.0536071985992547,0.1073365092682117,0,0,19.367346938775512,56.67024999786951,MDK,RNAlo MSC,1.2707768875084013
KEGG_2021_Human,membrane lipid metabolic process (GO:0006643),1/22,0.0536071985992547,0.1073365092682117,0,0,19.367346938775512,56.67024999786951,CYP1B1,RNAlo MSC,1.2707768875084013
KEGG_2021_Human,cellular response to organic cyclic compound (GO:0071407),2/150,0.0541636617411515,0.1082042242510731,0,0,5.574887387387387,16.25495026487543,SFRP1;CYP1B1,RNAlo MSC,1.2662919827974375
KEGG_2021_Human,negative regulation of protein phosphorylation (GO:0001933),2/152,0.0554491879134877,0.1098182388701223,0,0,5.5,15.907585158720506,SFRP1;THY1,RNAlo MSC,1.2561048099706147
KEGG_2021_Human,artery development (GO:0060840),1/23,0.0559757805878795,0.1098182388701223,0,0,18.4860853432282,53.29235549319145,EFEMP2,RNAlo MSC,1.2519998414265567
KEGG_2021_Human,regulation of neural precursor cell proliferation (GO:2000177),1/23,0.0559757805878795,0.1098182388701223,0,0,18.4860853432282,53.29235549319145,MDK,RNAlo MSC,1.2519998414265567
KEGG_2021_Human,regulation of protein export from nucleus (GO:0046825),1/23,0.0559757805878795,0.1098182388701223,0,0,18.4860853432282,53.29235549319145,GAS6,RNAlo MSC,1.2519998414265567
KEGG_2021_Human,regulation of steroid metabolic process (GO:0019218),1/23,0.0559757805878795,0.1098182388701223,0,0,18.4860853432282,53.29235549319145,APOE,RNAlo MSC,1.2519998414265567
KEGG_2021_Human,positive regulation of cholesterol efflux (GO:0010875),1/23,0.0559757805878795,0.1098182388701223,0,0,18.4860853432282,53.29235549319145,APOE,RNAlo MSC,1.2519998414265567
KEGG_2021_Human,regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/23,0.0559757805878795,0.1098182388701223,0,0,18.4860853432282,53.29235549319145,LBP,RNAlo MSC,1.2519998414265567
KEGG_2021_Human,positive regulation of morphogenesis of an epithelium (GO:1905332),1/23,0.0559757805878795,0.1098182388701223,0,0,18.4860853432282,53.29235549319145,MDK,RNAlo MSC,1.2519998414265567
KEGG_2021_Human,positive regulation of Wnt signaling pathway (GO:0030177),2/153,0.0560960059757507,0.1098182388701223,0,0,5.463300220750551,15.73807793899423,COL1A1;SFRP1,RNAlo MSC,1.2510680593221195
KEGG_2021_Human,negative regulation of protein depolymerization (GO:1901880),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,STMN2,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,negative regulation of protein tyrosine kinase activity (GO:0061099),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,THY1,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,cholesterol efflux (GO:0033344),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,APOE,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,regulation of keratinocyte proliferation (GO:0010837),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,MDK,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,defense response to fungus (GO:0050832),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,RARRES2,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,dendritic cell differentiation (GO:0097028),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,GAS6,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,dorsal/ventral pattern formation (GO:0009953),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,SFRP1,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,endocrine system development (GO:0035270),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,MDK,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,regulation of ruffle assembly (GO:1900027),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,PFN2,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,leukotriene metabolic process (GO:0006691),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,GGT5,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,lymphocyte activation involved in immune response (GO:0002285),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,MDK,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,protein kinase B signaling (GO:0043491),1/24,0.0583385530130099,0.111235549020468,0,0,17.68145519077196,50.24171555062859,GAS6,RNAlo MSC,1.2340443470047993
KEGG_2021_Human,cellular response to growth factor stimulus (GO:0071363),2/158,0.0593699722530508,0.1118477373489521,0,0,5.2868589743589745,14.929913680908546,SFRP1;STMN2,RNAlo MSC,1.2264331540442923
KEGG_2021_Human,skeletal system development (GO:0001501),2/158,0.0593699722530508,0.1118477373489521,0,0,5.2868589743589745,14.929913680908546,COL1A1;FRZB,RNAlo MSC,1.2264331540442923
KEGG_2021_Human,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,THY1,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,acylglycerol homeostasis (GO:0055090),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,APOE,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,regulation of calcium ion import (GO:0090279),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,CXCL12,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,cellular response to hexose stimulus (GO:0071331),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,GAS6,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,THY1,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,regulation of microtubule depolymerization (GO:0031114),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,STMN2,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,peptide catabolic process (GO:0043171),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,GGT5,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,regulation of neutrophil chemotaxis (GO:0090022),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,MDK,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,APOE,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,fat-soluble vitamin metabolic process (GO:0006775),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,RBP1,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,positive regulation of lipid metabolic process (GO:0045834),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,APOE,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,positive regulation of T cell migration (GO:2000406),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,CXCL12,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,positive regulation of vascular endothelial growth factor production (GO:0010575),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,CYP1B1,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,negative regulation of actin filament polymerization (GO:0030837),1/25,0.0606955298241754,0.1118477373489521,0,0,16.943877551020407,47.47480020477031,PFN2,RNAlo MSC,1.2168432931781568
KEGG_2021_Human,regulation of actin filament bundle assembly (GO:0032231),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,PFN2,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,regulation of biomineral tissue development (GO:0070167),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,GAS6,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,CXCL12,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,regulation of chondrocyte differentiation (GO:0032330),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,MDK,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,negative regulation of protein transport (GO:0051224),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,APOE,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,cellular response to drug (GO:0035690),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,GAS6,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,regulation of monocyte chemotaxis (GO:0090025),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,CXCL12,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,regulation of regulatory T cell differentiation (GO:0045589),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,MDK,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,glial cell development (GO:0021782),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,MDK,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,retinoic acid metabolic process (GO:0042573),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,ALDH1A3,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,positive regulation of microtubule polymerization or depolymerization (GO:0031112),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,STMN2,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,mononuclear cell differentiation (GO:1903131),1/26,0.0630467249540435,0.1133293890278206,0,0,16.26530612244898,44.95534064809558,GAS6,RNAlo MSC,1.2003374685092782
KEGG_2021_Human,protein transport (GO:0015031),3/369,0.0646744388528225,0.1147090993636421,0,0,3.415416811998605,9.352740604932352,TF;COPZ2;APOE,RNAlo MSC,1.1892673307471742
KEGG_2021_Human,protein peptidyl-prolyl isomerization (GO:0000413),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,PPIC,RNAlo MSC,1.184474368421492
KEGG_2021_Human,negative regulation of catalytic activity (GO:0043086),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,HP,RNAlo MSC,1.184474368421492
KEGG_2021_Human,negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,GAS6,RNAlo MSC,1.184474368421492
KEGG_2021_Human,regulation of blood coagulation (GO:0030193),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,APOE,RNAlo MSC,1.184474368421492
KEGG_2021_Human,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,PFN2,RNAlo MSC,1.184474368421492
KEGG_2021_Human,cellular lipid catabolic process (GO:0044242),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,CYP1B1,RNAlo MSC,1.184474368421492
KEGG_2021_Human,positive regulation of calcium ion transmembrane transport (GO:1904427),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,THY1,RNAlo MSC,1.184474368421492
KEGG_2021_Human,regulation of vascular endothelial growth factor production (GO:0010574),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,CYP1B1,RNAlo MSC,1.184474368421492
KEGG_2021_Human,regulation of vasculature development (GO:1901342),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,SFRP1,RNAlo MSC,1.184474368421492
KEGG_2021_Human,microtubule polymerization or depolymerization (GO:0031109),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,STMN2,RNAlo MSC,1.184474368421492
KEGG_2021_Human,positive regulation of toll-like receptor signaling pathway (GO:0034123),1/27,0.0653921522588676,0.1147090993636421,0,0,15.638932496075354,42.652889831563165,LBP,RNAlo MSC,1.184474368421492
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),3/371,0.065510771195163,0.1147090993636421,0,0,3.396507863089732,9.257320432758746,RARRES2;GAS6;PFN2,RNAlo MSC,1.1836872880076514
KEGG_2021_Human,negative regulation of axonogenesis (GO:0050771),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,THY1,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,receptor clustering (GO:0043113),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,THY1,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,regulation of microtubule polymerization or depolymerization (GO:0031110),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,STMN2,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,regulation of neuron migration (GO:2001222),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,MDK,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,regulation of small molecule metabolic process (GO:0062012),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,APOE,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,positive regulation of cell communication (GO:0010647),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,NMB,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,positive regulation of fibroblast proliferation (GO:0048146),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,GAS6,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,response to interferon-beta (GO:0035456),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,IFITM3,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,positive regulation of monooxygenase activity (GO:0032770),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,APOE,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,keratan sulfate biosynthetic process (GO:0018146),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,FMOD,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,T cell activation involved in immune response (GO:0002286),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,MDK,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,positive regulation of response to wounding (GO:1903036),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,MDK,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,protein depolymerization (GO:0051261),1/28,0.0677318256109869,0.1156044169166164,0,0,15.058956916099774,40.54171043527237,STMN2,RNAlo MSC,1.1692072184717057
KEGG_2021_Human,neuron projection development (GO:0031175),2/171,0.0681810821272572,0.1161456806005021,0,0,4.876972386587771,13.097539204308813,STMN2;APOE,RNAlo MSC,1.166336110203534
KEGG_2021_Human,positive regulation of ERK1 and ERK2 cascade (GO:0070374),2/172,0.0688760185279422,0.1169280010418914,0,0,4.848039215686274,12.970673059288286,APOE;GAS6,RNAlo MSC,1.1619319658128364
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),3/379,0.068906376040614,0.1169280010418914,0,0,3.3228836577636938,8.888735598390964,SFRP1;FRZB;CYP1B1,RNAlo MSC,1.1617405901223166
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),3/381,0.0697677490315496,0.1173100990817269,0,0,3.3049645390070923,8.799743799293005,SFRP1;GAS6;FSTL1,RNAlo MSC,1.1563452887586665
KEGG_2021_Human,negative regulation of epithelial to mesenchymal transition (GO:0010719),1/29,0.0700657588372089,0.1173100990817269,0,0,14.520408163265309,38.5999069065122,SFRP1,RNAlo MSC,1.1544941700666143
KEGG_2021_Human,negative regulation of interferon-gamma production (GO:0032689),1/29,0.0700657588372089,0.1173100990817269,0,0,14.520408163265309,38.5999069065122,GAS6,RNAlo MSC,1.1544941700666143
KEGG_2021_Human,negative regulation of wound healing (GO:0061045),1/29,0.0700657588372089,0.1173100990817269,0,0,14.520408163265309,38.5999069065122,APOE,RNAlo MSC,1.1544941700666143
KEGG_2021_Human,regulation of neuronal synaptic plasticity (GO:0048168),1/29,0.0700657588372089,0.1173100990817269,0,0,14.520408163265309,38.5999069065122,APOE,RNAlo MSC,1.1544941700666143
KEGG_2021_Human,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/29,0.0700657588372089,0.1173100990817269,0,0,14.520408163265309,38.5999069065122,SFRP1,RNAlo MSC,1.1544941700666143
KEGG_2021_Human,lipid catabolic process (GO:0016042),1/29,0.0700657588372089,0.1173100990817269,0,0,14.520408163265309,38.5999069065122,HSD11B1,RNAlo MSC,1.1544941700666143
KEGG_2021_Human,positive regulation of developmental process (GO:0051094),2/177,0.0723859658020668,0.1198385986030643,0,0,4.708333333333333,12.362872542539025,MDK;APOE,RNAlo MSC,1.140345626696904
KEGG_2021_Human,negative regulation of cytoskeleton organization (GO:0051494),1/30,0.0723939657090184,0.1198385986030643,0,0,14.019000703729768,36.80874147674154,PFN2,RNAlo MSC,1.1402976322627019
KEGG_2021_Human,negative regulation of interleukin-1 production (GO:0032692),1/30,0.0723939657090184,0.1198385986030643,0,0,14.019000703729768,36.80874147674154,GAS6,RNAlo MSC,1.1402976322627019
KEGG_2021_Human,regulation of long-term synaptic potentiation (GO:1900271),1/30,0.0723939657090184,0.1198385986030643,0,0,14.019000703729768,36.80874147674154,APOE,RNAlo MSC,1.1402976322627019
KEGG_2021_Human,regulation of macrophage activation (GO:0043030),1/30,0.0723939657090184,0.1198385986030643,0,0,14.019000703729768,36.80874147674154,LBP,RNAlo MSC,1.1402976322627019
KEGG_2021_Human,estrogen metabolic process (GO:0008210),1/30,0.0723939657090184,0.1198385986030643,0,0,14.019000703729768,36.80874147674154,CYP1B1,RNAlo MSC,1.1402976322627019
KEGG_2021_Human,activation of protein kinase B activity (GO:0032148),1/31,0.0747164600026276,0.1216217932264994,0,0,13.551020408163266,35.15209038871121,GAS6,RNAlo MSC,1.126583712764908
KEGG_2021_Human,negative regulation of interleukin-6 production (GO:0032715),1/31,0.0747164600026276,0.1216217932264994,0,0,13.551020408163266,35.15209038871121,GAS6,RNAlo MSC,1.126583712764908
KEGG_2021_Human,regulation of developmental growth (GO:0048638),1/31,0.0747164600026276,0.1216217932264994,0,0,13.551020408163266,35.15209038871121,APOE,RNAlo MSC,1.126583712764908
KEGG_2021_Human,cellular nitrogen compound biosynthetic process (GO:0044271),1/31,0.0747164600026276,0.1216217932264994,0,0,13.551020408163266,35.15209038871121,CYP1B1,RNAlo MSC,1.126583712764908
KEGG_2021_Human,negative regulation of response to DNA damage stimulus (GO:2001021),1/31,0.0747164600026276,0.1216217932264994,0,0,13.551020408163266,35.15209038871121,CXCL12,RNAlo MSC,1.126583712764908
KEGG_2021_Human,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/31,0.0747164600026276,0.1216217932264994,0,0,13.551020408163266,35.15209038871121,FSTL1,RNAlo MSC,1.126583712764908
KEGG_2021_Human,positive regulation of locomotion (GO:0040017),1/31,0.0747164600026276,0.1216217932264994,0,0,13.551020408163266,35.15209038871121,RARRES2,RNAlo MSC,1.126583712764908
KEGG_2021_Human,triglyceride homeostasis (GO:0070328),1/31,0.0747164600026276,0.1216217932264994,0,0,13.551020408163266,35.15209038871121,APOE,RNAlo MSC,1.126583712764908
KEGG_2021_Human,prostaglandin metabolic process (GO:0006693),1/31,0.0747164600026276,0.1216217932264994,0,0,13.551020408163266,35.15209038871121,PTGDS,RNAlo MSC,1.126583712764908
KEGG_2021_Human,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,SFRP1,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,regulation of cell morphogenesis (GO:0022604),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,SPARC,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,STMN2,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,regulation of chemotaxis (GO:0050920),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,RARRES2,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,cellular response to glucose stimulus (GO:0071333),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,GAS6,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,peptidyl-proline modification (GO:0018208),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,PPIC,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,SFRP1,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,positive regulation of immune effector process (GO:0002699),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,LBP,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,intra-Golgi vesicle-mediated transport (GO:0006891),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,COPZ2,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,long-chain fatty acid transport (GO:0015909),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,APOE,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,positive regulation of receptor signaling pathway via STAT (GO:1904894),1/32,0.0770332554327668,0.1228897123872995,0,0,13.113232389730086,33.61600807740255,CYP1B1,RNAlo MSC,1.1133217484244988
KEGG_2021_Human,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),2/185,0.078120393358315,0.1243982350760125,0,0,4.5006830601092895,11.474510084124317,COPZ2;GAS6,RNAlo MSC,1.1072355785829093
KEGG_2021_Human,apoptotic cell clearance (GO:0043277),1/33,0.0793443657059371,0.1245423168848548,0,0,12.70280612244898,32.18837516559274,GAS6,RNAlo MSC,1.1004839073426347
KEGG_2021_Human,regulation of cholesterol efflux (GO:0010874),1/33,0.0793443657059371,0.1245423168848548,0,0,12.70280612244898,32.18837516559274,APOE,RNAlo MSC,1.1004839073426347
KEGG_2021_Human,negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.0793443657059371,0.1245423168848548,0,0,12.70280612244898,32.18837516559274,EFEMP2,RNAlo MSC,1.1004839073426347
KEGG_2021_Human,positive regulation of cholesterol transport (GO:0032376),1/33,0.0793443657059371,0.1245423168848548,0,0,12.70280612244898,32.18837516559274,APOE,RNAlo MSC,1.1004839073426347
KEGG_2021_Human,keratan sulfate metabolic process (GO:0042339),1/33,0.0793443657059371,0.1245423168848548,0,0,12.70280612244898,32.18837516559274,FMOD,RNAlo MSC,1.1004839073426347
KEGG_2021_Human,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),1/33,0.0793443657059371,0.1245423168848548,0,0,12.70280612244898,32.18837516559274,CYP1B1,RNAlo MSC,1.1004839073426347
KEGG_2021_Human,primary alcohol metabolic process (GO:0034308),1/33,0.0793443657059371,0.1245423168848548,0,0,12.70280612244898,32.18837516559274,CYP1B1,RNAlo MSC,1.1004839073426347
KEGG_2021_Human,muscle cell development (GO:0055001),1/33,0.0793443657059371,0.1245423168848548,0,0,12.70280612244898,32.18837516559274,EFEMP2,RNAlo MSC,1.1004839073426347
KEGG_2021_Human,regulation of GTPase activity (GO:0043087),2/189,0.0810402447075638,0.1259125931972839,0,0,4.403520499108734,11.065207700859313,SFRP1;THY1,RNAlo MSC,1.0912992562585337
KEGG_2021_Human,negative regulation of blood vessel endothelial cell migration (GO:0043537),1/34,0.0816498044624026,0.1259125931972839,0,0,12.317254174397032,30.85861216573232,APOE,RNAlo MSC,1.0880448509885652
KEGG_2021_Human,regulation of activated T cell proliferation (GO:0046006),1/34,0.0816498044624026,0.1259125931972839,0,0,12.317254174397032,30.85861216573232,IGFBP2,RNAlo MSC,1.0880448509885652
KEGG_2021_Human,regulation of amyloid-beta formation (GO:1902003),1/34,0.0816498044624026,0.1259125931972839,0,0,12.317254174397032,30.85861216573232,APOE,RNAlo MSC,1.0880448509885652
KEGG_2021_Human,regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.0816498044624026,0.1259125931972839,0,0,12.317254174397032,30.85861216573232,CYP1B1,RNAlo MSC,1.0880448509885652
KEGG_2021_Human,cell-substrate junction assembly (GO:0007044),1/34,0.0816498044624026,0.1259125931972839,0,0,12.317254174397032,30.85861216573232,THY1,RNAlo MSC,1.0880448509885652
KEGG_2021_Human,positive regulation of calcium ion transport into cytosol (GO:0010524),1/34,0.0816498044624026,0.1259125931972839,0,0,12.317254174397032,30.85861216573232,THY1,RNAlo MSC,1.0880448509885652
KEGG_2021_Human,female gamete generation (GO:0007292),1/34,0.0816498044624026,0.1259125931972839,0,0,12.317254174397032,30.85861216573232,MDK,RNAlo MSC,1.0880448509885652
KEGG_2021_Human,positive regulation of interleukin-12 production (GO:0032735),1/34,0.0816498044624026,0.1259125931972839,0,0,12.317254174397032,30.85861216573232,MDK,RNAlo MSC,1.0880448509885652
KEGG_2021_Human,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/34,0.0816498044624026,0.1259125931972839,0,0,12.317254174397032,30.85861216573232,THY1,RNAlo MSC,1.0880448509885652
KEGG_2021_Human,negative regulation of neurogenesis (GO:0050768),1/35,0.0839495853612937,0.1274467798490107,0,0,11.95438175270108,29.61744503578088,THY1,RNAlo MSC,1.0759814445616303
KEGG_2021_Human,cellular response to hydrogen peroxide (GO:0070301),1/35,0.0839495853612937,0.1274467798490107,0,0,11.95438175270108,29.61744503578088,CYP1B1,RNAlo MSC,1.0759814445616303
KEGG_2021_Human,regulation of lipid biosynthetic process (GO:0046890),1/35,0.0839495853612937,0.1274467798490107,0,0,11.95438175270108,29.61744503578088,APOE,RNAlo MSC,1.0759814445616303
KEGG_2021_Human,embryonic skeletal system development (GO:0048706),1/35,0.0839495853612937,0.1274467798490107,0,0,11.95438175270108,29.61744503578088,COL1A1,RNAlo MSC,1.0759814445616303
KEGG_2021_Human,regulation of protein polymerization (GO:0032271),1/35,0.0839495853612937,0.1274467798490107,0,0,11.95438175270108,29.61744503578088,PFN2,RNAlo MSC,1.0759814445616303
KEGG_2021_Human,regulation of T cell receptor signaling pathway (GO:0050856),1/35,0.0839495853612937,0.1274467798490107,0,0,11.95438175270108,29.61744503578088,THY1,RNAlo MSC,1.0759814445616303
KEGG_2021_Human,response to estrogen (GO:0043627),1/35,0.0839495853612937,0.1274467798490107,0,0,11.95438175270108,29.61744503578088,SFRP1,RNAlo MSC,1.0759814445616303
KEGG_2021_Human,positive regulation of lipid biosynthetic process (GO:0046889),1/35,0.0839495853612937,0.1274467798490107,0,0,11.95438175270108,29.61744503578088,APOE,RNAlo MSC,1.0759814445616303
KEGG_2021_Human,positive regulation of lymphocyte activation (GO:0051251),1/35,0.0839495853612937,0.1274467798490107,0,0,11.95438175270108,29.61744503578088,THY1,RNAlo MSC,1.0759814445616303
KEGG_2021_Human,negative regulation of macromolecule metabolic process (GO:0010605),2/194,0.0847375162198589,0.1284211668228551,0,0,4.287760416666667,10.58303673172677,SFRP1;APOE,RNAlo MSC,1.0719242699529004
KEGG_2021_Human,protein localization to membrane (GO:0072657),2/195,0.0854831524975729,0.1287066750686186,0,0,4.265328151986183,10.490301477724982,THY1;GAS6,RNAlo MSC,1.0681194700473418
KEGG_2021_Human,regulation of androgen receptor signaling pathway (GO:0060765),1/36,0.0862437219743075,0.1287066750686186,0,0,11.612244897959185,28.456712045041098,SFRP1,RNAlo MSC,1.0642725091375862
KEGG_2021_Human,cyclic-nucleotide-mediated signaling (GO:0019935),1/36,0.0862437219743075,0.1287066750686186,0,0,11.612244897959185,28.456712045041098,APOE,RNAlo MSC,1.0642725091375862
KEGG_2021_Human,positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/36,0.0862437219743075,0.1287066750686186,0,0,11.612244897959185,28.456712045041098,GAS6,RNAlo MSC,1.0642725091375862
KEGG_2021_Human,positive regulation of innate immune response (GO:0045089),1/36,0.0862437219743075,0.1287066750686186,0,0,11.612244897959185,28.456712045041098,LBP,RNAlo MSC,1.0642725091375862
KEGG_2021_Human,retina homeostasis (GO:0001895),1/36,0.0862437219743075,0.1287066750686186,0,0,11.612244897959185,28.456712045041098,TF,RNAlo MSC,1.0642725091375862
KEGG_2021_Human,macrophage activation (GO:0042116),1/36,0.0862437219743075,0.1287066750686186,0,0,11.612244897959185,28.456712045041098,LBP,RNAlo MSC,1.0642725091375862
KEGG_2021_Human,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/36,0.0862437219743075,0.1287066750686186,0,0,11.612244897959185,28.456712045041098,MDK,RNAlo MSC,1.0642725091375862
KEGG_2021_Human,transferrin transport (GO:0033572),1/36,0.0862437219743075,0.1287066750686186,0,0,11.612244897959185,28.456712045041098,TF,RNAlo MSC,1.0642725091375862
KEGG_2021_Human,organelle organization (GO:0006996),3/420,0.0875282858129556,0.1304023105586237,0,0,2.9898974437471297,7.28277207572745,MDK;THY1;APOE,RNAlo MSC,1.0578515768365675
KEGG_2021_Human,regulation of signal transduction (GO:0009966),2/198,0.0877321663879582,0.130484897216608,0,0,4.199404761904762,10.219111519148855,IGFBP4;IGFBP2,RNAlo MSC,1.0568411463883935
KEGG_2021_Human,regulation of actin cytoskeleton reorganization (GO:2000249),1/37,0.0885322278902676,0.1307896274210845,0,0,11.289115646258503,27.36920368672352,MDK,RNAlo MSC,1.0528986067362665
KEGG_2021_Human,regulation of microtubule cytoskeleton organization (GO:0070507),1/37,0.0885322278902676,0.1307896274210845,0,0,11.289115646258503,27.36920368672352,STMN2,RNAlo MSC,1.0528986067362665
KEGG_2021_Human,positive regulation of calcium ion transport (GO:0051928),1/37,0.0885322278902676,0.1307896274210845,0,0,11.289115646258503,27.36920368672352,CXCL12,RNAlo MSC,1.0528986067362665
KEGG_2021_Human,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),1/37,0.0885322278902676,0.1307896274210845,0,0,11.289115646258503,27.36920368672352,EFEMP2,RNAlo MSC,1.0528986067362665
KEGG_2021_Human,negative regulation of endothelial cell migration (GO:0010596),1/38,0.0908151166313484,0.133266256292079,0,0,10.983452840595698,26.34852930034076,APOE,RNAlo MSC,1.0418418549683985
KEGG_2021_Human,regulation of axon extension (GO:0030516),1/38,0.0908151166313484,0.133266256292079,0,0,10.983452840595698,26.34852930034076,APOE,RNAlo MSC,1.0418418549683985
KEGG_2021_Human,negative regulation of innate immune response (GO:0045824),1/38,0.0908151166313484,0.133266256292079,0,0,10.983452840595698,26.34852930034076,SERPING1,RNAlo MSC,1.0418418549683985
KEGG_2021_Human,positive regulation of signaling (GO:0023056),1/38,0.0908151166313484,0.133266256292079,0,0,10.983452840595698,26.34852930034076,NMB,RNAlo MSC,1.0418418549683985
KEGG_2021_Human,negative regulation of cellular metabolic process (GO:0031324),1/39,0.0930924017046572,0.1348076130121807,0,0,10.693877551020408,25.38900533231373,APOE,RNAlo MSC,1.0310857651239858
KEGG_2021_Human,regulation of cellular component biogenesis (GO:0044087),1/39,0.0930924017046572,0.1348076130121807,0,0,10.693877551020408,25.38900533231373,APOE,RNAlo MSC,1.0310857651239858
KEGG_2021_Human,negative regulation of secretion by cell (GO:1903531),1/39,0.0930924017046572,0.1348076130121807,0,0,10.693877551020408,25.38900533231373,APOE,RNAlo MSC,1.0310857651239858
KEGG_2021_Human,cellular response to ketone (GO:1901655),1/39,0.0930924017046572,0.1348076130121807,0,0,10.693877551020408,25.38900533231373,SFRP1,RNAlo MSC,1.0310857651239858
KEGG_2021_Human,regulation of nitric-oxide synthase activity (GO:0050999),1/39,0.0930924017046572,0.1348076130121807,0,0,10.693877551020408,25.38900533231373,APOE,RNAlo MSC,1.0310857651239858
KEGG_2021_Human,regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.0930924017046572,0.1348076130121807,0,0,10.693877551020408,25.38900533231373,TF,RNAlo MSC,1.0310857651239858
KEGG_2021_Human,regulation of T cell differentiation (GO:0045580),1/39,0.0930924017046572,0.1348076130121807,0,0,10.693877551020408,25.38900533231373,MDK,RNAlo MSC,1.0310857651239858
KEGG_2021_Human,regulation of viral entry into host cell (GO:0046596),1/39,0.0930924017046572,0.1348076130121807,0,0,10.693877551020408,25.38900533231373,IFITM3,RNAlo MSC,1.0310857651239858
KEGG_2021_Human,regulation of inflammatory response (GO:0050727),2/206,0.0938158179234975,0.1356317499255827,0,0,4.033088235294118,9.543987931843056,MDK;APOE,RNAlo MSC,1.0277239307283335
KEGG_2021_Human,regulation of microtubule polymerization (GO:0031113),1/40,0.0953640965755271,0.1369690210619091,0,0,10.419152276295131,24.485561288951835,STMN2,RNAlo MSC,1.0206151011238414
KEGG_2021_Human,digestive tract development (GO:0048565),1/40,0.0953640965755271,0.1369690210619091,0,0,10.419152276295131,24.485561288951835,RARRES2,RNAlo MSC,1.0206151011238414
KEGG_2021_Human,fatty acid derivative biosynthetic process (GO:1901570),1/40,0.0953640965755271,0.1369690210619091,0,0,10.419152276295131,24.485561288951835,GGT5,RNAlo MSC,1.0206151011238414
KEGG_2021_Human,stem cell differentiation (GO:0048863),1/40,0.0953640965755271,0.1369690210619091,0,0,10.419152276295131,24.485561288951835,SFRP1,RNAlo MSC,1.0206151011238414
KEGG_2021_Human,acylglycerol metabolic process (GO:0006639),1/41,0.0976302146847681,0.1390874533353504,0,0,10.158163265306122,23.633660200289185,APOE,RNAlo MSC,1.0104157556925017
KEGG_2021_Human,regulation of viral transcription (GO:0046782),1/41,0.0976302146847681,0.1390874533353504,0,0,10.158163265306122,23.633660200289185,IFITM3,RNAlo MSC,1.0104157556925017
KEGG_2021_Human,response to growth factor (GO:0070848),1/41,0.0976302146847681,0.1390874533353504,0,0,10.158163265306122,23.633660200289185,SFRP1,RNAlo MSC,1.0104157556925017
KEGG_2021_Human,positive regulation of TOR signaling (GO:0032008),1/41,0.0976302146847681,0.1390874533353504,0,0,10.158163265306122,23.633660200289185,GAS6,RNAlo MSC,1.0104157556925017
KEGG_2021_Human,visual system development (GO:0150063),1/41,0.0976302146847681,0.1390874533353504,0,0,10.158163265306122,23.633660200289185,CHRDL1,RNAlo MSC,1.0104157556925017
KEGG_2021_Human,negative regulation of protein catabolic process (GO:0042177),1/42,0.0998907694703361,0.1411187917360108,0,0,9.909905425584869,22.829231064333683,TIMP4,RNAlo MSC,1.00047464143678
KEGG_2021_Human,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/42,0.0998907694703361,0.1411187917360108,0,0,9.909905425584869,22.829231064333683,SFRP1,RNAlo MSC,1.00047464143678
KEGG_2021_Human,positive regulation of ATPase activity (GO:0032781),1/42,0.0998907694703361,0.1411187917360108,0,0,9.909905425584869,22.829231064333683,PFN2,RNAlo MSC,1.00047464143678
KEGG_2021_Human,positive regulation of protein tyrosine kinase activity (GO:0061098),1/42,0.0998907694703361,0.1411187917360108,0,0,9.909905425584869,22.829231064333683,GAS6,RNAlo MSC,1.00047464143678
KEGG_2021_Human,positive regulation of GTPase activity (GO:0043547),2/214,0.100019348409027,0.1411187917360108,0,0,3.879323899371069,8.931722866735825,SFRP1;THY1,RNAlo MSC,0.9999159790553556
KEGG_2021_Human,positive regulation of protein modification process (GO:0031401),2/214,0.100019348409027,0.1411187917360108,0,0,3.879323899371069,8.931722866735825,RARRES2;GAS6,RNAlo MSC,0.9999159790553556
KEGG_2021_Human,extracellular structure organization (GO:0043062),2/216,0.1015881472155216,0.142611357040846,0,0,3.842679127725857,8.78754780712842,COL1A1;SPARC,RNAlo MSC,0.9931569603511173
KEGG_2021_Human,regulation of cell-substrate adhesion (GO:0010810),1/43,0.1021457742794159,0.142611357040846,0,0,9.673469387755102,22.068611238785657,THY1,RNAlo MSC,0.9907795952096249
KEGG_2021_Human,cellular glucose homeostasis (GO:0001678),1/43,0.1021457742794159,0.142611357040846,0,0,9.673469387755102,22.068611238785657,GAS6,RNAlo MSC,0.9907795952096249
KEGG_2021_Human,negative regulation of proteolysis (GO:0045861),1/43,0.1021457742794159,0.142611357040846,0,0,9.673469387755102,22.068611238785657,TIMP4,RNAlo MSC,0.9907795952096249
KEGG_2021_Human,glutathione metabolic process (GO:0006749),1/43,0.1021457742794159,0.142611357040846,0,0,9.673469387755102,22.068611238785657,GGT5,RNAlo MSC,0.9907795952096249
KEGG_2021_Human,positive regulation of T cell differentiation (GO:0045582),1/43,0.1021457742794159,0.142611357040846,0,0,9.673469387755102,22.068611238785657,MDK,RNAlo MSC,0.9907795952096249
KEGG_2021_Human,regulation of cell growth (GO:0001558),2/217,0.1023751607426323,0.142611357040846,0,0,3.824612403100775,8.716716836108898,SFRP1;FRZB,RNAlo MSC,0.9898054033308324
KEGG_2021_Human,external encapsulating structure organization (GO:0045229),2/217,0.1023751607426323,0.142611357040846,0,0,3.824612403100775,8.716716836108898,COL1A1;SPARC,RNAlo MSC,0.9898054033308324
KEGG_2021_Human,cellular response to lipid (GO:0071396),2/219,0.1039543502969196,0.1440556014545363,0,0,3.788978494623656,8.577502457974575,SFRP1;LBP,RNAlo MSC,0.9831573315329525
KEGG_2021_Human,regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.1043952424647777,0.1440556014545363,0,0,9.448030374940672,21.34849709415977,GAS6,RNAlo MSC,0.9813192926974915
KEGG_2021_Human,embryonic organ morphogenesis (GO:0048562),1/44,0.1043952424647777,0.1440556014545363,0,0,9.448030374940672,21.34849709415977,ALDH1A3,RNAlo MSC,0.9813192926974915
KEGG_2021_Human,positive regulation of biosynthetic process (GO:0009891),1/44,0.1043952424647777,0.1440556014545363,0,0,9.448030374940672,21.34849709415977,APOE,RNAlo MSC,0.9813192926974915
KEGG_2021_Human,lymphocyte chemotaxis (GO:0048247),1/44,0.1043952424647777,0.1440556014545363,0,0,9.448030374940672,21.34849709415977,GAS6,RNAlo MSC,0.9813192926974915
KEGG_2021_Human,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.1043952424647777,0.1440556014545363,0,0,9.448030374940672,21.34849709415977,TF,RNAlo MSC,0.9813192926974915
KEGG_2021_Human,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),1/45,0.1066391873529346,0.1469213882182281,0,0,9.232838589981448,20.665901611884028,CYP1B1,RNAlo MSC,0.9720831731354668
KEGG_2021_Human,positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.1088776222085674,0.1497706258549777,0,0,9.02721088435374,20.01811780873028,GAS6,RNAlo MSC,0.9630613723103648
KEGG_2021_Human,regulation of cellular metabolic process (GO:0031323),1/47,0.1111105603036554,0.1523653393243575,0,0,8.830523513753327,19.4026870705364,CYP1B1,RNAlo MSC,0.9542446623584087
KEGG_2021_Human,regulation of T cell activation (GO:0050863),1/47,0.1111105603036554,0.1523653393243575,0,0,8.830523513753327,19.4026870705364,THY1,RNAlo MSC,0.9542446623584087
KEGG_2021_Human,inflammatory response (GO:0006954),2/230,0.1127586124121412,0.1543844553119503,0,0,3.6041666666666665,7.866115081211615,GGT5;HP,RNAlo MSC,0.9478502771198579
KEGG_2021_Human,negative regulation of MAP kinase activity (GO:0043407),1/48,0.1133380148369131,0.1544559923126304,0,0,8.642205818497612,18.81737166641443,APOE,RNAlo MSC,0.9456243984787533
KEGG_2021_Human,cellular response to alcohol (GO:0097306),1/48,0.1133380148369131,0.1544559923126304,0,0,8.642205818497612,18.81737166641443,SFRP1,RNAlo MSC,0.9456243984787533
KEGG_2021_Human,regulation of protein metabolic process (GO:0051246),1/48,0.1133380148369131,0.1544559923126304,0,0,8.642205818497612,18.81737166641443,APOE,RNAlo MSC,0.9456243984787533
KEGG_2021_Human,aminoglycan biosynthetic process (GO:0006023),1/49,0.1155599990222406,0.1560326254079101,0,0,8.46173469387755,18.260130793597916,SDC3,RNAlo MSC,0.9371924705024297
KEGG_2021_Human,regulation of cellular protein metabolic process (GO:0032268),1/49,0.1155599990222406,0.1560326254079101,0,0,8.46173469387755,18.260130793597916,APOE,RNAlo MSC,0.9371924705024297
KEGG_2021_Human,cellular defense response (GO:0006968),1/49,0.1155599990222406,0.1560326254079101,0,0,8.46173469387755,18.260130793597916,LBP,RNAlo MSC,0.9371924705024297
KEGG_2021_Human,positive regulation of actin filament polymerization (GO:0030838),1/49,0.1155599990222406,0.1560326254079101,0,0,8.46173469387755,18.260130793597916,PFN2,RNAlo MSC,0.9371924705024297
KEGG_2021_Human,response to glucose (GO:0009749),1/49,0.1155599990222406,0.1560326254079101,0,0,8.46173469387755,18.260130793597916,GAS6,RNAlo MSC,0.9371924705024297
KEGG_2021_Human,secondary alcohol metabolic process (GO:1902652),1/49,0.1155599990222406,0.1560326254079101,0,0,8.46173469387755,18.260130793597916,APOE,RNAlo MSC,0.9371924705024297
KEGG_2021_Human,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/50,0.1177765260040411,0.1587815434931781,0,0,8.28862973760933,17.7290996615035,MDK,RNAlo MSC,0.928941259997044
KEGG_2021_Human,neutrophil degranulation (GO:0043312),3/481,0.1186966169654727,0.1597769162521448,0,0,2.6001958515089467,5.541497039756371,CFD;SLPI;HP,RNAlo MSC,0.9255616589237978
KEGG_2021_Human,regulation of ERK1 and ERK2 cascade (GO:0070372),2/238,0.1192811662769016,0.1598016791553299,0,0,3.4805790960451977,7.400657287256659,APOE;GAS6,RNAlo MSC,0.9234281232007147
KEGG_2021_Human,regulation of axonogenesis (GO:0050770),1/51,0.1199876089220907,0.1598016791553299,0,0,8.122448979591837,17.22257115519733,THY1,RNAlo MSC,0.9208636010741894
KEGG_2021_Human,regulation of epithelial cell migration (GO:0010632),1/51,0.1199876089220907,0.1598016791553299,0,0,8.122448979591837,17.22257115519733,PFN2,RNAlo MSC,0.9208636010741894
KEGG_2021_Human,regulation of interleukin-12 production (GO:0032655),1/51,0.1199876089220907,0.1598016791553299,0,0,8.122448979591837,17.22257115519733,MDK,RNAlo MSC,0.9208636010741894
KEGG_2021_Human,cholesterol transport (GO:0030301),1/51,0.1199876089220907,0.1598016791553299,0,0,8.122448979591837,17.22257115519733,APOE,RNAlo MSC,0.9208636010741894
KEGG_2021_Human,regulation of smoothened signaling pathway (GO:0008589),1/51,0.1199876089220907,0.1598016791553299,0,0,8.122448979591837,17.22257115519733,SFRP1,RNAlo MSC,0.9208636010741894
KEGG_2021_Human,regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.1199876089220907,0.1598016791553299,0,0,8.122448979591837,17.22257115519733,MDK,RNAlo MSC,0.9208636010741894
KEGG_2021_Human,neutrophil activation involved in immune response (GO:0002283),3/485,0.1208716599427582,0.1605657565402931,0,0,2.578087754921868,5.447566347932984,CFD;SLPI;HP,RNAlo MSC,0.9176755136408634
KEGG_2021_Human,axonogenesis (GO:0007409),2/240,0.1209266562339864,0.1605657565402931,0,0,3.450980392156863,7.290441318878535,CXCL12;S100B,RNAlo MSC,0.9174779557207333
KEGG_2021_Human,negative regulation of protein metabolic process (GO:0051248),1/52,0.1221932608707862,0.1615156034667986,0,0,7.962785114045619,16.738979733033663,APOE,RNAlo MSC,0.9129527453809976
KEGG_2021_Human,regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.1221932608707862,0.1615156034667986,0,0,7.962785114045619,16.738979733033663,THY1,RNAlo MSC,0.9129527453809976
KEGG_2021_Human,protein homotetramerization (GO:0051289),1/52,0.1221932608707862,0.1615156034667986,0,0,7.962785114045619,16.738979733033663,ALDH1A3,RNAlo MSC,0.9129527453809976
KEGG_2021_Human,neutrophil mediated immunity (GO:0002446),3/488,0.1225128127530552,0.1616948384533567,0,0,2.561745996929151,5.3784873208449016,CFD;SLPI;HP,RNAlo MSC,0.9118184891201561
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),4/764,0.1230654595125794,0.1621807180083318,0,0,2.1956521739130435,4.5999766581612365,SFRP1;FRZB;CYP1B1;S100B,RNAlo MSC,0.9098638223570947
KEGG_2021_Human,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.1243934949128716,0.1634407803115309,0,0,7.809262166405024,16.276887238960814,GAS6,RNAlo MSC,0.9052023302345248
KEGG_2021_Human,positive regulation of phagocytosis (GO:0050766),1/53,0.1243934949128716,0.1634407803115309,0,0,7.809262166405024,16.276887238960814,GAS6,RNAlo MSC,0.9052023302345248
KEGG_2021_Human,regulation of proteasomal protein catabolic process (GO:0061136),1/54,0.1265883240687765,0.1655820488935335,0,0,7.661532537543319,15.834970375184442,APOE,RNAlo MSC,0.8976063498190403
KEGG_2021_Human,glycosaminoglycan metabolic process (GO:0030203),1/54,0.1265883240687765,0.1655820488935335,0,0,7.661532537543319,15.834970375184442,SDC3,RNAlo MSC,0.8976063498190403
KEGG_2021_Human,unsaturated fatty acid metabolic process (GO:0033559),1/54,0.1265883240687765,0.1655820488935335,0,0,7.661532537543319,15.834970375184442,CYP1B1,RNAlo MSC,0.8976063498190403
KEGG_2021_Human,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/55,0.1287777613922166,0.1674491897392876,0,0,7.519274376417234,15.412009607623004,GAS6,RNAlo MSC,0.8901591287349465
KEGG_2021_Human,negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/55,0.1287777613922166,0.1674491897392876,0,0,7.519274376417234,15.412009607623004,GAS6,RNAlo MSC,0.8901591287349465
KEGG_2021_Human,regulation of blood vessel endothelial cell migration (GO:0043535),1/55,0.1287777613922166,0.1674491897392876,0,0,7.519274376417234,15.412009607623004,APOE,RNAlo MSC,0.8901591287349465
KEGG_2021_Human,triglyceride metabolic process (GO:0006641),1/55,0.1287777613922166,0.1674491897392876,0,0,7.519274376417234,15.412009607623004,APOE,RNAlo MSC,0.8901591287349465
KEGG_2021_Human,positive regulation of signal transduction (GO:0009967),2/252,0.1309169770529217,0.1692874112013577,0,0,3.283333333333333,6.675646802845627,SFRP1;GAS6,RNAlo MSC,0.8830040313535863
KEGG_2021_Human,blood vessel morphogenesis (GO:0048514),1/56,0.1309618198144747,0.1692874112013577,0,0,7.382189239332097,15.00687933540933,CYP1B1,RNAlo MSC,0.8828552987007785
KEGG_2021_Human,chemokine-mediated signaling pathway (GO:0070098),1/56,0.1309618198144747,0.1692874112013577,0,0,7.382189239332097,15.00687933540933,CXCL12,RNAlo MSC,0.8828552987007785
KEGG_2021_Human,sensory organ development (GO:0007423),1/56,0.1309618198144747,0.1692874112013577,0,0,7.382189239332097,15.00687933540933,CHRDL1,RNAlo MSC,0.8828552987007785
KEGG_2021_Human,positive regulation of phosphorylation (GO:0042327),2/253,0.1317582069542016,0.1700667605179783,0,0,3.270086321381142,6.627767796360294,RARRES2;GAS6,RNAlo MSC,0.880222323941479
KEGG_2021_Human,regulation of reactive oxygen species metabolic process (GO:2000377),1/57,0.1331405122852093,0.171347745678915,0,0,7.25,14.618539131965724,CYP1B1,RNAlo MSC,0.8756897763447542
KEGG_2021_Human,positive regulation of proteolysis (GO:0045862),1/57,0.1331405122852093,0.171347745678915,0,0,7.25,14.618539131965724,APOE,RNAlo MSC,0.8756897763447542
KEGG_2021_Human,chordate embryonic development (GO:0043009),1/58,0.1353138517398134,0.1726957176847354,0,0,7.122448979591836,14.246025949065045,COL1A1,RNAlo MSC,0.8686577434892403
KEGG_2021_Human,regulation of phagocytosis (GO:0050764),1/58,0.1353138517398134,0.1726957176847354,0,0,7.122448979591836,14.246025949065045,GAS6,RNAlo MSC,0.8686577434892403
KEGG_2021_Human,eye development (GO:0001654),1/58,0.1353138517398134,0.1726957176847354,0,0,7.122448979591836,14.246025949065045,CHRDL1,RNAlo MSC,0.8686577434892403
KEGG_2021_Human,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/58,0.1353138517398134,0.1726957176847354,0,0,7.122448979591836,14.246025949065045,GAS6,RNAlo MSC,0.8686577434892403
KEGG_2021_Human,positive regulation of protein binding (GO:0032092),1/58,0.1353138517398134,0.1726957176847354,0,0,7.122448979591836,14.246025949065045,APOE,RNAlo MSC,0.8686577434892403
KEGG_2021_Human,positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.1353667229633477,0.1726957176847354,0,0,2.442871502764282,4.885175568190959,COL1A1;SFRP1;APOE,RNAlo MSC,0.8684880846140173
KEGG_2021_Human,phospholipid transport (GO:0015914),1/59,0.1374818510452552,0.1751399232880859,0,0,6.9992962702322306,13.8884471557023,APOE,RNAlo MSC,0.8617546291873563
KEGG_2021_Human,cellular response to chemokine (GO:1990869),1/60,0.1396445230534406,0.1773808320288646,0,0,6.88031822898651,13.544974303558986,CXCL12,RNAlo MSC,0.8549760929333525
KEGG_2021_Human,Notch signaling pathway (GO:0007219),1/60,0.1396445230534406,0.1773808320288646,0,0,6.88031822898651,13.544974303558986,MDK,RNAlo MSC,0.8549760929333525
KEGG_2021_Human,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.1790859957485864,0,0,6.76530612244898,13.214837540593155,APOE,RNAlo MSC,0.848318009451734
KEGG_2021_Human,negative regulation of response to stimulus (GO:0048585),1/61,0.1418018805927374,0.1790859957485864,0,0,6.76530612244898,13.214837540593155,THY1,RNAlo MSC,0.848318009451734
KEGG_2021_Human,pattern recognition receptor signaling pathway (GO:0002221),1/61,0.1418018805927374,0.1790859957485864,0,0,6.76530612244898,13.214837540593155,LBP,RNAlo MSC,0.848318009451734
KEGG_2021_Human,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.1790859957485864,0,0,6.76530612244898,13.214837540593155,LBP,RNAlo MSC,0.848318009451734
KEGG_2021_Human,regulation of protein phosphorylation (GO:0001932),2/266,0.1428070813555834,0.1800967353106999,0,0,3.1070075757575757,6.047046555927847,RARRES2;GAS6,RNAlo MSC,0.8452502567236859
KEGG_2021_Human,negative regulation of signal transduction (GO:0009968),2/267,0.1436652916283004,0.1809194718356391,0,0,3.095125786163522,6.005376764494242,SFRP1;FRZB,RNAlo MSC,0.8426481412255155
KEGG_2021_Human,negative regulation of kinase activity (GO:0033673),1/62,0.1439539364695556,0.1810236196806,0,0,6.654064904650385,12.897320592663672,THY1,RNAlo MSC,0.8417764546925935
KEGG_2021_Human,cellular response to reactive oxygen species (GO:0034614),1/63,0.1461007034145454,0.1831990275340733,0,0,6.54641211323239,12.591756250239603,CYP1B1,RNAlo MSC,0.8353476931121088
KEGG_2021_Human,monocarboxylic acid biosynthetic process (GO:0072330),1/63,0.1461007034145454,0.1831990275340733,0,0,6.54641211323239,12.591756250239603,ALDH1A3,RNAlo MSC,0.8353476931121088
KEGG_2021_Human,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.1482421941802595,0.1850921714267729,0,0,6.442176870748299,12.297522293260638,CXCL14,RNAlo MSC,0.8290281655096747
KEGG_2021_Human,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/64,0.1482421941802595,0.1850921714267729,0,0,6.442176870748299,12.297522293260638,CXCL12,RNAlo MSC,0.8290281655096747
KEGG_2021_Human,protein catabolic process (GO:0030163),1/64,0.1482421941802595,0.1850921714267729,0,0,6.442176870748299,12.297522293260638,APOE,RNAlo MSC,0.8290281655096747
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),2/274,0.1497038344955427,0.1864353067573076,0,0,3.014399509803922,5.724635176902424,APOE;GAS6,RNAlo MSC,0.8247670755492156
KEGG_2021_Human,cellular response to type I interferon (GO:0071357),1/65,0.1503784214913892,0.1864353067573076,0,0,6.341198979591836,12.01403781811508,IFITM3,RNAlo MSC,0.8228144782361342
KEGG_2021_Human,chemical homeostasis (GO:0048878),1/65,0.1503784214913892,0.1864353067573076,0,0,6.341198979591836,12.01403781811508,RBP1,RNAlo MSC,0.8228144782361342
KEGG_2021_Human,steroid biosynthetic process (GO:0006694),1/65,0.1503784214913892,0.1864353067573076,0,0,6.341198979591836,12.01403781811508,HSD11B1,RNAlo MSC,0.8228144782361342
KEGG_2021_Human,type I interferon signaling pathway (GO:0060337),1/65,0.1503784214913892,0.1864353067573076,0,0,6.341198979591836,12.01403781811508,IFITM3,RNAlo MSC,0.8228144782361342
KEGG_2021_Human,cellular response to nutrient levels (GO:0031669),1/66,0.1525093979756266,0.1882805629502469,0,0,6.243328100470958,11.740759916332207,SFRP1,RNAlo MSC,0.8167033932798328
KEGG_2021_Human,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.1882805629502469,0,0,6.243328100470958,11.740759916332207,HP,RNAlo MSC,0.8167033932798328
KEGG_2021_Human,positive regulation of T cell proliferation (GO:0042102),1/66,0.1525093979756266,0.1882805629502469,0,0,6.243328100470958,11.740759916332207,IGFBP2,RNAlo MSC,0.8167033932798328
KEGG_2021_Human,cell chemotaxis (GO:0060326),1/69,0.158870948881139,0.195311278414715,0,0,5.966986794717887,10.977245117600177,CXCL12,RNAlo MSC,0.7989555105590889
KEGG_2021_Human,cellular response to decreased oxygen levels (GO:0036294),1/69,0.158870948881139,0.195311278414715,0,0,5.966986794717887,10.977245117600177,SFRP1,RNAlo MSC,0.7989555105590889
KEGG_2021_Human,positive regulation of protein polymerization (GO:0032273),1/69,0.158870948881139,0.195311278414715,0,0,5.966986794717887,10.977245117600177,PFN2,RNAlo MSC,0.7989555105590889
KEGG_2021_Human,protein tetramerization (GO:0051262),1/71,0.16308595979881,0.1991007759210473,0,0,5.795918367346939,10.51076961698872,ALDH1A3,RNAlo MSC,0.7875834261109624
KEGG_2021_Human,cellular response to BMP stimulus (GO:0071773),1/71,0.16308595979881,0.1991007759210473,0,0,5.795918367346939,10.51076961698872,SFRP1,RNAlo MSC,0.7875834261109624
KEGG_2021_Human,cholesterol homeostasis (GO:0042632),1/71,0.16308595979881,0.1991007759210473,0,0,5.795918367346939,10.51076961698872,APOE,RNAlo MSC,0.7875834261109624
KEGG_2021_Human,regulation of TOR signaling (GO:0032006),1/71,0.16308595979881,0.1991007759210473,0,0,5.795918367346939,10.51076961698872,GAS6,RNAlo MSC,0.7875834261109624
KEGG_2021_Human,gland development (GO:0048732),1/71,0.16308595979881,0.1991007759210473,0,0,5.795918367346939,10.51076961698872,MDK,RNAlo MSC,0.7875834261109624
KEGG_2021_Human,sterol homeostasis (GO:0055092),1/72,0.1651856959101235,0.2011055771537377,0,0,5.713998275366484,10.28911103101624,APOE,RNAlo MSC,0.78202756268309
KEGG_2021_Human,positive regulation of secretion by cell (GO:1903532),1/72,0.1651856959101235,0.2011055771537377,0,0,5.713998275366484,10.28911103101624,NMB,RNAlo MSC,0.78202756268309
KEGG_2021_Human,regulation of actin filament polymerization (GO:0030833),1/73,0.1672802691231711,0.2028129055989894,0,0,5.634353741496598,10.074701240888364,PFN2,RNAlo MSC,0.7765552814899175
KEGG_2021_Human,regulation of Rho protein signal transduction (GO:0035023),1/73,0.1672802691231711,0.2028129055989894,0,0,5.634353741496598,10.074701240888364,APOE,RNAlo MSC,0.7765552814899175
KEGG_2021_Human,insulin receptor signaling pathway (GO:0008286),1/73,0.1672802691231711,0.2028129055989894,0,0,5.634353741496598,10.074701240888364,RARRES2,RNAlo MSC,0.7765552814899175
KEGG_2021_Human,regulation of cytokine-mediated signaling pathway (GO:0001959),1/74,0.1693696918266344,0.2047812367477465,0,0,5.556891249650545,9.867213018330611,GAS6,RNAlo MSC,0.7711643026835198
KEGG_2021_Human,negative regulation of protein binding (GO:0032091),1/74,0.1693696918266344,0.2047812367477465,0,0,5.556891249650545,9.867213018330611,SLPI,RNAlo MSC,0.7711643026835198
KEGG_2021_Human,integrin-mediated signaling pathway (GO:0007229),1/75,0.1714539764404576,0.2070165457296184,0,0,5.4815223386651954,9.666337985731484,THY1,RNAlo MSC,0.7658524380723842
KEGG_2021_Human,regulation of BMP signaling pathway (GO:0030510),1/76,0.1735331353639065,0.2080977162140161,0,0,5.408163265306122,9.4717853003048,FSTL1,RNAlo MSC,0.7606175863963804
KEGG_2021_Human,cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.1735331353639065,0.2080977162140161,0,0,5.408163265306122,9.4717853003048,S100B,RNAlo MSC,0.7606175863963804
KEGG_2021_Human,cellular response to hormone stimulus (GO:0032870),1/76,0.1735331353639065,0.2080977162140161,0,0,5.408163265306122,9.4717853003048,SFRP1,RNAlo MSC,0.7606175863963804
KEGG_2021_Human,positive regulation of growth (GO:0045927),1/76,0.1735331353639065,0.2080977162140161,0,0,5.408163265306122,9.4717853003048,SFRP1,RNAlo MSC,0.7606175863963804
KEGG_2021_Human,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.2080977162140161,0,0,5.408163265306122,9.4717853003048,LBP,RNAlo MSC,0.7606175863963804
KEGG_2021_Human,cholesterol metabolic process (GO:0008203),1/77,0.1756071809118701,0.2097265108988231,0,0,5.336734693877551,9.283280446293812,APOE,RNAlo MSC,0.7554577289388229
KEGG_2021_Human,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1756071809118701,0.2097265108988231,0,0,5.336734693877551,9.283280446293812,MDK,RNAlo MSC,0.7554577289388229
KEGG_2021_Human,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.1756071809118701,0.2097265108988231,0,0,5.336734693877551,9.283280446293812,LBP,RNAlo MSC,0.7554577289388229
KEGG_2021_Human,negative regulation of blood vessel morphogenesis (GO:2000181),1/78,0.1776761254379788,0.2116223770460479,0,0,5.267161410018553,9.10056411919043,SPARC,RNAlo MSC,0.7503709249641564
KEGG_2021_Human,negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.1776761254379788,0.2116223770460479,0,0,5.267161410018553,9.10056411919043,APOE,RNAlo MSC,0.7503709249641564
KEGG_2021_Human,axon development (GO:0061564),1/79,0.1797399811935544,0.2132138238449856,0,0,5.199372056514914,8.923391206941128,S100B,RNAlo MSC,0.745355308086215
KEGG_2021_Human,negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/79,0.1797399811935544,0.2132138238449856,0,0,5.199372056514914,8.923391206941128,CYP1B1,RNAlo MSC,0.745355308086215
KEGG_2021_Human,regulation of ion transport (GO:0043269),1/79,0.1797399811935544,0.2132138238449856,0,0,5.199372056514914,8.923391206941128,TF,RNAlo MSC,0.745355308086215
KEGG_2021_Human,response to interferon-gamma (GO:0034341),1/80,0.181798760490535,0.2150755188037419,0,0,5.133298889175924,8.751529842637671,IFITM3,RNAlo MSC,0.7404090821369118
KEGG_2021_Human,skin development (GO:0043588),1/80,0.181798760490535,0.2150755188037419,0,0,5.133298889175924,8.751529842637671,COL1A1,RNAlo MSC,0.7404090821369118
KEGG_2021_Human,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2169212429044157,0,0,5.0688775510204085,8.584760541358477,LBP,RNAlo MSC,0.7355305181562768
KEGG_2021_Human,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.1838524754991919,0.2169212429044157,0,0,5.0688775510204085,8.584760541358477,LBP,RNAlo MSC,0.7355305181562768
KEGG_2021_Human,positive regulation of cytoskeleton organization (GO:0051495),1/82,0.1859011384602527,0.2190443709203245,0,0,5.00604686318972,8.422875391899517,PFN2,RNAlo MSC,0.7307179505966239
KEGG_2021_Human,regulation of defense response (GO:0031347),1/83,0.1879447615357932,0.2208602211095751,0,0,4.944748631159781,8.265677319811374,APOE,RNAlo MSC,0.7259697745939766
KEGG_2021_Human,long-chain fatty acid metabolic process (GO:0001676),1/83,0.1879447615357932,0.2208602211095751,0,0,4.944748631159781,8.265677319811374,CYP1B1,RNAlo MSC,0.7259697745939766
KEGG_2021_Human,negative regulation of defense response (GO:0031348),1/85,0.1920169366451308,0.2247441908269907,0,0,4.826530612244898,7.964604221414354,APOE,RNAlo MSC,0.716660463134361
KEGG_2021_Human,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",1/85,0.1920169366451308,0.2247441908269907,0,0,4.826530612244898,7.964604221414354,COPZ2,RNAlo MSC,0.716660463134361
KEGG_2021_Human,positive regulation of protein catabolic process (GO:0045732),1/85,0.1920169366451308,0.2247441908269907,0,0,4.826530612244898,7.964604221414354,APOE,RNAlo MSC,0.716660463134361
KEGG_2021_Human,negative regulation of gene expression (GO:0010629),2/322,0.1923280195400404,0.2248089483719356,0,0,2.5559895833333335,4.213684115542283,SFRP1;APOE,RNAlo MSC,0.7159574404356035
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),2/323,0.1932342825020938,0.2253183696161202,0,0,2.5478971962616823,4.188365716592005,SFRP1;LBP,RNAlo MSC,0.7139158210847405
KEGG_2021_Human,negative regulation of cellular amide metabolic process (GO:0034249),1/86,0.1940455128548384,0.2253183696161202,0,0,4.769507803121249,7.820383303288144,APOE,RNAlo MSC,0.7120963955156414
KEGG_2021_Human,regulation of interferon-gamma production (GO:0032649),1/86,0.1940455128548384,0.2253183696161202,0,0,4.769507803121249,7.820383303288144,GAS6,RNAlo MSC,0.7120963955156414
KEGG_2021_Human,positive regulation of endothelial cell migration (GO:0010595),1/86,0.1940455128548384,0.2253183696161202,0,0,4.769507803121249,7.820383303288144,SPARC,RNAlo MSC,0.7120963955156414
KEGG_2021_Human,response to interleukin-1 (GO:0070555),1/86,0.1940455128548384,0.2253183696161202,0,0,4.769507803121249,7.820383303288144,SFRP1,RNAlo MSC,0.7120963955156414
KEGG_2021_Human,negative regulation of angiogenesis (GO:0016525),1/87,0.196069097589664,0.2270681644022591,0,0,4.713811105837684,7.6801565438185,SPARC,RNAlo MSC,0.7075908500030543
KEGG_2021_Human,calcium ion transmembrane transport (GO:0070588),1/87,0.196069097589664,0.2270681644022591,0,0,4.713811105837684,7.6801565438185,GAS6,RNAlo MSC,0.7075908500030543
KEGG_2021_Human,negative regulation of binding (GO:0051100),1/88,0.1980877029036425,0.2288030103183992,0,0,4.659394792399718,7.5437717166037235,SLPI,RNAlo MSC,0.703142484213379
KEGG_2021_Human,sensory perception of mechanical stimulus (GO:0050954),1/88,0.1980877029036425,0.2288030103183992,0,0,4.659394792399718,7.5437717166037235,COL1A1,RNAlo MSC,0.703142484213379
KEGG_2021_Human,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),1/89,0.2001013407742902,0.2299203641053609,0,0,4.6062152133580705,7.411084001248333,GAS6,RNAlo MSC,0.6987500013741589
KEGG_2021_Human,second-messenger-mediated signaling (GO:0019932),1/89,0.2001013407742902,0.2299203641053609,0,0,4.6062152133580705,7.411084001248333,APOE,RNAlo MSC,0.6987500013741589
KEGG_2021_Human,transforming growth factor beta receptor signaling pathway (GO:0007179),1/89,0.2001013407742902,0.2299203641053609,0,0,4.6062152133580705,7.411084001248333,FMOD,RNAlo MSC,0.6987500013741589
KEGG_2021_Human,protein import (GO:0017038),1/89,0.2001013407742902,0.2299203641053609,0,0,4.6062152133580705,7.411084001248333,APOE,RNAlo MSC,0.6987500013741589
KEGG_2021_Human,negative regulation of protein kinase activity (GO:0006469),1/90,0.2021100231923967,0.2316228297081053,0,0,4.55423068103646,7.281955543769811,THY1,RNAlo MSC,0.6944121480917811
KEGG_2021_Human,positive regulation of binding (GO:0051099),1/90,0.2021100231923967,0.2316228297081053,0,0,4.55423068103646,7.281955543769811,APOE,RNAlo MSC,0.6944121480917811
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),3/621,0.2024454460334983,0.2317051394055273,0,0,1.9966948977483991,3.1892904723776496,IFITM3;CXCL12;LBP,RNAlo MSC,0.6936919881460838
KEGG_2021_Human,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.2041137620931186,0.2327055731256177,0,0,4.503401360544218,7.156255051106618,MDK,RNAlo MSC,0.6901277125812961
KEGG_2021_Human,sensory perception of sound (GO:0007605),1/91,0.2041137620931186,0.2327055731256177,0,0,4.503401360544218,7.156255051106618,COL1A1,RNAlo MSC,0.6901277125812961
KEGG_2021_Human,toll-like receptor signaling pathway (GO:0002224),1/91,0.2041137620931186,0.2327055731256177,0,0,4.503401360544218,7.156255051106618,LBP,RNAlo MSC,0.6901277125812961
KEGG_2021_Human,cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.2061125694363157,0.2334702945032494,0,0,4.453689167974883,7.03385741012878,SFRP1,RNAlo MSC,0.6858955226779435
KEGG_2021_Human,regulation of lipid metabolic process (GO:0019216),1/92,0.2061125694363157,0.2334702945032494,0,0,4.453689167974883,7.03385741012878,RARRES2,RNAlo MSC,0.6858955226779435
KEGG_2021_Human,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2334702945032494,0,0,4.453689167974883,7.03385741012878,SFRP1,RNAlo MSC,0.6858955226779435
KEGG_2021_Human,positive regulation of cellular component biogenesis (GO:0044089),1/92,0.2061125694363157,0.2334702945032494,0,0,4.453689167974883,7.03385741012878,PFN2,RNAlo MSC,0.6858955226779435
KEGG_2021_Human,T cell activation (GO:0042110),1/92,0.2061125694363157,0.2334702945032494,0,0,4.453689167974883,7.03385741012878,MDK,RNAlo MSC,0.6858955226779435
KEGG_2021_Human,regulation of epithelial cell proliferation (GO:0050678),1/93,0.2081064570390282,0.2351228479913955,0,0,4.40505767524401,6.914643337844717,SFRP1,RNAlo MSC,0.6817144444740324
KEGG_2021_Human,visual perception (GO:0007601),1/93,0.2081064570390282,0.2351228479913955,0,0,4.40505767524401,6.914643337844717,COL1A1,RNAlo MSC,0.6817144444740324
KEGG_2021_Human,negative regulation of cellular protein metabolic process (GO:0032269),1/94,0.2100954368002021,0.236155868219153,0,0,4.357472021066491,6.79849904676328,APOE,RNAlo MSC,0.6775833802166729
KEGG_2021_Human,negative regulation of MAPK cascade (GO:0043409),1/94,0.2100954368002021,0.236155868219153,0,0,4.357472021066491,6.79849904676328,APOE,RNAlo MSC,0.6775833802166729
KEGG_2021_Human,positive regulation of epithelial cell migration (GO:0010634),1/94,0.2100954368002021,0.236155868219153,0,0,4.357472021066491,6.79849904676328,SPARC,RNAlo MSC,0.6775833802166729
KEGG_2021_Human,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.236155868219153,0,0,4.357472021066491,6.79849904676328,SFRP1,RNAlo MSC,0.6775833802166729
KEGG_2021_Human,sensory perception of light stimulus (GO:0050953),1/95,0.2120795205832498,0.2380816073980543,0,0,4.310898827616153,6.685315939697291,COL1A1,RNAlo MSC,0.6735012670190429
KEGG_2021_Human,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2419019726880486,0,0,4.220663265306122,6.46742313757927,CXCL12,RNAlo MSC,0.6654798083211632
KEGG_2021_Human,regulation of MAP kinase activity (GO:0043405),1/97,0.2160330472811356,0.2419019726880486,0,0,4.220663265306122,6.46742313757927,APOE,RNAlo MSC,0.6654798083211632
KEGG_2021_Human,positive regulation of defense response (GO:0031349),1/98,0.2180025137484037,0.2437967043064209,0,0,4.176940879444562,6.362519703204576,MDK,RNAlo MSC,0.6615384985937142
KEGG_2021_Human,cell-matrix adhesion (GO:0007160),1/100,0.2219269115603851,0.2478700829244962,0,0,4.092145949288806,6.1603458876211565,THY1,RNAlo MSC,0.6537900306498672
KEGG_2021_Human,epithelial cell differentiation (GO:0030855),1/101,0.2238818662412048,0.2497362441954556,0,0,4.051020408163265,6.062906014187368,FSTL1,RNAlo MSC,0.6499810815451941
KEGG_2021_Human,regulation of cell death (GO:0010941),1/102,0.2258320069783284,0.2506393107751902,0,0,4.010709234188725,5.967790506031058,HP,RNAlo MSC,0.6462145058611213
KEGG_2021_Human,positive regulation of cell growth (GO:0030307),1/102,0.2258320069783284,0.2506393107751902,0,0,4.010709234188725,5.967790506031058,SFRP1,RNAlo MSC,0.6462145058611213
KEGG_2021_Human,intrinsic apoptotic signaling pathway (GO:0097193),1/102,0.2258320069783284,0.2506393107751902,0,0,4.010709234188725,5.967790506031058,CYP1B1,RNAlo MSC,0.6462145058611213
KEGG_2021_Human,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.2506393107751902,0,0,4.010709234188725,5.967790506031058,CYP1B1,RNAlo MSC,0.6462145058611213
KEGG_2021_Human,cellular response to organonitrogen compound (GO:0071417),1/103,0.2277773453985499,0.2524795543572829,0,0,3.971188475390156,5.874923343943355,SFRP1,RNAlo MSC,0.64248947278397
KEGG_2021_Human,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2539899723428391,0,0,3.932435109966317,5.78423168094792,CXCL12,RNAlo MSC,0.6388051756325536
KEGG_2021_Human,regulation of insulin secretion (GO:0050796),1/104,0.2297178930745814,0.2539899723428391,0,0,3.932435109966317,5.78423168094792,SFRP1,RNAlo MSC,0.6388051756325536
KEGG_2021_Human,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.2558085031403069,0,0,3.894427001569859,5.6956456810845415,APOE,RNAlo MSC,0.6351608308934773
KEGG_2021_Human,regulation of cell cycle process (GO:0010564),1/106,0.2335846623503299,0.2572943837167167,0,0,3.857142857142857,5.6090983677319475,SFRP1,RNAlo MSC,0.6315556772929499
KEGG_2021_Human,protein localization to nucleus (GO:0034504),1/106,0.2335846623503299,0.2572943837167167,0,0,3.857142857142857,5.6090983677319475,COL1A1,RNAlo MSC,0.6315556772929499
KEGG_2021_Human,cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.2431685532271013,0.2671814478582776,0,0,3.6808905380333954,5.20478084558139,CXCL12,RNAlo MSC,0.6140925891155178
KEGG_2021_Human,regulation of protein serine/threonine kinase activity (GO:0071900),1/111,0.2431685532271013,0.2671814478582776,0,0,3.6808905380333954,5.20478084558139,THY1,RNAlo MSC,0.6140925891155178
KEGG_2021_Human,activation of protein kinase activity (GO:0032147),1/114,0.2488624078588274,0.27207718471133,0,0,3.582625970742279,4.982913653406146,GAS6,RNAlo MSC,0.6040407011916724
KEGG_2021_Human,cellular response to transforming growth factor beta stimulus (GO:0071560),1/114,0.2488624078588274,0.27207718471133,0,0,3.582625970742279,4.982913653406146,SFRP1,RNAlo MSC,0.6040407011916724
KEGG_2021_Human,positive regulation of cellular component organization (GO:0051130),1/114,0.2488624078588274,0.27207718471133,0,0,3.582625970742279,4.982913653406146,APOE,RNAlo MSC,0.6040407011916724
KEGG_2021_Human,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.27207718471133,0,0,3.582625970742279,4.982913653406146,GAS6,RNAlo MSC,0.6040407011916724
KEGG_2021_Human,calcium ion transport (GO:0006816),1/115,0.2507510141385882,0.2731228518312504,0,0,3.5510204081632653,4.9121080927455,GAS6,RNAlo MSC,0.6007573018413346
KEGG_2021_Human,cellular response to molecule of bacterial origin (GO:0071219),1/115,0.2507510141385882,0.2731228518312504,0,0,3.5510204081632653,4.9121080927455,LBP,RNAlo MSC,0.6007573018413346
KEGG_2021_Human,positive regulation of protein metabolic process (GO:0051247),1/115,0.2507510141385882,0.2731228518312504,0,0,3.5510204081632653,4.9121080927455,APOE,RNAlo MSC,0.6007573018413346
KEGG_2021_Human,regulation of protein-containing complex assembly (GO:0043254),1/116,0.2526349665899778,0.2748343262779585,0,0,3.5199645075421473,4.8428011439058265,APOE,RNAlo MSC,0.5975065399797567
KEGG_2021_Human,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.2782294954311218,0,0,3.4594453165881736,4.708511372057024,APOE,RNAlo MSC,0.5911006880374128
KEGG_2021_Human,regulation of protein binding (GO:0043393),1/118,0.2563889548341396,0.2782294954311218,0,0,3.4594453165881736,4.708511372057024,SLPI,RNAlo MSC,0.5911006880374128
KEGG_2021_Human,cellular response to lipopolysaccharide (GO:0071222),1/120,0.2601244621662815,0.2819351445674001,0,0,3.4009603841536613,4.579716458908873,LBP,RNAlo MSC,0.5848188047272944
KEGG_2021_Human,protein homooligomerization (GO:0051260),1/121,0.2619853133921213,0.283602328167087,0,0,3.372448979591837,4.517283552621874,ALDH1A3,RNAlo MSC,0.5817230540677998
KEGG_2021_Human,defense response to symbiont (GO:0140546),1/124,0.2675403902734135,0.2889041806515116,0,0,3.2896963663514187,4.337414433160371,IFITM3,RNAlo MSC,0.5726106437410472
KEGG_2021_Human,fatty acid metabolic process (GO:0006631),1/124,0.2675403902734135,0.2889041806515116,0,0,3.2896963663514187,4.337414433160371,GGT5,RNAlo MSC,0.5726106437410472
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),2/404,0.2679393411370432,0.288979976514676,0,0,2.026119402985074,2.6683884405969245,COL1A1;RARRES2,RNAlo MSC,0.5719635148936996
KEGG_2021_Human,regulation of protein secretion (GO:0050708),1/125,0.2693829605231016,0.2901809096811352,0,0,3.263001974983542,4.279822783786303,APOE,RNAlo MSC,0.5696298784899082
KEGG_2021_Human,cellular response to insulin stimulus (GO:0032869),1/129,0.2767079241059198,0.2977065670613262,0,0,3.1603954081632653,4.060453122404681,RARRES2,RNAlo MSC,0.5579784037567757
KEGG_2021_Human,regulation of primary metabolic process (GO:0080090),1/130,0.2785278903472666,0.2992983075981019,0,0,3.135738016136687,4.008216604624779,APOE,RNAlo MSC,0.5551313103019286
KEGG_2021_Human,cellular response to hypoxia (GO:0071456),1/131,0.2803433684983951,0.3005144157440114,0,0,3.111459968602826,3.956968446025251,SFRP1,RNAlo MSC,0.5523097126477655
KEGG_2021_Human,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.3005144157440114,0,0,3.111459968602826,3.956968446025251,TF,RNAlo MSC,0.5523097126477655
KEGG_2021_Human,defense response to virus (GO:0051607),1/133,0.2839609038772722,0.3040214793034376,0,0,3.0640074211502784,3.857336278341556,IFITM3,RNAlo MSC,0.546741450090894
KEGG_2021_Human,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3055786640032609,0,0,3.0408163265306123,3.80890385676326,GAS6,RNAlo MSC,0.5439940297149167
KEGG_2021_Human,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.3082933390309879,0,0,2.99546485260771,3.714691124222948,GAS6,RNAlo MSC,0.5385707850387818
KEGG_2021_Human,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3082933390309879,0,0,2.99546485260771,3.714691124222948,GGT5,RNAlo MSC,0.5385707850387818
KEGG_2021_Human,cellular calcium ion homeostasis (GO:0006874),1/136,0.289353816496661,0.3082933390309879,0,0,2.99546485260771,3.714691124222948,CXCL12,RNAlo MSC,0.5385707850387818
KEGG_2021_Human,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.309823655191392,0,0,2.9732893157262907,3.668866926816198,GGT5,RNAlo MSC,0.5358942544628899
KEGG_2021_Human,regulation of cellular component organization (GO:0051128),1/139,0.2947069182263764,0.3132374620568137,0,0,2.929902395740905,3.579678317757992,APOE,RNAlo MSC,0.5306096689947516
KEGG_2021_Human,neuron projection morphogenesis (GO:0048812),1/140,0.2964824884084789,0.3143644237769034,0,0,2.9086771399207163,3.5362740390257685,S100B,RNAlo MSC,0.5280009529309525
KEGG_2021_Human,protein localization to cell periphery (GO:1990778),1/140,0.2964824884084789,0.3143644237769034,0,0,2.9086771399207163,3.5362740390257685,GAS6,RNAlo MSC,0.5280009529309525
KEGG_2021_Human,positive regulation of cellular catabolic process (GO:0031331),1/141,0.2982536777952956,0.3158614250386323,0,0,2.8877551020408165,3.4936375609484274,APOE,RNAlo MSC,0.5254141922968343
KEGG_2021_Human,protein localization to organelle (GO:0033365),1/142,0.3000204969826995,0.3173502007795342,0,0,2.8671298306556667,3.4517504575709377,COL1A1,RNAlo MSC,0.522849073872343
KEGG_2021_Human,nervous system development (GO:0007399),2/447,0.3078904676985005,0.3252833186381995,0,0,1.826310861423221,2.1514146195112085,MDK;S100B,RNAlo MSC,0.5116037566636256
KEGG_2021_Human,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3276783548180339,0,0,2.749271137026239,3.215201203875706,GAS6,RNAlo MSC,0.5078961191737069
KEGG_2021_Human,positive regulation of protein kinase activity (GO:0045860),1/154,0.3208852696222714,0.3381992230191566,0,0,2.640656262505002,3.0015590720273457,GAS6,RNAlo MSC,0.493650218923809
KEGG_2021_Human,cellular response to interleukin-1 (GO:0071347),1/155,0.3225962281219006,0.339595310801378,0,0,2.6233766233766236,2.9679671260643183,SFRP1,RNAlo MSC,0.4913407148001928
KEGG_2021_Human,negative regulation of nucleic acid-templated transcription (GO:1903507),2/464,0.3236043277850015,0.3401698133372317,0,0,1.7575757575757576,1.982956235178162,SFRP1;GAS6,RNAlo MSC,0.48998567889976286
KEGG_2021_Human,regulation of cell differentiation (GO:0045595),1/156,0.3243029619756543,0.3401698133372317,0,0,2.6063199473337724,2.934917292064671,MDK,RNAlo MSC,0.4890490847411261
KEGG_2021_Human,peptidyl-serine phosphorylation (GO:0018105),1/156,0.3243029619756543,0.3401698133372317,0,0,2.6063199473337724,2.934917292064671,GAS6,RNAlo MSC,0.4890490847411261
KEGG_2021_Human,cellular response to starvation (GO:0009267),1/158,0.3277037968552589,0.3425108649652468,0,0,2.5728584427401535,2.8703970097526006,SFRP1,RNAlo MSC,0.48451852674781976
KEGG_2021_Human,organonitrogen compound biosynthetic process (GO:1901566),1/158,0.3277037968552589,0.3425108649652468,0,0,2.5728584427401535,2.8703970097526006,APOE,RNAlo MSC,0.48451852674781976
KEGG_2021_Human,T cell receptor signaling pathway (GO:0050852),1/158,0.3277037968552589,0.3425108649652468,0,0,2.5728584427401535,2.8703970097526006,THY1,RNAlo MSC,0.48451852674781976
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3473966881997837,0,0,2.524234693877551,2.7773973646136283,GAS6,RNAlo MSC,0.4778511096570981
KEGG_2021_Human,peptide biosynthetic process (GO:0043043),1/162,0.3344552195120095,0.3487380046868996,0,0,2.5084294587400175,2.747363087126053,GGT5,RNAlo MSC,0.47566202205377284
KEGG_2021_Human,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3587423397497507,0,0,2.4175730172308443,2.5766088705447237,FMOD,RNAlo MSC,0.46286379212748074
KEGG_2021_Human,peptidyl-serine modification (GO:0018209),1/169,0.3461106816465725,0.3600370286003991,0,0,2.403061224489796,2.5496399471999527,GAS6,RNAlo MSC,0.4607849973294511
KEGG_2021_Human,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),1/171,0.3494039111808349,0.3630331417588107,0,0,2.3745498199279713,2.4969025061029213,S100B,RNAlo MSC,0.4566722378913039
KEGG_2021_Human,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.3744339857742452,0,0,2.279833967485299,2.3241173885161555,GGT5,RNAlo MSC,0.44273020383203454
KEGG_2021_Human,protein stabilization (GO:0050821),1/179,0.3624150547196057,0.3752212403987437,0,0,2.266911258885577,2.300835957547096,PFN2,RNAlo MSC,0.4407937700298507
KEGG_2021_Human,regulation of immune response (GO:0050776),1/179,0.3624150547196057,0.3752212403987437,0,0,2.266911258885577,2.300835957547096,COL1A1,RNAlo MSC,0.4407937700298507
KEGG_2021_Human,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.3797571608399586,0,0,2.2289998872477166,2.2329492942532405,GAS6,RNAlo MSC,0.4350639775318079
KEGG_2021_Human,antigen receptor-mediated signaling pathway (GO:0050851),1/185,0.3720057294778557,0.3842456359706642,0,0,2.192324755989352,2.1678716160963645,THY1,RNAlo MSC,0.4294503712432232
KEGG_2021_Human,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.3935433440205331,0,0,2.122448979591837,2.045536603225051,SFRP1,RNAlo MSC,0.41855670871419515
KEGG_2021_Human,cellular response to tumor necrosis factor (GO:0071356),1/194,0.3861272144560919,0.3978966254477196,0,0,2.089140319340171,1.988001678572607,SFRP1,RNAlo MSC,0.4132695879859197
KEGG_2021_Human,regulation of macromolecule metabolic process (GO:0060255),1/200,0.3953681557510544,0.4069421649943522,0,0,2.025535842477695,1.8795714928238216,APOE,RNAlo MSC,0.40299831311675843
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),2/546,0.3979281971141292,0.4090981114190872,0,0,1.4863664215686274,1.3696624285648409,GAS6;S100B,RNAlo MSC,0.40019528574129115
KEGG_2021_Human,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/547,0.3988146050031916,0.4095304179880905,0,0,1.4835626911314983,1.3637777909312412,SFRP1;GAS6,RNAlo MSC,0.3992289457561903
KEGG_2021_Human,axon guidance (GO:0007411),1/203,0.3999373645428959,0.4102041346945222,0,0,1.9951505354617096,1.8284503867148747,CXCL12,RNAlo MSC,0.398008019580524
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4159135399229124,0,0,1.9560134733505052,1.7632653144438126,GAS6,RNAlo MSC,0.3914985283218076
KEGG_2021_Human,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.4410224628015614,0,0,1.805344559348403,1.519514184420898,S100B,RNAlo MSC,0.36553500108915365
KEGG_2021_Human,membrane organization (GO:0061024),1/242,0.4563449373288627,0.4664269766419422,0,0,1.6689812854602422,1.3093263562491473,TF,RNAlo MSC,0.3407067631514444
KEGG_2021_Human,cellular component assembly (GO:0022607),1/261,0.4819092749521712,0.4919840333135407,0,0,1.5455259026687598,1.1282329953702568,GAS6,RNAlo MSC,0.31703471507296654
KEGG_2021_Human,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.4993930048824009,0,0,1.510204081632653,1.0781219104526054,CXCL12,RNAlo MSC,0.3100391544580995
KEGG_2021_Human,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.500131225608812,0,0,1.504471451501949,1.0700627976731167,S100B,RNAlo MSC,0.3088941088615854
KEGG_2021_Human,inorganic cation transmembrane transport (GO:0098662),1/274,0.4987179596066677,0.5073762575165057,0,0,1.4709576138147566,1.0233666205889618,GAS6,RNAlo MSC,0.30214499188263844
KEGG_2021_Human,regulation of gene expression (GO:0010468),3/1079,0.5107084384516999,0.5189742397676812,0,0,1.1196314165941628,0.7523435208329574,SFRP1;APOE;GAS6,RNAlo MSC,0.2918269662236996
KEGG_2021_Human,proteolysis (GO:0006508),1/287,0.51499186851511,0.5227226933311567,0,0,1.4031682603111175,0.9311483055746664,GGT5,RNAlo MSC,0.28819962821492023
KEGG_2021_Human,regulation of cell cycle (GO:0051726),1/296,0.5259539383992272,0.5332335776850297,0,0,1.359737115185057,0.8736877155004001,SFRP1,RNAlo MSC,0.2790522884983112
KEGG_2021_Human,chemical synaptic transmission (GO:0007268),1/306,0.5378493420766995,0.5446654051675334,0,0,1.314486450317832,0.8152139890333826,APOE,RNAlo MSC,0.2693393582885023
KEGG_2021_Human,cellular macromolecule biosynthetic process (GO:0034645),1/314,0.5471545986718139,0.5534509691973813,0,0,1.2803677381495728,0.7720923294539072,APOE,RNAlo MSC,0.26188994631047774
KEGG_2021_Human,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.5699452760615937,0,0,1.2208810353409656,0.6989624697257846,COPZ2,RNAlo MSC,0.24863646405532092
KEGG_2021_Human,intracellular protein transport (GO:0006886),1/336,0.5718075736459911,0.5770595375830381,0,0,1.1949436491014316,0.6679170434332091,COPZ2,RNAlo MSC,0.2427500966679934
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",3/1183,0.5741266920581598,0.5787355072467001,0,0,1.015326361341507,0.5634098665849442,COL1A1;SFRP1;APOE,RNAlo MSC,0.24099226162550894
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6253884127661458,0,0,1.042628017264347,0.4965325169788531,GAS6,RNAlo MSC,0.20682480102083725
KEGG_2021_Human,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6399252474492547,0,0,1.0,0.4521084323403523,GAS6,RNAlo MSC,0.19634819738734471
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",2/948,0.6926945411260426,0.6958611447426188,0,0,0.8370331219168429,0.3073302326128318,SFRP1;GAS6,RNAlo MSC,0.15945823486666727
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),1/482,0.7051444771556823,0.7075593555021058,0,0,0.8260426831855403,0.2885801301950252,GAS6,RNAlo MSC,0.1517218912312197
KEGG_2021_Human,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7171801484738407,0,0,0.8021026592455164,0.2684686706444305,GAS6,RNAlo MSC,0.1453610219101508
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",4/2244,0.8272634931131488,0.8282057066588357,0,0,0.6875,0.130372014787288,COL1A1;SFRP1;APOE;GAS6,RNAlo MSC,0.08235614053342308
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),1/2206,0.9971209346049892,0.9971209346049892,0,0,0.1642371234207968,0.00047353141012936674,APOE,RNAlo MSC,0.0012521656136179045
KEGG_2021_Human,positive regulation of leukocyte tethering or rolling (GO:1903238),2/5,6.0956786529959696e-05,0.0132276226770012,0,0,277.0416666666667,2688.78505476905,SELP;SELE,SEC,4.214977935846465
KEGG_2021_Human,negative regulation of synapse organization (GO:1905809),2/5,6.0956786529959696e-05,0.0132276226770012,0,0,277.0416666666667,2688.78505476905,ROBO2;ARHGEF15,SEC,4.214977935846465
KEGG_2021_Human,calcitonin family receptor signaling pathway (GO:0097646),2/7,0.00012760097078443218,0.0184301365661118,0,0,166.20833333333334,1490.3240703269437,CALCRL;RAMP3,SEC,3.8941460215026447
KEGG_2021_Human,forebrain neuron development (GO:0021884),2/8,0.0001698630098259154,0.0184301365661118,0,0,138.5,1202.2517804391236,ROBO2;LHX6,SEC,3.7699011848597213
KEGG_2021_Human,positive regulation of protein kinase A signaling (GO:0010739),2/9,0.00021804660985203623,0.0189264457351567,0,0,118.70833333333331,1000.8064198202924,RAMP3;TCIM,SEC,3.6614506612675517
KEGG_2021_Human,regulation of leukocyte tethering or rolling (GO:1903236),2/10,0.00027212309342677823,0.0196835704245369,0,0,103.86458333333331,852.6509585567859,SELP;SELE,SEC,3.5652346007331377
KEGG_2021_Human,positive regulation of calcium ion import (GO:0090280),2/13,0.00046942457388711873,0.0291043235810013,0,0,75.52651515151516,578.8354329773197,RAMP3;STC1,SEC,3.3284341792789096
KEGG_2021_Human,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),2/16,0.0007187392304892979,0.037749954507944,0,0,59.333333333333336,429.45537567816734,SELP;SELE,SEC,3.14342864967499
KEGG_2021_Human,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),4/170,0.0008555920003709937,0.037749954507944,0,0,10.363541121005762,73.2051208766897,SELP;ROBO2;SELE;MPZL2,SEC,3.067733284655648
KEGG_2021_Human,leukocyte tethering or rolling (GO:0050901),2/18,0.000913470506242016,0.037749954507944,0,0,51.911458333333336,363.2898548418271,SELP;SELE,SEC,3.039305470405725
KEGG_2021_Human,leukocyte adhesion to vascular endothelial cell (GO:0061756),2/19,0.0010193089566942,0.037749954507944,0,0,48.85539215686274,336.54673838088314,SELP;SELE,SEC,2.9916941596143727
KEGG_2021_Human,regulation of acute inflammatory response (GO:0002673),2/20,0.0011307590059983,0.037749954507944,0,0,46.138888888888886,313.0461870363529,C2CD4B;DNASE1L3,SEC,2.9466299446036754
KEGG_2021_Human,regulation of protein kinase A signaling (GO:0010738),2/20,0.0011307590059983,0.037749954507944,0,0,46.138888888888886,313.0461870363529,RAMP3;TCIM,SEC,2.9466299446036754
KEGG_2021_Human,response to interleukin-1 (GO:0070555),3/86,0.0013002540770145,0.0403078763874517,0,0,15.27839015637016,101.52789088565108,CCL14;CCL23;SELE,SEC,2.8859717757979877
KEGG_2021_Human,outflow tract septum morphogenesis (GO:0003148),2/25,0.0017712212130127,0.0498425295971655,0,0,36.09963768115942,228.73040961874747,ROBO2;GATA6,SEC,2.751727195110795
KEGG_2021_Human,calcium ion homeostasis (GO:0055074),3/97,0.001837512611877,0.0498425295971655,0,0,13.483023992756904,84.93418557118899,CCL14;CCL23;STC1,SEC,2.735769671427555
KEGG_2021_Human,leukocyte cell-cell adhesion (GO:0007159),2/28,0.0022210873543451,0.0540543595475052,0,0,31.92948717948718,195.08145262248803,SELP;SELE,SEC,2.6534343605132076
KEGG_2021_Human,cellular metal ion homeostasis (GO:0006875),3/104,0.0022418858798504,0.0540543595475052,0,0,12.544133136717926,76.5247046664134,CCL14;CCL23;STC1,SEC,2.6493864983479414
KEGG_2021_Human,inflammatory response (GO:0006954),4/230,0.0025930075543636,0.055749053473196,0,0,7.58907272027703,45.19244886807738,CCL14;CCL23;ACKR1;SELE,SEC,2.5861962179727827
KEGG_2021_Human,response to tumor necrosis factor (GO:0034612),3/110,0.0026292225152408,0.055749053473196,0,0,11.83714456154305,70.32527008978302,CCL14;CCL23;SELE,SEC,2.5801726573124935
KEGG_2021_Human,cellular divalent inorganic cation homeostasis (GO:0072503),3/111,0.0026975348454772,0.055749053473196,0,0,11.72695035460993,69.36980081998614,CCL14;CCL23;STC1,SEC,2.5690329365984437
KEGG_2021_Human,response to lipid (GO:0033993),3/114,0.00290902931217,0.0573872146128086,0,0,11.40828062104658,66.623626679358,SELP;GATA6;SELE,SEC,2.536251902661656
KEGG_2021_Human,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),3/118,0.0032065354536986,0.060505929865445,0,0,11.009250693802036,63.22132915202483,RAMP3;CALCRL;ADGRL4,SEC,2.4939639538566616
KEGG_2021_Human,lymphocyte migration (GO:0072676),2/40,0.0044964248068071,0.0766876830336451,0,0,21.833333333333332,117.99765363023796,CCL14;CCL23,SEC,2.3471326648462743
KEGG_2021_Human,cellular calcium ion homeostasis (GO:0006874),3/136,0.0047734885794893,0.0766876830336451,0,0,9.51063829787234,50.83129816395182,CCL14;CCL23;STC1,SEC,2.3211641121418585
KEGG_2021_Human,organic substance transport (GO:0071702),3/136,0.0047734885794893,0.0766876830336451,0,0,9.51063829787234,50.83129816395182,RAMP3;CALCRL;SLCO2A1,SEC,2.3211641121418585
KEGG_2021_Human,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/42,0.0049475924537835,0.0766876830336451,0,0,20.739583333333332,110.1034239545967,SELP;SELE,SEC,2.3056060815494894
KEGG_2021_Human,monocyte chemotaxis (GO:0002548),2/42,0.0049475924537835,0.0766876830336451,0,0,20.739583333333332,110.1034239545967,CCL14;CCL23,SEC,2.3056060815494894
KEGG_2021_Human,lymphocyte chemotaxis (GO:0048247),2/44,0.0054187658916089,0.0793902388500094,0,0,19.75,103.05327189846057,CCL14;CCL23,SEC,2.266099611522887
KEGG_2021_Human,nitrogen compound transport (GO:0071705),3/143,0.0054878045288024,0.0793902388500094,0,0,9.03191489361702,47.013167330286905,RAMP3;CALCRL;AQP1,SEC,2.2606013662470708
KEGG_2021_Human,receptor internalization (GO:0031623),2/49,0.0066828970303688,0.0935605584251639,0,0,17.64450354609929,88.36726791367238,CALCRL;RAMP3,SEC,2.175035230405133
KEGG_2021_Human,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),3/165,0.0081362517216861,0.1005244771923098,0,0,7.796690307328605,37.51319597515579,RAMP3;CALCRL;ADGRL4,SEC,2.08957562355039
KEGG_2021_Human,chemokine-mediated signaling pathway (GO:0070098),2/56,0.0086546685435214,0.1005244771923098,0,0,15.351851851851851,72.91602120992282,CCL14;CCL23,SEC,2.0627495600792987
KEGG_2021_Human,positive regulation of ERK1 and ERK2 cascade (GO:0070374),3/172,0.0091115611350234,0.1005244771923098,0,0,7.471106634772756,35.10083699792174,CCL14;CCL23;RAMP3,SEC,2.0404072065351544
KEGG_2021_Human,receptor metabolic process (GO:0043112),2/58,0.0092602829393189,0.1005244771923098,0,0,14.802083333333334,69.30366021141536,RAMP3;CALCRL,SEC,2.033375743652011
KEGG_2021_Human,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),2/60,0.0098843204040546,0.1005244771923098,0,0,14.290229885057473,65.97521300057967,ROBO2;MPZL2,SEC,2.0050531852188076
KEGG_2021_Human,cellular response to chemokine (GO:1990869),2/60,0.0098843204040546,0.1005244771923098,0,0,14.290229885057473,65.97521300057967,CCL14;CCL23,SEC,2.0050531852188076
KEGG_2021_Human,response to retinoic acid (GO:0032526),2/62,0.0105265894654256,0.1005244771923098,0,0,13.8125,62.9000654557375,GATA6;AQP1,SEC,1.977712314119832
KEGG_2021_Human,axon choice point recognition (GO:0016198),1/5,0.0124387771927725,0.1005244771923098,0,0,101.76530612244898,446.4379351400606,ROBO2,SEC,1.9052223113279663
KEGG_2021_Human,carbon dioxide transport (GO:0015670),1/5,0.0124387771927725,0.1005244771923098,0,0,101.76530612244898,446.4379351400606,AQP1,SEC,1.9052223113279663
KEGG_2021_Human,response to salt stress (GO:0009651),1/5,0.0124387771927725,0.1005244771923098,0,0,101.76530612244898,446.4379351400606,AQP1,SEC,1.9052223113279663
KEGG_2021_Human,positive regulation of myoblast proliferation (GO:2000288),1/5,0.0124387771927725,0.1005244771923098,0,0,101.76530612244898,446.4379351400606,GATA6,SEC,1.9052223113279663
KEGG_2021_Human,cellular response to salt stress (GO:0071472),1/5,0.0124387771927725,0.1005244771923098,0,0,101.76530612244898,446.4379351400606,AQP1,SEC,1.9052223113279663
KEGG_2021_Human,negative regulation of transforming growth factor beta1 production (GO:0032911),1/5,0.0124387771927725,0.1005244771923098,0,0,101.76530612244898,446.4379351400606,GATA6,SEC,1.9052223113279663
KEGG_2021_Human,positive regulation of protein kinase C activity (GO:1900020),1/5,0.0124387771927725,0.1005244771923098,0,0,101.76530612244898,446.4379351400606,TCIM,SEC,1.9052223113279663
KEGG_2021_Human,prostaglandin transport (GO:0015732),1/5,0.0124387771927725,0.1005244771923098,0,0,101.76530612244898,446.4379351400606,SLCO2A1,SEC,1.9052223113279663
KEGG_2021_Human,regulation of protein kinase C activity (GO:1900019),1/5,0.0124387771927725,0.1005244771923098,0,0,101.76530612244898,446.4379351400606,TCIM,SEC,1.9052223113279663
KEGG_2021_Human,cellular response to tumor necrosis factor (GO:0071356),3/194,0.0126088864195478,0.1005244771923098,0,0,6.603208198730088,28.878163305605018,CCL14;CCL23;PLVAP,SEC,1.899323267368311
KEGG_2021_Human,cellular response to decreased oxygen levels (GO:0036294),2/69,0.0129153730394233,0.1005244771923098,0,0,12.36504975124378,53.77976800231812,GATA6;AQP1,SEC,1.888893045423814
KEGG_2021_Human,neutrophil chemotaxis (GO:0030593),2/70,0.013274200561286,0.1005244771923098,0,0,12.182598039215684,52.65237170003471,CCL14;CCL23,SEC,1.8769916248436092
KEGG_2021_Human,regulation of angiogenesis (GO:0045765),3/203,0.0142323787832344,0.1005244771923098,0,0,6.303191489361702,26.80265596371328,ECSCR;GATA6;AQP1,SEC,1.8467225063744226
KEGG_2021_Human,granulocyte chemotaxis (GO:0071621),2/73,0.0143765335552059,0.1005244771923098,0,0,11.666079812206572,49.48935398933624,CCL14;CCL23,SEC,1.8423458176616205
KEGG_2021_Human,response to molecule of bacterial origin (GO:0002237),2/73,0.0143765335552059,0.1005244771923098,0,0,11.666079812206572,49.48935398933624,SELP;SELE,SEC,1.8423458176616205
KEGG_2021_Human,defense response to Gram-negative bacterium (GO:0050829),2/73,0.0143765335552059,0.1005244771923098,0,0,11.666079812206572,49.48935398933624,SELP;AQP1,SEC,1.8423458176616205
KEGG_2021_Human,regulation of saliva secretion (GO:0046877),1/6,0.0149082847993736,0.1005244771923098,0,0,81.40816326530613,342.3895623444841,AQP1,SEC,1.8265723193247598
KEGG_2021_Human,amylin receptor signaling pathway (GO:0097647),1/6,0.0149082847993736,0.1005244771923098,0,0,81.40816326530613,342.3895623444841,RAMP3,SEC,1.8265723193247598
KEGG_2021_Human,retinal ganglion cell axon guidance (GO:0031290),1/6,0.0149082847993736,0.1005244771923098,0,0,81.40816326530613,342.3895623444841,ROBO2,SEC,1.8265723193247598
KEGG_2021_Human,cellular hyperosmotic response (GO:0071474),1/6,0.0149082847993736,0.1005244771923098,0,0,81.40816326530613,342.3895623444841,AQP1,SEC,1.8265723193247598
KEGG_2021_Human,cellular water homeostasis (GO:0009992),1/6,0.0149082847993736,0.1005244771923098,0,0,81.40816326530613,342.3895623444841,AQP1,SEC,1.8265723193247598
KEGG_2021_Human,cerebral cortex cell migration (GO:0021795),1/6,0.0149082847993736,0.1005244771923098,0,0,81.40816326530613,342.3895623444841,LHX6,SEC,1.8265723193247598
KEGG_2021_Human,cellular response to hormone stimulus (GO:0032870),2/76,0.0155171628224907,0.1005244771923098,0,0,11.19144144144144,46.62140287744705,ROBO2;RAMP3,SEC,1.8091876827669675
KEGG_2021_Human,neutrophil migration (GO:1990266),2/77,0.0159057771109684,0.1005244771923098,0,0,11.041666666666666,45.72434655376785,CCL14;CCL23,SEC,1.7984451076467942
KEGG_2021_Human,positive regulation of GTPase activity (GO:0043547),3/214,0.0163712299817738,0.1005244771923098,0,0,5.971261470202682,24.55519908720985,CCL14;CCL23;ARHGEF15,SEC,1.785918690519014
KEGG_2021_Human,response to interferon-gamma (GO:0034341),2/80,0.0170965192165363,0.1005244771923098,0,0,10.615384615384617,43.19273030214829,CCL14;CCL23,SEC,1.7670923012410087
KEGG_2021_Human,ammonium transport (GO:0015696),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,AQP1,SEC,1.7601566430186848
KEGG_2021_Human,regulation of transforming growth factor beta activation (GO:1901388),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,GATA6,SEC,1.7601566430186848
KEGG_2021_Human,regulation of transforming growth factor beta1 production (GO:0032908),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,GATA6,SEC,1.7601566430186848
KEGG_2021_Human,regulation of transforming growth factor beta2 production (GO:0032909),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,GATA6,SEC,1.7601566430186848
KEGG_2021_Human,atrioventricular valve formation (GO:0003190),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,OLFM1,SEC,1.7601566430186848
KEGG_2021_Human,glycerol transport (GO:0015793),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,AQP1,SEC,1.7601566430186848
KEGG_2021_Human,hemostasis (GO:0007599),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,VWF,SEC,1.7601566430186848
KEGG_2021_Human,hyperosmotic response (GO:0006972),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,AQP1,SEC,1.7601566430186848
KEGG_2021_Human,smooth muscle cell migration (GO:0014909),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,PLAT,SEC,1.7601566430186848
KEGG_2021_Human,coronary vasculature development (GO:0060976),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,GATA6,SEC,1.7601566430186848
KEGG_2021_Human,endothelial cell morphogenesis (GO:0001886),1/7,0.0173717414502839,0.1005244771923098,0,0,67.83673469387755,274.9362107684438,STC1,SEC,1.7601566430186848
KEGG_2021_Human,proximal/distal pattern formation (GO:0009954),1/8,0.0198291614511851,0.1051061158660877,0,0,58.142857142857146,227.9549801512961,HOXD9,SEC,1.702695651141308
KEGG_2021_Human,forebrain neuron differentiation (GO:0021879),1/8,0.0198291614511851,0.1051061158660877,0,0,58.142857142857146,227.9549801512961,LHX6,SEC,1.702695651141308
KEGG_2021_Human,regulation of anion transport (GO:0044070),1/8,0.0198291614511851,0.1051061158660877,0,0,58.142857142857146,227.9549801512961,STC1,SEC,1.702695651141308
KEGG_2021_Human,regulation of extent of cell growth (GO:0061387),1/8,0.0198291614511851,0.1051061158660877,0,0,58.142857142857146,227.9549801512961,OLFM1,SEC,1.702695651141308
KEGG_2021_Human,vascular associated smooth muscle cell differentiation (GO:0035886),1/8,0.0198291614511851,0.1051061158660877,0,0,58.142857142857146,227.9549801512961,GATA6,SEC,1.702695651141308
KEGG_2021_Human,water homeostasis (GO:0030104),1/8,0.0198291614511851,0.1051061158660877,0,0,58.142857142857146,227.9549801512961,AQP1,SEC,1.702695651141308
KEGG_2021_Human,metal ion transport (GO:0030001),2/88,0.0204505278871254,0.1051061158660877,0,0,9.624031007751938,37.43504172973695,RAMP3;CALCRL,SEC,1.6892954771184148
KEGG_2021_Human,regulation of ERK1 and ERK2 cascade (GO:0070372),3/238,0.0216346238036121,0.1051061158660877,0,0,5.354911724762336,20.527841473575418,CCL14;CCL23;RAMP3,SEC,1.6648506521840387
KEGG_2021_Human,regulation of cellular extravasation (GO:0002691),1/9,0.0222805591236868,0.1051061158660877,0,0,50.87244897959184,193.52086993316271,PLVAP,SEC,1.652073914876897
KEGG_2021_Human,icosanoid transport (GO:0071715),1/9,0.0222805591236868,0.1051061158660877,0,0,50.87244897959184,193.52086993316271,SLCO2A1,SEC,1.652073914876897
KEGG_2021_Human,regulation of DNA-templated transcription in response to stress (GO:0043620),1/9,0.0222805591236868,0.1051061158660877,0,0,50.87244897959184,193.52086993316271,TCIM,SEC,1.652073914876897
KEGG_2021_Human,intestinal epithelial cell differentiation (GO:0060575),1/9,0.0222805591236868,0.1051061158660877,0,0,50.87244897959184,193.52086993316271,GATA6,SEC,1.652073914876897
KEGG_2021_Human,cellular response to nitric oxide (GO:0071732),1/9,0.0222805591236868,0.1051061158660877,0,0,50.87244897959184,193.52086993316271,AQP1,SEC,1.652073914876897
KEGG_2021_Human,cellular response to reactive nitrogen species (GO:1902170),1/9,0.0222805591236868,0.1051061158660877,0,0,50.87244897959184,193.52086993316271,AQP1,SEC,1.652073914876897
KEGG_2021_Human,regulation of leukocyte mediated cytotoxicity (GO:0001910),1/9,0.0222805591236868,0.1051061158660877,0,0,50.87244897959184,193.52086993316271,DNASE1L3,SEC,1.652073914876897
KEGG_2021_Human,one-carbon compound transport (GO:0019755),1/9,0.0222805591236868,0.1051061158660877,0,0,50.87244897959184,193.52086993316271,AQP1,SEC,1.652073914876897
KEGG_2021_Human,plasminogen activation (GO:0031639),1/9,0.0222805591236868,0.1051061158660877,0,0,50.87244897959184,193.52086993316271,PLAT,SEC,1.652073914876897
KEGG_2021_Human,positive regulation of cell activation (GO:0050867),1/10,0.024725948817258,0.1101846697978383,0,0,45.21768707482993,167.3010120823387,SELP,SEC,1.606847034080906
KEGG_2021_Human,regulation of actin filament-based movement (GO:1903115),1/10,0.024725948817258,0.1101846697978383,0,0,45.21768707482993,167.3010120823387,STC1,SEC,1.606847034080906
KEGG_2021_Human,negative regulation of transforming growth factor beta production (GO:0071635),1/10,0.024725948817258,0.1101846697978383,0,0,45.21768707482993,167.3010120823387,GATA6,SEC,1.606847034080906
KEGG_2021_Human,positive regulation of receptor recycling (GO:0001921),1/10,0.024725948817258,0.1101846697978383,0,0,45.21768707482993,167.3010120823387,RAMP3,SEC,1.606847034080906
KEGG_2021_Human,muscle cell migration (GO:0014812),1/10,0.024725948817258,0.1101846697978383,0,0,45.21768707482993,167.3010120823387,PLAT,SEC,1.606847034080906
KEGG_2021_Human,organic anion transport (GO:0015711),2/99,0.0254700751762328,0.1101846697978383,0,0,8.527920962199312,31.299610767204847,SLCO2A1;AQP1,SEC,1.5939697731920623
KEGG_2021_Human,calcium-mediated signaling (GO:0019722),2/102,0.0269177264019109,0.1101846697978383,0,0,8.270833333333334,29.898816321570965,SELP;SELE,SEC,1.5699616254585989
KEGG_2021_Human,positive regulation of vasculature development (GO:1904018),2/102,0.0269177264019109,0.1101846697978383,0,0,8.270833333333334,29.898816321570965,GATA6;AQP1,SEC,1.5699616254585989
KEGG_2021_Human,regulation of synapse maturation (GO:0090128),1/11,0.0271653448579923,0.1101846697978383,0,0,40.69387755102041,146.73452100035948,ARHGEF15,SEC,1.5659847773237099
KEGG_2021_Human,positive regulation of cellular extravasation (GO:0002693),1/11,0.0271653448579923,0.1101846697978383,0,0,40.69387755102041,146.73452100035948,PLVAP,SEC,1.5659847773237099
KEGG_2021_Human,negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),1/11,0.0271653448579923,0.1101846697978383,0,0,40.69387755102041,146.73452100035948,ZNF366,SEC,1.5659847773237099
KEGG_2021_Human,columnar/cuboidal epithelial cell differentiation (GO:0002065),1/11,0.0271653448579923,0.1101846697978383,0,0,40.69387755102041,146.73452100035948,GATA6,SEC,1.5659847773237099
KEGG_2021_Human,positive regulation of transforming growth factor beta production (GO:0071636),1/11,0.0271653448579923,0.1101846697978383,0,0,40.69387755102041,146.73452100035948,GATA6,SEC,1.5659847773237099
KEGG_2021_Human,regulation of myeloid leukocyte mediated immunity (GO:0002886),1/11,0.0271653448579923,0.1101846697978383,0,0,40.69387755102041,146.73452100035948,DNASE1L3,SEC,1.5659847773237099
KEGG_2021_Human,protein kinase C signaling (GO:0070528),1/11,0.0271653448579923,0.1101846697978383,0,0,40.69387755102041,146.73452100035948,PLVAP,SEC,1.5659847773237099
KEGG_2021_Human,positive regulation of cellular metabolic process (GO:0031325),2/105,0.0283980432384044,0.1141180626432176,0,0,8.028721682847896,28.593770697553435,RAMP3;SELE,SEC,1.546711583898058
KEGG_2021_Human,gas transport (GO:0015669),1/12,0.029598761568907,0.114695201079515,0,0,36.99257884972171,130.2147194065139,AQP1,SEC,1.5287264597194943
KEGG_2021_Human,cardiocyte differentiation (GO:0035051),1/12,0.029598761568907,0.114695201079515,0,0,36.99257884972171,130.2147194065139,GATA6,SEC,1.5287264597194943
KEGG_2021_Human,smooth muscle cell differentiation (GO:0051145),1/12,0.029598761568907,0.114695201079515,0,0,36.99257884972171,130.2147194065139,GATA6,SEC,1.5287264597194943
KEGG_2021_Human,polyol transport (GO:0015791),1/12,0.029598761568907,0.114695201079515,0,0,36.99257884972171,130.2147194065139,AQP1,SEC,1.5287264597194943
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),3/274,0.0310750535699626,0.1193502057465823,0,0,4.63507890398053,16.089980771839137,CCL14;CCL23;RAMP3,SEC,1.5075881140099185
KEGG_2021_Human,response to nitric oxide (GO:0071731),1/13,0.032026213248763,0.120864143912723,0,0,33.90816326530612,116.6847899929619,AQP1,SEC,1.4944944088974865
KEGG_2021_Human,DNA catabolic process (GO:0006308),1/13,0.032026213248763,0.120864143912723,0,0,33.90816326530612,116.6847899929619,DNASE1L3,SEC,1.4944944088974865
KEGG_2021_Human,calcium ion transport (GO:0006816),2/115,0.033561350657856,0.1215472191034478,0,0,7.31452802359882,24.82828874550635,RAMP3;CALCRL,SEC,1.4741605695522084
KEGG_2021_Human,positive regulation of angiogenesis (GO:0045766),2/116,0.0340965412337713,0.1215472191034478,0,0,7.25,24.49455514200503,GATA6;AQP1,SEC,1.467289673772098
KEGG_2021_Human,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),1/14,0.0344477141698711,0.1215472191034478,0,0,31.298273155416013,105.4223689491126,CARD10,SEC,1.4628395910668823
KEGG_2021_Human,aorta development (GO:0035904),1/14,0.0344477141698711,0.1215472191034478,0,0,31.298273155416013,105.4223689491126,ROBO2,SEC,1.4628395910668823
KEGG_2021_Human,heart process (GO:0003015),1/14,0.0344477141698711,0.1215472191034478,0,0,31.298273155416013,105.4223689491126,RAMP3,SEC,1.4628395910668823
KEGG_2021_Human,carbohydrate transport (GO:0008643),1/14,0.0344477141698711,0.1215472191034478,0,0,31.298273155416013,105.4223689491126,AQP1,SEC,1.4628395910668823
KEGG_2021_Human,sodium-independent organic anion transport (GO:0043252),1/14,0.0344477141698711,0.1215472191034478,0,0,31.298273155416013,105.4223689491126,SLCO2A1,SEC,1.4628395910668823
KEGG_2021_Human,cGMP-mediated signaling (GO:0019934),1/14,0.0344477141698711,0.1215472191034478,0,0,31.298273155416013,105.4223689491126,AQP1,SEC,1.4628395910668823
KEGG_2021_Human,cellular response to interferon-gamma (GO:0071346),2/121,0.0368223679095263,0.1240206427102724,0,0,6.943627450980392,22.92542614889691,CCL14;CCL23,SEC,1.4338882870711436
KEGG_2021_Human,positive regulation of acute inflammatory response (GO:0002675),1/15,0.0368632785936063,0.1240206427102724,0,0,29.06122448979592,95.91771596133704,C2CD4B,SEC,1.4334060415588732
KEGG_2021_Human,fibrinolysis (GO:0042730),1/15,0.0368632785936063,0.1240206427102724,0,0,29.06122448979592,95.91771596133704,PLAT,SEC,1.4334060415588732
KEGG_2021_Human,central nervous system neuron development (GO:0021954),1/15,0.0368632785936063,0.1240206427102724,0,0,29.06122448979592,95.91771596133704,LHX6,SEC,1.4334060415588732
KEGG_2021_Human,regulation of integrin activation (GO:0033623),1/15,0.0368632785936063,0.1240206427102724,0,0,29.06122448979592,95.91771596133704,SELP,SEC,1.4334060415588732
KEGG_2021_Human,positive regulation of secretion (GO:0051047),1/15,0.0368632785936063,0.1240206427102724,0,0,29.06122448979592,95.91771596133704,AQP1,SEC,1.4334060415588732
KEGG_2021_Human,cellular response to organic substance (GO:0071310),2/123,0.0379356146383277,0.1253268205791023,0,0,6.828168044077135,22.34084340876857,ROBO2;RAMP3,SEC,1.420952875040757
KEGG_2021_Human,platelet degranulation (GO:0002576),2/125,0.0390617280151273,0.1253268205791023,0,0,6.716463414634147,21.77888563484535,SELP;VWF,SEC,1.408248548277182
KEGG_2021_Human,activation of NF-kappaB-inducing kinase activity (GO:0007250),1/16,0.0392729207344652,0.1253268205791023,0,0,27.122448979591837,87.80133530116419,CARD10,SEC,1.405906798966597
KEGG_2021_Human,apoptotic DNA fragmentation (GO:0006309),1/16,0.0392729207344652,0.1253268205791023,0,0,27.122448979591837,87.80133530116419,DNASE1L3,SEC,1.405906798966597
KEGG_2021_Human,positive regulation of endothelial cell apoptotic process (GO:2000353),1/16,0.0392729207344652,0.1253268205791023,0,0,27.122448979591837,87.80133530116419,ECSCR,SEC,1.405906798966597
KEGG_2021_Human,neutrophil activation (GO:0042119),1/16,0.0392729207344652,0.1253268205791023,0,0,27.122448979591837,87.80133530116419,DNASE1L3,SEC,1.405906798966597
KEGG_2021_Human,platelet-derived growth factor receptor signaling pathway (GO:0048008),1/16,0.0392729207344652,0.1253268205791023,0,0,27.122448979591837,87.80133530116419,PLAT,SEC,1.405906798966597
KEGG_2021_Human,epithelial cell morphogenesis (GO:0003382),1/17,0.0416766547912334,0.1272631176103496,0,0,25.426020408163264,80.79916728086499,STC1,SEC,1.3801071472903907
KEGG_2021_Human,regulation of receptor recycling (GO:0001919),1/17,0.0416766547912334,0.1272631176103496,0,0,25.426020408163264,80.79916728086499,RAMP3,SEC,1.3801071472903907
KEGG_2021_Human,pulmonary valve morphogenesis (GO:0003184),1/17,0.0416766547912334,0.1272631176103496,0,0,25.426020408163264,80.79916728086499,ROBO2,SEC,1.3801071472903907
KEGG_2021_Human,regulation of transferase activity (GO:0051338),1/17,0.0416766547912334,0.1272631176103496,0,0,25.426020408163264,80.79916728086499,LDB2,SEC,1.3801071472903907
KEGG_2021_Human,mesonephric tubule development (GO:0072164),1/17,0.0416766547912334,0.1272631176103496,0,0,25.426020408163264,80.79916728086499,ROBO2,SEC,1.3801071472903907
KEGG_2021_Human,embryo development ending in birth or egg hatching (GO:0009792),1/17,0.0416766547912334,0.1272631176103496,0,0,25.426020408163264,80.79916728086499,NR5A2,SEC,1.3801071472903907
KEGG_2021_Human,regulation of response to external stimulus (GO:0032101),2/130,0.0419323175536405,0.1272631176103496,0,0,6.452473958333333,20.46530163526616,GATA6;SELE,SEC,1.3774511339488533
KEGG_2021_Human,cellular response to hypoxia (GO:0071456),2/131,0.0425157677463691,0.1281378000133625,0,0,6.4021317829457365,20.217165618082923,GATA6;AQP1,SEC,1.3714499740612387
KEGG_2021_Human,pulmonary valve development (GO:0003177),1/18,0.0440744949316926,0.1284486725995907,0,0,23.92917166866747,74.70385911458476,ROBO2,SEC,1.3558126557645607
KEGG_2021_Human,fluid transport (GO:0042044),1/18,0.0440744949316926,0.1284486725995907,0,0,23.92917166866747,74.70385911458476,AQP1,SEC,1.3558126557645607
KEGG_2021_Human,cellular response to glucocorticoid stimulus (GO:0071385),1/18,0.0440744949316926,0.1284486725995907,0,0,23.92917166866747,74.70385911458476,AQP1,SEC,1.3558126557645607
KEGG_2021_Human,water transport (GO:0006833),1/18,0.0440744949316926,0.1284486725995907,0,0,23.92917166866747,74.70385911458476,AQP1,SEC,1.3558126557645607
KEGG_2021_Human,protein localization to plasma membrane (GO:0072659),2/136,0.0454786698217006,0.1284486725995907,0,0,6.161691542288557,19.042780777221537,RAB3C;RAMP3,SEC,1.3421922462170102
KEGG_2021_Human,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),2/136,0.0454786698217006,0.1284486725995907,0,0,6.161691542288557,19.042780777221537,RAMP3;CALCRL,SEC,1.3421922462170102
KEGG_2021_Human,regulation of inflammatory response to antigenic stimulus (GO:0002861),2/137,0.0460802533373535,0.1284486725995907,0,0,6.1157407407407405,18.820401760879264,RAMP3;CALCRL,SEC,1.3364851419391792
KEGG_2021_Human,negative regulation of calcium ion transport (GO:0051926),1/19,0.0464664552952436,0.1284486725995907,0,0,22.598639455782312,69.35578082800635,STC1,SEC,1.3328604565168853
KEGG_2021_Human,atrioventricular valve morphogenesis (GO:0003181),1/19,0.0464664552952436,0.1284486725995907,0,0,22.598639455782312,69.35578082800635,OLFM1,SEC,1.3328604565168853
KEGG_2021_Human,negative regulation of nervous system development (GO:0051961),1/19,0.0464664552952436,0.1284486725995907,0,0,22.598639455782312,69.35578082800635,ROBO2,SEC,1.3328604565168853
KEGG_2021_Human,cellular response to copper ion (GO:0071280),1/19,0.0464664552952436,0.1284486725995907,0,0,22.598639455782312,69.35578082800635,AQP1,SEC,1.3328604565168853
KEGG_2021_Human,ureteric bud development (GO:0001657),1/19,0.0464664552952436,0.1284486725995907,0,0,22.598639455782312,69.35578082800635,ROBO2,SEC,1.3328604565168853
KEGG_2021_Human,myeloid cell activation involved in immune response (GO:0002275),1/19,0.0464664552952436,0.1284486725995907,0,0,22.598639455782312,69.35578082800635,DNASE1L3,SEC,1.3328604565168853
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),4/546,0.0471837441916468,0.1296059808808526,0,0,3.1137493983635487,9.50847474832882,SELP;RAMP3;VWF;TCIM,SEC,1.3262075993289288
KEGG_2021_Human,protein localization to cell periphery (GO:1990778),2/140,0.0479026862337682,0.1307532441852543,0,0,5.981884057971015,18.176455370515885,RAB3C;RAMP3,SEC,1.319640132017756
KEGG_2021_Human,cardiac epithelial to mesenchymal transition (GO:0060317),1/20,0.0488525499820277,0.1325125418262503,0,0,21.40816326530612,64.63014669364038,OLFM1,SEC,1.3111127622579986
KEGG_2021_Human,receptor-mediated endocytosis (GO:0006898),2/143,0.0497512691479657,0.1341121168336469,0,0,5.8537234042553195,17.565380826397597,RAMP3;CALCRL,SEC,1.3031958359850326
KEGG_2021_Human,calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.0512327930672156,0.1355794645803144,0,0,20.336734693877553,60.42807445408675,SELP,SEC,1.2904519669693806
KEGG_2021_Human,cellular response to estradiol stimulus (GO:0071392),1/21,0.0512327930672156,0.1355794645803144,0,0,20.336734693877553,60.42807445408675,RAMP3,SEC,1.2904519669693806
KEGG_2021_Human,cellular response to inorganic substance (GO:0071241),1/21,0.0512327930672156,0.1355794645803144,0,0,20.336734693877553,60.42807445408675,AQP1,SEC,1.2904519669693806
KEGG_2021_Human,positive regulation of hydrolase activity (GO:0051345),2/149,0.0535249876216422,0.1390948473115962,0,0,5.613095238095238,16.432935090777736,CCL14;CCL23,SEC,1.271443424469827
KEGG_2021_Human,cellular response to osmotic stress (GO:0071470),1/22,0.0536071985992547,0.1390948473115962,0,0,19.367346938775512,56.67024999786951,AQP1,SEC,1.2707768875084013
KEGG_2021_Human,regulation of platelet activation (GO:0010543),1/22,0.0536071985992547,0.1390948473115962,0,0,19.367346938775512,56.67024999786951,SELP,SEC,1.2707768875084013
KEGG_2021_Human,response to cytokine (GO:0034097),2/150,0.0541636617411515,0.1390948473115962,0,0,5.574887387387387,16.25495026487543,SELP;SELE,SEC,1.2662919827974375
KEGG_2021_Human,cellular response to organic cyclic compound (GO:0071407),2/150,0.0541636617411515,0.1390948473115962,0,0,5.574887387387387,16.25495026487543,RAMP3;AQP1,SEC,1.2662919827974375
KEGG_2021_Human,artery development (GO:0060840),1/23,0.0559757805878795,0.1396177515812627,0,0,18.4860853432282,53.29235549319145,ROBO2,SEC,1.2519998414265567
KEGG_2021_Human,positive regulation of epithelial cell apoptotic process (GO:1904037),1/23,0.0559757805878795,0.1396177515812627,0,0,18.4860853432282,53.29235549319145,ECSCR,SEC,1.2519998414265567
KEGG_2021_Human,response to copper ion (GO:0046688),1/23,0.0559757805878795,0.1396177515812627,0,0,18.4860853432282,53.29235549319145,AQP1,SEC,1.2519998414265567
KEGG_2021_Human,positive regulation of receptor internalization (GO:0002092),1/23,0.0559757805878795,0.1396177515812627,0,0,18.4860853432282,53.29235549319145,SELE,SEC,1.2519998414265567
KEGG_2021_Human,"DNA catabolic process, endonucleolytic (GO:0000737)",1/23,0.0559757805878795,0.1396177515812627,0,0,18.4860853432282,53.29235549319145,DNASE1L3,SEC,1.2519998414265567
KEGG_2021_Human,cellular response to interleukin-1 (GO:0071347),2/155,0.0573976675935087,0.1423462156319017,0,0,5.391339869281046,15.407110195493528,CCL14;CCL23,SEC,1.2411057551952243
KEGG_2021_Human,apoptotic nuclear changes (GO:0030262),1/24,0.0583385530130099,0.1430448136025215,0,0,17.68145519077196,50.24171555062859,DNASE1L3,SEC,1.2340443470047993
KEGG_2021_Human,regulation of monooxygenase activity (GO:0032768),1/24,0.0583385530130099,0.1430448136025215,0,0,17.68145519077196,50.24171555062859,NOSTRIN,SEC,1.2340443470047993
KEGG_2021_Human,response to lipopolysaccharide (GO:0032496),2/159,0.060032623780291,0.1447354941961106,0,0,5.25291932059448,14.77576411894998,SELP;SELE,SEC,1.2216126749949432
KEGG_2021_Human,negative regulation of cell junction assembly (GO:1901889),1/25,0.0606955298241754,0.1447354941961106,0,0,16.943877551020407,47.47480020477031,ROBO2,SEC,1.2168432931781568
KEGG_2021_Human,regulation of calcium ion import (GO:0090279),1/25,0.0606955298241754,0.1447354941961106,0,0,16.943877551020407,47.47480020477031,STC1,SEC,1.2168432931781568
KEGG_2021_Human,negative regulation of ion transport (GO:0043271),1/25,0.0606955298241754,0.1447354941961106,0,0,16.943877551020407,47.47480020477031,STC1,SEC,1.2168432931781568
KEGG_2021_Human,cardiac conduction system development (GO:0003161),1/25,0.0606955298241754,0.1447354941961106,0,0,16.943877551020407,47.47480020477031,GATA6,SEC,1.2168432931781568
KEGG_2021_Human,positive regulation of filopodium assembly (GO:0051491),1/26,0.0630467249540435,0.1471090248927682,0,0,16.26530612244898,44.95534064809558,GPM6A,SEC,1.2003374685092782
KEGG_2021_Human,negative regulation of signaling receptor activity (GO:2000272),1/26,0.0630467249540435,0.1471090248927682,0,0,16.26530612244898,44.95534064809558,RAMP3,SEC,1.2003374685092782
KEGG_2021_Human,metanephros development (GO:0001656),1/26,0.0630467249540435,0.1471090248927682,0,0,16.26530612244898,44.95534064809558,ROBO2,SEC,1.2003374685092782
KEGG_2021_Human,endothelial cell development (GO:0001885),1/26,0.0630467249540435,0.1471090248927682,0,0,16.26530612244898,44.95534064809558,STC1,SEC,1.2003374685092782
KEGG_2021_Human,protein transport (GO:0015031),3/369,0.0646744388528225,0.1493694425281502,0,0,3.415416811998605,9.352740604932352,RAB3C;RAMP3;CALCRL,SEC,1.1892673307471742
KEGG_2021_Human,acute inflammatory response (GO:0002526),1/27,0.0653921522588676,0.1493694425281502,0,0,15.638932496075354,42.652889831563165,C2CD4B,SEC,1.184474368421492
KEGG_2021_Human,positive regulation of calcium ion transmembrane transport (GO:1904427),1/27,0.0653921522588676,0.1493694425281502,0,0,15.638932496075354,42.652889831563165,RAMP3,SEC,1.184474368421492
KEGG_2021_Human,regulation of cardiac muscle cell contraction (GO:0086004),1/27,0.0653921522588676,0.1493694425281502,0,0,15.638932496075354,42.652889831563165,STC1,SEC,1.184474368421492
KEGG_2021_Human,positive regulation of fibroblast proliferation (GO:0048146),1/28,0.0677318256109869,0.1531021474748349,0,0,15.058956916099774,40.54171043527237,AQP1,SEC,1.1692072184717057
KEGG_2021_Human,ventricular septum morphogenesis (GO:0060412),1/28,0.0677318256109869,0.1531021474748349,0,0,15.058956916099774,40.54171043527237,ROBO2,SEC,1.1692072184717057
KEGG_2021_Human,negative regulation of programmed cell death (GO:0043069),3/381,0.0697677490315496,0.1551456088538197,0,0,3.3049645390070923,8.799743799293005,TCIM;GATA6;AQP1,SEC,1.1563452887586665
KEGG_2021_Human,regulation of response to biotic stimulus (GO:0002831),1/29,0.0700657588372089,0.1551456088538197,0,0,14.520408163265309,38.5999069065122,GATA6,SEC,1.1544941700666143
KEGG_2021_Human,positive regulation of leukocyte migration (GO:0002687),1/29,0.0700657588372089,0.1551456088538197,0,0,14.520408163265309,38.5999069065122,PLVAP,SEC,1.1544941700666143
KEGG_2021_Human,positive regulation of viral genome replication (GO:0045070),1/29,0.0700657588372089,0.1551456088538197,0,0,14.520408163265309,38.5999069065122,NR5A2,SEC,1.1544941700666143
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),3/384,0.0710690821644848,0.1565684348192204,0,0,3.27843859943039,8.668528964802487,OLFM1;RAMP3;SELE,SEC,1.148319293302099
KEGG_2021_Human,defense response to bacterium (GO:0042742),2/176,0.0716793261504705,0.1569597786752151,0,0,4.735632183908046,12.48100918849243,SELP;AQP1,SEC,1.144606086081811
KEGG_2021_Human,negative regulation of Notch signaling pathway (GO:0045746),1/30,0.0723939657090184,0.1569597786752151,0,0,14.019000703729768,36.80874147674154,TCIM,SEC,1.1402976322627019
KEGG_2021_Human,negative regulation of immune response (GO:0050777),2/178,0.073094899664538,0.1569597786752151,0,0,4.681344696969697,12.246382216533686,RAMP3;CALCRL,SEC,1.1361129257073213
KEGG_2021_Human,regulated exocytosis (GO:0045055),2/180,0.0745195887056104,0.1569597786752151,0,0,4.628277153558052,12.018216055401329,SELP;VWF,SEC,1.1277295507615273
KEGG_2021_Human,renal water homeostasis (GO:0003091),1/31,0.0747164600026276,0.1569597786752151,0,0,13.551020408163266,35.15209038871121,AQP1,SEC,1.126583712764908
KEGG_2021_Human,regulation of developmental growth (GO:0048638),1/31,0.0747164600026276,0.1569597786752151,0,0,13.551020408163266,35.15209038871121,OLFM1,SEC,1.126583712764908
KEGG_2021_Human,cellular response to cAMP (GO:0071320),1/31,0.0747164600026276,0.1569597786752151,0,0,13.551020408163266,35.15209038871121,AQP1,SEC,1.126583712764908
KEGG_2021_Human,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/31,0.0747164600026276,0.1569597786752151,0,0,13.551020408163266,35.15209038871121,ECSCR,SEC,1.126583712764908
KEGG_2021_Human,embryonic skeletal system morphogenesis (GO:0048704),1/31,0.0747164600026276,0.1569597786752151,0,0,13.551020408163266,35.15209038871121,HOXD9,SEC,1.126583712764908
KEGG_2021_Human,activation of phospholipase C activity (GO:0007202),1/32,0.0770332554327668,0.1569597786752151,0,0,13.113232389730086,33.61600807740255,SELE,SEC,1.1133217484244988
KEGG_2021_Human,negative regulation of chemotaxis (GO:0050922),1/32,0.0770332554327668,0.1569597786752151,0,0,13.113232389730086,33.61600807740255,ROBO2,SEC,1.1133217484244988
KEGG_2021_Human,aortic valve morphogenesis (GO:0003180),1/32,0.0770332554327668,0.1569597786752151,0,0,13.113232389730086,33.61600807740255,ROBO2,SEC,1.1133217484244988
KEGG_2021_Human,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),1/32,0.0770332554327668,0.1569597786752151,0,0,13.113232389730086,33.61600807740255,ZNF366,SEC,1.1133217484244988
KEGG_2021_Human,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/32,0.0770332554327668,0.1569597786752151,0,0,13.113232389730086,33.61600807740255,CARD10,SEC,1.1133217484244988
KEGG_2021_Human,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),1/32,0.0770332554327668,0.1569597786752151,0,0,13.113232389730086,33.61600807740255,ZNF366,SEC,1.1133217484244988
KEGG_2021_Human,modulation by host of symbiont process (GO:0051851),1/32,0.0770332554327668,0.1569597786752151,0,0,13.113232389730086,33.61600807740255,AQP1,SEC,1.1133217484244988
KEGG_2021_Human,regulation of GTPase activity (GO:0043087),2/189,0.0810402447075638,0.162738153638476,0,0,4.403520499108734,11.065207700859313,CCL14;CCL23,SEC,1.0912992562585337
KEGG_2021_Human,negative regulation of blood vessel endothelial cell migration (GO:0043537),1/34,0.0816498044624026,0.162738153638476,0,0,12.317254174397032,30.85861216573232,CARD10,SEC,1.0880448509885652
KEGG_2021_Human,positive regulation of calcium ion transport into cytosol (GO:0010524),1/34,0.0816498044624026,0.162738153638476,0,0,12.317254174397032,30.85861216573232,RAMP3,SEC,1.0880448509885652
KEGG_2021_Human,negative regulation of epithelial cell migration (GO:0010633),1/35,0.0839495853612937,0.162738153638476,0,0,11.95438175270108,29.61744503578088,STC1,SEC,1.0759814445616303
KEGG_2021_Human,bicarbonate transport (GO:0015701),1/35,0.0839495853612937,0.162738153638476,0,0,11.95438175270108,29.61744503578088,AQP1,SEC,1.0759814445616303
KEGG_2021_Human,response to estrogen (GO:0043627),1/35,0.0839495853612937,0.162738153638476,0,0,11.95438175270108,29.61744503578088,ZNF366,SEC,1.0759814445616303
KEGG_2021_Human,cellular response to hydrogen peroxide (GO:0070301),1/35,0.0839495853612937,0.162738153638476,0,0,11.95438175270108,29.61744503578088,AQP1,SEC,1.0759814445616303
KEGG_2021_Human,muscle cell differentiation (GO:0042692),1/35,0.0839495853612937,0.162738153638476,0,0,11.95438175270108,29.61744503578088,GATA6,SEC,1.0759814445616303
KEGG_2021_Human,embryonic skeletal system development (GO:0048706),1/35,0.0839495853612937,0.162738153638476,0,0,11.95438175270108,29.61744503578088,HOXD9,SEC,1.0759814445616303
KEGG_2021_Human,protein localization to membrane (GO:0072657),2/195,0.0854831524975729,0.162738153638476,0,0,4.265328151986183,10.490301477724982,RAB3C;RAMP3,SEC,1.0681194700473418
KEGG_2021_Human,regulation of receptor internalization (GO:0002090),1/36,0.0862437219743075,0.162738153638476,0,0,11.612244897959185,28.456712045041098,SELE,SEC,1.0642725091375862
KEGG_2021_Human,aortic valve development (GO:0003176),1/36,0.0862437219743075,0.162738153638476,0,0,11.612244897959185,28.456712045041098,ROBO2,SEC,1.0642725091375862
KEGG_2021_Human,regulation of cardiac muscle contraction (GO:0055117),1/36,0.0862437219743075,0.162738153638476,0,0,11.612244897959185,28.456712045041098,STC1,SEC,1.0642725091375862
KEGG_2021_Human,regulation of cell cycle G1/S phase transition (GO:1902806),1/36,0.0862437219743075,0.162738153638476,0,0,11.612244897959185,28.456712045041098,TCIM,SEC,1.0642725091375862
KEGG_2021_Human,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/36,0.0862437219743075,0.162738153638476,0,0,11.612244897959185,28.456712045041098,SELP,SEC,1.0642725091375862
KEGG_2021_Human,cellular response to heat (GO:0034605),1/36,0.0862437219743075,0.162738153638476,0,0,11.612244897959185,28.456712045041098,TCIM,SEC,1.0642725091375862
KEGG_2021_Human,cyclic-nucleotide-mediated signaling (GO:0019935),1/36,0.0862437219743075,0.162738153638476,0,0,11.612244897959185,28.456712045041098,AQP1,SEC,1.0642725091375862
KEGG_2021_Human,positive regulation of calcium ion transport (GO:0051928),1/37,0.0885322278902676,0.1652946681828241,0,0,11.289115646258503,27.36920368672352,STC1,SEC,1.0528986067362665
KEGG_2021_Human,generation of neurons (GO:0048699),2/202,0.0907585666054427,0.1652946681828241,0,0,4.114583333333333,9.87315836367001,GPM6A;LHX6,SEC,1.042112371758702
KEGG_2021_Human,negative regulation of endothelial cell migration (GO:0010596),1/38,0.0908151166313484,0.1652946681828241,0,0,10.983452840595698,26.34852930034076,STC1,SEC,1.0418418549683985
KEGG_2021_Human,regulation of axon extension (GO:0030516),1/38,0.0908151166313484,0.1652946681828241,0,0,10.983452840595698,26.34852930034076,OLFM1,SEC,1.0418418549683985
KEGG_2021_Human,response to cAMP (GO:0051591),1/38,0.0908151166313484,0.1652946681828241,0,0,10.983452840595698,26.34852930034076,AQP1,SEC,1.0418418549683985
KEGG_2021_Human,response to estradiol (GO:0032355),1/38,0.0908151166313484,0.1652946681828241,0,0,10.983452840595698,26.34852930034076,RAMP3,SEC,1.0418418549683985
KEGG_2021_Human,positive regulation of signaling (GO:0023056),1/38,0.0908151166313484,0.1652946681828241,0,0,10.983452840595698,26.34852930034076,RAMP3,SEC,1.0418418549683985
KEGG_2021_Human,ventricular septum development (GO:0003281),1/38,0.0908151166313484,0.1652946681828241,0,0,10.983452840595698,26.34852930034076,ROBO2,SEC,1.0418418549683985
KEGG_2021_Human,negative regulation of transcription by RNA polymerase II (GO:0000122),4/684,0.0910263264877764,0.1652946681828241,0,0,2.4641943734015346,5.9057042827231845,GATA6;LDB2;HOXD9;ZNF366,SEC,1.0408329835599175
KEGG_2021_Human,response to peptide (GO:1901652),1/39,0.0930924017046572,0.1662637956371244,0,0,10.693877551020408,25.38900533231373,RAMP3,SEC,1.0310857651239858
KEGG_2021_Human,cellular response to ketone (GO:1901655),1/39,0.0930924017046572,0.1662637956371244,0,0,10.693877551020408,25.38900533231373,AQP1,SEC,1.0310857651239858
KEGG_2021_Human,odontogenesis (GO:0042476),1/39,0.0930924017046572,0.1662637956371244,0,0,10.693877551020408,25.38900533231373,AQP1,SEC,1.0310857651239858
KEGG_2021_Human,regulation of nitric-oxide synthase activity (GO:0050999),1/39,0.0930924017046572,0.1662637956371244,0,0,10.693877551020408,25.38900533231373,NOSTRIN,SEC,1.0310857651239858
KEGG_2021_Human,regulation of inflammatory response (GO:0050727),2/206,0.0938158179234975,0.1668691187655652,0,0,4.033088235294118,9.543987931843056,SELE;DNASE1L3,SEC,1.0277239307283335
KEGG_2021_Human,negative regulation of blood coagulation (GO:0030195),1/40,0.0953640965755271,0.1668871690071725,0,0,10.419152276295131,24.485561288951835,PLAT,SEC,1.0206151011238414
KEGG_2021_Human,bone development (GO:0060348),1/40,0.0953640965755271,0.1668871690071725,0,0,10.419152276295131,24.485561288951835,STC1,SEC,1.0206151011238414
KEGG_2021_Human,stem cell differentiation (GO:0048863),1/40,0.0953640965755271,0.1668871690071725,0,0,10.419152276295131,24.485561288951835,GPM6A,SEC,1.0206151011238414
KEGG_2021_Human,digestive tract development (GO:0048565),1/40,0.0953640965755271,0.1668871690071725,0,0,10.419152276295131,24.485561288951835,GATA6,SEC,1.0206151011238414
KEGG_2021_Human,response to growth factor (GO:0070848),1/41,0.0976302146847681,0.1688108094549378,0,0,10.158163265306122,23.633660200289185,GATA6,SEC,1.0104157556925017
KEGG_2021_Human,regulation of filopodium assembly (GO:0051489),1/41,0.0976302146847681,0.1688108094549378,0,0,10.158163265306122,23.633660200289185,GPM6A,SEC,1.0104157556925017
KEGG_2021_Human,nucleobase-containing compound catabolic process (GO:0034655),1/41,0.0976302146847681,0.1688108094549378,0,0,10.158163265306122,23.633660200289185,DNASE1L3,SEC,1.0104157556925017
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),2/212,0.0984576089228105,0.1690579672750504,0,0,3.9166666666666665,9.079339326341122,RAMP3;CALCRL,SEC,1.0067507154273545
KEGG_2021_Human,positive regulation of epithelial to mesenchymal transition (GO:0010718),1/42,0.0998907694703361,0.1690579672750504,0,0,9.909905425584869,22.829231064333683,OLFM1,SEC,1.00047464143678
KEGG_2021_Human,regulation of chemokine production (GO:0032642),1/42,0.0998907694703361,0.1690579672750504,0,0,9.909905425584869,22.829231064333683,ACKR1,SEC,1.00047464143678
KEGG_2021_Human,skeletal system morphogenesis (GO:0048705),1/42,0.0998907694703361,0.1690579672750504,0,0,9.909905425584869,22.829231064333683,HOXD9,SEC,1.00047464143678
KEGG_2021_Human,nervous system development (GO:0007399),3/447,0.1008432425551151,0.1690579672750504,0,0,2.8041978148361126,6.433357037369621,ROBO2;GPM6A;LDB2,SEC,0.9963531982876066
KEGG_2021_Human,positive regulation of axonogenesis (GO:0050772),1/43,0.1021457742794159,0.1690579672750504,0,0,9.673469387755102,22.068611238785657,ROBO2,SEC,0.9907795952096249
KEGG_2021_Human,negative regulation of proteolysis (GO:0045861),1/43,0.1021457742794159,0.1690579672750504,0,0,9.673469387755102,22.068611238785657,PLAT,SEC,0.9907795952096249
KEGG_2021_Human,positive regulation of phospholipase C activity (GO:0010863),1/43,0.1021457742794159,0.1690579672750504,0,0,9.673469387755102,22.068611238785657,SELE,SEC,0.9907795952096249
KEGG_2021_Human,cellular response to retinoic acid (GO:0071300),1/43,0.1021457742794159,0.1690579672750504,0,0,9.673469387755102,22.068611238785657,AQP1,SEC,0.9907795952096249
KEGG_2021_Human,male gonad development (GO:0008584),1/43,0.1021457742794159,0.1690579672750504,0,0,9.673469387755102,22.068611238785657,GATA6,SEC,0.9907795952096249
KEGG_2021_Human,development of primary male sexual characteristics (GO:0046546),1/43,0.1021457742794159,0.1690579672750504,0,0,9.673469387755102,22.068611238785657,GATA6,SEC,0.9907795952096249
KEGG_2021_Human,cellular response to lipid (GO:0071396),2/219,0.1039543502969196,0.1690579672750504,0,0,3.788978494623656,8.577502457974575,RAMP3;AQP1,SEC,0.9831573315329525
KEGG_2021_Human,response to amyloid-beta (GO:1904645),1/44,0.1043952424647777,0.1690579672750504,0,0,9.448030374940672,21.34849709415977,RAMP3,SEC,0.9813192926974915
KEGG_2021_Human,regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.1043952424647777,0.1690579672750504,0,0,9.448030374940672,21.34849709415977,ECSCR,SEC,0.9813192926974915
KEGG_2021_Human,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.1043952424647777,0.1690579672750504,0,0,9.448030374940672,21.34849709415977,SELE,SEC,0.9813192926974915
KEGG_2021_Human,positive regulation of stress fiber assembly (GO:0051496),1/44,0.1043952424647777,0.1690579672750504,0,0,9.448030374940672,21.34849709415977,ARHGEF15,SEC,0.9813192926974915
KEGG_2021_Human,embryonic organ morphogenesis (GO:0048562),1/44,0.1043952424647777,0.1690579672750504,0,0,9.448030374940672,21.34849709415977,HOXD9,SEC,0.9813192926974915
KEGG_2021_Human,positive regulation of Notch signaling pathway (GO:0045747),1/45,0.1066391873529346,0.1714126196710134,0,0,9.232838589981448,20.665901611884028,ROBO2,SEC,0.9720831731354668
KEGG_2021_Human,zymogen activation (GO:0031638),1/45,0.1066391873529346,0.1714126196710134,0,0,9.232838589981448,20.665901611884028,PLAT,SEC,0.9720831731354668
KEGG_2021_Human,establishment of protein localization to extracellular region (GO:0035592),1/46,0.1088776222085674,0.1737238530827878,0,0,9.02721088435374,20.01811780873028,RAB3C,SEC,0.9630613723103648
KEGG_2021_Human,regulation of fibroblast proliferation (GO:0048145),1/46,0.1088776222085674,0.1737238530827878,0,0,9.02721088435374,20.01811780873028,AQP1,SEC,0.9630613723103648
KEGG_2021_Human,epithelial to mesenchymal transition (GO:0001837),1/47,0.1111105603036554,0.1753526660792235,0,0,8.830523513753327,19.4026870705364,OLFM1,SEC,0.9542446623584087
KEGG_2021_Human,regulation of synapse assembly (GO:0051963),1/47,0.1111105603036554,0.1753526660792235,0,0,8.830523513753327,19.4026870705364,ROBO2,SEC,0.9542446623584087
KEGG_2021_Human,regulation of protein localization to nucleus (GO:1900180),1/47,0.1111105603036554,0.1753526660792235,0,0,8.830523513753327,19.4026870705364,CARD10,SEC,0.9542446623584087
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),4/742,0.1138085215723413,0.1789597766753483,0,0,2.2636974195828916,4.919552976765135,OLFM1;TCIM;GATA6;AQP1,SEC,0.943825218316277
KEGG_2021_Human,response to hydrogen peroxide (GO:0042542),1/49,0.1155599990222406,0.1804066171786059,0,0,8.46173469387755,18.260130793597916,AQP1,SEC,0.9371924705024297
KEGG_2021_Human,cellular response to mechanical stimulus (GO:0071260),1/49,0.1155599990222406,0.1804066171786059,0,0,8.46173469387755,18.260130793597916,AQP1,SEC,0.9371924705024297
KEGG_2021_Human,chloride transmembrane transport (GO:1902476),1/50,0.1177765260040411,0.1825536153062637,0,0,8.28862973760933,17.7290996615035,ANO2,SEC,0.928941259997044
KEGG_2021_Human,neuron migration (GO:0001764),1/50,0.1177765260040411,0.1825536153062637,0,0,8.28862973760933,17.7290996615035,GPM6A,SEC,0.928941259997044
KEGG_2021_Human,regulation of axonogenesis (GO:0050770),1/51,0.1199876089220907,0.1836284924904296,0,0,8.122448979591837,17.22257115519733,ROBO2,SEC,0.9208636010741894
KEGG_2021_Human,gonad development (GO:0008406),1/51,0.1199876089220907,0.1836284924904296,0,0,8.122448979591837,17.22257115519733,GATA6,SEC,0.9208636010741894
KEGG_2021_Human,positive regulation of actin filament bundle assembly (GO:0032233),1/51,0.1199876089220907,0.1836284924904296,0,0,8.122448979591837,17.22257115519733,ARHGEF15,SEC,0.9208636010741894
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),3/485,0.1208716599427582,0.1836284924904296,0,0,2.578087754921868,5.447566347932984,TCIM;GATA6;AQP1,SEC,0.9176755136408634
KEGG_2021_Human,regulation of exocytosis (GO:0017157),1/52,0.1221932608707862,0.1836284924904296,0,0,7.962785114045619,16.738979733033663,RAB3C,SEC,0.9129527453809976
KEGG_2021_Human,positive regulation of protein localization to cell periphery (GO:1904377),1/52,0.1221932608707862,0.1836284924904296,0,0,7.962785114045619,16.738979733033663,RAMP3,SEC,0.9129527453809976
KEGG_2021_Human,positive regulation of protein localization to plasma membrane (GO:1903078),1/52,0.1221932608707862,0.1836284924904296,0,0,7.962785114045619,16.738979733033663,RAMP3,SEC,0.9129527453809976
KEGG_2021_Human,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.1221932608707862,0.1836284924904296,0,0,7.962785114045619,16.738979733033663,GPM6A,SEC,0.9129527453809976
KEGG_2021_Human,epidermal cell differentiation (GO:0009913),1/53,0.1243934949128716,0.1836284924904296,0,0,7.809262166405024,16.276887238960814,GATA6,SEC,0.9052023302345248
KEGG_2021_Human,negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.1243934949128716,0.1836284924904296,0,0,7.809262166405024,16.276887238960814,AQP1,SEC,0.9052023302345248
KEGG_2021_Human,heart morphogenesis (GO:0003007),1/53,0.1243934949128716,0.1836284924904296,0,0,7.809262166405024,16.276887238960814,OLFM1,SEC,0.9052023302345248
KEGG_2021_Human,cardiac muscle tissue development (GO:0048738),1/53,0.1243934949128716,0.1836284924904296,0,0,7.809262166405024,16.276887238960814,GATA6,SEC,0.9052023302345248
KEGG_2021_Human,cellular macromolecule catabolic process (GO:0044265),1/53,0.1243934949128716,0.1836284924904296,0,0,7.809262166405024,16.276887238960814,DNASE1L3,SEC,0.9052023302345248
KEGG_2021_Human,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.1243934949128716,0.1836284924904296,0,0,7.809262166405024,16.276887238960814,TCIM,SEC,0.9052023302345248
KEGG_2021_Human,regulation of proteolysis (GO:0030162),1/54,0.1265883240687765,0.1849809179994915,0,0,7.661532537543319,15.834970375184442,PLAT,SEC,0.8976063498190403
KEGG_2021_Human,regulation of humoral immune response (GO:0002920),1/54,0.1265883240687765,0.1849809179994915,0,0,7.661532537543319,15.834970375184442,GATA6,SEC,0.8976063498190403
KEGG_2021_Human,regulation of proteasomal protein catabolic process (GO:0061136),1/54,0.1265883240687765,0.1849809179994915,0,0,7.661532537543319,15.834970375184442,ECSCR,SEC,0.8976063498190403
KEGG_2021_Human,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/55,0.1287777613922166,0.1875488202826242,0,0,7.519274376417234,15.412009607623004,AQP1,SEC,0.8901591287349465
KEGG_2021_Human,monocarboxylic acid transport (GO:0015718),1/57,0.1331405122852093,0.1932541215109727,0,0,7.25,14.618539131965724,SLCO2A1,SEC,0.8756897763447542
KEGG_2021_Human,regulation of calcium ion transport (GO:0051924),1/58,0.1353138517398134,0.1957540388502635,0,0,7.122448979591836,14.246025949065045,STC1,SEC,0.8686577434892403
KEGG_2021_Human,regulation of secretion by cell (GO:1903530),1/59,0.1374818510452552,0.1982296456931586,0,0,6.9992962702322306,13.8884471557023,RAB3C,SEC,0.8617546291873563
KEGG_2021_Human,anterior/posterior pattern specification (GO:0009952),1/63,0.1461007034145454,0.2085779779010286,0,0,6.54641211323239,12.591756250239603,HOXD9,SEC,0.8353476931121088
KEGG_2021_Human,cellular response to reactive oxygen species (GO:0034614),1/63,0.1461007034145454,0.2085779779010286,0,0,6.54641211323239,12.591756250239603,AQP1,SEC,0.8353476931121088
KEGG_2021_Human,positive regulation of viral process (GO:0048524),1/63,0.1461007034145454,0.2085779779010286,0,0,6.54641211323239,12.591756250239603,NR5A2,SEC,0.8353476931121088
KEGG_2021_Human,protein secretion (GO:0009306),1/64,0.1482421941802595,0.2109413517187956,0,0,6.442176870748299,12.297522293260638,RAB3C,SEC,0.8290281655096747
KEGG_2021_Human,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/65,0.1503784214913892,0.2125870844536251,0,0,6.341198979591836,12.01403781811508,CALCRL,SEC,0.8228144782361342
KEGG_2021_Human,inorganic anion transmembrane transport (GO:0098661),1/65,0.1503784214913892,0.2125870844536251,0,0,6.341198979591836,12.01403781811508,ANO2,SEC,0.8228144782361342
KEGG_2021_Human,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.214899606238383,0,0,6.243328100470958,11.740759916332207,RAMP3,SEC,0.8167033932798328
KEGG_2021_Human,regulation of viral genome replication (GO:0045069),1/67,0.1546351363099914,0.2171898031020591,0,0,6.148423005565863,11.477180657220888,NR5A2,SEC,0.8106918184915987
KEGG_2021_Human,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.1567556490806558,0.2194579087129182,0,0,6.0563508985683825,11.222824361971773,CARD10,SEC,0.8047767993307415
KEGG_2021_Human,synapse assembly (GO:0007416),1/69,0.158870948881139,0.2217041537440976,0,0,5.966986794717887,10.977245117600177,GPM6A,SEC,0.7989555105590889
KEGG_2021_Human,kidney development (GO:0001822),1/70,0.1609810482853106,0.2232133385170121,0,0,5.880212954747116,10.740024519792764,ROBO2,SEC,0.7932252488723367
KEGG_2021_Human,cellular response to light stimulus (GO:0071482),1/70,0.1609810482853106,0.2232133385170121,0,0,5.880212954747116,10.740024519792764,AQP1,SEC,0.7932252488723367
KEGG_2021_Human,positive regulation of cellular protein localization (GO:1903829),1/71,0.16308595979881,0.2246962112783605,0,0,5.795918367346939,10.51076961698872,CARD10,SEC,0.7875834261109624
KEGG_2021_Human,nucleic acid metabolic process (GO:0090304),1/71,0.16308595979881,0.2246962112783605,0,0,5.795918367346939,10.51076961698872,DNASE1L3,SEC,0.7875834261109624
KEGG_2021_Human,positive regulation of neurogenesis (GO:0050769),1/72,0.1651856959101235,0.2268689621044102,0,0,5.713998275366484,10.28911103101624,ROBO2,SEC,0.78202756268309
KEGG_2021_Human,regulation of stress fiber assembly (GO:0051492),1/74,0.1693696918266344,0.2304277311998726,0,0,5.556891249650545,9.867213018330611,ARHGEF15,SEC,0.7711643026835198
KEGG_2021_Human,negative regulation of protein binding (GO:0032091),1/74,0.1693696918266344,0.2304277311998726,0,0,5.556891249650545,9.867213018330611,CCL23,SEC,0.7711643026835198
KEGG_2021_Human,NIK/NF-kappaB signaling (GO:0038061),1/74,0.1693696918266344,0.2304277311998726,0,0,5.556891249650545,9.867213018330611,CARD10,SEC,0.7711643026835198
KEGG_2021_Human,nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.1714539764404576,0.2325344555473706,0,0,5.4815223386651954,9.666337985731484,DNASE1L3,SEC,0.7658524380723842
KEGG_2021_Human,regulation of epithelial to mesenchymal transition (GO:0010717),1/76,0.1735331353639065,0.2338924867948305,0,0,5.408163265306122,9.4717853003048,OLFM1,SEC,0.7606175863963804
KEGG_2021_Human,chloride transport (GO:0006821),1/76,0.1735331353639065,0.2338924867948305,0,0,5.408163265306122,9.4717853003048,ANO2,SEC,0.7606175863963804
KEGG_2021_Human,negative regulation of developmental process (GO:0051093),1/77,0.1756071809118701,0.2345031277407742,0,0,5.336734693877551,9.283280446293812,ARHGEF15,SEC,0.7554577289388229
KEGG_2021_Human,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.1756071809118701,0.2345031277407742,0,0,5.336734693877551,9.283280446293812,SELP,SEC,0.7554577289388229
KEGG_2021_Human,cellular response to UV (GO:0034644),1/77,0.1756071809118701,0.2345031277407742,0,0,5.336734693877551,9.283280446293812,AQP1,SEC,0.7554577289388229
KEGG_2021_Human,protein modification process (GO:0036211),1/78,0.1776761254379788,0.2358147964528526,0,0,5.267161410018553,9.10056411919043,PLAT,SEC,0.7503709249641564
KEGG_2021_Human,negative regulation of blood vessel morphogenesis (GO:2000181),1/78,0.1776761254379788,0.2358147964528526,0,0,5.267161410018553,9.10056411919043,ECSCR,SEC,0.7503709249641564
KEGG_2021_Human,regulation of ion transport (GO:0043269),1/79,0.1797399811935544,0.2378266824329348,0,0,5.199372056514914,8.923391206941128,STC1,SEC,0.745355308086215
KEGG_2021_Human,skin development (GO:0043588),1/80,0.181798760490535,0.2383705802202181,0,0,5.133298889175924,8.751529842637671,GATA6,SEC,0.7404090821369118
KEGG_2021_Human,regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.181798760490535,0.2383705802202181,0,0,5.133298889175924,8.751529842637671,TCIM,SEC,0.7404090821369118
KEGG_2021_Human,regulation of protein localization to plasma membrane (GO:1903076),1/80,0.181798760490535,0.2383705802202181,0,0,5.133298889175924,8.751529842637671,RAMP3,SEC,0.7404090821369118
KEGG_2021_Human,regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.1859011384602527,0.2427619836503996,0,0,5.00604686318972,8.422875391899517,RAMP3,SEC,0.7307179505966239
KEGG_2021_Human,epidermis development (GO:0008544),1/83,0.1879447615357932,0.2427619836503996,0,0,4.944748631159781,8.265677319811374,GATA6,SEC,0.7259697745939766
KEGG_2021_Human,regulation of defense response (GO:0031347),1/83,0.1879447615357932,0.2427619836503996,0,0,4.944748631159781,8.265677319811374,SELE,SEC,0.7259697745939766
KEGG_2021_Human,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1/83,0.1879447615357932,0.2427619836503996,0,0,4.944748631159781,8.265677319811374,GPM6A,SEC,0.7259697745939766
KEGG_2021_Human,regulation of Notch signaling pathway (GO:0008593),1/83,0.1879447615357932,0.2427619836503996,0,0,4.944748631159781,8.265677319811374,TCIM,SEC,0.7259697745939766
KEGG_2021_Human,cellular response to oxygen-containing compound (GO:1901701),2/323,0.1932342825020938,0.2488536457148626,0,0,2.5478971962616823,4.188365716592005,RAMP3;AQP1,SEC,0.7139158210847405
KEGG_2021_Human,positive regulation of proteasomal protein catabolic process (GO:1901800),1/86,0.1940455128548384,0.2491590312988162,0,0,4.769507803121249,7.820383303288144,ECSCR,SEC,0.7120963955156414
KEGG_2021_Human,negative regulation of angiogenesis (GO:0016525),1/87,0.196069097589664,0.2510147149083014,0,0,4.713811105837684,7.6801565438185,ECSCR,SEC,0.7075908500030543
KEGG_2021_Human,positive regulation of inflammatory response (GO:0050729),1/89,0.2001013407742902,0.2531894515919591,0,0,4.6062152133580705,7.411084001248333,C2CD4B,SEC,0.6987500013741589
KEGG_2021_Human,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),1/89,0.2001013407742902,0.2531894515919591,0,0,4.6062152133580705,7.411084001248333,AQP1,SEC,0.6987500013741589
KEGG_2021_Human,regulation of endothelial cell migration (GO:0010594),1/89,0.2001013407742902,0.2531894515919591,0,0,4.6062152133580705,7.411084001248333,STC1,SEC,0.6987500013741589
KEGG_2021_Human,second-messenger-mediated signaling (GO:0019932),1/89,0.2001013407742902,0.2531894515919591,0,0,4.6062152133580705,7.411084001248333,SELE,SEC,0.6987500013741589
KEGG_2021_Human,cytokine-mediated signaling pathway (GO:0019221),3/621,0.2024454460334983,0.2554108243562158,0,0,1.9966948977483991,3.1892904723776496,CCL14;CCL23;PLVAP,SEC,0.6936919881460838
KEGG_2021_Human,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.2081064570390282,0.2617918908838789,0,0,4.40505767524401,6.914643337844717,RAMP3,SEC,0.6817144444740324
KEGG_2021_Human,negative regulation of cellular protein metabolic process (GO:0032269),1/94,0.2100954368002021,0.2627706615887253,0,0,4.357472021066491,6.79849904676328,PLAT,SEC,0.6775833802166729
KEGG_2021_Human,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.2627706615887253,0,0,4.357472021066491,6.79849904676328,LDB2,SEC,0.6775833802166729
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",4/948,0.21159142351009,0.2637321258828952,0,0,1.7507369196757554,2.7190662035683872,GATA6;LDB2;HOXD9;ZNF366,SEC,0.6745019396506919
KEGG_2021_Human,regulation of cell cycle phase transition (GO:1901987),1/95,0.2120795205832498,0.2637321258828952,0,0,4.310898827616153,6.685315939697291,TCIM,SEC,0.6735012670190429
KEGG_2021_Human,regulation of vesicle-mediated transport (GO:0060627),1/96,0.2140587201245348,0.2654328129544231,0,0,4.26530612244898,6.5749903239841245,RAB3C,SEC,0.6694670755856718
KEGG_2021_Human,regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.2180025137484037,0.2695529657173995,0,0,4.176940879444562,6.362519703204576,RAMP3,SEC,0.6615384985937142
KEGG_2021_Human,response to UV (GO:0009411),1/99,0.2199671313012003,0.2712094743884117,0,0,4.134110787172012,6.26018948804807,AQP1,SEC,0.6576422090003602
KEGG_2021_Human,epithelial cell differentiation (GO:0030855),1/101,0.2238818662412048,0.2744766382731156,0,0,4.051020408163265,6.062906014187368,GATA6,SEC,0.6499810815451941
KEGG_2021_Human,positive regulation of protein localization to membrane (GO:1905477),1/101,0.2238818662412048,0.2744766382731156,0,0,4.051020408163265,6.062906014187368,RAMP3,SEC,0.6499810815451941
KEGG_2021_Human,regulation of cell death (GO:0010941),1/102,0.2258320069783284,0.2753120534511082,0,0,4.010709234188725,5.967790506031058,RAMP3,SEC,0.6462145058611213
KEGG_2021_Human,cell junction assembly (GO:0034329),1/102,0.2258320069783284,0.2753120534511082,0,0,4.010709234188725,5.967790506031058,GPM6A,SEC,0.6462145058611213
KEGG_2021_Human,cellular response to organonitrogen compound (GO:0071417),1/103,0.2277773453985499,0.2769057924452959,0,0,3.971188475390156,5.874923343943355,AQP1,SEC,0.64248947278397
KEGG_2021_Human,activation of GTPase activity (GO:0090630),1/105,0.2316536615468536,0.2808315338305432,0,0,3.894427001569859,5.6956456810845415,ARHGEF15,SEC,0.6351608308934773
KEGG_2021_Human,positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.2335846623503299,0.2815992873890088,0,0,3.857142857142857,5.6090983677319475,TCIM,SEC,0.6315556772929499
KEGG_2021_Human,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.2335846623503299,0.2815992873890088,0,0,3.857142857142857,5.6090983677319475,SELP,SEC,0.6315556772929499
KEGG_2021_Human,lipid transport (GO:0006869),1/109,0.239349173739861,0.2877494221692512,0,0,3.749433106575964,5.361058744932435,SLCO2A1,SEC,0.6209680674126086
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),2/379,0.24470533557908,0.2930052228485414,0,0,2.163240495137047,3.045194735705852,CCL23;GATA6,SEC,0.6113565611455968
KEGG_2021_Human,protein-containing complex subunit organization (GO:0043933),1/112,0.2450711886958998,0.2930052228485414,0,0,3.647545504688362,5.129202360192396,CARD10,SEC,0.6107077427090284
KEGG_2021_Human,activation of protein kinase activity (GO:0032147),1/114,0.2488624078588274,0.2959076301663866,0,0,3.582625970742279,4.982913653406146,CARD10,SEC,0.6040407011916724
KEGG_2021_Human,negative regulation of cell motility (GO:2000146),1/114,0.2488624078588274,0.2959076301663866,0,0,3.582625970742279,4.982913653406146,STC1,SEC,0.6040407011916724
KEGG_2021_Human,regulation of protein-containing complex assembly (GO:0043254),1/116,0.2526349665899778,0.2987563365123988,0,0,3.5199645075421473,4.8428011439058265,SELP,SEC,0.5975065399797567
KEGG_2021_Human,tumor necrosis factor-mediated signaling pathway (GO:0033209),1/116,0.2526349665899778,0.2987563365123988,0,0,3.5199645075421473,4.8428011439058265,PLVAP,SEC,0.5975065399797567
KEGG_2021_Human,positive regulation of cell projection organization (GO:0031346),1/117,0.2545142764118688,0.3001608585944323,0,0,3.4894440534834623,4.774949480472317,ROBO2,SEC,0.5942878518616017
KEGG_2021_Human,epithelium development (GO:0060429),1/122,0.2638415777635164,0.3094790398631517,0,0,3.3444088379153314,4.456111874258477,GATA6,SEC,0.5786567646257991
KEGG_2021_Human,potassium ion transport (GO:0006813),1/122,0.2638415777635164,0.3094790398631517,0,0,3.3444088379153314,4.456111874258477,AQP1,SEC,0.5786567646257991
KEGG_2021_Human,regulation of phosphorylation (GO:0042325),1/125,0.2693829605231016,0.3151272368383452,0,0,3.263001974983542,4.279822783786303,LDB2,SEC,0.5696298784899082
KEGG_2021_Human,synapse organization (GO:0050808),1/126,0.2712209880572274,0.3160876881899201,0,0,3.236734693877551,4.223360488574632,GPM6A,SEC,0.5666767062328689
KEGG_2021_Human,regulation of cell migration (GO:0030334),2/408,0.2716606168083876,0.3160876881899201,0,0,2.0057471264367814,2.6138931132295458,STC1;LDB2,SEC,0.5659733175722854
KEGG_2021_Human,plasma membrane bounded cell projection organization (GO:0120036),1/128,0.274883458910421,0.3189824095377613,0,0,3.1854411055760887,4.113704308580095,GPM6A,SEC,0.5608513930050725
KEGG_2021_Human,cellular protein metabolic process (GO:0044267),2/417,0.2800329921032276,0.3235878242774029,0,0,1.9613453815261044,2.4964942594636463,GATA6;PLAT,SEC,0.552790799213849
KEGG_2021_Human,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.3235878242774029,0,0,3.111459968602826,3.956968446025251,AQP1,SEC,0.5523097126477655
KEGG_2021_Human,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3260291859331644,0,0,3.0640074211502784,3.857336278341556,C2CD4B,SEC,0.546741450090894
KEGG_2021_Human,regulation of cell motility (GO:2000145),1/133,0.2839609038772722,0.3260291859331644,0,0,3.0640074211502784,3.857336278341556,LDB2,SEC,0.546741450090894
KEGG_2021_Human,neuron projection morphogenesis (GO:0048812),1/140,0.2964824884084789,0.3386142104454733,0,0,2.9086771399207163,3.5362740390257685,GPM6A,SEC,0.5280009529309525
KEGG_2021_Human,transcription initiation from RNA polymerase II promoter (GO:0006367),1/140,0.2964824884084789,0.3386142104454733,0,0,2.9086771399207163,3.5362740390257685,NR5A2,SEC,0.5280009529309525
KEGG_2021_Human,neuron development (GO:0048666),1/143,0.3017829564686885,0.3437632627491097,0,0,2.8467950560505892,3.410594866305226,GPM6A,SEC,0.5203052911363482
KEGG_2021_Human,negative regulation of cell migration (GO:0030336),1/144,0.3035410668561185,0.3448607932344383,0,0,2.826744683887541,3.370153465117457,STC1,SEC,0.5177825437898177
KEGG_2021_Human,brain development (GO:0007420),1/150,0.3139989845586295,0.3548842690063677,0,0,2.712094233666621,3.141596466170354,ROBO2,SEC,0.5030717563895143
KEGG_2021_Human,regulation of cytokine production (GO:0001817),1/150,0.3139989845586295,0.3548842690063677,0,0,2.712094233666621,3.141596466170354,ACKR1,SEC,0.5030717563895143
KEGG_2021_Human,skeletal system development (GO:0001501),1/158,0.3277037968552589,0.3694115528186554,0,0,2.5728584427401535,2.8703970097526006,STC1,SEC,0.48451852674781976
KEGG_2021_Human,positive regulation of protein kinase B signaling (GO:0051897),1/161,0.3327736194132171,0.3732305009391333,0,0,2.524234693877551,2.7773973646136283,RAMP3,SEC,0.4778511096570981
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),2/474,0.3328115296392732,0.3732305009391333,0,0,1.7194562146892656,1.8917094920733264,CCL14;AQP1,SEC,0.47780163679243126
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),2/482,0.3401543782991926,0.3795038565086107,0,0,1.6901041666666667,1.8225334796372663,OLFM1;RAMP3,SEC,0.46832393464331673
KEGG_2021_Human,cellular response to cytokine stimulus (GO:0071345),2/482,0.3401543782991926,0.3795038565086107,0,0,1.6901041666666667,1.8225334796372663,CCL14;CCL23,SEC,0.46832393464331673
KEGG_2021_Human,"DNA-templated transcription, initiation (GO:0006352)",1/168,0.3444579462443567,0.3833198683847457,0,0,2.4175730172308443,2.5766088705447237,NR5A2,SEC,0.46286379212748074
KEGG_2021_Human,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.3878294052493155,0,0,2.3745498199279713,2.4969025061029213,GPM6A,SEC,0.4566722378913039
KEGG_2021_Human,cation transport (GO:0006812),1/174,0.3543133002736421,0.391277283253844,0,0,2.333018756635602,2.4206789693623425,AQP1,SEC,0.45061254473982715
KEGG_2021_Human,neuron differentiation (GO:0030182),1/174,0.3543133002736421,0.391277283253844,0,0,2.333018756635602,2.4206789693623425,LHX6,SEC,0.45061254473982715
KEGG_2021_Human,positive regulation of nucleic acid-templated transcription (GO:1903508),2/511,0.3665685304553946,0.4037836096894449,0,0,1.591437459070072,1.5971185548456277,NR5A2;GATA6,SEC,0.43584482152384213
KEGG_2021_Human,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.4242511672758073,0,0,2.089140319340171,1.988001678572607,OLFM1,SEC,0.4132695879859197
KEGG_2021_Human,positive regulation of transcription by RNA polymerase II (GO:0045944),3/908,0.3977118667386928,0.4358761367792744,0,0,1.3432467379804869,1.2385104166535874,NR5A2;GATA6;LDB2,SEC,0.40043145054722185
KEGG_2021_Human,axon guidance (GO:0007411),1/203,0.3999373645428959,0.4372111239587326,0,0,1.9951505354617096,1.8284503867148747,ROBO2,SEC,0.398008019580524
KEGG_2021_Human,regulation of protein kinase B signaling (GO:0051896),1/207,0.4059770389691228,0.4426985801824102,0,0,1.9560134733505052,1.7632653144438126,RAMP3,SEC,0.3914985283218076
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4529300540765793,0,0,1.8910606496119575,1.656759537391559,STC1,SEC,0.3804856946694876
KEGG_2021_Human,extracellular structure organization (GO:0043062),1/216,0.41934932166703,0.4549940140087276,0,0,1.8732795443758896,1.627975467192003,VWF,SEC,0.3774240551539837
KEGG_2021_Human,external encapsulating structure organization (GO:0045229),1/217,0.4208167942393084,0.4554476027427927,0,0,1.8645124716553287,1.613843141672166,VWF,SEC,0.375906936392536
KEGG_2021_Human,axonogenesis (GO:0007409),1/240,0.4535831041409784,0.4896892218835439,0,0,1.6831184356587825,1.3306343458644796,ROBO2,SEC,0.34334313117644527
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),2/625,0.4660144680358849,0.501861734807876,0,0,1.2926029962546817,0.9869522795970046,CCL14;RAMP3,SEC,0.33160059985375573
KEGG_2021_Human,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.5048474921977137,0,0,1.6016749329213755,1.2094704650298027,VWF,SEC,0.32794816113488356
KEGG_2021_Human,positive regulation of cell differentiation (GO:0045597),1/258,0.4779525975371456,0.511882342714095,0,0,1.563805288652426,1.154469433244659,OLFM1,SEC,0.3206151737830371
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),6/2206,0.478857675442218,0.511882342714095,0,0,1.100206611570248,0.8101391784721939,NR5A2;GATA6;LHX6;LDB2;HOXD9;ZNF366,SEC,0.31979354703381785
KEGG_2021_Human,cellular component assembly (GO:0022607),1/261,0.4819092749521712,0.5138786863126347,0,0,1.5455259026687598,1.1282329953702568,CARD10,SEC,0.31703471507296654
KEGG_2021_Human,protein-containing complex assembly (GO:0065003),1/267,0.4897346646287026,0.5196695463297235,0,0,1.510204081632653,1.0781219104526054,CARD10,SEC,0.3100391544580995
KEGG_2021_Human,negative regulation of signal transduction (GO:0009968),1/267,0.4897346646287026,0.5196695463297235,0,0,1.510204081632653,1.0781219104526054,TCIM,SEC,0.3100391544580995
KEGG_2021_Human,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5197706637308906,0,0,1.504471451501949,1.0700627976731167,ROBO2,SEC,0.3088941088615854
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",6/2244,0.4960895197517082,0.523851220370417,0,0,1.079210333902023,0.7565252409314136,NR5A2;TCIM;GATA6;LHX6;HOXD9;ZNF366,SEC,0.30443994765052834
KEGG_2021_Human,DNA metabolic process (GO:0006259),1/277,0.5025203266713362,0.5293539363479609,0,0,1.4547471162377994,1.0010394055052982,DNASE1L3,SEC,0.29884636657880626
KEGG_2021_Human,regulation of gene expression (GO:0010468),3/1079,0.5107084384516999,0.5366766641356847,0,0,1.1196314165941628,0.7523435208329574,OLFM1;NR5A2;RAMP3,SEC,0.2918269662236996
KEGG_2021_Human,positive regulation of programmed cell death (GO:0043068),1/286,0.5137586327573376,0.5385698094832717,0,0,1.4081632653061225,0.937839142501346,OLFM1,SEC,0.289240867544339
KEGG_2021_Human,proteolysis (GO:0006508),1/287,0.51499186851511,0.5385698094832717,0,0,1.4031682603111175,0.9311483055746664,PLAT,SEC,0.28819962821492023
KEGG_2021_Human,regulation of cell cycle (GO:0051726),1/296,0.5259539383992272,0.5487115607338092,0,0,1.359737115185057,0.8736877155004001,GATA6,SEC,0.2790522884983112
KEGG_2021_Human,extracellular matrix organization (GO:0030198),1/300,0.5307476794848257,0.5523848750513534,0,0,1.341273633199099,0.8496546643160489,VWF,SEC,0.2751118959639202
KEGG_2021_Human,MAPK cascade (GO:0000165),1/303,0.5343117772273281,0.5547639026714364,0,0,1.32774699283687,0.8321996277505203,PLVAP,SEC,0.2722052530518486
KEGG_2021_Human,positive regulation of apoptotic process (GO:0043065),1/310,0.5425251558593591,0.5619472974772359,0,0,1.2972062611452349,0.7932686422257892,OLFM1,SEC,0.2655801196036423
KEGG_2021_Human,transcription by RNA polymerase II (GO:0006366),1/320,0.5540128017436795,0.5724798951351355,0,0,1.255901733734246,0.7416947278731473,NR5A2,SEC,0.2564801997798679
KEGG_2021_Human,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5734533431790013,0,0,1.2479496471485791,0.7319104885681406,OLFM1,SEC,0.2547095446988111
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",3/1183,0.5741266920581598,0.5893509431298242,0,0,1.015326361341507,0.5634098665849442,NR5A2;GATA6;LDB2,SEC,0.24099226162550894
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),2/764,0.5744134768292987,0.5893509431298242,0,0,1.0492125984251968,0.5816895490313783,CCL14;CCL23,SEC,0.24077537927422193
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),1/345,0.5815093765862647,0.5952242203736766,0,0,1.1631466540104414,0.6305745813190116,OLFM1,SEC,0.23544327806907975
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6212252284660599,0,0,1.0799779371207945,0.5367673309131087,RAMP3,SEC,0.21585171499242045
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.6399826390088766,0.6520010923235974,0,0,0.989871879272801,0.4417939051458828,PLAT,SEC,0.19383180708628664
KEGG_2021_Human,regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.663134010332821,0.6740050596825394,0,0,0.928642785785643,0.3814661952932429,NR5A2,SEC,0.17839869773857764
KEGG_2021_Human,regulation of intracellular signal transduction (GO:1902531),1/437,0.6691136001848389,0.6784936973836917,0,0,0.9134057292641828,0.3670077257341264,VWF,SEC,0.1745001427028418
KEGG_2021_Human,negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.6912187085983104,0.6992748707031857,0,0,0.8589500595054437,0.3172093937483807,GATA6,SEC,0.16038451570993173
KEGG_2021_Human,regulation of cellular macromolecule biosynthetic process (GO:2000112),1/468,0.6943679720033368,0.700827208952205,0,0,0.8514180832932745,0.3105575044475373,NR5A2,SEC,0.15841031937391015
KEGG_2021_Human,neutrophil activation involved in immune response (GO:0002283),1/485,0.7074048097353064,0.7123287411255754,0,0,0.8207960870298533,0.2841203737887477,DNASE1L3,SEC,0.15033199168778996
KEGG_2021_Human,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7504933808556635,0.7539678872485137,0,0,0.7252747252747253,0.2081715773755284,GATA6,SEC,0.1246531337611999
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),1/566,0.7624057114769476,0.7641664636974487,0,0,0.700198663536211,0.1899473973942179,CCL23,SEC,0.11781385888910202
KEGG_2021_Human,cellular protein modification process (GO:0006464),1/1025,0.9281942108891912,0.9281942108891912,0,0,0.3771922831632653,0.0281062148400667,PLAT,SEC,0.032361144586154744
GO_Biological_Process_2021,extracellular matrix organization (GO:0030198),5/300,0.0008957269205494731,0.1607654015366435,0,0,7.4030131826742,51.953420899616845,ADAMTS14;ADAMTS18;ADAM12;HAS2;TLL1,THY1+ MSC,3.047824373122375
GO_Biological_Process_2021,acute inflammatory response (GO:0002526),2/27,0.0020657293545543,0.1607654015366435,0,0,33.208333333333336,205.3029465636782,HP;LBP,THY1+ MSC,2.684926579003782
GO_Biological_Process_2021,synapse organization (GO:0050808),3/126,0.0038560473771467,0.1607654015366435,0,0,10.289050337311885,57.18770048343562,FLRT3;PAK3;PDZRN3,THY1+ MSC,2.41385763879748
GO_Biological_Process_2021,neuron projection morphogenesis (GO:0048812),3/140,0.005174274872555,0.1607654015366435,0,0,9.231091784438576,48.59298474885369,CNTNAP2;FLRT3;PAK3,THY1+ MSC,2.286150504018583
GO_Biological_Process_2021,renal system development (GO:0072001),2/57,0.0089551608364968,0.1607654015366435,0,0,15.071969696969695,71.07225417227201,HAS2;WNT4,THY1+ MSC,2.0479266097283184
GO_Biological_Process_2021,neuron projection development (GO:0031175),3/171,0.0089682253768461,0.1607654015366435,0,0,7.51595744680851,35.43073044803733,CNTNAP2;FLRT3;PAK3,THY1+ MSC,2.0472934861969025
GO_Biological_Process_2021,regulation of secretion by cell (GO:1903530),2/59,0.0095700107879558,0.1607654015366435,0,0,14.541666666666666,67.6059670933825,SNCAIP;STXBP5L,THY1+ MSC,2.019087572657113
GO_Biological_Process_2021,regulation of respiratory burst involved in inflammatory response (GO:0060264),1/5,0.0124387771927725,0.1607654015366435,0,0,101.76530612244898,446.4379351400606,LBP,THY1+ MSC,1.9052223113279663
GO_Biological_Process_2021,pyridine-containing compound metabolic process (GO:0072524),1/5,0.0124387771927725,0.1607654015366435,0,0,101.76530612244898,446.4379351400606,AOX1,THY1+ MSC,1.9052223113279663
GO_Biological_Process_2021,regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070),1/5,0.0124387771927725,0.1607654015366435,0,0,101.76530612244898,446.4379351400606,MRAP,THY1+ MSC,1.9052223113279663
GO_Biological_Process_2021,non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030),1/5,0.0124387771927725,0.1607654015366435,0,0,101.76530612244898,446.4379351400606,WNT4,THY1+ MSC,1.9052223113279663
GO_Biological_Process_2021,negative regulation of hydrogen peroxide metabolic process (GO:0010727),1/5,0.0124387771927725,0.1607654015366435,0,0,101.76530612244898,446.4379351400606,HP,THY1+ MSC,1.9052223113279663
GO_Biological_Process_2021,metanephric mesenchymal cell differentiation (GO:0072162),1/5,0.0124387771927725,0.1607654015366435,0,0,101.76530612244898,446.4379351400606,WNT4,THY1+ MSC,1.9052223113279663
GO_Biological_Process_2021,protein localization to axon (GO:0099612),1/5,0.0124387771927725,0.1607654015366435,0,0,101.76530612244898,446.4379351400606,CNTNAP2,THY1+ MSC,1.9052223113279663
GO_Biological_Process_2021,kidney development (GO:0001822),2/70,0.013274200561286,0.1607654015366435,0,0,12.182598039215684,52.65237170003471,HAS2;WNT4,THY1+ MSC,1.8769916248436092
GO_Biological_Process_2021,cellular response to lipoteichoic acid (GO:0071223),1/6,0.0149082847993736,0.1607654015366435,0,0,81.40816326530613,342.3895623444841,LBP,THY1+ MSC,1.8265723193247598
GO_Biological_Process_2021,chitin catabolic process (GO:0006032),1/6,0.0149082847993736,0.1607654015366435,0,0,81.40816326530613,342.3895623444841,CHI3L2,THY1+ MSC,1.8265723193247598
GO_Biological_Process_2021,chitin metabolic process (GO:0006030),1/6,0.0149082847993736,0.1607654015366435,0,0,81.40816326530613,342.3895623444841,CHI3L2,THY1+ MSC,1.8265723193247598
GO_Biological_Process_2021,mesenchymal cell differentiation involved in kidney development (GO:0072161),1/6,0.0149082847993736,0.1607654015366435,0,0,81.40816326530613,342.3895623444841,WNT4,THY1+ MSC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),1/6,0.0149082847993736,0.1607654015366435,0,0,81.40816326530613,342.3895623444841,LIF,THY1+ MSC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of gap junction assembly (GO:1903598),1/6,0.0149082847993736,0.1607654015366435,0,0,81.40816326530613,342.3895623444841,CNTNAP2,THY1+ MSC,1.8265723193247598
GO_Biological_Process_2021,vacuole organization (GO:0007033),1/6,0.0149082847993736,0.1607654015366435,0,0,81.40816326530613,342.3895623444841,NDP,THY1+ MSC,1.8265723193247598
GO_Biological_Process_2021,response to lipoteichoic acid (GO:0070391),1/6,0.0149082847993736,0.1607654015366435,0,0,81.40816326530613,342.3895623444841,LBP,THY1+ MSC,1.8265723193247598
GO_Biological_Process_2021,vocal learning (GO:0042297),1/6,0.0149082847993736,0.1607654015366435,0,0,81.40816326530613,342.3895623444841,CNTNAP2,THY1+ MSC,1.8265723193247598
GO_Biological_Process_2021,imitative learning (GO:0098596),1/6,0.0149082847993736,0.1607654015366435,0,0,81.40816326530613,342.3895623444841,CNTNAP2,THY1+ MSC,1.8265723193247598
GO_Biological_Process_2021,extracellular structure organization (GO:0043062),3/216,0.0167785010572714,0.1607654015366435,0,0,5.914593946658676,24.176830822166,ADAMTS14;ADAMTS18;ADAM12,THY1+ MSC,1.775246840386538
GO_Biological_Process_2021,external encapsulating structure organization (GO:0045229),3/217,0.0169842657929789,0.1607654015366435,0,0,5.886657387154504,23.99088324962961,ADAMTS14;ADAMTS18;ADAM12,THY1+ MSC,1.7699532223559038
GO_Biological_Process_2021,negative regulation of steroid metabolic process (GO:0045939),1/7,0.0173717414502839,0.1607654015366435,0,0,67.83673469387755,274.9362107684438,WNT4,THY1+ MSC,1.7601566430186848
GO_Biological_Process_2021,cellular response to platelet-derived growth factor stimulus (GO:0036120),1/7,0.0173717414502839,0.1607654015366435,0,0,67.83673469387755,274.9362107684438,HAS2,THY1+ MSC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of respiratory burst (GO:0060267),1/7,0.0173717414502839,0.1607654015366435,0,0,67.83673469387755,274.9362107684438,LBP,THY1+ MSC,1.7601566430186848
GO_Biological_Process_2021,regulation of aldosterone biosynthetic process (GO:0032347),1/7,0.0173717414502839,0.1607654015366435,0,0,67.83673469387755,274.9362107684438,WNT4,THY1+ MSC,1.7601566430186848
GO_Biological_Process_2021,regulation of male gonad development (GO:2000018),1/7,0.0173717414502839,0.1607654015366435,0,0,67.83673469387755,274.9362107684438,WNT4,THY1+ MSC,1.7601566430186848
GO_Biological_Process_2021,detection of molecule of bacterial origin (GO:0032490),1/7,0.0173717414502839,0.1607654015366435,0,0,67.83673469387755,274.9362107684438,LBP,THY1+ MSC,1.7601566430186848
GO_Biological_Process_2021,positive regulation of urine volume (GO:0035810),1/7,0.0173717414502839,0.1607654015366435,0,0,67.83673469387755,274.9362107684438,HAS2,THY1+ MSC,1.7601566430186848
GO_Biological_Process_2021,pericardium morphogenesis (GO:0003344),1/7,0.0173717414502839,0.1607654015366435,0,0,67.83673469387755,274.9362107684438,FLRT3,THY1+ MSC,1.7601566430186848
GO_Biological_Process_2021,regulation of cortisol biosynthetic process (GO:2000064),1/7,0.0173717414502839,0.1607654015366435,0,0,67.83673469387755,274.9362107684438,WNT4,THY1+ MSC,1.7601566430186848
GO_Biological_Process_2021,hyaluronan biosynthetic process (GO:0030213),1/7,0.0173717414502839,0.1607654015366435,0,0,67.83673469387755,274.9362107684438,HAS2,THY1+ MSC,1.7601566430186848
GO_Biological_Process_2021,cellular response to lipid (GO:0071396),3/219,0.0174000582463563,0.1607654015366435,0,0,5.831560283687943,23.625293607147455,BRINP1;ADCY2;LBP,THY1+ MSC,1.7594492979226422
GO_Biological_Process_2021,cell migration involved in heart development (GO:0060973),1/8,0.0198291614511851,0.1607654015366435,0,0,58.142857142857146,227.9549801512961,FLRT3,THY1+ MSC,1.702695651141308
GO_Biological_Process_2021,collagen fibril organization (GO:0030199),2/89,0.0208876608034354,0.1607654015366435,0,0,9.512931034482758,36.80169347929862,ADAMTS14;TLL1,THY1+ MSC,1.6801101936742149
GO_Biological_Process_2021,cellular response to forskolin (GO:1904322),1/9,0.0222805591236868,0.1607654015366435,0,0,50.87244897959184,193.52086993316271,ADCY2,THY1+ MSC,1.652073914876897
GO_Biological_Process_2021,regulation of gap junction assembly (GO:1903596),1/9,0.0222805591236868,0.1607654015366435,0,0,50.87244897959184,193.52086993316271,CNTNAP2,THY1+ MSC,1.652073914876897
GO_Biological_Process_2021,neuronal ion channel clustering (GO:0045161),1/9,0.0222805591236868,0.1607654015366435,0,0,50.87244897959184,193.52086993316271,CNTNAP2,THY1+ MSC,1.652073914876897
GO_Biological_Process_2021,glucosamine-containing compound catabolic process (GO:1901072),1/9,0.0222805591236868,0.1607654015366435,0,0,50.87244897959184,193.52086993316271,CHI3L2,THY1+ MSC,1.652073914876897
GO_Biological_Process_2021,response to forskolin (GO:1904321),1/9,0.0222805591236868,0.1607654015366435,0,0,50.87244897959184,193.52086993316271,ADCY2,THY1+ MSC,1.652073914876897
GO_Biological_Process_2021,regulation of nephron tubule epithelial cell differentiation (GO:0072182),1/9,0.0222805591236868,0.1607654015366435,0,0,50.87244897959184,193.52086993316271,LIF,THY1+ MSC,1.652073914876897
GO_Biological_Process_2021,negative regulation of platelet aggregation (GO:0090331),1/9,0.0222805591236868,0.1607654015366435,0,0,50.87244897959184,193.52086993316271,ADAMTS18,THY1+ MSC,1.652073914876897
GO_Biological_Process_2021,adrenal gland development (GO:0030325),1/10,0.024725948817258,0.1607654015366435,0,0,45.21768707482993,167.3010120823387,WNT4,THY1+ MSC,1.606847034080906
GO_Biological_Process_2021,receptor recycling (GO:0001881),1/10,0.024725948817258,0.1607654015366435,0,0,45.21768707482993,167.3010120823387,NSG1,THY1+ MSC,1.606847034080906
GO_Biological_Process_2021,regulation of urine volume (GO:0035809),1/10,0.024725948817258,0.1607654015366435,0,0,45.21768707482993,167.3010120823387,HAS2,THY1+ MSC,1.606847034080906
GO_Biological_Process_2021,negative regulation of hormone secretion (GO:0046888),1/10,0.024725948817258,0.1607654015366435,0,0,45.21768707482993,167.3010120823387,LIF,THY1+ MSC,1.606847034080906
GO_Biological_Process_2021,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),1/10,0.024725948817258,0.1607654015366435,0,0,45.21768707482993,167.3010120823387,LBP,THY1+ MSC,1.606847034080906
GO_Biological_Process_2021,cAMP biosynthetic process (GO:0006171),1/10,0.024725948817258,0.1607654015366435,0,0,45.21768707482993,167.3010120823387,ADCY2,THY1+ MSC,1.606847034080906
GO_Biological_Process_2021,cell differentiation involved in metanephros development (GO:0072202),1/10,0.024725948817258,0.1607654015366435,0,0,45.21768707482993,167.3010120823387,WNT4,THY1+ MSC,1.606847034080906
GO_Biological_Process_2021,nervous system development (GO:0007399),4/447,0.0252678658610057,0.1607654015366435,0,0,3.829031308273629,14.084026486919814,SNTG2;FLRT3;LSAMP;NDP,THY1+ MSC,1.5974314373016392
GO_Biological_Process_2021,positive regulation of alcohol biosynthetic process (GO:1902932),1/11,0.0271653448579923,0.1607654015366435,0,0,40.69387755102041,146.73452100035948,WNT4,THY1+ MSC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of steroid biosynthetic process (GO:0010894),1/11,0.0271653448579923,0.1607654015366435,0,0,40.69387755102041,146.73452100035948,WNT4,THY1+ MSC,1.5659847773237099
GO_Biological_Process_2021,regulation of inclusion body assembly (GO:0090083),1/11,0.0271653448579923,0.1607654015366435,0,0,40.69387755102041,146.73452100035948,SNCAIP,THY1+ MSC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of homotypic cell-cell adhesion (GO:0034111),1/11,0.0271653448579923,0.1607654015366435,0,0,40.69387755102041,146.73452100035948,ADAMTS18,THY1+ MSC,1.5659847773237099
GO_Biological_Process_2021,metanephric mesenchyme development (GO:0072075),1/11,0.0271653448579923,0.1607654015366435,0,0,40.69387755102041,146.73452100035948,WNT4,THY1+ MSC,1.5659847773237099
GO_Biological_Process_2021,positive regulation of macrophage differentiation (GO:0045651),1/11,0.0271653448579923,0.1607654015366435,0,0,40.69387755102041,146.73452100035948,LIF,THY1+ MSC,1.5659847773237099
GO_Biological_Process_2021,cellular response to fluid shear stress (GO:0071498),1/12,0.029598761568907,0.1696056020059597,0,0,36.99257884972171,130.2147194065139,HAS2,THY1+ MSC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of oxidoreductase activity (GO:0051354),1/12,0.029598761568907,0.1696056020059597,0,0,36.99257884972171,130.2147194065139,HP,THY1+ MSC,1.5287264597194943
GO_Biological_Process_2021,macrophage activation involved in immune response (GO:0002281),1/13,0.032026213248763,0.1696792504336223,0,0,33.90816326530612,116.6847899929619,LBP,THY1+ MSC,1.4944944088974865
GO_Biological_Process_2021,regulation of oxidoreductase activity (GO:0051341),1/13,0.032026213248763,0.1696792504336223,0,0,33.90816326530612,116.6847899929619,HP,THY1+ MSC,1.4944944088974865
GO_Biological_Process_2021,activation of protein kinase activity (GO:0032147),2/114,0.0330295301793541,0.1696792504336223,0,0,7.380208333333333,25.169117576656426,ADCY2;PAK3,THY1+ MSC,1.4810976037825534
GO_Biological_Process_2021,renal absorption (GO:0070293),1/14,0.0344477141698711,0.1696792504336223,0,0,31.298273155416013,105.4223689491126,HAS2,THY1+ MSC,1.4628395910668823
GO_Biological_Process_2021,cAMP metabolic process (GO:0046058),1/14,0.0344477141698711,0.1696792504336223,0,0,31.298273155416013,105.4223689491126,ADCY2,THY1+ MSC,1.4628395910668823
GO_Biological_Process_2021,acute-phase response (GO:0006953),1/15,0.0368632785936063,0.1696792504336223,0,0,29.06122448979592,95.91771596133704,LBP,THY1+ MSC,1.4334060415588732
GO_Biological_Process_2021,mammary gland epithelium development (GO:0061180),1/15,0.0368632785936063,0.1696792504336223,0,0,29.06122448979592,95.91771596133704,WNT4,THY1+ MSC,1.4334060415588732
GO_Biological_Process_2021,clathrin coat assembly (GO:0048268),1/15,0.0368632785936063,0.1696792504336223,0,0,29.06122448979592,95.91771596133704,NSG1,THY1+ MSC,1.4334060415588732
GO_Biological_Process_2021,regulation of macrophage differentiation (GO:0045649),1/15,0.0368632785936063,0.1696792504336223,0,0,29.06122448979592,95.91771596133704,LIF,THY1+ MSC,1.4334060415588732
GO_Biological_Process_2021,catecholamine metabolic process (GO:0006584),1/15,0.0368632785936063,0.1696792504336223,0,0,29.06122448979592,95.91771596133704,SNCAIP,THY1+ MSC,1.4334060415588732
GO_Biological_Process_2021,myoblast fusion (GO:0007520),1/15,0.0368632785936063,0.1696792504336223,0,0,29.06122448979592,95.91771596133704,ADAM12,THY1+ MSC,1.4334060415588732
GO_Biological_Process_2021,regulation of hormone secretion (GO:0046883),1/16,0.0392729207344652,0.1696792504336223,0,0,27.122448979591837,87.80133530116419,LIF,THY1+ MSC,1.405906798966597
GO_Biological_Process_2021,positive regulation of collagen biosynthetic process (GO:0032967),1/16,0.0392729207344652,0.1696792504336223,0,0,27.122448979591837,87.80133530116419,WNT4,THY1+ MSC,1.405906798966597
GO_Biological_Process_2021,dendritic spine morphogenesis (GO:0060997),1/16,0.0392729207344652,0.1696792504336223,0,0,27.122448979591837,87.80133530116419,PAK3,THY1+ MSC,1.405906798966597
GO_Biological_Process_2021,regulation of neurotransmitter transport (GO:0051588),1/16,0.0392729207344652,0.1696792504336223,0,0,27.122448979591837,87.80133530116419,SNCAIP,THY1+ MSC,1.405906798966597
GO_Biological_Process_2021,negative regulation of platelet activation (GO:0010544),1/16,0.0392729207344652,0.1696792504336223,0,0,27.122448979591837,87.80133530116419,ADAMTS18,THY1+ MSC,1.405906798966597
GO_Biological_Process_2021,plasma membrane bounded cell projection organization (GO:0120036),2/128,0.0407746939326368,0.1696792504336223,0,0,6.555555555555555,20.975769396496517,CNTNAP2;FLRT3,THY1+ MSC,1.3896092902230834
GO_Biological_Process_2021,activation of protein kinase A activity (GO:0034199),1/17,0.0416766547912334,0.1696792504336223,0,0,25.426020408163264,80.79916728086499,ADCY2,THY1+ MSC,1.3801071472903907
GO_Biological_Process_2021,regulation of steroid biosynthetic process (GO:0050810),1/17,0.0416766547912334,0.1696792504336223,0,0,25.426020408163264,80.79916728086499,WNT4,THY1+ MSC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of collagen metabolic process (GO:0010714),1/17,0.0416766547912334,0.1696792504336223,0,0,25.426020408163264,80.79916728086499,WNT4,THY1+ MSC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of macrophage activation (GO:0043032),1/17,0.0416766547912334,0.1696792504336223,0,0,25.426020408163264,80.79916728086499,LBP,THY1+ MSC,1.3801071472903907
GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),1/18,0.0440744949316926,0.1696792504336223,0,0,23.92917166866747,74.70385911458476,LIF,THY1+ MSC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.0440744949316926,0.1696792504336223,0,0,23.92917166866747,74.70385911458476,LIF,THY1+ MSC,1.3558126557645607
GO_Biological_Process_2021,amyloid precursor protein metabolic process (GO:0042982),1/18,0.0440744949316926,0.1696792504336223,0,0,23.92917166866747,74.70385911458476,NSG1,THY1+ MSC,1.3558126557645607
GO_Biological_Process_2021,response to axon injury (GO:0048678),1/18,0.0440744949316926,0.1696792504336223,0,0,23.92917166866747,74.70385911458476,FLRT3,THY1+ MSC,1.3558126557645607
GO_Biological_Process_2021,carbohydrate derivative transport (GO:1901264),1/18,0.0440744949316926,0.1696792504336223,0,0,23.92917166866747,74.70385911458476,LBP,THY1+ MSC,1.3558126557645607
GO_Biological_Process_2021,regulation of platelet aggregation (GO:0090330),1/18,0.0440744949316926,0.1696792504336223,0,0,23.92917166866747,74.70385911458476,ADAMTS18,THY1+ MSC,1.3558126557645607
GO_Biological_Process_2021,cellular response to glucagon stimulus (GO:0071377),1/19,0.0464664552952436,0.1696792504336223,0,0,22.598639455782312,69.35578082800635,ADCY2,THY1+ MSC,1.3328604565168853
GO_Biological_Process_2021,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),1/19,0.0464664552952436,0.1696792504336223,0,0,22.598639455782312,69.35578082800635,MRAP,THY1+ MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of collagen biosynthetic process (GO:0032965),1/19,0.0464664552952436,0.1696792504336223,0,0,22.598639455782312,69.35578082800635,WNT4,THY1+ MSC,1.3328604565168853
GO_Biological_Process_2021,positive regulation of leukocyte activation (GO:0002696),1/19,0.0464664552952436,0.1696792504336223,0,0,22.598639455782312,69.35578082800635,LBP,THY1+ MSC,1.3328604565168853
GO_Biological_Process_2021,dopamine metabolic process (GO:0042417),1/19,0.0464664552952436,0.1696792504336223,0,0,22.598639455782312,69.35578082800635,SNCAIP,THY1+ MSC,1.3328604565168853
GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),1/19,0.0464664552952436,0.1696792504336223,0,0,22.598639455782312,69.35578082800635,LIF,THY1+ MSC,1.3328604565168853
GO_Biological_Process_2021,myeloid cell activation involved in immune response (GO:0002275),1/19,0.0464664552952436,0.1696792504336223,0,0,22.598639455782312,69.35578082800635,LBP,THY1+ MSC,1.3328604565168853
GO_Biological_Process_2021,lipopolysaccharide-mediated signaling pathway (GO:0031663),1/20,0.0488525499820277,0.1696792504336223,0,0,21.40816326530612,64.63014669364038,LBP,THY1+ MSC,1.3111127622579986
GO_Biological_Process_2021,toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.0488525499820277,0.1696792504336223,0,0,21.40816326530612,64.63014669364038,LBP,THY1+ MSC,1.3111127622579986
GO_Biological_Process_2021,positive regulation of embryonic development (GO:0040019),1/20,0.0488525499820277,0.1696792504336223,0,0,21.40816326530612,64.63014669364038,WNT4,THY1+ MSC,1.3111127622579986
GO_Biological_Process_2021,hepaticobiliary system development (GO:0061008),1/20,0.0488525499820277,0.1696792504336223,0,0,21.40816326530612,64.63014669364038,WNT4,THY1+ MSC,1.3111127622579986
GO_Biological_Process_2021,cardiac epithelial to mesenchymal transition (GO:0060317),1/20,0.0488525499820277,0.1696792504336223,0,0,21.40816326530612,64.63014669364038,HAS2,THY1+ MSC,1.3111127622579986
GO_Biological_Process_2021,neuron development (GO:0048666),2/143,0.0497512691479657,0.1696792504336223,0,0,5.8537234042553195,17.565380826397597,CNTNAP2;FLRT3,THY1+ MSC,1.3031958359850326
GO_Biological_Process_2021,negative regulation of cell communication (GO:0010648),1/21,0.0512327930672156,0.1696792504336223,0,0,20.336734693877553,60.42807445408675,LIF,THY1+ MSC,1.2904519669693806
GO_Biological_Process_2021,cyclic purine nucleotide metabolic process (GO:0052652),1/21,0.0512327930672156,0.1696792504336223,0,0,20.336734693877553,60.42807445408675,ADCY2,THY1+ MSC,1.2904519669693806
GO_Biological_Process_2021,response to glucagon (GO:0033762),1/21,0.0512327930672156,0.1696792504336223,0,0,20.336734693877553,60.42807445408675,ADCY2,THY1+ MSC,1.2904519669693806
GO_Biological_Process_2021,myotube differentiation (GO:0014902),1/21,0.0512327930672156,0.1696792504336223,0,0,20.336734693877553,60.42807445408675,ADAM12,THY1+ MSC,1.2904519669693806
GO_Biological_Process_2021,negative regulation of protein localization to cell periphery (GO:1904376),1/21,0.0512327930672156,0.1696792504336223,0,0,20.336734693877553,60.42807445408675,MRAP,THY1+ MSC,1.2904519669693806
GO_Biological_Process_2021,negative regulation of protein localization to plasma membrane (GO:1903077),1/21,0.0512327930672156,0.1696792504336223,0,0,20.336734693877553,60.42807445408675,MRAP,THY1+ MSC,1.2904519669693806
GO_Biological_Process_2021,negative regulation of small molecule metabolic process (GO:0062014),1/22,0.0536071985992547,0.174051385435509,0,0,19.367346938775512,56.67024999786951,WNT4,THY1+ MSC,1.2707768875084013
GO_Biological_Process_2021,negative regulation of lipid biosynthetic process (GO:0051055),1/22,0.0536071985992547,0.174051385435509,0,0,19.367346938775512,56.67024999786951,WNT4,THY1+ MSC,1.2707768875084013
GO_Biological_Process_2021,regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/23,0.0559757805878795,0.174051385435509,0,0,18.4860853432282,53.29235549319145,LBP,THY1+ MSC,1.2519998414265567
GO_Biological_Process_2021,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),1/23,0.0559757805878795,0.174051385435509,0,0,18.4860853432282,53.29235549319145,MRAP,THY1+ MSC,1.2519998414265567
GO_Biological_Process_2021,positive regulation of histone acetylation (GO:0035066),1/23,0.0559757805878795,0.174051385435509,0,0,18.4860853432282,53.29235549319145,LIF,THY1+ MSC,1.2519998414265567
GO_Biological_Process_2021,hyaluronan metabolic process (GO:0030212),1/23,0.0559757805878795,0.174051385435509,0,0,18.4860853432282,53.29235549319145,HAS2,THY1+ MSC,1.2519998414265567
GO_Biological_Process_2021,positive regulation of morphogenesis of an epithelium (GO:1905332),1/23,0.0559757805878795,0.174051385435509,0,0,18.4860853432282,53.29235549319145,LIF,THY1+ MSC,1.2519998414265567
GO_Biological_Process_2021,supramolecular fiber organization (GO:0097435),3/351,0.0573776228581519,0.174051385435509,0,0,3.595377842993397,10.275952639346544,ADAMTS14;TLL1;SNCAIP,THY1+ MSC,1.2412574484387946
GO_Biological_Process_2021,extracellular matrix assembly (GO:0085029),1/24,0.0583385530130099,0.174051385435509,0,0,17.68145519077196,50.24171555062859,HAS2,THY1+ MSC,1.2340443470047993
GO_Biological_Process_2021,neuromuscular junction development (GO:0007528),1/24,0.0583385530130099,0.174051385435509,0,0,17.68145519077196,50.24171555062859,PDZRN3,THY1+ MSC,1.2340443470047993
GO_Biological_Process_2021,mammary gland development (GO:0030879),1/24,0.0583385530130099,0.174051385435509,0,0,17.68145519077196,50.24171555062859,WNT4,THY1+ MSC,1.2340443470047993
GO_Biological_Process_2021,endocrine system development (GO:0035270),1/24,0.0583385530130099,0.174051385435509,0,0,17.68145519077196,50.24171555062859,WNT4,THY1+ MSC,1.2340443470047993
GO_Biological_Process_2021,cellular response to growth factor stimulus (GO:0071363),2/158,0.0593699722530508,0.1752886901322185,0,0,5.2868589743589745,14.929913680908546,HAS2;WNT4,THY1+ MSC,1.2264331540442923
GO_Biological_Process_2021,negative regulation of signaling (GO:0023057),1/25,0.0606955298241754,0.1752886901322185,0,0,16.943877551020407,47.47480020477031,LIF,THY1+ MSC,1.2168432931781568
GO_Biological_Process_2021,cAMP-mediated signaling (GO:0019933),1/25,0.0606955298241754,0.1752886901322185,0,0,16.943877551020407,47.47480020477031,ADCY2,THY1+ MSC,1.2168432931781568
GO_Biological_Process_2021,cellular polysaccharide biosynthetic process (GO:0033692),1/25,0.0606955298241754,0.1752886901322185,0,0,16.943877551020407,47.47480020477031,HAS2,THY1+ MSC,1.2168432931781568
GO_Biological_Process_2021,negative regulation of protein localization to membrane (GO:1905476),1/26,0.0630467249540435,0.1806338707016644,0,0,16.26530612244898,44.95534064809558,MRAP,THY1+ MSC,1.2003374685092782
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),2/166,0.0647425290365929,0.181588976657317,0,0,5.0269308943089435,13.760403766207606,LIF;PAK3,THY1+ MSC,1.1888103397622347
GO_Biological_Process_2021,negative regulation of catalytic activity (GO:0043086),1/27,0.0653921522588676,0.181588976657317,0,0,15.638932496075354,42.652889831563165,HP,THY1+ MSC,1.184474368421492
GO_Biological_Process_2021,positive regulation of toll-like receptor signaling pathway (GO:0034123),1/27,0.0653921522588676,0.181588976657317,0,0,15.638932496075354,42.652889831563165,LBP,THY1+ MSC,1.184474368421492
GO_Biological_Process_2021,dendritic spine organization (GO:0097061),1/27,0.0653921522588676,0.181588976657317,0,0,15.638932496075354,42.652889831563165,PAK3,THY1+ MSC,1.184474368421492
GO_Biological_Process_2021,regulation of protein transport (GO:0051223),1/28,0.0677318256109869,0.1866502980577578,0,0,15.058956916099774,40.54171043527237,STXBP5L,THY1+ MSC,1.1692072184717057
GO_Biological_Process_2021,regulation of actin polymerization or depolymerization (GO:0008064),1/29,0.0700657588372089,0.1911617654228189,0,0,14.520408163265309,38.5999069065122,PAK3,THY1+ MSC,1.1544941700666143
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),4/625,0.0704280188399859,0.1911617654228189,0,0,2.7065742491073306,7.180985632016276,LIF;HP;HAS2;LBP,THY1+ MSC,1.1522545282619854
GO_Biological_Process_2021,regulation of long-term synaptic potentiation (GO:1900271),1/30,0.0723939657090184,0.1935868268218936,0,0,14.019000703729768,36.80874147674154,NSG1,THY1+ MSC,1.1402976322627019
GO_Biological_Process_2021,regulation of macrophage activation (GO:0043030),1/30,0.0723939657090184,0.1935868268218936,0,0,14.019000703729768,36.80874147674154,LBP,THY1+ MSC,1.1402976322627019
GO_Biological_Process_2021,aminoglycan catabolic process (GO:0006026),1/31,0.0747164600026276,0.1954539279778882,0,0,13.551020408163266,35.15209038871121,CHI3L2,THY1+ MSC,1.126583712764908
GO_Biological_Process_2021,renal water homeostasis (GO:0003091),1/31,0.0747164600026276,0.1954539279778882,0,0,13.551020408163266,35.15209038871121,ADCY2,THY1+ MSC,1.126583712764908
GO_Biological_Process_2021,positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/31,0.0747164600026276,0.1954539279778882,0,0,13.551020408163266,35.15209038871121,HAS2,THY1+ MSC,1.126583712764908
GO_Biological_Process_2021,liver development (GO:0001889),1/32,0.0770332554327668,0.1986357515087774,0,0,13.113232389730086,33.61600807740255,WNT4,THY1+ MSC,1.1133217484244988
GO_Biological_Process_2021,positive regulation of immune effector process (GO:0002699),1/32,0.0770332554327668,0.1986357515087774,0,0,13.113232389730086,33.61600807740255,LBP,THY1+ MSC,1.1133217484244988
GO_Biological_Process_2021,neuron projection extension (GO:1990138),1/33,0.0793443657059371,0.2003029092296734,0,0,12.70280612244898,32.18837516559274,FLRT3,THY1+ MSC,1.1004839073426347
GO_Biological_Process_2021,vasculogenesis (GO:0001570),1/33,0.0793443657059371,0.2003029092296734,0,0,12.70280612244898,32.18837516559274,HAS2,THY1+ MSC,1.1004839073426347
GO_Biological_Process_2021,regulation of neurotransmitter secretion (GO:0046928),1/33,0.0793443657059371,0.2003029092296734,0,0,12.70280612244898,32.18837516559274,SNCAIP,THY1+ MSC,1.1004839073426347
GO_Biological_Process_2021,regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.0816498044624026,0.2046915236869954,0,0,12.317254174397032,30.85861216573232,LIF,THY1+ MSC,1.0880448509885652
GO_Biological_Process_2021,regulation of protein polymerization (GO:0032271),1/35,0.0839495853612937,0.2048288396889805,0,0,11.95438175270108,29.61744503578088,PAK3,THY1+ MSC,1.0759814445616303
GO_Biological_Process_2021,positive regulation of myeloid leukocyte differentiation (GO:0002763),1/36,0.0862437219743075,0.2048288396889805,0,0,11.612244897959185,28.456712045041098,LIF,THY1+ MSC,1.0642725091375862
GO_Biological_Process_2021,activation of adenylate cyclase activity (GO:0007190),1/36,0.0862437219743075,0.2048288396889805,0,0,11.612244897959185,28.456712045041098,ADCY2,THY1+ MSC,1.0642725091375862
GO_Biological_Process_2021,positive regulation of bone mineralization (GO:0030501),1/36,0.0862437219743075,0.2048288396889805,0,0,11.612244897959185,28.456712045041098,WNT4,THY1+ MSC,1.0642725091375862
GO_Biological_Process_2021,macrophage activation (GO:0042116),1/36,0.0862437219743075,0.2048288396889805,0,0,11.612244897959185,28.456712045041098,LBP,THY1+ MSC,1.0642725091375862
GO_Biological_Process_2021,cyclic-nucleotide-mediated signaling (GO:0019935),1/36,0.0862437219743075,0.2048288396889805,0,0,11.612244897959185,28.456712045041098,ADCY2,THY1+ MSC,1.0642725091375862
GO_Biological_Process_2021,dendrite morphogenesis (GO:0048813),1/36,0.0862437219743075,0.2048288396889805,0,0,11.612244897959185,28.456712045041098,PAK3,THY1+ MSC,1.0642725091375862
GO_Biological_Process_2021,positive regulation of innate immune response (GO:0045089),1/36,0.0862437219743075,0.2048288396889805,0,0,11.612244897959185,28.456712045041098,LBP,THY1+ MSC,1.0642725091375862
GO_Biological_Process_2021,negative regulation of secretion by cell (GO:1903531),1/39,0.0930924017046572,0.2168152065508468,0,0,10.693877551020408,25.38900533231373,LIF,THY1+ MSC,1.0310857651239858
GO_Biological_Process_2021,cellular response to ketone (GO:1901655),1/39,0.0930924017046572,0.2168152065508468,0,0,10.693877551020408,25.38900533231373,ADCY2,THY1+ MSC,1.0310857651239858
GO_Biological_Process_2021,regulation of cellular component biogenesis (GO:0044087),1/39,0.0930924017046572,0.2168152065508468,0,0,10.693877551020408,25.38900533231373,SNCAIP,THY1+ MSC,1.0310857651239858
GO_Biological_Process_2021,positive regulation of ossification (GO:0045778),1/40,0.0953640965755271,0.2206823004087519,0,0,10.419152276295131,24.485561288951835,WNT4,THY1+ MSC,1.0206151011238414
GO_Biological_Process_2021,positive regulation of biomineral tissue development (GO:0070169),1/41,0.0976302146847681,0.2230665031721602,0,0,10.158163265306122,23.633660200289185,WNT4,THY1+ MSC,1.0104157556925017
GO_Biological_Process_2021,visual system development (GO:0150063),1/41,0.0976302146847681,0.2230665031721602,0,0,10.158163265306122,23.633660200289185,ADAMTS18,THY1+ MSC,1.0104157556925017
GO_Biological_Process_2021,positive regulation of neuron differentiation (GO:0045666),1/43,0.1021457742794159,0.2276211389806737,0,0,9.673469387755102,22.068611238785657,BRINP1,THY1+ MSC,0.9907795952096249
GO_Biological_Process_2021,cellular response to retinoic acid (GO:0071300),1/43,0.1021457742794159,0.2276211389806737,0,0,9.673469387755102,22.068611238785657,BRINP1,THY1+ MSC,0.9907795952096249
GO_Biological_Process_2021,male gonad development (GO:0008584),1/43,0.1021457742794159,0.2276211389806737,0,0,9.673469387755102,22.068611238785657,WNT4,THY1+ MSC,0.9907795952096249
GO_Biological_Process_2021,development of primary male sexual characteristics (GO:0046546),1/43,0.1021457742794159,0.2276211389806737,0,0,9.673469387755102,22.068611238785657,WNT4,THY1+ MSC,0.9907795952096249
GO_Biological_Process_2021,positive regulation of biosynthetic process (GO:0009891),1/44,0.1043952424647777,0.2297968446938095,0,0,9.448030374940672,21.34849709415977,WNT4,THY1+ MSC,0.9813192926974915
GO_Biological_Process_2021,positive regulation of osteoblast differentiation (GO:0045669),1/44,0.1043952424647777,0.2297968446938095,0,0,9.448030374940672,21.34849709415977,WNT4,THY1+ MSC,0.9813192926974915
GO_Biological_Process_2021,action potential (GO:0001508),1/45,0.1066391873529346,0.2319081122554784,0,0,9.232838589981448,20.665901611884028,KCND2,THY1+ MSC,0.9720831731354668
GO_Biological_Process_2021,zymogen activation (GO:0031638),1/45,0.1066391873529346,0.2319081122554784,0,0,9.232838589981448,20.665901611884028,HP,THY1+ MSC,0.9720831731354668
GO_Biological_Process_2021,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.1088776222085674,0.2353582132772027,0,0,9.02721088435374,20.01811780873028,LBP,THY1+ MSC,0.9630613723103648
GO_Biological_Process_2021,epithelial to mesenchymal transition (GO:0001837),1/47,0.1111105603036554,0.236503025179917,0,0,8.830523513753327,19.4026870705364,WNT4,THY1+ MSC,0.9542446623584087
GO_Biological_Process_2021,regulation of protein localization to nucleus (GO:1900180),1/47,0.1111105603036554,0.236503025179917,0,0,8.830523513753327,19.4026870705364,LIF,THY1+ MSC,0.9542446623584087
GO_Biological_Process_2021,purine ribonucleotide biosynthetic process (GO:0009152),1/48,0.1133380148369131,0.236503025179917,0,0,8.642205818497612,18.81737166641443,ADCY2,THY1+ MSC,0.9456243984787533
GO_Biological_Process_2021,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.1133380148369131,0.236503025179917,0,0,8.642205818497612,18.81737166641443,LBP,THY1+ MSC,0.9456243984787533
GO_Biological_Process_2021,negative regulation of mitotic cell cycle (GO:0045930),1/48,0.1133380148369131,0.236503025179917,0,0,8.642205818497612,18.81737166641443,BRINP1,THY1+ MSC,0.9456243984787533
GO_Biological_Process_2021,cellular response to alcohol (GO:0097306),1/48,0.1133380148369131,0.236503025179917,0,0,8.642205818497612,18.81737166641443,ADCY2,THY1+ MSC,0.9456243984787533
GO_Biological_Process_2021,response to hydrogen peroxide (GO:0042542),1/49,0.1155599990222406,0.2383837694115935,0,0,8.46173469387755,18.260130793597916,HP,THY1+ MSC,0.9371924705024297
GO_Biological_Process_2021,cellular defense response (GO:0006968),1/49,0.1155599990222406,0.2383837694115935,0,0,8.46173469387755,18.260130793597916,LBP,THY1+ MSC,0.9371924705024297
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),3/482,0.1192389583091006,0.2419861833568422,0,0,2.5946342113445566,5.517815916066961,LIF;HAS2;LBP,THY1+ MSC,0.92358182668994
GO_Biological_Process_2021,regulation of axonogenesis (GO:0050770),1/51,0.1199876089220907,0.2419861833568422,0,0,8.122448979591837,17.22257115519733,PAK3,THY1+ MSC,0.9208636010741894
GO_Biological_Process_2021,mesenchymal cell differentiation (GO:0048762),1/51,0.1199876089220907,0.2419861833568422,0,0,8.122448979591837,17.22257115519733,WNT4,THY1+ MSC,0.9208636010741894
GO_Biological_Process_2021,gonad development (GO:0008406),1/51,0.1199876089220907,0.2419861833568422,0,0,8.122448979591837,17.22257115519733,WNT4,THY1+ MSC,0.9208636010741894
GO_Biological_Process_2021,negative regulation of cellular biosynthetic process (GO:0031327),1/52,0.1221932608707862,0.2423723471118342,0,0,7.962785114045619,16.738979733033663,WNT4,THY1+ MSC,0.9129527453809976
GO_Biological_Process_2021,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.1221932608707862,0.2423723471118342,0,0,7.962785114045619,16.738979733033663,CNTNAP2,THY1+ MSC,0.9129527453809976
GO_Biological_Process_2021,regulation of exocytosis (GO:0017157),1/52,0.1221932608707862,0.2423723471118342,0,0,7.962785114045619,16.738979733033663,STXBP5L,THY1+ MSC,0.9129527453809976
GO_Biological_Process_2021,blood vessel morphogenesis (GO:0048514),1/56,0.1309618198144747,0.2569413964838335,0,0,7.382189239332097,15.00687933540933,HAS2,THY1+ MSC,0.8828552987007785
GO_Biological_Process_2021,sensory organ development (GO:0007423),1/56,0.1309618198144747,0.2569413964838335,0,0,7.382189239332097,15.00687933540933,ADAMTS18,THY1+ MSC,0.8828552987007785
GO_Biological_Process_2021,positive regulation of cell junction assembly (GO:1901890),1/57,0.1331405122852093,0.2584071233062396,0,0,7.25,14.618539131965724,CNTNAP2,THY1+ MSC,0.8756897763447542
GO_Biological_Process_2021,regulation of bone mineralization (GO:0030500),1/57,0.1331405122852093,0.2584071233062396,0,0,7.25,14.618539131965724,WNT4,THY1+ MSC,0.8756897763447542
GO_Biological_Process_2021,eye development (GO:0001654),1/58,0.1353138517398134,0.259735507994547,0,0,7.122448979591836,14.246025949065045,ADAMTS18,THY1+ MSC,0.8686577434892403
GO_Biological_Process_2021,receptor metabolic process (GO:0043112),1/58,0.1353138517398134,0.259735507994547,0,0,7.122448979591836,14.246025949065045,NSG1,THY1+ MSC,0.8686577434892403
GO_Biological_Process_2021,positive regulation of cell differentiation (GO:0045597),2/258,0.1359834100026853,0.259735507994547,0,0,3.2054036458333335,6.395493110208526,BRINP1;WNT4,THY1+ MSC,0.8665140723928182
GO_Biological_Process_2021,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),1/59,0.1374818510452552,0.2598478964782048,0,0,6.9992962702322306,13.8884471557023,LIF,THY1+ MSC,0.8617546291873563
GO_Biological_Process_2021,response to reactive oxygen species (GO:0000302),1/59,0.1374818510452552,0.2598478964782048,0,0,6.9992962702322306,13.8884471557023,HP,THY1+ MSC,0.8617546291873563
GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.1396445230534406,0.2625607959494378,0,0,6.88031822898651,13.544974303558986,ADCY2,THY1+ MSC,0.8549760929333525
GO_Biological_Process_2021,pattern recognition receptor signaling pathway (GO:0002221),1/61,0.1418018805927374,0.2638684479071042,0,0,6.76530612244898,13.214837540593155,LBP,THY1+ MSC,0.848318009451734
GO_Biological_Process_2021,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.2638684479071042,0,0,6.76530612244898,13.214837540593155,LBP,THY1+ MSC,0.848318009451734
GO_Biological_Process_2021,response to retinoic acid (GO:0032526),1/62,0.1439539364695556,0.2661907778262254,0,0,6.654064904650385,12.897320592663672,BRINP1,THY1+ MSC,0.8417764546925935
GO_Biological_Process_2021,central nervous system development (GO:0007417),2/268,0.1445246328363994,0.2661907778262254,0,0,3.0833333333333335,5.964108059214085,CNTNAP2;SNTG2,THY1+ MSC,0.8400581252728833
GO_Biological_Process_2021,amyloid fibril formation (GO:1990000),1/63,0.1461007034145454,0.2677276849373141,0,0,6.54641211323239,12.591756250239603,SNCAIP,THY1+ MSC,0.8353476931121088
GO_Biological_Process_2021,extracellular matrix disassembly (GO:0022617),1/66,0.1525093979756266,0.2752794633460061,0,0,6.243328100470958,11.740759916332207,TLL1,THY1+ MSC,0.8167033932798328
GO_Biological_Process_2021,positive regulation of cell death (GO:0010942),1/66,0.1525093979756266,0.2752794633460061,0,0,6.243328100470958,11.740759916332207,HP,THY1+ MSC,0.8167033932798328
GO_Biological_Process_2021,cellular component disassembly (GO:0022411),1/66,0.1525093979756266,0.2752794633460061,0,0,6.243328100470958,11.740759916332207,TLL1,THY1+ MSC,0.8167033932798328
GO_Biological_Process_2021,positive regulation of protein localization to nucleus (GO:1900182),1/68,0.1567556490806558,0.2784097696412194,0,0,6.0563508985683825,11.222824361971773,LIF,THY1+ MSC,0.8047767993307415
GO_Biological_Process_2021,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),1/68,0.1567556490806558,0.2784097696412194,0,0,6.0563508985683825,11.222824361971773,LIF,THY1+ MSC,0.8047767993307415
GO_Biological_Process_2021,canonical Wnt signaling pathway (GO:0060070),1/68,0.1567556490806558,0.2784097696412194,0,0,6.0563508985683825,11.222824361971773,WNT4,THY1+ MSC,0.8047767993307415
GO_Biological_Process_2021,negative regulation of cellular catabolic process (GO:0031330),1/69,0.158870948881139,0.2784097696412194,0,0,5.966986794717887,10.977245117600177,HP,THY1+ MSC,0.7989555105590889
GO_Biological_Process_2021,synapse assembly (GO:0007416),1/69,0.158870948881139,0.2784097696412194,0,0,5.966986794717887,10.977245117600177,FLRT3,THY1+ MSC,0.7989555105590889
GO_Biological_Process_2021,cellular response to decreased oxygen levels (GO:0036294),1/69,0.158870948881139,0.2784097696412194,0,0,5.966986794717887,10.977245117600177,KCND2,THY1+ MSC,0.7989555105590889
GO_Biological_Process_2021,defense response to Gram-positive bacterium (GO:0050830),1/70,0.1609810482853106,0.2803525308922402,0,0,5.880212954747116,10.740024519792764,LBP,THY1+ MSC,0.7932252488723367
GO_Biological_Process_2021,positive regulation of cellular protein localization (GO:1903829),1/71,0.16308595979881,0.2803525308922402,0,0,5.795918367346939,10.51076961698872,LIF,THY1+ MSC,0.7875834261109624
GO_Biological_Process_2021,gland development (GO:0048732),1/71,0.16308595979881,0.2803525308922402,0,0,5.795918367346939,10.51076961698872,WNT4,THY1+ MSC,0.7875834261109624
GO_Biological_Process_2021,negative regulation of neuron apoptotic process (GO:0043524),1/71,0.16308595979881,0.2803525308922402,0,0,5.795918367346939,10.51076961698872,TOX3,THY1+ MSC,0.7875834261109624
GO_Biological_Process_2021,cell junction organization (GO:0034330),1/72,0.1651856959101235,0.2808752425742547,0,0,5.713998275366484,10.28911103101624,PAK3,THY1+ MSC,0.78202756268309
GO_Biological_Process_2021,regulation of actin filament polymerization (GO:0030833),1/73,0.1672802691231711,0.2808752425742547,0,0,5.634353741496598,10.074701240888364,PAK3,THY1+ MSC,0.7765552814899175
GO_Biological_Process_2021,regulation of actin filament-based process (GO:0032970),1/73,0.1672802691231711,0.2808752425742547,0,0,5.634353741496598,10.074701240888364,PAK3,THY1+ MSC,0.7765552814899175
GO_Biological_Process_2021,defense response to Gram-negative bacterium (GO:0050829),1/73,0.1672802691231711,0.2808752425742547,0,0,5.634353741496598,10.074701240888364,LBP,THY1+ MSC,0.7765552814899175
GO_Biological_Process_2021,response to molecule of bacterial origin (GO:0002237),1/73,0.1672802691231711,0.2808752425742547,0,0,5.634353741496598,10.074701240888364,LBP,THY1+ MSC,0.7765552814899175
GO_Biological_Process_2021,fibroblast growth factor receptor signaling pathway (GO:0008543),1/75,0.1714539764404576,0.2847520993925921,0,0,5.4815223386651954,9.666337985731484,FLRT3,THY1+ MSC,0.7658524380723842
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",5/1183,0.1720230163025516,0.2847520993925921,0,0,1.7706093189964158,3.116497260687803,TOX3;LIF;GLIS3;NDP;WNT4,THY1+ MSC,0.7644134415549481
GO_Biological_Process_2021,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.2847520993925921,0,0,5.408163265306122,9.4717853003048,LBP,THY1+ MSC,0.7606175863963804
GO_Biological_Process_2021,water-soluble vitamin metabolic process (GO:0006767),1/76,0.1735331353639065,0.2847520993925921,0,0,5.408163265306122,9.4717853003048,AOX1,THY1+ MSC,0.7606175863963804
GO_Biological_Process_2021,cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.1735331353639065,0.2847520993925921,0,0,5.408163265306122,9.4717853003048,PAK3,THY1+ MSC,0.7606175863963804
GO_Biological_Process_2021,positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.1756071809118701,0.2868515489103398,0,0,5.336734693877551,9.283280446293812,LBP,THY1+ MSC,0.7554577289388229
GO_Biological_Process_2021,negative regulation of blood vessel morphogenesis (GO:2000181),1/78,0.1776761254379788,0.2878480374433471,0,0,5.267161410018553,9.10056411919043,WNT4,THY1+ MSC,0.7503709249641564
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),2/306,0.1779160016431225,0.2878480374433471,0,0,2.6927083333333335,4.648809448291678,KCND2;NSG1,THY1+ MSC,0.7497849900117082
GO_Biological_Process_2021,axon development (GO:0061564),1/79,0.1797399811935544,0.2878480374433471,0,0,5.199372056514914,8.923391206941128,PAK3,THY1+ MSC,0.745355308086215
GO_Biological_Process_2021,regulation of neuron differentiation (GO:0045664),1/79,0.1797399811935544,0.2878480374433471,0,0,5.199372056514914,8.923391206941128,BRINP1,THY1+ MSC,0.745355308086215
GO_Biological_Process_2021,negative regulation of cell cycle (GO:0045786),1/80,0.181798760490535,0.2878480374433471,0,0,5.133298889175924,8.751529842637671,BRINP1,THY1+ MSC,0.7404090821369118
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.2878480374433471,0,0,5.133298889175924,8.751529842637671,LIF,THY1+ MSC,0.7404090821369118
GO_Biological_Process_2021,regulation of protein localization to plasma membrane (GO:1903076),1/80,0.181798760490535,0.2878480374433471,0,0,5.133298889175924,8.751529842637671,MRAP,THY1+ MSC,0.7404090821369118
GO_Biological_Process_2021,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.2885684506748187,0,0,5.0688775510204085,8.584760541358477,LBP,THY1+ MSC,0.7355305181562768
GO_Biological_Process_2021,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.1838524754991919,0.2885684506748187,0,0,5.0688775510204085,8.584760541358477,LBP,THY1+ MSC,0.7355305181562768
GO_Biological_Process_2021,regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.1859011384602527,0.289268581828238,0,0,5.00604686318972,8.422875391899517,MRAP,THY1+ MSC,0.7307179505966239
GO_Biological_Process_2021,ephrin receptor signaling pathway (GO:0048013),1/82,0.1859011384602527,0.289268581828238,0,0,5.00604686318972,8.422875391899517,PAK3,THY1+ MSC,0.7307179505966239
GO_Biological_Process_2021,regulation of osteoblast differentiation (GO:0045667),1/83,0.1879447615357932,0.2911933858988041,0,0,4.944748631159781,8.265677319811374,WNT4,THY1+ MSC,0.7259697745939766
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),2/323,0.1932342825020938,0.2980869367684965,0,0,2.5478971962616823,4.188365716592005,BRINP1;LBP,THY1+ MSC,0.7139158210847405
GO_Biological_Process_2021,response to interleukin-1 (GO:0070555),1/86,0.1940455128548384,0.2980869367684965,0,0,4.769507803121249,7.820383303288144,HAS2,THY1+ MSC,0.7120963955156414
GO_Biological_Process_2021,positive regulation of inflammatory response (GO:0050729),1/89,0.2001013407742902,0.3060872204216897,0,0,4.6062152133580705,7.411084001248333,LBP,THY1+ MSC,0.6987500013741589
GO_Biological_Process_2021,regulation of actin cytoskeleton organization (GO:0032956),1/91,0.2041137620931186,0.308741234715809,0,0,4.503401360544218,7.156255051106618,PAK3,THY1+ MSC,0.6901277125812961
GO_Biological_Process_2021,toll-like receptor signaling pathway (GO:0002224),1/91,0.2041137620931186,0.308741234715809,0,0,4.503401360544218,7.156255051106618,LBP,THY1+ MSC,0.6901277125812961
GO_Biological_Process_2021,cellular response to fibroblast growth factor stimulus (GO:0044344),1/92,0.2061125694363157,0.308741234715809,0,0,4.453689167974883,7.03385741012878,FLRT3,THY1+ MSC,0.6858955226779435
GO_Biological_Process_2021,Wnt signaling pathway (GO:0016055),1/92,0.2061125694363157,0.308741234715809,0,0,4.453689167974883,7.03385741012878,WNT4,THY1+ MSC,0.6858955226779435
GO_Biological_Process_2021,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.308741234715809,0,0,4.453689167974883,7.03385741012878,LIF,THY1+ MSC,0.6858955226779435
GO_Biological_Process_2021,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.2081064570390282,0.3104397974838396,0,0,4.40505767524401,6.914643337844717,LIF,THY1+ MSC,0.6817144444740324
GO_Biological_Process_2021,regulation of vesicle-mediated transport (GO:0060627),1/96,0.2140587201245348,0.3180049298969427,0,0,4.26530612244898,6.5749903239841245,STXBP5L,THY1+ MSC,0.6694670755856718
GO_Biological_Process_2021,glycosaminoglycan biosynthetic process (GO:0006024),1/97,0.2160330472811356,0.3186190585553592,0,0,4.220663265306122,6.46742313757927,HAS2,THY1+ MSC,0.6654798083211632
GO_Biological_Process_2021,regulation of neuron apoptotic process (GO:0043523),1/98,0.2180025137484037,0.3186190585553592,0,0,4.176940879444562,6.362519703204576,TOX3,THY1+ MSC,0.6615384985937142
GO_Biological_Process_2021,negative regulation of neuron death (GO:1901215),1/98,0.2180025137484037,0.3186190585553592,0,0,4.176940879444562,6.362519703204576,TOX3,THY1+ MSC,0.6615384985937142
GO_Biological_Process_2021,regulation of peptidyl-serine phosphorylation (GO:0033135),1/98,0.2180025137484037,0.3186190585553592,0,0,4.176940879444562,6.362519703204576,LIF,THY1+ MSC,0.6615384985937142
GO_Biological_Process_2021,regulation of cell death (GO:0010941),1/102,0.2258320069783284,0.3261014180767062,0,0,4.010709234188725,5.967790506031058,HP,THY1+ MSC,0.6462145058611213
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),1/102,0.2258320069783284,0.3261014180767062,0,0,4.010709234188725,5.967790506031058,ADAM12,THY1+ MSC,0.6462145058611213
GO_Biological_Process_2021,cell junction assembly (GO:0034329),1/102,0.2258320069783284,0.3261014180767062,0,0,4.010709234188725,5.967790506031058,FLRT3,THY1+ MSC,0.6462145058611213
GO_Biological_Process_2021,protein processing (GO:0016485),1/106,0.2335846623503299,0.3346192980494805,0,0,3.857142857142857,5.6090983677319475,HP,THY1+ MSC,0.6315556772929499
GO_Biological_Process_2021,cellular response to peptide hormone stimulus (GO:0071375),1/106,0.2335846623503299,0.3346192980494805,0,0,3.857142857142857,5.6090983677319475,ADCY2,THY1+ MSC,0.6315556772929499
GO_Biological_Process_2021,lipid transport (GO:0006869),1/109,0.239349173739861,0.3401773689767316,0,0,3.749433106575964,5.361058744932435,LBP,THY1+ MSC,0.6209680674126086
GO_Biological_Process_2021,modulation of chemical synaptic transmission (GO:0050804),1/109,0.239349173739861,0.3401773689767316,0,0,3.749433106575964,5.361058744932435,SNCAIP,THY1+ MSC,0.6209680674126086
GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),1/110,0.241261218690496,0.3402160154190198,0,0,3.714847406852649,5.282048795926194,LBP,THY1+ MSC,0.6175124827423236
GO_Biological_Process_2021,response to tumor necrosis factor (GO:0034612),1/110,0.241261218690496,0.3402160154190198,0,0,3.714847406852649,5.282048795926194,HAS2,THY1+ MSC,0.6175124827423236
GO_Biological_Process_2021,regulation of cytoskeleton organization (GO:0051493),1/112,0.2450711886958998,0.3442439654444351,0,0,3.647545504688362,5.129202360192396,PAK3,THY1+ MSC,0.6107077427090284
GO_Biological_Process_2021,cellular response to transforming growth factor beta stimulus (GO:0071560),1/114,0.2488624078588274,0.345500443145154,0,0,3.582625970742279,4.982913653406146,WNT4,THY1+ MSC,0.6040407011916724
GO_Biological_Process_2021,response to lipid (GO:0033993),1/114,0.2488624078588274,0.345500443145154,0,0,3.582625970742279,4.982913653406146,LBP,THY1+ MSC,0.6040407011916724
GO_Biological_Process_2021,cellular response to lectin (GO:1990858),1/115,0.2507510141385882,0.345500443145154,0,0,3.5510204081632653,4.9121080927455,PAK3,THY1+ MSC,0.6007573018413346
GO_Biological_Process_2021,cellular response to molecule of bacterial origin (GO:0071219),1/115,0.2507510141385882,0.345500443145154,0,0,3.5510204081632653,4.9121080927455,LBP,THY1+ MSC,0.6007573018413346
GO_Biological_Process_2021,stimulatory C-type lectin receptor signaling pathway (GO:0002223),1/115,0.2507510141385882,0.345500443145154,0,0,3.5510204081632653,4.9121080927455,PAK3,THY1+ MSC,0.6007573018413346
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),1/116,0.2526349665899778,0.3467727107946084,0,0,3.5199645075421473,4.8428011439058265,ADAM12,THY1+ MSC,0.5975065399797567
GO_Biological_Process_2021,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.2563889548341396,0.3505924723300166,0,0,3.4594453165881736,4.708511372057024,ADCY2,THY1+ MSC,0.5911006880374128
GO_Biological_Process_2021,innate immune response activating cell surface receptor signaling pathway (GO:0002220),1/119,0.2582590130323782,0.3518169951120322,0,0,3.429955032860602,4.6434466139665425,PAK3,THY1+ MSC,0.5879445130148351
GO_Biological_Process_2021,cellular response to lipopolysaccharide (GO:0071222),1/120,0.2601244621662815,0.3530260557970964,0,0,3.4009603841536613,4.579716458908873,LBP,THY1+ MSC,0.5848188047272944
GO_Biological_Process_2021,epithelium development (GO:0060429),1/122,0.2638415777635164,0.3553985431814531,0,0,3.3444088379153314,4.456111874258477,WNT4,THY1+ MSC,0.5786567646257991
GO_Biological_Process_2021,potassium ion transport (GO:0006813),1/122,0.2638415777635164,0.3553985431814531,0,0,3.3444088379153314,4.456111874258477,KCND2,THY1+ MSC,0.5786567646257991
GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.2656932663769877,0.3556106696708551,0,0,3.316828370692539,4.396166676729281,PAK3,THY1+ MSC,0.5756194520344882
GO_Biological_Process_2021,non-canonical Wnt signaling pathway (GO:0035567),1/124,0.2675403902734135,0.3556106696708551,0,0,3.2896963663514187,4.337414433160371,WNT4,THY1+ MSC,0.5726106437410472
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),1/124,0.2675403902734135,0.3556106696708551,0,0,3.2896963663514187,4.337414433160371,LBP,THY1+ MSC,0.5726106437410472
GO_Biological_Process_2021,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),2/404,0.2679393411370432,0.3556106696708551,0,0,2.026119402985074,2.6683884405969245,FLRT3;PAK3,THY1+ MSC,0.5719635148936996
GO_Biological_Process_2021,regulation of protein secretion (GO:0050708),1/125,0.2693829605231016,0.3562170283840281,0,0,3.263001974983542,4.279822783786303,STXBP5L,THY1+ MSC,0.5696298784899082
GO_Biological_Process_2021,circulatory system development (GO:0072359),1/126,0.2712209880572274,0.3573386010535003,0,0,3.236734693877551,4.223360488574632,FLRT3,THY1+ MSC,0.5666767062328689
GO_Biological_Process_2021,positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.2785278903472666,0.3656311578740481,0,0,3.135738016136687,4.008216604624779,DKK2,THY1+ MSC,0.5551313103019286
GO_Biological_Process_2021,cellular response to hypoxia (GO:0071456),1/131,0.2803433684983951,0.3666810001011618,0,0,3.111459968602826,3.956968446025251,KCND2,THY1+ MSC,0.5523097126477655
GO_Biological_Process_2021,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.372420349320715,0,0,3.0408163265306123,3.80890385676326,LIF,THY1+ MSC,0.5439940297149167
GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.3743968736748911,0,0,2.99546485260771,3.714691124222948,MRAP,THY1+ MSC,0.5385707850387818
GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3743968736748911,0,0,2.99546485260771,3.714691124222948,ADCY2,THY1+ MSC,0.5385707850387818
GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3753659858885927,0,0,2.9732893157262907,3.668866926816198,ADCY2,THY1+ MSC,0.5358942544628899
GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),1/139,0.2947069182263764,0.3768668250544397,0,0,2.929902395740905,3.579678317757992,SNCAIP,THY1+ MSC,0.5306096689947516
GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),1/139,0.2947069182263764,0.3768668250544397,0,0,2.929902395740905,3.579678317757992,KCND2,THY1+ MSC,0.5306096689947516
GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),1/140,0.2964824884084789,0.3768668250544397,0,0,2.9086771399207163,3.5362740390257685,MRAP,THY1+ MSC,0.5280009529309525
GO_Biological_Process_2021,enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.2964824884084789,0.3768668250544397,0,0,2.9086771399207163,3.5362740390257685,LIF,THY1+ MSC,0.5280009529309525
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3822584115270054,0,0,2.8467950560505892,3.410594866305226,HP,THY1+ MSC,0.5203052911363482
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3949603952113772,0,0,2.712094233666621,3.141596466170354,ADCY2,THY1+ MSC,0.5030717563895143
GO_Biological_Process_2021,brain development (GO:0007420),1/150,0.3139989845586295,0.3949603952113772,0,0,2.712094233666621,3.141596466170354,CNTNAP2,THY1+ MSC,0.5030717563895143
GO_Biological_Process_2021,positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.3191700762858281,0.4000708247888331,0,0,2.6581632653061225,3.0357052873752,DKK2,THY1+ MSC,0.4959778325880012
GO_Biological_Process_2021,positive regulation of protein kinase activity (GO:0045860),1/154,0.3208852696222714,0.4008290046146712,0,0,2.640656262505002,3.0015590720273457,PAK3,THY1+ MSC,0.493650218923809
GO_Biological_Process_2021,cellular response to interleukin-1 (GO:0071347),1/155,0.3225962281219006,0.4015766839724348,0,0,2.6233766233766236,2.9679671260643183,HAS2,THY1+ MSC,0.4913407148001928
GO_Biological_Process_2021,regulation of cell differentiation (GO:0045595),1/156,0.3243029619756543,0.4023139837567396,0,0,2.6063199473337724,2.934917292064671,LIF,THY1+ MSC,0.4890490847411261
GO_Biological_Process_2021,skeletal system development (GO:0001501),1/158,0.3277037968552589,0.4037579203575032,0,0,2.5728584427401535,2.8703970097526006,TLL1,THY1+ MSC,0.48451852674781976
GO_Biological_Process_2021,T cell receptor signaling pathway (GO:0050852),1/158,0.3277037968552589,0.4037579203575032,0,0,2.5728584427401535,2.8703970097526006,PAK3,THY1+ MSC,0.48451852674781976
GO_Biological_Process_2021,response to lipopolysaccharide (GO:0032496),1/159,0.329397918202972,0.4044647907186153,0,0,2.556445362955309,2.8389038953772054,LBP,THY1+ MSC,0.4822791499015975
GO_Biological_Process_2021,positive regulation of cell population proliferation (GO:0008284),2/474,0.3328115296392732,0.4072710583043309,0,0,1.7194562146892656,1.8917094920733264,LIF;HAS2,THY1+ MSC,0.47780163679243126
GO_Biological_Process_2021,heart development (GO:0007507),1/164,0.3378059691212722,0.4098679767531498,0,0,2.4774007762614247,2.6886824434754057,FLRT3,THY1+ MSC,0.4713326805982654
GO_Biological_Process_2021,negative regulation of canonical Wnt signaling pathway (GO:0090090),1/165,0.3394751386404204,0.4098679767531498,0,0,2.4621702339472376,2.6600168495918335,DKK2,THY1+ MSC,0.46919202564454415
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.4098679767531498,0,0,2.4621702339472376,2.6600168495918335,ADCY2,THY1+ MSC,0.46919202564454415
GO_Biological_Process_2021,regulation of neuron projection development (GO:0010975),1/165,0.3394751386404204,0.4098679767531498,0,0,2.4621702339472376,2.6600168495918335,PAK3,THY1+ MSC,0.46919202564454415
GO_Biological_Process_2021,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.414497728647376,0,0,2.4175730172308443,2.5766088705447237,NSG1,THY1+ MSC,0.46286379212748074
GO_Biological_Process_2021,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.3477593333218013,0.4170801306616953,0,0,2.388721168940949,2.523073857975914,FLRT3,THY1+ MSC,0.45872120538836164
GO_Biological_Process_2021,neuron differentiation (GO:0030182),1/174,0.3543133002736421,0.423533448340347,0,0,2.333018756635602,2.4206789693623425,WNT4,THY1+ MSC,0.45061254473982715
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),1/176,0.3575660373570176,0.4260110214055557,0,0,2.306122448979592,2.3716975343886144,LBP,THY1+ MSC,0.4466437384468818
GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.427048458674103,0,0,2.279833967485299,2.3241173885161555,ADCY2,THY1+ MSC,0.44273020383203454
GO_Biological_Process_2021,regulation of mitotic cell cycle (GO:0007346),1/178,0.3608027143922477,0.427048458674103,0,0,2.279833967485299,2.3241173885161555,BRINP1,THY1+ MSC,0.44273020383203454
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),2/511,0.3665685304553946,0.4324550310274427,0,0,1.591437459070072,1.5971185548456277,NDP;WNT4,THY1+ MSC,0.43584482152384213
GO_Biological_Process_2021,antigen receptor-mediated signaling pathway (GO:0050851),1/185,0.3720057294778557,0.4374399620244493,0,0,2.192324755989352,2.1678716160963645,PAK3,THY1+ MSC,0.4294503712432232
GO_Biological_Process_2021,negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.3814549819175133,0.4470949625721503,0,0,2.122448979591837,2.045536603225051,DKK2,THY1+ MSC,0.41855670871419515
GO_Biological_Process_2021,cellular response to tumor necrosis factor (GO:0071356),1/194,0.3861272144560919,0.4482055447544989,0,0,2.089140319340171,1.988001678572607,HAS2,THY1+ MSC,0.4132695879859197
GO_Biological_Process_2021,negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3861272144560919,0.4482055447544989,0,0,2.089140319340171,1.988001678572607,WNT4,THY1+ MSC,0.4132695879859197
GO_Biological_Process_2021,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4482055447544989,0,0,2.089140319340171,1.988001678572607,TOX3,THY1+ MSC,0.4132695879859197
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.4485620840839937,0,0,2.0782663580896275,1.969329769675335,MRAP,THY1+ MSC,0.4115300469974289
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),3/908,0.3977118667386928,0.458053892995905,0,0,1.3432467379804869,1.2385104166535874,TOX3;LIF;GLIS3,THY1+ MSC,0.40043145054722185
GO_Biological_Process_2021,generation of neurons (GO:0048699),1/202,0.398418067592006,0.458053892995905,0,0,2.0051781906792567,1.8452720554356252,WNT4,THY1+ MSC,0.39966097527446726
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),1/203,0.3999373645428959,0.4583409161904299,0,0,1.9951505354617096,1.8284503867148747,ADAM12,THY1+ MSC,0.398008019580524
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),1/212,0.4134429066373548,0.4723192699243199,0,0,1.909178837411742,1.6862551884518755,ADCY2,THY1+ MSC,0.3835844547796231
GO_Biological_Process_2021,positive regulation of cell motility (GO:2000147),1/221,0.4266504252883283,0.4843421494625362,0,0,1.8302411873840445,1.5589816483293069,HAS2,THY1+ MSC,0.3699278171231457
GO_Biological_Process_2021,"transcription, DNA-templated (GO:0006351)",1/221,0.4266504252883283,0.4843421494625362,0,0,1.8302411873840445,1.5589816483293069,GLIS3,THY1+ MSC,0.3699278171231457
GO_Biological_Process_2021,inflammatory response (GO:0006954),1/230,0.4395663655385589,0.4974403070828206,0,0,1.7575082434720612,1.4446130242039086,HP,THY1+ MSC,0.35697554604801474
GO_Biological_Process_2021,apoptotic process (GO:0006915),1/231,0.4409837467017168,0.4974847892478743,0,0,1.749778172138421,1.4326260836369302,NSG1,THY1+ MSC,0.35557741698984124
GO_Biological_Process_2021,axonogenesis (GO:0007409),1/240,0.4535831041409784,0.5101043632239665,0,0,1.6831184356587825,1.3306343458644796,PAK3,THY1+ MSC,0.34334313117644527
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.5146975311997133,0,0,1.655076845553036,1.2884811006593149,KCND2,THY1+ MSC,0.33809924509335265
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),2/621,0.4626694381715867,0.5171011367800087,0,0,1.3012250942380184,1.0029093993298663,LIF;LBP,THY1+ MSC,0.33472918706115434
GO_Biological_Process_2021,regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.4712922312950381,0.5251126404244099,0,0,1.5952380952380951,1.2000608149186214,DKK2,THY1+ MSC,0.32670971902140344
GO_Biological_Process_2021,cellular component assembly (GO:0022607),1/261,0.4819092749521712,0.5352899946391809,0,0,1.5455259026687598,1.1282329953702568,HAS2,THY1+ MSC,0.31703471507296654
GO_Biological_Process_2021,positive regulation of cell migration (GO:0030335),1/269,0.4923172958360867,0.5451734472295316,0,0,1.498781602193116,1.0620843946744252,HAS2,THY1+ MSC,0.30775490655057164
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.5488938518841678,0,0,1.4709576138147566,1.0233666205889618,LIF,THY1+ MSC,0.30214499188263844
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),1/274,0.4987179596066677,0.5488938518841678,0,0,1.4709576138147566,1.0233666205889618,KCND2,THY1+ MSC,0.30214499188263844
GO_Biological_Process_2021,regulation of cell cycle (GO:0051726),1/296,0.5259539383992272,0.577110552468453,0,0,1.359737115185057,0.8736877155004001,BRINP1,THY1+ MSC,0.2790522884983112
GO_Biological_Process_2021,innate immune response (GO:0045087),1/302,0.5331267023920349,0.5832083017076503,0,0,1.3322259136212624,0.8379649939237771,LBP,THY1+ MSC,0.2731695646873957
GO_Biological_Process_2021,transcription by RNA polymerase II (GO:0006366),1/320,0.5540128017436795,0.6042254423851006,0,0,1.255901733734246,0.7416947278731473,GLIS3,THY1+ MSC,0.2564801997798679
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.6048665575876395,0,0,1.2479496471485791,0.7319104885681406,WNT4,THY1+ MSC,0.2547095446988111
GO_Biological_Process_2021,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.6115423028921917,0,0,1.2208810353409656,0.6989624697257846,CNTNAP2,THY1+ MSC,0.24863646405532092
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),1/335,0.5707160845076258,0.6168518158899788,0,0,1.1985824269827692,0.6722410367689661,LBP,THY1+ MSC,0.2435798875448389
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),2/764,0.5744134768292987,0.6189948212996322,0,0,1.0492125984251968,0.5816895490313783,LIF;HAS2,THY1+ MSC,0.24077537927422193
GO_Biological_Process_2021,positive regulation of multicellular organismal process (GO:0051240),1/345,0.5815093765862647,0.6247764432965522,0,0,1.1631466540104414,0.6305745813190116,LBP,THY1+ MSC,0.23544327806907975
GO_Biological_Process_2021,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6516667852521246,0,0,1.0799779371207945,0.5367673309131087,LIF,THY1+ MSC,0.21585171499242045
GO_Biological_Process_2021,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6795826838045659,0,0,1.0,0.4521084323403523,PAK3,THY1+ MSC,0.19634819738734471
GO_Biological_Process_2021,regulation of cell migration (GO:0030334),1/408,0.643643262264238,0.6843633115808878,0,0,0.9799428370856942,0.4317732474155183,HAS2,THY1+ MSC,0.19135477263518083
GO_Biological_Process_2021,protein modification by small protein conjugation (GO:0032446),1/409,0.644552703427983,0.6843633115808878,0,0,0.9774909963985594,0.4293127610136149,PDZRN3,THY1+ MSC,0.19074156570833578
GO_Biological_Process_2021,organelle organization (GO:0006996),1/420,0.6544076492323022,0.692789329539182,0,0,0.9512931664312504,0.4033718992390181,NDP,THY1+ MSC,0.18415163293091988
GO_Biological_Process_2021,regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.663134010332821,0.6999747886846445,0,0,0.928642785785643,0.3814661952932429,BNC2,THY1+ MSC,0.17839869773857764
GO_Biological_Process_2021,regulation of intracellular signal transduction (GO:1902531),1/437,0.6691136001848389,0.7042274334306905,0,0,0.9134057292641828,0.3670077257341264,PAK3,THY1+ MSC,0.1745001427028418
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",5/2244,0.6741952652975136,0.7075130545709373,0,0,0.8789141978065604,0.3464991772661544,TOX3;BNC2;GLIS3;NDP;WNT4,THY1+ MSC,0.1712143017444203
GO_Biological_Process_2021,negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.6912187085983104,0.7223828181360362,0,0,0.8589500595054437,0.3172093937483807,WNT4,THY1+ MSC,0.16038451570993173
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",2/948,0.6926945411260426,0.7223828181360362,0,0,0.8370331219168429,0.3073302326128318,GLIS3;WNT4,THY1+ MSC,0.15945823486666727
GO_Biological_Process_2021,regulation of cellular macromolecule biosynthetic process (GO:2000112),1/468,0.6943679720033368,0.7223828181360362,0,0,0.8514180832932745,0.3105575044475373,BNC2,THY1+ MSC,0.15841031937391015
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),1/481,0.7043872370804651,0.7296375323269874,0,0,0.8278061224489796,0.2900856337670249,HP,THY1+ MSC,0.15218852169360617
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7296375323269874,0,0,0.8207960870298533,0.2841203737887477,TOX3,THY1+ MSC,0.15033199168778996
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),1/485,0.7074048097353064,0.7296375323269874,0,0,0.8207960870298533,0.2841203737887477,HP,THY1+ MSC,0.15033199168778996
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),1/488,0.7096481586491704,0.7298660549069815,0,0,0.815614130662532,0.2797442143304909,HP,THY1+ MSC,0.14895691977455572
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7338436093002527,0,0,0.8021026592455164,0.2684686706444305,PAK3,THY1+ MSC,0.1453610219101508
GO_Biological_Process_2021,protein ubiquitination (GO:0016567),1/525,0.7359678224271717,0.7526469798759461,0,0,0.7565820221218258,0.231944503707841,PDZRN3,THY1+ MSC,0.13314117322745964
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.763177776025055,0,0,0.726642950758285,0.2091870484536521,LIF,THY1+ MSC,0.12502533841998253
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7504933808556635,0.763177776025055,0,0,0.7252747252747253,0.2081715773755284,WNT4,THY1+ MSC,0.1246531337611999
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),2/1079,0.7597673074922179,0.7704381966423896,0,0,0.7301532033426184,0.200604530418796,BNC2;WNT4,THY1+ MSC,0.11931939791106433
GO_Biological_Process_2021,negative regulation of cellular process (GO:0048523),1/566,0.7624057114769476,0.7709480723898545,0,0,0.700198663536211,0.1899473973942179,BRINP1,THY1+ MSC,0.11781385888910202
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.8248462645529242,0.831758384088284,0,0,0.5757014372366809,0.1108560647358729,GLIS3,THY1+ MSC,0.0836269880293983
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.8540583406672724,0,0,0.5290423861852434,0.0863986224716518,TOX3,THY1+ MSC,0.07092521499844862
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),3/2206,0.924809545507298,0.9273784609114848,0,0,0.5142021035145498,0.0401938720592393,TOX3;LIF;GLIS3,THY1+ MSC,0.03394769628973127
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),1/1025,0.9281942108891912,0.9281942108891912,0,0,0.3771922831632653,0.0281062148400667,PAK3,THY1+ MSC,0.032361144586154744
KEGG_2021_Human,muscle contraction (GO:0006936),7/129,3.126094204242394e-08,1.2035462686333216e-05,0,0,26.457491422035837,457.2091676514456,DES;HRC;CASQ2;MYH11;ADRA1A;ACTG2;CACNA1H,VSMC,7.504997938739675
KEGG_2021_Human,regulation of heart contraction (GO:0008016),4/93,8.565533047784326e-05,0.0163493146957443,0,0,19.40498290180752,181.7311402990522,DES;HRC;CASQ2;CACNA1H,VSMC,4.067245604968423
KEGG_2021_Human,positive regulation of phospholipase C activity (GO:0010863),3/43,0.0001690886138794749,0.0163493146957443,0,0,31.77127659574468,275.93632160450045,NTF3;AVPR1A;ADRA1A,VSMC,3.771885636020247
KEGG_2021_Human,negative regulation of potassium ion transmembrane transporter activity (GO:1901017),2/8,0.0001698630098259154,0.0163493146957443,0,0,138.5,1202.2517804391236,CASQ2;KCNAB1,VSMC,3.7699011848597213
KEGG_2021_Human,regulation of cell communication by electrical coupling (GO:0010649),2/13,0.00046942457388711873,0.0345785131088444,0,0,75.52651515151516,578.8354329773197,CASQ2;HRC,VSMC,3.3284341792789096
KEGG_2021_Human,smooth muscle contraction (GO:0006939),2/14,0.0005467878206419364,0.0345785131088444,0,0,69.22916666666667,520.0114050756229,MYH11;ADRA1A,VSMC,3.2621811676355046
KEGG_2021_Human,positive regulation of vasoconstriction (GO:0045907),2/16,0.0007187392304892979,0.0345785131088444,0,0,59.333333333333336,429.45537567816734,AVPR1A;ADRA1A,VSMC,3.14342864967499
KEGG_2021_Human,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),2/17,0.0008132713373134499,0.0345785131088444,0,0,55.375,393.96243373102385,CASQ2;HRC,VSMC,3.089764533572175
KEGG_2021_Human,positive regulation of heart rate (GO:0010460),2/17,0.0008132713373134499,0.0345785131088444,0,0,55.375,393.96243373102385,HRC;ADRA1A,VSMC,3.089764533572175
KEGG_2021_Human,regulation of smooth muscle contraction (GO:0006940),2/20,0.0011307590059983,0.0345785131088444,0,0,46.138888888888886,313.0461870363529,CNN1;MYOCD,VSMC,2.9466299446036754
KEGG_2021_Human,positive regulation of heart contraction (GO:0045823),2/20,0.0011307590059983,0.0345785131088444,0,0,46.138888888888886,313.0461870363529,HRC;ADRA1A,VSMC,2.9466299446036754
KEGG_2021_Human,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),2/21,0.0012477930702112,0.0345785131088444,0,0,43.708333333333336,292.25047477799524,CASQ2;HRC,VSMC,2.9038574306125264
KEGG_2021_Human,calcium ion transport into cytosol (GO:0060402),2/21,0.0012477930702112,0.0345785131088444,0,0,43.708333333333336,292.25047477799524,GRIN2A;ADRA1A,VSMC,2.9038574306125264
KEGG_2021_Human,regulation of cation channel activity (GO:2001257),3/89,0.0014352931477222,0.0345785131088444,0,0,14.743196437407224,96.51465720793364,GRIN2A;HRC;KCNAB1,VSMC,2.8430593885216617
KEGG_2021_Human,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),2/23,0.0014985033958486,0.0345785131088444,0,0,39.541666666666664,257.15086234948103,CASQ2;HRC,VSMC,2.8243422685363964
KEGG_2021_Human,regulation of calcium ion transmembrane transport (GO:1903169),2/23,0.0014985033958486,0.0345785131088444,0,0,39.541666666666664,257.15086234948103,CASQ2;HRC,VSMC,2.8243422685363964
KEGG_2021_Human,cardiac muscle cell differentiation (GO:0055007),2/24,0.0016321249773357,0.0345785131088444,0,0,37.74242424242424,242.22606459531664,MYOCD;MYH11,VSMC,2.7872465889099036
KEGG_2021_Human,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),2/25,0.0017712212130127,0.0345785131088444,0,0,36.09963768115942,228.73040961874747,CASQ2;HRC,VSMC,2.751727195110795
KEGG_2021_Human,supramolecular fiber organization (GO:0097435),5/351,0.0017941549079361,0.0345785131088444,0,0,6.29543994861914,39.8074591656481,DES;COL4A6;COL4A5;MYH11;MYOZ1,VSMC,2.7461400625419454
KEGG_2021_Human,membrane depolarization during action potential (GO:0086010),2/26,0.0019157650058532,0.0345785131088444,0,0,34.59375,216.47517339281177,SCN4B;CACNA1H,VSMC,2.7176577640050135
KEGG_2021_Human,regulation of potassium ion transmembrane transporter activity (GO:1901016),2/26,0.0019157650058532,0.0345785131088444,0,0,34.59375,216.47517339281177,CASQ2;KCNAB1,VSMC,2.7176577640050135
KEGG_2021_Human,negative regulation of cation channel activity (GO:2001258),2/27,0.0020657293545543,0.0345785131088444,0,0,33.208333333333336,205.3029465636782,CASQ2;KCNAB1,VSMC,2.684926579003782
KEGG_2021_Human,positive regulation of striated muscle cell differentiation (GO:0051155),2/27,0.0020657293545543,0.0345785131088444,0,0,33.208333333333336,205.3029465636782,MYOCD;RBM24,VSMC,2.684926579003782
KEGG_2021_Human,regulation of vasoconstriction (GO:0019229),2/30,0.0025478771667966,0.039237308368668,0,0,29.645833333333332,177.0595839464994,AVPR1A;ADRA1A,VSMC,2.5938215131766835
KEGG_2021_Human,regulation of cation transmembrane transport (GO:1904062),2/30,0.0025478771667966,0.039237308368668,0,0,29.645833333333332,177.0595839464994,HRC;KCNAB1,VSMC,2.5938215131766835
KEGG_2021_Human,regulation of potassium ion transport (GO:0043266),2/31,0.0027192556482504,0.0402659009452468,0,0,28.62212643678161,169.08226656127547,CASQ2;KCNAB1,VSMC,2.565549960707733
KEGG_2021_Human,activation of phospholipase C activity (GO:0007202),2/32,0.0028959211173454,0.0412936900065922,0,0,27.666666666666668,161.69650653172428,AVPR1A;ADRA1A,VSMC,2.5382132721600397
KEGG_2021_Human,cardiac muscle contraction (GO:0060048),2/34,0.0032650074009337,0.0448938517628392,0,0,25.934895833333332,148.46413612460563,CASQ2;SCN4B,VSMC,2.4861158299536776
KEGG_2021_Human,regulation of blood circulation (GO:1903522),2/35,0.0034573756419477,0.0458996421430994,0,0,25.147727272727273,142.5183432834292,DES;CACNA1H,VSMC,2.461253432039241
KEGG_2021_Human,heart contraction (GO:0060047),2/41,0.0047194951697385,0.0601155522205306,0,0,21.272435897435894,113.93630347986566,CASQ2;SCN4B,VSMC,2.3261044540613445
KEGG_2021_Human,inorganic cation transmembrane transport (GO:0098662),4/274,0.0048404730359388,0.0601155522205306,0,0,6.338164251207729,33.78712362691089,KCNAB1;SCN4B;KCNK3;CACNA1H,VSMC,2.315112194789583
KEGG_2021_Human,regulation of release of sequestered calcium ion into cytosol (GO:0051279),2/52,0.007499481830469,0.0902281407728309,0,0,16.583333333333332,81.14094572244915,HRC;CASQ2,VSMC,2.12496874273393
KEGG_2021_Human,striated muscle contraction (GO:0006941),2/54,0.0080676700842631,0.0941228176497369,0,0,15.943910256410255,76.8479024006269,CASQ2;SCN4B,VSMC,2.0932518699428635
KEGG_2021_Human,cation transport (GO:0006812),3/174,0.0094022629376098,0.1020930090714268,0,0,7.382978723404255,34.45492114000981,KCNAB1;SCN4B;KCNK3,VSMC,2.02676760777909
KEGG_2021_Human,positive regulation of action potential (GO:0045760),1/5,0.0124387771927725,0.1020930090714268,0,0,101.76530612244898,446.4379351400606,ADRA1A,VSMC,1.9052223113279663
KEGG_2021_Human,positive regulation of cardiac muscle contraction (GO:0060452),1/5,0.0124387771927725,0.1020930090714268,0,0,101.76530612244898,446.4379351400606,ADRA1A,VSMC,1.9052223113279663
KEGG_2021_Human,negative regulation of skeletal muscle cell differentiation (GO:2001015),1/5,0.0124387771927725,0.1020930090714268,0,0,101.76530612244898,446.4379351400606,MYOCD,VSMC,1.9052223113279663
KEGG_2021_Human,positive regulation of smooth muscle cell differentiation (GO:0051152),1/5,0.0124387771927725,0.1020930090714268,0,0,101.76530612244898,446.4379351400606,MYOCD,VSMC,1.9052223113279663
KEGG_2021_Human,positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),1/5,0.0124387771927725,0.1020930090714268,0,0,101.76530612244898,446.4379351400606,MYOCD,VSMC,1.9052223113279663
KEGG_2021_Human,positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),1/5,0.0124387771927725,0.1020930090714268,0,0,101.76530612244898,446.4379351400606,RBM24,VSMC,1.9052223113279663
KEGG_2021_Human,positive regulation of synaptic transmission (GO:0050806),2/73,0.0143765335552059,0.1020930090714268,0,0,11.666079812206572,49.48935398933624,GRIN2A;ADRA1A,VSMC,1.8423458176616205
KEGG_2021_Human,regulation of relaxation of cardiac muscle (GO:1901897),1/6,0.0149082847993736,0.1020930090714268,0,0,81.40816326530613,342.3895623444841,HRC,VSMC,1.8265723193247598
KEGG_2021_Human,regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),1/6,0.0149082847993736,0.1020930090714268,0,0,81.40816326530613,342.3895623444841,RBM24,VSMC,1.8265723193247598
KEGG_2021_Human,positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),1/6,0.0149082847993736,0.1020930090714268,0,0,81.40816326530613,342.3895623444841,ADRA1A,VSMC,1.8265723193247598
KEGG_2021_Human,"neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",1/6,0.0149082847993736,0.1020930090714268,0,0,81.40816326530613,342.3895623444841,GRIP2,VSMC,1.8265723193247598
KEGG_2021_Human,mineralocorticoid biosynthetic process (GO:0006705),1/6,0.0149082847993736,0.1020930090714268,0,0,81.40816326530613,342.3895623444841,CACNA1H,VSMC,1.8265723193247598
KEGG_2021_Human,negative regulation of cell cycle (GO:0045786),2/80,0.0170965192165363,0.1020930090714268,0,0,10.615384615384617,43.19273030214829,MYOCD;NUPR2,VSMC,1.7670923012410087
KEGG_2021_Human,positive regulation of blood circulation (GO:1903524),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,HRC,VSMC,1.7601566430186848
KEGG_2021_Human,excitatory chemical synaptic transmission (GO:0098976),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,GRIN2A,VSMC,1.7601566430186848
KEGG_2021_Human,positive regulation of cardiac muscle cell differentiation (GO:2000727),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,MYOCD,VSMC,1.7601566430186848
KEGG_2021_Human,aldehyde biosynthetic process (GO:0046184),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,CACNA1H,VSMC,1.7601566430186848
KEGG_2021_Human,regulation of smooth muscle cell differentiation (GO:0051150),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,MYOCD,VSMC,1.7601566430186848
KEGG_2021_Human,regulation of striated muscle cell differentiation (GO:0051153),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,RBM24,VSMC,1.7601566430186848
KEGG_2021_Human,negative regulation of cytoplasmic translation (GO:2000766),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,RBM24,VSMC,1.7601566430186848
KEGG_2021_Human,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,MYOCD,VSMC,1.7601566430186848
KEGG_2021_Human,AV node cell action potential (GO:0086016),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,SCN4B,VSMC,1.7601566430186848
KEGG_2021_Human,response to caffeine (GO:0031000),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,CASQ2,VSMC,1.7601566430186848
KEGG_2021_Human,cellular response to caffeine (GO:0071313),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,CASQ2,VSMC,1.7601566430186848
KEGG_2021_Human,"neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,GRIP2,VSMC,1.7601566430186848
KEGG_2021_Human,nicotinamide nucleotide biosynthetic process (GO:0019359),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,NMNAT2,VSMC,1.7601566430186848
KEGG_2021_Human,collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,COL4A6,VSMC,1.7601566430186848
KEGG_2021_Human,positive regulation of striated muscle contraction (GO:0045989),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,ADRA1A,VSMC,1.7601566430186848
KEGG_2021_Human,"positive regulation of synaptic transmission, GABAergic (GO:0032230)",1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,ADRA1A,VSMC,1.7601566430186848
KEGG_2021_Human,positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,MYOCD,VSMC,1.7601566430186848
KEGG_2021_Human,regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),1/7,0.0173717414502839,0.1020930090714268,0,0,67.83673469387755,274.9362107684438,NTF3,VSMC,1.7601566430186848
KEGG_2021_Human,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),2/81,0.0175016586979588,0.1020930090714268,0,0,10.48048523206751,42.398379802278754,GPR20;ADRA1A,VSMC,1.7569207896432026
KEGG_2021_Human,response to potassium ion (GO:0035864),1/8,0.0198291614511851,0.104578454228853,0,0,58.142857142857146,227.9549801512961,CACNA1H,VSMC,1.702695651141308
KEGG_2021_Human,positive regulation of muscle contraction (GO:0045933),1/8,0.0198291614511851,0.104578454228853,0,0,58.142857142857146,227.9549801512961,MYOCD,VSMC,1.702695651141308
KEGG_2021_Human,positive regulation of myotube differentiation (GO:0010831),1/8,0.0198291614511851,0.104578454228853,0,0,58.142857142857146,227.9549801512961,RBM24,VSMC,1.702695651141308
KEGG_2021_Human,skeletal myofibril assembly (GO:0014866),1/8,0.0198291614511851,0.104578454228853,0,0,58.142857142857146,227.9549801512961,MYH11,VSMC,1.702695651141308
KEGG_2021_Human,cellular response to potassium ion (GO:0035865),1/8,0.0198291614511851,0.104578454228853,0,0,58.142857142857146,227.9549801512961,CACNA1H,VSMC,1.702695651141308
KEGG_2021_Human,elastic fiber assembly (GO:0048251),1/8,0.0198291614511851,0.104578454228853,0,0,58.142857142857146,227.9549801512961,MYH11,VSMC,1.702695651141308
KEGG_2021_Human,negative regulation of amyloid-beta clearance (GO:1900222),1/8,0.0198291614511851,0.104578454228853,0,0,58.142857142857146,227.9549801512961,MYOCD,VSMC,1.702695651141308
KEGG_2021_Human,collagen fibril organization (GO:0030199),2/89,0.0208876608034354,0.1059014229953014,0,0,9.512931034482758,36.80169347929862,COL4A6;COL4A5,VSMC,1.6801101936742149
KEGG_2021_Human,regulation of skeletal muscle cell differentiation (GO:2001014),1/9,0.0222805591236868,0.1059014229953014,0,0,50.87244897959184,193.52086993316271,MYOCD,VSMC,1.652073914876897
KEGG_2021_Human,ketone biosynthetic process (GO:0042181),1/9,0.0222805591236868,0.1059014229953014,0,0,50.87244897959184,193.52086993316271,CACNA1H,VSMC,1.652073914876897
KEGG_2021_Human,positive regulation of protein kinase C signaling (GO:0090037),1/9,0.0222805591236868,0.1059014229953014,0,0,50.87244897959184,193.52086993316271,ADRA1A,VSMC,1.652073914876897
KEGG_2021_Human,neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),1/9,0.0222805591236868,0.1059014229953014,0,0,50.87244897959184,193.52086993316271,GRIP2,VSMC,1.652073914876897
KEGG_2021_Human,collagen-activated signaling pathway (GO:0038065),1/9,0.0222805591236868,0.1059014229953014,0,0,50.87244897959184,193.52086993316271,COL4A6,VSMC,1.652073914876897
KEGG_2021_Human,positive regulation of smooth muscle contraction (GO:0045987),1/9,0.0222805591236868,0.1059014229953014,0,0,50.87244897959184,193.52086993316271,MYOCD,VSMC,1.652073914876897
KEGG_2021_Human,nucleoside diphosphate catabolic process (GO:0009134),1/9,0.0222805591236868,0.1059014229953014,0,0,50.87244897959184,193.52086993316271,ENTPD3,VSMC,1.652073914876897
KEGG_2021_Human,negative regulation of delayed rectifier potassium channel activity (GO:1902260),1/10,0.024725948817258,0.109572338500281,0,0,45.21768707482993,167.3010120823387,KCNAB1,VSMC,1.606847034080906
KEGG_2021_Human,cellular response to purine-containing compound (GO:0071415),1/10,0.024725948817258,0.109572338500281,0,0,45.21768707482993,167.3010120823387,CASQ2,VSMC,1.606847034080906
KEGG_2021_Human,lipid phosphorylation (GO:0046834),1/10,0.024725948817258,0.109572338500281,0,0,45.21768707482993,167.3010120823387,DGKB,VSMC,1.606847034080906
KEGG_2021_Human,nerve growth factor signaling pathway (GO:0038180),1/10,0.024725948817258,0.109572338500281,0,0,45.21768707482993,167.3010120823387,NTF3,VSMC,1.606847034080906
KEGG_2021_Human,regulation of peptidyl-lysine acetylation (GO:2000756),1/10,0.024725948817258,0.109572338500281,0,0,45.21768707482993,167.3010120823387,MYOCD,VSMC,1.606847034080906
KEGG_2021_Human,regulation of peptidyl-serine phosphorylation (GO:0033135),2/98,0.0249948795228368,0.109572338500281,0,0,8.6171875,31.789531066243494,NTF3;HRC,VSMC,1.6021489522377872
KEGG_2021_Human,glucocorticoid biosynthetic process (GO:0006704),1/11,0.0271653448579923,0.109572338500281,0,0,40.69387755102041,146.73452100035948,CACNA1H,VSMC,1.5659847773237099
KEGG_2021_Human,glycerolipid metabolic process (GO:0046486),1/11,0.0271653448579923,0.109572338500281,0,0,40.69387755102041,146.73452100035948,DGKB,VSMC,1.5659847773237099
KEGG_2021_Human,regulation of cardiac muscle cell differentiation (GO:2000725),1/11,0.0271653448579923,0.109572338500281,0,0,40.69387755102041,146.73452100035948,MYOCD,VSMC,1.5659847773237099
KEGG_2021_Human,induction of positive chemotaxis (GO:0050930),1/11,0.0271653448579923,0.109572338500281,0,0,40.69387755102041,146.73452100035948,NTF3,VSMC,1.5659847773237099
KEGG_2021_Human,negative regulation of potassium ion transmembrane transport (GO:1901380),1/11,0.0271653448579923,0.109572338500281,0,0,40.69387755102041,146.73452100035948,CASQ2,VSMC,1.5659847773237099
KEGG_2021_Human,negative regulation of voltage-gated potassium channel activity (GO:1903817),1/11,0.0271653448579923,0.109572338500281,0,0,40.69387755102041,146.73452100035948,KCNAB1,VSMC,1.5659847773237099
KEGG_2021_Human,positive regulation of acrosome reaction (GO:2000344),1/11,0.0271653448579923,0.109572338500281,0,0,40.69387755102041,146.73452100035948,CACNA1H,VSMC,1.5659847773237099
KEGG_2021_Human,negative regulation of calcineurin-mediated signaling (GO:0106057),1/12,0.029598761568907,0.109572338500281,0,0,36.99257884972171,130.2147194065139,MYOZ1,VSMC,1.5287264597194943
KEGG_2021_Human,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),1/12,0.029598761568907,0.109572338500281,0,0,36.99257884972171,130.2147194065139,MYOZ1,VSMC,1.5287264597194943
KEGG_2021_Human,regulation of sequestering of calcium ion (GO:0051282),1/12,0.029598761568907,0.109572338500281,0,0,36.99257884972171,130.2147194065139,CASQ2,VSMC,1.5287264597194943
KEGG_2021_Human,positive regulation of cardiocyte differentiation (GO:1905209),1/12,0.029598761568907,0.109572338500281,0,0,36.99257884972171,130.2147194065139,MYOCD,VSMC,1.5287264597194943
KEGG_2021_Human,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),1/12,0.029598761568907,0.109572338500281,0,0,36.99257884972171,130.2147194065139,HRC,VSMC,1.5287264597194943
KEGG_2021_Human,cardiocyte differentiation (GO:0035051),1/12,0.029598761568907,0.109572338500281,0,0,36.99257884972171,130.2147194065139,MYOCD,VSMC,1.5287264597194943
KEGG_2021_Human,inorganic ion transmembrane transport (GO:0098660),1/12,0.029598761568907,0.109572338500281,0,0,36.99257884972171,130.2147194065139,CACNA1H,VSMC,1.5287264597194943
KEGG_2021_Human,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),1/12,0.029598761568907,0.109572338500281,0,0,36.99257884972171,130.2147194065139,CASQ2,VSMC,1.5287264597194943
KEGG_2021_Human,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),1/12,0.029598761568907,0.109572338500281,0,0,36.99257884972171,130.2147194065139,CASQ2,VSMC,1.5287264597194943
KEGG_2021_Human,smooth muscle cell differentiation (GO:0051145),1/12,0.029598761568907,0.109572338500281,0,0,36.99257884972171,130.2147194065139,MYOCD,VSMC,1.5287264597194943
KEGG_2021_Human,positive regulation of calcium ion-dependent exocytosis (GO:0045956),1/13,0.032026213248763,0.1110819108177816,0,0,33.90816326530612,116.6847899929619,CACNA1H,VSMC,1.4944944088974865
KEGG_2021_Human,cardiac cell development (GO:0055006),1/13,0.032026213248763,0.1110819108177816,0,0,33.90816326530612,116.6847899929619,MYH11,VSMC,1.4944944088974865
KEGG_2021_Human,negative regulation of potassium ion transport (GO:0043267),1/13,0.032026213248763,0.1110819108177816,0,0,33.90816326530612,116.6847899929619,CASQ2,VSMC,1.4944944088974865
KEGG_2021_Human,regulation of histone modification (GO:0031056),1/13,0.032026213248763,0.1110819108177816,0,0,33.90816326530612,116.6847899929619,MYOCD,VSMC,1.4944944088974865
KEGG_2021_Human,positive regulation of sodium ion transport (GO:0010765),1/13,0.032026213248763,0.1110819108177816,0,0,33.90816326530612,116.6847899929619,SCN4B,VSMC,1.4944944088974865
KEGG_2021_Human,regulation of membrane repolarization (GO:0060306),1/13,0.032026213248763,0.1110819108177816,0,0,33.90816326530612,116.6847899929619,CASQ2,VSMC,1.4944944088974865
KEGG_2021_Human,detection of calcium ion (GO:0005513),1/13,0.032026213248763,0.1110819108177816,0,0,33.90816326530612,116.6847899929619,CASQ2,VSMC,1.4944944088974865
KEGG_2021_Human,activation of cysteine-type endopeptidase activity (GO:0097202),1/14,0.0344477141698711,0.1133535893623965,0,0,31.298273155416013,105.4223689491126,GRIN2A,VSMC,1.4628395910668823
KEGG_2021_Human,regulation of acrosome reaction (GO:0060046),1/14,0.0344477141698711,0.1133535893623965,0,0,31.298273155416013,105.4223689491126,CACNA1H,VSMC,1.4628395910668823
KEGG_2021_Human,striated muscle cell development (GO:0055002),1/14,0.0344477141698711,0.1133535893623965,0,0,31.298273155416013,105.4223689491126,MYOZ1,VSMC,1.4628395910668823
KEGG_2021_Human,nucleoside phosphate biosynthetic process (GO:1901293),1/14,0.0344477141698711,0.1133535893623965,0,0,31.298273155416013,105.4223689491126,NMNAT2,VSMC,1.4628395910668823
KEGG_2021_Human,nucleoside phosphate catabolic process (GO:1901292),1/14,0.0344477141698711,0.1133535893623965,0,0,31.298273155416013,105.4223689491126,ENTPD3,VSMC,1.4628395910668823
KEGG_2021_Human,regulation of protein kinase C signaling (GO:0090036),1/14,0.0344477141698711,0.1133535893623965,0,0,31.298273155416013,105.4223689491126,ADRA1A,VSMC,1.4628395910668823
KEGG_2021_Human,"regulation of synaptic transmission, GABAergic (GO:0032228)",1/15,0.0368632785936063,0.1142086412114838,0,0,29.06122448979592,95.91771596133704,ADRA1A,VSMC,1.4334060415588732
KEGG_2021_Human,C21-steroid hormone biosynthetic process (GO:0006700),1/15,0.0368632785936063,0.1142086412114838,0,0,29.06122448979592,95.91771596133704,CACNA1H,VSMC,1.4334060415588732
KEGG_2021_Human,response to ethanol (GO:0045471),1/15,0.0368632785936063,0.1142086412114838,0,0,29.06122448979592,95.91771596133704,GRIN2A,VSMC,1.4334060415588732
KEGG_2021_Human,regulation of cytoplasmic translation (GO:2000765),1/15,0.0368632785936063,0.1142086412114838,0,0,29.06122448979592,95.91771596133704,RBM24,VSMC,1.4334060415588732
KEGG_2021_Human,nucleobase-containing small molecule catabolic process (GO:0034656),1/15,0.0368632785936063,0.1142086412114838,0,0,29.06122448979592,95.91771596133704,ENTPD3,VSMC,1.4334060415588732
KEGG_2021_Human,regulation of phospholipase C activity (GO:1900274),1/15,0.0368632785936063,0.1142086412114838,0,0,29.06122448979592,95.91771596133704,NTF3,VSMC,1.4334060415588732
KEGG_2021_Human,myoblast fusion (GO:0007520),1/15,0.0368632785936063,0.1142086412114838,0,0,29.06122448979592,95.91771596133704,CACNA1H,VSMC,1.4334060415588732
KEGG_2021_Human,regulation of mRNA catabolic process (GO:0061013),2/122,0.0373773734873947,0.1142086412114838,0,0,6.885416666666667,22.63022834568748,CSDC2;RBM24,VSMC,1.4273912198113348
KEGG_2021_Human,potassium ion transport (GO:0006813),2/122,0.0373773734873947,0.1142086412114838,0,0,6.885416666666667,22.63022834568748,KCNAB1;KCNK3,VSMC,1.4273912198113348
KEGG_2021_Human,3'-UTR-mediated mRNA destabilization (GO:0061158),1/16,0.0392729207344652,0.115435338810251,0,0,27.122448979591837,87.80133530116419,RBM24,VSMC,1.405906798966597
KEGG_2021_Human,regulation of systemic arterial blood pressure by hormone (GO:0001990),1/16,0.0392729207344652,0.115435338810251,0,0,27.122448979591837,87.80133530116419,AVPR1A,VSMC,1.405906798966597
KEGG_2021_Human,regulation of amyloid-beta clearance (GO:1900221),1/16,0.0392729207344652,0.115435338810251,0,0,27.122448979591837,87.80133530116419,MYOCD,VSMC,1.405906798966597
KEGG_2021_Human,nucleoside diphosphate metabolic process (GO:0009132),1/16,0.0392729207344652,0.115435338810251,0,0,27.122448979591837,87.80133530116419,ENTPD3,VSMC,1.405906798966597
KEGG_2021_Human,regulation of cell population proliferation (GO:0042127),5/764,0.0413571138631448,0.115435338810251,0,0,2.8093983311374617,8.949368815489745,MYOCD;NTF3;NUPR2;AVPR1A;ADRA1A,VSMC,1.3834497764190727
KEGG_2021_Human,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/17,0.0416766547912334,0.115435338810251,0,0,25.426020408163264,80.79916728086499,ADRA1A,VSMC,1.3801071472903907
KEGG_2021_Human,positive regulation of positive chemotaxis (GO:0050927),1/17,0.0416766547912334,0.115435338810251,0,0,25.426020408163264,80.79916728086499,NTF3,VSMC,1.3801071472903907
KEGG_2021_Human,stabilization of membrane potential (GO:0030322),1/17,0.0416766547912334,0.115435338810251,0,0,25.426020408163264,80.79916728086499,KCNK3,VSMC,1.3801071472903907
KEGG_2021_Human,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),1/17,0.0416766547912334,0.115435338810251,0,0,25.426020408163264,80.79916728086499,CNN1,VSMC,1.3801071472903907
KEGG_2021_Human,positive regulation of regulated secretory pathway (GO:1903307),1/17,0.0416766547912334,0.115435338810251,0,0,25.426020408163264,80.79916728086499,CACNA1H,VSMC,1.3801071472903907
KEGG_2021_Human,membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,0.0416766547912334,0.115435338810251,0,0,25.426020408163264,80.79916728086499,SCN4B,VSMC,1.3801071472903907
KEGG_2021_Human,positive regulation of stem cell differentiation (GO:2000738),1/17,0.0416766547912334,0.115435338810251,0,0,25.426020408163264,80.79916728086499,RBM24,VSMC,1.3801071472903907
KEGG_2021_Human,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",1/17,0.0416766547912334,0.115435338810251,0,0,25.426020408163264,80.79916728086499,COX4I2,VSMC,1.3801071472903907
KEGG_2021_Human,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/18,0.0440744949316926,0.116223839374669,0,0,23.92917166866747,74.70385911458476,SCN4B,VSMC,1.3558126557645607
KEGG_2021_Human,regulation of delayed rectifier potassium channel activity (GO:1902259),1/18,0.0440744949316926,0.116223839374669,0,0,23.92917166866747,74.70385911458476,KCNAB1,VSMC,1.3558126557645607
KEGG_2021_Human,RNA destabilization (GO:0050779),1/18,0.0440744949316926,0.116223839374669,0,0,23.92917166866747,74.70385911458476,RBM24,VSMC,1.3558126557645607
KEGG_2021_Human,cellular response to alkaloid (GO:0071312),1/18,0.0440744949316926,0.116223839374669,0,0,23.92917166866747,74.70385911458476,CASQ2,VSMC,1.3558126557645607
KEGG_2021_Human,intermediate filament organization (GO:0045109),1/18,0.0440744949316926,0.116223839374669,0,0,23.92917166866747,74.70385911458476,DES,VSMC,1.3558126557645607
KEGG_2021_Human,positive regulation of myoblast differentiation (GO:0045663),1/18,0.0440744949316926,0.116223839374669,0,0,23.92917166866747,74.70385911458476,RBM24,VSMC,1.3558126557645607
KEGG_2021_Human,nucleotide biosynthetic process (GO:0009165),1/18,0.0440744949316926,0.116223839374669,0,0,23.92917166866747,74.70385911458476,NMNAT2,VSMC,1.3558126557645607
KEGG_2021_Human,excitatory postsynaptic potential (GO:0060079),1/19,0.0464664552952436,0.1192639019244586,0,0,22.598639455782312,69.35578082800635,GRIN2A,VSMC,1.3328604565168853
KEGG_2021_Human,cardiac muscle cell contraction (GO:0086003),1/19,0.0464664552952436,0.1192639019244586,0,0,22.598639455782312,69.35578082800635,SCN4B,VSMC,1.3328604565168853
KEGG_2021_Human,striated muscle cell differentiation (GO:0051146),1/19,0.0464664552952436,0.1192639019244586,0,0,22.598639455782312,69.35578082800635,MYOCD,VSMC,1.3328604565168853
KEGG_2021_Human,positive regulation of actin cytoskeleton reorganization (GO:2000251),1/19,0.0464664552952436,0.1192639019244586,0,0,22.598639455782312,69.35578082800635,NTF3,VSMC,1.3328604565168853
KEGG_2021_Human,potassium ion transmembrane transport (GO:0071805),2/139,0.0472922793944307,0.1205796527606348,0,0,6.025851581508515,18.3873330672393,KCNAB1;KCNK3,VSMC,1.3252097533441285
KEGG_2021_Human,negative regulation of axon extension involved in axon guidance (GO:0048843),1/20,0.0488525499820277,0.1221313749550694,0,0,21.40816326530612,64.63014669364038,SEMA5B,VSMC,1.3111127622579986
KEGG_2021_Human,adrenergic receptor signaling pathway (GO:0071875),1/20,0.0488525499820277,0.1221313749550694,0,0,21.40816326530612,64.63014669364038,ADRA1A,VSMC,1.3111127622579986
KEGG_2021_Human,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/20,0.0488525499820277,0.1221313749550694,0,0,21.40816326530612,64.63014669364038,MYOCD,VSMC,1.3111127622579986
KEGG_2021_Human,negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,0.0512327930672156,0.1240542473640126,0,0,20.336734693877553,60.42807445408675,CASQ2,VSMC,1.2904519669693806
KEGG_2021_Human,long-term synaptic potentiation (GO:0060291),1/21,0.0512327930672156,0.1240542473640126,0,0,20.336734693877553,60.42807445408675,GRIN2A,VSMC,1.2904519669693806
KEGG_2021_Human,neurotrophin signaling pathway (GO:0038179),1/21,0.0512327930672156,0.1240542473640126,0,0,20.336734693877553,60.42807445408675,NTF3,VSMC,1.2904519669693806
KEGG_2021_Human,myotube differentiation (GO:0014902),1/21,0.0512327930672156,0.1240542473640126,0,0,20.336734693877553,60.42807445408675,CACNA1H,VSMC,1.2904519669693806
KEGG_2021_Human,NAD biosynthetic process (GO:0009435),1/21,0.0512327930672156,0.1240542473640126,0,0,20.336734693877553,60.42807445408675,NMNAT2,VSMC,1.2904519669693806
KEGG_2021_Human,regulation of mRNA stability (GO:0043488),2/146,0.0516255263806262,0.1242239228533818,0,0,5.730902777777778,16.984900248335105,CSDC2;RBM24,VSMC,1.2871355071895687
KEGG_2021_Human,positive regulation of cytosolic calcium ion concentration (GO:0007204),2/147,0.0522559027547516,0.1243299485585125,0,0,5.691091954022989,16.797840801779476,GPR20;ADRA1A,VSMC,1.281864645139883
KEGG_2021_Human,regulation of cytosolic calcium ion concentration (GO:0051480),2/148,0.052889062238365,0.1243299485585125,0,0,5.651826484018265,16.61387585032132,HRC;ADRA1A,VSMC,1.2766341332705589
KEGG_2021_Human,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/22,0.0536071985992547,0.1243299485585125,0,0,19.367346938775512,56.67024999786951,MYOCD,VSMC,1.2707768875084013
KEGG_2021_Human,regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.0536071985992547,0.1243299485585125,0,0,19.367346938775512,56.67024999786951,SCN4B,VSMC,1.2707768875084013
KEGG_2021_Human,cellular response to nerve growth factor stimulus (GO:1990090),1/22,0.0536071985992547,0.1243299485585125,0,0,19.367346938775512,56.67024999786951,NTF3,VSMC,1.2707768875084013
KEGG_2021_Human,neuronal action potential (GO:0019228),1/22,0.0536071985992547,0.1243299485585125,0,0,19.367346938775512,56.67024999786951,CACNA1H,VSMC,1.2707768875084013
KEGG_2021_Human,positive regulation of multicellular organismal process (GO:0051240),3/345,0.0550388186280638,0.1267686795666683,0,0,3.6595744680851063,10.611728649113475,EBF2;AVPR1A;ADRA1A,VSMC,1.2593308965170802
KEGG_2021_Human,positive regulation of receptor internalization (GO:0002092),1/23,0.0559757805878795,0.1267686795666683,0,0,18.4860853432282,53.29235549319145,NTF3,VSMC,1.2519998414265567
KEGG_2021_Human,nucleotide metabolic process (GO:0009117),1/23,0.0559757805878795,0.1267686795666683,0,0,18.4860853432282,53.29235549319145,NMNAT2,VSMC,1.2519998414265567
KEGG_2021_Human,diacylglycerol metabolic process (GO:0046339),1/23,0.0559757805878795,0.1267686795666683,0,0,18.4860853432282,53.29235549319145,DGKB,VSMC,1.2519998414265567
KEGG_2021_Human,extracellular matrix assembly (GO:0085029),1/24,0.0583385530130099,0.1283448166286219,0,0,17.68145519077196,50.24171555062859,MYH11,VSMC,1.2340443470047993
KEGG_2021_Human,regulation of axon extension involved in axon guidance (GO:0048841),1/24,0.0583385530130099,0.1283448166286219,0,0,17.68145519077196,50.24171555062859,SEMA5B,VSMC,1.2340443470047993
KEGG_2021_Human,axon extension (GO:0048675),1/24,0.0583385530130099,0.1283448166286219,0,0,17.68145519077196,50.24171555062859,SEMA5B,VSMC,1.2340443470047993
KEGG_2021_Human,cardiac muscle cell development (GO:0055013),1/24,0.0583385530130099,0.1283448166286219,0,0,17.68145519077196,50.24171555062859,MYH11,VSMC,1.2340443470047993
KEGG_2021_Human,positive regulation of phospholipase activity (GO:0010518),1/24,0.0583385530130099,0.1283448166286219,0,0,17.68145519077196,50.24171555062859,NTF3,VSMC,1.2340443470047993
KEGG_2021_Human,negative regulation of ion transport (GO:0043271),1/25,0.0606955298241754,0.1298209943461529,0,0,16.943877551020407,47.47480020477031,CASQ2,VSMC,1.2168432931781568
KEGG_2021_Human,"chemical synaptic transmission, postsynaptic (GO:0099565)",1/25,0.0606955298241754,0.1298209943461529,0,0,16.943877551020407,47.47480020477031,GRIN2A,VSMC,1.2168432931781568
KEGG_2021_Human,regulation of myotube differentiation (GO:0010830),1/25,0.0606955298241754,0.1298209943461529,0,0,16.943877551020407,47.47480020477031,RBM24,VSMC,1.2168432931781568
KEGG_2021_Human,peripheral nervous system development (GO:0007422),1/25,0.0606955298241754,0.1298209943461529,0,0,16.943877551020407,47.47480020477031,NTF3,VSMC,1.2168432931781568
KEGG_2021_Human,energy derivation by oxidation of organic compounds (GO:0015980),1/25,0.0606955298241754,0.1298209943461529,0,0,16.943877551020407,47.47480020477031,COX4I2,VSMC,1.2168432931781568
KEGG_2021_Human,heart development (GO:0007507),2/164,0.0633842647819243,0.1348228836521595,0,0,5.089506172839506,14.03960451512792,MYOCD;LDB3,VSMC,1.1980185428525092
KEGG_2021_Human,positive regulation of muscle cell differentiation (GO:0051149),1/27,0.0653921522588676,0.1372460676854208,0,0,15.638932496075354,42.652889831563165,MYOCD,VSMC,1.184474368421492
KEGG_2021_Human,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/28,0.0677318256109869,0.1372460676854208,0,0,15.058956916099774,40.54171043527237,CASQ2,VSMC,1.1692072184717057
KEGG_2021_Human,regulation of sodium ion transmembrane transport (GO:1902305),1/28,0.0677318256109869,0.1372460676854208,0,0,15.058956916099774,40.54171043527237,SCN4B,VSMC,1.1692072184717057
KEGG_2021_Human,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),1/28,0.0677318256109869,0.1372460676854208,0,0,15.058956916099774,40.54171043527237,GPR20,VSMC,1.1692072184717057
KEGG_2021_Human,regulation of calcineurin-NFAT signaling cascade (GO:0070884),1/28,0.0677318256109869,0.1372460676854208,0,0,15.058956916099774,40.54171043527237,MYOZ1,VSMC,1.1692072184717057
KEGG_2021_Human,calcium ion import (GO:0070509),1/28,0.0677318256109869,0.1372460676854208,0,0,15.058956916099774,40.54171043527237,CACNA1H,VSMC,1.1692072184717057
KEGG_2021_Human,sarcomere organization (GO:0045214),1/28,0.0677318256109869,0.1372460676854208,0,0,15.058956916099774,40.54171043527237,MYOZ1,VSMC,1.1692072184717057
KEGG_2021_Human,cytosolic calcium ion transport (GO:0060401),1/28,0.0677318256109869,0.1372460676854208,0,0,15.058956916099774,40.54171043527237,ADRA1A,VSMC,1.1692072184717057
KEGG_2021_Human,regulation of muscle contraction (GO:0006937),1/28,0.0677318256109869,0.1372460676854208,0,0,15.058956916099774,40.54171043527237,CNN1,VSMC,1.1692072184717057
KEGG_2021_Human,negative regulation of cell population proliferation (GO:0008285),3/379,0.068906376040614,0.1388950511813425,0,0,3.3228836577636938,8.888735598390964,MYOCD;NUPR2;ADRA1A,VSMC,1.1617405901223166
KEGG_2021_Human,regulation of calcium ion transmembrane transporter activity (GO:1901019),1/29,0.0700657588372089,0.1390480265583785,0,0,14.520408163265309,38.5999069065122,HRC,VSMC,1.1544941700666143
KEGG_2021_Human,negative regulation of mRNA catabolic process (GO:1902373),1/29,0.0700657588372089,0.1390480265583785,0,0,14.520408163265309,38.5999069065122,RBM24,VSMC,1.1544941700666143
KEGG_2021_Human,negative regulation of wound healing (GO:0061045),1/29,0.0700657588372089,0.1390480265583785,0,0,14.520408163265309,38.5999069065122,MYOZ1,VSMC,1.1544941700666143
KEGG_2021_Human,response to alcohol (GO:0097305),1/30,0.0723939657090184,0.1422024326427147,0,0,14.019000703729768,36.80874147674154,GRIN2A,VSMC,1.1402976322627019
KEGG_2021_Human,cardiac muscle cell action potential (GO:0086001),1/30,0.0723939657090184,0.1422024326427147,0,0,14.019000703729768,36.80874147674154,SCN4B,VSMC,1.1402976322627019
KEGG_2021_Human,negative regulation of axon extension (GO:0030517),1/31,0.0747164600026276,0.1424051341634239,0,0,13.551020408163266,35.15209038871121,SEMA5B,VSMC,1.126583712764908
KEGG_2021_Human,activation of protein kinase B activity (GO:0032148),1/31,0.0747164600026276,0.1424051341634239,0,0,13.551020408163266,35.15209038871121,NTF3,VSMC,1.126583712764908
KEGG_2021_Human,regulation of calcium ion-dependent exocytosis (GO:0017158),1/31,0.0747164600026276,0.1424051341634239,0,0,13.551020408163266,35.15209038871121,CACNA1H,VSMC,1.126583712764908
KEGG_2021_Human,cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.0747164600026276,0.1424051341634239,0,0,13.551020408163266,35.15209038871121,SCN4B,VSMC,1.126583712764908
KEGG_2021_Human,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/31,0.0747164600026276,0.1424051341634239,0,0,13.551020408163266,35.15209038871121,NTF3,VSMC,1.126583712764908
KEGG_2021_Human,positive regulation of Rho protein signal transduction (GO:0035025),1/31,0.0747164600026276,0.1424051341634239,0,0,13.551020408163266,35.15209038871121,GPR20,VSMC,1.126583712764908
KEGG_2021_Human,negative regulation of chemotaxis (GO:0050922),1/32,0.0770332554327668,0.1432744122783345,0,0,13.113232389730086,33.61600807740255,SEMA5B,VSMC,1.1133217484244988
KEGG_2021_Human,negative regulation of developmental growth (GO:0048640),1/32,0.0770332554327668,0.1432744122783345,0,0,13.113232389730086,33.61600807740255,MYOZ1,VSMC,1.1133217484244988
KEGG_2021_Human,skeletal muscle organ development (GO:0060538),1/32,0.0770332554327668,0.1432744122783345,0,0,13.113232389730086,33.61600807740255,MYOZ1,VSMC,1.1133217484244988
KEGG_2021_Human,membrane depolarization (GO:0051899),1/32,0.0770332554327668,0.1432744122783345,0,0,13.113232389730086,33.61600807740255,CACNA1H,VSMC,1.1133217484244988
KEGG_2021_Human,regulation of NMDA receptor activity (GO:2000310),1/32,0.0770332554327668,0.1432744122783345,0,0,13.113232389730086,33.61600807740255,GRIN2A,VSMC,1.1133217484244988
KEGG_2021_Human,RNA stabilization (GO:0043489),1/33,0.0793443657059371,0.1440923622489895,0,0,12.70280612244898,32.18837516559274,RBM24,VSMC,1.1004839073426347
KEGG_2021_Human,negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.0793443657059371,0.1440923622489895,0,0,12.70280612244898,32.18837516559274,CNN1,VSMC,1.1004839073426347
KEGG_2021_Human,regulation of histone acetylation (GO:0035065),1/33,0.0793443657059371,0.1440923622489895,0,0,12.70280612244898,32.18837516559274,MYOCD,VSMC,1.1004839073426347
KEGG_2021_Human,neuron projection extension (GO:1990138),1/33,0.0793443657059371,0.1440923622489895,0,0,12.70280612244898,32.18837516559274,SEMA5B,VSMC,1.1004839073426347
KEGG_2021_Human,muscle cell development (GO:0055001),1/33,0.0793443657059371,0.1440923622489895,0,0,12.70280612244898,32.18837516559274,MYH11,VSMC,1.1004839073426347
KEGG_2021_Human,striated muscle tissue development (GO:0014706),1/34,0.0816498044624026,0.1455882448833248,0,0,12.317254174397032,30.85861216573232,MYOZ1,VSMC,1.0880448509885652
KEGG_2021_Human,regulation of myoblast differentiation (GO:0045661),1/34,0.0816498044624026,0.1455882448833248,0,0,12.317254174397032,30.85861216573232,RBM24,VSMC,1.0880448509885652
KEGG_2021_Human,regulation of trans-synaptic signaling (GO:0099177),1/35,0.0839495853612937,0.1455882448833248,0,0,11.95438175270108,29.61744503578088,NTF3,VSMC,1.0759814445616303
KEGG_2021_Human,cellular response to amyloid-beta (GO:1904646),1/35,0.0839495853612937,0.1455882448833248,0,0,11.95438175270108,29.61744503578088,GRIN2A,VSMC,1.0759814445616303
KEGG_2021_Human,semaphorin-plexin signaling pathway (GO:0071526),1/35,0.0839495853612937,0.1455882448833248,0,0,11.95438175270108,29.61744503578088,SEMA5B,VSMC,1.0759814445616303
KEGG_2021_Human,regulation of ion transmembrane transport (GO:0034765),1/35,0.0839495853612937,0.1455882448833248,0,0,11.95438175270108,29.61744503578088,CASQ2,VSMC,1.0759814445616303
KEGG_2021_Human,positive regulation of reproductive process (GO:2000243),1/35,0.0839495853612937,0.1455882448833248,0,0,11.95438175270108,29.61744503578088,CACNA1H,VSMC,1.0759814445616303
KEGG_2021_Human,regulation of muscle cell differentiation (GO:0051147),1/35,0.0839495853612937,0.1455882448833248,0,0,11.95438175270108,29.61744503578088,MYOCD,VSMC,1.0759814445616303
KEGG_2021_Human,muscle cell differentiation (GO:0042692),1/35,0.0839495853612937,0.1455882448833248,0,0,11.95438175270108,29.61744503578088,MYOCD,VSMC,1.0759814445616303
KEGG_2021_Human,regulation of postsynaptic membrane potential (GO:0060078),1/35,0.0839495853612937,0.1455882448833248,0,0,11.95438175270108,29.61744503578088,GRIN2A,VSMC,1.0759814445616303
KEGG_2021_Human,regulation of receptor internalization (GO:0002090),1/36,0.0862437219743075,0.1469196148677364,0,0,11.612244897959185,28.456712045041098,NTF3,VSMC,1.0642725091375862
KEGG_2021_Human,regulation of sodium ion transport (GO:0002028),1/36,0.0862437219743075,0.1469196148677364,0,0,11.612244897959185,28.456712045041098,SCN4B,VSMC,1.0642725091375862
KEGG_2021_Human,regulation of cardiac muscle contraction (GO:0055117),1/36,0.0862437219743075,0.1469196148677364,0,0,11.612244897959185,28.456712045041098,ADRA1A,VSMC,1.0642725091375862
KEGG_2021_Human,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/36,0.0862437219743075,0.1469196148677364,0,0,11.612244897959185,28.456712045041098,CDH6,VSMC,1.0642725091375862
KEGG_2021_Human,regulation of actin cytoskeleton reorganization (GO:2000249),1/37,0.0885322278902676,0.1475537131504461,0,0,11.289115646258503,27.36920368672352,NTF3,VSMC,1.0528986067362665
KEGG_2021_Human,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),1/37,0.0885322278902676,0.1475537131504461,0,0,11.289115646258503,27.36920368672352,CNN1,VSMC,1.0528986067362665
KEGG_2021_Human,glutamate receptor signaling pathway (GO:0007215),1/37,0.0885322278902676,0.1475537131504461,0,0,11.289115646258503,27.36920368672352,GRIN2A,VSMC,1.0528986067362665
KEGG_2021_Human,skeletal muscle tissue development (GO:0007519),1/37,0.0885322278902676,0.1475537131504461,0,0,11.289115646258503,27.36920368672352,MYOZ1,VSMC,1.0528986067362665
KEGG_2021_Human,neural crest cell migration (GO:0001755),1/37,0.0885322278902676,0.1475537131504461,0,0,11.289115646258503,27.36920368672352,SEMA5B,VSMC,1.0528986067362665
KEGG_2021_Human,actin-myosin filament sliding (GO:0033275),1/38,0.0908151166313484,0.1487822123534858,0,0,10.983452840595698,26.34852930034076,DES,VSMC,1.0418418549683985
KEGG_2021_Human,regulation of cell communication (GO:0010646),1/38,0.0908151166313484,0.1487822123534858,0,0,10.983452840595698,26.34852930034076,CASQ2,VSMC,1.0418418549683985
KEGG_2021_Human,mRNA destabilization (GO:0061157),1/38,0.0908151166313484,0.1487822123534858,0,0,10.983452840595698,26.34852930034076,RBM24,VSMC,1.0418418549683985
KEGG_2021_Human,muscle filament sliding (GO:0030049),1/38,0.0908151166313484,0.1487822123534858,0,0,10.983452840595698,26.34852930034076,DES,VSMC,1.0418418549683985
KEGG_2021_Human,regulation of heart rate by cardiac conduction (GO:0086091),1/39,0.0930924017046572,0.1512260534020803,0,0,10.693877551020408,25.38900533231373,SCN4B,VSMC,1.0310857651239858
KEGG_2021_Human,regulation of ion transmembrane transporter activity (GO:0032412),1/39,0.0930924017046572,0.1512260534020803,0,0,10.693877551020408,25.38900533231373,SCN4B,VSMC,1.0310857651239858
KEGG_2021_Human,regulation of sodium ion transmembrane transporter activity (GO:2000649),1/40,0.0953640965755271,0.1542654503427645,0,0,10.419152276295131,24.485561288951835,SCN4B,VSMC,1.0206151011238414
KEGG_2021_Human,acylglycerol metabolic process (GO:0006639),1/41,0.0976302146847681,0.1566151360568156,0,0,10.158163265306122,23.633660200289185,DGKB,VSMC,1.0104157556925017
KEGG_2021_Human,nucleobase-containing compound catabolic process (GO:0034655),1/41,0.0976302146847681,0.1566151360568156,0,0,10.158163265306122,23.633660200289185,ENTPD3,VSMC,1.0104157556925017
KEGG_2021_Human,calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.0998907694703361,0.158917133248262,0,0,9.909905425584869,22.829231064333683,GRIN2A,VSMC,1.00047464143678
KEGG_2021_Human,cellular respiration (GO:0045333),1/42,0.0998907694703361,0.158917133248262,0,0,9.909905425584869,22.829231064333683,COX4I2,VSMC,1.00047464143678
KEGG_2021_Human,extracellular structure organization (GO:0043062),2/216,0.1015881472155216,0.1601281607527467,0,0,3.842679127725857,8.78754780712842,COL4A6;COL4A5,VSMC,0.9931569603511173
KEGG_2021_Human,lipid modification (GO:0030258),1/43,0.1021457742794159,0.1601281607527467,0,0,9.673469387755102,22.068611238785657,DGKB,VSMC,0.9907795952096249
KEGG_2021_Human,myofibril assembly (GO:0030239),1/43,0.1021457742794159,0.1601281607527467,0,0,9.673469387755102,22.068611238785657,MYOZ1,VSMC,0.9907795952096249
KEGG_2021_Human,external encapsulating structure organization (GO:0045229),2/217,0.1023751607426323,0.1601281607527467,0,0,3.824612403100775,8.716716836108898,COL4A6;COL4A5,VSMC,0.9898054033308324
KEGG_2021_Human,response to amyloid-beta (GO:1904645),1/44,0.1043952424647777,0.1601281607527467,0,0,9.448030374940672,21.34849709415977,GRIN2A,VSMC,0.9813192926974915
KEGG_2021_Human,cation transmembrane transport (GO:0098655),1/44,0.1043952424647777,0.1601281607527467,0,0,9.448030374940672,21.34849709415977,CACNA1H,VSMC,0.9813192926974915
KEGG_2021_Human,positive regulation of mRNA catabolic process (GO:0061014),1/44,0.1043952424647777,0.1601281607527467,0,0,9.448030374940672,21.34849709415977,RBM24,VSMC,0.9813192926974915
KEGG_2021_Human,positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.1043952424647777,0.1601281607527467,0,0,9.448030374940672,21.34849709415977,NTF3,VSMC,0.9813192926974915
KEGG_2021_Human,mRNA stabilization (GO:0048255),1/44,0.1043952424647777,0.1601281607527467,0,0,9.448030374940672,21.34849709415977,RBM24,VSMC,0.9813192926974915
KEGG_2021_Human,positive regulation of cell motility (GO:2000147),2/221,0.1055403360927836,0.1610042632583523,0,0,3.7539954337899544,8.441467129790793,SEMA5B;NTF3,VSMC,0.97658152714763
KEGG_2021_Human,action potential (GO:0001508),1/45,0.1066391873529346,0.1610042632583523,0,0,9.232838589981448,20.665901611884028,CACNA1H,VSMC,0.9720831731354668
KEGG_2021_Human,neural crest cell development (GO:0014032),1/45,0.1066391873529346,0.1610042632583523,0,0,9.232838589981448,20.665901611884028,SEMA5B,VSMC,0.9720831731354668
KEGG_2021_Human,zymogen activation (GO:0031638),1/45,0.1066391873529346,0.1610042632583523,0,0,9.232838589981448,20.665901611884028,GRIN2A,VSMC,0.9720831731354668
KEGG_2021_Human,phosphatidic acid biosynthetic process (GO:0006654),1/48,0.1133380148369131,0.1704497488758263,0,0,8.642205818497612,18.81737166641443,DGKB,VSMC,0.9456243984787533
KEGG_2021_Human,adherens junction organization (GO:0034332),1/49,0.1155599990222406,0.1731151736325395,0,0,8.46173469387755,18.260130793597916,CDH6,VSMC,0.9371924705024297
KEGG_2021_Human,positive regulation of ion transport (GO:0043270),1/50,0.1177765260040411,0.1750732143303313,0,0,8.28862973760933,17.7290996615035,SCN4B,VSMC,0.928941259997044
KEGG_2021_Human,phosphatidic acid metabolic process (GO:0046473),1/50,0.1177765260040411,0.1750732143303313,0,0,8.28862973760933,17.7290996615035,DGKB,VSMC,0.928941259997044
KEGG_2021_Human,blood circulation (GO:0008015),1/51,0.1199876089220907,0.1776739593654036,0,0,8.122448979591837,17.22257115519733,AVPR1A,VSMC,0.9208636010741894
KEGG_2021_Human,ameboidal-type cell migration (GO:0001667),1/52,0.1221932608707862,0.1795587993711935,0,0,7.962785114045619,16.738979733033663,SEMA5B,VSMC,0.9129527453809976
KEGG_2021_Human,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.1221932608707862,0.1795587993711935,0,0,7.962785114045619,16.738979733033663,NTF3,VSMC,0.9129527453809976
KEGG_2021_Human,anterograde trans-synaptic signaling (GO:0098916),2/244,0.1242347823719992,0.1814071800812711,0,0,3.3932506887052343,7.076902888304532,GRIN2A;KCNK3,VSMC,0.9057567964507174
KEGG_2021_Human,cardiac muscle tissue development (GO:0048738),1/53,0.1243934949128716,0.1814071800812711,0,0,7.809262166405024,16.276887238960814,MYOCD,VSMC,0.9052023302345248
KEGG_2021_Human,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/54,0.1265883240687765,0.1832199427311238,0,0,7.661532537543319,15.834970375184442,RBM24,VSMC,0.8976063498190403
KEGG_2021_Human,regulation of potassium ion transmembrane transport (GO:1901379),1/54,0.1265883240687765,0.1832199427311238,0,0,7.661532537543319,15.834970375184442,KCNAB1,VSMC,0.8976063498190403
KEGG_2021_Human,regulation of cardiac conduction (GO:1903779),1/55,0.1287777613922166,0.1856907795355932,0,0,7.519274376417234,15.412009607623004,CASQ2,VSMC,0.8901591287349465
KEGG_2021_Human,renal system development (GO:0072001),1/57,0.1331405122852093,0.1905542647948163,0,0,7.25,14.618539131965724,MYOCD,VSMC,0.8756897763447542
KEGG_2021_Human,cellular response to peptide (GO:1901653),1/57,0.1331405122852093,0.1905542647948163,0,0,7.25,14.618539131965724,GRIN2A,VSMC,0.8756897763447542
KEGG_2021_Human,regulation of calcium ion transport (GO:0051924),1/58,0.1353138517398134,0.1915287974993683,0,0,7.122448979591836,14.246025949065045,HRC,VSMC,0.8686577434892403
KEGG_2021_Human,regulation of neurotransmitter receptor activity (GO:0099601),1/58,0.1353138517398134,0.1915287974993683,0,0,7.122448979591836,14.246025949065045,GRIN2A,VSMC,0.8686577434892403
KEGG_2021_Human,muscle organ development (GO:0007517),1/58,0.1353138517398134,0.1915287974993683,0,0,7.122448979591836,14.246025949065045,CACNA1H,VSMC,0.8686577434892403
KEGG_2021_Human,protein polymerization (GO:0051258),1/59,0.1374818510452552,0.1938846617304881,0,0,6.9992962702322306,13.8884471557023,CASQ2,VSMC,0.8617546291873563
KEGG_2021_Human,positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/62,0.1439539364695556,0.2022710421196311,0,0,6.654064904650385,12.897320592663672,GRIN2A,VSMC,0.8417764546925935
KEGG_2021_Human,central nervous system development (GO:0007417),2/268,0.1445246328363994,0.2023344859709592,0,0,3.0833333333333335,5.964108059214085,GRIN2A;HAPLN2,VSMC,0.8400581252728833
KEGG_2021_Human,positive regulation of cell migration (GO:0030335),2/269,0.1453850943051252,0.2028016714038885,0,0,3.071629213483146,5.923235274252741,SEMA5B;NTF3,VSMC,0.837480117499467
KEGG_2021_Human,positive regulation of Ras protein signal transduction (GO:0046579),1/63,0.1461007034145454,0.2030641545653428,0,0,6.54641211323239,12.591756250239603,GPR20,VSMC,0.8353476931121088
KEGG_2021_Human,cell-cell junction assembly (GO:0007043),1/66,0.1525093979756266,0.2104520366330332,0,0,6.243328100470958,11.740759916332207,CDH6,VSMC,0.8167033932798328
KEGG_2021_Human,cellular response to nutrient levels (GO:0031669),1/66,0.1525093979756266,0.2104520366330332,0,0,6.243328100470958,11.740759916332207,NUPR2,VSMC,0.8167033932798328
KEGG_2021_Human,aerobic electron transport chain (GO:0019646),1/70,0.1609810482853106,0.2205612227396604,0,0,5.880212954747116,10.740024519792764,COX4I2,VSMC,0.7932252488723367
KEGG_2021_Human,wound healing (GO:0042060),1/70,0.1609810482853106,0.2205612227396604,0,0,5.880212954747116,10.740024519792764,MYOZ1,VSMC,0.7932252488723367
KEGG_2021_Human,negative regulation of neuron apoptotic process (GO:0043524),1/71,0.16308595979881,0.2218660583835402,0,0,5.795918367346939,10.51076961698872,NTF3,VSMC,0.7875834261109624
KEGG_2021_Human,mitochondrial ATP synthesis coupled electron transport (GO:0042775),1/71,0.16308595979881,0.2218660583835402,0,0,5.795918367346939,10.51076961698872,COX4I2,VSMC,0.7875834261109624
KEGG_2021_Human,regulation of Rho protein signal transduction (GO:0035023),1/73,0.1672802691231711,0.2267707873676791,0,0,5.634353741496598,10.074701240888364,GPR20,VSMC,0.7765552814899175
KEGG_2021_Human,negative regulation of cellular process (GO:0048523),3/566,0.1678713329989042,0.2267735551037829,0,0,2.197989493972261,3.922438566092192,MYOCD;NUPR2;ADRA1A,VSMC,0.7750234609992368
KEGG_2021_Human,extracellular matrix organization (GO:0030198),2/300,0.1725587566609558,0.2319800594274445,0,0,2.7477628635346756,4.8278673881252745,COL4A6;COL4A5,VSMC,0.7630629971198796
KEGG_2021_Human,actomyosin structure organization (GO:0031032),1/76,0.1735331353639065,0.2319800594274445,0,0,5.408163265306122,9.4717853003048,MYOZ1,VSMC,0.7606175863963804
KEGG_2021_Human,cellular response to hormone stimulus (GO:0032870),1/76,0.1735331353639065,0.2319800594274445,0,0,5.408163265306122,9.4717853003048,CACNA1H,VSMC,0.7606175863963804
KEGG_2021_Human,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.1756071809118701,0.233940362114429,0,0,5.336734693877551,9.283280446293812,NTF3,VSMC,0.7554577289388229
KEGG_2021_Human,negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.1776761254379788,0.2353871499402137,0,0,5.267161410018553,9.10056411919043,MYOCD,VSMC,0.7503709249641564
KEGG_2021_Human,chemical synaptic transmission (GO:0007268),2/306,0.1779160016431225,0.2353871499402137,0,0,2.6927083333333335,4.648809448291678,GRIN2A;KCNK3,VSMC,0.7497849900117082
KEGG_2021_Human,regulation of neuron differentiation (GO:0045664),1/79,0.1797399811935544,0.2369859341079399,0,0,5.199372056514914,8.923391206941128,NTF3,VSMC,0.745355308086215
KEGG_2021_Human,positive regulation of cytoskeleton organization (GO:0051495),1/82,0.1859011384602527,0.2417970888756665,0,0,5.00604686318972,8.422875391899517,NTF3,VSMC,0.7307179505966239
KEGG_2021_Human,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.1859011384602527,0.2417970888756665,0,0,5.00604686318972,8.422875391899517,MYOCD,VSMC,0.7307179505966239
KEGG_2021_Human,cell-cell junction organization (GO:0045216),1/82,0.1859011384602527,0.2417970888756665,0,0,5.00604686318972,8.422875391899517,CDH6,VSMC,0.7307179505966239
KEGG_2021_Human,regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.1859011384602527,0.2417970888756665,0,0,5.00604686318972,8.422875391899517,RGS5,VSMC,0.7307179505966239
KEGG_2021_Human,vascular transport (GO:0010232),1/84,0.1899833569114356,0.2462747219222313,0,0,4.884927464961889,8.112979399077096,AVPR1A,VSMC,0.7212844428267129
KEGG_2021_Human,transport across blood-brain barrier (GO:0150104),1/86,0.1940455128548384,0.2506963840574255,0,0,4.769507803121249,7.820383303288144,AVPR1A,VSMC,0.7120963955156414
KEGG_2021_Human,calcium ion transmembrane transport (GO:0070588),1/87,0.196069097589664,0.2516220085734022,0,0,4.713811105837684,7.6801565438185,GRIN2A,VSMC,0.7075908500030543
KEGG_2021_Human,sodium ion transmembrane transport (GO:0035725),1/87,0.196069097589664,0.2516220085734022,0,0,4.713811105837684,7.6801565438185,SCN4B,VSMC,0.7075908500030543
KEGG_2021_Human,second-messenger-mediated signaling (GO:0019932),1/89,0.2001013407742902,0.2559435754089759,0,0,4.6062152133580705,7.411084001248333,RCAN2,VSMC,0.6987500013741589
KEGG_2021_Human,sodium ion transport (GO:0006814),1/90,0.2021100231923967,0.2559617070035288,0,0,4.55423068103646,7.281955543769811,SCN4B,VSMC,0.6944121480917811
KEGG_2021_Human,negative regulation of translation (GO:0017148),1/90,0.2021100231923967,0.2559617070035288,0,0,4.55423068103646,7.281955543769811,RBM24,VSMC,0.6944121480917811
KEGG_2021_Human,"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.2021100231923967,0.2559617070035288,0,0,4.55423068103646,7.281955543769811,RBM24,VSMC,0.6944121480917811
KEGG_2021_Human,regulation of stem cell differentiation (GO:2000736),1/91,0.2041137620931186,0.2576517980519694,0,0,4.503401360544218,7.156255051106618,RBM24,VSMC,0.6901277125812961
KEGG_2021_Human,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.2061125694363157,0.2593246380162796,0,0,4.453689167974883,7.03385741012878,NTF3,VSMC,0.6858955226779435
KEGG_2021_Human,positive regulation of peptidyl-serine phosphorylation (GO:0033138),1/93,0.2081064570390282,0.2609804102932438,0,0,4.40505767524401,6.914643337844717,NTF3,VSMC,0.6817144444740324
KEGG_2021_Human,positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.2160330472811356,0.2698744945116895,0,0,4.220663265306122,6.46742313757927,EBF2,VSMC,0.6654798083211632
KEGG_2021_Human,cellular response to DNA damage stimulus (GO:0006974),2/350,0.2179021682137168,0.2698744945116895,0,0,2.3469827586206895,3.5761189553619586,NUPR2;RBM24,VSMC,0.6617384483284671
KEGG_2021_Human,negative regulation of neuron death (GO:1901215),1/98,0.2180025137484037,0.2698744945116895,0,0,4.176940879444562,6.362519703204576,NTF3,VSMC,0.6615384985937142
KEGG_2021_Human,regulation of neuron apoptotic process (GO:0043523),1/98,0.2180025137484037,0.2698744945116895,0,0,4.176940879444562,6.362519703204576,NTF3,VSMC,0.6615384985937142
KEGG_2021_Human,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2777805836634391,0,0,4.010709234188725,5.967790506031058,RCAN2,VSMC,0.6462145058611213
KEGG_2021_Human,cell junction assembly (GO:0034329),1/102,0.2258320069783284,0.2777805836634391,0,0,4.010709234188725,5.967790506031058,CDH6,VSMC,0.6462145058611213
KEGG_2021_Human,activation of GTPase activity (GO:0090630),1/105,0.2316536615468536,0.28313225300171,0,0,3.894427001569859,5.6956456810845415,NTF3,VSMC,0.6351608308934773
KEGG_2021_Human,positive regulation of cellular metabolic process (GO:0031325),1/105,0.2316536615468536,0.28313225300171,0,0,3.894427001569859,5.6956456810845415,NTF3,VSMC,0.6351608308934773
KEGG_2021_Human,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.2335846623503299,0.2845889082432817,0,0,3.857142857142857,5.6090983677319475,NTF3,VSMC,0.6315556772929499
KEGG_2021_Human,response to calcium ion (GO:0051592),1/107,0.2355109070084182,0.2860305968398771,0,0,3.8205621871390063,5.524525481436682,CASQ2,VSMC,0.6279889749729552
KEGG_2021_Human,modulation of chemical synaptic transmission (GO:0050804),1/109,0.239349173739861,0.2897780877039198,0,0,3.749433106575964,5.361058744932435,NTF3,VSMC,0.6209680674126086
KEGG_2021_Human,positive regulation of metabolic process (GO:0009893),1/113,0.2469691364760274,0.2980661991952054,0,0,3.614795918367347,5.055262825364014,EBF2,VSMC,0.6073573167632206
KEGG_2021_Human,activation of protein kinase activity (GO:0032147),1/114,0.2488624078588274,0.299060302404141,0,0,3.582625970742279,4.982913653406146,NTF3,VSMC,0.6040407011916724
KEGG_2021_Human,positive regulation of macromolecule metabolic process (GO:0010604),2/384,0.2493463820044915,0.299060302404141,0,0,2.1343804537521813,2.9644671728961822,NTF3;ACTG2,VSMC,0.6031969289771376
KEGG_2021_Human,calcium ion transport (GO:0006816),1/115,0.2507510141385882,0.2998109951657033,0,0,3.5510204081632653,4.9121080927455,CACNA1H,VSMC,0.6007573018413346
KEGG_2021_Human,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.2563889548341396,0.3056029337806308,0,0,3.4594453165881736,4.708511372057024,ADRA1A,VSMC,0.5911006880374128
KEGG_2021_Human,cytoskeleton organization (GO:0007010),1/120,0.2601244621662815,0.309098512142032,0,0,3.4009603841536613,4.579716458908873,DES,VSMC,0.5848188047272944
KEGG_2021_Human,cellular response to organic substance (GO:0071310),1/123,0.2656932663769877,0.3147443309388932,0,0,3.316828370692539,4.396166676729281,CACNA1H,VSMC,0.5756194520344882
KEGG_2021_Human,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),2/404,0.2679393411370432,0.3164314304839314,0,0,2.026119402985074,2.6683884405969245,NTF3;COL4A6,VSMC,0.5719635148936996
KEGG_2021_Human,circulatory system development (GO:0072359),1/126,0.2712209880572274,0.3188699313147232,0,0,3.236734693877551,4.223360488574632,LDB3,VSMC,0.5666767062328689
KEGG_2021_Human,regulation of cell migration (GO:0030334),2/408,0.2716606168083876,0.3188699313147232,0,0,2.0057471264367814,2.6138931132295458,SEMA5B;NTF3,VSMC,0.5659733175722854
KEGG_2021_Human,cellular response to metal ion (GO:0071248),1/131,0.2803433684983951,0.3280613886683347,0,0,3.111459968602826,3.956968446025251,CACNA1H,VSMC,0.5523097126477655
KEGG_2021_Human,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.285762982719773,0.3333901465064018,0,0,3.0408163265306123,3.80890385676326,NTF3,VSMC,0.5439940297149167
KEGG_2021_Human,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.3355458414193207,0,0,2.99546485260771,3.714691124222948,GPR20,VSMC,0.5385707850387818
KEGG_2021_Human,cellular calcium ion homeostasis (GO:0006874),1/136,0.289353816496661,0.3355458414193207,0,0,2.99546485260771,3.714691124222948,HRC,VSMC,0.5385707850387818
KEGG_2021_Human,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3366063011387312,0,0,2.9732893157262907,3.668866926816198,GPR20,VSMC,0.5358942544628899
KEGG_2021_Human,neuron projection morphogenesis (GO:0048812),1/140,0.2964824884084789,0.3407336060813862,0,0,2.9086771399207163,3.5362740390257685,NTF3,VSMC,0.5280009529309525
KEGG_2021_Human,enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.2964824884084789,0.3407336060813862,0,0,2.9086771399207163,3.5362740390257685,NTF3,VSMC,0.5280009529309525
KEGG_2021_Human,nervous system development (GO:0007399),2/447,0.3078904676985005,0.3527911609045318,0,0,1.826310861423221,2.1514146195112085,NTF3;HAPLN2,VSMC,0.5116037566636256
KEGG_2021_Human,brain development (GO:0007420),1/150,0.3139989845586295,0.3587228755343393,0,0,2.712094233666621,3.141596466170354,GRIN2A,VSMC,0.5030717563895143
KEGG_2021_Human,negative regulation of protein phosphorylation (GO:0001933),1/152,0.3174506378807152,0.3615931822014064,0,0,2.6759021489390458,3.0704182805545575,NTF3,VSMC,0.4983237959237088
KEGG_2021_Human,regulation of cell differentiation (GO:0045595),1/156,0.3243029619756543,0.3683086736301679,0,0,2.6063199473337724,2.934917292064671,NTF3,VSMC,0.4890490847411261
KEGG_2021_Human,skeletal system development (GO:0001501),1/158,0.3277037968552589,0.3699881577398085,0,0,2.5728584427401535,2.8703970097526006,HAPLN2,VSMC,0.48451852674781976
KEGG_2021_Human,cellular response to starvation (GO:0009267),1/158,0.3277037968552589,0.3699881577398085,0,0,2.5728584427401535,2.8703970097526006,NUPR2,VSMC,0.48451852674781976
KEGG_2021_Human,positive regulation of cell population proliferation (GO:0008284),2/474,0.3328115296392732,0.3746562541260824,0,0,1.7194562146892656,1.8917094920733264,NTF3;AVPR1A,VSMC,0.47780163679243126
KEGG_2021_Human,positive regulation of gene expression (GO:0010628),2/482,0.3401543782991926,0.3817993346510228,0,0,1.6901041666666667,1.8225334796372663,RBM24;ACTG2,VSMC,0.46832393464331673
KEGG_2021_Human,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.3817993346510228,0,0,2.4471243042671613,2.6317886779390967,ADRA1A,VSMC,0.4670671197091842
KEGG_2021_Human,cellular protein-containing complex assembly (GO:0034622),1/168,0.3444579462443567,0.3843950994321083,0,0,2.4175730172308443,2.5766088705447237,CASQ2,VSMC,0.46286379212748074
KEGG_2021_Human,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.3477593333218013,0.386957639678883,0,0,2.388721168940949,2.523073857975914,CDH6,VSMC,0.45872120538836164
KEGG_2021_Human,neuron projection development (GO:0031175),1/171,0.3494039111808349,0.387667163702079,0,0,2.3745498199279713,2.4969025061029213,NTF3,VSMC,0.4566722378913039
KEGG_2021_Human,positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.3510444250368044,0.38836811390566,0,0,2.360544217687075,2.4711180018684864,ADRA1A,VSMC,0.45463791963821665
KEGG_2021_Human,glycerophospholipid biosynthetic process (GO:0046474),1/177,0.359186378521905,0.3962371224382046,0,0,2.2929035250463823,2.3477357103628296,DGKB,VSMC,0.44468014150624274
KEGG_2021_Human,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.3968829858314725,0,0,2.279833967485299,2.3241173885161555,GPR20,VSMC,0.44273020383203454
KEGG_2021_Human,negative regulation of cell differentiation (GO:0045596),1/191,0.3814549819175133,0.4184050371459903,0,0,2.122448979591837,2.045536603225051,MYOCD,VSMC,0.41855670871419515
KEGG_2021_Human,regulation of programmed cell death (GO:0043067),1/194,0.3861272144560919,0.4223266408113505,0,0,2.089140319340171,1.988001678572607,NTF3,VSMC,0.4132695879859197
KEGG_2021_Human,regulation of signal transduction (GO:0009966),1/198,0.3923030921692546,0.42786597871151,0,0,2.0463068476121413,1.914771355908193,RGS5,VSMC,0.4063782687077012
KEGG_2021_Human,positive regulation of intracellular signal transduction (GO:1902533),2/546,0.3979281971141292,0.4327750166354229,0,0,1.4863664215686274,1.3696624285648409,NTF3;ADRA1A,VSMC,0.40019528574129115
KEGG_2021_Human,axon guidance (GO:0007411),1/203,0.3999373645428959,0.4337348883070843,0,0,1.9951505354617096,1.8284503867148747,SEMA5B,VSMC,0.398008019580524
KEGG_2021_Human,negative regulation of inflammatory response (GO:0050728),1/212,0.4134429066373548,0.4471222445375888,0,0,1.909178837411742,1.6862551884518755,GPR20,VSMC,0.3835844547796231
KEGG_2021_Human,positive regulation of GTPase activity (GO:0043547),1/214,0.416403436812339,0.4478081652870126,0,0,1.8910606496119575,1.656759537391559,NTF3,VSMC,0.3804856946694876
KEGG_2021_Human,negative regulation of multicellular organismal process (GO:0051241),1/214,0.416403436812339,0.4478081652870126,0,0,1.8910606496119575,1.656759537391559,MYOCD,VSMC,0.3804856946694876
KEGG_2021_Human,apoptotic process (GO:0006915),1/231,0.4409837467017168,0.4729212882455738,0,0,1.749778172138421,1.4326260836369302,ADRA1A,VSMC,0.35557741698984124
KEGG_2021_Human,regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.4508075224789805,0.4821136004289096,0,0,1.697494187548437,1.352418759111272,ADRA1A,VSMC,0.34600884563424106
KEGG_2021_Human,axonogenesis (GO:0007409),1/240,0.4535831041409784,0.4837382135575532,0,0,1.6831184356587825,1.3306343458644796,SEMA5B,VSMC,0.34334313117644527
KEGG_2021_Human,positive regulation of DNA-binding transcription factor activity (GO:0051091),1/246,0.4618276248188864,0.4911702639648377,0,0,1.641399416909621,1.2680853834334544,MYOCD,VSMC,0.33552009275365935
KEGG_2021_Human,positive regulation of cellular process (GO:0048522),2/625,0.4660144680358849,0.4942577691289688,0,0,1.2926029962546817,0.9869522795970046,NTF3;AVPR1A,VSMC,0.33160059985375573
KEGG_2021_Human,positive regulation of signal transduction (GO:0009967),1/252,0.4699502001103142,0.49706271165514,0,0,1.6016749329213755,1.2094704650298027,NTF3,VSMC,0.32794816113488356
KEGG_2021_Human,positive regulation of cell differentiation (GO:0045597),1/258,0.4779525975371456,0.5041417809638385,0,0,1.563805288652426,1.154469433244659,RBM24,VSMC,0.3206151737830371
KEGG_2021_Human,regulation of protein phosphorylation (GO:0001932),1/266,0.4884385252284191,0.5137946235326266,0,0,1.5159799768964188,1.086262808220724,HRC,VSMC,0.3111900887192418
KEGG_2021_Human,positive regulation of MAPK cascade (GO:0043410),1/274,0.4987179596066677,0.52317824100427,0,0,1.4709576138147566,1.0233666205889618,ADRA1A,VSMC,0.30214499188263844
KEGG_2021_Human,negative regulation of transcription by RNA polymerase II (GO:0000122),2/684,0.5139408816832591,0.5376827158914532,0,0,1.1771749755620724,0.7835830337156338,NUPR2;MYOZ1,VSMC,0.2890868347700152
KEGG_2021_Human,regulation of cell cycle (GO:0051726),1/296,0.5259539383992272,0.548759529224126,0,0,1.359737115185057,0.8736877155004001,NUPR2,VSMC,0.2790522884983112
KEGG_2021_Human,post-translational protein modification (GO:0043687),1/345,0.5815093765862647,0.6050840810424646,0,0,1.1631466540104414,0.6305745813190116,HRC,VSMC,0.23544327806907975
KEGG_2021_Human,positive regulation of protein phosphorylation (GO:0001934),1/371,0.6083426776453351,0.6312990051036497,0,0,1.0799779371207945,0.5367673309131087,NTF3,VSMC,0.21585171499242045
KEGG_2021_Human,phosphorylation (GO:0016310),1/400,0.6362851720940257,0.6585209442370965,0,0,1.0,0.4521084323403523,DGKB,VSMC,0.19634819738734471
KEGG_2021_Human,cellular protein metabolic process (GO:0044267),1/417,0.6517468120762254,0.6727145379339056,0,0,0.9583006279434853,0.41024765313154,HRC,VSMC,0.1859210844420885
KEGG_2021_Human,organelle organization (GO:0006996),1/420,0.6544076492323022,0.6736549330332522,0,0,0.9512931664312504,0.4033718992390181,DES,VSMC,0.18415163293091988
KEGG_2021_Human,organelle assembly (GO:0070925),1/425,0.658798168385351,0.6746780214706749,0,0,0.939834424335772,0.3922286762298742,MYOZ1,VSMC,0.18124761694193237
KEGG_2021_Human,regulation of transcription by RNA polymerase II (GO:0006357),5/2206,0.6589063274622694,0.6746780214706749,0,0,0.8960068655661568,0.3737906767782196,MYOCD;EBF2;NUPR2;FHL5;MYOZ1,VSMC,0.1811763219125431
KEGG_2021_Human,positive regulation of transcription by RNA polymerase II (GO:0045944),2/908,0.6694431207036386,0.6836488102676416,0,0,0.8758278145695364,0.3514776504163603,MYOCD;FHL5,VSMC,0.17428631695508484
KEGG_2021_Human,"negative regulation of transcription, DNA-templated (GO:0045892)",2/948,0.6926945411260426,0.705522217813562,0,0,0.8370331219168429,0.3073302326128318,NUPR2;MYOZ1,VSMC,0.15945823486666727
KEGG_2021_Human,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7186038304699023,0,0,0.8207960870298533,0.2841203737887477,NTF3,VSMC,0.15033199168778996
KEGG_2021_Human,positive regulation of nucleic acid-templated transcription (GO:1903508),1/511,0.7262961571675228,0.735852685551306,0,0,0.7779111644657863,0.2487739813280452,MYOCD,VSMC,0.13888625368433627
KEGG_2021_Human,"positive regulation of transcription, DNA-templated (GO:0045893)",2/1183,0.8038594904607679,0.8122989601768915,0,0,0.6621860005644934,0.1445755914280007,MYOCD;FHL5,VSMC,0.09481985653812466
KEGG_2021_Human,regulation of apoptotic process (GO:0042981),1/742,0.8493267155112211,0.855996820606859,0,0,0.5290423861852434,0.0863986224716518,NTF3,VSMC,0.07092521499844862
KEGG_2021_Human,cellular protein modification process (GO:0006464),1/1025,0.9281942108891912,0.9326352586676364,0,0,0.3771922831632653,0.0281062148400667,HRC,VSMC,0.032361144586154744
KEGG_2021_Human,"regulation of transcription, DNA-templated (GO:0006355)",3/2244,0.9302128294243438,0.9326352586676364,0,0,0.5044005810475947,0.036489281349511,MYOCD;EBF2;NUPR2,VSMC,0.03141767502685046
KEGG_2021_Human,regulation of gene expression (GO:0010468),1/1079,0.9377418517471742,0.9377418517471742,0,0,0.3572753776835409,0.0229658682151355,ACTG2,VSMC,0.027916700844649738
GO_Biological_Process_2021,regulation of interferon-alpha production (GO:0032647),3/25,3.252704029670916e-05,0.0144094788514421,0,0,57.81818181818182,597.4606436592223,IRF7;TLR7;LILRA4,pDC,4.487755452281791
GO_Biological_Process_2021,positive regulation of interferon-alpha production (GO:0032727),2/20,0.0011307590059983,0.1315546325625252,0,0,46.138888888888886,313.0461870363529,IRF7;TLR7,pDC,2.9466299446036754
GO_Biological_Process_2021,positive regulation of interferon-beta production (GO:0032728),2/36,0.0036549257227984,0.1315546325625252,0,0,24.40686274509804,136.96349152286243,IRF7;TLR7,pDC,2.437121444562911
GO_Biological_Process_2021,positive regulation of cation channel activity (GO:2001259),2/40,0.0044964248068071,0.1315546325625252,0,0,21.833333333333332,117.99765363023796,LRRC26;P2RY6,pDC,2.3471326648462743
GO_Biological_Process_2021,regulation of chemokine production (GO:0032642),2/42,0.0049475924537835,0.1315546325625252,0,0,20.739583333333332,110.1034239545967,TLR7;LILRB4,pDC,2.3056060815494894
GO_Biological_Process_2021,regulation of cytokine production involved in inflammatory response (GO:1900015),2/43,0.0051806911627924,0.1315546325625252,0,0,20.232723577235777,106.48111760263689,PLD4;LILRB4,pDC,2.2856122965939503
GO_Biological_Process_2021,proteolysis (GO:0006508),4/287,0.0056959581367739,0.1315546325625252,0,0,6.043017360577662,31.23030437987747,PROC;VASH2;GZMB;PHEX,pDC,2.2444332112663723
GO_Biological_Process_2021,regulation of cytokine production (GO:0001817),3/150,0.0062631723305451,0.1315546325625252,0,0,8.598784194528875,43.62222089301041,IRF7;IRF8;PLD4,pDC,2.2032056385661116
GO_Biological_Process_2021,regulation of interferon-beta production (GO:0032648),2/49,0.0066828970303688,0.1315546325625252,0,0,17.64450354609929,88.36726791367238,IRF7;TLR7,pDC,2.175035230405133
GO_Biological_Process_2021,cellular response to type I interferon (GO:0071357),2/65,0.0115237618661231,0.1315546325625252,0,0,13.15277777777778,58.70537343689256,IRF7;IRF8,pDC,1.9384057248186684
GO_Biological_Process_2021,type I interferon signaling pathway (GO:0060337),2/65,0.0115237618661231,0.1315546325625252,0,0,13.15277777777778,58.70537343689256,IRF7;IRF8,pDC,1.9384057248186684
GO_Biological_Process_2021,"positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,LILRB4,pDC,1.9052223113279663
GO_Biological_Process_2021,regulation of sodium:proton antiporter activity (GO:0032415),1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,DRD4,pDC,1.9052223113279663
GO_Biological_Process_2021,negative regulation of interferon-alpha production (GO:0032687),1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,LILRA4,pDC,1.9052223113279663
GO_Biological_Process_2021,negative regulation of interleukin-5 production (GO:0032714),1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,LILRB4,pDC,1.9052223113279663
GO_Biological_Process_2021,positive regulation of leukocyte tethering or rolling (GO:1903238),1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,FUT7,pDC,1.9052223113279663
GO_Biological_Process_2021,short-term memory (GO:0007614),1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,CUX2,pDC,1.9052223113279663
GO_Biological_Process_2021,regulation of glial cell migration (GO:1903975),1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,GPR183,pDC,1.9052223113279663
GO_Biological_Process_2021,regulation of inositol trisphosphate biosynthetic process (GO:0032960),1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,P2RY6,pDC,1.9052223113279663
GO_Biological_Process_2021,thorax and anterior abdomen determination (GO:0007356),1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,TIFAB,pDC,1.9052223113279663
GO_Biological_Process_2021,peristalsis (GO:0030432),1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,TIFAB,pDC,1.9052223113279663
GO_Biological_Process_2021,"zygotic determination of anterior/posterior axis, embryo (GO:0007354)",1/5,0.0124387771927725,0.1315546325625252,0,0,101.76530612244898,446.4379351400606,TIFAB,pDC,1.9052223113279663
GO_Biological_Process_2021,interferon-gamma-mediated signaling pathway (GO:0060333),2/68,0.0125608922452035,0.1315546325625252,0,0,12.553030303030305,54.94671101969335,IRF7;IRF8,pDC,1.9009795100092206
GO_Biological_Process_2021,regulation of saliva secretion (GO:0046877),1/6,0.0149082847993736,0.1315546325625252,0,0,81.40816326530613,342.3895623444841,TIFAB,pDC,1.8265723193247598
GO_Biological_Process_2021,regulation of thymocyte apoptotic process (GO:0070243),1/6,0.0149082847993736,0.1315546325625252,0,0,81.40816326530613,342.3895623444841,PTCRA,pDC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of endothelial cell development (GO:1901552),1/6,0.0149082847993736,0.1315546325625252,0,0,81.40816326530613,342.3895623444841,PROC,pDC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of establishment of endothelial barrier (GO:1903142),1/6,0.0149082847993736,0.1315546325625252,0,0,81.40816326530613,342.3895623444841,PROC,pDC,1.8265723193247598
GO_Biological_Process_2021,negative regulation of myeloid cell apoptotic process (GO:0033033),1/6,0.0149082847993736,0.1315546325625252,0,0,81.40816326530613,342.3895623444841,IRF7,pDC,1.8265723193247598
GO_Biological_Process_2021,negative regulation of relaxation of muscle (GO:1901078),1/6,0.0149082847993736,0.1315546325625252,0,0,81.40816326530613,342.3895623444841,TIFAB,pDC,1.8265723193247598
GO_Biological_Process_2021,cellular water homeostasis (GO:0009992),1/6,0.0149082847993736,0.1315546325625252,0,0,81.40816326530613,342.3895623444841,SCT,pDC,1.8265723193247598
GO_Biological_Process_2021,neurotransmitter loading into synaptic vesicle (GO:0098700),1/6,0.0149082847993736,0.1315546325625252,0,0,81.40816326530613,342.3895623444841,SLC32A1,pDC,1.8265723193247598
GO_Biological_Process_2021,regulation of macrophage apoptotic process (GO:2000109),1/6,0.0149082847993736,0.1315546325625252,0,0,81.40816326530613,342.3895623444841,IRF7,pDC,1.8265723193247598
GO_Biological_Process_2021,trigeminal nerve development (GO:0021559),1/6,0.0149082847993736,0.1315546325625252,0,0,81.40816326530613,342.3895623444841,TIFAB,pDC,1.8265723193247598
GO_Biological_Process_2021,positive regulation of type I interferon production (GO:0032481),2/77,0.0159057771109684,0.1315546325625252,0,0,11.041666666666666,45.72434655376785,IRF7;TLR7,pDC,1.7984451076467942
GO_Biological_Process_2021,axon development (GO:0061564),2/79,0.0166954776383478,0.1315546325625252,0,0,10.75378787878788,44.01113934918422,VASH2;SLITRK5,pDC,1.7774011517679502
GO_Biological_Process_2021,regulation of relaxation of muscle (GO:1901077),1/7,0.0173717414502839,0.1315546325625252,0,0,67.83673469387755,274.9362107684438,TIFAB,pDC,1.7601566430186848
GO_Biological_Process_2021,negative regulation of digestive system process (GO:0060457),1/7,0.0173717414502839,0.1315546325625252,0,0,67.83673469387755,274.9362107684438,TIFAB,pDC,1.7601566430186848
GO_Biological_Process_2021,regulation of toll-like receptor 7 signaling pathway (GO:0034155),1/7,0.0173717414502839,0.1315546325625252,0,0,67.83673469387755,274.9362107684438,LILRA4,pDC,1.7601566430186848
GO_Biological_Process_2021,"regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",1/7,0.0173717414502839,0.1315546325625252,0,0,67.83673469387755,274.9362107684438,LILRB4,pDC,1.7601566430186848
GO_Biological_Process_2021,inhibitory postsynaptic potential (GO:0060080),1/7,0.0173717414502839,0.1315546325625252,0,0,67.83673469387755,274.9362107684438,DRD4,pDC,1.7601566430186848
GO_Biological_Process_2021,regulation of dopamine metabolic process (GO:0042053),1/7,0.0173717414502839,0.1315546325625252,0,0,67.83673469387755,274.9362107684438,DRD4,pDC,1.7601566430186848
GO_Biological_Process_2021,negative regulation of T cell apoptotic process (GO:0070233),1/7,0.0173717414502839,0.1315546325625252,0,0,67.83673469387755,274.9362107684438,PTCRA,pDC,1.7601566430186848
GO_Biological_Process_2021,thyroid hormone transport (GO:0070327),1/7,0.0173717414502839,0.1315546325625252,0,0,67.83673469387755,274.9362107684438,CRYM,pDC,1.7601566430186848
GO_Biological_Process_2021,regulation of muscle organ development (GO:0048634),1/7,0.0173717414502839,0.1315546325625252,0,0,67.83673469387755,274.9362107684438,TIFAB,pDC,1.7601566430186848
GO_Biological_Process_2021,regulation of interferon-gamma production (GO:0032649),2/86,0.0195880530452788,0.1315546325625252,0,0,9.854166666666666,38.754815869716495,TLR7;LILRB4,pDC,1.7080087285643422
GO_Biological_Process_2021,immune response-inhibiting cell surface receptor signaling pathway (GO:0002767),1/8,0.0198291614511851,0.1315546325625252,0,0,58.142857142857146,227.9549801512961,LILRB4,pDC,1.702695651141308
GO_Biological_Process_2021,regulation of dopamine uptake involved in synaptic transmission (GO:0051584),1/8,0.0198291614511851,0.1315546325625252,0,0,58.142857142857146,227.9549801512961,DRD4,pDC,1.702695651141308
GO_Biological_Process_2021,regulation of microvillus organization (GO:0032530),1/8,0.0198291614511851,0.1315546325625252,0,0,58.142857142857146,227.9549801512961,CDHR5,pDC,1.702695651141308
GO_Biological_Process_2021,regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),1/8,0.0198291614511851,0.1315546325625252,0,0,58.142857142857146,227.9549801512961,IRF7,pDC,1.702695651141308
GO_Biological_Process_2021,regulation of myeloid leukocyte differentiation (GO:0002761),1/8,0.0198291614511851,0.1315546325625252,0,0,58.142857142857146,227.9549801512961,IRF7,pDC,1.702695651141308
GO_Biological_Process_2021,peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),1/8,0.0198291614511851,0.1315546325625252,0,0,58.142857142857146,227.9549801512961,EGLN3,pDC,1.702695651141308
GO_Biological_Process_2021,water homeostasis (GO:0030104),1/8,0.0198291614511851,0.1315546325625252,0,0,58.142857142857146,227.9549801512961,SCT,pDC,1.702695651141308
GO_Biological_Process_2021,positive regulation of neuron projection development (GO:0010976),2/88,0.0204505278871254,0.1315546325625252,0,0,9.624031007751938,37.43504172973695,CUX2;PACSIN1,pDC,1.6892954771184148
GO_Biological_Process_2021,regulation of type I interferon production (GO:0032479),2/89,0.0208876608034354,0.1315546325625252,0,0,9.512931034482758,36.80169347929862,IRF7;IRF8,pDC,1.6801101936742149
GO_Biological_Process_2021,"positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",1/9,0.0222805591236868,0.1315546325625252,0,0,50.87244897959184,193.52086993316271,LILRB4,pDC,1.652073914876897
GO_Biological_Process_2021,fucose catabolic process (GO:0019317),1/9,0.0222805591236868,0.1315546325625252,0,0,50.87244897959184,193.52086993316271,FUT7,pDC,1.652073914876897
GO_Biological_Process_2021,regulation of cell adhesion molecule production (GO:0060353),1/9,0.0222805591236868,0.1315546325625252,0,0,50.87244897959184,193.52086993316271,FUT7,pDC,1.652073914876897
GO_Biological_Process_2021,regulation of cellular extravasation (GO:0002691),1/9,0.0222805591236868,0.1315546325625252,0,0,50.87244897959184,193.52086993316271,FUT7,pDC,1.652073914876897
GO_Biological_Process_2021,positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/9,0.0222805591236868,0.1315546325625252,0,0,50.87244897959184,193.52086993316271,P2RY6,pDC,1.652073914876897
GO_Biological_Process_2021,hormone transport (GO:0009914),1/9,0.0222805591236868,0.1315546325625252,0,0,50.87244897959184,193.52086993316271,CRYM,pDC,1.652073914876897
GO_Biological_Process_2021,L-fucose catabolic process (GO:0042355),1/9,0.0222805591236868,0.1315546325625252,0,0,50.87244897959184,193.52086993316271,FUT7,pDC,1.652073914876897
GO_Biological_Process_2021,L-fucose metabolic process (GO:0042354),1/9,0.0222805591236868,0.1315546325625252,0,0,50.87244897959184,193.52086993316271,FUT7,pDC,1.652073914876897
GO_Biological_Process_2021,negative regulation of T cell cytokine production (GO:0002725),1/9,0.0222805591236868,0.1315546325625252,0,0,50.87244897959184,193.52086993316271,LILRB4,pDC,1.652073914876897
GO_Biological_Process_2021,arachidonate transport (GO:1903963),1/10,0.024725948817258,0.1315546325625252,0,0,45.21768707482993,167.3010120823387,DRD4,pDC,1.606847034080906
GO_Biological_Process_2021,arachidonic acid secretion (GO:0050482),1/10,0.024725948817258,0.1315546325625252,0,0,45.21768707482993,167.3010120823387,DRD4,pDC,1.606847034080906
GO_Biological_Process_2021,positive regulation of dendritic spine morphogenesis (GO:0061003),1/10,0.024725948817258,0.1315546325625252,0,0,45.21768707482993,167.3010120823387,CUX2,pDC,1.606847034080906
GO_Biological_Process_2021,response to histamine (GO:0034776),1/10,0.024725948817258,0.1315546325625252,0,0,45.21768707482993,167.3010120823387,DRD4,pDC,1.606847034080906
GO_Biological_Process_2021,I-kappaB phosphorylation (GO:0007252),1/10,0.024725948817258,0.1315546325625252,0,0,45.21768707482993,167.3010120823387,TLR7,pDC,1.606847034080906
GO_Biological_Process_2021,cellular response to purine-containing compound (GO:0071415),1/10,0.024725948817258,0.1315546325625252,0,0,45.21768707482993,167.3010120823387,P2RY6,pDC,1.606847034080906
GO_Biological_Process_2021,negative regulation of voltage-gated calcium channel activity (GO:1901386),1/10,0.024725948817258,0.1315546325625252,0,0,45.21768707482993,167.3010120823387,DRD4,pDC,1.606847034080906
GO_Biological_Process_2021,regulation of leukocyte tethering or rolling (GO:1903236),1/10,0.024725948817258,0.1315546325625252,0,0,45.21768707482993,167.3010120823387,FUT7,pDC,1.606847034080906
GO_Biological_Process_2021,cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),1/10,0.024725948817258,0.1315546325625252,0,0,45.21768707482993,167.3010120823387,IRF7,pDC,1.606847034080906
GO_Biological_Process_2021,positive regulation of vasculature development (GO:1904018),2/102,0.0269177264019109,0.1315546325625252,0,0,8.270833333333334,29.898816321570965,VASH2;CCR3,pDC,1.5699616254585989
GO_Biological_Process_2021,regulation of T cell mediated immunity (GO:0002709),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,FUT7,pDC,1.5659847773237099
GO_Biological_Process_2021,positive regulation of ceramide biosynthetic process (GO:2000304),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,SMPD3,pDC,1.5659847773237099
GO_Biological_Process_2021,regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,LILRA4,pDC,1.5659847773237099
GO_Biological_Process_2021,positive regulation of dendrite development (GO:1900006),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,PACSIN1,pDC,1.5659847773237099
GO_Biological_Process_2021,regulation of coagulation (GO:0050818),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,PROC,pDC,1.5659847773237099
GO_Biological_Process_2021,sphingomyelin metabolic process (GO:0006684),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,SMPD3,pDC,1.5659847773237099
GO_Biological_Process_2021,T cell chemotaxis (GO:0010818),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,GPR183,pDC,1.5659847773237099
GO_Biological_Process_2021,positive regulation of sphingolipid biosynthetic process (GO:0090154),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,SMPD3,pDC,1.5659847773237099
GO_Biological_Process_2021,positive regulation of voltage-gated potassium channel activity (GO:1903818),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,LRRC26,pDC,1.5659847773237099
GO_Biological_Process_2021,peptidyl-proline hydroxylation (GO:0019511),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,EGLN3,pDC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of activated T cell proliferation (GO:0046007),1/11,0.0271653448579923,0.1315546325625252,0,0,40.69387755102041,146.73452100035948,LILRB4,pDC,1.5659847773237099
GO_Biological_Process_2021,negative regulation of transcription by RNA polymerase II (GO:0000122),5/684,0.0275333707502929,0.1315546325625252,0,0,3.1534936998854524,11.32847367927841,CUX2;IRF7;IRF8;CRYM;LILRB4,pDC,1.560140617206737
GO_Biological_Process_2021,negative regulation of hemostasis (GO:1900047),1/12,0.029598761568907,0.1315546325625252,0,0,36.99257884972171,130.2147194065139,PROC,pDC,1.5287264597194943
GO_Biological_Process_2021,negative regulation of leukocyte apoptotic process (GO:2000107),1/12,0.029598761568907,0.1315546325625252,0,0,36.99257884972171,130.2147194065139,IRF7,pDC,1.5287264597194943
GO_Biological_Process_2021,hemidesmosome assembly (GO:0031581),1/12,0.029598761568907,0.1315546325625252,0,0,36.99257884972171,130.2147194065139,KRT5,pDC,1.5287264597194943
GO_Biological_Process_2021,lysine catabolic process (GO:0006554),1/12,0.029598761568907,0.1315546325625252,0,0,36.99257884972171,130.2147194065139,CRYM,pDC,1.5287264597194943
GO_Biological_Process_2021,lysine metabolic process (GO:0006553),1/12,0.029598761568907,0.1315546325625252,0,0,36.99257884972171,130.2147194065139,CRYM,pDC,1.5287264597194943
GO_Biological_Process_2021,regulation of leukocyte cell-cell adhesion (GO:1903037),1/12,0.029598761568907,0.1315546325625252,0,0,36.99257884972171,130.2147194065139,FUT7,pDC,1.5287264597194943
GO_Biological_Process_2021,cochlea morphogenesis (GO:0090103),1/12,0.029598761568907,0.1315546325625252,0,0,36.99257884972171,130.2147194065139,TIFAB,pDC,1.5287264597194943
GO_Biological_Process_2021,phasic smooth muscle contraction (GO:0014821),1/12,0.029598761568907,0.1315546325625252,0,0,36.99257884972171,130.2147194065139,TIFAB,pDC,1.5287264597194943
GO_Biological_Process_2021,regulation of interleukin-6 production (GO:0032675),2/110,0.0309363405009925,0.1315546325625252,0,0,7.655092592592593,26.607752397672005,TLR7;LILRB4,pDC,1.5095310608442127
GO_Biological_Process_2021,icosanoid secretion (GO:0032309),1/13,0.032026213248763,0.1315546325625252,0,0,33.90816326530612,116.6847899929619,DRD4,pDC,1.4944944088974865
GO_Biological_Process_2021,regulation of interleukin-5 production (GO:0032674),1/13,0.032026213248763,0.1315546325625252,0,0,33.90816326530612,116.6847899929619,LILRB4,pDC,1.4944944088974865
GO_Biological_Process_2021,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),1/13,0.032026213248763,0.1315546325625252,0,0,33.90816326530612,116.6847899929619,FUT7,pDC,1.4944944088974865
GO_Biological_Process_2021,mature B cell differentiation involved in immune response (GO:0002313),1/13,0.032026213248763,0.1315546325625252,0,0,33.90816326530612,116.6847899929619,GPR183,pDC,1.4944944088974865
GO_Biological_Process_2021,toll-like receptor 9 signaling pathway (GO:0034162),1/13,0.032026213248763,0.1315546325625252,0,0,33.90816326530612,116.6847899929619,TLR7,pDC,1.4944944088974865
GO_Biological_Process_2021,cranial nerve development (GO:0021545),1/13,0.032026213248763,0.1315546325625252,0,0,33.90816326530612,116.6847899929619,TIFAB,pDC,1.4944944088974865
GO_Biological_Process_2021,plasma membrane tubulation (GO:0097320),1/13,0.032026213248763,0.1315546325625252,0,0,33.90816326530612,116.6847899929619,PACSIN1,pDC,1.4944944088974865
GO_Biological_Process_2021,cellular amide metabolic process (GO:0043603),2/115,0.033561350657856,0.1315546325625252,0,0,7.31452802359882,24.82828874550635,SMPD3;FUT7,pDC,1.4741605695522084
GO_Biological_Process_2021,positive regulation of angiogenesis (GO:0045766),2/116,0.0340965412337713,0.1315546325625252,0,0,7.25,24.49455514200503,VASH2;CCR3,pDC,1.467289673772098
GO_Biological_Process_2021,sphingolipid metabolic process (GO:0006665),2/116,0.0340965412337713,0.1315546325625252,0,0,7.25,24.49455514200503,SMPD3;FUT7,pDC,1.467289673772098
GO_Biological_Process_2021,positive regulation of alpha-beta T cell differentiation (GO:0046638),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,LILRB4,pDC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of coagulation (GO:0050819),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,PROC,pDC,1.4628395910668823
GO_Biological_Process_2021,genitalia development (GO:0048806),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,TIFAB,pDC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,LILRB4,pDC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of secretion (GO:0051048),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,TIFAB,pDC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of T cell differentiation (GO:0045581),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,LILRB4,pDC,1.4628395910668823
GO_Biological_Process_2021,negative regulation of T cell mediated immunity (GO:0002710),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,LILRB4,pDC,1.4628395910668823
GO_Biological_Process_2021,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,LRRC26,pDC,1.4628395910668823
GO_Biological_Process_2021,neuromuscular process controlling balance (GO:0050885),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,TIFAB,pDC,1.4628395910668823
GO_Biological_Process_2021,positive regulation of regulatory T cell differentiation (GO:0045591),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,LILRB4,pDC,1.4628395910668823
GO_Biological_Process_2021,T-helper cell differentiation (GO:0042093),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,GPR183,pDC,1.4628395910668823
GO_Biological_Process_2021,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),1/14,0.0344477141698711,0.1315546325625252,0,0,31.298273155416013,105.4223689491126,DRD4,pDC,1.4628395910668823
GO_Biological_Process_2021,cellular response to interferon-gamma (GO:0071346),2/121,0.0368223679095263,0.1348674719795976,0,0,6.943627450980392,22.92542614889691,IRF7;IRF8,pDC,1.4338882870711436
GO_Biological_Process_2021,positive regulation of exosomal secretion (GO:1903543),1/15,0.0368632785936063,0.1348674719795976,0,0,29.06122448979592,95.91771596133704,SMPD3,pDC,1.4334060415588732
GO_Biological_Process_2021,catecholamine metabolic process (GO:0006584),1/15,0.0368632785936063,0.1348674719795976,0,0,29.06122448979592,95.91771596133704,DRD4,pDC,1.4334060415588732
GO_Biological_Process_2021,positive regulation of secretion (GO:0051047),1/15,0.0368632785936063,0.1348674719795976,0,0,29.06122448979592,95.91771596133704,SCT,pDC,1.4334060415588732
GO_Biological_Process_2021,protein hydroxylation (GO:0018126),1/15,0.0368632785936063,0.1348674719795976,0,0,29.06122448979592,95.91771596133704,EGLN3,pDC,1.4334060415588732
GO_Biological_Process_2021,potassium ion transport (GO:0006813),2/122,0.0373773734873947,0.1348674719795976,0,0,6.885416666666667,22.63022834568748,LRRC26;KCNK10,pDC,1.4273912198113348
GO_Biological_Process_2021,defense response to symbiont (GO:0140546),2/124,0.038497072428768,0.1348674719795976,0,0,6.771857923497268,22.05711333941876,IRF7;TLR7,pDC,1.4145722958518654
GO_Biological_Process_2021,B cell activation involved in immune response (GO:0002312),1/16,0.0392729207344652,0.1348674719795976,0,0,27.122448979591837,87.80133530116419,GPR183,pDC,1.405906798966597
GO_Biological_Process_2021,regulation of ceramide biosynthetic process (GO:2000303),1/16,0.0392729207344652,0.1348674719795976,0,0,27.122448979591837,87.80133530116419,SMPD3,pDC,1.405906798966597
GO_Biological_Process_2021,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),1/16,0.0392729207344652,0.1348674719795976,0,0,27.122448979591837,87.80133530116419,FUT7,pDC,1.405906798966597
GO_Biological_Process_2021,regulation of leukocyte activation (GO:0002694),1/16,0.0392729207344652,0.1348674719795976,0,0,27.122448979591837,87.80133530116419,LILRB4,pDC,1.405906798966597
GO_Biological_Process_2021,dendritic cell chemotaxis (GO:0002407),1/16,0.0392729207344652,0.1348674719795976,0,0,27.122448979591837,87.80133530116419,GPR183,pDC,1.405906798966597
GO_Biological_Process_2021,regulation of monocyte differentiation (GO:0045655),1/16,0.0392729207344652,0.1348674719795976,0,0,27.122448979591837,87.80133530116419,IRF7,pDC,1.405906798966597
GO_Biological_Process_2021,negative regulation of chemokine production (GO:0032682),1/17,0.0416766547912334,0.1367611709075291,0,0,25.426020408163264,80.79916728086499,LILRB4,pDC,1.3801071472903907
GO_Biological_Process_2021,negative regulation of cytokine production involved in immune response (GO:0002719),1/17,0.0416766547912334,0.1367611709075291,0,0,25.426020408163264,80.79916728086499,LILRB4,pDC,1.3801071472903907
GO_Biological_Process_2021,negative regulation of interleukin-10 production (GO:0032693),1/17,0.0416766547912334,0.1367611709075291,0,0,25.426020408163264,80.79916728086499,LILRB4,pDC,1.3801071472903907
GO_Biological_Process_2021,response to purine-containing compound (GO:0014074),1/17,0.0416766547912334,0.1367611709075291,0,0,25.426020408163264,80.79916728086499,P2RY6,pDC,1.3801071472903907
GO_Biological_Process_2021,regulation of establishment of endothelial barrier (GO:1903140),1/17,0.0416766547912334,0.1367611709075291,0,0,25.426020408163264,80.79916728086499,PROC,pDC,1.3801071472903907
GO_Biological_Process_2021,stabilization of membrane potential (GO:0030322),1/17,0.0416766547912334,0.1367611709075291,0,0,25.426020408163264,80.79916728086499,KCNK10,pDC,1.3801071472903907
GO_Biological_Process_2021,defense response to virus (GO:0051607),2/133,0.043691853040543,0.1372309313052862,0,0,6.303753180661578,19.734489511742076,IRF7;TLR7,pDC,1.3595995357844428
GO_Biological_Process_2021,regulation of adaptive immune response (GO:0002819),1/18,0.0440744949316926,0.1372309313052862,0,0,23.92917166866747,74.70385911458476,IRF7,pDC,1.3558126557645607
GO_Biological_Process_2021,positive regulation of excitatory postsynaptic potential (GO:2000463),1/18,0.0440744949316926,0.1372309313052862,0,0,23.92917166866747,74.70385911458476,CUX2,pDC,1.3558126557645607
GO_Biological_Process_2021,T cell migration (GO:0072678),1/18,0.0440744949316926,0.1372309313052862,0,0,23.92917166866747,74.70385911458476,GPR183,pDC,1.3558126557645607
GO_Biological_Process_2021,dendritic cell migration (GO:0036336),1/18,0.0440744949316926,0.1372309313052862,0,0,23.92917166866747,74.70385911458476,GPR183,pDC,1.3558126557645607
GO_Biological_Process_2021,pyroptosis (GO:0070269),1/19,0.0464664552952436,0.1372309313052862,0,0,22.598639455782312,69.35578082800635,GZMB,pDC,1.3328604565168853
GO_Biological_Process_2021,regulation of T cell cytokine production (GO:0002724),1/19,0.0464664552952436,0.1372309313052862,0,0,22.598639455782312,69.35578082800635,LILRB4,pDC,1.3328604565168853
GO_Biological_Process_2021,negative regulation of cytokine production involved in inflammatory response (GO:1900016),1/19,0.0464664552952436,0.1372309313052862,0,0,22.598639455782312,69.35578082800635,LILRB4,pDC,1.3328604565168853
GO_Biological_Process_2021,aspartate family amino acid catabolic process (GO:0009068),1/19,0.0464664552952436,0.1372309313052862,0,0,22.598639455782312,69.35578082800635,CRYM,pDC,1.3328604565168853
GO_Biological_Process_2021,negative regulation of immune system process (GO:0002683),1/19,0.0464664552952436,0.1372309313052862,0,0,22.598639455782312,69.35578082800635,LILRB4,pDC,1.3328604565168853
GO_Biological_Process_2021,negative regulation of protein localization to nucleus (GO:1900181),1/19,0.0464664552952436,0.1372309313052862,0,0,22.598639455782312,69.35578082800635,LILRB4,pDC,1.3328604565168853
GO_Biological_Process_2021,regulation of exosomal secretion (GO:1903541),1/19,0.0464664552952436,0.1372309313052862,0,0,22.598639455782312,69.35578082800635,SMPD3,pDC,1.3328604565168853
GO_Biological_Process_2021,negative regulation of T cell receptor signaling pathway (GO:0050860),1/19,0.0464664552952436,0.1372309313052862,0,0,22.598639455782312,69.35578082800635,LILRB4,pDC,1.3328604565168853
GO_Biological_Process_2021,neuromuscular process (GO:0050905),1/19,0.0464664552952436,0.1372309313052862,0,0,22.598639455782312,69.35578082800635,TIFAB,pDC,1.3328604565168853
GO_Biological_Process_2021,dopamine metabolic process (GO:0042417),1/19,0.0464664552952436,0.1372309313052862,0,0,22.598639455782312,69.35578082800635,DRD4,pDC,1.3328604565168853
GO_Biological_Process_2021,potassium ion transmembrane transport (GO:0071805),2/139,0.0472922793944307,0.1387448991505486,0,0,6.025851581508515,18.3873330672393,LRRC26;KCNK10,pDC,1.3252097533441285
GO_Biological_Process_2021,neuron projection morphogenesis (GO:0048812),2/140,0.0479026862337682,0.1396111184313115,0,0,5.981884057971015,18.176455370515885,SLITRK5;PACSIN1,pDC,1.319640132017756
GO_Biological_Process_2021,positive regulation of dendrite morphogenesis (GO:0050775),1/20,0.0488525499820277,0.1396237396260535,0,0,21.40816326530612,64.63014669364038,CUX2,pDC,1.3111127622579986
GO_Biological_Process_2021,negative regulation of osteoclast differentiation (GO:0045671),1/20,0.0488525499820277,0.1396237396260535,0,0,21.40816326530612,64.63014669364038,LILRB4,pDC,1.3111127622579986
GO_Biological_Process_2021,natural killer cell mediated immunity (GO:0002228),1/20,0.0488525499820277,0.1396237396260535,0,0,21.40816326530612,64.63014669364038,GZMB,pDC,1.3111127622579986
GO_Biological_Process_2021,regulation of lipid catabolic process (GO:0050994),1/21,0.0512327930672156,0.1445613205654554,0,0,20.336734693877553,60.42807445408675,SCT,pDC,1.2904519669693806
GO_Biological_Process_2021,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),1/21,0.0512327930672156,0.1445613205654554,0,0,20.336734693877553,60.42807445408675,P2RY6,pDC,1.2904519669693806
GO_Biological_Process_2021,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),1/22,0.0536071985992547,0.144804810850426,0,0,19.367346938775512,56.67024999786951,P2RY6,pDC,1.2707768875084013
GO_Biological_Process_2021,positive regulation of dendritic spine development (GO:0060999),1/22,0.0536071985992547,0.144804810850426,0,0,19.367346938775512,56.67024999786951,CUX2,pDC,1.2707768875084013
GO_Biological_Process_2021,regulation of voltage-gated calcium channel activity (GO:1901385),1/22,0.0536071985992547,0.144804810850426,0,0,19.367346938775512,56.67024999786951,DRD4,pDC,1.2707768875084013
GO_Biological_Process_2021,negative regulation of interleukin-2 production (GO:0032703),1/22,0.0536071985992547,0.144804810850426,0,0,19.367346938775512,56.67024999786951,LILRB4,pDC,1.2707768875084013
GO_Biological_Process_2021,positive regulation of lipid catabolic process (GO:0050996),1/22,0.0536071985992547,0.144804810850426,0,0,19.367346938775512,56.67024999786951,SCT,pDC,1.2707768875084013
GO_Biological_Process_2021,osteoclast differentiation (GO:0030316),1/22,0.0536071985992547,0.144804810850426,0,0,19.367346938775512,56.67024999786951,GPR183,pDC,1.2707768875084013
GO_Biological_Process_2021,natural killer cell mediated cytotoxicity (GO:0042267),1/22,0.0536071985992547,0.144804810850426,0,0,19.367346938775512,56.67024999786951,GZMB,pDC,1.2707768875084013
GO_Biological_Process_2021,response to nutrient levels (GO:0031667),1/23,0.0559757805878795,0.1484866514995846,0,0,18.4860853432282,53.29235549319145,SCT,pDC,1.2519998414265567
GO_Biological_Process_2021,oligosaccharide biosynthetic process (GO:0009312),1/23,0.0559757805878795,0.1484866514995846,0,0,18.4860853432282,53.29235549319145,FUT7,pDC,1.2519998414265567
GO_Biological_Process_2021,ear morphogenesis (GO:0042471),1/23,0.0559757805878795,0.1484866514995846,0,0,18.4860853432282,53.29235549319145,TIFAB,pDC,1.2519998414265567
GO_Biological_Process_2021,carbohydrate biosynthetic process (GO:0016051),1/24,0.0583385530130099,0.1502556917718803,0,0,17.68145519077196,50.24171555062859,FUT7,pDC,1.2340443470047993
GO_Biological_Process_2021,inner ear morphogenesis (GO:0042472),1/24,0.0583385530130099,0.1502556917718803,0,0,17.68145519077196,50.24171555062859,TIFAB,pDC,1.2340443470047993
GO_Biological_Process_2021,negative regulation of protein tyrosine kinase activity (GO:0061099),1/24,0.0583385530130099,0.1502556917718803,0,0,17.68145519077196,50.24171555062859,LILRB4,pDC,1.2340443470047993
GO_Biological_Process_2021,lymphocyte activation involved in immune response (GO:0002285),1/24,0.0583385530130099,0.1502556917718803,0,0,17.68145519077196,50.24171555062859,GPR183,pDC,1.2340443470047993
GO_Biological_Process_2021,dendritic cell differentiation (GO:0097028),1/24,0.0583385530130099,0.1502556917718803,0,0,17.68145519077196,50.24171555062859,IRF8,pDC,1.2340443470047993
GO_Biological_Process_2021,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/25,0.0606955298241754,0.153459885465062,0,0,16.943877551020407,47.47480020477031,LILRB4,pDC,1.2168432931781568
GO_Biological_Process_2021,positive regulation of lipid metabolic process (GO:0045834),1/25,0.0606955298241754,0.153459885465062,0,0,16.943877551020407,47.47480020477031,SCT,pDC,1.2168432931781568
GO_Biological_Process_2021,"chemical synaptic transmission, postsynaptic (GO:0099565)",1/25,0.0606955298241754,0.153459885465062,0,0,16.943877551020407,47.47480020477031,DRD4,pDC,1.2168432931781568
GO_Biological_Process_2021,regulation of regulatory T cell differentiation (GO:0045589),1/26,0.0630467249540435,0.153459885465062,0,0,16.26530612244898,44.95534064809558,LILRB4,pDC,1.2003374685092782
GO_Biological_Process_2021,negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.0630467249540435,0.153459885465062,0,0,16.26530612244898,44.95534064809558,LILRB4,pDC,1.2003374685092782
GO_Biological_Process_2021,negative regulation of protein transport (GO:0051224),1/26,0.0630467249540435,0.153459885465062,0,0,16.26530612244898,44.95534064809558,DRD4,pDC,1.2003374685092782
GO_Biological_Process_2021,negative regulation of signaling receptor activity (GO:2000272),1/26,0.0630467249540435,0.153459885465062,0,0,16.26530612244898,44.95534064809558,LILRB4,pDC,1.2003374685092782
GO_Biological_Process_2021,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/26,0.0630467249540435,0.153459885465062,0,0,16.26530612244898,44.95534064809558,GZMB,pDC,1.2003374685092782
GO_Biological_Process_2021,mononuclear cell differentiation (GO:1903131),1/26,0.0630467249540435,0.153459885465062,0,0,16.26530612244898,44.95534064809558,IRF8,pDC,1.2003374685092782
GO_Biological_Process_2021,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/26,0.0630467249540435,0.153459885465062,0,0,16.26530612244898,44.95534064809558,GZMB,pDC,1.2003374685092782
GO_Biological_Process_2021,negative regulation of cation channel activity (GO:2001258),1/27,0.0653921522588676,0.1540889545248848,0,0,15.638932496075354,42.652889831563165,DRD4,pDC,1.184474368421492
GO_Biological_Process_2021,regulation of toll-like receptor signaling pathway (GO:0034121),1/27,0.0653921522588676,0.1540889545248848,0,0,15.638932496075354,42.652889831563165,IRF7,pDC,1.184474368421492
GO_Biological_Process_2021,regulation of blood coagulation (GO:0030193),1/27,0.0653921522588676,0.1540889545248848,0,0,15.638932496075354,42.652889831563165,PROC,pDC,1.184474368421492
GO_Biological_Process_2021,regulation of vasculature development (GO:1901342),1/27,0.0653921522588676,0.1540889545248848,0,0,15.638932496075354,42.652889831563165,VASH2,pDC,1.184474368421492
GO_Biological_Process_2021,modulation of excitatory postsynaptic potential (GO:0098815),1/27,0.0653921522588676,0.1540889545248848,0,0,15.638932496075354,42.652889831563165,CUX2,pDC,1.184474368421492
GO_Biological_Process_2021,presynaptic endocytosis (GO:0140238),1/27,0.0653921522588676,0.1540889545248848,0,0,15.638932496075354,42.652889831563165,PACSIN1,pDC,1.184474368421492
GO_Biological_Process_2021,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/28,0.0677318256109869,0.1570952813909277,0,0,15.058956916099774,40.54171043527237,DRD4,pDC,1.1692072184717057
GO_Biological_Process_2021,sulfur compound transport (GO:0072348),1/28,0.0677318256109869,0.1570952813909277,0,0,15.058956916099774,40.54171043527237,SLC35F3,pDC,1.1692072184717057
GO_Biological_Process_2021,positive regulation of synapse assembly (GO:0051965),1/28,0.0677318256109869,0.1570952813909277,0,0,15.058956916099774,40.54171043527237,CUX2,pDC,1.1692072184717057
GO_Biological_Process_2021,neuron projection development (GO:0031175),2/171,0.0681810821272572,0.1573136426165362,0,0,4.876972386587771,13.097539204308813,VASH2;PACSIN1,pDC,1.166336110203534
GO_Biological_Process_2021,positive regulation of ERK1 and ERK2 cascade (GO:0070374),2/172,0.0688760185279422,0.1580936591081783,0,0,4.848039215686274,12.970673059288286,P2RY6;GPR183,pDC,1.1619319658128364
GO_Biological_Process_2021,negative regulation of interferon-gamma production (GO:0032689),1/29,0.0700657588372089,0.1583629141065487,0,0,14.520408163265309,38.5999069065122,LILRB4,pDC,1.1544941700666143
GO_Biological_Process_2021,negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.0700657588372089,0.1583629141065487,0,0,14.520408163265309,38.5999069065122,LILRB4,pDC,1.1544941700666143
GO_Biological_Process_2021,negative regulation of wound healing (GO:0061045),1/29,0.0700657588372089,0.1583629141065487,0,0,14.520408163265309,38.5999069065122,PROC,pDC,1.1544941700666143
GO_Biological_Process_2021,positive regulation of B cell proliferation (GO:0030890),1/30,0.0723939657090184,0.1603526340454757,0,0,14.019000703729768,36.80874147674154,GPR183,pDC,1.1402976322627019
GO_Biological_Process_2021,negative regulation of interleukin-1 production (GO:0032692),1/30,0.0723939657090184,0.1603526340454757,0,0,14.019000703729768,36.80874147674154,LILRB4,pDC,1.1402976322627019
GO_Biological_Process_2021,synaptic vesicle cycle (GO:0099504),1/30,0.0723939657090184,0.1603526340454757,0,0,14.019000703729768,36.80874147674154,SLC32A1,pDC,1.1402976322627019
GO_Biological_Process_2021,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/30,0.0723939657090184,0.1603526340454757,0,0,14.019000703729768,36.80874147674154,IRF7,pDC,1.1402976322627019
GO_Biological_Process_2021,negative regulation of interleukin-6 production (GO:0032715),1/31,0.0747164600026276,0.1614604477129953,0,0,13.551020408163266,35.15209038871121,LILRB4,pDC,1.126583712764908
GO_Biological_Process_2021,positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/31,0.0747164600026276,0.1614604477129953,0,0,13.551020408163266,35.15209038871121,FUT7,pDC,1.126583712764908
GO_Biological_Process_2021,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/31,0.0747164600026276,0.1614604477129953,0,0,13.551020408163266,35.15209038871121,LILRB4,pDC,1.126583712764908
GO_Biological_Process_2021,vitamin transport (GO:0051180),1/31,0.0747164600026276,0.1614604477129953,0,0,13.551020408163266,35.15209038871121,SLC35F3,pDC,1.126583712764908
GO_Biological_Process_2021,MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/31,0.0747164600026276,0.1614604477129953,0,0,13.551020408163266,35.15209038871121,IRF7,pDC,1.126583712764908
GO_Biological_Process_2021,activation of phospholipase C activity (GO:0007202),1/32,0.0770332554327668,0.162503486460551,0,0,13.113232389730086,33.61600807740255,P2RY6,pDC,1.1133217484244988
GO_Biological_Process_2021,hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.0770332554327668,0.162503486460551,0,0,13.113232389730086,33.61600807740255,PLD4,pDC,1.1133217484244988
GO_Biological_Process_2021,regulation of chemotaxis (GO:0050920),1/32,0.0770332554327668,0.162503486460551,0,0,13.113232389730086,33.61600807740255,GPR183,pDC,1.1133217484244988
GO_Biological_Process_2021,regulation of dendrite morphogenesis (GO:0048814),1/32,0.0770332554327668,0.162503486460551,0,0,13.113232389730086,33.61600807740255,CUX2,pDC,1.1133217484244988
GO_Biological_Process_2021,regulation of dendritic spine morphogenesis (GO:0061001),1/32,0.0770332554327668,0.162503486460551,0,0,13.113232389730086,33.61600807740255,CUX2,pDC,1.1133217484244988
GO_Biological_Process_2021,regulation of activated T cell proliferation (GO:0046006),1/34,0.0816498044624026,0.1682365738457876,0,0,12.317254174397032,30.85861216573232,LILRB4,pDC,1.0880448509885652
GO_Biological_Process_2021,cell-substrate junction assembly (GO:0007044),1/34,0.0816498044624026,0.1682365738457876,0,0,12.317254174397032,30.85861216573232,KRT5,pDC,1.0880448509885652
GO_Biological_Process_2021,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/34,0.0816498044624026,0.1682365738457876,0,0,12.317254174397032,30.85861216573232,GZMB,pDC,1.0880448509885652
GO_Biological_Process_2021,synaptic vesicle recycling (GO:0036465),1/34,0.0816498044624026,0.1682365738457876,0,0,12.317254174397032,30.85861216573232,PACSIN1,pDC,1.0880448509885652
GO_Biological_Process_2021,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/34,0.0816498044624026,0.1682365738457876,0,0,12.317254174397032,30.85861216573232,P2RY6,pDC,1.0880448509885652
GO_Biological_Process_2021,regulation of T cell receptor signaling pathway (GO:0050856),1/35,0.0839495853612937,0.1705947996103355,0,0,11.95438175270108,29.61744503578088,LILRB4,pDC,1.0759814445616303
GO_Biological_Process_2021,negative regulation of T cell proliferation (GO:0042130),1/35,0.0839495853612937,0.1705947996103355,0,0,11.95438175270108,29.61744503578088,LILRB4,pDC,1.0759814445616303
GO_Biological_Process_2021,regulation of postsynaptic membrane potential (GO:0060078),1/35,0.0839495853612937,0.1705947996103355,0,0,11.95438175270108,29.61744503578088,DRD4,pDC,1.0759814445616303
GO_Biological_Process_2021,negative regulation of cellular protein localization (GO:1903828),1/36,0.0862437219743075,0.1728776870344717,0,0,11.612244897959185,28.456712045041098,LILRB4,pDC,1.0642725091375862
GO_Biological_Process_2021,negative regulation of toll-like receptor signaling pathway (GO:0034122),1/36,0.0862437219743075,0.1728776870344717,0,0,11.612244897959185,28.456712045041098,LILRA4,pDC,1.0642725091375862
GO_Biological_Process_2021,regulation of osteoclast differentiation (GO:0045670),1/36,0.0862437219743075,0.1728776870344717,0,0,11.612244897959185,28.456712045041098,LILRB4,pDC,1.0642725091375862
GO_Biological_Process_2021,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),1/37,0.0885322278902676,0.1758734392618322,0,0,11.289115646258503,27.36920368672352,P2RY6,pDC,1.0528986067362665
GO_Biological_Process_2021,positive regulation of exocytosis (GO:0045921),1/37,0.0885322278902676,0.1758734392618322,0,0,11.289115646258503,27.36920368672352,SMPD3,pDC,1.0528986067362665
GO_Biological_Process_2021,synaptic vesicle endocytosis (GO:0048488),1/38,0.0908151166313484,0.1793040606746224,0,0,10.983452840595698,26.34852930034076,PACSIN1,pDC,1.0418418549683985
GO_Biological_Process_2021,regulation of angiogenesis (GO:0045765),2/203,0.0915200219539462,0.1793040606746224,0,0,4.093905472636816,9.789336578359592,VASH2;CCR3,pDC,1.0384838843718929
GO_Biological_Process_2021,regulation of protein tyrosine kinase activity (GO:0061097),1/39,0.0930924017046572,0.1793040606746224,0,0,10.693877551020408,25.38900533231373,LILRB4,pDC,1.0310857651239858
GO_Biological_Process_2021,negative regulation of lymphocyte proliferation (GO:0050672),1/39,0.0930924017046572,0.1793040606746224,0,0,10.693877551020408,25.38900533231373,LILRB4,pDC,1.0310857651239858
GO_Biological_Process_2021,regulation of dendrite development (GO:0050773),1/39,0.0930924017046572,0.1793040606746224,0,0,10.693877551020408,25.38900533231373,PACSIN1,pDC,1.0310857651239858
GO_Biological_Process_2021,negative regulation of protein secretion (GO:0050709),1/39,0.0930924017046572,0.1793040606746224,0,0,10.693877551020408,25.38900533231373,DRD4,pDC,1.0310857651239858
GO_Biological_Process_2021,negative regulation of secretion by cell (GO:1903531),1/39,0.0930924017046572,0.1793040606746224,0,0,10.693877551020408,25.38900533231373,DRD4,pDC,1.0310857651239858
GO_Biological_Process_2021,regulation of inflammatory response (GO:0050727),2/206,0.0938158179234975,0.1799151832905168,0,0,4.033088235294118,9.543987931843056,PROC;TLR7,pDC,1.0277239307283335
GO_Biological_Process_2021,negative regulation of blood coagulation (GO:0030195),1/40,0.0953640965755271,0.1805397212946946,0,0,10.419152276295131,24.485561288951835,PROC,pDC,1.0206151011238414
GO_Biological_Process_2021,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.0953640965755271,0.1805397212946946,0,0,10.419152276295131,24.485561288951835,LILRB4,pDC,1.0206151011238414
GO_Biological_Process_2021,response to organonitrogen compound (GO:0010243),1/40,0.0953640965755271,0.1805397212946946,0,0,10.419152276295131,24.485561288951835,DRD4,pDC,1.0206151011238414
GO_Biological_Process_2021,negative regulation of inflammatory response (GO:0050728),2/212,0.0984576089228105,0.1856030670332131,0,0,3.9166666666666665,9.079339326341122,PROC;SCT,pDC,1.0067507154273545
GO_Biological_Process_2021,negative regulation of multicellular organismal process (GO:0051241),2/214,0.100019348409027,0.1869858595280217,0,0,3.879323899371069,8.931722866735825,TIFAB;PROC,pDC,0.9999159790553556
GO_Biological_Process_2021,regulation of cell-cell adhesion (GO:0022407),1/43,0.1021457742794159,0.1869858595280217,0,0,9.673469387755102,22.068611238785657,FUT7,pDC,0.9907795952096249
GO_Biological_Process_2021,signal release from synapse (GO:0099643),1/43,0.1021457742794159,0.1869858595280217,0,0,9.673469387755102,22.068611238785657,SLC32A1,pDC,0.9907795952096249
GO_Biological_Process_2021,positive regulation of peptide hormone secretion (GO:0090277),1/43,0.1021457742794159,0.1869858595280217,0,0,9.673469387755102,22.068611238785657,SCT,pDC,0.9907795952096249
GO_Biological_Process_2021,positive regulation of phospholipase C activity (GO:0010863),1/43,0.1021457742794159,0.1869858595280217,0,0,9.673469387755102,22.068611238785657,P2RY6,pDC,0.9907795952096249
GO_Biological_Process_2021,negative regulation of type I interferon production (GO:0032480),1/43,0.1021457742794159,0.1869858595280217,0,0,9.673469387755102,22.068611238785657,LILRA4,pDC,0.9907795952096249
GO_Biological_Process_2021,positive regulation of T cell differentiation (GO:0045582),1/43,0.1021457742794159,0.1869858595280217,0,0,9.673469387755102,22.068611238785657,LILRB4,pDC,0.9907795952096249
GO_Biological_Process_2021,lymphocyte chemotaxis (GO:0048247),1/44,0.1043952424647777,0.1895372639831825,0,0,9.448030374940672,21.34849709415977,GPR183,pDC,0.9813192926974915
GO_Biological_Process_2021,neurotransmitter secretion (GO:0007269),1/44,0.1043952424647777,0.1895372639831825,0,0,9.448030374940672,21.34849709415977,SLC32A1,pDC,0.9813192926974915
GO_Biological_Process_2021,positive regulation of nervous system development (GO:0051962),1/45,0.1066391873529346,0.1904885483764115,0,0,9.232838589981448,20.665901611884028,CUX2,pDC,0.9720831731354668
GO_Biological_Process_2021,negative regulation of T cell activation (GO:0050868),1/45,0.1066391873529346,0.1904885483764115,0,0,9.232838589981448,20.665901611884028,LILRB4,pDC,0.9720831731354668
GO_Biological_Process_2021,regulation of insulin receptor signaling pathway (GO:0046626),1/45,0.1066391873529346,0.1904885483764115,0,0,9.232838589981448,20.665901611884028,FUT7,pDC,0.9720831731354668
GO_Biological_Process_2021,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.1066391873529346,0.1904885483764115,0,0,9.232838589981448,20.665901611884028,LILRB4,pDC,0.9720831731354668
GO_Biological_Process_2021,regulation of B cell proliferation (GO:0030888),1/46,0.1088776222085674,0.1905715611295445,0,0,9.02721088435374,20.01811780873028,GPR183,pDC,0.9630613723103648
GO_Biological_Process_2021,negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.1088776222085674,0.1905715611295445,0,0,9.02721088435374,20.01811780873028,LILRA4,pDC,0.9630613723103648
GO_Biological_Process_2021,positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.1088776222085674,0.1905715611295445,0,0,9.02721088435374,20.01811780873028,P2RY6,pDC,0.9630613723103648
GO_Biological_Process_2021,regulation of synapse assembly (GO:0051963),1/47,0.1111105603036554,0.1905715611295445,0,0,8.830523513753327,19.4026870705364,CUX2,pDC,0.9542446623584087
GO_Biological_Process_2021,positive regulation of cell-cell adhesion (GO:0022409),1/47,0.1111105603036554,0.1905715611295445,0,0,8.830523513753327,19.4026870705364,FUT7,pDC,0.9542446623584087
GO_Biological_Process_2021,glycosphingolipid metabolic process (GO:0006687),1/47,0.1111105603036554,0.1905715611295445,0,0,8.830523513753327,19.4026870705364,SMPD3,pDC,0.9542446623584087
GO_Biological_Process_2021,polyol metabolic process (GO:0019751),1/47,0.1111105603036554,0.1905715611295445,0,0,8.830523513753327,19.4026870705364,PLD4,pDC,0.9542446623584087
GO_Biological_Process_2021,regulation of protein localization to nucleus (GO:1900180),1/47,0.1111105603036554,0.1905715611295445,0,0,8.830523513753327,19.4026870705364,LILRB4,pDC,0.9542446623584087
GO_Biological_Process_2021,cellular protein modification process (GO:0006464),5/1025,0.111757480484359,0.1905715611295445,0,0,2.0620915032679736,4.518917033723159,EGLN3;FUT7;PROC;PPM1J;PHEX,pDC,0.9517233977320464
GO_Biological_Process_2021,inflammatory response (GO:0006954),2/230,0.1127586124121412,0.1905715611295445,0,0,3.6041666666666665,7.866115081211615,FUT7;CCR3,pDC,0.9478502771198579
GO_Biological_Process_2021,inositol phosphate metabolic process (GO:0043647),1/48,0.1133380148369131,0.1905715611295445,0,0,8.642205818497612,18.81737166641443,PLD4,pDC,0.9456243984787533
GO_Biological_Process_2021,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),1/48,0.1133380148369131,0.1905715611295445,0,0,8.642205818497612,18.81737166641443,LILRA4,pDC,0.9456243984787533
GO_Biological_Process_2021,regulation of interleukin-10 production (GO:0032653),1/48,0.1133380148369131,0.1905715611295445,0,0,8.642205818497612,18.81737166641443,LILRB4,pDC,0.9456243984787533
GO_Biological_Process_2021,regulation of interleukin-2 production (GO:0032663),1/48,0.1133380148369131,0.1905715611295445,0,0,8.642205818497612,18.81737166641443,LILRB4,pDC,0.9456243984787533
GO_Biological_Process_2021,cognition (GO:0050890),1/48,0.1133380148369131,0.1905715611295445,0,0,8.642205818497612,18.81737166641443,CUX2,pDC,0.9456243984787533
GO_Biological_Process_2021,apoptotic process (GO:0006915),2/231,0.1135686052781033,0.1905715611295445,0,0,3.5882459970887917,7.805684373606142,EGLN3;GZMB,pDC,0.9447417076995079
GO_Biological_Process_2021,receptor internalization (GO:0031623),1/49,0.1155599990222406,0.191018953607659,0,0,8.46173469387755,18.260130793597916,LILRB4,pDC,0.9371924705024297
GO_Biological_Process_2021,cellular defense response (GO:0006968),1/49,0.1155599990222406,0.191018953607659,0,0,8.46173469387755,18.260130793597916,CCR3,pDC,0.9371924705024297
GO_Biological_Process_2021,cellular response to mechanical stimulus (GO:0071260),1/49,0.1155599990222406,0.191018953607659,0,0,8.46173469387755,18.260130793597916,TLR7,pDC,0.9371924705024297
GO_Biological_Process_2021,oligosaccharide metabolic process (GO:0009311),1/49,0.1155599990222406,0.191018953607659,0,0,8.46173469387755,18.260130793597916,FUT7,pDC,0.9371924705024297
GO_Biological_Process_2021,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/50,0.1177765260040411,0.1932407445177415,0,0,8.28862973760933,17.7290996615035,CUX2,pDC,0.928941259997044
GO_Biological_Process_2021,positive regulation of ion transport (GO:0043270),1/50,0.1177765260040411,0.1932407445177415,0,0,8.28862973760933,17.7290996615035,DRD4,pDC,0.928941259997044
GO_Biological_Process_2021,regulation of ERK1 and ERK2 cascade (GO:0070372),2/238,0.1192811662769016,0.1949872939508023,0,0,3.4805790960451977,7.400657287256659,P2RY6;GPR183,pDC,0.9234281232007147
GO_Biological_Process_2021,glycolipid metabolic process (GO:0006664),1/52,0.1221932608707862,0.1982843024386751,0,0,7.962785114045619,16.738979733033663,SMPD3,pDC,0.9129527453809976
GO_Biological_Process_2021,plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.1221932608707862,0.1982843024386751,0,0,7.962785114045619,16.738979733033663,PACSIN1,pDC,0.9129527453809976
GO_Biological_Process_2021,positive regulation of B cell activation (GO:0050871),1/53,0.1243934949128716,0.1996605733565295,0,0,7.809262166405024,16.276887238960814,GPR183,pDC,0.9052023302345248
GO_Biological_Process_2021,positive regulation of chemokine production (GO:0032722),1/53,0.1243934949128716,0.1996605733565295,0,0,7.809262166405024,16.276887238960814,TLR7,pDC,0.9052023302345248
GO_Biological_Process_2021,positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.1243934949128716,0.1996605733565295,0,0,7.809262166405024,16.276887238960814,TLR7,pDC,0.9052023302345248
GO_Biological_Process_2021,inorganic anion transport (GO:0015698),1/54,0.1265883240687765,0.2024499189980793,0,0,7.661532537543319,15.834970375184442,CLIC3,pDC,0.8976063498190403
GO_Biological_Process_2021,ceramide metabolic process (GO:0006672),1/55,0.1287777613922166,0.2052106053839999,0,0,7.519274376417234,15.412009607623004,FUT7,pDC,0.8901591287349465
GO_Biological_Process_2021,positive regulation of signal transduction (GO:0009967),2/252,0.1309169770529217,0.207200307777901,0,0,3.283333333333333,6.675646802845627,P2RY6;CUX2,pDC,0.8830040313535863
GO_Biological_Process_2021,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/56,0.1309618198144747,0.207200307777901,0,0,7.382189239332097,15.00687933540933,GZMB,pDC,0.8828552987007785
GO_Biological_Process_2021,positive regulation of cell junction assembly (GO:1901890),1/57,0.1331405122852093,0.2091533579515877,0,0,7.25,14.618539131965724,CUX2,pDC,0.8756897763447542
GO_Biological_Process_2021,positive regulation of interferon-gamma production (GO:0032729),1/57,0.1331405122852093,0.2091533579515877,0,0,7.25,14.618539131965724,TLR7,pDC,0.8756897763447542
GO_Biological_Process_2021,receptor metabolic process (GO:0043112),1/58,0.1353138517398134,0.2118163827587892,0,0,7.122448979591836,14.246025949065045,LILRB4,pDC,0.8686577434892403
GO_Biological_Process_2021,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.1396445230534406,0.2163025304638958,0,0,6.88031822898651,13.544974303558986,DRD4,pDC,0.8549760929333525
GO_Biological_Process_2021,response to organic cyclic compound (GO:0014070),1/60,0.1396445230534406,0.2163025304638958,0,0,6.88031822898651,13.544974303558986,DRD4,pDC,0.8549760929333525
GO_Biological_Process_2021,cellular protein catabolic process (GO:0044257),1/60,0.1396445230534406,0.2163025304638958,0,0,6.88031822898651,13.544974303558986,GZMB,pDC,0.8549760929333525
GO_Biological_Process_2021,positive regulation of interleukin-8 production (GO:0032757),1/61,0.1418018805927374,0.217364128382639,0,0,6.76530612244898,13.214837540593155,TLR7,pDC,0.848318009451734
GO_Biological_Process_2021,regulation of endocytosis (GO:0030100),1/61,0.1418018805927374,0.217364128382639,0,0,6.76530612244898,13.214837540593155,PACSIN1,pDC,0.848318009451734
GO_Biological_Process_2021,pattern recognition receptor signaling pathway (GO:0002221),1/61,0.1418018805927374,0.217364128382639,0,0,6.76530612244898,13.214837540593155,TLR7,pDC,0.848318009451734
GO_Biological_Process_2021,I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/62,0.1439539364695556,0.2199020477793557,0,0,6.654064904650385,12.897320592663672,TLR7,pDC,0.8417764546925935
GO_Biological_Process_2021,anterior/posterior pattern specification (GO:0009952),1/63,0.1461007034145454,0.2224144728956825,0,0,6.54641211323239,12.591756250239603,TIFAB,pDC,0.8353476931121088
GO_Biological_Process_2021,plasma membrane organization (GO:0007009),1/64,0.1482421941802595,0.2249016850063527,0,0,6.442176870748299,12.297522293260638,PACSIN1,pDC,0.8290281655096747
GO_Biological_Process_2021,positive regulation of MAPK cascade (GO:0043410),2/274,0.1497038344955427,0.2255741451752566,0,0,3.014399509803922,5.724635176902424,P2RY6;GPR183,pDC,0.8247670755492156
GO_Biological_Process_2021,inorganic cation transmembrane transport (GO:0098662),2/274,0.1497038344955427,0.2255741451752566,0,0,3.014399509803922,5.724635176902424,LRRC26;KCNK10,pDC,0.8247670755492156
GO_Biological_Process_2021,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",1/65,0.1503784214913892,0.2258225109175777,0,0,6.341198979591836,12.01403781811508,DRD4,pDC,0.8228144782361342
GO_Biological_Process_2021,positive regulation of catabolic process (GO:0009896),1/67,0.1546351363099914,0.2314302884639399,0,0,6.148423005565863,11.477180657220888,SCT,pDC,0.8106918184915987
GO_Biological_Process_2021,cell chemotaxis (GO:0060326),1/69,0.158870948881139,0.2361739273635725,0,0,5.966986794717887,10.977245117600177,CCR3,pDC,0.7989555105590889
GO_Biological_Process_2021,cellular response to decreased oxygen levels (GO:0036294),1/69,0.158870948881139,0.2361739273635725,0,0,5.966986794717887,10.977245117600177,EGLN3,pDC,0.7989555105590889
GO_Biological_Process_2021,defense response to Gram-positive bacterium (GO:0050830),1/70,0.1609810482853106,0.2385103825765638,0,0,5.880212954747116,10.740024519792764,MPEG1,pDC,0.7932252488723367
GO_Biological_Process_2021,myeloid leukocyte differentiation (GO:0002573),1/71,0.16308595979881,0.2408236006362428,0,0,5.795918367346939,10.51076961698872,GPR183,pDC,0.7875834261109624
GO_Biological_Process_2021,positive regulation of neurogenesis (GO:0050769),1/72,0.1651856959101235,0.2431138315222084,0,0,5.713998275366484,10.28911103101624,CUX2,pDC,0.78202756268309
GO_Biological_Process_2021,neurotransmitter transport (GO:0006836),1/73,0.1672802691231711,0.2445714825794217,0,0,5.634353741496598,10.074701240888364,SLC32A1,pDC,0.7765552814899175
GO_Biological_Process_2021,defense response to Gram-negative bacterium (GO:0050829),1/73,0.1672802691231711,0.2445714825794217,0,0,5.634353741496598,10.074701240888364,MPEG1,pDC,0.7765552814899175
GO_Biological_Process_2021,proteolysis involved in cellular protein catabolic process (GO:0051603),1/74,0.1693696918266344,0.2468117548657864,0,0,5.556891249650545,9.867213018330611,GZMB,pDC,0.7711643026835198
GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/75,0.1714539764404576,0.2471870706309022,0,0,5.4815223386651954,9.666337985731484,EGLN3,pDC,0.7658524380723842
GO_Biological_Process_2021,positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.1714539764404576,0.2471870706309022,0,0,5.4815223386651954,9.666337985731484,GPR183,pDC,0.7658524380723842
GO_Biological_Process_2021,regulation of T cell proliferation (GO:0042129),1/76,0.1735331353639065,0.2471870706309022,0,0,5.408163265306122,9.4717853003048,LILRB4,pDC,0.7606175863963804
GO_Biological_Process_2021,positive regulation of interleukin-6 production (GO:0032755),1/76,0.1735331353639065,0.2471870706309022,0,0,5.408163265306122,9.4717853003048,TLR7,pDC,0.7606175863963804
GO_Biological_Process_2021,cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.1735331353639065,0.2471870706309022,0,0,5.408163265306122,9.4717853003048,SLITRK5,pDC,0.7606175863963804
GO_Biological_Process_2021,chloride transport (GO:0006821),1/76,0.1735331353639065,0.2471870706309022,0,0,5.408163265306122,9.4717853003048,CLIC3,pDC,0.7606175863963804
GO_Biological_Process_2021,phospholipid metabolic process (GO:0006644),1/76,0.1735331353639065,0.2471870706309022,0,0,5.408163265306122,9.4717853003048,SMPD3,pDC,0.7606175863963804
GO_Biological_Process_2021,positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.1756071809118701,0.249339683153713,0,0,5.336734693877551,9.283280446293812,VASH2,pDC,0.7554577289388229
GO_Biological_Process_2021,protein modification process (GO:0036211),1/78,0.1776761254379788,0.2510088812990551,0,0,5.267161410018553,9.10056411919043,PHEX,pDC,0.7503709249641564
GO_Biological_Process_2021,chemical synaptic transmission (GO:0007268),2/306,0.1779160016431225,0.2510088812990551,0,0,2.6927083333333335,4.648809448291678,SLC32A1;DRD4,pDC,0.7497849900117082
GO_Biological_Process_2021,positive regulation of cell adhesion (GO:0045785),1/80,0.181798760490535,0.253727871171782,0,0,5.133298889175924,8.751529842637671,FUT7,pDC,0.7404090821369118
GO_Biological_Process_2021,response to interferon-gamma (GO:0034341),1/80,0.181798760490535,0.253727871171782,0,0,5.133298889175924,8.751529842637671,IRF8,pDC,0.7404090821369118
GO_Biological_Process_2021,regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.181798760490535,0.253727871171782,0,0,5.133298889175924,8.751529842637671,TLR7,pDC,0.7404090821369118
GO_Biological_Process_2021,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),1/81,0.1838524754991919,0.253727871171782,0,0,5.0688775510204085,8.584760541358477,EGLN3,pDC,0.7355305181562768
GO_Biological_Process_2021,positive regulation of cellular amide metabolic process (GO:0034250),1/81,0.1838524754991919,0.253727871171782,0,0,5.0688775510204085,8.584760541358477,SMPD3,pDC,0.7355305181562768
GO_Biological_Process_2021,regulation of interleukin-8 production (GO:0032677),1/81,0.1838524754991919,0.253727871171782,0,0,5.0688775510204085,8.584760541358477,TLR7,pDC,0.7355305181562768
GO_Biological_Process_2021,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.1838524754991919,0.253727871171782,0,0,5.0688775510204085,8.584760541358477,P2RY6,pDC,0.7355305181562768
GO_Biological_Process_2021,epidermis development (GO:0008544),1/83,0.1879447615357932,0.2569738560504827,0,0,4.944748631159781,8.265677319811374,KRT5,pDC,0.7259697745939766
GO_Biological_Process_2021,glycoprotein biosynthetic process (GO:0009101),1/83,0.1879447615357932,0.2569738560504827,0,0,4.944748631159781,8.265677319811374,FUT7,pDC,0.7259697745939766
GO_Biological_Process_2021,regulation of interleukin-1 beta production (GO:0032651),1/83,0.1879447615357932,0.2569738560504827,0,0,4.944748631159781,8.265677319811374,LILRB4,pDC,0.7259697745939766
GO_Biological_Process_2021,negative regulation of defense response (GO:0031348),1/85,0.1920169366451308,0.2609309905944569,0,0,4.826530612244898,7.964604221414354,PROC,pDC,0.716660463134361
GO_Biological_Process_2021,B cell activation (GO:0042113),1/85,0.1920169366451308,0.2609309905944569,0,0,4.826530612244898,7.964604221414354,GPR183,pDC,0.716660463134361
GO_Biological_Process_2021,negative regulation of cellular amide metabolic process (GO:0034249),1/86,0.1940455128548384,0.2620797627886995,0,0,4.769507803121249,7.820383303288144,GZMB,pDC,0.7120963955156414
GO_Biological_Process_2021,regulation of neuron death (GO:1901214),1/86,0.1940455128548384,0.2620797627886995,0,0,4.769507803121249,7.820383303288144,EGLN3,pDC,0.7120963955156414
GO_Biological_Process_2021,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.196069097589664,0.2640079338365385,0,0,4.713811105837684,7.6801565438185,EGLN3,pDC,0.7075908500030543
GO_Biological_Process_2021,sensory perception of mechanical stimulus (GO:0050954),1/88,0.1980877029036425,0.2659177345039807,0,0,4.659394792399718,7.5437717166037235,CRYM,pDC,0.703142484213379
GO_Biological_Process_2021,positive regulation of inflammatory response (GO:0050729),1/89,0.2001013407742902,0.2667848107243534,0,0,4.6062152133580705,7.411084001248333,TLR7,pDC,0.6987500013741589
GO_Biological_Process_2021,second-messenger-mediated signaling (GO:0019932),1/89,0.2001013407742902,0.2667848107243534,0,0,4.6062152133580705,7.411084001248333,CCR3,pDC,0.6987500013741589
GO_Biological_Process_2021,cellular amino acid catabolic process (GO:0009063),1/90,0.2021100231923967,0.2667848107243534,0,0,4.55423068103646,7.281955543769811,CRYM,pDC,0.6944121480917811
GO_Biological_Process_2021,negative regulation of protein kinase activity (GO:0006469),1/90,0.2021100231923967,0.2667848107243534,0,0,4.55423068103646,7.281955543769811,LILRB4,pDC,0.6944121480917811
GO_Biological_Process_2021,negative regulation of translation (GO:0017148),1/90,0.2021100231923967,0.2667848107243534,0,0,4.55423068103646,7.281955543769811,GZMB,pDC,0.6944121480917811
GO_Biological_Process_2021,cytokine-mediated signaling pathway (GO:0019221),3/621,0.2024454460334983,0.2667848107243534,0,0,1.9966948977483991,3.1892904723776496,IRF7;IRF8;LILRB4,pDC,0.6936919881460838
GO_Biological_Process_2021,sensory perception of sound (GO:0007605),1/91,0.2041137620931186,0.2667848107243534,0,0,4.503401360544218,7.156255051106618,CRYM,pDC,0.6901277125812961
GO_Biological_Process_2021,toll-like receptor signaling pathway (GO:0002224),1/91,0.2041137620931186,0.2667848107243534,0,0,4.503401360544218,7.156255051106618,TLR7,pDC,0.6901277125812961
GO_Biological_Process_2021,positive regulation of cytokine production (GO:0001819),2/335,0.2041536136242794,0.2667848107243534,0,0,2.4545795795795797,3.9000386874614623,IRF7;TLR7,pDC,0.6900429284365769
GO_Biological_Process_2021,positive regulation of cellular component biogenesis (GO:0044089),1/92,0.2061125694363157,0.2677650095609615,0,0,4.453689167974883,7.03385741012878,SMPD3,pDC,0.6858955226779435
GO_Biological_Process_2021,regulation of endothelial cell proliferation (GO:0001936),1/92,0.2061125694363157,0.2677650095609615,0,0,4.453689167974883,7.03385741012878,VASH2,pDC,0.6858955226779435
GO_Biological_Process_2021,negative regulation of cellular protein metabolic process (GO:0032269),1/94,0.2100954368002021,0.2697747202970711,0,0,4.357472021066491,6.79849904676328,GZMB,pDC,0.6775833802166729
GO_Biological_Process_2021,hemopoiesis (GO:0030097),1/94,0.2100954368002021,0.2697747202970711,0,0,4.357472021066491,6.79849904676328,PLD4,pDC,0.6775833802166729
GO_Biological_Process_2021,negative regulation of MAPK cascade (GO:0043409),1/94,0.2100954368002021,0.2697747202970711,0,0,4.357472021066491,6.79849904676328,LILRB4,pDC,0.6775833802166729
GO_Biological_Process_2021,regulation of kinase activity (GO:0043549),1/94,0.2100954368002021,0.2697747202970711,0,0,4.357472021066491,6.79849904676328,DRD4,pDC,0.6775833802166729
GO_Biological_Process_2021,"negative regulation of transcription, DNA-templated (GO:0045892)",4/948,0.21159142351009,0.270910406401647,0,0,1.7507369196757554,2.7190662035683872,CUX2;IRF7;IRF8;CRYM,pDC,0.6745019396506919
GO_Biological_Process_2021,regulation of vesicle-mediated transport (GO:0060627),1/96,0.2140587201245348,0.2732795764125905,0,0,4.26530612244898,6.5749903239841245,PACSIN1,pDC,0.6694670755856718
GO_Biological_Process_2021,protein maturation (GO:0051604),1/97,0.2160330472811356,0.2742195986978311,0,0,4.220663265306122,6.46742313757927,PHEX,pDC,0.6654798083211632
GO_Biological_Process_2021,calcium ion homeostasis (GO:0055074),1/97,0.2160330472811356,0.2742195986978311,0,0,4.220663265306122,6.46742313757927,DRD4,pDC,0.6654798083211632
GO_Biological_Process_2021,positive regulation of defense response (GO:0031349),1/98,0.2180025137484037,0.2751427737622304,0,0,4.176940879444562,6.362519703204576,TLR7,pDC,0.6615384985937142
GO_Biological_Process_2021,regulation of neuron apoptotic process (GO:0043523),1/98,0.2180025137484037,0.2751427737622304,0,0,4.176940879444562,6.362519703204576,EGLN3,pDC,0.6615384985937142
GO_Biological_Process_2021,positive regulation of protein localization to membrane (GO:1905477),1/101,0.2238818662412048,0.2817604168887891,0,0,4.051020408163265,6.062906014187368,GZMB,pDC,0.6499810815451941
GO_Biological_Process_2021,calcium-mediated signaling (GO:0019722),1/102,0.2258320069783284,0.2834095724968823,0,0,4.010709234188725,5.967790506031058,CCR3,pDC,0.6462145058611213
GO_Biological_Process_2021,cellular response to organonitrogen compound (GO:0071417),1/103,0.2277773453985499,0.2850434011625921,0,0,3.971188475390156,5.874923343943355,P2RY6,pDC,0.64248947278397
GO_Biological_Process_2021,cellular metal ion homeostasis (GO:0006875),1/104,0.2297178930745814,0.2866620468508157,0,0,3.932435109966317,5.78423168094792,DRD4,pDC,0.6388051756325536
GO_Biological_Process_2021,protein processing (GO:0016485),1/106,0.2335846623503299,0.2906685545539217,0,0,3.857142857142857,5.6090983677319475,PHEX,pDC,0.6315556772929499
GO_Biological_Process_2021,Fc-epsilon receptor signaling pathway (GO:0038095),1/111,0.2431685532271013,0.3009041035743181,0,0,3.6808905380333954,5.20478084558139,LILRA4,pDC,0.6140925891155178
GO_Biological_Process_2021,cellular divalent inorganic cation homeostasis (GO:0072503),1/111,0.2431685532271013,0.3009041035743181,0,0,3.6808905380333954,5.20478084558139,DRD4,pDC,0.6140925891155178
GO_Biological_Process_2021,Fc receptor signaling pathway (GO:0038093),1/112,0.2450711886958998,0.3024137509534363,0,0,3.647545504688362,5.129202360192396,LILRA4,pDC,0.6107077427090284
GO_Biological_Process_2021,positive regulation of kinase activity (GO:0033674),1/114,0.2488624078588274,0.3062390185596127,0,0,3.582625970742279,4.982913653406146,DRD4,pDC,0.6040407011916724
GO_Biological_Process_2021,cellular response to lectin (GO:1990858),1/115,0.2507510141385882,0.3068582852579961,0,0,3.5510204081632653,4.9121080927455,CLEC4C,pDC,0.6007573018413346
GO_Biological_Process_2021,stimulatory C-type lectin receptor signaling pathway (GO:0002223),1/115,0.2507510141385882,0.3068582852579961,0,0,3.5510204081632653,4.9121080927455,CLEC4C,pDC,0.6007573018413346
GO_Biological_Process_2021,ion transport (GO:0006811),1/116,0.2526349665899778,0.3083120942131134,0,0,3.5199645075421473,4.8428011439058265,SLC32A1,pDC,0.5975065399797567
GO_Biological_Process_2021,positive regulation of cell projection organization (GO:0031346),1/117,0.2545142764118688,0.3097522649737854,0,0,3.4894440534834623,4.774949480472317,CUX2,pDC,0.5942878518616017
GO_Biological_Process_2021,negative regulation of response to external stimulus (GO:0032102),1/118,0.2563889548341396,0.3111789232644489,0,0,3.4594453165881736,4.708511372057024,PROC,pDC,0.5911006880374128
GO_Biological_Process_2021,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),1/119,0.2582590130323782,0.3117404435240969,0,0,3.429955032860602,4.6434466139665425,EGLN3,pDC,0.5879445130148351
GO_Biological_Process_2021,innate immune response activating cell surface receptor signaling pathway (GO:0002220),1/119,0.2582590130323782,0.3117404435240969,0,0,3.429955032860602,4.6434466139665425,CLEC4C,pDC,0.5879445130148351
GO_Biological_Process_2021,cytoskeleton organization (GO:0007010),1/120,0.2601244621662815,0.3131389585316921,0,0,3.4009603841536613,4.579716458908873,PACSIN1,pDC,0.5848188047272944
GO_Biological_Process_2021,regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.2656932663769877,0.3181138297432583,0,0,3.316828370692539,4.396166676729281,VASH2,pDC,0.5756194520344882
GO_Biological_Process_2021,positive regulation of epithelial cell proliferation (GO:0050679),1/123,0.2656932663769877,0.3181138297432583,0,0,3.316828370692539,4.396166676729281,VASH2,pDC,0.5756194520344882
GO_Biological_Process_2021,regulation of tumor necrosis factor production (GO:0032680),1/124,0.2675403902734135,0.3194619754477686,0,0,3.2896963663514187,4.337414433160371,LILRA4,pDC,0.5726106437410472
GO_Biological_Process_2021,regulation of protein secretion (GO:0050708),1/125,0.2693829605231016,0.3207974503003603,0,0,3.263001974983542,4.279822783786303,DRD4,pDC,0.5696298784899082
GO_Biological_Process_2021,protein glycosylation (GO:0006486),1/130,0.2785278903472666,0.3307985400102924,0,0,3.135738016136687,4.008216604624779,FUT7,pDC,0.5551313103019286
GO_Biological_Process_2021,cellular protein metabolic process (GO:0044267),2/417,0.2800329921032276,0.3311789659861041,0,0,1.9613453815261044,2.4964942594636463,PROC;PHEX,pDC,0.552790799213849
GO_Biological_Process_2021,cellular response to hypoxia (GO:0071456),1/131,0.2803433684983951,0.3311789659861041,0,0,3.111459968602826,3.956968446025251,EGLN3,pDC,0.5523097126477655
GO_Biological_Process_2021,regulation of cell adhesion (GO:0030155),1/133,0.2839609038772722,0.3345603202596585,0,0,3.0640074211502784,3.857336278341556,FUT7,pDC,0.546741450090894
GO_Biological_Process_2021,protein localization to plasma membrane (GO:0072659),1/136,0.289353816496661,0.33732563344216,0,0,2.99546485260771,3.714691124222948,PACSIN1,pDC,0.5385707850387818
GO_Biological_Process_2021,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.289353816496661,0.33732563344216,0,0,2.99546485260771,3.714691124222948,SCT,pDC,0.5385707850387818
GO_Biological_Process_2021,cellular calcium ion homeostasis (GO:0006874),1/136,0.289353816496661,0.33732563344216,0,0,2.99546485260771,3.714691124222948,DRD4,pDC,0.5385707850387818
GO_Biological_Process_2021,organic substance transport (GO:0071702),1/136,0.289353816496661,0.33732563344216,0,0,2.99546485260771,3.714691124222948,SLC35F3,pDC,0.5385707850387818
GO_Biological_Process_2021,regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.2911425929329805,0.3385201277409721,0,0,2.9732893157262907,3.668866926816198,SCT,pDC,0.5358942544628899
GO_Biological_Process_2021,regulation of cellular component organization (GO:0051128),1/139,0.2947069182263764,0.3399874082663666,0,0,2.929902395740905,3.579678317757992,PACSIN1,pDC,0.5306096689947516
GO_Biological_Process_2021,positive regulation of response to external stimulus (GO:0032103),1/139,0.2947069182263764,0.3399874082663666,0,0,2.929902395740905,3.579678317757992,TLR7,pDC,0.5306096689947516
GO_Biological_Process_2021,protein dephosphorylation (GO:0006470),1/139,0.2947069182263764,0.3399874082663666,0,0,2.929902395740905,3.579678317757992,PPM1J,pDC,0.5306096689947516
GO_Biological_Process_2021,protein localization to cell periphery (GO:1990778),1/140,0.2964824884084789,0.3411473827661199,0,0,2.9086771399207163,3.5362740390257685,PACSIN1,pDC,0.5280009529309525
GO_Biological_Process_2021,receptor-mediated endocytosis (GO:0006898),1/143,0.3017829564686885,0.3454518080507209,0,0,2.8467950560505892,3.410594866305226,LILRB4,pDC,0.5203052911363482
GO_Biological_Process_2021,nitrogen compound transport (GO:0071705),1/143,0.3017829564686885,0.3454518080507209,0,0,2.8467950560505892,3.410594866305226,SLC35F3,pDC,0.5203052911363482
GO_Biological_Process_2021,positive regulation of cytosolic calcium ion concentration (GO:0007204),1/147,0.3087894082520855,0.3518283646453511,0,0,2.7682415431926195,3.252948903166252,CCR3,pDC,0.5103376047629952
GO_Biological_Process_2021,positive regulation of intracellular protein transport (GO:0090316),1/148,0.3105302270346101,0.3518283646453511,0,0,2.749271137026239,3.215201203875706,GZMB,pDC,0.5078961191737069
GO_Biological_Process_2021,regulation of cytosolic calcium ion concentration (GO:0051480),1/148,0.3105302270346101,0.3518283646453511,0,0,2.749271137026239,3.215201203875706,CCR3,pDC,0.5078961191737069
GO_Biological_Process_2021,positive regulation of transferase activity (GO:0051347),1/148,0.3105302270346101,0.3518283646453511,0,0,2.749271137026239,3.215201203875706,DRD4,pDC,0.5078961191737069
GO_Biological_Process_2021,positive regulation of hydrolase activity (GO:0051345),1/149,0.3122667490151626,0.3528932903411149,0,0,2.7305570876999448,3.1780885451938787,RGS7,pDC,0.5054742581266645
GO_Biological_Process_2021,brain development (GO:0007420),1/150,0.3139989845586295,0.3530496196940936,0,0,2.712094233666621,3.141596466170354,SCT,pDC,0.5030717563895143
GO_Biological_Process_2021,cellular response to organic cyclic compound (GO:0071407),1/150,0.3139989845586295,0.3530496196940936,0,0,2.712094233666621,3.141596466170354,P2RY6,pDC,0.5030717563895143
GO_Biological_Process_2021,dephosphorylation (GO:0016311),1/153,0.3191700762858281,0.3579553007458781,0,0,2.6581632653061225,3.0357052873752,PPM1J,pDC,0.4959778325880012
GO_Biological_Process_2021,skeletal system development (GO:0001501),1/158,0.3277037968552589,0.3665979343608073,0,0,2.5728584427401535,2.8703970097526006,PHEX,pDC,0.48451852674781976
GO_Biological_Process_2021,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.3394751386404204,0.378809789465255,0,0,2.4621702339472376,2.6600168495918335,CCR3,pDC,0.46919202564454415
GO_Biological_Process_2021,regulation of MAPK cascade (GO:0043408),1/166,0.3411401847271476,0.3797113111410211,0,0,2.4471243042671613,2.6317886779390967,LILRB4,pDC,0.4670671197091842
GO_Biological_Process_2021,defense response to bacterium (GO:0042742),1/176,0.3575660373570176,0.3969968785693203,0,0,2.306122448979592,2.3716975343886144,MPEG1,pDC,0.4466437384468818
GO_Biological_Process_2021,positive regulation of developmental process (GO:0051094),1/177,0.359186378521905,0.3976010011834968,0,0,2.2929035250463823,2.3477357103628296,PACSIN1,pDC,0.44468014150624274
GO_Biological_Process_2021,regulation of translation (GO:0006417),1/178,0.3608027143922477,0.3976010011834968,0,0,2.279833967485299,2.3241173885161555,GZMB,pDC,0.44273020383203454
GO_Biological_Process_2021,negative regulation of immune response (GO:0050777),1/178,0.3608027143922477,0.3976010011834968,0,0,2.279833967485299,2.3241173885161555,SCT,pDC,0.44273020383203454
GO_Biological_Process_2021,regulation of immune response (GO:0050776),1/179,0.3624150547196057,0.398386772309641,0,0,2.266911258885577,2.300835957547096,IRF7,pDC,0.4407937700298507
GO_Biological_Process_2021,negative regulation of cytokine production (GO:0001818),1/182,0.367228198764465,0.4026784456748961,0,0,2.2289998872477166,2.2329492942532405,LILRB4,pDC,0.4350639775318079
GO_Biological_Process_2021,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),1/185,0.3720057294778557,0.4069099707621978,0,0,2.192324755989352,2.1678716160963645,PROC,pDC,0.4294503712432232
GO_Biological_Process_2021,regulation of GTPase activity (GO:0043087),1/189,0.3783208179838206,0.4127983309527895,0,0,2.1452453321754232,2.085205747179162,RGS7,pDC,0.42213975998471215
GO_Biological_Process_2021,protein localization to membrane (GO:0072657),1/195,0.3876769258565263,0.4219677595932216,0,0,2.0782663580896275,1.969329769675335,PACSIN1,pDC,0.4115300469974289
GO_Biological_Process_2021,regulation of signal transduction (GO:0009966),1/198,0.3923030921692546,0.4249150851613198,0,0,2.0463068476121413,1.914771355908193,FUT7,pDC,0.4063782687077012
GO_Biological_Process_2021,negative regulation of intracellular signal transduction (GO:1902532),1/198,0.3923030921692546,0.4249150851613198,0,0,2.0463068476121413,1.914771355908193,LILRB4,pDC,0.4063782687077012
GO_Biological_Process_2021,positive regulation of transcription by RNA polymerase II (GO:0045944),3/908,0.3977118667386928,0.4297228218664413,0,0,1.3432467379804869,1.2385104166535874,SPIB;IRF7;IRF8,pDC,0.40043145054722185
GO_Biological_Process_2021,phosphate-containing compound metabolic process (GO:0006796),1/212,0.4134429066373548,0.4456331086139858,0,0,1.909178837411742,1.6862551884518755,PLD4,pDC,0.3835844547796231
GO_Biological_Process_2021,positive regulation of GTPase activity (GO:0043547),1/214,0.416403436812339,0.4477347633686073,0,0,1.8910606496119575,1.656759537391559,RGS7,pDC,0.3804856946694876
GO_Biological_Process_2021,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),1/224,0.4309878220097169,0.4622944434632073,0,0,1.805344559348403,1.519514184420898,LILRB4,pDC,0.36553500108915365
GO_Biological_Process_2021,axonogenesis (GO:0007409),1/240,0.4535831041409784,0.4853558336581002,0,0,1.6831184356587825,1.3306343458644796,SLITRK5,pDC,0.34334313117644527
GO_Biological_Process_2021,anterograde trans-synaptic signaling (GO:0098916),1/244,0.4590930887709353,0.49006804415789,0,0,1.655076845553036,1.2884811006593149,DRD4,pDC,0.33809924509335265
GO_Biological_Process_2021,positive regulation of phosphorylation (GO:0042327),1/253,0.4712922312950381,0.5018809097685143,0,0,1.5952380952380951,1.2000608149186214,DRD4,pDC,0.32670971902140344
GO_Biological_Process_2021,central nervous system development (GO:0007417),1/268,0.4910275855522238,0.5216432143876143,0,0,1.504471451501949,1.0700627976731167,SCT,pDC,0.3088941088615854
GO_Biological_Process_2021,innate immune response (GO:0045087),1/302,0.5331267023920349,0.5650122707169173,0,0,1.3322259136212624,0.8379649939237771,IRF7,pDC,0.2731695646873957
GO_Biological_Process_2021,negative regulation of gene expression (GO:0010629),1/322,0.5562761693049759,0.5874969029550422,0,0,1.2479496471485791,0.7319104885681406,GZMB,pDC,0.2547095446988111
GO_Biological_Process_2021,cellular response to oxygen-containing compound (GO:1901701),1/323,0.5574036279487686,0.5874969029550422,0,0,1.2440106477373558,0.7270814983759607,P2RY6,pDC,0.2538302089398956
GO_Biological_Process_2021,regulation of apoptotic process (GO:0042981),2/742,0.5583209845238664,0.5874969029550422,0,0,1.0816441441441442,0.6304051823091851,EGLN3;PROC,pDC,0.25311604886163686
GO_Biological_Process_2021,cellular protein localization (GO:0034613),1/329,0.5641096589005535,0.5921814665709602,0,0,1.2208810353409656,0.6989624697257846,PACSIN1,pDC,0.24863646405532092
GO_Biological_Process_2021,"positive regulation of transcription, DNA-templated (GO:0045893)",3/1183,0.5741266920581598,0.6012721621318317,0,0,1.015326361341507,0.5634098665849442,SPIB;IRF7;IRF8,pDC,0.24099226162550894
GO_Biological_Process_2021,post-translational protein modification (GO:0043687),1/345,0.5815093765862647,0.6075675797823472,0,0,1.1631466540104414,0.6305745813190116,PROC,pDC,0.23544327806907975
GO_Biological_Process_2021,cellular response to DNA damage stimulus (GO:0006974),1/350,0.5868058377702841,0.6116587908993784,0,0,1.1461902812701013,0.6109896633619631,IRF7,pDC,0.23150557427863594
GO_Biological_Process_2021,negative regulation of programmed cell death (GO:0043069),1/381,0.6182077951423556,0.6428780592677548,0,0,1.0510204081632653,0.5054679174936134,PROC,pDC,0.20886552310647807
GO_Biological_Process_2021,positive regulation of macromolecule metabolic process (GO:0010604),1/384,0.62111954988037,0.6443933503442715,0,0,1.042628017264347,0.4965325169788531,CUX2,pDC,0.20682480102083725
GO_Biological_Process_2021,organelle organization (GO:0006996),1/420,0.6544076492323022,0.677342496752126,0,0,0.9512931664312504,0.4033718992390181,PACSIN1,pDC,0.18415163293091988
GO_Biological_Process_2021,regulation of transcription by RNA polymerase II (GO:0006357),5/2206,0.6589063274622694,0.6804090980554437,0,0,0.8960068655661568,0.3737906767782196,SPIB;CUX2;IRF7;IRF8;CRYM,pDC,0.1811763219125431
GO_Biological_Process_2021,neutrophil degranulation (GO:0043312),1/481,0.7043872370804651,0.7220744947298174,0,0,0.8278061224489796,0.2900856337670249,CLEC4C,pDC,0.15218852169360617
GO_Biological_Process_2021,positive regulation of gene expression (GO:0010628),1/482,0.7051444771556823,0.7220744947298174,0,0,0.8260426831855403,0.2885801301950252,CUX2,pDC,0.1517218912312197
GO_Biological_Process_2021,cellular response to cytokine stimulus (GO:0071345),1/482,0.7051444771556823,0.7220744947298174,0,0,0.8260426831855403,0.2885801301950252,IRF8,pDC,0.1517218912312197
GO_Biological_Process_2021,negative regulation of apoptotic process (GO:0043066),1/485,0.7074048097353064,0.7220744947298174,0,0,0.8207960870298533,0.2841203737887477,PROC,pDC,0.15033199168778996
GO_Biological_Process_2021,neutrophil activation involved in immune response (GO:0002283),1/485,0.7074048097353064,0.7220744947298174,0,0,0.8207960870298533,0.2841203737887477,CLEC4C,pDC,0.15033199168778996
GO_Biological_Process_2021,neutrophil mediated immunity (GO:0002446),1/488,0.7096481586491704,0.7226991592680058,0,0,0.815614130662532,0.2797442143304909,CLEC4C,pDC,0.14895691977455572
GO_Biological_Process_2021,protein phosphorylation (GO:0006468),1/496,0.7155483392622962,0.7270365006724707,0,0,0.8021026592455164,0.2684686706444305,TLR7,pDC,0.1453610219101508
GO_Biological_Process_2021,positive regulation of nucleic acid-templated transcription (GO:1903508),1/511,0.7262961571675228,0.7362681867853835,0,0,0.7779111644657863,0.2487739813280452,IRF7,pDC,0.13888625368433627
GO_Biological_Process_2021,positive regulation of intracellular signal transduction (GO:1902533),1/546,0.7498504588798914,0.7573315893372641,0,0,0.726642950758285,0.2091870484536521,TLR7,pDC,0.12502533841998253
GO_Biological_Process_2021,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7504933808556635,0.7573315893372641,0,0,0.7252747252747253,0.2081715773755284,GZMB,pDC,0.1246531337611999
GO_Biological_Process_2021,positive regulation of cellular process (GO:0048522),1/625,0.7959537647207185,0.8013807222074507,0,0,0.6320643642072213,0.1442460501716775,FUT7,pDC,0.09911215878223603
GO_Biological_Process_2021,"regulation of transcription, DNA-templated (GO:0006355)",4/2244,0.8272634931131488,0.8310152549866779,0,0,0.6875,0.130372014787288,SPIB;CUX2;IRF7;IRF8,pDC,0.08235614053342308
GO_Biological_Process_2021,regulation of cell population proliferation (GO:0042127),1/764,0.8577067842472734,0.8596472973338057,0,0,0.5131997753229732,0.0787725634671716,EGLN3,pDC,0.06666115474745983
GO_Biological_Process_2021,regulation of gene expression (GO:0010468),1/1079,0.9377418517471742,0.9377418517471742,0,0,0.3572753776835409,0.0229658682151355,CUX2,pDC,0.027916700844649738
